<SEC-DOCUMENT>0000883984-22-000014.txt : 20220225
<SEC-HEADER>0000883984-22-000014.hdr.sgml : 20220225
<ACCEPTANCE-DATETIME>20220225165347
ACCESSION NUMBER:		0000883984-22-000014
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		139
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220225
DATE AS OF CHANGE:		20220225

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICU MEDICAL INC/DE
		CENTRAL INDEX KEY:			0000883984
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				330022692
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34634
		FILM NUMBER:		22681343

	BUSINESS ADDRESS:	
		STREET 1:		951 CALLE AMANECER
		CITY:			SAN CLEMENTE
		STATE:			CA
		ZIP:			92763-6212
		BUSINESS PHONE:		949-366-2183

	MAIL ADDRESS:	
		STREET 1:		951 CALLE AMANECER
		CITY:			SAN CLEMENTE
		STATE:			CA
		ZIP:			92763-6212
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>icui-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:79121b2d-e854-41aa-aab3-7b5c5847e030,g:aa7e8fee-abd8-4fff-b3c4-f8ba25538e22,d:c100f0970bae445782808747a3ec391d--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:icui="http://www.icumed.com/20211231" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:country="http://xbrl.sec.gov/country/2021" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>icui-20211231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF80L2ZyYWc6MzBhNTFjMjEyM2Q1NGM3ZDg1OThjMThhY2FkYTMyZjkvdGFibGU6YTJmYTVmNmI4YWNkNDRhMzg4NTZiYzcxZTgzZDMxZTMvdGFibGVyYW5nZTphMmZhNWY2YjhhY2Q0NGEzODg1NmJjNzFlODNkMzFlM18zLTEtMS0xLTg3NDU_af6f1b60-5599-477a-baf8-829ae9cfd993">0000883984</ix:nonNumeric><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF80L2ZyYWc6MzBhNTFjMjEyM2Q1NGM3ZDg1OThjMThhY2FkYTMyZjkvdGFibGU6YTJmYTVmNmI4YWNkNDRhMzg4NTZiYzcxZTgzZDMxZTMvdGFibGVyYW5nZTphMmZhNWY2YjhhY2Q0NGEzODg1NmJjNzFlODNkMzFlM180LTEtMS0xLTg3NDU_9f50cd5a-5e3c-4da9-8ad7-f2241ab8c301">ICU MEDICAL INC/DE</ix:nonNumeric><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF80L2ZyYWc6MzBhNTFjMjEyM2Q1NGM3ZDg1OThjMThhY2FkYTMyZjkvdGFibGU6YTJmYTVmNmI4YWNkNDRhMzg4NTZiYzcxZTgzZDMxZTMvdGFibGVyYW5nZTphMmZhNWY2YjhhY2Q0NGEzODg1NmJjNzFlODNkMzFlM182LTEtMS0xLTg3NDU_4751f54b-dba3-45de-a8a3-4fe840652c94">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF80L2ZyYWc6MzBhNTFjMjEyM2Q1NGM3ZDg1OThjMThhY2FkYTMyZjkvdGFibGU6YTJmYTVmNmI4YWNkNDRhMzg4NTZiYzcxZTgzZDMxZTMvdGFibGVyYW5nZTphMmZhNWY2YjhhY2Q0NGEzODg1NmJjNzFlODNkMzFlM183LTEtMS0xLTg3NDU_63cc9a07-a8b6-482c-ad4d-93ade5a9f9ea">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF80L2ZyYWc6MzBhNTFjMjEyM2Q1NGM3ZDg1OThjMThhY2FkYTMyZjkvdGFibGU6YTJmYTVmNmI4YWNkNDRhMzg4NTZiYzcxZTgzZDMxZTMvdGFibGVyYW5nZTphMmZhNWY2YjhhY2Q0NGEzODg1NmJjNzFlODNkMzFlM184LTEtMS0xLTg3NDU_d19e0aeb-0d06-4a86-9e4c-d4c206d8b780">2021</ix:nonNumeric><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF80L2ZyYWc6MzBhNTFjMjEyM2Q1NGM3ZDg1OThjMThhY2FkYTMyZjkvdGFibGU6YTJmYTVmNmI4YWNkNDRhMzg4NTZiYzcxZTgzZDMxZTMvdGFibGVyYW5nZTphMmZhNWY2YjhhY2Q0NGEzODg1NmJjNzFlODNkMzFlM185LTEtMS0xLTg3NDU_7cb79e46-88c5-4c65-b864-d50d63a25dbc">FY</ix:nonNumeric><ix:nonNumeric contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDg3L2ZyYWc6ODBlYzk2MTA3Y2IyNDY4MGI0NjA5NzE5MDM0NGI2OTYvdGFibGU6YmNmMzk5NmY1ZTlkNDYzMTlhM2YxMTFiN2Q5Nzk5ZmYvdGFibGVyYW5nZTpiY2YzOTk2ZjVlOWQ0NjMxOWEzZjExMWI3ZDk3OTlmZl8zLTAtMS0xLTY1Mzky_183f49ff-343a-4922-abb2-2ad39af1e6d0">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDg3L2ZyYWc6ODBlYzk2MTA3Y2IyNDY4MGI0NjA5NzE5MDM0NGI2OTYvdGFibGU6YmNmMzk5NmY1ZTlkNDYzMTlhM2YxMTFiN2Q5Nzk5ZmYvdGFibGVyYW5nZTpiY2YzOTk2ZjVlOWQ0NjMxOWEzZjExMWI3ZDk3OTlmZl8zLTAtMS0xLTY1Mzky_8bf0d2e1-4fd7-4ef6-987c-fd2590d2eb0c">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDg3L2ZyYWc6ODBlYzk2MTA3Y2IyNDY4MGI0NjA5NzE5MDM0NGI2OTYvdGFibGU6YmNmMzk5NmY1ZTlkNDYzMTlhM2YxMTFiN2Q5Nzk5ZmYvdGFibGVyYW5nZTpiY2YzOTk2ZjVlOWQ0NjMxOWEzZjExMWI3ZDk3OTlmZl80LTAtMS0xLTY1Mzk1_617451f3-58a4-4fb4-82aa-0e0b18483762">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDg3L2ZyYWc6ODBlYzk2MTA3Y2IyNDY4MGI0NjA5NzE5MDM0NGI2OTYvdGFibGU6YmNmMzk5NmY1ZTlkNDYzMTlhM2YxMTFiN2Q5Nzk5ZmYvdGFibGVyYW5nZTpiY2YzOTk2ZjVlOWQ0NjMxOWEzZjExMWI3ZDk3OTlmZl80LTAtMS0xLTY1Mzk1_6b3c7fb4-a72d-4140-b334-0b3ac4be28a9">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDg3L2ZyYWc6ODBlYzk2MTA3Y2IyNDY4MGI0NjA5NzE5MDM0NGI2OTYvdGFibGU6YmNmMzk5NmY1ZTlkNDYzMTlhM2YxMTFiN2Q5Nzk5ZmYvdGFibGVyYW5nZTpiY2YzOTk2ZjVlOWQ0NjMxOWEzZjExMWI3ZDk3OTlmZl80LTAtMS0xLTY1Mzk1_861eeb11-5630-4175-94e7-a84af39d07f5">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDg3L2ZyYWc6ODBlYzk2MTA3Y2IyNDY4MGI0NjA5NzE5MDM0NGI2OTYvdGFibGU6YmNmMzk5NmY1ZTlkNDYzMTlhM2YxMTFiN2Q5Nzk5ZmYvdGFibGVyYW5nZTpiY2YzOTk2ZjVlOWQ0NjMxOWEzZjExMWI3ZDk3OTlmZl80LTAtMS0xLTY1Mzk1_f114f16b-caea-4dbb-a129-02e6cdb2d05d">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDg3L2ZyYWc6ODBlYzk2MTA3Y2IyNDY4MGI0NjA5NzE5MDM0NGI2OTYvdGFibGU6YmNmMzk5NmY1ZTlkNDYzMTlhM2YxMTFiN2Q5Nzk5ZmYvdGFibGVyYW5nZTpiY2YzOTk2ZjVlOWQ0NjMxOWEzZjExMWI3ZDk3OTlmZl81LTAtMS0xLTY1Mzk4_4f79efad-b8df-4163-80b2-e84c5ca47c50">http://fasb.org/us-gaap/2021-01-31#OtherLiabilities</ix:nonNumeric><ix:nonNumeric contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDg3L2ZyYWc6ODBlYzk2MTA3Y2IyNDY4MGI0NjA5NzE5MDM0NGI2OTYvdGFibGU6YmNmMzk5NmY1ZTlkNDYzMTlhM2YxMTFiN2Q5Nzk5ZmYvdGFibGVyYW5nZTpiY2YzOTk2ZjVlOWQ0NjMxOWEzZjExMWI3ZDk3OTlmZl81LTAtMS0xLTY1Mzk4_a1df565a-dce3-420d-a71a-8ea4d9835108">http://fasb.org/us-gaap/2021-01-31#OtherLiabilities</ix:nonNumeric><ix:nonNumeric contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDg3L2ZyYWc6ODBlYzk2MTA3Y2IyNDY4MGI0NjA5NzE5MDM0NGI2OTYvdGFibGU6YmNmMzk5NmY1ZTlkNDYzMTlhM2YxMTFiN2Q5Nzk5ZmYvdGFibGVyYW5nZTpiY2YzOTk2ZjVlOWQ0NjMxOWEzZjExMWI3ZDk3OTlmZl81LTAtMS0xLTY1Mzk4_b3381cc5-8bc9-4010-9933-c35a4f0f1621">http://fasb.org/us-gaap/2021-01-31#OtherLiabilities</ix:nonNumeric><ix:nonNumeric contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDg3L2ZyYWc6ODBlYzk2MTA3Y2IyNDY4MGI0NjA5NzE5MDM0NGI2OTYvdGFibGU6YmNmMzk5NmY1ZTlkNDYzMTlhM2YxMTFiN2Q5Nzk5ZmYvdGFibGVyYW5nZTpiY2YzOTk2ZjVlOWQ0NjMxOWEzZjExMWI3ZDk3OTlmZl81LTAtMS0xLTY1Mzk4_da781fc6-cfa7-486c-8070-b39f7b1eca8d">http://fasb.org/us-gaap/2021-01-31#OtherLiabilities</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="icui-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff2e09ea6c244b5c8c8c4fdbeea287ee_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i111df2377a904008a8e4287e7d182606_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="iaec5d516f9924448a7889b3f61aba166_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d447798df3d4ad09d5a02f448f0900b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3327972bb1d4aee95a27cb29ac758f6_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff400e2a4d53433e99e9a76ec4ff42c0_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i422a41397eba44439e3bee3a84f24f5e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3707592634d449b6b164fd6ab5039af3_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e68fd2b373c4657b269de98d476f2f3_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9a14d7ab14041cd9287ff968eeab854_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2b82bbcf5cb45739937a1040ed30f6b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8036f14fb1574f22a813b07a891d10cb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief0e41eadf634f478517bbf4796fb3b7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd39fbd084c64997a80b35884325a837_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf8bb0aa0f8d4c368a4f3c52cf44f0fe_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied11d81291954b6892d0bd3f457a6c62_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f8426b518ec486c8093f691d9ae22b4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b6766362c85475b9f3e56635902ffc6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia53abf8ff1024f4b9dbcd962fb14bb16_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8029282b701e4da19cb4312a7342adee_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba8b292d4a8c426ea02ac921339f2ece_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58538562a9b846b1a8eb28ee06dd457c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12d0faf21deb41648f175a8130fa683f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i056b6066b5c84b8f82444aed64ff2939_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a9e3ee9b34c4d4c81e04d5c21845153_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic917d118fe1544a48c9f7cdb26a0bafe_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaea909186292457f815372e15f122f61_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i319e066bf7c149958ff00b3b5180cad9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1f24ebe96e244d1a070e358c2f9088e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ee1c30a74b842b18319e3e21627fde1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76af68ce1a5649a285c27467729f3ea8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64123b55baa546a6ae8585911227ac9b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6257893a382b432986c682223e96eed6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i545572fcbd214019b1a486fff73e3d60_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib07f493ac3464b04ace456f723c0d4c1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98729f24bb67493bbbb1a901004ee439_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i124369e0a3a6454fae9d78635beb32e1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i893bab2162e3420fa787264425d1b71f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80df96ad8b8e4475847100ff81957f59_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5dc13d8d15f4d6b9e43ee2747cf2dde_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7594d76a22343b78ed45f29024ebce9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i675d4957f6a54a509db9f8b824f52efb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib79fc9d04ebf42eca924b5dba9ff0f88_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33f36a22d5f5402fa34702e2b60d0b7c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03ab38e8bc4e4afab23f9031aff6bbbc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7af9cf8a39fa459fb6db8a6392a90dd2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f7846d15c1c45d0b3c2a14b3b40dbd8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i874c262496e7470aad6329cb331b77e1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9697a3ca30dd4537a13752d309cbf40a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:InternationalDistributorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0eb01a36c95d4e93ae0a960275048e71_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:InternationalDistributorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i034d4febd93748bfa4de828a28a09376_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:InternationalDistributorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignInfusionSystemSupplierMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if41332d164fe48da8c8206c9a376b3d9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:TotalAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if148011629fb4765963a61b648e50f64_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignInfusionSystemSupplierMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0e931c53af9433c927233b79bd0bca8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:TotalAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>icui:segment</xbrli:measure></xbrli:unit><xbrli:context id="i61afae90e5b84b36ad1ae6cc021d0eb0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6086d7242cd44ebcb7bd1c37761445d5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia714b658a4174f91844900438be27249_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i072ea93b43554548bfb1b2e60418ef0a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id27451c8315e494eb9d5b71d3102e1d3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:MoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i396219abad3d4dd5aecaca9b955a4a80_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:MoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a69e96fceee4aa4a6456cdac483fa6b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bb5314a15ad4728830028bd25e4817c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2b2515c8fa54706a4876347394a8195_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefe3d36c64db435783d6b6b62e9f4928_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i868fc2b21a40468eb90303a40fa1cde7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:InstrumentsPlacedwithCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b8361146b8345eba9e837855e840ccf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:InstrumentsPlacedwithCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife75bb8b09044301a656828fd088ef78_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib215ff3938424c87b3535b21a2d24f0c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i822011b5ee894121826591876ad1fae1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i318960434e7e4294b988d5e93c86f870_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4df894472d734b8ea99f933093d6cae5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50ca67d9370d4702bb30549193450259_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic799598d554f43749764085e6183fa72_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fd10f7ed125461b83e7cc71c92b31ff_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1743cebe76c945e1b53dd6ed012b1f15_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:FurniturefixturesandmoldsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i980084a01dc24101ade4b0ce4d4f2ce3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:FurniturefixturesandmoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40993659cc874b8bb50c9566a7d7ee5a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica576ec13c89445ca41b2ba35b3a09d6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2faa6bd24f85459f9cccb242cb8eb478_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:InstrumentsPlacedwithCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7d30235ed5b4d94bcfbe47e561d432b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:InstrumentsPlacedwithCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89ee2db57d0940749f8358a063c8a2a1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3bf6d7cdae3492fbe677ee76c1cb8ac_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignDistibutorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5bfa62a49ec4bacbfe8ca5e5984c085_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8086db60836949cea234f284bb9446be_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife577e5d213f40d098d9178ce5ed5c02_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f08a7535a0c4ae593f5fdb4d1908ae3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23400b23c1e244b8be1368b5b1d1feda_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9ad9660b38a4c59af223be9f97ad9a2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94bfb3c1291d4f5ea822b381ec4471a5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67322613ac0a460da4f4187ecad1ca17_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabdb763a977547f398fe485e2aa320a0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51d012416f844ef69b4d06482f83559a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ad98788582c4b17b4c46945d8400c45_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac77f6f1c1154bc8a57fd11e9cacd63c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61f07bcb26004cbfb2eb785632880532_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5895f4898494fbcb93a3646e38e38e9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2a1a60f23694878b292a8b8e642f7f7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6da6e9834cb04c8aa17f5c4e02ded7c8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib00800b3296448d1a1aaa2ee891468e8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9c99a7ffc344097b04bba35817b6ec1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if022b8b9f44c46cc9f1a9647646caf11_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c1c4ee566ca4ff0a0939c34c6f27d97_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i921788560f30477b876f3a224b358d25_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4906e0126214b09aa3b35cb86a5cbd3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0af18a5e59b4620b0a5bf6fba3fc7a7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e2d8c5d74764c0c8112c9015c783cbe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85668d0214784e5a8fb9f8869bea0496_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84b90248fb4943b1a217759d4dab622c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fa85a3402ad4c77b8d5f87d4e48cabc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fabf3a8e3e34339833d25e4808ff80b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3dc15f5f21ee4966a24eaabd60b1d494_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i810debf07d694305bd3dc90b59bb25a0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4751e08bde88447d8b34bf752eed3cdc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2247e3aa5f7f425e92dffe9649cbcb7b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1ed14983dc8444fb29c6fdb143af063_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad22bdcd21ac4a51bb81dc8d8fc119a9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:LongtermInvestmentsDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0aa1b29ef9844f29ed55e5350042310_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:LongtermInvestmentsDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e6c4333e95b489298867ff378f75de9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffa9110d543f4303a3b7762b85f661f3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i647dc634368041129731810420d0ebbc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:LongtermInvestmentsDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b51175d4f8a42ccb2a3d0734e66cec3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:LongtermInvestmentsDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i9ea7d76b8a79439aab91f9877efd14d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a64787f750d4031b14422894f232878_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i759cb9fbaf1d4095916b580d6bb94af5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e8704f54a08458a9efc29f3cc118593_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77e6107e400341429951759a6c1961be_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i950f58e7689540a3b89af236c51c45e0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a9284e3c72d412b809403911420ec57_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i181ab8ea3259409b94a0dae321287166_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id188fafa38884adabaef94e04b547494_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignDistibutorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71c95811c4714cd09165d99d35d0be39_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62ae2a31a4354af79bd9d1817c9ee7bd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SpecialTerminationBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e461e5413d14edd9b72b130ce815fe5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a3cc5377db948c0a5ce1d48fee18dc4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65b0aab89680416c8c6ea3f7a118a6bd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SpecialTerminationBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4b6eb1be3574e0cb8dab5f37e8dedec_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5df89ac1ac0b4ffcaf4459845544da7b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a26f1d531b748e2a99def41eaf38247_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SpecialTerminationBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0513f1469ce44ac7b878215e135b1461_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc1517ed4db74def880ae3ff1b172041_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8eac04e1e58f46a1be1d57dae1515d50_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SpecialTerminationBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie475f7d09c704e268b2c10ef5f50cc45_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a19a43c357247ff976618cccfe634e3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id18d76e7cad1483da6d29083e9a8f281_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SpecialTerminationBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19701020e9b7421080322ea64ddfa6fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c2abd8a14954e2d908b7a6ad1bff678_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9e8a812a73f4a1d8f7f8110a8759bf4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib25ed464299245f3a253cac238e6e16b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c6cc917f0a04f9e98f2098b917cb28f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52b0fc63199747a09f8aaf3d7b68b362_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i201b9c34887c4c05be4d0d4326d1e331_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ce76eb5aa3f457a94d4842e2df5c4b4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:IVSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb7d360b50434c90b1362f13d39de454_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:IVSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie65b63b2aa354165aa8b2d1156015ecd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:IVSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47789bab6a1046d49538401de29b23ca_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:CriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba69653f43264a18a0f9f7bbc4521bfb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:CriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16a80a38aab0404bb60ce11730e5d9b2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:CriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4099adac88a94f2c844d6d0a67f5b93f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fd4ad49e5ca42958f511cd87f3b86e1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b6da943f3c548f58f42328ecef541e1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ef1d9853e504ab394c35a1dda0b5652_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba50cb76497a4bde9e14f5743b6475c3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46c1f41659ba4557a83903554fac974b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i928b25071431497386ecd55fee9d4139_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd6c4227c1cd44dc9eef66faca80e3c1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d1cf0743c804ef8a6831ae5bd16c05a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e571091fc1f4ae5aa5c04d2eccc5543_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e8278d8b555471884d28845b03e9a66_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62815f424b0f4a83a52362d984e6bdab_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i513e00d1325e4cbab47333544fe16795_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:InternationalSalesDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43801ce9ae0d4d64b094552e36f505d8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:InternationalSalesDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47aa34896b3a48b98371a8adb7a428c8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:InternationalSalesDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07b1db2fc46e4252ad0d15476844f7ab_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44cab7a364ba4dfeb44c1c2c019c7508_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideea602385704c09a9de5340c5673d94_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57358508c9e84334b935ca3d7b783237_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief31f8281f40440b9b7259476db1babf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2ba2c623a754ec09109f4e760fdc883_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0c2e107da6f4265945c3cd1be9af667_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14ae100f3ea54791b971967ebffeb16c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc815bf8be984d60b72cea6a09a89ff5_I20111231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">icui:A2011PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2011-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f3ac8f1b7404ea9b5d205028ace120c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">icui:A2011PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia405cf3a4ef6453097157cd7f886bc0c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">icui:A2011PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7101eb3934f4304b875384f0d2bf58d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">icui:A2003PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa3af7f9a9464ef699356948deed2cb8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">icui:TimebasedstockoptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67a16227998c4b09be060e7ac75710c0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">icui:TimebasedstockoptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a3a1155df674ed5a67b00576eacf44c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">icui:TimebasedstockoptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id78700fe30fa41ee9a54f1ac70463ee7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i182dfcd4a48e49328d223a8303c254eb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5f9119ec4544a9ab30550ab201d84f9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87391b560fa94e0e87d7e644dc34a031_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">icui:PerformanceRestrictedStockUnitsPRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bfb9cc3e6314f24bd71705af4bba7a2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">icui:PerformanceRestrictedStockUnitsPRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i518455bc726645ca83b1172f9d758adb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">icui:PerformanceRestrictedStockUnitsPRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4831e0eda5014d4185f0331a3269b612_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied69c2626ecd45eebbc3a906d06e9175_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i785cacd032d543efb047f2c5a292c791_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7623b8fcbec644baa23b06274170ec0b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51e354dd1c9a473aa838a7df3a9b11d5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c17620dcf9644348c9d2eced453eca5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e48c0d8b6804bfc8fcdb345373f3e79_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">icui:RestrictedStockAndPerformanceRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i376e73f5e55842518de67690861c3be5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">icui:RestrictedStockAndPerformanceRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f1a091230074ec5961f1c78910f1b75_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">icui:RestrictedStockAndPerformanceRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i193283f0dbb449a3bd6eff38a5f33bd4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6091cecaf413499e962152be722b5f2f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia164440f0483491b8db221971138e931_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge3MemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37ff8ade5acb448ea4d633f24092926d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a83e789750f44daa32ae75c26ff6a9b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge5Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3abfe315de2d4710b658cda2c9136055_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6492f863fad145e99f24ecbdf6e97c41_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33eac537b9e347e786d5a3bbfd58eaa1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5700616ce493458ca1d063d5449a9a0f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:UsGaap_InterestRateSwap2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf93883b30164701858e3d30c68ab759_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:UsGaap_InterestRateSwap2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3bc9bb5a4a44cc78110749aecdb5636_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:UsGaap_InterestRateSwap2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9398faa8a97348f0a664d0a940cc1df1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaeebd3cacab24dc38bf7ae3d6bb6c231_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0698571e6787437d90d0b0048700239f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie89eb1993f904410907120b3b745456d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cb35882a84d40c69f565d43f607d507_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib612e7e55d2c4ebf87498ce95fb1a17a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d5a1bdc1c724bc7b475abaf04f05670_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa89d23d7e2a43d19cb3b0e7f251e771_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48cb839aacc34533888f3bb68369bf70_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i275a397a6a9f4699b14f84e0917f5cf6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d6c14d6d9e54ea98f1e56d587002e2b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7275aca2da2849a582d9e7ba1f1cedbe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c479368de1144bfb45d95026be0cd76_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62d03683ea954674a5322351789e0906_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i237a6bf9b93147d2ba3fd48effc174cc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i544809a7b69540748709fce0559278a0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f8134bb52614717bbcc1d971c2e9f87_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i117c77f98cd34cbb84dd2f1e0aaf77ac_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4eb6e79360c467f8c9a58e50160406d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94cc3a526443461c92bb879f72405e63_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba75d31130ff4518a24b52c40ad06517_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic43efddee26741cfa82e26fbb5d22949_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30a2923e460d49549d45431e449f5c22_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb6f3d45751d49a59460c1b52b47c868_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0660e1ab42834fa5b8f6de068d1ac560_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6adeef3935784865bfb3756361fd2fe0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70ee7aca58f04d14ba4afb3526f496a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedb19205fd444f879bcad70f1358784e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafc678f466ad4ed5a96daa25baf1c6f2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7b4be9668d0488da88397ffbc79a2e8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i102a8b308c97481c8dc3ea2c01523124_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i765f5892367e40028ae56cc662e3184a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61230b4e893e4a7d9cd519aeed4a1b65_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i054679d6ffef4f87a4f43e136c98ca11_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06483eccc4414d90bd57c57ccef5aad0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id82c332d5c3f4a3aa2e643ec24082edb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4052c8cf471f453cbde9f738554a1b28_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84762f9663364789a2d8c3ece37ff567_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ddfa9b22060462886127f5b80779ec2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c9c90aaec48427e913d473bf39547d4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05bb705b5592489b842c36481960323d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i695d74244e1a4ea2809a46299c1c17d2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if00269ccb40e47d28d49e0860aba7a70_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie94168586b384dfe833911f3c4123fd5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55daea74768c4c5f8155e5eaa03cc29c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idab760f167ab477b84968687e30e7446_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignDistibutorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0473993225046b8a38d55e04612297f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignDistibutorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4f13d3f94f44a08bc3233dd5ceb89a4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:HospiraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d20c02b38e041509fe7e05408566fbd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">icui:RevenueGrossProfitVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dcd382934d440328d704d280ebf3fa4_I20191102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">icui:RevenueGrossProfitVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95dc6e540f5b4198be6fed8fbf400d56_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec592b00b8524a088ab236591b84114e_I20191102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83746611e0ea468aad18f290522ef413_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a648c0e1a8241a38f2f3a48870c1bb0_I20191102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a0167f7320946b3a2e58b4124c3e79b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CreditRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c5018212e424aa8ad9252ca55f1861c_I20191102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CreditRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i016a88407f61445a9ead2c5fe9666972_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffbaa78bab214394916b2fcdbc6715c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id686138862cd4f2faa2e433db45c3af8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ec7606edab34323b337692160cb6ced_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b1af846c2bd49b2b73f2cce81980df9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3279fafd14f4fafa391f0e6aebb36f4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1ccba1757384a43b8a31386dda4223f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i375d2dcaee564df4bba09294bc8b4ce1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96688b63cabc48858140503c0d9eb461_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i544bab0abcfd41739edc7808545eb541_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if18f162b786b481ead18bd1c0072862f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbcc6f28c8de4784b50d3d46d2b1dc73_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac9bf1a987b04a68a63b86dddb2a0ad7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a4e9901f5af47dbac4bd58d52cec2e3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76ecdfc58eff40d4b5a5696b57877d65_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9d041120aa546daa089ac02aad807b6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e58a71511c74a519d97f5aaf72d0d67_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bb94fa0fb71402cbf3e8e652d8f7e4c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf9c0633da1b47ee8d93b6e4abeff18b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23cd4418967541a1a5d36e2d99a5356e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24b5d0557ec344d89ca4d7fdcdfbfa6b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5809c6220648406e9d0413ce194ce911_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i322c2f5703b44dfebfc8fa4655888d5a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8f6c1cca4c146c39148c7ba09392200_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaee1dd2e4cd844c88f833890aa55e7ea_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a287e50d1874b7c8137eb644e17fa5c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib494916ad242431f84438805dad01887_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fd62c35036b40778820f92e3d9b31f2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife8f7b6aa0ab423b9e32b2a38ffe5dd5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie770d12c9b6a464ca982cfc743bc4e2d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01a24e6ac0b149afaca642972f237000_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic658275ab067426dbbc345457231980a_I20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">icui:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia241e4af05fc4638bc449fe9c9c45c66_I20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">icui:TermLoanBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39ca865e5711457ca9a490c54dd29de5_I20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d9fbc7afe1b4667b19bef534f27f322_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">icui:PricingLevelIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ee969a0a9d645a88b99b6c08a883d11_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">icui:PricingLevelIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b1d712704db4bc9b1287e528b4fed69_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">icui:PricingLevelIIMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7d6cf9ceff24a8a9996f36321364cbb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">icui:PricingLevelIIMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bfb75a2163f47d9a268020ba497c76a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">icui:PricingLevelIIIMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7211233eb22e4fb993b5b3ecf7bfb508_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">icui:PricingLevelIIIMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bdd6b3003b648508919a57e2a1ae6fc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">icui:PricingLevelIVMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5a860996ab84b0a8023cd70138248b9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">icui:PricingLevelIVMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bbe71fc4ce44374909c77242133cc3c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">icui:NonCurrentDeferredTaxAssetGrossTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e809f26dc1b4522960c604ea2772a74_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">icui:NonCurrentDeferredTaxAssetGrossTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3378e7cbe8924f58b0946d1751a4a296_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">icui:NoncurrentDeferredTaxLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f1986d9725d4d0baf2ce688675446f5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">icui:NoncurrentDeferredTaxLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f5e02d0a1f949ef98ced46fdc0d1d50_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">icui:NoncurrentDeferredTaxLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7a407c6102b4d9782e78a7113bb6c88_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">icui:NoncurrentDeferredTaxLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9b8ee97cdce469498415c24ca271fac_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01e4254c272a4140957a890acc5f08ce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia52cc31c151d481581d13119d97ac269_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifef2db95b0fe4155898c6b50b40a55f6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide8f1f0b08d646aa86685a2ef40bd3b2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1f2b53b42ec4dd496263af4d74f1006_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:MexicoPropertyAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i469eea898b364fc3adb69caed769582e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:MexicoPropertyAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e940da7d7cb495fa0d13df19d4106c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherLATAMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i598572737bef40c49c83df77162958d2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherLATAMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i342c737b0a1648d6ba7796d841c38920_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87f6347567e542658b4828a26d58c87f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f99fb6f9174410c9b82675718bfbea9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ItalyPropertyAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49906b818a8e4420af6213c3e7c5009b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ItalyPropertyAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia092500ef9e34307ae74beb9776f0c1c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:ES</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c52e251690c4d43bfe606ddbb907b05_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:ES</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69deda722fca436a895908b95f39e170_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0af277c5a24e49468f57a06b083d2822_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95f6b83243a54af7b0115785403ce5b4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5384480be0b946b0b4bd8da2f47aee38_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84bcb872e0ac41e9a0c750276b31fe07_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide1aa2e08f8e459ab222c3218dbdd087_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76e08a5b358b42e5b6adbc18bbf17124_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:UnitedStatespropertyandequipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bcbed561d384cd2aa2a8565325c8308_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:UnitedStatespropertyandequipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacf190989aae41dc9261dadb464d18de_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica0fe141910f4870ad2649c6e2c3aaab_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i294f1ac4a2cc4a3fac63275cef02abee_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i056e77d665474f4b8ca05d305c52c5db_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i120cd5defe214e6c86186272a3b74955_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9263e86b21d4e6990c6889c0a2fd058_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cc638a528464d0f81f7797bbcdbbbdd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e04a8561492427c808a2ab01e617e39_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie681a10b3ae94591ac7dfed446027fb8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8eecf95d67de49c6b71ed63b59bd24ad_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0781799e0fe043e198c4b49c6f20f38d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93f94790b59e412589fd19a9227e911d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida1ac0b3c24f469f9c5c81ce2c02be68_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea23642417df4dbfadbd0379840568e7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99fa1bc9d43d4f38b2df61bedf27dda6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i584e4e98f720480b9d2272ffc9f61fad_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id83a5ec19c054e738002317e4071cb7c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ecb60225e2140c6841d03b54d853f07_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief758a58c87848b8a344c5b692208a0f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f7b24069c454353805dd5bcf4122778_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id093068459e64f16a5340be5d8b2912d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c08f27a7f1249ebb9616a92cf37d858_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:HospiraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11985c61f5dd4877b3fb40210f033aa6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:HospiraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf6924776c764e04bf39a28785afe1cd_I20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib79ae2a24b744dc99c3023b42abeeff9_D20220106-20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-06</xbrli:startDate><xbrli:endDate>2022-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b2d21d6799a45898560ea2c84c80514_I20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2140366dbbe94dc99b723319eb6c790e_I20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">icui:TermLoansLineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78e8a542027645189940c1af26b316ab_D20220106-20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-06</xbrli:startDate><xbrli:endDate>2022-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafe2bcda32da45689d560de2ebd12309_D20220106-20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanAAndCreditLineApplicableMarginSpreadAxis">icui:PricingLevel5Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-06</xbrli:startDate><xbrli:endDate>2022-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27a054a4a2d34e3b8e8d3b53146ca889_D20220106-20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanAAndCreditLineApplicableMarginSpreadAxis">icui:PricingLevelIVMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-06</xbrli:startDate><xbrli:endDate>2022-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c133097393142f18b109c568537343f_D20220106-20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanAAndCreditLineApplicableMarginSpreadAxis">icui:PricingLevelIIIMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-06</xbrli:startDate><xbrli:endDate>2022-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cf95c725a97468eb9aa94749e698281_D20220106-20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanAAndCreditLineApplicableMarginSpreadAxis">icui:PricingLevelIIMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-06</xbrli:startDate><xbrli:endDate>2022-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic553bac988d9412da422b9c62def2f16_D20220106-20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanAAndCreditLineApplicableMarginSpreadAxis">icui:PricingLevelIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-06</xbrli:startDate><xbrli:endDate>2022-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i595c992a5ff64197a1dedaa5a2c28018_D20220106-20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanBApplicableMarginAxis">icui:PricingLevelIIMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-06</xbrli:startDate><xbrli:endDate>2022-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd3bfc829b78437eb5cd91c39c6156b4_D20220106-20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanBApplicableMarginAxis">icui:PricingLevelIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-06</xbrli:startDate><xbrli:endDate>2022-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecae4385e0b9406785f4b23d06865339_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i870395a6aa054f6bacfe43ca3565e846_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2c1a3da41264443b2bfbe1037ea8817_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d12c957c1c943f3b34b05d9ed53aafe_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a98c1779cac4386957e351f01e76fa5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie20ee1ac93ab48868926f61f94817b56_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bd524a6cefd4a91928cd5550b9aab92_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5aefe03f40c54e77a419eeec553d95eb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i245c4ea3235a4b6e8de7f653118777e4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id97bb342dec84b8eb092e237e601cbab_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idda3b662db294f219a192b0347c136af_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf8bf1ccc2ee4806a1f944d440ddd63a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea50319693fd4506aaf0fc2e7a8505fc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a4c1f26c3014290b2257c8a6c97e92a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dbfa44cf2124deea69cb9774393fdd6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieff747a718fd489ebe9871999b3764e6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a1683bbea2043caa4198e6f9ed83d74_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59cffeff11d847a38379503c52f7cf32_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6a5483b520c4d7d8560fae11ca7ee8a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i673942985fc343f3ac8ca57d29d0dd83_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fa8f3589249483da23fe23fa443806b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ic100f0970bae445782808747a3ec391d_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTQz_7948bac7-9b5c-4240-9f02-bffc20e6bce8">10-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTQ4_98dbb217-d44c-487e-bb09-46ce9c25ed57">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8yMDc_51c99447-4a97-4dc2-bb2f-653dcc2d5f70">December&#160;31, 2021</ix:nonNumeric> or</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTM2_e713e252-046c-4681-b73a-a34dfbe5f813">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File No. <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTQ2_53e87431-204f-4b1e-91c1-0507c8849e91">001-34634</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of Registrant as specified in its charter)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.908%"><tr><td style="width:1.0%"></td><td style="width:47.027%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.029%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6Mjg4NDE2OGY5OWU5NGY1MjgwYjkyZTdjOGNlNDg1NjcvdGFibGVyYW5nZToyODg0MTY4Zjk5ZTk0ZjUyODBiOTJlN2M4Y2U0ODU2N18wLTAtMS0xLTg3NDU_00ac9b90-99ed-4a75-94a3-549ff895c274">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6Mjg4NDE2OGY5OWU5NGY1MjgwYjkyZTdjOGNlNDg1NjcvdGFibGVyYW5nZToyODg0MTY4Zjk5ZTk0ZjUyODBiOTJlN2M4Y2U0ODU2N18wLTItMS0xLTg3NDU_b134c60a-2381-4825-8bc7-c36f68208667">33-0022692</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.774%"><tr><td style="width:1.0%"></td><td style="width:22.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.095%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6OTAxODdiMzY2N2YyNDYzZmIyZTVhMTAwOTRhNTE0MTUvdGFibGVyYW5nZTo5MDE4N2IzNjY3ZjI0NjNmYjJlNWExMDA5NGE1MTQxNV8wLTAtMS0xLTg3NDU_b431b0b3-a64d-406a-94ae-5aeb31c847f0">951 Calle Amanecer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6OTAxODdiMzY2N2YyNDYzZmIyZTVhMTAwOTRhNTE0MTUvdGFibGVyYW5nZTo5MDE4N2IzNjY3ZjI0NjNmYjJlNWExMDA5NGE1MTQxNV8xLTAtMS0xLTg3NDU_526be72e-fa20-426f-8df5-6b2a22c59eaf">San Clemente</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6OTAxODdiMzY2N2YyNDYzZmIyZTVhMTAwOTRhNTE0MTUvdGFibGVyYW5nZTo5MDE4N2IzNjY3ZjI0NjNmYjJlNWExMDA5NGE1MTQxNV8xLTItMS0xLTg3NDU_04aaeadb-40c4-4797-a08c-46c008aff901">California</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6OTAxODdiMzY2N2YyNDYzZmIyZTVhMTAwOTRhNTE0MTUvdGFibGVyYW5nZTo5MDE4N2IzNjY3ZjI0NjNmYjJlNWExMDA5NGE1MTQxNV8xLTQtMS0xLTg3NDU_eeea12a8-a35b-4230-9d6b-1d08f182c488">92673</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s Telephone Number, Including Area Code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTM3_08470f82-cda1-4165-aa07-1926548a2ff6">949</ix:nonNumeric>) <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTM4_c8818e66-b9d6-492f-a39b-a7dbb2782087">366-2183</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.926%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6MmFkZWU1MDhjMzI1NDI2ODllNzg3MDE5ZmY3YzY2ODcvdGFibGVyYW5nZToyYWRlZTUwOGMzMjU0MjY4OWU3ODcwMTlmZjdjNjY4N18xLTItMS0xLTg3NDU_15fd6a11-de56-44f8-ba2d-98b5a27761e7">The NASDAQ Stock Market LLC</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6MmFkZWU1MDhjMzI1NDI2ODllNzg3MDE5ZmY3YzY2ODcvdGFibGVyYW5nZToyYWRlZTUwOGMzMjU0MjY4OWU3ODcwMTlmZjdjNjY4N18yLTAtMS0xLTg3NDU_5df85aa3-5dd9-4d41-a900-fadb01328f7f">Common stock, par value $0.10 per share</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6MmFkZWU1MDhjMzI1NDI2ODllNzg3MDE5ZmY3YzY2ODcvdGFibGVyYW5nZToyYWRlZTUwOGMzMjU0MjY4OWU3ODcwMTlmZjdjNjY4N18yLTEtMS0xLTg3NDU_921ddaa1-ccbd-422b-9e3f-b79619b59d8e">ICUI</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Global Select Market)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Registered Pursuant to Section 12(g) of the Act:&#160; None</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. &#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTM5_655c2a58-1279-4bc8-8386-ae640fa21fb6">Yes</ix:nonNumeric>&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Yes&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTQw_ec926891-5264-4dd7-8ac1-2002bd588e95">No</ix:nonNumeric> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTQx_50fdc2d5-8014-497e-b534-0f12de1c6144">Yes</ix:nonNumeric>&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160; <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTQy_2be813b4-a4ad-405a-94b9-7126f5155710">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160; No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company.&#160; See definition of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company," in Rule 12b-2 of the Exchange Act:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.322%"><tr><td style="width:1.0%"></td><td style="width:32.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6OTUwYzRkY2M5NGQzNGZkY2JkMGNmYTQ4ODAxMGUzODQvdGFibGVyYW5nZTo5NTBjNGRjYzk0ZDM0ZmRjYmQwY2ZhNDg4MDEwZTM4NF8wLTAtMS0xLTg3NDU_099f6956-2a73-4932-a891-70b5428ef63c">Large Accelerated Filer</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Small reporting company </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6OTUwYzRkY2M5NGQzNGZkY2JkMGNmYTQ4ODAxMGUzODQvdGFibGVyYW5nZTo5NTBjNGRjYzk0ZDM0ZmRjYmQwY2ZhNDg4MDEwZTM4NF8yLTQtMS0xLTg3NDU_91ee0890-2fd3-464c-b6a3-ab33b5d7e64c">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6OTUwYzRkY2M5NGQzNGZkY2JkMGNmYTQ4ODAxMGUzODQvdGFibGVyYW5nZTo5NTBjNGRjYzk0ZDM0ZmRjYmQwY2ZhNDg4MDEwZTM4NF80LTQtMS0xLTg3NDU_de2607f1-5525-43de-a395-51a126107cd9">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTQ1_fbecb50f-f619-4cea-9eb0-f449d57944b4">&#9746;</ix:nonNumeric></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTQ3_f9206899-7278-43b9-91aa-32d3090bd4e7">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Yes&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of the voting stock held by non-affiliates of registrant as of June&#160;30, 2021, the last business day of registrant&#8217;s most recently completed second fiscal quarter, was $<ix:nonFraction unitRef="usd" contextRef="iff2e09ea6c244b5c8c8c4fdbeea287ee_I20200630" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8yOTEy_e178d2c9-6737-4c9f-9b1f-0c3d3cd9de09">4,104,813,741</ix:nonFraction>*.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares outstanding of registrant&#8217;s common stock, $.10 par value, as of January&#160;31, 2022 was <ix:nonFraction unitRef="shares" contextRef="i111df2377a904008a8e4287e7d182606_I20220131" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zMDEx_dc6a2021-645f-47c4-a4e5-4f4d1d0f7010">23,786,887</ix:nonFraction>.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTQ0_1adc27cf-f6d9-4575-99e8-dbe803dc9881" escape="true">Portions of the Proxy Statement for registrant&#8217;s 2022 Annual Meeting of Stockholders filed or to be filed pursuant to Regulation 14A within 120 days following registrant&#8217;s fiscal year ended December&#160;31, 2021, are incorporated by reference into Part III of this Report.</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160; Without acknowledging that any person other than Dr. George A. Lopez is an affiliate, all directors and executive officers have been included as affiliates solely for purposes of this computation.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ic100f0970bae445782808747a3ec391d_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU Medical, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form 10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Year Ended December&#160;31, 2021 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.005%"><tr><td style="width:1.0%"></td><td style="width:10.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.211%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_13">Item 1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_13">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_16">Item 1A</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_16">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_16">18</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_19">Item 1B</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_19">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_19">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_22">Item 2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_22">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_22">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_25">Item 3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_25">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_25">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_28">Item 4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_28">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_28">40</a></span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_34">Item 5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_34">Market for the Registrant&#8217;s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_34">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_1452">Item 6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_1452">Reserved</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_1452">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_40">Item 7</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_40">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_40">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_43">Item 7A</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_43">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_43">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_46">Item 8</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_46">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_46">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_49">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_49">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_121">Item 9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_121">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_121">102</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_124">Item 9A</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_124">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_124">102</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_127">Item 9B</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_127">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_127">104</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_1480">Item 9C</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_1480">Disclosure Regarding Foreign Jurisdiction</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_1480">s</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_1480"> that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_1480">104</a></span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART III</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_133">Item 10</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_133">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_133">104</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_136">Item 11</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_136">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_136">104</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_139">Item 12</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_139">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_139">104</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_142">Item 13</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_142">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_142">104</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_145">Item 14</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_145">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_145">104</a></span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART IV</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_151">Item 15</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_151">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_151">105</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_163">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_163">108</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ic100f0970bae445782808747a3ec391d_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. BUSINESS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">First person pronouns used in this Report, such as &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our,&#8221; refer to ICU Medical, Inc. ("ICU") and its subsidiaries unless context requires otherwise.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes from Prior Periodic Reports</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this report we have complied with the disclosures required by the Securities and Exchange Commission ("SEC") release No. 33-10890 "Management's Discussion and Analysis, Selected Financial Data, Supplementary Financial Information."</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis, Selected Financial Data, and Supplementary Financial Information</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, the SEC issued Release No. 33-10890, &#8220;Management&#8217;s Discussion and Analysis, Selected Financial Data, and Supplementary Financial Information&#8221; which became fully effective on August 9, 2021. This release was adopted to modernize, simplify, and enhance certain financial disclosure requirements in Regulation S-K. Specifically, the SEC eliminated the requirement for selected financial data, only requiring quarterly disclosure when there are retrospective changes affecting comprehensive income, and amending the matters required to be presented under Management&#8217;s Discussion and Analysis (&#8220;MD&amp;A&#8221;) to, among other things, eliminate the requirement of the contractual obligations table.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have eliminated from this document the items discussed above that are no longer required. Information on our contractual obligations is still disclosed in a narrative within the &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Item 7 of Part II of this report.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Background and Overview of Business</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ICU is one of the world's leading pure-play infusion therapy companies with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needlefree connectors designed to help meet clinical, safety and workflow goals. In addition, ICU manufactures automated pharmacy IV compounding systems with workflow technology, closed system transfer devices for preparing and administering hazardous IV drugs and cardiac monitoring systems for critically ill patients.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Headquartered in San Clemente, California, ICU was founded in 1984. In 1992, we had our initial public offering and reincorporated under Delaware law. Our primary customers are acute care hospitals, wholesalers, ambulatory clinics and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. Since our inception we have grown organically and through acquisition, and we currently serve customers in more than 90 countries throughout the world.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2017, we acquired Pfizer Inc.'s ("Pfizer") Hospira Infusion Systems ("HIS") business. The HIS acquisition complemented our legacy non-dedicated infusion sets and oncology business by expanding our product portfolio to include a complete intravenous infusion therapy product-line from IV solutions to IV pumps to non-dedicated infusion sets. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we acquired Pursuit Vascular, Inc. ("Pursuit"). Pursuit was a privately-held medical device company with a primary focus on innovative catheter disinfecting products and technologies to reduce costly bloodstream infections and lower healthcare costs. Pursuit&#8217;s primary product is the ClearGuard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> HD cap, which is used for the maintenance of hemodialysis catheters. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, we entered into a definitive agreement to acquire Smiths Medical 2020 Limited ("Smiths Medical"), the holding company of Smiths Group plc's global medical device business and, on January 6, 2022, the acquisition closed. The Smiths Medical acquisition complements and broadens our existing product portfolio to include syringe and ambulatory infusion devices, vascular access, and vital care products, and significantly strengthens and expands our global market reach. The following business discussion is as of December 31, 2021 and as such does not incorporate the Smiths Medical acquisition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Products</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, our primary product offerings are listed below, which we present in four product lines as follows:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Infusion Consumables</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Infusion therapy sets, used in hospitals and ambulatory clinics, consist of a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient&#8217;s vein, that may or may not be used with an IV pump.&#160;Our primary Infusion Consumable products are:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Clave&#8482; needlefree products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including the MicroClave, MicroClave Clear, and NanoClave&#8482; brand of connectors, accessories, extension and administration sets used for the administration of IV fluids and medications and the Neutron catheter patency device, used to help maintain patency of central venous catheters;</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">SwabCap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and SwabTip disinfecting caps, used to protect and disinfect any needlefree connector, including competitive brands of connectors, and male luers; </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">ClearGuard HD </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">antimicrobial barrier caps for hemodialysis catheters; and</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Tego</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hemodialysis connector used to cap and protect hemodialysis central venous catheter hubs.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Closed System Transfer Devices ("CSTD") and hazardous drug compounding systems</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are used to prepare and deliver hazardous IV medications such as those used in chemotherapy, which, if released, can have harmful effects to the healthcare worker and environment.&#160;Our products are:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">ChemoLock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> CSTD, which utilizes a proprietary needlefree connection method, is used for the preparation and administration of hazardous drugs. ChemoLock is used to limit the escape of hazardous drug or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury;</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">ChemoClave</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an ISO Connection standard and universally compatible CSTD used for the preparation and administration of hazardous drugs. ChemoClave utilizes standard ISO luer locking connections, making it compatible with all brands of needlefree connectors and pump delivery systems. ChemoClave also is used to limit the escape of hazardous drug or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminate the risk of needlestick injury; and</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Diana</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hazardous drug compounding system, an automated sterile compounding system that incorporates ChemoClave and ChemoLock CSTD consumables and IV workflow technology for the accurate, safe, and efficient preparation of hazardous drugs. It is a user-controlled automated system that provides repeatable accuracy of drug mixes and minimizes clinician exposure to hazardous drugs while helping to maintain the sterility of the drugs being mixed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of hazardous drugs typically takes place in a pharmacy where drugs are removed from vials and prepared for delivery to a patient. Those prepared drugs are then transferred to a nursing unit where the chemotherapy is administered via an infusion pump set to a patient. Components of the ChemoClave and ChemoLock product lines are used both in pharmacies and on the nursing floors for the preparation and administration of hazardous drugs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Infusion Systems</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer a wide range of infusion pumps, dedicated IV sets, software and professional services. Our primary Infusion System products are dedicated IV sets and the following:</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Infusion Pump Hardware:</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Plum 360&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plum 360&#8482; infusion pump is an ICU Medical MedNet&#8482; ready large volume infusion pump with an extensive drug library and wireless capability. Plum 360 was named the 2018, 2019 and 2020 Best in KLAS winner as top-performing IV smart pump and was the first medical device to be awarded UL Cybersecurity Assurance Program Certification. Also, in 2021 and 2022, the Plum 360 won the  award as the top-performing Smart Pump EMR-Integrated; and</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">LifeCare PCA&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The LifeCare PCA infusion pump is an ICU Medical MedNet&#8482; ready patient-controlled analgesia pump ("PCA"), providing complete IV Electronic Health Records ("IV-EHR") interoperability since 2016.</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IV Medication Safety Software:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">ICU Medical MedNet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482;: ICU Medical MedNet is an enterprise-class medication management platform for any sized healthcare system that can help reduce medication errors, improve quality of care, streamline workflows and maximize revenue capture. ICU Medical MedNet connects our industry-leading smart pumps to a hospital&#8217;s EHR, asset tracking systems, and alarm notification platforms with the largest array of integration partners. </span></div><div style="padding-left:72pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Professional Services: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In addition to the products above, our teams of clinical, information technology, and professional services experts work with customers to develop and deliver safe and efficient infusion systems, providing customized and personalized configuration, implementation, and data analytics services to complement our infusion hardware and software.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IV Solutions</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide a broad portfolio of IV solutions to meet our customers&#8217; clinical needs, providing a consistent supply of IV solutions, irrigation, and nutritionals to help provide safe and effective patient care. Our primary IV Solutions products are:</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IV Therapy and Diluents:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Including Sodium Chloride, Dextrose, Balanced Electrolyte Solutions, Lactated Ringer's, Ringer's, Mannitol, Sodium Chloride/Dextrose and Sterile Water.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Irrigation:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Including Sodium Chloride Irrigation, Sterile Water Irrigation, Physiologic Solutions, Ringer's Irrigation, Acetic Acid Irrigation, Glycine Irrigation, Sorbitol-Mannitol Irrigation, Flexible Containers and Pour Bottle Options.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Care</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Critical Care products help clinicians get accurate real-time access to patients&#8217; hemodynamic and cardiac status with an extensive portfolio of monitoring systems and advanced sensors &amp; catheters.&#160;Measurements provided by our systems help clinicians determine how well the heart is pumping blood and how efficiently oxygen from the blood is being used by the tissues. Our primary Critical Care products are:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cogent&#8482; 2-in-1 hemodynamic monitoring system;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">CardioFlo&#8482; hemodynamic monitoring system;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">TDQ&#8482; and OptiQ&#8482; cardiac output monitoring catheters;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">TriOx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">venous oximetry catheters;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Transpac&#8482; blood pressure transducers; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SafeSet&#8482; closed blood sampling and conservation system.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to our reporting segment and primary product lines is set forth in Part II, Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations" of this Annual Report on Form 10-K, and is incorporated herein by reference. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Manufacturing</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we operate four primary manufacturing facilities globally, which are discussed in Part I, Item 2 of this report. We operate four main service centers globally. We also rely on certain outside manufacturers for certain product lines in Infusion Systems and IV Solutions.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our four primary manufacturing sites are:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">La Aurora de Heredia, Costa Rica, which manufactures most of our infusion pumps and dedicated disposables, as well as a portion of our non-dedicated infusion consumables products; </span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ensenada, Mexico, which manufactures infusion consumables products;</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Salt Lake City, Utah, which produces primarily our proprietary brands of connector and CSTD components, and sends those products to Costa Rica or Mexico for finished goods assembly; and</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Austin, Texas, which produces our IV Solutions products. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we leverage a long-term supply agreement with Pfizer (described below) to provide additional IV Solution products to us.</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have four main regional device service centers in Sligo, Ireland; San Laurent, Quebec, Canada; Taipei, Taiwan and Rydalmere, Australia. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In 2017, we entered into two Manufacturing and Supply Agreements ("MSAs") with Pfizer under which, (i) Pfizer manufactures and supplies us with certain agreed upon products for an initial five-year term with a one-time two-year option to extend and (ii) we manufacture and supply Pfizer certain agreed upon products for a term of five or ten years depending on the product, with a one-time two-year option to extend. The initial supply price will be annually updated and is in full consideration for all costs associated with the manufacture, documentation, packaging and certification of the products. In January 2021, we amended our MSA with Pfizer, whereby we manufacture and supply certain agreed upon products to Pfizer. The amendments include a change to the term of the agreement to end on December 31, 2024 with Pfizer's unilateral election to extend through December 31, 2025. Other changes to the terms of the MSA include (i) amendments to our level of supply of products to Pfizer, (ii) certain changes to our manufacturing lines, (iii) updates to our supply price with added volume price tiers for annual periods and (iv) certain minimum purchase requirements for certain products. On February 1, 2022, effective as of January 1, 2022, upon our request, Pfizer executed a Product Addendum (the "Product Addendum") to our MSA agreement, whereby Pfizer manufactures and supplies to us certain agreed upon products. The Product Addendum includes the supply of additional product to us subject to certain time and pricing terms and conditions. The Product Addendum expires on November 30, 2022.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase many of the components and raw materials used in manufacturing our products from numerous suppliers in various countries. Certain components and raw materials are available only from a sole supplier. We work closely with our suppliers to ensure continuity of supply while maintaining high quality and reliability. We have generally been able to obtain adequate supplies of such raw materials and components.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales, Marketing and Administration</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We ship around the world with the majority of our sales denominated in United States ("U.S.") dollars, Euro and Canadian dollars. We are not dependent on any single customer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distribution </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are marketed to medical product manufacturers, independent distributors and directly to end users.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. distribution of solutions, IV sets and accessories is supported by a network of two owned and one leased distribution centers, which include King of Prussia, Pennsylvania; Los Angeles, California; and Dallas, Texas. We also utilize a number of public warehouses as part of our supply chain.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internationally, we manage distribution by utilizing international regional hubs and through independent distributors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products and operations are subject to extensive and rigorous regulation by the Food and Drug Administration ("FDA") and other federal, state and local authorities, as well as foreign regulatory authorities. The FDA regulates, among other things, the research, development, testing, manufacturing, approval, labeling, storage, recordkeeping, advertising, promotion and marketing, distribution, post-approval monitoring and reporting and import and export of drug products, medical devices and combination drug/device products in the U.S. to assure the safety and effectiveness of such medical products for their </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intended uses and otherwise meet the applicable requirements of the Federal Food, Drug and Cosmetic Act (&#8220;FDC Act&#8221;). The Federal Trade Commission ("FTC") also regulates the advertising of our products. Further, we are subject to laws directed at preventing fraud and abuse, which subject our sales and marketing, training and other practices to government scrutiny. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Device Regulation in the U.S.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our products are regulated by the FDA as medical devices in the U.S. Unless an exemption applies, each new or significantly modified medical device we seek to commercially distribute in the U.S. will require either a pre-market notification to the FDA requesting permission for commercial distribution under Section 510(k) of the FDC Act, also referred to as a 510(k) clearance, or approval from the FDA of a pre-market approval ("PMA") application. Under the FDC Act, medical devices are classified into one of three classes&#8212;Class I, Class II or Class III&#8212;depending on the degree of risk associated with each medical device and the extent of manufacturer and regulatory control needed to ensure its safety and effectiveness. Class I devices are those that pose the lowest risk to the patient and are those for which safety and effectiveness can be assured by adherence to the FDA's General Controls for medical devices, which include compliance with the applicable portions of current good manufacturing practices ("cGMPs") for medical devices known as the Quality System Regulation ("QSR"), facility registration and product listing, reporting of adverse medical events, and truthful and non-misleading labeling, advertising, and promotional materials. Class II devices are subject to the FDA's General Controls, and special controls as deemed necessary by the FDA to ensure the safety and effectiveness of the device. Devices deemed by the FDA to pose the greatest risks, such as life sustaining, life supporting or some implantable devices, or devices that have a new intended use, or use advanced technology that is not substantially equivalent to that of a legally marketed device, are placed into Class III.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturers of most Class II devices are required to obtain from the FDA a 510(k) clearance for permission to commercially distribute the device. Class III devices require approval of a PMA application evidencing safety and effectiveness of the device.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 510(k) process, applicants must demonstrate to the FDA that the device is as safe and effective as, or substantially equivalent to, a legally marketed device, the "predicate" device. A predicate device is a legally marketed device that is not subject to pre-market approval, i.e., a device that was legally marketed prior to May 28, 1976 (pre-amendments device) and for which a PMA is not required, a device that has been reclassified from Class III to Class II or I, or a device that was found substantially equivalent through the 510(k) process. Applicants must submit performance data to establish substantial equivalence. In some instances, data from human clinical trials must also be submitted in support of a 510(k) pre-market notification. If so, these data must be collected in a manner that conforms to the applicable Investigational Device Exemption ("IDE") regulations. If the FDA agrees that the device is substantially equivalent to a lawfully marketed predicate device, it will grant 510(k) clearance to authorize the device for commercialization. If the FDA determines that the device is "not substantially equivalent," the device is automatically designated as a Class III device. The device sponsor must then fulfill more rigorous PMA requirements, or can request a risk-based classification determination for the device in accordance with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> classification process, which is a route to market for novel medical devices that are low to moderate risk and are not substantially equivalent to a predicate device.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a device receives 510(k) clearance, any modification that could significantly affect its safety or effectiveness, or that would constitute a major change or modification in its intended use, will require a new 510(k) clearance or, depending on the modification, PMA approval or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> classification. The FDA requires each manufacturer to determine whether the proposed change requires submission of a 510(k), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> classification request or a PMA in the first instance, but the FDA can review any such decision and disagree with a manufacturer&#8217;s determination. If the FDA disagrees with a manufacturer&#8217;s determination not to seek a new 510(k) or other form of marketing authorization for the modification to the 510(k)-cleared product, the FDA can require the manufacturer to cease marketing and/or request the recall of the modified device until 510(k) clearance or PMA approval is obtained or a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> classification is granted.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the PMA application process, the applicant must demonstrate to the satisfaction of the FDA that the device is safe and effective for its intended use. This approval process applies to most Class III devices, and generally requires clinical data to support the safety and effectiveness of the device, obtained in adherence with IDE requirements. Following receipt of a PMA application, the FDA determines whether the application is sufficiently complete to permit a substantive review. If FDA accepts the application for review, it has 180 days under the FDC Act to complete its review of a PMA, although in practice, the FDA's review often takes significantly longer, and can take up to several years. An advisory panel of experts from outside the FDA may be convened to review and evaluate the application and provide recommendations to the FDA as to the approvability of the device. The FDA may or may not accept the panel's recommendation. In addition, the FDA will generally conduct a pre-approval inspection of the applicant or its third-party manufacturers' or suppliers' facilities to ensure compliance with the QSR. The FDA will approve the new device for commercial distribution if it determines that the data and information in the PMA constitute valid scientific evidence and that there is reasonable assurance that the device is safe and effective for its intended </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">use(s). The FDA may approve a PMA with post-approval conditions intended to ensure the safety and effectiveness of the device, including, among other things, restrictions on labeling, promotion, sale and distribution, and collection of long-term follow-up data from patients in the clinical study that supported PMA approval or requirements to conduct additional clinical studies post-approval. Certain changes to an approved device, such as changes in manufacturing facilities, methods, or quality control procedures, or changes in the design performance specifications, which affect the safety or effectiveness of the device, require submission of a PMA supplement, or in some cases a new PMA. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a device is cleared or approved or otherwise authorized for marketing, numerous pervasive regulatory requirements continue to apply unless explicitly exempt. These include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishment registration and device listing with the FDA;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">QSR requirements, which require manufacturers, including third-party manufacturers, to follow stringent design, testing, control, documentation and other quality assurance procedures during all aspects of the design and manufacturing process;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">clearance or approval of product modifications to 510(k)-cleared devices that could significantly affect safety or effectiveness or that would constitute a major change in intended use of cleared devices;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">medical device reporting regulations, which require that a manufacturer report to the FDA if a device it markets may have caused or contributed to a death or serious injury, or has malfunctioned and the device or a similar device that it markets would be likely to cause or contribute to a death or serious injury, if the malfunction were to recur;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">correction, removal and recall reporting regulations, which require that manufacturers report to the FDA field corrections and product recalls or removals if undertaken to reduce a risk to health posed by the device or to remedy a violation of the FDC Act that may present a risk to health;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">complying with requirements governing Unique Device Identifiers on devices and also requiring the submission of certain information about each device to the FDA's Global Unique Device Identification Database;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the FDA's recall authority, whereby the agency can order device manufacturers to recall from the market a product that is in violation of governing laws and regulations; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">post-market surveillance activities and regulations, which apply when deemed by the FDA to be necessary to protect public health or to provide additional safety and effectiveness data for the device.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Drug Regulation in the U.S. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our IV solutions products are regulated by the FDA as drugs. In the U.S., the FDA regulates drugs under the FDC Act, and its implementing regulations, and biologics under the FDC Act and its implementing regulations. The process required by the FDA before a drug may be marketed in the U.S. generally involves the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">completion of preclinical laboratory tests and animal studies performed in accordance with the FDA's Good Laboratory Practice requirements;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">submission to the FDA of an investigational new drug application ("IND"), which must become effective before clinical trials may begin;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approval by an institutional review board ("IRB") or ethics committee at each clinical site before the trial is commenced;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">performance of adequate and well-controlled human clinical trials to establish the safety and efficacy of the proposed product candidate for its intended purpose;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">preparation of and submission to the FDA of a New Drug Application ("NDA") or abbreviated new drug application ("ANDA") after completion of all required clinical trials;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">satisfactory completion of an FDA Advisory Committee review, if applicable;</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a determination by the FDA within 60 days of its receipt of an NDA to file the application for review;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">satisfactory completion of an FDA pre-approval inspection of the manufacturing facility or facilities at which the proposed product is produced to assess compliance with cGMPs and to assure that the facilities, methods and controls are adequate to preserve the product's continued safety, purity and potency, and of selected clinical investigation sites to assess compliance with Good Clinical Practices ("GCPs"); and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FDA review and approval of the NDA to permit commercial marketing of the product for particular indications for use in the U.S.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to beginning clinical trials of a drug product in the U.S., an IND must be submitted to the FDA. An IND is a request for authorization from the FDA to administer an investigational new drug product to humans. An IND must become effective before human clinical trials may begin. Assuming successful completion of all required testing in accordance with all applicable regulatory requirements, the results of product development, nonclinical studies and clinical trials are submitted to the FDA as part of an NDA requesting approval to market the product for one or more indications. The NDA must include all relevant data available from preclinical and clinical studies, including negative or ambiguous results as well as positive findings, together with detailed information relating to the product&#8217;s chemistry, manufacturing, controls, and proposed labeling, among other things. The submission of an NDA requires payment of a substantial application user fee to the FDA, unless a waiver or exemption applies.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the FDA evaluates an NDA and conducts inspections of manufacturing facilities where the investigational product and/or its drug substance will be produced and of select clinical trial sites, the FDA may issue an approval letter or a Complete Response Letter ("CRL"). An approval letter authorizes commercial marketing of the product with specific prescribing information for specific indications. A CRL will generally describe all of the deficiencies that the FDA has identified in the NDA. In issuing the CRL, the FDA may recommend actions that the applicant might take to place the NDA in condition for approval, including requests for additional information or clarification. The FDA may delay or refuse approval of an NDA if applicable regulatory criteria are not satisfied, require additional testing or information and/or require post-marketing testing and surveillance to monitor safety or efficacy of a product.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If regulatory approval of a drug is granted, such approval will be granted for particular indications and may include limitations on the indicated uses for which such drug may be marketed. The FDA also may condition approval on, among other things, changes to proposed labeling or the development of adequate controls and specifications. Once approved, the FDA may withdraw the approval if compliance with pre- and post-marketing requirements is not maintained or if problems occur after the product reaches the marketplace. The FDA may require one or more post-market studies and surveillance to further assess and monitor the drug&#8217;s safety and effectiveness after commercialization, and may limit further marketing of the drug based on the results of these post-marketing studies.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any drugs manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to record-keeping, reporting of adverse experiences, periodic reporting, product sampling and distribution, and advertising and promotion of the product. After approval, most changes to the approved product, such as adding new indications or other labeling claims, are subject to prior FDA review and approval. There also are continuing, annual program fees for any marketed products. Drug manufacturers and their subcontractors are required to register their establishments with the FDA and certain state agencies, and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP, which impose certain procedural and documentation requirements upon us and our third-party manufacturers. FDA regulations also require investigation and correction of any deviations from cGMP and impose reporting requirements upon us and any third-party manufacturers that we may decide to use. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain compliance with cGMP and other aspects of regulatory compliance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Post-Market Enforcement</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may withdraw marketing authorizations for drugs or medical devices if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information, imposition of post-market studies or clinical studies to assess new safety risks, or imposition of distribution restrictions or other restrictions. Other potential consequences include, among other things: complete withdrawal of the product from the market, product recalls, fines, warning letters, untitled letters, clinical holds on clinical studies, refusal of the FDA to approve pending applications or supplements to approved applications, product seizures or detention, refusal to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">permit the import or export of products, consent decrees, corporate integrity agreements, debarment or exclusion from federal healthcare programs, the issuance of corrective information, injunctions, or the imposition of civil or criminal penalties.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the FDA closely regulates the marketing, labeling, advertising and promotion of drugs and medical devices. A company can make only those claims relating to safety and efficacy, purity and potency that are cleared or approved by the FDA and in accordance with the provisions of the authorized label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses. Failure to comply with these requirements can result in, among other things, adverse publicity, warning letters, corrective advertising and potential civil and criminal penalties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulation of Medical Devices in the European Union</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Union ("EU") has adopted specific directives and regulations regulating the design, manufacture, clinical investigation, conformity assessment, labeling and adverse event reporting for medical devices.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until May 25, 2021, medical devices were regulated by Council Directive 93/42/EEC (the "EU Medical Devices Directive") which has been repealed and replaced by Regulation (EU) No 2017/745 (the "EU Medical Devices Regulation"). Our current certificates have been granted under the EU Medical Devices Directive whose regime is described below. However, as of May 26, 2021, some of the EU Medical Devices Regulation requirements apply in place of the corresponding requirements of the EU Medical Devices Directive with regard to registration of economic operators and of devices, post-market surveillance and vigilance requirements. Pursuing marketing of medical devices in the EU will notably require that our devices be certified under the new regime set forth in the EU Medical Devices Regulation when our current certificates expire.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Devices Directive</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the EU Medical Devices Directive, all medical devices placed on the market in the EU must meet the relevant essential requirements laid down in Annex I to the EU Medical Devices Directive, including the requirement that a medical device must be designed and manufactured in such a way that it will not compromise the clinical condition or safety of patients, or the safety and health of users and others. In addition, the device must achieve the performance intended by the manufacturer and be designed, manufactured, and packaged in a suitable manner. The European Commission has adopted various standards applicable to medical devices. These include standards governing common requirements, such as sterilization and safety of medical electrical equipment and product standards for certain types of medical devices. There are also harmonized standards relating to design and manufacture. While not mandatory, compliance with these standards is viewed as the easiest way to satisfy the essential requirements as a practical matter as it creates a rebuttable presumption that the device satisfies that essential requirement.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To demonstrate compliance with the essential requirements laid down in Annex I to the EU Medical Devices Directive, medical device manufacturers must undergo a conformity assessment procedure, which varies according to the type of medical device and its (risk) classification. As a general rule, demonstration of conformity of medical devices and their manufacturers with the essential requirements must be based, among other things, on the evaluation of clinical data supporting the safety and performance of the products during normal conditions of use. Specifically, a manufacturer must demonstrate that the device achieves its intended performance during normal conditions of use, that the known and foreseeable risks, and any adverse events, are minimized and acceptable when weighed against the benefits of its intended performance, and that any claims made about the performance and safety of the device are supported by suitable evidence. Except for low-risk medical devices (Class I non-sterile, non-measuring devices), where the manufacturer can self-declare the conformity of its products with the essential requirements (except for any parts which relate to sterility or metrology), a conformity assessment procedure requires the intervention of a notified body. Notified bodies are independent organizations designated by EU member states to assess the conformity of devices before being placed on the market. A notified body would typically audit and examine a product's technical dossiers and the manufacturers' quality system (the notified body must presume that quality systems which implement the relevant harmonized standards &#8211; which is ISO 13485:2016 for Medical Devices Quality Management Systems &#8211; conform to these requirements). If satisfied that the relevant product conforms to the relevant essential requirements, the notified body issues a certificate of conformity, which the manufacturer uses as a basis for its own declaration of conformity. The manufacturer may then apply the European Conformity ("CE") mark to the device, which allows the device to be placed on the market throughout the EU.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the term of the certificate of conformity, the manufacturer will be subject to periodic surveillance audits to verify continued compliance with the applicable requirements. In particular, there will be a new audit by the notified body before it will renew the relevant certificate(s).</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Devices Regulation</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulatory landscape related to medical devices in the EU recently evolved. On April 5, 2017, the EU Medical Devices Regulation was adopted with the aim of ensuring better protection of public health and patient safety. The EU Medical Devices Regulation establishes a uniform, transparent, predictable and sustainable regulatory framework across the EU for medical devices and ensure a high level of safety and health while supporting innovation. Unlike the EU Medical Devices Directive, the EU Medical Devices Regulation is directly applicable in EU member states without the need for member states to implement into national law. This aims to increase harmonization across the EU.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The EU Medical Devices Regulation became effective on May 26, 2021. The new Regulation among other things:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strengthens the rules on placing devices on the market (e.g. reclassification of certain devices and wider scope than the EU Medical Devices Directive) and reinforces surveillance once they are available;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishes explicit provisions on manufacturers' responsibilities for the follow-up of the quality, performance and safety of devices placed on the market;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishes explicit provisions on importers' and distributors' obligations and responsibilities;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">imposes an obligation to identify a responsible person who is ultimately responsible for all aspects of compliance with the requirements of the new regulation;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">improves the traceability of medical devices throughout the supply chain to the end-user or patient through the introduction of a unique identification number, to increase the ability of manufacturers and regulatory authorities to trace specific devices through the supply chain and to facilitate the prompt and efficient recall of medical devices that have been found to present a safety risk;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sets up a central database (Eudamed) to provide patients, healthcare professionals and the public with comprehensive information on products available in the EU; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strengthens rules for the assessment of certain high-risk devices, such as implants, which may have to undergo a clinical evaluation consultation procedure by experts before they are placed on the market.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Devices lawfully placed on the market pursuant to the EU Medical Devices Directive prior to May 26, 2021 may generally continue to be made available on the market or put into service until May 26, 2025, provided that the requirements of the transitional provisions are fulfilled. In particular, the certificate in question must still be valid. However, even in this case, manufacturers must comply with a number of new or reinforced requirements set forth in the EU Medical Devices Regulation, in particular the obligations described below.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The EU Medical Devices Regulation requires that before placing a device, other than a custom-made device, on the market, manufacturers (as well as other economic operators such as authorized representatives and importers) must register by submitting identification information to the electronic system (Eudamed), unless they have already registered. The information to be submitted by manufacturers (and authorized representatives) also includes the name, address and contact details of the person or persons responsible for regulatory compliance. The new Regulation also requires that before placing a device, other than a custom-made device, on the market, manufacturers must assign a unique identifier to the device and provide it along with other core data to the unique device identifier ("UDI") database. These new requirements aim at ensuring better identification and traceability of the devices. Each device &#8211; and as applicable, each package &#8211; will have a UDI composed of two parts: a device identifier ("UDI-DI") specific to a device, and a production identifier ("UDI-PI") to identify the unit producing the device. Manufacturers are also notably responsible for entering the necessary data on Eudamed, which includes the UDI database, and for keeping it up to date. The obligations for registration in Eudamed will become applicable at a later date (as Eudamed is not yet fully functional). Until Eudamed is fully functional, the corresponding provisions of the EU Medical Devices Directive continue to apply for the purpose of meeting the obligations laid down in the provisions regarding exchange of information, including, and in particular, information regarding registration of devices and economic operators.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All manufacturers placing medical devices on the market in the EU must comply with the EU medical device vigilance system which has been reinforced by the EU Medical Devices Regulation. Under this system, serious incidents and Field Safety Corrective Actions ("FSCAs") must be reported to the relevant authorities of the EU member states. These reports will have to be submitted through Eudamed &#8211; once functional &#8211; and aim to ensure that, in addition to reporting to the relevant authorities of the EU member states, other actors such as the economic operators in the supply chain will also be informed. Until Eudamed is </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fully functional, the corresponding provisions of the EU Medical Devices Directive continue to apply. A serious incident is defined as any malfunction or deterioration in the characteristics or performance of a device made available on the market, including use-error due to ergonomic features, as well as any inadequacy in the information supplied by the manufacturer and any undesirable side-effect, which, directly or indirectly, might have led or might lead to the death of a patient or user or of other persons or to a temporary or permanent serious deterioration of a patient's, user's or other person's state of health or a serious public health threat. Manufacturers are required to take FSCAs defined as any corrective action for technical or medical reasons to prevent or reduce a risk of a serious incident associated with the use of a medical device that is made available on the market. An FSCA may include the recall, modification, exchange, destruction or retrofitting of the device. FSCAs must be communicated by the manufacturer or its legal representative to its customers and/or to the end users of the device through Field Safety Notices. For similar serious incidents that occur with the same device or device type and for which the root cause has been identified or a FSCA implemented or where the incidents are common and well documented, manufacturers may provide periodic summary reports instead of individual serious incident reports.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The advertising and promotion of medical devices is subject to some general principles set forth in EU legislation. According to the EU Medical Devices Regulation, only devices that are CE marked may be marketed and advertised in the EU in accordance with their intended purpose. Directive 2006/114/EC concerning misleading and comparative advertising and Directive 2005/29/EC on unfair commercial practices, while not specific to the advertising of medical devices, also apply to the advertising thereof and contain general rules, for example, requiring that advertisements are evidenced, balanced and not misleading. Specific requirements are defined at a national level. EU member states' laws related to the advertising and promotion of medical devices, which vary between jurisdictions, may limit or restrict the advertising and promotion of products to the general public and may impose limitations on promotional activities with healthcare professionals.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many EU member states have adopted specific anti-gift statutes that further limit commercial practices for medical devices, in particular vis-&#224;-vis healthcare professionals and organizations. Additionally, there has been a recent trend of increased regulation of payments and transfers of value provided to healthcare professionals or entities and many EU member states have adopted national "Sunshine Acts" which impose reporting and transparency requirements (often on an annual basis), similar to the requirements in the U.S., on medical device manufacturers. Certain countries also mandate implementation of commercial compliance programs.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aforementioned EU rules are generally applicable in the European Economic Area ("EEA") which consists of the 27 EU member states plus Norway, Liechtenstein and Iceland.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Brexit</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1, 2021, the Medicines and Healthcare Products Regulatory Agency ("MHRA") has become the sovereign regulatory authority responsible for Great Britain (i.e. England, Wales and Scotland) medical device market according to the requirements provided in the&#8239;Medical Devices Regulations 2002&#8239;(SI 2002 No 618, as amended) that sought to give effect to the three pre-existing EU directives governing active implantable medical devices, general medical devices and in vitro diagnostic medical devices whereas Northern Ireland continues to be governed by EU rules according to the Northern Ireland Protocol. Following the end of the United Kingdom's ("UK's") withdrawal from the EU ("Brexit") transitional period on January 1, 2021, new regulations require medical devices to be registered with the MHRA (but manufacturers were given a grace period of four to 12 months, depending on the classification of the device, to comply with the new registration process) before being placed on the Great Britain market. The MHRA only registers devices where the manufacturer or their UK responsible person has a registered place of business in the UK. Manufacturers based outside the UK need to appoint a UK responsible person that has a registered place of business in the UK to register devices with the MHRA in line with the grace periods. By July 1, 2023, in Great Britain, all medical devices will require a UK Conformity Assessed ("UKCA") mark but CE marks issued by EU notified bodies will remain valid until this time. Manufacturers may choose to use the UKCA mark on a voluntary basis until June 30, 2023. However, UKCA marking will not be recognized in the EU. The rules for placing medical devices on the market in Northern Ireland, which is part of the UK, differ from those in the rest of the UK. Compliance with this legislation is a prerequisite to be able to affix the UKCA mark to our products, without which they cannot be sold or marketed in Great Britain.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An MHRA public consultation was opened until end of November 2021 on the post-Brexit regulatory framework for medical devices and diagnostics. MHRA seeks to amend the UK Medical Devices Regulations 2002 (which are based on EU legislation, primarily the EU Medical Devices Directive and the EU In Vitro Diagnostic Medical Devices Directive 98/79/EC), in particular to create a new access pathway to support innovation, create an innovative framework for regulating software and artificial intelligence as medical devices, reform IVD regulation and foster sustainability through the reuse and remanufacture of medical devices. The regime is expected to come into force in July 2023, coinciding with the end of the acceptance period for EU CE marks in Great Britain, subject to appropriate transitional arrangements. The consultation indicated that the MHRA </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">will publish guidance in relation to the changes to the regulatory framework and may rely more heavily on guidance to add flexibility to the regime.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the trade deal between the UK and the EU generally provides for cooperation and exchange of information between the parties in the areas of product safety and compliance, including market surveillance, enforcement activities and measures, standardization-related activities, exchanges of officials, and coordinated product recalls. As such, processes for compliance and reporting should reflect requirements from regulatory authorities.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Northern Ireland Protocol, Northern Ireland follows EU rules on medical devices and devices marketed in Northern Ireland require assessment according to the EU regulatory regime. Such assessment may be conducted by an EU notified body, in which case a CE mark is required before placing the device on the market in the EU or Northern Ireland. Alternatively, if a UK notified body conducts such assessment, a 'UKNI' mark is applied and the device may only be placed on the market in Northern Ireland and not the EU.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Manufacturing Regulation</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must also comply with FDA and International Organization for Standardization ("ISO") governing medical device manufacturing practices. The FDA, state, foreign agencies and ISO require manufacturers to register and subject manufacturers to periodic FDA, state, foreign agencies and notified bodies and ISO inspections and audits of their manufacturing facilities. We are a FDA and ISO registered medical device manufacturer, and must demonstrate that we and our contract manufacturers comply with the FDA's QSR, cGMPs and similar foreign requirements. The FDA, other regulatory agencies and notified bodies outside the U.S. monitor compliance with these requirements through inspections and audits of manufacturing facilities. If an inspector observes conditions that might be violative, the manufacturer must correct those conditions or explain them satisfactorily, or face potential regulatory action that might include physical removal of the product from the marketplace.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Healthcare Laws  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to additional healthcare regulation and enforcement by the federal government and by authorities in the states and foreign jurisdictions in which we conduct our business. These laws include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Anti-Kickback Statute, which prohibits, among other things, persons from knowingly and willfully soliciting, receiving, offering or paying remuneration, directly or indirectly, in exchange for or to induce either the referral of an individual for, or the purchase, order or recommendation of, any good or service for which payment may be made under federal healthcare programs, such as the Medicare and Medicaid programs. A person or entity does not need to have actual knowledge of the federal Anti-Kickback Statute or specific intent to violate it to have committed a violation;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal false claims laws which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, claims for payment from Medicare, Medicaid or other federal third-party payors that are false or fraudulent. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act; </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Civil Monetary Penalties Law, which prohibits, among other things, offering or transferring remuneration to a federal healthcare beneficiary that a person knows or should know is likely to influence the beneficiary&#8217;s decision to order or receive items or services reimbursable by the government from a particular provider or supplier;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal criminal laws that prohibit executing a scheme to defraud any federal healthcare benefit program or making false statements relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it to have committed a violation;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act, which governs the conduct of certain electronic healthcare transactions and protects the security and privacy of protected health information; </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Physician Payment Sunshine Act, which requires manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children's Health Insurance Program (with certain exceptions) to report annually to the Centers for Medicare &amp; Medicaid Services ("CMS") information related to payments or other "transfers of value" made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), certain health care professionals (physician assistants, nurse practitioners, clinical nurse </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">specialists, anesthesiologist assistants, certified registered nurse anesthetists, anesthesiology assistants and certified nurse midwives), and teaching hospitals and ownership and investment interests held by the physicians described above and their immediate family members; and</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">analogous state and foreign law equivalents of each of the above federal laws, such as anti-kickback and false claims laws which may apply to items or services reimbursed by any third-party payor, including commercial insurers; state laws that require pharmaceutical and device companies to comply with the industry's voluntary compliance guidelines and the applicable compliance guidance promulgated by the federal government or otherwise restrict payments that may be made to healthcare providers and other potential referral sources; state laws that require device manufacturers to track and report information related to payments and other "transfers of value" to physicians and other healthcare providers or pricing, marketing expenditures and information. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of any of the laws described above include civil and criminal penalties, damages, fines, the curtailment or restructuring of an entity&#8217;s operations, the debarment, suspension or exclusion from federal and state healthcare programs and/or imprisonment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Coverage and Reimbursement</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our profitability and operations are subject to changes in legislative, regulatory and reimbursement policies and decisions as well as changes in private payer reimbursement coverage and payment decisions and policies. Our products are purchased by hospitals, physicians and other healthcare providers that typically bill various third-party payors, such as governmental programs, private insurance plans and managed care plans, for the healthcare services and products provided to their patients. The ability of our customers to obtain appropriate coverage and reimbursement for healthcare services and products from third-party payors is critical because it affects which products customer purchase and the prices they are willing to pay since our products are not separately reimbursed by any third-party payor. Third-party payors are increasingly reducing coverage and reimbursement for certain healthcare services and products and challenging prices charged for healthcare services and products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., there have been, and we expect that there will continue to be, a number of federal and state proposals to limit payments by governmental payors for medical devices, and the procedures in which medical devices are used. For example, in March 2010, comprehensive healthcare reform legislation was enacted through the passage of the Patient Protection and Affordable Care Act, as amended by the Health Care and Education and Reconciliation Act (the "ACA"), which, among other things, provided incentives to programs that increase the federal government&#8217;s comparative effectiveness research, and implemented payment system reforms including a national pilot program on payment bundling to encourage hospitals, physicians and other providers to improve the coordination, quality and efficiency of certain healthcare services through bundled payment models.  </span></div><div style="padding-right:11.25pt;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since its enactment, there have been judicial, executive and Congressional challenges to certain aspects of the ACA. On June 17, 2021, the U.S. Supreme Court dismissed the most recent judicial challenge to the ACA brought by several states without specifically ruling on the constitutionality of the ACA. Prior to the Supreme Court's decision, President Biden issued an executive order to initiate a special enrollment period for purposes of obtaining health insurance coverage through the ACA marketplace from February 15, 2021 through August 15, 2021. The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA.</span></div><div style="padding-right:11.25pt;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, other legislative changes have been proposed and adopted since the Affordable Care Act was enacted. On August 2, 2011, the Budget Control Act of 2011 was signed into law, which, among other things, included reductions to Medicare payments to providers of 2% per fiscal year, which went into effect on April 1, 2013, and will stay in effect through 2030, with the exception of a temporary suspension from May 1, 2020 through March 31, 2021 unless additional Congressional action is taken. On January 2, 2013, the American Taxpayer Relief Act of 2012, was signed into law, which, among other things, further reduced Medicare payments to several providers, including hospitals. We cannot predict whether future healthcare initiatives will be implemented at the federal or state level or internationally, or the effect any future legislation or regulation will have on us. Such legislation and regulation of healthcare costs may, however, result in decreased lower reimbursements by governmental and private payors to our customers, which may adversely affect our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Data Privacy and Security</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical device companies may be subject to U.S. federal and state and foreign data privacy, security and data breach notification laws governing the collection, use, disclosure and protection of health-related and other personal information. In the U.S., numerous federal and state laws and regulations, including data breach notification laws, health information privacy and security laws and consumer protection laws and regulations govern the collection, use, disclosure, and protection of health-related and other personal information. In addition, certain foreign laws govern the privacy and security of personal data, including health-related data. For example, the General Data Protection Regulation ("GDPR") imposes strict requirements for processing the personal data of individuals within the EEA. Further, from January 1, 2021, companies have had to comply with the GDPR and also the UK GDPR, which, together with the amended UK Data Protection Act 2018, retains the GDPR in UK national law. The UK GDPR mirrors the fines under the GDPR, i.e., fines up to the greater of &#8364;20 million (&#163;17.5 million) or 4% of global turnover. Privacy and security laws, regulations, and other obligations are constantly evolving, may conflict with each other to complicate compliance efforts, and can result in investigations, proceedings, or actions that lead to significant civil and/or criminal penalties and restrictions on data processing.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EU, the GDPR went into effect in May 2018 and imposes stringent data protection requirements for controllers and processors of personal data of persons within the EEA. The GDPR applies to any company established in the EEA as well as to those outside the EEA if they collect and use personal data in connection with the offering of goods or services to individuals in the EEA or the monitoring of their behavior. Companies that must comply with the GDPR face increased compliance obligations and risk, including more robust regulatory enforcement of data protection requirements and potential fines for noncompliance of up to &#8364;20 million or 4% of the annual global revenues of the noncompliant company, whichever is greater. Data privacy laws in the EU and the EEA are developing rapidly and, in July 2020, the Court of Justice of the European Union ("CJEU") limited how organizations could lawfully transfer personal data from the EEA to the U.S. by invalidating the Privacy Shield for purposes of international transfers and imposing further restrictions on use of the standard contractual clauses ("SCCs"). While the CJEU upheld the adequacy of the SCCs, it made clear that reliance on them alone may not necessarily be sufficient in all circumstances. Use of the SCCs must now be assessed on a case-by-case basis taking into account the legal regime applicable in the destination country, in particular applicable surveillance laws and rights of individuals and additional measures and/or contractual provisions may need to be put in place, however, the nature of these additional measures is currently uncertain. The CJEU went on to state that if a competent supervisory authority believes that the SCCs cannot be complied with in the destination country and the required level of protection cannot be secured by other means, such supervisory authority is under an obligation to suspend or prohibit that transfer. The European Commission issued revised SCCs on June 4, 2021 to account for the decision of the CJEU and recommendations made by the European Data Protection Board. The revised SCCs must be used for relevant new data transfers from September 27, 2021; existing standard contractual clauses arrangements must be migrated to the revised clauses by December 27, 2022. There is some uncertainty around whether the revised clauses can be used for all types of data transfers, particularly whether they can be relied on for data transfers to non-EEA entities subject to the GDPR. The revised SCCs apply only to the transfer of personal data outside of the EEA and not the UK; the UK&#8217;s Information Commissioner&#8217;s Office launched a public consultation on its draft revised data transfers mechanisms in August 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 2021, companies have to comply with the GDPR and also the UK GDPR. The relationship between the UK and the EU in relation to certain aspects of data protection law remains uncertain, and it is unclear how UK data protection laws and regulations will develop in the medium to longer term. The European Commission has adopted an adequacy decision in favor of the UK, enabling data transfers from EU member states to the UK without additional safeguards. However, the UK adequacy decision will automatically expire in June 2025 unless the European Commission re-assesses and renews/extends that decision, and remains under review by the Commission during this period. In September 2021, the UK government launched a consultation on its proposals for wide-ranging reform of UK data protection laws following Brexit. There is a risk that any material changes which are made to the UK data protection regime could result in the European Commission reviewing the UK adequacy decision, and the UK losing its adequacy decision if the European Commission deems the UK to no longer provide adequate protection for personal data.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our industry is highly competitive.&#160;We believe our ability to effectively compete in this industry will be determined by our ability to provide a wide breadth of cost-effective, high quality products.&#160;We believe the added breadth of our acquired product portfolios have increased our competitiveness as we can now provide a one-stop shop for customers and offer more flexible competitive pricing.&#160;We also believe our acquired infusion pump product offering will enable us to pull through a larger volume of higher margin infusion consumables, and we believe we have a wider customer reach through our unified distribution channels.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Infusion Consumables</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our ability to effectively compete in the Infusion Consumables market depends upon our ability to differentiate our products based on continued innovation, safety, quality, convenience, reliability, patent protection, ease of use and the pricing of our products, in addition to access to distribution channels.&#160;We encounter significant competition in this market both from global, large, established medical device manufacturers and from smaller companies. We compete with products and systems marketed by Becton Dickinson ("BD"), Baxter International ("Baxter"), and B. Braun Medical, Inc. ("B. Braun").&#160;Our CSTD used for the preparation and safe handling of oncology drugs, compete with similar products from BD, and EquaShield. We believe that our current CSTD product offering provides benefits over these competing systems in several areas related to safety, ease of use, quality, and cost; however, ongoing innovation in this market space will be required.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Infusion Systems</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face strong global competitors in the Infusion Systems market. In the United States ("U.S.") our competitors include BD, Baxter, and to a lesser extent B. Braun. Outside of the U.S., our primary competitors are BD, B. Braun, Fresenius Kabi, a division of Fresenius Group and a large number of local market pump manufacturers.&#160;These competitors benefit from greater financial, research and development and marketing resources than we have. The smart pump market in recent years has been troubled with security concerns and product recalls. We believe our ability to effectively compete in this market segment will be determined by our ability to build our brand strength using the development of technological advancements aimed at increasing the quality, reliability,  safety and security of our pumps while at the same time focusing on manufacturing efficiency and cost-effectiveness, which are operationally challenging with evolving product lines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IV Solutions</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in the IV solutions market only in the U.S. and Canada. Our primary competitors in the U.S. include Baxter and B. Braun.&#160;Demand for IV solutions is typically high and raw materials required to produce IV solutions are readily available.&#160;Our ability to compete will depend on our ability to maximize production, develop innovations in our product line, focus on cost-effectiveness and our ability to maintain the appropriate quality infrastructure.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Care</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary competitor in Critical Care is Edwards Lifesciences.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patents</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have U.S. and/or certain foreign patents and/or pending patent applications relating to the technologies found in the Clave / MicroClave connector, MicroClave Clear connector, Neutron connector, Tego connector, ChemoClave system, ChemoLock connector, SwabCap disinfecting cap, Diana hazardous drug compounding system, ClearGuard antimicrobial barrier cap, Cogent hemodynamic monitoring system, and other products. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the acquisition of HIS, we acquired rights, title and interest to a substantial number of patents and patent applications and related provisionals, divisionals, continuations, continuations-in-part, reissues, reexaminations, extensions, and substitutions of any of the foregoing (&#8220;Patent Rights&#8221;), that were primarily used or held for use by Pfizer in the HIS business.  There is however, no single patent or group of patents that we acquired that we believe is material in relation to our business as a whole. Since the acquisition, we have filed additional patent applications on technologies relating to infusion pumps, software for operating infusion pumps, and software for communicating information to and from infusion pumps.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success may depend in part on our ability to obtain patent protection for our products and to operate without infringing the proprietary rights of third parties.&#160;While we have obtained certain patents and applied for additional U.S. and foreign patents covering certain of our products, there is no assurance that any additional patents will be issued, that the scope of any patent protection will prevent competitors from introducing similar devices or that any of our patents will be held valid if subsequently challenged.&#160;Our patents are important in preventing others from introducing competing products that are as effective as our products.&#160;The loss of patent protection on the Clave / MicroClave connector, Neutron connector, Tego connector, Swabcap disinfecting cap, Clearguard antimicrobial barrier cap, ChemoClave system, and ChemoLock connector could adversely affect our ability to exclude other manufacturers from producing effective competitive products and could have an adverse impact on our financial results. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fact that a patent is issued to us does not eliminate the possibility that patents owned by others may contain claims that are infringed by our products.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been substantial litigation regarding patent and other intellectual property rights in the medical device industry.&#160;Litigation, which would result in substantial cost to us and in diversion of our resources, may be necessary to defend us against claimed infringement of the rights of others and to determine the scope and validity of the proprietary rights of others.&#160;Adverse determinations in such litigation could subject us to significant liabilities to third parties or could require us to seek licenses from third parties and could prevent us from manufacturing, selling or using our products, any of which could have a material adverse effect on our business.&#160;In addition, we have initiated litigation, and may continue to initiate litigation in the future, to enforce our intellectual property rights against those we believe to be infringing on our patents.&#160; Such litigation could result in substantial cost and diversion of resources.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality/Quarterly Results</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no significant seasonal aspects to our business.&#160;We can experience fluctuations in net sales as a result of variations in the ordering patterns of our largest customers, which may be driven more by COVID-19 pandemic surges and its impact on hospital admissions and procedure volumes along with production scheduling and customer inventory levels, and less by seasonality.&#160;Our expenses often do not fluctuate in the same manner as net sales, which may cause fluctuations in operating income that are disproportionate to fluctuations in our revenue.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development costs include personnel costs and expenses related to the development of new products.  Research and development costs were $47.5 million in 2021, $42.9 million in 2020 and $48.6 million in 2019.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital Management</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our employees are the foundation of our business and are key to executing our strategy globally. The knowledge, skills and abilities of our diverse workforce is paramount in upholding our mission of connecting patients and caregivers through safe, life-saving, life enhancing IV therapy products, systems, and services. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the health and well-being of our employees are cornerstones for our successful operations. Whether you are a machine operator in one of our four manufacturing locations, a material handler in a distribution center, a service technician supporting our products in the field, or a clinician training the use of our products in a hospital, we strive to prioritize the safety of our team members. This includes designing our work environments with a safety first mindset, providing personal protective equipment and safety training beginning day one.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to attract and retain talented individuals globally begins with our commitment to offer a career that gives people a unique opportunity to work in an exhilarating, fast-paced, inspiring, and collaborative environment where what they do makes a difference. We offer competitive salaries and participation to all employees in incentive plans based on individual and company performance.  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the development of our workforce is critical for personal growth and the success of our company as well. We reinforce this with challenging, yet rewarding assignments, continued learning and training programs through our global iLearning platform, and support continued education globally through tuition reimbursement programs. Our team believes in diversity, collaboration, and removing barriers to communication&#8212;all to create an environment where innovation and creativity can flourish. This is principal for us in attracting, developing, retaining and rewarding talent on a global scale.  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, our leadership team, with its broad, and deep category knowledge and averaging approximately 17 years of experience in IV therapy has the necessary experience to effectively lead the execution of our strategy. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, we had approximately 8,500 employees located in over 20 countries. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Geographic Data</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding financial data by geography is set forth in Part II, Item 8. "Financial Statements and Supplementary Data" of this Annual Report on Form 10-K in Notes 4 and 13 to the Consolidated Financial Statements, and is incorporated herein by reference.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Pandemic</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the World Health Organization characterized a novel strain of coronavirus ("COVID-19") as a global pandemic. The COVID-19 pandemic continues to have widespread and unpredictable impact on global economies, financial markets, and business practices, and continues to impact our business operations, including our employees, customers and suppliers. See &#8220;Part II. Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; for discussion regarding the impact of the COVID-19 pandemic on our financial results. Also, see &#8220;Part I. Item 1A. Risk Factors&#8221; for discussion of the risks and uncertainties associated with the COVID-19 pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our website address is http://www.icumed.com.&#160;We make available our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and amendments to those reports free of charge on our website as soon as reasonably practicable after filing them with the Securities and Exchange Commission ("SEC").&#160;We also have our code of ethics posted on our website (http://www.icumed.com).&#160;The information on our website is not incorporated into this Annual Report.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC on its website (http://www.sec.gov).</span></div><div><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_16"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In evaluating an investment in our common stock, investors should consider carefully, among other things, the following risk factors, as well as the other information contained in this Annual Report and our other reports and registration statements filed with the SEC. Any of the following risks, as well as additional risks and uncertainties not currently known to us or that we currently deem immaterial, could materially and adversely affect our results of operations or financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Factors Summary</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to a number of risks and uncertainties, detail below. These risks include, among others, the following:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not realize the anticipated benefits of the Smiths Medical Transaction, which could adversely impact our business and our operating results.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The COVID-19 pandemic has had a material impact on the global economy and has disrupted our operations and could continue to have an adverse impact on our employees, suppliers and customers, which could adversely and materially impact our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We operate in a highly competitive industry, our ability to compete effectively to maintain or gain market share depends upon numerous factors, such as product innovation, the quality, convenience and reliability of our products, access to distribution channels and patent protection and pricing. We can give no assurance that we will be successful in implementing any of our competitive strategies.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are dependent on certain key suppliers; any supply interruptions could materially harm our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Damage to our manufacturing facilities or any other supply chain restrictions could materially impact our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in or failure to comply with certain federal, state, foreign, legal and health regulations may harm our business and financial condition.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We depend on the leadership of our executive management team and other key personnel; the loss of one or more of our key employees could disrupt our business.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our stock price may be volatile and you may be unable to sell your shares at or above your purchase price.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to our Strategic Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We may not realize the anticipated benefits of the Smiths Medical Transaction, which could adversely impact our business and our operating results.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Smiths Medical acquisition that closed on January 6, 2022 was a significant transaction for us and the Smiths Medical business significantly expands our global presence. The success of our business will depend, in part, on our ability to realize our anticipated benefits, opportunities and synergies from combining the businesses of our company and the Smiths Medical business. We can provide no assurance that the anticipated benefits of the Smiths Medical transaction will be fully realized in the time frame anticipated or at all. Integrating the operations of the Smiths Medical business with that of our own is a complex, costly and time-consuming process and the nature of a carve out acquisition makes it inherently more difficult to assume operations on closing day as well as to integrate activities, as certain systems, processes and people may not all have transferred with the acquired business to support such activities. The integration process may disrupt the businesses and, if implemented ineffectively, would restrict the realization of the full expected benefits. The failure to meet the challenges involved in integrating the two businesses could cause an interruption of, or a loss of momentum in, the activities of the combined businesses and could adversely affect the results of operations of the combined businesses. Potential difficulties that may be encountered in the integration process include the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">challenges in preserving important strategic customer and other third-party relationships of both businesses;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the diversion of management&#8217;s attention to integration matters;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">challenges in maintaining employee morale and retaining or attracting key employees;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential incompatibility of corporate cultures;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs, delays and other difficulties consolidating corporate and administrative infrastructures and information systems and implementing common systems and procedures including, in particular, our internal controls over financial reporting; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">coordinating and integrating a geographically dispersed organization, including operations in jurisdictions we did not operate in prior to the Smiths Medical transaction.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any one or all of these factors may increase operating costs or lower anticipated financial performance. Achieving the anticipated benefits and the potential benefits underlying our reasons for the Smiths Medical business acquisition will depend on successful integration of the businesses. Because of the significance of the Smiths Medical business acquisition to us, our failure to successfully integrate the Smiths Medical business with that of our own could have a material adverse impact on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Smiths Medical business acquisition has resulted in organizational change and significant growth to our business. If we fail to effectively manage this growth and change to our business in a manner that preserves our reputation with customers and the key aspects of our corporate culture, our business, financial condition and results of operations could be harmed.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Smiths Medical business has resulted in significant growth in our personnel and operations. We will continue to incur significant expenditures and the allocation of management time to assimilate the Smiths Medical business employees in a manner that preserves the key aspects of our corporate culture, including a focus on strong customer satisfaction, but there can be no assurance that we will be successful in our efforts. If we do not effectively integrate, train and manage our combined employee base and maintain strong customer relationships, our corporate culture could be undermined, the quality of our products and customer service could suffer, and our reputation could be harmed, each of which could adversely impact our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The actual impact of the Smiths Medical acquisition on our financial results may be worse than the assumptions we have used.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made certain assumptions relating to the impact on our financial results of the Smiths Medical acquisition. These assumptions relate to numerous matters, including the acquisition costs, transaction and integration costs, and other financial and strategic risks of the acquisition. If one or more of these assumptions are incorrect, it could have an adverse effect on our business and operating results, and the perceived benefits from the acquisition may not be realized.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If we are unable to effectively manage our internal growth or growth through acquisitions of companies, assets or products, our financial performance may be adversely affected.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to continue to expand our marketing and distribution capability, which may include external expansion through acquisitions both in the U.S. and foreign markets. We may also consider expanding our product offerings through acquisitions of companies or product lines. We can provide no assurance that we will be able to identify, acquire, develop or profitably manage additional companies or operations or successfully integrate such companies or operations into our existing operations without substantial costs, delays or other problems. We recently acquired the Smiths Medical business, which </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes syringe and ambulatory infusion devices, vascular access, and vital care products, but we have significant integration efforts to achieve the anticipated benefits. See &#8220;We may not realize the anticipated benefits of the Smiths Medical Transaction, which could adversely impact our business and our operating results.&#8221;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have additional production facilities outside the U.S. to reduce labor costs. The expansion of our marketing, distribution and product offerings both internally and through acquisitions or by contract may place substantial burdens on our management resources and financial controls. Decentralization of assembly and manufacturing could place further burdens on management to manage those operations and maintain efficiencies and quality control.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increasing burdens on our management resources and financial controls resulting from internal growth and acquisitions could adversely affect our operating results. In addition, acquisitions may involve a number of special risks in addition to the difficulty of integrating cultures and operations and the diversion of management&#8217;s attention, including adverse short-term effects on our reported operating results, dependence on retention, hiring and training of key personnel, risks associated with unanticipated problems or legal liabilities and amortization of acquired intangible assets, some or all of which could materially and adversely affect our operations and financial performance.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">As a result of the Smiths Medical acquisition, we have used a significant portion of our cash on hand and incurred a substantial amount of debt to finance the cash consideration portion and certain other amounts paid in connection with the Smiths Medical transaction, which could adversely affect our business, including by restricting our ability to engage in additional transactions or incur additional indebtedness.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the financing of the Smiths Medical acquisition transaction, we have significantly less cash, cash equivalents and investment securities on hand than the approximately $571.9 million of cash, cash equivalents and investment securities we had as of December 31, 2021. Although our management believes that we continue to have sufficient access to cash to meet our business objectives and capital needs, we do have a decreased availability of cash, cash equivalents and investment securities and we expect to have such decreased availability of cash for a period of time following the consummation of the Smiths Medical transaction which could constrain our ability to grow our business. In connection with the Smiths Medical transaction and the payment of the cash consideration, we entered into Senior Secured Credit Facilities (the "Senior Secured Credit Facilities") of $2.2 billion consisting of a term loan A facility of $850.0 million, a term loan B facility of $850.0 million and a revolving credit facility of $500.0 million. As a result of the credit facilities, we incurred additional borrowing costs. Our more leveraged financial position following the Smiths Medical transaction could make us vulnerable to general economic downturns and industry conditions, and place us at a competitive disadvantage relative to our competitors. In the event that we do not have adequate capital to maintain or develop our business, additional capital may not be available to us on a timely basis, on favorable terms, or at all. Moreover, our senior secured credit facilities have certain restrictions that may limit how we operate our business, including limiting our ability to engage in certain transactions and to incur additional indebtedness, and our business may be materially and adversely affected if these restrictions prevent us from implementing our business plan.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We have and may continue to acquire businesses, form strategic alliances or make investments in businesses or technologies that could adversely impact our business and our operating results and such transactions could result in unforeseen operating difficulties, expenditures and require significant management resources, charges or write-downs.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have and may continue to seek to supplement our internal growth through acquisitions of complementary businesses, technologies, services, or products, as well as investments and strategic alliances. We compete for those opportunities with others including our competitors, some of which have greater financial or operational resources than we do. We may not be able to identify suitable acquisition candidates or strategic partners, we may have inadequate access to information or insufficient time to complete due diligence, and we may not be able to complete such transactions on favorable terms, if at all. Such transactions are inherently risky, and the integration of any newly-acquired business requires significant effort and management attention that otherwise would be available for ongoing development of our other businesses.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of any acquisition, investment or alliance may be affected by a number of factors, including our ability to properly assess and value the potential business opportunity or to successfully integrate any business we may acquire into our existing business. Integration of an acquired business also may disrupt our ongoing operations and require management resources that we would otherwise focus on developing our existing business. For example, we acquired the HIS business in February 2017, which includes IV pumps, solutions, and devices in order to create a leading pure-play infusion therapy company and we acquired Smiths Medical in January 2022, which includes syringe and ambulatory infusion devices, vascular access, and vital care products. We invested significant time and resources into the HIS integration in order to achieve the anticipated benefits of the transaction and we intend to do the same with the Smiths Medical integration.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any acquisition could result in the incurrence of debt, contingent liabilities or future write-offs of intangible assets or goodwill, any of which could have a material adverse effect on our financial condition, results of operations </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and cash flows. We may also experience losses related to investments in other companies, which could have an adverse effect on our results of operations and financial condition. As such, there can be no assurance that any past or future transactions will be successful.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Business and Operating Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are dependent on single and limited source third-party suppliers, which subjects our business and results of operations to risks of supplier business interruptions, and a loss or degradation in performance in our suppliers could have an adverse effect on our business and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have risk mitigation plans in place with key suppliers, we have materials (such as resins) that are critical to our ability to manufacture our products, the supply of which is currently from a sole supplier. We cannot be certain that our current suppliers will continue to provide us with the quantities of materials that we require or satisfy our anticipated specifications and quality requirements on a timely basis or at all. Any supply interruption in limited or sole sourced raw materials could materially harm our ability to manufacture our products until a new source of supply, if any, could be identified and qualified. Although we believe there are other suppliers of these raw materials, we may be unable to find a sufficient alternative supply channel in a reasonable time or on commercially reasonable terms. The price and supply of these materials may be impacted or disrupted for reasons beyond our control including supplier shutdowns, transportation delays, inflationary pricing pressures, work stoppages, labor shortages and governmental regulatory actions. We have experienced, and may continue to experience, significant challenges to our global transportation channels and other aspects of the global supply chain network, including to the cost and availability of raw materials and components due to shortages and resulting cost inflation.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the COVID-19 pandemic continues to impact supply channels resulting in raw material shortages and supply chain disruptions generally. Furthermore, our contract manufacturers could require us to move to another one of their production facilities. An interruption in our commercial operations could occur if we encounter delays or difficulties in securing these components, materials or services and if we cannot then obtain an acceptable substitute. Additionally, we are subject to FDA and foreign regulations, which could further delay our ability to obtain a qualified alternative supplier. Any performance failure on the part of our suppliers could delay the development and manufacture of our products, which could have a material adverse effect on our business. Due to the highly competitive nature of the healthcare industry and the cost controls of our customers and third party payors, we may be unable to pass along cost increases for any key components or raw materials increases through higher prices to our customers. If the cost of key components or raw materials increases and we are unable to fully recover those increased costs through price increases or offset these increases through other cost reductions, we could experience an adverse effect on our financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Damage to any of our manufacturing facilities or disruption to our supply chain network could impair our ability to produce our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                A severe weather event, other natural or man-made disaster, or any other significant disruption, such as outbreak of disease (including the COVID-19 pandemic), work stoppages, labor shortages and similar interruptions affecting our manufacturing facilities or our suppliers and logistics partners could materially and adversely impact our business, financial condition and results of operations. The COVID-19 pandemic has caused us to temporarily shut down some of our facilities, to date these shut downs have not had a material impact on our business. Additionally, in 2021, we have experienced supply chain disruptions and general supply constraints as a result of the continued economic uncertainty and in part due to COVID-19 infections and quarantine protocols.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a single manufacturing facility for our Clave products located in Salt Lake City, Utah. Our Salt Lake City facility also produces other components on which our manufacturing operations in Mexico and Costa Rica rely. Our IV Solutions are manufactured at our manufacturing facility in Austin, Texas and by a third party manufacturer, Pfizer, in Rocky Mount, North Carolina or our suppliers&#8217; facilities. If our facilities are inoperable, for even a short period of time, it could adversely affect our ability to manufacture and distribute our products in a timely or cost-effective manner, and our ability to make product sales. Furthermore, our facilities and the equipment we use to perform our manufacturing processes could be unavailable or costly and time-consuming to repair or replace.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Damage to any of our facilities, work stoppages or labor shortages could render us unable to manufacture our products or require us to reduce the output of products at our facilities. Two of our manufacturing facilities are located near known earthquake fault zones and are vulnerable to damage from earthquakes. We carry insurance for damage to our property and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disruption of our business, but this insurance may not cover all of the risks associated with damage or disruption to our facilities and business, may not provide coverage in amounts sufficient to cover our potential losses and may not continue to be available to us on acceptable terms, if at all. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prolonged periods of inflation could have a material adverse effect on our results of operations.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also experienced a significant increase in material component inflation in 2021, as well as inflation in other costs, such as freight and labor prices. Continued supply chain disruptions and delays, as well as continued heightened inflation, could lead to continued inefficiencies and heightened costs that could negatively impact our performance and our results of operations. Additionally the majority of our sales are conducted pursuant to long-term contracts. Although we have attempted to minimize the effect of inflation on our business through contractual protections, the presence of longer pricing periods within our contracts along with sustained or higher than anticipated inflation increases the likelihood that the contract protections do not adequately mitigate the financial impact of inflation. If our contractual protections do not adequately protect us in the context of substantial cost increases and inflationary pressures, it could have a material adverse effect on our results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The COVID-19 pandemic has disrupted how we, our suppliers and our customers operate and the duration and extent to which this will impact our business, future results of operations, liquidity and overall financial performance remains uncertain.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The COVID-19 pandemic has created significant volatility, uncertainty, and economic disruption. We operate globally and the COVID-19 pandemic and its adverse effects have impacted most of the locations where we, our customers and our suppliers conduct business and, as a result, we have experienced some disruption to our operations, most notably due to reduced demand for our disposable product portfolio.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Many hospitals are limiting access to their facilities to essential personnel and prioritizing their time and attention to COVID patients, which may negatively affect demand for our products by limiting the ability of our sales personnel to negotiate new and maintain existing contracts with customers. We have also experienced significant reductions in demand for certain products as our health care customers re-prioritize the treatment of patients, delay elective procedures and shift resources and operations to fight COVID-19 and the complications it causes. For example, during 2020, we have experienced lower demand from hospital customers for our Infusion Consumables non-dedicated sets and lower demand for our Infusion Systems dedicated sets. Additionally, the COVID-19 pandemic could potentially adversely affect our distributors if they are not able to maintain their historical levels of sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our manufacturing, distribution and pump service facilities are operating under our business continuity plan due to the need for our critical healthcare products; however, we have taken certain precautionary measures including the following to maximize the safety of our employees and to mitigate disruption to our operations:</span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">implemented physical distancing measures;</span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enhanced hygiene protocols and increased frequency of cleaning procedures;</span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquired additional personal protective equipment;</span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developed contingency plans and protocols to assess employee illness;</span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">helped employees with childcare issues due to school and daycare closures;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">initiated a visitor pre-entry questionnaire to limit potential exposure in our facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;While we anticipate that the foregoing measures are temporary, we cannot predict the specific duration for which these precautionary measures will stay in effect, and we may elect to take additional measures as the information available to us continues to develop. These actions, and any future actions we may take in response to the COVID-19 pandemic, could negatively impact our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The duration and extent of the impact on our business from the COVID-19 pandemic depends on future developments that cannot be fully predicted at this time, as such, the impact of the COVID-19 pandemic on our future results of operations and overall financial performance remain uncertain and cannot as yet be quantified. Additional factors that have contributed or may contribute to the adverse impact of the COVID-19 pandemic on our business, results of operations, financial condition and liquidity include, without limitation, the following:</span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lost revenue or additional costs associated with either disruptions at our production and distribution facilities or interruptions in our supply chain, including shortages of raw materials or components for our product;</span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">labor shortages as a result of COVID-19 infections and quarantine protocols;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fluctuations in demand from customers as a result of an increase in COVID-19 patient admissions in hospitals offset by the decline in non-COVID-19 patient admissions;</span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">healthcare customers that defer the more profitable elective procedures may experience financial difficulties and may be unable to pay within payment terms for the products they purchased;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential lower demand in future periods due to over-purchasing of our products due to the COVID-19 pandemic and supply chain disruption;</span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduced revenue due to delays in implementation of our infusion systems and oncology products at hospital locations due to restricted access;</span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher operating costs related to additional compensation paid to our manufacturing and distribution facility workers;</span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">volatility in cash flow, revenue and income due to foreign currency fluctuations and volatility;</span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lower income due to a delay in cost savings projects as a result of the travel and social distancing requirements of COVID-19.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent the COVID-19 pandemic and related containment measures continue to adversely affect regional, national and global economic conditions and financial markets, as well as the business, results of operations, financial conditions and liquidity of us, our suppliers and our customers, it may also have the effect of heightening many of the risks described in this "Risk Factors" section and elsewhere in this Annual Report on Form 10-K for the year ended December 31, 2021, including the risks resulting from our dependency on key personnel; impairment of our supply chain or manufacturing facilities; and the impact of negative economic conditions. In addition, in light of the COVID-19 pandemic and the measures taken to limit its spread, our historical information regarding our business, results of operations, financial condition or liquidity may not be representative of the future results of operations, financial condition, liquidity or other financial or operating results of us or our business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We may be unable to realize any benefit from our cost reduction and restructuring efforts and our profitability may be hurt or our business otherwise might be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have engaged in restructuring activities in the past and may engage in other restructuring activities in the future. These types of cost reduction and restructuring activities are complex. If we do not successfully manage our current restructuring activities, or any other restructuring activities that we may take in the future, any expected efficiencies and benefits might be delayed or not realized, and our operations and business could be disrupted. In addition, the costs associated with implementing restructuring activities might exceed expectations, which could result in additional future charges.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are subject to risks associated with debt financing. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit agreements governing our Credit Facility and Senior Secured Credit Facilities contain, among other things, certain customary restrictive covenants that limit our ability to incur additional indebtedness and liens, merge with other companies or consummate certain changes of control, acquire other companies, make certain investments, pay dividends, enter into certain transactions with affiliates, and transfer or dispose of assets as well as financial covenants. While we have not previously breached and are not currently in breach of these or any other covenants contained in our credit agreements, there can be no guarantee that we will not breach these covenants in the future. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, our ability to comply with these covenants may be affected by events beyond our control, including the COVID-19 pandemic, supply chain interruptions or general economic environment, including increases in inflation and interest rates. These covenants could also limit our ability to seek capital through the incurrence of new indebtedness or, if we are unable to meet our obligations, require us to repay any outstanding amounts with sources of capital we may otherwise use to fund our business. As such, these restrictive covenants contained in our Credit Facility and our Senior Secured Credit Facilities may restrict our ability to pursue our business strategies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market and Other External Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If we are unable to compete successfully with our competitors, we may be unable to maintain market share, in which case our sales may not grow and our profitability may be adversely affected.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consumable medical device segment of the health care industry and in particular the infusion products market is intensely competitive and is experiencing both horizontal and vertical consolidation. We believe that our ability to compete depends upon numerous factors including, among other things, continued product innovation, the quality, convenience and reliability of our products, access to distribution channels, patent protection and pricing. The ability to compete effectively depends on our ability to differentiate our products based on these factors, as well as our ability to perceive and respond to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">changing customer needs. We encounter significant competition in our markets both from large established medical device manufacturers and from smaller companies. Many of these companies have introduced competitive products with features not provided by the conventional products and methods they are intended to replace. Most of our current and prospective competitors have economic and other resources substantially greater than ours and are well established in the healthcare industry. Several large, established competitors offer broad product lines and have been successful in obtaining full-line contracts with a significant number of hospitals and group purchasing organizations to supply all of their infusion product requirements. Due to the highly competitive nature of the group purchasing organizations ("GPOs") or integrated delivery networks ("IDNs") contracting processes, we may not be able to obtain or maintain contract positions with major GPOs and IDNs across our products portfolio. Furthermore, the increasing leverage of organized buying groups may reduce market prices for our products thereby affecting our profitability. While having a contract with a GPO or IDN can facilitate sales to members of that GPO or IDN, it is no assurance that the sales volume of those products will be maintained. The members of such groups may choose to purchase from our competitors due to the price or quality offered by such competitors, which could result in a decline in our sales and profitability. In addition, distributors of our products may begin to negotiate terms of sale more aggressively in an effort to increase their profitability. Failure to negotiate distribution arrangements having advantageous pricing or other terms of sale could adversely affect our results of operations and financial condition. In addition, if we fail to implement distribution arrangements successfully, it could cause us to lose market share to our competitors. Moreover, there is no assurance that our competitors will not substantially increase resources devoted to the development, manufacture and marketing of products competitive with our products. The successful implementation of such a strategy by one or more of our competitors could materially and adversely affect us.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If we do not successfully develop and commercialize enhanced or new products that remain competitive with new products or alternative technologies developed by others, we could lose revenue opportunities and customers, and our ability to grow our business would be impaired.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical device industry is characterized by rapid product development and technological advances, which places our products at risk of obsolescence. Our long-term success and profit margins depend upon the development and successful commercialization of new products, new or improved technologies and additional applications of our technology. The research and development process is time-consuming and costly, and may not result in products or applications that we can successfully commercialize.&#160; We can give no assurance that any such new products will be successful or that they will be accepted in the marketplace.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product development requires substantial investment that may be difficult for us to fund and may be challenging to</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">recover through commercial product sales.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Innovations generally require a substantial investment in product development before we can determine their commercial viability, and we may not have the financial resources necessary to fund these innovations. Even if we succeed in creating new product candidates from these innovations, those innovations still may fail to result in commercially successful products. The success of new product offerings for device products depends on several factors, including our ability to anticipate and meet customers' or patients' needs, obtain timely regulatory approvals, clearances or certifications, and manufacture quality products in an economic and timely manner. Even if we are able to develop successful new products or enhancements, we may not produce sales exceeding the costs of development, and we may not avoid infringing the proprietary rights of third parties. Moreover, innovations may not be successful due to difficulties encountered in achieving positive clinical outcomes, meeting safety, efficacy or other regulatory requirements of government agencies or notified bodies, or obtaining favorable pricing on those products. Finally, innovations may not be accepted quickly in the marketplace because of, among other things, entrenched patterns of clinical practice and uncertainty over third-party reimbursement.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If demand for our products were to decline significantly, we might not be able to recover the cost of our expensive automated molding and assembly equipment and tooling, which could have an adverse effect on our results of operations.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our production tooling is relatively expensive, with each "module," which consists of an automated assembly machine and the molds and molding machines that mold the components, costing several million dollars. Most of the modules are for the Clave product family. If the demand for these products changes significantly, which could happen with the loss of a customer or a change in product mix, it may be necessary for us to recognize an impairment charge for the value of the production tooling because its cost may not be recovered through production of saleable product, which could adversely affect our financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been and will be ordering production molds and equipment for our new products.&#160;We expect to order semi-automated or fully automated assembly machines for other new Infusion Consumables products in 2021.&#160;We also are adding additional IV Solutions capacity as we transition certain product lines to our Austin manufacturing facility from Rocky Mount.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not achieve significant sales of these new/transitioned products, it might be necessary for us to recognize an impairment charge for the value of the production tooling because its costs may not be recovered through production of saleable product, which could adversely affect our financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Continuing pressures to reduce healthcare costs and inadequate coverage and reimbursement may adversely affect our prices. If we cannot reduce manufacturing costs of existing and new products, our sales may not grow and our profitability may decline.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Increasing awareness of healthcare costs, public interest in healthcare reform and continuing pressure from Medicare, Medicaid, GPOs and other payors, both domestic and international, to reduce costs in the healthcare industry, as well as increasing competition from other protective products, could make it more difficult for us to sell our products at current prices. Our products are purchased by hospitals, physicians and other healthcare providers that typically bill various third-party payors, such as governmental programs, private insurance plans and managed care plans, for the healthcare services and products provided to their patients. The ability of our customers to obtain appropriate coverage and reimbursement for healthcare services and products from third-party payors is critical because it affects which products customers purchase and the prices they are willing to pay. Because there is often no separate reimbursement for supplies used in surgical procedures, the additional cost associated with the use of our products can affect the profit margin of the hospital or surgery center where the procedure is performed. Some of our target customers may be unwilling to adopt our products in light of the additional associated cost. Further, any decline in the amount payors are willing to reimburse our customers could make it difficult for existing customers to continue using or to adopt our products and could create additional pricing pressure for us. If we are forced to lower the price we charge for our products, our gross margins will decrease, which could have a material adverse effect on our business, financial condition and results of operations and impair our ability to grow our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Third-party payors are developing increasingly sophisticated methods of controlling healthcare costs. In addition, no uniform policy of coverage and reimbursement for procedures using our products exists among third-party payors. Therefore, coverage and reimbursement for procedures using our products can differ significantly from payor to payor. Payors continually review new and existing technologies for possible coverage and can, without notice, deny or reverse coverage for new or existing products and procedures. There can be no assurance that third-party payor policies will provide coverage for procedures in which our products are used. If we are not successful in reversing existing non-coverage policies, or if third-party payors that currently cover or reimburse our products and related procedures reverse or limit their coverage in the future, or if other third-party payors issue similar policies, this could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Further, we believe that future coverage and reimbursement may be subject to increased restrictions, such as</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">additional prior authorization requirements. Third-party coverage and reimbursement for procedures using our products or any of our products in development for which we may receive regulatory approval or certification may not be available or adequate, which could have an adverse effect on our business, financial condition and results of operations and impair our ability to grow our business.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Implementation of further legislative or administrative reforms in the reimbursement system in the U.S. and abroad or adverse decisions relating to coverage or reimbursement could have an impact on acceptance of and demand for our products and the prices that our customers are willing to pay for them. In the event that the market will not accept current prices for our products, our sales and profits could be adversely affected. We believe that our ability to increase our market share and operate profitably in the long term may depend in part on our ability to reduce manufacturing costs on a per unit basis through high volume production using highly automated molding and assembly systems. If we are unable to reduce unit manufacturing costs, we may be unable to increase our market share for our products or may lose market share to alternative products, including competitors&#8217; products. Similarly, if we cannot reduce unit manufacturing costs of new products as production volumes increase, we may not be able to sell new products profitably or gain any meaningful market share. Any of these results would adversely affect our future results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Failure to protect our information systems against security breaches, service interruptions, or misappropriation of data could disrupt operations, compromise sensitive data, and expose us to liability, possibly causing our business and reputation to suffer.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend heavily on information technology infrastructure and systems to achieve our business objectives. Any incident that impairs or compromises this infrastructure, including security breaches, malicious attacks or more general service interruptions, could impede our ability to process orders, manufacture and ship product in a timely manner, protect sensitive data and otherwise carry on business in the normal course. Any such events could result in the loss of customers, revenue, or both, and could require us to incur significant expense to remediate, including legal claims or proceedings. Further, as cyber </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">security related incidents continue to evolve, and regulatory focus on these issues continues to expand, additional investment in protective measures, and vulnerability remediation, may be required.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to execute our business strategy depends, in part, on the continued and uninterrupted performance of our information technology systems, which support our operations. Despite the implementation of security measures, our internal computer systems, and  those of third parties on which we rely, are vulnerable to damage from, among others, computer viruses, malware, natural disasters, terrorism, war, telecommunication and electrical failures, cyber-attacks or cyber-intrusions over the Internet, attachments to emails, persons inside our organization, or persons with access to systems inside our organization or similar disruptive problems. The risk of a security breach or disruption, particularly through cyber-attacks or cyber intrusion, including by computer hackers, foreign governments, and cyber terrorists, has generally increased as the number, intensity and sophistication of attempted attacks and intrusions from around the world have increased. Because the techniques used to obtain unauthorized access, disable or degrade service, or sabotage systems change frequently and often are not foreseeable or recognized until launched against a target, we may be unable to anticipate these techniques or to implement adequate preventative measures. If an actual or perceived breach of our security occurs, public perception of the effectiveness of our security measures and brand could be harmed and our results of operations could be negatively affected. Data security breaches and other incidents may also result from non-technical means (e.g., actions by employees or contractors).  Any such security breach may compromise information stored on our networks and may result in significant data losses or theft of personally identifiable information. Any compromise of our security could result in a violation of applicable security, privacy or data protection, consumer and other laws, regulatory or other governmental investigations, enforcement actions, and legal and financial exposure, including potential contractual liability. A number of proposed and enacted federal, state and international laws and regulations obligate companies to notify individuals of security breaches involving particular personally identifiable information, which could result from breaches experienced by us or by third parties, including collaborators, vendors, contractors or other organizations with which we expect to form strategic relationships. Any such compromise could also result in damage to our reputation and a loss of confidence in our security and privacy or data protection measures. In addition, a cybersecurity attack could result in other negative consequences, including disruption of our internal operations, increased cyber security protection costs, lost revenue, regulatory actions or litigations. Any of these effects could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in and failures to comply with foreign, federal, and state data privacy and security laws, regulations and standards may adversely affect our business, operations and financial performance. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are subject to various federal, state and foreign laws that govern the collection, use, disclosure, retention and security of personal information, including patient health information. The global data protection landscape is rapidly evolving, and implementation standards and enforcement practices are likely to remain uncertain for the foreseeable future. This evolution may create uncertainty in our business, affect our or our collaborators', service providers' and contractors' ability to operate in certain jurisdictions or to collect, store, transfer, use and share personal information, necessitate the acceptance of more onerous obligations in our contracts, result in liability or impose additional costs on us. In the U.S., numerous federal and state laws and regulations could apply to our operations or the operations of our partners, including state data breach notification laws, federal and state health information privacy laws, and federal and state consumer protection laws and regulations (e.g. Section 5 of the Federal Trade Commission Act (the "FTC Act")). For example, the privacy, security and breach notification rules promulgated under the Health Insurance Portability and Accountability Act of 1996 ("HIPAA"), as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, establish a set of national privacy and security standards for the protection of protected health information ("PHI") by health plans, health care clearinghouses and certain health care providers, called covered entities, and the business associates with whom such covered entities contract for services that involve creating, receiving, maintaining or transmitting PHI, as well as their covered subcontractors. HIPAA also requires covered entities to provide individuals with certain rights with respect to their PHI, and requires covered entities to enter into a written business associate contract or other arrangement with the business associate that establishes specifically what the business associate has been engaged to do and requires the business associate to comply with the requirements of HIPAA.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HIPAA requires the notification of patients, and other compliance actions, in the event of a breach of unsecured PHI. If notification to patients of a breach is required, such notification must be provided without unreasonable delay and in no event later than 60 calendar days after discovery of the breach. In addition, if the PHI of 500 or more individuals is improperly used or disclosed, we would be required to report the improper use or disclosure to the U.S. Department of Health and Human Services ("HHS") which would post the violation on its website, and to the media. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Penalties for failure to comply with a requirement of HIPAA vary significantly depending on the nature of violation and could include civil monetary or criminal penalties.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HIPAA authorizes state attorneys general to file suit on behalf of their </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">residents for violations. Courts are able to award damages, costs and attorneys&#8217; fees related to violations of HIPAA in such cases. While HIPAA does not create a private right of action allowing individuals to file suit against us in civil court for violations of HIPAA, its standards have been used as the basis for duty of care cases in state civil suits such as those for negligence or recklessness in the misuse or breach of PHI.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain states have also adopted privacy and security laws and regulations, some of which may be more stringent than HIPAA. Such laws and regulations will be subject to interpretation by various courts and other governmental authorities, thus creating potentially complex compliance issues for us and our future customers and strategic partners. For example, California enacted the California Consumer Privacy Act of 2018 (the "CCPA") went into effect on January 1, 2020. The CCPA applies to certain businesses that collect personal information from California residents. The CCPA gives California residents expanded rights to access and delete their personal information, opt out of certain personal information sharing and receive detailed information about how their personal information is used by requiring covered companies to provide new disclosures to California consumers (as that term is broadly defined) and provide such consumers new ways to opt-out of certain sales of personal information. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. Although there are limited exemptions for health-related information, including PHI maintained by covered entities and business associates, the CCPA may increase our compliance costs and potential liability. Further, the California Privacy Rights Act ("CPRA") recently passed in California. The CPRA will impose additional data protection obligations on covered businesses, including additional consumer rights processes, limitations on data uses, new audit requirements for higher risk data, and opt outs for certain uses of sensitive data. It will also create a new California data protection agency authorized to issue substantive regulations and could result in increased privacy and information security enforcement. The majority of the provisions will go into effect on January 1, 2023, and additional compliance investment and potential business process changes may be required. Similar laws have passed in Virginia and Colorado, and have been proposed in other states and at the federal level, reflecting a trend toward more stringent privacy legislation in the U.S. The enactment of such laws could have potentially conflicting requirements that would make compliance challenging. In addition, the CCPA has prompted a number of proposals for new federal and state privacy legislation that, if passed, could increase our potential liability, increase our compliance costs and adversely affect our business. If we fail to comply with applicable laws and regulations we could be subject to penalties or sanctions, including criminal penalties if we knowingly obtain or disclose individually identifiable health information from a covered entity in a manner that is not authorized or permitted by HIPAA or applicable state laws.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, the FTC and many state Attorneys General continue to enforce federal and state consumer protection laws against companies for online collection, use, dissemination and security practices that appear to be unfair or deceptive. For example, according to the FTC, failing to take appropriate steps to keep consumers' personal information secure can constitute unfair acts or practices in or affecting commerce in violation of Section 5(a) of the FTC Act. The FTC expects a company's data security measures to be reasonable and appropriate in light of the sensitivity and volume of consumer information it holds, the size and complexity of its business, and the cost of available tools to improve security and reduce vulnerabilities. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign data protection laws, including the GDPR, which became effective in May 2018, and EU and EEA member state data protection legislation, may also apply to health-related and other personal data obtained outside of the U.S. The GDPR imposes strict requirements for processing the personal data of individuals within the EEA. The GDPR has and will continue to increase compliance burdens on us, including by mandating potentially burdensome documentation requirements and granting certain rights to individuals to control how we collect, use, disclose, retain and process data about them. Fines for non-compliance with the GDPR are significant-the greater of &#8364;20 million or 4% of global turnover. The GDPR provides that EU and EEA member states may impose further obligations relating to the processing of genetic, biometric or health data, which could limit our ability to collect, use and share personal data, or could cause our compliance costs to increase, ultimately having an adverse impact on our business. Data privacy laws in the EU and the EEA are developing rapidly and, in July 2020, the Court of Justice of the EU (the "CJEU") limited how organizations could lawfully transfer personal data from the EEA to the U.S. by invalidating the Privacy Shield for purposes of international transfers and imposing further restrictions on use of the standard contractual clauses ("SCCs"). While the CJEU upheld the adequacy of the SCCs, it made clear that reliance on them alone may not necessarily be sufficient in all circumstances. Use of the SCCs must now be assessed on a case-by-case basis taking into account the legal regime applicable in the destination country, in particular applicable surveillance laws and rights of individuals and additional measures and/or contractual provisions may need to be put in place, however, the nature of these additional measures is currently uncertain. The CJEU went on to state that if a competent supervisory authority believes that the SCCs cannot be complied with in the destination country and the required level of protection cannot be secured by other means, such supervisory authority is under an obligation to suspend or prohibit that transfer. The European Commission issued revised SCCs on June 4, 2021 to account for the decision of the CJEU and recommendations made by the European Data Protection Board. The revised SCCs must be used for relevant new data transfers from September 27, 2021; existing standard contractual clauses arrangements must be migrated to the revised clauses by December 27, 2022. There is some uncertainty around whether the revised clauses can be used for all types of data transfers, particularly whether they can be relied on for data transfers to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">non-EEA entities subject to the GDPR. The revised SCCs apply only to the transfer of personal data outside of the EEA and not the UK; the UK's Information Commissioner's Office launched a public consultation on its draft revised data transfers mechanisms in August 2021. As supervisory authorities issue further guidance on personal data export mechanisms, including circumstances where the SCCs cannot be used, and/or start taking enforcement action, we could suffer additional costs, complaints and/or regulatory investigations or fines, and/or if we are otherwise unable to transfer personal data between and among countries and regions in which we operate, it could affect the manner in which we provide our services, the geographical location or segregation of our relevant systems and operations, and could adversely affect our financial results.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, from January 1, 2021, companies have to comply with the GDPR and also the UK GDPR, which, together with the amended UK Data Protection Act 2018, retains the GDPR in UK national law. The UK GDPR mirrors the fines under the GDPR, e.g. fines up to the greater of &#8364;20 million (&#163;17.5 million) or 4% of global turnover. The European Commission has adopted an adequacy decision in favor of the UK, enabling data transfers from EU member states to the UK without additional safeguards. However, the UK adequacy decision will automatically expire in June 2025 unless the European Commission re-assesses and renews/extends that decision, and remains under review by the Commission during this period. The relationship between the UK and the EU in relation to certain aspects of data protection law remains unclear, and it is unclear how UK data protection laws and regulations will develop in the medium to longer term, and how data transfers to and from the UK will be regulated in the long term.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If we cannot obtain additional custom tooling and equipment on a timely basis to enable us to meet demand for our products, we might be unable to increase our sales or might lose customers, in which case our sales could decline.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expanded our manufacturing capacity substantially in recent years, and we expect that continued expansion may be necessary. Molds and automated assembly machines generally have a long lead-time with vendors, often nine months or longer.  Inability to secure such tooling in a timely manner, or unexpected increases in production demands, could cause us to be unable to meet customer orders. Such inability could cause customers to seek alternatives to our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost volatility or loss of supply of our raw materials could have an adverse effect on our profitability.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of the materials used in our products are resins, plastics and other material that depend upon oil or natural gas as their raw material. Crude oil markets are affected by political uncertainty in the Middle East, and there is no assurance that crude oil supplies will not be interrupted in the future.&#160;New laws or regulations adopted in response to climate change could also increase energy costs as well as the costs of certain raw materials and components. Any such regulations or interruptions could have an adverse effect on our ability to produce, or the cost to produce, our products.&#160;Also, crude oil and natural gas prices have been volatile in recent years. Our suppliers have historically passed some of their cost increases on to us, and if such prices are sustained or increase further, our suppliers may pass further cost increases on to us. In addition to the effect on resin prices, transportation costs have increased because of the effect of higher crude oil prices, and we believe most of these costs have been passed on to us. Our ability to recover these increased costs may depend upon our ability to raise prices on our products.  In the past, we have rarely raised prices and it is uncertain that we would be able to raise them to recover higher prices from our suppliers. Our inability to raise prices in those circumstances, or to otherwise recover these costs, could have an adverse effect on our profitability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business could suffer if we lose the services of key personnel.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are dependent upon the management and leadership of our executive team, as well as other members of our senior management team.&#160;If one or more of these individuals were unable or unwilling to continue in his or her present position, our business would be disrupted and we might not be able to find replacements on a timely basis or with the same level of skill and experience, which could have an adverse effect on our business.&#160;We do not have "key person" life insurance policies on any of our employees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The price of our common stock has been and may continue to be highly volatile due to many factors.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market for small and mid-market capitalization companies can be highly volatile, and we have experienced significant volatility in the price of our common stock in the past. From January&#160;2019 through December&#160;2021, our trading price ranged from a high of $282.00 per share to a low of $148.89 per share.&#160;We believe that factors such as quarter-to-quarter fluctuations in financial results, differences between stock analysts&#8217; expectations and actual quarterly and annual results, new product introductions by us or our competitors, acquisitions or divestitures, changing regulatory environments, litigation, changes in healthcare reimbursement policies, sales or the perception in the market of possible sales of common stock by insiders, market rumors, general economic trends (including the COVID-19 pandemic) and substantial product orders could contribute to the volatility in the price of our common stock. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our common stock is held by, or included in accounts managed by, institutional investors or managers. Several of those institutions own or manage a significant percentage of our outstanding shares, with the ten largest interests accounting for approximately 58% of our outstanding shares at the end of 2021. If one or more of the institutions or if our other large stockholders should decide to reduce or eliminate their position in our common stock, it could cause a significant decrease in the price of our common stock.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disruptions at the FDA, other government agencies or notified bodies caused by funding shortages or global health concerns could hinder their ability to hire, retain, or deploy key leadership and other personnel, or otherwise prevent new or modified products from being developed, cleared, approved, certified, or commercialized in a timely manner, or at all, which could negatively impact our business.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of other government agencies that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disruptions at the FDA, foreign regulatory authorities and notified bodies to review and approve or certify new products can be affected by a variety of factors, including government budget and funding levels, statutory, regulatory and policy changes, a government agency's ability to hire and retain key personnel and accept the payment of user fees, and other events that may otherwise affect the government's ability to perform routine functions. Average review times at the FDA, other government agencies, foreign regulatory authorities and notified bodies have fluctuated in recent years as a result. In addition, government funding of other government agencies that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable. For example, over the last several years, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA, have had to furlough critical FDA employees and stop critical activities.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separately, in response to the COVID-19 pandemic, on March 10, 2020, the FDA announced its intention to postpone most foreign inspections of manufacturing facilities and products and on March 18, 2020, the FDA temporarily postponed routine surveillance inspections of domestic manufacturing facilities. Subsequently, in July 2020 the FDA resumed certain on-site inspections of domestic manufacturing facilities subject to a risk-based prioritization system. The FDA utilized this risk-based assessment system to assist in determining when and where it was safest to conduct prioritized domestic inspections. In May 2021, the FDA outlined a detailed plan to move toward a more consistent state of inspectional operations, and in July 2021, the FDA resumed standard inspectional operations of domestic facilities and was continuing to maintain this level of operation as of September 2021. More recently, the FDA has continued to monitor and implement changes to its inspectional activities to ensure the safety of its employees and those of the firms it regulates as it adapts to the evolving COVID-19 pandemic. Regulatory authorities and notified bodies outside the U.S. may adopt similar restrictions or other policy measures in response to the COVID-19 pandemic. If a prolonged government shutdown occurs, or if global health concerns continue to prevent the FDA, other regulatory authorities or notified bodies from conducting their regular inspections, audits, reviews, or other regulatory activities, it could significantly impact the ability of the FDA or other regulatory authorities or notified bodies to timely review and process our regulatory submissions, which could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For instance, in the EU, notified bodies must be officially designated to certify products and services in accordance with the EU Medical Devices Regulation. While several notified bodies have been designated the COVID-19 pandemic has significantly slowed down their designation process and the current designated notified bodies are facing a large amount of requests with the new regulation as a consequence of which review times have lengthened. This situation could impact our ability to grow our business in the EU and EEA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal, Compliance, and Regulatory Risks</span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are subject to certain fraud and abuse and transparency laws, which, if violated, could subject us to substantial penalties. Additionally, any challenge to or investigation into our practices under these laws could cause adverse publicity and be costly to respond to, and thus could harm our business.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are numerous U.S. federal and state, as well as foreign, laws pertaining to healthcare fraud and abuse, including anti-kickback, false claims and transparency laws regarding payments and other transfers of value made to physicians and other </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">licensed healthcare professionals. Our business practices and relationships with providers are subject to scrutiny under these laws. The healthcare laws and regulations that may affect our ability to operate include, but are not limited to:</span></div><div><span><br/></span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Anti-Kickback Statute, which prohibits, among other things, persons and entities from knowingly and willfully soliciting, offering, receiving or providing remuneration, directly or indirectly, in cash or in kind, to induce either the referral of an individual or furnishing or arranging for a good or service, for which payment may be made, in whole or in part, under federal healthcare programs, such as Medicare and Medicaid. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it to have committed a violation. The U.S. government has interpreted this law broadly to apply to the marketing and sales activities of manufacturers;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal civil and criminal false claims laws, including the federal civil False Claims Act, which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, claims for payment from Medicare, Medicaid or other federal healthcare programs that are false or fraudulent. Private individuals can bring False Claims Act "qui tam" actions, on behalf of the government and such individuals, commonly known as "whistleblowers," may share in amounts paid by the entity to the government in fines or settlement. Moreover, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Civil Monetary Penalties Law, which prohibits, among other things, offering or transferring remuneration to a federal healthcare beneficiary that a person knows or should know is likely to influence the beneficiary&#8217;s decision to order or receive items or services reimbursable by the government from a particular provider or supplier;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Physician Sunshine Act, which require certain applicable manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program ("CHIP") to report annually to the U.S. Department of Health and Human Services' CMS information related to payments and other transfers of value to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), certain other healthcare providers (physician assistants, nurse practitioners, clinical nurse specialists, anesthesiologist assistants, certified registered nurse anesthetists, anesthesiology assistants and certified nurse midwives, and teaching hospitals), and applicable manufacturers and GPOs, to report annually ownership and investment interests held by physicians and their immediate family members;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, which created additional federal criminal statutes that prohibit, among other things, executing a scheme to defraud any healthcare benefit program and making false statements relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it to have committed a violation; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">analogous state and foreign law equivalents of each of the above federal laws, such as anti-kickback and false claims laws which may apply to items or services reimbursed by any third-party payor, including commercial insurers or patients; state laws that require device companies to comply with the industry&#8217;s voluntary compliance guidelines and the applicable compliance guidance promulgated by the federal government or otherwise restrict payments that may be made to healthcare providers and other potential referral sources; state laws that require device manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures; consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially harm customers; and state laws related to insurance fraud in the case of claims involving private insurers.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws and regulations, among other things, constrain our business, marketing and other promotional activities by limiting the kinds of financial arrangements, including sales programs, we may have with hospitals, physicians or other potential purchasers of our products. Due to the breadth of these laws, the narrowness of statutory exceptions and regulatory safe harbors available, and the range of interpretations to which they are subject, it is possible that some of our current or future practices might be challenged under one or more of these laws.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To enforce compliance with the healthcare regulatory laws, certain enforcement bodies have recently increased their scrutiny of interactions between healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. Responding to investigations can be time-and resource-consuming and can divert management's attention from the business. Additionally, as a result of these investigations, healthcare providers and entities may have to agree to additional compliance and reporting requirements as part of a consent decree or corporate integrity agreement. Any such investigation or settlement could increase our costs or otherwise have an adverse effect on our business. Even an unsuccessful challenge or investigation into our practices could cause adverse publicity, and be costly to respond to. If our operations are found to be in violation of any of the healthcare laws or regulations described above or any other healthcare regulations that apply to us, we may be subject to penalties, including administrative, civil and criminal penalties, damages, fines, exclusion from participation in government healthcare programs, such as Medicare and Medicaid, imprisonment, contractual damages, reputational harm, disgorgement and the curtailment or restructuring of our operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthcare regulation and reform measures could adversely affect our revenue and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our profitability and operations are subject to risks relating to changes in government and private reimbursement programs and policies and changes in legal requirements in the U.S. and in the world. There have been, and we expect there will continue to be, a number of legislative and regulatory changes to the healthcare system that could affect our future revenues and profitability in the U.S. and abroad.  Federal and state lawmakers regularly propose and, at times, enact legislation that results in significant changes to the healthcare system, some of which are intended to contain or reduce the costs of medical products and services. For example, in 2010, the ACA was signed into law introducing comprehensive health insurance and healthcare reforms in the U.S.&#160;The ACA, among other things, provided incentives to programs that increase the federal government's comparative effectiveness research, and implemented payment system reforms including a national pilot program on payment bundling to encourage hospitals, physicians and other providers to improve the coordination, quality and efficiency of certain healthcare services through bundled payment models. Additionally, the ACA has expanded eligibility criteria for Medicaid programs and created a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate there will continue to be proposals by legislators at both the federal and state levels, regulators and commercial payors to reduce costs while expanding individual healthcare benefits. The ultimate implementation of any healthcare reform legislation and any new laws and regulations, and its impact on us, is impossible to predict, particularly in light of the new presidential administration. Any significant reforms made to the healthcare system in the U.S., or in other jurisdictions, may have an adverse effect on our financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business could be materially and adversely affected if we fail to defend and enforce our patents or other proprietary rights, if our products are found to infringe patents or other proprietary rights owned by others or if the cost to protect our patent or other proprietary rights becomes excessive or as our patents expire.</span></div><div><span><br/></span></div><div style="text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on a combination of patents, trademarks, copyrights, trade secrets, business methods, software and nondisclosure agreements to protect our proprietary intellectual property. Our efforts to protect our intellectual and proprietary rights may not be sufficient. Further, there is no assurance that patents pending will issue or that the protection from patents which have issued or may issue in the future will be broad enough to prevent competitors from introducing similar devices, that such patents, if challenged, will be upheld by the courts or that we will be able to prove infringement and damages in litigation.</span></div><div style="text-indent:40.5pt"><span><br/></span></div><div style="text-indent:38.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally have multiple patents covering various features of a product, and as each patent expires, the protection afforded by that patent is no longer available to us, even though protection of features that are covered by other unexpired patents may continue to be available to us.&#160;The loss of patent protection on certain features of our products may make it possible for others to manufacture and sell products with features identical or similar to ours, which could adversely affect our business.  </span></div><div style="text-indent:38.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; If we fail to develop and successfully launch new products prior to the expiration of patents for our existing products, our sales and profits with respect to those products could decline significantly. We may not be able to develop and successfully launch more advanced replacement products before these and other patents expire.</span></div><div style="text-indent:38.25pt"><span><br/></span></div><div style="text-indent:38.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our ability to enforce and protect our intellectual property rights may be limited in certain countries outside of the U.S., which could make it easier for competitors to obtain market position in such countries by utilizing technologies that are similar to those developed by us.</span></div><div style="text-indent:38.25pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If others choose to manufacture and sell products similar to or substantially the same as our products, it could have a material adverse effect on our business through loss of unit volume or price erosion, or both, and could adversely affect our ability to secure new business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:38.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, we have faced patent infringement claims related to our Clave products, the CLC2000 Connector and Tego Connector. We believe these claims had no merit, and all have been settled or dismissed. We may also face claims in the future. Additionally, there has been substantial litigation regarding patent and other intellectual property rights in the medical device industry. Patent infringement litigation, which may be necessary to enforce patents issued to us or to defend ourselves against claimed infringement of the rights of others, can be expensive and may involve a substantial commitment of our resources which may divert resources from other uses. Adverse determinations in litigation or settlements could subject us to significant liabilities to third parties, could require us to seek licenses from third parties, could prevent us from manufacturing and selling our products or could fail to prevent competitors from manufacturing products similar to ours. Any of these results could materially and adversely affect our business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:38.25pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time we become aware of newly issued patents on medical devices, which we review to evaluate any infringement risk. We are aware of a number of patents for infusion connection systems that have been issued to others. While we believe these patents will not affect our ability to market our products, there is no assurance that these or other issued or pending patents might not interfere with our right or ability to manufacture and sell our products.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our ability to market our products in the U.S. and other countries may be adversely affected if our products fail to comply with the applicable requirements of the FDA and regulatory agencies in other countries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We and our products are subject to extensive regulation in the U.S. and elsewhere, including by the FDA and its foreign counterparts. The FDA and foreign regulatory agencies and notified bodies regulate, among other things, with respect to medical devices: design, development and manufacturing; testing, labeling, content and language of instructions for use and storage; clinical trials; product safety; establishment registration and device listing; marketing, sales and distribution; pre-market clearance, approval and certification; record keeping procedures; advertising and promotion; recalls and field safety corrective actions; post-market surveillance, including reporting of deaths or serious injuries and malfunctions that, if they were to recur, could lead to death or serious injury; post-market approval studies; and product import and export.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the U.S., our medical device products are subject to clearance or approval by the U.S. FDA under the FDC Act. Before we can market a new medical device, or a new use of, new claim for, or significant modification to, an existing product, we must first receive either clearance under Section&#160;510(k) of the FDC Act or approval of PMA application from the FDA, unless an exemption applies. Under the 510(k) process, the manufacturer must submit to the FDA a pre-market notification, demonstrating that the device is "substantially equivalent," as defined in the FDC Act, to a legally marketed predicate device. To be "substantially equivalent," the proposed device must have the same intended use as the predicate device, and either have the same technological characteristics as the predicate device or have different technological characteristics and not raise different questions of safety or effectiveness than the predicate device. If the manufacturer is unable to demonstrate substantial equivalence to FDA's satisfaction, or if there is no available predicate device, then the manufacturer may be required to seek approval through the PMA application process, which is generally more costly and time consuming than the 510(k) process. Through the PMA application process, the applicant must submit data and information demonstrating reasonable assurance of the safety and effectiveness of the device for its intended use to the FDA's satisfaction. Accordingly, a PMA application typically includes, but is not limited to, extensive technical information regarding device design and development, pre-clinical and clinical trial data, manufacturing information, labeling and financial disclosure information for the clinical investigators in device studies.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently market certain products that have received 510(k) clearance, and we may pursue 510(k) clearance for future products. However, certain of our new products may require a longer time for clearance than we have experienced in the past and there can be no assurance that a PMA application will not be required. Further, there is no assurance that other new products developed by us or any manufacturers that we might acquire will be eligible for 510(k) clearance rather than undergoing a more time consuming pre-market approval procedure or that, in any case, they will receive clearance or approval from the FDA. For example, in 2022, we acquired Smiths Medical, which has marketed its PORT-A-CATH implantable access systems pursuant to PMA approval. FDA regulatory processes are time consuming and expensive. Uncertainties as to the time required to obtain FDA clearances or approvals could adversely affect the timing and expense of new product introductions.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulations to which we are subject are complex and have tended to become more stringent over time. Regulatory changes could result in restrictions on our ability to continue or expand our operations, higher than anticipated costs, or lower than anticipated sales. The FDA enforces these regulatory requirements through periodic unannounced inspections. Even after we have obtained the proper regulatory clearance or approval to market a product, we have ongoing responsibilities under FDA regulations and applicable foreign laws and regulations. The FDA, state and foreign regulatory authorities have broad enforcement powers. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We do not know whether we will pass or be found compliant in any future inspections by FDA or other regulatory authorities. Our failure to comply with applicable regulatory requirements could result in enforcement action by the FDA, state or foreign regulatory authorities which may include any of the following sanctions:</span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">untitled letters or warning letters; </span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fines, injunctions, consent decrees and civil penalties; </span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">recalls, termination of distribution, administrative detention, or seizure of our products; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">customer notifications or repair, replacement or refunds; </span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operating restrictions or partial suspension or total shutdown of production; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in or refusal to grant our requests for future 510(k) clearances, PMA approvals or foreign regulatory approvals of new products, new intended uses, or modifications to existing products; </span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">withdrawals or suspensions of current 510(k) clearances or PMAs or foreign regulatory approvals, resulting in prohibitions on sales of our products; </span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FDA refusal to issue certificates to foreign governments needed to export products for sale in other countries; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">criminal prosecution. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The FDA's and other regulatory authorities' policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval or certification of our product candidates. We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the U.S. or abroad.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the FDA may change its clearance and approval policies, adopt additional regulations or revise existing regulations, or take other actions which may prevent or delay approval or clearance of our future products under development. For example, in November 2018, FDA officials announced steps that the FDA intended to take to modernize the pre-market notification pathway under Section 510(k) of the FDC Act. Among other things, the FDA announced that it planned to develop proposals to drive manufacturers utilizing the 510(k) pathway toward the use of newer predicates. These proposals included plans to potentially sunset certain older devices that were used as predicates under the 510(k) clearance pathway, and to potentially publish a list of devices that have been cleared on the basis of demonstrated substantial equivalence to predicate devices that are more than 10 years old. These proposals have not yet been finalized or adopted, and the FDA may work with Congress to implement such proposals through legislation. Accordingly, it is unclear the extent to which any proposals, if adopted, could impose additional regulatory requirements on us that could delay our ability to obtain new 510(k) clearances, increase the costs of compliance, or restrict our ability to maintain our current clearances, or otherwise create competition that may negatively affect our business. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More recently, in September 2019, the FDA issued revised final guidance describing an optional "safety and performance based" pre-market review pathway for manufacturers of "certain, well-understood device types" to demonstrate substantial equivalence under the 510(k) clearance pathway by demonstrating that such device meets objective safety and performance criteria established by the FDA, thereby obviating the need for manufacturers to compare the safety and performance of their medical devices to specific predicate devices in the clearance process. The FDA maintains a list of device types appropriate for the "safety and performance based pathway" and continues to develop product-specific guidance documents that identify the performance criteria for each such device type, as well as recommended testing methods, where feasible. The FDA may establish performance criteria for classes of devices for which we or our competitors seek or currently have received clearance, and it is unclear the extent to which such performance standards, if established, could impact our ability to obtain new 510(k) clearances or otherwise create competition that may negatively affect our business.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, FDA and foreign regulations and guidance are often revised or reinterpreted by the FDA and foreign counterparts in ways that may significantly affect our business and our products. Any new statutes, regulations or revisions or reinterpretations of existing regulations may impose additional costs or lengthen review times of any future products or make it more difficult to obtain clearance, approval, or certification to manufacture, market or distribute our products. We cannot determine what effect changes in regulations, statutes, legal interpretation or policies, when and if promulgated, enacted or adopted may have on our business in the future. Such changes could, among other things, require: additional testing prior to obtaining clearance, approval, or certification; changes to manufacturing methods; recall, replacement or discontinuance of our products; or additional record keeping.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For instance, the EU landscape concerning medical devices recently evolved. On May 25, 2017, the EU Medical Devices Regulation entered into force, which repeals and replaces the EU Medical Devices Directive. Unlike directives, which must be implemented into the national laws of the EU member states, regulations are directly applicable (i.e., without the need for adoption of EU member state laws implementing them) in all EU member states and are intended to eliminate current differences in the regulation of medical devices among EU member states. Devices lawfully placed on the market pursuant to the EU Medical Devices Directive prior to May 26, 2021 may generally continue to be made available on the market or put into service until May 26, 2025, provided that the requirements of the transitional provisions are fulfilled. In particular, the certificate in question must still be valid. However, even in this case, manufacturers must comply with a number of new or reinforced requirements set forth in the EU Medical Devices Regulation with regard to registration of economic operators and of devices, post-market surveillance, market surveillance and vigilance requirements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the transitional provisions and in order to sell our products in EU member states, our products must comply with the general safety and performance requirements of the EU Medical Devices Regulation, which repeals and replaces EU </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Devices Directive. Compliance with these requirements is a prerequisite to be able to affix the CE mark to our products, without which they cannot be sold or marketed in the EU. See &#8211; Government Regulation.  To demonstrate compliance with the general safety and performance requirements, we must undergo a conformity assessment procedure, which varies according to the type of medical device and its (risk) classification. Except for low risk medical devices (Class I), where the manufacturer can self-assess the conformity of its products with the general safety and performance requirements (except for any parts which relate to sterility, metrology or reuse aspects), a conformity assessment procedure requires the intervention of a notified body. The notified body would typically audit and examine the technical file and the quality system for the manufacture, design and final inspection of our devices. If satisfied that the relevant product conforms to the relevant general safety and performance requirements, the notified body issues a certificate of conformity, which the manufacturer uses as a basis for its own declaration of conformity. The manufacturer may then apply the CE mark to the device, which allows the device to be placed on the market throughout the EU. If we fail to comply with applicable laws and regulations, we would be unable to affix the CE mark to our products, which would prevent us from selling them within the EU.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aforementioned EU rules are generally applicable in the EEA. Non-compliance with the above requirements would also prevent us from selling our products in these three countries. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If we or our component manufacturers fail to comply with the FDA's Quality System Regulation or Good Manufacturing Practice regulations or other requirements, our manufacturing operations could be interrupted, and our product sales and operating results could suffer.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and some of our component manufacturers are required to comply with regulatory requirements known as the FDA's Quality System Regulation, or QSR, a complex regulatory scheme which covers the procedures and documentation of the design, testing, production, control, quality assurance, inspection, complaint handling, recordkeeping, management review, labeling, packaging, sterilization, storage and shipping of our device products. The FDA's cGMPs apply to the manufacture of medical device components and finished medical devices. The FDA audits compliance with these regulatory requirements through periodic announced and unannounced inspections of manufacturing and other facilities. The FDA may conduct inspections or audits at any time, and we and some of our component suppliers are subject to such inspections. Although we believe our manufacturing facilities and those of our critical component suppliers are in compliance with the QSR requirements, and with applicable cGMPs for our products, we cannot provide assurance that any future inspection will not result in adverse findings. For example, on October 1, 2021, Smiths Medical received a Warning Letter from the FDA following an inspection of Smiths Medical&#8217;s Minneapolis, Minnesota Facility on March 30, 2021.  The Warning Letter cited, among other things, failures to comply with FDA's medical device reporting requirements and failures to comply with applicable portions of the QSR. Although we believe Smiths Medical will be able to successfully resolve the issues identified in the Warning Letter, there is no guarantee that Smiths Medical will be able to do so in a timely manner or that similar compliance issues will not be identified in a future FDA inspection.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our manufacturing facilities or those of any of our component suppliers are found to be in violation of applicable laws and regulations, or we or our suppliers have significant noncompliance issues or fail to timely and adequately respond to any adverse inspectional observations or product safety issues, or if any corrective action plan that we or our suppliers propose in response to observed deficiencies is not sufficient, the FDA or foreign regulatory authorities could take enforcement action, including any of the following sanctions:</span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">untitled letters or warning letters; </span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fines, injunctions, consent decrees and civil penalties; </span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">customer notifications or repair, replacement, refunds, recall, detention or seizure of our products; </span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operating restrictions or partial suspension or total shutdown of production;</span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusing or delaying our requests for clearance or approval or certifications of new products or modified products; </span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">withdrawing clearances, approvals, or certifications that have already been granted; </span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusal to grant export approval for our products; or </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">criminal prosecution. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Any of these sanctions could adversely affect our business, financial conditions and operating results.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To market our products in the EU, we must conform to additional requirements and demonstrate conformance to harmonized quality standards. A notified body would typically audit and examine a product's technical dossiers and the manufacturers' quality system (the notified body must presume that quality systems which implement the relevant harmonized standards &#8211; which is ISO 13485:2016 for Medical Devices Quality Management Systems &#8211; conform to these requirements). Subject to the transitional provisions, manufacturers of medical devices must also comply with the EU Medical Devices </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulation. Compliance with these requirements assure that medical devices are both safe and effective and do not compromise the clinical condition or safety of patients, or the safety and health of users and &#8211; where applicable &#8211; other persons and meet all applicable established standards prior to being marketed in the EU. There is no assurance that we will continue to meet the requirements for distribution of our products in Europe. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the EU Medical Devices Regulation, among other things:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strengthens the rules on placing devices on the market (e.g. reclassification of certain devices and wider scope than the EU Medical Devices Directive) and reinforces surveillance once they are available;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishes explicit provisions on manufacturers' responsibilities for the follow-up of the quality, performance and safety of devices placed on the market;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishes explicit provisions on importers' and distributors' obligations and responsibilities;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">imposes an obligation to identify a responsible person who is ultimately responsible for all aspects of compliance with the requirements of the new regulation;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">improves the traceability of medical devices throughout the supply chain to the end-user or patient through the introduction of a unique identification number, to increase the ability of manufacturers and regulatory authorities to trace specific devices through the supply chain and to facilitate the prompt and efficient recall of medical devices that have been found to present a safety risk;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sets up a central database (Eudamed) to provide patients, healthcare professionals and the public with comprehensive information on products available in the EU; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strengthens rules for the assessment of certain high-risk devices, such as implants, which may have to undergo a clinical evaluation consultation procedure by experts before they are placed on the market.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a result of these new requirements, we may be subject to risks associated with additional testing, modification, certification, or amendment of our existing certifications, or we may be required to modify products already installed at our customers' facilities to comply with the official interpretations of the EU Medical Devices Regulation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Distribution of our products in other countries may be subject to regulation in those countries, and there is no assurance that we will obtain necessary approvals or certifications in countries in which we want to introduce our products.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The misuse or off-label use of our products may harm our reputation in the marketplace, result in injuries that lead to product liability suits or result in costly investigations, fines or sanctions by regulatory bodies if we are deemed to have engaged in the promotion of these uses, any of which could be costly to our business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products have been cleared, approved or certified by the FDA, foreign regulatory authorities and notified bodies for specific indications of use. We train our marketing personnel and direct sales force to not promote our products for uses outside of the FDA-cleared or approved indications for use, known as "off-label uses." We cannot, however, prevent a physician from using our products off-label, when in the physician's independent professional medical judgment he or she deems it appropriate. There may be increased risk of injury to patients if physicians attempt to use our products off-label. Furthermore, the use of our products for indications other than those cleared or approved by the FDA or approved by any foreign body may not effectively treat such conditions, which could harm our reputation in the marketplace among physicians and patients.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA or any foreign regulatory authorities determine that our promotional materials or training constitute promotion of an off-label use, it could request that we modify our training or promotional materials or subject us to regulatory or enforcement actions, including the issuance or imposition of an untitled letter, which is used for violators that do not necessitate a warning letter, injunction, seizure, civil fine or criminal penalties. It is also possible that enforcement authorities might take action under other regulatory authority, such as false claims laws, if they consider our business activities to constitute promotion of an off-label use, which could result in significant penalties, including, but not limited to, criminal, civil and administrative penalties, damages, fines, disgorgement, exclusion from participation in government healthcare programs and the curtailment of our operations. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, physicians may misuse our products or use improper techniques if they are not adequately trained, potentially leading to injury and an increased risk of product liability. If our products are misused or used with improper technique, we may become subject to costly litigation by our customers or their patients.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation, product liability claims or product recalls could be costly and could expose us to loss.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The use of our products exposes us to an inherent risk of product liability. Further, the medical device industry has historically been subject to extensive litigation and we cannot offer any assurance that we will not face product liability or other suits in the future. Patients, healthcare workers, healthcare providers or others who claim that our products have resulted in injury could initiate product liability litigation seeking large damage awards against us. Costs of the defense of such litigation, even if successful, could be substantial. We maintain insurance against product liability and defense costs in the amount of $40 million per occurrence. However, legal proceedings are inherently unpredictable, and the outcome can result in judgments that affect how we operate our business, or we may enter into settlements of claims for monetary damages that exceed our insurance coverage, if any is available. A successful claim against us in excess of insurance coverage could materially and adversely affect us, and result in substantial liabilities and reputational harm including product recalls or withdrawals from the market, withdrawal of clinical trial participants, the inability to commercialize our existing or new products, distraction of management&#8217;s attention from our primary business or decreased demand for our products or, if cleared or approved, products in development. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we may attempt to manage our product liability exposure by proactively recalling or withdrawing from the market any defective products, any recall or market withdrawal of our products may delay the supply of those products to our customers and may impact our reputation. We can provide no assurance that we will be successful in initiating appropriate market recall or market withdrawal efforts that may be required in the future or that these efforts will have the intended effect of preventing product malfunctions and the accompanying product liability that may result. Such recalls and withdrawals may also be used by our competitors to harm our reputation for safety or be perceived by patients as a safety risk when considering the use of our products, either of which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we generally offer a limited warranty for product returns which are due to defects in quality and workmanship. We attempt to estimate our potential liability for future product returns and establish reserves on our financial statements in amounts that we believe will be sufficient to address our warranty obligations; however, our actual liability for product returns may significantly exceed the amount of our reserves.  If we underestimate our potential liability for future product returns, or if unanticipated events result in returns that exceed our historical experience, our financial condition and operating results could be materially and adversely affected.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our products may cause or contribute to adverse medical events or be subject to failures or malfunctions that we are required to report to the FDA and foreign regulatory authorities, and if we fail to do so, we would be subject to sanctions that could harm our reputation, business, financial condition and results of operations. The discovery of serious safety issues with our products, or a recall of our products either voluntarily or at the direction of the FDA or another governmental authority, could have a negative impact on us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are subject to the FDA's medical device reporting regulations and similar foreign regulations, which require us to report to the FDA and foreign regulatory authorities when we receive or become aware of information that reasonably suggests that one or more of our products may have caused or contributed to a death or serious injury or malfunctioned in a way that, if the malfunction were to recur, it could cause or contribute to a death or serious injury. The timing of our obligation to report is triggered by the date we become aware of the adverse event as well as the nature of the event. We may fail to report adverse events of which we become aware within the prescribed timeframe. We may also fail to recognize that we have become aware of a reportable adverse event, especially if it is not reported to us as an adverse event or if it is an adverse event that is unexpected or removed in time from the use of the product. If we fail to comply with our reporting obligations, the FDA or foreign regulatory authorities could take action, including warning letters, untitled letters, administrative actions, criminal prosecution, imposition of civil monetary penalties, revocation of our device clearances or approvals, seizure of our products or delay in clearance, approval, or certification of future products. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA and foreign regulatory bodies have the authority to require the recall of commercialized products in the event of material deficiencies or defects in design or manufacture of a product or in the event that a product poses an unacceptable risk to health. The FDA&#8217;s authority to require a recall must be based on a finding that there is reasonable probability that the device could cause serious injury or death. We may also choose to voluntarily recall a product if any material deficiency is found. A government-mandated or voluntary recall by us could occur as a result of an unacceptable risk to health, component failures, malfunctions, manufacturing defects, labeling or design deficiencies, packaging defects or other deficiencies or failures to comply with applicable regulations. Product defects or other errors may occur in the future. For example, on June 26, 2020, Smiths Medical ASD initiated Class 1 recalls of a Medfusion Syringe Pump. Although we plan to work with the FDA to complete the Class 1 recall, and ultimately close, this product recall, we can provide no assurance that we will be able to do so </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in a timely manner, or at all. In addition, the costs associated with conducting and closing this recall, including any liabilities we may incur, could have a material adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Depending on the corrective action we take to redress a product's deficiencies or defects, the FDA or foreign regulatory agencies may require, or we may decide, that we will need to obtain new clearances, approvals or certifications for the device before we may market or distribute the corrected device. Seeking such clearances, approvals or certifications may delay our ability to replace the recalled devices in a timely manner. Moreover, if we do not adequately address problems associated with our devices, we may face additional regulatory enforcement action, including FDA or foreign regulatory authorities warning letters, product seizure, injunctions, administrative penalties or civil or criminal fines. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Companies are required to maintain certain records of recalls and corrections, even if they are not reportable to the FDA or foreign regulatory authorities. We may initiate voluntary withdrawals or corrections for our products in the future that we determine do not require notification of the FDA or foreign regulatory authorities. If the FDA or foreign regulatory authorities disagree with our determinations, it could require us to report those actions as recalls and we may be subject to enforcement action. A future recall announcement could harm our reputation with customers, potentially lead to product liability claims against us and negatively affect our sales. Any corrective action, whether voluntary or involuntary, as well as defending ourselves in a lawsuit, will require the dedication of our time and capital, distract management from operating our business and may harm our reputation and financial results.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Geographic Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Any significant changes in U.S. trade, tax or other policies that restrict imports or increase import tariffs could have a material adverse effect on our results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A significant amount of our products are manufactured outside of the U.S. The U.S. government has recently initiated substantial changes in U.S. trade policy and U.S. trade agreements, including the initiation of tariffs on certain foreign goods. In response to these tariffs, certain foreign governments, including China, have instituted or are considering imposing tariffs on certain U.S. goods.  For example, in 2018, the U.S. imposed tariffs on steel and aluminum as well as on goods imported from China and certain other countries, which has resulted in retaliatory tariffs by China and other countries. Additional tariffs imposed by the U.S. on a broader range of imports, or further retaliatory trade measures taken by other countries in response, could prevent or make it difficult for us to obtain the components needed for new products which would affect our sales. Increased tariffs would require us to increase our prices which likely would decrease customer and consumer demand for our products. Additionally, we are subject to income taxes in the U.S. and numerous foreign jurisdictions. Any significant changes in current U.S. trade, tax or other policies could have a material adverse effect upon our results of operations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International sales pose additional risks related to competition with larger international companies and established local companies and our possibly higher cost structure.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have undertaken an initiative to increase our international sales, and have distribution arrangements in all the principal countries in Western Europe, the Pacific Rim, Middle East, Latin America, Canada and South Africa. We plan to sell in most other areas of the world. We export most of our products sold internationally from the U.S. and Mexico. Our principal competitors in international markets consist of much larger companies as well as smaller companies already established in the countries into which we sell our products. Our cost structure is often higher than that of our competitors because of the relatively high cost of transporting product to some local markets as well as our competitors&#8217; lower local labor costs in some markets.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our international sales are subject to higher credit risks than sales in the U.S. Many of our distributors are small and may not be well capitalized. Payment terms are relatively long. The European hospitals tend to be significantly slower in payment which has resulted in an increase to our days sales outstanding from previous years.&#160;Our prices to our international distributors, outside of Europe, for product shipped to the customers from the U.S., Costa Rica or Mexico are generally denominated in U.S. dollars, but their resale prices are set in their local currency. A decline in the value of the local currency in relation to the U.S. dollar may adversely affect their ability to profitably sell in their market the products they buy from us, and may adversely affect their ability to make payment to us for the products they purchase. Legal recourse for non-payment of indebtedness may be uncertain. These factors all contribute to a potential for credit losses.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are dependent on manufacturing in Mexico, and could be adversely affected by increased labor costs and any economic, social or political disruptions.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of the material we use in manufacturing is imported into Mexico, and substantially all of the products we manufacture in Mexico are exported.  Business activity in the Ensenada area has expanded significantly, providing increased employment opportunities. This could have an adverse effect on our ability to hire or retain necessary personnel and result in an increase in labor rates. We continue to take steps to compete for labor through attractive employment conditions and benefits, but there is no assurance that these steps will continue to be successful or that we will not face increasing labor costs in the future.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Any political or economic disruption in Mexico or a change in the local economies could have an adverse effect on our operations. We depend on our ability to move goods across borders quickly, and any disruption in the free flow of goods across national borders could have an adverse effect on our business. Additionally, political and social instability resulting from violence in certain areas of Mexico has raised concerns about the safety of our personnel.&#160; These concerns may hinder our ability to send domestic personnel abroad and to hire and retain local personnel.&#160; Such concerns may require us to conduct more operations from the U.S. rather than Mexico, which may negatively impact our operations and result in higher costs and inefficiencies.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our operations may be adversely impacted by our exposure to risks related to foreign currency exchange rates.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We market our products in certain foreign markets through our subsidiaries and other international distributors. The related sales agreements may provide for payments in a foreign currency. Accordingly, our operating results are subject to fluctuations in foreign currency exchange rates. When the U.S. dollar weakens against these currencies, the dollar value of foreign-currency denominated revenue and expense increases, and when the dollar strengthens against these currencies, the dollar value of foreign-currency denominated revenue and expense decreases. We are exposed to foreign currency risk on outstanding foreign currency denominated receivables and payables. Changes in exchange rates may adversely affect our results of operations. Our primary foreign currency exchange rate exposures are currently with the Euro, Mexican Peso, Costa Rican Col&#243;n, and the Canadian Dollar against the U.S. dollar. Disruptions in the financial markets could also, among other things, create volatility in currency exchange rates.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently do not hedge against our foreign currency exchange rate risks, other than certain exposures related to the Mexican Peso and therefore believe our exposure to these risks may be higher than if we entered into hedging transactions, including forward exchange contracts or similar instruments. If we decide in the future to enter into forward foreign exchange contracts to attempt to reduce the risk related to foreign currency exchange rates, these contracts may not mitigate the potential adverse impact on our financial results due to the limitations and difficulty forecasting future activity. In addition, these types of contracts may themselves cause financial harm to us and have inherent levels of counter-party risk over which we would have no control. During 2021, we recorded $1.0 million in foreign exchange losses due to the volatility of foreign exchange rates as a result of continued uncertainty caused by the ongoing COVID-19 pandemic. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We could be adversely affected by violations of the U.S. Foreign Corrupt Practices Act and other worldwide anti-bribery laws.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Foreign Corrupt Practices Act and anti-bribery laws in other jurisdictions generally prohibit companies and their intermediaries from making improper payments for the purpose of obtaining or retaining business or other commercial advantage. Our policies mandate compliance with these anti-bribery laws, which often carry substantial penalties, including criminal and civil fines, potential loss of export licenses, possible suspension of the ability to do business with the federal government, denial of government reimbursement for products and exclusion from participation in government healthcare programs. We operate in jurisdictions that have experienced governmental and private sector corruption to some degree, and, in certain circumstances, strict compliance with anti-bribery laws may conflict with certain local customs and practices. We cannot assure that our internal control policies and procedures always will protect us from reckless or other inappropriate acts committed by our affiliates, employees, distributors or other agents. Violations of these laws, or allegations of such violations, could have a material adverse effect on our business, financial position and results of operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risk Factors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are subject to risks associated with doing business outside of the U.S.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a global market and global operations are subject to a number of risks. Sales to customers outside of the U.S. made up approximately 28% of our revenue in 2021 and as our operations and sales located in Europe and other areas outside the U.S. increase, we may face new challenges and uncertainties, although we can give no assurance that such operations and sales will increase. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risks associated with our operations outside the U.S. also include:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">economic and political uncertainty;</span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in non-U.S. government programs; </span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">multiple non-U.S. regulatory requirements that are subject to change and that could restrict our ability to manufacture and sell our products;  </span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">different local medical practices, product preferences and product requirements; </span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">possible failure to comply with trade protection and restriction measures and import or export licensing requirements; </span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulty in establishing, staffing and managing non-U.S. operations; </span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">different labor regulations or work stoppages or strikes; </span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">political instability and actual or anticipated military or political conflicts; </span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">economic instability, including the European financial crisis or other economic instability in other parts of the world and the impact on interest rates, inflation and the credit worthiness of our customers; </span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">uncertainties regarding judicial systems and procedures; </span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">minimal or diminished protection of intellectual property in some countries;</span></div><div style="margin-bottom:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">natural disasters or outbreak of diseases (including COVID-19); and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">imposition of government controls.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risks, individually or in the aggregate, could have an adverse effect on our results of operations and financial condition. The occurrence or allegation of these types of risks may adversely affect our business, performance, prospects, value, financial condition, and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our operating results may be adversely affected by unfavorable economic conditions that affect our customers&#8217; ability to buy our products and could affect our relationships with our suppliers.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disruptions in financial markets worldwide and other worldwide macro-economic challenges may cause our customers and suppliers to experience cash flow concerns. If job losses and the resulting loss of health insurance and personal savings cause individuals to forego or postpone treatment, the resulting decreased hospital use could affect the demand for our products.  As a result, customers may modify, delay or cancel plans to purchase our products and suppliers may increase their prices, reduce their output or change terms of sales. Additionally, if customers&#8217; or suppliers&#8217; operating and financial performance deteriorates, or if they are unable to make scheduled payments or obtain credit, customers may not be able to pay, or may delay payment of, accounts receivable owed to us and suppliers may impose different payment terms. Any inability of current and/or potential customers to pay us for our products or any demands by suppliers for different payment terms may adversely affect our earnings and cash flow.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_19"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B. UNRESOLVED STAFF COMMENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_22"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. PROPERTIES</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our material properties used by us in connection with our corporate administrative operations, manufacturing, distribution, research and development and service centers as of December 31, 2021, are as follows:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Approximate Square Footage</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Primary Use</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Owned/Leased</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">San Clemente, California, U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Headquarters and R&amp;D</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Owned </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">San Clemente, California, U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,108</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Headquarters</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">San Diego, California, U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,779</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Offices and R&amp;D</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lake Forest, Illinois, U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137,498</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Offices</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Houten, Netherlands</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,341</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Offices</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Montreal, Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,414</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Offices/Device service center</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chennai, India</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,879</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rydalmere, NSW Australia</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,735</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Offices/Device service center</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Austin, Texas, U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">594,602</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Manufacturing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ensenada, Baja California, Mexico</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265,021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Manufacturing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">La Aurora, Costa Rica</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">626,869</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Manufacturing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Salt Lake City, Utah, U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">450,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Manufacturing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Round Rock, Texas, U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,960</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warehouse/Manufacturing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dallas, Texas, U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">610,806</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution Warehouse</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">King of Prussia, Pennsylvania, U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,571</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution Warehouse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Santa Fe Springs, California, U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,794</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution Warehouse</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sligo, Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Device service center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the above, we own and lease additional office and building space, research and development, and sales and support offices primarily in North America, Europe, South America, and Asia.  We believe our existing facilities, both owned and leased, are in good condition and suitable for the conduct of our business. </span></div><div><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_25"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. LEGAL PROCEEDINGS</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain legal proceedings in which we are involved are discussed in Part II, Item 8. "Financial Statements and Supplementary Data" of this Annual Report on Form 10-K in Note 15. Commitments and Contingencies to the Consolidated Financial Statements, and is incorporated herein by reference.</span><span style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_28"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. MINE SAFETY DISCLOSURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_31"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div style="text-align:center"><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Market Information for Common Stock</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock has been traded on the NASDAQ Global Select Market under the symbol &#8220;ICUI&#8221; since our initial public offering on March&#160;31, 1992.&#160; </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never paid dividends and do not anticipate paying dividends in the foreseeable future as the Board of Directors intends to retain future earnings for use in our business to pay down our long-term debt or to purchase our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares.&#160;Any future determination as to payment of dividends or purchase of our shares will depend upon our financial condition, results of operations and such other factors as the Board of Directors deems relevant.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholders</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January&#160;31, 2022, we had 48 stockholders of record.  This does not include persons whose stock is in nominee or &#8220;street name&#8221; accounts through brokers.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities authorized for issuance under equity compensation plans are discussed in Part III, Item 12 of this Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Repurchase of Equity Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock repurchasing activity during the fourth quarter of 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>price&#160;paid<br/>per&#160;share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>purchased<br/>as&#160;part&#160;of&#160;a<br/>publicly<br/>announced<br/>program</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">dollar&#160;value&#160;that</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">may&#160;yet&#160;be</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">purchased</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">under&#160;the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/01/2021 - 10/31/2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/01/2021 - 11/30/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/01/2021 - 12/31/2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021 total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">____________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our&#160;common stock purchase plan, which authorized the repurchase of up to $100.0 million of our common stock, was authorized by our Board of Directors and publicly announced in August 2019.&#160;This plan has no expiration date. We are not obligated to make any purchases under our stock purchase program. Subject to applicable state and federal corporate and securities laws, purchases under a stock purchase program may be made at such times and in such amounts as we deem appropriate. Purchases made under our stock purchase program can be discontinued at any time we feel additional purchases are not warranted.</span></div><div><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_1452"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. RESERVED</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. See "Changes From Prior Periodic Reports" in Part I, Item 1 of this Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion should be read in conjunction with our Consolidated Financial Statements and Notes thereto.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Overview and Highlights</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are one of the world's leading pure-play infusion therapy companies with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and nondedicated IV sets and needlefree connectors designed to help meet clinical, safety and workflow goals. In addition, we manufacture automated pharmacy IV compounding systems with workflow technology, closed system transfer devices for preparing and administering hazardous IV drugs and cardiac monitoring systems for critically ill patients. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Smiths Medical 2020 Limited  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During September 2021, we entered into a definitive agreement to acquire Smiths Medical 2020 Limited ("Smiths Medical"), the holding company of Smiths Group plc's global medical device business and, on January 6, 2022, the acquisition closed for a purchase price of $1.9 billion in cash, 2.5 million of fully paid and non-assessable shares of our common stock, par value $0.10 per share and a potential contingent earn-out payment of $100.0 million in cash, based on our common stock performance and other considerations. Results of operations of acquired companies are included in our consolidated financial results from the date of acquisition; accordingly, Smiths Medical will be consolidated beginning in the first quarter of 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To partially finance the acquisition, on January 6, 2022 we entered into a credit agreement with Wells Fargo Bank, National Association and other lenders. The credit agreement provides for $2.2 billion of Senior Secured Credit Facilities, including a term loan A facility of $850.0 million, a term loan B facility of $850.0 million and a revolving credit facility of $500.0 million. See "Liquidity and Capital Resources" in the remainder of this item and Note 17 in our accompanying consolidated financial statements for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The novel coronavirus and its variants ("COVID-19") continues to have an impact on our business operations. Our manufacturing, distribution and pump service facilities continue to operate under our business continuity plan and our precautionary safety measures implemented to maximize the safety of our employees and to mitigate disruption to our business remain in effect. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we continually monitor the ongoing and evolving impact of the effect of the COVID-19 pandemic on our operations the overall impact will not be fully reflected in our results of operations until future periods. The duration and extent of the impact from the COVID-19 pandemic depends on future developments that cannot be fully predicted at this time, as such, the impact of the pandemic on our overall financial performance remains uncertain and cannot as yet be quantified. See &#8220;Part I. Item 1A. Risk Factors&#8221; for discussion of the risks and uncertainties associated with the COVID-19 pandemic.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Results of Operations</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our total worldwide revenue by domestic and international markets by amount and as a percentage of total revenue (in millions, except percentages):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:21.773%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.420%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Revenue</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,316.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, for the periods indicated, total revenue by product line as a percentage of total revenue:&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.246%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product&#160;line</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Consumables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Systems</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV Solutions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we manage our product distribution in the U.S. through a network of two owned and one leased distribution facilities in combination with independent distributors and third-party fulfillment and logistics providers. Our end customers, which include healthcare providers and original equipment manufacturer suppliers, may order and receive our products directly from us or through an independent full-line distributor. Internationally, we manage distribution utilizing international regional hubs and through independent distributors.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S. a substantial amount of our products are sold to group purchasing organization ("GPO") member hospitals.  We believe that as healthcare providers continue to either consolidate or join major buying organizations, the success of our products will depend, in part, on our ability, either independently or through strategic relationships to secure long-term contracts with large healthcare providers and major buying organizations.&#160; Although we believe that we are not dependent on any single distributor, large healthcare provider or major buying organization for distribution of our products, the loss of a strategic relationship with any one of these organizations or a decline in demand for our products could have a material adverse effect on our operating results.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that achievement of our growth objectives worldwide will require increased efforts by us in sales and marketing and product acquisition and development; however, there is no assurance that we will be successful in implementing our growth strategy. Product development or acquisition efforts may not succeed, and even if we do develop or acquire additional products, there is no assurance that we will achieve profitable sales of such products.&#160;Increased expenditures for sales and marketing and product acquisition and development may not yield desired results when expected, or at all. While we have taken steps to control these risks, there are certain risks that may be outside of our control, and there is no assurance that steps we have taken will succeed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality/Quarterly Results</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There are no significant seasonal aspects to our business.&#160; We can experience fluctuations in net sales as a result of variations in the ordering patterns of our largest customers, which may be driven more by COVID-19 pandemic surges and its impact on hospital admissions and procedure volumes along with production scheduling and customer inventory levels, and less by seasonality.&#160;Our expenses often do not fluctuate in the same manner as net sales, which may cause fluctuations in operating income that are disproportionate to fluctuations in our revenue.&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We present income statement data in Item 8. Financial Statements and Supplementary Data. The following table shows, for the three most recent years, the percentages of each income statement caption in relation to total revenues:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.246%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage&#160;of&#160;Revenues</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, strategic transaction and integration expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent earn-out</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract settlement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues were $1.3 billion, $1.3 billion and $1.3 billion for 2021, 2020 and 2019, respectively.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to comparing changes in revenue on a U.S. GAAP basis, we also compare the changes in revenue from one period to another using constant currency. We provide constant currency information to enhance the visibility of underlying business trends, excluding the effects of changes in foreign currency translation rates. To calculate our constant currency results, we apply the average exchange rate for revenues from the prior year to the current year results. These results should be considered in addition to, not as a substitute for, results reported in accordance with GAAP. Results on a constant currency basis, as we present them, may not be comparable to similarly titled measures used by other companies and are not measures of performance presented in accordance with GAAP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Infusion Consumables</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our total Infusion Consumables revenue (in millions, except percentages):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:24.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ change </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% change </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ change </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% change </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 over 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020 over 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Consumables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Infusion Consumables revenue increased in 2021, as compared to 2020. The increase was due to lower hospital census in 2020 driven by the onset of the COVID-19 pandemic, growth in our global oncology, U.S. core infusion and renal products </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the impact from foreign exchange.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a constant currency basis, Infusion Consumables revenue would have been $546.3 million, an increase of $72.6 million or 15.3%, as compared to 2020. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Infusion Consumables revenue decreased in 2020, as compared to 2019. The decrease was mostly driven by overall lower demand for our products due to the COVID-19 pandemic, partially offset by sales from new customers and sales of our ClearGuard HD product, which we acquired in our fourth quarter 2019 acquisition of Pursuit. On a constant currency basis, Infusion Consumables revenue was comparable at $474.0 million for 2020, as the full year impact of foreign currency was negligible.&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Infusion Systems</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our total Infusion Systems revenue (in millions, except percentages):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:24.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.902%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ change </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% change </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ change </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% change </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 over 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020 over 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Systems</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Infusion Systems revenue decreased in 2021, as compared to 2020. The decrease was primarily due to large volume pump sales driven by higher COVID-19-related purchases during the second and third quarters of 2020 and a decline in sales of our non-large volume pump business, which has been partially offset by higher dedicated set sales in 2021 as a result of higher hospital census and larger install base of large volume pump from new customer installations. On a constant currency basis, Infusion Systems revenue in 2021 would have been $351.4 million, a decrease of $8.3 million or 2.3%, as compared to 2020. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Infusion Systems revenue increased in 2020, as compared to 2019. The increase in revenue was primarily due to high demand for our infusion pumps during the COVID-19 pandemic, offset partially by lower demand for our dedicated infusion sets and losses of our non-core ambulatory pump business. On a constant currency basis Infusion Systems revenue in 2020 would have been $364.7 million, an increase of $36.4 million or 11.1%, as compared to 2019. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IV Solutions</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our total IV Solutions revenue (in millions, except percentages):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:24.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ change </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% change </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ change </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% change </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 over 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020 over 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV Solutions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IV Solutions sales decreased in 2021, as compared to 2020, primarily due to lower contract manufacturing sales to Pfizer and lower production volumes due to supply constraints in the market. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IV Solutions sales decreased in 2020, as compared to 2019, due to lower contract manufacturing sales to Pfizer and higher sales in the first quarter of 2019 to non-contracted customers.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Care</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our total Critical Care revenue (in millions, except percentages):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:24.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ change </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% change </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ change </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% change </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 over 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020 over 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Critical Care revenue increased for 2021, as compared to 2020 due primarily to higher U.S. hospital census as a result of the COVID-19 pandemic.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Critical Care revenue increased in 2020, as compared to 2019, primarily as a result of growth in the Asia region and improved manufacturing capacity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Margins</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margins were 37.3%, 36.3% and 37.3% for 2021, 2020 and 2019, respectively.&#160; </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in gross margin in 2021, as compared to 2020 was primarily due to product mix and increased plant volumes, partially offset by increased costs for raw materials, direct labor and freight.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in gross margin in 2020, as compared to 2019 was primarily due to lower IV Solutions manufacturing volumes and unfavorable product mix as a result of lower demand for our consumables products during the COVID-19 pandemic.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative ("SG&amp;A") Expenses</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our SG&amp;A expenses (in millions, except percentages):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:23.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.105%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ change </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% change </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ change </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% change </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 over 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020 over 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated SG&amp;A expenses increased in 2021, as compared to 2020. Compensation expense increased $7.9 million, dealer fees increased $5.7 million, stock compensation increased $2.9 million, legal expenses increased $2.3 million and computer expenses increased $1.5 million. Offsetting these increases was a $2.3 million decrease in bad debt expense and $1.6 million decrease in commissions. Compensation expense increased primarily due to increased headcount and annual compensation merit increases. Dealer fees increased due to an increase in revenue from U.S. distributors in the current year. Stock compensation increased due to a change during the current year in the number of performance shares expected to vest. Legal fees increased due to additional services performed in the current year related to various legal matters. Computer expenses increased due to increased maintenance costs as well as increased hardware, software and software subscriptions based on operational needs. Bad debt expense is adjusted quarterly, if deemed necessary, based on an assessment of our accounts receivables and our expectations regarding the collectability of those accounts. Commissions decreased due to the commission plan structure in the prior year, which included certain guaranteed payments.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated SG&amp;A expenses increased in 2020, as compared to 2019. Dealer fees increased $9.3 million, depreciation and amortization expense increased $7.1 million, compensation expense increased $5.5 million, and stock compensation increased $2.0 million. Offsetting these expense increases was a $6.3 decrease in bad debt expense, a $6.3 million decrease in travel expenses, a $3.7 million decrease in consulting expenses, and a $2.8 million decrease in sales and marketing expenses. Dealer fees increased due to a change to a distribution model from a direct model in Canada and an increase in revenue from distributors. Depreciation and amortization expense increased primarily as a result of the increase in amortization base due to the November 2019 acquisition of Pursuit. Compensation expense increased as a result of lower incentive compensation recognized in the prior year due to results below performance targets. Stock compensation increased in the current year due to a change in the number of performance shares estimated to vest on one of our non-executive performance awards. Bad debt expense is estimated based on an analysis of the expected losses on the accounts receivables at the reporting date, which varies from period-to-period due to the quality of those receivables. Travel expenses decreased in the current year, as compared to prior year, due to travel restrictions in response to COVID-19. Consulting expense was higher in 2019 due to charges incurred related to tax compliance and IT infrastructure expenses. Sales and marketing expenses decreased due to the impact of COVID-19 on trade shows, conferences, and related expenses.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development ("R&amp;D") Expenses</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our total R&amp;D expenses (in millions, except percentages):</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:24.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ change </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% change </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ change </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% change </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 over 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020 over 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses increased in 2021, as compared to 2020, and decreased in 2020, as compared to 2019. Fluctuations in our R&amp;D expenses are due to the timing and nature of various R&amp;D projects. R&amp;D expenses are primarily related to compensation and benefit expenses, consulting fees, production supplies, samples, travel costs, utilities and other miscellaneous administrative costs incurred on our R&amp;D projects in progress during each year.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring, Strategic Transaction and Integration Expenses</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, strategic transaction and integration expenses were $18.0 million, $28.4 million and $80.6 million in 2021, 2020 and 2019, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Charges</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we adjusted certain facility restructuring liabilities by $2.0 million to reflect actual amounts owed resulting in annual net restructuring credits of $(1.8) million.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, restructuring charges were $7.9 million. These charges were primarily related to severance and costs related to office and other facility closures. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, restructuring charges were $8.4 million. These charges were primarily related to a one-time charge to move our U.S. pump service depot to our existing Salt Lake City facility and other plant restructuring. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Strategic Transaction and Integration Expenses</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we incurred $19.8 million in strategic transaction and integration expenses primarily related to integration costs associated with acquisitions, the Hospira Infusion Systems ("HIS") earn-out dispute with Pfizer, one-time costs incurred to comply with regulatory initiatives and transaction expenses incurred in connection with entering into the definitive agreement to acquire Smiths Medical.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we incurred $20.5 million in strategic transaction and integration expenses primarily related to the integration of HIS, which included the migration of IT systems at our Austin facility. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we incurred $72.2 million in strategic transaction and integration expenses primarily related to the integration of the HIS business. Integration expenses included a one-time strategic supply chain restructuring charge of $22.1 million, which reduced our contracted commitments to our third party manufacturer and we incurred charges related to our final Pfizer separation costs and clean-up, which included a $12.7 million non-cash write-off of related assets.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in fair value of contingent earn-out</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the end of the second quarter of 2021, the measurement period related to the Pursuit earn-out liability ended and in October 2021 the $26.3 million earn-out was finalized and paid to Pursuit's former shareholders. There were no changes in the fair value of our earn-outs during 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the fair value revaluation of our Pursuit contingent earn-out liability resulted in an increase in value of $9.0 million.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the fair value revaluation of our HIS contingent earn-out liability resulted in a change in value of $47.4 million reducing the liability balance to zero. The earn-out period ended on December 31, 2019 and as of that date we determined we did not meet the necessary performance targets that would require payout of any of the HIS earn-out liability. Pfizer disputed our determination that the performance targets requiring payout of the HIS earn-out liability were not met, and the dispute entered into binding arbitration. In August 2021, the arbitrator concluded that the necessary performance targets that would require payout of the HIS earn-out were not met, and as a result Pfizer is not entitled to any payments in connection with the HIS earn-out liability.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Settlement</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we recorded $0.1 million in contract settlement expense. In 2020, we recorded $1.0 million in contract settlement income related to the resolution of a dispute with one of our suppliers. In</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019, we incurred a $5.7 million charge related to the resolution of a dispute with a product partner, which resulted in a redefinition of our contractual arrangement and in the rights and remedies determined under such arrangement.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense was $0.9 million, $1.8 million and $0.5 million in 2021, 2020 and 2019, respectively.  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021 and 2019, interest expense primarily includes the per annum commitment fee charged on the unused portion of the revolver under our five-year Revolving Credit Facility ("Credit Facility") and the amortization of financing costs that were incurred in 2017 in connection with entering into the Credit Facility. The per annum commitment fee was based on the consolidated total leverage ratio in effect and ranged between 0.15% to 0.30% on the unused portion of the Credit Facility (see Note 11: Long-Term Obligations in our accompanying consolidated financial statements for additional information). </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, interest expense was primarily related to borrowings under our Credit Facility and the amortization of financing costs. Borrowing under the Credit Facility bore interest, at our option, based on the Base Rate (as defined in Note 11 in our accompanying consolidated financial statements) plus applicable margin or the London Interbank Offered Rate plus applicable margin (see Note 11: Long-Term Obligations in our accompanying consolidated financial statements for additional information). </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we entered into senior secured credit facilities that refinanced our existing Credit Facility in full,  see "Liquidity and Capital Resources" in the remainder of this item for additional information and the estimated impact to future interest expense.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net was $0.8 million, $1.1 million and $7.9 million in 2021, 2020 and 2019, respectively.&#160; In 2021, other income, net was primarily related to $2.8 million of interest income and $0.7 million of miscellaneous income partially offset by $1.7 million of loss from disposed assets and $1.0 million in foreign exchange losses. In 2020, other income, net was primarily related to interest income of $3.7 million, miscellaneous income, net of $2.8 million and gain from the disposal of property, plant and equipment of $1.8 million, which was mostly offset by $7.2 million in foreign exchange losses incurred as a result of the strengthening of the U.S. dollar from the impact of COVID-19 during the first half of the year. In 2019, other income, net was primarily due to interest income of $6.8 million related to our banking and investment accounts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes were accrued at an estimated annual effective tax rate of 16%, 11% and 12% in 2021, 2020 and 2019, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate in 2021 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, global intangible low-taxed income (&#8220;GILTI&#8221;), foreign-derived intangible income (&#8220;FDII&#8221;) and tax credits. The effective tax rate in 2021 included a tax benefit of $4.9 million related to the excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the period. The effective tax rate for 2021 also included U.S. federal and state return-to-provision adjustments net of related reserve changes for the year ended December 31, 2020 of $0.9 million tax provision primarily due to changes in estimates for GILTI, FDII, subpart F, and related foreign tax credits along with other prior period adjustments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">    </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate in 2020 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, global intangible low-taxed income ("GILTI"), foreign-derived intangible income ("FDII") and tax credits. The effective tax rate in 2020 included a tax benefit of $5.3 million related to the excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the period. The effective tax rate for 2020 also included U.S. federal and state return-to-provision adjustments net of related reserve changes for the year ended December 31, 2019 of $3.8 million tax benefit primarily due to changes in estimates for GILTI, FDII, and related foreign tax credits. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate in 2019 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, GILTI and tax credits. The effective tax rate for 2019 included a tax benefit of $9.6 million related to the excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the period. The effective tax rate for 2019 was also impacted by the repatriation of certain intellectual property and assets from a liquidation of one of our foreign subsidiaries to the U.S. parent. In accordance with the changes to the accounting for income tax effects of such intra-entity transfers of assets, we recorded a net tax benefit of $3.8 million related to the liquidation. Lastly, the effective tax rate during 2019 included a tax expense of $2.2 million related to return-to-provision adjustments for the year ended December 31, 2018 primarily due to changes in estimates for our U.S. GILTI inclusion.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly evaluate our liquidity and capital resources, including our access to external capital, to ensure we can adequately meet our principal cash requirements, which include working capital requirements, planned capital investments in our business, commitments, acquisition restructuring and integration expenses, investments in quality systems and quality compliance objectives, repayment of outstanding borrowings, income tax obligations and acquisition opportunities in accordance with our growth strategy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Liquidity</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary sources of liquidity are cash and cash equivalents, our short-term investment portfolio, cash flows from our operations and access to borrowing arrangements.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Funds generated from operations are held in cash and cash equivalents and investment securities. During 2021, our cash and cash equivalents and short-term investment securities increased by $156.5 million from $410.8 million at December&#160;31, 2020 to $567.2 million at December&#160;31, 2021. Our short-term investment portfolio consists of investment-grade corporate bonds and is primarily intended to facilitate capital preservation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Facilities and Access to Capital</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 8, 2017, we entered into a five year revolving Credit Facility with various lenders which includes $150.0 million in borrowing capacity available for revolving credit loans and may also be used to borrow, on same-day notice under a swingline, the lesser of $10.0 million and the aggregate unused amount of the revolving credit available. Our five-year $150.0 million Credit Facility provides us with fast, flexible funding for operational needs. There were no outstanding borrowings under the Credit Facility at December 31, 2021. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of our obligations under the Credit Facility are guaranteed by ICU Medical, Inc. and certain of our existing subsidiaries. The obligations under the Credit Facility are secured by a pledge of 100% of the capital stock of certain subsidiaries owned by us and a security interest in substantially all of our tangible and intangible assets and the tangible and intangible assets of each guarantor.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facility contains certain financial covenants pertaining to Consolidated Fixed Charge Coverage and Consolidated Total Leverage ratios, see below under "Financial Covenants". In addition, the Credit Facility has restrictions pertaining to limitations on debt, liens, negative pledges, loans, advances, acquisitions, other investments, dividends, distributions, redemptions, repurchases of equity interests, fundamental changes and asset sales and other dispositions, prepayments, redemptions and purchases of subordinated debt and other junior debt, transactions with affiliates, dividend and payment restrictions affecting subsidiaries, changes in line of business, fiscal year and accounting practices and amendment of organizational documents and junior debt documents.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenants</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facility contains certain negative financial covenants, including, Consolidated Total Leverage and Consolidated Fixed Charge Coverage Ratios.   </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Leverage Ratio is defined as the ratio of Consolidated Total Funded Indebtedness on such date, to Consolidated Adjusted EBITDA, as defined under the Credit Facility Agreement, for the most recently completed four fiscal quarters.  The maximum Consolidated Leverage Ratio is not more than 3.00 to 1.00.  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Fixed Charge Coverage Ratio is defined as the ratio of: (a) Consolidated Adjusted EBITDA less the sum of (i) capital expenditures, (ii) federal, state, local and foreign income taxes paid in cash and (iii) cash restricted payments </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">made after the closing date, to (b) Consolidated Fixed Charges for the most recently completed four fiscal quarters, calculated on a pro forma basis. The minimum Consolidated Fixed Charge Coverage Ratio is 2.00 to 1.00. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into Senior Secured Credit Facilities in January 2022 which terminated our existing Credit Facility, see below.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Senior Secured Credit Facilities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into a credit agreement with various lenders dated January 6, 2022 in connection with the closing of the Smiths Medical acquisition. The credit agreement provides for senior secured credit facilities, which include a five-year term loan A facility of $850.0 million, a seven-year term loan B facility of $850.0 million and a five-year revolving credit facility of $500.0 million. The proceeds from the term loans were used to finance a portion of the cash consideration for the Smiths Medical acquisition (see Note 17: Subsequent Events in our accompanying consolidated financial statements for additional information). The outstanding aggregate principal amount of the term loans is $1.7 billion as of the issuance of this report, which includes the term loan A that will mature in January 2027 and the term loan B that will mature in January 2029. The proceeds of future borrowings under the $500.0 million revolving credit facility, which expires in January 2027, may be used as a source of liquidity to support our ongoing working capital requirements and other general corporate purposes. There are no outstanding borrowings under the $500.0 million revolving credit facility as of the issuance of this report. Our existing $150.0 million Credit Facility, described above which was set to expire in November 2022, was terminated  upon entering into the new Senior Secured Credit Facilities. As part of entering into the Senior Secured Credit Facilities we were assigned issuer and term loan B facility credit ratings. At the time of this report, our issuer and term loan B credit ratings assigned and outlook were as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuer/Term Loan B <br/>Credit Ratings</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outlook</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Moody's</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ba3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fitch</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BB/BBB-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Standard &amp; Poor's</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BB/BB</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash and cash equivalents along with cash flows expected to be generated from future operations and the funds received under the Senior Secured Credit Facilities will provide us with sufficient liquidity to finance our cash requirements for the next twelve months. In the event that we experience downturns, cyclical fluctuations in our business that are more severe or longer than anticipated, fail to achieve anticipated revenue and expense levels, or have significant unplanned cash expenditures, we may need to obtain or seek alternative sources of capital or financing, and we can provide no assurances that the terms of such capital or financing will be available to us on favorable terms, if at all. Our ability to generate cash flows from operations, issue debt or enter into other financing arrangements on acceptable terms could be adversely affected if there is a material decline in the demand for our products or in the solvency of our customers or suppliers, deterioration in our key financial ratios or credit ratings or other significantly unfavorable changes in conditions. See Part I. Item 1A. Risk Factors&#8221; for discussion of the risks and uncertainties associated with our debt financing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Uses of Liquidity</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capital Expenditures</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our capital expenditures relate to the expansion and maintenance of our business. While we can provide no assurances, we estimate that our capital expenditures in 2022 will be in the range of $100 million to $120.0 million. We anticipate making additional investments in machinery and equipment in our manufacturing operations in Costa Rica, Europe, Mexico and the U.S. to support new and existing products and in infusion pumps that get placed with customers outside the U.S.&#160;We expect to use our cash and cash equivalents to fund our capital purchases.&#160;Amounts of spending are estimates and actual spending may substantially differ from those amounts. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Acquisitions</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, we entered into a definitive agreement to acquire Smiths Medical and on January 6, 2022 the acquisition was completed. We financed the $1.9 billion cash portion of the purchase price at closing with a combination of proceeds from the Senior Secured Credit Facilities and our cash and cash equivalents. See above and Note 17: Subsequent Events in our accompanying consolidated financial statements for additional information. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contractual Obligations</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal commitments at December 31, 2021 include both short and long-term future obligations. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have non-cancelable operating lease agreements where we are contractually obligated for certain lease payment amounts. For more information regarding our operating lease obligations, (see Note 5: Leases in our accompanying consolidated financial statements). </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Debt Obligations</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed above, in January 2022, we incurred borrowings under Senior Secured Credit Facilities. The principal repayment obligations and estimated interest payments on the term loans and estimated commitment fee payments on the revolver are estimated in the below table. Interest payments on the term loans were estimated using an Adjusted Term SOFR rate and a starting applicable margin on of 1.75% for term loan A and 2.50% for term loan B and the revolver commitment fees were estimated using the initial rate of 0.25%. The applicable margin rate and commitment fee rate will change from time to time in accordance with a preset pricing grid based on the leverage ratio (see Note 17: Subsequent Events in our accompanying consolidated financial statements for pricing grids related to the Senior Secured Credit Facilities). We expect to fund these obligations with our existing cash and cash equivalents and cash generated from our future operations. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A Principal Payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A Interest Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B Principal Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B Interest Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver Commitment Fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,554.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Minimum Purchase Obligations</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February 1, 2022, effective as of January 1, 2022, upon our request, Pfizer executed a Product Addendum to our MSA agreement, see under Part I Item 1 Business Section above for further detail. The Product Addendum includes a minimum purchase obligation of $29.6 million. The Product Addendum expires on November 30, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Future Capital Investments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the January 2022 acquisition of Smiths Medical we estimate the investment needed over the next three years for restructuring and integration expenses along with spending to support quality systems and quality compliance objectives to be in the range of $200.0 million to $300.0 million. We expect to fund these obligations with our cash and cash equivalents and cash generated from our operations.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnifications </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we have agreed to indemnify our officers and directors to the maximum extent permitted under Delaware law and to indemnify customers as to certain intellectual property matters related to sales of our products. There is no maximum limit on the indemnification that may be required under these agreements.&#160;Although we can provide no assurances, we have never incurred, nor do we expect to incur, any liability for indemnification.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Historical Cash Flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Operating Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash provided by operations was $267.5 million in 2021. Net income plus adjustments for non-cash net expenses contributed $252.5 million to cash provided by operations. Net cash provided by operations as a result of changes in operating assets and liabilities was $15.0 million. The changes in operating assets and liabilities included a $20.8 million decrease in inventories, a $13.8 million decrease in accounts receivable, a $6.3 million increase in accrued liabilities, a $2.3 million increase in accounts payable, and $0.9 million in net changes in income taxes, including excess tax benefits and deferred income taxes. Offsetting these amounts was a $21.0 million increase in other assets and a $8.0 million increase in prepaid expenses and other current assets. The decrease in inventory was primarily due to the timing of production and customer purchases. The decrease in accounts receivable is primarily due to collection efforts. The increase in accrued liabilities was primarily due to the accrual of incentive bonuses, deferred revenue collected on certain arrangements and accruals related to the Smiths Medical transaction. The increase in accounts payable was primarily due to the timing of payments. The net changes in income taxes was a result of the timing of payments. The increase in other assets was primarily due to the purchase of spare parts.  The net increase in prepaid expenses and other current assets was primarily due to an increase in deferred costs. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash provided by operations was $222.8 million in 2020. Net income plus adjustments for non-cash net expenses contributed $239.7 million to cash provided by operations. Net cash used in operations as a result of changes in operating assets and liabilities was $17.0 million. The changes in operating assets and liabilities included a $46.4 million decrease in accounts payable, a $29.4 million decrease in accrued liabilities, $18.0 million in net changes in income taxes, including excess tax benefits and deferred income taxes, a $16.1 million increase in other assets, and a $4.3 million increase in prepaid expenses and other current assets. Offsetting these amounts was a $78.0 million decrease in accounts receivable and a $19.2 million decrease in inventories. The decrease in accounts payable was due to the payment of integration-related expenses with extended payment terms and the timing of other payments. The decrease in accrued liabilities was due to the payment of one-time accrued supply chain reorganization costs. The increase in other assets was due to the purchase of spare parts. The net changes in income taxes was a result of the timing of payments. The increase in prepaid expenses and other current assets was primarily due to an increase in deferred costs. The decrease in accounts receivable is primarily due to collection efforts. The decrease in inventory was primarily due to improved inventory management and increased demand for certain products driven by the COVID-19 pandemic at the end of the year. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our cash provided by operations was $101.9 million in 2019. Net income plus adjustments for non-cash net expenses contributed $213.6 million to cash provided by operations. Net cash used in operations as a result of changes in operating assets and liabilities was $111.6 million. The changes in operating assets and liabilities included a $43.7 million decrease in accrued liabilities, a $29.8 million increase in other assets, a $25.0 million increase in inventories, a $23.7 million increase in accounts receivable, and a $2.7 million decrease in accounts payable. Offsetting these amounts was a $8.6 million decrease in prepaid expenses and other current assets and $4.7 million in net changes in income taxes, including excess tax benefits and deferred income taxes. The decrease in accrued liabilities was primarily a result of the payout of accrued compensation, partially offset by an increase in certain accruals including $22.1 million in accrued costs related to the initial ramp down of IV Solution production. The increase in other assets was primarily related to the purchase of spare parts. The increase in inventory was primarily due to an increase in our finished goods safety stock. The increase in accounts receivable was mainly due to the reclassification of receivables from Pfizer and the timing of revenue and collections. Beginning in 2019, receivables from Pfizer were included in accounts receivable and not in a separate related-party receivable line item as in the prior year. As of December 31, 2018, Pfizer had sold all of its shares of our common stock thereby ending its related-party relationship with us. The decrease in accounts payable was due to the timing of payments. The decrease in prepaid expenses and other current assets was primarily due to the collection of receivable amounts owed from Pfizer. The net changes in income taxes was a result of the timing of payments. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Investing Activities</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in our investing cash flows (in thousands):</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:42.823%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.272%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Variance</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Cash Flows:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,542)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92,005)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97,312)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,958)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,627)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,385)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,728)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,452)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,452)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in non-marketable equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investment securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,034)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,825)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,040)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of investment securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,900)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,392)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90,687)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,139)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166,888)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,452&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,749&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">__________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our purchases of property, plant and equipment will vary from period to period based on additional investments needed to support new and existing products and expansion of our manufacturing facilities.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we sold our Farmers Branch, Texas, U.S. distribution facility for $6.0 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we recorded a $6.6 million intangible asset related to a three-year non-compete agreement with one of our international distributors, of which $2.6 million was non-cash offset with a contingent earn-out.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business acquisitions will vary from period to period based upon our current growth strategy and our ability to execute on desirable target companies. In 2021, we acquired a small foreign infusion systems supplier for approximately $15.4 million. In 2019, we acquired Pursuit for approximately $75.0 million in cash consideration and we acquired a small foreign distributor for approximately $4.6 million. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we paid $3.3 million to acquire approximately a 20% non-marketable equity interest in a non public company.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(6)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our purchases of investment securities will vary from period to period based on current cash needs, planning for known future transactions and changes in our investment strategy. Our investment policy allows for the purchase of securities with final maturities in excess of one year. If cash is not needed for known future transactions our investment strategy takes advantage of the long-term securities with higher yields. Typically, our longer term securities have maturities up to three years.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(7)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from the sale of our investment securities will vary based on the maturity dates of the investments.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Financing Activities</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in our financing cash flows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:42.823%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.272%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Variance</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Cash Flows:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from short-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of short-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,821)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(607)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of contingent earn-out</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax withholding payments related to net share settlement of equity awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,335)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,876)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,639)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,870)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,907)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,830)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,867&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">__________________________ </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, as a result of market uncertainty caused by COVID-19, we borrowed $150.0 million under our revolving Credit Facility as a precautionary measure to increase liquidity. We had fully repaid all amounts borrowed as of December 31, 2020.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from the exercise of stock options will vary from period to period based on the volume of options exercised and the exercise price of the specific options exercised.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, we paid $26.3 million in cash related to the settlement of the Pursuit contingent earn-out. Of the $26.3 million, the amount recorded as the acquisition date fair value, which is considered financing cash flows, was $17.3 million (see Note 8: Fair Value Measurements).</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, our employees surrendered 40,350 shares of our common stock from vested restricted stock awards as consideration for approximately $8.3 million in minimum statutory withholding obligations paid on their behalf. In 2020, our employees surrendered 67,041 shares of our common stock from vested restricted stock awards as consideration for approximately $12.9 million in minimum statutory withholding obligations paid on their behalf.  In 2019, our employees surrendered 80,186 shares of our common stock from vested restricted stock awards as consideration for approximately $18.6 million in minimum statutory withholding obligations paid on their behalf.    </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock purchase plan, which authorized the repurchase of up to $100.0 million of our common stock, was approved by our Board of Directors in August 2019.&#160;This plan has no expiration date. As of December 31, 2021, all of the $100.0 million available for purchase was remaining under the plan. We are limited on share purchases in accordance with the terms and conditions of our Credit Facility (see Note 11: Long-Term Obligations in our accompanying consolidated financial statements).&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 1: Basis of Presentation and Summary of Significant Accounting Policies to the Consolidated Financial Statements in Part II, Item 8 of this Annual Report on Form&#160;10-K.&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant accounting policies are summarized in Note 1 to the Consolidated Financial Statements.&#160;In preparing our consolidated financial statements in accordance with GAAP and pursuant to the rules and regulations of the SEC, we make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. We base our estimates, assumptions and judgments on historical experience and other factors that we believe are reasonable. We evaluate our estimates, assumptions and judgments on a regular basis and apply our accounting policies on a consistent basis. We believe that the estimates, assumptions and judgments involved in the accounting for revenue recognition, accounts receivable and business combinations have the most potential impact on our consolidated financial statements. Historically, our estimates, assumptions and judgments relative to our critical accounting policies have not differed materially from actual results.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenues when we transfer control of promised goods to our customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods. We offer certain volume-based rebates to our distribution customers, which we consider variable consideration when calculating the transaction price. Rebates are offered on both a fixed and tiered/variable basis. In both cases, we use information available at the time and our historical experience with each customer to estimate the most likely rebate amount. We also provide chargebacks to distributors that sell to end customers at prices determined under a contract between us and the end customer. Chargebacks are the difference between prices we charge our distribution customers and contracted prices we have with the end customer which are processed as credits to our distribution customers. In estimating the expected value of chargeback amounts for use in determining the transaction price, we use information available at the time, including our historical experience. We also warrant products against defects and have a policy permitting the return of defective products, for which we accrue and expense at the time of sale using information available and our historical experience.  Our revenues are recorded at the net sales price, which includes an estimate for variable consideration related to rebates, chargebacks and product returns.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vast majority of our sales of Infusion Consumables, Infusion Systems, IV Solutions and Critical Care products are sold on a standalone basis and control of these products transfers to the customer upon shipment.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our software license renewals are considered to be transferred to a customer at a point in time at the start of each renewal period, therefore revenue is recognized at that time.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Arrangements with Multiple Deliverables</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain circumstances, we enter into arrangements in which we provide multiple deliverables to our customers.  These bundled arrangements typically consist of the sale of infusion systems equipment, along with annual software licenses and related software implementation services, as well as infusion consumables, IV solutions and extended warranties.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our most significant judgments related to these arrangements are (i) identifying the various performance obligations and (ii) estimating the relative standalone selling price of each performance obligation, typically using a directly observable method or calculated on a cost plus margin basis method. Revenue related to the bundled equipment, software and software implementation services is recognized upon implementation. The transaction price allocated to the extended service-type warranty is recognized as revenue over the period the warranty service is provided.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are stated at net realizable value. An allowance is provided for estimated collection losses based on an analysis of the age of the receivable, on specific past due accounts for which we consider collection to be doubtful and based on current receivables where known economic conditions specific to individual significant customers may indicate collection is doubtful. We rely on prior payment trends, financial status and other factors to estimate the cash which ultimately will be received. Such amounts cannot be known with certainty at the financial statement date. We regularly review individual past due balances for collectability. Loss exposure is with international customers for whom normal payment terms are long in comparison to those of our other customers and with domestic distributors. If actual collection losses exceed expectations, we could be required to accrue additional bad debt expense, which could have an adverse effect on our operating results in the period in which the accrual occurs.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The application of the acquisition method of accounting for business combinations requires the use of significant estimates, assumptions and judgments in the determination of the estimated fair value of assets acquired and liabilities assumed in order to properly allocate the purchase price at the acquisition date. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe the estimates, assumptions and judgments we have made are reasonable, they are based in part on historical experience, industry data, information obtained from the management of the acquired companies and assistance from independent third-party appraisal firms, and are inherently uncertain. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Examples of critical estimates in valuing certain of the tangible and intangible assets we have acquired, and certain liabilities assumed include but are not limited to: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Inventories</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - we used the comparative sales method, which estimates the selling price of finished goods and work-in-progress inventory, reduced by estimated costs expected to be incurred in selling the inventory and a profit on those costs.  The fair value of inventory is recognized in our statements of operations as the inventory is sold.  Based on internal forecasts and estimates of inventory turnover, acquisition date inventory is sold and recognized in cost of goods sold over an estimated period of six months after the acquisition date.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Property, Plant and Equipment - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the fair value estimate of acquired property, plant and equipment is determined based upon the nature of the asset using either the cost approach, the sales comparison approach or the income capitalization approach.  The cost approach measures the value of an asset by estimating the cost to acquire or reproduce comparable assets. The sales comparison approach measures the value of an asset through an analysis of comparable property sales. The income approach values the asset based on its earnings potential.  The fair value of land was estimated using a sales comparison approach.  Land and building improvements were valued using the cost approach.  Personal property assets, such as, leasehold improvements, tooling, laboratory equipment, furniture and fixtures, and equipment, computer hardware, computer software, dies and molds were all valued using the cost approach.  Transportation equipment and major manufacturing and equipment were valued using the sales comparison method.  Construction-in-progress assets were valued based on the cost approach less adjustments for the nature of the assets.  The fair value of property, plant and equipment will be recognized in our statements of operations over the expected useful life of the individual depreciable assets.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Identifiable Intangible Assets - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the significant acquired identifiable intangible assets generally is determined using varying methods under the income approach. This method starts with a forecast of all of the expected future net cash flows associated with the asset and then adjusts the forecast to present value by applying an appropriate discount rate that reflects the risk factors associated with the cash flow streams.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Earn-out Liability - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the earn-out liabilities were valued using a Monte Carlo simulation and a probability-weighted cash flow model, as appropriate (see Note 8: Fair Value Measurements to the consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K for details).</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unanticipated events and circumstances may occur which may affect the accuracy or validity of such assumptions, estimates or actual results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward Looking Statements</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various portions of this Annual Report on Form&#160;10-K, including this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, and documents referenced herein, describe trends in our business and finances that we perceive and state some of our expectations and beliefs about our future. These statements about the future are &#8220;forward looking statements,&#8221; within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, and Section&#160;21E of the Securities Exchange Act of 1934, as amended, and we may identify them by using words such as "anticipate," "believe," "expect," "estimate," "intend," "plan," "will," "continue," "could," "may," and by similar expressions and statements about aims, goals and plans. The forward looking statements are based on the best information currently available to us and assumptions that we believe are reasonable, but we do not intend the statements to be representations as to future results. They include, without limitation, statements about:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">future growth; future operating results and various elements of operating results, including future expenditures and effects with respect to sales and marketing and product development and acquisition efforts; future sales and unit volumes of products; expected increases and decreases in sales; deferred revenue; accruals for restructuring charges, future license, royalty and revenue share income; production costs; gross margins; litigation expense; future SG&amp;A and R&amp;D expenses; manufacturing expenses; future costs of expanding our business; income; losses; cash flow; amortization; source of funds for capital purchases and operations; future tax rates; alternative sources of capital or financing; changes in working capital items such as receivables and inventory; selling prices; and income taxes;</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">factors affecting operating results, such as shipments to specific customers; reduced dependence on current proprietary products; loss of a strategic relationship; change in demand; domestic and international sales; expansion in international markets, selling prices; future increases or decreases in sales of certain products and in certain markets and distribution channels; maintaining strategic relationships and securing long-term and multi-product contracts with large healthcare providers and major buying organizations; increases in systems capabilities; introduction, development and sales of new products, acquisition and integration of businesses and product lines (including the Smiths Medical business); benefits of our products over competing systems; qualification of our new products for the expedited Section 510(k) clearance procedure; possibility of lengthier clearance process for new products; planned increases in marketing; warranty claims; rebates; product returns; bad debt expense; amortization expense; inventory requirements; lives of property, plant and equipment; manufacturing efficiencies and cost savings; unit manufacturing costs; establishment or expansion of production facilities inside or outside of the U.S.; planned new orders for semi-automated or fully automated assembly machines for new products; adequacy of production capacity; results of R&amp;D; our plans to repurchase shares of our common stock; asset impairment losses; relocation of manufacturing facilities and personnel; effect of expansion of manufacturing facilities on production efficiencies and resolution of production inefficiencies; the effect of costs to customers and delivery times; business seasonality and fluctuations in quarterly results; customer ordering patterns and the effects of new accounting pronouncements; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new or extended contracts with manufacturers and buying organizations; dependence on a small number of customers; loss of larger distributors and the ability to locate other distributors; the impact of our acquisition of the Smiths Medical business; growth of our Clave products in future years; design features of Clave products; the outcome of our strategic initiatives; regulatory approvals and compliance; outcome of litigation; patent protection and intellectual property landscape; patent infringement claims and the impact of newly issued patents on other medical devices; competitive and market factors, including continuing development of competing products by other manufacturers; improved production processes and higher volume production; innovation requirements; consolidation of the healthcare provider market and downward pressure on selling prices; distribution or financial capabilities of competitors; healthcare reform legislation; use of treasury stock; working capital requirements; liquidity and realizable value of our investment securities; future investment alternatives; foreign currency denominated financial instruments; foreign exchange risk; commodity price risk; our expectations regarding liquidity and capital resources over the next twelve months; capital expenditures; plans to convert existing space; acquisitions of other businesses or product lines, indemnification liabilities and contractual liabilities. </span></div><div style="padding-left:72pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements involve certain risks and uncertainties, which may cause actual results to differ materially from those discussed in each such statement.&#160; First, one should consider the factors and risks described in the statements themselves or otherwise discussed herein. Those factors are uncertain, and if one or more of them turn out differently than we currently expect, our operating results may differ materially from our current expectations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Second, investors should read the forward looking statements in conjunction with the Risk Factors discussed in Item 1A of this Annual Report on Form&#160;10-K.&#160; Also, actual future operating results are subject to other important factors and risks that we cannot predict or control, including without limitation, the following:</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impacts of the COVID-19 pandemic on us, our business and on domestic and global economies generally;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the integration of Smiths Medical by the Company being more difficult, time-consuming or costly than expected;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic and business conditions, both in the U.S. and internationally;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unexpected changes in our arrangements with Pfizer or our other large customers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">outcome of litigation;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fluctuations in foreign exchange rates and other risks of doing business internationally;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased competition for skilled workers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreases in availability of the raw materials need to manufacture our products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of price and safety considerations on the healthcare industry;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competitive factors, such as product innovation, new technologies, marketing and distribution strength and price erosion;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the successful development and marketing of new products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unanticipated market shifts and trends;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of legislation affecting government reimbursement of healthcare costs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes by our major customers and independent distributors in their strategies that might affect their efforts to market our products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effects of additional governmental regulations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unanticipated production problems;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquisition and integration expenses (including as it relates to the Smiths Medical acquisition); </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability of patent protection and the cost of enforcing and of defending patent claims;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">natural disasters and outbreak of disease or illness;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">labor shortages;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">supply chain constraints or disruptions;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impact of inflation on raw materials, freight charges and labor, especially in the U.S.; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interest rate increases.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward looking statements in this report are subject to additional risks and uncertainties, including those detailed from time to time in our other filings with the Securities and Exchange Commission. These forward-looking statements are made only as of the date hereof and, except as required by law, we undertake no obligation to update or revise any of them, whether as a result of new information, future events or otherwise.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="ic100f0970bae445782808747a3ec391d_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Risk    </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we were to incur borrowings under our Credit Facility, we would face market risk stemming from changes in interest rates.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Smiths Medical acquisition on January 6, 2022 we entered into Senior Secured Credit Facilities totaling approximately $2.2 billion consisting of a variable-rate term loan A facility of $850.0 million, a variable-rate term loan B facility of $850.0 million and a revolving credit facility of $500.0 million. We will be exposed to changes in interest rates on all of these variable-rate debt instruments. In order to mitigate a portion of the interest rate risk exposure associated with these debt instruments in November 2021 we entered into forward-starting interest rate swaps to achieve a targeted mix of fixed and variable-rate debt (see Note 7: Derivatives and Hedging Activities to the Consolidated Financial Statements in Part II, Item 8 of this Annual Report on Form 10-K).</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Exchange Risk</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We transact business globally in multiple currencies, some of which are considered volatile. Our international revenues and expenses and working capital positions denominated in these foreign currencies expose us to the risk of fluctuations in foreign currency exchange rates against the U.S. dollar. As the receiver of foreign currencies we are adversely affected by the strengthening of the U.S. dollar relative to the foreign currency. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our European operations, our net Euro asset position at December&#160;31, 2021 was approximately &#8364;35.9 million. A 10% change in the conversion of the Euro to the U.S. dollar for our cash, accounts receivable, accounts payable and accrued liabilities from the December&#160;31, 2021 spot rate would impact our consolidated amounts on these balance sheet items by approximately $4.1 million, or 0.9% of these net assets.&#160;We expect that in the future, with the growth of our European distribution operations, net Euro denominated instruments will continue to increase. We currently do not hedge our Euro foreign currency exposures.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have manufacturing facilities and conduct business transactions denominated in the Mexican Peso. We hedge a portion of our manufacturing spend, which reduces our exposure to the foreign currency exchange risk related to the Mexican Peso (see Note 7: Derivatives and Hedging Activities to the Consolidated Financial Statements in Part II, Item 8 of this Annual Report on Form 10-K). </span></div><div><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8.&#160; FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND SCHEDULE</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page No.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_49">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_49">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_52">Consolidated Balance Sheets as of December 31, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_52">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_55">Consolidated Statements of Operations for the Years Ended December 31, 2021, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_55">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_58">Consolidated Statements of Comprehensive Income for the Years Ended December&#160;31, 2021, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_58">62</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_61">Consolidated Statements of Stockholders&#8217; Equity for the Years Ended December&#160;31, 2021, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_61">63</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_64">Consolidated Statements of Cash Flows for the Years Ended December&#160;31, 2021, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_64">64</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_67">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_67">66</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_157">Schedule II-Valuation and Qualifying Accounts</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic100f0970bae445782808747a3ec391d_157">107</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="ic100f0970bae445782808747a3ec391d_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">To the stockholders and the Board of Directors of ICU Medical, Inc. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Opinion on the Financial Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have audited the accompanying consolidated balance sheets of ICU Medical, Inc. and subsidiaries (the "Company") as of December 31, 2021 and 2020, the related consolidated statements of operations, comprehensive income, stockholders' equity, and cash flows, for each of the three years in the period ended December 31, 2021, and the related notes and the schedule listed in the Index at Item 15 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2021, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 25, 2022, expressed an unqualified opinion on the Company's internal control over financial reporting. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis for Opinion</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:83%">Critical Audit Matter</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:83%">Revenue Recognition &#8211; Chargeback Reserve &#8212; Refer to Notes 1 and 4 to the financial statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:83%">Critical Audit Matter Description</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">The Company recognizes revenue for product sales net of a reserve for estimated chargebacks. Chargebacks are the difference between prices the Company charges distribution customers and contracted prices the Company has with the end-customer which are processed as credits to the distribution customers. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Chargebacks are accounted for as variable consideration when determining the transaction price for purposes of recognizing revenue. The Company estimates and reserves for chargebacks as a reduction of revenue at the time of sale to its distribution customers using information available at that time, including historical experience. Accounts receivable as of December 31, 2021 of $106 million and total revenues for the year ended December 31, 2021 of $1,316 million are recorded net of estimated chargebacks. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Given the subjectivity and complexity of evaluating management&#8217;s assumptions used in the determination of the chargeback reserve, including the chargeback amount related to monthly sales to distribution customers and the time to settle chargeback obligations, auditing the chargeback reserve requires a high degree of auditor judgment and an increased extent of effort. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:83%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Our audit procedures related to the chargeback reserve included the following, among others: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">We tested the effectiveness of controls related to management&#8217;s assessment of assumptions related to estimating the provision for chargeback reserves, the provisioning, processing, and monitoring of chargeback transactions, and the reconciliation of chargeback reserves. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">We tested chargeback estimates for purposes of determining whether revenues recognized at the time of sale were recorded in the proper period. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">We evaluated the methods and assumptions used by management to estimate the chargeback reserve by:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13pt">Analyzing trends in the chargeback provision as a percent of revenues and the chargeback reserve as a percent of revenues.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13pt">Testing the underlying data, including historical sales to distribution customers and chargeback settlements with distribution customers, that are utilized as the basis for the chargeback reserve, to test whether the inputs to the estimate were reasonable.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13pt">Developing an expectation of the chargeback reserve based on monthly sales to distribution customers, historical experience, and the time to settle chargeback obligations, and comparing our expectation to the amount recorded by management.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13pt">Performing retrospective reviews comparing management&#8217;s estimates of expected chargeback reserves to actual amounts incurred subsequent to the dates of estimation, to assess management&#8217;s ability to reasonably estimate these obligations and to identify potential bias in management&#8217;s assessment of the reserve.  </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF80OS9mcmFnOjNlMDM4Njc2ODgyNjQ1YzU5NzU3MjYwYmQ2YTY1MWU5L3RleHRyZWdpb246M2UwMzg2NzY4ODI2NDVjNTk3NTcyNjBiZDZhNjUxZTlfMTA5OTUxMTYzNDMzOA_bfac6f05-5717-41bb-916b-2f1b561129bf">DELOITTE &amp; TOUCHE LLP</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF80OS9mcmFnOjNlMDM4Njc2ODgyNjQ1YzU5NzU3MjYwYmQ2YTY1MWU5L3RleHRyZWdpb246M2UwMzg2NzY4ODI2NDVjNTk3NTcyNjBiZDZhNjUxZTlfMTA5OTUxMTYzNDMzOQ_3f72d778-f913-47d1-8667-eb65f541c7ad">Costa Mesa, California</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 25, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have served as the Company's auditor since 2008</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="ic100f0970bae445782808747a3ec391d_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ICU MEDICAL,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Amounts in thousands, except par value data)&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CURRENT ASSETS:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNC0xLTEtMS04NzQ1_be862e00-5c80-421b-9a74-67e08c3a5bf0">552,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNC0zLTEtMS04NzQ1_b5230bd8-d1b1-4b74-8ee0-86a6f0c831f0">396,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNS0xLTEtMS04NzQ1_c5e959e9-7a65-4e4b-8c34-0413febc356b">14,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNS0zLTEtMS04NzQ1_375af930-cbfc-4da2-a222-9dd0e5da66ef">14,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENT SECURITIES</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNi0xLTEtMS04NzQ1_ee243567-9ba2-4f77-8537-8bee9ab03791">567,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNi0zLTEtMS04NzQ1_6250ca6b-5cbb-459c-8f9f-955cf6c4a001">410,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="0" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNy0wLTEtMS04NzQ1L3RleHRyZWdpb246MmM0ZjQ0ZGNmNjc3NDI1NGI3ZGNmNzViZTYxMWE5NjdfNjc_043e0510-ae9c-4e9d-acab-b8475cbdf614">7,038</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="0" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNy0wLTEtMS04NzQ1L3RleHRyZWdpb246MmM0ZjQ0ZGNmNjc3NDI1NGI3ZGNmNzViZTYxMWE5NjdfNzQ_a725de35-4c6e-45f9-8945-ac93e1b2e165">21,490</ix:nonFraction> at December&#160;31, 2021 and 2020, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNy0xLTEtMS04NzQ1_f2029a9e-3595-4b8f-8370-f055c5d208e8">105,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNy0zLTEtMS04NzQ1_9aaebf11-c426-424a-a49e-f39483552233">124,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfOC0xLTEtMS04NzQ1_8b5118d9-0082-4fa4-9091-0a71c5ecc207">290,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfOC0zLTEtMS04NzQ1_2464f2f4-3f4d-4f48-b7fb-badfed502d59">314,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfOS0xLTEtMS04NzQ1_04aac45a-c878-4760-89dd-bb909f0e340d">19,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfOS0zLTEtMS04NzQ1_74de9765-9aa2-490f-aec4-8108ac20930a">29,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTAtMS0xLTEtODc0NQ_3b934c93-30e0-4dc4-92e9-30132f0665f4">46,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTAtMy0xLTEtODc0NQ_773a865c-e480-492c-963f-77109437bb70">41,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL CURRENT ASSETS</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTQtMS0xLTEtODc0NQ_e60950da-01cc-44c9-a267-6f83293f72f2">1,029,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTQtMy0xLTEtODc0NQ_a17ee69b-da83-4931-b3be-cb9c80d5aa8d">920,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PROPERTY, PLANT AND EQUIPMENT, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTYtMS0xLTEtODc0NQ_50186003-65a9-43d6-8a00-0b55a9d231c2">468,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTYtMy0xLTEtODc0NQ_7c47a791-49de-4c60-b0ac-52182336b856">466,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OPERATING LEASE RIGHT-OF-USE ASSETS</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTctMS0xLTEtODc0NQ_a20eb12c-1fd6-430b-8994-5879504e36f5">39,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTctMy0xLTEtODc0NQ_9b817b6a-5e79-497e-8a6c-b75014fa171e">46,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LONG-TERM INVESTMENT SECURITIES</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTgtMS0xLTEtODc0NQ_f93df599-8900-4e07-99ef-dbef51697c42">4,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTgtMy0xLTEtODc0NQ_166338bf-3c43-4f26-9aa4-805cd4b41e89">12,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GOODWILL</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTktMS0xLTEtODc0NQ_64c9654d-2ad3-492d-a592-5befc0adfffb">43,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTktMy0xLTEtODc0NQ_fbd34a96-24f8-493d-bb2e-69587a5ded6a">33,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INTANGIBLE ASSETS, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjAtMS0xLTEtODc0NQ_c488fb17-8b27-47c3-b4cd-cf7c5f21a824">188,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjAtMy0xLTEtODc0NQ_a94ccf0f-9f4e-4577-a2b2-161cb73d81e8">197,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEFERRED INCOME TAXES</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjEtMS0xLTEtODc0NQ_dcd6f307-4023-43f4-bea8-79dad6919139">42,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjEtMy0xLTEtODc0NQ_d62abc1a-5d92-4f38-bdb2-77bf77dc39c0">31,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OTHER ASSETS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjItMS0xLTEtODc0NQ_c459ed8a-bc14-488b-9b65-04b410dbb961">63,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjItMy0xLTEtODc0NQ_2032b903-f944-4395-b2b4-f7fc4aa0f363">55,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL ASSETS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjMtMS0xLTEtODc0NQ_61d44823-1c7b-4ab7-a595-089c40ce689f">1,880,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjMtMy0xLTEtODc0NQ_810ea136-b1b5-4627-b473-e6024ff44837">1,763,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CURRENT LIABILITIES:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjYtMS0xLTEtODc0NQ_9e82c8fa-30e0-4214-ad25-ab667c22153a">81,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjYtMy0xLTEtODc0NQ_c2b56b56-5f54-4d72-8785-c647894f96eb">71,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjctMS0xLTEtODc0NQ_2290d8d7-5f8b-4fc8-b919-656635fc9434">118,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjctMy0xLTEtODc0NQ_3b7b951f-43c5-43a0-b1ae-12c9350a4863">97,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjgtMS0xLTEtODc0NQ_1d48a509-b9f8-4572-82b3-0804a65347a6">1,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjgtMy0xLTEtODc0NQ_4f71636d-d161-4060-8494-a4757ea5aa27">303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjktMS0xLTEtODc0NQ_c851dbe2-e016-4c00-a1ba-739b12823c07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjktMy0xLTEtODc0NQ_91072bcd-03c6-41a2-bc90-37c571a244db">26,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL CURRENT LIABILITIES</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzAtMS0xLTEtODc0NQ_dd132f3b-f2d8-4110-acd9-5a3fb1de9221">200,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzAtMy0xLTEtODc0NQ_f69c0710-3af0-420a-83cc-dbb2848cbd89">195,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CONTINGENT EARN-OUT LIABILITY</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzItMS0xLTEtODc0NQ_5f07b7da-4b63-4e04-9fa1-6999bb46caa2">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzItMy0xLTEtODc0NQ_1ac3d8bd-b601-4f48-a686-1a1792122154">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OTHER LONG-TERM LIABILITIES</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:OtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzQtMS0xLTEtODc0NQ_0953d799-aa18-4ede-9094-c1c45c52e891">41,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:OtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzQtMy0xLTEtODc0NQ_b4a843c5-3f2a-43b0-b182-42a6e1e74aa5">47,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEFERRED INCOME TAXES</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzUtMS0xLTEtODc0NQ_b8fc1301-798d-4d43-b393-8d507c13f2d0">1,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzUtMy0xLTEtODc0NQ_9fd04d20-bde7-492e-aba2-48ec74f7373c">1,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INCOME TAX LIABILITY</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzYtMS0xLTEtODc0NQ_7aa986cc-18ef-4d9c-901f-3e60998d1205">18,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzYtMy0xLTEtODc0NQ_3a3ec2d5-98a5-4c82-8b04-4b2cd664cdcb">16,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COMMITMENTS AND CONTINGENCIES (Note 15)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzctMS0xLTEtODc0NQ_619a73cf-0fe1-4c6b-92f0-96ac17df34d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzctMy0xLTEtODc0NQ_e7265247-a13e-439c-947c-22577e6753b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">STOCKHOLDERS&#8217; EQUITY:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="0" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzktMC0xLTEtODc0NS90ZXh0cmVnaW9uOmVkN2Q4ZGZmZTA1NDQ2YWRiMTE3MGQ3Zjg4MmRmZTA1XzMz_9ae021f8-f6b3-42ed-94ce-edb6d1e5b779"><ix:nonFraction unitRef="usdPerShare" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="0" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzktMC0xLTEtODc0NS90ZXh0cmVnaW9uOmVkN2Q4ZGZmZTA1NDQ2YWRiMTE3MGQ3Zjg4MmRmZTA1XzMz_ab4ef109-64ed-489c-a7b8-786ea28e4c53">1.00</ix:nonFraction></ix:nonFraction> par value; Authorized&#8212;<ix:nonFraction unitRef="shares" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="0" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzktMC0xLTEtODc0NS90ZXh0cmVnaW9uOmVkN2Q4ZGZmZTA1NDQ2YWRiMTE3MGQ3Zjg4MmRmZTA1XzU3_0c603099-ea2d-4511-9567-620d30f538a8"><ix:nonFraction unitRef="shares" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="0" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzktMC0xLTEtODc0NS90ZXh0cmVnaW9uOmVkN2Q4ZGZmZTA1NDQ2YWRiMTE3MGQ3Zjg4MmRmZTA1XzU3_4359d950-8ca2-4bc6-ae0a-ff9a74c2c006">500</ix:nonFraction></ix:nonFraction> shares; Issued and outstanding&#8212; <ix:nonFraction unitRef="shares" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzktMC0xLTEtODc0NS90ZXh0cmVnaW9uOmVkN2Q4ZGZmZTA1NDQ2YWRiMTE3MGQ3Zjg4MmRmZTA1Xzky_6c59eff7-1b73-4c48-95fd-38416d85fd18"><ix:nonFraction unitRef="shares" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzktMC0xLTEtODc0NS90ZXh0cmVnaW9uOmVkN2Q4ZGZmZTA1NDQ2YWRiMTE3MGQ3Zjg4MmRmZTA1Xzky_ca3136af-ab9f-40e2-a688-4a5e07b4a2ad">none</ix:nonFraction></ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzktMS0xLTEtODc0NQ_783e8b57-50e4-48b3-93e4-75f63fc3ea5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzktMy0xLTEtODc0NQ_0d3e139a-5c00-493c-b04e-ed2b2e5d3187">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="1" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDAtMC0xLTEtODc0NS90ZXh0cmVnaW9uOmNjNzYwYmU5MmI4MjRjMTlhOWM2NzVlNzY0MTI3NmNiXzE4_71f8b000-a7c4-44d6-a0aa-40e35b7bd9cd"><ix:nonFraction unitRef="usdPerShare" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="1" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDAtMC0xLTEtODc0NS90ZXh0cmVnaW9uOmNjNzYwYmU5MmI4MjRjMTlhOWM2NzVlNzY0MTI3NmNiXzE4_b92537b7-15e7-48e7-ab78-138899c2ea1a">0.10</ix:nonFraction></ix:nonFraction> par value; Authorized&#8212;<ix:nonFraction unitRef="shares" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="0" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDAtMC0xLTEtODc0NS90ZXh0cmVnaW9uOmNjNzYwYmU5MmI4MjRjMTlhOWM2NzVlNzY0MTI3NmNiXzQ0_513efa95-eeb5-4ccf-a6b5-1798bcde32d0"><ix:nonFraction unitRef="shares" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="0" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDAtMC0xLTEtODc0NS90ZXh0cmVnaW9uOmNjNzYwYmU5MmI4MjRjMTlhOWM2NzVlNzY0MTI3NmNiXzQ0_6d1aea0d-ffd3-43e7-b19d-a4be465bff45">80,000</ix:nonFraction></ix:nonFraction> shares; Issued&#8212;21,280 and <ix:nonFraction unitRef="shares" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="0" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDAtMC0xLTEtODc0NS90ZXh0cmVnaW9uOmNjNzYwYmU5MmI4MjRjMTlhOWM2NzVlNzY0MTI3NmNiXzEyMg_6b639fa2-f27a-4eba-b667-8ccf399e05b2">21,058</ix:nonFraction> shares at December 31, 2021 and 2020, respectively, and outstanding&#8212;<ix:nonFraction unitRef="shares" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDAtMC0xLTEtODc0NS90ZXh0cmVnaW9uOmNjNzYwYmU5MmI4MjRjMTlhOWM2NzVlNzY0MTI3NmNiXzI3NDg3NzkwNjk3MDk_9a2b1036-b648-4663-863b-2f491f428af7"><ix:nonFraction unitRef="shares" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="0" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDAtMC0xLTEtODc0NS90ZXh0cmVnaW9uOmNjNzYwYmU5MmI4MjRjMTlhOWM2NzVlNzY0MTI3NmNiXzI3NDg3NzkwNjk3MDk_e5e41535-e7b0-4885-adfe-67b2c336731a">21,280</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDAtMC0xLTEtODc0NS90ZXh0cmVnaW9uOmNjNzYwYmU5MmI4MjRjMTlhOWM2NzVlNzY0MTI3NmNiXzE2NA_cca48221-6d74-4dca-8b0b-3cc17c531ac1">21,058</ix:nonFraction> shares at December 31, 2021 and 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDAtMS0xLTEtODc0NQ_3efe70d0-83a7-4fa3-bb4c-b05f522ea5c4">2,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDAtMy0xLTEtODc0NQ_57a91be4-18ae-42ca-80e1-a9968f11bd22">2,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDEtMS0xLTEtODc0NQ_468fba64-bacd-4e48-bd87-d2dd8fca9564">721,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDEtMy0xLTEtODc0NQ_ec9cde76-7ac9-49fe-8e5b-8fadc6e60939">693,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost (<ix:nonFraction unitRef="shares" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="0" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDItMC0xLTEtODc0NS90ZXh0cmVnaW9uOjQ2ZjcxZDNhZjZmMzRkMzI5MWMxZmIwYTYzODU1NmM2XzI5_d72bada5-33d1-42b0-ba3f-a826f5ef6848">119</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="0" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDItMC0xLTEtODc0NS90ZXh0cmVnaW9uOjQ2ZjcxZDNhZjZmMzRkMzI5MWMxZmIwYTYzODU1NmM2XzM2_eea72cd5-3af4-4658-9c18-100a004ff593">209</ix:nonFraction> shares, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDItMS0xLTEtODc0NQ_b4f5cc9f-0009-4ef3-840c-0cd6f4bd9bde">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDItMy0xLTEtODc0NQ_72fa09a5-12cf-405a-a98c-c802434534d4">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDMtMS0xLTEtODc0NQ_604fc261-5062-4fa0-8115-d2877d08fc4b">911,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDMtMy0xLTEtODc0NQ_6be182b7-fa0a-4c00-898c-8a5f799290d3">808,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDQtMS0xLTEtODc0NQ_2285dd33-5b73-49b6-aae5-d4b8ad55604e">19,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDQtMy0xLTEtODc0NQ_5985178c-6121-4140-bb01-3a0720ee7959">1,522</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL STOCKHOLDERS' EQUITY</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDUtMS0xLTEtODc0NQ_322a70f8-b4b9-4562-b189-de80e8b4de0c">1,616,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDUtMy0xLTEtODc0NQ_e15173a5-1a8f-476c-9a07-53763d282642">1,502,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDYtMS0xLTEtODc0NQ_09e792ff-07d4-4175-9f68-edaf50a2a498">1,880,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDYtMy0xLTEtODc0NQ_b91d98fd-f653-42ae-b6d8-c1315b6086b1">1,763,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="ic100f0970bae445782808747a3ec391d_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ICU MEDICAL,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Amounts in thousands, except per share data)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.979%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL REVENUES</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfNC0xLTEtMS04NzQ1_b4e46ad9-cc6c-4b54-8681-afbf79aa4449">1,316,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfNC0zLTEtMS04NzQ1_a9c5a9fb-5e1b-4479-ad5f-13df44db98d4">1,271,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfNC01LTEtMS04NzQ1_5c137366-f433-4233-bd22-de2e9b340dce">1,266,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COST OF GOODS SOLD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfNS0xLTEtMS04NzQ1_f090fd48-b734-4ea9-93ff-9344c1c8008c">824,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfNS0zLTEtMS04NzQ1_9ea999e7-46fb-4964-b98e-b713551975ec">809,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfNS01LTEtMS04NzQ1_b8f8d7ce-cf5e-4b9b-bcfb-80c323f35fe8">794,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GROSS PROFIT</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfNi0xLTEtMS04NzQ1_237e63fa-ade1-44b7-97b3-607c621520ca">491,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfNi0zLTEtMS04NzQ1_43ac3142-f8be-4f18-8d65-c0c1cddf2a5e">461,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfNi01LTEtMS04NzQ1_06679ee7-2271-4eec-ad29-e08571d4b92f">471,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OPERATING EXPENSES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfOC0xLTEtMS04NzQ1_2397c4ad-b3b5-4207-a512-1430da4da5b7">302,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfOC0zLTEtMS04NzQ1_1cb2a1e0-9637-444a-9c69-9b576ffe9a0a">283,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfOC01LTEtMS04NzQ1_87e2b29f-737e-4660-a684-26035e45a12d">276,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfOS0xLTEtMS04NzQ1_dcb46f0c-8c86-4626-8b6c-2d20f72e22af">47,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfOS0zLTEtMS04NzQ1_5f6a6fea-2875-4b45-8ca6-1e0846fb3ff3">42,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfOS01LTEtMS04NzQ1_dbbdde5b-be38-42ba-8df5-d8f15b570264">48,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, strategic transaction and integration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="icui:Restructuringandstrategictransactionexpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTAtMS0xLTEtODc0NQ_10491053-583a-4a02-9fc0-10b76c2567e0">18,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="icui:Restructuringandstrategictransactionexpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTAtMy0xLTEtODc0NQ_5293c252-453c-4acb-9101-146281d07d1d">28,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="icui:Restructuringandstrategictransactionexpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTAtNS0xLTEtODc0NQ_feecece5-05d7-4d19-a0ed-33ccb2339497">80,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent earn-out</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTEtMS0xLTEtODc0NQ_7a25e072-6574-4b17-ad9a-69a56148479f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTEtMy0xLTEtODc0NQ_a7087672-8932-41d0-a9b8-e6ab5e83c3ca">9,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTEtNS0xLTEtODc0NQ_214d232e-a16f-47e3-aee1-681d05593e32">47,400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="icui:Contractsettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTItMS0xLTEtODc0NQ_51a750d2-0971-4825-9511-b9c168a5c1b5">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" sign="-" name="icui:Contractsettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTItMy0xLTEtODc0NQ_4bef7c5e-3c56-4683-87ec-7b4b5297da16">975</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="icui:Contractsettlements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTItNS0xLTEtODc0NQ_30d85500-025c-4daf-a571-8831e382bba7">5,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL OPERATING EXPENSES</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTYtMS0xLTEtODc0NQ_dd461f8e-159f-4251-9857-6ba49d5889a5">368,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTYtMy0xLTEtODc0NQ_dd426815-d871-4fd0-a5e9-b602b586a409">363,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTYtNS0xLTEtODc0NQ_6afa7b28-dd7e-48e9-acd7-06d65461f38e">364,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INCOME FROM OPERATIONS</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTctMS0xLTEtODc0NQ_ecd2228e-9d51-4981-b12a-e39d777941a9">123,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTctMy0xLTEtODc0NQ_1c4e94ef-e61a-4301-8993-04e2d158c861">98,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTctNS0xLTEtODc0NQ_51604cea-b94c-4b71-899c-a82b06acafa0">107,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INTEREST EXPENSE</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTktMS0xLTEtODc0NQ_b1ae97b9-b53d-4003-b9b1-2d5833d37da6">858</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTktMy0xLTEtODc0NQ_d0574d11-d35b-489b-8bd5-27cf7abd9a76">1,753</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTktNS0xLTEtODc0NQ_648ad2e3-bcf9-4e6b-8af3-0eb466ba7abe">549</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OTHER INCOME, NET</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjAtMS0xLTEtODc0NQ_5db30ea8-7fae-4bec-843d-936d170bb6f6">799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjAtMy0xLTEtODc0NQ_16f6cc9c-6661-4dd8-b582-d3eb59f401b9">1,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjAtNS0xLTEtODc0NQ_ac9a0b43-88a7-4ab8-9a4d-b17a6468ff06">7,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INCOME BEFORE INCOME TAXES</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjEtMS0xLTEtODc0NQ_c28dae4b-eaff-493f-a2b1-bb00a7074a57">123,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjEtMy0xLTEtODc0NQ_47d4b94e-96a1-42f7-88cd-ff208063473d">97,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjEtNS0xLTEtODc0NQ_02db70e9-1116-47b6-8292-5d8cf53a8da3">114,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PROVISION FOR INCOME TAXES</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjItMS0xLTEtODc0NQ_b77c0bd1-2883-4cab-9d0f-191469c4dd9f">20,051</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjItMy0xLTEtODc0NQ_22347c32-70d1-481e-a038-a7efb697f80a">10,624</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjItNS0xLTEtODc0NQ_715b6093-0156-4e47-b282-993b833e9a74">13,672</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NET INCOME</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjMtMS0xLTEtODc0NQ_313eda6e-2fef-423e-bfab-c8a79b856b30">103,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjMtMy0xLTEtODc0NQ_e0504d74-241c-4eb7-8d03-1407a541251f">86,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjMtNS0xLTEtODc0NQ_b688684e-c7aa-4815-90a7-a20abe3117f1">101,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NET INCOME PER SHARE</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjUtMS0xLTEtODc0NQ_5675b253-d24c-4a58-8bcf-4ac6046b3345">4.86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjUtMy0xLTEtODc0NQ_6190e9b1-d79b-4c90-98a4-0bb192f787d5">4.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjUtNS0xLTEtODc0NQ_a339271e-eb55-4517-9883-e9b0938b761a">4.90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjYtMS0xLTEtODc0NQ_a30ec008-6dec-48a7-a416-5b0382813d18">4.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjYtMy0xLTEtODc0NQ_4714c107-0c18-4939-a289-2c0e6e908dbd">4.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjYtNS0xLTEtODc0NQ_1633bdce-c8d5-49c2-953d-85e239a76025">4.69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WEIGHTED AVERAGE NUMBER OF SHARES</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjgtMS0xLTEtODc0NQ_f5750c6f-5bf5-4d55-a75e-a197831edc81">21,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjgtMy0xLTEtODc0NQ_0664f538-51ba-4803-9c32-2e483e50dcdd">20,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjgtNS0xLTEtODc0NQ_1e836993-9cb0-4e78-8713-84f5adc46130">20,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjktMS0xLTEtODc0NQ_2d5d79e9-0356-4310-957c-0a11b0e1d117">21,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjktMy0xLTEtODc0NQ_4a2269bb-776f-4d0b-8580-6022db91127e">21,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjktNS0xLTEtODc0NQ_90987149-1555-4a1c-bb42-f6c94f0fe831">21,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="ic100f0970bae445782808747a3ec391d_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ICU MEDICAL,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Amounts in thousands)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.037%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NET INCOME</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfMi0xLTEtMS04NzQ1_3a6d1cfd-8eca-4b4b-90f9-63c17825c496">103,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfMi0zLTEtMS04NzQ1_f5f944e5-692a-4016-9c96-f8ecd7539ca7">86,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfMi01LTEtMS04NzQ1_35af07ee-ffcc-4881-b9e7-59d09fd2d7c1">101,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge adjustments, net of tax of $(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNC0wLTEtMS04NzQ1L3RleHRyZWdpb246NmUwMzMxZjEzZDg4NDVmYmE5NmI5OWJmM2I5OTZlMDhfNDc_0eb4c832-0e1f-4805-a0a9-2b7c2c2681a3">954</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNC0wLTEtMS04NzQ1L3RleHRyZWdpb246NmUwMzMxZjEzZDg4NDVmYmE5NmI5OWJmM2I5OTZlMDhfNTE_6d26f057-e24d-4f54-8b6f-33eb73db0135">285</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNC0wLTEtMS04NzQ1L3RleHRyZWdpb246NmUwMzMxZjEzZDg4NDVmYmE5NmI5OWJmM2I5OTZlMDhfNTg_8d114ea6-a36d-44be-92e9-ae22a9b450bd">392</ix:nonFraction> for the years ended December 31, 2021, 2020 and 2019, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNC0xLTEtMS04NzQ1_6d6ada08-c13d-44bd-a688-b2147beee773">3,021</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNC0zLTEtMS04NzQ1_bbdf4d68-cbe0-4704-8f6c-99c2a10edfbb">904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNC01LTEtMS04NzQ1_7ebe92e8-7d14-4e88-83a7-763655aaf667">1,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="0" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNS0wLTEtMS04NzQ1L3RleHRyZWdpb246OTQ0YzY4MmUxMGM5NDk3YTg3ZjhmY2QxZTE1ZGM5ZWFfNTk_54435ec0-03e5-4aca-a5fa-7d6e3b44672c"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="0" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNS0wLTEtMS04NzQ1L3RleHRyZWdpb246OTQ0YzY4MmUxMGM5NDk3YTg3ZjhmY2QxZTE1ZGM5ZWFfNTk_72efd34a-a46f-4d9d-b378-2334b0e75abb"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="0" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNS0wLTEtMS04NzQ1L3RleHRyZWdpb246OTQ0YzY4MmUxMGM5NDk3YTg3ZjhmY2QxZTE1ZGM5ZWFfNTk_e03cda36-5773-42f5-812f-6e3528386596">0</ix:nonFraction></ix:nonFraction></ix:nonFraction> for all periods </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNS0xLTEtMS04NzQ1_6de75926-c584-4882-a153-c81e7f2225fb">14,664</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNS0zLTEtMS04NzQ1_a854f0b5-5ab4-405f-862a-e8c7a6d5de7a">12,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNS01LTEtMS04NzQ1_8019c7e9-d552-4c88-b226-587102be83a7">372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="0" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNi0wLTEtMS04NzQ1L3RleHRyZWdpb246MzM3OTcwNGY1MDZhNGQ5MGJkMTdmOTYxYWI4OTFkMjRfMzc_367e71ee-5326-4fd9-8a4f-57dcabd3f98c"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="0" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNi0wLTEtMS04NzQ1L3RleHRyZWdpb246MzM3OTcwNGY1MDZhNGQ5MGJkMTdmOTYxYWI4OTFkMjRfMzc_4dbe6494-2c50-44bf-976d-8a274332b045"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="0" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNi0wLTEtMS04NzQ1L3RleHRyZWdpb246MzM3OTcwNGY1MDZhNGQ5MGJkMTdmOTYxYWI4OTFkMjRfMzc_5158c52e-94d1-456c-8f72-9615a9d99ac6">0</ix:nonFraction></ix:nonFraction></ix:nonFraction> for all periods</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNi0xLTEtMS04NzQ1_2852075f-a3e1-4ca0-8f7a-13e37b2b1373">62</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNi0zLTEtMS04NzQ1_68979b2a-61ff-4b83-b93d-0c3a3f5e5309">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNi01LTEtMS04NzQ1_70266819-67ff-41f8-a3fd-1271ff4ea79a">71</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNy0xLTEtMS04NzQ1_f250a1b4-0868-4c68-86e7-1a4c018dee8f">17,747</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNy0zLTEtMS04NzQ1_66c4f158-b01a-45e4-aaa9-8ba2c426efe9">13,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNy01LTEtMS04NzQ1_e7050b96-220e-46a2-a24f-a3c1a7438425">1,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COMPREHENSIVE INCOME</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfOC0xLTEtMS04NzQ1_e961a025-9885-435b-ad39-3913763b7916">85,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfOC0zLTEtMS04NzQ1_1a219f54-83ec-4ee2-a21e-b2e63c209429">100,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfOC01LTEtMS04NzQ1_88031267-c106-4f22-ac06-3906cf8311b6">102,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="ic100f0970bae445782808747a3ec391d_61"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ICU MEDICAL,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Amounts in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.082%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.334%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.249%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.816%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, January 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie3327972bb1d4aee95a27cb29ac758f6_I20181231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMy0yLTEtMS04NzQ1_17ecb8db-ecdd-474f-bbac-222764950366">20,491</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff400e2a4d53433e99e9a76ec4ff42c0_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMy00LTEtMS04NzQ1_af656856-ba12-4d30-baf7-ecc819ad2504">2,049</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i422a41397eba44439e3bee3a84f24f5e_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMy02LTEtMS04NzQ1_2a9bdf93-8c5d-4af2-b250-ad39c3ffccf6">657,899</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3707592634d449b6b164fd6ab5039af3_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMy04LTEtMS04NzQ1_28a16d62-379b-4a01-b97d-55b17eaf604b">95</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e68fd2b373c4657b269de98d476f2f3_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMy0xMC0xLTEtODc0NQ_b543ae7e-179c-4ba7-b929-7c5189bde1a7">620,747</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9a14d7ab14041cd9287ff968eeab854_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMy0xMi0xLTEtODc0NQ_be0d532d-632e-4d2f-b407-91db545f9e94">16,945</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2b82bbcf5cb45739937a1040ed30f6b_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMy0xNC0xLTEtODc0NQ_a9c6a48a-9547-44ac-a088-5a5046439c00">1,263,655</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of restricted stock and exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8036f14fb1574f22a813b07a891d10cb_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfNS0yLTEtMS04NzQ1_d4633d0e-78e0-48c8-8865-37d0a6da0347">331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief0e41eadf634f478517bbf4796fb3b7_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfNS00LTEtMS04NzQ1_c942ae10-f33c-4904-8e91-dcd206d6ad02">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd39fbd084c64997a80b35884325a837_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfNS02LTEtMS04NzQ1_38ea1428-80cc-4d53-8b34-9ea34bf7ed02">10,870</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf8bb0aa0f8d4c368a4f3c52cf44f0fe_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfNS04LTEtMS04NzQ1_681440a9-faf6-4ef9-8120-7c981f051073">18,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfNS0xNC0xLTEtODc0NQ_558dfecb-447d-481a-a337-0e0aec8c7f3e">7,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax withholding payments related to net share settlement of equity awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8036f14fb1574f22a813b07a891d10cb_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfNi0yLTEtMS04NzQ1_e1d8736e-f0bf-4e0a-8300-bcb7f04eb79c">80</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd39fbd084c64997a80b35884325a837_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfNi02LTEtMS04NzQ1_b046dcd6-ce59-4250-8b10-8a9b6f8e97d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf8bb0aa0f8d4c368a4f3c52cf44f0fe_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfNi04LTEtMS04NzQ1_315523b9-6150-4e26-8211-a08b418fd762">18,639</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfNi0xNC0xLTEtODc0NQ_ac7eb4da-0198-45f9-b8b1-0c1c4560bb83">18,639</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd39fbd084c64997a80b35884325a837_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfOC02LTEtMS04NzQ1_e75dcaaf-41a6-437f-aaf7-6efb3864dc06">21,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfOC0xNC0xLTEtODc0NQ_5de07dc1-f67c-4274-ae5a-45d40c85ca9f">21,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied11d81291954b6892d0bd3f457a6c62_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfOS0xMi0xLTEtODc0NQ_c0890074-292f-4c9b-9f51-b1d29b9d8c46">1,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfOS0xNC0xLTEtODc0NQ_50adde52-3b70-4767-8fef-cd265a6c2f95">1,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f8426b518ec486c8093f691d9ae22b4_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTAtMTAtMS0xLTg3NDU_a8de4270-4718-4f7c-a311-f3186c07f56d">101,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTAtMTQtMS0xLTg3NDU_d45b1d4f-6483-4342-9f9e-75494b7a2ff8">101,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b6766362c85475b9f3e56635902ffc6_I20191231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTEtMi0xLTEtODc0NQ_48620ba0-201d-4ca3-8f41-4b5130bb76a8">20,742</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53abf8ff1024f4b9dbcd962fb14bb16_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTEtNC0xLTEtODc0NQ_26401b19-d5aa-46e3-ad7b-91c610c4577d">2,074</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8029282b701e4da19cb4312a7342adee_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTEtNi0xLTEtODc0NQ_46492de5-56ce-4b45-907c-6bff9f076917">668,947</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba8b292d4a8c426ea02ac921339f2ece_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTEtOC0xLTEtODc0NQ_56f03672-d721-462a-8eb5-66d34b93d496">157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58538562a9b846b1a8eb28ee06dd457c_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTEtMTAtMS0xLTg3NDU_8009841f-8870-405d-8fe1-2888e03edc31">721,782</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12d0faf21deb41648f175a8130fa683f_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTEtMTItMS0xLTg3NDU_932aca02-fa4e-4ece-9224-9e373b58a6ab">15,402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTEtMTQtMS0xLTg3NDU_3d20d010-f8e6-4326-9e19-8b4a2dc786df">1,377,244</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of restricted stock and exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6a9e3ee9b34c4d4c81e04d5c21845153_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTMtMi0xLTEtODc0NQ_5e57085d-f913-4474-b65f-20ca76e6827f">383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic917d118fe1544a48c9f7cdb26a0bafe_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTMtNC0xLTEtODc0NQ_44c9b78d-448b-4fec-ab16-6ac9111d147f">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea909186292457f815372e15f122f61_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTMtNi0xLTEtODc0NQ_5d5d0288-7c01-4b13-b7fe-0bead617fb91">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i319e066bf7c149958ff00b3b5180cad9_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTMtOC0xLTEtODc0NQ_e90553da-e0a1-4dad-ac97-6c90c2066a6a">12,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTMtMTQtMS0xLTg3NDU_b2719b09-cbdb-4a14-970d-f4799bd4477a">13,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax withholding payments related to net share settlement of equity awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6a9e3ee9b34c4d4c81e04d5c21845153_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTQtMi0xLTEtODc0NQ_aa929f3f-312a-46b2-b36d-e29183fe0574">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea909186292457f815372e15f122f61_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTQtNi0xLTEtODc0NQ_24e199ed-1560-42f4-8523-dff200fd813d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i319e066bf7c149958ff00b3b5180cad9_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTQtOC0xLTEtODc0NQ_22fccf1f-db0f-47d5-8f2b-00ab7cbf3f3a">12,876</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTQtMTQtMS0xLTg3NDU_5c00863c-80d5-4723-89da-6d733e57d6d6">12,876</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea909186292457f815372e15f122f61_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTYtNi0xLTEtODc0NQ_8075773f-05ae-4251-b704-14f18a201baf">23,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTYtMTQtMS0xLTg3NDU_48555ea2-eebc-4090-a270-a89d0cf1deab">23,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1f24ebe96e244d1a070e358c2f9088e_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTctMTItMS0xLTg3NDU_bc3d4c74-54f5-4025-96ae-299c289dd4f6">13,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTctMTQtMS0xLTg3NDU_219d8623-88f0-4930-b1d2-6ac39fd391e4">13,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ee1c30a74b842b18319e3e21627fde1_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTgtMTAtMS0xLTg3NDU_4d0f819a-2203-443f-aa83-89ded6c90891">86,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTgtMTQtMS0xLTg3NDU_b05c36a3-9cc1-48da-bcb3-a1e8d29c7be9">86,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76af68ce1a5649a285c27467729f3ea8_I20201231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTktMi0xLTEtODc0NQ_8cfe244c-663a-4a36-8843-945a68816849">21,058</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64123b55baa546a6ae8585911227ac9b_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTktNC0xLTEtODc0NQ_a7547a83-1405-425d-92d4-f0b4a1b0535a">2,106</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6257893a382b432986c682223e96eed6_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTktNi0xLTEtODc0NQ_c2e850ad-fd36-4622-9f8c-09fcd48be898">693,068</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i545572fcbd214019b1a486fff73e3d60_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTktOC0xLTEtODc0NQ_4cb9e3f9-e6fe-4bf4-9f0d-a98bb7f7ddab">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib07f493ac3464b04ace456f723c0d4c1_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTktMTAtMS0xLTg3NDU_7a981145-6fa6-420f-bf53-c3b7127d6a85">808,652</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98729f24bb67493bbbb1a901004ee439_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTktMTItMS0xLTg3NDU_7788378f-473a-4aeb-ab32-3d1ad1a581b0">1,522</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTktMTQtMS0xLTg3NDU_c1868137-ad42-4e27-8965-25a49114a435">1,502,265</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of restricted stock and exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i124369e0a3a6454fae9d78635beb32e1_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjEtMi0xLTEtODc0NQ_70df0685-a9e4-4559-8b23-dd162aab78a0">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893bab2162e3420fa787264425d1b71f_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjEtNC0xLTEtODc0NQ_40af3370-480d-45fd-9484-7b11fb1364ec">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80df96ad8b8e4475847100ff81957f59_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjEtNi0xLTEtODc0NQ_0b69cab9-f7d8-430e-8aff-8c63a2568627">1,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5dc13d8d15f4d6b9e43ee2747cf2dde_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjEtOC0xLTEtODc0NQ_b0992ed9-6631-4b66-9384-6c52fd1b6bce">8,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjEtMTQtMS0xLTg3NDU_8a64b940-0e31-4ab6-ae22-f4137a90e7ee">9,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax withholding payments related to net share settlement of equity awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i124369e0a3a6454fae9d78635beb32e1_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjItMi0xLTEtODc0NQ_ccd9f3c5-c984-459d-be7d-c9ff3480abe9">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80df96ad8b8e4475847100ff81957f59_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjItNi0xLTEtODc0NQ_1cbed48a-c73d-44d9-b427-ddedc19d1acf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5dc13d8d15f4d6b9e43ee2747cf2dde_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjItOC0xLTEtODc0NQ_7e2f8dd5-fb07-45e3-bd59-bfcb58939f93">8,335</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjItMTQtMS0xLTg3NDU_ad94aefd-aa5b-4f5b-8881-4e25256d5e32">8,335</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80df96ad8b8e4475847100ff81957f59_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjQtNi0xLTEtODc0NQ_761a1fed-f02c-4260-bac4-ea4552cafd45">27,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjQtMTQtMS0xLTg3NDU_053cf07f-5c18-410d-88f4-b849b15b731a">27,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7594d76a22343b78ed45f29024ebce9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjUtMTItMS0xLTg3NDU_123e8293-c7a6-4fdb-b067-a1bc50a92312">17,747</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjUtMTQtMS0xLTg3NDU_9de04528-3785-4f36-ab86-b2f08689caa8">17,747</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i675d4957f6a54a509db9f8b824f52efb_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjYtMTAtMS0xLTg3NDU_0ff00ac2-c45c-46ea-b99a-bd93399316cc">103,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjYtMTQtMS0xLTg3NDU_dd873180-6fba-4054-b3e9-9263ea82278b">103,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib79fc9d04ebf42eca924b5dba9ff0f88_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjctMi0xLTEtODc0NQ_eb13ca11-04f3-4a05-9b7b-582a800a016f">21,280</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33f36a22d5f5402fa34702e2b60d0b7c_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjctNC0xLTEtODc0NQ_1cff1dc8-2e5c-43fb-89e8-01a53fef970e">2,128</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03ab38e8bc4e4afab23f9031aff6bbbc_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjctNi0xLTEtODc0NQ_efbc4126-8e83-4c42-8a21-1d10050cda28">721,412</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7af9cf8a39fa459fb6db8a6392a90dd2_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjctOC0xLTEtODc0NQ_17a7aebb-78ce-4a62-87fb-c5b7b0b029c8">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7846d15c1c45d0b3c2a14b3b40dbd8_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjctMTAtMS0xLTg3NDU_9597abb5-415e-458b-a5d3-c479d7b9135e">911,787</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i874c262496e7470aad6329cb331b77e1_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjctMTItMS0xLTg3NDU_713bfaae-83df-4026-9baa-be7eaf72057a">19,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjctMTQtMS0xLTg3NDU_926a01e9-bee6-4796-a93b-b434265a75a7">1,616,031</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;padding-right:36pt;text-align:center;text-indent:36pt"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="ic100f0970bae445782808747a3ec391d_64"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ICU MEDICAL,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Amounts in thousands)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.979%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMy0xLTEtMS04NzQ1_3a6d1cfd-8eca-4b4b-90f9-63c17825c496">103,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMy0zLTEtMS04NzQ1_f5f944e5-692a-4016-9c96-f8ecd7539ca7">86,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMy01LTEtMS04NzQ1_35af07ee-ffcc-4881-b9e7-59d09fd2d7c1">101,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNS0xLTEtMS04NzQ1_499554ce-cfc9-4c7b-99c2-db3c05912464">89,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNS0zLTEtMS04NzQ1_9e07c5b7-2bef-4e8a-8fc8-b608b17789ae">85,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNS01LTEtMS04NzQ1_9b49141a-cdb0-410c-9ed4-ca4cd559539c">76,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncash lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="icui:Operatingleaserightofuseassetamortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNi0xLTEtMS04NzQ1_11d79424-f288-47e0-a1d6-1d84135ee61f">9,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="icui:Operatingleaserightofuseassetamortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNi0zLTEtMS04NzQ1_6a17c61e-4ee1-443c-898f-638e3c390e34">9,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="icui:Operatingleaserightofuseassetamortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNi01LTEtMS04NzQ1_a5c46bd5-62b4-41c6-a46f-4ecb96cf230d">8,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNy0xLTEtMS04NzQ1_e4e7d05b-92bf-408e-b8d1-2ae62717f92b">345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNy0zLTEtMS04NzQ1_55ae0caa-3a86-4ae9-8560-65a390e8d87c">7,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNy01LTEtMS04NzQ1_ccee6cb8-6bf3-40d5-83e7-1131f510237f">14,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for warranty and returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="icui:ProvisionForWarrantyAndReturns" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfOC0xLTEtMS04NzQ1_b507b89a-df21-492d-88a5-542e67933daa">831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" sign="-" name="icui:ProvisionForWarrantyAndReturns" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfOC0zLTEtMS04NzQ1_40e7ddef-0f5e-4795-b1b3-21c4ae0ed996">1,576</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="icui:ProvisionForWarrantyAndReturns" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfOC01LTEtMS04NzQ1_09a292a7-2221-4dca-b407-6f7f39776151">134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfOS0xLTEtMS04NzQ1_81f52037-07be-44ac-a337-72cc0ccad14b">27,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfOS0zLTEtMS04NzQ1_1b48ae7b-dbd0-43a7-8af4-6de70d7c2696">23,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfOS01LTEtMS04NzQ1_c0748ef3-1532-4326-95c3-84930b0d3644">21,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss (gain) on disposal or write-off of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTAtMS0xLTEtODc0NQ_c6ee09b4-a23b-4204-b147-cbfaece9a5dd">1,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTAtMy0xLTEtODc0NQ_dcbbef2c-bc9b-4b62-8cac-dd97066df83f">1,789</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTAtNS0xLTEtODc0NQ_2dd59982-d357-481c-b8a7-22247844eea8">12,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bond premium amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:InvestmentIncomeAmortizationOfPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTMtMS0xLTEtODc0NQ_a62e1a89-0b8d-4382-ab75-90b9d7bf1190">655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:InvestmentIncomeAmortizationOfPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTMtMy0xLTEtODc0NQ_00e8d4e4-7519-40df-a016-aa7499d2e492">231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:InvestmentIncomeAmortizationOfPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTMtNS0xLTEtODc0NQ_57b9edf7-a6cc-4945-91bd-71ca2d7e912a">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt issuance cost amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTQtMS0xLTEtODc0NQ_947330ea-6f2b-4cda-b025-678f01b457df">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTQtMy0xLTEtODc0NQ_c1ad53de-8728-4870-b9f4-a1d113cc97d8">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTQtNS0xLTEtODc0NQ_1304a9f9-51fc-43fc-ab74-33029484e591">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of contingent earn-out</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTYtMS0xLTEtODc0NQ_e275091d-2127-4f1f-8b91-f05e75649c3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTYtMy0xLTEtODc0NQ_f1481d7c-7325-4a81-ba7e-d7976a506118">9,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTYtNS0xLTEtODc0NQ_ebf63212-f82e-421b-afb1-ce701b92dde3">47,400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Product-related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:ProductionRelatedImpairmentsOrCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTctMS0xLTEtODc0NQ_69a4fffc-eda9-4b64-9c30-2768ca47cd21">3,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:ProductionRelatedImpairmentsOrCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTctMy0xLTEtODc0NQ_238e2dda-b211-4144-9fdb-30fbaa5ca9dd">2,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:ProductionRelatedImpairmentsOrCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTctNS0xLTEtODc0NQ_871f4d7a-f3f9-4fc6-867d-8050b9598272">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Usage of spare parts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="icui:Sparepartsusage" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTgtMS0xLTEtODc0NQ_bca70bd7-5fcc-4a77-b16c-a2d0f3279103">13,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="icui:Sparepartsusage" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTgtMy0xLTEtODc0NQ_a1eb0871-b172-4440-aa3c-a3cfaf6fc448">11,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="icui:Sparepartsusage" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTgtNS0xLTEtODc0NQ_cb74bea0-dbad-4a8c-8db2-ad3684b46dc1">24,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTktMS0xLTEtODc0NQ_9b40d17b-c906-4aa7-8fae-a16b57bb0c45">2,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTktMy0xLTEtODc0NQ_b97d1b5b-d476-4d4a-ad75-18805f445cc0">6,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTktNS0xLTEtODc0NQ_239a72c8-8525-4a39-bff5-c5ae00021f87">447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of amounts acquired:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjEtMS0xLTEtODc0NQ_4f930708-d036-4aa3-89d1-37f9a1cab539">13,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjEtMy0xLTEtODc0NQ_d3b11d2f-47d4-43ab-b5c7-c76875a999ce">78,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjEtNS0xLTEtODc0NQ_e03d5ca2-a0b4-497c-89b5-ebc8c1562fa8">23,684</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjItMS0xLTEtODc0NQ_9bd07f34-690f-484c-889a-a27cd9b451ac">20,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjItMy0xLTEtODc0NQ_5fa6544b-cd1b-4a8f-a2bd-6cb8594f128e">19,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjItNS0xLTEtODc0NQ_b8491991-4de8-4cf7-8221-6b0d0acb87ee">24,997</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjMtMS0xLTEtODc0NQ_dfd5b0c4-f1fa-4787-89ff-f5a6d57c4f8c">7,973</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjMtMy0xLTEtODc0NQ_bc0e4fe8-b4fb-43a3-93f0-635b9abaf7a0">4,311</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjMtNS0xLTEtODc0NQ_9ceb76ea-6ab7-4219-a63f-50db35c1cb69">8,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjUtMS0xLTEtODc0NQ_a831c4a4-c881-4806-a88a-7b7dda565f5d">21,038</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjUtMy0xLTEtODc0NQ_60ba61df-3431-4e58-b496-5fa6665b551d">16,069</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjUtNS0xLTEtODc0NQ_6b7bf07e-2222-4778-b420-212921cba92d">29,837</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjYtMS0xLTEtODc0NQ_c74f2860-8e29-42b9-9341-c5d4d6c41f54">2,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjYtMy0xLTEtODc0NQ_1bb7a2c9-6382-4730-a6fe-4c08f7938da7">46,415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjYtNS0xLTEtODc0NQ_9e04e485-33aa-49ee-b5f8-693156823e7c">2,697</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjctMS0xLTEtODc0NQ_12858dde-dd50-409a-92f1-e6d304c1e041">6,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjctMy0xLTEtODc0NQ_db5df8ac-5760-4451-aea9-006eae6c2e0b">29,379</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjctNS0xLTEtODc0NQ_6f7006d4-133e-4136-a2fe-900a32806f4c">43,689</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes, including excess tax benefits and deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjgtMS0xLTEtODc0NQ_dc6974a4-5ae6-4442-b96c-af9cf857db4d">874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" sign="-" name="icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjgtMy0xLTEtODc0NQ_7683dbe3-f1ac-48a0-af6e-1e89d5406422">18,037</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjgtNS0xLTEtODc0NQ_cb138622-9c3e-40fb-ae9a-ea5ad2c13ca7">4,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjktMS0xLTEtODc0NQ_c909aa2b-edd7-4101-a9f4-8d88127df4d5">267,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjktMy0xLTEtODc0NQ_8cafd522-7bf7-4a1e-a427-e072ae976229">222,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjktNS0xLTEtODc0NQ_c80e1d46-e921-4bfc-85c9-09ce3fbac002">101,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzEtMS0xLTEtODc0NQ_3f2b894a-04ae-4850-977f-05851fdbdb17">68,542</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzEtMy0xLTEtODc0NQ_9fe36bb5-1d84-40dd-8669-c21bf64d8ad8">92,005</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzEtNS0xLTEtODc0NQ_6ca88aaa-de34-4cee-a70b-97debec88842">97,312</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleOfOtherPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzItMS0xLTEtODc0NQ_10792096-30ad-403c-926c-8207bc05df3a">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleOfOtherPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzItMy0xLTEtODc0NQ_7a894dd9-daa3-47b7-8741-e02b3d527d11">6,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromSaleOfOtherPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzItNS0xLTEtODc0NQ_5aa0dfec-6aa9-42a6-898c-cf63458fdafe">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible asset additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzQtMS0xLTEtODc0NQ_dcc92de4-d900-4d5a-9f71-06a813f7c829">12,627</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzQtMy0xLTEtODc0NQ_3a8b5f9f-c544-4fcd-9eaf-71bbe1f27035">8,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzQtNS0xLTEtODc0NQ_d5ce28dc-1472-4483-8458-12410a6de5dc">8,728</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzUtMS0xLTEtODc0NQ_42f98701-904d-4d1c-b729-91d393e489fe">14,452</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzUtMy0xLTEtODc0NQ_f343aa70-19a1-4305-bb63-093bab342505">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzUtNS0xLTEtODc0NQ_feea72ee-3405-47fa-a80d-ec8eeda4dd31">76,133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investments in non-marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzctMS0xLTEtMjQ5NTM_09526fa0-1282-4c5f-8d39-ab202a4191f9">3,250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzctMy0xLTEtMjQ5NTM_0fd2e8fa-3d03-4fd0-95f0-25feae44dc50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzctNS0xLTEtMjQ5NTM_488d819e-b5d4-45a0-9e8d-a2e9128939c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzctMS0xLTEtODc0NQ_db751ebc-82b6-4f12-bdb0-96389afbff00">10,034</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzctMy0xLTEtODc0NQ_1ed9b6ee-dd8c-4ae0-ad3c-4fce3dc38aa7">32,825</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzctNS0xLTEtODc0NQ_dc835783-4a4e-43e9-a16f-b17165864f8c">26,040</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzgtMS0xLTEtODc0NQ_5f628486-0389-43bd-93e2-049e2288c76d">18,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzgtMy0xLTEtODc0NQ_cd7f7cc8-dfca-451d-8168-2fdb9eb8c0ce">28,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzgtNS0xLTEtODc0NQ_1d71d1e9-5432-4a41-ab0a-40c7f7cee20b">41,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzktMS0xLTEtODc0NQ_03a5f077-08be-4c5a-9244-fda373e6af0a">90,687</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzktMy0xLTEtODc0NQ_b972ed5a-4b3d-4db2-8bea-5bd7c65e8fdc">98,139</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzktNS0xLTEtODc0NQ_ddf0aeb9-9ab9-4017-9b0c-ebf47f0a70e0">166,888</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from short-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDEtMS0xLTEtODc0NQ_f49d5334-d7ef-46e2-ade4-96c1e66c8a0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDEtMy0xLTEtODc0NQ_71c499e0-3caa-4812-b271-3e7a1896efc6">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDEtNS0xLTEtODc0NQ_54363569-e78d-4ec6-bef1-b9d1417179f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment of short-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDItMS0xLTEtODc0NQ_65523de5-36f5-429c-9239-808e54a6da79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDItMy0xLTEtODc0NQ_18506b43-2bf1-42d6-90c1-10968d73a446">150,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDItNS0xLTEtODc0NQ_d7694741-d453-4d0c-94ee-f27cf989e31f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDMtMS0xLTEtODc0NQ_2b8600b2-398b-4493-8966-a40fd4906238">9,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDMtMy0xLTEtODc0NQ_f95331b8-08b3-486c-abef-445d64f2ba84">13,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDMtNS0xLTEtODc0NQ_8feb54f0-682a-4136-88a8-acfa8651b877">7,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDQtMS0xLTEtODc0NQ_244f34be-8658-4c60-9271-61d66342a685">607</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDQtMy0xLTEtODc0NQ_4de97240-7a73-48ff-adbe-a2b1ecd9892c">357</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDQtNS0xLTEtODc0NQ_6c1b3465-748e-4797-bc01-d9c1da518a31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of contingent earn-out</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDYtMS0xLTEtNTgxNjI_e1ce0975-bc6e-4634-8a02-70122512d843">17,300</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDYtMy0xLTEtNTgxNjk_370b5aa1-5ffa-4098-b9db-51406c41342b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDYtNS0xLTEtNTgxNzY_285dd73d-e147-4cc3-b0c2-d89b73bb196e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax withholding payments related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDUtMS0xLTEtODc0NQ_fc68720b-173c-40d8-88ef-a3b95b920d6d">8,335</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDUtMy0xLTEtODc0NQ_24cb3912-aa51-408f-9ca4-3b0353f168a9">12,876</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDUtNS0xLTEtODc0NQ_a70eec36-eb74-407b-9bfd-88e6208ce621">18,639</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDYtMS0xLTEtODc0NQ_a5484f9c-6db5-4401-bfad-514fbe59a4c4">16,870</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDYtMy0xLTEtODc0NQ_5d833182-629d-4693-aca9-de3b9b9dc011">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDYtNS0xLTEtODc0NQ_6f268661-8cb6-48a0-964b-2f4c28fb2f08">10,907</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDctMS0xLTEtODc0NQ_125b9a67-6a57-46af-8c44-c9018b457af6">3,251</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDctMy0xLTEtODc0NQ_6df7fd78-4504-42af-94ed-11ea878ac78e">2,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDctNS0xLTEtODc0NQ_fea31aad-6c6a-4f39-a805-d4b3decd2b5d">234</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDgtMS0xLTEtODc0NQ_f15c9ed3-5d79-4971-a7c2-884a70ea2e01">156,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDgtMy0xLTEtODc0NQ_6ad3267b-8475-4c92-8e6c-97836822edf0">127,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDgtNS0xLTEtODc0NQ_fea1e88d-9b95-4a54-afc7-e6f244948457">76,111</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CASH AND CASH EQUIVALENTS, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDktMS0xLTEtODc0NQ_b5230bd8-d1b1-4b74-8ee0-86a6f0c831f0">396,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDktMy0xLTEtODc0NQ_a7fa5d51-29e2-47a4-9309-8ab5383d5dba">268,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2b82bbcf5cb45739937a1040ed30f6b_I20181231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDktNS0xLTEtODc0NQ_282a475e-dbcf-455b-8e7f-3b7fdac439e8">344,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CASH AND CASH EQUIVALENTS, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNTAtMS0xLTEtODc0NQ_0618aa5d-e0e1-4d95-9c24-67b640d710e7">552,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNTAtMy0xLTEtODc0NQ_5ad7c183-b5cd-4e55-95b6-19a9e902ebb3">396,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNTAtNS0xLTEtODc0NQ_73c3a701-30af-4f63-a7d5-1aac36fa9755">268,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ICU MEDICAL,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CONSOLIDATED STATEMENTS OF CASH FLOWS - CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Amounts in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.979%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid during the year for income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMy0xLTEtMS04NzQ1_6c54b4ad-5f3a-47d7-9bdf-94065676dea2">19,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMy0zLTEtMS04NzQ1_3138e347-5363-4167-88b6-2efcfec490d6">31,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMy01LTEtMS04NzQ1_a6e2ffb5-48f7-4e1e-a03f-25b78c10c846">9,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid during the year for interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfNC0xLTEtMS04NzQ1_c12bee9c-d73f-40fe-b6e2-8d243c59c161">858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfNC0zLTEtMS04NzQ1_abb5bfc4-cad7-4401-bd4f-0dc8f882e496">1,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfNC01LTEtMS04NzQ1_04b41d1c-80c0-4d6f-84a0-425483077ef2">549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable for property, plant and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfNy0xLTEtMS04NzQ1_f20f0a42-b442-45dd-bf26-17376859959f">9,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfNy0zLTEtMS04NzQ1_8bc48067-cfa3-4a06-857f-9dfc66d874f2">2,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfNy01LTEtMS04NzQ1_3638bd7b-efc5-451a-9feb-e5b70e19b179">13,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete agreement with associated contingent earn-out liability</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9697a3ca30dd4537a13752d309cbf40a_D20210101-20211231" decimals="-3" name="us-gaap:LiabilitiesAssumed1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfOC0xLTEtMS0yNTA3Ng_744de93a-1582-4e60-b135-1261ad3a8813">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb01a36c95d4e93ae0a960275048e71_D20200101-20201231" decimals="-3" name="us-gaap:LiabilitiesAssumed1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfOC0zLTEtMS0yNTA3Ng_88fae376-4ea6-48cb-b498-12f642328f96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i034d4febd93748bfa4de828a28a09376_D20190101-20191231" decimals="-3" name="us-gaap:LiabilitiesAssumed1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfOC01LTEtMS0yNTA3Ng_5d507865-ea59-4e9f-a426-ebc56a0c47e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Detail of assets acquired and liabilities assumed in acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231" decimals="-3" name="us-gaap:FairValueOfAssetsAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMTEtMS0xLTEtNjQwNzY_1a0d6584-a27e-436f-9bd3-7a365bf414ac">4,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if41332d164fe48da8c8206c9a376b3d9_D20190101-20191231" decimals="-3" name="us-gaap:FairValueOfAssetsAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMTEtNS0xLTEtNjA4MjM_b99e56c0-a002-442d-b306-ca964d962c10">91,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231" decimals="-3" name="icui:NetCashPaidReceivedforcurrentandprioracquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMTItMS0xLTEtNjQwNzY_652efa58-a329-478f-acec-a28043f2ad4b">14,452</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if41332d164fe48da8c8206c9a376b3d9_D20190101-20191231" decimals="-3" name="icui:NetCashPaidReceivedforcurrentandprioracquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMTItNS0xLTEtNjA4MjM_1ccef729-430d-48c4-88ec-c80a186111da">76,133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if148011629fb4765963a61b648e50f64_I20211231" decimals="-3" name="us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMTMtMS0xLTEtNjQwNzY_72e3b659-3bff-48bd-a425-01109c8c9c12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0e931c53af9433c927233b79bd0bca8_I20191231" decimals="-3" name="us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMTMtNS0xLTEtNjA4MjM_14fd450d-f74a-4fd6-998c-f57d5f4c23f4">17,300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill, acquired during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMTQtMS0xLTEtNjQwNzY_a2bac172-3786-40b0-8afc-88158eeb3523">10,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if41332d164fe48da8c8206c9a376b3d9_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMTQtNS0xLTEtNjA4MjM_33636896-c5da-4b51-9d4b-fd45e103a5c0">20,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Liabilities assumed/Adjustments to liabilities assumed</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231" decimals="-3" name="us-gaap:LiabilitiesAssumed1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMTUtMS0xLTEtNjQwNzY_ee8dbe94-6ba9-4ae7-828c-5dcb30b0b0f5">766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if41332d164fe48da8c8206c9a376b3d9_D20190101-20191231" decimals="-3" name="us-gaap:LiabilitiesAssumed1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMTUtNS0xLTEtNjA4MjM_67b6469a-adbc-44a9-99ad-96d43b5be456">17,612</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="ic100f0970bae445782808747a3ec391d_67"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="text-align:center"><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1. <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1NjE_eb4f0da4-9f1a-4424-9d73-dc37f0be4ff3" continuedAt="if55af660062148e9a419b8a455adedf2" escape="true">BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if55af660062148e9a419b8a455adedf2" continuedAt="i201d3364a57c445e9c581bfd64d0d039"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1MDE_600e0f4f-7677-46a0-8bea-ce54dc997f37" continuedAt="i7b2e0607be3b40a9990fc6886a5c8b1c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Basis of Presentation and Preparation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ICU Medical,&#160;Inc. ("ICU" or "we"), a Delaware corporation, operates in <ix:nonFraction unitRef="segment" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="0" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTgz_8f1e1524-f3c9-42b7-b200-59408e11d9dd">one</ix:nonFraction> business segment engaged in the development, manufacturing and sale of innovative medical devices used in infusion therapy and critical care applications. We are one of the world's leading pure-play infusion therapy companies with a wide-ranging product portfolio that includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needlefree connectors designed to help meet clinical, safety and workflow goals. We sell the majority of our products through our direct sales force and through independent distributors throughout the U.S. and internationally. Additionally, we sell our products on an original equipment manufacturer basis to other medical device manufacturers. The manufacturing for all product groups occurs in Salt Lake City, Utah, Austin, Texas, Mexico and Costa Rica. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All subsidiaries are wholly owned and are included in the consolidated financial statements.&#160; All intercompany accounts and transactions have been eliminated.  Results of operations of companies purchased are included from the dates of acquisition.</span></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7b2e0607be3b40a9990fc6886a5c8b1c">The consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation.  These consolidated financial statements were prepared in accordance with accounting principles generally accepted in the U.S. ("GAAP").</ix:continuation>  <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM2Njc_a95f7d9a-0fe9-49e8-b9b6-c9ab9c3a32e4" escape="true">Preparing financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;Actual results could differ from those estimates.</ix:nonNumeric>&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash, Cash Equivalents</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1NjI_704fb350-25da-4a4c-af8c-5de93f1b1c4d" escape="true">Cash equivalents are short-term, highly liquid investments that are readily convertible to known amounts of cash and have original maturities of three months or less from the date of purchase.</ix:nonNumeric> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounts Receivable</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM2NDY_95495be5-9970-48d8-85f5-efd1005f0aa8" escape="true">Accounts receivable are stated at net realizable value.&#160; An allowance is provided for estimated collection losses based on an assessment of various factors.&#160; We consider prior payment trends, the age of the accounts receivable balances, financial status and other factors to estimate the cash which ultimately will be received.&#160; Such amounts cannot be known with certainty at the financial statement date.&#160; We regularly review individual past due balances for collectability.</ix:nonNumeric></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventories</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM2MTU_6c1cfc3f-b547-43a4-905c-ce425e55c9db" escape="true">Inventories are stated at the lower of cost or net realizable value with cost determined using the first-in, first-out method.</ix:nonNumeric>&#160; Inventory costs include material, labor and overhead related to the manufacturing of our products.&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM2Mzc_689ec4cf-c96a-4f79-b47c-6769f8aca576" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjJjZjFiYzFmZjRiMTQ1YWE5ZjcwMWM2NGU0OGQxMDQwL3RhYmxlcmFuZ2U6MmNmMWJjMWZmNGIxNDVhYTlmNzAxYzY0ZTQ4ZDEwNDBfMi0xLTEtMS04NzQ1_198b789e-b4a7-4ef3-8339-ca7f8f316162">135,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjJjZjFiYzFmZjRiMTQ1YWE5ZjcwMWM2NGU0OGQxMDQwL3RhYmxlcmFuZ2U6MmNmMWJjMWZmNGIxNDVhYTlmNzAxYzY0ZTQ4ZDEwNDBfMi0zLTEtMS04NzQ1_1114882b-de67-428d-ba5a-01acb719cec3">126,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:InventoryWorkInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjJjZjFiYzFmZjRiMTQ1YWE5ZjcwMWM2NGU0OGQxMDQwL3RhYmxlcmFuZ2U6MmNmMWJjMWZmNGIxNDVhYTlmNzAxYzY0ZTQ4ZDEwNDBfMy0xLTEtMS04NzQ1_afc0bd3a-bcb7-41c5-87d1-286e33cabfaa">36,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:InventoryWorkInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjJjZjFiYzFmZjRiMTQ1YWE5ZjcwMWM2NGU0OGQxMDQwL3RhYmxlcmFuZ2U6MmNmMWJjMWZmNGIxNDVhYTlmNzAxYzY0ZTQ4ZDEwNDBfMy0zLTEtMS04NzQ1_d60f2400-97c8-4113-8b3d-0ac5536a4c7d">33,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjJjZjFiYzFmZjRiMTQ1YWE5ZjcwMWM2NGU0OGQxMDQwL3RhYmxlcmFuZ2U6MmNmMWJjMWZmNGIxNDVhYTlmNzAxYzY0ZTQ4ZDEwNDBfNC0xLTEtMS04NzQ1_ab8604be-974c-4a53-9e3f-4bf188bb74aa">118,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjJjZjFiYzFmZjRiMTQ1YWE5ZjcwMWM2NGU0OGQxMDQwL3RhYmxlcmFuZ2U6MmNmMWJjMWZmNGIxNDVhYTlmNzAxYzY0ZTQ4ZDEwNDBfNC0zLTEtMS04NzQ1_ef5b13d3-7615-4aac-9c8b-3cf091d4d77e">155,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjJjZjFiYzFmZjRiMTQ1YWE5ZjcwMWM2NGU0OGQxMDQwL3RhYmxlcmFuZ2U6MmNmMWJjMWZmNGIxNDVhYTlmNzAxYzY0ZTQ4ZDEwNDBfNS0xLTEtMS04NzQ1_5675f141-a54d-4422-9248-c5a35ada4597">290,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjJjZjFiYzFmZjRiMTQ1YWE5ZjcwMWM2NGU0OGQxMDQwL3RhYmxlcmFuZ2U6MmNmMWJjMWZmNGIxNDVhYTlmNzAxYzY0ZTQ4ZDEwNDBfNS0zLTEtMS04NzQ1_dcbda5a2-b9f8-4ce6-9717-c67dc36808b9">314,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><div style="margin-top:5pt"><span><br/></span></div><ix:continuation id="i201d3364a57c445e9c581bfd64d0d039" continuedAt="ie66e31d67c2543c19ab95a4379830ef0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Property, Plant and Equipment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM2NDM_e1b71ad6-f842-4b40-9128-b60ed42f25c6" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consists of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61afae90e5b84b36ad1ae6cc021d0eb0_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfMi0xLTEtMS04NzQ1_4431e0d7-b649-48f2-9989-83215198394f">321,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6086d7242cd44ebcb7bd1c37761445d5_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfMi0zLTEtMS04NzQ1_f76ab6bd-e088-4554-a572-af5fb0163b6c">291,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, building and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia714b658a4174f91844900438be27249_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfMy0xLTEtMS04NzQ1_e3ead90e-ef1e-41cb-a225-1db4d035a20e">243,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i072ea93b43554548bfb1b2e60418ef0a_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfMy0zLTEtMS04NzQ1_c6a07408-8be4-45e4-88ae-afde69068b21">241,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id27451c8315e494eb9d5b71d3102e1d3_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfNC0xLTEtMS04NzQ1_96236f73-e008-403a-a241-9e0b05cc4b89">60,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i396219abad3d4dd5aecaca9b955a4a80_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfNC0zLTEtMS04NzQ1_57667333-35ee-48e9-9877-d59b9ab8ee2f">60,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a69e96fceee4aa4a6456cdac483fa6b_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfNS0xLTEtMS04NzQ1_245491a3-2054-4cef-9868-7b203cf2bda5">102,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb5314a15ad4728830028bd25e4817c_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfNS0zLTEtMS04NzQ1_e6fdeff9-5e6b-402a-b6a8-9e015dfc968d">98,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b2515c8fa54706a4876347394a8195_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfNi0xLTEtMS04NzQ1_3baf4b2f-bbb5-438c-8d2f-9ca5b99200ed">7,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefe3d36c64db435783d6b6b62e9f4928_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfNi0zLTEtMS04NzQ1_665dbe09-55b7-4081-a182-2f9a27857fdf">7,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments placed with customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i868fc2b21a40468eb90303a40fa1cde7_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfNy0xLTEtMS04NzQ1_8dcc3541-d9b2-47ce-82d7-d15a8c11d4ee">97,384</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b8361146b8345eba9e837855e840ccf_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfNy0zLTEtMS04NzQ1_6fa195c7-4b56-4293-9e52-4c9f3dc68d5a">90,383</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife75bb8b09044301a656828fd088ef78_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfOC0xLTEtMS04NzQ1_e4bba9f9-436a-4c6d-8fa8-67931c58ef8d">72,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib215ff3938424c87b3535b21a2d24f0c_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfOC0zLTEtMS04NzQ1_23b2c603-e92e-4204-91ce-7c179b80809e">53,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, cost</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfOS0xLTEtMS04NzQ1_05c6ba87-af84-4685-9d22-90dcce91488a">905,104</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfOS0zLTEtMS04NzQ1_d89dc577-3c91-4916-9d62-ef5fd4318471">843,096</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfMTAtMS0xLTEtODc0NQ_392bebae-4823-4e20-9326-23497b538361">436,739</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfMTAtMy0xLTEtODc0NQ_cd3f5d35-c594-4a58-bb0d-2fc6ef3bcb5e">376,468</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfMTEtMS0xLTEtODc0NQ_b588747c-13ce-4d57-bb1b-97c9ca5320c7">468,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfMTEtMy0xLTEtODc0NQ_0443d440-ce92-45a7-9c19-83b30dcfee1d">466,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instruments placed with customers consist of drug-delivery and monitoring systems placed with customers under operating leases.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1MjA_8f0d5009-9e98-4fa2-b209-d7546d0bbbfd" continuedAt="i744164a8e4ed4c5592840adb1b5b024b" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All property, plant and equipment are stated at cost.&#160; We use the straight-line method for depreciating property, plant  and equipment over their estimated useful lives.&#160; Estimated useful lives are:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i822011b5ee894121826591876ad1fae1_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfMC0xLTEtMS04NzQ1L3RleHRyZWdpb246MWVkYTI2NGYwYTA1NDQ5ZTg0MzQzNTg2MTNiMzAxZGNfNA_915a3dc8-9f8a-487f-bb3a-0c7bc6d2ea85">15</ix:nonNumeric> - <ix:nonNumeric contextRef="i318960434e7e4294b988d5e93c86f870_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfMC0xLTEtMS04NzQ1L3RleHRyZWdpb246MWVkYTI2NGYwYTA1NDQ5ZTg0MzQzNTg2MTNiMzAxZGNfOQ_f97f0e4d-3d3c-4cc5-938f-15987f6c031e">30</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building improvements</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4df894472d734b8ea99f933093d6cae5_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfMS0xLTEtMS04NzQ1L3RleHRyZWdpb246YmMyN2EyM2FlYTIzNDE1MTkzNmYxMzhlZTc1YjM1MzNfNA_3f5a7a19-d1f7-42e1-871f-6d490f1abcf6">15</ix:nonNumeric> - <ix:nonNumeric contextRef="i50ca67d9370d4702bb30549193450259_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfMS0xLTEtMS04NzQ1L3RleHRyZWdpb246YmMyN2EyM2FlYTIzNDE1MTkzNmYxMzhlZTc1YjM1MzNfOQ_46ad0728-138c-40ba-be6b-5c45fb593d35">30</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and molds</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic799598d554f43749764085e6183fa72_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfMi0xLTEtMS04NzQ1L3RleHRyZWdpb246ZGI0M2QwMzNlMzc1NDM5Nzk3NjY5NjIxM2Q0NGZkY2ZfNA_41cfc21d-2270-4f5d-aeca-d8accd6e1e54">2</ix:nonNumeric> - <ix:nonNumeric contextRef="i4fd10f7ed125461b83e7cc71c92b31ff_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfMi0xLTEtMS04NzQ1L3RleHRyZWdpb246ZGI0M2QwMzNlMzc1NDM5Nzk3NjY5NjIxM2Q0NGZkY2ZfOQ_5b38b0f0-2f5c-4c8d-b27e-4e551a9f873e">15</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and office equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1743cebe76c945e1b53dd6ed012b1f15_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfMy0xLTEtMS04NzQ1L3RleHRyZWdpb246MDM0YzMwNmJmOGE4NDExOWI2NmM4NGZkNWJhYzljN2VfNA_455655ad-5819-4f58-b050-84b3f0b4c904">2</ix:nonNumeric> - <ix:nonNumeric contextRef="i980084a01dc24101ade4b0ce4d4f2ce3_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfMy0xLTEtMS04NzQ1L3RleHRyZWdpb246MDM0YzMwNmJmOGE4NDExOWI2NmM4NGZkNWJhYzljN2VfOQ_2dfb4496-411b-424d-852a-626111e75913">5</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i40993659cc874b8bb50c9566a7d7ee5a_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfNC0xLTEtMS04NzQ1L3RleHRyZWdpb246MTYyYzQ3YzRkZDI5NDhlOGFkZmZlYjFhNDFiMTkwZDJfNA_94776586-0047-4c04-b526-12895ba12881">3</ix:nonNumeric> - <ix:nonNumeric contextRef="ica576ec13c89445ca41b2ba35b3a09d6_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfNC0xLTEtMS04NzQ1L3RleHRyZWdpb246MTYyYzQ3YzRkZDI5NDhlOGFkZmZlYjFhNDFiMTkwZDJfOQ_616e049b-973f-4f38-8031-c11e0359e64a">5</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments placed with customers<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2faa6bd24f85459f9cccb242cb8eb478_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfNS0xLTEtMS04NzQ1L3RleHRyZWdpb246NDUxODE3MjU1ZDIzNDQ0Mzk0YjVmYTEzNDQ1NTY0NGNfNA_fe1b31d3-10e0-4ce3-9701-bae62079055e">3</ix:nonNumeric> - <ix:nonNumeric contextRef="ib7d30235ed5b4d94bcfbe47e561d432b_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfNS0xLTEtMS04NzQ1L3RleHRyZWdpb246NDUxODE3MjU1ZDIzNDQ0Mzk0YjVmYTEzNDQ1NTY0NGNfOQ_8f040703-3bb1-4cbd-9a81-bfc5c97b3875">10</ix:nonNumeric> years</span></div></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><ix:continuation id="i744164a8e4ed4c5592840adb1b5b024b"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize expenditures that materially increase the life of the related assets; maintenance and repairs are expensed as incurred.&#160;The costs and related accumulated depreciation applicable to property, plant and equipment sold or retired are removed from the accounts and any gain or loss is reflected in the statements of operations at the time of disposal. Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMzkzNQ_3c74f379-c13c-4369-a184-4161921f19df">65.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMzkzOQ_2fac7ccb-7bd8-4ae3-aa12-f79b8a812dc9">62.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMzk0Ng_d1f05750-1c33-41b8-970f-e3b7b0efda76">59.3</ix:nonFraction> million in 2021, 2020 and 2019, respectively.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1ODI_248ef9b1-4115-40ee-872f-d98f01c47f63" continuedAt="id9ee60231b904f868f4edeb87732d664" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Goodwill</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:nonNumeric><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id9ee60231b904f868f4edeb87732d664">We test goodwill for impairment on an annual basis in the month of November, or more frequently if an event occurs or circumstances change that would indicate that impairment may exist.&#160;Generally, we first perform a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If, based on an assessment of relevant qualitative factors, we determine that this is not the case, then the quantitative impairment test is not required to be performed. Conversely, if we determine based on the qualitative assessment that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, we will perform the quantitative impairment test. For the quantitative impairment test, we calculate the estimated fair value of the reporting unit. If the estimated fair value of the reporting unit is less than its carrying amount, the goodwill of the reporting unit is determined to be impaired. An impairment charge is recorded in an amount equal to the excess of the carrying amount over its estimated fair value, limited to the total amount of goodwill allocated to the reporting unit. For our annual impairment test for the year ended December 31, 2021, we performed a qualitative assessment and concluded that it was more likely than not that the fair value of our reporting unit exceeded its carrying amount, and therefore, no further impairment testing was required.</ix:continuation> There were no accumulated impairment losses as of December&#160;31, 2021, 2020 and 2019. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><div style="text-indent:18pt"><span><br/></span></div><ix:continuation id="ie66e31d67c2543c19ab95a4379830ef0" continuedAt="i18ab963cbe3542c1a61deb9fc2f9ae14"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1NDE_7aa429b1-e043-467b-b339-cf2724b1d3e0" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the carrying amount of our goodwill for 2021, 2020 and 2019 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:78.665%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2b82bbcf5cb45739937a1040ed30f6b_I20181231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2NmU4ZTg3MjU3YjQyZDhiY2I4MDhiMGQ4N2M1ZGMyL3RhYmxlcmFuZ2U6YTY2ZThlODcyNTdiNDJkOGJjYjgwOGIwZDg3YzVkYzJfMS0yLTEtMS04NzQ1_5b71ee5a-553a-4d72-922d-dbc5efe60f3f">11,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2NmU4ZTg3MjU3YjQyZDhiY2I4MDhiMGQ4N2M1ZGMyL3RhYmxlcmFuZ2U6YTY2ZThlODcyNTdiNDJkOGJjYjgwOGIwZDg3YzVkYzJfMi0yLTEtMS04NzQ1_ee5b9311-6416-4d2b-964a-1091205675d6">20,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2NmU4ZTg3MjU3YjQyZDhiY2I4MDhiMGQ4N2M1ZGMyL3RhYmxlcmFuZ2U6YTY2ZThlODcyNTdiNDJkOGJjYjgwOGIwZDg3YzVkYzJfMy0yLTEtMS04NzQ1_642d1632-4c52-4791-9d6b-e18e9d7c40e7">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2NmU4ZTg3MjU3YjQyZDhiY2I4MDhiMGQ4N2M1ZGMyL3RhYmxlcmFuZ2U6YTY2ZThlODcyNTdiNDJkOGJjYjgwOGIwZDg3YzVkYzJfNC0yLTEtMS04NzQ1_06dceb19-f689-432b-8f19-a4c56ae62218">31,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2NmU4ZTg3MjU3YjQyZDhiY2I4MDhiMGQ4N2M1ZGMyL3RhYmxlcmFuZ2U6YTY2ZThlODcyNTdiNDJkOGJjYjgwOGIwZDg3YzVkYzJfNi0yLTEtMS04NzQ1_e5a8517d-f6df-4475-a1c7-e2e697408297">1,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2NmU4ZTg3MjU3YjQyZDhiY2I4MDhiMGQ4N2M1ZGMyL3RhYmxlcmFuZ2U6YTY2ZThlODcyNTdiNDJkOGJjYjgwOGIwZDg3YzVkYzJfNy0yLTEtMS04NzQ1_fbd34a96-24f8-493d-bb2e-69587a5ded6a">33,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2NmU4ZTg3MjU3YjQyZDhiY2I4MDhiMGQ4N2M1ZGMyL3RhYmxlcmFuZ2U6YTY2ZThlODcyNTdiNDJkOGJjYjgwOGIwZDg3YzVkYzJfOC0yLTEtMS04NzQ1_ba643052-a7ec-4b11-b2f6-45bc99dbce18">10,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2NmU4ZTg3MjU3YjQyZDhiY2I4MDhiMGQ4N2M1ZGMyL3RhYmxlcmFuZ2U6YTY2ZThlODcyNTdiNDJkOGJjYjgwOGIwZDg3YzVkYzJfOS0yLTEtMS04NzQ1_192ee25c-e390-45cf-a483-d371aede3cf5">188</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2NmU4ZTg3MjU3YjQyZDhiY2I4MDhiMGQ4N2M1ZGMyL3RhYmxlcmFuZ2U6YTY2ZThlODcyNTdiNDJkOGJjYjgwOGIwZDg3YzVkYzJfMTAtMi0xLTEtODc0NQ_64c9654d-2ad3-492d-a592-5befc0adfffb">43,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we acquired Pursuit Vascular, Inc. ("Pursuit"), which resulted in $<ix:nonFraction unitRef="usd" contextRef="i89ee2db57d0940749f8358a063c8a2a1_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMzI5ODUzNDkyMjEwMg_80724b3b-8826-4236-b098-21dec644148f">19.1</ix:nonFraction>&#160;million of goodwill. We also acquired a small foreign distributor, which resulted in $<ix:nonFraction unitRef="usd" contextRef="ia3bf6d7cdae3492fbe677ee76c1cb8ac_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMzI5ODUzNDkyMjExNw_22d89b3b-9330-4122-8f86-b61753cee06d">0.9</ix:nonFraction>&#160;million of goodwill.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, "Other" relates to a $<ix:nonFraction unitRef="usd" contextRef="ic5bfa62a49ec4bacbfe8ca5e5984c085_D20200101-20201231" decimals="-5" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfNDk3OA_19eaf289-2518-4ca9-bbe7-7ae023ef1383">1.3</ix:nonFraction>&#160;million measurement period adjustment to deferred taxes related to the Pursuit acquisition and foreign currency translation.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In 2021, we acquired a small foreign infusion systems supplier, which resulted in $<ix:nonFraction unitRef="usd" contextRef="i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjc0ODc3OTEyNTkzNA_cf2de229-cb73-447f-a284-61419713114a">10.6</ix:nonFraction>&#160;million of goodwill.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Intangible Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM0OTk_85ad02c1-a550-415b-b8c1-8e261a1b1c9f" continuedAt="ie2e6a80998a447129e74b6b330caf244" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1ODY_f9944f4e-6596-4280-bbea-9c558f57ce00" escape="true">Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis</ix:nonNumeric>, were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.362%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life<br/>in Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8086db60836949cea234f284bb9446be_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMi0yLTEtMS04NzQ1_baff1868-f7f8-48c4-96c8-43d64c3ecb91">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife577e5d213f40d098d9178ce5ed5c02_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMi00LTEtMS04NzQ1_08af983d-5271-4af0-85cb-4a1fdb4d0036">27,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife577e5d213f40d098d9178ce5ed5c02_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMi02LTEtMS04NzQ1_883782f6-d0ce-4115-bebd-b2800891d71e">16,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife577e5d213f40d098d9178ce5ed5c02_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMi04LTEtMS04NzQ1_96ae8154-bc9b-4d1c-9b71-3b817ea08f2e">10,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3f08a7535a0c4ae593f5fdb4d1908ae3_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMy0yLTEtMS04NzQ1_eca7e56b-5a82-4736-98d9-447427d237c9">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23400b23c1e244b8be1368b5b1d1feda_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMy00LTEtMS04NzQ1_cd018c94-26cc-4e8b-8938-9f68aed39c12">10,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23400b23c1e244b8be1368b5b1d1feda_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMy02LTEtMS04NzQ1_c608d97d-5c3c-476d-bace-e6decdb6d3b0">6,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23400b23c1e244b8be1368b5b1d1feda_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMy04LTEtMS04NzQ1_9e1f9e60-effd-453c-9201-4e39080ef1ab">4,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia9ad9660b38a4c59af223be9f97ad9a2_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNC0yLTEtMS04NzQ1_2c154102-df41-4abe-b96a-11eba540bf9a">9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94bfb3c1291d4f5ea822b381ec4471a5_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNC00LTEtMS04NzQ1_86f658cc-07f8-465d-b4ab-481a185b56d6">57,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94bfb3c1291d4f5ea822b381ec4471a5_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNC02LTEtMS04NzQ1_9e5e7da4-5b9e-49b4-8da9-a0c2f96bb0c9">33,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94bfb3c1291d4f5ea822b381ec4471a5_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNC04LTEtMS04NzQ1_8c8e7c8b-6a0f-4605-b5f8-a795a5ad438a">24,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i67322613ac0a460da4f4187ecad1ca17_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNS0yLTEtMS04NzQ1_62ebf4af-74f6-4690-93df-f902ceed0526">4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabdb763a977547f398fe485e2aa320a0_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNS00LTEtMS04NzQ1_4ddecb94-23c7-4729-b8d7-df17882ecc00">425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabdb763a977547f398fe485e2aa320a0_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNS02LTEtMS04NzQ1_a26ba8a4-e0f2-4223-ade6-5fb3aa8b2ef9">425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabdb763a977547f398fe485e2aa320a0_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNS04LTEtMS04NzQ1_35f7f732-390e-4e92-89cb-77d19ac63850">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i51d012416f844ef69b4d06482f83559a_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNi0yLTEtMS04NzQ1_65c71bdb-1cb7-4358-a2a9-4530d57d2d5b">15</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad98788582c4b17b4c46945d8400c45_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNi00LTEtMS04NzQ1_b953c626-1bcb-4c40-8006-9cd9f67d687d">18,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad98788582c4b17b4c46945d8400c45_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNi02LTEtMS04NzQ1_59811b66-f73f-4a28-95b5-4eb53c172eb7">4,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad98788582c4b17b4c46945d8400c45_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNi04LTEtMS04NzQ1_fa15407b-8651-4803-96a7-a6da58a98212">13,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iac77f6f1c1154bc8a57fd11e9cacd63c_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNy0yLTEtMS04NzQ1_11e9ef1f-1659-438f-9fb6-6ee14dafa22b">13</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f07bcb26004cbfb2eb785632880532_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNy00LTEtMS04NzQ1_b49406b3-b8d2-4434-9400-8162fd0a2185">152,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f07bcb26004cbfb2eb785632880532_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNy02LTEtMS04NzQ1_0d76be99-5907-4057-a2fd-b2443f1255dc">49,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f07bcb26004cbfb2eb785632880532_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNy04LTEtMS04NzQ1_b9c907d1-c0be-4aa3-965f-3ff0967c614a">103,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id5895f4898494fbcb93a3646e38e38e9_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfOC0yLTEtMS04NzQ1_a0350469-137b-45b2-b403-4f0bc7a39e53">3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2a1a60f23694878b292a8b8e642f7f7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfOC00LTEtMS04NzQ1_4b780244-6ac1-469a-b605-67d1170edc91">9,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2a1a60f23694878b292a8b8e642f7f7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfOC02LTEtMS04NzQ1_9015ce54-cf77-42ce-91d3-85d06d9462a2">2,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2a1a60f23694878b292a8b8e642f7f7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfOC04LTEtMS04NzQ1_46f52efa-b869-409d-b26a-742083315138">6,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfOS00LTEtMS04NzQ1_95669cf7-69df-4348-91ba-cf1e52ad4e87">275,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfOS02LTEtMS04NzQ1_e414347e-6d82-4363-b2af-11d0ad087c8e">112,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfOS04LTEtMS04NzQ1_ee1cc144-dcc6-4a0f-9869-fb700508d87b">162,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6da6e9834cb04c8aa17f5c4e02ded7c8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMTEtNC0xLTEtODc0NQ_dfa7d21d-8348-4a97-a2b6-1ef3640cf1e0">25,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6da6e9834cb04c8aa17f5c4e02ded7c8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMTEtOC0xLTEtODc0NQ_6f68045e-7625-497b-ab55-95f09c50a843">25,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMTMtNC0xLTEtODc0NQ_3c25c24a-3f26-4bc7-a8e7-6e839c8b6187">301,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMTMtNi0xLTEtODc0NQ_1c347630-f7b8-47e6-8246-25bb1a8dbbbb">112,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMTMtOC0xLTEtODc0NQ_4679d0fe-0e14-4053-a77a-b787d038385a">188,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i18ab963cbe3542c1a61deb9fc2f9ae14" continuedAt="i26019f8f273c4e02b2caa16078f4a973"><ix:continuation id="ie2e6a80998a447129e74b6b330caf244"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.362%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life<br/>in Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib00800b3296448d1a1aaa2ee891468e8_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMi0yLTEtMS04NzQ1_45cb6ac9-f25a-4401-a042-040bd418a2ee">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9c99a7ffc344097b04bba35817b6ec1_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMi00LTEtMS04NzQ1_0e29737a-e233-4db5-ad3e-548c2666e938">24,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9c99a7ffc344097b04bba35817b6ec1_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMi02LTEtMS04NzQ1_7b80604f-5820-4842-8c5a-ce6c09ca3d3f">15,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9c99a7ffc344097b04bba35817b6ec1_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMi04LTEtMS04NzQ1_725c9995-fcaa-4d8d-971f-724c88809ccc">9,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if022b8b9f44c46cc9f1a9647646caf11_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMy0yLTEtMS04NzQ1_cfc32bfe-dcef-490b-b270-ab74c83419da">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c1c4ee566ca4ff0a0939c34c6f27d97_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMy00LTEtMS04NzQ1_a5ece1ae-e6b5-4c2c-b34f-962c1b8702c9">10,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c1c4ee566ca4ff0a0939c34c6f27d97_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMy02LTEtMS04NzQ1_c5f4ce79-977b-4a7b-a169-a520009cbc2c">5,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c1c4ee566ca4ff0a0939c34c6f27d97_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMy04LTEtMS04NzQ1_dab0443f-5a29-4ba6-8066-31610da45f99">4,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i921788560f30477b876f3a224b358d25_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNC0yLTEtMS04NzQ1_eb0d38be-5b29-43f0-8098-85380402f315">9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4906e0126214b09aa3b35cb86a5cbd3_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNC00LTEtMS04NzQ1_d45c124f-91b4-4e58-8f89-161fd06722c9">58,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4906e0126214b09aa3b35cb86a5cbd3_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNC02LTEtMS04NzQ1_f072f360-b337-4996-ab4d-06d30b40216f">26,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4906e0126214b09aa3b35cb86a5cbd3_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNC04LTEtMS04NzQ1_43558b69-025d-40d7-a84b-67982cce75f3">31,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic0af18a5e59b4620b0a5bf6fba3fc7a7_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNS0yLTEtMS04NzQ1_e86d3d6c-21e4-4e68-9ff3-815e7d68701e">4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e2d8c5d74764c0c8112c9015c783cbe_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNS00LTEtMS04NzQ1_0da7c15d-1ba1-4c6d-8e73-d663acc88fbd">425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e2d8c5d74764c0c8112c9015c783cbe_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNS02LTEtMS04NzQ1_b3556f5e-23cd-4de1-af8d-8ca21e2053a6">425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e2d8c5d74764c0c8112c9015c783cbe_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNS04LTEtMS04NzQ1_ac890db8-1515-433d-bfde-1e54c4cfe480">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i85668d0214784e5a8fb9f8869bea0496_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNi0yLTEtMS04NzQ1_3aef9a87-09df-49d9-b29d-c534adff8c68">15</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84b90248fb4943b1a217759d4dab622c_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNi00LTEtMS04NzQ1_c72589be-746f-485f-9b49-4eb2e270d331">18,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84b90248fb4943b1a217759d4dab622c_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNi02LTEtMS04NzQ1_d97cb2d9-20ca-4102-bfef-1fbdf84f9a83">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84b90248fb4943b1a217759d4dab622c_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNi04LTEtMS04NzQ1_e363f086-7fdb-4542-9531-8c9d9328e615">14,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8fa85a3402ad4c77b8d5f87d4e48cabc_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNy0yLTEtMS04NzQ1_975a4818-a868-4370-a886-4168f21852d5">13</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fabf3a8e3e34339833d25e4808ff80b_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNy00LTEtMS04NzQ1_3914b489-99bc-4a92-b3d1-2a5f46dd29be">152,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fabf3a8e3e34339833d25e4808ff80b_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNy02LTEtMS04NzQ1_7d3f5d77-61b2-4825-beba-f47d04408ab5">36,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fabf3a8e3e34339833d25e4808ff80b_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNy04LTEtMS04NzQ1_8c6f2dae-b973-4b0e-afc1-d4679f08ecd1">115,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3dc15f5f21ee4966a24eaabd60b1d494_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfOC0yLTEtMS04NzQ1_4e11085d-99a6-4955-9f23-4034587a2110">3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i810debf07d694305bd3dc90b59bb25a0_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfOC00LTEtMS04NzQ1_e527e393-44ee-4c98-b58f-5cd302f8dfd4">2,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i810debf07d694305bd3dc90b59bb25a0_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfOC02LTEtMS04NzQ1_84659ab7-f916-479b-ad96-b97f899ba6e8">972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i810debf07d694305bd3dc90b59bb25a0_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfOC04LTEtMS04NzQ1_624cd94b-48e9-415f-82b5-287a491c185d">1,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfOS00LTEtMS04NzQ1_143566c2-fa5b-42a2-9c0b-201a54d703f1">267,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfOS02LTEtMS04NzQ1_e0c84a3f-b17c-4d36-86e9-5354dfe6d31c">89,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfOS04LTEtMS04NzQ1_791f66e0-9b3a-4c90-a954-05400b11ae4f">177,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4751e08bde88447d8b34bf752eed3cdc_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMTEtNC0xLTEtODc0NQ_6ac9cdeb-b3d4-4607-8ea1-a46426228471">19,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4751e08bde88447d8b34bf752eed3cdc_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMTEtOC0xLTEtODc0NQ_0b7cc9c8-2be2-4974-aefe-ce0fa4e0e4a4">19,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMTMtNC0xLTEtODc0NQ_0419da22-5dcf-4c6f-ac5b-dc9fb3563540">286,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMTMtNi0xLTEtODc0NQ_c8a8334e-9f0a-4ca0-95f0-57416f239ade">89,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMTMtOC0xLTEtODc0NQ_8c72c6e9-8882-4310-88fe-29e51ce18571">197,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfNTYyNg_e1749a11-face-4814-bb5f-6616d406cd30">23.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfNTYzMA_e8ae960d-ea1e-4d3d-a7ed-54ed045427f6">23.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfNTYzNw_9d070d44-8d53-4a5e-9f9f-a1a953aeef95">17.7</ix:nonFraction> million in 2021, 2020 and 2019, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM2Nzc_45ed9156-3c49-4df3-bcf6-f3af104d18ce" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, estimated annual amortization for our intangible assets for each of the next five years is approximately (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:78.665%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdiZjFhOGRiYTQyMDQ3MzhiNWYwODFjMGEzZTA0YjFlL3RhYmxlcmFuZ2U6N2JmMWE4ZGJhNDIwNDczOGI1ZjA4MWMwYTNlMDRiMWVfMC0yLTEtMS04NzQ1_8f28c5b7-1065-4dfb-8686-d198e1f5843c">25,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdiZjFhOGRiYTQyMDQ3MzhiNWYwODFjMGEzZTA0YjFlL3RhYmxlcmFuZ2U6N2JmMWE4ZGJhNDIwNDczOGI1ZjA4MWMwYTNlMDRiMWVfMS0yLTEtMS04NzQ1_18c9dc9a-7916-4139-b081-2173e52581cb">24,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdiZjFhOGRiYTQyMDQ3MzhiNWYwODFjMGEzZTA0YjFlL3RhYmxlcmFuZ2U6N2JmMWE4ZGJhNDIwNDczOGI1ZjA4MWMwYTNlMDRiMWVfMi0yLTEtMS04NzQ1_d8f471fa-812f-46b5-8575-fb5d220620fc">23,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdiZjFhOGRiYTQyMDQ3MzhiNWYwODFjMGEzZTA0YjFlL3RhYmxlcmFuZ2U6N2JmMWE4ZGJhNDIwNDczOGI1ZjA4MWMwYTNlMDRiMWVfMy0yLTEtMS04NzQ1_78797b54-b39f-48ff-9807-5d4f9171ebbd">16,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdiZjFhOGRiYTQyMDQ3MzhiNWYwODFjMGEzZTA0YjFlL3RhYmxlcmFuZ2U6N2JmMWE4ZGJhNDIwNDczOGI1ZjA4MWMwYTNlMDRiMWVfNC0yLTEtMS04NzQ1_0ba4a717-ee9b-4906-8a4d-8734e6abd7e6">15,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdiZjFhOGRiYTQyMDQ3MzhiNWYwODFjMGEzZTA0YjFlL3RhYmxlcmFuZ2U6N2JmMWE4ZGJhNDIwNDczOGI1ZjA4MWMwYTNlMDRiMWVfNS0yLTEtMS04NzQ1_641a1126-72e6-4708-83d0-323423fd6a6f">58,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdiZjFhOGRiYTQyMDQ3MzhiNWYwODFjMGEzZTA0YjFlL3RhYmxlcmFuZ2U6N2JmMWE4ZGJhNDIwNDczOGI1ZjA4MWMwYTNlMDRiMWVfNi0yLTEtMS04NzQ1_0b09df2f-d452-4d31-8627-56ceb0885dc8">162,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our intangible assets that are not subject to amortization are reviewed annually for impairment or more often if there are indications of possible impairment.  We perform our annual intangible assets impairment test in November of each year. We did not have any intangible asset impairments in 2021, 2020 or 2019.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1NjU_d3a12278-a4e4-486a-bb41-7fc2e25533ff" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-Lived Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically evaluate the recoverability of long-lived assets whenever events and changes in circumstances indicate that the carrying amount of an asset may not be fully recoverable. When indicators of impairment are present, the carrying values of the assets are evaluated in relation to the operating performance and future undiscounted cash flows of the underlying business. The net book value of the underlying asset is adjusted to fair value if the sum of the expected discounted cash flows is less than book value. Fair values are based on estimates of market prices and assumptions concerning the amount and timing of estimated future cash flows and discount rates, reflecting varying degrees of perceived risk. We did not have any long-lived asset impairments in 2021, 2020 or 2019.</span></div></ix:nonNumeric><div style="text-indent:24.75pt"><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM2MjM_35cde9f0-d1a5-42dd-a632-cdf38b814255" continuedAt="i217556c1fdd444b6a9f184ca436026a0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investment Securities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments, exclusive of cash equivalents, are marketable securities intended to be sold within one year and may include trading securities, available-for-sale securities, and held-to-maturity securities (if maturing within one year at </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i26019f8f273c4e02b2caa16078f4a973" continuedAt="i609ac5bbb4924a17bdbb2e36fad65efb"><ix:continuation id="i217556c1fdd444b6a9f184ca436026a0" continuedAt="i888d1e4bb43b468aa3f09759f248340f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the time of acquisition).  Long-term investments are marketable securities intended to be sold after one year and may include trading securities, available-for-sale securities, and held-to-maturity securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Available-for-sale Securities </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment securities are considered available-for-sale and currently consist of short-term and long-term corporate bonds. These securities are considered &#8220;investment grade&#8221; and are carried at fair value. We assess our investment in available-for-sale debt securities for impairment each reporting period. If an unrealized loss exists, we determine whether any portion of the decline in fair value below the carrying value is credit-related by reviewing several factors, including, but not limited to, the extent of the fair value decline and changes in the financial condition of the issuer. We record an impairment for credit-related losses through an allowance, limited to the amount of the unrealized loss. If we either intend to sell or it is more likely than not we will be required to sell the debt security before its anticipated recovery, any allowance is written off and the amortized cost basis is written down to fair value through a charge against net earnings. Unrealized gains and non-credit-related unrealized losses are recorded, net of tax, in other comprehensive income (loss). We did not have any investments in available-for-sale debt securities in unrealized loss positions as of December 31, 2021 or 2020.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i888d1e4bb43b468aa3f09759f248340f">The amortized cost of the debt securities is adjusted for the amortization of premiums computed under the effective interest method. Such amortization is included in other income, net in the consolidated statements of operations. Realized gains and losses are accounted for on the specific identification method. There have been no realized gains or losses on the disposal of these investments. The scheduled maturities of the debt securities are between 2022 and 2024. All short-term investment securities are callable within one year.</ix:continuation>  </span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1MDM_1a0d0e1b-f453-49c5-9fd8-a2196501fa41" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term and long-term investments in available-for-sale securities consist of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.943%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2247e3aa5f7f425e92dffe9649cbcb7b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfMi0xLTEtMS04NzQ1_b8168d3e-4816-4ccf-83ed-5ebbbfc0f8a8">14,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1ed14983dc8444fb29c6fdb143af063_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfMi0zLTEtMS04NzQ1_96764c35-638f-4a52-8bfa-140f9ef9956a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2247e3aa5f7f425e92dffe9649cbcb7b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfMi01LTEtMS04NzQ1_178bb7b8-f808-40b5-8802-96371fc675d5">14,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad22bdcd21ac4a51bb81dc8d8fc119a9_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfMy0xLTEtMS04NzQ1_c44d2d72-bc9a-4687-afaf-219eb8a59df0">4,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0aa1b29ef9844f29ed55e5350042310_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfMy0zLTEtMS04NzQ1_d232077d-f1e1-4c0e-8a08-5a182b1be091">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad22bdcd21ac4a51bb81dc8d8fc119a9_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfMy01LTEtMS04NzQ1_4be8e255-b909-41aa-b5e0-45711cb2fccd">4,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfNC0xLTEtMS04NzQ1_dbc2aa74-f442-40bd-971a-09e46ab8753d">19,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfNC0zLTEtMS04NzQ1_7bf86bdc-8c81-4be3-8596-e7be68298547">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfNC01LTEtMS04NzQ1_d0b2fa4a-04f6-4b04-b319-ba32467d3ba6">19,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e6c4333e95b489298867ff378f75de9_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfOC0xLTEtMS04NzQ1_59f56800-78ee-4159-a5f6-f3113191b62c">14,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffa9110d543f4303a3b7762b85f661f3_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfOC0zLTEtMS04NzQ1_fdfe82e9-b0bf-4c82-8945-69ed1a746baa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e6c4333e95b489298867ff378f75de9_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfOC01LTEtMS04NzQ1_1fff95b3-998f-45e4-86e7-1d1d4ff78d4b">14,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i647dc634368041129731810420d0ebbc_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfOS0xLTEtMS04NzQ1_912967b1-014c-41c3-af81-613282595016">12,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b51175d4f8a42ccb2a3d0734e66cec3_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfOS0zLTEtMS04NzQ1_dcb6ec73-4555-4749-8579-355996b7d663">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i647dc634368041129731810420d0ebbc_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfOS01LTEtMS04NzQ1_a3f81aac-79a7-47c5-9774-12794ef922f2">12,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfMTAtMS0xLTEtODc0NQ_c1abfe54-d837-43a6-b1b9-32f485c444e2">27,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfMTAtMy0xLTEtODc0NQ_d5a5400f-f12a-418c-843e-69251a3405f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfMTAtNS0xLTEtODc0NQ_c7a95891-412e-4427-8405-690a4302355c">27,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Non-Marketable Equity Securities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2021, we acquired approximately a <ix:nonFraction unitRef="number" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="1" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTA5OTUxMTY4NjY3Mw_24c24164-9e56-42f5-a974-6426baf2f088">20.0</ix:nonFraction>% non-marketable equity interest in a nonpublic company and entered into a three-year distribution agreement where we have the exclusive rights to market, sell and distribute the company's products in exchange for a cash payment of $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTA5OTUxMTY4NjY4MA_d5dcf0f6-35df-41f5-89ec-f8c18ee0ace3">3.3</ix:nonFraction>&#160;million. In addition, we were granted an exclusive license for all of the seller's intellectual property. At the expiration of the distribution agreement we have the right but not the obligation to acquire the remaining interest in the business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTA5OTUxMTY4NjY5NQ_c752c77b-2c2a-49c3-9ae5-ec3e94622de8" continuedAt="if6ea43583983415d98d8d58bebc5787f" escape="true">We apply the equity method of accounting for investments when we determine we have a significant influence, but not a controlling interest in the investee. We determine whether we have significant influence by considering key factors such as ownership interest, representation on the board of directors, participation in policy making decisions, business relationship and material intra-entity transactions, among other factors. Our equity method investment is reported at cost and adjusted each period for our share of the investee's income or (loss) and dividend paid, if any. We eliminate any intra-entity profits to the extent of our beneficial interest. We record our share of the investee's income or (loss) on a one quarter lag. We report our </ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i609ac5bbb4924a17bdbb2e36fad65efb" continuedAt="i2237e8c824bd43a2bfa639ebc0dbebf3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if6ea43583983415d98d8d58bebc5787f">proportionate share of the investee's income or (loss) resulting from this investment in other income, net in our consolidated statements of operations. The carrying value of our equity method investment is reported in other assets on the consolidated balance sheets. We assess our equity method investments for impairment on an annual basis or whenever events or circumstances indicate that the carrying value of the investment may not be recoverable.</ix:continuation> During 2021, there were no indications that our non-marketable equity method investment was impaired. Our recorded share of the investee's loss was not material for the year ended December 31, 2021. We did not receive any dividend distributions from this investment during 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTA5OTUxMTY4NjY5OA_a0d992b6-c023-4249-8afa-b37d6f909b10" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-marketable equity method investment consists of the following (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjZhYThiNjA1YTcwOTQ1MzM4OTc5ZTc0MDQ5MmZjMmM5L3RhYmxlcmFuZ2U6NmFhOGI2MDVhNzA5NDUzMzg5NzllNzQwNDkyZmMyYzlfMi0xLTEtMS0yNjMwMQ_18fec6fc-ffde-4589-89ce-9f6c1b897a13">3,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjZhYThiNjA1YTcwOTQ1MzM4OTc5ZTc0MDQ5MmZjMmM5L3RhYmxlcmFuZ2U6NmFhOGI2MDVhNzA5NDUzMzg5NzllNzQwNDkyZmMyYzlfMi0zLTEtMS0yNjI5NA_d4f4adf5-70a4-435c-a755-af4da5369c7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1MDQ_af8b5cb3-9a6b-4823-82c1-6f54bc7d8dbf" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Income Taxes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred taxes are determined based on the differences between the financial statements and the tax bases using rates as enacted in the laws. A valuation allowance is established if it is &#8220;more likely than not&#8221; that all or a portion of the deferred tax assets will not be realized.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize interest and penalties related to unrecognized tax benefits in the tax provision. We recognize liabilities for uncertain tax positions when it is more likely than not that a tax position will not be sustained upon examination and settlement with various taxing authorities. Liabilities for uncertain tax positions are measured based upon the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. We have not recorded any material interest or penalties during any of the years presented.</span></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM2MzM_9f24bdb5-d42d-4379-ab1f-4c9d8aaaa98b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Foreign Currency</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, the functional currency of our international subsidiaries is the local currency. Generally, we translate the financial statements of these subsidiaries to U.S. dollars at the exchange rate in effect at the balance sheet date and revenues and expenses are translated at the average monthly exchange rates during the year. Certain of our international subsidiaries consolidate first with another subsidiary that utilizes a functional currency other than U.S. dollars.&#160;In those cases, we follow a step by step translation process utilizing the same sequence as the consolidation process.&#160;Translation adjustments are recorded as a component of accumulated other comprehensive loss, a separate component of stockholders' equity on our consolidated balance sheets and the effect of exchange rate changes on cash and cash equivalents are reflected on our consolidated statements of cash flows.&#160;Gains and losses for transactions denominated in a currency other than the functional currency of the entity are included in our consolidated statements of operations in other income, net. Foreign currency transaction losses (gains), net were $<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTA4MTA_7ccf9a78-bfb0-4b3a-b32f-f1101c52e1c5">1.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTA4MjA_a564638d-58b7-4478-89bd-55da3bdbf116">7.2</ix:nonFraction> million and $(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjc0ODc3OTEwNzYxNw_604153f3-ab82-4277-9489-b802cd87b278">0.7</ix:nonFraction>) million in 2021, 2020 and 2019, respectively.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM2NjM_08d29617-ea27-4ecb-8795-cbccf097bcad" continuedAt="i18ea2c0b614f4e389258499850d5f218" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revenue Recognition</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenues when we transfer control of promised goods to our customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods.  We offer certain volume-based rebates to our distribution customers, which we consider variable consideration when calculating the transaction price. Rebates are offered on both a fixed and tiered/variable basis. In both cases, we use information available at the time and our historical experience with each customer to estimate the most likely rebate amount. We also provide chargebacks to distributors that sell to end customers at prices determined under a contract between us and the end customer. Chargebacks are the difference between prices we charge our distribution customers and contracted prices we have with the end customer which are processed as credits to our distribution customers. In estimating the expected value of chargeback amounts for use in determining the transaction price, we use information available at the time, including our historical experience. We also warrant products against defects and have a policy permitting the return of defective products, for which we accrue and expense at the time of sale using information available and our historical experience. Our revenues are recorded at the net sales price, which includes an estimate for variable consideration related to rebates, chargebacks and product returns.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i2237e8c824bd43a2bfa639ebc0dbebf3" continuedAt="ic64a8812a7c34359bb126c4f1c6b4798"><ix:continuation id="i18ea2c0b614f4e389258499850d5f218"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vast majority of our sales of Infusion Consumables, Infusion Systems, IV Solutions and Critical Care products are sold on a standalone basis and control of these products transfers to the customer upon shipment.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our software license renewals are considered to be transferred to a customer at a point in time at the start of each renewal period, therefore revenue is recognized at that time.&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Arrangements with Multiple Deliverables</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain circumstances, we enter into arrangements in which we provide multiple deliverables to our customers.  These bundled arrangements typically consist of the sale of infusion systems equipment, along with annual software licenses and related software implementation services, as well as infusion consumables, IV solutions and extended warranties. Our most significant judgments related to these arrangements are (i) identifying the various performance obligations and (ii) estimating the relative standalone selling price of each performance obligation, typically using a directly observable method or calculated on a cost plus margin basis method.  Revenue related to the bundled equipment, software and software implementation services are typically combined into a single performance obligation and recognized upon implementation. As annual software licenses are renewed, we recognize revenue for the license at a point in time, at the start of each annual renewal period. The transaction price allocated to the extended service-type warranty is recognized as revenue over the period the warranty service is provided. Consumables and solutions are separate performance obligations, recognized at a point in time.</span></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Shipping Costs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs to ship finished goods to our customers are included in cost of goods sold on the consolidated statements of operations.</span></div><div style="text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1OTY_2189f462-434c-47e9-b108-e0fcbee39336" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Advertising Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising expenses are expensed as incurred and reflected in selling, general and administrative expenses in our consolidated statements of operations and were $<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTQzMTU_7d752931-c78c-41dc-a3e3-4c97e3ff8da1">0.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTQzMjU_7c0a5b3f-7693-48c7-bffc-d9cc10194728">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTQzMzg_7988845e-c467-473b-b929-292607e750cb">0.1</ix:nonFraction> million in 2021, 2020 and 2019, respectively.</span></div></ix:nonNumeric><div style="text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:PensionAndOtherPostretirementPlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM2NjY_aff2d1f3-8671-43f6-b3c2-7b5cc58495e7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Post-retirement and Post-employment Benefits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sponsor a Section&#160;401(k)&#160;retirement plan ("plan") for employees.&#160;Our contributions to our 401(k) plan were approximately $<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTQ1MjA_f861a963-0c2f-4996-a99a-a21c68551bf9">11.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTQ1MzA_82e4785a-8023-4f15-a5dc-916da3a0c5f7">10.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTQ1NDM_a9e923bf-2b15-4879-a0cc-953c64cf70bc">11.4</ix:nonFraction> million in 2021, 2020 and 2019, respectively. We also have post-retirement and post-employment obligations related to employees located in certain international countries. These obligations are immaterial to our financial statements taken as a whole.</span></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM0OTY_5177003d-2be8-4eae-8a0e-4d8f33877766" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Research and Development</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our research and development costs are expensed as incurred.  In certain circumstances when an asset will have an alternative future use we capitalize the costs related to those assets.  Research and development costs include salaries and related benefits, consulting fees, production supplies, samples, travel costs, utilities and other miscellaneous administrative costs.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1MTk_286d4592-fc41-4ae9-9f11-6f338fe93042" continuedAt="i55245327f4474ac3b79ee565be400527" escape="true">Net Income Per Share</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i55245327f4474ac3b79ee565be400527">Net income per share is computed by dividing net income by the weighted-average number of common shares outstanding. Diluted net income per share is computed by dividing net income by the weighted-average number of common shares outstanding plus dilutive securities.&#160;Dilutive securities include outstanding common stock options and unvested restricted stock units, less the number of shares that could have been purchased with the proceeds from the exercise of the options, using the treasury stock method. Options that are anti-dilutive, where their exercise price exceeds the average market price of the common stock, are not included in the treasury stock method calculation. Restricted stock units that are anti-dilutive are not included in the treasury stock method.</ix:continuation> There were <ix:nonFraction unitRef="shares" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTU5ODE_9357ce38-44a1-4ce9-b722-e375954eb383">12,354</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTU5ODU_1411b910-24af-4c88-b65f-4cb909bac165">12,083</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMzI5ODUzNDkyMTc3MA_4d026c43-d5aa-425e-a786-518e7854b274">10,760</ix:nonFraction> anti-dilutive shares in 2021, 2020 and 2019, respectively. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ic64a8812a7c34359bb126c4f1c6b4798" continuedAt="i692480f3fa2d4be8aabb2eefef1ff54f"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1MzM_a0dad772-ad3a-466b-a0d0-8aff66f390c6" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of net earnings per common share (&#8220;EPS&#8221;) &#8212; basic and diluted (in thousands, except per share data):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.246%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year&#160;ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfMi0yLTEtMS04NzQ1_3a6d1cfd-8eca-4b4b-90f9-63c17825c496">103,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfMi00LTEtMS04NzQ1_f5f944e5-692a-4016-9c96-f8ecd7539ca7">86,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfMi02LTEtMS04NzQ1_35af07ee-ffcc-4881-b9e7-59d09fd2d7c1">101,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding (basic)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfMy0yLTEtMS04NzQ1_f5750c6f-5bf5-4d55-a75e-a197831edc81">21,206</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfMy00LTEtMS04NzQ1_0664f538-51ba-4803-9c32-2e483e50dcdd">20,907</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfMy02LTEtMS04NzQ1_1e836993-9cb0-4e78-8713-84f5adc46130">20,629</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNC0yLTEtMS04NzQ1_f912632a-efd7-44d5-8e71-f6b26fa74834">575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNC00LTEtMS04NzQ1_8fe0d04f-4cd8-422d-9d03-b297b6226b4b">684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNC02LTEtMS04NzQ1_83ec19f9-5331-4a8a-ab07-dcffec5edebf">916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common and common equivalent shares outstanding&#160;(diluted)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNS0yLTEtMS04NzQ1_a9bd1780-f7c4-4e65-ab71-156df367843c">21,781</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNS00LTEtMS04NzQ1_3a2ed1b5-78ef-4d33-9197-1d67ccf5145f">21,591</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNS02LTEtMS04NzQ1_2eab2570-c0d1-4069-8c72-408d9c1666e5">21,545</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNi0yLTEtMS04NzQ1_206e50a9-3bb0-419e-ac1e-67e010fa709f">4.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNi00LTEtMS04NzQ1_9cf2c877-92de-4b4f-8e4e-6edc367de1d4">4.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNi02LTEtMS04NzQ1_e7c6347d-2a79-4f93-a528-68c2457a728f">4.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; diluted</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNy0yLTEtMS04NzQ1_42c385a8-1dcc-44b3-892e-30d3195f1781">4.74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNy00LTEtMS04NzQ1_b028fcec-5d1e-4aff-a113-aa7be7bff87e">4.02</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNy02LTEtMS04NzQ1_37254d23-e2f7-436c-8955-e6cbfeec69fa">4.69</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">New Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" xsi:nil="true" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1MDA_2a897739-de88-4141-b399-b2ea0fceaaa5" escape="true"></ix:nonNumeric><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM0OTU_ffeb54ee-0fdb-4851-87f0-fc415b523569" continuedAt="i695eeb9a8338454389143d1f2af48321" escape="true">Recently Issued Accounting Standards </ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i692480f3fa2d4be8aabb2eefef1ff54f"><ix:continuation id="i695eeb9a8338454389143d1f2af48321">In March 2020, the Financial Accounting Standards Board ("FASB")  issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide optional guidance for a limited period of time to ease the potential burden for reference rate reform on financial reporting. Due to concerns about structural risks of interbank offered rates and, particularly, the risk of cessation of the London Interbank Offered Rate ("LIBOR"), regulators around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation. The amendments in this update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued as a result of reference rate reform. Optional expedients may be applied to contracts that are modified as a result of the reference rate reform. Modifications of contracts within the scope of Topic 470, Debt, should be accounted for by prospectively adjusting the effective interest rate. Modifications of contracts within the scope of ASC 842, Leases, should be accounted for as a continuation of the existing contracts with no reassessments of the lease classification and the discount rate (incremental borrowing rate). Exceptions to Topic 815, Derivatives and Hedging, results in not having a dedesignation of a hedging relationship if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. In November 2021, we entered into two forward-starting swaps whereby the variable leg of the swap references LIBOR, these swaps will be amended in early 2022 to transition to an alternative reference rate (see Note 7: Derivatives and Hedging Activities). The amendments in this ASU allow for certain expedients that will allow us to assume that our hedged interest payments are probable of occurring regardless of any expected modification in their terms related to reference rate reform and will allow us to continue hedge accounting for a cash flow hedge for which the hedged interest rate risk changes if the hedge is highly effective under ASC 815, Derivatives and Hedging or the optional expedient under this ASU is elected. The impact of this ASU on our contracts has not been and is not expected to be material.</ix:continuation></ix:continuation>  </span></div><div style="text-indent:36pt"><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2. <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMjM4Mg_23fdf71e-8351-438a-a2ca-b81480d7afb1" continuedAt="if2c661a70edc48059e53bc725356324b" escape="true">ACQUISITIONS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if2c661a70edc48059e53bc725356324b" continuedAt="i4730a8e58c2741f38df0f3734e4cae25"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 Acquisitions</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2019, we acquired <ix:nonFraction unitRef="number" contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfODA_7dffff5f-bcfb-4207-8e4d-e4ec2804ee2c">100</ix:nonFraction>% interest in Pursuit for cash consideration of approximately $<ix:nonFraction unitRef="usd" contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMTQz_8290d728-5c09-419f-aeac-a8493bc925a6">75.0</ix:nonFraction> million.  Additionally, Pursuit's equity holders were potentially entitled up to $<ix:nonFraction unitRef="usd" contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231" decimals="-6" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMjE4_1fd991da-2c26-418e-a1f4-bbdc65571e4d">50.0</ix:nonFraction> million in additional cash consideration contingent upon the achievement of certain sales and gross profit targets for specific customers. The earn-out paid was calculated as a percentage of gross profit achieved during the earn-out period against a pre-determined target gross profit, not to exceed $<ix:nonFraction unitRef="usd" contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfNTQy_206b6143-59ca-4425-a150-b26d3e4a9dc9">50.0</ix:nonFraction> million. As of June 30, 2021, the earn-out measurement period ended and based on the actual sales and gross profit achieved during the measurement period, we calculated the actual earn-out amount to be $<ix:nonFraction unitRef="usd" contextRef="i8a64787f750d4031b14422894f232878_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMTA5OTUxMTYzMzg2MQ_0b8dc04b-3ae6-4935-88a5-9adcec66878c">26.3</ix:nonFraction>&#160;million. The $<ix:nonFraction unitRef="usd" contextRef="i8a64787f750d4031b14422894f232878_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMTA5OTUxMTYzMzg3Ng_d3eafc9b-1c0c-4541-90ad-ec8b73fbef7a">26.3</ix:nonFraction>&#160;million earn-out calculation was finalized and accepted by Pursuit's former equity holders and was paid out in during the fourth quarter of 2021.  The acquisition of Pursuit and their ClearGuard HD is a natural extension of our needlefree IV connector and other infection control technologies, which together provides us the best of breed solutions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i4730a8e58c2741f38df0f3734e4cae25"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Final Purchase Price</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMjM4NQ_0599bba2-685a-4331-b210-7c808fc1f35c" continuedAt="i033224ddc29c44b685904eeb0e426e48" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the final purchase price and the final allocation of the purchase price related to the assets and liabilities purchased (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:78.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.373%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration for acquired assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231" decimals="-3" name="icui:Paymenttoacquirebusinessnetofworkingcapitaladjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfMC0yLTEtMS04NzQ1_7a8b36b3-88ff-4b40-8d90-7956fbe69064">71,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfMS0yLTEtMS04NzQ1_38805567-3fd3-4762-aa8e-a28e1479f43e">17,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfMi0yLTEtMS04NzQ1_61bc630d-3174-46da-bb61-c29180bb5748">88,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Final Purchase Price Allocation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231" decimals="-3" name="us-gaap:BusinessCombinationAcquiredReceivablesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfNS0yLTEtMS04NzQ1_bd97424c-4137-443c-a9ff-1c41967d0e96">973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfNi0yLTEtMS04NzQ1_7ed9861a-836c-4415-b35f-b6024fd83090">2,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfNy0yLTEtMS04NzQ1_24247c02-cad0-436f-a9c0-0b9e61cfab4d">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfOC0yLTEtMS04NzQ1_c12ab45b-15b5-40a4-9735-25ab3dfef251">609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfOS0yLTEtMS04NzQ1_3591e892-676d-4288-827d-740d1c3194d3">82,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfMTAtMi0xLTEtODc0NQ_2bf402f5-0b19-4c37-81f5-070a15e1c494">215</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfMTEtMi0xLTEtODc0NQ_dad0ab4f-f8e1-4fad-89e8-37a421387967">2,065</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfMTItMi0xLTEtODc0NQ_ecb1a16a-43ea-4405-944f-c7b29a449b11">84,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - not tax deductible</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231" decimals="-3" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfMTMtMi0xLTEtODc0NQ_90b9e8b5-3b16-4721-ac30-b144c8b18cbb">20,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfMTQtMi0xLTEtODc0NQ_132581ca-91da-4785-86ff-663876de74c4">15,769</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfMTUtMi0xLTEtODc0NQ_2991d388-d3b6-4c13-af79-965fbe590943">88,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_______________________________________________</span></div></ix:nonNumeric><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"><ix:continuation id="i033224ddc29c44b685904eeb0e426e48" continuedAt="ie29aa4bd411e49e1b70f87dae6ace872">(1)&#160;&#160;&#160;&#160;</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie29aa4bd411e49e1b70f87dae6ace872">Identifiable intangible assets included $<ix:nonFraction unitRef="usd" contextRef="i759cb9fbaf1d4095916b580d6bb94af5_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMTAzNQ_7ef7f44c-c957-40e8-8859-ff30eab1bf08">69.0</ix:nonFraction> million of developed technology, $<ix:nonFraction unitRef="usd" contextRef="i4e8704f54a08458a9efc29f3cc118593_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMTA2Mw_e582951f-406d-4a14-9d5b-e6d9e84b6ec3">10.8</ix:nonFraction> million of trade name and $<ix:nonFraction unitRef="usd" contextRef="i77e6107e400341429951759a6c1961be_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMTA4NA_65fac3e0-7d92-4267-93af-9af1a92bf669">2.5</ix:nonFraction> million of non-compete agreement. The weighted-average amortization periods for the identifiable intangible assets are as follows: approximately <ix:nonNumeric contextRef="i950f58e7689540a3b89af236c51c45e0_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMTIwOQ_741c8900-4bd7-4ce7-9ec8-e2974c2c9925">fifteen years</ix:nonNumeric> for developed technology, <ix:nonNumeric contextRef="i1a9284e3c72d412b809403911420ec57_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMTI4OQ_e40e0fa5-c441-45b4-993a-d781c42615b1">fifteen years</ix:nonNumeric> for trade name and <ix:nonNumeric contextRef="i181ab8ea3259409b94a0dae321287166_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMTM2Mw_0f3c1db5-011b-424a-9441-a344ca869d8a">three years</ix:nonNumeric> for the non-compete agreement.</ix:continuation> </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The identifiable intangible assets acquired have been valued as Level 3 assets at fair market value. The estimated fair value of identifiable intangible assets were developed using the income approach and are based on critical estimates, judgments and assumptions derived from: analysis of market conditions; discount rate; discounted cash flows; royalty rates; and estimated useful lives. Fixed assets were valued with the consideration of remaining economic lives. The raw materials inventory was valued at historical cost and adjusted for any obsolescence and finished goods inventory was valued at estimated sales proceeds less a nominal profit and costs to sell. The trade receivables, prepaid expenses and other current assets and assumed liabilities were recorded at their carrying values as of the date of the acquisition, as their carrying values approximated their fair values due to their short-term nature.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, we also acquired a small foreign distributor for approximately $<ix:nonFraction unitRef="usd" contextRef="id188fafa38884adabaef94e04b547494_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMjM2Nw_37a56f60-54e4-4886-9910-83ae0cee96d1">4.6</ix:nonFraction>&#160;million in cash.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Acquisitions</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During November 2021, we acquired a small foreign infusion systems supplier and paid an initial gross cash payment of approximately $<ix:nonFraction unitRef="usd" contextRef="i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMjc0ODc3OTA3MjUzMg_af6bda2f-7672-4339-b419-e96ffe13f430">15.4</ix:nonFraction>&#160;million. The total consideration and purchase price allocation is preliminary pending the finalization of the valuation. In addition to the initial cash consideration, total consideration for the acquisition includes an additional holdback of $<ix:nonFraction unitRef="usd" contextRef="if148011629fb4765963a61b648e50f64_I20211231" decimals="-5" name="icui:BusinessCombinationConsiderationCashHoldback" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMTA5OTUxMTYzMzg5MQ_78fd4fd8-bd84-4eb3-9532-83fba3b7e576">0.5</ix:nonFraction>&#160;million, to be paid two years from the completion date of the acquisition, and also a potential earn-out payment of up to $<ix:nonFraction unitRef="usd" contextRef="i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMjc0ODc3OTA3Mjk2NA_9405feed-5cd2-406c-b429-e99514b6e91f">2.5</ix:nonFraction>&#160;million, consisting of (i) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-6" name="icui:ShortTermContingentConsiderationGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMjc0ODc3OTA3Mzg1Nw_aeaabf28-0521-4c35-b2dc-83ac1f347eda">1.0</ix:nonFraction>&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="icui:LongTermContingentConsiderationGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMjc0ODc3OTA3Mzg4NQ_27801c87-1562-4c7c-b096-a73c036f381f">1.5</ix:nonFraction>&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><div id="ic100f0970bae445782808747a3ec391d_76"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3. <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMjk0MQ_4843cdc9-37d7-47d9-92d9-c382e8a9442f" continuedAt="id793042dedc44cab9d94d9482a115404" escape="true">RESTRUCTURING, STRATEGIC TRANSACTION AND INTEGRATION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id793042dedc44cab9d94d9482a115404" continuedAt="i601716f90f8646778563a17ae3eafc0b"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, strategic transaction and integration expenses were $<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-5" name="icui:Restructuringandstrategictransactionexpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMTM2_131ca6c5-027a-40cb-860b-81015077ea5d">18.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-5" name="icui:Restructuringandstrategictransactionexpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMTQx_4e8a091d-c87b-4d03-908a-52a34f303e02">28.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-5" name="icui:Restructuringandstrategictransactionexpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMTQ5_b1c38b62-e7da-41dc-ad9d-b11b4402691d">80.6</ix:nonFraction> million in 2021, 2020 and 2019, respectively.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring charges were $(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMjY2_62a63336-927f-4c17-a3bf-302d995436c9">1.8</ix:nonFraction>) million, $<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMjcw_d9e197ce-8a9b-4418-87ab-7e3dbed99b99">7.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMjc3_dbe5410b-eb03-4ff8-89c1-7acb34a9ec4e">8.4</ix:nonFraction> million in 2021, 2020 and 2019, respectively, and are included in the above restructuring, strategic transaction and integration expenses in our consolidated statement of operations.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we adjusted certain facility restructuring liabilities by $<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-6" name="icui:RestructuringAdjustmentsSeveranceAndFacility" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMTY0OTI2NzQ0OTYxOQ_5b9247f8-9882-43d2-84ab-6727cfd21ff4">2.0</ix:nonFraction>&#160;million, shown in the table below under "Other adjustments," to reflect actual amounts owed which resulted in net restructuring credits of $(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMjc0ODc3OTA3NjM2OA_be2d69c0-4e3a-4114-b070-937c9b69dc63">1.8</ix:nonFraction>)&#160;million. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, restructuring charges were primarily related to severance and costs related to office and other facility closures.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, restructuring charges were primarily related to severance and facility closure costs.  These charges were primarily related to a one-time charge to move our U.S. pump service depot to our existing Salt Lake City facility and other plant restructuring. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2015, we incurred restructuring charges related to an agreement with Dr. Lopez, a member of our Board of Directors and a former employee in our research and development department, pursuant to which we bought out Dr. Lopez's right to employment under his then-existing employment agreement. The buy-out, including payroll taxes, was paid in equal monthly installments until December 2020. This has been fully paid as of December 31, 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMjk0Nw_5932d11c-4666-4ce2-9b61-44a6723242b9" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity in our restructuring-related accrual by major type of cost (in thousands): </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.022%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Severance Pay and Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Employment Agreement Buyout</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retention and Facility Closure Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71c95811c4714cd09165d99d35d0be39_I20191231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMS0xLTEtMS04NzQ1_8c785520-fd16-4c2c-90a5-650dfede8508">3,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62ae2a31a4354af79bd9d1817c9ee7bd_I20191231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMS0zLTEtMS04NzQ1_376eb5fc-07bc-439e-8b9f-9d56cd121309">460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e461e5413d14edd9b72b130ce815fe5_I20191231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMS01LTEtMS04NzQ1_fe743d48-16f8-4c02-b387-8eeb548ef7f7">1,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMS04LTEtMS02MTQ2MA_f0f9f4c0-a109-4f3a-a2a9-21331f57c744">5,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges incurred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a3cc5377db948c0a5ce1d48fee18dc4_D20200101-20201231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMi0xLTEtMS04NzQ1_dd1f7a84-3b8e-4ba9-9500-0a59400014fa">4,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65b0aab89680416c8c6ea3f7a118a6bd_D20200101-20201231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMi0zLTEtMS04NzQ1_7bd68306-9132-438f-a473-99dc01287a30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b6eb1be3574e0cb8dab5f37e8dedec_D20200101-20201231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMi01LTEtMS04NzQ1_71fcf805-f052-41cc-824e-94b2b989ec07">3,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMi04LTEtMS02MTQ3NQ_980b707b-58e5-48ed-a99e-c28cf858d717">7,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a3cc5377db948c0a5ce1d48fee18dc4_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMy0xLTEtMS04NzQ1_ec86afaa-be4e-49b1-b23f-7fe0206e25e0">6,331</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65b0aab89680416c8c6ea3f7a118a6bd_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMy0zLTEtMS04NzQ1_6e7c371e-89f6-4808-8ca7-d3f1827cfcc3">460</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4b6eb1be3574e0cb8dab5f37e8dedec_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMy01LTEtMS04NzQ1_d2a54106-e7bd-44e3-bfe4-58f518f50067">3,570</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMy04LTEtMS02MTQ4MQ_3f83dba9-63bf-46f3-932a-62a58485988f">10,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a3cc5377db948c0a5ce1d48fee18dc4_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNC0xLTEtMS04NzQ1_5f09adc9-97cb-402e-b279-d55dbdf296a9">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65b0aab89680416c8c6ea3f7a118a6bd_D20200101-20201231" decimals="-3" name="us-gaap:RestructuringReserveTranslationAdjustment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNC0zLTEtMS04NzQ1_93ebc8a8-8ac6-4c68-a70b-8e95cc449830">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b6eb1be3574e0cb8dab5f37e8dedec_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNC01LTEtMS04NzQ1_374d5454-e5b6-4046-8852-fc905fc73d9b">281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNC04LTEtMS02MTUwMQ_7055ca43-37be-43bc-96b3-b51dc9e15c86">304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5df89ac1ac0b4ffcaf4459845544da7b_I20201231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNS0xLTEtMS04NzQ1_5358550d-05e8-46c1-8fc6-d9b1679f2f8b">1,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a26f1d531b748e2a99def41eaf38247_I20201231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNS0zLTEtMS04NzQ1_7a2c509f-5033-4287-8e3b-010019ffc6be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0513f1469ce44ac7b878215e135b1461_I20201231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNS01LTEtMS04NzQ1_ab872cab-a0e7-4456-8589-84da5734f639">1,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNS04LTEtMS02MTQ2Mw_20581f43-5772-4ad9-a2eb-c917149308e9">3,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges incurred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc1517ed4db74def880ae3ff1b172041_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNi0xLTEtMS04NzQ1_f5f4dc08-bee9-407f-b55b-e5595c2b8d08">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8eac04e1e58f46a1be1d57dae1515d50_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNi0zLTEtMS04NzQ1_7bc03070-ab8d-48b2-81a8-3b67ff143f82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie475f7d09c704e268b2c10ef5f50cc45_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNi01LTEtMS04NzQ1_74a06f13-f0ac-4478-a058-43a165db0107">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNi04LTEtMS02MTQ3OA_e1397216-6889-4b62-a6aa-4fe25523de8e">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc1517ed4db74def880ae3ff1b172041_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNy0xLTEtMS0yNzEyNQ_89402447-54b2-4f2f-a6e4-ba28c96a3814">969</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8eac04e1e58f46a1be1d57dae1515d50_D20210101-20211231" decimals="INF" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNy0zLTEtMS0yNzE1MA_dc84f20c-7351-4b47-bf8d-86f46d1b222a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie475f7d09c704e268b2c10ef5f50cc45_D20210101-20211231" decimals="INF" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNy02LTEtMS0yNzIwNA_8ae1ee70-586c-4704-9fd3-26d4189f09eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNy04LTEtMS02MTQ4NA_901cacad-4891-4ef5-a405-0b9308ec3d7d">969</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc1517ed4db74def880ae3ff1b172041_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfOC0xLTEtMS0yNzEyOA_556a0539-b497-46ca-b74c-f128072ef453">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8eac04e1e58f46a1be1d57dae1515d50_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringReserveTranslationAdjustment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfOC0zLTEtMS0yNzE1Mw_f411ad1b-cf9f-46f5-bb94-b355713aa459">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie475f7d09c704e268b2c10ef5f50cc45_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfOC02LTEtMS0yNzIwOQ_fbb43598-828d-4900-887f-faae80c8fa86">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfOC04LTEtMS02MTQ5NA_3e2781d4-0f57-455c-b2c3-7f6665c1949c">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc1517ed4db74def880ae3ff1b172041_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfOS0xLTEtMS0yNzEzNQ_91fab4c3-cbbf-4654-b53a-99b0ae03e61e">528</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8eac04e1e58f46a1be1d57dae1515d50_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfOS0zLTEtMS0yNzE2MA_0a239626-44d6-42c5-8bb6-cb29514a9baa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie475f7d09c704e268b2c10ef5f50cc45_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfOS02LTEtMS0yNzIxNg_50bdfad6-8525-44c6-a889-1c3fcabba3e5">1,429</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfOS04LTEtMS02MTQ5MQ_444f39f9-6a10-4bb5-8b2f-36edb50e2058">1,957</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a19a43c357247ff976618cccfe634e3_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMTAtMi0xLTEtNjE0NTE_7687209c-1e8c-4f18-b3f1-e1e6154279fc">499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id18d76e7cad1483da6d29083e9a8f281_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMTAtNC0xLTEtNjE0NTc_f8a7a785-a7cb-41c9-81d5-228241d24c2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19701020e9b7421080322ea64ddfa6fc_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMTAtNi0xLTEtNjE0NzI_4b23a39f-2e06-4263-ada0-c0cc5370810c">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMTAtOC0xLTEtNjE0NjY_8ceeb7ad-f519-4639-a426-172ba1bd3f13">664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_______________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated liabilities related to a prior year's facility closure restructuring were adjusted to actual amounts owed.</span></div></ix:nonNumeric></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="i601716f90f8646778563a17ae3eafc0b" continuedAt="ie8e8ac2534824fbdbb7b78fef41c7647">Strategic Transaction and Integration Expenses</ix:continuation></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie8e8ac2534824fbdbb7b78fef41c7647">We incurred $<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-5" name="icui:StrategicTransactionandIntegration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMTk5NQ_61bda43d-edde-40b0-9305-aee8fda5b113">19.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-5" name="icui:StrategicTransactionandIntegration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMTk5OQ_7f1ba574-5682-470c-9a7a-e96333132138">20.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-5" name="icui:StrategicTransactionandIntegration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMjAwNg_6b8d08e5-183d-4f4b-9071-5c1e9461d388">72.2</ix:nonFraction> million in strategic transaction and integration expenses in 2021, 2020 and 2019, respectively, which are included in restructuring, strategic transaction and integration expenses in our consolidated statement of operations. The strategic transaction and integration expenses during 2021 were related to integration costs associated with acquisitions, the Hospira Infusion Systems ("HIS") earn-out dispute with Pfizer, one-time costs incurred to comply with regulatory initiatives and transaction expenses incurred in connection with entering into a definitive agreement to acquire Smiths Medical 2020 Limited ("Smiths Medical")  (see Note 17: Subsequent Events). The integration expenses during 2020 were related to the integration of HIS and included expenses for the migration of IT systems at our Austin facility. The strategic transaction and integration expenses during 2019 were primarily related to HIS, including a one-time strategic supply chain restructuring charge of $<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-5" name="icui:Supplychainrestructuringcosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMjUyMA_73cb04c7-e4a1-4ab6-b3b0-188f1d9791c7">22.1</ix:nonFraction> million, which reduced our contracted commitments to our third party manufacturer and charges related to our Pfizer separation costs, which included a $<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-5" name="icui:Cleanupcosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMjY2Ng_988c17ae-1ba2-4d5d-8c4e-47f4a9e4d40e">12.7</ix:nonFraction> million non-cash write-off of related assets.</ix:continuation> </span></div><div style="margin-bottom:8pt"><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4:  <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfNDg4Nw_eaf4f141-d28c-4503-91b5-45338339509b" continuedAt="i25e9e68e314f4843831b7f03ff546f8e" escape="true">REVENUE</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i25e9e68e314f4843831b7f03ff546f8e" continuedAt="i458c6b8388ff400a80dd46f789e9a3ae"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary product lines are Infusion Consumables, Infusion Systems, IV Solutions and Critical Care. The vast majority of our sales of these products are made on a stand-alone basis to hospitals and distributors. Revenue is typically recognized upon transfer of control of the products, which we deem to be at point of shipment. However, for purposes of revenue recognition for our software licenses and  renewals, we consider the control of these products to be transferred to a customer at a certain point in time; therefore, we recognize revenue at the start of the applicable license term.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment is typically due in full within 30 days of delivery or the start of the contract term. Revenue is recorded in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We offer certain volume-based rebates to our distribution customers, which we record as variable consideration when calculating the transaction price. Rebates are offered on both a fixed and tiered/variable basis. In both cases, we use information available at the time and our historical experience with each customer to estimate the most likely rebate amount. We also provide chargebacks to distributors that sell to end customers at prices determined under a contract between us and the end customer. Chargebacks are the difference between the prices we charge our distribution customers and the contracted prices we have with the end customer which are processed as credits to our distribution customers. In estimating the expected value of chargeback amounts in order to determine the transaction price, we use information available at the time, including our historical experience.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also warrant products against defects and have a policy permitting the return of defective products, for which we accrue and expense at the time of sale using information available at that time and our historical experience. We also provide for extended service-type warranties, which we consider to be separate performance obligations. We allocate a portion of the transaction price to the extended service-type warranty based on its estimated relative selling price, and recognize revenue over the period the warranty service is provided. Our revenues are recorded at the net sales price, which includes an estimate for variable consideration related to rebates, chargebacks and product returns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Arrangements with Multiple Performance Obligations</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also enter into arrangements which include multiple performance obligations, (see Note 1: Basis of Presentation and Summary of Significant Accounting Policies). </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant judgments related to these arrangements include: </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Identifying the various performance obligations of these arrangements.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Estimating the relative standalone selling price of each performance obligation, typically using a directly observable method or calculated on a cost plus margin basis method. </span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i458c6b8388ff400a80dd46f789e9a3ae" continuedAt="i271bbd8f55fc44df97c94c36ab7475e2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue disaggregated</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfNDg5MA_bf82b0fa-f50f-48f9-8a15-172eba753d98" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents our revenues disaggregated by product line (in thousands) and our disaggregated product line revenue as a percentage of total revenue:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product line</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Consumables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2abd8a14954e2d908b7a6ad1bff678_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfMy0xLTEtMS04NzQ1_a73830d8-53b4-4862-8349-6d800f856df6">555,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9c2abd8a14954e2d908b7a6ad1bff678_D20210101-20211231" decimals="2" name="icui:Percentageofrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfMy0zLTEtMS04NzQ1_ecf651ed-7d46-4d76-9271-c60650ce8da8">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e8a812a73f4a1d8f7f8110a8759bf4_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfMy01LTEtMS04NzQ1_92fc1f7d-0c60-4e8d-bf78-9d4a669ddf4b">473,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia9e8a812a73f4a1d8f7f8110a8759bf4_D20200101-20201231" decimals="2" name="icui:Percentageofrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfMy03LTEtMS04NzQ1_53328c33-8906-4e1f-a386-5db60b6c5997">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib25ed464299245f3a253cac238e6e16b_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfMy05LTEtMS04NzQ1_d9c6467e-c791-46ea-916f-c8a939f1a71c">477,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib25ed464299245f3a253cac238e6e16b_D20190101-20191231" decimals="2" name="icui:Percentageofrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfMy0xMS0xLTEtODc0NQ_80019bfe-1408-4bb9-822e-9054ea7674fb">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c6cc917f0a04f9e98f2098b917cb28f_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNC0xLTEtMS04NzQ1_a6ba308c-c4eb-4f22-b1ef-e26f84314b17">352,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3c6cc917f0a04f9e98f2098b917cb28f_D20210101-20211231" decimals="2" name="icui:Percentageofrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNC0zLTEtMS04NzQ1_3545c7bd-50d3-421d-8502-65d7b8cb0a77">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52b0fc63199747a09f8aaf3d7b68b362_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNC01LTEtMS04NzQ1_3449cb10-4a22-43ec-a83a-b554a69f5ab6">359,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52b0fc63199747a09f8aaf3d7b68b362_D20200101-20201231" decimals="2" name="icui:Percentageofrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNC03LTEtMS04NzQ1_b75393e9-ef46-4930-9e91-b7d505b8f227">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i201b9c34887c4c05be4d0d4326d1e331_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNC05LTEtMS04NzQ1_5815cb98-6e7d-467c-9d3b-5e8f7a1662e7">328,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i201b9c34887c4c05be4d0d4326d1e331_D20190101-20191231" decimals="2" name="icui:Percentageofrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNC0xMS0xLTEtODc0NQ_f23614be-6a85-4bf1-a643-c8baf74d95b1">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ce76eb5aa3f457a94d4842e2df5c4b4_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNS0xLTEtMS04NzQ1_5cd18793-27ce-4690-9b4a-a35ad0c7ec32">359,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9ce76eb5aa3f457a94d4842e2df5c4b4_D20210101-20211231" decimals="2" name="icui:Percentageofrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNS0zLTEtMS04NzQ1_b161586a-73f9-4c05-881c-397e846720ad">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb7d360b50434c90b1362f13d39de454_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNS01LTEtMS04NzQ1_d78bf9e4-a8d1-4d6f-af98-37b77cd57492">388,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb7d360b50434c90b1362f13d39de454_D20200101-20201231" decimals="2" name="icui:Percentageofrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNS03LTEtMS04NzQ1_cb9b44f0-c777-4107-8e5f-ae37a0056b86">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie65b63b2aa354165aa8b2d1156015ecd_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNS05LTEtMS04NzQ1_fab84c1e-2eba-4ec7-8ba6-06b7319cfb95">414,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie65b63b2aa354165aa8b2d1156015ecd_D20190101-20191231" decimals="2" name="icui:Percentageofrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNS0xMS0xLTEtODc0NQ_9f98a69b-8baf-49dd-97f4-fa6f63b3d220">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47789bab6a1046d49538401de29b23ca_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNi0xLTEtMS04NzQ1_028a81de-e90c-4654-b72e-e716a5c2ce79">49,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i47789bab6a1046d49538401de29b23ca_D20210101-20211231" decimals="2" name="icui:Percentageofrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNi0zLTEtMS04NzQ1_f069fed1-92ee-4ec9-a088-eb1263b8a295">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba69653f43264a18a0f9f7bbc4521bfb_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNi01LTEtMS04NzQ1_358b706e-c3a9-41dd-8478-0ed1b1446645">48,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iba69653f43264a18a0f9f7bbc4521bfb_D20200101-20201231" decimals="2" name="icui:Percentageofrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNi03LTEtMS04NzQ1_90b09fd9-4e19-4710-8152-120e21545602">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16a80a38aab0404bb60ce11730e5d9b2_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNi05LTEtMS04NzQ1_737b45a2-6125-4157-9de7-be3c4a1b1392">45,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i16a80a38aab0404bb60ce11730e5d9b2_D20190101-20191231" decimals="2" name="icui:Percentageofrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNi0xMS0xLTEtODc0NQ_0f168cb7-a5e8-4f30-8470-c6d8b22b392e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfOC0xLTEtMS04NzQ1_473b3464-fd35-4b0f-b709-0158129afbc8">1,316,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="2" name="icui:Percentageofrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfOC0zLTEtMS04NzQ1_4473ea01-4c1d-4674-b809-f24df9ed8f79">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfOC01LTEtMS04NzQ1_e720ce43-641f-480e-91f0-ef65772333e7">1,271,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="2" name="icui:Percentageofrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfOC03LTEtMS04NzQ1_3ea19bc4-ba52-4472-a513-a5c7ad5b8dff">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfOC05LTEtMS04NzQ1_2645f623-5509-4a6a-909e-6af77740e803">1,266,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="2" name="icui:Percentageofrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfOC0xMS0xLTEtODc0NQ_e651575d-b206-4fce-ad8a-951ded60a38e">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report revenue on a "where sold" basis, which reflects the revenue within the country or region in which the ultimate sale is made to our external customer.&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents our revenues disaggregated by geography (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:60.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.070%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.218%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geography</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4099adac88a94f2c844d6d0a67f5b93f_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfMi0xLTEtMS04NzQ1_9c4829e0-458c-4dec-9c2c-d8bb35082e45">147,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fd4ad49e5ca42958f511cd87f3b86e1_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfMi0zLTEtMS04NzQ1_9e4f9896-a23b-4792-a767-1e8638c3e6f4">132,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b6da943f3c548f58f42328ecef541e1_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfMi01LTEtMS04NzQ1_37da2e13-331e-451c-bb2f-b8e9dfe22f69">130,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ef1d9853e504ab394c35a1dda0b5652_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfMy0xLTEtMS04NzQ1_bedb31cd-38a6-4757-9d9b-7529e1bf0844">227,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba50cb76497a4bde9e14f5743b6475c3_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfMy0zLTEtMS04NzQ1_6da8a65d-a663-43b0-b712-06f7414c9968">227,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46c1f41659ba4557a83903554fac974b_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfMy01LTEtMS04NzQ1_5f4cc54b-d59f-4400-9ff2-e430fe706881">212,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Foreign</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i928b25071431497386ecd55fee9d4139_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfNC0xLTEtMS04NzQ1_98ada7b7-21b4-4f7c-9dc7-e552d9d6570c">374,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6c4227c1cd44dc9eef66faca80e3c1_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfNC0zLTEtMS04NzQ1_98b54372-7749-42b4-b064-90491843216d">360,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d1cf0743c804ef8a6831ae5bd16c05a_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfNC01LTEtMS04NzQ1_1ce038c2-4b57-4b65-86bb-3528dc779583">342,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e571091fc1f4ae5aa5c04d2eccc5543_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfNS0xLTEtMS04NzQ1_f5516799-e6be-480d-bf51-18ab310b5d38">941,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e8278d8b555471884d28845b03e9a66_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfNS0zLTEtMS04NzQ1_890ebfdb-9dad-4be4-8072-4cf368a4e9e2">910,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62815f424b0f4a83a52362d984e6bdab_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfNS01LTEtMS04NzQ1_35700b98-674b-47b4-b270-da5cef8b4052">923,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfNi0xLTEtMS04NzQ1_33080287-e38f-44ea-a9b3-eb69f9f6354e">1,316,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfNi0zLTEtMS04NzQ1_20fc5537-f77f-4fff-bba4-a1add7669938">1,271,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfNi01LTEtMS04NzQ1_83021c07-206e-45f1-92db-5f0d19d4558f">1,266,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Domestic sales accounted for <ix:nonFraction unitRef="number" contextRef="i9e571091fc1f4ae5aa5c04d2eccc5543_D20210101-20211231" decimals="2" name="icui:Percentoftotalrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfMzE1MA_6422e6d5-e063-4a17-8394-125efebbe598">72</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i7e8278d8b555471884d28845b03e9a66_D20200101-20201231" decimals="2" name="icui:Percentoftotalrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfMzE1NA_cd3822c2-4c6b-408f-b9cd-c9cf0ef5aa7d">72</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i62815f424b0f4a83a52362d984e6bdab_D20190101-20191231" decimals="2" name="icui:Percentoftotalrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfMzE2MQ_e67bd440-8926-487d-bb7a-59ea90d0fa2e">73</ix:nonFraction>% of total revenue in 2021, 2020 and 2019, respectively.  International sales accounted for <ix:nonFraction unitRef="number" contextRef="i513e00d1325e4cbab47333544fe16795_D20210101-20211231" decimals="2" name="icui:Percentoftotalrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfMzI0OA_09a9ff0f-661b-4765-8125-d87d5b6142f6">28</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i43801ce9ae0d4d64b094552e36f505d8_D20200101-20201231" decimals="2" name="icui:Percentoftotalrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfMzI1Mg_7c7cba33-62b2-4a8c-bfbf-d37cf8cf4360">28</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i47aa34896b3a48b98371a8adb7a428c8_D20190101-20191231" decimals="2" name="icui:Percentoftotalrevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfMzI1OQ_a30d7f26-7e8a-41cb-8d9d-73a957512cdf">27</ix:nonFraction>% of total revenue in 2021, 2020 and 2019, respectively.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract balances</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfNDg5Mg_105d9c12-c11c-44da-ac72-df93eb2bbebc" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contract balances (deferred revenue) are recorded in accrued liabilities and other long-term liabilities in our consolidated balance sheet (see Note 10: Accrued Liabilities and Other Long-term Liabilities). The following table presents the changes in our contract balances for the years ended December 31, 2021 and 2020, (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:79.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfMS0xLTEtMS04NzQ1_717cb7d3-8bdf-4afb-955d-26fe77d76511">4,855</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07b1db2fc46e4252ad0d15476844f7ab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfMi0xLTEtMS04NzQ1_317cdbb6-11a1-45a8-93c3-c4d77f8d56bc">14,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07b1db2fc46e4252ad0d15476844f7ab_D20200101-20201231" decimals="-3" name="us-gaap:DeferredRevenueAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfMy0xLTEtMS04NzQ1_06618e72-c875-474e-afaa-4cf5143f1a83">14,341</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44cab7a364ba4dfeb44c1c2c019c7508_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfNC0xLTEtMS04NzQ1_11150432-2dba-4838-b99b-634dddaa3aa9">5,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44cab7a364ba4dfeb44c1c2c019c7508_D20200101-20201231" decimals="-3" name="us-gaap:DeferredRevenueAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfNS0xLTEtMS04NzQ1_3b204e80-6e8a-43ba-8c74-8c346596ab6d">7,363</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfNi0xLTEtMS04NzQ1_e81bc6a0-1c13-423e-a379-1505d65f8b86">6,430</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideea602385704c09a9de5340c5673d94_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfNy0xLTEtMS04NzQ1_190562ff-2ccb-4240-9edb-62e83486e5a3">10,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideea602385704c09a9de5340c5673d94_D20210101-20211231" decimals="-3" name="us-gaap:DeferredRevenueAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfOC0xLTEtMS04NzQ1_6e45e334-3c23-4382-819b-3ac9a39d0178">13,725</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57358508c9e84334b935ca3d7b783237_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfOS0xLTEtMS04NzQ1_b1522fe9-ed0b-4b94-a47a-eae41d13c905">7,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57358508c9e84334b935ca3d7b783237_D20210101-20211231" decimals="-3" name="us-gaap:DeferredRevenueAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfMTAtMS0xLTEtODc0NQ_6f74f640-1f0f-4133-a332-71c5634a13fc">4,615</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfMTEtMS0xLTEtODc0NQ_085a3a40-4f0e-403b-ac73-57dd275cfe31">7,461</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i271bbd8f55fc44df97c94c36ab7475e2"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During 2021, we recognized $<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfMTA5OTUxMTYzNTI1Nw_7da68ab4-d43b-4e59-8fc9-daf665d74231">5.1</ix:nonFraction>&#160;million in revenue that was included in the opening contract balances as of December 31, 2020. As of December 31, 2021, revenue from remaining performance obligations related to implementation of software and equipment is $<ix:nonFraction unitRef="usd" contextRef="ief31f8281f40440b9b7259476db1babf_I20211231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfMzkzNw_ded72942-07f6-48c7-9525-6b9457d739d3">5.6</ix:nonFraction> million. We expect to recognize substantially all of this revenue within the next three to six months dependent on implementation restrictions due to the novel coronavirus and its variants ("COVID-19").  Revenue from remaining performance obligations related to annual software licenses is $<ix:nonFraction unitRef="usd" contextRef="ic2ba2c623a754ec09109f4e760fdc883_I20211231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfNDEyMg_a87698c8-8c5c-4474-a443-63faac880c39">1.9</ix:nonFraction> million. We expect to recognize substantially all of this revenue over the next twelve months. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs to Obtain a Contract with a Customer</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the cost to obtain a contract, we may pay incremental commissions to sales employees upon entering into a sales contract. Under ASC Topic 606, we have elected to expense these costs as incurred as the period of benefit is less than one year.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Practical expedients and exemptions</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the practical expedient applied to sales commissions, under ASC Topic 606, we elected to apply the practical expedient for shipping and handling costs incurred after the customer has obtained control of a good. We will continue to treat these costs as a fulfillment cost rather than as an additional promised service.</span></div></ix:continuation><div style="margin-bottom:8pt"><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5. <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="icui:LesseeOperatingAndFinanceLeaseTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RleHRyZWdpb246MGQzYzA1ZmJhZDVkNDMxMGI0NTVmNDkzMTE5NmZmZDBfMTA5OTUxMTYzNTIxNg_bc4a5087-35b9-4762-9dc8-0a5108218071" continuedAt="ic7d804d683314217bb40698d69306044" escape="true">LEASES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic7d804d683314217bb40698d69306044" continuedAt="ief40dca56ea0423685e3df18878706ab"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at inception. Our operating lease assets are separately stated in operating lease right-of-use ("ROU") assets and our financing lease assets are included in other assets on our consolidated balance sheets. Our lease liabilities are included in accrued liabilities, and other long-term liabilities on our consolidated balance sheets. We have elected not to recognize an ROU asset and lease liability for leases with terms of twelve months or less.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease ROU assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. Most of our leases do not provide an implicit rate, therefore we use our incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term based on the information available at commencement date. Our lease ROU assets exclude lease incentives and initial direct costs incurred. Our lease terms include options to extend when it is reasonably certain that we will exercise that option. All of our leases have stated lease payments, which may include fixed rental increases. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leases are for corporate, research and development and sales and support offices, a distribution facility, device service centers and certain equipment. Our leases have original lease terms of <ix:nonNumeric contextRef="ie0c2e107da6f4265945c3cd1be9af667_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RleHRyZWdpb246MGQzYzA1ZmJhZDVkNDMxMGI0NTVmNDkzMTE5NmZmZDBfMTA5OTUxMTYzNTE5Nw_48d0bb3a-0b01-4254-bb56-1f813728137c">one year</ix:nonNumeric> to <ix:nonNumeric contextRef="i14ae100f3ea54791b971967ebffeb16c_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RleHRyZWdpb246MGQzYzA1ZmJhZDVkNDMxMGI0NTVmNDkzMTE5NmZmZDBfMjc1NA_84d0b303-da8b-4cf3-8bdf-ffbe615c7023">fifteen years</ix:nonNumeric>, some of which include options to extend the leases for up to an additional <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="icui:Optiontoextendinyears" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RleHRyZWdpb246MGQzYzA1ZmJhZDVkNDMxMGI0NTVmNDkzMTE5NmZmZDBfMjgzMw_1c7522e5-8bca-42c6-b6fd-8d0703e4dc05">five years</ix:nonNumeric>. For all of our leases, we do not include optional periods of extension in our current lease terms for the exercise of options to extend is not reasonably certain.&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RleHRyZWdpb246MGQzYzA1ZmJhZDVkNDMxMGI0NTVmNDkzMTE5NmZmZDBfMzY2Ng_f006110b-ec63-4ebf-a16a-8c47ffd4441f" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of our lease cost (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjNmMGVlZmVmYmM1YjQ2MzI5MjdlYTA0NWZmZjY1MjJmL3RhYmxlcmFuZ2U6M2YwZWVmZWZiYzViNDYzMjkyN2VhMDQ1ZmZmNjUyMmZfMi0xLTEtMS04NzQ1_dbeb0966-656a-4d05-9a50-4043516f683c">11,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjNmMGVlZmVmYmM1YjQ2MzI5MjdlYTA0NWZmZjY1MjJmL3RhYmxlcmFuZ2U6M2YwZWVmZWZiYzViNDYzMjkyN2VhMDQ1ZmZmNjUyMmZfMi0zLTEtMS04NzQ1_c80d3ac2-ee20-414c-b476-117935a020ae">11,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjNmMGVlZmVmYmM1YjQ2MzI5MjdlYTA0NWZmZjY1MjJmL3RhYmxlcmFuZ2U6M2YwZWVmZWZiYzViNDYzMjkyN2VhMDQ1ZmZmNjUyMmZfMy0xLTEtMS04NzQ1_12b81a0a-f452-4560-a509-8eeac2bb6040">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjNmMGVlZmVmYmM1YjQ2MzI5MjdlYTA0NWZmZjY1MjJmL3RhYmxlcmFuZ2U6M2YwZWVmZWZiYzViNDYzMjkyN2VhMDQ1ZmZmNjUyMmZfMy0zLTEtMS04NzQ1_5261c558-21e0-4eaa-a99f-092af63a08b2">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; reduction of ROU asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjNmMGVlZmVmYmM1YjQ2MzI5MjdlYTA0NWZmZjY1MjJmL3RhYmxlcmFuZ2U6M2YwZWVmZWZiYzViNDYzMjkyN2VhMDQ1ZmZmNjUyMmZfNC0xLTEtMS04NzQ1_899e2b8f-652d-431d-849f-6e7f86ff0e5c">648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjNmMGVlZmVmYmM1YjQ2MzI5MjdlYTA0NWZmZjY1MjJmL3RhYmxlcmFuZ2U6M2YwZWVmZWZiYzViNDYzMjkyN2VhMDQ1ZmZmNjUyMmZfNC0zLTEtMS04NzQ1_f293d702-724d-44bc-abb2-9e073d4c4e86">383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjNmMGVlZmVmYmM1YjQ2MzI5MjdlYTA0NWZmZjY1MjJmL3RhYmxlcmFuZ2U6M2YwZWVmZWZiYzViNDYzMjkyN2VhMDQ1ZmZmNjUyMmZfNS0xLTEtMS04NzQ1_b683b6e6-8321-4d0e-98b7-0af7ccf80e28">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjNmMGVlZmVmYmM1YjQ2MzI5MjdlYTA0NWZmZjY1MjJmL3RhYmxlcmFuZ2U6M2YwZWVmZWZiYzViNDYzMjkyN2VhMDQ1ZmZmNjUyMmZfNS0zLTEtMS04NzQ1_ad2a36ef-2f10-4783-a9bf-9305f86246d4">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjNmMGVlZmVmYmM1YjQ2MzI5MjdlYTA0NWZmZjY1MjJmL3RhYmxlcmFuZ2U6M2YwZWVmZWZiYzViNDYzMjkyN2VhMDQ1ZmZmNjUyMmZfNi0xLTEtMS04NzQ1_d12f2362-359e-40ec-a757-5a84e5afd975">12,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjNmMGVlZmVmYmM1YjQ2MzI5MjdlYTA0NWZmZjY1MjJmL3RhYmxlcmFuZ2U6M2YwZWVmZWZiYzViNDYzMjkyN2VhMDQ1ZmZmNjUyMmZfNi0zLTEtMS04NzQ1_99d884fd-b193-4f1e-b628-e76e0f8b2f35">12,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense on our finance leases is included in other income (expense), net in our consolidated statements of operations. The reduction of the operating and finance ROU assets is included as noncash lease expense in selling, general and administrative expenses in our consolidated statements of operations.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ief40dca56ea0423685e3df18878706ab" continuedAt="ic34a9b07f6914f5cb7e392ab71ee156a"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="icui:SupplementalCashFlowInformationLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RleHRyZWdpb246MGQzYzA1ZmJhZDVkNDMxMGI0NTVmNDkzMTE5NmZmZDBfMzY2Nw_9e480c01-80c2-4267-aee8-26712e29349a" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental cash flow information related to our leases (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjAxMTQ5MzYzYzU5NjQ0ZmNiOWZlN2E4MjUzZWVhMGJiL3RhYmxlcmFuZ2U6MDExNDkzNjNjNTk2NDRmY2I5ZmU3YTgyNTNlZWEwYmJfMy0xLTEtMS04NzQ1_e9d67167-11ce-48c4-9a2e-6b432944868e">11,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjAxMTQ5MzYzYzU5NjQ0ZmNiOWZlN2E4MjUzZWVhMGJiL3RhYmxlcmFuZ2U6MDExNDkzNjNjNTk2NDRmY2I5ZmU3YTgyNTNlZWEwYmJfMy0zLTEtMS04NzQ1_bfd9e4f0-561e-47ee-b561-41cd4b5572fb">10,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjAxMTQ5MzYzYzU5NjQ0ZmNiOWZlN2E4MjUzZWVhMGJiL3RhYmxlcmFuZ2U6MDExNDkzNjNjNTk2NDRmY2I5ZmU3YTgyNTNlZWEwYmJfNC0xLTEtMS04NzQ1_01cf5826-de72-4040-9167-a2e288ad3b72">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjAxMTQ5MzYzYzU5NjQ0ZmNiOWZlN2E4MjUzZWVhMGJiL3RhYmxlcmFuZ2U6MDExNDkzNjNjNTk2NDRmY2I5ZmU3YTgyNTNlZWEwYmJfNC0zLTEtMS04NzQ1_68b5f99a-a733-4070-a851-f9c2a2d47f45">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjAxMTQ5MzYzYzU5NjQ0ZmNiOWZlN2E4MjUzZWVhMGJiL3RhYmxlcmFuZ2U6MDExNDkzNjNjNTk2NDRmY2I5ZmU3YTgyNTNlZWEwYmJfNy0xLTEtMS04NzQ1_dc2783c1-9ee9-454c-8bcb-b44db77fce94">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjAxMTQ5MzYzYzU5NjQ0ZmNiOWZlN2E4MjUzZWVhMGJiL3RhYmxlcmFuZ2U6MDExNDkzNjNjNTk2NDRmY2I5ZmU3YTgyNTNlZWEwYmJfNy0zLTEtMS04NzQ1_bca0492c-0aa6-4a46-b383-0946aa095e7e">20,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjAxMTQ5MzYzYzU5NjQ0ZmNiOWZlN2E4MjUzZWVhMGJiL3RhYmxlcmFuZ2U6MDExNDkzNjNjNTk2NDRmY2I5ZmU3YTgyNTNlZWEwYmJfOC0xLTEtMS04NzQ1_f70f3744-604c-4fe4-a603-1cdd153f3aa0">558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjAxMTQ5MzYzYzU5NjQ0ZmNiOWZlN2E4MjUzZWVhMGJiL3RhYmxlcmFuZ2U6MDExNDkzNjNjNTk2NDRmY2I5ZmU3YTgyNTNlZWEwYmJfOC0zLTEtMS04NzQ1_9da6930e-9c74-4d52-81b2-d761b36a89c8">3,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="icui:SupplementalBalanceSheetInformationLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RleHRyZWdpb246MGQzYzA1ZmJhZDVkNDMxMGI0NTVmNDkzMTE5NmZmZDBfMzY3NA_3f1c4c2b-98bd-4395-8940-21448bb9395e" continuedAt="ic94fe00ccbe54b7da2b65c2726ed7427" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our operating leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfMy0xLTEtMS04NzQ1_3e2d1dcf-4bd1-4306-86f0-91c641d2a9b9">39,847</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfMy0zLTEtMS04NzQ1_94e46019-0cf4-40c8-9110-88a52ba2934c">46,571</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfNS0xLTEtMS04NzQ1_6e0805e7-5a5e-44df-b32a-d647c632a5cf">9,009</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfNS0zLTEtMS04NzQ1_1ef77f75-cc17-4632-9172-1b4335cdb208">8,740</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfNi0xLTEtMS04NzQ1_f6ba3e63-0dc5-4fc4-bf36-94aec9e28b63">33,971</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfNi0zLTEtMS04NzQ1_bf5d34f0-27a1-44f2-92a9-f07cb9a60786">41,019</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfNy0xLTEtMS04NzQ1_4d134dd1-0aa8-4d04-96b3-da4db9a0bc8d">42,980</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfNy0zLTEtMS04NzQ1_1bf667e7-7b06-41d9-8d10-b550cc5aa1c3">49,759</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfMTAtMS0xLTEtODc0NQ_0d6e7357-db6d-413d-8c3b-cba5f799c182">5.9</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfMTAtMy0xLTEtODc0NQ_ffc1b114-4470-4c21-8871-1e2350a43a6b">6.7</ix:nonNumeric> years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfMTMtMS0xLTEtODc0NQ_beeb8444-96aa-44b9-aa53-63540f57e9b9">4.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfMTMtMy0xLTEtODc0NQ_9c0373d3-cdc5-4afd-856a-19de239ac4e3">5.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our finance leases (in thousands, except lease term and discount rate):</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ic34a9b07f6914f5cb7e392ab71ee156a"><div style="margin-top:5pt;text-align:center"><ix:continuation id="ic94fe00ccbe54b7da2b65c2726ed7427"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfMy0xLTEtMS02MTI2NQ_2d5d1790-7c13-47ae-9153-48b1c1eae6d2">2,673</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfMy0xLTEtMS04NzQ1_3fe7fe4d-f189-4404-a3a8-de8802b839bc">2,915</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfNS0xLTEtMS02MTI2NQ_ac92e229-b12b-4608-b846-385602fd8e37">643</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfNS0xLTEtMS04NzQ1_9f17847e-a5b6-4fad-8fb8-6914f5cd99ce">554</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfNi0xLTEtMS02MTI2NQ_b6455b9a-0717-46bf-adfc-076a058caab4">2,067</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfNi0xLTEtMS04NzQ1_ef988101-0e67-471f-8b3d-f104b97cabaa">2,388</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfNy0xLTEtMS02MTI2NQ_241f9b0d-ee34-49df-bb3d-60480b96a63c">2,710</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfNy0xLTEtMS04NzQ1_62233404-17b4-49b5-b23a-b8cc2a6fb78d">2,942</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfMTAtMS0xLTEtNjEyNjU_365e61b8-9a0d-4b1b-855f-dcda4067474a">5.6</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfMTAtMS0xLTEtODc0NQ_487073e2-09f0-4e9b-8955-44c1fc7b4cf9">6.4</ix:nonNumeric> years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfMTMtMS0xLTEtNjEyNjU_c9286d19-d7fd-4244-a026-e51479539d7f">4.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfMTMtMS0xLTEtODc0NQ_6971c195-ab87-475e-a8fc-f6f729224cb5">4.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RleHRyZWdpb246MGQzYzA1ZmJhZDVkNDMxMGI0NTVmNDkzMTE5NmZmZDBfMzY3MQ_ac9ab9bf-06f9-4e06-ab1f-cc00ed52ca20" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the maturities of our operating and finance lease liabilities for each of the next five years are approximately (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfMS0xLTEtMS04NzQ1_9d52f08b-cb62-4712-a25c-613e52500be3">10,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfMS0zLTEtMS04NzQ1_497dddfb-b332-4978-b4e3-3e70cba3b56e"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfMS0zLTEtMS04NzQ1_cf11f681-13a2-44a3-bb0d-9798153d9763">749</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfMi0xLTEtMS04NzQ1_a4e9b401-64c6-4330-9f05-53a028c4c94b">9,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfMi0zLTEtMS04NzQ1_6d03e6fc-0504-4c50-89a7-9abb90ec175f">749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfMy0xLTEtMS04NzQ1_8bfacd4d-ecdb-4e76-bec4-bd22ac898442">8,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfMy0zLTEtMS04NzQ1_6c0ab786-ca49-467f-8b97-f090d3982cff">458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfNC0xLTEtMS04NzQ1_e2a874b4-f687-47bb-b9b2-2eb63c7fe781">5,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfNC0zLTEtMS04NzQ1_9209026b-43be-4e40-9011-01179985151c">267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfNS0xLTEtMS04NzQ1_eae3fdeb-0c75-4633-a427-3d4c5626f3bf">4,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfNS0zLTEtMS04NzQ1_873e6702-a501-4754-8df4-14f40e5777b1">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfNi0xLTEtMS04NzQ1_6a0410a5-af8c-4720-97a4-5c23b2cf5812">10,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfNi0zLTEtMS04NzQ1_f6b1926e-6e77-4acd-ad48-bbea752f46e2">615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfNy0xLTEtMS04NzQ1_a45b9c2a-1889-4c36-8d1c-26ef29d822cb">49,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfNy0zLTEtMS04NzQ1_25096603-22c0-4f5d-a9cb-616bec1c06dd">3,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfOC0xLTEtMS04NzQ1_e6d5b977-1f83-4a02-b9d7-9500975550a7">6,396</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfOC0zLTEtMS04NzQ1_7664a121-2716-413a-97f7-8f832a4b3d8f">342</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfOS0xLTEtMS04NzQ1_c5d633c4-9279-46b0-9c1b-960edf1c84e5">42,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfOS0zLTEtMS04NzQ1_623ff3ee-711f-46c9-a54b-211c0918ce8a">2,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="ic100f0970bae445782808747a3ec391d_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6. <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTA0Nzg_2e65c1da-5ea9-4618-8b44-9993ab067205" continuedAt="i75f1b8ff01ff4fc7ba8c76f31c0141e3" escape="true">SHARE-BASED AWARDS</ix:nonNumeric></span></div><ix:continuation id="i75f1b8ff01ff4fc7ba8c76f31c0141e3" continuedAt="i29fe0f553a6944c4a2dd697391f38012"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a stock incentive plan for employees and directors and an employee stock purchase plan.&#160; Shares to be issued under these plans will be issued either from authorized but unissued shares or from treasury shares.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incur stock compensation expense for stock options, restricted stock units ("RSU"), performance restricted stock units ("PRSU") and in years prior to 2018 stock purchased under our employee stock purchase plan ("ESPP"), which was suspended in 2017. We receive a tax benefit on stock compensation expense and direct tax benefits from the exercise of stock options and vesting of restricted stock units. We also have indirect tax benefits upon exercise of stock options and vesting of restricted stock units related to research and development tax credits which are recorded as a reduction of income tax expense.&#160; </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="icui:ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTA1MDI_1b455fbd-c4a2-4b09-856b-38599d5f6ad2" continuedAt="ia7828bf7a9f94afcaab9d482f96a3652" escape="true">The table below summarizes compensation costs and related tax benefits (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i29fe0f553a6944c4a2dd697391f38012" continuedAt="ia4aac77f315f46e2952a29bf3a4df305"><div style="margin-top:5pt"><ix:continuation id="ia7828bf7a9f94afcaab9d482f96a3652"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.246%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year&#160;ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjBjMzhmYmIyM2Y4MDQ0OTZhMjJmYjEyZGMzZTFhMWIwL3RhYmxlcmFuZ2U6MGMzOGZiYjIzZjgwNDQ5NmEyMmZiMTJkYzNlMWExYjBfMi0yLTEtMS04NzQ1_81f52037-07be-44ac-a337-72cc0ccad14b">27,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjBjMzhmYmIyM2Y4MDQ0OTZhMjJmYjEyZGMzZTFhMWIwL3RhYmxlcmFuZ2U6MGMzOGZiYjIzZjgwNDQ5NmEyMmZiMTJkYzNlMWExYjBfMi00LTEtMS04NzQ1_1b48ae7b-dbd0-43a7-8af4-6de70d7c2696">23,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjBjMzhmYmIyM2Y4MDQ0OTZhMjJmYjEyZGMzZTFhMWIwL3RhYmxlcmFuZ2U6MGMzOGZiYjIzZjgwNDQ5NmEyMmZiMTJkYzNlMWExYjBfMi02LTEtMS04NzQ1_c0748ef3-1532-4326-95c3-84930b0d3644">21,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit from stock-based compensation cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjBjMzhmYmIyM2Y4MDQ0OTZhMjJmYjEyZGMzZTFhMWIwL3RhYmxlcmFuZ2U6MGMzOGZiYjIzZjgwNDQ5NmEyMmZiMTJkYzNlMWExYjBfMy0yLTEtMS04NzQ1_1e221adf-2c2d-4734-a5ef-9b610708fe92">6,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjBjMzhmYmIyM2Y4MDQ0OTZhMjJmYjEyZGMzZTFhMWIwL3RhYmxlcmFuZ2U6MGMzOGZiYjIzZjgwNDQ5NmEyMmZiMTJkYzNlMWExYjBfMy00LTEtMS04NzQ1_a7f7c9ec-8f2c-480e-88d3-1d95f88b389a">5,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjBjMzhmYmIyM2Y4MDQ0OTZhMjJmYjEyZGMzZTFhMWIwL3RhYmxlcmFuZ2U6MGMzOGZiYjIzZjgwNDQ5NmEyMmZiMTJkYzNlMWExYjBfMy02LTEtMS04NzQ1_2c53f403-c9f5-4a5f-bb35-9a8687013488">4,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indirect tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="icui:IndirectTaxBenefitFromStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjBjMzhmYmIyM2Y4MDQ0OTZhMjJmYjEyZGMzZTFhMWIwL3RhYmxlcmFuZ2U6MGMzOGZiYjIzZjgwNDQ5NmEyMmZiMTJkYzNlMWExYjBfNC0yLTEtMS04NzQ1_6edddd7d-f970-4318-91cf-3e42fdb783fb">285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="icui:IndirectTaxBenefitFromStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjBjMzhmYmIyM2Y4MDQ0OTZhMjJmYjEyZGMzZTFhMWIwL3RhYmxlcmFuZ2U6MGMzOGZiYjIzZjgwNDQ5NmEyMmZiMTJkYzNlMWExYjBfNC00LTEtMS04NzQ1_68e12cde-b5d7-4b1c-be70-e3068ab4c74c">1,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="icui:IndirectTaxBenefitFromStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjBjMzhmYmIyM2Y4MDQ0OTZhMjJmYjEyZGMzZTFhMWIwL3RhYmxlcmFuZ2U6MGMzOGZiYjIzZjgwNDQ5NmEyMmZiMTJkYzNlMWExYjBfNC02LTEtMS04NzQ1_a1941d96-657c-4730-b08a-01720ba3b9ea">680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfOTc4_0cbca6cd-a608-400c-ad7b-98faeb1acc56">31.2</ix:nonFraction> million of unamortized stock compensation cost which we will recognize as an expense over a weighted-average period of approximately <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTEwNg_7fe20742-7907-4b11-84cd-214fe7ebc20f">0.9</ix:nonNumeric> years. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Option Plans</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 2011 Stock Incentive Plan ("2011 Plan") replaced our 2003 Stock Option Plan ("2003 Plan"). Our 2011 Plan initially had <ix:nonFraction unitRef="shares" contextRef="ifc815bf8be984d60b72cea6a09a89ff5_I20111231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTI4Mg_45a94953-0ae0-4468-88b9-9e916caa9ed9">650,000</ix:nonFraction> shares available for issuance, plus the remaining available shares for grant from the 2003 Plan and any shares that were forfeited, terminated or expired that would have otherwise returned to the 2003 Plan. In 2012, 2014 and 2017, our stockholders approved amendments to the 2011 plan that increased the shares available for issuance by <ix:nonFraction unitRef="shares" contextRef="i1f3ac8f1b7404ea9b5d205028ace120c_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTYyMg_c9c864eb-286a-4602-99ea-80f337777e0c">3,275,000</ix:nonFraction>, bringing the initial shares available for issuance to <ix:nonFraction unitRef="shares" contextRef="ia405cf3a4ef6453097157cd7f886bc0c_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTY4MA_f05d0734-82e6-44f1-ba84-de289876b893">3,925,000</ix:nonFraction>, plus the remaining <ix:nonFraction unitRef="shares" contextRef="ic7101eb3934f4304b875384f0d2bf58d_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTcwMw_7bdc1705-7952-494b-948e-b25cfede7df1">248,700</ix:nonFraction> shares that remained available for grant from the 2003 Plan. As of December&#160;31, 2021, the 2011 Plan has <ix:nonFraction unitRef="shares" contextRef="ia405cf3a4ef6453097157cd7f886bc0c_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTc5NQ_a858af0e-557c-4b6f-b017-69b081ad28d0">4,188,300</ix:nonFraction> shares of common stock reserved for issuance to employees, which includes <ix:nonFraction unitRef="shares" contextRef="ia405cf3a4ef6453097157cd7f886bc0c_I20211231" decimals="INF" name="icui:Sharestransferredfromsupersededplan" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTg3Mg_23f98a7f-5794-4319-859c-56ccf02c828b">263,300</ix:nonFraction> shares that transferred from the 2003 Plan.&#160;Shares issued as options or stock appreciation rights ("SARs") are charged against the 2011 Plan's share reserve as one share for one share issued.  Shares subject to awards other than options and SARs are charged against the 2011 Plan's share reserve as 2.09 shares for 1 share issued. Options may be granted with exercise prices at no less than fair market value at date of grant. Options granted under the 2011 Plan may be "non-statutory stock options" which expire no more than ten years from date of grant or "incentive stock options" as defined in Section&#160;422 of the Internal Revenue Code of 1986, as amended.&#160; </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Time-based Stock Options&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, all options granted under 2011 Plan and 2003 Plan have been non-statutory stock options. The majority of the time-based outstanding employee option grants vested 25% after one year from the grant date and the balance vested ratably on a monthly basis over 36 months. The outstanding employee option grants are all fully vested. The majority of the outstanding options granted to non-employee directors vest one year from the grant date. The options generally expire 10 years from the grant date.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of time-based option grants is calculated using the Black-Scholes option valuation model.&#160;The expected term for the option grants was based on historical experience and expected future employee behavior. We estimate the volatility of our common stock at the date of grant based on the historical volatility of our common stock, based on the average expected exercise term. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTA0ODY_a0fdecfc-a373-404e-89a3-68ca4e79f0e0" continuedAt="ie806b64579264f5ba8490fc042e14516" escape="true">The table below summarizes the total time-based stock options granted, total valuation and the weighted-average assumptions (dollars in thousands, except per option amounts):</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="ie806b64579264f5ba8490fc042e14516"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year&#160;ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of time-based options granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa3af7f9a9464ef699356948deed2cb8_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfMi0yLTEtMS04NzQ1_d023d071-c53e-4e90-ae82-1ba9c1d7543d">7,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67a16227998c4b09be060e7ac75710c0_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfMi00LTEtMS04NzQ1_c61b5c21-801f-45a9-a497-0362a072eae3">7,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6a3a1155df674ed5a67b00576eacf44c_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfMi02LTEtMS04NzQ1_fa652edf-26d9-4737-9015-4917e240aae0">6,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value of options granted (in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3af7f9a9464ef699356948deed2cb8_D20210101-20211231" decimals="-3" name="icui:Timebasedoptionsgrantdatefairvalue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfMy0yLTEtMS04NzQ1_3ac5033c-f0b7-4f0f-a339-bd441bb3dba9">528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67a16227998c4b09be060e7ac75710c0_D20200101-20201231" decimals="-3" name="icui:Timebasedoptionsgrantdatefairvalue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfMy00LTEtMS04NzQ1_b06cfc27-8c16-4487-ba59-bac659a0da55">425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a3a1155df674ed5a67b00576eacf44c_D20190101-20191231" decimals="-3" name="icui:Timebasedoptionsgrantdatefairvalue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfMy02LTEtMS04NzQ1_ef6d39ab-6b81-4ec6-8187-81c506a6bc17">424</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Weighted-average assumptions for stock option valuation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifa3af7f9a9464ef699356948deed2cb8_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfNS0yLTEtMS04NzQ1_b9139f8d-b990-4b41-9764-4de679bcc878">5.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i67a16227998c4b09be060e7ac75710c0_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfNS00LTEtMS04NzQ1_04a95bbb-814a-43b2-b096-d4762d79ecea">5.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6a3a1155df674ed5a67b00576eacf44c_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfNS02LTEtMS04NzQ1_4d2eb19a-000d-41c1-813f-7be3f08a3237">5.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifa3af7f9a9464ef699356948deed2cb8_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfNi0yLTEtMS04NzQ1_dc0f8aa1-4ff2-4bb0-8560-9b7c46a43d36">35.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i67a16227998c4b09be060e7ac75710c0_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfNi00LTEtMS04NzQ1_b4b6e177-67ff-42ce-b8f3-a08d00ff505e">35.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6a3a1155df674ed5a67b00576eacf44c_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfNi02LTEtMS04NzQ1_c556d323-8210-4d50-972f-7352a94334b2">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifa3af7f9a9464ef699356948deed2cb8_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfNy0yLTEtMS04NzQ1_bad6c435-bf4d-446f-8f33-c30798ba5b50">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i67a16227998c4b09be060e7ac75710c0_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfNy00LTEtMS04NzQ1_80ad430e-ac35-445a-a0b4-435a74f00fd9">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6a3a1155df674ed5a67b00576eacf44c_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfNy02LTEtMS04NzQ1_689e5190-6b44-43c7-8a5a-1a33b6c5e847">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifa3af7f9a9464ef699356948deed2cb8_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfOC0yLTEtMS04NzQ1_2fb908fa-958d-4ddd-add2-6924cb720544">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i67a16227998c4b09be060e7ac75710c0_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfOC00LTEtMS04NzQ1_5ac80ec9-0bca-4acb-b5ac-4475dd0682db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6a3a1155df674ed5a67b00576eacf44c_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfOC02LTEtMS04NzQ1_9011e748-036a-4dbc-adc2-0f83ed30b88b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant-price per option</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifa3af7f9a9464ef699356948deed2cb8_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfOS0yLTEtMS04NzQ1_a6f4cbe3-e3fb-4fab-8d73-844e90317a5d">200.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i67a16227998c4b09be060e7ac75710c0_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfOS00LTEtMS04NzQ1_9205e02c-72e7-493d-928e-15df35fe4061">181.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6a3a1155df674ed5a67b00576eacf44c_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfOS02LTEtMS04NzQ1_1c2125c9-99da-4213-8af6-b5ab595d41a4">225.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant-date fair value per option</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifa3af7f9a9464ef699356948deed2cb8_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfMTAtMi0xLTEtODc0NQ_fe3433f5-61c8-4c94-a13d-d054e6bd35ad">66.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i67a16227998c4b09be060e7ac75710c0_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfMTAtNC0xLTEtODc0NQ_3f6b8c6b-396f-43b7-b329-6bff9febf16c">59.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6a3a1155df674ed5a67b00576eacf44c_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfMTAtNi0xLTEtODc0NQ_4b3258e4-5775-425c-adfd-0199c345280b">67.73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ia4aac77f315f46e2952a29bf3a4df305" continuedAt="i23f37248674343508d043e1b440acbd3"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTA1MDU_17d8d7f5-c741-4970-9d4c-bd57f33fa5bf" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our stock option activity as of and for the year ended December&#160;31, 2021 is as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Contractual Life (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December&#160;31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id78700fe30fa41ee9a54f1ac70463ee7_I20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfMS0yLTEtMS04NzQ1_405d4168-f230-4710-af8f-dbef9d6afc5c">817,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id78700fe30fa41ee9a54f1ac70463ee7_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfMS00LTEtMS04NzQ1_eebad3e1-3a0f-4c48-9ecf-5bf93c54958e">70.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i182dfcd4a48e49328d223a8303c254eb_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfMi0yLTEtMS04NzQ1_02c48b66-4c3c-45ce-ba8a-54f52bbea15b">7,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i182dfcd4a48e49328d223a8303c254eb_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfMi00LTEtMS04NzQ1_d7978f2c-dde5-4dc5-a859-aa0807691339">200.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i182dfcd4a48e49328d223a8303c254eb_D20210101-20211231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfMy0yLTEtMS04NzQ1_19bbc59e-665a-4854-a2cc-ce81443bae27">162,612</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i182dfcd4a48e49328d223a8303c254eb_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfMy00LTEtMS04NzQ1_0ecbeed1-1e5e-44ce-b2e3-935798905aa0">57.64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i182dfcd4a48e49328d223a8303c254eb_D20210101-20211231" decimals="0" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNC0yLTEtMS04NzQ1_ae6de64f-4945-4121-9df3-dc58f7d11c4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i182dfcd4a48e49328d223a8303c254eb_D20210101-20211231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNC00LTEtMS04NzQ1_36c17165-11e6-4014-9eb3-f19d0786886d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December&#160;31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5f9119ec4544a9ab30550ab201d84f9_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNS0yLTEtMS04NzQ1_e499c96a-218b-448c-b247-fe85fa78d6e5">663,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib5f9119ec4544a9ab30550ab201d84f9_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNS00LTEtMS04NzQ1_ea2268a3-23c8-4385-a146-fcb5666c5bbf">74.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i182dfcd4a48e49328d223a8303c254eb_D20210101-20211231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNS02LTEtMS04NzQ1_d7b5ffbf-4c2d-40c9-99c9-53fea59c8311">2.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f9119ec4544a9ab30550ab201d84f9_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNS04LTEtMS04NzQ1_c6bce3ea-5f01-4dfb-a890-5e19c3a71ca3">108,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5f9119ec4544a9ab30550ab201d84f9_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNi0yLTEtMS04NzQ1_76d3960a-8eac-43f3-a0c7-7877d02749ab">656,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib5f9119ec4544a9ab30550ab201d84f9_I20211231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNi00LTEtMS04NzQ1_0c54eea6-8554-4023-80bb-6ded7eaab11c">73.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i182dfcd4a48e49328d223a8303c254eb_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNi02LTEtMS04NzQ1_39238907-4034-4376-8423-eccbf1df0ee0">2.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f9119ec4544a9ab30550ab201d84f9_I20211231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNi04LTEtMS04NzQ1_3083cd9c-b27f-4e42-b8ee-7eef4fe37f81">107,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest, December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5f9119ec4544a9ab30550ab201d84f9_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNy0yLTEtMS04NzQ1_95560369-c22d-49b9-8502-4ee0e0351bf7">663,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib5f9119ec4544a9ab30550ab201d84f9_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNy00LTEtMS04NzQ1_45588081-8efd-42dd-8533-839c83c386b6">74.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i182dfcd4a48e49328d223a8303c254eb_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNy02LTEtMS04NzQ1_19edd624-f91d-4775-876e-8c46c80a890d">2.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f9119ec4544a9ab30550ab201d84f9_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNy04LTEtMS04NzQ1_317ed89d-52ae-4f1a-8309-8c9941764ffc">108,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intrinsic values for options exercisable, outstanding and vested or expected to vest at December&#160;31, 2021 are based on our closing stock price of $<ix:nonFraction unitRef="usdPerShare" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfNDYxMw_bdc43451-6cf9-4d94-9c42-b4a336d09041">237.34</ix:nonFraction> at December&#160;31, 2021 and are before applicable taxes.&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="icui:ExercisedOptionsDataTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTA0Njg_6753fe14-949a-4472-b6ca-f17ea12de3d0" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information regarding stock option activity:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.246%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year&#160;ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value of options exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmI5ZjI1ZGM5M2Q0NjRjNmNiM2EwNTI0Yzc1MjMwYzkzL3RhYmxlcmFuZ2U6YjlmMjVkYzkzZDQ2NGM2Y2IzYTA1MjRjNzUyMzBjOTNfMi0yLTEtMS04NzQ1_6d49c178-2c2a-4f82-9c93-e408b0059c04">27,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmI5ZjI1ZGM5M2Q0NjRjNmNiM2EwNTI0Yzc1MjMwYzkzL3RhYmxlcmFuZ2U6YjlmMjVkYzkzZDQ2NGM2Y2IzYTA1MjRjNzUyMzBjOTNfMi00LTEtMS04NzQ1_e27f5c0c-bd7c-4e49-8291-4106b5745c13">32,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmI5ZjI1ZGM5M2Q0NjRjNmNiM2EwNTI0Yzc1MjMwYzkzL3RhYmxlcmFuZ2U6YjlmMjVkYzkzZDQ2NGM2Y2IzYTA1MjRjNzUyMzBjOTNfMi02LTEtMS04NzQ1_f0160cb8-2f0a-4db5-ba3b-76753a26dc7f">22,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmI5ZjI1ZGM5M2Q0NjRjNmNiM2EwNTI0Yzc1MjMwYzkzL3RhYmxlcmFuZ2U6YjlmMjVkYzkzZDQ2NGM2Y2IzYTA1MjRjNzUyMzBjOTNfMy0yLTEtMS04NzQ1_2b8600b2-398b-4493-8966-a40fd4906238">9,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmI5ZjI1ZGM5M2Q0NjRjNmNiM2EwNTI0Yzc1MjMwYzkzL3RhYmxlcmFuZ2U6YjlmMjVkYzkzZDQ2NGM2Y2IzYTA1MjRjNzUyMzBjOTNfMy00LTEtMS04NzQ1_f95331b8-08b3-486c-abef-445d64f2ba84">13,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmI5ZjI1ZGM5M2Q0NjRjNmNiM2EwNTI0Yzc1MjMwYzkzL3RhYmxlcmFuZ2U6YjlmMjVkYzkzZDQ2NGM2Y2IzYTA1MjRjNzUyMzBjOTNfMy02LTEtMS04NzQ1_8feb54f0-682a-4136-88a8-acfa8651b877">7,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit from stock option exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmI5ZjI1ZGM5M2Q0NjRjNmNiM2EwNTI0Yzc1MjMwYzkzL3RhYmxlcmFuZ2U6YjlmMjVkYzkzZDQ2NGM2Y2IzYTA1MjRjNzUyMzBjOTNfNC0yLTEtMS04NzQ1_e9f543ed-694d-4b9b-8cee-1ece81df3cfe">5,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmI5ZjI1ZGM5M2Q0NjRjNmNiM2EwNTI0Yzc1MjMwYzkzL3RhYmxlcmFuZ2U6YjlmMjVkYzkzZDQ2NGM2Y2IzYTA1MjRjNzUyMzBjOTNfNC00LTEtMS04NzQ1_35a9ff9b-1b73-414d-a1d0-bdd6607629f3">5,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmI5ZjI1ZGM5M2Q0NjRjNmNiM2EwNTI0Yzc1MjMwYzkzL3RhYmxlcmFuZ2U6YjlmMjVkYzkzZDQ2NGM2Y2IzYTA1MjRjNzUyMzBjOTNfNC02LTEtMS04NzQ1_07f51bdc-4157-4900-8597-75ab8f6fd4e9">9,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Awards</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we granted PRSUs to our executive officers. For the executive officers other than the Chief Executive Officer ("CEO"), Chief Operations Officer ("COO") and the Chief Financial Officer ("CFO"), the PRSUs will vest subject to a three-year time vesting and further subject to a determination by the Compensation Committee that the officers have met their individual performance goals for the applicable years. For the CEO, COO and the CFO, the performance shares will cliff-vest ending on March 6, 2024 and further be subject to the achievement of minimum three-year cumulative revenue and EPS targets, commencing on January 1, 2021 and ending on December 31, 2023, which when reviewed against a predetermined vesting matrix could result in 0% to 250% of the awarded units that could vest. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we granted PRSUs to our executive officers. For the executive officers other than the CEO, COO and the CFO, the PRSUs will vest subject to a three-year time vesting and further subject to a determination by the Compensation Committee that the officers have met their individual performance goals for the applicable years. For the CEO, COO and the CFO, the performance shares will cliff-vest ending on March 6, 2023 and further be subject to the achievement of minimum three-year cumulative revenue and EPS targets, which when reviewed against a predetermined vesting matrix could result in 0% to 250% of the awarded units that could vest. On February 15, 2021, the Compensation Committee made the determination that the executive officers other than the CEO, COO and CFO met their individual performance goals for 2021, therefore one-third of their 2020 PRSU shares awarded vested during 2021. Additionally, during February 2021, the Compensation Committee, modified the potential vesting percentages related to the 2020 PRSU awards for the CEO, COO and CFO, as the original potential percentages were established immediately before the onset of the COVID-19 pandemic. The Compensation Committee determined to adjust the CEO, COO and CFO's potential to earn from between 0% and 250% of the award granted, to an increased potential to earn between 50% and 300% of the award granted, subject to the same minimum threshold revenue and EPS targets to be achieved by the Company. The additional compensation expense as a result of modifying the 2020 PRSUs granted to our CEO, COO and CFO totaled $<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="icui:ModifiedPRSUIncrementalExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTA5OTUxMTY0NTM4OA_fe5f79af-362a-4e4a-b2ab-8be5b70ee1db">2.1</ix:nonFraction>&#160;million recognized over the remaining amortization period from the date of modification.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we granted PRSUs to our executive officers. For the executive officers other than the CEO and the COO, the PRSUs will vest subject to a three-year time vesting and further subject to a determination by the Compensation Committee that </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i23f37248674343508d043e1b440acbd3" continuedAt="ia54f3f667f5b49929e67f4f7f1eba094"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the officers have met their individual performance goals for the applicable years.  For the CEO and the COO, the performance shares will cliff-vest ending on March 6, 2022 and further subject to the achievement of a minimum Cumulative Adjusted EBITDA. If for the three year period ending on December 31, 2021 the Cumulative Adjusted EBITDA has a growth of at least 6% to 8%, 50% of the awarded units will vest. If on the vesting date the Cumulative Adjusted EBITDA has a growth of between 8% to 10%, 100% of the awarded units will vest. If on the vesting date the Cumulative Adjusted EBITDA has a growth of over 10%, 200% of the awarded units will vest. In 2019, we also granted PRSUs to one of our non-executive employees. These PRSUs will vest at the end of a three-year period ending on March 31, 2022, if certain minimum performance goals are met. On February 15, 2021, the Compensation Committee made the determination that the executive officers other than the CEO and COO met their individual performance goals for 2021, therefore one-third of their 2019 PRSU shares awarded vested during 2021. The performance period related to the 2019 CEO and COO PRSUs ended on December 31, 2021 and based on the Cumulative Adjusted EBITDA achieved during the performance period zero payout is expected, subject to Compensation Committee review and determination. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018, we granted PRSUs to our executive officers. For the executive officers other than the CEO and the COO, the PRSUs were to vest subject to a three-year time vesting and further subject to a determination by the Compensation Committee that the officers have met their individual performance goals for the applicable year. For the CEO and the COO, the performance shares were to cliff-vest ending on February 15, 2021 and further subject to the achievement of a minimum Cumulative Adjusted EBITDA.  If for the three year period ending on December 31, 2020 the Cumulative Adjusted EBITDA has a growth of at least 6% to 8%, 50% of the awarded units will vest. If on the vesting date the Cumulative Adjusted EBITDA has a growth of between 8% to 10%, 100% of the awarded units will vest. If on the vesting date the Cumulative Adjusted EBITDA has a growth of over 10%, 200% of the awarded units will vest. On February 15, 2021, the Compensation Committee made the determination that the executive officers other than the CEO and COO met their individual performance goals for 2021, therefore one-third of their 2018 PRSU shares awarded vested during 2021. Also on February 15, 2021, the Compensation Committee determined that the CEO and COO's 2018 PRSUs were earned at 100% of the awards granted.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, we granted PRSUs to our executive officers. The PRSUs were scheduled to vest, if at all, upon the achievement of a minimum Cumulative Adjusted EBITDA, subject to a three-year cliff vesting ending on December 31, 2019.  If at that date, our Cumulative Adjusted EBITDA is at least $600 million but less than $650 million, 100% of the awarded units will vest.  If our Cumulative Adjusted EBITDA is at least $650 million but less than $700 million, 200% of the awarded units will vest. If our Cumulative Adjusted EBITDA is at least $700 million, 300% of the awarded units will vest. On January 17, 2020, the Compensation Committee made the determination that the 2017 PRSU shares were earned by our executive officers at the 300% achievement level.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, we granted PRSUs to our executive officers, which vested on December 31, 2018. During the first quarter of 2019, the Compensation Committee determined the award granted vested at 300%, as a minimum specified compound annual growth rate ("CAGR") in adjusted EBITDA per share of greater than 12% was reached for the 3-year performance period January 1, 2016 through December 31, 2018. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock units are granted annually to our Board of Directors and vest on the first anniversary of the grant date, or the date of our annual meeting, whichever occurs first. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, 2020 and 2019, we granted RSUs to certain employees that vest ratably on the anniversary of the grant over three years. We recognize forfeitures as they occur.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant-date fair market value of our PRSUs and RSUs is determined by our stock price on the grant date.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTA0NjI_35d92019-d92b-48ae-a1dd-d224fa959cfe" continuedAt="iff8e71c4b5e04068b16fa01773994713" escape="true">The table below summarizes our restricted stock award activity (dollars in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ia54f3f667f5b49929e67f4f7f1eba094"><div style="margin-top:5pt;text-align:center"><ix:continuation id="iff8e71c4b5e04068b16fa01773994713"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.246%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year&#160;ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except shares and per share amounts)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRSU</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i87391b560fa94e0e87d7e644dc34a031_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMy0yLTEtMS04NzQ1_5ad0ffb0-5d05-43d5-8a12-54f25c80fe16">53,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8bfb9cc3e6314f24bd71705af4bba7a2_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMy00LTEtMS04NzQ1_a6598ef8-6305-4acb-a743-5064e103a84a">38,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i518455bc726645ca83b1172f9d758adb_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMy02LTEtMS04NzQ1_3966c4b0-86d1-4e82-b84d-74a4417be56b">37,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares earned</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4831e0eda5014d4185f0331a3269b612_D20210101-20211231" decimals="0" name="icui:PerformanceSharesEarned" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNC0yLTEtMS04NzQ1_10ea7389-3747-4e2f-9d17-e963cfaa308f">32,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied69c2626ecd45eebbc3a906d06e9175_D20200101-20201231" decimals="0" name="icui:PerformanceSharesEarned" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNC00LTEtMS04NzQ1_d078a244-c733-4d44-868f-453c4f384d04">80,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i785cacd032d543efb047f2c5a292c791_D20190101-20191231" decimals="0" name="icui:PerformanceSharesEarned" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNC02LTEtMS04NzQ1_f2918a69-caa9-48db-be49-aee8c95ce879">114,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i87391b560fa94e0e87d7e644dc34a031_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNS0yLTEtMS04NzQ1_4c789cfd-cce1-4576-9ac6-6dd9a08ccfc9">198.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8bfb9cc3e6314f24bd71705af4bba7a2_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNS00LTEtMS04NzQ1_93f00073-90d8-4d4a-9449-475712cb9c6b">188.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i518455bc726645ca83b1172f9d758adb_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNS02LTEtMS04NzQ1_f2da1a03-a4ec-4880-a957-cde7cf9f227c">231.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87391b560fa94e0e87d7e644dc34a031_D20210101-20211231" decimals="-3" name="icui:Grantdatefairvalueperformancerestrictedstockunits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNi0yLTEtMS04NzQ1_a9625752-a4b8-4c20-8722-b1456d4b12c6">10,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bfb9cc3e6314f24bd71705af4bba7a2_D20200101-20201231" decimals="-3" name="icui:Grantdatefairvalueperformancerestrictedstockunits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNi00LTEtMS04NzQ1_2be034cf-559f-4ac7-be3a-48a9f3076f1c">7,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i518455bc726645ca83b1172f9d758adb_D20190101-20191231" decimals="-3" name="icui:Grantdatefairvalueperformancerestrictedstockunits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNi02LTEtMS04NzQ1_214fb327-b794-4ef1-a5e9-9e8223702f9e">8,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87391b560fa94e0e87d7e644dc34a031_D20210101-20211231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNy0yLTEtMS04NzQ1_a234e387-beda-49c2-9f9f-d1e1fe7b6a0c">6,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bfb9cc3e6314f24bd71705af4bba7a2_D20200101-20201231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNy00LTEtMS04NzQ1_306ead8e-c388-404b-b9ea-c305614dc084">15,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i518455bc726645ca83b1172f9d758adb_D20190101-20191231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNy02LTEtMS04NzQ1_49fb62cf-5dd7-4ff4-9011-73ec24cf3a7f">26,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7623b8fcbec644baa23b06274170ec0b_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTAtMi0xLTEtODc0NQ_ea1553f3-4693-4692-a39e-50f22e942719">84,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i51e354dd1c9a473aa838a7df3a9b11d5_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTAtNC0xLTEtODc0NQ_697d40b5-3578-479c-989e-72ecd741ce87">87,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0c17620dcf9644348c9d2eced453eca5_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTAtNi0xLTEtODc0NQ_99a23e9c-7033-48c8-acfb-03b1b6a00517">61,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7623b8fcbec644baa23b06274170ec0b_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTEtMi0xLTEtODc0NQ_85826805-77eb-4f6b-9beb-057dc4d020ef">199.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i51e354dd1c9a473aa838a7df3a9b11d5_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTEtNC0xLTEtODc0NQ_b1d08ff8-da8b-46e7-8780-34203287fcd8">188.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0c17620dcf9644348c9d2eced453eca5_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTEtNi0xLTEtODc0NQ_ab045430-018e-4aa4-8ea9-9b45a35cdc7f">227.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7623b8fcbec644baa23b06274170ec0b_D20210101-20211231" decimals="-3" name="icui:Grantdatefairvalueofrestrictedstockunitsgranted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTItMi0xLTEtODc0NQ_2f0ee0aa-620b-4366-9587-05d3ff02ee0b">16,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51e354dd1c9a473aa838a7df3a9b11d5_D20200101-20201231" decimals="-3" name="icui:Grantdatefairvalueofrestrictedstockunitsgranted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTItNC0xLTEtODc0NQ_b2572bc3-6453-490e-940d-bc2b15e9faad">16,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c17620dcf9644348c9d2eced453eca5_D20190101-20191231" decimals="-3" name="icui:Grantdatefairvalueofrestrictedstockunitsgranted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTItNi0xLTEtODc0NQ_a8a906e5-b5ce-4bb1-b932-54a60eb60ba1">14,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7623b8fcbec644baa23b06274170ec0b_D20210101-20211231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTMtMi0xLTEtODc0NQ_1e97bc7e-00a2-44ba-9eba-19c15b94523d">13,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51e354dd1c9a473aa838a7df3a9b11d5_D20200101-20201231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTMtNC0xLTEtODc0NQ_67ccbc9c-89a2-4d54-a47a-449551e78aa8">12,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c17620dcf9644348c9d2eced453eca5_D20190101-20191231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTMtNi0xLTEtODc0NQ_c94d2cf5-f486-4c0c-bffc-fa01e176eeb4">16,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(a)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PRSU shares earned in 2019 were related to performance awards granted to executives in 2016 and 2018, PRSU shares earned in 2020 were related to performance awards granted to executives in 2017, 2018 and 2019. PRSU shares earned in 2021 were related to performance awards granted to executives in 2018, 2019 and 2020.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTA0NzQ_4f0701dd-e490-4f7f-93c6-f243c378d07a" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides a summary of our PRSU and RSU activity as of and for the year ended December&#160;31, 2021: &#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Grant-Date Fair Value Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Contractual Life (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e48c0d8b6804bfc8fcdb345373f3e79_I20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfMS0yLTEtMS04NzQ1_4b53fdd2-0225-4582-8adf-9f4ba0c0169a">220,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8e48c0d8b6804bfc8fcdb345373f3e79_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfMS00LTEtMS04NzQ1_e853196a-15b1-4534-979a-4c6fd66667a8">209.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in units due to performance expectations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i376e73f5e55842518de67690861c3be5_D20210101-20211231" decimals="0" name="icui:Changeinunitsduetoperformanceexpectations" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfMi0yLTEtMS04NzQ1_737700ef-e45f-4aa6-a15e-c9bbe46773b1">24,601</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i376e73f5e55842518de67690861c3be5_D20210101-20211231" decimals="2" name="icui:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfMi00LTEtMS04NzQ1_e50f2206-9c51-40e1-aa8d-61fc26866952">209.64</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i376e73f5e55842518de67690861c3be5_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfMy0yLTEtMS04NzQ1_0030ebd8-7743-4bb3-99bd-d80328c5e23e">137,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i376e73f5e55842518de67690861c3be5_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfMy00LTEtMS04NzQ1_da43825a-97a4-4adf-a288-32723a0343fb">198.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i376e73f5e55842518de67690861c3be5_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfNC0yLTEtMS04NzQ1_7e74f7b3-9f16-4cf7-8c92-b4069e8e23d7">99,363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i376e73f5e55842518de67690861c3be5_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfNC00LTEtMS04NzQ1_e5dcd8ee-15b4-48a4-b945-182c3261679e">219.77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i376e73f5e55842518de67690861c3be5_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfNS0yLTEtMS04NzQ1_bb06aea0-86b2-4488-b7b6-13f52f4cfe6a">7,871</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i376e73f5e55842518de67690861c3be5_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfNS00LTEtMS04NzQ1_1a85b3eb-a094-4929-a7a0-befcff816cd8">196.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested and expected to vest at December&#160;31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f1a091230074ec5961f1c78910f1b75_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfNi0yLTEtMS04NzQ1_0af90cbc-4bc0-4cae-8821-76f80b171d6b">275,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5f1a091230074ec5961f1c78910f1b75_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfNi00LTEtMS04NzQ1_c31f62e0-085c-4895-9c53-5e0709eb27ec">201.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i376e73f5e55842518de67690861c3be5_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfNi02LTEtMS04NzQ1_62a1ad35-54a5-4177-bf77-e1f260e6abf8">1.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1a091230074ec5961f1c78910f1b75_I20211231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfNi04LTEtMS04NzQ1_37cbced4-5107-4910-97bb-6ff6ac8bcc99">65,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(a)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Relates to 2019-2021 PRSUs granted to a non-executive employee and 2021 and 2020 CEO, COO and CFO PRSUs granted, assumes attainment of an increased payout rate based on performance expectations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ESPP</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an ESPP under which U.S. employees may purchase up to $25,000 annually of common stock at 85% of its fair market value at the beginning or the end of a six-month offering period, whichever is lower. There are <ix:nonFraction unitRef="shares" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="0" name="icui:ESPPOriginalIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfOTk3OA_11f26c48-0e2f-4966-a74c-98462c596894">750,000</ix:nonFraction> shares of common stock reserved for issuance under the ESPP, which is subject to an annual increase of the least of <ix:nonFraction unitRef="shares" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="0" name="icui:ESPPAnnualIssuanceIncreaseLimit" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTAwOTc_cf42d702-1008-4e51-8470-e016ff6d4fc8">300,000</ix:nonFraction> shares, two percent of the shares outstanding or such a number as determined by the Board.&#160;To date, there have been no increases.&#160;As of December&#160;31, 2021, there were <ix:nonFraction unitRef="shares" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="0" name="icui:SharesAvailableInEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTAyNTE_c1f9b633-6a18-4235-bacb-96569091b447">133,487</ix:nonFraction> shares available for future issuance. The ESPP is intended to constitute an &#8220;employee stock purchase plan&#8221; within the meaning of Section&#160;423 of the Internal Revenue Code.  We suspended our ESPP in 2017.</span></div></ix:continuation><div><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7. <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDQwNQ_c44dfef8-8223-445c-a964-22f636bf604b" continuedAt="i8a9bb821e8ec496cba274d2ddad4e913" escape="true">DERIVATIVES AND HEDGING ACTIVITIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i8a9bb821e8ec496cba274d2ddad4e913" continuedAt="i8531e02b158f4296a24267da9ada305a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Accounting and Hedging Program</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purposes of our cash flow hedging programs are to manage the foreign currency exchange rate risk on forecasted expenses denominated in currencies other than the functional currency of the operating unit, and to manage floating interest rate risk associated with future interest payments on variable-rate term loans issued in January 2022 subsequent to our fiscal year end. We do not issue derivatives for trading or speculative purposes.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i8531e02b158f4296a24267da9ada305a" continuedAt="i06087bc6319d495b8b99364e10069a33"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on hedged transactions. The par forward contract and forward-starting interest rate swaps are designated and qualify as cash flow hedges. Our derivative instruments are recorded at fair value on the consolidated balance sheets and are classified based on the instrument's maturity date. We record changes in the fair value of the effective portion of the gain or loss on the derivative instrument as a component of other comprehensive income (loss) and we reclassify that gain or loss into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We began hedging a portion of our Mexico forecasted expenses denominated in Pesos ("MXN") in May 2017 by entering into a two-year cross-currency par forward contract. The term of this currency forward contract was May 1, 2017 to May 1, 2019. The derivative instrument had a fixed forward rate of <ix:nonFraction unitRef="number" contextRef="i193283f0dbb449a3bd6eff38a5f33bd4_I20211231" decimals="2" name="us-gaap:DerivativeForwardExchangeRate1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTQ0Mw_1bd218be-e7e6-4dca-9937-5d40e70ffb5f">20.01</ix:nonFraction> MXN/USD over the term of the two-year contract.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2018, we entered into a six-month cross-currency par forward contract. The term of this six-month contract was May 1, 2019 to November 1, 2019. The derivative instrument had a fixed forward rate of <ix:nonFraction unitRef="number" contextRef="i6091cecaf413499e962152be722b5f2f_I20211231" decimals="2" name="us-gaap:DerivativeForwardExchangeRate1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTcwNQ_332fe69c-ad4a-41d5-a08c-fa641103a53d">20.43</ix:nonFraction> MXN/USD over the term of the six-month contract.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we entered into a one-year cross-currency par forward contract. The term of the one-year hedge was November 1, 2019 to November 3, 2020. The derivative instrument matured in equal monthly amounts at a fixed forward rate of <ix:nonFraction unitRef="number" contextRef="ia164440f0483491b8db221971138e931_I20211231" decimals="2" name="us-gaap:DerivativeForwardExchangeRate1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDI2OQ_4804e659-6419-4bb3-bf0f-7673f7dc587f">22.11</ix:nonFraction> MXN/USD.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, we entered into a one-year cross-currency par forward contract. The total notional amount of this outstanding derivative as of December 31, 2020 was approximately <ix:nonFraction unitRef="usd" contextRef="i37ff8ade5acb448ea4d633f24092926d_I20211231" decimals="-3" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMzg0ODI5MDcwMTYzMw_53e2abf7-df3c-42ad-94bd-7111963450a1">436.8</ix:nonFraction> million MXN. The term of this one-year contract was November 3, 2020 to December 1, 2021. The derivative instrument matured in equal monthly amounts at a fixed forward rate of <ix:nonFraction unitRef="number" contextRef="i37ff8ade5acb448ea4d633f24092926d_I20211231" decimals="2" name="us-gaap:DerivativeForwardExchangeRate1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMjM2NA_8ec414d2-a652-4b8b-8ed6-562400ab1172">24.26</ix:nonFraction> MXN/USD.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, we entered into a one-year cross-currency par forward contract. The total notional amount of this outstanding derivative as of December 31, 2021 was approximately <ix:nonFraction unitRef="usd" contextRef="i4a83e789750f44daa32ae75c26ff6a9b_I20211231" decimals="-3" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMjc0ODc3OTA3MzQwOQ_ba145a89-c036-45a3-8f49-3ee93d92f3c0">413.1</ix:nonFraction> million MXN. The term of this one-year contract is December 1, 2021 to December 1, 2022. The derivative instrument matures in equal monthly amounts at a fixed forward rate of <ix:nonFraction unitRef="number" contextRef="i4a83e789750f44daa32ae75c26ff6a9b_I20211231" decimals="2" name="us-gaap:DerivativeForwardExchangeRate1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMjc0ODc3OTA3MzYxNQ_17ae3af1-8cbb-4a60-ab44-41c42da810d0">21.60</ix:nonFraction> MXN/USD.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Floating Interest Rate Risk</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, in anticipation of entering into new senior secured credit facilities in January 2022, which includes a variable-rate term loan A and a variable-rate term loan B (see Note 17: Subsequent Events for additional information), we entered into two forward-starting interest rate swaps. Under the interest rate swap agreements we exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount. The term loan A swap has an initial notional amount of $<ix:nonFraction unitRef="usd" contextRef="i3abfe315de2d4710b658cda2c9136055_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDI3Nw_339fcddc-9c6a-47da-a310-6c10b5f1bcdf">300.0</ix:nonFraction>&#160;million, reducing to $<ix:nonFraction unitRef="usd" contextRef="i6492f863fad145e99f24ecbdf6e97c41_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDI5Mw_51c0d6f9-5164-46e6-8366-3d6b000755f7">150.0</ix:nonFraction>&#160;million evenly on a quarterly basis through its final maturity in April 2027. We will pay a fixed rate of <ix:nonFraction unitRef="number" contextRef="i33eac537b9e347e786d5a3bbfd58eaa1_I20211231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDM0Nw_8bd147a4-8206-4cb1-b782-9b1cac15e566">1.49</ix:nonFraction>% and will receive the greater of 3-month USD LIBOR or <ix:nonFraction unitRef="number" contextRef="i33eac537b9e347e786d5a3bbfd58eaa1_I20211231" decimals="-2" name="icui:DerivativeInterestRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDM1NA_7641ccce-156f-476a-b825-4bcd9ce0ed88">0</ix:nonFraction>%. The term loan B swap has an initial notional amount of $<ix:nonFraction unitRef="usd" contextRef="i5700616ce493458ca1d063d5449a9a0f_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDMwOQ_7ed20761-b728-44c6-8b34-f6b364c9cfc9">750.0</ix:nonFraction>&#160;million, reducing to $<ix:nonFraction unitRef="usd" contextRef="ibf93883b30164701858e3d30c68ab759_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDMyNQ_42b6bf89-8a51-4f4e-8ec7-ce9ec1adcb29">46.9</ix:nonFraction>&#160;million evenly on a quarterly basis through its final maturity in April 2026. We will pay a fixed rate of <ix:nonFraction unitRef="number" contextRef="ib3bc9bb5a4a44cc78110749aecdb5636_I20211231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDM1OA_b1e91806-2d3f-4bc3-91ac-177143865d5e">1.31</ix:nonFraction>% and will receive the greater of 3-month USD LIBOR or <ix:nonFraction unitRef="number" contextRef="ib3bc9bb5a4a44cc78110749aecdb5636_I20211231" decimals="2" name="icui:DerivativeInterestRateFloor" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDM2NA_7c325978-d0ed-42c5-84e9-477f1f5a1a49">0.50</ix:nonFraction>%. These forward-starting swaps will effectively convert the relevant portion of the floating-rate term loans to fixed rates.&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMzA2NQ_b47ba99e-46fc-4397-a43d-df1e985798dd" continuedAt="ib119af8c88754bc28f7aee4a3a1e3f1d" escape="true">The following table presents the fair values of our derivative instruments included within the consolidated balance sheets (in thousands):  </ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i06087bc6319d495b8b99364e10069a33" continuedAt="i58ac2776563d4862a7a68ce941800c1c"><ix:continuation id="ib119af8c88754bc28f7aee4a3a1e3f1d"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.022%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.132%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Balance Sheet Location</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Exchange Forward Contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward-Starting Interest Rate Swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Derivatives</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9398faa8a97348f0a664d0a940cc1df1_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNC0zLTEtMS04NzQ1_7752671f-45d4-4ea7-8c69-2c05b3d5aaf1">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeebd3cacab24dc38bf7ae3d6bb6c231_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNC01LTEtMS04NzQ1_b95719f3-666f-4d9a-bdd2-8dc2507921fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0698571e6787437d90d0b0048700239f_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNS02LTEtMS01NzcyOA_798684e4-8e5a-4279-a920-742d207bf8ff">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89eb1993f904410907120b3b745456d_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNS0zLTEtMS04NzQ1_28704dba-231d-40fc-8f48-4d88361006c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb35882a84d40c69f565d43f607d507_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNS01LTEtMS04NzQ1_551fe5dc-edef-494f-b0b6-d0d5e3e745b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib612e7e55d2c4ebf87498ce95fb1a17a_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNi02LTEtMS01NzcyOA_904ff70b-63d7-4319-a63c-eb66f34fc68a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d5a1bdc1c724bc7b475abaf04f05670_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNy0yLTEtMS01NzcyMA_b11ae1f9-98cb-4136-9c13-f79abf229bfe">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa89d23d7e2a43d19cb3b0e7f251e771_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNy00LTEtMS01NzcyMg_3ba592d4-ebf1-4c6a-9d40-6c623397d8c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48cb839aacc34533888f3bb68369bf70_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNy02LTEtMS01NzcyOA_7b624dcc-98b5-4457-963c-eefd250178f0">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i275a397a6a9f4699b14f84e0917f5cf6_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNi0zLTEtMS04NzQ1_104cf0f8-13a7-4469-9492-156c6e3e8a6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d6c14d6d9e54ea98f1e56d587002e2b_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNi01LTEtMS04NzQ1_e7360644-f514-443a-b5a7-d1854338d142">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7275aca2da2849a582d9e7ba1f1cedbe_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTAtNi0xLTEtNTc3Mjg_74a0e7bb-ab5a-4368-9db5-aa4d7cf77ec5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c479368de1144bfb45d95026be0cd76_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNy0zLTEtMS04NzQ1_330df7c7-cb8d-49ca-a564-b74bb62a2a67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62d03683ea954674a5322351789e0906_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNy01LTEtMS04NzQ1_e83f9396-eec3-4875-ad0e-3f9a0832f53a">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i237a6bf9b93147d2ba3fd48effc174cc_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTEtNi0xLTEtNTc3Mjg_a1526684-44ba-49b0-8ec4-cac1273ddbd7">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544809a7b69540748709fce0559278a0_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfOC0zLTEtMS04NzQ1_4c6f23e3-0a54-41b0-8872-ea31bb4145b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f8134bb52614717bbcc1d971c2e9f87_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfOC01LTEtMS04NzQ1_a8e84e0c-8a52-4f10-a890-1ff1a363a522">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i117c77f98cd34cbb84dd2f1e0aaf77ac_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTItNi0xLTEtNTc3Mjg_f885c478-2043-472f-8698-5eaebdf37327">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4eb6e79360c467f8c9a58e50160406d_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTUtMi0xLTEtNTc3MDQ_944dd375-5866-4d9a-8b5e-cf01260b74d2">3,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94cc3a526443461c92bb879f72405e63_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTUtNC0xLTEtNTc3MTI_a4559e03-9b9c-4a26-b159-42cf7e5850e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba75d31130ff4518a24b52c40ad06517_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTUtNi0xLTEtNTc3Mjg_51285bfd-3c19-498e-b33b-c5374e62f51e">3,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic43efddee26741cfa82e26fbb5d22949_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTYtMi0xLTEtNTc3MDY_c989f3fa-ac33-41ad-95bf-8ab5d1571426">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30a2923e460d49549d45431e449f5c22_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTYtNC0xLTEtNTc3MTI_8a3bfd32-7758-4b19-b919-2fb4d3eedbab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb6f3d45751d49a59460c1b52b47c868_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTYtNi0xLTEtNTc3Mjg_87fbb9c5-58eb-44b3-befb-a7ec67179cfd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0660e1ab42834fa5b8f6de068d1ac560_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTctMi0xLTEtNTc3MjY_675c517f-f7a2-4390-bb52-46b4a071f5b7">3,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6adeef3935784865bfb3756361fd2fe0_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTctNC0xLTEtNTc3MjQ_fb398232-8cda-4e11-81e1-869eba4965b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70ee7aca58f04d14ba4afb3526f496a9_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTctNi0xLTEtNTc3Mjg_359b109f-447b-427d-a945-559d67aa71e4">3,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedb19205fd444f879bcad70f1358784e_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMjAtMi0xLTEtNTc3MDg_32daed80-fa18-4d3c-9fd5-5373a7d59ce9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc678f466ad4ed5a96daa25baf1c6f2_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMjAtNC0xLTEtNTc3MTI_05d1aeef-69c8-4a5d-be94-d9e8e7c65948">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7b4be9668d0488da88397ffbc79a2e8_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMjAtNi0xLTEtNTc3Mjg_547cc8c1-d6dd-46db-978f-e640f32f77a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i102a8b308c97481c8dc3ea2c01523124_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMjEtMi0xLTEtNTc3MTA_9a9c0366-ee8d-47da-9f7e-0597578e76de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i765f5892367e40028ae56cc662e3184a_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMjEtNC0xLTEtNTc3MTI_6f14ac8a-cd43-4bf6-81bf-2d99c9c9c456">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61230b4e893e4a7d9cd519aeed4a1b65_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMjEtNi0xLTEtNTc3Mjg_bacf4d3d-a361-4b4b-9e28-cb5e6f9f92db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i054679d6ffef4f87a4f43e136c98ca11_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMjItMi0xLTEtNTc3MTg_10fcb31b-da39-4fe0-821d-0201fca0f5fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06483eccc4414d90bd57c57ccef5aad0_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMjItNC0xLTEtNTc3MTI_3ce2e50c-e3ab-451c-8aca-fbb8ce97a516">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id82c332d5c3f4a3aa2e643ec24082edb_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMjItNi0xLTEtNTc3Mjg_376ddf7c-97d8-4722-b2a0-d9162d5cf175">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the amounts affecting the Consolidated Statements of Operations (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Gain in the Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjFjNTYwY2U4YzMxYTRiY2Q5ODlmYjIxZTY4Mzc5N2I5L3RhYmxlcmFuZ2U6MWM1NjBjZThjMzFhNGJjZDk4OWZiMjFlNjgzNzk3YjlfMy0zLTEtMS04NzQ1_38830ac5-5ef7-4e7d-8d21-14aafb0150ef">3,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjFjNTYwY2U4YzMxYTRiY2Q5ODlmYjIxZTY4Mzc5N2I5L3RhYmxlcmFuZ2U6MWM1NjBjZThjMzFhNGJjZDk4OWZiMjFlNjgzNzk3YjlfMy01LTEtMS04NzQ1_50536675-c3b2-4a1a-9e3f-6b475e5b5e5b">790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjFjNTYwY2U4YzMxYTRiY2Q5ODlmYjIxZTY4Mzc5N2I5L3RhYmxlcmFuZ2U6MWM1NjBjZThjMzFhNGJjZDk4OWZiMjFlNjgzNzk3YjlfMy03LTEtMS04NzQ1_9439e5e6-6d2a-4b6b-b61c-833e8e45375a">916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4052c8cf471f453cbde9f738554a1b28_D20210101-20211231" decimals="-6" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjFjNTYwY2U4YzMxYTRiY2Q5ODlmYjIxZTY4Mzc5N2I5L3RhYmxlcmFuZ2U6MWM1NjBjZThjMzFhNGJjZDk4OWZiMjFlNjgzNzk3YjlfNC0zLTEtMS02MTgyMQ_5b64bb52-1fde-4ce7-ac99-82c48bec2be4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84762f9663364789a2d8c3ece37ff567_D20200101-20201231" decimals="-6" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjFjNTYwY2U4YzMxYTRiY2Q5ODlmYjIxZTY4Mzc5N2I5L3RhYmxlcmFuZ2U6MWM1NjBjZThjMzFhNGJjZDk4OWZiMjFlNjgzNzk3YjlfNC01LTEtMS02MTgyMw_1b72fa60-9739-47fb-99ae-023b408afb76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ddfa9b22060462886127f5b80779ec2_D20190101-20191231" decimals="-6" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjFjNTYwY2U4YzMxYTRiY2Q5ODlmYjIxZTY4Mzc5N2I5L3RhYmxlcmFuZ2U6MWM1NjBjZThjMzFhNGJjZDk4OWZiMjFlNjgzNzk3YjlfNC03LTEtMS02MTgyNQ_cbae653a-7180-49d3-8d1e-6717a4431b0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i58ac2776563d4862a7a68ce941800c1c"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMzA1OA_09a2f39b-c50c-4853-9c97-ca71c00d81ae" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized the following gains (losses) on our derivative instruments designated as cash flow hedges (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.070%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.460%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Other Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount of Gain Reclassified From Accumulated Other Comprehensive Income into Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain Reclassified From Accumulated Other Comprehensive Income into Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c9c90aaec48427e913d473bf39547d4_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNC0yLTEtMS04NzQ1_8f83b8ce-4a94-42ac-b9ee-6ab23e646709">950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05bb705b5592489b842c36481960323d_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNC00LTEtMS04NzQ1_88256923-9bcb-4896-bb29-fb7de9e6390a">1,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i695d74244e1a4ea2809a46299c1c17d2_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNC02LTEtMS04NzQ1_2ade07a2-2007-4f7d-8010-65b4e23f7460">2,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if00269ccb40e47d28d49e0860aba7a70_D20210101-20211231" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNC0xMC0xLTEtODc0NQ_1344950e-8041-4ff7-9e40-98f27d21c669">3,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie94168586b384dfe833911f3c4123fd5_D20200101-20201231" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNC0xMi0xLTEtODc0NQ_b40ed939-1749-468e-9764-a5c5b0f8a680">790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55daea74768c4c5f8155e5eaa03cc29c_D20190101-20191231" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNC0xNC0xLTEtODc0NQ_2c8b205a-8f3c-4abe-8215-baf76320b0e8">916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4052c8cf471f453cbde9f738554a1b28_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNS0yLTEtMS01NzczMw_9d521997-0b8d-4ac5-b258-6c7f7d8c241f">1,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84762f9663364789a2d8c3ece37ff567_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNS00LTEtMS02MTgyOQ_9bc6e235-d08c-4d11-ac24-2a95a1c01922">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ddfa9b22060462886127f5b80779ec2_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNS02LTEtMS02MTgzMQ_c6919199-a916-475f-ad2c-d00a770a242d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4052c8cf471f453cbde9f738554a1b28_D20210101-20211231" decimals="-6" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNS0xMC0xLTEtNjE4MzQ_f7bbd641-4347-44da-903f-ae72b84df74e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84762f9663364789a2d8c3ece37ff567_D20200101-20201231" decimals="-6" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNS0xMi0xLTEtNjE4Mzc_e8cd87c6-85b0-4018-961a-3753be47edce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ddfa9b22060462886127f5b80779ec2_D20190101-20191231" decimals="-6" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNS0xNC0xLTEtNjE4NDA_b162d5b9-f3d1-4286-8cb4-45d975d63201">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNi0yLTEtMS02MTg0Mw_70133f90-593b-4920-ae39-6c84ab7d70b2">530</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNi00LTEtMS02MTg0Ng_b0fa6d1a-fb1f-4f9c-b1db-ed4ddc94a549">1,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNi02LTEtMS02MTg0OQ_2538243f-1dfa-43eb-b60e-56e4e42833ed">2,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNi0xMC0xLTEtNjE4NTI_cf27d436-beac-46ef-801d-b11bb32d7cc3">3,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNi0xMi0xLTEtNjE4NTU_9eeea1c1-af1a-459d-9f9c-a607d3497f5f">790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNi0xNC0xLTEtNjE4NTg_252a98f4-6fda-48e9-b859-73324952b914">916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we expect an estimated $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMjgwNw_3dcb73f1-8eda-46bf-8db8-e0b795d997d7">1.1</ix:nonFraction> million in deferred gains on the outstanding foreign exchange forward contract and an estimated $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-5" sign="-" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDA5MA_02a106fa-67ff-4bdf-a7ea-ed5bbb4da93b">5.6</ix:nonFraction>&#160;million in deferred losses on the forward-starting interest rate swaps will be reclassified from accumulated other comprehensive loss to net income during the next 12 months concurrent with the underlying hedged transactions also being reported in net income.</span></div></ix:continuation><div style="margin-bottom:8pt"><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8. <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfNjE4OQ_66e1b5f4-e58c-4259-ac5b-c96b2e40a091" continuedAt="i3443d2be25e447d2be28c73f2744b8cf" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3443d2be25e447d2be28c73f2744b8cf" continuedAt="i5cb69884151f440f938d06d5cf36da5e"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1:  quoted prices in active markets for identical assets or liabilities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2:  inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3:  unobservable inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent earn-out liabilities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2019, we recognized an earn-out liability related to the acquisition of Pursuit (see Note 2: Acquisitions). Pursuit's former equity holders were entitled up to $<ix:nonFraction unitRef="usd" contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfMjkyNg_0c9c7eeb-ceb7-41b9-ad54-d5e818d712c1">50.0</ix:nonFraction> million in additional cash consideration contingent upon the achievement of certain sales and gross profit targets for specific customers. The earn-out was calculated as a percentage of gross profit achieved during the earn-out period against a pre-determined target gross profit, not to exceed $<ix:nonFraction unitRef="usd" contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfMzIyNQ_02aae66d-7e04-4ad4-a291-99e178cbf782">50.0</ix:nonFraction> million. During the earn-out period, we used a Monte Carlo simulation model to determine the fair value of the earn-out liability. The Monte Carlo simulation model utilized multiple input variables to determine the value of the earn-out liability including historical volatility, a risk-free interest rate, counter party credit risk and projected future gross profit (see the simulation input table below related to Pursuit). The historical volatility was based on the median of ICU and a certain peer group. The risk-free interest rate was equal to the yield, as of the valuation date, of the zero-coupon U.S. Treasury bill that was commensurate with the term of the earn-out. The counter party credit risk was based on a synthetic credit rating of B1. As of June 30, 2021, the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i5cb69884151f440f938d06d5cf36da5e" continuedAt="i8284b00ad70d4d75a82aeea14907a58e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">earn-out measurement period ended. Based on the actual sales and gross profit achieved during the measurement period, we calculated the actual earn-out amount to be $<ix:nonFraction unitRef="usd" contextRef="i8a64787f750d4031b14422894f232878_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfMjc0ODc3OTA3ODEwOQ_63c0be6f-43f3-44a9-bf6f-63f51b68d9cb">26.3</ix:nonFraction>&#160;million. The $<ix:nonFraction unitRef="usd" contextRef="i8a64787f750d4031b14422894f232878_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfMjc0ODc3OTA3ODEyNA_3c9b437d-5fe8-4178-9fc0-b40908dd0acc">26.3</ix:nonFraction>&#160;million earn-out calculation was finalized and accepted by Pursuit's former equity holders and was paid out in the fourth quarter of 2021. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out payment shall not exceed $<ix:nonFraction unitRef="usd" contextRef="idab760f167ab477b84968687e30e7446_D20210101-20211231" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfMjc0ODc3OTA3OTEyMQ_fbe1507b-1ade-4972-a977-2c1c673608b7">6.0</ix:nonFraction>&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of December 31, 2021, the fair value of the contingent earn-out was estimated at $<ix:nonFraction unitRef="usd" contextRef="ib0473993225046b8a38d55e04612297f_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfMjc0ODc3OTA3OTE1OA_67e0d85b-32f0-4c5b-ae0a-47ed8396943c">2.6</ix:nonFraction>&#160;million. The estimated fair value of the contingent earn-out is calculated using a probability-weighted cash flow model based on historical revenue streams and the likelihood that the revenue targets will be met.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $<ix:nonFraction unitRef="usd" contextRef="i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfMjc0ODc3OTA4Mjg5MQ_7868a7df-8834-42d0-99b3-15bf420e36df">2.5</ix:nonFraction>&#160;million, consisting of (i) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-6" name="icui:ShortTermContingentConsiderationGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfMjc0ODc3OTA4MjkwNQ_c0c8d9ce-19cd-4d3d-8ea0-e59a433ab70d">1.0</ix:nonFraction>&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="icui:LongTermContingentConsiderationGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfMjc0ODc3OTA4MjkxOQ_582af470-fabe-4ead-8178-d3913e7d517e">1.5</ix:nonFraction>&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. The initial estimated fair value of the contingent consideration related to this acquisition is immaterial. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contingent earn-out liabilities are separately stated on our consolidated balance sheets.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfNjE5NQ_eac4c231-1cd4-459c-82b4-5d84eda4273f" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of our Level 3 earn-out liabilities measured at estimated fair value based on an initial valuation and updated quarterly for the years ended December 31, 2021, 2020 and 2019 (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:78.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.373%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent earn-out liability, January 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2b82bbcf5cb45739937a1040ed30f6b_I20181231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmZhZDY1YmQwYjRkNDQzZWI4ZDcyYTE3Zjk2MjY5NWE1L3RhYmxlcmFuZ2U6ZmFkNjViZDBiNGQ0NDNlYjhkNzJhMTdmOTYyNjk1YTVfMS0yLTEtMS04NzQ1_85a5bc1c-7346-42f3-a26f-5dc4d5caf6f2">47,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition date fair value estimate of earn-out</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmZhZDY1YmQwYjRkNDQzZWI4ZDcyYTE3Zjk2MjY5NWE1L3RhYmxlcmFuZ2U6ZmFkNjViZDBiNGQ0NDNlYjhkNzJhMTdmOTYyNjk1YTVfMi0yLTEtMS04NzQ1_da2626b6-d912-48dd-942a-68fb26108114">17,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent earn-out (included in income from operations as a separate line item)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmZhZDY1YmQwYjRkNDQzZWI4ZDcyYTE3Zjk2MjY5NWE1L3RhYmxlcmFuZ2U6ZmFkNjViZDBiNGQ0NDNlYjhkNzJhMTdmOTYyNjk1YTVfMy0yLTEtMS04NzQ1_9a43f6bb-0c73-4acb-b2fe-ba90c9fc40d4">47,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent earn-out liability, December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmZhZDY1YmQwYjRkNDQzZWI4ZDcyYTE3Zjk2MjY5NWE1L3RhYmxlcmFuZ2U6ZmFkNjViZDBiNGQ0NDNlYjhkNzJhMTdmOTYyNjk1YTVfNC0yLTEtMS04NzQ1_32f36dbe-ca3f-457c-91af-c33f6d1db0f8">17,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent earn-out (included in income from operations as a separate line item)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmZhZDY1YmQwYjRkNDQzZWI4ZDcyYTE3Zjk2MjY5NWE1L3RhYmxlcmFuZ2U6ZmFkNjViZDBiNGQ0NDNlYjhkNzJhMTdmOTYyNjk1YTVfNi0yLTEtMS04NzQ1_16cb73ac-bf17-43e7-9f92-3889f8a60289">9,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent earn-out liability, December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmZhZDY1YmQwYjRkNDQzZWI4ZDcyYTE3Zjk2MjY5NWE1L3RhYmxlcmFuZ2U6ZmFkNjViZDBiNGQ0NDNlYjhkNzJhMTdmOTYyNjk1YTVfNy0yLTEtMS04NzQ1_1d052c38-97a3-4e41-9b66-72d881d92ed9">26,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent earn-out &#8212; non-compete arrangement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmZhZDY1YmQwYjRkNDQzZWI4ZDcyYTE3Zjk2MjY5NWE1L3RhYmxlcmFuZ2U6ZmFkNjViZDBiNGQ0NDNlYjhkNzJhMTdmOTYyNjk1YTVfOC0yLTEtMS04NzQ1_20bbd9f6-b200-4dd1-8b41-0217eb429c48">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfer of Pursuit earn-out liability into Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmZhZDY1YmQwYjRkNDQzZWI4ZDcyYTE3Zjk2MjY5NWE1L3RhYmxlcmFuZ2U6ZmFkNjViZDBiNGQ0NDNlYjhkNzJhMTdmOTYyNjk1YTVfMTAtMi0xLTEtNjIwMjE_57b3c7ef-c031-44b4-89fe-861fd4e86b9d">26,300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent earn-out liability, December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmZhZDY1YmQwYjRkNDQzZWI4ZDcyYTE3Zjk2MjY5NWE1L3RhYmxlcmFuZ2U6ZmFkNjViZDBiNGQ0NDNlYjhkNzJhMTdmOTYyNjk1YTVfMTAtMi0xLTEtODc0NQ_c4e52b7e-fae6-46dd-b103-a7d5828840fc">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Relates to our acquisition of Pursuit (see Note 2: Acquisitions).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of the HIS earn-out related to our 2017 acquisition of HIS from Pfizer which was based on actual results as compared to the earn-out performance targets. This adjustment reduced the HIS earn-out to zero.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Pursuit earn-out increased during 2020 primarily due to changes in the probabilities within the valuation model.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pursuit earn-out was transferred out of Level 3 and into Level 2 in the third quarter of 2021 when the amount of the actual payment was known, and subsequently settled during the fourth quarter of 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i8284b00ad70d4d75a82aeea14907a58e" continuedAt="i0c34ef66571348dc9cd63ed0b54bd610"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia4f13d3f94f44a08bc3233dd5ceb89a4_D20210101-20211231" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfNjIwNA_cefb7159-79c4-4621-b40b-ab4668d8fee1" escape="true">The following table provides quantitative information about Level 3 inputs for fair value measurement of the Pursuit earn-out liability as of the acquisition date to December 31, 2020:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfNjIxMQ_92977447-f4bf-44d3-9f85-7e44c273c5c5" escape="true"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pursuit Earn-out</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.443%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.546%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of<br/>December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At Acquisition<br/>November 2, 2019</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Simulation Input</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue/Gross Profit Volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4d20c02b38e041509fe7e05408566fbd_I20201231" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjVjYmViYzkwNTgyZDRhNDFiOTAxMjU5MWFmZDMwNWU2L3RhYmxlcmFuZ2U6NWNiZWJjOTA1ODJkNGE0MWI5MDEyNTkxYWZkMzA1ZTZfMi0zLTEtMS04NzQ1_76d150d5-03c3-4d97-a1cd-c5529b2ca6b2">25.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8dcd382934d440328d704d280ebf3fa4_I20191102" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjVjYmViYzkwNTgyZDRhNDFiOTAxMjU5MWFmZDMwNWU2L3RhYmxlcmFuZ2U6NWNiZWJjOTA1ODJkNGE0MWI5MDEyNTkxYWZkMzA1ZTZfMi01LTEtMS04NzQ1_a417f9bd-419f-439a-b973-c909a9de0a6f">20.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i95dc6e540f5b4198be6fed8fbf400d56_I20201231" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjVjYmViYzkwNTgyZDRhNDFiOTAxMjU5MWFmZDMwNWU2L3RhYmxlcmFuZ2U6NWNiZWJjOTA1ODJkNGE0MWI5MDEyNTkxYWZkMzA1ZTZfMy0zLTEtMS04NzQ1_1d147760-dfcd-4d17-bb56-342f406e5410">12.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iec592b00b8524a088ab236591b84114e_I20191102" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjVjYmViYzkwNTgyZDRhNDFiOTAxMjU5MWFmZDMwNWU2L3RhYmxlcmFuZ2U6NWNiZWJjOTA1ODJkNGE0MWI5MDEyNTkxYWZkMzA1ZTZfMy01LTEtMS04NzQ1_34571630-ee80-4b22-a396-46c2b3b7abb1">15.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i83746611e0ea468aad18f290522ef413_I20201231" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjVjYmViYzkwNTgyZDRhNDFiOTAxMjU5MWFmZDMwNWU2L3RhYmxlcmFuZ2U6NWNiZWJjOTA1ODJkNGE0MWI5MDEyNTkxYWZkMzA1ZTZfNC0zLTEtMS04NzQ1_0e8d09b8-750c-4efe-8a41-23cda689ea6e">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a648c0e1a8241a38f2f3a48870c1bb0_I20191102" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjVjYmViYzkwNTgyZDRhNDFiOTAxMjU5MWFmZDMwNWU2L3RhYmxlcmFuZ2U6NWNiZWJjOTA1ODJkNGE0MWI5MDEyNTkxYWZkMzA1ZTZfNC01LTEtMS04NzQ1_0c062fa2-3fa5-4cfc-8526-90f7e8d226c6">1.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Counter Party Risk</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3a0167f7320946b3a2e58b4124c3e79b_I20201231" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjVjYmViYzkwNTgyZDRhNDFiOTAxMjU5MWFmZDMwNWU2L3RhYmxlcmFuZ2U6NWNiZWJjOTA1ODJkNGE0MWI5MDEyNTkxYWZkMzA1ZTZfNS0zLTEtMS04NzQ1_220713e4-ace6-445c-8275-ef123d928ada">3.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c5018212e424aa8ad9252ca55f1861c_I20191102" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjVjYmViYzkwNTgyZDRhNDFiOTAxMjU5MWFmZDMwNWU2L3RhYmxlcmFuZ2U6NWNiZWJjOTA1ODJkNGE0MWI5MDEyNTkxYWZkMzA1ZTZfNS01LTEtMS04NzQ1_ce0be3d2-ec6f-4e59-a9ab-34057bf0d4b7">6.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments, Foreign Currency Contracts and Interest Rate Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our investments, which consist of corporate bonds, is estimated using observable market-based inputs such as quoted prices, interest rates and yield curves or Level 2 inputs.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our Level 2 forward currency contracts is estimated using observable market inputs such as known notional value amounts, spot and forward exchange rates. These inputs relate to liquid, heavily traded currencies with active markets which are available for the full term of the derivative. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our Level 2 forward-starting interest rate swaps is estimated using a pricing model that reflects the terms of the contracts, including the period to maturity, and relies on observable market inputs such as known notional value amounts and USD interest rate curves. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the Pursuit earn-out liability described above, there were no transfers between levels in 2021 or 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfNjE5Nw_93ff939f-0413-4baa-b385-596db96e11f5" continuedAt="i5dac189163c44fb5ab040e69cfb474b2" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our assets and liabilities measured at fair value on a recurring basis consisted of the following (Level 1, 2 and 3 inputs as defined above) (in thousands):&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.547%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNC0xLTEtMS04NzQ1_f17370d7-e6b4-4272-a80d-f5bab7ec685f">14,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i016a88407f61445a9ead2c5fe9666972_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNC0zLTEtMS04NzQ1_5a94689b-8f8a-445e-b085-e2ec4ac5a97f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffbaa78bab214394916b2fcdbc6715c6_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNC01LTEtMS04NzQ1_f1f5bb0a-37a7-49d8-9e2b-e3bd4deaddd6">14,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id686138862cd4f2faa2e433db45c3af8_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNC03LTEtMS04NzQ1_cd9ded31-5e66-4a1d-9693-c45f0598b020">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNS0xLTEtMS04NzQ1_b0465f11-e595-4d1a-8e94-efad68637e58">4,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i016a88407f61445a9ead2c5fe9666972_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNS0zLTEtMS04NzQ1_63e042b5-aa6e-42aa-a8a4-34e62d6c8560">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffbaa78bab214394916b2fcdbc6715c6_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNS01LTEtMS04NzQ1_c7ecf24f-73cc-4c62-97e3-233867030af4">4,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id686138862cd4f2faa2e433db45c3af8_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNS03LTEtMS04NzQ1_3b11a1f4-7b0e-4192-8ca3-86b9993ce74f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forwards:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7606edab34323b337692160cb6ced_I20211231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNy0xLTEtMS04NzQ1_d5f6427b-3ca2-4fe4-9c71-e03c76d30a02">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b1af846c2bd49b2b73f2cce81980df9_I20211231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNy0zLTEtMS04NzQ1_cf0f0e0c-973d-4f5d-a669-67389152b970">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3279fafd14f4fafa391f0e6aebb36f4_I20211231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNy01LTEtMS04NzQ1_f94641aa-0d8d-4184-aba5-0f3c581072f6">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1ccba1757384a43b8a31386dda4223f_I20211231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNy03LTEtMS04NzQ1_ffd32279-3e76-47f5-a58e-08801ff99a76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfOS0xLTEtMS04NzQ1_2f183339-52fa-421a-bccf-683bef2c6b19">20,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i016a88407f61445a9ead2c5fe9666972_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfOS0zLTEtMS04NzQ1_2ca7ecb3-a010-469e-bcc6-4b4fe7246a9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffbaa78bab214394916b2fcdbc6715c6_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfOS01LTEtMS04NzQ1_0583d1ce-0aa6-4c4c-a847-3f3b55454154">20,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id686138862cd4f2faa2e433db45c3af8_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfOS03LTEtMS04NzQ1_79a8f853-2f26-429c-989f-287cfe443169">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i375d2dcaee564df4bba09294bc8b4ce1_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTItMS0xLTEtODc0NQ_4c4c2a96-24de-4ff7-91f7-65b8f2f773ee">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96688b63cabc48858140503c0d9eb461_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTItMy0xLTEtODc0NQ_9822818f-7250-4854-9315-83bc48e7eda4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544bab0abcfd41739edc7808545eb541_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTItNS0xLTEtODc0NQ_37452b43-00ba-49ae-8484-2ec94f842834">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18f162b786b481ead18bd1c0072862f_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTItNy0xLTEtODc0NQ_a608f6bf-23c8-41b3-a39b-40c4a2d90b05">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTgtMS0xLTEtNjEyNzg_7a1a9fda-4e10-4acb-b5f9-84b2cb6c05ce">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i016a88407f61445a9ead2c5fe9666972_I20211231" decimals="-3" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTgtMy0xLTEtNjEyODI_4284d136-51c8-42ad-bb9d-32b37b5ed86f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffbaa78bab214394916b2fcdbc6715c6_I20211231" decimals="-3" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTgtNS0xLTEtNjEyODY_7e7812c2-56d8-4b09-babc-d47e0d843369">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id686138862cd4f2faa2e433db45c3af8_I20211231" decimals="-3" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTgtNy0xLTEtNjEyODg_98767c89-7cb3-45ff-b79b-6210ea496184">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbcc6f28c8de4784b50d3d46d2b1dc73_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTYtMS0xLTEtODc0NQ_3298d46e-cb6f-4ab5-9fb3-01a8a5c3b70d">4,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac9bf1a987b04a68a63b86dddb2a0ad7_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTYtMy0xLTEtODc0NQ_a17dd16e-686a-4c80-884e-8fa337ea3c3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a4e9901f5af47dbac4bd58d52cec2e3_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTYtNS0xLTEtODc0NQ_40518cc8-2662-49d9-a456-36f81e844f69">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ecdfc58eff40d4b5a5696b57877d65_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTYtNy0xLTEtODc0NQ_cbd17b10-0333-4bd4-9c6b-75ca6bdab93e">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><div style="text-align:center"><ix:continuation id="i0c34ef66571348dc9cd63ed0b54bd610"><ix:continuation id="i5dac189163c44fb5ab040e69cfb474b2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.397%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.547%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNC0xLTEtMS04NzQ1_b0de9108-a280-4c26-8c37-8b3e7c59490f">14,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9d041120aa546daa089ac02aad807b6_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNC0zLTEtMS04NzQ1_95e705d7-f471-4f3d-ba8f-633407448644">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e58a71511c74a519d97f5aaf72d0d67_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNC01LTEtMS04NzQ1_c9297711-8e04-468a-914c-3974d0d7bbfa">14,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb94fa0fb71402cbf3e8e652d8f7e4c_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNC03LTEtMS04NzQ1_50841f0a-2e2a-4d80-ab8e-9a3cd2105437">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNS0xLTEtMS04NzQ1_df7b6939-d296-4356-818f-56ae7e8d9484">12,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9d041120aa546daa089ac02aad807b6_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNS0zLTEtMS04NzQ1_794e22a6-ec7a-4bef-b670-7f20255f6201">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e58a71511c74a519d97f5aaf72d0d67_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNS01LTEtMS04NzQ1_cb2b63c7-d701-421d-8509-c5d1d4be3dc6">12,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb94fa0fb71402cbf3e8e652d8f7e4c_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNS03LTEtMS04NzQ1_33872d85-a282-4ad9-ab90-8df423095fbb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forwards:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf9c0633da1b47ee8d93b6e4abeff18b_I20201231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNy0xLTEtMS04NzQ1_e00cdbf8-2ece-44e8-99e9-e6ec52d16683">3,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23cd4418967541a1a5d36e2d99a5356e_I20201231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNy0zLTEtMS04NzQ1_d7a22d4f-17d5-4dc5-a00e-d0949f93c77a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b5d0557ec344d89ca4d7fdcdfbfa6b_I20201231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNy01LTEtMS04NzQ1_6f11c7b6-7a3d-47e8-a2d7-9891d892f433">3,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5809c6220648406e9d0413ce194ce911_I20201231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNy03LTEtMS04NzQ1_767e8007-471a-43ea-8e76-c0c1a16a38a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfOS0xLTEtMS04NzQ1_f2a738b5-f06b-48e8-aa6e-7bb5aa584cd6">31,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9d041120aa546daa089ac02aad807b6_I20201231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfOS0zLTEtMS04NzQ1_495239cd-279b-41d4-9aa3-413a126be564">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e58a71511c74a519d97f5aaf72d0d67_I20201231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfOS01LTEtMS04NzQ1_6c5a4ddd-a50c-41d6-9793-46750448922b">31,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb94fa0fb71402cbf3e8e652d8f7e4c_I20201231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfOS03LTEtMS04NzQ1_8c8acdef-c3cd-40aa-85b1-0c2c1713bfda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earn-out liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i322c2f5703b44dfebfc8fa4655888d5a_I20201231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfMTMtMS0xLTEtODc0NQ_6835e5ec-248d-4729-9304-0435f640a873">26,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8f6c1cca4c146c39148c7ba09392200_I20201231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfMTMtMy0xLTEtODc0NQ_b1b6f735-716b-423e-b3ec-41e96552da32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee1dd2e4cd844c88f833890aa55e7ea_I20201231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfMTMtNS0xLTEtODc0NQ_7ac8102b-3b3c-43c4-a871-e14f7a9dcf9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a287e50d1874b7c8137eb644e17fa5c_I20201231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfMTMtNy0xLTEtODc0NQ_28db5419-8d0a-40f4-871b-2d66313e693c">26,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib494916ad242431f84438805dad01887_I20201231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfMTctMS0xLTEtODc0NQ_2a7b4333-e469-46e1-bdb3-6c33eab9b222">26,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd62c35036b40778820f92e3d9b31f2_I20201231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfMTctMy0xLTEtODc0NQ_43ef41f5-21e7-43a6-b8d3-9089baeb1bd0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife8f7b6aa0ab423b9e32b2a38ffe5dd5_I20201231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfMTctNS0xLTEtODc0NQ_5d3fbd62-785b-427d-9b18-3ab67fa1c469">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie770d12c9b6a464ca982cfc743bc4e2d_I20201231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfMTctNy0xLTEtODc0NQ_56ce8680-5674-40f1-bcca-09f4c0cb4c94">26,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9. <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:OtherCurrentAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RleHRyZWdpb246MGFlZjM5YWY3ODMwNGVhMGI2ZjkxZGQ2MmM2NjI0YzJfMTQ2_1407fa98-f4f3-475d-b2d3-f6cf08a83d72" continuedAt="i079a9e6f1e604a0389bada203115d16f" escape="true">PREPAID EXPENSES AND OTHER CURRENT ASSETS AND OTHER ASSETS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i079a9e6f1e604a0389bada203115d16f"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RleHRyZWdpb246MGFlZjM5YWY3ODMwNGVhMGI2ZjkxZGQ2MmM2NjI0YzJfMTQ5_caa24563-c564-48a0-8d8b-995a47ba050b" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consist of the following (in thousands): &#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses and receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:OtherPrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfMi0xLTEtMS04NzQ1_ef86b563-8101-4b5d-86af-083d9947da73">14,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:OtherPrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfMi0zLTEtMS04NzQ1_532ba96b-757c-4f55-a0da-d12ec2eacfda">14,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:DeferredCostsAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfMy0xLTEtMS04NzQ1_ab8cf6c1-2e77-4d24-9409-351a8840c2fb">12,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:DeferredCostsAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfMy0zLTEtMS04NzQ1_96aaf74e-d1d9-4e42-b859-fe676a0c07e9">6,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance and property taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="icui:Prepaidinsuranceandpropertytaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfNC0xLTEtMS04NzQ1_03e1efb4-456f-41dc-af03-100325a13498">6,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="icui:Prepaidinsuranceandpropertytaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfNC0zLTEtMS04NzQ1_ed8776b8-52fc-4d4c-a393-877b250fcf61">6,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT/GST receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="icui:Prepaidothertaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfNS0xLTEtMS04NzQ1_fe4ad8f0-ea55-4603-841f-4c0c234250c1">4,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="icui:Prepaidothertaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfNS0zLTEtMS04NzQ1_3bc0fa7a-a277-4c16-b2da-617e492a4fac">3,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="icui:Deferredtaxcharge" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfNi0xLTEtMS04NzQ1_828546ec-a745-4d86-bc0c-3f0bb814350b">4,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="icui:Deferredtaxcharge" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfNi0zLTEtMS04NzQ1_072e16db-752a-4415-8d70-98584bf0845e">3,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forward contract</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfNy0xLTEtMS04NzQ1_25360d2a-3181-4560-99ed-fcbc1d4ec937">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfNy0zLTEtMS04NzQ1_4b9551f1-5ade-4f79-bd39-68100b82a183">3,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:DepositAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfOC0xLTEtMS04NzQ1_fd2d1868-89a1-47bf-9e92-a04c893fc878">1,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:DepositAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfOC0zLTEtMS04NzQ1_fb5fc987-96fe-4230-8541-ead4e058124b">1,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfOS0xLTEtMS04NzQ1_9f539fc5-5c54-44de-b926-30c81f62fb3d">2,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfOS0zLTEtMS04NzQ1_452b2595-1b5d-4f7a-943c-d7a23b9b0d1a">1,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfMTAtMS0xLTEtODc0NQ_819fc570-d610-4e32-89ae-f44c7de31bcf">46,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfMTAtMy0xLTEtODc0NQ_ec29d4af-471e-43e3-9a10-00ae64603748">41,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pump lease receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfMi0xLTEtMS0yODcyNA_19809c8e-a26a-4c98-ae4b-322a34b8b617">25,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfMi0zLTEtMS0yODcxNg_73f1a394-6eda-470b-89ac-9752e40ca667">28,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spare parts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="icui:SpareParts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfMy0xLTEtMS0yODcyNA_32658603-5dc8-40dc-86ca-602486a77451">28,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="icui:SpareParts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfMy0zLTEtMS0yODcxNg_5a11f361-1304-4bc6-853b-a6626e269a44">22,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfNC0xLTEtMS0yODcyNA_6cd969dc-3c96-43a0-b28d-958148305423">3,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfNC0zLTEtMS0yODcxNg_b1717af8-bc2b-4683-948d-f8a614b9ebea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNoncurrentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfNi0xLTEtMS01NjYyNQ_01520fb2-7f81-4bcf-9d85-d0587de89e45">2,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:DeferredFinanceCostsNoncurrentNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfNi0zLTEtMS01NjYyNQ_c2dc6bfe-3a95-46a6-b064-56e466a40e50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfNS0xLTEtMS0yODcyNA_b31bf858-a1cd-4400-afc8-a343474324f2">2,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfNS0zLTEtMS0yODcxNg_e96fe446-9b2b-478f-8d8e-0acd7421d464">2,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfNi0xLTEtMS0yODcyNA_d524931b-8188-406c-aa3a-8c15f5d5f143">526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfNi0zLTEtMS0yODcxNg_fb66df6a-ff87-45ed-b6b8-c8f3ada0e9d8">887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfNy0xLTEtMS0yODcyNA_82ffcc3e-a041-4ced-805c-725d0117d698">63,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfNy0zLTEtMS0yODcxNg_3fc08143-9002-4970-913f-9f7bc8f5d49e">55,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:5pt;text-indent:36pt"><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_97"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10. <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RleHRyZWdpb246YmZmZWNlNWYwYzhkNDA5Nzk5NDFmNTkzZDQ2ZjI5YzlfMzg2_8425368c-48e8-4baa-aa51-1ae1d3c6be45" continuedAt="ie498725f1d0448459724f920e6632752" escape="true">ACCRUED LIABILITIES AND OTHER LONG-TERM LIABILITIES</ix:nonNumeric></span></div><div style="margin-top:3pt;text-indent:36pt"><span><br/></span></div><ix:continuation id="ie498725f1d0448459724f920e6632752" continuedAt="ifb0925da24b24fc1b71b1bc6c857cc26"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RleHRyZWdpb246YmZmZWNlNWYwYzhkNDA5Nzk5NDFmNTkzZDQ2ZjI5YzlfMzc2_61d5010e-f66a-45d3-9d13-6727af18d9c3" continuedAt="iee49955181b9437f8a1666c86ac0713a" escape="true"><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="icui:AccruedSalariesAndBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMi0yLTEtMS04NzQ1_74c06152-821c-4a1f-b78e-560a61886f66">27,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="icui:AccruedSalariesAndBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMi00LTEtMS04NzQ1_8923d686-5eea-4d64-a881-ae56f894740c">25,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incentive compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:AccruedBonusesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMy0yLTEtMS04NzQ1_762979db-fc86-4201-b2c8-59ebc8db07fb">33,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:AccruedBonusesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMy00LTEtMS04NzQ1_164f6ebd-54ea-41fb-8aea-1f2d995eb1bf">27,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-ST</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfNS0yLTEtMS04NzQ1_e10b96e8-f03d-466b-9900-796852709a48">9,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfNS00LTEtMS04NzQ1_7badadb7-6b92-4d62-89f8-9361f7777165">8,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfNi0yLTEtMS04NzQ1_c181e898-7e31-4818-b06b-3eac649ebfb5">773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfNi00LTEtMS04NzQ1_a6f37dda-cd52-4485-b3a0-e1a1f92328f6">1,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal accrual</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="icui:Accruedlegalfees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTAtMi0xLTEtODc0NQ_fc24ef3b-7791-42d8-8917-ab9ff946da2e">3,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="icui:Accruedlegalfees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTAtNC0xLTEtODc0NQ_4b7765de-40da-489e-8dea-152daa7bbbf6">900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="icui:Accruedsalestaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTEtMi0xLTEtODc0NQ_e95d80a9-378f-4195-817e-b828bea981f4">1,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="icui:Accruedsalestaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTEtNC0xLTEtODc0NQ_a908f9a1-314e-48a7-82fe-7a4d29b85f81">2,146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranties and returns</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTItMi0xLTEtODc0NQ_7411c481-1d3f-49c0-a83a-a221175d718d">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTItNC0xLTEtODc0NQ_00c09305-9906-4ae7-878b-13b638b770e6">1,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTMtMi0xLTEtODc0NQ_792bc508-1de4-4e4d-953c-d1c63295f955">12,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTMtNC0xLTEtODc0NQ_761e4dc9-2a6f-45ee-a192-2342148dce55">5,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="icui:Accruedothertaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTQtMi0xLTEtODc0NQ_afee36dd-a57d-49d2-88db-67cc95c7b8d0">4,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="icui:Accruedothertaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTQtNC0xLTEtODc0NQ_80072b3b-e3ef-4ab4-9d16-a8754067a9d8">3,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="icui:Outsidesalescommissions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTUtMi0xLTEtODc0NQ_d63da7c6-2c79-4815-be00-8269e2239cd3">5,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="icui:Outsidesalescommissions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTUtNC0xLTEtODc0NQ_566c7912-957e-4f31-9249-94b0138abffd">5,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued freight</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="icui:Accruedfreight" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTYtMi0xLTEtODc0NQ_72f1ee34-268f-4c2a-8633-4e9771f53380">9,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="icui:Accruedfreight" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTYtNC0xLTEtODc0NQ_d517c4b1-7a56-4a8a-8f55-548e186503da">6,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring accrual</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:RestructuringReserveCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTctMi0xLTEtODc0NQ_7a1759d7-ccdd-4e5a-b16d-877289ca1fef">664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:RestructuringReserveCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTctNC0xLTEtODc0NQ_c9d86939-8190-4801-8b1f-9a08db455aaa">3,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMjMtMi0xLTEtODc0NQ_45cd9f8f-e32b-485e-bb33-217d23d7e6ef">9,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMjMtNC0xLTEtODc0NQ_2ebe1e8d-2a59-4cdf-b846-1d9d1f0ad5ef">5,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMjQtMi0xLTEtODc0NQ_71acd713-12ff-46cb-8c45-a32fb9656085">118,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMjQtNC0xLTEtODc0NQ_ab77a4a2-1376-4375-abf3-f19ce615a0a4">97,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-LT</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfMi0xLTEtMS04NzQ1_9f2c89a2-320f-4d5f-96d3-128bb73e8e1b">33,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfMi0zLTEtMS04NzQ1_288d4430-e680-4e4f-8d11-b697cf239acd">41,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liability-LT</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfMy0xLTEtMS04NzQ1_a78e77fa-dd2a-4c66-9ac8-19ab74bb695f">2,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfMy0zLTEtMS04NzQ1_1408c4d9-f550-4ec9-919d-7dc17754751b">2,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="icui:Liabilitiesforcontracts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfNC0xLTEtMS04NzQ1_52784a85-c0c4-4ffa-b69f-84a546527c1d">202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="icui:Liabilitiesforcontracts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfNC0zLTEtMS04NzQ1_63660187-42d2-4b16-bad8-6a8876535b7c">337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfNi0xLTEtMS01NTk1Ng_cd54e1ad-620f-45fd-828e-997b0caf1c4c">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfNi0zLTEtMS01NTk1Ng_2ab6ad55-5c16-420e-bfea-904da1c7a4ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfNi0xLTEtMS04NzQ1_28a087fc-8a4f-4259-a5ec-8ddd48b96a40">1,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfNi0zLTEtMS04NzQ1_1c55b083-dd67-4d48-82ce-9385031e975e">1,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:AccruedRentCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfOC0xLTEtMS04NzQ1_a9fbcd7b-469e-4227-a710-cacbee7acf5b">1,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:AccruedRentCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfOC0zLTEtMS04NzQ1_2e57784d-fad1-4119-8e48-bc082dda3c3e">1,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfMTAtMS0xLTEtODc0NQ_d88bcc04-95d2-4664-9eb2-5a617cfd028f">1,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfMTAtMy0xLTEtODc0NQ_caa1b2cd-148e-405f-8ddf-cfacd51c9a11">1,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfMTEtMS0xLTEtODc0NQ_31d501c4-ef87-4c55-ae89-8f34ec73ddae">41,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfMTEtMy0xLTEtODc0NQ_c9c23fbe-3d36-490c-9067-35eff81ea2f9">47,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"><ix:continuation id="ifb0925da24b24fc1b71b1bc6c857cc26" continuedAt="iaad84d81192b4aefa6b7fb3600165b77"><ix:continuation id="iee49955181b9437f8a1666c86ac0713a" continuedAt="i54841d957b4a4ca981a4426719d5b26d">(1)&#160;&#160;&#160;&#160;</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaad84d81192b4aefa6b7fb3600165b77"><ix:continuation id="i54841d957b4a4ca981a4426719d5b26d">Consists of contracts with customers and suppliers that were valued at below market at the time of the HIS acquisition.</ix:continuation></ix:continuation> </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><div id="ic100f0970bae445782808747a3ec391d_100"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11. <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzUwMTU_21a3a7ae-b7c5-4610-a73a-ea804e491788" continuedAt="i3ea0ae6882304671b5e084ef79ab0741" escape="true">LONG-TERM OBLIGATIONS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3ea0ae6882304671b5e084ef79ab0741" continuedAt="i57a676f15afd4edfbc70623eb1cdc9dd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Five-year Senior Secured Revolving Credit Facility ("Credit Facility")</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 8, 2017, we entered into a five-year Revolving Credit Facility ("Credit Facility") with various lenders for $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzIzMA_dde3f2de-7372-4e7d-ac6a-039b2c2dc49c">150.0</ix:nonFraction> million, with Wells Fargo Bank, N.A. as the administrative agent, swingline lender and issuing lender. During March 2020, as a result of market uncertainty caused by the COVID-19 pandemic, we preemptively borrowed $<ix:nonFraction unitRef="usd" contextRef="i01a24e6ac0b149afaca642972f237000_I20200331" decimals="-5" name="us-gaap:LinesOfCreditCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzEwOTk1MTE2MzYwOTg_2b88d309-8618-4b25-adff-043b4cb9af43">150.0</ix:nonFraction> million on our Credit Facility as a conservative measure to manage any potential short-term liquidity risk. As of December 31, 2020, we had fully repaid all amounts borrowed. As of December 31, 2021 and 2020, we had no borrowings and $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-6" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzY4MA_7dc10177-4b96-4393-8f4a-16317d3f65f1">150.0</ix:nonFraction> million of availability under the Credit Facility. The Credit Facility matures on <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:LineOfCreditFacilityExpirationDate1" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzc1Nw_facecaaa-67e1-45d1-b652-f2d807f81fda">November 8, 2022</ix:nonNumeric>.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facility has an accordion feature that would enable us to increase the borrowing capacity of the Credit Facility by the greater of (i) $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-6" name="icui:LineofCreditAccordion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzkwOQ_89bafa92-9e44-40ef-8419-33d8ce144e5b">100.0</ix:nonFraction> million and (ii) 2.00x Total Leverage.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Credit Facility, during the year ended December 31, 2017, we incurred $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-5" name="us-gaap:DebtIssuanceCostsLineOfCreditArrangementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzEwMzU_02dcfc08-d469-49e9-8881-dd94589158af">1.4</ix:nonFraction> million in financing costs, which were capitalized and are included in prepaid expenses and other current assets and other assets on our consolidated balance sheets, in accordance with the appropriate short-term or long-term classification.  These fees are being amortized to interest expense over the remaining term of the Credit Facility.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we completed the acquisition of Smiths Medical which was partially financed by entering into Senior Secured Credit Facilities consisting of a term loan A facility of $<ix:nonFraction unitRef="usd" contextRef="ic658275ab067426dbbc345457231980a_I20220106" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzEwOTk1MTE2MzYxMDA_e47246c5-a38d-4967-85a9-ddb26beb6e4d">850.0</ix:nonFraction>&#160;million, a term loan B facility of $<ix:nonFraction unitRef="usd" contextRef="ia241e4af05fc4638bc449fe9c9c45c66_I20220106" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzEwOTk1MTE2MzYwNjc_f340cb40-ec1f-4854-890d-c51e644c14d0">850.0</ix:nonFraction>&#160;million and a revolving credit facility of $<ix:nonFraction unitRef="usd" contextRef="i39ca865e5711457ca9a490c54dd29de5_I20220106" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzI3NDg3NzkwNzUwNTY_f6a487b9-05b2-4818-b27d-22c3fa8f3381">500.0</ix:nonFraction>&#160;million. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principal payments&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments, when drawn on the Credit Facility, are made at our discretion with the entire unpaid amount due at maturity.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:DebtInstrumentInterestRateTerms" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzUwMTg_d9f7404c-283c-493a-acf3-6189f085c30e">In general, borrowing under the Credit Facility (other than Swingline loans) bears interest, at our option, based on the Base Rate plus applicable margin or the London Interbank Offered Rate ("LIBOR") rate plus applicable margin, as defined below:</ix:nonNumeric> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(A) Base Rate is defined as the highest of: (a) the Prime Rate; (b) the Federal Funds Rate plus 0.50%; and (c) the daily LIBOR (as defined below) for a one month Interest Period plus 1%. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(B) LIBOR Rate, as determined by the Administrative Agent, is defined as the rate per annum obtained by dividing (1) LIBOR by (2) 1.00 - Eurodollar Reserve Percentage. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Swingline loans will bear interest at the Base Rate plus the applicable Interest Margin. The Credit Facility has a per annum commitment fee (see table below) that will accrue on the unused amounts of the commitments under the Credit Facility.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i57a676f15afd4edfbc70623eb1cdc9dd" continuedAt="if4c34c5619f64801b4f6a9fbb15d681e"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="icui:InterestMarginandCommitmentFeeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzUwMjE_9ea84cf8-db2b-4a2d-b184-859957cfe375" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable interest margins and the commitment fee with respect to the Credit Facility shall be based on the Total Leverage Ratio pursuant to the following pricing grid:&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total <br/>Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitment <br/>Fee</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIBOR <br/>+</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base Rate <br/>+</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.00 to 1.00</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7d9fbc7afe1b4667b19bef534f27f322_D20210101-20211231" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzEtMi0xLTEtODc0NQ_4e22e868-8f80-44b0-8963-e47e9444cee0">0.15</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ee969a0a9d645a88b99b6c08a883d11_I20211231" decimals="4" name="icui:LIBORBasisSpreadonVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzEtMy0xLTEtODc0NQ_6b0cdca3-00c6-4585-88ea-ac43712ce0c5">1.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7d9fbc7afe1b4667b19bef534f27f322_D20210101-20211231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzEtNC0xLTEtODc0NQ_ea8412eb-3aeb-47ed-8c15-dccda3769391">0.25</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 1.00 to 1.00 but less than 2.00 to 1.00</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2b1d712704db4bc9b1287e528b4fed69_D20210101-20211231" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzItMi0xLTEtODc0NQ_ef3a3ba3-750b-4964-bef3-fa4566828150">0.20</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id7d6cf9ceff24a8a9996f36321364cbb_I20211231" decimals="4" name="icui:LIBORBasisSpreadonVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzItMy0xLTEtODc0NQ_31f7d533-b98d-4079-b670-822e5642444a">1.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2b1d712704db4bc9b1287e528b4fed69_D20210101-20211231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzItNC0xLTEtODc0NQ_ae1f2cde-a4d3-43d0-8839-138e20de2ff2">0.50</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 2.00 to 1.00 but less than 2.50 to 1.00</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3bfb75a2163f47d9a268020ba497c76a_D20210101-20211231" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzMtMi0xLTEtODc0NQ_74d9c8cf-be34-4a40-a918-e3395aff806e">0.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7211233eb22e4fb993b5b3ecf7bfb508_I20211231" decimals="4" name="icui:LIBORBasisSpreadonVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzMtMy0xLTEtODc0NQ_dffd4976-9fbc-4154-8e01-49d8a62e7c79">1.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3bfb75a2163f47d9a268020ba497c76a_D20210101-20211231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzMtNC0xLTEtODc0NQ_eeb0dd8c-30f9-40c6-8a42-78d75fd032d5">0.75</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 2.50 to 1.00</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8bdd6b3003b648508919a57e2a1ae6fc_D20210101-20211231" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzQtMi0xLTEtODc0NQ_390480bc-c944-4dd4-9eac-42a17c9ab096">0.30</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id5a860996ab84b0a8023cd70138248b9_I20211231" decimals="4" name="icui:LIBORBasisSpreadonVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzQtMy0xLTEtODc0NQ_6dff69f7-b7a8-4124-bed3-d3182231bafa">2.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8bdd6b3003b648508919a57e2a1ae6fc_D20210101-20211231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzQtNC0xLTEtODc0NQ_de283985-3afc-4a95-be4f-efa054780450">1.00</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantors and Collateral</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations under the Credit Facility are unconditionally guaranteed, on a joint and several basis, by ICU Medical, Inc. and certain of our existing subsidiaries.  Our obligations are secured by: (i) 100% of the equity interests of our guarantor subsidiaries; and (ii) all of the tangible and intangible personal property and assets related to us and our guarantor subsidiaries (including, without limitation, all accounts, equipment, inventory and other goods, all instruments, intellectual property and other general intangibles, deposit accounts, securities accounts and other investment property and cash), and (iii) all products, profits and proceeds of the foregoing.  Notwithstanding the foregoing, the collateral shall not include certain excluded property.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Covenants</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facility contains certain financial covenants pertaining to Consolidated Fixed Charge Coverage and Consolidated Total Leverage Ratios.  In addition, the Credit Facility has restrictions pertaining to limitations on debt, liens, negative pledges, loans, advances, acquisitions, other investments, dividends, distributions, redemptions, repurchases of equity interests, fundamental changes and asset sales and other dispositions, prepayments, redemptions and purchases of subordinated debt and other junior debt, transactions with affiliates, dividend and payment restrictions affecting subsidiaries, changes in line of business, fiscal year and accounting practices and amendment of organizational documents and junior debt documents. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Leverage Ratio is defined as the ratio of Consolidated Total Funded Indebtedness on such date, to Consolidated Adjusted EBITDA, as defined under the Credit Facility Agreement, for the most recently completed four fiscal quarters.  The maximum Consolidated Leverage Ratio is not more than 3.00 to 1.00.  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Fixed Charge Coverage Ratio is defined as the ratio of: (a) Consolidated Adjusted EBITDA less the sum of (i) capital expenditures, (ii) federal, state, local and foreign income taxes paid in cash and (iii) cash restricted payments made after the closing date, to (b) Consolidated Fixed Charges for the most recently completed four fiscal quarters, calculated on a pro forma basis.  The minimum Consolidated Fixed Charge Coverage Ratio is 2.00 to 1.00. </span></div></ix:continuation><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if4c34c5619f64801b4f6a9fbb15d681e"> We entered into Senior Secured Credit Facilities in January 2022, which terminated our existing Credit Facility (see Note 17: Subsequent Events).</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:8pt"><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12. <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzQxODE_12bd2e35-c785-45e1-a793-3d70e90953fd" continuedAt="i5ba7046f6a014a0d9743934b5c9e12f8" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i5ba7046f6a014a0d9743934b5c9e12f8" continuedAt="i916255a59869475793567cccde3f4de2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzQxOTM_18563d6f-7342-430f-a919-20e8076117d9" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from continuing operations before taxes consisted of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.246%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpjMmIyYjMzNjU5OTc0ZjQ1YWZkNWZmNzY0MzFlYjk5Yi90YWJsZXJhbmdlOmMyYjJiMzM2NTk5NzRmNDVhZmQ1ZmY3NjQzMWViOTliXzItMi0xLTEtODc0NQ_4771cff0-b563-4422-9dec-43e1f813fdef">81,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpjMmIyYjMzNjU5OTc0ZjQ1YWZkNWZmNzY0MzFlYjk5Yi90YWJsZXJhbmdlOmMyYjJiMzM2NTk5NzRmNDVhZmQ1ZmY3NjQzMWViOTliXzItNC0xLTEtODc0NQ_70a2ec1f-5da8-421c-9956-667f404fb8e1">41,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpjMmIyYjMzNjU5OTc0ZjQ1YWZkNWZmNzY0MzFlYjk5Yi90YWJsZXJhbmdlOmMyYjJiMzM2NTk5NzRmNDVhZmQ1ZmY3NjQzMWViOTliXzItNi0xLTEtODc0NQ_d7bc5974-3452-4e48-a942-a6f02caac1d5">32,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpjMmIyYjMzNjU5OTc0ZjQ1YWZkNWZmNzY0MzFlYjk5Yi90YWJsZXJhbmdlOmMyYjJiMzM2NTk5NzRmNDVhZmQ1ZmY3NjQzMWViOTliXzMtMi0xLTEtODc0NQ_2534f9ff-c13f-4d9d-ab2b-40e85f506282">41,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpjMmIyYjMzNjU5OTc0ZjQ1YWZkNWZmNzY0MzFlYjk5Yi90YWJsZXJhbmdlOmMyYjJiMzM2NTk5NzRmNDVhZmQ1ZmY3NjQzMWViOTliXzMtNC0xLTEtODc0NQ_4ba42786-80a2-411a-8824-9bb73410f869">56,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpjMmIyYjMzNjU5OTc0ZjQ1YWZkNWZmNzY0MzFlYjk5Yi90YWJsZXJhbmdlOmMyYjJiMzM2NTk5NzRmNDVhZmQ1ZmY3NjQzMWViOTliXzMtNi0xLTEtODc0NQ_96d81df7-a218-400e-aeda-743eb8820db7">81,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpjMmIyYjMzNjU5OTc0ZjQ1YWZkNWZmNzY0MzFlYjk5Yi90YWJsZXJhbmdlOmMyYjJiMzM2NTk5NzRmNDVhZmQ1ZmY3NjQzMWViOTliXzQtMi0xLTEtODc0NQ_1a71dfb1-33fa-481e-9847-f40601a9673d">123,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpjMmIyYjMzNjU5OTc0ZjQ1YWZkNWZmNzY0MzFlYjk5Yi90YWJsZXJhbmdlOmMyYjJiMzM2NTk5NzRmNDVhZmQ1ZmY3NjQzMWViOTliXzQtNC0xLTEtODc0NQ_5eb38968-0b37-4490-8443-62a435fac82a">97,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpjMmIyYjMzNjU5OTc0ZjQ1YWZkNWZmNzY0MzFlYjk5Yi90YWJsZXJhbmdlOmMyYjJiMzM2NTk5NzRmNDVhZmQ1ZmY3NjQzMWViOTliXzQtNi0xLTEtODc0NQ_04a560a1-08ac-4b59-9471-4f4a697924f7">114,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i916255a59869475793567cccde3f4de2" continuedAt="iea8da6072f264601a5dc7865bb2b71a6"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzQxNzQ_1a79eaa9-6987-42c8-bd27-4dfe5a6e4bea" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision (benefit) for income taxes consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.246%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzMtMi0xLTEtODc0NQ_8ed9de1b-4a98-4530-884c-ea2c29fd7091">20,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzMtNC0xLTEtODc0NQ_f3cd6006-9702-411d-ac2f-e2b841e6bcd1">6,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzMtNi0xLTEtODc0NQ_cb712c2f-e3a8-4dae-b318-7d7895ea32e9">6,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzQtMi0xLTEtODc0NQ_ce7f4b1a-3fa4-4bed-b5ec-a5ba97059f52">3,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzQtNC0xLTEtODc0NQ_bbf3c7d7-6974-4fc7-b7cf-75ec64464f60">2,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzQtNi0xLTEtODc0NQ_355371db-a145-4b36-b049-3b88c097ec0e">2,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzUtMi0xLTEtODc0NQ_88334d7e-f83b-4b11-835d-6b24e99e6aa8">7,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzUtNC0xLTEtODc0NQ_1f1ead00-db50-4384-9b63-0692e5448aab">7,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzUtNi0xLTEtODc0NQ_18d8abac-6a8d-484d-bbca-89c66ce43aa4">7,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzYtMi0xLTEtODc0NQ_ee0b0af4-00c6-41fd-93cf-2d90d45c468e">31,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzYtNC0xLTEtODc0NQ_66417cdd-1d16-4fef-9afa-fee5add8d0aa">15,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzYtNi0xLTEtODc0NQ_44432ef6-cc6f-49db-bfeb-5f5e814a022d">17,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzgtMi0xLTEtODc0NQ_b462c746-c87b-4f38-af88-cf142705ec3c">8,154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzgtNC0xLTEtODc0NQ_f68929da-92f8-4b6f-8d6d-3c024eb3d930">5,319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzgtNi0xLTEtODc0NQ_976154cf-973d-4dd9-ac0a-cda233f2051a">6,720</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzktMi0xLTEtODc0NQ_a86a33c4-9027-4773-aa91-5248af909550">1,815</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzktNC0xLTEtODc0NQ_c6c92d1a-2b3b-4a7b-aefe-90f34e908562">1,850</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzktNi0xLTEtODc0NQ_5a16848c-8235-466d-911d-817eb0953d54">325</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzEwLTItMS0xLTg3NDU_a2dda1a8-afc7-4167-910f-a3e3a17063df">1,306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzEwLTQtMS0xLTg3NDU_7d2d9680-c0d9-4b17-845b-7ba5b8ed55d2">2,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzEwLTYtMS0xLTg3NDU_e94e9193-3b23-456e-964b-4785bbc02a19">3,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzExLTItMS0xLTg3NDU_7c161c68-7051-4a9a-99a8-6ff7cad3cb9e">11,275</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzExLTQtMS0xLTg3NDU_cd694d1c-f3a5-4520-930c-1742a1c446e4">5,120</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzExLTYtMS0xLTg3NDU_afaef56e-fdf5-4365-9459-f2cc37273dce">3,705</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzEyLTItMS0xLTg3NDU_af42b095-e6e2-4732-aebe-73e9744bb734">20,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzEyLTQtMS0xLTg3NDU_e6237a91-d8d0-4b36-a4cf-a460f6e078ef">10,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzEyLTYtMS0xLTg3NDU_ee0f954b-8aee-44b2-9787-4d8b02ab0b0d">13,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have accrued for tax contingencies for potential tax assessments, and in 2021 we recognized a $<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzMwOA_91675bc9-e423-4d8d-98f5-722aa72f5678">3.0</ix:nonFraction> million net increase, most of which related to various federal, state and foreign tax reserves.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzQxNjU_81b18f6a-6c62-4322-a00d-9aa5426c9412" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the provision for income taxes at the statutory rate to our effective tax rate is as follows (dollars in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:34.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal tax at the expected statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzMtMi0xLTEtODc0NQ_6b13d40b-0ebd-4594-be72-8a36506fb46c">25,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzMtNC0xLTEtODc0NQ_2b1a4c6f-512c-4f34-a2a7-79c8c9bc162b">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzMtNi0xLTEtODc0NQ_68a48be3-75ca-42d9-b7b1-6480214afb14">20,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzMtOC0xLTEtODc0NQ_48d482c6-bde5-48ec-9591-d1b5ba3f1148">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzMtMTAtMS0xLTg3NDU_6ed3247d-91fd-4872-b3e7-a007f927ddd6">24,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzMtMTItMS0xLTg3NDU_e79943c5-b47b-4a23-ac68-cd93b31c4b21">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income tax, net of federal effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzQtMi0xLTEtODc0NQ_78e9a81a-305d-44f3-ac98-588dfa22a1ef">2,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzQtNC0xLTEtODc0NQ_8834a0e5-569a-43fe-8074-d5aa4443bb4e">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzQtNi0xLTEtODc0NQ_8d1b8b60-4ed4-4dc8-9247-bb071befca13">2,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzQtOC0xLTEtODc0NQ_42e42437-2618-4d5e-82c1-0f6953860ce2">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzQtMTAtMS0xLTg3NDU_7590a8ca-e147-410e-b200-71d13f7325d1">1,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzQtMTItMS0xLTg3NDU_55fc5614-9c4f-4f96-bd57-10f11c68c1b5">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzUtMi0xLTEtODc0NQ_1815cdfd-d6bb-4001-99ab-b24152b8bb95">2,443</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzUtNC0xLTEtODc0NQ_2860017f-f52b-40f0-8745-40429ba88eb3">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzUtNi0xLTEtODc0NQ_ffcc7921-da68-4c8d-903d-e2d38be0ab0b">3,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzUtOC0xLTEtODc0NQ_ed59297b-24a3-4fa8-b1cf-be39af50cb34">3.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzUtMTAtMS0xLTg3NDU_4647ddda-42e9-4360-9e90-11c08ae39984">2,896</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzUtMTItMS0xLTg3NDU_206c0adf-4809-4d07-8f47-d68e5d63b77e">2.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global intangible low-taxed income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="icui:GILTItaxexpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzctMi0xLTEtODc0NQ_fc980aad-4067-4ecb-a961-a819bcb20bf2">711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="3" name="icui:GILTItaxexpensepercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzctNC0xLTEtODc0NQ_716f6275-3bcb-4a54-beb6-329dec456758">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="icui:GILTItaxexpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzctNi0xLTEtODc0NQ_21f0cc2c-7ae2-4d5b-9a29-c77dff10a8f7">163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="3" name="icui:GILTItaxexpensepercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzctOC0xLTEtODc0NQ_1248ab3d-f8cd-424d-bd8c-ae47346e0b3f">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="icui:GILTItaxexpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzctMTAtMS0xLTg3NDU_9118ca45-9c67-4bdf-bf59-14641cc1a5f8">6,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="3" name="icui:GILTItaxexpensepercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzctMTItMS0xLTg3NDU_b70faabd-2844-4a07-9d02-5960422171cd">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income tax differential</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzgtMi0xLTEtODc0NQ_0ba83ddd-6131-4c69-aec0-749694b8f629">2,983</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzgtNC0xLTEtODc0NQ_b2f8f967-2a7d-4072-8fb3-ffee0383fe45">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzgtNi0xLTEtODc0NQ_a9c746cc-7050-44fb-b585-f04d04fbeba6">3,888</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzgtOC0xLTEtODc0NQ_ae651bcd-6100-410b-bb74-c1ed075a797b">4.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzgtMTAtMS0xLTg3NDU_c9bb84d8-e5c6-4b65-8abb-b4d47c4c1ca3">5,939</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzgtMTItMS0xLTg3NDU_e2c391fe-7e48-4885-89f7-7e3828d1ece3">5.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzktMi0xLTEtODc0NQ_896ee625-ee71-4683-8ade-9b031aebfeed">4,263</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzktNC0xLTEtODc0NQ_492daa03-0d4c-4be7-aa9c-261d61148b95">3.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzktNi0xLTEtODc0NQ_041d9fde-e3ed-4d1a-bbed-027071b7e753">4,686</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzktOC0xLTEtODc0NQ_587f87d2-69a3-4b7a-b65e-e83970bb3abd">4.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzktMTAtMS0xLTg3NDU_a543819c-cadd-4a9e-9025-0a140c6e9fcf">8,446</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzktMTItMS0xLTg3NDU_3ab37661-ad8f-4491-a193-963c0025dbe2">7.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-derived intangible income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="icui:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEwLTItMS0xLTg3NDU_50f7cef9-0690-4ee7-a7b0-72ebedb3984b">3,775</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="3" sign="-" name="icui:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEwLTQtMS0xLTg3NDU_dbba470f-9815-4798-93a9-3721130d1d47">3.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" sign="-" name="icui:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEwLTYtMS0xLTg3NDU_104a0850-7429-4810-af61-d537aceb686d">2,718</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="3" sign="-" name="icui:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEwLTgtMS0xLTg3NDU_f07de74f-1657-46e9-8824-c49606e41581">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="icui:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEwLTEwLTEtMS04NzQ1_5675c494-87db-47c2-966f-a5b07389b69a">516</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="3" sign="-" name="icui:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEwLTEyLTEtMS04NzQ1_1c16af71-6f0f-4c44-9714-33b2b495afcf">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IP installment sale and repatriation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="icui:EffectiveIncomeTaxRateReconciliationIPMigration" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzExLTItMS0xLTg3NDU_9a1e2623-d550-464f-9e12-cf6c8fb7cf2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="3" name="icui:EffectiveTaxRateReconciliationIPMigrationPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzExLTQtMS0xLTg3NDU_18cacd4e-57c5-4725-99b6-7d142f1b9ce8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="icui:EffectiveIncomeTaxRateReconciliationIPMigration" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzExLTYtMS0xLTg3NDU_bc5fb965-2a51-4836-9287-d0800b4a5754">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="3" name="icui:EffectiveTaxRateReconciliationIPMigrationPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzExLTgtMS0xLTg3NDU_c00cb337-afe9-4bd6-9a81-247098165ed8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="icui:EffectiveIncomeTaxRateReconciliationIPMigration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzExLTEwLTEtMS04NzQ1_34a24609-64b6-48bb-a99f-26f3dfe55371">2,118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="3" sign="-" name="icui:EffectiveTaxRateReconciliationIPMigrationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzExLTEyLTEtMS04NzQ1_d0000759-bedd-4442-a2d6-35526f8094f5">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="icui:EffectiveIncomeTaxRateReconciliationContingentConsideration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEyLTItMS0xLTg3NDU_01585964-fad6-4fbb-9470-d87ca7d40695">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="3" name="icui:EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEyLTQtMS0xLTg3NDU_8314ff06-223b-4f94-a04c-3eb1ebe45a30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" sign="-" name="icui:EffectiveIncomeTaxRateReconciliationContingentConsideration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEyLTYtMS0xLTg3NDU_86959650-45ad-41cb-9ce9-b23148be0426">1,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="3" name="icui:EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEyLTgtMS0xLTg3NDU_9fd43a79-717e-439e-a69b-63c364859980">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="icui:EffectiveIncomeTaxRateReconciliationContingentConsideration" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEyLTEwLTEtMS04NzQ1_747a6605-41f2-4a3c-93cf-4943ac4e7672">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="3" name="icui:EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEyLTEyLTEtMS04NzQ1_3ed433ce-3785-458a-9b40-79daa0ba1638">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 162(m)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="icui:Effectiveincometaxreconciliationnondeductiblecompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEzLTItMS0xLTg3NDU_57bab3bf-c306-4599-b8f5-58f2006728d3">1,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="3" name="icui:Effectivetaxratereconciliationnondeductiblecomppercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEzLTQtMS0xLTg3NDU_e2a6ca72-dec0-499a-8a6d-0ff3d0fd3b82">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="icui:Effectiveincometaxreconciliationnondeductiblecompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEzLTYtMS0xLTg3NDU_d4c8d1e1-422c-4c62-8239-99109ea293c2">1,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="3" name="icui:Effectivetaxratereconciliationnondeductiblecomppercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEzLTgtMS0xLTg3NDU_564dd772-3d3d-4443-a0ac-59a920c5e891">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="icui:Effectiveincometaxreconciliationnondeductiblecompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEzLTEwLTEtMS04NzQ1_f7ce07d6-62c5-4d29-a09e-a98e6cafe1e5">203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="3" name="icui:Effectivetaxratereconciliationnondeductiblecomppercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEzLTEyLTEtMS04NzQ1_b5a03e39-a8bc-4f3b-8d05-9a47c9c4a8ff">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE0LTItMS0xLTg3NDU_63fb3e22-34ef-4b62-ac53-3a24149731ba">2,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE0LTQtMS0xLTg3NDU_cbcc03c6-35e7-4b2e-82eb-5ac460acbc06">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE0LTYtMS0xLTg3NDU_9e7083cd-43da-437f-84b3-02171f4703be">196</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE0LTgtMS0xLTg3NDU_c62935b4-78d8-4158-a543-aba5eb2a3dd0">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE0LTEwLTEtMS04NzQ1_6d4027b0-0141-4acc-8f61-b7959f3a81cb">1,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE0LTEyLTEtMS04NzQ1_9d527ab4-1aa4-4aa8-aeef-46f443c93e98">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE1LTItMS0xLTg3NDU_86c8baa9-ecdf-4114-be96-8e1b2eb7fbd5">20,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE1LTQtMS0xLTg3NDU_b01569e0-f8a5-4099-886a-1d170743a143">16.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE1LTYtMS0xLTg3NDU_90685b6f-3a5a-438e-a611-be1275679621">10,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE1LTgtMS0xLTg3NDU_6205db58-3bb5-448d-9898-386cdcf44dbf">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE1LTEwLTEtMS04NzQ1_239b7af1-0bdc-41fb-9022-2a2fa9aff0f4">13,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE1LTEyLTEtMS04NzQ1_9a3550ea-3c2c-4704-bec6-fb0cbf597dc0">11.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax credits in 2021, 2020 and 2019 consist principally of research and developmental tax credits.&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain intellectual property and assets were repatriated in 2019 from a liquidation of foreign subsidiaries to the U.S. parent. The tax effect of the repatriation is included as IP installment sale and repatriation.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="iea8da6072f264601a5dc7865bb2b71a6" continuedAt="i0316350cf3d941d6812655c80dfa9942"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzQyMDc_3a02d5d8-d742-4958-9a2f-be3b8d12719a" escape="true"><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of our deferred income tax assets (liabilities) are as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.131%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals/other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbe71fc4ce44374909c77242133cc3c_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzUtMi0xLTEtODc0NQ_7bd41e25-393b-4ce4-8f23-354b061058b8">6,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e809f26dc1b4522960c604ea2772a74_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzUtNC0xLTEtODc0NQ_b5aea8d2-5bd9-4f0d-bbcf-00700b5b1373">4,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired future tax deductions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbe71fc4ce44374909c77242133cc3c_I20211231" decimals="-3" name="icui:Noncurrentdeferredtaxassetacquiredfuturetaxdeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzktMi0xLTEtODc0NQ_e732697d-10d1-4c41-8d9e-ce206444d4f0">5,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e809f26dc1b4522960c604ea2772a74_I20201231" decimals="-3" name="icui:Noncurrentdeferredtaxassetacquiredfuturetaxdeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzktNC0xLTEtODc0NQ_ad001d0d-749c-4380-8ec4-4bacd1efbc59">7,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbe71fc4ce44374909c77242133cc3c_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzEwLTItMS0xLTg3NDU_097231f4-afb1-4764-bf6d-689f00ddb07b">7,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e809f26dc1b4522960c604ea2772a74_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzEwLTQtMS0xLTg3NDU_6f6cbcb8-f740-46ef-b798-63f44be8b692">7,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbe71fc4ce44374909c77242133cc3c_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzExLTItMS0xLTg3NDU_2faebc92-e995-431f-acbb-6fa9e01cd109">3,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e809f26dc1b4522960c604ea2772a74_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzExLTQtMS0xLTg3NDU_faf081eb-a2db-44e2-822d-6a7fafa07111">2,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbe71fc4ce44374909c77242133cc3c_I20211231" decimals="-3" name="icui:NoncurrentDeferredTaxAssetTaxCreditsState" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzEyLTItMS0xLTg3NDU_a0ecbfc2-4c54-45e3-9bc6-8f2970164910">11,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e809f26dc1b4522960c604ea2772a74_I20201231" decimals="-3" name="icui:NoncurrentDeferredTaxAssetTaxCreditsState" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzEyLTQtMS0xLTg3NDU_29ab9d1e-8d29-4bdd-ba97-0790aa12580c">12,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbe71fc4ce44374909c77242133cc3c_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE0LTItMS0xLTg3NDU_e3f4230b-e2d1-49d8-8951-37a724c8d39d">8,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e809f26dc1b4522960c604ea2772a74_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE0LTQtMS0xLTg3NDU_505dd009-0287-47a2-b931-5d890ebf0360">8,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbe71fc4ce44374909c77242133cc3c_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE1LTItMS0xLTg3NDU_e1f7a3b5-4cd1-42fa-aeb6-83d57fff7f47">926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e809f26dc1b4522960c604ea2772a74_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE1LTQtMS0xLTg3NDU_fc1e9344-7740-42ca-916e-82a49aab8f34">4,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbe71fc4ce44374909c77242133cc3c_I20211231" decimals="-3" name="icui:Noncurrentdeferredtaxassetaccruedrestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE2LTItMS0xLTg3NDU_da732b9a-4294-4051-9837-3b4c9377d989">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e809f26dc1b4522960c604ea2772a74_I20201231" decimals="-3" name="icui:Noncurrentdeferredtaxassetaccruedrestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE2LTQtMS0xLTg3NDU_1fc20443-212e-4bb7-95d8-5175bd51e61a">1,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chargebacks, discounts, customer concessions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbe71fc4ce44374909c77242133cc3c_I20211231" decimals="-3" name="icui:Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE3LTItMS0xLTg3NDU_be881679-fc06-4270-aa56-5071d82f2a3e">27,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e809f26dc1b4522960c604ea2772a74_I20201231" decimals="-3" name="icui:Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE3LTQtMS0xLTg3NDU_526f4e67-1622-43f0-8e1a-3973342242a6">22,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bbe71fc4ce44374909c77242133cc3c_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE4LTItMS0xLTg3NDU_ad6eb11f-f6e6-42d9-8267-2e931b84ca63">2,934</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e809f26dc1b4522960c604ea2772a74_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE4LTQtMS0xLTg3NDU_938a14ee-11c0-4c65-9ac9-c48cbb67a849">3,891</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="icui:Noncurrentdeferredtaxasset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE5LTItMS0xLTg3NDU_cfb576f7-b97d-4e58-856c-cbbee0d57423">69,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="icui:Noncurrentdeferredtaxasset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE5LTQtMS0xLTg3NDU_8fcccd78-9d5b-4696-bc40-1fff522b63c3">67,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3378e7cbe8924f58b0946d1751a4a296_I20211231" decimals="-3" name="icui:NoncurrentDeferredTaxLiabilityStateIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzIxLTItMS0xLTg3NDU_7ff6605b-4f58-4e87-9084-0658ece4ce02">2,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1986d9725d4d0baf2ce688675446f5_I20201231" decimals="-3" name="icui:NoncurrentDeferredTaxLiabilityStateIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzIxLTQtMS0xLTg3NDU_ab1fc8a2-bcd0-4b8b-845f-b11861a83235">2,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3378e7cbe8924f58b0946d1751a4a296_I20211231" decimals="-3" name="icui:NoncurrentDeferredTaxLiabilityForeign" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzIyLTItMS0xLTg3NDU_95cbda3e-2467-4ad1-86a8-870d18393bfc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1986d9725d4d0baf2ce688675446f5_I20201231" decimals="-3" name="icui:NoncurrentDeferredTaxLiabilityForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzIyLTQtMS0xLTg3NDU_18452de3-1d07-48f7-9da6-4b61b6b4af6e">776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3378e7cbe8924f58b0946d1751a4a296_I20211231" decimals="-3" name="icui:NoncurrentDeferredTaxLiabilityDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzI0LTItMS0xLTg3NDU_364e2b26-093e-47b8-a535-362e183bb481">20,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1986d9725d4d0baf2ce688675446f5_I20201231" decimals="-3" name="icui:NoncurrentDeferredTaxLiabilityDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzI0LTQtMS0xLTg3NDU_1cb62b57-93a3-4d48-9926-b970eafa25b9">25,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 481(a) adjustment - change in accounting method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5e02d0a1f949ef98ced46fdc0d1d50_D20210101-20211231" decimals="-3" name="icui:Deferredtaxliabilitychangeinaccountingmethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzI1LTItMS0xLTg3NDU_99aef881-729a-42d5-b536-23df52a40d88">4,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7a407c6102b4d9782e78a7113bb6c88_D20200101-20201231" decimals="-3" name="icui:Deferredtaxliabilitychangeinaccountingmethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzI1LTQtMS0xLTg3NDU_72e62832-d9a3-42d0-bcb7-e122e2dd3898">9,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3378e7cbe8924f58b0946d1751a4a296_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzI5LTItMS0xLTg3NDU_a1a9944d-bcfa-48aa-8b85-bc41d4b1bc71">28,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1986d9725d4d0baf2ce688675446f5_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzI5LTQtMS0xLTg3NDU_92e30b94-c4e2-4f18-abc1-1286f1a822c7">38,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset, net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzMxLTItMS0xLTg3NDU_438fd2be-66b4-4eee-b90b-697f701a00a1">41,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzMxLTQtMS0xLTg3NDU_dab4cebd-2cf5-4e0e-9bb9-3f7553d6fb72">29,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax Holidays and Carryforwards</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss ("NOL") carryforwards consist of: (a) federal NOL carryforwards of $<ix:nonFraction unitRef="usd" contextRef="if9b8ee97cdce469498415c24ca271fac_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzEwNzY_a858019d-310e-49ff-8960-27bfaa74472d">2.5</ix:nonFraction> million which will expire at various dates from 2023 to indefinite carryforward periods, (b) state NOL carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i01e4254c272a4140957a890acc5f08ce_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzExOTE_fb4e0e0e-a7fe-46ae-8818-196a020263c0">8.2</ix:nonFraction> million which will expire at various dates from 2022 to indefinite carryforward periods and (c) foreign NOL carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ia52cc31c151d481581d13119d97ac269_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzEzMTE_7e631e8e-5fad-4201-b42b-ef5f46cd9eca">15.0</ix:nonFraction> million which will expire at various dates from 2022 to indefinite carryforward periods. Under Section&#160;382 of the Internal Revenue Code, certain ownership changes limit the utilization of the NOL carryforwards, and the amount of federal NOL carryforwards recorded is the net federal benefit available.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other carryforwards include state research and development (&#8220;R&amp;D&#8221;) tax credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzE3MDY_f3974699-0c45-4375-a7c5-731f99b5b3bc">16.9</ix:nonFraction> million, which have an indefinite carryforward period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A substantial portion of our manufacturing operations in Costa Rica operate under various tax holiday and tax incentive programs due to expire in whole or in part in 2027. Certain of the holidays may be extended if specific conditions are met. The net impact of these tax holiday and tax incentives was an increase to our net earnings by $<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxHolidayAggregateDollarAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzIwOTY_5a82f3b3-5fbf-4bac-9a9c-a6fd51a0d78f">9.8</ix:nonFraction> million or $<ix:nonFraction unitRef="usdPerShare" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="2" name="us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzIxMDI_11345b2d-6420-4944-b7c9-d10e550dcc13">0.45</ix:nonFraction> per diluted share in 2021 and by $<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxHolidayAggregateDollarAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzIxMzg_98e22a5f-94c1-424f-b1e3-9a7a90440e46">8.0</ix:nonFraction> million or $<ix:nonFraction unitRef="usdPerShare" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="2" name="us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzIxNDQ_bbe0ebb3-ede8-4896-b0c4-e94cc40cb4d9">0.37</ix:nonFraction> per diluted share in 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency translation adjustments, and related tax effects, are an element of &#8220;other comprehensive income&#8221; and are not included in net income other than the revaluation of the associated deferred tax asset due to the Tax Act.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we have estimated $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-5" name="us-gaap:UndistributedEarningsOfForeignSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzI0NTQ_15d27cfc-14b0-4011-a72a-48da6ca35f95">98.6</ix:nonFraction> million of undistributed foreign earnings and profits. Such earnings were previously subject to U.S. tax as a result of the Tax Act and much of any future remittances would generally be subject to no U.S. tax as a result of dividends received deductions and/or foreign tax credit relief. We intend to invest substantially all of our foreign subsidiary earnings, as well as our capital in our foreign subsidiaries, indefinitely outside of the U.S. in those jurisdictions in which we incur significant additional costs upon repatriation of such amounts.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i0316350cf3d941d6812655c80dfa9942"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to taxation in the U.S. and various states and foreign jurisdictions. Our U.S. federal income tax returns for tax years 2018 and forward are subject to examination by the Internal Revenue Service. Our principal state income tax returns for tax years 2012 and forward are subject to examination by the state tax authorities. The total gross amount of unrecognized tax benefits as of December&#160;31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzM0MjQ_e3fd3db3-1eec-4516-b772-40a661db8a9a">21.5</ix:nonFraction> million which, if recognized, would impact the effective tax rate.  We believe that adequate provision has been made for any adjustments that may result from tax examinations. However, the outcome of tax examinations cannot be predicted with certainty. As of December 31, 2021, it is not possible to estimate the amount of change, if any, in the unrecognized tax benefits that is reasonably possible within the next twelve months. We recognize accrued interest and penalties related to unrecognized tax benefits as a component of income tax expense. We have not accrued any penalties or interest as of December 31, 2021 or 2020.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzQxOTY_06102cd2-bf6a-4737-8701-8dccef2046c3" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cumulative gross unrecognized tax benefits (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.246%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzItMi0xLTEtODc0NQ_dac4f8d8-96c2-4024-a94e-e40c388ebce9">18,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzItNC0xLTEtODc0NQ_f7f23c8d-224d-402c-be84-0d09c3dcc691">15,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2b82bbcf5cb45739937a1040ed30f6b_I20181231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzItNi0xLTEtODc0NQ_dc9c2fcb-db23-46a7-be94-bf0f772b50d1">10,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases to prior year tax positions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzMtMi0xLTEtODc0NQ_dec7d3e0-345d-4bf4-806a-6309d494674c">231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzMtNC0xLTEtODc0NQ_98b0801f-1060-47a8-bda4-492de22f9f41">502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzMtNi0xLTEtODc0NQ_ca5931d2-0be7-45b1-af0c-d94d10f0791d">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases to current year tax positions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzUtMi0xLTEtODc0NQ_13f1cc9d-8fcf-413f-b180-7598463b7ab5">3,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzUtNC0xLTEtODc0NQ_9a21ba16-ba02-47cb-8e11-d71ac6c98142">2,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzUtNi0xLTEtODc0NQ_640943b1-5829-49e5-bd30-afadb95fcd78">4,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases to prior year tax positions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzctMi0xLTEtODc0NQ_4dd87a1b-16f6-41d7-ac45-a3f07dbe642f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzctNC0xLTEtODc0NQ_c0688b1e-4cf0-49aa-a8ee-a9f2f77115d8">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzctNi0xLTEtODc0NQ_e605820c-e21f-4c8f-8f6f-5cf452d541e9">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease related to lapse of statute of limitations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzktMi0xLTEtODc0NQ_6c149858-67c5-40fe-ad98-5f83037155f3">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzktNC0xLTEtODc0NQ_f148e662-3fd0-4f51-b0e9-fce82f11eb30">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzktNi0xLTEtODc0NQ_34909606-a20d-4233-a12b-c004942e9b9c">163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease related to settlements with tax authorities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c16ae;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzEwLTItMS0xLTY3NjEy_7a749f8d-40b2-4f11-b106-ba2fe60e88f7">348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c16ae;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzEwLTQtMS0xLTY3NjE5_91fb2266-5dd8-414d-918a-ad05d7f50260">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c16ae;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzEwLTYtMS0xLTY3NjI2_f5223f96-2158-47a3-85c6-3d2ba70a1d60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzEwLTItMS0xLTg3NDU_49f7b9aa-4806-4a1f-87ac-5bc1ff267fce">21,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzEwLTQtMS0xLTg3NDU_9179e950-5f4d-4c7a-87c8-a13a075b341f">18,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzEwLTYtMS0xLTg3NDU_c8e14c66-f492-425e-8eee-ee9d83183ecf">15,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;text-indent:36pt"><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_106"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 13. <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="icui:InformationbyGeographicAreaandCustomerConcentrationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90ZXh0cmVnaW9uOjdhY2I1MzE0YzQ5YTQxOWRhYzU3NTU4MzU0NGEyODc2XzYwNg_6b5262dd-1f7f-489b-a459-1e74c0aee5d2" continuedAt="i9144ec9784704be08afd183ff922e002" escape="true">GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i9144ec9784704be08afd183ff922e002"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Significant Customers</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell products worldwide, on credit terms on an unsecured basis, as an OEM supplier, to independent medical supply distributors and directly to the end customer. The manufacturers and distributors, in turn, sell our products to healthcare providers. We do not currently derive a significant portion of our revenues from any one customer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Geographic Information</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90ZXh0cmVnaW9uOjdhY2I1MzE0YzQ5YTQxOWRhYzU3NTU4MzU0NGEyODc2XzYwMA_0cbd30e7-3338-42bf-9b58-0b1d298174d7" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents our gross long-lived assets, consisting of property, plant and equipment, by country or region (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.131%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costa Rica</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifef2db95b0fe4155898c6b50b40a55f6_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzItMi0xLTEtODc0NQ_451815a3-c87e-448f-9ce9-30033ef7d08e">115,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide8f1f0b08d646aa86685a2ef40bd3b2_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzItNC0xLTEtODc0NQ_8798f425-41f6-4c92-8a57-006862a50b7d">104,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f2b53b42ec4dd496263af4d74f1006_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzMtMi0xLTEtODc0NQ_a8173345-a282-4d7d-87dc-178960506dde">79,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i469eea898b364fc3adb69caed769582e_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzMtNC0xLTEtODc0NQ_63a4f3a4-f77f-40da-9c48-8fda03b5f7a6">76,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other LATAM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e940da7d7cb495fa0d13df19d4106c6_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzQtMi0xLTEtODc0NQ_e8f7a779-e754-4fef-bfd0-e2a59b8fdf33">36,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i598572737bef40c49c83df77162958d2_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzQtNC0xLTEtODc0NQ_a06ad6ad-b3e7-4e25-a663-366b543b486e">37,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342c737b0a1648d6ba7796d841c38920_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzUtMi0xLTEtODc0NQ_950672eb-15e0-4885-80a5-d6dc46b98026">4,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87f6347567e542658b4828a26d58c87f_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzUtNC0xLTEtODc0NQ_bceed620-d186-4454-a352-748e9743501a">4,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f99fb6f9174410c9b82675718bfbea9_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzYtMi0xLTEtODc0NQ_141cc189-b607-4cf8-a5ef-27984ce5ff05">12,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49906b818a8e4420af6213c3e7c5009b_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzYtNC0xLTEtODc0NQ_b63c6a25-3e31-4dd6-bda5-3adf8adaa884">11,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia092500ef9e34307ae74beb9776f0c1c_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzEwLTItMS0xLTg3NDU_925a64ad-a455-420b-a42e-094e523e1ad4">13,295</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c52e251690c4d43bfe606ddbb907b05_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzEwLTQtMS0xLTg3NDU_79638230-a653-4e66-8001-b3f67d2eafd3">8,701</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69deda722fca436a895908b95f39e170_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzExLTItMS0xLTg3NDU_45b65bb0-1e75-453e-9bc9-014517e73a3f">4,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0af277c5a24e49468f57a06b083d2822_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzExLTQtMS0xLTg3NDU_016f5eb3-3a7e-4e5c-9fb1-d510398569be">3,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95f6b83243a54af7b0115785403ce5b4_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzEyLTItMS0xLTg3NDU_a39f2408-8566-4ca9-a303-42df82f5d9b1">20,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5384480be0b946b0b4bd8da2f47aee38_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzEyLTQtMS0xLTg3NDU_dfed95f8-9405-4a9a-a2fa-29b03a5207b1">19,836</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Foreign </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84bcb872e0ac41e9a0c750276b31fe07_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzEzLTItMS0xLTg3NDU_73883340-00ae-4267-b870-78e1a3b61eab">286,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide1aa2e08f8e459ab222c3218dbdd087_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzEzLTQtMS0xLTg3NDU_10ae6c7a-3c37-44ab-aa0a-d1a62e812f4c">265,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76e08a5b358b42e5b6adbc18bbf17124_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzE0LTItMS0xLTg3NDU_1775b0ee-f203-4cfd-be10-63db22c5ce5d">618,374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bcbed561d384cd2aa2a8565325c8308_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzE0LTQtMS0xLTg3NDU_126770e7-b40d-40f1-9a18-356ddb0aa165">577,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Worldwide Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzE1LTItMS0xLTg3NDU_38f6ffac-726b-411c-884d-5a010dc971aa">905,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzE1LTQtMS0xLTg3NDU_2477e080-ac4c-43f9-91f9-14d1688e0ca3">843,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><div id="ic100f0970bae445782808747a3ec391d_109"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 14. <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0XzE1MTk_5c20f30b-ce8b-4a96-a9bb-c0e4c6096c02" continuedAt="i54cfc7deae904b3f9a5da8b1292ca3a8" escape="true">STOCKHOLDERS' EQUITY</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i54cfc7deae904b3f9a5da8b1292ca3a8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August&#160;2019, our Board of Directors approved a common stock purchase plan to purchase up to $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0XzE0OA_d3088025-d0ff-46ed-9ed9-a22951a57dc2">100.0</ix:nonFraction> million of our common stock. This plan has no expiration date. We have $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0XzIxNA_75ae42ae-c004-4aae-b94b-dd74c17545a0">100.0</ix:nonFraction> million remaining on this purchase plan. We did not purchase any of our common stock under our common stock purchase plan in 2021, 2020 or 2019. We are limited on share purchases in accordance with the terms and conditions of our Credit Facility (see Note 11: Long-Term Obligations).&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we withheld <ix:nonFraction unitRef="shares" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="0" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0XzUyOA_84d5bda5-b1cb-4b0b-be5b-e60347fb8625">40,350</ix:nonFraction> shares of our common stock from employee vested restricted stock units in consideration for $<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0XzYyMw_7240e4b7-03e1-4460-a655-64b2202f009f">8.3</ix:nonFraction> million in payments for the employees' share award income tax withholding obligations. We had <ix:nonFraction unitRef="shares" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="0" name="us-gaap:TreasuryStockCommonShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0XzE1MjQ_c61f09e4-c8a6-4ad3-8bbd-db78f78a1eb8">119</ix:nonFraction> shares remaining in treasury at December 31, 2021.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we withheld <ix:nonFraction unitRef="shares" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="0" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0Xzc4OQ_5ab98c8d-5b26-4094-9013-38b45feee425">67,041</ix:nonFraction> shares of our common stock from employee vested restricted stock units in consideration for $<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0Xzg4NA_7c987d6d-c3ab-4fab-844d-ef9865297f1c">12.9</ix:nonFraction> million in payments for the employees' share award income tax withholding obligations. We had <ix:nonFraction unitRef="shares" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="0" name="us-gaap:TreasuryStockCommonShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0Xzk3NA_d9aebdab-9a6b-4857-80bb-dfa16b77e5ea">209</ix:nonFraction> shares remaining in treasury at December 31, 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we withheld <ix:nonFraction unitRef="shares" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="0" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0XzEwNTA_64dbe780-86b5-4282-af76-5cbb5bd45ab9">80,186</ix:nonFraction> shares of our common stock from employee vested restricted stock units in consideration for $<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0XzExNDU_eb7f642e-372f-4c92-a94d-6ee0c4722e53">18.6</ix:nonFraction> million in payments for the employees' share award income tax withholding obligations. We had <ix:nonFraction unitRef="shares" contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231" decimals="0" name="us-gaap:TreasuryStockCommonShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0XzEyMzQ_c11a52c1-1085-4d6d-8a41-f8691171ff6f">850</ix:nonFraction> shares remaining in treasury at December 31, 2019.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use treasury stock to issue shares for stock option exercises and restricted stock grants.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive (Loss) Income ("AOCI")</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0XzE1MTY_a8fecf79-4081-4eb6-b946-bd0f13571c2b" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of AOCI, net of tax, were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:39.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacf190989aae41dc9261dadb464d18de_I20181231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEtMi0xLTEtODc0NQ_5d9c6cca-1fbc-4301-a9b5-de8478cecb44">17,682</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica0fe141910f4870ad2649c6e2c3aaab_I20181231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEtNC0xLTEtODc0NQ_ff43df70-b986-4084-acc9-d36c3aba0f36">638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i294f1ac4a2cc4a3fac63275cef02abee_I20181231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEtNi0xLTEtODc0NQ_9555e995-0147-464d-8fef-bac3fa88eee7">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic2b82bbcf5cb45739937a1040ed30f6b_I20181231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEtOC0xLTEtODc0NQ_a68099b7-bffa-4449-980c-730b1dd8686e">16,945</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i056e77d665474f4b8ca05d305c52c5db_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzItMi0xLTEtODc0NQ_18a7c4f5-ffc7-4164-9f62-081a9192dc94">372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i120cd5defe214e6c86186272a3b74955_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzItNC0xLTEtODc0NQ_67136bf6-bd2d-40e8-823a-ea842539818f">1,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9263e86b21d4e6990c6889c0a2fd058_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzItNi0xLTEtODc0NQ_80be2a29-ffb5-490f-96c4-b7b6c1de2980">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzItOC0xLTEtODc0NQ_b946a809-f3a4-4703-a25b-32bce32c6178">2,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i056e77d665474f4b8ca05d305c52c5db_D20190101-20191231" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzMtMi0xLTEtODc0NQ_40943115-d0e5-4932-a955-ceb9b9152e18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i120cd5defe214e6c86186272a3b74955_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzMtNC0xLTEtODc0NQ_b5ebd7b1-6048-45b1-95b4-e4883c98bb67">696</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9263e86b21d4e6990c6889c0a2fd058_D20190101-20191231" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzMtNi0xLTEtODc0NQ_59eda68e-24e3-419d-9092-b480e3b36ae3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzMtOC0xLTEtODc0NQ_684cb740-3220-48f4-a064-fbd80a25db67">696</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i056e77d665474f4b8ca05d305c52c5db_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzQtMi0xLTEtODc0NQ_6bc3e15f-532f-4dc9-b2e7-cbfbb0091586">372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i120cd5defe214e6c86186272a3b74955_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzQtNC0xLTEtODc0NQ_00bb20c0-7933-40e5-91c4-869550860ce8">1,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9263e86b21d4e6990c6889c0a2fd058_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzQtNi0xLTEtODc0NQ_8f1163ab-0c77-4fe7-8ed1-fb06367121b5">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzQtOC0xLTEtODc0NQ_db5e7191-5a95-4b7f-a574-8c5384fe13d1">1,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cc638a528464d0f81f7797bbcdbbbdd_I20191231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzUtMi0xLTEtODc0NQ_7df4e480-e706-40e8-88c8-ce5471f5853b">17,310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e04a8561492427c808a2ab01e617e39_I20191231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzUtNC0xLTEtODc0NQ_04c15b5d-3b03-4712-a6b3-4f18a80533d0">1,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie681a10b3ae94591ac7dfed446027fb8_I20191231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzUtNi0xLTEtODc0NQ_ac047456-a4d2-4105-af2d-68c9baa8e019">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzUtOC0xLTEtODc0NQ_d4e7b0c1-626a-4029-8c46-6a63b9c04049">15,402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8eecf95d67de49c6b71ed63b59bd24ad_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzYtMi0xLTEtODc0NQ_3b74d520-a667-4a65-b583-2ba75b08ad70">12,929</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0781799e0fe043e198c4b49c6f20f38d_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzYtNC0xLTEtODc0NQ_814358a3-0e06-4b63-b912-eb965362864a">1,505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93f94790b59e412589fd19a9227e911d_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzYtNi0xLTEtODc0NQ_b9010282-ce70-4851-909b-fca26037bacc">47</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzYtOC0xLTEtODc0NQ_69534f41-7eaa-415e-abea-2203c7f4066a">14,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8eecf95d67de49c6b71ed63b59bd24ad_D20200101-20201231" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzctMi0xLTEtODc0NQ_4dd4203f-6d88-4b5a-b74f-03029cc727b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0781799e0fe043e198c4b49c6f20f38d_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzctNC0xLTEtODc0NQ_3edb662b-f8ed-453c-b8f9-643ea65e3531">601</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93f94790b59e412589fd19a9227e911d_D20200101-20201231" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzctNi0xLTEtODc0NQ_12e53d41-39a0-495e-83c9-e7e05e3b7876">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzctOC0xLTEtODc0NQ_3feed551-a250-4543-988d-5380add721f7">601</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8eecf95d67de49c6b71ed63b59bd24ad_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzgtMi0xLTEtODc0NQ_0f8e3d1e-dbd5-4e8d-a126-114dc4348c64">12,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0781799e0fe043e198c4b49c6f20f38d_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzgtNC0xLTEtODc0NQ_1f8c1f1b-06fd-4a17-a29d-7d58de9755b4">904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93f94790b59e412589fd19a9227e911d_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzgtNi0xLTEtODc0NQ_d3586411-e6a0-400f-b6e9-c05b57aa574c">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzgtOC0xLTEtODc0NQ_56425810-eec5-445e-9bb1-11b97aafd6ed">13,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida1ac0b3c24f469f9c5c81ce2c02be68_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzktMi0xLTEtODc0NQ_4152a8c9-b540-41de-81b7-b1d0a0faabee">4,381</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea23642417df4dbfadbd0379840568e7_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzktNC0xLTEtODc0NQ_ec1dc8a6-07d7-4bef-946a-db52f3033e51">2,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99fa1bc9d43d4f38b2df61bedf27dda6_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzktNi0xLTEtODc0NQ_ce46aaed-b08f-4d10-b121-1bde0e9ae241">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzktOC0xLTEtODc0NQ_5b84fc90-ece8-4427-8294-bdb89c193bd8">1,522</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584e4e98f720480b9d2272ffc9f61fad_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEwLTItMS0xLTg3NDU_dc71e4e7-7782-40b6-a282-2717c58549c4">14,664</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id83a5ec19c054e738002317e4071cb7c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEwLTQtMS0xLTg3NDU_4d0c7454-b121-400a-bdc8-2c7166eda97c">403</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ecb60225e2140c6841d03b54d853f07_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEwLTYtMS0xLTg3NDU_33e5d188-a44b-4fd6-8b29-22f98d9327a7">62</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEwLTgtMS0xLTg3NDU_f98fda9b-ec34-48cd-9c7a-003ac263db47">15,129</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584e4e98f720480b9d2272ffc9f61fad_D20210101-20211231" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzExLTItMS0xLTg3NDU_28dd2a2c-49c1-49de-95b2-5e0434fd2470">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id83a5ec19c054e738002317e4071cb7c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzExLTQtMS0xLTg3NDU_7e807a33-efe8-4bef-ba60-1cc86d7d4970">2,618</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ecb60225e2140c6841d03b54d853f07_D20210101-20211231" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzExLTYtMS0xLTg3NDU_1d57acda-b637-4532-8c63-d3bd939f941b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzExLTgtMS0xLTg3NDU_11630af3-6d1e-4121-90bf-571dd0de5fc4">2,618</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584e4e98f720480b9d2272ffc9f61fad_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEyLTItMS0xLTg3NDU_48d139d5-4ba1-4c26-9ed9-a2707c98ed18">14,664</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id83a5ec19c054e738002317e4071cb7c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEyLTQtMS0xLTg3NDU_5ebe9935-e2fd-4a01-bc2a-0e2b1a2b442b">3,021</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ecb60225e2140c6841d03b54d853f07_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEyLTYtMS0xLTg3NDU_f8e711ff-17e8-40e2-858d-6b839cff2070">62</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEyLTgtMS0xLTg3NDU_673019f0-9c10-460d-b69f-0931355460b9">17,747</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief758a58c87848b8a344c5b692208a0f_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEzLTItMS0xLTg3NDU_8b69f861-1cbf-4382-86fa-336824c5e7cb">19,045</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f7b24069c454353805dd5bcf4122778_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEzLTQtMS0xLTg3NDU_b8a8b141-1202-4cc0-a81d-90861409754c">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id093068459e64f16a5340be5d8b2912d_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEzLTYtMS0xLTg3NDU_da100dd4-e4f2-471b-9298-895c5c61b34a">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEzLTgtMS0xLTg3NDU_997e5801-5605-407c-bdd8-215313fd57f0">19,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_112"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 15. <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzE5NDI_a2e445bc-b63d-44a0-b6d0-d4a584964935" continuedAt="i3dadadcbb8df40d49bb0600ed8dee1db" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3dadadcbb8df40d49bb0600ed8dee1db"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are involved in various legal proceedings, most of which are routine litigation, in the normal course of business.&#160; Our management does not believe that the resolution of the unsettled legal proceedings that we are involved with will have a material adverse impact on our financial position or results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Off Balance Sheet Arrangements</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we have agreed to indemnify our officers and directors to the maximum extent permitted under Delaware law and to indemnify customers as to certain intellectual property matters related to sales of our products.&#160;There is no maximum limit on the indemnification that may be required under these agreements.&#160;We have never incurred, nor do we expect to incur, any liability for indemnification.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, we recognized an earn-out liability in connection with our acquisition of HIS from Pfizer. Pfizer was entitled to receive between $<ix:nonFraction unitRef="usd" contextRef="i7c08f27a7f1249ebb9616a92cf37d858_D20210101-20211231" decimals="-3" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzEwOTk1MTE2MzUxODQ_77415147-7a33-435f-955b-2ec3f87535c5">191.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i11985c61f5dd4877b3fb40210f033aa6_D20210101-20211231" decimals="-3" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzMyOTg1MzQ4ODgxNDc_e8ce2a7a-921c-4d7c-9679-f671945c3982">225.0</ix:nonFraction> million in additional cash consideration based on the achievement of certain performance targets for the combined company for the three years ending December 31, 2019. As of December 31, 2019, we determined we did not meet the necessary performance targets that would require payout of any of the HIS earn-out liability. Pfizer disputed our determination that the performance targets requiring payout of the HIS earn-out liability were not met, therefore the dispute entered into binding arbitration. In August 2021, the arbitrator concluded that the necessary performance targets that would require payout of the HIS earn-out were not met, and as a result Pfizer is not entitled to any payments in connection with the HIS earn-out liability. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During November 2019, we acquired Pursuit (see Note 2: Acquisitions). Total consideration for the acquisition included a potential contractual earn-out of up to $<ix:nonFraction unitRef="usd" contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzE4Mzg_1965395e-2241-4cb9-a48a-3db4e9cda0cc">50.0</ix:nonFraction> million to be paid to former Pursuit equity holders, calculated based upon the achievement of certain performance targets during the earn-out period. As of June 30, 2021, the earn-out measurement period had ended and based on the actual sales and gross profit achieved during the measurement period we calculated the actual earn-out to be $<ix:nonFraction unitRef="usd" contextRef="i8a64787f750d4031b14422894f232878_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzEwOTk1MTE2MzUxOTk_40d7e3a5-70f4-4011-b7ff-cab03a8e81cc">26.3</ix:nonFraction>&#160;million. In October 2021, the $<ix:nonFraction unitRef="usd" contextRef="i8a64787f750d4031b14422894f232878_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzEwOTk1MTE2MzUyMTQ_31bb5b28-6821-4e7a-b646-dae31951a100">26.3</ix:nonFraction>&#160;million earn-out was finalized and paid to the former Pursuit equity holders (see Note 8: Fair Value Measurements).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out shall not exceed $<ix:nonFraction unitRef="usd" contextRef="idab760f167ab477b84968687e30e7446_D20210101-20211231" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzI3NDg3NzkwNzI2NDE_559aad0b-66e0-407d-80d2-f86494635378">6.0</ix:nonFraction>&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of December 31, 2021, the fair value of the contingent earn-out was estimated at $<ix:nonFraction unitRef="usd" contextRef="ib0473993225046b8a38d55e04612297f_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzI3NDg3NzkwNzI3MDg_8e33cd98-bde4-45d8-a194-4ed17a4c9e70">2.6</ix:nonFraction>&#160;million (see Note 8: Fair Value Measurements).</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $<ix:nonFraction unitRef="usd" contextRef="i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzI3NDg3NzkwNzY0OTk_a85ff838-8d62-4fd1-adda-091dbf3f525b">2.5</ix:nonFraction>&#160;million, consisting of (i) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-6" name="icui:ShortTermContingentConsiderationGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzI3NDg3NzkwNzY1MTM_124aa700-24bd-486a-8dc4-6a8f9279fc63">1.0</ix:nonFraction>&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" name="icui:LongTermContingentConsiderationGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzI3NDg3NzkwNzY1Mjc_411fe575-248f-49b9-bb27-d1c68588810e">1.5</ix:nonFraction>&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. The initial estimated fair value of the contingent consideration related to this acquisition is immaterial.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have non-cancelable operating lease agreements where we are contractually obligated to pay certain lease payment amounts (see Note 5: Leases).</span></div></ix:continuation><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><div id="ic100f0970bae445782808747a3ec391d_115"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 16. <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTUvZnJhZzo5MzBkZjFjOWMyMDU0Mjk5OTg4YmQ4Y2M0YmI4NmEyYy90ZXh0cmVnaW9uOjkzMGRmMWM5YzIwNTQyOTk5ODhiZDhjYzRiYjg2YTJjXzEwNDg_b309d593-c7d4-4aaa-959a-5e31fe2fd024" continuedAt="id379ea52da194311902fa57260604cf1" escape="true">COLLABORATIVE AND OTHER ARRANGEMENTS</ix:nonNumeric></span></div><ix:continuation id="id379ea52da194311902fa57260604cf1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2017, we entered into two Manufacturing and Supply Agreements ("MSAs") whereby (i) Pfizer will manufacture and supply us with certain agreed upon products for an initial five-year term with a one-time two-year option to extend and (ii) we will manufacture and supply Pfizer certain agreed upon products for a term of five or ten years depending on the product, also with a one-time two-year option to extend. The MSAs provide each party with mutually beneficial interests and both of the MSAs are to be jointly managed by both Pfizer and ICU. The initial supply price, which will be annually updated, is in full consideration for all costs associated with the manufacture, documentation, packaging and certification of the products. On January 1, 2021, we amended our MSA with Pfizer, whereby we manufacture and supply certain agreed upon products to Pfizer. The amendments included a change to the term of the agreement to end on December 31, 2024 with Pfizer's unilateral election to extend through December 31, 2025. Other changes to the terms of the MSA included (i) amendments to our level of supply of products to Pfizer, (ii) certain changes to our manufacturing lines, (iii) updates to our supply price with added volume price tiers for annual periods and (iv) certain minimum purchase requirements for certain products. On February 1, 2022, effective as of January 1, 2022, upon our request, Pfizer executed a Product Addendum (the "Product Addendum") to our MSA agreement, whereby Pfizer manufactures and supplies to us certain agreed upon products. The Product Addendum includes the supply of additional product to us subject to certain time and pricing terms and conditions. The Product Addendum includes a minimum purchase obligation of $<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-5" name="us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTUvZnJhZzo5MzBkZjFjOWMyMDU0Mjk5OTg4YmQ4Y2M0YmI4NmEyYy90ZXh0cmVnaW9uOjkzMGRmMWM5YzIwNTQyOTk5ODhiZDhjYzRiYjg2YTJjXzEwOTk1MTE2MzA4Mzc_82052778-a82c-418a-950b-4067eafaec00">29.6</ix:nonFraction>&#160;million. The Product Addendum expires on November 30, 2022.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_1459"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 17. <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MTQ1_ee5fe2f1-2e44-46cf-82a7-533c76025dc1" continuedAt="i50cc556d4ead44d9a802f67f0c1adbe2" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i50cc556d4ead44d9a802f67f0c1adbe2" continuedAt="ifc6fde50d27a4cf283cd60b8c4c94fad"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Smiths Medical 2020 Limited</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we completed the acquisition of Smiths Medical, the holding company of Smiths Group plc's global medical device business, from Smiths Group International Holdings Limited (the &#8220;Seller&#8221;). In accordance with the Share Sale and Purchase Agreement (the "Purchase Agreement"), we purchased <ix:nonFraction unitRef="number" contextRef="ibf6924776c764e04bf39a28785afe1cd_I20220106" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MDMz_30d029a5-4592-4d74-baed-57bbb8300c4e">100</ix:nonFraction>% of the equity interests of Smiths Medical for approximately $<ix:nonFraction unitRef="usd" contextRef="ib79ae2a24b744dc99c3023b42abeeff9_D20220106-20220106" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MDM5_3cbfa684-a28d-4151-8554-fe946a916f49">1.9</ix:nonFraction>&#160;billion in cash and issued of <ix:nonFraction unitRef="shares" contextRef="ib79ae2a24b744dc99c3023b42abeeff9_D20220106-20220106" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MDUz_8441f4bb-be73-425f-ba96-8483d648f844">2.5</ix:nonFraction>&#160;million of fully paid and non-assessable shares of our common stock, par value $<ix:nonFraction unitRef="usd" contextRef="i9b2d21d6799a45898560ea2c84c80514_I20220106" decimals="INF" name="us-gaap:CommonStockValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MDY2_dbb077c5-dddb-43ae-bded-37757e0b21db">0.10</ix:nonFraction> per share. The Purchase Agreement also includes a potential contingent earn-out payment of $<ix:nonFraction unitRef="usd" contextRef="ib79ae2a24b744dc99c3023b42abeeff9_D20220106-20220106" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MDcz_957a78a8-8a33-4179-9e73-7ceeaea4e623">100.0</ix:nonFraction>&#160;million in cash, which is to be based upon our common stock achieving a certain volume-weighted average price for certain periods from closing to the third or fourth anniversary of closing. The acquisition of Smiths Medical adds to and complements our current product portfolio and the combining of both businesses allows us to be a scaled U.S.-based global competitor that increases the stability of the medical supply chain and allows for future growth.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At closing, in connection with the issuance of the stock consideration to the Seller, we entered into a Shareholders Agreement (the &#8220;Shareholders Agreement&#8221;). The Shareholders Agreement imposes certain restrictions on the Seller including prohibiting certain transfers of the shares of our common stock issued (i) for 6 months following the closing of the acquisition transaction and (ii) to certain of our competitors and certain other parties, as well as customary standstill limitations. Under the Shareholders Agreement, the Seller has the right to designate one individual for election to our board of directors so long as the Seller beneficially owns at least <ix:nonFraction unitRef="number" contextRef="i9b2d21d6799a45898560ea2c84c80514_I20220106" decimals="2" name="icui:OwnershipShareMinimumRequirement" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MDg5_d88c9a5e-e024-4f75-a8bf-6fdd121d6f29">5.0</ix:nonFraction>% of the total outstanding shares of our common stock.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to account for the Smiths acquisition as a business combination, however the initial accounting for the business combination is incomplete. We are unable to provide preliminary estimates of asset and liability fair market values as the external valuation of the assets acquired and liabilities assumed is incomplete. We plan to file the required historical financial statements and the required pro forma financial statements of the combined results of ICU and Smiths Medical in a Form 8-K/A to amend the Current Report on Form 8-K filed on January 7, 2022 by March 22, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issuance of Senior Secured Credit Facilities</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, to partially finance the acquisition of Smiths Medical, we entered into a credit agreement (the "Credit Agreement") with Wells Fargo Bank, National Association, Wells Fargo Securities, LLC, Barclays Bank PLC and certain other financial institutions (the &#8220;Lenders&#8221;), pursuant to which, among other things, the Lenders provided us with credit facilities in the aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="i2140366dbbe94dc99b723319eb6c790e_I20220106" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8yNzQ4Nzc5MDc5MDc4_b95df4f7-1823-43c2-8b4c-94d90f6dc863">2.2</ix:nonFraction>&#160;billion consisting of (i) a five-year term loan A of $<ix:nonFraction unitRef="usd" contextRef="ic658275ab067426dbbc345457231980a_I20220106" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8yNzQ4Nzc5MDc5MTM4_b1d7de4e-4c09-46dc-894c-ac21d68dfc3d">850.0</ix:nonFraction>&#160;million, (ii) a seven-year Term Loan B of $<ix:nonFraction unitRef="usd" contextRef="ia241e4af05fc4638bc449fe9c9c45c66_I20220106" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8yNzQ4Nzc5MDc5MTA3_875f47ec-af64-428a-b818-ac6679172f40">850.0</ix:nonFraction>&#160;million and (iii) a five-year Revolving Credit Facility of $<ix:nonFraction unitRef="usd" contextRef="i39ca865e5711457ca9a490c54dd29de5_I20220106" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8yNzQ4Nzc5MDc5MTY5_c616c9f3-e763-4177-bc3f-f79e7f3178fc">500.0</ix:nonFraction>&#160;million. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principal Payments</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="ifc6fde50d27a4cf283cd60b8c4c94fad" continuedAt="i7a9b4848e8ad45a8b98bbb89d0358065"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments on the term loan A and term loan B Facilities are due on the last day of each calendar quarter commencing on June 30, 2022. The term loan A Facility will amortize in an amount equal to <ix:nonFraction unitRef="number" contextRef="i78e8a542027645189940c1af26b316ab_D20220106-20220106" decimals="3" name="icui:TermLoanAPaymentFirstYearsAsAOfOriginalDebt" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MDk1_ae03c055-bebd-4273-a027-c75657d45f34">2.50</ix:nonFraction>% of the original principal amount in the first two years, <ix:nonFraction unitRef="number" contextRef="i78e8a542027645189940c1af26b316ab_D20220106-20220106" decimals="3" name="icui:TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MTAy_46080f1a-68e0-485c-9d23-1c0de82ae93e">5.00</ix:nonFraction>% in the third and fourth years and <ix:nonFraction unitRef="number" contextRef="i78e8a542027645189940c1af26b316ab_D20220106-20220106" decimals="3" name="icui:TermLoanAPaymentYear5" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MTMx_cace5567-c855-402b-96fc-7bda0b92c6f8">7.50</ix:nonFraction>% in the fifth year, with a final payment of the outstanding principal balance due on the respective maturity date. The term loan B Facility will mature in twenty-seven consecutive quarterly installments in an amount equal to <ix:nonFraction unitRef="number" contextRef="i78e8a542027645189940c1af26b316ab_D20220106-20220106" decimals="4" name="icui:TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MTA5_f1135b41-0d29-44a9-9b83-6bbc0505ef61">0.25</ix:nonFraction>% of the aggregate principal amount of the term loan B outstanding on the Closing Date, with a final payment of the outstanding principal balance due on the respective maturity date. All outstanding revolving loans over the term of the revolver are to be paid by the applicable maturity date.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Terms</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, U.S. dollar revolving and term loans under the credit facilities may bear interest, at our option, on either (1) the Base Rate, as defined in the Credit Agreement, plus the applicable margin, as indicated below or (2) Adjusted Term secured overnight financing rate, as defined in the Credit Agreement, plus applicable margin as indicated below.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility Commitment Fee</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revolving credit facility has a per annum commitment fee at an initial rate of <ix:nonFraction unitRef="number" contextRef="i78e8a542027645189940c1af26b316ab_D20220106-20220106" decimals="4" name="icui:LineOfCreditSpread" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MTE2_3792f850-9612-44ef-88cf-7e2d143b516e">0.25</ix:nonFraction>% which is applied to the available amount of the revolving credit facility. The commitment fee after the quarter ending June 30, 2022 is calculated based on the leverage ratio as indicated below.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Applicable Interest Margins</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="us-gaap:ScheduleOfSubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MTQ2_8506daab-de5c-462f-89a7-c66ec3096327" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable interest margins with respect to revolving loans and the term loan A Facility shall initially be <ix:nonFraction unitRef="number" contextRef="i78e8a542027645189940c1af26b316ab_D20220106-20220106" decimals="4" name="icui:TermLoanAAndCreditLineSpread" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MTIz_0ee7ac62-7e32-4e2f-847c-e18effd39e2d">1.75</ix:nonFraction>% for RFR Loans, as defined in the Credit Agreement. The following pricing grid for the revolving credit facility and the term loan A Facility will become effective after the quarter ending June 30, 2022 and will be based on changes in the Leverage Ratio as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Applicable Margin for RFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitment Fee Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt;4.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iafe2bcda32da45689d560de2ebd12309_D20220106-20220106" decimals="4" name="icui:Spread" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY18xLTEtMS0xLTY4MDkz_3fcaf2a9-1730-4308-be0c-fd9b33b89368">2.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iafe2bcda32da45689d560de2ebd12309_D20220106-20220106" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY18xLTItMS0xLTY4MDg0_34d80ffd-0f5d-42dc-aa92-a92651154508">1.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iafe2bcda32da45689d560de2ebd12309_D20220106-20220106" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY18xLTMtMS0xLTY3OTQ5_3b074242-cd8c-4a77-8f84-8f2d2a738c38">0.35</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&lt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00 to 1.0 but &gt;3.00 to 1.0</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i27a054a4a2d34e3b8e8d3b53146ca889_D20220106-20220106" decimals="3" name="icui:Spread" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY18yLTEtMS0xLTY4MDkz_b9271095-4ac5-4c10-b3e8-d00de9d6ae84">2.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i27a054a4a2d34e3b8e8d3b53146ca889_D20220106-20220106" decimals="3" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY18yLTItMS0xLTY4MDg0_b38878c6-00e6-4cf9-b97b-6ea566168e13">1.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i27a054a4a2d34e3b8e8d3b53146ca889_D20220106-20220106" decimals="3" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY18yLTMtMS0xLTY4MDcx_c0f51381-1162-4272-a3c4-2bcda1dcb639">0.30</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&lt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00 to 1.0 but &gt;2.50 to 1.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3c133097393142f18b109c568537343f_D20220106-20220106" decimals="4" name="icui:Spread" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY18zLTEtMS0xLTY4MDkz_ac1410c0-c0c8-4406-b395-7e0a22b22faa">1.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3c133097393142f18b109c568537343f_D20220106-20220106" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY18zLTItMS0xLTY4MDg0_ea3be2c3-9563-439c-9073-86f4340a6c18">0.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3c133097393142f18b109c568537343f_D20220106-20220106" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY18zLTMtMS0xLTY4MDc1_d3dc4369-4965-4f65-97e6-db80f01ef6e8">0.25</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&lt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50 to 1.0 but &gt;2.00 to 1.0</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7cf95c725a97468eb9aa94749e698281_D20220106-20220106" decimals="3" name="icui:Spread" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY180LTEtMS0xLTY4MDkz_06ca3f7a-264b-446d-af94-3e9eb1919271">1.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7cf95c725a97468eb9aa94749e698281_D20220106-20220106" decimals="3" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY180LTItMS0xLTY4MDg0_fe0baf1f-7f00-4823-ab4d-86f87e467398">0.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7cf95c725a97468eb9aa94749e698281_D20220106-20220106" decimals="3" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY180LTMtMS0xLTY4MDc4_aed99cbc-49a8-41f0-a77f-7fadb837fb0b">0.20</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&lt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00 to 1.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic553bac988d9412da422b9c62def2f16_D20220106-20220106" decimals="4" name="icui:Spread" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY181LTEtMS0xLTY4MDkz_e142b531-ea27-4fb0-a239-94f5d4f8e44f">1.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic553bac988d9412da422b9c62def2f16_D20220106-20220106" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY181LTItMS0xLTY4MDg0_59aa1f82-6ec7-4ab1-991b-3d7301b9be74">0.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic553bac988d9412da422b9c62def2f16_D20220106-20220106" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY181LTMtMS0xLTY4MDgx_ff3fb11e-eb05-42aa-b7df-a2cd3de1142e">0.15</ix:nonFraction>%</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable interest margins for the term loan B Facility shall initially be set at <ix:nonFraction unitRef="number" contextRef="i78e8a542027645189940c1af26b316ab_D20220106-20220106" decimals="4" name="icui:TermLoanBInitialSpread" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MTM5_b3e2f434-8b4c-43c0-ae78-e224327db97f">2.50</ix:nonFraction>% for Eurocurrency Rate Loans. The following pricing grid will become effective on the Adjustment Date and will be based on changes in the Leverage Ratio as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.883%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Applicable Margin for Eurocurrency Rate Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Applicable Margin for Base Rate Loans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt;2.75 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i595c992a5ff64197a1dedaa5a2c28018_D20220106-20220106" decimals="3" name="icui:TermLoanBEuroRateLoanSpread" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6ZWRmNTg1ZjU4YThiNDdhNGE4ZTAzMGZmMzRlYTMwZTYvdGFibGVyYW5nZTplZGY1ODVmNThhOGI0N2E0YThlMDMwZmYzNGVhMzBlNl8xLTEtMS0xLTY4MTM0_7e7ffd2b-5658-4d3d-b127-4c3a31bf9cbb">2.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i595c992a5ff64197a1dedaa5a2c28018_D20220106-20220106" decimals="3" name="icui:TermLoanBBaseRateLoanSpread" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6ZWRmNTg1ZjU4YThiNDdhNGE4ZTAzMGZmMzRlYTMwZTYvdGFibGVyYW5nZTplZGY1ODVmNThhOGI0N2E0YThlMDMwZmYzNGVhMzBlNl8xLTItMS0xLTY4MTM0_19a6a478-c533-4284-9874-1569dfa0c692">1.50</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&lt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75 to 1.0</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifd3bfc829b78437eb5cd91c39c6156b4_D20220106-20220106" decimals="4" name="icui:TermLoanBEuroRateLoanSpread" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6ZWRmNTg1ZjU4YThiNDdhNGE4ZTAzMGZmMzRlYTMwZTYvdGFibGVyYW5nZTplZGY1ODVmNThhOGI0N2E0YThlMDMwZmYzNGVhMzBlNl8yLTEtMS0xLTY4MTE4_13703c56-0fb3-4b8e-88c5-07dab0c17ed7">2.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifd3bfc829b78437eb5cd91c39c6156b4_D20220106-20220106" decimals="4" name="icui:TermLoanBBaseRateLoanSpread" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6ZWRmNTg1ZjU4YThiNDdhNGE4ZTAzMGZmMzRlYTMwZTYvdGFibGVyYW5nZTplZGY1ODVmNThhOGI0N2E0YThlMDMwZmYzNGVhMzBlNl8yLTItMS0xLTY4MTE4_ef0f6660-b4f3-49e2-9e5e-0ed9faf8507b">1.25</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to the Loan Parties and the restricted subsidiaries of the Company, including, without limitation, restrictions on liens, indebtedness, investments, fundamental changes, dispositions, restricted payments and prepayment of junior indebtedness. The Credit Agreement contains financial covenants on the revolving credit facility and term loan A Facility that require the Loan Parties and the restricted subsidiaries of the Company to (i) not exceed a maximum secured net leverage ratio initially set at 4.50 to 1.00, with stepdowns to 4.00 to 1.00 on June 30, 2024 and (ii) a minimum interest coverage ratio of 3.00 to 1.00.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7a9b4848e8ad45a8b98bbb89d0358065">The Credit Agreement contains customary events of default, including, without limitation, payment defaults, covenant defaults, breaches of certain representations and warranties, cross defaults and cross-acceleration to certain material indebtedness, certain events of bankruptcy and insolvency, impairment of security, certain events under ERISA, material judgments and a change of control. If an event of default occurs and is not cured within any applicable grace period or is not waived, the administrative agent and the lenders are entitled to take various actions, including, without limitation, the acceleration of amounts due thereunder and termination of commitments under the Facilities.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><div id="ic100f0970bae445782808747a3ec391d_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.&#160;</span></div><div><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_124"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A. CONTROLS AND PROCEDURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disclosure Controls and Procedures</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive officer and principal financial officer have concluded, based on their evaluation of our disclosure controls and procedures (as defined in Regulations 13a-15(e)&#160;and 15(d)-15(e)&#160;under the Securities Exchange Act of 1934) as of the end of the period covered by this Report, that our disclosure controls and procedures are effective to ensure that the information we are required to disclose in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure and that such information is recorded, processed, summarized and reported within the time periods specified in the rules&#160;and forms of the Securities Exchange Commission.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Changes in Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There was no change in our internal control over financial reporting that occurred during our most recent fiscal quarter that has materially affected or is reasonably likely to materially affect our internal control over financial reporting.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Management&#8217;s Annual Report on Internal Control over Financial Reporting</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management of the Company is responsible for establishing and maintaining adequate internal control over the Company&#8217;s financial reporting.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has used the criteria in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission to evaluate the effectiveness of its internal control over financial reporting.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on this criteria, management of the Company has concluded that the Company has maintained effective internal control over its financial reporting as of December&#160;31, 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our independent registered public accounting firm that audited the December&#160;31, 2021 financial statements included in this Annual Report on Form&#160;10-K has independently assessed the effectiveness of our internal control over financial reporting and its report is below.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160; </span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">To the stockholders and the Board of Directors of ICU Medical, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Opinion on Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have audited the internal control over financial reporting of ICU Medical, Inc. and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2021, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> issued by COSO.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2021, of the Company and our report dated February 25, 2022, expressed an unqualified opinion on those financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis for Opinion </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="padding-right:36pt"><span><br/></span></div><div style="padding-right:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">/s/ DELOITTE &amp; TOUCHE LLP</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costa Mesa, California</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;25, 2022 </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><div id="ic100f0970bae445782808747a3ec391d_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9B. OTHER INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_1480"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="ic100f0970bae445782808747a3ec391d_130"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;III</span></div><div><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_133"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 10 of Form 10-K is set forth under the captions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Officers, Election of Directors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Audit Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compliance with Section&#160;16(a)&#160;Beneficial Ownership Reporting Compliance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our definitive </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proxy Statement to be filed in connection with our 2022 Annual Meeting of Stockholders, and such information is incorporated herein by reference.&#160; </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a Code of Business Conduct and Ethics for Directors and Officers. A copy is available on our website, www.icumed.com. We will disclose any future amendments to, or waivers from, the Code of Business Conduct and Ethics for Directors and Officers on our website.</span></div><div><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_136"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11. EXECUTIVE COMPENSATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 11 of Form 10-K is set forth under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Officer and Director Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Committee Interlocks and Insider Participation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our definitive Proxy Statement to be filed in connection with our 2022 Annual Meeting of Stockholders, and such information is incorporated herein by reference.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ic100f0970bae445782808747a3ec391d_139"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 12 of Form 10-K is set forth under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Security Ownership of Certain Beneficial Owners and Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Compensation Plan Information </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our definitive Proxy Statement to be filed in connection with our 2022 Annual Meeting of Stockholders, and such information is incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div id="ic100f0970bae445782808747a3ec391d_142"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 13 of Form 10-K is set forth under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transactions with Related Persons</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Policies and Procedures Regarding Transactions with Related Persons</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Director Independence</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our definitive Proxy Statement to be filed in connection with our 2022 Annual Meeting of Stockholders, and such information is incorporated herein by reference.</span></div><div><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_145"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information about aggregate fees billed to us by our principal accountant, Deloitte &amp; Touche LLP (PCAOB No. <ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDUvZnJhZzowNGY4MzEyZDJlOTA0YTFiYjM4MzVjNmRkNmM3NjM0Ni90ZXh0cmVnaW9uOjA0ZjgzMTJkMmU5MDRhMWJiMzgzNWM2ZGQ2Yzc2MzQ2XzEwOTk1MTE2MjgyMjA_f7af1fea-1467-4bc9-90b1-18dad723dd03">34</ix:nonNumeric>) as required by this Item 14 of Form 10-K is set forth under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ratification of Auditors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our definitive Proxy Statement to be filed in connection with our 2022 Annual Meeting of Stockholders, and such information is incorporated herein by reference.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><div id="ic100f0970bae445782808747a3ec391d_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;IV</span></div><div><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_151"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:3.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.071%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form 10-K Page No.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following documents are filed as part of this report:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Financial Statements.  See Index to Consolidated Financial Statements in Part II, Item 8 of this Form 10-K.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic100f0970bae445782808747a3ec391d_46">57</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic100f0970bae445782808747a3ec391d_154">Exhibits</a>. The exhibits listed in the accompanying Exhibit Index are filed or incorporated by reference as part of this Form 10-K.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic100f0970bae445782808747a3ec391d_154">105</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Statement Schedules.  The Financial Statement Schedules required to be filed as a part of this Report are:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic100f0970bae445782808747a3ec391d_157">Schedule II &#8212; Valuation and Qualifying Accounts</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic100f0970bae445782808747a3ec391d_157">107</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_154"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT&#160;INDEX</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.092%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000883984/000119312521267387/d228927dex21.htm">2.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Sale and Purchase Agreement, dated September 8, 2021, by and between Smiths Group International Holdings Limited, a private limited company incorporated in England and Wales, and ICU Medical, Inc., a Delaware corporation. Filed as an Exhibit to Registrant's Current Report on Form 8-K filed September 8, 2021, and incorporated herein by reference.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/883984/000119312521267387/d228927dex22.htm">2.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Put Option Deed from ICU Medical, Inc., a Delaware corporation to Smiths Group International Holdings Limited, a private limited company incorporated in England and Wales. Filed as an Exhibit to Registrant's Current Report on Form 8-K filed September 8, 2021, and incorporated herein by reference.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/883984/000088398414000046/exhibitamendedandrestatedc.htm">3.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registrant's Certificate of Incorporation, as amended and restated. Filed as an exhibit to Registrant's Current Report on Form 8-K filed on June 10, 2014, and incorporated herein by reference.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/883984/000088398416000073/exhibit31amendedandrestate.htm">3.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registrant's Bylaws, as amended and restated. Filed as an Exhibit&#160;to Registrant's Current Report on Form 8-K filed August 3, 2016, and incorporated herein by reference.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/883984/000088398420000014/exhibit41descriptionof.htm">4.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Description of Securities Registered Under Section 12 of the Exchange Act. Filed as an Exhibit to Registrant's Annual Report of Form 10-K for the year ended December 31, 2019, filed March 2, 3020, and incorporated herein by reference.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/883984/000110465910053238/a10-17276_1ex10d1.htm">10.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form&#160;of Indemnification Agreement with Directors and Executive Officers. Filed as an Exhibit&#160;to Registrant's Quarterly Report on Form&#160;10-Q for the Quarter ended September&#160;30, 2010, filed October 22, 2010 (File No. 001-34634), and incorporated herein by reference.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/883984/000101968702000543/icu_def14a-040202.txt">10.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registrant's 2002 Employee Stock Purchase Plan.*  Filed as an Exhibit&#160;to Registrant's definitive Proxy Statement filed pursuant to Regulation 14A on April&#160;3, 2002 (File No. 000-19974), and incorporated herein by reference.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit103executiveofficer.htm">10.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive officer compensation*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit104non-employeedire.htm">10.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-employee director compensation*</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/883984/000088398413000019/icui-def14ax2013.htm">10.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2008 Performance-Based Incentive Plan, as amended.*  Filed as Annex A&#160;to Registrant's proxy statement filed April 3, 2013 (File No. 001-34634), and incorporated herein by reference.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/883984/000088398412000080/icumedicalincamended2011st.htm">10.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated ICU Medical, Inc. 2011 Stock Incentive Plan.*  Filed as an Exhibit&#160;to Registrant's Quarterly Report on Form&#160;10-Q for the Quarter ended March 31, 2018, and incorporated herein by reference.<br/>&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.092%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/883984/000088398420000014/exhibit1012firstamendm.htm">10.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Amendment to ICU Medical, Inc. Amended and Restated 2011 Stock Incentive Plan. Filed as an exhibit to Registrant's Annual Report on Form 10-K for the year ended December 31, 2019, filed March 2, 2020 (File No.001-34634) and incorporated herein by reference.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/883984/000088398417000023/exhibit101amendedandrestat.htm">10</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.8</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Executive Employment Agreement, dated as of May 8, 2017, by and between ICU Medical, Inc. and Vivek Jain.*  Filed as an Exhibit&#160;to Registrant's Current Report on Form&#160;8-K filed May 8, 2017, and incorporated herein by reference.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/883984/000088398419000017/icui-ex101.htm">10.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letter agreement between the Registrant and Alison Burcar, effective April 1, 2019. Filed as an Exhibit&#160;to Registrant's Quarterly Report on Form&#160;10-Q for the Quarter ended March 31, 2019, and incorporated herein by reference.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/883984/000088398417000006/exhibit101icumedicalincexe.htm">10.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICU Medical, Inc. Executive Severance Plan.* Filed as an Exhibit to Registrant&#8217;s Current Report on Form 8-K filed January 6, 2017, and incorporated herein by reference.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/883984/000088398420000002/exhibit101.htm">10.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Amendment to the ICU Medical, Inc. Executive Severance Plan. Filed as an Exhibit to Registrant's Current Report on Form 8-K filed January 6, 2020, and incorporated herein by reference.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/883984/000088398422000005/exhibit102.htm">10.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit Agreement, dated as of January 6, 2022, by and among ICU Medical, Inc. as Borrower, certain subsidiaries as guarantors, Wells Fargo Bank, National Association, as Administrative Agent, Wells Fargo Securities, LLC and Barclays Bank PLC as joint bookrunners and joint lead arrangers and the other joint bookrunners and joint lead arrangers listed therein. Filed as an Exhibit to Registrant's Current Report on Form 8-K filed January 7, 2022.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/883984/000088398422000005/exhibit101.htm">10</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.14</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders Agreement, dated as of January 6, 2022, by and between ICU Medical, Inc. and Smiths Group International Holdings Limited. Filed as an Exhibit to Registrant's Current Report on Form 8-K filed January 7, 2022.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit21subsidiariesofreg.htm">21</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsidiaries of Registrant.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit231consentofdeloitt.htm">23.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of Deloitte&#160;&amp; Touche LLP</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311123121.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Executive Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312123121.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Financial Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit32123121.htm">32</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:16.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.467%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The instance document does not appear in the interactive data file because its XBRL (Extensible Business Reporting Language) tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Executive compensation plan or other arrangement</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><div id="ic100f0970bae445782808747a3ec391d_157"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ICU MEDICAL,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">VALUATION&#160;AND&#160;QUALIFYING&#160;ACCOUNTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><ix:nonNumeric contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90ZXh0cmVnaW9uOjU5Yjc1ZGIwZjdkNTRjMGZhMGNiZjFiM2FmMzNiZDY1Xzc4_b12573c0-a727-499e-8666-5ff6dfe0a008" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.888%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Amounts&#160;in&#160;thousands)<br/>Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to<br/>Costs&#160;and<br/>Expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to<br/>Other&#160;Accounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write-off/<br/>Disposals</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance<br/>at&#160;End<br/>of&#160;Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the year ended December&#160;31, 2019:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecae4385e0b9406785f4b23d06865339_I20181231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzMtMi0xLTEtODc0NQ_dcce6ac2-3eb0-4422-86e7-ff2d3e548c18">5,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i870395a6aa054f6bacfe43ca3565e846_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzMtNC0xLTEtODc0NQ_0dd2e18f-d41c-40db-aa51-ca4742baf0bd">14,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i870395a6aa054f6bacfe43ca3565e846_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzMtNi0xLTEtODc0NQ_e4b4c6dc-f1c6-4d9a-bb79-ca07ccfa1c89">431</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i870395a6aa054f6bacfe43ca3565e846_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzMtOC0xLTEtODc0NQ_200cd97f-4a7f-4c9b-a7c8-561c4ea9af39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2c1a3da41264443b2bfbe1037ea8817_I20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzMtMTAtMS0xLTg3NDU_bcb51693-916e-4386-ac4c-e74761dcade5">20,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty and return reserve - accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d12c957c1c943f3b34b05d9ed53aafe_I20181231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzQtMi0xLTEtODc0NQ_45cc1cc8-2ded-4081-a289-c4c2a9802a85">6,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a98c1779cac4386957e351f01e76fa5_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzQtNC0xLTEtODc0NQ_c772a6a2-4775-41f3-9cd6-9ded31163815">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a98c1779cac4386957e351f01e76fa5_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzQtNi0xLTEtODc0NQ_4f892952-4d3f-42fa-82b6-440a942f9c65">458</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a98c1779cac4386957e351f01e76fa5_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzQtOC0xLTEtODc0NQ_473cf296-f05b-469c-837e-894c1f2bae00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie20ee1ac93ab48868926f61f94817b56_I20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzQtMTAtMS0xLTg3NDU_c5e515ec-d525-498b-bbfe-8fa88643b8b0">6,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty and return reserve - inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic2b82bbcf5cb45739937a1040ed30f6b_I20181231" decimals="-3" sign="-" name="icui:WarrantyAndReturnReserveInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzUtMi0xLTEtODc0NQ_c61f9357-7a24-4baa-a42f-ac8a14eb69c9">2,538</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" sign="-" name="icui:WarrantyAndReturnReserveCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzUtNC0xLTEtODc0NQ_b827dbfe-8e6f-44bc-a245-6e9e32ed1ef6">217</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="icui:WarrantyAndReturnReserveInventoryChargedToOtherAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzUtNi0xLTEtODc0NQ_4064917b-9b20-466f-803c-8b25873236ab">722</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231" decimals="-3" name="icui:WarrantyAndReturnReserveInventoryWriteOffs" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzUtOC0xLTEtODc0NQ_f7200423-974f-4488-aa2f-04b7ae3ec10c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231" decimals="-3" sign="-" name="icui:WarrantyAndReturnReserveInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzUtMTAtMS0xLTg3NDU_168b19f4-286e-4fc3-9699-f95ef1dca9b1">3,477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd524a6cefd4a91928cd5550b9aab92_I20181231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzYtMi0xLTEtODc0NQ_af0353f6-5dec-4c3e-b1c6-325974decc24">5,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5aefe03f40c54e77a419eeec553d95eb_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzYtNC0xLTEtODc0NQ_588b18f9-3817-46b2-b5f8-e362a793048e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5aefe03f40c54e77a419eeec553d95eb_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzYtNi0xLTEtODc0NQ_128cc6c4-f9a9-4098-9ac6-54bd7ab6608a">1,584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5aefe03f40c54e77a419eeec553d95eb_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzYtOC0xLTEtODc0NQ_359a5c56-3aae-403f-a822-c3bdc77f5138">175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245c4ea3235a4b6e8de7f653118777e4_I20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzYtMTAtMS0xLTg3NDU_5b59ae3e-6298-4971-bc82-f0a624561da6">3,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the year ended December&#160;31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2c1a3da41264443b2bfbe1037ea8817_I20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzktMi0xLTEtODc0NQ_82eff267-2a16-4236-a2f8-4e361423b610">20,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97bb342dec84b8eb092e237e601cbab_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzktNC0xLTEtODc0NQ_0eb469d1-50f1-4191-9b32-570119d2be42">7,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97bb342dec84b8eb092e237e601cbab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzktNi0xLTEtODc0NQ_66f6ab93-d878-4261-bbe1-b6595d5e7f3f">5,866</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97bb342dec84b8eb092e237e601cbab_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzktOC0xLTEtODc0NQ_e6aaeace-e059-4d2b-9c88-0b34f66f66c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idda3b662db294f219a192b0347c136af_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzktMTAtMS0xLTg3NDU_60929999-fc11-4ae0-b2af-574582f3704b">21,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty and return reserve - accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie20ee1ac93ab48868926f61f94817b56_I20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzEwLTItMS0xLTg3NDU_9ca0e14e-9b9a-4f9f-9379-80b3cbf4278f">6,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf8bf1ccc2ee4806a1f944d440ddd63a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzEwLTQtMS0xLTg3NDU_61ca3563-e300-4675-8472-1189449549a0">3,609</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf8bf1ccc2ee4806a1f944d440ddd63a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzEwLTYtMS0xLTg3NDU_849377c8-7908-496b-b743-ea237dc64416">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf8bf1ccc2ee4806a1f944d440ddd63a_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzEwLTgtMS0xLTg3NDU_995d637a-03f8-42c2-b202-ab54cc04e6a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea50319693fd4506aaf0fc2e7a8505fc_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzEwLTEwLTEtMS04NzQ1_01b4db63-4d09-4103-a159-7a8f34d44b12">2,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty and return reserve - inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231" decimals="-3" sign="-" name="icui:WarrantyAndReturnReserveInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzExLTItMS0xLTg3NDU_91f09e61-0aa0-4ec2-b2e3-6fa690504caa">3,477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="icui:WarrantyAndReturnReserveCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzExLTQtMS0xLTg3NDU_a528984a-8c59-4095-8a34-991239406957">2,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="icui:WarrantyAndReturnReserveInventoryChargedToOtherAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzExLTYtMS0xLTg3NDU_cc36cee9-5fe1-4899-b480-f53302d3b14a">169</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231" decimals="-3" name="icui:WarrantyAndReturnReserveInventoryWriteOffs" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzExLTgtMS0xLTg3NDU_2360b59b-3309-468c-942c-61be419ee09c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" sign="-" name="icui:WarrantyAndReturnReserveInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzExLTEwLTEtMS04NzQ1_28e9a7c5-20ac-4cca-8197-f6a363240ae5">1,613</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245c4ea3235a4b6e8de7f653118777e4_I20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzEyLTItMS0xLTg3NDU_277aedca-d14f-4f04-a7ab-cc228138e5c1">3,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a4c1f26c3014290b2257c8a6c97e92a_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzEyLTQtMS0xLTg3NDU_d785e735-43d3-4a88-93bf-0d4e01eb895e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a4c1f26c3014290b2257c8a6c97e92a_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzEyLTYtMS0xLTg3NDU_75b72f1c-4ac5-4668-90e8-11ae1698967f">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a4c1f26c3014290b2257c8a6c97e92a_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzEyLTgtMS0xLTg3NDU_987054f9-381d-4797-ac86-ea591d41a150">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbfa44cf2124deea69cb9774393fdd6_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzEyLTEwLTEtMS04NzQ1_7d01c229-47fd-4b46-84fe-f04b264bd373">3,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the year ended December&#160;31, 2021:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idda3b662db294f219a192b0347c136af_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE1LTItMS0xLTg3NDU_390bc84e-5793-40ec-997a-5fd930c26f5f">21,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieff747a718fd489ebe9871999b3764e6_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE1LTQtMS0xLTg3NDU_9a910ba1-fb74-48a1-918a-9f59f69233da">345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieff747a718fd489ebe9871999b3764e6_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE1LTYtMS0xLTg3NDU_256e0ca7-5d4a-4979-8e1e-d6a3294da132">14,797</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieff747a718fd489ebe9871999b3764e6_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE1LTgtMS0xLTg3NDU_7effe8b9-6ec0-4608-809f-e9be76e9b66e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a1683bbea2043caa4198e6f9ed83d74_I20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE1LTEwLTEtMS04NzQ1_50a822c3-8119-4be3-90bf-9b52f771ca67">7,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty and return reserve - accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea50319693fd4506aaf0fc2e7a8505fc_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE2LTItMS0xLTg3NDU_d104e589-4462-4566-8571-8694ff234e7a">2,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59cffeff11d847a38379503c52f7cf32_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE2LTQtMS0xLTg3NDU_aed17a6c-fe33-4884-89f5-f3334a0a3a2d">568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59cffeff11d847a38379503c52f7cf32_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE2LTYtMS0xLTg3NDU_69977e55-f132-4c71-b7b6-70bb0e7d6b83">790</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59cffeff11d847a38379503c52f7cf32_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE2LTgtMS0xLTg3NDU_dde593d2-fc97-41ca-93bc-15935d08152e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6a5483b520c4d7d8560fae11ca7ee8a_I20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE2LTEwLTEtMS04NzQ1_71ec5740-b707-4c06-b139-a2a2ea12bdbe">2,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty and return reserve - inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231" decimals="-3" sign="-" name="icui:WarrantyAndReturnReserveInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE3LTItMS0xLTg3NDU_382bee80-6b0d-425e-9160-e4347e1f29a4">1,613</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="icui:WarrantyAndReturnReserveCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE3LTQtMS0xLTg3NDU_75d455fc-36eb-4171-bbef-324b747c35ca">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="icui:WarrantyAndReturnReserveInventoryChargedToOtherAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE3LTYtMS0xLTg3NDU_83fba672-d8e5-4b7b-9636-5744a5cd500f">533</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231" decimals="-3" name="icui:WarrantyAndReturnReserveInventoryWriteOffs" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE3LTgtMS0xLTg3NDU_7b286c85-2f65-41ea-b9a8-19d05be3c08e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231" decimals="-3" sign="-" name="icui:WarrantyAndReturnReserveInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE3LTEwLTEtMS04NzQ1_7c6de01f-878c-4a08-9156-0e4b83f66ac8">1,883</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbfa44cf2124deea69cb9774393fdd6_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE4LTItMS0xLTg3NDU_f1e977e6-c48f-4bfb-8d52-d223609ab3f4">3,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i673942985fc343f3ac8ca57d29d0dd83_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE4LTQtMS0xLTg3NDU_351925d6-63bf-4c70-aec9-442939e4e2f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i673942985fc343f3ac8ca57d29d0dd83_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE4LTYtMS0xLTg3NDU_bd033e44-5cfc-4866-bb0d-32d100c2f5c0">957</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i673942985fc343f3ac8ca57d29d0dd83_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE4LTgtMS0xLTg3NDU_767ba1e2-67e7-47b7-89a3-df0661e06930">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa8f3589249483da23fe23fa443806b_I20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE4LTEwLTEtMS04NzQ1_d9510bf7-7b0e-4de6-962c-82a1c599e505">2,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><div id="ic100f0970bae445782808747a3ec391d_160"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16. FORM 10-K SUMMARY</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;None</span></div><div><span><br/></span></div><div id="ic100f0970bae445782808747a3ec391d_163"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934, Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.276%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU MEDICAL,&#160;INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">/s/ Vivek Jain</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vivek Jain</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chairman of the Board and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 25, 2022</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of Registrant and in the capacities and on the dates indicated.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.304%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.615%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">/s/ Vivek Jain</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chairman of the Board and</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 25, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vivek Jain</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">/s/ Brian M. Bonnell</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 25, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brian M. Bonnell</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">/s/ Kevin J. McGrody</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chief Accounting Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 25, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kevin J. McGrody</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">/s/ George A. Lopez, M.D.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 25, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">George A. Lopez, M.D.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">/s/ David C. Greenberg</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 25, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">David C. Greenberg</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">/s/ Elisha W. Finney</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 25, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Elisha W. Finney</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">/s/ David F. Hoffmeister</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 25, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">David F. Hoffmeister</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">/s/ Donald M. Abbey</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 25, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Donald M. Abbey</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">/s/ Laurie Hernandez</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 25, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Laurie Hernandez</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">/s/ Kolleen T. Kennedy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 25, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kolleen T. Kennedy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">/s/ William Seeger</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 25, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">William Seeger</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>2
<FILENAME>exhibit103executiveofficer.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i737f6dd0daa7467abc1450355826bc2b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;10.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Officer Compensation</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual base salaries for our executive officers as of January&#160;1, 2021 are as follows&#58;</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:17.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.269%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vivek Jain</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,000&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christian Voigtlander</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Operating Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420,000&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian M. Bonnell</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer and Treasurer</font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395,000&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel Woolson</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Vice President, General Manager - Infusion Systems</font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,000&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia Sanzone</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Vice President, General Counsel</font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,000&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>3
<FILENAME>exhibit104non-employeedire.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic888966ed5594195aaefdba40da62fde_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;10.4</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Employee Director Compensation</font></div><div style="text-align:center"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently pay our non-employee directors the following&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">annual retainer of $93,500 for the Lead Director  </font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">annual retainer of $97,000 for the Chairperson of the Audit Committee</font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">annual retainer of $87,500 for the Chairperson of the Compensation Committee</font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">annual retainer of $85,000 for the Chairperson of the Nominating and Governance Committee</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The equity component of the director's compensation is valued at $170,000.  The annual equity package consists of 50% in stock options and 50% in restricted stock units.   The options become exercisable one year after the grant date and expire ten years after the grant date.  The restricted stock units vest one year from the grant date.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>4
<FILENAME>exhibit21subsidiariesofreg.htm
<DESCRIPTION>EX-21
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i613a906d43f34769a164c57c479eadca_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;21</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Subsidiaries of Registrant</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">State&#160;or Country of&#160;Incorporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Sales,&#160;Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical de Mexico, S. de R. L. de C.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Europe S.r.l.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU World,&#160;Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Bidco Ltd</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Germany GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical B.V.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Australia Holdings Pty Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medima s.p. z.o.o.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Poland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical SA Pty Ltd</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">South Africa</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EXC Holding Corp.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tangent Medical Technologies, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Excelsior Medical Corporation</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical France S.A.S.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Canada Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Latam LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU UK Medical Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Ireland Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Argentina S.R.L.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Argentina</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Costa Rica, Ltd</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bahamas</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Bahamas, Ltd</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bahamas</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Chile Limitada</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chile</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hospira Chile Limitada</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chile</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Colombia Limitada</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Colombia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical HIS Mexico S. de R.L. de C.V.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Peru S.R.L.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Peru</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Australia Pty Limited</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical Australia Pty Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medivet Pty Ltd</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Hong Kong Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical India LLP</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">India</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Philippines, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Philippines</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Unlimited Company</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Italia S.r.l.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Productos Farmac&#233;uticos y Hospitalarios, S.L.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICU Medical Aust MLA Pty Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Australia</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>exhibit231consentofdeloitt.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i438609799e814205aa9cdf534faed52b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;23.1</font></div><div style="text-align:right"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We consent to the incorporation by reference in Registration Statement No.</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">333-90464,</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> 333-175239, 333-198256, and 333-219106 </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">on Form S</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">-</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">8 </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">and </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">333</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">-</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">228390 on </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Form S</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">- </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">3</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> of our reports </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">dated February 25, 2022, relating</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> to the financial statements of ICU Medical, Inc. and the effectiveness of ICU Medical Inc.'s internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">December&#160;31, 2021.</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; DELOITTE &#38; TOUCHE LLP</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costa Mesa, California</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 25, 2022</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>exhibit311123121.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i295e51c43b9843a8aec405f82375e6b9_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Vivek Jain, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this annual report on Form&#160;10-K of ICU Medical,&#160;Inc.&#59;</font></div><div style="padding-left:36pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:36pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:108pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:72pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.728%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 25, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Vivek Jain</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>exhibit312123121.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i4459ecaf0c4e432ca888dcfd988adb2e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brian M. Bonnell, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%;padding-left:24pt">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I have reviewed this annual report on Form&#160;10-K of ICU Medical,&#160;Inc.&#59;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt"> Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.74pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.74pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt"> The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.74pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:4.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.265%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.547%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 25, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brian M. Bonnell</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>exhibit32123121.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i81505dfb0719425d87a8ab001b2dc208_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of ICU Medical,&#160;Inc. (the &#8220;Company&#8221;) on Form&#160;10-K for the period ended December&#160;31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Vivek Jain, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167;&#160;1350, as adopted pursuant to &#167;&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.095%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 25, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Vivek Jain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vivek Jain</font></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of ICU Medical,&#160;Inc. (the &#8220;Company&#8221;) on Form&#160;10-K for the period ended December&#160;31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Brian M. Bonnell, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167;&#160;1350, as adopted pursuant to &#167;&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.095%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 25, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brian M. Bonnell</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian M. Bonnell</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>icui-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:79121b2d-e854-41aa-aab3-7b5c5847e030,g:aa7e8fee-abd8-4fff-b3c4-f8ba25538e22-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:icui="http://www.icumed.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.icumed.com/20211231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icui-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icui-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icui-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icui-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformationDocument" roleURI="http://www.icumed.com/role/DocumentandEntityInformationDocument">
        <link:definition>000010001 - Document - Document and Entity Information Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.icumed.com/role/AuditInformation">
        <link:definition>000020002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.icumed.com/role/ConsolidatedBalanceSheets">
        <link:definition>100010003 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.icumed.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>140024001 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofIncome" roleURI="http://www.icumed.com/role/ConsolidatedStatementsofIncome">
        <link:definition>100030004 - Statement - Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StatementofComprehensiveIncome" roleURI="http://www.icumed.com/role/StatementofComprehensiveIncome">
        <link:definition>100040005 - Statement - Statement of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StatementofComprehensiveIncomeParenthetical" roleURI="http://www.icumed.com/role/StatementofComprehensiveIncomeParenthetical">
        <link:definition>140054002 - Statement - Statement of Comprehensive Income (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>100060006 - Statement - Consolidated Statements of Stockholders Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.icumed.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>100070007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandSummaryofSignificantAccountingPolicies" roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPolicies">
        <link:definition>210011001 - Disclosure - General and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>220022001 - Disclosure - General and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>230033001 - Disclosure - General and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandSummaryofSignificantAccountingPoliciesBasisofPresentationDetails" roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesBasisofPresentationDetails">
        <link:definition>240044003 - Disclosure - General and Summary of Significant Accounting Policies Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandSummaryofSignificantAccountingPoliciesInventoryDetails" roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInventoryDetails">
        <link:definition>240054004 - Disclosure - General and Summary of Significant Accounting Policies Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details" roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details">
        <link:definition>240064005 - Disclosure - General and Summary of Significant Accounting Policies Property and Equipment #1 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details" roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details">
        <link:definition>240074006 - Disclosure - General and Summary of Significant Accounting Policies Property and Equipment #2 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment3Details" roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment3Details">
        <link:definition>240084007 - Disclosure - General and Summary of Significant Accounting Policies Property and Equipment #3 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails" roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails">
        <link:definition>240094008 - Disclosure - General and Summary of Significant Accounting Policies Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details" roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details">
        <link:definition>240104009 - Disclosure - General and Summary of Significant Accounting Policies Intangible Assets #1 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets2Details" roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets2Details">
        <link:definition>240114010 - Disclosure - General and Summary of Significant Accounting Policies Intangible Assets #2 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails" roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails">
        <link:definition>240124011 - Disclosure - General and Summary of Significant Accounting Policies Future Estimated Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandSummaryofSignificantAccountingPoliciesInvestmentsDetails" roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsDetails">
        <link:definition>240134012 - Disclosure - General and Summary of Significant Accounting Policies Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandSummaryofSignificantAccountingPoliciesInvestmentsEquityMethodDetails" roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsEquityMethodDetails">
        <link:definition>240144013 - Disclosure - General and Summary of Significant Accounting Policies Investments-Equity Method (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandSummaryofSignificantAccountingPoliciesForeignCurrencyDetails" roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesForeignCurrencyDetails">
        <link:definition>240154014 - Disclosure - General and Summary of Significant Accounting Policies Foreign Currency (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandSummaryofSignificantAccountingPoliciesAdvertisingExpensesDetails" roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesAdvertisingExpensesDetails">
        <link:definition>240164015 - Disclosure - General and Summary of Significant Accounting Policies Advertising Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandSummaryofSignificantAccountingPoliciesPostretirementandPostemploymentBenefitsDetails" roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPostretirementandPostemploymentBenefitsDetails">
        <link:definition>240174016 - Disclosure - General and Summary of Significant Accounting Policies Post-retirement and Post-employment Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails" roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails">
        <link:definition>240184017 - Disclosure - General and Summary of Significant Accounting Policies Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandSummaryofSignificantAccountingPoliciesNewAccountingPronouncementsDetails" roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNewAccountingPronouncementsDetails">
        <link:definition>240194018 - Disclosure - General and Summary of Significant Accounting Policies New Accounting Pronouncements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsNotes" roleURI="http://www.icumed.com/role/AcquisitionsNotes">
        <link:definition>210201002 - Disclosure - Acquisitions (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsPursuitVascularTables" roleURI="http://www.icumed.com/role/AcquisitionsPursuitVascularTables">
        <link:definition>230213002 - Disclosure - Acquisitions Pursuit Vascular (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsTextDetails" roleURI="http://www.icumed.com/role/AcquisitionsTextDetails">
        <link:definition>240224019 - Disclosure - Acquisitions Text (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsPursuitVascularTableDetails" roleURI="http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails">
        <link:definition>240234020 - Disclosure - Acquisitions Pursuit Vascular Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsPursuitVascularIntangibleDetails" roleURI="http://www.icumed.com/role/AcquisitionsPursuitVascularIntangibleDetails">
        <link:definition>240244021 - Disclosure - Acquisitions Pursuit Vascular Intangible (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsForeignInfusionSystemsSupplierDetails" roleURI="http://www.icumed.com/role/AcquisitionsForeignInfusionSystemsSupplierDetails">
        <link:definition>240254022 - Disclosure - Acquisitions Foreign Infusion Systems Supplier (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringStrategicTransactionandIntegrationNotes" roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes">
        <link:definition>210261003 - Disclosure - Restructuring, Strategic Transaction and Integration (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringStrategicTransactionandIntegrationScheduleofRestructuringandRelatedCostsTables" roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationScheduleofRestructuringandRelatedCostsTables">
        <link:definition>230273003 - Disclosure - Restructuring, Strategic Transaction and Integration Schedule of Restructuring and Related Costs (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringStrategicTransactionandIntegrationDetails1" roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails1">
        <link:definition>240284023 - Disclosure - Restructuring, Strategic Transaction and Integration (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringStrategicTransactionandIntegrationDetails2" roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails2">
        <link:definition>240294024 - Disclosure - Restructuring, Strategic Transaction and Integration (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringStrategicTransactionandIntegrationStrategicTransactionandIntegrationExpensesDetails" roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationStrategicTransactionandIntegrationExpensesDetails">
        <link:definition>240304025 - Disclosure - Restructuring, Strategic Transaction and Integration Strategic Transaction and Integration Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNotes" roleURI="http://www.icumed.com/role/RevenueNotes">
        <link:definition>210311004 - Disclosure - Revenue (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.icumed.com/role/RevenueTables">
        <link:definition>230323004 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisaggregationofRevenueProductLineDetails" roleURI="http://www.icumed.com/role/RevenueDisaggregationofRevenueProductLineDetails">
        <link:definition>240334026 - Disclosure - Revenue Disaggregation of Revenue - Product Line (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisaggregationofRevenuebyGeographyDetails" roleURI="http://www.icumed.com/role/RevenueDisaggregationofRevenuebyGeographyDetails">
        <link:definition>240344027 - Disclosure - Revenue Disaggregation of Revenue by Geography (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueContractLiabilitiesDetails" roleURI="http://www.icumed.com/role/RevenueContractLiabilitiesDetails">
        <link:definition>240354028 - Disclosure - Revenue Contract Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueContractLiabilitiesTextDetails" roleURI="http://www.icumed.com/role/RevenueContractLiabilitiesTextDetails">
        <link:definition>240364029 - Disclosure - Revenue Contract Liabilities Text (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNotes" roleURI="http://www.icumed.com/role/LeasesNotes">
        <link:definition>210371005 - Disclosure - Leases (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.icumed.com/role/LeasesTables">
        <link:definition>230383005 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesDetails" roleURI="http://www.icumed.com/role/LeasesDetails">
        <link:definition>240394030 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCostDetails" roleURI="http://www.icumed.com/role/LeasesLeaseCostDetails">
        <link:definition>240404031 - Disclosure - Leases Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalCashFlowLeaseInformationDetails" roleURI="http://www.icumed.com/role/LeasesSupplementalCashFlowLeaseInformationDetails">
        <link:definition>240414032 - Disclosure - Leases Supplemental Cash Flow Lease Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetLeaseinformationDetails" roleURI="http://www.icumed.com/role/LeasesSupplementalBalanceSheetLeaseinformationDetails">
        <link:definition>240424033 - Disclosure - Leases Supplemental Balance Sheet Lease information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinanceLeasesSupplementalBalanceSheetInformationDetails" roleURI="http://www.icumed.com/role/FinanceLeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>240434034 - Disclosure - Finance Leases Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseMaturityDetails" roleURI="http://www.icumed.com/role/LeasesLeaseMaturityDetails">
        <link:definition>240444035 - Disclosure - Leases Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesFinanceLeaseMaturityDetails" roleURI="http://www.icumed.com/role/LeasesFinanceLeaseMaturityDetails">
        <link:definition>240454036 - Disclosure - Leases Finance Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedAwardShareawardsNotes" roleURI="http://www.icumed.com/role/ShareBasedAwardShareawardsNotes">
        <link:definition>210461006 - Disclosure - Share Based Award Share awards (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedAwardTables" roleURI="http://www.icumed.com/role/ShareBasedAwardTables">
        <link:definition>230473006 - Disclosure - Share Based Award (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedAwardStockBasedCompensationDetails" roleURI="http://www.icumed.com/role/ShareBasedAwardStockBasedCompensationDetails">
        <link:definition>240484037 - Disclosure - Share Based Award Stock Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedAwardStockOptionPlansDetails" roleURI="http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails">
        <link:definition>240494038 - Disclosure - Share Based Award Stock Option Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedAwardStockOptionsGrantedandValuationDetails" roleURI="http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails">
        <link:definition>240504039 - Disclosure - Share Based Award Stock Options Granted and Valuation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedAwardStockOptionActivityDetails" roleURI="http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails">
        <link:definition>240514040 - Disclosure - Share Based Award Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedAwardShareAwarddataDetails" roleURI="http://www.icumed.com/role/ShareBasedAwardShareAwarddataDetails">
        <link:definition>240524041 - Disclosure - Share Based Award Share Award data (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedAwardOptionsexerciseddataDetails" roleURI="http://www.icumed.com/role/ShareBasedAwardOptionsexerciseddataDetails">
        <link:definition>240534042 - Disclosure - Share Based Award Options exercised data (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedAwardRSUandPRSUDetails" roleURI="http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails">
        <link:definition>240544043 - Disclosure - Share Based Award RSU and PRSU (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedAwardRSUandPRSURollforwardDetails" roleURI="http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails">
        <link:definition>240554044 - Disclosure - Share Based Award RSU and PRSU Roll forward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedAwardESPPNarrativeDetails" roleURI="http://www.icumed.com/role/ShareBasedAwardESPPNarrativeDetails">
        <link:definition>240564045 - Disclosure - Share Based Award ESPP Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandHedgingActivitiesNotes" roleURI="http://www.icumed.com/role/DerivativesandHedgingActivitiesNotes">
        <link:definition>210571007 - Disclosure - Derivatives and Hedging Activities (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandHedgingActivitiesTables" roleURI="http://www.icumed.com/role/DerivativesandHedgingActivitiesTables">
        <link:definition>230583007 - Disclosure - Derivatives and Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandHedgingActivitiesDetails" roleURI="http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails">
        <link:definition>240594046 - Disclosure - Derivatives and Hedging Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails" roleURI="http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails">
        <link:definition>240604047 - Disclosure - Derivatives and Hedging Activities Derivative Balance Sheet Location (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails" roleURI="http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails">
        <link:definition>240614048 - Disclosure - Derivatives and Hedging Activities Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>240624049 - Disclosure - Derivatives and Hedging Activities Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementNotes" roleURI="http://www.icumed.com/role/FairValueMeasurementNotes">
        <link:definition>210631008 - Disclosure - Fair Value Measurement (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementTables" roleURI="http://www.icumed.com/role/FairValueMeasurementTables">
        <link:definition>230643008 - Disclosure - Fair Value Measurement (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementTextDetails" roleURI="http://www.icumed.com/role/FairValueMeasurementTextDetails">
        <link:definition>240654050 - Disclosure - Fair Value Measurement Text (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementDetails" roleURI="http://www.icumed.com/role/FairValueMeasurementDetails">
        <link:definition>240664051 - Disclosure - Fair Value Measurement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementFairValueInputsLiabilitiesHospiraQuantitativeInformationDetails" roleURI="http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesHospiraQuantitativeInformationDetails">
        <link:definition>240674052 - Disclosure - Fair Value Measurement Fair Value Inputs, Liabilities, Hospira Quantitative Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails" roleURI="http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails">
        <link:definition>240684053 - Disclosure - Fair Value Measurement Fair Value Inputs, Liabilities, Pursuit Quantitative Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementFairValueMeasurementsRecurringBasisDetails" roleURI="http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails">
        <link:definition>240694054 - Disclosure - Fair Value Measurement Fair Value Measurements, Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidsandOtherCurrentAssetsNotes" roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes">
        <link:definition>210701009 - Disclosure - Prepaids and Other Current Assets (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidsandOtherCurrentAssetsTables" roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables">
        <link:definition>230713009 - Disclosure - Prepaids and Other Current Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails" roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails">
        <link:definition>240724055 - Disclosure - Prepaids and Other Current Assets Prepaid Expenses and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesanOtherLongtermLiabilities" roleURI="http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilities">
        <link:definition>210731010 - Disclosure - Accrued Liabilities an Other Long-term Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesanOtherLongtermLiabilitiesTables" roleURI="http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesTables">
        <link:definition>230743010 - Disclosure - Accrued Liabilities an Other Long-term Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesanOtherLongtermLiabilitiesDetails" roleURI="http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesDetails">
        <link:definition>240754056 - Disclosure - Accrued Liabilities an Other Long-term Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesanOtherLongtermLiabilitiesOtherLongtermLiabilitiesDetails" roleURI="http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesOtherLongtermLiabilitiesDetails">
        <link:definition>240764057 - Disclosure - Accrued Liabilities an Other Long-term Liabilities Other Long-term Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsNotes" roleURI="http://www.icumed.com/role/LongTermObligationsNotes">
        <link:definition>210771011 - Disclosure - Long-Term Obligations (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsTables" roleURI="http://www.icumed.com/role/LongTermObligationsTables">
        <link:definition>230783011 - Disclosure - Long-Term Obligations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsDetails" roleURI="http://www.icumed.com/role/LongTermObligationsDetails">
        <link:definition>240794058 - Disclosure - Long-Term Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsLineofCreditPricingDetails" roleURI="http://www.icumed.com/role/LongTermObligationsLineofCreditPricingDetails">
        <link:definition>240804059 - Disclosure - Long-Term Obligations Line of Credit Pricing (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.icumed.com/role/IncomeTaxes">
        <link:definition>210811012 - Disclosure - Income Taxes:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncometaxdisclosureTables" roleURI="http://www.icumed.com/role/IncomeTaxesIncometaxdisclosureTables">
        <link:definition>230823012 - Disclosure - Income Taxes Income tax disclosure (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeLossfromContinuingOperationsDetails" roleURI="http://www.icumed.com/role/IncomeTaxesIncomeLossfromContinuingOperationsDetails">
        <link:definition>240834060 - Disclosure - Income Taxes Income (Loss) from Continuing Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTaxProvisionDetails" roleURI="http://www.icumed.com/role/IncomeTaxesTaxProvisionDetails">
        <link:definition>240844061 - Disclosure - Income Taxes Tax Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesChangeintaxespayableDetails" roleURI="http://www.icumed.com/role/IncomeTaxesChangeintaxespayableDetails">
        <link:definition>240854062 - Disclosure - Income Taxes Change in taxes payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesEffectivetaxrateDetails" roleURI="http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails">
        <link:definition>240864063 - Disclosure - Income Taxes Effective tax rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredincometaxassetsliabilitiesDetails" roleURI="http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails">
        <link:definition>240874064 - Disclosure - Income Taxes Deferred income tax assets (liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesOperatingLossCarryforwardsDetails" roleURI="http://www.icumed.com/role/IncomeTaxesOperatingLossCarryforwardsDetails">
        <link:definition>240884065 - Disclosure - Income Taxes Operating Loss Carryforwards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTaxCarryforwardsDetails" roleURI="http://www.icumed.com/role/IncomeTaxesTaxCarryforwardsDetails">
        <link:definition>240894066 - Disclosure - Income Taxes Tax Carryforwards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTaxHolidayDetails" roleURI="http://www.icumed.com/role/IncomeTaxesTaxHolidayDetails">
        <link:definition>240904067 - Disclosure - Income Taxes Tax Holiday (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUndistributedforeignearningsDetails" roleURI="http://www.icumed.com/role/IncomeTaxesUndistributedforeignearningsDetails">
        <link:definition>240914068 - Disclosure - Income Taxes Undistributed foreign earnings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUnrecognizedtaxbenefitsDetails" roleURI="http://www.icumed.com/role/IncomeTaxesUnrecognizedtaxbenefitsDetails">
        <link:definition>240924069 - Disclosure - Income Taxes Unrecognized tax benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeographicInformationandSignificantCustomersGeographicInformationandSignificantCustomersNotes" roleURI="http://www.icumed.com/role/GeographicInformationandSignificantCustomersGeographicInformationandSignificantCustomersNotes">
        <link:definition>210931013 - Disclosure - Geographic Information and Significant Customers Geographic Information and Significant Customers (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeographicInformationandSignificantCustomersGeographicInformationTables" roleURI="http://www.icumed.com/role/GeographicInformationandSignificantCustomersGeographicInformationTables">
        <link:definition>230943013 - Disclosure - Geographic Information and Significant Customers Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails" roleURI="http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails">
        <link:definition>240954070 - Disclosure - Geographic Information and Significant Customers Long Lived Assets by Geographic Location (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.icumed.com/role/StockholdersEquity">
        <link:definition>210961014 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.icumed.com/role/StockholdersEquityTables">
        <link:definition>230973014 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDetails" roleURI="http://www.icumed.com/role/StockholdersEquityDetails">
        <link:definition>240984071 - Disclosure - Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.icumed.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>240994072 - Disclosure - Stockholders' Equity Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.icumed.com/role/CommitmentsandContingencies">
        <link:definition>211001015 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://www.icumed.com/role/CommitmentsandContingenciesTables">
        <link:definition>231013015 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesContingenciesDetails" roleURI="http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails">
        <link:definition>241024073 - Disclosure - Commitments and Contingencies Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborativeandOtherArrangementsNotes" roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes">
        <link:definition>211031016 - Disclosure - Collaborative and Other Arrangements (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborativeandOtherArrangementsTables" roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsTables">
        <link:definition>231043016 - Disclosure - Collaborative and Other Arrangements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborativeandOtherArrangementsDetails" roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails">
        <link:definition>241054074 - Disclosure - Collaborative and Other Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.icumed.com/role/SubsequentEvents">
        <link:definition>211061017 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsTables" roleURI="http://www.icumed.com/role/SubsequentEventsTables">
        <link:definition>231073017 - Disclosure - Subsequent Events (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.icumed.com/role/SubsequentEventsDetails">
        <link:definition>241084075 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsCreditAgreementDetails" roleURI="http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails">
        <link:definition>241094076 - Disclosure - Subsequent Events Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsTermLoanACreditLineApplicableMarginDetails" roleURI="http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails">
        <link:definition>241104077 - Disclosure - Subsequent Events Term Loan A &amp; Credit Line Applicable Margin (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsTermLoanBApplicableMarginDetails" roleURI="http://www.icumed.com/role/SubsequentEventsTermLoanBApplicableMarginDetails">
        <link:definition>241114078 - Disclosure - Subsequent Events Term Loan B Applicable Margin (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SECScheduleArticle1209ValuationandQualifyingAccounts" roleURI="http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccounts">
        <link:definition>211121018 - Disclosure - SEC Schedule, Article 12-09, Valuation and Qualifying Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SECScheduleArticle1209ValuationandQualifyingAccountsDetails" roleURI="http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails">
        <link:definition>241134079 - Disclosure - SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="icui_LineofCreditAccordion" abstract="false" name="LineofCreditAccordion" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Supplychainrestructuringcosts" abstract="false" name="Supplychainrestructuringcosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_LongTermDebtDisclosureAbstract" abstract="true" name="LongTermDebtDisclosureAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_TermLoanAMember" abstract="true" name="TermLoanAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis" abstract="true" name="TermLoanAAndCreditLineApplicableMarginSpreadAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_EffectiveIncomeTaxRateReconciliationIPMigration" abstract="false" name="EffectiveIncomeTaxRateReconciliationIPMigration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ForeignInfusionSystemSupplierMember" abstract="true" name="ForeignInfusionSystemSupplierMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TotalAcquisitionsMember" abstract="true" name="TotalAcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount" abstract="false" name="TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="icui_GILTItaxexpensepercent" abstract="false" name="GILTItaxexpensepercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="icui_UnitedStatespropertyandequipmentMember" abstract="true" name="UnitedStatespropertyandequipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_InfusionSystemsMember" abstract="true" name="InfusionSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_IndirectTaxBenefitFromStockOptions" abstract="false" name="IndirectTaxBenefitFromStockOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_StockIncentivePlansLineItems" abstract="true" name="StockIncentivePlansLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_EquipmentrevenueMember" abstract="true" name="EquipmentrevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_EffectiveIncomeTaxRateReconciliationContingentConsideration" abstract="false" name="EffectiveIncomeTaxRateReconciliationContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_RevenueGrossProfitVolatilityMember" abstract="true" name="RevenueGrossProfitVolatilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_NonCurrentDeferredTaxAssetGrossTotalMember" abstract="true" name="NonCurrentDeferredTaxAssetGrossTotalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Hedge2Member" abstract="true" name="Hedge2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ContractassetandliabilitybalancesTable" abstract="true" name="ContractassetandliabilitybalancesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" abstract="false" name="IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TermLoanAAndCreditLineSpread" abstract="false" name="TermLoanAAndCreditLineSpread" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="icui_Effectiveincometaxreconciliationnondeductiblecompensation" abstract="false" name="Effectiveincometaxreconciliationnondeductiblecompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_OtherLATAMMember" abstract="true" name="OtherLATAMMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_LineOfCreditSpread" abstract="false" name="LineOfCreditSpread" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount" abstract="false" name="TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="icui_Hedge5Member" abstract="true" name="Hedge5Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_COntractLiabilityRollforwardRollForward" abstract="true" name="COntractLiabilityRollforwardRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_OwnershipShareMinimumRequirement" abstract="false" name="OwnershipShareMinimumRequirement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="icui_SpareParts" abstract="false" name="SpareParts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_CollaborativeandOtherArrangementsAbstract" abstract="true" name="CollaborativeandOtherArrangementsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_Changeinunitsduetoperformanceexpectations" abstract="false" name="Changeinunitsduetoperformanceexpectations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="icui_ModifiedPRSUIncrementalExpense" abstract="false" name="ModifiedPRSUIncrementalExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_StrategicTransactionandIntegration" abstract="false" name="StrategicTransactionandIntegration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Noncurrentdeferredtaxassetaccruedrestructuring" abstract="false" name="Noncurrentdeferredtaxassetaccruedrestructuring" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_SupplementalCashFlowInformationLeasesTableTextBlock" abstract="false" name="SupplementalCashFlowInformationLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_OtherLongtermLiabilitiesAbstract" abstract="true" name="OtherLongtermLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_SmithsMedicalMember" abstract="true" name="SmithsMedicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="icui_Sparepartsusage" abstract="false" name="Sparepartsusage" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_NetCashPaidReceivedforcurrentandprioracquisitions" abstract="false" name="NetCashPaidReceivedforcurrentandprioracquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" abstract="false" name="EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_SupplementalBalanceSheetInformationLeasesTableTextBlock" abstract="false" name="SupplementalBalanceSheetInformationLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_GILTItaxexpense" abstract="false" name="GILTItaxexpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_BusinessCombinationConsiderationCashHoldback" abstract="false" name="BusinessCombinationConsiderationCashHoldback" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ESPPOriginalIssuance" abstract="false" name="ESPPOriginalIssuance" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="icui_Cleanupcosts" abstract="false" name="Cleanupcosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_InternationalSalesDomain" abstract="true" name="InternationalSalesDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Deferredtaxcharge" abstract="false" name="Deferredtaxcharge" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_PursuitVascularInc.Member" abstract="true" name="PursuitVascularInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TermLoanBApplicableMarginAxis" abstract="true" name="TermLoanBApplicableMarginAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments" abstract="false" name="Paymenttoacquirebusinessnetofworkingcapitaladjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ProvisionForWarrantyAndReturns" abstract="false" name="ProvisionForWarrantyAndReturns" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_A2003PlanMember" abstract="true" name="A2003PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_NoncurrentDeferredTaxLiabilityForeign" abstract="false" name="NoncurrentDeferredTaxLiabilityForeign" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_IVSolutionsMember" abstract="true" name="IVSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_LIBORBasisSpreadonVariableRate" abstract="false" name="LIBORBasisSpreadonVariableRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="icui_OperatinglosscarryforwardsAbstract" abstract="true" name="OperatinglosscarryforwardsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_PricingLevelIIIMemberMember" abstract="true" name="PricingLevelIIIMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_LongTermContingentConsiderationGross" abstract="false" name="LongTermContingentConsiderationGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock" abstract="false" name="ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_MexicoPropertyAndEquipmentMember" abstract="true" name="MexicoPropertyAndEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ForeignMember" abstract="true" name="ForeignMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Deferredtaxliabilitychangeinaccountingmethod" abstract="false" name="Deferredtaxliabilitychangeinaccountingmethod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_PerformanceRestrictedStockUnitsPRSUsMember" abstract="true" name="PerformanceRestrictedStockUnitsPRSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Contractsettlements" abstract="false" name="Contractsettlements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Spread" abstract="false" name="Spread" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="icui_ShareawarddataAbstract" abstract="true" name="ShareawarddataAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_Accruedfreight" abstract="false" name="Accruedfreight" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ComputerEquipmentAndSoftwareMember" abstract="true" name="ComputerEquipmentAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Hedge4Member" abstract="true" name="Hedge4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_InformationbyGeographicAreaandCustomerConcentrationTextBlock" abstract="false" name="InformationbyGeographicAreaandCustomerConcentrationTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_EarnoutliabilityMember" abstract="true" name="EarnoutliabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TermLoanBEuroRateLoanSpread" abstract="false" name="TermLoanBEuroRateLoanSpread" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt" abstract="false" name="TermLoanAPaymentFirstYearsAsAOfOriginalDebt" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="icui_CommonStockSharesMember" abstract="true" name="CommonStockSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_WarrantyAndReturnReserveInventory" abstract="false" name="WarrantyAndReturnReserveInventory" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_RestructuringAdjustmentsSeveranceAndFacility" abstract="false" name="RestructuringAdjustmentsSeveranceAndFacility" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts" abstract="false" name="WarrantyAndReturnReserveInventoryChargedToOtherAccounts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_PricingLevelIIMemberMember" abstract="true" name="PricingLevelIIMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Accruedsalestaxes" abstract="false" name="Accruedsalestaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_A2011PlanMember" abstract="true" name="A2011PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_DeferredtaxassetsandliabilitiesTable" abstract="true" name="DeferredtaxassetsandliabilitiesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_StockIncentivePlansTable" abstract="true" name="StockIncentivePlansTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions" abstract="false" name="Noncurrentdeferredtaxassetacquiredfuturetaxdeductions" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain" abstract="true" name="TermLoanAAndCreditLineApplicableMarginSpreadDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Prepaidinsuranceandpropertytaxes" abstract="false" name="Prepaidinsuranceandpropertytaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_SharesAvailableInEmployeeStockPurchasePlan" abstract="false" name="SharesAvailableInEmployeeStockPurchasePlan" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="icui_Sharestransferredfromsupersededplan" abstract="false" name="Sharestransferredfromsupersededplan" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="icui_Accruedlegalfees" abstract="false" name="Accruedlegalfees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_CriticalCareMember" abstract="true" name="CriticalCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TermLoanBInitialSpread" abstract="false" name="TermLoanBInitialSpread" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="icui_TermLoanBBaseRateLoanSpread" abstract="false" name="TermLoanBBaseRateLoanSpread" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="icui_OtherforeigncountriesMember" abstract="true" name="OtherforeigncountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_UsGaap_InterestRateSwap2Member" abstract="true" name="UsGaap_InterestRateSwap2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TermLoanAPaymentYear5" abstract="false" name="TermLoanAPaymentYear5" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="icui_Operatingleaserightofuseassetamortization" abstract="false" name="Operatingleaserightofuseassetamortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TermLoanBApplicableMarginDomain" abstract="true" name="TermLoanBApplicableMarginDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Effectivetaxratereconciliationnondeductiblecomppercent" abstract="false" name="Effectivetaxratereconciliationnondeductiblecomppercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="icui_Grantdatefairvalueofrestrictedstockunitsgranted" abstract="false" name="Grantdatefairvalueofrestrictedstockunitsgranted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions" abstract="false" name="Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_DeferredtaxassetsandliabilitiesLineItems" abstract="true" name="DeferredtaxassetsandliabilitiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes" abstract="false" name="NoncurrentDeferredTaxLiabilityStateIncomeTaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_LongtermInvestmentsDomain" abstract="true" name="LongtermInvestmentsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_UnrecognizedTaxBenefitsRollForwardRollForward" abstract="true" name="UnrecognizedTaxBenefitsRollForwardRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_Hedge3MemberMember" abstract="true" name="Hedge3MemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ShortTermContingentConsiderationGross" abstract="false" name="ShortTermContingentConsiderationGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_PursuitVascularLLCMember" abstract="true" name="PursuitVascularLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_MoldsMember" abstract="true" name="MoldsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_SoftwarerevenueMember" abstract="true" name="SoftwarerevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TimebasedstockoptionMember" abstract="true" name="TimebasedstockoptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ESPPAnnualIssuanceIncreaseLimit" abstract="false" name="ESPPAnnualIssuanceIncreaseLimit" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="icui_DerivativeInterestRateFloor" abstract="false" name="DerivativeInterestRateFloor" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="icui_Optiontoextendinyears" abstract="false" name="Optiontoextendinyears" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="icui_Hedge1Member" abstract="true" name="Hedge1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_FurniturefixturesandmoldsMember" abstract="true" name="FurniturefixturesandmoldsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_WarrantyAndReturnReserveCosts" abstract="false" name="WarrantyAndReturnReserveCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_InfusionConsumablesMember" abstract="true" name="InfusionConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_WarrantyAndReturnReserveInventoryWriteOffs" abstract="false" name="WarrantyAndReturnReserveInventoryWriteOffs" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="icui_InternationalDistributorMember" abstract="true" name="InternationalDistributorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_InterestMarginandCommitmentFeeTableTextBlock" abstract="false" name="InterestMarginandCommitmentFeeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_PricingLevel5Member" abstract="true" name="PricingLevel5Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Restructuringandstrategictransactionexpense" abstract="false" name="Restructuringandstrategictransactionexpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_NoncurrentDeferredTaxAssetTaxCreditsState" abstract="false" name="NoncurrentDeferredTaxAssetTaxCreditsState" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_HospiraMember" abstract="true" name="HospiraMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Contingentconsiderationgross" abstract="false" name="Contingentconsiderationgross" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Accruedothertaxes" abstract="false" name="Accruedothertaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_UpFrontMaintenanceFee" abstract="false" name="UpFrontMaintenanceFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Grantdatefairvalueperformancerestrictedstockunits" abstract="false" name="Grantdatefairvalueperformancerestrictedstockunits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TermLoanBMember" abstract="true" name="TermLoanBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Percentoftotalrevenue" abstract="false" name="Percentoftotalrevenue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="icui_Outsidesalescommissions" abstract="false" name="Outsidesalescommissions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_EffectiveTaxRateReconciliationIPMigrationPercent" abstract="false" name="EffectiveTaxRateReconciliationIPMigrationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_TermLoansLineOfCreditMember" abstract="true" name="TermLoansLineOfCreditMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Prepaidothertaxes" abstract="false" name="Prepaidothertaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_NoncurrentDeferredTaxLiabilityMember" abstract="true" name="NoncurrentDeferredTaxLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Percentageofrevenue" abstract="false" name="Percentageofrevenue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="icui_Timebasedoptionsgrantdatefairvalue" abstract="false" name="Timebasedoptionsgrantdatefairvalue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ItalyPropertyAndEquipmentMember" abstract="true" name="ItalyPropertyAndEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_RestrictedStockAndPerformanceRestrictedStockUnitsMember" abstract="true" name="RestrictedStockAndPerformanceRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_LesseeOperatingAndFinanceLeaseTextBlock" abstract="false" name="LesseeOperatingAndFinanceLeaseTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_Liabilitiesforcontracts" abstract="false" name="Liabilitiesforcontracts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ForeignDistibutorMember" abstract="true" name="ForeignDistibutorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_AccruedSalariesAndBenefits" abstract="false" name="AccruedSalariesAndBenefits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_InstrumentsPlacedwithCustomersMember" abstract="true" name="InstrumentsPlacedwithCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ExercisedOptionsDataTableTextBlock" abstract="false" name="ExercisedOptionsDataTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_IncomeTaxDisclosuredeferredtaxesAbstract" abstract="true" name="IncomeTaxDisclosuredeferredtaxesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_PricingLevelIVMemberMember" abstract="true" name="PricingLevelIVMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_PricingLevelIMember" abstract="true" name="PricingLevelIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_PerformanceSharesEarned" abstract="false" name="PerformanceSharesEarned" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="icui_Noncurrentdeferredtaxasset" abstract="false" name="Noncurrentdeferredtaxasset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="icui_ContractassetandliabilitybalancesLineItems" abstract="true" name="ContractassetandliabilitybalancesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization" abstract="false" name="NoncurrentDeferredTaxLiabilityDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>icui-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:79121b2d-e854-41aa-aab3-7b5c5847e030,g:aa7e8fee-abd8-4fff-b3c4-f8ba25538e22-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.icumed.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="icui-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_4d643be1-6cd7-41c4-a5b3-0191ba6a027a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_5763de46-4a41-4c3f-9a47-4311c6ecb90c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_4d643be1-6cd7-41c4-a5b3-0191ba6a027a" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_5763de46-4a41-4c3f-9a47-4311c6ecb90c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d9dd55fe-8bd1-411d-966f-e20c79ba597d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_4d643be1-6cd7-41c4-a5b3-0191ba6a027a" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d9dd55fe-8bd1-411d-966f-e20c79ba597d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d0302506-f20f-4a9d-ae27-b2b8ee6fdc15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_4d643be1-6cd7-41c4-a5b3-0191ba6a027a" xlink:to="loc_us-gaap_InventoryNet_d0302506-f20f-4a9d-ae27-b2b8ee6fdc15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_ab583dea-0fbd-4a17-b93b-47c32f784b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_4d643be1-6cd7-41c4-a5b3-0191ba6a027a" xlink:to="loc_us-gaap_PrepaidTaxes_ab583dea-0fbd-4a17-b93b-47c32f784b7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0abb78fd-7efe-4bab-b7d3-45e976c1d1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_4d643be1-6cd7-41c4-a5b3-0191ba6a027a" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0abb78fd-7efe-4bab-b7d3-45e976c1d1fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_50a675aa-8bb8-4d68-beb1-42a029da4aba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_b2cbe507-dab1-4416-b93e-d6cdd82b0d15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_50a675aa-8bb8-4d68-beb1-42a029da4aba" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_b2cbe507-dab1-4416-b93e-d6cdd82b0d15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_92e48c0c-875e-4ea4-9fc6-adae7743fe72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_50a675aa-8bb8-4d68-beb1-42a029da4aba" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_92e48c0c-875e-4ea4-9fc6-adae7743fe72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7181e75b-dff9-4b8d-8797-894866922817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_50a675aa-8bb8-4d68-beb1-42a029da4aba" xlink:to="loc_us-gaap_Goodwill_7181e75b-dff9-4b8d-8797-894866922817" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4b1a0de0-5e4b-42ef-b0f4-e2355cf00b06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_50a675aa-8bb8-4d68-beb1-42a029da4aba" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4b1a0de0-5e4b-42ef-b0f4-e2355cf00b06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b287eb61-7f70-4dc4-8ba0-bfe13598975a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_50a675aa-8bb8-4d68-beb1-42a029da4aba" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b287eb61-7f70-4dc4-8ba0-bfe13598975a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b451cac4-a6d8-47fc-931c-11fc1c217641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_50a675aa-8bb8-4d68-beb1-42a029da4aba" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b451cac4-a6d8-47fc-931c-11fc1c217641" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_66b153bb-07d3-4b9b-81c6-2faf8f31074e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_50a675aa-8bb8-4d68-beb1-42a029da4aba" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_66b153bb-07d3-4b9b-81c6-2faf8f31074e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8551f152-4def-49c4-8ec7-904de84779bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_50a675aa-8bb8-4d68-beb1-42a029da4aba" xlink:to="loc_us-gaap_AssetsCurrent_8551f152-4def-49c4-8ec7-904de84779bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_3bc304c8-9458-47bb-b53a-3f2077246919" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2dc67980-4bce-4ee8-90bd-dd010ffba925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3bc304c8-9458-47bb-b53a-3f2077246919" xlink:to="loc_us-gaap_LiabilitiesCurrent_2dc67980-4bce-4ee8-90bd-dd010ffba925" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_d7569577-2989-48e3-8292-7f729185646c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3bc304c8-9458-47bb-b53a-3f2077246919" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_d7569577-2989-48e3-8292-7f729185646c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_fb0178fd-9478-4f8b-ba7b-4b3b2e1e6421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3bc304c8-9458-47bb-b53a-3f2077246919" xlink:to="loc_us-gaap_OtherLiabilities_fb0178fd-9478-4f8b-ba7b-4b3b2e1e6421" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_697d1883-9bfb-4cb4-baf9-ab6c3faa9b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3bc304c8-9458-47bb-b53a-3f2077246919" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_697d1883-9bfb-4cb4-baf9-ab6c3faa9b6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_fafe1dad-ecb6-4fde-92a1-3e71558df784" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3bc304c8-9458-47bb-b53a-3f2077246919" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_fafe1dad-ecb6-4fde-92a1-3e71558df784" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_16e6321e-e1c8-46b7-8013-3008265c2f41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3bc304c8-9458-47bb-b53a-3f2077246919" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_16e6321e-e1c8-46b7-8013-3008265c2f41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d862eac2-0ec1-4281-b5cf-59970fdbd9ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_01a3df7f-7f72-4b02-8b18-b7513f47b806" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d862eac2-0ec1-4281-b5cf-59970fdbd9ff" xlink:to="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_01a3df7f-7f72-4b02-8b18-b7513f47b806" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_aa04eec1-67fc-49d7-96d8-41b991fea282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d862eac2-0ec1-4281-b5cf-59970fdbd9ff" xlink:to="loc_us-gaap_CommonStockValue_aa04eec1-67fc-49d7-96d8-41b991fea282" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_2aab0cf2-56cd-425e-a93c-05a100e212c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d862eac2-0ec1-4281-b5cf-59970fdbd9ff" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_2aab0cf2-56cd-425e-a93c-05a100e212c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_f2ce45ac-4bf5-484e-9760-940bed68e6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d862eac2-0ec1-4281-b5cf-59970fdbd9ff" xlink:to="loc_us-gaap_TreasuryStockValue_f2ce45ac-4bf5-484e-9760-940bed68e6dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9c0e7a0c-59b2-44a3-acaf-5c1fce5d8118" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d862eac2-0ec1-4281-b5cf-59970fdbd9ff" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9c0e7a0c-59b2-44a3-acaf-5c1fce5d8118" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5e2575c9-97a5-424c-8499-fd10fb202fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d862eac2-0ec1-4281-b5cf-59970fdbd9ff" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5e2575c9-97a5-424c-8499-fd10fb202fc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_39e9252d-421c-4462-b70d-fe9e5ec50dae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_064089a1-9dd7-42c1-9443-91f5a81a5449" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_39e9252d-421c-4462-b70d-fe9e5ec50dae" xlink:to="loc_us-gaap_AccountsPayableCurrent_064089a1-9dd7-42c1-9443-91f5a81a5449" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_5755d03f-46ae-4a9f-b7cf-b47dba7bc8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_39e9252d-421c-4462-b70d-fe9e5ec50dae" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_5755d03f-46ae-4a9f-b7cf-b47dba7bc8d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_ea730434-a3c3-479d-a297-ff70e871fb08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_39e9252d-421c-4462-b70d-fe9e5ec50dae" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_ea730434-a3c3-479d-a297-ff70e871fb08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_b50cc0e5-fcec-4ba7-ac49-87f3a2a167f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_39e9252d-421c-4462-b70d-fe9e5ec50dae" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_b50cc0e5-fcec-4ba7-ac49-87f3a2a167f7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="icui-20211231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_810e0db9-b795-43da-adb7-1a8aa902b988" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_833891bf-fa62-46a5-b1d0-a087b573e1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_810e0db9-b795-43da-adb7-1a8aa902b988" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_833891bf-fa62-46a5-b1d0-a087b573e1b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3b64e757-fc81-47f5-b1bf-b5a25e6510ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_810e0db9-b795-43da-adb7-1a8aa902b988" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3b64e757-fc81-47f5-b1bf-b5a25e6510ef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="icui-20211231.xsd#ConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_732cb29d-c86b-49bd-91bb-149e9bbaa0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3f715f79-d627-4b0d-9a07-80c32bb40427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_732cb29d-c86b-49bd-91bb-149e9bbaa0c5" xlink:to="loc_us-gaap_InterestExpense_3f715f79-d627-4b0d-9a07-80c32bb40427" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_f35e75a5-6d7d-43da-a923-7c58f9594144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_732cb29d-c86b-49bd-91bb-149e9bbaa0c5" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_f35e75a5-6d7d-43da-a923-7c58f9594144" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a7a83506-9d92-4fb9-b493-a609c9d0acb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_732cb29d-c86b-49bd-91bb-149e9bbaa0c5" xlink:to="loc_us-gaap_OperatingIncomeLoss_a7a83506-9d92-4fb9-b493-a609c9d0acb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a036aa61-cd34-4609-bfd7-56328b2615ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7a1b6c1d-fc66-40b1-bf1d-3852bc207d70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a036aa61-cd34-4609-bfd7-56328b2615ea" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7a1b6c1d-fc66-40b1-bf1d-3852bc207d70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_180efd26-9c97-4598-abfe-7a0abb48a5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a036aa61-cd34-4609-bfd7-56328b2615ea" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_180efd26-9c97-4598-abfe-7a0abb48a5c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e7d19d80-9fab-4498-91bd-d4d84f28e468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cd9c2e83-3ec1-4501-b620-01ccb11f592c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_e7d19d80-9fab-4498-91bd-d4d84f28e468" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cd9c2e83-3ec1-4501-b620-01ccb11f592c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ad21c4e9-9b6b-4ad8-8531-9670353b74d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_e7d19d80-9fab-4498-91bd-d4d84f28e468" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ad21c4e9-9b6b-4ad8-8531-9670353b74d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringandstrategictransactionexpense_ccd09d2b-1f5c-4760-ab71-b126e0d7da59" xlink:href="icui-20211231.xsd#icui_Restructuringandstrategictransactionexpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_e7d19d80-9fab-4498-91bd-d4d84f28e468" xlink:to="loc_icui_Restructuringandstrategictransactionexpense_ccd09d2b-1f5c-4760-ab71-b126e0d7da59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_929fcc95-d00d-4e97-9ac9-3daede4e0576" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_e7d19d80-9fab-4498-91bd-d4d84f28e468" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_929fcc95-d00d-4e97-9ac9-3daede4e0576" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contractsettlements_266225fb-c612-4599-a231-bd69c7b729e6" xlink:href="icui-20211231.xsd#icui_Contractsettlements"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_e7d19d80-9fab-4498-91bd-d4d84f28e468" xlink:to="loc_icui_Contractsettlements_266225fb-c612-4599-a231-bd69c7b729e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_46840989-63e4-48d5-9d6a-9b13a7095a11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ee5db2f3-7e48-4e56-9aa9-998838141b40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_46840989-63e4-48d5-9d6a-9b13a7095a11" xlink:to="loc_us-gaap_Revenues_ee5db2f3-7e48-4e56-9aa9-998838141b40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_114cc677-6994-4dcb-859e-4594097d3f73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_46840989-63e4-48d5-9d6a-9b13a7095a11" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_114cc677-6994-4dcb-859e-4594097d3f73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_57513e2b-221a-4b2a-b088-f33a2c6cdd2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_90ed0471-a51b-4dec-829a-fd878a2b94b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_57513e2b-221a-4b2a-b088-f33a2c6cdd2e" xlink:to="loc_us-gaap_GrossProfit_90ed0471-a51b-4dec-829a-fd878a2b94b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_62c5491c-27d0-4e41-b5fd-f031ce4b0247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_57513e2b-221a-4b2a-b088-f33a2c6cdd2e" xlink:to="loc_us-gaap_OperatingExpenses_62c5491c-27d0-4e41-b5fd-f031ce4b0247" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/StatementofComprehensiveIncome" xlink:type="simple" xlink:href="icui-20211231.xsd#StatementofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/StatementofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e8bfb0cb-0334-46e1-add1-25269158cb67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_f97d7c2b-38c3-41be-aab5-dc2a6ff976aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e8bfb0cb-0334-46e1-add1-25269158cb67" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_f97d7c2b-38c3-41be-aab5-dc2a6ff976aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_6b4497c8-0407-45a0-8561-88c6028a4f19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e8bfb0cb-0334-46e1-add1-25269158cb67" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_6b4497c8-0407-45a0-8561-88c6028a4f19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_194c4e69-c1f7-41cd-818b-2b41d5e55823" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e8bfb0cb-0334-46e1-add1-25269158cb67" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_194c4e69-c1f7-41cd-818b-2b41d5e55823" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/StatementofComprehensiveIncomeParenthetical" xlink:type="simple" xlink:href="icui-20211231.xsd#StatementofComprehensiveIncomeParenthetical"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/StatementofComprehensiveIncomeParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_8636049c-14b9-49ec-8d4b-2b9c88fb25f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_109e0c68-566d-463d-ab15-cc34c0beabe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8636049c-14b9-49ec-8d4b-2b9c88fb25f4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_109e0c68-566d-463d-ab15-cc34c0beabe7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2d2970ac-5743-44e0-88f5-0df5ba2d3837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8636049c-14b9-49ec-8d4b-2b9c88fb25f4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2d2970ac-5743-44e0-88f5-0df5ba2d3837" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c86c1b2c-0032-4611-9b8e-6cb17d8678e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8636049c-14b9-49ec-8d4b-2b9c88fb25f4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c86c1b2c-0032-4611-9b8e-6cb17d8678e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2c6b095c-28f1-473a-bf90-87c97c8cd2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8636049c-14b9-49ec-8d4b-2b9c88fb25f4" xlink:to="loc_us-gaap_NetIncomeLoss_2c6b095c-28f1-473a-bf90-87c97c8cd2ac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="icui-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6ac0a8a5-9877-47b4-857b-49d2b80bbf85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5092f50f-b49b-47e4-b250-168a4199e137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6ac0a8a5-9877-47b4-857b-49d2b80bbf85" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5092f50f-b49b-47e4-b250-168a4199e137" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment_d0d3a5f1-0bbb-4dea-8f09-c71e9f39c64e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6ac0a8a5-9877-47b4-857b-49d2b80bbf85" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment_d0d3a5f1-0bbb-4dea-8f09-c71e9f39c64e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_f19c829d-47c2-4db5-916f-7668f8f4bb48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6ac0a8a5-9877-47b4-857b-49d2b80bbf85" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_f19c829d-47c2-4db5-916f-7668f8f4bb48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d8233feb-fde9-4c14-bf83-2a21862db283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6ac0a8a5-9877-47b4-857b-49d2b80bbf85" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d8233feb-fde9-4c14-bf83-2a21862db283" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_ff3599e0-03e7-48cc-84f8-f2128e371446" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6ac0a8a5-9877-47b4-857b-49d2b80bbf85" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_ff3599e0-03e7-48cc-84f8-f2128e371446" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_c258c2c9-b993-421d-9670-e065ee550679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6ac0a8a5-9877-47b4-857b-49d2b80bbf85" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_c258c2c9-b993-421d-9670-e065ee550679" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_e4a44cd1-a497-40ee-87e1-50c0cd340183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6ac0a8a5-9877-47b4-857b-49d2b80bbf85" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_e4a44cd1-a497-40ee-87e1-50c0cd340183" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ea0ad97a-5dc8-4436-a917-ed07eef68bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ea0ad97a-5dc8-4436-a917-ed07eef68bb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8f89668e-57a4-4f34-9ff0-ef093201aa6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:to="loc_us-gaap_ShareBasedCompensation_8f89668e-57a4-4f34-9ff0-ef093201aa6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_67c0fadb-9ba8-455b-83a2-025d152ed823" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_67c0fadb-9ba8-455b-83a2-025d152ed823" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_edd4b4e0-34d0-4ba6-87f4-1766a8806edc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_edd4b4e0-34d0-4ba6-87f4-1766a8806edc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_690825e1-17da-4f70-b831-ce78d2b08e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_690825e1-17da-4f70-b831-ce78d2b08e80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProvisionForWarrantyAndReturns_5e026b72-9c94-4834-b74d-5ffead113952" xlink:href="icui-20211231.xsd#icui_ProvisionForWarrantyAndReturns"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:to="loc_icui_ProvisionForWarrantyAndReturns_5e026b72-9c94-4834-b74d-5ffead113952" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_be5d2b2a-1fea-470d-b190-011da81bb41f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:to="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_be5d2b2a-1fea-470d-b190-011da81bb41f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8a913d4d-5347-4975-8e55-51701151db5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:to="loc_us-gaap_NetIncomeLoss_8a913d4d-5347-4975-8e55-51701151db5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Operatingleaserightofuseassetamortization_6cd92d5a-3613-45ea-94a3-018ebb1189ab" xlink:href="icui-20211231.xsd#icui_Operatingleaserightofuseassetamortization"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:to="loc_icui_Operatingleaserightofuseassetamortization_6cd92d5a-3613-45ea-94a3-018ebb1189ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionRelatedImpairmentsOrCharges_d5134828-8336-49f9-94ff-28140eb19c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:to="loc_us-gaap_ProductionRelatedImpairmentsOrCharges_d5134828-8336-49f9-94ff-28140eb19c7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Sparepartsusage_fb2b1d10-3b28-4c91-94e6-fa734e362ba0" xlink:href="icui-20211231.xsd#icui_Sparepartsusage"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:to="loc_icui_Sparepartsusage_fb2b1d10-3b28-4c91-94e6-fa734e362ba0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1595fcf1-4527-4c43-b305-410cad638c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1595fcf1-4527-4c43-b305-410cad638c3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_53841e51-5ac3-403a-9ccc-ba669b2a2c75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_53841e51-5ac3-403a-9ccc-ba669b2a2c75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_38ffab5d-b802-4181-a773-1eada83c255c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_38ffab5d-b802-4181-a773-1eada83c255c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_9546409f-7fdb-40c5-814f-5bac566e99ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_9546409f-7fdb-40c5-814f-5bac566e99ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_b5a0eeb7-a821-4ad0-8acb-fef607c0686b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_b5a0eeb7-a821-4ad0-8acb-fef607c0686b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_4911a7ca-e39a-4e82-8951-39fbe5c4a3d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_4911a7ca-e39a-4e82-8951-39fbe5c4a3d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_0b7f0b06-b62a-49d3-b949-c0ba45968808" xlink:href="icui-20211231.xsd#icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:to="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_0b7f0b06-b62a-49d3-b949-c0ba45968808" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_dbb13966-deca-44f5-ba89-a2b21462cb13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_dbb13966-deca-44f5-ba89-a2b21462cb13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_f15ef710-7c86-4b08-8571-fd5eee18b0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d22d8b22-42f2-4599-857e-a27c4f87cb9f" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_f15ef710-7c86-4b08-8571-fd5eee18b0a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_067a03c2-ba65-47e0-9fdc-2523d78929cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_d513f696-0576-4a69-a305-bba96cea8eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_067a03c2-ba65-47e0-9fdc-2523d78929cb" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_d513f696-0576-4a69-a305-bba96cea8eb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_f34f7db6-9dcf-49c8-942b-c9a30e89c1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_067a03c2-ba65-47e0-9fdc-2523d78929cb" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_f34f7db6-9dcf-49c8-942b-c9a30e89c1b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_ef9dcf79-b838-4543-8a05-cd245fb5b822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_067a03c2-ba65-47e0-9fdc-2523d78929cb" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_ef9dcf79-b838-4543-8a05-cd245fb5b822" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_9182b540-b4fa-4f8a-a2b7-8553506a5746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_067a03c2-ba65-47e0-9fdc-2523d78929cb" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_9182b540-b4fa-4f8a-a2b7-8553506a5746" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_f3e5e4c2-9a79-426e-9fe8-363cfb857c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_067a03c2-ba65-47e0-9fdc-2523d78929cb" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_f3e5e4c2-9a79-426e-9fe8-363cfb857c24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_a81ab1c1-6dd3-4de1-94da-dd0a982ba253" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_067a03c2-ba65-47e0-9fdc-2523d78929cb" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_a81ab1c1-6dd3-4de1-94da-dd0a982ba253" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d29436bf-b289-4393-8446-cd291e20398c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_91a69236-87ee-452f-81f8-59853a53f366" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d29436bf-b289-4393-8446-cd291e20398c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_91a69236-87ee-452f-81f8-59853a53f366" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b4d7fa18-3901-4838-b635-967bf46a9766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d29436bf-b289-4393-8446-cd291e20398c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b4d7fa18-3901-4838-b635-967bf46a9766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5e384f5c-f1d7-4892-afa6-b2eae0c30395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d29436bf-b289-4393-8446-cd291e20398c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5e384f5c-f1d7-4892-afa6-b2eae0c30395" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_e267b0ff-a9c0-4c01-a215-cec774237515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d29436bf-b289-4393-8446-cd291e20398c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_e267b0ff-a9c0-4c01-a215-cec774237515" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInventoryDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_7bc1dda2-ecc8-4d5f-9669-5aa8abac1d99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_705fa5dc-a9bb-4ca7-94cf-b753531152e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_7bc1dda2-ecc8-4d5f-9669-5aa8abac1d99" xlink:to="loc_us-gaap_InventoryRawMaterials_705fa5dc-a9bb-4ca7-94cf-b753531152e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_53e8e8ff-af68-4903-9a1e-593d62ad691e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_7bc1dda2-ecc8-4d5f-9669-5aa8abac1d99" xlink:to="loc_us-gaap_InventoryWorkInProcess_53e8e8ff-af68-4903-9a1e-593d62ad691e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_17ecfdb7-03e2-4c4b-b190-ef3c909598eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_7bc1dda2-ecc8-4d5f-9669-5aa8abac1d99" xlink:to="loc_us-gaap_InventoryFinishedGoods_17ecfdb7-03e2-4c4b-b190-ef3c909598eb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6a3e36cd-0c09-49c1-b36d-16552c891c16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_2c2ed2a8-bf36-487a-a335-ca506e159825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_6a3e36cd-0c09-49c1-b36d-16552c891c16" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_2c2ed2a8-bf36-487a-a335-ca506e159825" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_87e35af8-9d26-4cd1-9a60-cee6c71e4104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_6a3e36cd-0c09-49c1-b36d-16552c891c16" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_87e35af8-9d26-4cd1-9a60-cee6c71e4104" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e13a9f77-8efc-40ec-9f57-eab19eaea30d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_474502cb-461a-4b18-8ced-0958479a4755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e13a9f77-8efc-40ec-9f57-eab19eaea30d" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_474502cb-461a-4b18-8ced-0958479a4755" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsAndOtherAssets_aab9018b-75f5-4829-a944-af09a8c7bc48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsAndOtherAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e13a9f77-8efc-40ec-9f57-eab19eaea30d" xlink:to="loc_us-gaap_DeferredCostsAndOtherAssets_aab9018b-75f5-4829-a944-af09a8c7bc48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Prepaidinsuranceandpropertytaxes_36f2dffc-191d-4368-9335-590956ec366f" xlink:href="icui-20211231.xsd#icui_Prepaidinsuranceandpropertytaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e13a9f77-8efc-40ec-9f57-eab19eaea30d" xlink:to="loc_icui_Prepaidinsuranceandpropertytaxes_36f2dffc-191d-4368-9335-590956ec366f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Prepaidothertaxes_6430d0bd-7d5f-4a53-885d-c6fd79131f22" xlink:href="icui-20211231.xsd#icui_Prepaidothertaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e13a9f77-8efc-40ec-9f57-eab19eaea30d" xlink:to="loc_icui_Prepaidothertaxes_6430d0bd-7d5f-4a53-885d-c6fd79131f22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Deferredtaxcharge_8d4b740b-5299-433f-a7ec-4941626076d7" xlink:href="icui-20211231.xsd#icui_Deferredtaxcharge"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e13a9f77-8efc-40ec-9f57-eab19eaea30d" xlink:to="loc_icui_Deferredtaxcharge_8d4b740b-5299-433f-a7ec-4941626076d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_e141f873-5dab-4f35-908e-45c6f5ca291f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e13a9f77-8efc-40ec-9f57-eab19eaea30d" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_e141f873-5dab-4f35-908e-45c6f5ca291f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositAssets_a0648542-2d9b-4d3f-b72d-f4497357b552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e13a9f77-8efc-40ec-9f57-eab19eaea30d" xlink:to="loc_us-gaap_DepositAssets_a0648542-2d9b-4d3f-b72d-f4497357b552" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_4845b2ac-a038-4976-8680-7f2590e8267a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e13a9f77-8efc-40ec-9f57-eab19eaea30d" xlink:to="loc_us-gaap_OtherAssetsCurrent_4845b2ac-a038-4976-8680-7f2590e8267a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#IncomeTaxesEffectivetaxrateDetails"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_70c88b4c-78f4-491f-b56c-38ac8c36b660" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_6fafb6ec-4342-4b0b-a3ff-8c18612898ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_70c88b4c-78f4-491f-b56c-38ac8c36b660" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_6fafb6ec-4342-4b0b-a3ff-8c18612898ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Effectiveincometaxreconciliationnondeductiblecompensation_77d03d95-b21b-4447-a3f0-f8592f411c87" xlink:href="icui-20211231.xsd#icui_Effectiveincometaxreconciliationnondeductiblecompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_70c88b4c-78f4-491f-b56c-38ac8c36b660" xlink:to="loc_icui_Effectiveincometaxreconciliationnondeductiblecompensation_77d03d95-b21b-4447-a3f0-f8592f411c87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_e3d62fa4-ea7a-453d-8057-169596729cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_70c88b4c-78f4-491f-b56c-38ac8c36b660" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_e3d62fa4-ea7a-453d-8057-169596729cbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GILTItaxexpense_7e87f745-4aef-44ee-888d-063e78726373" xlink:href="icui-20211231.xsd#icui_GILTItaxexpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_70c88b4c-78f4-491f-b56c-38ac8c36b660" xlink:to="loc_icui_GILTItaxexpense_7e87f745-4aef-44ee-888d-063e78726373" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_f74bcc63-b0f2-489e-a107-3b9f0bf08f52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_70c88b4c-78f4-491f-b56c-38ac8c36b660" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_f74bcc63-b0f2-489e-a107-3b9f0bf08f52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_a488950c-4f11-4eea-b717-32ba3035e385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_70c88b4c-78f4-491f-b56c-38ac8c36b660" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_a488950c-4f11-4eea-b717-32ba3035e385" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EffectiveIncomeTaxRateReconciliationIPMigration_00e72a15-1c39-4cba-a7c0-e853536466d5" xlink:href="icui-20211231.xsd#icui_EffectiveIncomeTaxRateReconciliationIPMigration"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_70c88b4c-78f4-491f-b56c-38ac8c36b660" xlink:to="loc_icui_EffectiveIncomeTaxRateReconciliationIPMigration_00e72a15-1c39-4cba-a7c0-e853536466d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EffectiveIncomeTaxRateReconciliationContingentConsideration_429e3cc5-75b7-419c-b0e0-d56279739eed" xlink:href="icui-20211231.xsd#icui_EffectiveIncomeTaxRateReconciliationContingentConsideration"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_70c88b4c-78f4-491f-b56c-38ac8c36b660" xlink:to="loc_icui_EffectiveIncomeTaxRateReconciliationContingentConsideration_429e3cc5-75b7-419c-b0e0-d56279739eed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome_e9ab7e37-9276-4524-834e-599b7aff90a2" xlink:href="icui-20211231.xsd#icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_70c88b4c-78f4-491f-b56c-38ac8c36b660" xlink:to="loc_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome_e9ab7e37-9276-4524-834e-599b7aff90a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_a3bda198-e321-4f2c-98df-f4d2a0b00614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_70c88b4c-78f4-491f-b56c-38ac8c36b660" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_a3bda198-e321-4f2c-98df-f4d2a0b00614" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCredits_651bc821-9963-48c4-8ef5-85d1c7c1b1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCredits"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_70c88b4c-78f4-491f-b56c-38ac8c36b660" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCredits_651bc821-9963-48c4-8ef5-85d1c7c1b1cc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#IncomeTaxesDeferredincometaxassetsliabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_bc43b32d-fe50-416f-ad4c-acbd1a51969c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_8875d988-79c3-445f-8916-074173304218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_bc43b32d-fe50-416f-ad4c-acbd1a51969c" xlink:to="loc_us-gaap_DeferredTaxLiabilities_8875d988-79c3-445f-8916-074173304218" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>icui-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:79121b2d-e854-41aa-aab3-7b5c5847e030,g:aa7e8fee-abd8-4fff-b3c4-f8ba25538e22-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.icumed.com/role/AuditInformation" xlink:type="simple" xlink:href="icui-20211231.xsd#AuditInformation"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/AuditInformation" xlink:type="extended" id="i632e5b2db4164418a413a10710d0ece9_AuditInformation">
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLineItems_81a8c8fa-3747-4e21-bd78-7bea4c442447" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_4b0fdbe3-360e-4d75-b76d-a89bf6b7613e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AuditorLineItems_81a8c8fa-3747-4e21-bd78-7bea4c442447" xlink:to="loc_dei_AuditorName_4b0fdbe3-360e-4d75-b76d-a89bf6b7613e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_510f5205-b47c-4c99-9b81-135cac9dd792" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AuditorLineItems_81a8c8fa-3747-4e21-bd78-7bea4c442447" xlink:to="loc_dei_AuditorLocation_510f5205-b47c-4c99-9b81-135cac9dd792" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_56ade0b7-f3f9-4ad3-9aa8-1d12df4ff6f3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AuditorLineItems_81a8c8fa-3747-4e21-bd78-7bea4c442447" xlink:to="loc_dei_AuditorFirmId_56ade0b7-f3f9-4ad3-9aa8-1d12df4ff6f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorTable_470b6a4c-0e56-497d-944d-85f18d275025" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_AuditorLineItems_81a8c8fa-3747-4e21-bd78-7bea4c442447" xlink:to="loc_dei_AuditorTable_470b6a4c-0e56-497d-944d-85f18d275025" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_7dee6a5c-fe5a-449c-aa27-a4c7e108d3a6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_AuditorTable_470b6a4c-0e56-497d-944d-85f18d275025" xlink:to="loc_dei_LegalEntityAxis_7dee6a5c-fe5a-449c-aa27-a4c7e108d3a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7dee6a5c-fe5a-449c-aa27-a4c7e108d3a6_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_7dee6a5c-fe5a-449c-aa27-a4c7e108d3a6" xlink:to="loc_dei_EntityDomain_7dee6a5c-fe5a-449c-aa27-a4c7e108d3a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f0afa126-6f6b-4ca9-a9cf-020711f649e7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_7dee6a5c-fe5a-449c-aa27-a4c7e108d3a6" xlink:to="loc_dei_EntityDomain_f0afa126-6f6b-4ca9-a9cf-020711f649e7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="icui-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/ConsolidatedBalanceSheets" xlink:type="extended" id="i782d876fd4e84d458c765acebd0d9073_ConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_15267072-2051-4318-8eab-eaaa4b65ddd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15267072-2051-4318-8eab-eaaa4b65ddd2" xlink:to="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_dfdce09e-b84a-45cb-94e8-a10f913ad8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:to="loc_us-gaap_AssetsCurrentAbstract_dfdce09e-b84a-45cb-94e8-a10f913ad8b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e84c95fc-7ad0-4c29-a1f8-4965b697e73b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dfdce09e-b84a-45cb-94e8-a10f913ad8b4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e84c95fc-7ad0-4c29-a1f8-4965b697e73b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_1108b5c2-257e-4ad7-898f-03d8c2af5887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dfdce09e-b84a-45cb-94e8-a10f913ad8b4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_1108b5c2-257e-4ad7-898f-03d8c2af5887" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_0ffd47d9-a084-493b-89c2-9a418d7c5ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dfdce09e-b84a-45cb-94e8-a10f913ad8b4" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_0ffd47d9-a084-493b-89c2-9a418d7c5ae3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f56c79c3-c9ab-461a-af6e-3f2a56cc44b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dfdce09e-b84a-45cb-94e8-a10f913ad8b4" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f56c79c3-c9ab-461a-af6e-3f2a56cc44b4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_67201777-b74f-4e52-b056-f86f669f6c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dfdce09e-b84a-45cb-94e8-a10f913ad8b4" xlink:to="loc_us-gaap_InventoryNet_67201777-b74f-4e52-b056-f86f669f6c90" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_77df12b3-ecd6-43ee-84c6-84512cab146a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dfdce09e-b84a-45cb-94e8-a10f913ad8b4" xlink:to="loc_us-gaap_PrepaidTaxes_77df12b3-ecd6-43ee-84c6-84512cab146a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_889a4ae1-b6b5-4ba9-9ef2-8164ad76a0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dfdce09e-b84a-45cb-94e8-a10f913ad8b4" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_889a4ae1-b6b5-4ba9-9ef2-8164ad76a0c6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9636c861-29d7-4d00-ba07-5f70f3dd40dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dfdce09e-b84a-45cb-94e8-a10f913ad8b4" xlink:to="loc_us-gaap_AssetsCurrent_9636c861-29d7-4d00-ba07-5f70f3dd40dd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a8733971-c243-486f-9d50-f1cdc11f144f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a8733971-c243-486f-9d50-f1cdc11f144f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_eaff121e-1d78-49af-9ac2-b0ba58d5eab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_eaff121e-1d78-49af-9ac2-b0ba58d5eab0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_f9970f7d-7842-4af3-8bd3-2bddceba6d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_f9970f7d-7842-4af3-8bd3-2bddceba6d14" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b03445a5-365b-4d21-83f5-894557e871b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:to="loc_us-gaap_Goodwill_b03445a5-365b-4d21-83f5-894557e871b1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_29701989-1728-4bbe-aedc-0856a4607bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_29701989-1728-4bbe-aedc-0856a4607bd0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_510d6626-30b3-4ce9-af52-5fe43b8cb414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_510d6626-30b3-4ce9-af52-5fe43b8cb414" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b86ce56a-a2cd-4586-bb19-53faf2b15cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b86ce56a-a2cd-4586-bb19-53faf2b15cb7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_bf9f80e3-7fa5-41a2-9b7a-cc1457c1def3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:to="loc_us-gaap_Assets_bf9f80e3-7fa5-41a2-9b7a-cc1457c1def3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a597816f-4a22-41ea-a7ba-45a2b8286807" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15267072-2051-4318-8eab-eaaa4b65ddd2" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a597816f-4a22-41ea-a7ba-45a2b8286807" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_2702a891-0e11-4370-9b5e-24cee3edb01e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a597816f-4a22-41ea-a7ba-45a2b8286807" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_2702a891-0e11-4370-9b5e-24cee3edb01e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a4a5e46f-ea2a-4493-8db3-4ec6f2fde6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2702a891-0e11-4370-9b5e-24cee3edb01e" xlink:to="loc_us-gaap_AccountsPayableCurrent_a4a5e46f-ea2a-4493-8db3-4ec6f2fde6e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_de33b207-53b2-4a23-bf6e-83e4f060c7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2702a891-0e11-4370-9b5e-24cee3edb01e" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_de33b207-53b2-4a23-bf6e-83e4f060c7e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_3b5452f2-448a-4d1b-b9bd-f202ee09fd49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2702a891-0e11-4370-9b5e-24cee3edb01e" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_3b5452f2-448a-4d1b-b9bd-f202ee09fd49" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_366f0699-6e3c-42e2-a742-f36422a27d72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2702a891-0e11-4370-9b5e-24cee3edb01e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_366f0699-6e3c-42e2-a742-f36422a27d72" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_37b8f6b0-6c04-4e6a-aae8-8a6118e5e02e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2702a891-0e11-4370-9b5e-24cee3edb01e" xlink:to="loc_us-gaap_LiabilitiesCurrent_37b8f6b0-6c04-4e6a-aae8-8a6118e5e02e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_ed369667-9db0-4b58-b35d-1379a0201ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a597816f-4a22-41ea-a7ba-45a2b8286807" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_ed369667-9db0-4b58-b35d-1379a0201ba4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_ac3e98a8-a51a-46a2-b8e0-56bea59f5f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a597816f-4a22-41ea-a7ba-45a2b8286807" xlink:to="loc_us-gaap_OtherLiabilities_ac3e98a8-a51a-46a2-b8e0-56bea59f5f4e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e47d39a4-789e-4389-bc2c-e51d6d3b56f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a597816f-4a22-41ea-a7ba-45a2b8286807" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e47d39a4-789e-4389-bc2c-e51d6d3b56f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_5b1ad894-0242-410a-9038-82c6d8bdf690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a597816f-4a22-41ea-a7ba-45a2b8286807" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_5b1ad894-0242-410a-9038-82c6d8bdf690" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_92eaba50-a570-4c5d-a236-645ed88a7e70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a597816f-4a22-41ea-a7ba-45a2b8286807" xlink:to="loc_us-gaap_CommitmentsAndContingencies_92eaba50-a570-4c5d-a236-645ed88a7e70" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_aa019921-0952-4c17-bfe7-85dba7ea4b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a597816f-4a22-41ea-a7ba-45a2b8286807" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_aa019921-0952-4c17-bfe7-85dba7ea4b3b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_a2ecd64a-7451-416d-ad0c-a0745e458e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_aa019921-0952-4c17-bfe7-85dba7ea4b3b" xlink:to="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_a2ecd64a-7451-416d-ad0c-a0745e458e80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3c90e86a-d931-4c79-967c-794243445186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_aa019921-0952-4c17-bfe7-85dba7ea4b3b" xlink:to="loc_us-gaap_CommonStockValue_3c90e86a-d931-4c79-967c-794243445186" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1966b99a-c569-42b1-89f8-fd5f015089c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_aa019921-0952-4c17-bfe7-85dba7ea4b3b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1966b99a-c569-42b1-89f8-fd5f015089c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_79ea34e6-ed9f-4fac-afea-2d93f4765e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_aa019921-0952-4c17-bfe7-85dba7ea4b3b" xlink:to="loc_us-gaap_TreasuryStockValue_79ea34e6-ed9f-4fac-afea-2d93f4765e5e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3d0c3a30-fa3e-4007-b3ec-e802f7aa5a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_aa019921-0952-4c17-bfe7-85dba7ea4b3b" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3d0c3a30-fa3e-4007-b3ec-e802f7aa5a3d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3db2ae83-3655-4ac4-925e-55153fdd3182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_aa019921-0952-4c17-bfe7-85dba7ea4b3b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3db2ae83-3655-4ac4-925e-55153fdd3182" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4f8f4883-308c-414d-b95d-8ac92fc1c786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_aa019921-0952-4c17-bfe7-85dba7ea4b3b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4f8f4883-308c-414d-b95d-8ac92fc1c786" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_063264ba-8a9e-4098-bd3c-ae018987c338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a597816f-4a22-41ea-a7ba-45a2b8286807" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_063264ba-8a9e-4098-bd3c-ae018987c338" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_815ba3f3-a9f2-4dc9-a758-c534636204a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_15267072-2051-4318-8eab-eaaa4b65ddd2" xlink:to="loc_us-gaap_StatementTable_815ba3f3-a9f2-4dc9-a758-c534636204a0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_481d5305-d5f7-477d-bb68-baba7be3f41c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_815ba3f3-a9f2-4dc9-a758-c534636204a0" xlink:to="loc_srt_StatementScenarioAxis_481d5305-d5f7-477d-bb68-baba7be3f41c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_481d5305-d5f7-477d-bb68-baba7be3f41c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_481d5305-d5f7-477d-bb68-baba7be3f41c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_481d5305-d5f7-477d-bb68-baba7be3f41c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_52c6160d-f1a3-4a77-821c-a9fde3482144" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_481d5305-d5f7-477d-bb68-baba7be3f41c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_52c6160d-f1a3-4a77-821c-a9fde3482144" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="icui-20211231.xsd#ConsolidatedStatementsofIncome"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/ConsolidatedStatementsofIncome" xlink:type="extended" id="i91447087852b4863969636485a432a4e_ConsolidatedStatementsofIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_35d7a73e-c5cc-4e6f-bad5-fefd35f06ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_RevenuesAbstract_35d7a73e-c5cc-4e6f-bad5-fefd35f06ef1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0cdb274b-be8c-48c3-b7fa-8c3a9b018638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_35d7a73e-c5cc-4e6f-bad5-fefd35f06ef1" xlink:to="loc_us-gaap_Revenues_0cdb274b-be8c-48c3-b7fa-8c3a9b018638" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4583ce40-b9df-4fdb-8356-2f3794ff8796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4583ce40-b9df-4fdb-8356-2f3794ff8796" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a9137ded-e180-45c3-8581-5fb6cb60ee9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_GrossProfit_a9137ded-e180-45c3-8581-5fb6cb60ee9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_fe01fc27-0c06-48bc-a937-85a805f0e221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_OperatingExpensesAbstract_fe01fc27-0c06-48bc-a937-85a805f0e221" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8dd99195-2f38-4fe6-8300-174516682659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fe01fc27-0c06-48bc-a937-85a805f0e221" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8dd99195-2f38-4fe6-8300-174516682659" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_822428bc-0b39-4355-8eb5-bfb17175960d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fe01fc27-0c06-48bc-a937-85a805f0e221" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_822428bc-0b39-4355-8eb5-bfb17175960d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringandstrategictransactionexpense_c67f2b6e-0bba-488d-82e0-9946594cd7ee" xlink:href="icui-20211231.xsd#icui_Restructuringandstrategictransactionexpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fe01fc27-0c06-48bc-a937-85a805f0e221" xlink:to="loc_icui_Restructuringandstrategictransactionexpense_c67f2b6e-0bba-488d-82e0-9946594cd7ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_fca80432-afcb-42a0-85d4-411fdbb0cdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fe01fc27-0c06-48bc-a937-85a805f0e221" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_fca80432-afcb-42a0-85d4-411fdbb0cdfe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contractsettlements_aa9b22ff-b2f1-4c04-ac01-294ca582e5f8" xlink:href="icui-20211231.xsd#icui_Contractsettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fe01fc27-0c06-48bc-a937-85a805f0e221" xlink:to="loc_icui_Contractsettlements_aa9b22ff-b2f1-4c04-ac01-294ca582e5f8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6cdd707c-cf28-4cab-99c0-1aaeaea0d66a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fe01fc27-0c06-48bc-a937-85a805f0e221" xlink:to="loc_us-gaap_OperatingExpenses_6cdd707c-cf28-4cab-99c0-1aaeaea0d66a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_59d6e0ac-4d73-467f-8b68-5fb54028d1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_OperatingIncomeLoss_59d6e0ac-4d73-467f-8b68-5fb54028d1e1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_4fb2a991-b917-4405-93c9-bbcbbb3b0be4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_InterestExpense_4fb2a991-b917-4405-93c9-bbcbbb3b0be4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b6229e52-c4f3-40ed-bca0-7e4bc7ef0dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_b6229e52-c4f3-40ed-bca0-7e4bc7ef0dc2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_0b73c418-a252-473b-ad87-c144637f7938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_0b73c418-a252-473b-ad87-c144637f7938" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9ffd0ca5-0df9-44bd-90ca-b57d507ec433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9ffd0ca5-0df9-44bd-90ca-b57d507ec433" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6d033949-2f91-42d2-88d0-0fd765f5205c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_NetIncomeLoss_6d033949-2f91-42d2-88d0-0fd765f5205c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d88b9ca7-1252-4f1d-90cb-75f05c863877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_EarningsPerShareBasic_d88b9ca7-1252-4f1d-90cb-75f05c863877" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_312c682e-c532-42b3-a9d5-d0099feb2127" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_EarningsPerShareDiluted_312c682e-c532-42b3-a9d5-d0099feb2127" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ce2d1e10-5a04-4981-a057-f9ede068f28f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ce2d1e10-5a04-4981-a057-f9ede068f28f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f7766a8a-9de6-4212-b04a-4cda3e8240db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ce2d1e10-5a04-4981-a057-f9ede068f28f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f7766a8a-9de6-4212-b04a-4cda3e8240db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_852ca4b6-e342-4d6c-86a7-43129639136c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ce2d1e10-5a04-4981-a057-f9ede068f28f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_852ca4b6-e342-4d6c-86a7-43129639136c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ca6c9532-38ca-45fa-8032-32ec45bdb0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_StatementTable_ca6c9532-38ca-45fa-8032-32ec45bdb0b1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9ce8dd5e-82ec-4104-8973-a7afa8944a01" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ca6c9532-38ca-45fa-8032-32ec45bdb0b1" xlink:to="loc_srt_ProductOrServiceAxis_9ce8dd5e-82ec-4104-8973-a7afa8944a01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9ce8dd5e-82ec-4104-8973-a7afa8944a01_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_9ce8dd5e-82ec-4104-8973-a7afa8944a01" xlink:to="loc_srt_ProductsAndServicesDomain_9ce8dd5e-82ec-4104-8973-a7afa8944a01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b34cf841-81ac-4565-ae1e-3594d074b45b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_9ce8dd5e-82ec-4104-8973-a7afa8944a01" xlink:to="loc_srt_ProductsAndServicesDomain_b34cf841-81ac-4565-ae1e-3594d074b45b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/StatementofComprehensiveIncome" xlink:type="simple" xlink:href="icui-20211231.xsd#StatementofComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/StatementofComprehensiveIncome" xlink:type="extended" id="id3aae23f55a04ab0bb62aa323989c12e_StatementofComprehensiveIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2ac19b1d-966b-46d0-8aac-d42fc634eeb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c12087b1-799a-4a09-b0de-e9385ea158ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ac19b1d-966b-46d0-8aac-d42fc634eeb2" xlink:to="loc_us-gaap_NetIncomeLoss_c12087b1-799a-4a09-b0de-e9385ea158ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_abd44712-13fb-4f98-9cfd-e943fd8fe923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ac19b1d-966b-46d0-8aac-d42fc634eeb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_abd44712-13fb-4f98-9cfd-e943fd8fe923" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d3e09bf7-e140-4da7-87a0-ae702b8bf84f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ac19b1d-966b-46d0-8aac-d42fc634eeb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d3e09bf7-e140-4da7-87a0-ae702b8bf84f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_54b044e4-3f01-4c91-852a-4bf7f85bb050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ac19b1d-966b-46d0-8aac-d42fc634eeb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_54b044e4-3f01-4c91-852a-4bf7f85bb050" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_373e8922-40eb-4bcd-8347-46a742e61852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ac19b1d-966b-46d0-8aac-d42fc634eeb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_373e8922-40eb-4bcd-8347-46a742e61852" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_653521ef-edac-4867-864e-694fbc41c9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ac19b1d-966b-46d0-8aac-d42fc634eeb2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_653521ef-edac-4867-864e-694fbc41c9d5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d48127e5-0280-4b0f-b5d7-4838b739b40f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2ac19b1d-966b-46d0-8aac-d42fc634eeb2" xlink:to="loc_us-gaap_StatementTable_d48127e5-0280-4b0f-b5d7-4838b739b40f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_3b531d8e-4cf5-4069-8975-1b9725f1f1ac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d48127e5-0280-4b0f-b5d7-4838b739b40f" xlink:to="loc_srt_StatementScenarioAxis_3b531d8e-4cf5-4069-8975-1b9725f1f1ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3b531d8e-4cf5-4069-8975-1b9725f1f1ac_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_3b531d8e-4cf5-4069-8975-1b9725f1f1ac" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3b531d8e-4cf5-4069-8975-1b9725f1f1ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_29f20c6a-0f88-465f-a9fe-60c6351aca79" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_3b531d8e-4cf5-4069-8975-1b9725f1f1ac" xlink:to="loc_srt_ScenarioUnspecifiedDomain_29f20c6a-0f88-465f-a9fe-60c6351aca79" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="icui-20211231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i84e17e241f6945359eae0843370d9ae7_ConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6bbe099a-2065-460d-832c-ef43d21af34b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6bbe099a-2065-460d-832c-ef43d21af34b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d2be5d13-e8ec-4368-80ea-b1261210618d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d2be5d13-e8ec-4368-80ea-b1261210618d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0709cba2-5e8c-4ef1-9ae3-d46e2fc3a635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:to="loc_us-gaap_StockholdersEquity_0709cba2-5e8c-4ef1-9ae3-d46e2fc3a635" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6846bd8f-6dd7-48ad-8cb0-e088bd236ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6846bd8f-6dd7-48ad-8cb0-e088bd236ae9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_6500c7cf-da06-47e0-b7dc-a69074a5a174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_6500c7cf-da06-47e0-b7dc-a69074a5a174" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_9229ed96-f993-484a-a90c-e537863ed7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_9229ed96-f993-484a-a90c-e537863ed7a8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_05486dfb-bf47-4d23-acb1-bf8aae89413c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_05486dfb-bf47-4d23-acb1-bf8aae89413c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_65bb2f85-6083-4c33-9a21-c26748a9ce0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_65bb2f85-6083-4c33-9a21-c26748a9ce0e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_890056cf-5474-4e13-afb4-da7f19b51d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_890056cf-5474-4e13-afb4-da7f19b51d20" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b19cdaf2-8076-418b-bca2-776df9c728df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:to="loc_us-gaap_NetIncomeLoss_b19cdaf2-8076-418b-bca2-776df9c728df" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cf1c2a9d-4c9b-4277-849b-e61eced54fec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a1a9f8c0-a9c5-41f7-9540-042b1c748391" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9cedd24a-765c-4e9f-b775-e824cd0f3182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_6bbe099a-2065-460d-832c-ef43d21af34b" xlink:to="loc_us-gaap_StatementTable_9cedd24a-765c-4e9f-b775-e824cd0f3182" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9259a533-0559-484b-8b0a-d08bad3ecfe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9cedd24a-765c-4e9f-b775-e824cd0f3182" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9259a533-0559-484b-8b0a-d08bad3ecfe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9259a533-0559-484b-8b0a-d08bad3ecfe4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9259a533-0559-484b-8b0a-d08bad3ecfe4" xlink:to="loc_us-gaap_EquityComponentDomain_9259a533-0559-484b-8b0a-d08bad3ecfe4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c7f1cd4a-83e6-45bd-a8e2-7fb7391246d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9259a533-0559-484b-8b0a-d08bad3ecfe4" xlink:to="loc_us-gaap_EquityComponentDomain_c7f1cd4a-83e6-45bd-a8e2-7fb7391246d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CommonStockSharesMember_cd910e7b-15d3-44a3-84b1-7981bf8c7920" xlink:href="icui-20211231.xsd#icui_CommonStockSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c7f1cd4a-83e6-45bd-a8e2-7fb7391246d4" xlink:to="loc_icui_CommonStockSharesMember_cd910e7b-15d3-44a3-84b1-7981bf8c7920" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2997ece3-dbfa-4156-b2b7-c928c2e18a72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c7f1cd4a-83e6-45bd-a8e2-7fb7391246d4" xlink:to="loc_us-gaap_CommonStockMember_2997ece3-dbfa-4156-b2b7-c928c2e18a72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_c0c6501f-a40d-4414-8c05-76a5b0924b65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c7f1cd4a-83e6-45bd-a8e2-7fb7391246d4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_c0c6501f-a40d-4414-8c05-76a5b0924b65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_c334cefc-9446-4c45-becf-5a9fa1e533b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c7f1cd4a-83e6-45bd-a8e2-7fb7391246d4" xlink:to="loc_us-gaap_TreasuryStockMember_c334cefc-9446-4c45-becf-5a9fa1e533b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1587ca18-3e41-493b-836e-2535b399c4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c7f1cd4a-83e6-45bd-a8e2-7fb7391246d4" xlink:to="loc_us-gaap_RetainedEarningsMember_1587ca18-3e41-493b-836e-2535b399c4d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_37937f71-8773-4b6d-abb2-b8bf152eac02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c7f1cd4a-83e6-45bd-a8e2-7fb7391246d4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_37937f71-8773-4b6d-abb2-b8bf152eac02" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="icui-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended" id="ie8397325b4264f0199a3b535bccb1023_ConsolidatedStatementsofCashFlows">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5a888d6a-08d1-49fa-852c-3cb69e935ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_d622effa-673e-481a-9b92-ebe88d6042e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5a888d6a-08d1-49fa-852c-3cb69e935ec0" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_d622effa-673e-481a-9b92-ebe88d6042e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_97a10eec-0aa2-4275-979e-42d6d81b797e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_d622effa-673e-481a-9b92-ebe88d6042e7" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_97a10eec-0aa2-4275-979e-42d6d81b797e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_97a10eec-0aa2-4275-979e-42d6d81b797e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_850f8e3a-c3ce-4fd8-8b48-c0e1479b8a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_NetIncomeLoss_850f8e3a-c3ce-4fd8-8b48-c0e1479b8a2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_8661c320-e60f-41da-bf35-fcb7baa08ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_8661c320-e60f-41da-bf35-fcb7baa08ea7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Operatingleaserightofuseassetamortization_c1ae0339-5f0c-4b9f-8f09-d66ba1bc9f9a" xlink:href="icui-20211231.xsd#icui_Operatingleaserightofuseassetamortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_icui_Operatingleaserightofuseassetamortization_c1ae0339-5f0c-4b9f-8f09-d66ba1bc9f9a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_e6cd1e6b-f7ea-4fcf-9c39-d9a5e11ab4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_e6cd1e6b-f7ea-4fcf-9c39-d9a5e11ab4e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProvisionForWarrantyAndReturns_5138c3c3-d9d6-4db4-8ee3-7da91baf6f5f" xlink:href="icui-20211231.xsd#icui_ProvisionForWarrantyAndReturns"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_icui_ProvisionForWarrantyAndReturns_5138c3c3-d9d6-4db4-8ee3-7da91baf6f5f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ae1472b1-096a-4138-83ed-6cd6a4776a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_ShareBasedCompensation_ae1472b1-096a-4138-83ed-6cd6a4776a5a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_bdd8f302-b0f1-4c38-ade9-872189784f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_bdd8f302-b0f1-4c38-ade9-872189784f6c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_e2eab5dd-8d87-49ab-a683-0fbaa3576c49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_e2eab5dd-8d87-49ab-a683-0fbaa3576c49" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_f6b50eab-060c-46c2-b162-7d90ab68ede3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_f6b50eab-060c-46c2-b162-7d90ab68ede3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b398f845-9bbd-45b7-9705-d05ee1d8b61f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b398f845-9bbd-45b7-9705-d05ee1d8b61f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionRelatedImpairmentsOrCharges_4144d2b8-f83e-4cf1-b0fe-89726460f2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_ProductionRelatedImpairmentsOrCharges_4144d2b8-f83e-4cf1-b0fe-89726460f2d8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Sparepartsusage_7d3df8c5-3d99-409b-b68e-e4df3232eacb" xlink:href="icui-20211231.xsd#icui_Sparepartsusage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_icui_Sparepartsusage_7d3df8c5-3d99-409b-b68e-e4df3232eacb" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_a324b292-9f19-4da6-a0c8-d89f7c00c612" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_a324b292-9f19-4da6-a0c8-d89f7c00c612" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5c89e122-735c-4c4e-bdc9-6c5be58cfe60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5c89e122-735c-4c4e-bdc9-6c5be58cfe60" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_55b4535d-ab77-45c4-a4f6-719e48333e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_55b4535d-ab77-45c4-a4f6-719e48333e7e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1e6ad5d1-138c-4406-9236-f2c298119c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1e6ad5d1-138c-4406-9236-f2c298119c21" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e389c631-0853-49f0-98cb-3019d9511a87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e389c631-0853-49f0-98cb-3019d9511a87" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_bc173d4c-cdf6-4929-9119-c1c7bb0b91bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_bc173d4c-cdf6-4929-9119-c1c7bb0b91bf" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_d83a92e8-8c28-463c-b749-b8282d847570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_d83a92e8-8c28-463c-b749-b8282d847570" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_8b6370af-b81f-42cf-961a-23dfc4ab1db5" xlink:href="icui-20211231.xsd#icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_8b6370af-b81f-42cf-961a-23dfc4ab1db5" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_85ea4da9-a94d-48a0-bc36-f392b461312f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_97a10eec-0aa2-4275-979e-42d6d81b797e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_85ea4da9-a94d-48a0-bc36-f392b461312f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_92770442-25b5-4b7f-b14d-b3bb37aff145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_97a10eec-0aa2-4275-979e-42d6d81b797e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_92770442-25b5-4b7f-b14d-b3bb37aff145" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e45805ea-5040-466b-937a-17f2a3de8bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_92770442-25b5-4b7f-b14d-b3bb37aff145" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e45805ea-5040-466b-937a-17f2a3de8bf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment_527127d6-eb7a-4bde-9cf8-4e059c3bb8f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_92770442-25b5-4b7f-b14d-b3bb37aff145" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment_527127d6-eb7a-4bde-9cf8-4e059c3bb8f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_791a1d06-e3f4-46aa-896f-8c98498b907e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_92770442-25b5-4b7f-b14d-b3bb37aff145" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_791a1d06-e3f4-46aa-896f-8c98498b907e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_bc8399d4-f228-40a6-b2a3-c9c8bc35e358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_92770442-25b5-4b7f-b14d-b3bb37aff145" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_bc8399d4-f228-40a6-b2a3-c9c8bc35e358" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_475b7e67-e4f6-4155-8714-2408e7c295bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_92770442-25b5-4b7f-b14d-b3bb37aff145" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_475b7e67-e4f6-4155-8714-2408e7c295bd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_4b10d4f3-d8ff-4cda-96a0-3a464bdfc896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_92770442-25b5-4b7f-b14d-b3bb37aff145" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_4b10d4f3-d8ff-4cda-96a0-3a464bdfc896" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_dc80af41-a849-48f8-ba05-fbb56c201c79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_92770442-25b5-4b7f-b14d-b3bb37aff145" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_dc80af41-a849-48f8-ba05-fbb56c201c79" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_281d6680-6751-485e-9fd1-bbb84ac29c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_97a10eec-0aa2-4275-979e-42d6d81b797e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_281d6680-6751-485e-9fd1-bbb84ac29c5f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b780457-97af-449b-bd63-4ccd0810eb5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_97a10eec-0aa2-4275-979e-42d6d81b797e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b780457-97af-449b-bd63-4ccd0810eb5a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_35f4a0bd-de63-4251-89f9-6df85d6f3525" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b780457-97af-449b-bd63-4ccd0810eb5a" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_35f4a0bd-de63-4251-89f9-6df85d6f3525" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_a383271a-4751-4748-b51b-45a8ff6df43a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b780457-97af-449b-bd63-4ccd0810eb5a" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_a383271a-4751-4748-b51b-45a8ff6df43a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_d33c6ca2-daf7-4cce-bd33-fd7f1a13d980" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b780457-97af-449b-bd63-4ccd0810eb5a" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_d33c6ca2-daf7-4cce-bd33-fd7f1a13d980" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_def8ba45-c1d0-4ddc-8bfd-7cdcc4382a45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b780457-97af-449b-bd63-4ccd0810eb5a" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_def8ba45-c1d0-4ddc-8bfd-7cdcc4382a45" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_855b0442-618d-482b-ad34-61e7a881dce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b780457-97af-449b-bd63-4ccd0810eb5a" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_855b0442-618d-482b-ad34-61e7a881dce2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_733129f6-336c-49b7-9806-37d061048979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b780457-97af-449b-bd63-4ccd0810eb5a" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_733129f6-336c-49b7-9806-37d061048979" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_721a7a2a-1ec0-40b0-8c3e-561e37787e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_97a10eec-0aa2-4275-979e-42d6d81b797e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_721a7a2a-1ec0-40b0-8c3e-561e37787e29" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAbstract_91c38c3c-6630-44c2-a838-0fcd64b252b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_d622effa-673e-481a-9b92-ebe88d6042e7" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAbstract_91c38c3c-6630-44c2-a838-0fcd64b252b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_6be183bd-1212-4082-ae0e-7572961ee2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAbstract_91c38c3c-6630-44c2-a838-0fcd64b252b3" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_6be183bd-1212-4082-ae0e-7572961ee2dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0a26fcf4-5a91-4987-9d23-7325e5fef86e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAbstract_91c38c3c-6630-44c2-a838-0fcd64b252b3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0a26fcf4-5a91-4987-9d23-7325e5fef86e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0e59aa67-0796-4e1f-b7e5-07647e7acbfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5a888d6a-08d1-49fa-852c-3cb69e935ec0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0e59aa67-0796-4e1f-b7e5-07647e7acbfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_83909daa-9cca-4d30-9702-4a6bb44166e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_88687425-be68-470a-aac2-2af8c349529c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5a888d6a-08d1-49fa-852c-3cb69e935ec0" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_88687425-be68-470a-aac2-2af8c349529c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_a7de8e8b-1b29-4e01-b153-48662d66204d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_88687425-be68-470a-aac2-2af8c349529c" xlink:to="loc_us-gaap_IncomeTaxesPaid_a7de8e8b-1b29-4e01-b153-48662d66204d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_32710778-4608-4434-ac3f-0469c2cbb2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_88687425-be68-470a-aac2-2af8c349529c" xlink:to="loc_us-gaap_InterestPaidNet_32710778-4608-4434-ac3f-0469c2cbb2fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f7d20094-45b9-4598-9d40-8641e0dd0282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5a888d6a-08d1-49fa-852c-3cb69e935ec0" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f7d20094-45b9-4598-9d40-8641e0dd0282" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_ebf204fa-5759-4608-8d61-bece94408564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f7d20094-45b9-4598-9d40-8641e0dd0282" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_ebf204fa-5759-4608-8d61-bece94408564" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_b7ecd8f5-32be-4f96-a3fc-14cde1641365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f7d20094-45b9-4598-9d40-8641e0dd0282" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_b7ecd8f5-32be-4f96-a3fc-14cde1641365" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NetCashPaidReceivedforcurrentandprioracquisitions_c497f8a0-9900-4c4e-9f16-a3b45d823996" xlink:href="icui-20211231.xsd#icui_NetCashPaidReceivedforcurrentandprioracquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f7d20094-45b9-4598-9d40-8641e0dd0282" xlink:to="loc_icui_NetCashPaidReceivedforcurrentandprioracquisitions_c497f8a0-9900-4c4e-9f16-a3b45d823996" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_bd34d331-6628-4268-8e11-543c79ca8a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f7d20094-45b9-4598-9d40-8641e0dd0282" xlink:to="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_bd34d331-6628-4268-8e11-543c79ca8a4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_d90773af-5522-4a08-b59c-b3ba76f0c7da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f7d20094-45b9-4598-9d40-8641e0dd0282" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_d90773af-5522-4a08-b59c-b3ba76f0c7da" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_3f5cbd41-4a70-4200-948d-e20ea9b0b520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f7d20094-45b9-4598-9d40-8641e0dd0282" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_3f5cbd41-4a70-4200-948d-e20ea9b0b520" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_107fa45a-ec43-4971-843d-6dc5b7e3b03a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f7d20094-45b9-4598-9d40-8641e0dd0282" xlink:to="loc_us-gaap_LiabilitiesAssumed1_107fa45a-ec43-4971-843d-6dc5b7e3b03a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_34531e7b-49e5-43dc-9caa-ab46b2b01ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5a888d6a-08d1-49fa-852c-3cb69e935ec0" xlink:to="loc_us-gaap_StatementTable_34531e7b-49e5-43dc-9caa-ab46b2b01ebb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_d99dd388-9c4b-4041-a528-79fb55852c03" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_34531e7b-49e5-43dc-9caa-ab46b2b01ebb" xlink:to="loc_srt_StatementScenarioAxis_d99dd388-9c4b-4041-a528-79fb55852c03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_d99dd388-9c4b-4041-a528-79fb55852c03_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_d99dd388-9c4b-4041-a528-79fb55852c03" xlink:to="loc_srt_ScenarioUnspecifiedDomain_d99dd388-9c4b-4041-a528-79fb55852c03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_d7cff203-558c-466f-adcb-f5522dc6c4d6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_d99dd388-9c4b-4041-a528-79fb55852c03" xlink:to="loc_srt_ScenarioUnspecifiedDomain_d7cff203-558c-466f-adcb-f5522dc6c4d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_63511aa3-6c0e-42b1-8a93-e73963d8f361" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_34531e7b-49e5-43dc-9caa-ab46b2b01ebb" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_63511aa3-6c0e-42b1-8a93-e73963d8f361" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63511aa3-6c0e-42b1-8a93-e73963d8f361_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_63511aa3-6c0e-42b1-8a93-e73963d8f361" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63511aa3-6c0e-42b1-8a93-e73963d8f361_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c081f08d-4b40-4bf1-819a-92269f800b81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_63511aa3-6c0e-42b1-8a93-e73963d8f361" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c081f08d-4b40-4bf1-819a-92269f800b81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InternationalDistributorMember_ce5a28a1-d61d-4d11-a104-ddefb872ca35" xlink:href="icui-20211231.xsd#icui_InternationalDistributorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c081f08d-4b40-4bf1-819a-92269f800b81" xlink:to="loc_icui_InternationalDistributorMember_ce5a28a1-d61d-4d11-a104-ddefb872ca35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularLLCMember_dc613888-31cc-4624-b477-4f69ccc1e3ef" xlink:href="icui-20211231.xsd#icui_PursuitVascularLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c081f08d-4b40-4bf1-819a-92269f800b81" xlink:to="loc_icui_PursuitVascularLLCMember_dc613888-31cc-4624-b477-4f69ccc1e3ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_c4e48f7c-78e2-4c02-88f3-da707157cc4b" xlink:href="icui-20211231.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c081f08d-4b40-4bf1-819a-92269f800b81" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_c4e48f7c-78e2-4c02-88f3-da707157cc4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TotalAcquisitionsMember_54ab4fbb-c472-4df7-8eaf-1317f06d70fa" xlink:href="icui-20211231.xsd#icui_TotalAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c081f08d-4b40-4bf1-819a-92269f800b81" xlink:to="loc_icui_TotalAcquisitionsMember_54ab4fbb-c472-4df7-8eaf-1317f06d70fa" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details" xlink:type="extended" id="ie76b64e716314aa598504ac5bba637ed_GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_98909775-eb34-4264-8430-04bbb1148bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_7726981d-46fd-4443-bde1-219a5cace5da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_98909775-eb34-4264-8430-04bbb1148bd5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_7726981d-46fd-4443-bde1-219a5cace5da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3f4cf066-34df-4d78-bc20-4fd55d3f1656" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_98909775-eb34-4264-8430-04bbb1148bd5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3f4cf066-34df-4d78-bc20-4fd55d3f1656" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_edde4be2-7094-453e-97d7-c741f0997634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_98909775-eb34-4264-8430-04bbb1148bd5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_edde4be2-7094-453e-97d7-c741f0997634" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eb630ccb-2338-4872-8001-7dc355c36e88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_98909775-eb34-4264-8430-04bbb1148bd5" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eb630ccb-2338-4872-8001-7dc355c36e88" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_371c564c-53d9-4e58-8972-2f8133bb0879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eb630ccb-2338-4872-8001-7dc355c36e88" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_371c564c-53d9-4e58-8972-2f8133bb0879" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_371c564c-53d9-4e58-8972-2f8133bb0879_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_371c564c-53d9-4e58-8972-2f8133bb0879" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_371c564c-53d9-4e58-8972-2f8133bb0879_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6984fa2b-0f31-47ae-a0a5-bde769b77bae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_371c564c-53d9-4e58-8972-2f8133bb0879" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6984fa2b-0f31-47ae-a0a5-bde769b77bae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_e30f9182-5d6c-47eb-abfd-c6ba2df6a58a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6984fa2b-0f31-47ae-a0a5-bde769b77bae" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_e30f9182-5d6c-47eb-abfd-c6ba2df6a58a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember_52a8d358-5ac8-45ac-964f-8b4ee0222964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6984fa2b-0f31-47ae-a0a5-bde769b77bae" xlink:to="loc_us-gaap_LandBuildingsAndImprovementsMember_52a8d358-5ac8-45ac-964f-8b4ee0222964" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MoldsMember_3e54a1e3-6fe3-43a4-89ed-e624917289ca" xlink:href="icui-20211231.xsd#icui_MoldsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6984fa2b-0f31-47ae-a0a5-bde769b77bae" xlink:to="loc_icui_MoldsMember_3e54a1e3-6fe3-43a4-89ed-e624917289ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ComputerEquipmentAndSoftwareMember_46285db6-7d4f-4443-a0a3-90c206278e7a" xlink:href="icui-20211231.xsd#icui_ComputerEquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6984fa2b-0f31-47ae-a0a5-bde769b77bae" xlink:to="loc_icui_ComputerEquipmentAndSoftwareMember_46285db6-7d4f-4443-a0a3-90c206278e7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_c3c8f2a9-012d-491a-99cf-50565d9664d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6984fa2b-0f31-47ae-a0a5-bde769b77bae" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_c3c8f2a9-012d-491a-99cf-50565d9664d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InstrumentsPlacedwithCustomersMember_4de3f08d-91e9-4aa5-8e1b-9002f96d2268" xlink:href="icui-20211231.xsd#icui_InstrumentsPlacedwithCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6984fa2b-0f31-47ae-a0a5-bde769b77bae" xlink:to="loc_icui_InstrumentsPlacedwithCustomersMember_4de3f08d-91e9-4aa5-8e1b-9002f96d2268" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_1462c414-94f8-4da1-81d4-288dcefaa9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6984fa2b-0f31-47ae-a0a5-bde769b77bae" xlink:to="loc_us-gaap_ConstructionInProgressMember_1462c414-94f8-4da1-81d4-288dcefaa9d2" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details" xlink:type="extended" id="i5de79b40b8524f868ff708ab9bb54c5d_GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a8664a63-182e-482e-bec8-0abd8cf9502a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_4e767a81-cc21-4fc5-aa96-fb47f1735314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a8664a63-182e-482e-bec8-0abd8cf9502a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_4e767a81-cc21-4fc5-aa96-fb47f1735314" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_42bbd676-97af-4d80-9063-d10d99d9bf2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a8664a63-182e-482e-bec8-0abd8cf9502a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_42bbd676-97af-4d80-9063-d10d99d9bf2b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ec526f2-69e0-43bc-8306-ac5a5186def8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_42bbd676-97af-4d80-9063-d10d99d9bf2b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ec526f2-69e0-43bc-8306-ac5a5186def8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0ec526f2-69e0-43bc-8306-ac5a5186def8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ec526f2-69e0-43bc-8306-ac5a5186def8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0ec526f2-69e0-43bc-8306-ac5a5186def8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46222615-b6a1-4257-b1fe-3468b58476d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ec526f2-69e0-43bc-8306-ac5a5186def8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46222615-b6a1-4257-b1fe-3468b58476d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_f01c98d9-e179-457b-8189-c63f2f5ff82e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46222615-b6a1-4257-b1fe-3468b58476d9" xlink:to="loc_us-gaap_BuildingMember_f01c98d9-e179-457b-8189-c63f2f5ff82e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember_1a7561e1-c089-45ce-bb8c-981c67c4b79e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46222615-b6a1-4257-b1fe-3468b58476d9" xlink:to="loc_us-gaap_BuildingImprovementsMember_1a7561e1-c089-45ce-bb8c-981c67c4b79e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_78a6781a-c46e-4139-b189-f2924eff97a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46222615-b6a1-4257-b1fe-3468b58476d9" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_78a6781a-c46e-4139-b189-f2924eff97a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_FurniturefixturesandmoldsMember_c2f0e811-b9c1-411a-86ec-a14fb2557fe2" xlink:href="icui-20211231.xsd#icui_FurniturefixturesandmoldsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46222615-b6a1-4257-b1fe-3468b58476d9" xlink:to="loc_icui_FurniturefixturesandmoldsMember_c2f0e811-b9c1-411a-86ec-a14fb2557fe2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ComputerEquipmentAndSoftwareMember_952e002c-2eeb-427a-8d95-5a9b9f12f786" xlink:href="icui-20211231.xsd#icui_ComputerEquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46222615-b6a1-4257-b1fe-3468b58476d9" xlink:to="loc_icui_ComputerEquipmentAndSoftwareMember_952e002c-2eeb-427a-8d95-5a9b9f12f786" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InstrumentsPlacedwithCustomersMember_5ed0099e-27bc-4f41-b4fe-123917e239c9" xlink:href="icui-20211231.xsd#icui_InstrumentsPlacedwithCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46222615-b6a1-4257-b1fe-3468b58476d9" xlink:to="loc_icui_InstrumentsPlacedwithCustomersMember_5ed0099e-27bc-4f41-b4fe-123917e239c9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6990349d-c357-4c40-81f7-abd0352cfc3c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_42bbd676-97af-4d80-9063-d10d99d9bf2b" xlink:to="loc_srt_RangeAxis_6990349d-c357-4c40-81f7-abd0352cfc3c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6990349d-c357-4c40-81f7-abd0352cfc3c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6990349d-c357-4c40-81f7-abd0352cfc3c" xlink:to="loc_srt_RangeMember_6990349d-c357-4c40-81f7-abd0352cfc3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9c89afc0-afbe-4e51-80cb-ebb6b70ded7c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6990349d-c357-4c40-81f7-abd0352cfc3c" xlink:to="loc_srt_RangeMember_9c89afc0-afbe-4e51-80cb-ebb6b70ded7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_304281aa-f9a2-4ca7-873f-69f3758068ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9c89afc0-afbe-4e51-80cb-ebb6b70ded7c" xlink:to="loc_srt_MinimumMember_304281aa-f9a2-4ca7-873f-69f3758068ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cd778607-b373-4a5b-815b-81e4aa7f5b2e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9c89afc0-afbe-4e51-80cb-ebb6b70ded7c" xlink:to="loc_srt_MaximumMember_cd778607-b373-4a5b-815b-81e4aa7f5b2e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails" xlink:type="extended" id="icf8af3dc1a15476b82db20053592ec76_GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_ba4490b6-a338-4e71-9cef-f9e5b619b209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_5ff6743f-b1b1-414b-b77f-d2c212b4f661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_ba4490b6-a338-4e71-9cef-f9e5b619b209" xlink:to="loc_us-gaap_GoodwillRollForward_5ff6743f-b1b1-414b-b77f-d2c212b4f661" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_97cd1a43-4ba6-45c3-89ac-013f6908f1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_5ff6743f-b1b1-414b-b77f-d2c212b4f661" xlink:to="loc_us-gaap_Goodwill_97cd1a43-4ba6-45c3-89ac-013f6908f1fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_3a918e86-848e-4394-8997-d215d9b46665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_5ff6743f-b1b1-414b-b77f-d2c212b4f661" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_3a918e86-848e-4394-8997-d215d9b46665" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_ea8a43b4-8cee-4de5-993d-a30a17148f90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_5ff6743f-b1b1-414b-b77f-d2c212b4f661" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_ea8a43b4-8cee-4de5-993d-a30a17148f90" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_b80b016a-cb29-44ab-83fa-619d10c78c58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_5ff6743f-b1b1-414b-b77f-d2c212b4f661" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_b80b016a-cb29-44ab-83fa-619d10c78c58" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a7b07b22-2c73-4273-83e2-20930020e68a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_3afd44fe-3564-4adc-9073-128ac93f8610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_ba4490b6-a338-4e71-9cef-f9e5b619b209" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_3afd44fe-3564-4adc-9073-128ac93f8610" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_16d243bf-f97a-4a49-81e7-d59ad6614415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_3afd44fe-3564-4adc-9073-128ac93f8610" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_16d243bf-f97a-4a49-81e7-d59ad6614415" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16d243bf-f97a-4a49-81e7-d59ad6614415_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_16d243bf-f97a-4a49-81e7-d59ad6614415" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16d243bf-f97a-4a49-81e7-d59ad6614415_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16e029aa-5feb-4ad7-9b15-a378feeb91f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_16d243bf-f97a-4a49-81e7-d59ad6614415" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16e029aa-5feb-4ad7-9b15-a378feeb91f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularLLCMember_2bfa2c7d-4474-4d0f-a931-07632bcce6db" xlink:href="icui-20211231.xsd#icui_PursuitVascularLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16e029aa-5feb-4ad7-9b15-a378feeb91f9" xlink:to="loc_icui_PursuitVascularLLCMember_2bfa2c7d-4474-4d0f-a931-07632bcce6db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignDistibutorMember_45871777-8663-452b-a1ec-7e42c7192dd3" xlink:href="icui-20211231.xsd#icui_ForeignDistibutorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16e029aa-5feb-4ad7-9b15-a378feeb91f9" xlink:to="loc_icui_ForeignDistibutorMember_45871777-8663-452b-a1ec-7e42c7192dd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_367cb985-f3c0-4aaa-aa19-ad4cfec5526c" xlink:href="icui-20211231.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16e029aa-5feb-4ad7-9b15-a378feeb91f9" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_367cb985-f3c0-4aaa-aa19-ad4cfec5526c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details" xlink:type="extended" id="if46543f751624374a178f677dba2a022_GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f10f0af0-eade-4581-adf7-f00178b9e6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_a9fadbd8-050f-4350-8f47-01982dc1dfda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f10f0af0-eade-4581-adf7-f00178b9e6fa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_a9fadbd8-050f-4350-8f47-01982dc1dfda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_bc1e349e-50a1-48f1-9946-3d1065f75969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f10f0af0-eade-4581-adf7-f00178b9e6fa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_bc1e349e-50a1-48f1-9946-3d1065f75969" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9a2dcaef-7194-4fed-9fbf-3bb2c6e877d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f10f0af0-eade-4581-adf7-f00178b9e6fa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9a2dcaef-7194-4fed-9fbf-3bb2c6e877d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a18c3c19-a825-4602-9cd9-bb60655f0dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f10f0af0-eade-4581-adf7-f00178b9e6fa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a18c3c19-a825-4602-9cd9-bb60655f0dfb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2f1f7e91-dd05-48c8-b01f-32e124a52b59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f10f0af0-eade-4581-adf7-f00178b9e6fa" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2f1f7e91-dd05-48c8-b01f-32e124a52b59" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7b8d5b2e-50b0-469a-b774-ec92f5508006" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f10f0af0-eade-4581-adf7-f00178b9e6fa" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7b8d5b2e-50b0-469a-b774-ec92f5508006" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_aca22d7e-e365-4b0f-b6d7-0e38afea1898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f10f0af0-eade-4581-adf7-f00178b9e6fa" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_aca22d7e-e365-4b0f-b6d7-0e38afea1898" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_88e260b5-0f2f-4306-b0ad-513ae291cb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_aca22d7e-e365-4b0f-b6d7-0e38afea1898" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_88e260b5-0f2f-4306-b0ad-513ae291cb9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_88e260b5-0f2f-4306-b0ad-513ae291cb9e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_88e260b5-0f2f-4306-b0ad-513ae291cb9e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_88e260b5-0f2f-4306-b0ad-513ae291cb9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_faf3a55f-80e9-4a80-8bd4-f3f2b2f37cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_88e260b5-0f2f-4306-b0ad-513ae291cb9e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_faf3a55f-80e9-4a80-8bd4-f3f2b2f37cfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_1318570b-145e-46c5-a56f-58c235b5fb62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_faf3a55f-80e9-4a80-8bd4-f3f2b2f37cfa" xlink:to="loc_us-gaap_PatentsMember_1318570b-145e-46c5-a56f-58c235b5fb62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_5efc319f-b785-4088-b26b-207fcf186116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_faf3a55f-80e9-4a80-8bd4-f3f2b2f37cfa" xlink:to="loc_us-gaap_CustomerContractsMember_5efc319f-b785-4088-b26b-207fcf186116" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_dad797d1-06c6-4928-9638-5989864dcb40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_faf3a55f-80e9-4a80-8bd4-f3f2b2f37cfa" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_dad797d1-06c6-4928-9638-5989864dcb40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_d94f7cdc-8a75-4fa9-b9ca-c826968853c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_faf3a55f-80e9-4a80-8bd4-f3f2b2f37cfa" xlink:to="loc_us-gaap_TrademarksMember_d94f7cdc-8a75-4fa9-b9ca-c826968853c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_3c5e480c-433d-4407-a107-03e309c3340d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_faf3a55f-80e9-4a80-8bd4-f3f2b2f37cfa" xlink:to="loc_us-gaap_TradeNamesMember_3c5e480c-433d-4407-a107-03e309c3340d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_3075c419-f15f-477f-bec6-d57d4c3e69c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_faf3a55f-80e9-4a80-8bd4-f3f2b2f37cfa" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_3075c419-f15f-477f-bec6-d57d4c3e69c0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_878cd86e-c5e9-476a-b198-9e6c31469297" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_faf3a55f-80e9-4a80-8bd4-f3f2b2f37cfa" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_878cd86e-c5e9-476a-b198-9e6c31469297" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_68ce218d-422a-46ae-a024-c0584363fd75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_faf3a55f-80e9-4a80-8bd4-f3f2b2f37cfa" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_68ce218d-422a-46ae-a024-c0584363fd75" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails" xlink:type="extended" id="id5c01d9290c244c4ab7535e25e2356ae_GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fd25ca95-c0b5-4e09-9b0d-2bf4d310d57d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d10b09c1-9684-4d46-a709-44526c1b811b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fd25ca95-c0b5-4e09-9b0d-2bf4d310d57d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d10b09c1-9684-4d46-a709-44526c1b811b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_4fc7aa1a-49a9-4b9d-8f68-f6c7b667b141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fd25ca95-c0b5-4e09-9b0d-2bf4d310d57d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_4fc7aa1a-49a9-4b9d-8f68-f6c7b667b141" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0b1fd276-68e4-4f21-bbee-37da92410792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fd25ca95-c0b5-4e09-9b0d-2bf4d310d57d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0b1fd276-68e4-4f21-bbee-37da92410792" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_19e839b0-1b2c-4147-bca4-2902eaa1aa0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fd25ca95-c0b5-4e09-9b0d-2bf4d310d57d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_19e839b0-1b2c-4147-bca4-2902eaa1aa0c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_768a9cab-b5d1-4a68-99f5-3ce9bc48da38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fd25ca95-c0b5-4e09-9b0d-2bf4d310d57d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_768a9cab-b5d1-4a68-99f5-3ce9bc48da38" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0cdcf654-d381-40da-a515-6a78d8b82be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fd25ca95-c0b5-4e09-9b0d-2bf4d310d57d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0cdcf654-d381-40da-a515-6a78d8b82be5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0fdbc365-9872-48ac-a24c-6fbe5a5a6fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fd25ca95-c0b5-4e09-9b0d-2bf4d310d57d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0fdbc365-9872-48ac-a24c-6fbe5a5a6fa0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e409fb9c-2ec7-460c-93a5-9176132a9f75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fd25ca95-c0b5-4e09-9b0d-2bf4d310d57d" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e409fb9c-2ec7-460c-93a5-9176132a9f75" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82d9711d-f00e-4b9a-8b68-524580035b89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e409fb9c-2ec7-460c-93a5-9176132a9f75" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82d9711d-f00e-4b9a-8b68-524580035b89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_82d9711d-f00e-4b9a-8b68-524580035b89_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82d9711d-f00e-4b9a-8b68-524580035b89" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_82d9711d-f00e-4b9a-8b68-524580035b89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_63d3608c-7c69-4b88-b344-f7ea7b3c7a65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82d9711d-f00e-4b9a-8b68-524580035b89" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_63d3608c-7c69-4b88-b344-f7ea7b3c7a65" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsDetails" xlink:type="extended" id="ia1faaf7382384dffb7ec356af246f277_GeneralandSummaryofSignificantAccountingPoliciesInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ba2794c4-31ee-4422-b3dd-1ee569fe8bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a5c46c1e-5a23-431b-ab19-a1fcfb4f8db1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ba2794c4-31ee-4422-b3dd-1ee569fe8bd6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a5c46c1e-5a23-431b-ab19-a1fcfb4f8db1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_c3003860-d032-47dd-8999-87c0733c2ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ba2794c4-31ee-4422-b3dd-1ee569fe8bd6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_c3003860-d032-47dd-8999-87c0733c2ce5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ceb4a8a5-897e-41b1-aa7d-ebfc4501e636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ba2794c4-31ee-4422-b3dd-1ee569fe8bd6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ceb4a8a5-897e-41b1-aa7d-ebfc4501e636" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_6c079923-21d9-40a7-abbd-9738b014daac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ba2794c4-31ee-4422-b3dd-1ee569fe8bd6" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_6c079923-21d9-40a7-abbd-9738b014daac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_f87292e2-f90a-4ab1-8341-85b0fb1c418a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_6c079923-21d9-40a7-abbd-9738b014daac" xlink:to="loc_us-gaap_InvestmentTypeAxis_f87292e2-f90a-4ab1-8341-85b0fb1c418a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_f87292e2-f90a-4ab1-8341-85b0fb1c418a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_f87292e2-f90a-4ab1-8341-85b0fb1c418a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_f87292e2-f90a-4ab1-8341-85b0fb1c418a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_2afdcbbd-892e-4364-b46c-47eeaa22c523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_f87292e2-f90a-4ab1-8341-85b0fb1c418a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_2afdcbbd-892e-4364-b46c-47eeaa22c523" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_a66eefbe-e597-4bc0-966e-cc7ff52fa5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2afdcbbd-892e-4364-b46c-47eeaa22c523" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_a66eefbe-e597-4bc0-966e-cc7ff52fa5e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongtermInvestmentsDomain_bddf82bd-7bf6-4999-bffe-e19a5f73d706" xlink:href="icui-20211231.xsd#icui_LongtermInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2afdcbbd-892e-4364-b46c-47eeaa22c523" xlink:to="loc_icui_LongtermInvestmentsDomain_bddf82bd-7bf6-4999-bffe-e19a5f73d706" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails" xlink:type="extended" id="i971f75d3a26a403c8dc30eefd96b39c0_GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_639cd4e7-12a8-432a-bdb5-5cdd5d9c3dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a68a24cd-f8b6-4b5a-8765-64e3a0a869eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_639cd4e7-12a8-432a-bdb5-5cdd5d9c3dd8" xlink:to="loc_us-gaap_NetIncomeLoss_a68a24cd-f8b6-4b5a-8765-64e3a0a869eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_33f2d535-0f05-4031-a13b-3c5eb05bb599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_639cd4e7-12a8-432a-bdb5-5cdd5d9c3dd8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_33f2d535-0f05-4031-a13b-3c5eb05bb599" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_b1fe3c63-883c-4739-8f80-8ddd65d80da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_639cd4e7-12a8-432a-bdb5-5cdd5d9c3dd8" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_b1fe3c63-883c-4739-8f80-8ddd65d80da2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_47761e4e-7eef-444e-839f-3c8912afb42b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_639cd4e7-12a8-432a-bdb5-5cdd5d9c3dd8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_47761e4e-7eef-444e-839f-3c8912afb42b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_fc2e9975-dd60-486f-9962-ed80ea7c5c13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_639cd4e7-12a8-432a-bdb5-5cdd5d9c3dd8" xlink:to="loc_us-gaap_EarningsPerShareBasic_fc2e9975-dd60-486f-9962-ed80ea7c5c13" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_46ac474e-4cea-41b9-8eb2-b60cbd8a61c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_639cd4e7-12a8-432a-bdb5-5cdd5d9c3dd8" xlink:to="loc_us-gaap_EarningsPerShareDiluted_46ac474e-4cea-41b9-8eb2-b60cbd8a61c8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_28498bbd-8841-4f21-996f-a886084cd694" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_639cd4e7-12a8-432a-bdb5-5cdd5d9c3dd8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_28498bbd-8841-4f21-996f-a886084cd694" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_38f7b4ab-f1ce-4136-a1f6-bd9d14c0fed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_639cd4e7-12a8-432a-bdb5-5cdd5d9c3dd8" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_38f7b4ab-f1ce-4136-a1f6-bd9d14c0fed8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1f47e962-b039-4069-b991-b0c3e5c5255a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_38f7b4ab-f1ce-4136-a1f6-bd9d14c0fed8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1f47e962-b039-4069-b991-b0c3e5c5255a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1f47e962-b039-4069-b991-b0c3e5c5255a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1f47e962-b039-4069-b991-b0c3e5c5255a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1f47e962-b039-4069-b991-b0c3e5c5255a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_df5c8904-84de-4001-b34e-5c0b6b95cc85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1f47e962-b039-4069-b991-b0c3e5c5255a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_df5c8904-84de-4001-b34e-5c0b6b95cc85" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AcquisitionsPursuitVascularTables" xlink:type="simple" xlink:href="icui-20211231.xsd#AcquisitionsPursuitVascularTables"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/AcquisitionsPursuitVascularTables" xlink:type="extended" id="i5026d4466df34ed59424e09d924554eb_AcquisitionsPursuitVascularTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_57b35e04-831f-4fd3-9fe6-091e2d882654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_67076bb4-f61e-482c-83c6-646c5ff7232b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57b35e04-831f-4fd3-9fe6-091e2d882654" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_67076bb4-f61e-482c-83c6-646c5ff7232b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9fae65fd-b297-4b54-9588-c31864a02431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57b35e04-831f-4fd3-9fe6-091e2d882654" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9fae65fd-b297-4b54-9588-c31864a02431" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ccf0fe67-41c3-4519-b902-a430845cf819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9fae65fd-b297-4b54-9588-c31864a02431" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ccf0fe67-41c3-4519-b902-a430845cf819" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ccf0fe67-41c3-4519-b902-a430845cf819_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ccf0fe67-41c3-4519-b902-a430845cf819" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ccf0fe67-41c3-4519-b902-a430845cf819_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a9ff3a3-bdd7-4a66-b4f7-e4e79f11b193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ccf0fe67-41c3-4519-b902-a430845cf819" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a9ff3a3-bdd7-4a66-b4f7-e4e79f11b193" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_81c3035f-1bc3-4648-a801-5699b61d3f3e" xlink:href="icui-20211231.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a9ff3a3-bdd7-4a66-b4f7-e4e79f11b193" xlink:to="loc_icui_PursuitVascularInc.Member_81c3035f-1bc3-4648-a801-5699b61d3f3e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AcquisitionsTextDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#AcquisitionsTextDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/AcquisitionsTextDetails" xlink:type="extended" id="i8f96e54d17b2479189b50792cbe13db4_AcquisitionsTextDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f3eb0451-f227-4046-8af0-8b993b78b229" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b9a88792-1237-4755-aa6e-a0499c918d47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3eb0451-f227-4046-8af0-8b993b78b229" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b9a88792-1237-4755-aa6e-a0499c918d47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_60708386-0295-468a-8532-29e52bf17796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3eb0451-f227-4046-8af0-8b993b78b229" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_60708386-0295-468a-8532-29e52bf17796" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_0274679b-9d7d-451c-8bd1-8976706a7c41" xlink:href="icui-20211231.xsd#icui_Contingentconsiderationgross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3eb0451-f227-4046-8af0-8b993b78b229" xlink:to="loc_icui_Contingentconsiderationgross_0274679b-9d7d-451c-8bd1-8976706a7c41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_051715f4-ab44-4a49-817c-ab60ebde4dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3eb0451-f227-4046-8af0-8b993b78b229" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_051715f4-ab44-4a49-817c-ab60ebde4dcb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5512131d-cedc-4f04-b133-ee3351310164" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3eb0451-f227-4046-8af0-8b993b78b229" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5512131d-cedc-4f04-b133-ee3351310164" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5d4107f0-95d2-4492-8560-64cf9c4362d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5512131d-cedc-4f04-b133-ee3351310164" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5d4107f0-95d2-4492-8560-64cf9c4362d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5d4107f0-95d2-4492-8560-64cf9c4362d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5d4107f0-95d2-4492-8560-64cf9c4362d7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5d4107f0-95d2-4492-8560-64cf9c4362d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21c12abd-8d2a-46b0-aa68-211a9556bfa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5d4107f0-95d2-4492-8560-64cf9c4362d7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21c12abd-8d2a-46b0-aa68-211a9556bfa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_92baab59-ae00-48c0-9663-148006c07aa4" xlink:href="icui-20211231.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21c12abd-8d2a-46b0-aa68-211a9556bfa2" xlink:to="loc_icui_PursuitVascularInc.Member_92baab59-ae00-48c0-9663-148006c07aa4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignDistibutorMember_406752a7-4c0e-4dcd-8324-c41495bee62f" xlink:href="icui-20211231.xsd#icui_ForeignDistibutorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21c12abd-8d2a-46b0-aa68-211a9556bfa2" xlink:to="loc_icui_ForeignDistibutorMember_406752a7-4c0e-4dcd-8324-c41495bee62f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularLLCMember_8f12d8d5-b694-4add-bfb3-64adaeeeca0b" xlink:href="icui-20211231.xsd#icui_PursuitVascularLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21c12abd-8d2a-46b0-aa68-211a9556bfa2" xlink:to="loc_icui_PursuitVascularLLCMember_8f12d8d5-b694-4add-bfb3-64adaeeeca0b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#AcquisitionsPursuitVascularTableDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails" xlink:type="extended" id="i2ae70560888c403c9e4ac8444eb0c05b_AcquisitionsPursuitVascularTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments_e4f78b5d-4b08-4b5a-aac5-7dd2b78758be" xlink:href="icui-20211231.xsd#icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments_e4f78b5d-4b08-4b5a-aac5-7dd2b78758be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_893a64bc-a04f-499c-abad-9301dee402bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_893a64bc-a04f-499c-abad-9301dee402bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_bcc70f06-73a8-446c-834f-def446c52778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_bcc70f06-73a8-446c-834f-def446c52778" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesFairValue_0aaf5894-32da-4386-ae79-23c3de7e7865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquiredReceivablesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationAcquiredReceivablesFairValue_0aaf5894-32da-4386-ae79-23c3de7e7865" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_97f81b0a-4e3d-4059-9af4-79c414964879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_97f81b0a-4e3d-4059-9af4-79c414964879" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_bbb2683d-cbf2-4d52-9a8d-8e28b85096ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_bbb2683d-cbf2-4d52-9a8d-8e28b85096ba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_73be0025-2605-4a38-b7e8-98ced1634472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_73be0025-2605-4a38-b7e8-98ced1634472" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7c540868-c885-44ee-9f97-ab17f2d4306c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7c540868-c885-44ee-9f97-ab17f2d4306c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_45f42ab5-cb42-4d2b-86ac-08350a34abe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_45f42ab5-cb42-4d2b-86ac-08350a34abe5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_a84cbb97-d5d0-459e-8185-ca80760fa5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_a84cbb97-d5d0-459e-8185-ca80760fa5fd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_edb8af83-5351-48bf-bf92-7ea79e2da5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_edb8af83-5351-48bf-bf92-7ea79e2da5cb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_03c5009d-e090-41d4-80dc-69c580f4a999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_03c5009d-e090-41d4-80dc-69c580f4a999" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_149160d4-c3d9-438d-8bef-5a59ebf09944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_149160d4-c3d9-438d-8bef-5a59ebf09944" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f63e9d31-95e2-418f-89ee-17bad071a347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f63e9d31-95e2-418f-89ee-17bad071a347" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0581b8a7-2b44-462a-95e8-bbc29d5a28d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f63e9d31-95e2-418f-89ee-17bad071a347" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0581b8a7-2b44-462a-95e8-bbc29d5a28d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0581b8a7-2b44-462a-95e8-bbc29d5a28d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0581b8a7-2b44-462a-95e8-bbc29d5a28d7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0581b8a7-2b44-462a-95e8-bbc29d5a28d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1be31d5b-5131-42cc-b299-80ff3e2760bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0581b8a7-2b44-462a-95e8-bbc29d5a28d7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1be31d5b-5131-42cc-b299-80ff3e2760bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_709dced6-e39c-4cee-9525-4dc26bbfc3c5" xlink:href="icui-20211231.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1be31d5b-5131-42cc-b299-80ff3e2760bb" xlink:to="loc_icui_PursuitVascularInc.Member_709dced6-e39c-4cee-9525-4dc26bbfc3c5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AcquisitionsPursuitVascularIntangibleDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#AcquisitionsPursuitVascularIntangibleDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/AcquisitionsPursuitVascularIntangibleDetails" xlink:type="extended" id="ice81505568e14df19c96862be217587d_AcquisitionsPursuitVascularIntangibleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_23e25766-5a18-4a77-bf23-e9975a34bb8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_edf8058a-0b7c-4a84-87b9-b4a1072f07b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_23e25766-5a18-4a77-bf23-e9975a34bb8a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_edf8058a-0b7c-4a84-87b9-b4a1072f07b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_3a879f52-2114-43b2-8412-9a2468753bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_23e25766-5a18-4a77-bf23-e9975a34bb8a" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_3a879f52-2114-43b2-8412-9a2468753bb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_0e3c03dc-bf2f-4400-89e7-bfa1acf10b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_23e25766-5a18-4a77-bf23-e9975a34bb8a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_0e3c03dc-bf2f-4400-89e7-bfa1acf10b7d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_81ada68c-0580-44f2-a917-643ecfbe8948" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_0e3c03dc-bf2f-4400-89e7-bfa1acf10b7d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_81ada68c-0580-44f2-a917-643ecfbe8948" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81ada68c-0580-44f2-a917-643ecfbe8948_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_81ada68c-0580-44f2-a917-643ecfbe8948" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81ada68c-0580-44f2-a917-643ecfbe8948_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9edb395d-70e9-463a-acf3-e1a9524a3669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_81ada68c-0580-44f2-a917-643ecfbe8948" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9edb395d-70e9-463a-acf3-e1a9524a3669" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_bc7b86fb-e255-4415-8049-8605962096d2" xlink:href="icui-20211231.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9edb395d-70e9-463a-acf3-e1a9524a3669" xlink:to="loc_icui_PursuitVascularInc.Member_bc7b86fb-e255-4415-8049-8605962096d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ea4af82c-7a6f-48d7-b374-27b0914ac4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_0e3c03dc-bf2f-4400-89e7-bfa1acf10b7d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ea4af82c-7a6f-48d7-b374-27b0914ac4ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ea4af82c-7a6f-48d7-b374-27b0914ac4ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ea4af82c-7a6f-48d7-b374-27b0914ac4ba" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ea4af82c-7a6f-48d7-b374-27b0914ac4ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dc8034f8-edb0-432a-8f79-ec8fb164b3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ea4af82c-7a6f-48d7-b374-27b0914ac4ba" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dc8034f8-edb0-432a-8f79-ec8fb164b3b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_177d0951-1359-41e3-a7b0-b11673f50894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dc8034f8-edb0-432a-8f79-ec8fb164b3b6" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_177d0951-1359-41e3-a7b0-b11673f50894" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_be74d156-d319-4a57-b733-cdbfd8c6ac3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dc8034f8-edb0-432a-8f79-ec8fb164b3b6" xlink:to="loc_us-gaap_TradeNamesMember_be74d156-d319-4a57-b733-cdbfd8c6ac3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_4c95e8c9-0fcb-40c2-ae80-2ff07aa0ae1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dc8034f8-edb0-432a-8f79-ec8fb164b3b6" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_4c95e8c9-0fcb-40c2-ae80-2ff07aa0ae1f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AcquisitionsForeignInfusionSystemsSupplierDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#AcquisitionsForeignInfusionSystemsSupplierDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/AcquisitionsForeignInfusionSystemsSupplierDetails" xlink:type="extended" id="i4af933c4ab2543a68b81d5a20c3963be_AcquisitionsForeignInfusionSystemsSupplierDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5cc7dd2b-e640-47ee-994d-9f240a312343" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_9374c97e-af08-4a5d-8344-e2b7ae293116" xlink:href="icui-20211231.xsd#icui_Contingentconsiderationgross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5cc7dd2b-e640-47ee-994d-9f240a312343" xlink:to="loc_icui_Contingentconsiderationgross_9374c97e-af08-4a5d-8344-e2b7ae293116" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermContingentConsiderationGross_64f1772f-b9b9-4d13-bfd7-c6fa7571d9a8" xlink:href="icui-20211231.xsd#icui_ShortTermContingentConsiderationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5cc7dd2b-e640-47ee-994d-9f240a312343" xlink:to="loc_icui_ShortTermContingentConsiderationGross_64f1772f-b9b9-4d13-bfd7-c6fa7571d9a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermContingentConsiderationGross_e61c000f-b32b-442b-9b07-6b606b85274e" xlink:href="icui-20211231.xsd#icui_LongTermContingentConsiderationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5cc7dd2b-e640-47ee-994d-9f240a312343" xlink:to="loc_icui_LongTermContingentConsiderationGross_e61c000f-b32b-442b-9b07-6b606b85274e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_38d4a3d4-d027-4afd-93a4-b66ce323dc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5cc7dd2b-e640-47ee-994d-9f240a312343" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_38d4a3d4-d027-4afd-93a4-b66ce323dc8e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationConsiderationCashHoldback_5875c9e6-9094-4481-abf4-c1ea04110748" xlink:href="icui-20211231.xsd#icui_BusinessCombinationConsiderationCashHoldback"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5cc7dd2b-e640-47ee-994d-9f240a312343" xlink:to="loc_icui_BusinessCombinationConsiderationCashHoldback_5875c9e6-9094-4481-abf4-c1ea04110748" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a696eb6e-8120-4e4b-b6a2-c1388e2a2286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5cc7dd2b-e640-47ee-994d-9f240a312343" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a696eb6e-8120-4e4b-b6a2-c1388e2a2286" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bbae4c1f-196a-445e-b7a3-7cf14c993584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a696eb6e-8120-4e4b-b6a2-c1388e2a2286" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bbae4c1f-196a-445e-b7a3-7cf14c993584" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bbae4c1f-196a-445e-b7a3-7cf14c993584_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bbae4c1f-196a-445e-b7a3-7cf14c993584" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bbae4c1f-196a-445e-b7a3-7cf14c993584_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_61d4c34d-281d-45af-b88b-afb4708420e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bbae4c1f-196a-445e-b7a3-7cf14c993584" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_61d4c34d-281d-45af-b88b-afb4708420e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_ea77c5ee-f77f-4524-ae7d-89bd21a5991b" xlink:href="icui-20211231.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_61d4c34d-281d-45af-b88b-afb4708420e3" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_ea77c5ee-f77f-4524-ae7d-89bd21a5991b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails1" xlink:type="simple" xlink:href="icui-20211231.xsd#RestructuringStrategicTransactionandIntegrationDetails1"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails1" xlink:type="extended" id="i889ba9981e134d9883647c667eaa8bc4_RestructuringStrategicTransactionandIntegrationDetails1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_641c0385-c7f9-497b-bd9c-2a98a8145787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_92478776-bd65-4dd8-84e9-77ef328c43d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_641c0385-c7f9-497b-bd9c-2a98a8145787" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_92478776-bd65-4dd8-84e9-77ef328c43d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RestructuringAdjustmentsSeveranceAndFacility_6fb68e56-0353-4d8d-b918-e70cd5af6fbd" xlink:href="icui-20211231.xsd#icui_RestructuringAdjustmentsSeveranceAndFacility"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_641c0385-c7f9-497b-bd9c-2a98a8145787" xlink:to="loc_icui_RestructuringAdjustmentsSeveranceAndFacility_6fb68e56-0353-4d8d-b918-e70cd5af6fbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6182709b-4e98-41be-9c6f-e63a868061da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_641c0385-c7f9-497b-bd9c-2a98a8145787" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6182709b-4e98-41be-9c6f-e63a868061da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_dbf05479-c297-4d56-aa68-5021005a9112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6182709b-4e98-41be-9c6f-e63a868061da" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_dbf05479-c297-4d56-aa68-5021005a9112" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_dbf05479-c297-4d56-aa68-5021005a9112_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_dbf05479-c297-4d56-aa68-5021005a9112" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_dbf05479-c297-4d56-aa68-5021005a9112_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_2c6976d0-83dc-4490-86eb-ab16f80ddfbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_dbf05479-c297-4d56-aa68-5021005a9112" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_2c6976d0-83dc-4490-86eb-ab16f80ddfbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_c3c4e54a-49b9-4617-aaea-d24e22aea4b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_2c6976d0-83dc-4490-86eb-ab16f80ddfbb" xlink:to="loc_us-gaap_FacilityClosingMember_c3c4e54a-49b9-4617-aaea-d24e22aea4b0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails2" xlink:type="simple" xlink:href="icui-20211231.xsd#RestructuringStrategicTransactionandIntegrationDetails2"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails2" xlink:type="extended" id="i090df861ef5f4cefa20b231c01f027dd_RestructuringStrategicTransactionandIntegrationDetails2">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_59145e0a-8648-4e0f-a609-3f6b7b943311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_e761d2b8-c32b-4501-bbff-8943677cc319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_59145e0a-8648-4e0f-a609-3f6b7b943311" xlink:to="loc_us-gaap_RestructuringReserve_e761d2b8-c32b-4501-bbff-8943677cc319" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_0c5b71a4-9afa-47f7-9697-89c477262f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_59145e0a-8648-4e0f-a609-3f6b7b943311" xlink:to="loc_us-gaap_RestructuringCosts_0c5b71a4-9afa-47f7-9697-89c477262f5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_5f2a02f5-473e-4850-9e18-8e183ac743d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_59145e0a-8648-4e0f-a609-3f6b7b943311" xlink:to="loc_us-gaap_PaymentsForRestructuring_5f2a02f5-473e-4850-9e18-8e183ac743d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_3f9ce30c-3da0-4265-a4ac-434340abeaff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_59145e0a-8648-4e0f-a609-3f6b7b943311" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_3f9ce30c-3da0-4265-a4ac-434340abeaff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_f45e9dee-2d95-43b3-ba2c-b9bf0a399b54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_59145e0a-8648-4e0f-a609-3f6b7b943311" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_f45e9dee-2d95-43b3-ba2c-b9bf0a399b54" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8790be9f-4f8a-4b42-99e9-0fb1cf0ffdbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_59145e0a-8648-4e0f-a609-3f6b7b943311" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8790be9f-4f8a-4b42-99e9-0fb1cf0ffdbb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_67e7d35f-c8cd-461a-b8c0-050e397e1687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8790be9f-4f8a-4b42-99e9-0fb1cf0ffdbb" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_67e7d35f-c8cd-461a-b8c0-050e397e1687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_67e7d35f-c8cd-461a-b8c0-050e397e1687_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_67e7d35f-c8cd-461a-b8c0-050e397e1687" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_67e7d35f-c8cd-461a-b8c0-050e397e1687_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_bfb750fe-ad85-4e90-83d3-6575c1bebdfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_67e7d35f-c8cd-461a-b8c0-050e397e1687" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_bfb750fe-ad85-4e90-83d3-6575c1bebdfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_957025f5-a363-41c4-bf4f-6ac0b3976ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_bfb750fe-ad85-4e90-83d3-6575c1bebdfb" xlink:to="loc_us-gaap_EmployeeSeveranceMember_957025f5-a363-41c4-bf4f-6ac0b3976ef0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SpecialTerminationBenefitsMember_5b40b5c8-a0db-4206-9623-2a730add452d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SpecialTerminationBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_bfb750fe-ad85-4e90-83d3-6575c1bebdfb" xlink:to="loc_us-gaap_SpecialTerminationBenefitsMember_5b40b5c8-a0db-4206-9623-2a730add452d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_3bb6a556-7d39-4faf-8707-9dbe9881cdd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_bfb750fe-ad85-4e90-83d3-6575c1bebdfb" xlink:to="loc_us-gaap_FacilityClosingMember_3bb6a556-7d39-4faf-8707-9dbe9881cdd8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDisaggregationofRevenueProductLineDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#RevenueDisaggregationofRevenueProductLineDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RevenueDisaggregationofRevenueProductLineDetails" xlink:type="extended" id="i19e96e9fe3fa4a52ad507bea5fd45436_RevenueDisaggregationofRevenueProductLineDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c4b7cde9-5189-45e2-bef0-d3c31dc8bc74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_1e1d833c-8323-4b79-abab-5aab9ec35848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c4b7cde9-5189-45e2-bef0-d3c31dc8bc74" xlink:to="loc_us-gaap_Revenues_1e1d833c-8323-4b79-abab-5aab9ec35848" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Percentageofrevenue_ce17f8ef-e7b1-4053-bfbc-1e7fb40bdd0f" xlink:href="icui-20211231.xsd#icui_Percentageofrevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c4b7cde9-5189-45e2-bef0-d3c31dc8bc74" xlink:to="loc_icui_Percentageofrevenue_ce17f8ef-e7b1-4053-bfbc-1e7fb40bdd0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_f050c84b-d2ac-4c2e-956f-84b03b409ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c4b7cde9-5189-45e2-bef0-d3c31dc8bc74" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_f050c84b-d2ac-4c2e-956f-84b03b409ebf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_fba5e580-b566-4abc-9788-aea5862e57a8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f050c84b-d2ac-4c2e-956f-84b03b409ebf" xlink:to="loc_srt_ProductOrServiceAxis_fba5e580-b566-4abc-9788-aea5862e57a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fba5e580-b566-4abc-9788-aea5862e57a8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_fba5e580-b566-4abc-9788-aea5862e57a8" xlink:to="loc_srt_ProductsAndServicesDomain_fba5e580-b566-4abc-9788-aea5862e57a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7c9b333e-e2c8-41dd-841b-a2e9d7dee86b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_fba5e580-b566-4abc-9788-aea5862e57a8" xlink:to="loc_srt_ProductsAndServicesDomain_7c9b333e-e2c8-41dd-841b-a2e9d7dee86b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionConsumablesMember_bff4c654-9dde-48ef-bdb9-107c4ddc83c4" xlink:href="icui-20211231.xsd#icui_InfusionConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7c9b333e-e2c8-41dd-841b-a2e9d7dee86b" xlink:to="loc_icui_InfusionConsumablesMember_bff4c654-9dde-48ef-bdb9-107c4ddc83c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionSystemsMember_6a94d0f1-1173-43dc-b873-76332875be45" xlink:href="icui-20211231.xsd#icui_InfusionSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7c9b333e-e2c8-41dd-841b-a2e9d7dee86b" xlink:to="loc_icui_InfusionSystemsMember_6a94d0f1-1173-43dc-b873-76332875be45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IVSolutionsMember_a84d03f6-079c-401c-83b4-668636556319" xlink:href="icui-20211231.xsd#icui_IVSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7c9b333e-e2c8-41dd-841b-a2e9d7dee86b" xlink:to="loc_icui_IVSolutionsMember_a84d03f6-079c-401c-83b4-668636556319" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CriticalCareMember_8917d7ab-5790-4219-a324-5996bce7c5dd" xlink:href="icui-20211231.xsd#icui_CriticalCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7c9b333e-e2c8-41dd-841b-a2e9d7dee86b" xlink:to="loc_icui_CriticalCareMember_8917d7ab-5790-4219-a324-5996bce7c5dd" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDisaggregationofRevenuebyGeographyDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#RevenueDisaggregationofRevenuebyGeographyDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RevenueDisaggregationofRevenuebyGeographyDetails" xlink:type="extended" id="i9ac80483bda44d62a7cc03fca67b6af6_RevenueDisaggregationofRevenuebyGeographyDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_9e03a600-2247-47c2-a697-ad92375ab191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Percentoftotalrevenue_6975b757-a371-4f0e-976b-f78b64661129" xlink:href="icui-20211231.xsd#icui_Percentoftotalrevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9e03a600-2247-47c2-a697-ad92375ab191" xlink:to="loc_icui_Percentoftotalrevenue_6975b757-a371-4f0e-976b-f78b64661129" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a590dcaa-b80f-4b68-b01e-381243289f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9e03a600-2247-47c2-a697-ad92375ab191" xlink:to="loc_us-gaap_Revenues_a590dcaa-b80f-4b68-b01e-381243289f2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_79283f46-b9a1-4ebf-b2b5-6e5170b7a754" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9e03a600-2247-47c2-a697-ad92375ab191" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_79283f46-b9a1-4ebf-b2b5-6e5170b7a754" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f2327687-3ba1-40d0-b4ae-87c7d23abf17" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_79283f46-b9a1-4ebf-b2b5-6e5170b7a754" xlink:to="loc_srt_StatementGeographicalAxis_f2327687-3ba1-40d0-b4ae-87c7d23abf17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f2327687-3ba1-40d0-b4ae-87c7d23abf17_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f2327687-3ba1-40d0-b4ae-87c7d23abf17" xlink:to="loc_srt_SegmentGeographicalDomain_f2327687-3ba1-40d0-b4ae-87c7d23abf17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d2dbb542-e5b6-4b1f-a778-46e26f70b355" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f2327687-3ba1-40d0-b4ae-87c7d23abf17" xlink:to="loc_srt_SegmentGeographicalDomain_d2dbb542-e5b6-4b1f-a778-46e26f70b355" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_7c4b4273-23a5-4bc5-bcb2-40426a17e41e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d2dbb542-e5b6-4b1f-a778-46e26f70b355" xlink:to="loc_us-gaap_EMEAMember_7c4b4273-23a5-4bc5-bcb2-40426a17e41e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherforeigncountriesMember_626cff77-3124-4a61-975c-624a33933b77" xlink:href="icui-20211231.xsd#icui_OtherforeigncountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d2dbb542-e5b6-4b1f-a778-46e26f70b355" xlink:to="loc_icui_OtherforeigncountriesMember_626cff77-3124-4a61-975c-624a33933b77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignMember_0bed0b9e-b506-4cf7-b491-fbe7db516abf" xlink:href="icui-20211231.xsd#icui_ForeignMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d2dbb542-e5b6-4b1f-a778-46e26f70b355" xlink:to="loc_icui_ForeignMember_0bed0b9e-b506-4cf7-b491-fbe7db516abf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_44935cba-880c-46b6-985d-1808ee970e5f" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d2dbb542-e5b6-4b1f-a778-46e26f70b355" xlink:to="loc_country_US_44935cba-880c-46b6-985d-1808ee970e5f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InternationalSalesDomain_e383f2e3-ef22-4f63-b235-6ee071e60388" xlink:href="icui-20211231.xsd#icui_InternationalSalesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d2dbb542-e5b6-4b1f-a778-46e26f70b355" xlink:to="loc_icui_InternationalSalesDomain_e383f2e3-ef22-4f63-b235-6ee071e60388" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueContractLiabilitiesDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#RevenueContractLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RevenueContractLiabilitiesDetails" xlink:type="extended" id="i19512709623e430597c6b05a29d9d9c3_RevenueContractLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesLineItems_2cf71310-0509-436f-9b0c-573c0c4978f6" xlink:href="icui-20211231.xsd#icui_ContractassetandliabilitybalancesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_COntractLiabilityRollforwardRollForward_553b60be-69f3-499d-bfb7-04161c79e66a" xlink:href="icui-20211231.xsd#icui_COntractLiabilityRollforwardRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_2cf71310-0509-436f-9b0c-573c0c4978f6" xlink:to="loc_icui_COntractLiabilityRollforwardRollForward_553b60be-69f3-499d-bfb7-04161c79e66a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_9051a92e-df9b-477f-b4c4-ea79a9b655c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_COntractLiabilityRollforwardRollForward_553b60be-69f3-499d-bfb7-04161c79e66a" xlink:to="loc_us-gaap_ContractWithCustomerLiability_9051a92e-df9b-477f-b4c4-ea79a9b655c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_5833759c-fa83-402d-b9a4-706c0f9bf271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_COntractLiabilityRollforwardRollForward_553b60be-69f3-499d-bfb7-04161c79e66a" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_5833759c-fa83-402d-b9a4-706c0f9bf271" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueAdditions_c3f18b96-a30e-4a5a-9813-77166de458e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_COntractLiabilityRollforwardRollForward_553b60be-69f3-499d-bfb7-04161c79e66a" xlink:to="loc_us-gaap_DeferredRevenueAdditions_c3f18b96-a30e-4a5a-9813-77166de458e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_c364101d-ee51-4a6b-b8ed-291cd976c405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesTable_66d914dc-d92f-48b9-bbbf-5dc2417f7308" xlink:href="icui-20211231.xsd#icui_ContractassetandliabilitybalancesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_2cf71310-0509-436f-9b0c-573c0c4978f6" xlink:to="loc_icui_ContractassetandliabilitybalancesTable_66d914dc-d92f-48b9-bbbf-5dc2417f7308" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_728bdeb9-929f-4d68-935b-1f152372ce89" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_66d914dc-d92f-48b9-bbbf-5dc2417f7308" xlink:to="loc_srt_ProductOrServiceAxis_728bdeb9-929f-4d68-935b-1f152372ce89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_728bdeb9-929f-4d68-935b-1f152372ce89_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_728bdeb9-929f-4d68-935b-1f152372ce89" xlink:to="loc_srt_ProductsAndServicesDomain_728bdeb9-929f-4d68-935b-1f152372ce89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1d02e4dd-8f52-4bb0-ade6-e3e621ee3522" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_728bdeb9-929f-4d68-935b-1f152372ce89" xlink:to="loc_srt_ProductsAndServicesDomain_1d02e4dd-8f52-4bb0-ade6-e3e621ee3522" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EquipmentrevenueMember_c0bc4a3f-3311-4f98-842c-7271389a52c7" xlink:href="icui-20211231.xsd#icui_EquipmentrevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1d02e4dd-8f52-4bb0-ade6-e3e621ee3522" xlink:to="loc_icui_EquipmentrevenueMember_c0bc4a3f-3311-4f98-842c-7271389a52c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SoftwarerevenueMember_727fd294-6336-4f15-96f2-25d67f49448d" xlink:href="icui-20211231.xsd#icui_SoftwarerevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1d02e4dd-8f52-4bb0-ade6-e3e621ee3522" xlink:to="loc_icui_SoftwarerevenueMember_727fd294-6336-4f15-96f2-25d67f49448d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueContractLiabilitiesTextDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#RevenueContractLiabilitiesTextDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RevenueContractLiabilitiesTextDetails" xlink:type="extended" id="i901977201a6949d2842fcf2d6fc80d7d_RevenueContractLiabilitiesTextDetails">
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesLineItems_9148698e-62fa-4bd9-89b3-75291de0ebec" xlink:href="icui-20211231.xsd#icui_ContractassetandliabilitybalancesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_0ff2b126-3324-400a-8733-711860a8966a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_9148698e-62fa-4bd9-89b3-75291de0ebec" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_0ff2b126-3324-400a-8733-711860a8966a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_d5413aff-ae5f-4f50-bd06-9c393a05aa35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_9148698e-62fa-4bd9-89b3-75291de0ebec" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_d5413aff-ae5f-4f50-bd06-9c393a05aa35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesTable_5e238cda-a8dd-4d37-89c7-55431a39411e" xlink:href="icui-20211231.xsd#icui_ContractassetandliabilitybalancesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_9148698e-62fa-4bd9-89b3-75291de0ebec" xlink:to="loc_icui_ContractassetandliabilitybalancesTable_5e238cda-a8dd-4d37-89c7-55431a39411e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0a964030-9b18-46b8-b8a2-5220b413eb47" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_5e238cda-a8dd-4d37-89c7-55431a39411e" xlink:to="loc_srt_ProductOrServiceAxis_0a964030-9b18-46b8-b8a2-5220b413eb47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0a964030-9b18-46b8-b8a2-5220b413eb47_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_0a964030-9b18-46b8-b8a2-5220b413eb47" xlink:to="loc_srt_ProductsAndServicesDomain_0a964030-9b18-46b8-b8a2-5220b413eb47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_92468c7f-1d72-4b64-b272-8997c7b61efa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_0a964030-9b18-46b8-b8a2-5220b413eb47" xlink:to="loc_srt_ProductsAndServicesDomain_92468c7f-1d72-4b64-b272-8997c7b61efa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EquipmentrevenueMember_419d9707-e026-4661-ad03-ef5c97a541c9" xlink:href="icui-20211231.xsd#icui_EquipmentrevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_92468c7f-1d72-4b64-b272-8997c7b61efa" xlink:to="loc_icui_EquipmentrevenueMember_419d9707-e026-4661-ad03-ef5c97a541c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SoftwarerevenueMember_dfd3fbe4-a895-4382-8d0c-88dfa712eb74" xlink:href="icui-20211231.xsd#icui_SoftwarerevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_92468c7f-1d72-4b64-b272-8997c7b61efa" xlink:to="loc_icui_SoftwarerevenueMember_dfd3fbe4-a895-4382-8d0c-88dfa712eb74" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#LeasesDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/LeasesDetails" xlink:type="extended" id="if6a564b1254344be9beeac3b9ab3d38f_LeasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4b761bf-37a7-4598-a822-49187144d3be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Optiontoextendinyears_3a164583-6108-45c6-a672-8f55aeaa5cfb" xlink:href="icui-20211231.xsd#icui_Optiontoextendinyears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4b761bf-37a7-4598-a822-49187144d3be" xlink:to="loc_icui_Optiontoextendinyears_3a164583-6108-45c6-a672-8f55aeaa5cfb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_82779e3d-46b7-4b81-bf9b-b68a68f47eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4b761bf-37a7-4598-a822-49187144d3be" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_82779e3d-46b7-4b81-bf9b-b68a68f47eb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_66102017-1f14-4b4e-a428-9919b715ab5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4b761bf-37a7-4598-a822-49187144d3be" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_66102017-1f14-4b4e-a428-9919b715ab5f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ed5015d9-3f36-4196-9d59-9a3bdda0c7cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_66102017-1f14-4b4e-a428-9919b715ab5f" xlink:to="loc_srt_RangeAxis_ed5015d9-3f36-4196-9d59-9a3bdda0c7cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ed5015d9-3f36-4196-9d59-9a3bdda0c7cc_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ed5015d9-3f36-4196-9d59-9a3bdda0c7cc" xlink:to="loc_srt_RangeMember_ed5015d9-3f36-4196-9d59-9a3bdda0c7cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0a0acd3e-312f-4e5a-aef6-6de4fa51d7ba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ed5015d9-3f36-4196-9d59-9a3bdda0c7cc" xlink:to="loc_srt_RangeMember_0a0acd3e-312f-4e5a-aef6-6de4fa51d7ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_704e7962-445d-4eda-a5cb-9f78f82234e4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0a0acd3e-312f-4e5a-aef6-6de4fa51d7ba" xlink:to="loc_srt_MinimumMember_704e7962-445d-4eda-a5cb-9f78f82234e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e02cd580-00a9-4f5d-8373-84c5938e3173" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0a0acd3e-312f-4e5a-aef6-6de4fa51d7ba" xlink:to="loc_srt_MaximumMember_e02cd580-00a9-4f5d-8373-84c5938e3173" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#ShareBasedAwardStockOptionPlansDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails" xlink:type="extended" id="ib64d1fddbeee46b9ac0a5a4115e6e711_ShareBasedAwardStockOptionPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_icui_StockIncentivePlansLineItems_e9dcabfe-2dc9-4a42-8d57-2b0e7fc615d4" xlink:href="icui-20211231.xsd#icui_StockIncentivePlansLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_58fd230d-3ada-478b-872a-5c06614410a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_StockIncentivePlansLineItems_e9dcabfe-2dc9-4a42-8d57-2b0e7fc615d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_58fd230d-3ada-478b-872a-5c06614410a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_fd980ffc-0a3a-42ea-9ef3-335f2ff5ecfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_StockIncentivePlansLineItems_e9dcabfe-2dc9-4a42-8d57-2b0e7fc615d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_fd980ffc-0a3a-42ea-9ef3-335f2ff5ecfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Sharestransferredfromsupersededplan_bda14d69-f8f8-4d9a-a0c7-4ca71ee93211" xlink:href="icui-20211231.xsd#icui_Sharestransferredfromsupersededplan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_StockIncentivePlansLineItems_e9dcabfe-2dc9-4a42-8d57-2b0e7fc615d4" xlink:to="loc_icui_Sharestransferredfromsupersededplan_bda14d69-f8f8-4d9a-a0c7-4ca71ee93211" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_062b08f6-2782-4b8b-b86b-a5537168ac03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_StockIncentivePlansLineItems_e9dcabfe-2dc9-4a42-8d57-2b0e7fc615d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_062b08f6-2782-4b8b-b86b-a5537168ac03" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_StockIncentivePlansTable_a143d03d-aaf7-497b-8ee9-72432479ccb4" xlink:href="icui-20211231.xsd#icui_StockIncentivePlansTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_icui_StockIncentivePlansLineItems_e9dcabfe-2dc9-4a42-8d57-2b0e7fc615d4" xlink:to="loc_icui_StockIncentivePlansTable_a143d03d-aaf7-497b-8ee9-72432479ccb4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_df719b4d-4abb-443f-b2cf-6439bc52b282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_StockIncentivePlansTable_a143d03d-aaf7-497b-8ee9-72432479ccb4" xlink:to="loc_us-gaap_AwardTypeAxis_df719b4d-4abb-443f-b2cf-6439bc52b282" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_df719b4d-4abb-443f-b2cf-6439bc52b282_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_df719b4d-4abb-443f-b2cf-6439bc52b282" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_df719b4d-4abb-443f-b2cf-6439bc52b282_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_54efda05-001a-49f2-a98a-24139a1424b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_df719b4d-4abb-443f-b2cf-6439bc52b282" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_54efda05-001a-49f2-a98a-24139a1424b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8306b634-4686-4100-b320-805b5ffcfbf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_54efda05-001a-49f2-a98a-24139a1424b0" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8306b634-4686-4100-b320-805b5ffcfbf8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_46db19f9-387b-485c-b7d0-9b1d437f717f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_54efda05-001a-49f2-a98a-24139a1424b0" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_46db19f9-387b-485c-b7d0-9b1d437f717f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b76405f2-ad71-4ff8-9d08-760008c9f3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_StockIncentivePlansTable_a143d03d-aaf7-497b-8ee9-72432479ccb4" xlink:to="loc_us-gaap_PlanNameAxis_b76405f2-ad71-4ff8-9d08-760008c9f3a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b76405f2-ad71-4ff8-9d08-760008c9f3a2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_b76405f2-ad71-4ff8-9d08-760008c9f3a2" xlink:to="loc_us-gaap_PlanNameDomain_b76405f2-ad71-4ff8-9d08-760008c9f3a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_206456c4-41d0-414c-a316-afd399c83710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_b76405f2-ad71-4ff8-9d08-760008c9f3a2" xlink:to="loc_us-gaap_PlanNameDomain_206456c4-41d0-414c-a316-afd399c83710" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_A2011PlanMember_e139f772-1e1e-484c-9590-a6a7b09b07a3" xlink:href="icui-20211231.xsd#icui_A2011PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_206456c4-41d0-414c-a316-afd399c83710" xlink:to="loc_icui_A2011PlanMember_e139f772-1e1e-484c-9590-a6a7b09b07a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_A2003PlanMember_0a415448-270a-40b1-b896-bd9bd720c5fa" xlink:href="icui-20211231.xsd#icui_A2003PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_206456c4-41d0-414c-a316-afd399c83710" xlink:to="loc_icui_A2003PlanMember_0a415448-270a-40b1-b896-bd9bd720c5fa" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#ShareBasedAwardStockOptionsGrantedandValuationDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails" xlink:type="extended" id="i8fda3967b06b43dbaaca453c5c26fc06_ShareBasedAwardStockOptionsGrantedandValuationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de5589b5-8cc3-4d37-8197-a3e38263ed3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_fe85bf0b-5e05-4558-bf70-b9ded66f6c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de5589b5-8cc3-4d37-8197-a3e38263ed3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_fe85bf0b-5e05-4558-bf70-b9ded66f6c0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Timebasedoptionsgrantdatefairvalue_e94fe7e3-bea8-40a2-bbfc-2deb05e152dc" xlink:href="icui-20211231.xsd#icui_Timebasedoptionsgrantdatefairvalue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de5589b5-8cc3-4d37-8197-a3e38263ed3a" xlink:to="loc_icui_Timebasedoptionsgrantdatefairvalue_e94fe7e3-bea8-40a2-bbfc-2deb05e152dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_46efe5c6-c427-4b2f-8ac8-c0903270fab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de5589b5-8cc3-4d37-8197-a3e38263ed3a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_46efe5c6-c427-4b2f-8ac8-c0903270fab2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_869b6672-7548-47e5-aae9-d68f7adefb72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de5589b5-8cc3-4d37-8197-a3e38263ed3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_869b6672-7548-47e5-aae9-d68f7adefb72" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ad25d547-ba6a-4291-8738-0df35a593449" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de5589b5-8cc3-4d37-8197-a3e38263ed3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ad25d547-ba6a-4291-8738-0df35a593449" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e01c2b4d-7edf-4d39-8cb2-25b1580d600e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de5589b5-8cc3-4d37-8197-a3e38263ed3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e01c2b4d-7edf-4d39-8cb2-25b1580d600e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0c3a7946-012c-436d-9c34-fa8b5e89ef4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de5589b5-8cc3-4d37-8197-a3e38263ed3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0c3a7946-012c-436d-9c34-fa8b5e89ef4c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ce249b3b-400e-4850-b8ac-671828ea4196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de5589b5-8cc3-4d37-8197-a3e38263ed3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ce249b3b-400e-4850-b8ac-671828ea4196" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1f3418-4a15-4c47-ab83-a186e4a93f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de5589b5-8cc3-4d37-8197-a3e38263ed3a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1f3418-4a15-4c47-ab83-a186e4a93f06" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b3f7d965-2858-42f2-93f6-eb397e7adc52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1f3418-4a15-4c47-ab83-a186e4a93f06" xlink:to="loc_us-gaap_PlanNameAxis_b3f7d965-2858-42f2-93f6-eb397e7adc52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b3f7d965-2858-42f2-93f6-eb397e7adc52_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_b3f7d965-2858-42f2-93f6-eb397e7adc52" xlink:to="loc_us-gaap_PlanNameDomain_b3f7d965-2858-42f2-93f6-eb397e7adc52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e1b5ac3a-b04e-4d6b-9719-412e13205cce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_b3f7d965-2858-42f2-93f6-eb397e7adc52" xlink:to="loc_us-gaap_PlanNameDomain_e1b5ac3a-b04e-4d6b-9719-412e13205cce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_A2011PlanMember_dc1d5007-938e-4f57-933e-630031db5ca8" xlink:href="icui-20211231.xsd#icui_A2011PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_e1b5ac3a-b04e-4d6b-9719-412e13205cce" xlink:to="loc_icui_A2011PlanMember_dc1d5007-938e-4f57-933e-630031db5ca8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_A2003PlanMember_e76abbce-e403-4fcd-b73e-fd2b5144ec5a" xlink:href="icui-20211231.xsd#icui_A2003PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_e1b5ac3a-b04e-4d6b-9719-412e13205cce" xlink:to="loc_icui_A2003PlanMember_e76abbce-e403-4fcd-b73e-fd2b5144ec5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c71e8fcf-9910-44c6-b879-c3a9901a0c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1f3418-4a15-4c47-ab83-a186e4a93f06" xlink:to="loc_us-gaap_AwardTypeAxis_c71e8fcf-9910-44c6-b879-c3a9901a0c6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c71e8fcf-9910-44c6-b879-c3a9901a0c6a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c71e8fcf-9910-44c6-b879-c3a9901a0c6a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c71e8fcf-9910-44c6-b879-c3a9901a0c6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d66b4d8-ff27-4932-8b4d-58149d8d4ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c71e8fcf-9910-44c6-b879-c3a9901a0c6a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d66b4d8-ff27-4932-8b4d-58149d8d4ab9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimebasedstockoptionMember_9f2a434a-4b8b-46ad-b2fc-f24daeade7e6" xlink:href="icui-20211231.xsd#icui_TimebasedstockoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d66b4d8-ff27-4932-8b4d-58149d8d4ab9" xlink:to="loc_icui_TimebasedstockoptionMember_9f2a434a-4b8b-46ad-b2fc-f24daeade7e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_8fdd8fe3-127e-4e96-90c7-e7dd614137aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d66b4d8-ff27-4932-8b4d-58149d8d4ab9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_8fdd8fe3-127e-4e96-90c7-e7dd614137aa" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#ShareBasedAwardStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails" xlink:type="extended" id="i2e8e17d5c7bb406c9ac6a88b419b8428_ShareBasedAwardStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_70083047-ede1-409f-b83e-bc0739ebfcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_70083047-ede1-409f-b83e-bc0739ebfcc5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_51bd39b5-9c88-4fef-8dcd-1da99d024f20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_51bd39b5-9c88-4fef-8dcd-1da99d024f20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b4c58420-4c54-425b-8f97-4da7e65308af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b4c58420-4c54-425b-8f97-4da7e65308af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_f6957bf2-f559-451e-8736-1165209fa1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_f6957bf2-f559-451e-8736-1165209fa1f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bea95758-edc3-4599-9a7f-90d09d5ee3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9fe469ee-f9bc-4a66-a7da-8c1139d78a08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9fe469ee-f9bc-4a66-a7da-8c1139d78a08" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_322376e2-943e-4d10-af78-1c1a9c2799e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_322376e2-943e-4d10-af78-1c1a9c2799e4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_06cc6ba8-59df-4acb-8321-cb182fee76f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_06cc6ba8-59df-4acb-8321-cb182fee76f7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9f570060-027a-4f2f-ae97-ea1e163f2f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9f570060-027a-4f2f-ae97-ea1e163f2f0f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6117838b-c547-43c2-90af-72132a5a7657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6117838b-c547-43c2-90af-72132a5a7657" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_3e67e3e3-3ed9-4b33-b093-e5f37792eaf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_3e67e3e3-3ed9-4b33-b093-e5f37792eaf4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d113bf8e-5c2b-4d61-b039-0fad5392da00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_37451acb-3ad0-4c65-a2fa-73b1eabf317f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_37451acb-3ad0-4c65-a2fa-73b1eabf317f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_41b0d2f0-3ad1-4c63-ada9-02f7f68c838d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_41b0d2f0-3ad1-4c63-ada9-02f7f68c838d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_2ee57938-4f5a-4f3c-bd0c-410950dc0c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_2ee57938-4f5a-4f3c-bd0c-410950dc0c8b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4382b97b-8b58-4750-96ca-dd8f3117fc3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4382b97b-8b58-4750-96ca-dd8f3117fc3c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_6244b9f4-424b-4b33-9977-83644923acdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_6244b9f4-424b-4b33-9977-83644923acdb" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a42cb44b-beee-49d0-8013-613fa8a07eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a42cb44b-beee-49d0-8013-613fa8a07eb1" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ac119be7-da2b-4753-a010-0f1281c65a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ac119be7-da2b-4753-a010-0f1281c65a2f" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2910b010-f5fd-48d1-bcf4-775605306425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2910b010-f5fd-48d1-bcf4-775605306425" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fab86346-a9bb-4527-8a9f-b5edf57656f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fab86346-a9bb-4527-8a9f-b5edf57656f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a0136923-4107-482a-8cb8-583f50ac718d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fab86346-a9bb-4527-8a9f-b5edf57656f5" xlink:to="loc_us-gaap_AwardTypeAxis_a0136923-4107-482a-8cb8-583f50ac718d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0136923-4107-482a-8cb8-583f50ac718d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a0136923-4107-482a-8cb8-583f50ac718d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0136923-4107-482a-8cb8-583f50ac718d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6244c363-4dc4-41e5-a30b-eafd2c1d001f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a0136923-4107-482a-8cb8-583f50ac718d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6244c363-4dc4-41e5-a30b-eafd2c1d001f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_40d47416-39a8-412c-be33-ba237ade23bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6244c363-4dc4-41e5-a30b-eafd2c1d001f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_40d47416-39a8-412c-be33-ba237ade23bb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#ShareBasedAwardRSUandPRSUDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails" xlink:type="extended" id="i58e5a6dab20d446b96968549ddd3ac79_ShareBasedAwardRSUandPRSUDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_230b90e7-5e46-4c58-ab48-9d0d7177747c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2575ea4d-037c-476b-9149-544be5ff5962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_230b90e7-5e46-4c58-ab48-9d0d7177747c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2575ea4d-037c-476b-9149-544be5ff5962" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PerformanceSharesEarned_d8fc194c-d0cb-4416-a7b6-c04715027752" xlink:href="icui-20211231.xsd#icui_PerformanceSharesEarned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_230b90e7-5e46-4c58-ab48-9d0d7177747c" xlink:to="loc_icui_PerformanceSharesEarned_d8fc194c-d0cb-4416-a7b6-c04715027752" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9c1a3876-c554-40fb-84fa-56a212957125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_230b90e7-5e46-4c58-ab48-9d0d7177747c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9c1a3876-c554-40fb-84fa-56a212957125" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Grantdatefairvalueperformancerestrictedstockunits_49daa903-3fc1-4d4a-b64d-75cde174ca0a" xlink:href="icui-20211231.xsd#icui_Grantdatefairvalueperformancerestrictedstockunits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_230b90e7-5e46-4c58-ab48-9d0d7177747c" xlink:to="loc_icui_Grantdatefairvalueperformancerestrictedstockunits_49daa903-3fc1-4d4a-b64d-75cde174ca0a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Grantdatefairvalueofrestrictedstockunitsgranted_354eb5d1-7936-4e52-b527-14ae850b44cd" xlink:href="icui-20211231.xsd#icui_Grantdatefairvalueofrestrictedstockunitsgranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_230b90e7-5e46-4c58-ab48-9d0d7177747c" xlink:to="loc_icui_Grantdatefairvalueofrestrictedstockunitsgranted_354eb5d1-7936-4e52-b527-14ae850b44cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_eb0bee38-aefa-4433-824b-0dd8daf78abe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_230b90e7-5e46-4c58-ab48-9d0d7177747c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_eb0bee38-aefa-4433-824b-0dd8daf78abe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ModifiedPRSUIncrementalExpense_2e0e0537-acbd-411d-a8af-9eee26f17c27" xlink:href="icui-20211231.xsd#icui_ModifiedPRSUIncrementalExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_230b90e7-5e46-4c58-ab48-9d0d7177747c" xlink:to="loc_icui_ModifiedPRSUIncrementalExpense_2e0e0537-acbd-411d-a8af-9eee26f17c27" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ac00d23-be41-49c6-91a2-a339117b45e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_230b90e7-5e46-4c58-ab48-9d0d7177747c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ac00d23-be41-49c6-91a2-a339117b45e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_25b0196c-6a6a-41ec-a1fd-9a0f2bd06742" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ac00d23-be41-49c6-91a2-a339117b45e4" xlink:to="loc_us-gaap_AwardTypeAxis_25b0196c-6a6a-41ec-a1fd-9a0f2bd06742" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_25b0196c-6a6a-41ec-a1fd-9a0f2bd06742_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_25b0196c-6a6a-41ec-a1fd-9a0f2bd06742" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_25b0196c-6a6a-41ec-a1fd-9a0f2bd06742_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d193992d-3cf9-4d91-a759-2b603c013cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_25b0196c-6a6a-41ec-a1fd-9a0f2bd06742" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d193992d-3cf9-4d91-a759-2b603c013cf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PerformanceRestrictedStockUnitsPRSUsMember_4fe37f10-e1b1-4ca0-bc26-cbeb4678b9b6" xlink:href="icui-20211231.xsd#icui_PerformanceRestrictedStockUnitsPRSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d193992d-3cf9-4d91-a759-2b603c013cf6" xlink:to="loc_icui_PerformanceRestrictedStockUnitsPRSUsMember_4fe37f10-e1b1-4ca0-bc26-cbeb4678b9b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_241f4a64-70e7-43ef-aed0-f229b3078d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d193992d-3cf9-4d91-a759-2b603c013cf6" xlink:to="loc_us-gaap_PerformanceSharesMember_241f4a64-70e7-43ef-aed0-f229b3078d7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_de2e1d3b-5fe1-4a4c-956b-c5f1a74fd727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d193992d-3cf9-4d91-a759-2b603c013cf6" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_de2e1d3b-5fe1-4a4c-956b-c5f1a74fd727" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#ShareBasedAwardRSUandPRSURollforwardDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails" xlink:type="extended" id="i9fcc8805d1a349d6a67a2e8a69601567_ShareBasedAwardRSUandPRSURollforwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_005c6dea-33eb-49e9-b49f-6f3e68e8d4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_005c6dea-33eb-49e9-b49f-6f3e68e8d4c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_54f64d2e-90f5-4f07-9799-cd2e04d1e614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_54f64d2e-90f5-4f07-9799-cd2e04d1e614" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Changeinunitsduetoperformanceexpectations_8a623c21-7085-4745-8f80-91c78873ae90" xlink:href="icui-20211231.xsd#icui_Changeinunitsduetoperformanceexpectations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_icui_Changeinunitsduetoperformanceexpectations_8a623c21-7085-4745-8f80-91c78873ae90" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue_70bbaf69-67ae-4bf5-abb2-5a0b1a75602a" xlink:href="icui-20211231.xsd#icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue_70bbaf69-67ae-4bf5-abb2-5a0b1a75602a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_129e8eac-6e3d-43cb-a343-22f262ca7de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_129e8eac-6e3d-43cb-a343-22f262ca7de1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0ac0ffe3-e9e9-4b11-83f5-bfacbefb768c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0ac0ffe3-e9e9-4b11-83f5-bfacbefb768c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d513bce4-0dc5-46f1-850e-04af633e96c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d513bce4-0dc5-46f1-850e-04af633e96c6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_6408eb8e-0bec-49dd-b388-dff672387ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_6408eb8e-0bec-49dd-b388-dff672387ee7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_51d838c2-3730-43bb-9a73-934e71a6eefd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_51d838c2-3730-43bb-9a73-934e71a6eefd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue_721aec4f-4c13-4e76-ac84-6d218c79f040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue_721aec4f-4c13-4e76-ac84-6d218c79f040" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_acb38243-b9d1-487e-b7e6-ef588ad76f03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_acb38243-b9d1-487e-b7e6-ef588ad76f03" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_151ba53f-7772-41cf-93a6-2ec12fa1dbdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_151ba53f-7772-41cf-93a6-2ec12fa1dbdc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_83773412-6a27-4a30-9f00-5dbf40fec515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_83773412-6a27-4a30-9f00-5dbf40fec515" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_806a3fe4-b4c3-495c-8299-0816b054675b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_83773412-6a27-4a30-9f00-5dbf40fec515" xlink:to="loc_us-gaap_AwardTypeAxis_806a3fe4-b4c3-495c-8299-0816b054675b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_806a3fe4-b4c3-495c-8299-0816b054675b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_806a3fe4-b4c3-495c-8299-0816b054675b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_806a3fe4-b4c3-495c-8299-0816b054675b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cdcb6780-7daf-4305-8602-1ea5142f5805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_806a3fe4-b4c3-495c-8299-0816b054675b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cdcb6780-7daf-4305-8602-1ea5142f5805" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RestrictedStockAndPerformanceRestrictedStockUnitsMember_b875b2f5-af9f-4a6c-8805-b5c04607e7f3" xlink:href="icui-20211231.xsd#icui_RestrictedStockAndPerformanceRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cdcb6780-7daf-4305-8602-1ea5142f5805" xlink:to="loc_icui_RestrictedStockAndPerformanceRestrictedStockUnitsMember_b875b2f5-af9f-4a6c-8805-b5c04607e7f3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#DerivativesandHedgingActivitiesDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails" xlink:type="extended" id="ife7d4b4fa2934ca6883236e4f7c79954_DerivativesandHedgingActivitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_9c35f56b-8732-40be-84c9-1a60c6dee34a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeForwardExchangeRate1_8eeebdd7-8aff-4283-8ddb-4a2397ccac96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeForwardExchangeRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9c35f56b-8732-40be-84c9-1a60c6dee34a" xlink:to="loc_us-gaap_DerivativeForwardExchangeRate1_8eeebdd7-8aff-4283-8ddb-4a2397ccac96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_ff7b3e83-1bdb-47bf-a25c-4e4c7439117b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9c35f56b-8732-40be-84c9-1a60c6dee34a" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_ff7b3e83-1bdb-47bf-a25c-4e4c7439117b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_f8ae0bdb-67ab-474e-9164-f79aafb1d0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9c35f56b-8732-40be-84c9-1a60c6dee34a" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_f8ae0bdb-67ab-474e-9164-f79aafb1d0e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_d6522698-b415-4803-8a47-64646876e0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9c35f56b-8732-40be-84c9-1a60c6dee34a" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_d6522698-b415-4803-8a47-64646876e0e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DerivativeInterestRateFloor_73ae46ef-a428-47b2-a0d0-0e17327f4177" xlink:href="icui-20211231.xsd#icui_DerivativeInterestRateFloor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9c35f56b-8732-40be-84c9-1a60c6dee34a" xlink:to="loc_icui_DerivativeInterestRateFloor_73ae46ef-a428-47b2-a0d0-0e17327f4177" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_190961fa-59e9-42e2-bf5b-eec371ad4f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9c35f56b-8732-40be-84c9-1a60c6dee34a" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_190961fa-59e9-42e2-bf5b-eec371ad4f7f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_4f0329f5-0bd0-4aad-a941-26a51793380f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9c35f56b-8732-40be-84c9-1a60c6dee34a" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_4f0329f5-0bd0-4aad-a941-26a51793380f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_8eed295c-b3c9-4e02-adcc-aebf81581e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_9c35f56b-8732-40be-84c9-1a60c6dee34a" xlink:to="loc_us-gaap_DerivativeTable_8eed295c-b3c9-4e02-adcc-aebf81581e4f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4ec07973-4981-47a2-9925-8379344d3252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_8eed295c-b3c9-4e02-adcc-aebf81581e4f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4ec07973-4981-47a2-9925-8379344d3252" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4ec07973-4981-47a2-9925-8379344d3252_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4ec07973-4981-47a2-9925-8379344d3252" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4ec07973-4981-47a2-9925-8379344d3252_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d12f9fb6-b8e1-4b4c-9965-da9934a3e477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4ec07973-4981-47a2-9925-8379344d3252" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d12f9fb6-b8e1-4b4c-9965-da9934a3e477" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge1Member_d1f70b6f-26c0-47fc-9a65-d7c638baf8b1" xlink:href="icui-20211231.xsd#icui_Hedge1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d12f9fb6-b8e1-4b4c-9965-da9934a3e477" xlink:to="loc_icui_Hedge1Member_d1f70b6f-26c0-47fc-9a65-d7c638baf8b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge2Member_5f9075cc-5cc4-4f60-9aca-f24afd99b0c9" xlink:href="icui-20211231.xsd#icui_Hedge2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d12f9fb6-b8e1-4b4c-9965-da9934a3e477" xlink:to="loc_icui_Hedge2Member_5f9075cc-5cc4-4f60-9aca-f24afd99b0c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge3MemberMember_0e419e68-b913-4f28-aedb-71722df29ba6" xlink:href="icui-20211231.xsd#icui_Hedge3MemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d12f9fb6-b8e1-4b4c-9965-da9934a3e477" xlink:to="loc_icui_Hedge3MemberMember_0e419e68-b913-4f28-aedb-71722df29ba6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge4Member_021d924d-21aa-4706-b01d-df2cfdf07e70" xlink:href="icui-20211231.xsd#icui_Hedge4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d12f9fb6-b8e1-4b4c-9965-da9934a3e477" xlink:to="loc_icui_Hedge4Member_021d924d-21aa-4706-b01d-df2cfdf07e70" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge5Member_6dadb024-d533-43d6-af82-9b3fa089ac88" xlink:href="icui-20211231.xsd#icui_Hedge5Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d12f9fb6-b8e1-4b4c-9965-da9934a3e477" xlink:to="loc_icui_Hedge5Member_6dadb024-d533-43d6-af82-9b3fa089ac88" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_fb7442ec-6027-4f4b-91e2-4aeba977c950" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d12f9fb6-b8e1-4b4c-9965-da9934a3e477" xlink:to="loc_us-gaap_InterestRateSwapMember_fb7442ec-6027-4f4b-91e2-4aeba977c950" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_UsGaap_InterestRateSwap2Member_0808407a-6d38-4f75-8ffa-5e8a426e4b7f" xlink:href="icui-20211231.xsd#icui_UsGaap_InterestRateSwap2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d12f9fb6-b8e1-4b4c-9965-da9934a3e477" xlink:to="loc_icui_UsGaap_InterestRateSwap2Member_0808407a-6d38-4f75-8ffa-5e8a426e4b7f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_968c9780-80fd-45c7-b0e1-2891618dccce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_8eed295c-b3c9-4e02-adcc-aebf81581e4f" xlink:to="loc_srt_RangeAxis_968c9780-80fd-45c7-b0e1-2891618dccce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_968c9780-80fd-45c7-b0e1-2891618dccce_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_968c9780-80fd-45c7-b0e1-2891618dccce" xlink:to="loc_srt_RangeMember_968c9780-80fd-45c7-b0e1-2891618dccce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_35183fec-42d6-42f2-b1d1-5357b6391909" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_968c9780-80fd-45c7-b0e1-2891618dccce" xlink:to="loc_srt_RangeMember_35183fec-42d6-42f2-b1d1-5357b6391909" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b80f9768-9afc-4154-9e3a-1b8cd6e445d3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_35183fec-42d6-42f2-b1d1-5357b6391909" xlink:to="loc_srt_MaximumMember_b80f9768-9afc-4154-9e3a-1b8cd6e445d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_61ea4afd-7410-4aa1-9147-a84189d6b01d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_35183fec-42d6-42f2-b1d1-5357b6391909" xlink:to="loc_srt_MinimumMember_61ea4afd-7410-4aa1-9147-a84189d6b01d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails" xlink:type="extended" id="i69aa797f4d844660ae11db2386bec5c6_DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_c0df4992-ba9a-4d3c-bc98-eb7a642b49a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_f131a96f-076e-472d-b6d8-fb5853027647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_c0df4992-ba9a-4d3c-bc98-eb7a642b49a4" xlink:to="loc_us-gaap_DerivativeAssets_f131a96f-076e-472d-b6d8-fb5853027647" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_8c17dc40-8a8e-4b31-8ea2-f767a4e8d9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_c0df4992-ba9a-4d3c-bc98-eb7a642b49a4" xlink:to="loc_us-gaap_DerivativeLiabilities_8c17dc40-8a8e-4b31-8ea2-f767a4e8d9dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_dc97b7d8-8588-4654-8448-608f23dbed45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_c0df4992-ba9a-4d3c-bc98-eb7a642b49a4" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_dc97b7d8-8588-4654-8448-608f23dbed45" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3d651f73-e39c-4a8a-9aba-36edf78074b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_dc97b7d8-8588-4654-8448-608f23dbed45" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3d651f73-e39c-4a8a-9aba-36edf78074b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3d651f73-e39c-4a8a-9aba-36edf78074b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3d651f73-e39c-4a8a-9aba-36edf78074b9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3d651f73-e39c-4a8a-9aba-36edf78074b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bd0ff965-50d6-4b4f-846e-527f2d0a0c42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3d651f73-e39c-4a8a-9aba-36edf78074b9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bd0ff965-50d6-4b4f-846e-527f2d0a0c42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_f0e5a28f-5b5c-419e-8d10-42dce2cbd354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd0ff965-50d6-4b4f-846e-527f2d0a0c42" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_f0e5a28f-5b5c-419e-8d10-42dce2cbd354" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3df41b95-6780-4608-a636-f5dc0601fd8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd0ff965-50d6-4b4f-846e-527f2d0a0c42" xlink:to="loc_us-gaap_InterestRateSwapMember_3df41b95-6780-4608-a636-f5dc0601fd8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_098cbd38-24d2-4991-bcd5-53dcb42e644d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd0ff965-50d6-4b4f-846e-527f2d0a0c42" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_098cbd38-24d2-4991-bcd5-53dcb42e644d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_85619e68-7851-43c2-970a-015514bf8a26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd0ff965-50d6-4b4f-846e-527f2d0a0c42" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_85619e68-7851-43c2-970a-015514bf8a26" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsTotalMember_34a0e223-053e-4e1f-8173-26579517640f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsTotalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd0ff965-50d6-4b4f-846e-527f2d0a0c42" xlink:to="loc_us-gaap_AssetsTotalMember_34a0e223-053e-4e1f-8173-26579517640f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_a0bdabcd-f27d-4046-8fd6-47f13ba36c40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_dc97b7d8-8588-4654-8448-608f23dbed45" xlink:to="loc_us-gaap_HedgingDesignationAxis_a0bdabcd-f27d-4046-8fd6-47f13ba36c40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a0bdabcd-f27d-4046-8fd6-47f13ba36c40_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_a0bdabcd-f27d-4046-8fd6-47f13ba36c40" xlink:to="loc_us-gaap_HedgingDesignationDomain_a0bdabcd-f27d-4046-8fd6-47f13ba36c40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a91b4b8a-da47-40bc-acef-53bc8ada6e53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_a0bdabcd-f27d-4046-8fd6-47f13ba36c40" xlink:to="loc_us-gaap_HedgingDesignationDomain_a91b4b8a-da47-40bc-acef-53bc8ada6e53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ba05110e-ae1c-4893-bc88-7718dd2e6a09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_a91b4b8a-da47-40bc-acef-53bc8ada6e53" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ba05110e-ae1c-4893-bc88-7718dd2e6a09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d717c8a4-35e5-4927-aab6-95f9a11180cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_dc97b7d8-8588-4654-8448-608f23dbed45" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d717c8a4-35e5-4927-aab6-95f9a11180cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d717c8a4-35e5-4927-aab6-95f9a11180cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d717c8a4-35e5-4927-aab6-95f9a11180cd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d717c8a4-35e5-4927-aab6-95f9a11180cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e0fc0518-bd2d-4e27-9bb2-198e66462592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d717c8a4-35e5-4927-aab6-95f9a11180cd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e0fc0518-bd2d-4e27-9bb2-198e66462592" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_177fff04-44e1-40fe-986b-d1412df081be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e0fc0518-bd2d-4e27-9bb2-198e66462592" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_177fff04-44e1-40fe-986b-d1412df081be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_ff0cf67c-d567-49e9-a549-a91b25942f62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e0fc0518-bd2d-4e27-9bb2-198e66462592" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_ff0cf67c-d567-49e9-a549-a91b25942f62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_efa80666-6b89-4cc5-a33c-d8dafd66bd81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e0fc0518-bd2d-4e27-9bb2-198e66462592" xlink:to="loc_us-gaap_OtherAssetsMember_efa80666-6b89-4cc5-a33c-d8dafd66bd81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_998e1221-ddf8-4bc0-88fa-9b57b3d67664" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e0fc0518-bd2d-4e27-9bb2-198e66462592" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_998e1221-ddf8-4bc0-88fa-9b57b3d67664" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_d31ef893-0d5d-47be-845d-24f8234a91d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e0fc0518-bd2d-4e27-9bb2-198e66462592" xlink:to="loc_us-gaap_OtherLiabilitiesMember_d31ef893-0d5d-47be-845d-24f8234a91d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsTotalMember_988d2ef0-6c47-43a6-9a67-9dc7016e4927" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsTotalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e0fc0518-bd2d-4e27-9bb2-198e66462592" xlink:to="loc_us-gaap_AssetsTotalMember_988d2ef0-6c47-43a6-9a67-9dc7016e4927" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_c779450f-ece6-463d-a6de-d36d9281cd93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e0fc0518-bd2d-4e27-9bb2-198e66462592" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_c779450f-ece6-463d-a6de-d36d9281cd93" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesTotalMember_58816ae1-51bd-4f5e-934d-a377d3c0797b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesTotalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e0fc0518-bd2d-4e27-9bb2-198e66462592" xlink:to="loc_us-gaap_LiabilitiesTotalMember_58816ae1-51bd-4f5e-934d-a377d3c0797b" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i862f05c9924c47d4b15dc1c802fcc5c8_DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_ba015430-9e89-4ef0-88f2-2f9a7fcc5d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_8e05069f-c9e2-4dc6-8636-69cb6235250d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_ba015430-9e89-4ef0-88f2-2f9a7fcc5d1d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_8e05069f-c9e2-4dc6-8636-69cb6235250d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e2ad9bcc-ac5d-4510-8e4e-0bf894a7543a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_ba015430-9e89-4ef0-88f2-2f9a7fcc5d1d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e2ad9bcc-ac5d-4510-8e4e-0bf894a7543a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_961aac4e-ef8e-4ac8-8c93-e605cba50a92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_ba015430-9e89-4ef0-88f2-2f9a7fcc5d1d" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_961aac4e-ef8e-4ac8-8c93-e605cba50a92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1be7d52b-c0ff-4419-a056-45bf66f8b9af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_ba015430-9e89-4ef0-88f2-2f9a7fcc5d1d" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1be7d52b-c0ff-4419-a056-45bf66f8b9af" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_257e096e-2d1f-437f-a7b3-faab10a55ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1be7d52b-c0ff-4419-a056-45bf66f8b9af" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_257e096e-2d1f-437f-a7b3-faab10a55ab7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_257e096e-2d1f-437f-a7b3-faab10a55ab7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_257e096e-2d1f-437f-a7b3-faab10a55ab7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_257e096e-2d1f-437f-a7b3-faab10a55ab7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_aa8d7c8e-b43a-4c22-b0e9-4a06721ffabf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_257e096e-2d1f-437f-a7b3-faab10a55ab7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_aa8d7c8e-b43a-4c22-b0e9-4a06721ffabf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_afaa4b91-05bd-4295-a880-878b72b80c43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_aa8d7c8e-b43a-4c22-b0e9-4a06721ffabf" xlink:to="loc_us-gaap_CashFlowHedgingMember_afaa4b91-05bd-4295-a880-878b72b80c43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_22ae3b36-c454-461a-b8d1-38c7e6194813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1be7d52b-c0ff-4419-a056-45bf66f8b9af" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_22ae3b36-c454-461a-b8d1-38c7e6194813" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_22ae3b36-c454-461a-b8d1-38c7e6194813_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_22ae3b36-c454-461a-b8d1-38c7e6194813" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_22ae3b36-c454-461a-b8d1-38c7e6194813_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b8911d47-ae7d-486a-8e46-a8e25ac8b8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_22ae3b36-c454-461a-b8d1-38c7e6194813" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b8911d47-ae7d-486a-8e46-a8e25ac8b8b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_0dd7d788-d292-447d-b8a1-fbfdddb9a982" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b8911d47-ae7d-486a-8e46-a8e25ac8b8b2" xlink:to="loc_us-gaap_CostOfSalesMember_0dd7d788-d292-447d-b8a1-fbfdddb9a982" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f3d608d7-5177-4088-a0bc-4d9b8ec81803" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1be7d52b-c0ff-4419-a056-45bf66f8b9af" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f3d608d7-5177-4088-a0bc-4d9b8ec81803" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f3d608d7-5177-4088-a0bc-4d9b8ec81803_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f3d608d7-5177-4088-a0bc-4d9b8ec81803" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f3d608d7-5177-4088-a0bc-4d9b8ec81803_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e5ead52d-f434-43ce-aa02-e8a55f484597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f3d608d7-5177-4088-a0bc-4d9b8ec81803" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e5ead52d-f434-43ce-aa02-e8a55f484597" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_310edbab-8453-46ca-a08e-1c04246af554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e5ead52d-f434-43ce-aa02-e8a55f484597" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_310edbab-8453-46ca-a08e-1c04246af554" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_4ee30f43-4f9f-49e5-8dbe-167da8998e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e5ead52d-f434-43ce-aa02-e8a55f484597" xlink:to="loc_us-gaap_CashFlowHedgingMember_4ee30f43-4f9f-49e5-8dbe-167da8998e2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_8a00c176-e131-490e-a6ef-96d45ca3bc6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e5ead52d-f434-43ce-aa02-e8a55f484597" xlink:to="loc_us-gaap_InterestRateSwapMember_8a00c176-e131-490e-a6ef-96d45ca3bc6a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasurementTables" xlink:type="simple" xlink:href="icui-20211231.xsd#FairValueMeasurementTables"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasurementTables" xlink:type="extended" id="i1003c7210faf4e3cae334dd840d73fa3_FairValueMeasurementTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2b542fe5-c53c-42a8-89b8-c243d9baf3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_0f907446-1896-4ec1-a029-24212ebdfa30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2b542fe5-c53c-42a8-89b8-c243d9baf3e1" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_0f907446-1896-4ec1-a029-24212ebdfa30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_137f02ba-9508-480b-8d9c-4c69877b374b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2b542fe5-c53c-42a8-89b8-c243d9baf3e1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_137f02ba-9508-480b-8d9c-4c69877b374b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_02068a98-8a65-465b-9e25-041f6feac522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2b542fe5-c53c-42a8-89b8-c243d9baf3e1" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_02068a98-8a65-465b-9e25-041f6feac522" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_959668a3-9357-416f-a414-65a24f7cdff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2b542fe5-c53c-42a8-89b8-c243d9baf3e1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_959668a3-9357-416f-a414-65a24f7cdff0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_96108439-4678-4993-93ea-87cacd7d449f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_959668a3-9357-416f-a414-65a24f7cdff0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_96108439-4678-4993-93ea-87cacd7d449f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_96108439-4678-4993-93ea-87cacd7d449f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_96108439-4678-4993-93ea-87cacd7d449f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_96108439-4678-4993-93ea-87cacd7d449f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b44f9b7-89e6-48cc-b40c-2e8ee3addd87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_96108439-4678-4993-93ea-87cacd7d449f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b44f9b7-89e6-48cc-b40c-2e8ee3addd87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_HospiraMember_c89046d9-ddf2-49ac-8d90-dc34523e439b" xlink:href="icui-20211231.xsd#icui_HospiraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b44f9b7-89e6-48cc-b40c-2e8ee3addd87" xlink:to="loc_icui_HospiraMember_c89046d9-ddf2-49ac-8d90-dc34523e439b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_da4c1cc7-2e86-4554-a974-fdfc7e2da134" xlink:href="icui-20211231.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b44f9b7-89e6-48cc-b40c-2e8ee3addd87" xlink:to="loc_icui_PursuitVascularInc.Member_da4c1cc7-2e86-4554-a974-fdfc7e2da134" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasurementTextDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#FairValueMeasurementTextDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasurementTextDetails" xlink:type="extended" id="i522a46aec9ee4638ab58ae95a0e214a4_FairValueMeasurementTextDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8e30bbc5-98c7-43c4-80bd-dfcc58143911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_ceb2c863-5faf-4e1a-8e5d-83d00246ecbb" xlink:href="icui-20211231.xsd#icui_Contingentconsiderationgross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8e30bbc5-98c7-43c4-80bd-dfcc58143911" xlink:to="loc_icui_Contingentconsiderationgross_ceb2c863-5faf-4e1a-8e5d-83d00246ecbb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0e03f2fc-a632-4110-aa8f-1adecbd15da1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8e30bbc5-98c7-43c4-80bd-dfcc58143911" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0e03f2fc-a632-4110-aa8f-1adecbd15da1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermContingentConsiderationGross_c8932040-745a-42e3-a2f4-44f6a93c75a4" xlink:href="icui-20211231.xsd#icui_ShortTermContingentConsiderationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8e30bbc5-98c7-43c4-80bd-dfcc58143911" xlink:to="loc_icui_ShortTermContingentConsiderationGross_c8932040-745a-42e3-a2f4-44f6a93c75a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermContingentConsiderationGross_6f07b017-f60b-4547-8a18-3e77de7f482e" xlink:href="icui-20211231.xsd#icui_LongTermContingentConsiderationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8e30bbc5-98c7-43c4-80bd-dfcc58143911" xlink:to="loc_icui_LongTermContingentConsiderationGross_6f07b017-f60b-4547-8a18-3e77de7f482e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_994d5384-d375-4798-9b5e-2978b47c39a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8e30bbc5-98c7-43c4-80bd-dfcc58143911" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_994d5384-d375-4798-9b5e-2978b47c39a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d986e72b-d458-4718-978d-56b610a2d050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_994d5384-d375-4798-9b5e-2978b47c39a5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d986e72b-d458-4718-978d-56b610a2d050" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d986e72b-d458-4718-978d-56b610a2d050_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d986e72b-d458-4718-978d-56b610a2d050" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d986e72b-d458-4718-978d-56b610a2d050_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c45506a-3816-4a14-92ad-1195684ea57d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d986e72b-d458-4718-978d-56b610a2d050" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c45506a-3816-4a14-92ad-1195684ea57d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_HospiraMember_5657ddb4-2667-4e04-907a-d61b531223c3" xlink:href="icui-20211231.xsd#icui_HospiraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c45506a-3816-4a14-92ad-1195684ea57d" xlink:to="loc_icui_HospiraMember_5657ddb4-2667-4e04-907a-d61b531223c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_4f2ddd2c-b05d-492d-9b82-c5d5f7edee1b" xlink:href="icui-20211231.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c45506a-3816-4a14-92ad-1195684ea57d" xlink:to="loc_icui_PursuitVascularInc.Member_4f2ddd2c-b05d-492d-9b82-c5d5f7edee1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularLLCMember_0edaf43f-155b-44a8-b2f4-71726c5dae86" xlink:href="icui-20211231.xsd#icui_PursuitVascularLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c45506a-3816-4a14-92ad-1195684ea57d" xlink:to="loc_icui_PursuitVascularLLCMember_0edaf43f-155b-44a8-b2f4-71726c5dae86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignDistibutorMember_e737483e-c7a8-467d-8512-e35c0d584bcd" xlink:href="icui-20211231.xsd#icui_ForeignDistibutorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c45506a-3816-4a14-92ad-1195684ea57d" xlink:to="loc_icui_ForeignDistibutorMember_e737483e-c7a8-467d-8512-e35c0d584bcd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_015d200d-5cbc-4c3c-84b3-fc425553775f" xlink:href="icui-20211231.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c45506a-3816-4a14-92ad-1195684ea57d" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_015d200d-5cbc-4c3c-84b3-fc425553775f" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasurementDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#FairValueMeasurementDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasurementDetails" xlink:type="extended" id="i62fdab1f40b349b0bd6f9c6e6bfc7914_FairValueMeasurementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6ac2bf80-5c53-4bf7-83b7-9b4ccdb9180a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5ce31398-8062-4031-8945-a10825c60f78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6ac2bf80-5c53-4bf7-83b7-9b4ccdb9180a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5ce31398-8062-4031-8945-a10825c60f78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_f3101884-5633-49be-b6cf-892ed4997948" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6ac2bf80-5c53-4bf7-83b7-9b4ccdb9180a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_f3101884-5633-49be-b6cf-892ed4997948" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_21e349cc-924d-4d77-a663-6365af7d1590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6ac2bf80-5c53-4bf7-83b7-9b4ccdb9180a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_21e349cc-924d-4d77-a663-6365af7d1590" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_7c5ca3d7-bca4-4a94-b57f-e259239199d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6ac2bf80-5c53-4bf7-83b7-9b4ccdb9180a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_7c5ca3d7-bca4-4a94-b57f-e259239199d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_b4b5130c-2302-41f6-baae-eabcf6ade32c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6ac2bf80-5c53-4bf7-83b7-9b4ccdb9180a" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_b4b5130c-2302-41f6-baae-eabcf6ade32c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3a5835af-7000-4a5d-b6f4-28983ec1f9bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_b4b5130c-2302-41f6-baae-eabcf6ade32c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3a5835af-7000-4a5d-b6f4-28983ec1f9bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a5835af-7000-4a5d-b6f4-28983ec1f9bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3a5835af-7000-4a5d-b6f4-28983ec1f9bf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a5835af-7000-4a5d-b6f4-28983ec1f9bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7fb117bb-7c74-4fab-aa09-fa2d43d7fe73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3a5835af-7000-4a5d-b6f4-28983ec1f9bf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7fb117bb-7c74-4fab-aa09-fa2d43d7fe73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_e2a7060f-7cf8-4c95-8b32-8c5b08f9a621" xlink:href="icui-20211231.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7fb117bb-7c74-4fab-aa09-fa2d43d7fe73" xlink:to="loc_icui_PursuitVascularInc.Member_e2a7060f-7cf8-4c95-8b32-8c5b08f9a621" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_HospiraMember_e5e9d91b-3d13-459a-992b-5d46ca7116d8" xlink:href="icui-20211231.xsd#icui_HospiraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7fb117bb-7c74-4fab-aa09-fa2d43d7fe73" xlink:to="loc_icui_HospiraMember_e5e9d91b-3d13-459a-992b-5d46ca7116d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularLLCMember_448dc160-04cf-4403-9631-e9ada09712f9" xlink:href="icui-20211231.xsd#icui_PursuitVascularLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7fb117bb-7c74-4fab-aa09-fa2d43d7fe73" xlink:to="loc_icui_PursuitVascularLLCMember_448dc160-04cf-4403-9631-e9ada09712f9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesHospiraQuantitativeInformationDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#FairValueMeasurementFairValueInputsLiabilitiesHospiraQuantitativeInformationDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesHospiraQuantitativeInformationDetails" xlink:type="extended" id="i5e300d91c6fe4af7aa6b63d77313f904_FairValueMeasurementFairValueInputsLiabilitiesHospiraQuantitativeInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2935ac32-cdcc-4cc3-9b5a-e8f8505850c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_6e0ad42c-eb26-47f8-8e23-5b7d7ef18658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2935ac32-cdcc-4cc3-9b5a-e8f8505850c7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_6e0ad42c-eb26-47f8-8e23-5b7d7ef18658" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_0c754a63-a655-454f-af4f-02ed58cbffd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2935ac32-cdcc-4cc3-9b5a-e8f8505850c7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_0c754a63-a655-454f-af4f-02ed58cbffd9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_59d26c2a-ff80-414c-adae-086649e4acda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_0c754a63-a655-454f-af4f-02ed58cbffd9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_59d26c2a-ff80-414c-adae-086649e4acda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_59d26c2a-ff80-414c-adae-086649e4acda_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_59d26c2a-ff80-414c-adae-086649e4acda" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_59d26c2a-ff80-414c-adae-086649e4acda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b2f926eb-1527-4dce-8588-9ac80f529901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_59d26c2a-ff80-414c-adae-086649e4acda" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b2f926eb-1527-4dce-8588-9ac80f529901" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_HospiraMember_970df24d-0306-4333-83fc-a509af2ca86f" xlink:href="icui-20211231.xsd#icui_HospiraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b2f926eb-1527-4dce-8588-9ac80f529901" xlink:to="loc_icui_HospiraMember_970df24d-0306-4333-83fc-a509af2ca86f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_55fdf48b-845e-42d0-916a-6685ff116370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_0c754a63-a655-454f-af4f-02ed58cbffd9" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_55fdf48b-845e-42d0-916a-6685ff116370" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_55fdf48b-845e-42d0-916a-6685ff116370_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_55fdf48b-845e-42d0-916a-6685ff116370" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_55fdf48b-845e-42d0-916a-6685ff116370_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_13b5fbbf-9a67-4fae-b3e4-713ce3e03307" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_55fdf48b-845e-42d0-916a-6685ff116370" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_13b5fbbf-9a67-4fae-b3e4-713ce3e03307" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_c9023fc5-5846-49f0-9955-67a6641e3e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_13b5fbbf-9a67-4fae-b3e4-713ce3e03307" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_c9023fc5-5846-49f0-9955-67a6641e3e02" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails" xlink:type="extended" id="i6497931180914bf2967f909e95775257_FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_f560d621-8157-4656-802b-b7d5f2327554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_a0ac10e8-8db8-436b-8c44-cfaf0f39993e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_f560d621-8157-4656-802b-b7d5f2327554" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_a0ac10e8-8db8-436b-8c44-cfaf0f39993e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fe464819-113d-45fc-b182-fb1a8e72dc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_f560d621-8157-4656-802b-b7d5f2327554" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fe464819-113d-45fc-b182-fb1a8e72dc9c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_45afda0e-f0ad-431e-83c4-00bd3ab9e031" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fe464819-113d-45fc-b182-fb1a8e72dc9c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_45afda0e-f0ad-431e-83c4-00bd3ab9e031" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45afda0e-f0ad-431e-83c4-00bd3ab9e031_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_45afda0e-f0ad-431e-83c4-00bd3ab9e031" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45afda0e-f0ad-431e-83c4-00bd3ab9e031_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_456c33c6-c8d5-4e70-b5a8-c21daedc4290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_45afda0e-f0ad-431e-83c4-00bd3ab9e031" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_456c33c6-c8d5-4e70-b5a8-c21daedc4290" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_2a2bf8a5-8c47-4b53-8c56-bae3df78ce8f" xlink:href="icui-20211231.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_456c33c6-c8d5-4e70-b5a8-c21daedc4290" xlink:to="loc_icui_PursuitVascularInc.Member_2a2bf8a5-8c47-4b53-8c56-bae3df78ce8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_16720be0-ab80-4547-8caf-87f777ea0d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fe464819-113d-45fc-b182-fb1a8e72dc9c" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_16720be0-ab80-4547-8caf-87f777ea0d3c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_16720be0-ab80-4547-8caf-87f777ea0d3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_16720be0-ab80-4547-8caf-87f777ea0d3c" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_16720be0-ab80-4547-8caf-87f777ea0d3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_cf8126e0-6682-49bb-b905-b47a1927579c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_16720be0-ab80-4547-8caf-87f777ea0d3c" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_cf8126e0-6682-49bb-b905-b47a1927579c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RevenueGrossProfitVolatilityMember_14f559e5-9d6a-4ad3-b98b-b120ab18c7e6" xlink:href="icui-20211231.xsd#icui_RevenueGrossProfitVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_cf8126e0-6682-49bb-b905-b47a1927579c" xlink:to="loc_icui_RevenueGrossProfitVolatilityMember_14f559e5-9d6a-4ad3-b98b-b120ab18c7e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_ae94e771-bb13-408c-b5a2-8f9e67f50e06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_cf8126e0-6682-49bb-b905-b47a1927579c" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_ae94e771-bb13-408c-b5a2-8f9e67f50e06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_01257086-1623-451b-b429-26a531fa0269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_cf8126e0-6682-49bb-b905-b47a1927579c" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_01257086-1623-451b-b429-26a531fa0269" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditRiskMember_cc0ea43c-480d-45a7-9f7c-bbcdcea45d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_cf8126e0-6682-49bb-b905-b47a1927579c" xlink:to="loc_us-gaap_CreditRiskMember_cc0ea43c-480d-45a7-9f7c-bbcdcea45d20" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#FairValueMeasurementFairValueMeasurementsRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails" xlink:type="extended" id="i8715f7e6067d4a9883a2a5f51c9af001_FairValueMeasurementFairValueMeasurementsRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7c60e730-b0a3-42b7-82bf-1a5c16a117b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_440d5bed-2d2c-4536-a811-52e43aaa1f38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7c60e730-b0a3-42b7-82bf-1a5c16a117b3" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_440d5bed-2d2c-4536-a811-52e43aaa1f38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_3308f8ac-afbb-476d-aef3-f9734d4c09cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7c60e730-b0a3-42b7-82bf-1a5c16a117b3" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_3308f8ac-afbb-476d-aef3-f9734d4c09cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_ced2c7cf-9433-495c-9b2b-1a589d651a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonfinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7c60e730-b0a3-42b7-82bf-1a5c16a117b3" xlink:to="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_ced2c7cf-9433-495c-9b2b-1a589d651a7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_c5423d64-2a8c-4c23-b9d8-d0ea2887d628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7c60e730-b0a3-42b7-82bf-1a5c16a117b3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_c5423d64-2a8c-4c23-b9d8-d0ea2887d628" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesNoncurrent_3b8c2520-20e4-48df-a0ef-258e9f52e522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7c60e730-b0a3-42b7-82bf-1a5c16a117b3" xlink:to="loc_us-gaap_DebtSecuritiesNoncurrent_3b8c2520-20e4-48df-a0ef-258e9f52e522" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_d478cd7f-fe31-40b0-a1c8-db7b3f7e1c97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativeLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7c60e730-b0a3-42b7-82bf-1a5c16a117b3" xlink:to="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_d478cd7f-fe31-40b0-a1c8-db7b3f7e1c97" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c356bfbe-9638-4bf8-a267-e2ac61d62b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7c60e730-b0a3-42b7-82bf-1a5c16a117b3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c356bfbe-9638-4bf8-a267-e2ac61d62b8a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_8831b74b-6585-43bb-b305-a3e230025d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c356bfbe-9638-4bf8-a267-e2ac61d62b8a" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_8831b74b-6585-43bb-b305-a3e230025d8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8831b74b-6585-43bb-b305-a3e230025d8b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_8831b74b-6585-43bb-b305-a3e230025d8b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8831b74b-6585-43bb-b305-a3e230025d8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a02e9c02-d264-4062-ab94-e91a9a64b078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_8831b74b-6585-43bb-b305-a3e230025d8b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a02e9c02-d264-4062-ab94-e91a9a64b078" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EarnoutliabilityMember_a5b523d9-4b4c-4d2c-8acb-8332e958715b" xlink:href="icui-20211231.xsd#icui_EarnoutliabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a02e9c02-d264-4062-ab94-e91a9a64b078" xlink:to="loc_icui_EarnoutliabilityMember_a5b523d9-4b4c-4d2c-8acb-8332e958715b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesTotalMember_649abcfb-242f-45ab-93a5-cc3201eb0666" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesTotalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a02e9c02-d264-4062-ab94-e91a9a64b078" xlink:to="loc_us-gaap_LiabilitiesTotalMember_649abcfb-242f-45ab-93a5-cc3201eb0666" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b941e21f-b340-4af0-a5c5-d68f80027237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c356bfbe-9638-4bf8-a267-e2ac61d62b8a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b941e21f-b340-4af0-a5c5-d68f80027237" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b941e21f-b340-4af0-a5c5-d68f80027237_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b941e21f-b340-4af0-a5c5-d68f80027237" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b941e21f-b340-4af0-a5c5-d68f80027237_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0338e7d2-99aa-4efb-8e50-2336edf2904c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b941e21f-b340-4af0-a5c5-d68f80027237" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0338e7d2-99aa-4efb-8e50-2336edf2904c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_99f22829-7595-4f5d-8c17-cfd849794af6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0338e7d2-99aa-4efb-8e50-2336edf2904c" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_99f22829-7595-4f5d-8c17-cfd849794af6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_91a47a0d-bbad-485c-828a-0f15c509329a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c356bfbe-9638-4bf8-a267-e2ac61d62b8a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_91a47a0d-bbad-485c-828a-0f15c509329a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_91a47a0d-bbad-485c-828a-0f15c509329a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_91a47a0d-bbad-485c-828a-0f15c509329a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_91a47a0d-bbad-485c-828a-0f15c509329a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d69c9cfa-13bd-4f56-be22-9d039cc07114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_91a47a0d-bbad-485c-828a-0f15c509329a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d69c9cfa-13bd-4f56-be22-9d039cc07114" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_360e56d5-33e1-421b-b135-55490e86063f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d69c9cfa-13bd-4f56-be22-9d039cc07114" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_360e56d5-33e1-421b-b135-55490e86063f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d923f78e-b0cf-44fb-9347-e21cf92a94c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d69c9cfa-13bd-4f56-be22-9d039cc07114" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d923f78e-b0cf-44fb-9347-e21cf92a94c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_0822122f-dd87-40d7-bf73-f84d9ac45a59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d69c9cfa-13bd-4f56-be22-9d039cc07114" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_0822122f-dd87-40d7-bf73-f84d9ac45a59" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#LongTermObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/LongTermObligationsDetails" xlink:type="extended" id="ifc1c35fb1bec4bb49fd917db591f42ca_LongTermObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_446acf90-e6f9-4fe9-9200-cab636150544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6d2656c7-b1b8-406d-be06-7b43616fc8df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_446acf90-e6f9-4fe9-9200-cab636150544" xlink:to="loc_us-gaap_LongTermDebt_6d2656c7-b1b8-406d-be06-7b43616fc8df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a428f719-ab33-49f2-bc6b-5de6bfa3beda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_446acf90-e6f9-4fe9-9200-cab636150544" xlink:to="loc_us-gaap_DebtInstrumentTable_a428f719-ab33-49f2-bc6b-5de6bfa3beda" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_74291fa6-6106-432e-b13d-1379653b5cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a428f719-ab33-49f2-bc6b-5de6bfa3beda" xlink:to="loc_us-gaap_DebtInstrumentAxis_74291fa6-6106-432e-b13d-1379653b5cb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_74291fa6-6106-432e-b13d-1379653b5cb8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_74291fa6-6106-432e-b13d-1379653b5cb8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_74291fa6-6106-432e-b13d-1379653b5cb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7d2da801-9023-44bc-8994-cd07c3cbad44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_74291fa6-6106-432e-b13d-1379653b5cb8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7d2da801-9023-44bc-8994-cd07c3cbad44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_06b2e41c-8345-4a9c-afef-0333f3bda914" xlink:href="icui-20211231.xsd#icui_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d2da801-9023-44bc-8994-cd07c3cbad44" xlink:to="loc_icui_TermLoanAMember_06b2e41c-8345-4a9c-afef-0333f3bda914" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_295054af-d674-46ac-bf7e-ed387bce57ef" xlink:href="icui-20211231.xsd#icui_TermLoanBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d2da801-9023-44bc-8994-cd07c3cbad44" xlink:to="loc_icui_TermLoanBMember_295054af-d674-46ac-bf7e-ed387bce57ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_8d19fa72-7960-4826-9f59-b4950fa94784" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d2da801-9023-44bc-8994-cd07c3cbad44" xlink:to="loc_us-gaap_LineOfCreditMember_8d19fa72-7960-4826-9f59-b4950fa94784" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ae98648d-9e92-45eb-aa78-98d318b565a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a428f719-ab33-49f2-bc6b-5de6bfa3beda" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ae98648d-9e92-45eb-aa78-98d318b565a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ae98648d-9e92-45eb-aa78-98d318b565a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ae98648d-9e92-45eb-aa78-98d318b565a7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ae98648d-9e92-45eb-aa78-98d318b565a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c30c280a-8dcb-48ce-99e1-fdc0ffa47925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ae98648d-9e92-45eb-aa78-98d318b565a7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c30c280a-8dcb-48ce-99e1-fdc0ffa47925" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_229326ce-19cd-4fb4-803a-c191e9202783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c30c280a-8dcb-48ce-99e1-fdc0ffa47925" xlink:to="loc_us-gaap_SubsequentEventMember_229326ce-19cd-4fb4-803a-c191e9202783" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsLineofCreditPricingDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#LongTermObligationsLineofCreditPricingDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/LongTermObligationsLineofCreditPricingDetails" xlink:type="extended" id="ie49727a781574a87959f6433a6f9b2fd_LongTermObligationsLineofCreditPricingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_d5fb409e-fb29-4f2b-ad24-65996c6d367a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_3edcfec4-7ea2-4a58-b9a1-f2e09c2ed852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d5fb409e-fb29-4f2b-ad24-65996c6d367a" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_3edcfec4-7ea2-4a58-b9a1-f2e09c2ed852" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LIBORBasisSpreadonVariableRate_1c5eca87-4f64-41cc-a43c-6d6145241b08" xlink:href="icui-20211231.xsd#icui_LIBORBasisSpreadonVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d5fb409e-fb29-4f2b-ad24-65996c6d367a" xlink:to="loc_icui_LIBORBasisSpreadonVariableRate_1c5eca87-4f64-41cc-a43c-6d6145241b08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4fca441f-9d71-4ac8-b4fc-d0d004b49f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d5fb409e-fb29-4f2b-ad24-65996c6d367a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4fca441f-9d71-4ac8-b4fc-d0d004b49f2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_8bc3b17c-6851-415c-b6f0-f364efab41a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d5fb409e-fb29-4f2b-ad24-65996c6d367a" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_8bc3b17c-6851-415c-b6f0-f364efab41a4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2766b3c9-7a2b-4cb1-b7fe-f2088049594c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_8bc3b17c-6851-415c-b6f0-f364efab41a4" xlink:to="loc_us-gaap_CreditFacilityAxis_2766b3c9-7a2b-4cb1-b7fe-f2088049594c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2766b3c9-7a2b-4cb1-b7fe-f2088049594c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_2766b3c9-7a2b-4cb1-b7fe-f2088049594c" xlink:to="loc_us-gaap_CreditFacilityDomain_2766b3c9-7a2b-4cb1-b7fe-f2088049594c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b42be04c-079c-46bf-8b49-c75fcb3aef28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_2766b3c9-7a2b-4cb1-b7fe-f2088049594c" xlink:to="loc_us-gaap_CreditFacilityDomain_b42be04c-079c-46bf-8b49-c75fcb3aef28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIMember_16d51bcb-dfff-4388-a7e2-c1e2290d361c" xlink:href="icui-20211231.xsd#icui_PricingLevelIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b42be04c-079c-46bf-8b49-c75fcb3aef28" xlink:to="loc_icui_PricingLevelIMember_16d51bcb-dfff-4388-a7e2-c1e2290d361c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIIMemberMember_a6fbdf90-b6b6-4b44-9696-81a39fcd9147" xlink:href="icui-20211231.xsd#icui_PricingLevelIIMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b42be04c-079c-46bf-8b49-c75fcb3aef28" xlink:to="loc_icui_PricingLevelIIMemberMember_a6fbdf90-b6b6-4b44-9696-81a39fcd9147" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIIIMemberMember_c26a24e4-e328-4a93-a16c-5ca32d3e0d4e" xlink:href="icui-20211231.xsd#icui_PricingLevelIIIMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b42be04c-079c-46bf-8b49-c75fcb3aef28" xlink:to="loc_icui_PricingLevelIIIMemberMember_c26a24e4-e328-4a93-a16c-5ca32d3e0d4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIVMemberMember_07858faf-59c1-43c8-9710-e079c10c46d4" xlink:href="icui-20211231.xsd#icui_PricingLevelIVMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b42be04c-079c-46bf-8b49-c75fcb3aef28" xlink:to="loc_icui_PricingLevelIVMemberMember_07858faf-59c1-43c8-9710-e079c10c46d4" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#IncomeTaxesDeferredincometaxassetsliabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails" xlink:type="extended" id="i89dc3a9d807b419cbc6e24f927bf3f47_IncomeTaxesDeferredincometaxassetsliabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:href="icui-20211231.xsd#icui_DeferredtaxassetsandliabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_26c61cff-7ebc-4258-9eb8-831a1e7809b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_26c61cff-7ebc-4258-9eb8-831a1e7809b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions_ef82d5bb-62df-4487-8f83-e8eee0ba942f" xlink:href="icui-20211231.xsd#icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions_ef82d5bb-62df-4487-8f83-e8eee0ba942f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_fb7bd65f-7fc7-4915-b208-b95535bf9809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_fb7bd65f-7fc7-4915-b208-b95535bf9809" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_6d173e8e-9b25-4526-999d-268d7887db49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_6d173e8e-9b25-4526-999d-268d7887db49" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NoncurrentDeferredTaxAssetTaxCreditsState_2b12d513-f70b-40a4-9649-7c8704f00627" xlink:href="icui-20211231.xsd#icui_NoncurrentDeferredTaxAssetTaxCreditsState"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_icui_NoncurrentDeferredTaxAssetTaxCreditsState_2b12d513-f70b-40a4-9649-7c8704f00627" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_41a68afe-c256-412c-9233-f146326e77e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_41a68afe-c256-412c-9233-f146326e77e9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_5a0b8922-1c82-4a0b-98fe-4a27626b66e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_5a0b8922-1c82-4a0b-98fe-4a27626b66e0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Noncurrentdeferredtaxassetaccruedrestructuring_59563d96-d734-4c7c-97ed-df9e8635c610" xlink:href="icui-20211231.xsd#icui_Noncurrentdeferredtaxassetaccruedrestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_icui_Noncurrentdeferredtaxassetaccruedrestructuring_59563d96-d734-4c7c-97ed-df9e8635c610" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions_c2fec132-abf9-4824-9acf-11b38356c1e9" xlink:href="icui-20211231.xsd#icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions_c2fec132-abf9-4824-9acf-11b38356c1e9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_c2685d35-4478-4c66-9418-4b51d770f434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_c2685d35-4478-4c66-9418-4b51d770f434" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Noncurrentdeferredtaxasset_c400b21c-1d25-4aec-ae43-422abeeeeb29" xlink:href="icui-20211231.xsd#icui_Noncurrentdeferredtaxasset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_icui_Noncurrentdeferredtaxasset_c400b21c-1d25-4aec-ae43-422abeeeeb29" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes_59ddfe4c-f0f2-4228-9208-79611300e648" xlink:href="icui-20211231.xsd#icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes_59ddfe4c-f0f2-4228-9208-79611300e648" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NoncurrentDeferredTaxLiabilityForeign_b2a6147e-b173-429a-b573-80a84085ffe0" xlink:href="icui-20211231.xsd#icui_NoncurrentDeferredTaxLiabilityForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_icui_NoncurrentDeferredTaxLiabilityForeign_b2a6147e-b173-429a-b573-80a84085ffe0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization_98144daa-087b-447c-9b44-66877db27db7" xlink:href="icui-20211231.xsd#icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization_98144daa-087b-447c-9b44-66877db27db7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Deferredtaxliabilitychangeinaccountingmethod_c734edd6-5b2a-465e-ab17-20fb0dacccbc" xlink:href="icui-20211231.xsd#icui_Deferredtaxliabilitychangeinaccountingmethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_icui_Deferredtaxliabilitychangeinaccountingmethod_c734edd6-5b2a-465e-ab17-20fb0dacccbc" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_4529c9f2-ca0d-4d01-b8ef-223ca7b6269d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_us-gaap_DeferredTaxLiabilities_4529c9f2-ca0d-4d01-b8ef-223ca7b6269d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_44b63621-f600-48a2-a08d-baf2b74045cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_44b63621-f600-48a2-a08d-baf2b74045cc" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DeferredtaxassetsandliabilitiesTable_fe05d425-8434-4b67-8252-49b2f386194b" xlink:href="icui-20211231.xsd#icui_DeferredtaxassetsandliabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_icui_DeferredtaxassetsandliabilitiesTable_fe05d425-8434-4b67-8252-49b2f386194b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c5b96e76-07ea-4cd1-bd95-93055cd07338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesTable_fe05d425-8434-4b67-8252-49b2f386194b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c5b96e76-07ea-4cd1-bd95-93055cd07338" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c5b96e76-07ea-4cd1-bd95-93055cd07338_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c5b96e76-07ea-4cd1-bd95-93055cd07338" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c5b96e76-07ea-4cd1-bd95-93055cd07338_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_910068b6-a697-4244-a8e9-41859bb1f0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c5b96e76-07ea-4cd1-bd95-93055cd07338" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_910068b6-a697-4244-a8e9-41859bb1f0aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NonCurrentDeferredTaxAssetGrossTotalMember_dd47e525-e9df-43ef-b756-79dec6fe762c" xlink:href="icui-20211231.xsd#icui_NonCurrentDeferredTaxAssetGrossTotalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_910068b6-a697-4244-a8e9-41859bb1f0aa" xlink:to="loc_icui_NonCurrentDeferredTaxAssetGrossTotalMember_dd47e525-e9df-43ef-b756-79dec6fe762c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NoncurrentDeferredTaxLiabilityMember_485c8b0b-791d-4f3b-913d-be092c930138" xlink:href="icui-20211231.xsd#icui_NoncurrentDeferredTaxLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_910068b6-a697-4244-a8e9-41859bb1f0aa" xlink:to="loc_icui_NoncurrentDeferredTaxLiabilityMember_485c8b0b-791d-4f3b-913d-be092c930138" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxesOperatingLossCarryforwardsDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#IncomeTaxesOperatingLossCarryforwardsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/IncomeTaxesOperatingLossCarryforwardsDetails" xlink:type="extended" id="iafc636c5ffbf46baa83e8a0c14f3c288_IncomeTaxesOperatingLossCarryforwardsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_508454ac-20eb-494e-8028-840fcd903466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_741ac238-2242-47d1-aa5a-981f2556c7fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_508454ac-20eb-494e-8028-840fcd903466" xlink:to="loc_us-gaap_OperatingLossCarryforwards_741ac238-2242-47d1-aa5a-981f2556c7fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_b54bc055-5d12-47c7-87a3-4fe5566681f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_508454ac-20eb-494e-8028-840fcd903466" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_b54bc055-5d12-47c7-87a3-4fe5566681f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_96f7fa00-3763-4b1a-9f3f-0fe0ff057ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_b54bc055-5d12-47c7-87a3-4fe5566681f1" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_96f7fa00-3763-4b1a-9f3f-0fe0ff057ddf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_96f7fa00-3763-4b1a-9f3f-0fe0ff057ddf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_96f7fa00-3763-4b1a-9f3f-0fe0ff057ddf" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_96f7fa00-3763-4b1a-9f3f-0fe0ff057ddf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_fb34bfe6-af53-4c9d-bdd9-a82fa8f95401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_96f7fa00-3763-4b1a-9f3f-0fe0ff057ddf" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_fb34bfe6-af53-4c9d-bdd9-a82fa8f95401" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_861bfab8-ac6e-47da-8d6c-926b5846bfe9" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_fb34bfe6-af53-4c9d-bdd9-a82fa8f95401" xlink:to="loc_country_US_861bfab8-ac6e-47da-8d6c-926b5846bfe9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_40457ac2-8d7c-4403-b18e-00629c965a42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_fb34bfe6-af53-4c9d-bdd9-a82fa8f95401" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_40457ac2-8d7c-4403-b18e-00629c965a42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_43902eee-3391-4407-987e-96d4ac61fd63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_fb34bfe6-af53-4c9d-bdd9-a82fa8f95401" xlink:to="loc_us-gaap_ForeignCountryMember_43902eee-3391-4407-987e-96d4ac61fd63" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxesTaxHolidayDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#IncomeTaxesTaxHolidayDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/IncomeTaxesTaxHolidayDetails" xlink:type="extended" id="ifeb98386b88c4e66964a5df2deb7f732_IncomeTaxesTaxHolidayDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayLineItems_34227461-0078-4717-99a1-948c4e315fce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxHolidayLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_8ef14d08-0272-4a53-a765-d892e1296b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxHolidayAggregateDollarAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxHolidayLineItems_34227461-0078-4717-99a1-948c4e315fce" xlink:to="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_8ef14d08-0272-4a53-a765-d892e1296b3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare_c86f0791-0bc1-4c27-a783-5fe3ff60470b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxHolidayLineItems_34227461-0078-4717-99a1-948c4e315fce" xlink:to="loc_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare_c86f0791-0bc1-4c27-a783-5fe3ff60470b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayTable_a279f898-6d82-4264-8207-61ebf7322f73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxHolidayTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxHolidayLineItems_34227461-0078-4717-99a1-948c4e315fce" xlink:to="loc_us-gaap_IncomeTaxHolidayTable_a279f898-6d82-4264-8207-61ebf7322f73" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_951b7387-5910-40a9-97b6-b782cc3603ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxHolidayTable_a279f898-6d82-4264-8207-61ebf7322f73" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_951b7387-5910-40a9-97b6-b782cc3603ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_951b7387-5910-40a9-97b6-b782cc3603ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_951b7387-5910-40a9-97b6-b782cc3603ac" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_951b7387-5910-40a9-97b6-b782cc3603ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_79ed2118-f82d-46dd-9aa3-682629e36b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_951b7387-5910-40a9-97b6-b782cc3603ac" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_79ed2118-f82d-46dd-9aa3-682629e36b3d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails" xlink:type="extended" id="i4066237eeb7641228d52fdcaad23cba8_GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ad567993-7e2e-4593-ab62-e62a9577576b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_39880e11-059b-4ef8-9c36-ecaee53830ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ad567993-7e2e-4593-ab62-e62a9577576b" xlink:to="loc_us-gaap_NoncurrentAssets_39880e11-059b-4ef8-9c36-ecaee53830ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8520bc45-0d40-4075-a780-c41c6c281d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ad567993-7e2e-4593-ab62-e62a9577576b" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8520bc45-0d40-4075-a780-c41c6c281d9e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_1f032593-f14a-41c5-900c-95c5ba944631" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8520bc45-0d40-4075-a780-c41c6c281d9e" xlink:to="loc_srt_StatementGeographicalAxis_1f032593-f14a-41c5-900c-95c5ba944631" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1f032593-f14a-41c5-900c-95c5ba944631_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_1f032593-f14a-41c5-900c-95c5ba944631" xlink:to="loc_srt_SegmentGeographicalDomain_1f032593-f14a-41c5-900c-95c5ba944631_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_1f032593-f14a-41c5-900c-95c5ba944631" xlink:to="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CR_9dae563d-3da8-4d15-a54b-382583bc288a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:to="loc_country_CR_9dae563d-3da8-4d15-a54b-382583bc288a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MexicoPropertyAndEquipmentMember_c45a73a3-b1ff-4c9a-9916-dba12234b260" xlink:href="icui-20211231.xsd#icui_MexicoPropertyAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:to="loc_icui_MexicoPropertyAndEquipmentMember_c45a73a3-b1ff-4c9a-9916-dba12234b260" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherLATAMMember_bce45535-d18f-4f34-b505-76e67fcfeab8" xlink:href="icui-20211231.xsd#icui_OtherLATAMMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:to="loc_icui_OtherLATAMMember_bce45535-d18f-4f34-b505-76e67fcfeab8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_9b0a0411-f0db-44be-a8f0-0942cfc931c3" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:to="loc_country_CA_9b0a0411-f0db-44be-a8f0-0942cfc931c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ItalyPropertyAndEquipmentMember_29ec74b0-d80b-42f6-9f81-dda47accb481" xlink:href="icui-20211231.xsd#icui_ItalyPropertyAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:to="loc_icui_ItalyPropertyAndEquipmentMember_29ec74b0-d80b-42f6-9f81-dda47accb481" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_ES_a13a2bb9-a814-4c9e-b8a0-701d629ced1d" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_ES"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:to="loc_country_ES_a13a2bb9-a814-4c9e-b8a0-701d629ced1d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_085d8dfc-6d0c-47ac-8908-beac551ccf8b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:to="loc_srt_EuropeMember_085d8dfc-6d0c-47ac-8908-beac551ccf8b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_5087dcc0-c85c-4f09-81d7-3c9bc0966b69" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:to="loc_srt_AsiaPacificMember_5087dcc0-c85c-4f09-81d7-3c9bc0966b69" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignMember_828f3e03-5bea-4455-95ac-2fed7b04530d" xlink:href="icui-20211231.xsd#icui_ForeignMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:to="loc_icui_ForeignMember_828f3e03-5bea-4455-95ac-2fed7b04530d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_UnitedStatespropertyandequipmentMember_fad2a4b8-1d78-41dc-8506-2bb00e6df992" xlink:href="icui-20211231.xsd#icui_UnitedStatespropertyandequipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:to="loc_icui_UnitedStatespropertyandequipmentMember_fad2a4b8-1d78-41dc-8506-2bb00e6df992" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#StockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/StockholdersEquityDetails" xlink:type="extended" id="i624047ab8410478bbbd236106bac2919_StockholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_24cdb581-0f55-4531-9f55-cc41c75f3a17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3ddbbd12-e32e-4dfd-ac85-b5a1b28f28c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_24cdb581-0f55-4531-9f55-cc41c75f3a17" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3ddbbd12-e32e-4dfd-ac85-b5a1b28f28c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_e6215a1b-b4db-4b6f-90d7-047e115fe8af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_24cdb581-0f55-4531-9f55-cc41c75f3a17" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_e6215a1b-b4db-4b6f-90d7-047e115fe8af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_7c1496c8-5912-49ae-9e72-4156cf251c03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_24cdb581-0f55-4531-9f55-cc41c75f3a17" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_7c1496c8-5912-49ae-9e72-4156cf251c03" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_794d82fa-b493-4390-9a06-b3ee3cb5eb05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_24cdb581-0f55-4531-9f55-cc41c75f3a17" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_794d82fa-b493-4390-9a06-b3ee3cb5eb05" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_725013eb-8e93-4fbe-b1e3-46e3ebfdda5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_24cdb581-0f55-4531-9f55-cc41c75f3a17" xlink:to="loc_us-gaap_TreasuryStockCommonShares_725013eb-8e93-4fbe-b1e3-46e3ebfdda5a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_5e840027-cab8-41f2-9caf-094ff93ccbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_24cdb581-0f55-4531-9f55-cc41c75f3a17" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_5e840027-cab8-41f2-9caf-094ff93ccbf3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9cff217e-abf0-47ca-a9db-2eb862a6cec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_5e840027-cab8-41f2-9caf-094ff93ccbf3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9cff217e-abf0-47ca-a9db-2eb862a6cec0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9cff217e-abf0-47ca-a9db-2eb862a6cec0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9cff217e-abf0-47ca-a9db-2eb862a6cec0" xlink:to="loc_us-gaap_EquityComponentDomain_9cff217e-abf0-47ca-a9db-2eb862a6cec0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_879ab89c-b2f7-409f-af51-4cb797796cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9cff217e-abf0-47ca-a9db-2eb862a6cec0" xlink:to="loc_us-gaap_EquityComponentDomain_879ab89c-b2f7-409f-af51-4cb797796cdd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i6ea553859bec4766a62d297f17af76f3_StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4e8eead3-e2d2-4e9c-9401-6910bf360a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_efc5249e-cb0f-44bd-89a8-351b94c39915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4e8eead3-e2d2-4e9c-9401-6910bf360a63" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_efc5249e-cb0f-44bd-89a8-351b94c39915" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_ab4ce26c-8050-41ad-bc26-92310004174c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4e8eead3-e2d2-4e9c-9401-6910bf360a63" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_ab4ce26c-8050-41ad-bc26-92310004174c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5663e0e4-8712-4a7c-b9aa-30da3bd7d0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4e8eead3-e2d2-4e9c-9401-6910bf360a63" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5663e0e4-8712-4a7c-b9aa-30da3bd7d0ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a61fff28-4829-480e-ad16-bebad1179e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4e8eead3-e2d2-4e9c-9401-6910bf360a63" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a61fff28-4829-480e-ad16-bebad1179e1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e8383c2f-d4f2-405d-af09-d0f08350d908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4e8eead3-e2d2-4e9c-9401-6910bf360a63" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e8383c2f-d4f2-405d-af09-d0f08350d908" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_73cf4de6-c901-42ff-8a11-f497fd10cd51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e8383c2f-d4f2-405d-af09-d0f08350d908" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_73cf4de6-c901-42ff-8a11-f497fd10cd51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_73cf4de6-c901-42ff-8a11-f497fd10cd51_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_73cf4de6-c901-42ff-8a11-f497fd10cd51" xlink:to="loc_us-gaap_EquityComponentDomain_73cf4de6-c901-42ff-8a11-f497fd10cd51_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_34c01fcb-5cfe-4b53-8cbd-9049d11aac1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_73cf4de6-c901-42ff-8a11-f497fd10cd51" xlink:to="loc_us-gaap_EquityComponentDomain_34c01fcb-5cfe-4b53-8cbd-9049d11aac1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_9ba0d6d7-b026-4f05-9e05-0d6fb17f30b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_34c01fcb-5cfe-4b53-8cbd-9049d11aac1c" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_9ba0d6d7-b026-4f05-9e05-0d6fb17f30b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_741f4381-ab76-4883-b8b1-451d673bf2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_34c01fcb-5cfe-4b53-8cbd-9049d11aac1c" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_741f4381-ab76-4883-b8b1-451d673bf2a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3752b0ba-094b-4e91-bf20-6bf6ec1ba4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_34c01fcb-5cfe-4b53-8cbd-9049d11aac1c" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3752b0ba-094b-4e91-bf20-6bf6ec1ba4f1" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#CommitmentsandContingenciesContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails" xlink:type="extended" id="i2924a94f2fab4627b16930798cf32d73_CommitmentsandContingenciesContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_fc2e00de-94fa-4137-bd2f-5c97c55400ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_be5774a7-86cb-4aea-a586-cda4d845e635" xlink:href="icui-20211231.xsd#icui_Contingentconsiderationgross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc2e00de-94fa-4137-bd2f-5c97c55400ee" xlink:to="loc_icui_Contingentconsiderationgross_be5774a7-86cb-4aea-a586-cda4d845e635" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b8c23235-657e-4805-b56d-98946f8369a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc2e00de-94fa-4137-bd2f-5c97c55400ee" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b8c23235-657e-4805-b56d-98946f8369a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermContingentConsiderationGross_c7c31fed-4671-4828-8a6a-4b93d9d2a81a" xlink:href="icui-20211231.xsd#icui_ShortTermContingentConsiderationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc2e00de-94fa-4137-bd2f-5c97c55400ee" xlink:to="loc_icui_ShortTermContingentConsiderationGross_c7c31fed-4671-4828-8a6a-4b93d9d2a81a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermContingentConsiderationGross_4ae23257-6f88-4b38-9933-c391e5d9d602" xlink:href="icui-20211231.xsd#icui_LongTermContingentConsiderationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc2e00de-94fa-4137-bd2f-5c97c55400ee" xlink:to="loc_icui_LongTermContingentConsiderationGross_4ae23257-6f88-4b38-9933-c391e5d9d602" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d74e37f0-21fe-400e-bcb2-4629867f4b36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc2e00de-94fa-4137-bd2f-5c97c55400ee" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d74e37f0-21fe-400e-bcb2-4629867f4b36" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c4643712-cd03-4a96-be9e-7b0e62269007" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d74e37f0-21fe-400e-bcb2-4629867f4b36" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c4643712-cd03-4a96-be9e-7b0e62269007" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c4643712-cd03-4a96-be9e-7b0e62269007_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c4643712-cd03-4a96-be9e-7b0e62269007" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c4643712-cd03-4a96-be9e-7b0e62269007_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6632443-0273-49b4-963e-5f9440a888ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c4643712-cd03-4a96-be9e-7b0e62269007" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6632443-0273-49b4-963e-5f9440a888ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_HospiraMember_b1f87c13-78ed-40d7-9c1c-aa04ba61d387" xlink:href="icui-20211231.xsd#icui_HospiraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6632443-0273-49b4-963e-5f9440a888ec" xlink:to="loc_icui_HospiraMember_b1f87c13-78ed-40d7-9c1c-aa04ba61d387" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_afdd86d0-7aa3-4edc-a828-4cfbc7972566" xlink:href="icui-20211231.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6632443-0273-49b4-963e-5f9440a888ec" xlink:to="loc_icui_PursuitVascularInc.Member_afdd86d0-7aa3-4edc-a828-4cfbc7972566" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularLLCMember_f2a4e692-405e-428f-a31a-93c0c1c23424" xlink:href="icui-20211231.xsd#icui_PursuitVascularLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6632443-0273-49b4-963e-5f9440a888ec" xlink:to="loc_icui_PursuitVascularLLCMember_f2a4e692-405e-428f-a31a-93c0c1c23424" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignDistibutorMember_199e429b-6f94-4cc6-b8f6-c65b8e067891" xlink:href="icui-20211231.xsd#icui_ForeignDistibutorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6632443-0273-49b4-963e-5f9440a888ec" xlink:to="loc_icui_ForeignDistibutorMember_199e429b-6f94-4cc6-b8f6-c65b8e067891" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_7f5fa587-1e1d-4d18-91f4-2d1685f3a290" xlink:href="icui-20211231.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6632443-0273-49b4-963e-5f9440a888ec" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_7f5fa587-1e1d-4d18-91f4-2d1685f3a290" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5432938f-4b6c-408a-81e5-f161adfd2448" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d74e37f0-21fe-400e-bcb2-4629867f4b36" xlink:to="loc_srt_RangeAxis_5432938f-4b6c-408a-81e5-f161adfd2448" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5432938f-4b6c-408a-81e5-f161adfd2448_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5432938f-4b6c-408a-81e5-f161adfd2448" xlink:to="loc_srt_RangeMember_5432938f-4b6c-408a-81e5-f161adfd2448_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c9e5a6f9-fa93-4f41-9fa6-f1f2599f36b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5432938f-4b6c-408a-81e5-f161adfd2448" xlink:to="loc_srt_RangeMember_c9e5a6f9-fa93-4f41-9fa6-f1f2599f36b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bba7437d-b9c7-4dd3-aaa4-160f706277d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c9e5a6f9-fa93-4f41-9fa6-f1f2599f36b2" xlink:to="loc_srt_MinimumMember_bba7437d-b9c7-4dd3-aaa4-160f706277d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ac3d0b4d-c197-4831-b917-46de8424e1da" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c9e5a6f9-fa93-4f41-9fa6-f1f2599f36b2" xlink:to="loc_srt_MaximumMember_ac3d0b4d-c197-4831-b917-46de8424e1da" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/SubsequentEventsDetails" xlink:type="extended" id="i5ce132161deb4faf8c31e5028464456b_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_e5900682-975d-401a-9552-0b3965cca1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_6a8235c3-8568-42a6-a3a1-a2c985e47597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_e5900682-975d-401a-9552-0b3965cca1f9" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_6a8235c3-8568-42a6-a3a1-a2c985e47597" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_609c0583-7d7c-4655-b752-1333ee29af30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_e5900682-975d-401a-9552-0b3965cca1f9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_609c0583-7d7c-4655-b752-1333ee29af30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f335a211-87ab-452e-b480-8ead9d0e6322" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_e5900682-975d-401a-9552-0b3965cca1f9" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f335a211-87ab-452e-b480-8ead9d0e6322" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_fe1dc53f-ed36-42a2-8c15-6a9bfa80f770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_e5900682-975d-401a-9552-0b3965cca1f9" xlink:to="loc_us-gaap_CommonStockValue_fe1dc53f-ed36-42a2-8c15-6a9bfa80f770" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_dbb285b1-87ad-47b8-8f9c-e4437aca5731" xlink:href="icui-20211231.xsd#icui_Contingentconsiderationgross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_e5900682-975d-401a-9552-0b3965cca1f9" xlink:to="loc_icui_Contingentconsiderationgross_dbb285b1-87ad-47b8-8f9c-e4437aca5731" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OwnershipShareMinimumRequirement_aa5ab0f3-9257-418a-b887-7c4b3536fe40" xlink:href="icui-20211231.xsd#icui_OwnershipShareMinimumRequirement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_e5900682-975d-401a-9552-0b3965cca1f9" xlink:to="loc_icui_OwnershipShareMinimumRequirement_aa5ab0f3-9257-418a-b887-7c4b3536fe40" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_8b79f191-d923-4db8-9044-7a215b07f5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_e5900682-975d-401a-9552-0b3965cca1f9" xlink:to="loc_us-gaap_SubsequentEventTable_8b79f191-d923-4db8-9044-7a215b07f5a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_3229d181-2c02-4ac1-82e4-cf96b26e2f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_8b79f191-d923-4db8-9044-7a215b07f5a5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_3229d181-2c02-4ac1-82e4-cf96b26e2f2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3229d181-2c02-4ac1-82e4-cf96b26e2f2b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3229d181-2c02-4ac1-82e4-cf96b26e2f2b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3229d181-2c02-4ac1-82e4-cf96b26e2f2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_07fe0a59-e245-4c90-99b0-79128a948c69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3229d181-2c02-4ac1-82e4-cf96b26e2f2b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_07fe0a59-e245-4c90-99b0-79128a948c69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_135bc26f-f9c0-4553-8e40-c9b7ddefe2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_07fe0a59-e245-4c90-99b0-79128a948c69" xlink:to="loc_us-gaap_SubsequentEventMember_135bc26f-f9c0-4553-8e40-c9b7ddefe2d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4d01f249-17b7-44d9-8dcd-8b1ec82760c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_8b79f191-d923-4db8-9044-7a215b07f5a5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4d01f249-17b7-44d9-8dcd-8b1ec82760c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4d01f249-17b7-44d9-8dcd-8b1ec82760c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4d01f249-17b7-44d9-8dcd-8b1ec82760c2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4d01f249-17b7-44d9-8dcd-8b1ec82760c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6db065dd-e4a0-48d8-b011-7e742cd47960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4d01f249-17b7-44d9-8dcd-8b1ec82760c2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6db065dd-e4a0-48d8-b011-7e742cd47960" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_fcf51fbb-3153-478e-908a-360331becd5a" xlink:href="icui-20211231.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6db065dd-e4a0-48d8-b011-7e742cd47960" xlink:to="loc_icui_SmithsMedicalMember_fcf51fbb-3153-478e-908a-360331becd5a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#SubsequentEventsCreditAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails" xlink:type="extended" id="i60fe110db8c6435b90aa7ed4f75e915b_SubsequentEventsCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_8809571c-7c14-492a-b1a3-b09f85a2be73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_54a2cb65-99a9-41c9-bd5b-129885c36300" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_8809571c-7c14-492a-b1a3-b09f85a2be73" xlink:to="loc_us-gaap_LongTermDebt_54a2cb65-99a9-41c9-bd5b-129885c36300" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt_31f905c9-f6c8-4e04-91ca-c34ef906fbeb" xlink:href="icui-20211231.xsd#icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_8809571c-7c14-492a-b1a3-b09f85a2be73" xlink:to="loc_icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt_31f905c9-f6c8-4e04-91ca-c34ef906fbeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount_f1e7d07f-9db7-4ed0-b902-f047cbc8be34" xlink:href="icui-20211231.xsd#icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_8809571c-7c14-492a-b1a3-b09f85a2be73" xlink:to="loc_icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount_f1e7d07f-9db7-4ed0-b902-f047cbc8be34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAPaymentYear5_6721ed40-fff0-4097-934e-0ff4a933a186" xlink:href="icui-20211231.xsd#icui_TermLoanAPaymentYear5"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_8809571c-7c14-492a-b1a3-b09f85a2be73" xlink:to="loc_icui_TermLoanAPaymentYear5_6721ed40-fff0-4097-934e-0ff4a933a186" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount_7b870b0b-cbda-4f51-ac67-b971fab4ffe6" xlink:href="icui-20211231.xsd#icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_8809571c-7c14-492a-b1a3-b09f85a2be73" xlink:to="loc_icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount_7b870b0b-cbda-4f51-ac67-b971fab4ffe6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LineOfCreditSpread_5e9d1766-b533-4b3e-9892-b2f75f1a9aa7" xlink:href="icui-20211231.xsd#icui_LineOfCreditSpread"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_8809571c-7c14-492a-b1a3-b09f85a2be73" xlink:to="loc_icui_LineOfCreditSpread_5e9d1766-b533-4b3e-9892-b2f75f1a9aa7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAAndCreditLineSpread_6a5aa4e1-835d-456c-9fa3-9f5ac5a46b96" xlink:href="icui-20211231.xsd#icui_TermLoanAAndCreditLineSpread"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_8809571c-7c14-492a-b1a3-b09f85a2be73" xlink:to="loc_icui_TermLoanAAndCreditLineSpread_6a5aa4e1-835d-456c-9fa3-9f5ac5a46b96" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBInitialSpread_1e30c274-413c-41f8-96e8-bc7adc521a17" xlink:href="icui-20211231.xsd#icui_TermLoanBInitialSpread"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_8809571c-7c14-492a-b1a3-b09f85a2be73" xlink:to="loc_icui_TermLoanBInitialSpread_1e30c274-413c-41f8-96e8-bc7adc521a17" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_e3274774-ac8f-4660-9f53-9ca2ce2b038a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_8809571c-7c14-492a-b1a3-b09f85a2be73" xlink:to="loc_us-gaap_SubsequentEventTable_e3274774-ac8f-4660-9f53-9ca2ce2b038a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b26fb542-64eb-40d1-ab12-b94cd4c5417c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_e3274774-ac8f-4660-9f53-9ca2ce2b038a" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b26fb542-64eb-40d1-ab12-b94cd4c5417c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b26fb542-64eb-40d1-ab12-b94cd4c5417c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b26fb542-64eb-40d1-ab12-b94cd4c5417c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b26fb542-64eb-40d1-ab12-b94cd4c5417c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9d5b4a97-40f9-4ef9-85c4-501b041a0b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b26fb542-64eb-40d1-ab12-b94cd4c5417c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9d5b4a97-40f9-4ef9-85c4-501b041a0b51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_59aad036-7c87-44cf-a253-c5ca45daeff5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_9d5b4a97-40f9-4ef9-85c4-501b041a0b51" xlink:to="loc_us-gaap_SubsequentEventMember_59aad036-7c87-44cf-a253-c5ca45daeff5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_95d96d6e-3904-4313-b074-365e6d9aa0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_e3274774-ac8f-4660-9f53-9ca2ce2b038a" xlink:to="loc_us-gaap_DebtInstrumentAxis_95d96d6e-3904-4313-b074-365e6d9aa0e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_95d96d6e-3904-4313-b074-365e6d9aa0e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_95d96d6e-3904-4313-b074-365e6d9aa0e2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_95d96d6e-3904-4313-b074-365e6d9aa0e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fec06b46-c0d1-4e03-a940-5d9d0ed36e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_95d96d6e-3904-4313-b074-365e6d9aa0e2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fec06b46-c0d1-4e03-a940-5d9d0ed36e8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoansLineOfCreditMember_86118222-7f74-4f9b-a479-8dcde1d3ee63" xlink:href="icui-20211231.xsd#icui_TermLoansLineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fec06b46-c0d1-4e03-a940-5d9d0ed36e8a" xlink:to="loc_icui_TermLoansLineOfCreditMember_86118222-7f74-4f9b-a479-8dcde1d3ee63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_0c640a14-b68a-4b76-8beb-7a99f1852761" xlink:href="icui-20211231.xsd#icui_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fec06b46-c0d1-4e03-a940-5d9d0ed36e8a" xlink:to="loc_icui_TermLoanAMember_0c640a14-b68a-4b76-8beb-7a99f1852761" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_73ca755e-202f-4bd1-a0e1-2798f13b8366" xlink:href="icui-20211231.xsd#icui_TermLoanBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fec06b46-c0d1-4e03-a940-5d9d0ed36e8a" xlink:to="loc_icui_TermLoanBMember_73ca755e-202f-4bd1-a0e1-2798f13b8366" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_c2b78cf2-6131-4595-9647-17cfea971ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fec06b46-c0d1-4e03-a940-5d9d0ed36e8a" xlink:to="loc_us-gaap_LineOfCreditMember_c2b78cf2-6131-4595-9647-17cfea971ac5" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#SubsequentEventsTermLoanACreditLineApplicableMarginDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails" xlink:type="extended" id="ieabcde2275fd41dd8e1875cccca0df65_SubsequentEventsTermLoanACreditLineApplicableMarginDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_3cddb6f4-2ed5-494d-8841-ae8ff0027aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Spread_3a7c3ad5-d82e-4075-8351-72040f4f1523" xlink:href="icui-20211231.xsd#icui_Spread"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_3cddb6f4-2ed5-494d-8841-ae8ff0027aa6" xlink:to="loc_icui_Spread_3a7c3ad5-d82e-4075-8351-72040f4f1523" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9fe75d5d-eb53-48bf-ac50-82e3f04c8df7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_3cddb6f4-2ed5-494d-8841-ae8ff0027aa6" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9fe75d5d-eb53-48bf-ac50-82e3f04c8df7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7154dd13-0fd3-48ad-87dc-6b22bb4e582f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_3cddb6f4-2ed5-494d-8841-ae8ff0027aa6" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7154dd13-0fd3-48ad-87dc-6b22bb4e582f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAAndCreditLineSpread_fb671e45-026b-43e5-a4a6-91db15d3ead9" xlink:href="icui-20211231.xsd#icui_TermLoanAAndCreditLineSpread"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_3cddb6f4-2ed5-494d-8841-ae8ff0027aa6" xlink:to="loc_icui_TermLoanAAndCreditLineSpread_fb671e45-026b-43e5-a4a6-91db15d3ead9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_24bea94c-de28-41a9-a68a-407f950e86ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_3cddb6f4-2ed5-494d-8841-ae8ff0027aa6" xlink:to="loc_us-gaap_SubsequentEventTable_24bea94c-de28-41a9-a68a-407f950e86ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9241b820-9925-4614-adc9-a032594e05d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_24bea94c-de28-41a9-a68a-407f950e86ac" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9241b820-9925-4614-adc9-a032594e05d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9241b820-9925-4614-adc9-a032594e05d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9241b820-9925-4614-adc9-a032594e05d8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9241b820-9925-4614-adc9-a032594e05d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c6c3f33f-064d-430c-8a63-b6fb29267c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9241b820-9925-4614-adc9-a032594e05d8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c6c3f33f-064d-430c-8a63-b6fb29267c9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_70445149-b5c0-471a-a94d-4bf4810f7f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c6c3f33f-064d-430c-8a63-b6fb29267c9f" xlink:to="loc_us-gaap_SubsequentEventMember_70445149-b5c0-471a-a94d-4bf4810f7f45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis_1b97ffc0-5489-43a1-9f70-c6873de29ac0" xlink:href="icui-20211231.xsd#icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_24bea94c-de28-41a9-a68a-407f950e86ac" xlink:to="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis_1b97ffc0-5489-43a1-9f70-c6873de29ac0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain_1b97ffc0-5489-43a1-9f70-c6873de29ac0_default" xlink:href="icui-20211231.xsd#icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis_1b97ffc0-5489-43a1-9f70-c6873de29ac0" xlink:to="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain_1b97ffc0-5489-43a1-9f70-c6873de29ac0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain_8b47605c-1564-428a-a372-b8fe2a850530" xlink:href="icui-20211231.xsd#icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis_1b97ffc0-5489-43a1-9f70-c6873de29ac0" xlink:to="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain_8b47605c-1564-428a-a372-b8fe2a850530" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevel5Member_5e109094-32a0-40ba-9d1d-50a77edc26ac" xlink:href="icui-20211231.xsd#icui_PricingLevel5Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain_8b47605c-1564-428a-a372-b8fe2a850530" xlink:to="loc_icui_PricingLevel5Member_5e109094-32a0-40ba-9d1d-50a77edc26ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIVMemberMember_71c73642-996f-4b4f-ab16-335f0b2f4983" xlink:href="icui-20211231.xsd#icui_PricingLevelIVMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain_8b47605c-1564-428a-a372-b8fe2a850530" xlink:to="loc_icui_PricingLevelIVMemberMember_71c73642-996f-4b4f-ab16-335f0b2f4983" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIIIMemberMember_0b682553-886a-4472-b69a-4514b1db63f1" xlink:href="icui-20211231.xsd#icui_PricingLevelIIIMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain_8b47605c-1564-428a-a372-b8fe2a850530" xlink:to="loc_icui_PricingLevelIIIMemberMember_0b682553-886a-4472-b69a-4514b1db63f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIIMemberMember_a05ccb16-123e-4ad1-af67-5d9cc715b3f9" xlink:href="icui-20211231.xsd#icui_PricingLevelIIMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain_8b47605c-1564-428a-a372-b8fe2a850530" xlink:to="loc_icui_PricingLevelIIMemberMember_a05ccb16-123e-4ad1-af67-5d9cc715b3f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIMember_8becc828-bb4c-4dc2-9c29-baf2cf7d3e41" xlink:href="icui-20211231.xsd#icui_PricingLevelIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain_8b47605c-1564-428a-a372-b8fe2a850530" xlink:to="loc_icui_PricingLevelIMember_8becc828-bb4c-4dc2-9c29-baf2cf7d3e41" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/SubsequentEventsTermLoanBApplicableMarginDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#SubsequentEventsTermLoanBApplicableMarginDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/SubsequentEventsTermLoanBApplicableMarginDetails" xlink:type="extended" id="idd2dfa588f954d8a8d7c131ab63047a5_SubsequentEventsTermLoanBApplicableMarginDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_8b8c710b-08db-4751-aa22-d32ceadafd09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBEuroRateLoanSpread_4e407f02-09d7-4236-9825-e4b74e140717" xlink:href="icui-20211231.xsd#icui_TermLoanBEuroRateLoanSpread"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_8b8c710b-08db-4751-aa22-d32ceadafd09" xlink:to="loc_icui_TermLoanBEuroRateLoanSpread_4e407f02-09d7-4236-9825-e4b74e140717" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBBaseRateLoanSpread_aab33583-4ce0-47bb-af0a-ea7ad1deb78d" xlink:href="icui-20211231.xsd#icui_TermLoanBBaseRateLoanSpread"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_8b8c710b-08db-4751-aa22-d32ceadafd09" xlink:to="loc_icui_TermLoanBBaseRateLoanSpread_aab33583-4ce0-47bb-af0a-ea7ad1deb78d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBInitialSpread_ec122530-9d09-46ad-8eb3-feb57c7c3223" xlink:href="icui-20211231.xsd#icui_TermLoanBInitialSpread"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_8b8c710b-08db-4751-aa22-d32ceadafd09" xlink:to="loc_icui_TermLoanBInitialSpread_ec122530-9d09-46ad-8eb3-feb57c7c3223" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_c9bfaacb-8dcd-4a3c-8eb4-053eb14580a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_8b8c710b-08db-4751-aa22-d32ceadafd09" xlink:to="loc_us-gaap_SubsequentEventTable_c9bfaacb-8dcd-4a3c-8eb4-053eb14580a0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6ecff371-a16a-43fa-83e3-b08130c80b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_c9bfaacb-8dcd-4a3c-8eb4-053eb14580a0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6ecff371-a16a-43fa-83e3-b08130c80b8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6ecff371-a16a-43fa-83e3-b08130c80b8d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6ecff371-a16a-43fa-83e3-b08130c80b8d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6ecff371-a16a-43fa-83e3-b08130c80b8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_580e3582-dd6f-4937-8f88-893ae0e9a65f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6ecff371-a16a-43fa-83e3-b08130c80b8d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_580e3582-dd6f-4937-8f88-893ae0e9a65f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_7f81f866-01b3-4c71-8dfe-f5006cfbd16c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_580e3582-dd6f-4937-8f88-893ae0e9a65f" xlink:to="loc_us-gaap_SubsequentEventMember_7f81f866-01b3-4c71-8dfe-f5006cfbd16c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBApplicableMarginAxis_a8a9eac2-13d6-464a-9203-40726f8b1b67" xlink:href="icui-20211231.xsd#icui_TermLoanBApplicableMarginAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_c9bfaacb-8dcd-4a3c-8eb4-053eb14580a0" xlink:to="loc_icui_TermLoanBApplicableMarginAxis_a8a9eac2-13d6-464a-9203-40726f8b1b67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBApplicableMarginDomain_a8a9eac2-13d6-464a-9203-40726f8b1b67_default" xlink:href="icui-20211231.xsd#icui_TermLoanBApplicableMarginDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TermLoanBApplicableMarginAxis_a8a9eac2-13d6-464a-9203-40726f8b1b67" xlink:to="loc_icui_TermLoanBApplicableMarginDomain_a8a9eac2-13d6-464a-9203-40726f8b1b67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBApplicableMarginDomain_63696b94-bdad-4477-a2a6-4ddd966e44f6" xlink:href="icui-20211231.xsd#icui_TermLoanBApplicableMarginDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TermLoanBApplicableMarginAxis_a8a9eac2-13d6-464a-9203-40726f8b1b67" xlink:to="loc_icui_TermLoanBApplicableMarginDomain_63696b94-bdad-4477-a2a6-4ddd966e44f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIIMemberMember_27283f12-b08f-46d5-b1d1-669aaa307648" xlink:href="icui-20211231.xsd#icui_PricingLevelIIMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanBApplicableMarginDomain_63696b94-bdad-4477-a2a6-4ddd966e44f6" xlink:to="loc_icui_PricingLevelIIMemberMember_27283f12-b08f-46d5-b1d1-669aaa307648" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIMember_a7ea4173-7bae-47b8-bf52-dee4d6a20d38" xlink:href="icui-20211231.xsd#icui_PricingLevelIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanBApplicableMarginDomain_63696b94-bdad-4477-a2a6-4ddd966e44f6" xlink:to="loc_icui_PricingLevelIMember_a7ea4173-7bae-47b8-bf52-dee4d6a20d38" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#SECScheduleArticle1209ValuationandQualifyingAccountsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails" xlink:type="extended" id="i71dccdae10114ca590d5ca6cbb38a46a_SECScheduleArticle1209ValuationandQualifyingAccountsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_7ca6484e-522f-4ad8-937c-c925e6fe84f5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_7ca6484e-522f-4ad8-937c-c925e6fe84f5" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_998289bb-f8ed-4e5d-957c-bfaa51483c22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_998289bb-f8ed-4e5d-957c-bfaa51483c22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_755bfca8-e341-4206-9bde-842196ce572a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_755bfca8-e341-4206-9bde-842196ce572a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_74202e3a-5904-4381-9f3b-5820fb210cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_74202e3a-5904-4381-9f3b-5820fb210cd4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_0e6660b6-c5ac-47e2-9150-d37624c3d18a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_0e6660b6-c5ac-47e2-9150-d37624c3d18a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_3553b4cc-dc48-47e9-b42b-33951a707ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_WarrantyAndReturnReserveInventoryWriteOffs_a903127c-307a-432d-a2e1-3229e5549c3c" xlink:href="icui-20211231.xsd#icui_WarrantyAndReturnReserveInventoryWriteOffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:to="loc_icui_WarrantyAndReturnReserveInventoryWriteOffs_a903127c-307a-432d-a2e1-3229e5549c3c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts_f022e6d2-4299-4e76-a28f-18aa729b34f9" xlink:href="icui-20211231.xsd#icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:to="loc_icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts_f022e6d2-4299-4e76-a28f-18aa729b34f9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_WarrantyAndReturnReserveCosts_9985b3dc-c895-4caa-907b-6a7e723e7282" xlink:href="icui-20211231.xsd#icui_WarrantyAndReturnReserveCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:to="loc_icui_WarrantyAndReturnReserveCosts_9985b3dc-c895-4caa-907b-6a7e723e7282" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_WarrantyAndReturnReserveInventory_1c2344dc-81f9-462d-87a8-63789d70f970" xlink:href="icui-20211231.xsd#icui_WarrantyAndReturnReserveInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:to="loc_icui_WarrantyAndReturnReserveInventory_1c2344dc-81f9-462d-87a8-63789d70f970" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_e2baaa03-0718-4aef-bbd1-997a68b19eca" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_7ca6484e-522f-4ad8-937c-c925e6fe84f5" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_e2baaa03-0718-4aef-bbd1-997a68b19eca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_26cbc099-69af-464c-b149-2d3fcdd96903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_e2baaa03-0718-4aef-bbd1-997a68b19eca" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_26cbc099-69af-464c-b149-2d3fcdd96903" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_26cbc099-69af-464c-b149-2d3fcdd96903_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_26cbc099-69af-464c-b149-2d3fcdd96903" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_26cbc099-69af-464c-b149-2d3fcdd96903_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_5718ecd5-b5bc-4d2e-8191-3cf4f544ced0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_26cbc099-69af-464c-b149-2d3fcdd96903" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_5718ecd5-b5bc-4d2e-8191-3cf4f544ced0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_6570b451-948a-43e4-b96f-42bfad321a24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_5718ecd5-b5bc-4d2e-8191-3cf4f544ced0" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_6570b451-948a-43e4-b96f-42bfad321a24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantyReservesMember_3448eed1-e3e3-4c32-b26b-db3c83b58d72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantyReservesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_5718ecd5-b5bc-4d2e-8191-3cf4f544ced0" xlink:to="loc_us-gaap_WarrantyReservesMember_3448eed1-e3e3-4c32-b26b-db3c83b58d72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_d5262aab-cf53-4489-a801-78a99238b2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_5718ecd5-b5bc-4d2e-8191-3cf4f544ced0" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_d5262aab-cf53-4489-a801-78a99238b2ad" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaap_OtherLiabilities" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>icui-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:79121b2d-e854-41aa-aab3-7b5c5847e030,g:aa7e8fee-abd8-4fff-b3c4-f8ba25538e22-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_icui_FurniturefixturesandmoldsMember_7420c912-60b4-48f3-9928-033056dd7b12_terseLabel_en-US" xlink:label="lab_icui_FurniturefixturesandmoldsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, fixtures and molds [Member]</link:label>
    <link:label id="lab_icui_FurniturefixturesandmoldsMember_label_en-US" xlink:label="lab_icui_FurniturefixturesandmoldsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, fixtures and molds [Member]</link:label>
    <link:label id="lab_icui_FurniturefixturesandmoldsMember_documentation_en-US" xlink:label="lab_icui_FurniturefixturesandmoldsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, fixtures and molds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_FurniturefixturesandmoldsMember" xlink:href="icui-20211231.xsd#icui_FurniturefixturesandmoldsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_FurniturefixturesandmoldsMember" xlink:to="lab_icui_FurniturefixturesandmoldsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_c230f4a9-cfc9-4919-a2c0-6e3b0ab37fd4_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL DISCLSOURE OF CASH FLOW INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Accruedfreight_8eb41510-baaf-455d-81c9-c008d7eaaf4a_terseLabel_en-US" xlink:label="lab_icui_Accruedfreight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued freight</link:label>
    <link:label id="lab_icui_Accruedfreight_label_en-US" xlink:label="lab_icui_Accruedfreight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued freight</link:label>
    <link:label id="lab_icui_Accruedfreight_documentation_en-US" xlink:label="lab_icui_Accruedfreight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued freight</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedfreight" xlink:href="icui-20211231.xsd#icui_Accruedfreight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Accruedfreight" xlink:to="lab_icui_Accruedfreight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_385f82da-e486-4c66-a12d-79ef716b3c29_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_60828e27-bc59-434c-87b4-49889c7283a2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_a4924dc4-eccd-4e9a-b7a5-36b504957f5c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_bc0d62f9-1ef1-4761-842e-a1763c9e3e9d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investment securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_788f2229-bf1e-476f-8bfe-b75d1dbd65bc_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, outstanding shares</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InternationalDistributorMember_cfc07690-1329-4ced-8c45-f816a74e6e91_terseLabel_en-US" xlink:label="lab_icui_InternationalDistributorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Distributor</link:label>
    <link:label id="lab_icui_InternationalDistributorMember_label_en-US" xlink:label="lab_icui_InternationalDistributorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Distributor [Member]</link:label>
    <link:label id="lab_icui_InternationalDistributorMember_documentation_en-US" xlink:label="lab_icui_InternationalDistributorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Distributor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InternationalDistributorMember" xlink:href="icui-20211231.xsd#icui_InternationalDistributorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InternationalDistributorMember" xlink:to="lab_icui_InternationalDistributorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_EffectiveIncomeTaxRateReconciliationContingentConsideration_5bd4093f-6236-4486-b18b-1681564cde42_negatedTerseLabel_en-US" xlink:label="lab_icui_EffectiveIncomeTaxRateReconciliationContingentConsideration" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Contingent Consideration</link:label>
    <link:label id="lab_icui_EffectiveIncomeTaxRateReconciliationContingentConsideration_label_en-US" xlink:label="lab_icui_EffectiveIncomeTaxRateReconciliationContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Contingent Consideration</link:label>
    <link:label id="lab_icui_EffectiveIncomeTaxRateReconciliationContingentConsideration_documentation_en-US" xlink:label="lab_icui_EffectiveIncomeTaxRateReconciliationContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EffectiveIncomeTaxRateReconciliationContingentConsideration" xlink:href="icui-20211231.xsd#icui_EffectiveIncomeTaxRateReconciliationContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_EffectiveIncomeTaxRateReconciliationContingentConsideration" xlink:to="lab_icui_EffectiveIncomeTaxRateReconciliationContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4ef41ce7-0d68-4263-8db0-d1a3338919a8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_e3fc9f96-9895-4c4e-8b74-eca88bf3511b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_944f7230-da99-4f5f-97ae-1c0eda504dc5_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_2f4a9071-401c-4ad8-b126-472b30a7545e_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_7c74ee90-c621-4b3a-a11d-2b873d236791_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_3b3f798c-ba0f-4cd0-8945-3c44fc443dde_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset and Liability [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_90d5052f-65a6-448f-bb60-d1f5ec423dc4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_991ef079-e8c3-4590-a1b5-2cd9c111be0c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_3698e954-4680-480d-b62c-aa1a7c0e1b7c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_f1a25a9d-ce01-422c-922c-12297caba194_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2b1744af-2aa9-4f80-9827-27463b38ce2b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_86b77400-cc37-4a5e-ae0b-c4e3e70b96ff_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_41b2edc2-6c51-441a-a1ad-7351cd17ad72_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_53fc3a9c-964a-4c39-b65a-ca1d9c64f7a3_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_43804081-01e2-4d15-9811-785414d16be6_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_e2253bf4-2dd9-4bc8-b47d-9cbbf262d532_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected stock price volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_8508e658-96c4-4dbd-906a-f275a67980aa_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_OwnershipShareMinimumRequirement_f6e917fa-ffd1-458f-ab19-624b588550c0_terseLabel_en-US" xlink:label="lab_icui_OwnershipShareMinimumRequirement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership Share % Minimum Requirement</link:label>
    <link:label id="lab_icui_OwnershipShareMinimumRequirement_label_en-US" xlink:label="lab_icui_OwnershipShareMinimumRequirement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership Share % Minimum Requirement</link:label>
    <link:label id="lab_icui_OwnershipShareMinimumRequirement_documentation_en-US" xlink:label="lab_icui_OwnershipShareMinimumRequirement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership Share % Minimum Requirement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OwnershipShareMinimumRequirement" xlink:href="icui-20211231.xsd#icui_OwnershipShareMinimumRequirement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_OwnershipShareMinimumRequirement" xlink:to="lab_icui_OwnershipShareMinimumRequirement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_50034eca-5cbf-41d0-bf47-4bdb9f6c4409_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_85bc682d-bcf4-4309-a332-f97485b38ccf_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Timebasedoptionsgrantdatefairvalue_50fc667b-30bb-4c5d-9a21-3aa067a4cd3d_terseLabel_en-US" xlink:label="lab_icui_Timebasedoptionsgrantdatefairvalue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time based options grant date fair value</link:label>
    <link:label id="lab_icui_Timebasedoptionsgrantdatefairvalue_label_en-US" xlink:label="lab_icui_Timebasedoptionsgrantdatefairvalue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time based options grant date fair value</link:label>
    <link:label id="lab_icui_Timebasedoptionsgrantdatefairvalue_documentation_en-US" xlink:label="lab_icui_Timebasedoptionsgrantdatefairvalue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time based options grant date fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Timebasedoptionsgrantdatefairvalue" xlink:href="icui-20211231.xsd#icui_Timebasedoptionsgrantdatefairvalue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Timebasedoptionsgrantdatefairvalue" xlink:to="lab_icui_Timebasedoptionsgrantdatefairvalue" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SoftwarerevenueMember_bbcb2355-f953-4383-b370-dbdba21386ab_terseLabel_en-US" xlink:label="lab_icui_SoftwarerevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software revenue [Member]</link:label>
    <link:label id="lab_icui_SoftwarerevenueMember_label_en-US" xlink:label="lab_icui_SoftwarerevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software revenue [Member]</link:label>
    <link:label id="lab_icui_SoftwarerevenueMember_documentation_en-US" xlink:label="lab_icui_SoftwarerevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SoftwarerevenueMember" xlink:href="icui-20211231.xsd#icui_SoftwarerevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SoftwarerevenueMember" xlink:to="lab_icui_SoftwarerevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ExercisedOptionsDataTableTextBlock_0f936ad8-f9e4-4e20-8a24-71f47e0d3fb5_terseLabel_en-US" xlink:label="lab_icui_ExercisedOptionsDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised Options Data [Table Text Block]</link:label>
    <link:label id="lab_icui_ExercisedOptionsDataTableTextBlock_label_en-US" xlink:label="lab_icui_ExercisedOptionsDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised Options Data [Table Text Block]</link:label>
    <link:label id="lab_icui_ExercisedOptionsDataTableTextBlock_documentation_en-US" xlink:label="lab_icui_ExercisedOptionsDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised Options Data [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ExercisedOptionsDataTableTextBlock" xlink:href="icui-20211231.xsd#icui_ExercisedOptionsDataTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ExercisedOptionsDataTableTextBlock" xlink:to="lab_icui_ExercisedOptionsDataTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_33b71911-a71a-41dd-b803-f591e8c4bc68_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged&#160;to Costs&#160;and Expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedBonusesCurrent_385a558c-b6a5-444a-b3e6-e307a8939b32_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedBonusesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive compensation</link:label>
    <link:label id="lab_us-gaap_AccruedBonusesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedBonusesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Bonuses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedBonusesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedBonusesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedBonusesCurrent" xlink:to="lab_us-gaap_AccruedBonusesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_96eebb6f-c419-491b-82ef-70ac2b862c42_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_cdad25de-dfd4-47b5-bc66-01f3ddd7473b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_b3daf16b-bd0a-4175-a979-ad6fd0e6aade_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Liabilities Arising from Contingencies, Amount Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:to="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_cf36b05a-1d72-4c3e-af5e-b02106178877_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_7873d584-1dbf-4cee-a91b-061117a5e259_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_4e8d03ba-f349-4ecf-94f2-d786dd860c5f_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8d5d0b87-1066-4a54-a464-1d420fd6d724_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock purchase plan remaining available</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_e518234e-3ee1-443a-97a5-ea4a5a6a5d55_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increases Resulting from Prior Period Tax Positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_ca7e9471-c4c2-49df-971b-98ea1554df7d_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_b6b091aa-8fed-4022-9556-5401f997c003_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0fe4db50-1340-4fc5-bb46-689d8991752c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_24e79de2-6c9a-4a4d-ac77-d239ac5ac84c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_70a56db3-526e-44b2-b25b-59bfde7feace_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_4678c9f6-f73e-41c1-8001-1db173cbeefd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of assets acquired</link:label>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfAssetsAcquired" xlink:to="lab_us-gaap_FairValueOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_72ff10d7-d127-4cd5-838c-140e0cfbf48a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_6d75de34-e3da-4647-97d4-eb9f5b0162f7_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_EffectiveTaxRateReconciliationIPMigrationPercent_28d1355a-b7ba-4092-85fa-f9a3b7d3223e_terseLabel_en-US" xlink:label="lab_icui_EffectiveTaxRateReconciliationIPMigrationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EffectiveTaxRateReconciliationIPMigrationPercent</link:label>
    <link:label id="lab_icui_EffectiveTaxRateReconciliationIPMigrationPercent_label_en-US" xlink:label="lab_icui_EffectiveTaxRateReconciliationIPMigrationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EffectiveTaxRateReconciliationIPMigrationPercent</link:label>
    <link:label id="lab_icui_EffectiveTaxRateReconciliationIPMigrationPercent_documentation_en-US" xlink:label="lab_icui_EffectiveTaxRateReconciliationIPMigrationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EffectiveTaxRateReconciliationIPMigrationPercent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EffectiveTaxRateReconciliationIPMigrationPercent" xlink:href="icui-20211231.xsd#icui_EffectiveTaxRateReconciliationIPMigrationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_EffectiveTaxRateReconciliationIPMigrationPercent" xlink:to="lab_icui_EffectiveTaxRateReconciliationIPMigrationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_1c26abd0-5806-4b61-94a9-6aa7e44ea426_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_770f0f40-febc-4109-a862-de0da87e06e2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquiredReceivablesFairValue_d03241b8-6fa6-4c84-b852-f2d991c613ae_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquiredReceivablesFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquired Receivable, Fair Value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquiredReceivablesFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquiredReceivablesFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquired Receivable, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquiredReceivablesFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquiredReceivablesFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquiredReceivablesFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_8fc32ac5-058f-436d-b8c8-065d000b7ecb_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_43695fbd-70cd-4c4b-95cf-ba229858c00c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_56c049e0-d26c-4883-b431-24c4d7b152f2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanBBaseRateLoanSpread_a4c0cba0-4bea-4ab4-83af-20bc0fd4e9c0_terseLabel_en-US" xlink:label="lab_icui_TermLoanBBaseRateLoanSpread" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Base Rate Loan Spread</link:label>
    <link:label id="lab_icui_TermLoanBBaseRateLoanSpread_label_en-US" xlink:label="lab_icui_TermLoanBBaseRateLoanSpread" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Base Rate Loan Spread</link:label>
    <link:label id="lab_icui_TermLoanBBaseRateLoanSpread_documentation_en-US" xlink:label="lab_icui_TermLoanBBaseRateLoanSpread" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Base Rate Loan Spread</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBBaseRateLoanSpread" xlink:href="icui-20211231.xsd#icui_TermLoanBBaseRateLoanSpread"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanBBaseRateLoanSpread" xlink:to="lab_icui_TermLoanBBaseRateLoanSpread" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_22ac8a15-5142-48e4-8d5f-ba1f7d052a5e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_2f9b9f56-39e2-4428-b91e-1b9c9e630f7c_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Percentageofrevenue_72a4b96f-0764-4088-b20e-b355913fbd40_terseLabel_en-US" xlink:label="lab_icui_Percentageofrevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenue</link:label>
    <link:label id="lab_icui_Percentageofrevenue_label_en-US" xlink:label="lab_icui_Percentageofrevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenue</link:label>
    <link:label id="lab_icui_Percentageofrevenue_documentation_en-US" xlink:label="lab_icui_Percentageofrevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Percentageofrevenue" xlink:href="icui-20211231.xsd#icui_Percentageofrevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Percentageofrevenue" xlink:to="lab_icui_Percentageofrevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CR_01f1435d-8970-4aed-923e-2bf446865802_terseLabel_en-US" xlink:label="lab_country_CR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COSTA RICA</link:label>
    <link:label id="lab_country_CR_label_en-US" xlink:label="lab_country_CR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COSTA RICA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CR" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CR" xlink:to="lab_country_CR" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_EarnoutliabilityMember_6ecb59fd-3c21-436a-8ba7-261ac5b4289a_terseLabel_en-US" xlink:label="lab_icui_EarnoutliabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out liability [Member]</link:label>
    <link:label id="lab_icui_EarnoutliabilityMember_label_en-US" xlink:label="lab_icui_EarnoutliabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out liability [Member]</link:label>
    <link:label id="lab_icui_EarnoutliabilityMember_documentation_en-US" xlink:label="lab_icui_EarnoutliabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EarnoutliabilityMember" xlink:href="icui-20211231.xsd#icui_EarnoutliabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_EarnoutliabilityMember" xlink:to="lab_icui_EarnoutliabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_662c6ce1-3f0b-47dd-ae5d-f7cd3b11b893_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_3dcb86f7-831e-48f5-8a2e-24611d878caf_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable for property and equipment</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Hedge1Member_91fe5028-2ac3-46e7-b195-08888ce4649a_terseLabel_en-US" xlink:label="lab_icui_Hedge1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 1 [Member]</link:label>
    <link:label id="lab_icui_Hedge1Member_label_en-US" xlink:label="lab_icui_Hedge1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 1 [Member]</link:label>
    <link:label id="lab_icui_Hedge1Member_documentation_en-US" xlink:label="lab_icui_Hedge1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge1Member" xlink:href="icui-20211231.xsd#icui_Hedge1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Hedge1Member" xlink:to="lab_icui_Hedge1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ab8e3473-9276-411a-8396-0447a652a70f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_7cbc0100-ee36-4272-89b8-8329092e27f0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_831e2684-ef36-4088-bc40-f1d530592185_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_065a9712-a52a-4a89-8469-f6edb6a46e2c_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ShortTermContingentConsiderationGross_aaa6613f-75da-410c-bbcd-396ac992322e_terseLabel_en-US" xlink:label="lab_icui_ShortTermContingentConsiderationGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term contingent consideration-gross</link:label>
    <link:label id="lab_icui_ShortTermContingentConsiderationGross_label_en-US" xlink:label="lab_icui_ShortTermContingentConsiderationGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term contingent consideration-gross</link:label>
    <link:label id="lab_icui_ShortTermContingentConsiderationGross_documentation_en-US" xlink:label="lab_icui_ShortTermContingentConsiderationGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term contingent consideration-gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermContingentConsiderationGross" xlink:href="icui-20211231.xsd#icui_ShortTermContingentConsiderationGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ShortTermContingentConsiderationGross" xlink:to="lab_icui_ShortTermContingentConsiderationGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense_9e897a30-0595-4dc6-af30-044b85957eaf_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Benefits Cost (Reversal of Cost)</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Benefits Cost (Reversal of Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_271247d4-9388-4749-8376-c42cdccacb58_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_fe687a59-0264-4f8b-b543-1e55390a9691_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_UsGaap_InterestRateSwap2Member_d6c7d432-526e-4be3-9dda-f719e2b7a826_terseLabel_en-US" xlink:label="lab_icui_UsGaap_InterestRateSwap2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">us-gaap_InterestRateSwap 2</link:label>
    <link:label id="lab_icui_UsGaap_InterestRateSwap2Member_label_en-US" xlink:label="lab_icui_UsGaap_InterestRateSwap2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">us-gaap_InterestRateSwap 2 [Member]</link:label>
    <link:label id="lab_icui_UsGaap_InterestRateSwap2Member_documentation_en-US" xlink:label="lab_icui_UsGaap_InterestRateSwap2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">us-gaap_InterestRateSwap 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_UsGaap_InterestRateSwap2Member" xlink:href="icui-20211231.xsd#icui_UsGaap_InterestRateSwap2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_UsGaap_InterestRateSwap2Member" xlink:to="lab_icui_UsGaap_InterestRateSwap2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_9862c4fd-6b17-4cd0-a649-5e57f376267c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate" xlink:to="lab_us-gaap_DerivativeFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_a178d29b-a0ab-43f6-9639-5db76a2a2edc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_cc92c7c6-424b-4b19-9805-2cce31801046_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_OtherLongtermLiabilitiesAbstract_a8a6ea9e-1444-4581-a1e1-c0c1d2090c37_terseLabel_en-US" xlink:label="lab_icui_OtherLongtermLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Liabilities [Abstract]</link:label>
    <link:label id="lab_icui_OtherLongtermLiabilitiesAbstract_label_en-US" xlink:label="lab_icui_OtherLongtermLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Liabilities [Abstract]</link:label>
    <link:label id="lab_icui_OtherLongtermLiabilitiesAbstract_documentation_en-US" xlink:label="lab_icui_OtherLongtermLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherLongtermLiabilitiesAbstract" xlink:href="icui-20211231.xsd#icui_OtherLongtermLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_OtherLongtermLiabilitiesAbstract" xlink:to="lab_icui_OtherLongtermLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_76f746bd-d156-4534-a8da-faac203114a3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3596c61c-87d9-4163-9d47-b6c56ac78920_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_fd436d0c-af10-41fb-99ac-a21d6de9f6d6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Earn-out Liability</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_ad4bac0f-a599-4467-bd04-ccf7f76072a2_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_CollaborativeandOtherArrangementsAbstract_23018389-09a1-4a98-83af-53876473a5dc_terseLabel_en-US" xlink:label="lab_icui_CollaborativeandOtherArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative and Other Arrangements [Abstract]</link:label>
    <link:label id="lab_icui_CollaborativeandOtherArrangementsAbstract_label_en-US" xlink:label="lab_icui_CollaborativeandOtherArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative and Other Arrangements [Abstract]</link:label>
    <link:label id="lab_icui_CollaborativeandOtherArrangementsAbstract_documentation_en-US" xlink:label="lab_icui_CollaborativeandOtherArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative and Other Arrangements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CollaborativeandOtherArrangementsAbstract" xlink:href="icui-20211231.xsd#icui_CollaborativeandOtherArrangementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_CollaborativeandOtherArrangementsAbstract" xlink:to="lab_icui_CollaborativeandOtherArrangementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_7b71167b-3eb1-41f3-a39b-0467c82cf1e4_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw Materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Restructuringandstrategictransactionexpense_899d287c-b387-4a76-9b0b-8c29376937cb_terseLabel_en-US" xlink:label="lab_icui_Restructuringandstrategictransactionexpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, strategic transaction and integration expenses</link:label>
    <link:label id="lab_icui_Restructuringandstrategictransactionexpense_label_en-US" xlink:label="lab_icui_Restructuringandstrategictransactionexpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and strategic transaction expense</link:label>
    <link:label id="lab_icui_Restructuringandstrategictransactionexpense_documentation_en-US" xlink:label="lab_icui_Restructuringandstrategictransactionexpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and strategic transaction expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringandstrategictransactionexpense" xlink:href="icui-20211231.xsd#icui_Restructuringandstrategictransactionexpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Restructuringandstrategictransactionexpense" xlink:to="lab_icui_Restructuringandstrategictransactionexpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_5e0f9168-e44b-4194-a2a8-1ae7c92bbfd6_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_MexicoPropertyAndEquipmentMember_578390b5-be27-463e-9840-dad37e19db93_terseLabel_en-US" xlink:label="lab_icui_MexicoPropertyAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mexico Property and Equipment [Member]</link:label>
    <link:label id="lab_icui_MexicoPropertyAndEquipmentMember_label_en-US" xlink:label="lab_icui_MexicoPropertyAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mexico Property and Equipment [Member]</link:label>
    <link:label id="lab_icui_MexicoPropertyAndEquipmentMember_documentation_en-US" xlink:label="lab_icui_MexicoPropertyAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign property and equipment: Mexico</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MexicoPropertyAndEquipmentMember" xlink:href="icui-20211231.xsd#icui_MexicoPropertyAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_MexicoPropertyAndEquipmentMember" xlink:to="lab_icui_MexicoPropertyAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_d92feaf8-36c4-4d4e-aef7-73b46cb78da3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Unrealized Currency Losses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Unrealized Currency Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:to="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanBMember_b7aa991d-4c9d-4537-8518-1715042e26bd_terseLabel_en-US" xlink:label="lab_icui_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B</link:label>
    <link:label id="lab_icui_TermLoanBMember_label_en-US" xlink:label="lab_icui_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B [Member]</link:label>
    <link:label id="lab_icui_TermLoanBMember_documentation_en-US" xlink:label="lab_icui_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember" xlink:href="icui-20211231.xsd#icui_TermLoanBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanBMember" xlink:to="lab_icui_TermLoanBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_0af120a0-9ffa-4a3f-9928-510a6a02c1fc_terseLabel_en-US" xlink:label="lab_us-gaap_NonfinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonfinancial Liabilities Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_NonfinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonfinancial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonfinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_NonfinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_068b6e76-eb5d-420d-932f-af6604e949fe_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_e56180b1-78e1-463c-95b1-6d2abaead28d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ESPPOriginalIssuance_663ed3a1-e85e-4969-aa47-510fdd082e19_terseLabel_en-US" xlink:label="lab_icui_ESPPOriginalIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Original Issuance</link:label>
    <link:label id="lab_icui_ESPPOriginalIssuance_label_en-US" xlink:label="lab_icui_ESPPOriginalIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Original Issuance</link:label>
    <link:label id="lab_icui_ESPPOriginalIssuance_documentation_en-US" xlink:label="lab_icui_ESPPOriginalIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Original Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ESPPOriginalIssuance" xlink:href="icui-20211231.xsd#icui_ESPPOriginalIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ESPPOriginalIssuance" xlink:to="lab_icui_ESPPOriginalIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_936fd8f9-15e3-4fcb-89e6-b44f8ca7150b_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_0937734c-e991-4a45-94c3-f3fd490d5c7f_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off/ Disposals</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_f91509a4-b678-47bd-bb28-19d54121d871_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_1039aa2b-a890-479f-87ab-4baa8f9c361b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:to="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_fe9e908d-df24-4d27-940d-34dc6d56a851_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_c261f6aa-a545-408d-8ed6-3d1462438c00_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_9f14babe-ed4d-455f-a11b-12f5812d1d15_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER LONG-TERM LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Other than Long-term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:to="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_c2dadb20-851b-4f4e-846a-ac9971d54cc8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f4b0b3d1-d573-477d-8a55-d19e2bb201cc_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_A2003PlanMember_48522c35-5ef9-4199-9579-75427e8cda0f_terseLabel_en-US" xlink:label="lab_icui_A2003PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2003 Plan [Member]</link:label>
    <link:label id="lab_icui_A2003PlanMember_label_en-US" xlink:label="lab_icui_A2003PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2003 Plan [Member]</link:label>
    <link:label id="lab_icui_A2003PlanMember_documentation_en-US" xlink:label="lab_icui_A2003PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2003 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_A2003PlanMember" xlink:href="icui-20211231.xsd#icui_A2003PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_A2003PlanMember" xlink:to="lab_icui_A2003PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilities_783e99cb-515c-4903-85ea-7b18d8c9e982_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilities_label_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilities" xlink:to="lab_us-gaap_OtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanBInitialSpread_56ef9a0d-ab45-4c2c-84cc-5396d3d4d713_terseLabel_en-US" xlink:label="lab_icui_TermLoanBInitialSpread" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Initial Spread</link:label>
    <link:label id="lab_icui_TermLoanBInitialSpread_label_en-US" xlink:label="lab_icui_TermLoanBInitialSpread" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Initial Spread</link:label>
    <link:label id="lab_icui_TermLoanBInitialSpread_documentation_en-US" xlink:label="lab_icui_TermLoanBInitialSpread" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Initial Spread</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBInitialSpread" xlink:href="icui-20211231.xsd#icui_TermLoanBInitialSpread"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanBInitialSpread" xlink:to="lab_icui_TermLoanBInitialSpread" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_bc353227-252a-44f0-8fd2-9ab3a7d2cb32_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_76a1ed41-d2bb-4f57-8d51-6a0eec27f40c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation, State and Local Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_3240afb3-4fb9-4520-aca1-1c51c24316a9_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_684b3352-357f-4ea1-bcb6-ec137361d141_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increases Resulting from Current Period Tax Positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization_53eb9d26-5ffb-4805-976e-a8efd4a521a9_terseLabel_en-US" xlink:label="lab_icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent deferred tax liability - depreciation and amortization</link:label>
    <link:label id="lab_icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization_label_en-US" xlink:label="lab_icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent deferred tax liability - depreciation and amortization</link:label>
    <link:label id="lab_icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization_documentation_en-US" xlink:label="lab_icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent deferred tax liability - depreciation and amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization" xlink:href="icui-20211231.xsd#icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization" xlink:to="lab_icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_06b39cbd-c32d-4332-ae98-72821b4b0e58_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_e464fad1-a02a-4db1-acaf-17066dd528bd_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_aa13f9c1-cc4f-4342-bc83-f1925788a346_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_0b7c8df6-5e42-4623-a4c9-3aa46d211b8b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_d6334ac1-7510-4142-abaf-4baab9593130_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_e742d734-07fe-4f40-b4c3-766267834ee5_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1b167686-4e09-43c8-afb8-88ea44948e96_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_StrategicTransactionandIntegration_c837f4d7-eedc-4fae-a079-010ee0b83b23_terseLabel_en-US" xlink:label="lab_icui_StrategicTransactionandIntegration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Transaction and Integration</link:label>
    <link:label id="lab_icui_StrategicTransactionandIntegration_label_en-US" xlink:label="lab_icui_StrategicTransactionandIntegration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Transaction and Integration</link:label>
    <link:label id="lab_icui_StrategicTransactionandIntegration_documentation_en-US" xlink:label="lab_icui_StrategicTransactionandIntegration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Transaction and Integration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_StrategicTransactionandIntegration" xlink:href="icui-20211231.xsd#icui_StrategicTransactionandIntegration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_StrategicTransactionandIntegration" xlink:to="lab_icui_StrategicTransactionandIntegration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_d6a2011b-de67-46a3-a847-83881ab94248_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_OtherLATAMMember_cd1bc202-c6d5-4b84-aa1e-a750e8f1d2a6_terseLabel_en-US" xlink:label="lab_icui_OtherLATAMMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other LATAM [Member]</link:label>
    <link:label id="lab_icui_OtherLATAMMember_label_en-US" xlink:label="lab_icui_OtherLATAMMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other LATAM [Member]</link:label>
    <link:label id="lab_icui_OtherLATAMMember_documentation_en-US" xlink:label="lab_icui_OtherLATAMMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other LATAM [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherLATAMMember" xlink:href="icui-20211231.xsd#icui_OtherLATAMMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_OtherLATAMMember" xlink:to="lab_icui_OtherLATAMMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_fef2b8ec-3ddc-4f6b-a38c-11810fd64622_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_73cd5e9f-e468-4a7d-b1a5-204436941a32_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_3a2cf2eb-49fc-447e-8873-2ba4502729a2_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_af89d2b5-f7e6-4021-9b23-3cd972280af3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_367f67ea-aac4-49db-96ec-fe4aaab1c2b9_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_bf8054b3-ac1e-443f-8d92-1eb28bec86f7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_6c3789a1-29fa-452f-9db1-be0b6a0d98ba_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_9a546071-4a5f-48b7-9d5b-4cf0ea122d3c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock and exercise of stock options, including excess income tax benefits</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SpecialTerminationBenefitsMember_8b7d7f7e-ed5f-4d88-ab57-aee760081bb5_terseLabel_en-US" xlink:label="lab_us-gaap_SpecialTerminationBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Termination Benefits [Member]</link:label>
    <link:label id="lab_us-gaap_SpecialTerminationBenefitsMember_label_en-US" xlink:label="lab_us-gaap_SpecialTerminationBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Termination Benefits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SpecialTerminationBenefitsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SpecialTerminationBenefitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SpecialTerminationBenefitsMember" xlink:to="lab_us-gaap_SpecialTerminationBenefitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoansLineOfCreditMember_17b7274b-2c9a-49ae-9c21-cc95f1419e29_terseLabel_en-US" xlink:label="lab_icui_TermLoansLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loans &amp; Line of Credit</link:label>
    <link:label id="lab_icui_TermLoansLineOfCreditMember_label_en-US" xlink:label="lab_icui_TermLoansLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loans &amp; Line of Credit [Member]</link:label>
    <link:label id="lab_icui_TermLoansLineOfCreditMember_documentation_en-US" xlink:label="lab_icui_TermLoansLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loans &amp; Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoansLineOfCreditMember" xlink:href="icui-20211231.xsd#icui_TermLoansLineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoansLineOfCreditMember" xlink:to="lab_icui_TermLoansLineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_31fb7a98-57e5-479e-98b3-1a82616c190c_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2c5365c5-6e0a-43a1-97f3-61999ed9cb2d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent earn-out</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_1d408945-34e0-4c7e-a96a-1302e8ac034a_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_PricingLevel5Member_19f31c27-b2a3-4c4d-9e3b-ec32c7233978_terseLabel_en-US" xlink:label="lab_icui_PricingLevel5Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level 5</link:label>
    <link:label id="lab_icui_PricingLevel5Member_label_en-US" xlink:label="lab_icui_PricingLevel5Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level 5 [Member]</link:label>
    <link:label id="lab_icui_PricingLevel5Member_documentation_en-US" xlink:label="lab_icui_PricingLevel5Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level 5</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevel5Member" xlink:href="icui-20211231.xsd#icui_PricingLevel5Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_PricingLevel5Member" xlink:to="lab_icui_PricingLevel5Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_811020a5-68a6-4884-8726-cf6af8a90a91_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_43926b88-3857-4d8b-a989-616c413d430b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_e47608d3-2657-4887-95d6-abe7524933e2_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_25ee2efe-44d8-401b-b8c6-39c8c86f07be_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_5f22626f-93d6-44bd-82de-df6cea79dab1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsCurrent" xlink:to="lab_us-gaap_DerivativeAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_6549edb9-e90d-49ca-a2fb-5ce0bceb8903_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_015a9063-369a-4cf9-a20b-d63ec9790317_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_7ab560d3-6545-404f-b1c4-2e94915ae173_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_6ef596bc-3f41-41c6-bfe8-ff33df5ddf26_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT LIABILITIES:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_CriticalCareMember_dfc77a18-03db-441d-bc50-c9d7725fd2cf_terseLabel_en-US" xlink:label="lab_icui_CriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Critical Care [Member]</link:label>
    <link:label id="lab_icui_CriticalCareMember_label_en-US" xlink:label="lab_icui_CriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Critical Care [Member]</link:label>
    <link:label id="lab_icui_CriticalCareMember_documentation_en-US" xlink:label="lab_icui_CriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Critical Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CriticalCareMember" xlink:href="icui-20211231.xsd#icui_CriticalCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_CriticalCareMember" xlink:to="lab_icui_CriticalCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_077cd3fb-c210-4537-b529-fdaecd88abbf_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_country_ES_c7df37a5-36bd-469e-a9d9-4e3997adbd85_terseLabel_en-US" xlink:label="lab_country_ES" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPAIN</link:label>
    <link:label id="lab_country_ES_label_en-US" xlink:label="lab_country_ES" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPAIN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_ES" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_ES"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_ES" xlink:to="lab_country_ES" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_f03796f0-37ef-445f-ad79-8f6d7fd0e9b3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ForeignDistibutorMember_0f83a61b-f312-42d4-b853-baa84a4ef9b9_terseLabel_en-US" xlink:label="lab_icui_ForeignDistibutorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Distibutor [Member]</link:label>
    <link:label id="lab_icui_ForeignDistibutorMember_label_en-US" xlink:label="lab_icui_ForeignDistibutorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Distibutor [Member]</link:label>
    <link:label id="lab_icui_ForeignDistibutorMember_documentation_en-US" xlink:label="lab_icui_ForeignDistibutorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Distibutor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignDistibutorMember" xlink:href="icui-20211231.xsd#icui_ForeignDistibutorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ForeignDistibutorMember" xlink:to="lab_icui_ForeignDistibutorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LineofCreditAccordion_79174103-2afb-422b-801a-9ac7665f34e6_terseLabel_en-US" xlink:label="lab_icui_LineofCreditAccordion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Accordion</link:label>
    <link:label id="lab_icui_LineofCreditAccordion_label_en-US" xlink:label="lab_icui_LineofCreditAccordion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Accordion</link:label>
    <link:label id="lab_icui_LineofCreditAccordion_documentation_en-US" xlink:label="lab_icui_LineofCreditAccordion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Accordion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LineofCreditAccordion" xlink:href="icui-20211231.xsd#icui_LineofCreditAccordion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LineofCreditAccordion" xlink:to="lab_icui_LineofCreditAccordion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_9114b5b9-b361-40fc-ae0b-8f72a428c287_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_d246d515-5ee1-44cb-a5ae-677fd24ba0e5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_37cd3692-be57-496b-a579-c112c5f8c08a_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_30750dc8-24bb-4870-b22d-e8382a0bbd29_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.10 par value - Authorized-80,000 shares; Issued 21,280 and 21,058 shares at December 31, 2021 and 2020, respectively, and outstanding 21,280 and 21,058 shares at December 31, 2021 and 2020, respectively.</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_101a46bc-b1ca-42c2-b7fe-175431bcb63e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_c49eb156-fa94-4462-8035-80ce174856f5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_6f0056e5-ebce-4871-84ca-60b53b2fb3d8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeAmortizationOfPremium_60089889-0a05-4f91-ac78-ad0d5ed904e3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bond premium amortization</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeAmortizationOfPremium_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Amortization of Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:to="lab_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_40fafa86-309e-44ef-9b55-c7f0b7d8adbf_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_16ddc4de-f630-4d28-b371-69983185f9ac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Deferredtaxliabilitychangeinaccountingmethod_67174d38-dfe3-4c7d-94dc-0b1856402fa4_terseLabel_en-US" xlink:label="lab_icui_Deferredtaxliabilitychangeinaccountingmethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability, change in accounting method</link:label>
    <link:label id="lab_icui_Deferredtaxliabilitychangeinaccountingmethod_label_en-US" xlink:label="lab_icui_Deferredtaxliabilitychangeinaccountingmethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability, change in accounting method</link:label>
    <link:label id="lab_icui_Deferredtaxliabilitychangeinaccountingmethod_documentation_en-US" xlink:label="lab_icui_Deferredtaxliabilitychangeinaccountingmethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability, change in accounting method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Deferredtaxliabilitychangeinaccountingmethod" xlink:href="icui-20211231.xsd#icui_Deferredtaxliabilitychangeinaccountingmethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Deferredtaxliabilitychangeinaccountingmethod" xlink:to="lab_icui_Deferredtaxliabilitychangeinaccountingmethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_e09bb41f-8073-49e0-bd9d-5ff6dc7ca1d4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_d834f195-99b3-4683-b324-23ddbdf6d21a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_93e29177-781a-430f-8d73-076b6c6181f0_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLineItems_1ed2b6ef-4f09-4eec-952c-5a62bfb94f98_terseLabel_en-US" xlink:label="lab_dei_AuditorLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor [Line Items]</link:label>
    <link:label id="lab_dei_AuditorLineItems_label_en-US" xlink:label="lab_dei_AuditorLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLineItems" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLineItems" xlink:to="lab_dei_AuditorLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_d684cc0f-f4f1-4e7e-80a5-f8b664e2e2d9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_d37857b2-05e7-449f-8221-5355dfaacfe4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_091c7f11-a178-42e7-b552-cfe9878dc719_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_570dff4c-91a0-4042-8724-da54a67c8154_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_9cf1e56a-5811-4ae0-a66c-587eb7956211_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_1f39c87a-0756-4266-863f-521e0ba9e759_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandBuildingsAndImprovementsMember_06dc351f-910f-4fe1-ad43-4cf0750a6976_terseLabel_en-US" xlink:label="lab_us-gaap_LandBuildingsAndImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, Buildings and Improvements [Member]</link:label>
    <link:label id="lab_us-gaap_LandBuildingsAndImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LandBuildingsAndImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, Buildings and Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandBuildingsAndImprovementsMember" xlink:to="lab_us-gaap_LandBuildingsAndImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_40a2a21f-22fa-475d-9741-20ed7dcc5e7f_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_05e8ab4a-a89c-4dd1-aeb4-f3619ef5631f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SmithsMedicalMember_c844c46c-d2fc-4e3c-8589-ab5346d52a34_terseLabel_en-US" xlink:label="lab_icui_SmithsMedicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Medical</link:label>
    <link:label id="lab_icui_SmithsMedicalMember_label_en-US" xlink:label="lab_icui_SmithsMedicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Medical [Member]</link:label>
    <link:label id="lab_icui_SmithsMedicalMember_documentation_en-US" xlink:label="lab_icui_SmithsMedicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Medical</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember" xlink:href="icui-20211231.xsd#icui_SmithsMedicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SmithsMedicalMember" xlink:to="lab_icui_SmithsMedicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_826df39e-b799-4199-b57f-41b95b11044d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ed7667a1-0e6f-4fdd-8a0d-90f47f7b51d6_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a894212a-15a0-40c3-892d-42c2914d1fa6_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Contingentconsiderationgross_9826e672-2239-4453-b61a-fddc94ce2cb0_terseLabel_en-US" xlink:label="lab_icui_Contingentconsiderationgross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration gross</link:label>
    <link:label id="lab_icui_Contingentconsiderationgross_label_en-US" xlink:label="lab_icui_Contingentconsiderationgross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration gross</link:label>
    <link:label id="lab_icui_Contingentconsiderationgross_documentation_en-US" xlink:label="lab_icui_Contingentconsiderationgross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross" xlink:href="icui-20211231.xsd#icui_Contingentconsiderationgross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Contingentconsiderationgross" xlink:to="lab_icui_Contingentconsiderationgross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_e80ff43b-6b60-436b-bf1e-2f51e78bc11a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_48dba280-0b53-473e-a3a8-e5a6b5f06717_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Effectivetaxratereconciliationnondeductiblecomppercent_0ef06203-8f97-48dd-bd7f-7a593ae77650_terseLabel_en-US" xlink:label="lab_icui_Effectivetaxratereconciliationnondeductiblecomppercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effectivetaxratereconciliationnondeductiblecomppercent</link:label>
    <link:label id="lab_icui_Effectivetaxratereconciliationnondeductiblecomppercent_label_en-US" xlink:label="lab_icui_Effectivetaxratereconciliationnondeductiblecomppercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effectivetaxratereconciliationnondeductiblecomppercent</link:label>
    <link:label id="lab_icui_Effectivetaxratereconciliationnondeductiblecomppercent_documentation_en-US" xlink:label="lab_icui_Effectivetaxratereconciliationnondeductiblecomppercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effectivetaxratereconciliationnondeductiblecomppercent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Effectivetaxratereconciliationnondeductiblecomppercent" xlink:href="icui-20211231.xsd#icui_Effectivetaxratereconciliationnondeductiblecomppercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Effectivetaxratereconciliationnondeductiblecomppercent" xlink:to="lab_icui_Effectivetaxratereconciliationnondeductiblecomppercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0ffdfdf2-b7a6-485b-bd0b-0eda8b1d2347_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_IncomeTaxDisclosuredeferredtaxesAbstract_98220124-699b-4cb2-b638-51c9d23eb41e_terseLabel_en-US" xlink:label="lab_icui_IncomeTaxDisclosuredeferredtaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure deferred taxes [Abstract]</link:label>
    <link:label id="lab_icui_IncomeTaxDisclosuredeferredtaxesAbstract_label_en-US" xlink:label="lab_icui_IncomeTaxDisclosuredeferredtaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure deferred taxes [Abstract]</link:label>
    <link:label id="lab_icui_IncomeTaxDisclosuredeferredtaxesAbstract_documentation_en-US" xlink:label="lab_icui_IncomeTaxDisclosuredeferredtaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure deferred taxes [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IncomeTaxDisclosuredeferredtaxesAbstract" xlink:href="icui-20211231.xsd#icui_IncomeTaxDisclosuredeferredtaxesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_IncomeTaxDisclosuredeferredtaxesAbstract" xlink:to="lab_icui_IncomeTaxDisclosuredeferredtaxesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_d5a675c8-b4cf-4cef-b04b-d0b6e60b477a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_a834abc8-a242-449b-ad14-97a858be0367_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_d765bd2b-3b5d-4b1b-a6ac-f58b06f5e0f4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_WarrantyAndReturnReserveCosts_d83cc687-c33a-4aa0-8c40-5dadaea147c3_terseLabel_en-US" xlink:label="lab_icui_WarrantyAndReturnReserveCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty and Return Reserve costs</link:label>
    <link:label id="lab_icui_WarrantyAndReturnReserveCosts_label_en-US" xlink:label="lab_icui_WarrantyAndReturnReserveCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty and Return Reserve costs</link:label>
    <link:label id="lab_icui_WarrantyAndReturnReserveCosts_documentation_en-US" xlink:label="lab_icui_WarrantyAndReturnReserveCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty and Return Reserve costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_WarrantyAndReturnReserveCosts" xlink:href="icui-20211231.xsd#icui_WarrantyAndReturnReserveCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_WarrantyAndReturnReserveCosts" xlink:to="lab_icui_WarrantyAndReturnReserveCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_5328a2d0-f164-4172-9254-ba8bf388c004_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_84d5b9d6-5086-45b9-8bfc-a746e3b70c41_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_96229146-69fa-4eba-8106-7b56a2fc66eb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_DeferredtaxassetsandliabilitiesLineItems_db6dda04-648f-4b56-a01c-157184bca776_terseLabel_en-US" xlink:label="lab_icui_DeferredtaxassetsandliabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets and liabilities [Line Items]</link:label>
    <link:label id="lab_icui_DeferredtaxassetsandliabilitiesLineItems_label_en-US" xlink:label="lab_icui_DeferredtaxassetsandliabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets and liabilities [Line Items]</link:label>
    <link:label id="lab_icui_DeferredtaxassetsandliabilitiesLineItems_documentation_en-US" xlink:label="lab_icui_DeferredtaxassetsandliabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Deferred tax assets and liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DeferredtaxassetsandliabilitiesLineItems" xlink:href="icui-20211231.xsd#icui_DeferredtaxassetsandliabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems" xlink:to="lab_icui_DeferredtaxassetsandliabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_a67cf51d-86b7-4c5f-8712-bf5870d830d0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRentCurrentAndNoncurrent_0ea1ecda-ff7b-4d6e-9a5b-b78c73de3503_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued rent</link:label>
    <link:label id="lab_us-gaap_AccruedRentCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRentCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c81bedea-3579-4dda-be21-f93fca027c00_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08549b16-b1b9-4efc-8150-aca33d763d34_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_WarrantyAndReturnReserveInventoryWriteOffs_d2daffd3-e7c1-4ae2-b028-1b4bd34922d6_terseLabel_en-US" xlink:label="lab_icui_WarrantyAndReturnReserveInventoryWriteOffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty and return reserve - inventory write-offs</link:label>
    <link:label id="lab_icui_WarrantyAndReturnReserveInventoryWriteOffs_label_en-US" xlink:label="lab_icui_WarrantyAndReturnReserveInventoryWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty and return reserve - inventory write-offs</link:label>
    <link:label id="lab_icui_WarrantyAndReturnReserveInventoryWriteOffs_documentation_en-US" xlink:label="lab_icui_WarrantyAndReturnReserveInventoryWriteOffs" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty and return reserve - inventory write-offs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_WarrantyAndReturnReserveInventoryWriteOffs" xlink:href="icui-20211231.xsd#icui_WarrantyAndReturnReserveInventoryWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_WarrantyAndReturnReserveInventoryWriteOffs" xlink:to="lab_icui_WarrantyAndReturnReserveInventoryWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3aa3e96-3828-4e24-be76-4b6ef588d29d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_41ce45d3-3cd7-48d7-87be-e50b09159d07_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerContractsMember_5b079692-c75a-4e49-bf21-6c6d6feae583_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Contracts [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerContractsMember_label_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerContractsMember" xlink:to="lab_us-gaap_CustomerContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_77b73266-0089-400d-b997-61c3ccc91f1e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_0f4577cf-6b08-43d3-ab3d-59353fee12c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_UnrecognizedTaxBenefitsRollForwardRollForward_label_en-US" xlink:label="lab_icui_UnrecognizedTaxBenefitsRollForwardRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits roll forward [Roll Forward]</link:label>
    <link:label id="lab_icui_UnrecognizedTaxBenefitsRollForwardRollForward_documentation_en-US" xlink:label="lab_icui_UnrecognizedTaxBenefitsRollForwardRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits roll forward</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_UnrecognizedTaxBenefitsRollForwardRollForward" xlink:href="icui-20211231.xsd#icui_UnrecognizedTaxBenefitsRollForwardRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_UnrecognizedTaxBenefitsRollForwardRollForward" xlink:to="lab_icui_UnrecognizedTaxBenefitsRollForwardRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_3af99518-51a7-41df-9e0c-d7975e6fe2a3_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_07fc136c-eefa-49d5-8f02-227bc459faab_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FacilityClosingMember_360df246-4196-4893-882d-240d3ea1b403_terseLabel_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:label id="lab_us-gaap_FacilityClosingMember_label_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FacilityClosingMember" xlink:to="lab_us-gaap_FacilityClosingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_8613f691-35bf-4f52-b396-4b885163a8a3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_e7fb627a-8937-4d91-a016-83e7b1284b70_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_e340d891-9ffb-429c-a8bb-dd5e067befac_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3c7103c3-295e-4934-bdfe-b288be978874_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_0659dbb8-01d1-4397-a412-88bb231289ad_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_9c77434f-c40e-45a3-99ba-a4e25d10991e_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9311868f-45c4-445e-869e-01982201034e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8dc1941f-72a6-4e16-9cb9-ee56cac78e07_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_a828d12e-85fe-4021-9fbc-9d5eb6f5ac6a_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_c95b742b-9d8e-489c-a0a3-6d8abeb549fe_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_cd90d880-6554-42ec-b7b3-3e2fd3c6a28f_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_81fe15f8-b978-46ec-aa6d-a72d2cbdab3f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Exercisable, Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_b4b1e34d-f374-4422-9180-99c14e991a97_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_NoncurrentDeferredTaxLiabilityForeign_7f966f5c-b587-42b0-9d77-09bb41cfa2e2_terseLabel_en-US" xlink:label="lab_icui_NoncurrentDeferredTaxLiabilityForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent deferred tax liability - foreign</link:label>
    <link:label id="lab_icui_NoncurrentDeferredTaxLiabilityForeign_label_en-US" xlink:label="lab_icui_NoncurrentDeferredTaxLiabilityForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent deferred tax liability - foreign</link:label>
    <link:label id="lab_icui_NoncurrentDeferredTaxLiabilityForeign_documentation_en-US" xlink:label="lab_icui_NoncurrentDeferredTaxLiabilityForeign" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent deferred tax liability - foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NoncurrentDeferredTaxLiabilityForeign" xlink:href="icui-20211231.xsd#icui_NoncurrentDeferredTaxLiabilityForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_NoncurrentDeferredTaxLiabilityForeign" xlink:to="lab_icui_NoncurrentDeferredTaxLiabilityForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_60a08ffb-c2c6-4d32-966d-cab9c7369542_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_2d94c6d4-0426-42ba-b303-93d2143562c1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_35f104b5-cc2a-4d3f-a631-1056da9bb512_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_724a7486-0b01-4b87-89d4-68fb48373669_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_54f969e2-5a1d-4ce9-8d95-d525c858eced_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_CommonStockSharesMember_00f72e47-25a7-4d4d-8b8d-cc9cff8071af_terseLabel_en-US" xlink:label="lab_icui_CommonStockSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Shares [Member]</link:label>
    <link:label id="lab_icui_CommonStockSharesMember_label_en-US" xlink:label="lab_icui_CommonStockSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Shares [Member]</link:label>
    <link:label id="lab_icui_CommonStockSharesMember_documentation_en-US" xlink:label="lab_icui_CommonStockSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CommonStockSharesMember" xlink:href="icui-20211231.xsd#icui_CommonStockSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_CommonStockSharesMember" xlink:to="lab_icui_CommonStockSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_706ef1d9-48c2-4dd4-91fa-f9eecc388f30_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_65b626d7-74c3-4d7a-ac27-783501b3bd49_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_67022f89-9775-4683-9fb8-9baff20eb810_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Accruedothertaxes_fcd43458-b6f4-4636-9343-e9527b1b4600_terseLabel_en-US" xlink:label="lab_icui_Accruedothertaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued other taxes</link:label>
    <link:label id="lab_icui_Accruedothertaxes_label_en-US" xlink:label="lab_icui_Accruedothertaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued other taxes</link:label>
    <link:label id="lab_icui_Accruedothertaxes_documentation_en-US" xlink:label="lab_icui_Accruedothertaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued other taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedothertaxes" xlink:href="icui-20211231.xsd#icui_Accruedothertaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Accruedothertaxes" xlink:to="lab_icui_Accruedothertaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Hedge5Member_3de29a38-1c67-4aae-8ae6-a77ada83a2de_terseLabel_en-US" xlink:label="lab_icui_Hedge5Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 5</link:label>
    <link:label id="lab_icui_Hedge5Member_label_en-US" xlink:label="lab_icui_Hedge5Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 5 [Member]</link:label>
    <link:label id="lab_icui_Hedge5Member_documentation_en-US" xlink:label="lab_icui_Hedge5Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 5</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge5Member" xlink:href="icui-20211231.xsd#icui_Hedge5Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Hedge5Member" xlink:to="lab_icui_Hedge5Member" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue_5938b249-469b-4247-b728-b97c7db33c98_terseLabel_en-US" xlink:label="lab_icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue</link:label>
    <link:label id="lab_icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue_label_en-US" xlink:label="lab_icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue</link:label>
    <link:label id="lab_icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue_documentation_en-US" xlink:label="lab_icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue" xlink:href="icui-20211231.xsd#icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue" xlink:to="lab_icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_e07bff9a-c589-4215-bf45-2c3be48fff26_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit from stock-based compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_MoldsMember_de4f3813-bf30-4b07-994f-e213a9c2ec74_terseLabel_en-US" xlink:label="lab_icui_MoldsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molds [Member]</link:label>
    <link:label id="lab_icui_MoldsMember_label_en-US" xlink:label="lab_icui_MoldsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molds [Member]</link:label>
    <link:label id="lab_icui_MoldsMember_documentation_en-US" xlink:label="lab_icui_MoldsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MoldsMember" xlink:href="icui-20211231.xsd#icui_MoldsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_MoldsMember" xlink:to="lab_icui_MoldsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_829e1da1-23c4-4961-8457-1aac99056f73_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_bdc88059-1a54-4491-b66f-8097942d0516_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_dd6abe56-32bb-40b6-a450-ef3d05013605_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_fd4689ef-3161-4d01-b351-5fa3461103de_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_8ce35543-b5f6-4f94-82c7-be4bc032c553_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged&#160;to Other&#160;Accounts</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_472b6a56-3c95-4679-8639-17d7f99ef76c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_1f4b968d-01af-499f-827e-640d1efbe03b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_bbc84454-8b74-4fbf-8097-7530a115f14b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_86a72043-3e9e-4cbb-967f-9cc8dba22b74_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_bb3bc768-6585-4419-b4fc-9ce68f6f0494_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_HospiraMember_8f6c3700-1265-45cc-8996-6b5c56be7a47_terseLabel_en-US" xlink:label="lab_icui_HospiraMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hospira [Member]</link:label>
    <link:label id="lab_icui_HospiraMember_label_en-US" xlink:label="lab_icui_HospiraMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hospira [Member]</link:label>
    <link:label id="lab_icui_HospiraMember_documentation_en-US" xlink:label="lab_icui_HospiraMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hospira [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_HospiraMember" xlink:href="icui-20211231.xsd#icui_HospiraMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_HospiraMember" xlink:to="lab_icui_HospiraMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_54e7f78c-382f-4a84-a90e-c7d03746cc6d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_59bfd1a2-9131-4ad8-8e16-67dfb7b8f6ae_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_RestrictedStockAndPerformanceRestrictedStockUnitsMember_df243ee0-f047-4263-b701-36262fdcda58_terseLabel_en-US" xlink:label="lab_icui_RestrictedStockAndPerformanceRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock and Performance Restricted Stock Units [Member]</link:label>
    <link:label id="lab_icui_RestrictedStockAndPerformanceRestrictedStockUnitsMember_label_en-US" xlink:label="lab_icui_RestrictedStockAndPerformanceRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock and Performance Restricted Stock Units [Member]</link:label>
    <link:label id="lab_icui_RestrictedStockAndPerformanceRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_icui_RestrictedStockAndPerformanceRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock and Performance Restricted Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RestrictedStockAndPerformanceRestrictedStockUnitsMember" xlink:href="icui-20211231.xsd#icui_RestrictedStockAndPerformanceRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_RestrictedStockAndPerformanceRestrictedStockUnitsMember" xlink:to="lab_icui_RestrictedStockAndPerformanceRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes_976b42ce-88cd-44fc-9836-32aa262fe71e_terseLabel_en-US" xlink:label="lab_icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent deferred tax liability - state income taxes</link:label>
    <link:label id="lab_icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes_label_en-US" xlink:label="lab_icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent deferred tax liability - state income taxes</link:label>
    <link:label id="lab_icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes_documentation_en-US" xlink:label="lab_icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent deferred tax liability - state income taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes" xlink:href="icui-20211231.xsd#icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes" xlink:to="lab_icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_9d05ff56-01a1-41ff-9991-a61f238b0d2a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_414b1c25-17e3-4eda-bca8-d8eac4370539_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1451da69-89ac-4134-bf77-46f51757ccca_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_f4c3eda8-1924-45a0-b9b6-082937bc781b_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_b4d4ebec-d50c-44fc-ba95-00a97c14083b_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for doubtful accounts of $7,038 at December 31, 2021 and $21,490 at December 31, 2020</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_3f93b21e-903b-484c-9395-bf4af6b36d8e_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_935ab2a3-d43f-4b3b-85bd-aeb21620a22e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9ef95c41-cb1a-4213-843e-e87fb79fd761_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_4a5f8935-196c-4b49-8ede-d9f7faeac7ec_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_f81362c5-0d89-4cd0-952b-c3bdc85afef7_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_c0427d96-51bc-4010-966d-d217da672bec_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_5032a77b-c74e-4585-8f6d-521440f14a95_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InformationbyGeographicAreaandCustomerConcentrationTextBlock_7f685c44-bfc8-42b1-98ad-9807f0456d12_terseLabel_en-US" xlink:label="lab_icui_InformationbyGeographicAreaandCustomerConcentrationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information by Geographic Area and Customer Concentration [Text Block]</link:label>
    <link:label id="lab_icui_InformationbyGeographicAreaandCustomerConcentrationTextBlock_label_en-US" xlink:label="lab_icui_InformationbyGeographicAreaandCustomerConcentrationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information by Geographic Area and Customer Concentration [Text Block]</link:label>
    <link:label id="lab_icui_InformationbyGeographicAreaandCustomerConcentrationTextBlock_documentation_en-US" xlink:label="lab_icui_InformationbyGeographicAreaandCustomerConcentrationTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information by Geographic Area and Customer Concentration [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InformationbyGeographicAreaandCustomerConcentrationTextBlock" xlink:href="icui-20211231.xsd#icui_InformationbyGeographicAreaandCustomerConcentrationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InformationbyGeographicAreaandCustomerConcentrationTextBlock" xlink:to="lab_icui_InformationbyGeographicAreaandCustomerConcentrationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_PerformanceRestrictedStockUnitsPRSUsMember_fff76a4b-078e-49bc-821e-eaae2e0eb36a_terseLabel_en-US" xlink:label="lab_icui_PerformanceRestrictedStockUnitsPRSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock Units (PRSUs) [Member]</link:label>
    <link:label id="lab_icui_PerformanceRestrictedStockUnitsPRSUsMember_label_en-US" xlink:label="lab_icui_PerformanceRestrictedStockUnitsPRSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock Units (PRSUs) [Member]</link:label>
    <link:label id="lab_icui_PerformanceRestrictedStockUnitsPRSUsMember_documentation_en-US" xlink:label="lab_icui_PerformanceRestrictedStockUnitsPRSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock Units (PRSUs) stock units issued if the measurement period goal is met.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PerformanceRestrictedStockUnitsPRSUsMember" xlink:href="icui-20211231.xsd#icui_PerformanceRestrictedStockUnitsPRSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_PerformanceRestrictedStockUnitsPRSUsMember" xlink:to="lab_icui_PerformanceRestrictedStockUnitsPRSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f4a015bc-9ff5-4e41-9512-fd3b7f0d25d0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_32247d58-c60f-4eab-8614-d1191bf686d0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_GILTItaxexpense_507c7ca6-addf-4d7c-a8a3-12e3e337d819_terseLabel_en-US" xlink:label="lab_icui_GILTItaxexpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GILTItaxexpense</link:label>
    <link:label id="lab_icui_GILTItaxexpense_label_en-US" xlink:label="lab_icui_GILTItaxexpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GILTItaxexpense</link:label>
    <link:label id="lab_icui_GILTItaxexpense_documentation_en-US" xlink:label="lab_icui_GILTItaxexpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GILTItaxexpense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GILTItaxexpense" xlink:href="icui-20211231.xsd#icui_GILTItaxexpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_GILTItaxexpense" xlink:to="lab_icui_GILTItaxexpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_9ea7e909-6631-4f8c-b257-eb661d6bb663_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_00c293e5-5e91-408b-ad6a-5a9dc6e43109_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:to="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_6c267849-6de8-4e89-9fc3-08c436b358b7_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_3f0cc74c-67d0-4f7d-81b3-c4c11c4eaff3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Percentoftotalrevenue_709a6d9b-d423-4d86-a68a-36ffb81f0b0e_terseLabel_en-US" xlink:label="lab_icui_Percentoftotalrevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of total revenue</link:label>
    <link:label id="lab_icui_Percentoftotalrevenue_label_en-US" xlink:label="lab_icui_Percentoftotalrevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of total revenue</link:label>
    <link:label id="lab_icui_Percentoftotalrevenue_documentation_en-US" xlink:label="lab_icui_Percentoftotalrevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of total revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Percentoftotalrevenue" xlink:href="icui-20211231.xsd#icui_Percentoftotalrevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Percentoftotalrevenue" xlink:to="lab_icui_Percentoftotalrevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_77bf7554-e7be-4bf7-b411-7b6c69ffb171_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_966b3587-811a-487e-a058-4182b5a99179_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value per option</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_3b7a119a-9bfd-4d4e-beca-ee528e881b65_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a8438a0d-25bf-49e7-8106-9c6e6975a977_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_a0595aa4-a81d-45f7-a147-ab787b37e365_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0d78d065-496d-45f4-b08d-3b9af86859cf_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investment Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_8df26acd-8d02-4df9-8f73-c6d6de745949_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_2c99e7d6-186f-43e8-b6cd-071ce2f82af0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_ccbcddf5-3a41-4c8a-b32f-50803f3c1bfd_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments [Member]</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ContractassetandliabilitybalancesTable_5b6771c4-c3ae-4af6-9f2c-848d192a00e1_terseLabel_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset and liability balances [Table]</link:label>
    <link:label id="lab_icui_ContractassetandliabilitybalancesTable_label_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset and liability balances [Table]</link:label>
    <link:label id="lab_icui_ContractassetandliabilitybalancesTable_documentation_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset and liability balances [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesTable" xlink:href="icui-20211231.xsd#icui_ContractassetandliabilitybalancesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ContractassetandliabilitybalancesTable" xlink:to="lab_icui_ContractassetandliabilitybalancesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4f369571-d18d-46bf-83a6-ef72bf03aaf5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_34f5a822-1fc4-44e4-abad-bfc4bd41fc74_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_7dbc7c78-7faf-4d76-81ba-51ae1f954732_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_edaac6a2-3b97-49d1-8084-23d91cc780f7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investment securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_fe967f5d-c2ab-4219-b092-e1627b8a23c8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_dc77c014-9e88-4ed6-8718-4607fda79b27_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_9ab9d8b6-69d7-4f7b-b97a-223106a5912b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_92537456-4c31-496a-bfe8-ffcda72e4838_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_bc91bc2d-56d2-46d0-867c-ade128e615e4_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Securities, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_4d2bcaa6-44c3-40dc-8a34-c9d062441e45_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Amortization Life in Years</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_a0a14a2c-9575-4757-95e4-5c91013fcc6a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_6f01a912-3bd2-4f75-bb15-3b33a92b887d_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7f75b598-b91d-4e15-82ea-17b91b13acca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_61698b1e-a0a1-4f31-a3ef-20397d56e5e4_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue_2ba1ef39-4557-44bc-b1fa-28bc1d9b1091_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Intrinsic Value, Amount Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Intrinsic Value, Amount Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_a4137088-a14a-47ce-a7e2-2cb0c1a096a7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_79c54f34-91a0-4cb4-9519-cd6c6ffe5d16_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount_d191e80c-4def-4ee0-bb9e-7c7091d74532_terseLabel_en-US" xlink:label="lab_icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A Payment Year 3 and 4 as a % of Original Debt Amount</link:label>
    <link:label id="lab_icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount_label_en-US" xlink:label="lab_icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A Payment Year 3 and 4 as a % of Original Debt Amount</link:label>
    <link:label id="lab_icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount_documentation_en-US" xlink:label="lab_icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A Payment Year 3 and 4 as a % of Original Debt Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount" xlink:href="icui-20211231.xsd#icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount" xlink:to="lab_icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Supplychainrestructuringcosts_bcdae24e-6090-4974-980d-f9f480f021c0_terseLabel_en-US" xlink:label="lab_icui_Supplychainrestructuringcosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplychainrestructuringcosts</link:label>
    <link:label id="lab_icui_Supplychainrestructuringcosts_label_en-US" xlink:label="lab_icui_Supplychainrestructuringcosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplychainrestructuringcosts</link:label>
    <link:label id="lab_icui_Supplychainrestructuringcosts_documentation_en-US" xlink:label="lab_icui_Supplychainrestructuringcosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplychainrestructuringcosts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Supplychainrestructuringcosts" xlink:href="icui-20211231.xsd#icui_Supplychainrestructuringcosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Supplychainrestructuringcosts" xlink:to="lab_icui_Supplychainrestructuringcosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_59182a54-9f5a-45b7-8fbf-c3020cefe8fb_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesNoncurrent_5270ac28-4550-4abe-8157-eed16ac84f5b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesNoncurrent" xlink:to="lab_us-gaap_DebtSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ForeignMember_dfb76345-fd7e-4f28-afb7-6559e84ac60d_terseLabel_en-US" xlink:label="lab_icui_ForeignMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign [Member]</link:label>
    <link:label id="lab_icui_ForeignMember_label_en-US" xlink:label="lab_icui_ForeignMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign [Member]</link:label>
    <link:label id="lab_icui_ForeignMember_documentation_en-US" xlink:label="lab_icui_ForeignMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignMember" xlink:href="icui-20211231.xsd#icui_ForeignMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ForeignMember" xlink:to="lab_icui_ForeignMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dc41f320-55b0-4f4c-91b9-f65d43987a49_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanAMember_a94585a3-e13e-40dc-899b-42cc74aefb89_terseLabel_en-US" xlink:label="lab_icui_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A</link:label>
    <link:label id="lab_icui_TermLoanAMember_label_en-US" xlink:label="lab_icui_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A [Member]</link:label>
    <link:label id="lab_icui_TermLoanAMember_documentation_en-US" xlink:label="lab_icui_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember" xlink:href="icui-20211231.xsd#icui_TermLoanAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanAMember" xlink:to="lab_icui_TermLoanAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount_5dddf658-5425-47cd-b216-cc66e035d8df_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Holiday, Aggregate Dollar Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount_label_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Holiday, Aggregate Dollar Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxHolidayAggregateDollarAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:to="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_StockIncentivePlansLineItems_84ab9bfe-6a1d-4352-b7ac-0e84956f2c79_terseLabel_en-US" xlink:label="lab_icui_StockIncentivePlansLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plans [Line Items]</link:label>
    <link:label id="lab_icui_StockIncentivePlansLineItems_label_en-US" xlink:label="lab_icui_StockIncentivePlansLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plans [Line Items]</link:label>
    <link:label id="lab_icui_StockIncentivePlansLineItems_documentation_en-US" xlink:label="lab_icui_StockIncentivePlansLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Stock Incentive Plans [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_StockIncentivePlansLineItems" xlink:href="icui-20211231.xsd#icui_StockIncentivePlansLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_StockIncentivePlansLineItems" xlink:to="lab_icui_StockIncentivePlansLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanBApplicableMarginAxis_57f543a2-81cf-428b-acb2-77ba3b05c062_terseLabel_en-US" xlink:label="lab_icui_TermLoanBApplicableMarginAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Applicable Margin [Axis]</link:label>
    <link:label id="lab_icui_TermLoanBApplicableMarginAxis_label_en-US" xlink:label="lab_icui_TermLoanBApplicableMarginAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Applicable Margin [Axis]</link:label>
    <link:label id="lab_icui_TermLoanBApplicableMarginAxis_documentation_en-US" xlink:label="lab_icui_TermLoanBApplicableMarginAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Applicable Margin</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBApplicableMarginAxis" xlink:href="icui-20211231.xsd#icui_TermLoanBApplicableMarginAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanBApplicableMarginAxis" xlink:to="lab_icui_TermLoanBApplicableMarginAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_5017dfbe-7de9-4d88-897f-0e789d09677d_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:to="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_a46c42ca-483f-45db-bb2d-b00229384d7c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:to="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_cb5333f9-5d3b-40ea-893d-28f74f7dbafa_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InternationalSalesDomain_b9f4754d-e634-40c8-9786-2b99b1f080c8_terseLabel_en-US" xlink:label="lab_icui_InternationalSalesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Sales [Domain]</link:label>
    <link:label id="lab_icui_InternationalSalesDomain_label_en-US" xlink:label="lab_icui_InternationalSalesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Sales [Domain]</link:label>
    <link:label id="lab_icui_InternationalSalesDomain_documentation_en-US" xlink:label="lab_icui_InternationalSalesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Sales [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InternationalSalesDomain" xlink:href="icui-20211231.xsd#icui_InternationalSalesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InternationalSalesDomain" xlink:to="lab_icui_InternationalSalesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_6674da39-27a2-4ea5-b725-396de6d4fefd_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_81091cc8-4432-49e5-ac7f-447c9d296b50_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_147043fb-6f43-493a-8667-fe493c12fb76_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_069de85a-6456-4df0-9287-1b392f221e08_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1ac4a877-dbf7-42d5-b397-0c5799803350_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_839ef10e-e462-40a9-94e0-daeee94ce836_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_46472e28-e734-4cc0-9bc8-dcccde390d62_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_ace1fdc7-3903-4bd3-b8b8-28e1c9ab5311_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_a3f6dd81-a3ac-45d0-9b88-3f9ca55f17d3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation, Foreign Income Tax Rate Differential</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_1ef9116e-48d6-40a7-96f3-49309f402f39_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_7341abc9-8eca-4e18-acef-0555242c9004_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt_12d1c60a-e5f8-4825-8b7a-37cd7f6794b5_terseLabel_en-US" xlink:label="lab_icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A Payment First Years as a % of Original Debt</link:label>
    <link:label id="lab_icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt_label_en-US" xlink:label="lab_icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A Payment First Years as a % of Original Debt</link:label>
    <link:label id="lab_icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt_documentation_en-US" xlink:label="lab_icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A Payment First Years as a % of Original Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt" xlink:href="icui-20211231.xsd#icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt" xlink:to="lab_icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e00c667-aa1d-4f63-826f-576a14140db4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_fde7079d-7a44-46a0-812d-731200c1f3db_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_578e9a3a-b4e7-4665-b062-f3325506d89e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WEIGHTED AVERAGE NUMBER OF SHARES</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_RevenueGrossProfitVolatilityMember_0f246a8b-4f76-4aed-8cde-789e48aba3a1_terseLabel_en-US" xlink:label="lab_icui_RevenueGrossProfitVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue/Gross Profit Volatility [Member]</link:label>
    <link:label id="lab_icui_RevenueGrossProfitVolatilityMember_label_en-US" xlink:label="lab_icui_RevenueGrossProfitVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue/Gross Profit Volatility [Member]</link:label>
    <link:label id="lab_icui_RevenueGrossProfitVolatilityMember_documentation_en-US" xlink:label="lab_icui_RevenueGrossProfitVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue/Gross Profit Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RevenueGrossProfitVolatilityMember" xlink:href="icui-20211231.xsd#icui_RevenueGrossProfitVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_RevenueGrossProfitVolatilityMember" xlink:to="lab_icui_RevenueGrossProfitVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_82997b3a-822a-4006-b28d-c8a433fa4cf5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ItalyPropertyAndEquipmentMember_e9d4b00b-7cec-46a7-b66b-e0572f02b550_terseLabel_en-US" xlink:label="lab_icui_ItalyPropertyAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Italy Property and Equipment [Member]</link:label>
    <link:label id="lab_icui_ItalyPropertyAndEquipmentMember_label_en-US" xlink:label="lab_icui_ItalyPropertyAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Italy Property and Equipment [Member]</link:label>
    <link:label id="lab_icui_ItalyPropertyAndEquipmentMember_documentation_en-US" xlink:label="lab_icui_ItalyPropertyAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign property and equipment: Italy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ItalyPropertyAndEquipmentMember" xlink:href="icui-20211231.xsd#icui_ItalyPropertyAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ItalyPropertyAndEquipmentMember" xlink:to="lab_icui_ItalyPropertyAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_35fb65a6-0b81-430f-9c38-c79e1029bbd7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_62a388c8-b7fb-47b3-9a7f-89cec501f4ff_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_0bb84a44-f298-4095-adc1-a9979948b8b0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Hedge2Member_42f8da49-7498-4fd1-8291-e30dfd0e9d1f_terseLabel_en-US" xlink:label="lab_icui_Hedge2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 2 [Member]</link:label>
    <link:label id="lab_icui_Hedge2Member_label_en-US" xlink:label="lab_icui_Hedge2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 2 [Member]</link:label>
    <link:label id="lab_icui_Hedge2Member_documentation_en-US" xlink:label="lab_icui_Hedge2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge2Member" xlink:href="icui-20211231.xsd#icui_Hedge2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Hedge2Member" xlink:to="lab_icui_Hedge2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount_6cb9663e-ae28-4362-9678-27e59925704b_terseLabel_en-US" xlink:label="lab_icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Quarterly Payments as a % of Original Debt Amount</link:label>
    <link:label id="lab_icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount_label_en-US" xlink:label="lab_icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Quarterly Payments as a % of Original Debt Amount</link:label>
    <link:label id="lab_icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount_documentation_en-US" xlink:label="lab_icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Quarterly Payments as a % of Original Debt Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount" xlink:href="icui-20211231.xsd#icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount" xlink:to="lab_icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_aeffcb81-39ab-49fc-9b8f-c6a7187c5783_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivative Liabilities, at Fair Value</link:label>
    <link:label id="lab_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_label_en-US" xlink:label="lab_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivative Liabilities, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativeLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:to="lab_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f0fce207-c5a9-49b4-bcf9-6cf1a2e1e76c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_eba09e82-0bb0-447d-a0e3-c5b479ccbb0f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_1ee31a0d-9001-4fbc-8eb2-7fbf7555350d_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts_56ada763-e815-402b-a3fe-aaccda0c52c7_negatedTerseLabel_en-US" xlink:label="lab_icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty and return reserve - inventory - charged to other accounts</link:label>
    <link:label id="lab_icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts_label_en-US" xlink:label="lab_icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty and return reserve - inventory - charged to other accounts</link:label>
    <link:label id="lab_icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts_documentation_en-US" xlink:label="lab_icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty and return reserve - inventory - charged to other accounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts" xlink:href="icui-20211231.xsd#icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts" xlink:to="lab_icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_fac127f4-0778-41a2-9b5b-916756c28a8d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_4ad1ed5f-7e63-4945-984d-74bbdca5d52e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_5b205572-e3f9-4c28-b8ab-2bf4f01a93a6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUES:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_208b6eea-b3b8-4fe2-9d9f-3e51213fdd61_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_7a714c66-7cde-45f0-a796-2f0f5e93a17b_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_57a7f8d3-5712-4b28-95c2-8e57b6b1ae05_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset additions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_6bb69431-2b22-4afe-9b39-35f502fc8e25_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_fe8ba760-0686-4724-8118-6a60f3946aed_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_47469aa9-01b0-474d-a029-d377dbdb42dc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_da59fb68-f056-4667-995d-f106b1dfb97d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_6a3b1ca8-874d-4423-919e-689d25410f8a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_a47f405d-2332-4aed-a3fe-ac6076e05b05_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_07ca41c1-9b20-41cf-99c5-2d0a209b4430_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Effectiveincometaxreconciliationnondeductiblecompensation_76e02593-2cf4-4357-8076-9330b7581961_terseLabel_en-US" xlink:label="lab_icui_Effectiveincometaxreconciliationnondeductiblecompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effectiveincometaxreconciliation,nondeductiblecompensation</link:label>
    <link:label id="lab_icui_Effectiveincometaxreconciliationnondeductiblecompensation_label_en-US" xlink:label="lab_icui_Effectiveincometaxreconciliationnondeductiblecompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effectiveincometaxreconciliation,nondeductiblecompensation</link:label>
    <link:label id="lab_icui_Effectiveincometaxreconciliationnondeductiblecompensation_documentation_en-US" xlink:label="lab_icui_Effectiveincometaxreconciliationnondeductiblecompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effectiveincometaxreconciliation,nondeductiblecompensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Effectiveincometaxreconciliationnondeductiblecompensation" xlink:href="icui-20211231.xsd#icui_Effectiveincometaxreconciliationnondeductiblecompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Effectiveincometaxreconciliationnondeductiblecompensation" xlink:to="lab_icui_Effectiveincometaxreconciliationnondeductiblecompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_8628f6b8-1e56-472e-872b-b036b444ce79_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SpareParts_b00fd8aa-3b6b-463c-a11d-8eeb570bca27_terseLabel_en-US" xlink:label="lab_icui_SpareParts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spare parts</link:label>
    <link:label id="lab_icui_SpareParts_label_en-US" xlink:label="lab_icui_SpareParts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spare parts</link:label>
    <link:label id="lab_icui_SpareParts_documentation_en-US" xlink:label="lab_icui_SpareParts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spare parts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SpareParts" xlink:href="icui-20211231.xsd#icui_SpareParts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SpareParts" xlink:to="lab_icui_SpareParts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSubsequentEventsTextBlock_144f58b4-ff03-40de-a20b-2225b0b77737_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Subsequent Events</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Subsequent Events [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSubsequentEventsTextBlock" xlink:to="lab_us-gaap_ScheduleOfSubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments_21c938b5-2804-43d8-9166-bf63c6c6df27_terseLabel_en-US" xlink:label="lab_icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to acquire business, net of working capital adjustments</link:label>
    <link:label id="lab_icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments_label_en-US" xlink:label="lab_icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to acquire business, net of working capital adjustments</link:label>
    <link:label id="lab_icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments_documentation_en-US" xlink:label="lab_icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to acquire business, net of working capital adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments" xlink:href="icui-20211231.xsd#icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments" xlink:to="lab_icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_EffectiveIncomeTaxRateReconciliationIPMigration_88c41bf3-59c8-464c-a873-5b66eeb5b76e_terseLabel_en-US" xlink:label="lab_icui_EffectiveIncomeTaxRateReconciliationIPMigration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EffectiveIncomeTaxRateReconciliationIPMigration</link:label>
    <link:label id="lab_icui_EffectiveIncomeTaxRateReconciliationIPMigration_label_en-US" xlink:label="lab_icui_EffectiveIncomeTaxRateReconciliationIPMigration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EffectiveIncomeTaxRateReconciliationIPMigration</link:label>
    <link:label id="lab_icui_EffectiveIncomeTaxRateReconciliationIPMigration_documentation_en-US" xlink:label="lab_icui_EffectiveIncomeTaxRateReconciliationIPMigration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EffectiveIncomeTaxRateReconciliationIPMigration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EffectiveIncomeTaxRateReconciliationIPMigration" xlink:href="icui-20211231.xsd#icui_EffectiveIncomeTaxRateReconciliationIPMigration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_EffectiveIncomeTaxRateReconciliationIPMigration" xlink:to="lab_icui_EffectiveIncomeTaxRateReconciliationIPMigration" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Operatingleaserightofuseassetamortization_4b1e4085-5335-4bba-84c8-4dc57d1b23ac_terseLabel_en-US" xlink:label="lab_icui_Operatingleaserightofuseassetamortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operatingleaserightofuseassetamortization</link:label>
    <link:label id="lab_icui_Operatingleaserightofuseassetamortization_label_en-US" xlink:label="lab_icui_Operatingleaserightofuseassetamortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operatingleaserightofuseassetamortization</link:label>
    <link:label id="lab_icui_Operatingleaserightofuseassetamortization_documentation_en-US" xlink:label="lab_icui_Operatingleaserightofuseassetamortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operatingleaserightofuseassetamortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Operatingleaserightofuseassetamortization" xlink:href="icui-20211231.xsd#icui_Operatingleaserightofuseassetamortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Operatingleaserightofuseassetamortization" xlink:to="lab_icui_Operatingleaserightofuseassetamortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_786e4d6f-088c-4c85-abe3-5a6b834d51b8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_f7c5abf2-fcb8-46bc-a710-48eade2594d8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term obligations</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_c2d78920-11cb-404b-b651-8a233131281f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment, cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1f642de0-2c2f-4987-b575-133d70c62969_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment, net of taxes of $0 for all periods</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_8f58501a-4c84-4dc3-bb9f-ade14537ca90_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_30dd4bea-1946-4f4c-ab0f-6e0963f63094_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_6cf923e4-2560-4201-9ec1-214f6815c7a8_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ProvisionForWarrantyAndReturns_abb92b64-e40f-4e3a-8fdb-dfaecb4786d6_terseLabel_en-US" xlink:label="lab_icui_ProvisionForWarrantyAndReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for warranty and returns</link:label>
    <link:label id="lab_icui_ProvisionForWarrantyAndReturns_label_en-US" xlink:label="lab_icui_ProvisionForWarrantyAndReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for warranty and returns</link:label>
    <link:label id="lab_icui_ProvisionForWarrantyAndReturns_documentation_en-US" xlink:label="lab_icui_ProvisionForWarrantyAndReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for warranty and returns</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProvisionForWarrantyAndReturns" xlink:href="icui-20211231.xsd#icui_ProvisionForWarrantyAndReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ProvisionForWarrantyAndReturns" xlink:to="lab_icui_ProvisionForWarrantyAndReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_dd06063d-f0b6-46b0-bc33-207851290c2b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished Goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f94171d5-024f-417c-9c84-ca2146e45bd4_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_50818f2b-3d5f-4e78-83a9-c649e4724b3b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_75ebcf7e-e839-40f6-98bf-1ae68dcff618_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_b9b5722b-add6-47aa-a3c8-1f770b126d7b_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_c1d361e6-c590-4db4-a1e2-e451dfc423b5_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_6f2f4749-9060-40d8-b2a9-9628915e1e80_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_DeferredtaxassetsandliabilitiesTable_376cdd77-80d2-42b3-ad7d-b8f81eebe7ac_terseLabel_en-US" xlink:label="lab_icui_DeferredtaxassetsandliabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets and liabilities [Table]</link:label>
    <link:label id="lab_icui_DeferredtaxassetsandliabilitiesTable_label_en-US" xlink:label="lab_icui_DeferredtaxassetsandliabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets and liabilities [Table]</link:label>
    <link:label id="lab_icui_DeferredtaxassetsandliabilitiesTable_documentation_en-US" xlink:label="lab_icui_DeferredtaxassetsandliabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets and liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DeferredtaxassetsandliabilitiesTable" xlink:href="icui-20211231.xsd#icui_DeferredtaxassetsandliabilitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesTable" xlink:to="lab_icui_DeferredtaxassetsandliabilitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4819ae00-edc1-4d76-a661-5c9986432ae9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate, Continuing Operations</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_b181377e-7f18-4404-985d-0c6fdce62ae7_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance cost amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_b86e5ded-c574-40c4-839c-a065c77b20ba_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductionRelatedImpairmentsOrCharges_eade8474-6c74-4fb4-9717-1dbc8c377a1e_terseLabel_en-US" xlink:label="lab_us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Production Related Impairments or Charges</link:label>
    <link:label id="lab_us-gaap_ProductionRelatedImpairmentsOrCharges_label_en-US" xlink:label="lab_us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Production Related Impairments or Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:to="lab_us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_2f91e39b-4557-44df-a038-b042251bcd46_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxHolidayTable_9db17193-40a0-4899-b2c4-31d7d50fc0b5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Holiday [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxHolidayTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Holiday [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxHolidayTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxHolidayTable" xlink:to="lab_us-gaap_IncomeTaxHolidayTable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Grantdatefairvalueofrestrictedstockunitsgranted_5cfd1f47-15fd-4950-a7c9-58a282375277_terseLabel_en-US" xlink:label="lab_icui_Grantdatefairvalueofrestrictedstockunitsgranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value of restricted stock units granted</link:label>
    <link:label id="lab_icui_Grantdatefairvalueofrestrictedstockunitsgranted_label_en-US" xlink:label="lab_icui_Grantdatefairvalueofrestrictedstockunitsgranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value of restricted stock units granted</link:label>
    <link:label id="lab_icui_Grantdatefairvalueofrestrictedstockunitsgranted_documentation_en-US" xlink:label="lab_icui_Grantdatefairvalueofrestrictedstockunitsgranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value of restricted stock units granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Grantdatefairvalueofrestrictedstockunitsgranted" xlink:href="icui-20211231.xsd#icui_Grantdatefairvalueofrestrictedstockunitsgranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Grantdatefairvalueofrestrictedstockunitsgranted" xlink:to="lab_icui_Grantdatefairvalueofrestrictedstockunitsgranted" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_649a897f-9ccb-4adc-b123-d347e47ccd79_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_bde27e51-ce6f-4cd7-a924-64760dbbba3e_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TotalAcquisitionsMember_00076d05-57a2-4179-bee1-f43e6afc3ac0_terseLabel_en-US" xlink:label="lab_icui_TotalAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Acquisitions</link:label>
    <link:label id="lab_icui_TotalAcquisitionsMember_label_en-US" xlink:label="lab_icui_TotalAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Acquisitions [Member]</link:label>
    <link:label id="lab_icui_TotalAcquisitionsMember_documentation_en-US" xlink:label="lab_icui_TotalAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TotalAcquisitionsMember" xlink:href="icui-20211231.xsd#icui_TotalAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TotalAcquisitionsMember" xlink:to="lab_icui_TotalAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_NoncurrentDeferredTaxLiabilityMember_e9ef40e2-f073-45a7-b494-308b507107bb_terseLabel_en-US" xlink:label="lab_icui_NoncurrentDeferredTaxLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent deferred tax liability [Member]</link:label>
    <link:label id="lab_icui_NoncurrentDeferredTaxLiabilityMember_label_en-US" xlink:label="lab_icui_NoncurrentDeferredTaxLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent deferred tax liability [Member]</link:label>
    <link:label id="lab_icui_NoncurrentDeferredTaxLiabilityMember_documentation_en-US" xlink:label="lab_icui_NoncurrentDeferredTaxLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent deferred tax liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NoncurrentDeferredTaxLiabilityMember" xlink:href="icui-20211231.xsd#icui_NoncurrentDeferredTaxLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_NoncurrentDeferredTaxLiabilityMember" xlink:to="lab_icui_NoncurrentDeferredTaxLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_c0e007c4-97af-4a44-aafe-1c42c3402e60_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_PricingLevelIIMemberMember_bb4ea101-0d29-4ea4-af50-42a421f520a1_terseLabel_en-US" xlink:label="lab_icui_PricingLevelIIMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II [Member] [Member]</link:label>
    <link:label id="lab_icui_PricingLevelIIMemberMember_label_en-US" xlink:label="lab_icui_PricingLevelIIMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II [Member] [Member]</link:label>
    <link:label id="lab_icui_PricingLevelIIMemberMember_documentation_en-US" xlink:label="lab_icui_PricingLevelIIMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIIMemberMember" xlink:href="icui-20211231.xsd#icui_PricingLevelIIMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_PricingLevelIIMemberMember" xlink:to="lab_icui_PricingLevelIIMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_46bb1559-bcfe-41a0-9cdf-76590a172478_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_705afd31-947f-4205-bd1b-32d02ae4ad31_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5ed87277-f70b-4dd6-a21f-af86e818c72a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_a9078526-a13d-4a42-8a8c-b95bc7ccafdb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f42b5d74-14d5-42cd-abc6-2b03a918451c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c8b68f73-dee9-4909-9d37-eba787388e89_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average common and common equivalent shares outstandding (diluted)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_7159b48b-b9ee-4330-9057-524534ce38b9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_4f33732c-eec8-47b0-b154-b66b4774f347_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_c97171e4-100d-482b-a312-d5ebb0a887f2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_ab0a3edf-a564-4b23-9728-712e2d915bc5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_45869b2f-61f1-43be-84a0-1ecf3cc2f84e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_1ac4f760-ba2d-49e5-b5d1-eac576029417_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and Expected to Vest</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_78c3f773-fec9-4f3b-ad56-968d6c67f88c_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50f481ad-48f7-48d1-9b3e-fb23b3268b80_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_798a564f-d45a-4213-8629-cfa191cb8192_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3871bee3-6ca5-4c39-8d61-5c811ba8ec1b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_900cceae-ab40-4474-8894-563fd97dfaed_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7c5a2afe-6729-45f2-8266-934c44ca1f92_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_7ae0672a-6414-478f-af2f-e96de04894d5_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_7b996276-2252-4a70-bfea-38f6036682cf_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Remaining Minimum Amount Committed</link:label>
    <link:label id="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_label_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Remaining Minimum Amount Committed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:to="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_548acde2-8843-471f-b52d-b5d910df9fa5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ec432d3f-e4d6-4fee-ac3e-46534eda2c36_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_91f17241-6ddb-4c24-846a-293f80d5c2ac_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c9a2fa0a-5c28-4f39-9166-44997e210a16_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_c904561a-5579-4b27-85a0-f9c657ab854c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_6d740d1e-fb31-4f20-8d62-e6d17b2dad57_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_e17c10dd-0013-475b-a161-e7a30fbd3e35_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_AccruedSalariesAndBenefits_b8e7dbcb-af9e-44bb-b71c-e8fe17de25d6_terseLabel_en-US" xlink:label="lab_icui_AccruedSalariesAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Salaries and benefits</link:label>
    <link:label id="lab_icui_AccruedSalariesAndBenefits_label_en-US" xlink:label="lab_icui_AccruedSalariesAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued salaries and benefits</link:label>
    <link:label id="lab_icui_AccruedSalariesAndBenefits_documentation_en-US" xlink:label="lab_icui_AccruedSalariesAndBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued salaries and benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AccruedSalariesAndBenefits" xlink:href="icui-20211231.xsd#icui_AccruedSalariesAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_AccruedSalariesAndBenefits" xlink:to="lab_icui_AccruedSalariesAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LIBORBasisSpreadonVariableRate_9993de32-2c10-4c88-be66-d6b0b38d0270_terseLabel_en-US" xlink:label="lab_icui_LIBORBasisSpreadonVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR Basis Spread on Variable Rate</link:label>
    <link:label id="lab_icui_LIBORBasisSpreadonVariableRate_label_en-US" xlink:label="lab_icui_LIBORBasisSpreadonVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR Basis Spread on Variable Rate</link:label>
    <link:label id="lab_icui_LIBORBasisSpreadonVariableRate_documentation_en-US" xlink:label="lab_icui_LIBORBasisSpreadonVariableRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LIBORBasisSpreadonVariableRate" xlink:href="icui-20211231.xsd#icui_LIBORBasisSpreadonVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LIBORBasisSpreadonVariableRate" xlink:to="lab_icui_LIBORBasisSpreadonVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_dcca69e5-d01a-4671-8c3c-287d71a736dd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a282a73e-399a-463a-9791-5cb5da63f59b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_f8848728-1dd5-4f14-b466-64b6b8e8135a_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_4b2a90bf-b69b-4fc6-9e0c-eb30c48d3c5b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_StockIncentivePlansTable_85db6e0f-26e3-4d21-a5ac-b972d8b973a1_terseLabel_en-US" xlink:label="lab_icui_StockIncentivePlansTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plans [Table]</link:label>
    <link:label id="lab_icui_StockIncentivePlansTable_label_en-US" xlink:label="lab_icui_StockIncentivePlansTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plans [Table]</link:label>
    <link:label id="lab_icui_StockIncentivePlansTable_documentation_en-US" xlink:label="lab_icui_StockIncentivePlansTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plans [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_StockIncentivePlansTable" xlink:href="icui-20211231.xsd#icui_StockIncentivePlansTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_StockIncentivePlansTable" xlink:to="lab_icui_StockIncentivePlansTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeForwardExchangeRate1_fc5b5b3e-5567-4d41-86cc-4da9bfe7b7b7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeForwardExchangeRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Forward Exchange Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeForwardExchangeRate1_label_en-US" xlink:label="lab_us-gaap_DerivativeForwardExchangeRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Forward Exchange Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeForwardExchangeRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeForwardExchangeRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeForwardExchangeRate1" xlink:to="lab_us-gaap_DerivativeForwardExchangeRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_RestructuringAdjustmentsSeveranceAndFacility_f2604b63-98b9-4fd8-b3aa-a058bce0dac3_terseLabel_en-US" xlink:label="lab_icui_RestructuringAdjustmentsSeveranceAndFacility" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Adjustments - Severance and Facility</link:label>
    <link:label id="lab_icui_RestructuringAdjustmentsSeveranceAndFacility_label_en-US" xlink:label="lab_icui_RestructuringAdjustmentsSeveranceAndFacility" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Adjustments - Severance and Facility</link:label>
    <link:label id="lab_icui_RestructuringAdjustmentsSeveranceAndFacility_documentation_en-US" xlink:label="lab_icui_RestructuringAdjustmentsSeveranceAndFacility" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Adjustments - Severance and Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RestructuringAdjustmentsSeveranceAndFacility" xlink:href="icui-20211231.xsd#icui_RestructuringAdjustmentsSeveranceAndFacility"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_RestructuringAdjustmentsSeveranceAndFacility" xlink:to="lab_icui_RestructuringAdjustmentsSeveranceAndFacility" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_6cd04041-4d71-41d2-b3f9-6b297e277024_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_0f4a1969-02f4-4340-b544-32c562eee319_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_b66d1f06-7a4a-4688-a2a5-5abaa48e4a4d_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL</link:label>
    <link:label id="lab_us-gaap_Goodwill_68c47568-93e0-4a47-8f3c-8a658aa74c57_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL</link:label>
    <link:label id="lab_us-gaap_Goodwill_268581c6-1926-41c4-ae0e-e01946ebb0ed_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditRiskMember_a4f443cd-2c9e-4b46-bb35-3ce0dd29c722_terseLabel_en-US" xlink:label="lab_us-gaap_CreditRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Risk [Member]</link:label>
    <link:label id="lab_us-gaap_CreditRiskMember_label_en-US" xlink:label="lab_us-gaap_CreditRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditRiskMember" xlink:to="lab_us-gaap_CreditRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesTotalMember_ef682240-2dac-4eb9-9c9c-3a137e894c8b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesTotalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Total [Member]</link:label>
    <link:label id="lab_us-gaap_LiabilitiesTotalMember_label_en-US" xlink:label="lab_us-gaap_LiabilitiesTotalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Total [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesTotalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesTotalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesTotalMember" xlink:to="lab_us-gaap_LiabilitiesTotalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_6d6ef863-92c9-4556-b4a1-ce3e450a9189_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_952467bd-34d2-445f-8f9b-a9f0eeb4e737_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or expired</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCredits_6d1bd847-c681-4c1e-8bd3-56a71ed36eb7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation, Tax Credits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCredits_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ContractassetandliabilitybalancesLineItems_97a5ded1-9229-4ade-81ef-432a02d2812e_terseLabel_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset and liability balances [Line Items]</link:label>
    <link:label id="lab_icui_ContractassetandliabilitybalancesLineItems_label_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset and liability balances [Line Items]</link:label>
    <link:label id="lab_icui_ContractassetandliabilitybalancesLineItems_documentation_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Contract asset and liability balances [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesLineItems" xlink:href="icui-20211231.xsd#icui_ContractassetandliabilitybalancesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems" xlink:to="lab_icui_ContractassetandliabilitybalancesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_6a240f18-48a1-4876-97ff-b2fc644f36f7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_3d3ea733-eaf2-4be2-ac0b-da6104594422_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_0288a66a-7bd2-4222-9774-1df4df804607_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_e4b718d4-0892-4b95-88a9-efb0888bb347_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_cb88830c-4866-40a7-9fba-5ed0c13c8cab_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ba5aa13f-ffdc-4b04-a86b-9d37fb85cece_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_6dec2356-37b6-4f75-8486-b36de6b98c4e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_aab4bec3-5ef5-4b7a-8abd-1269c5a3575c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f6fb6977-acea-490e-84e8-6bc1a91a5d7e_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_0ef9efcf-43cf-4f1f-b622-b6ae7ca2157b_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_c43cefb7-22dd-48ff-b5a7-e6cb8f492661_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Realized</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Realized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_30435c10-0633-476b-947e-4064226bafcd_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_269626ac-1eb3-47af-9046-2ab3d1d674ed_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in Process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_c8ca8de0-0022-4ae7-9f4a-ea75af06e9e3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98bd4942-cb1e-4ecf-9a99-ccfa4829e394_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_71d6e1e3-cf4e-41e4-acd9-b5f8734f0ead_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_9ca15dfd-4f5a-4330-b798-e2e743bd0c63_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_6de4beda-5375-4ef6-b0ba-48651b34c20b_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_e46e4f8c-3acd-4a71-8dcc-15ef1d748752_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_e40ff2e1-6e84-437c-ae08-a6872787a9f5_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_3bd59139-ecd3-4e21-9cc3-62b9d778b79c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6490b48a-faee-48cb-addd-25cd2b8b1e6e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_19984a2b-6371-4c5c-9948-7ad64a710269_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_a6fbcc3b-ce01-4a58-a7b4-87843cc7449b_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_d75b9c43-2448-41e1-8251-cfc8390ae478_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Cleanupcosts_fa4c481b-e37d-4829-b383-23eaa5fd5461_terseLabel_en-US" xlink:label="lab_icui_Cleanupcosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cleanupcosts</link:label>
    <link:label id="lab_icui_Cleanupcosts_label_en-US" xlink:label="lab_icui_Cleanupcosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cleanupcosts</link:label>
    <link:label id="lab_icui_Cleanupcosts_documentation_en-US" xlink:label="lab_icui_Cleanupcosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cleanupcosts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Cleanupcosts" xlink:href="icui-20211231.xsd#icui_Cleanupcosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Cleanupcosts" xlink:to="lab_icui_Cleanupcosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_cfb99aa9-2d2c-4f28-a62c-e5a31c5f8a82_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Changeinunitsduetoperformanceexpectations_663386e5-7db2-4ed2-9626-9c265e29708f_terseLabel_en-US" xlink:label="lab_icui_Changeinunitsduetoperformanceexpectations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in units due to performance expectations</link:label>
    <link:label id="lab_icui_Changeinunitsduetoperformanceexpectations_label_en-US" xlink:label="lab_icui_Changeinunitsduetoperformanceexpectations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in units due to performance expectations</link:label>
    <link:label id="lab_icui_Changeinunitsduetoperformanceexpectations_documentation_en-US" xlink:label="lab_icui_Changeinunitsduetoperformanceexpectations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in units due to performance expectations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Changeinunitsduetoperformanceexpectations" xlink:href="icui-20211231.xsd#icui_Changeinunitsduetoperformanceexpectations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Changeinunitsduetoperformanceexpectations" xlink:to="lab_icui_Changeinunitsduetoperformanceexpectations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_eb444534-7c14-43f5-9786-9c5e1c1b3fe5_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_4b474d43-c225-4b16-a578-fb5a18aa1032_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_94f0951e-9a78-4fdc-a4cb-09c81d206765_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Dividend Yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_a2deb86c-0f72-42a7-afbd-44ab34b65854_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a85befc4-ebff-4656-be78-926c35b6fcb3_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c7d98c01-b577-47ea-899e-fdd73f358f1d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_66b2e3c3-00ac-4774-8ef6-500dcaf5bbec_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_bc0a290d-23ac-4884-a7db-7667b59601c0_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross_65bc3a02-94ee-48f1-a00e-0d9d6a102c1e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Line of Credit Arrangements, Gross</link:label>
    <link:label id="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross_label_en-US" xlink:label="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Line of Credit Arrangements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross" xlink:to="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a5056b15-85e9-41d2-8cda-b34c0e82b96f_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_295f3f67-297a-44b5-bf6e-b77a3ddd236b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_e0bfac17-55e8-49de-9a68-9640e4a67df0_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_ac55457c-fc7b-4efb-9c01-bf2a3444f6be_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_43aea3e5-8789-4ce0-85c9-7eeebc721240_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0f864a6e-4355-433b-a747-0190e1a99420_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_8b7444c7-dc30-4393-a85a-373b520f1cf0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Intrinsic Value, Amount Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Intrinsic Value, Amount Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_GILTItaxexpensepercent_e4e49acb-9a31-40d5-ae43-eec848a8461b_terseLabel_en-US" xlink:label="lab_icui_GILTItaxexpensepercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GILTItaxexpensepercent</link:label>
    <link:label id="lab_icui_GILTItaxexpensepercent_label_en-US" xlink:label="lab_icui_GILTItaxexpensepercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GILTItaxexpensepercent</link:label>
    <link:label id="lab_icui_GILTItaxexpensepercent_documentation_en-US" xlink:label="lab_icui_GILTItaxexpensepercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GILTItaxexpensepercent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GILTItaxexpensepercent" xlink:href="icui-20211231.xsd#icui_GILTItaxexpensepercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_GILTItaxexpensepercent" xlink:to="lab_icui_GILTItaxexpensepercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_6126709e-7334-4f26-8640-006174db9fd2_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_f32762d0-4257-47c3-9da8-4d5e8c555a2d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Deferredtaxcharge_352363ea-eb4c-47a0-92a1-3acb339bab5d_terseLabel_en-US" xlink:label="lab_icui_Deferredtaxcharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax charge</link:label>
    <link:label id="lab_icui_Deferredtaxcharge_label_en-US" xlink:label="lab_icui_Deferredtaxcharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax charge</link:label>
    <link:label id="lab_icui_Deferredtaxcharge_documentation_en-US" xlink:label="lab_icui_Deferredtaxcharge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Deferredtaxcharge" xlink:href="icui-20211231.xsd#icui_Deferredtaxcharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Deferredtaxcharge" xlink:to="lab_icui_Deferredtaxcharge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_9cd0b0f5-0f01-4e4f-b599-d54716706528_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_5b65e7c3-a2c9-485f-9400-281a97bba06f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain_c27f3ff9-a3f7-4ef7-b934-0d12c4e5dde9_terseLabel_en-US" xlink:label="lab_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A and Credit Line Applicable Margin Spread [Domain]</link:label>
    <link:label id="lab_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain_label_en-US" xlink:label="lab_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A and Credit Line Applicable Margin Spread [Domain]</link:label>
    <link:label id="lab_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain_documentation_en-US" xlink:label="lab_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A and Credit Line Applicable Margin Spread [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain" xlink:href="icui-20211231.xsd#icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain" xlink:to="lab_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_cb7b01b3-7260-47a0-b9e2-cce01f3a48d4_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_1bbd2b29-3429-4d43-b81e-e2f58300259b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_fce7d940-dc16-4153-9201-9c7d7a9465c7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_f6768265-ba57-460d-9531-eedffc34f61c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LongTermContingentConsiderationGross_87f04881-5865-4014-8e21-9791531aa741_terseLabel_en-US" xlink:label="lab_icui_LongTermContingentConsiderationGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term contingent consideration-gross</link:label>
    <link:label id="lab_icui_LongTermContingentConsiderationGross_label_en-US" xlink:label="lab_icui_LongTermContingentConsiderationGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term contingent consideration-gross</link:label>
    <link:label id="lab_icui_LongTermContingentConsiderationGross_documentation_en-US" xlink:label="lab_icui_LongTermContingentConsiderationGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term contingent consideration-gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermContingentConsiderationGross" xlink:href="icui-20211231.xsd#icui_LongTermContingentConsiderationGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LongTermContingentConsiderationGross" xlink:to="lab_icui_LongTermContingentConsiderationGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxHolidayLineItems_f11fbf43-8a96-40af-be67-14c335344b77_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Holiday [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxHolidayLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Holiday [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxHolidayLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxHolidayLineItems" xlink:to="lab_us-gaap_IncomeTaxHolidayLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_fe612c7c-161a-434f-a407-f5437e7e39ec_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_da02e9a2-ba18-42c6-8ef1-52d3dfabf4ee_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Outstanding, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bf0bb9b8-aafb-4d3d-9368-e906dc1598f5_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Outstanding, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_39707e57-b61c-4142-a9db-da8b481f377c_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_40ed4ecf-6959-4f92-8586-6be3742dd4b0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ce3344d7-4b7b-425d-8c8e-9e416c6c96b8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_b44be045-30e9-4b92-909c-4aad22788e68_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Sharestransferredfromsupersededplan_1a66ae89-4be0-487b-9452-4201653cbe0c_terseLabel_en-US" xlink:label="lab_icui_Sharestransferredfromsupersededplan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares transferred from superseded plan</link:label>
    <link:label id="lab_icui_Sharestransferredfromsupersededplan_label_en-US" xlink:label="lab_icui_Sharestransferredfromsupersededplan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares transferred from superseded plan</link:label>
    <link:label id="lab_icui_Sharestransferredfromsupersededplan_documentation_en-US" xlink:label="lab_icui_Sharestransferredfromsupersededplan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares transferred from superseded plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Sharestransferredfromsupersededplan" xlink:href="icui-20211231.xsd#icui_Sharestransferredfromsupersededplan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Sharestransferredfromsupersededplan" xlink:to="lab_icui_Sharestransferredfromsupersededplan" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_NetCashPaidReceivedforcurrentandprioracquisitions_67a408ca-5a2c-4401-b653-1ff0be110ab5_negatedTerseLabel_en-US" xlink:label="lab_icui_NetCashPaidReceivedforcurrentandprioracquisitions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquisitions, net of cash acquired</link:label>
    <link:label id="lab_icui_NetCashPaidReceivedforcurrentandprioracquisitions_label_en-US" xlink:label="lab_icui_NetCashPaidReceivedforcurrentandprioracquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Paid (Received) for current and prior acquisitions</link:label>
    <link:label id="lab_icui_NetCashPaidReceivedforcurrentandprioracquisitions_documentation_en-US" xlink:label="lab_icui_NetCashPaidReceivedforcurrentandprioracquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Paid (Received) for current and prior acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NetCashPaidReceivedforcurrentandprioracquisitions" xlink:href="icui-20211231.xsd#icui_NetCashPaidReceivedforcurrentandprioracquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_NetCashPaidReceivedforcurrentandprioracquisitions" xlink:to="lab_icui_NetCashPaidReceivedforcurrentandprioracquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanBEuroRateLoanSpread_1cfa0c16-9dbe-4e9e-b9c0-7c9a52d1fe9f_terseLabel_en-US" xlink:label="lab_icui_TermLoanBEuroRateLoanSpread" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Euro Rate Loan Spread</link:label>
    <link:label id="lab_icui_TermLoanBEuroRateLoanSpread_label_en-US" xlink:label="lab_icui_TermLoanBEuroRateLoanSpread" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Euro Rate Loan Spread</link:label>
    <link:label id="lab_icui_TermLoanBEuroRateLoanSpread_documentation_en-US" xlink:label="lab_icui_TermLoanBEuroRateLoanSpread" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Euro Rate Loan Spread</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBEuroRateLoanSpread" xlink:href="icui-20211231.xsd#icui_TermLoanBEuroRateLoanSpread"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanBEuroRateLoanSpread" xlink:to="lab_icui_TermLoanBEuroRateLoanSpread" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0475f703-a258-4caf-9449-027333695280_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent_493ae216-2b4b-477f-a2fb-986e339d1373_terseLabel_en-US" xlink:label="lab_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome,Percent</link:label>
    <link:label id="lab_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent_label_en-US" xlink:label="lab_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome,Percent</link:label>
    <link:label id="lab_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent_documentation_en-US" xlink:label="lab_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome,Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent" xlink:href="icui-20211231.xsd#icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent" xlink:to="lab_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_1f07dfe9-ee3d-41b7-919f-0282f999a2ba_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_28d99003-83fd-4d45-985f-1541bc724c27_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived Assets by Geographic Areas [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived Assets by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_32335fd1-2dc6-46a0-9fea-9ad041770ce1_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c6a6aa0c-d7e5-48bc-bbf2-d685c7bdebf0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_9cde68c3-e8f7-4d5a-8c2c-6302396a9f62_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0fd45e5c-2f87-4dfd-b143-779f4aceffec_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_NoncurrentDeferredTaxAssetTaxCreditsState_d04d8417-5798-4e9c-8521-f1c16cff8c92_terseLabel_en-US" xlink:label="lab_icui_NoncurrentDeferredTaxAssetTaxCreditsState" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent deferred tax asset - tax credits state</link:label>
    <link:label id="lab_icui_NoncurrentDeferredTaxAssetTaxCreditsState_label_en-US" xlink:label="lab_icui_NoncurrentDeferredTaxAssetTaxCreditsState" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent deferred tax asset - tax credits state</link:label>
    <link:label id="lab_icui_NoncurrentDeferredTaxAssetTaxCreditsState_documentation_en-US" xlink:label="lab_icui_NoncurrentDeferredTaxAssetTaxCreditsState" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent deferred tax asset - tax credits state</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NoncurrentDeferredTaxAssetTaxCreditsState" xlink:href="icui-20211231.xsd#icui_NoncurrentDeferredTaxAssetTaxCreditsState"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_NoncurrentDeferredTaxAssetTaxCreditsState" xlink:to="lab_icui_NoncurrentDeferredTaxAssetTaxCreditsState" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_2a1ed3fb-93ac-425c-a3b0-728ccf38cc21_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Hedge4Member_8a341ac0-7e3e-4fec-a8a7-cbef97db2d16_terseLabel_en-US" xlink:label="lab_icui_Hedge4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 4</link:label>
    <link:label id="lab_icui_Hedge4Member_label_en-US" xlink:label="lab_icui_Hedge4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 4 [Member]</link:label>
    <link:label id="lab_icui_Hedge4Member_documentation_en-US" xlink:label="lab_icui_Hedge4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 4</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge4Member" xlink:href="icui-20211231.xsd#icui_Hedge4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Hedge4Member" xlink:to="lab_icui_Hedge4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_c0f5035a-2896-4c11-8db2-0770335d0b0c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_35c213a0-1e34-464f-a829-4796c2e49224_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_7dd714bd-1b7f-44a0-bae5-06955432d759_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_cf5c18fc-d9b5-42bc-8e53-47763bcae522_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9298572e-449f-4381-94c3-76f8d4c75d82_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments, net of taxes of $0 for all periods</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a8d1a834-6655-4229-8794-ff179a93718f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Outsidesalescommissions_b36065c8-1be6-4ab3-b154-bcaa99873961_terseLabel_en-US" xlink:label="lab_icui_Outsidesalescommissions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside commissions</link:label>
    <link:label id="lab_icui_Outsidesalescommissions_label_en-US" xlink:label="lab_icui_Outsidesalescommissions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside sales commissions</link:label>
    <link:label id="lab_icui_Outsidesalescommissions_documentation_en-US" xlink:label="lab_icui_Outsidesalescommissions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside sales commissions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Outsidesalescommissions" xlink:href="icui-20211231.xsd#icui_Outsidesalescommissions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Outsidesalescommissions" xlink:to="lab_icui_Outsidesalescommissions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_68782fb0-6bcc-42b2-bdde-d1ce41f57baa_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, after Year Five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_5d496441-fd98-4c07-aa61-099bd2c0ba9c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_d90ec0c6-a0fa-43df-8d7b-e5c9b2bd6f54_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_40818142-f6fa-4f96-b2e6-e16f2d143b4f_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f1a3aa12-6c6f-4972-9a6d-54ef437da398_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_31a09f4b-bcb5-46df-9192-07ecb92eb191_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e6141820-93b8-42e0-ab85-26cfd4bae2a7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_f86f3e04-cc9d-4fb7-b804-4a6f311a02a1_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_NonCurrentDeferredTaxAssetGrossTotalMember_ef897b06-a35d-4cf8-a069-842a386dbc9b_terseLabel_en-US" xlink:label="lab_icui_NonCurrentDeferredTaxAssetGrossTotalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current deferred tax asset, gross total [Member]</link:label>
    <link:label id="lab_icui_NonCurrentDeferredTaxAssetGrossTotalMember_label_en-US" xlink:label="lab_icui_NonCurrentDeferredTaxAssetGrossTotalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current deferred tax asset, gross total [Member]</link:label>
    <link:label id="lab_icui_NonCurrentDeferredTaxAssetGrossTotalMember_documentation_en-US" xlink:label="lab_icui_NonCurrentDeferredTaxAssetGrossTotalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total of gross non-current deferred tax asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NonCurrentDeferredTaxAssetGrossTotalMember" xlink:href="icui-20211231.xsd#icui_NonCurrentDeferredTaxAssetGrossTotalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_NonCurrentDeferredTaxAssetGrossTotalMember" xlink:to="lab_icui_NonCurrentDeferredTaxAssetGrossTotalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_6354dc8d-8acb-4e84-acfa-c88152c10fd3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_cfd5fff0-11c9-4e50-810c-885f27ed69b1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome_ea12fabe-e4b6-46cc-98c3-42d2afec845f_terseLabel_en-US" xlink:label="lab_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome</link:label>
    <link:label id="lab_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome_label_en-US" xlink:label="lab_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome</link:label>
    <link:label id="lab_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome_documentation_en-US" xlink:label="lab_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" xlink:href="icui-20211231.xsd#icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" xlink:to="lab_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_1d7d2840-e59a-4e70-8c43-488062071e83_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InfusionConsumablesMember_43dc6632-6672-495e-80e4-3ee5c1e2e0b8_terseLabel_en-US" xlink:label="lab_icui_InfusionConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Consumables [Member]</link:label>
    <link:label id="lab_icui_InfusionConsumablesMember_label_en-US" xlink:label="lab_icui_InfusionConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Consumables [Member]</link:label>
    <link:label id="lab_icui_InfusionConsumablesMember_documentation_en-US" xlink:label="lab_icui_InfusionConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Consumables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionConsumablesMember" xlink:href="icui-20211231.xsd#icui_InfusionConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InfusionConsumablesMember" xlink:to="lab_icui_InfusionConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_4fc28c5b-5937-4f1d-b6ef-b9f4fffe8c32_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_6428c2a8-2f4a-4145-ac98-bfa3ee9fbebc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_76b7a15a-fb3d-4aea-a5f2-cf2d03b8307b_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicAreasLongLivedAssetsAbstract_b328154c-82b2-4aaf-afb3-76457b333795_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicAreasLongLivedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Areas, Long-Lived Assets [Abstract]</link:label>
    <link:label id="lab_us-gaap_GeographicAreasLongLivedAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_GeographicAreasLongLivedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Areas, Long-Lived Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicAreasLongLivedAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicAreasLongLivedAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicAreasLongLivedAssetsAbstract" xlink:to="lab_us-gaap_GeographicAreasLongLivedAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_c0f40b7e-0a1e-4648-b78d-7526151b701e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_528423d7-9165-44b5-b1e1-c90b49f32ba6_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_c916374a-9c62-431c-a322-9a1ad5a1d4d3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f113c59c-cb15-4c90-9771-7f317bf3565a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_acd84814-aebd-44e1-b5d3-2a2da7a9f76b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_076bbe4c-8629-4d51-aa73-e43079c50d0b_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAbstract_cd13e5ca-c6b4-4e46-96cf-37c57dd7b874_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash [Abstract]</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAbstract_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAbstract" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_001158ca-e709-4c9d-9038-d2d13b4f9ee6_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_7ccd3ebf-21d5-40ac-a746-acf3e5ebd347_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_8d8011af-2cc0-4a61-9aab-bf88b9bdefc8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_d244527c-8ae2-4124-91a4-9a71bedf3a39_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_45e8e973-aa35-49f2-933e-d97fd4c8ebad_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_76882f17-efb2-4d8a-a49c-9f7aaf129ccb_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payments to be Received</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payments to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d3ea19bf-5e1d-4a46-9383-3e7d8365a49d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_8c8bee34-317b-4c9d-8730-e211415c0493_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsTotalMember_84bfe82a-22ee-4e9b-ab73-5be9a15cc7e2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsTotalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Total</link:label>
    <link:label id="lab_us-gaap_AssetsTotalMember_label_en-US" xlink:label="lab_us-gaap_AssetsTotalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Total [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsTotalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsTotalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsTotalMember" xlink:to="lab_us-gaap_AssetsTotalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Grantdatefairvalueperformancerestrictedstockunits_60920f2a-ea7c-4905-ba86-1081fb497dce_terseLabel_en-US" xlink:label="lab_icui_Grantdatefairvalueperformancerestrictedstockunits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value performance restricted stock units</link:label>
    <link:label id="lab_icui_Grantdatefairvalueperformancerestrictedstockunits_label_en-US" xlink:label="lab_icui_Grantdatefairvalueperformancerestrictedstockunits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value performance restricted stock units</link:label>
    <link:label id="lab_icui_Grantdatefairvalueperformancerestrictedstockunits_documentation_en-US" xlink:label="lab_icui_Grantdatefairvalueperformancerestrictedstockunits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value performance restricted stock units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Grantdatefairvalueperformancerestrictedstockunits" xlink:href="icui-20211231.xsd#icui_Grantdatefairvalueperformancerestrictedstockunits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Grantdatefairvalueperformancerestrictedstockunits" xlink:to="lab_icui_Grantdatefairvalueperformancerestrictedstockunits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_71c509ba-559a-40e9-b081-02a1c26b1205_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_fdd5284d-96d2-4843-9c92-dbff3416274e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_7e28252f-d57c-4086-9ea8-eb9c475481ac_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit from stock option exercises</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_14c3c85f-595e-4349-b1b2-07981ab24664_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Other Adjustments, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_24ebe99a-4997-4425-b64c-76d3afd437d9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments, Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments, Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:to="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_3751a0bd-a885-4e7e-882a-a105ef019be6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_93a86f17-9170-4b5b-9a9c-19ef446ab21c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_377b10a9-604c-403b-ba53-0d3ba1258aa3_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range, Exercisable Options, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_84f775fa-2154-4311-97ff-395aab362df9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_5a619eee-54c4-4e3a-9899-9b907b70c161_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury stock,treasury stock acquired in lieu of cash payment on stock option exercises and income tax withholding obligations</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_33252c3e-d963-4eb4-b72d-649dd1c7203a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING EXPENSES:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_17f12a61-bea5-46e8-922b-4c382a95b56e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_908a8f1b-0877-42ce-bae7-4836b916d2bc_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_114cc7f5-5b31-42b7-b507-58be10a6b79b_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_49a530f2-1b27-4064-b33f-ee163c2fcd94_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LongtermInvestmentsDomain_261b0a7d-e168-4007-abb0-3a0fa0208360_terseLabel_en-US" xlink:label="lab_icui_LongtermInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments [Domain]</link:label>
    <link:label id="lab_icui_LongtermInvestmentsDomain_label_en-US" xlink:label="lab_icui_LongtermInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments [Domain]</link:label>
    <link:label id="lab_icui_LongtermInvestmentsDomain_documentation_en-US" xlink:label="lab_icui_LongtermInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongtermInvestmentsDomain" xlink:href="icui-20211231.xsd#icui_LongtermInvestmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LongtermInvestmentsDomain" xlink:to="lab_icui_LongtermInvestmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_6063bb02-10d8-4f57-8886-d4be04717ee2_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c318ba74-cf82-4906-bf3d-43fc23b74c65_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8143f79e-9e32-4e90-9307-2a433e529fb8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_98578d1b-86f6-4173-9c24-06954848aca4_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_ecbedccb-1a1d-4cdc-aad2-174b1363fee5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, authorized shares</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_OtherforeigncountriesMember_f96d2143-02ff-4f19-a6bb-aa85c874febc_terseLabel_en-US" xlink:label="lab_icui_OtherforeigncountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign countries [Member]</link:label>
    <link:label id="lab_icui_OtherforeigncountriesMember_label_en-US" xlink:label="lab_icui_OtherforeigncountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign countries [Member]</link:label>
    <link:label id="lab_icui_OtherforeigncountriesMember_documentation_en-US" xlink:label="lab_icui_OtherforeigncountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherforeigncountriesMember" xlink:href="icui-20211231.xsd#icui_OtherforeigncountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_OtherforeigncountriesMember" xlink:to="lab_icui_OtherforeigncountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_11424410-0200-4a49-bb57-4af0a153ac5c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_f18aeaac-970a-43f0-a72d-57ed7dd5d216_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_UpFrontMaintenanceFee_932dcf41-2e5e-4459-a13a-a66620ea4eba_terseLabel_en-US" xlink:label="lab_icui_UpFrontMaintenanceFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Up front maintenance fee</link:label>
    <link:label id="lab_icui_UpFrontMaintenanceFee_label_en-US" xlink:label="lab_icui_UpFrontMaintenanceFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Up front maintenance fee</link:label>
    <link:label id="lab_icui_UpFrontMaintenanceFee_documentation_en-US" xlink:label="lab_icui_UpFrontMaintenanceFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Up front maintenance fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_UpFrontMaintenanceFee" xlink:href="icui-20211231.xsd#icui_UpFrontMaintenanceFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_UpFrontMaintenanceFee" xlink:to="lab_icui_UpFrontMaintenanceFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_82c79868-6ce9-4b00-accd-01336a54116e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_62f2c519-edee-4484-9bdd-1ae42501ed5d_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_99f146a5-87d8-49dc-8f97-818d759725ab_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_ef3f6f4d-beff-4f35-a2b2-7d56342e7965_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_8ae735bc-8214-4621-bc39-8b2976c73da5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_a50f2bab-aa58-4fd4-b620-289100a194f1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_afb894a5-d29c-4723-a09e-bb7dd2477caa_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_e85413ce-e210-4089-a2d2-c8baa995dc33_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_14faa8fd-3d67-4817-94f2-9d09c0a50be9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Spread_87f325a5-1687-47d6-abbc-2ed1c23c2249_terseLabel_en-US" xlink:label="lab_icui_Spread" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">spread</link:label>
    <link:label id="lab_icui_Spread_label_en-US" xlink:label="lab_icui_Spread" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">spread</link:label>
    <link:label id="lab_icui_Spread_documentation_en-US" xlink:label="lab_icui_Spread" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">spread</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Spread" xlink:href="icui-20211231.xsd#icui_Spread"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Spread" xlink:to="lab_icui_Spread" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent_53b17e17-1223-4ffc-94c9-4eb4babdcef9_terseLabel_en-US" xlink:label="lab_icui_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Contingent Consideration, Percent</link:label>
    <link:label id="lab_icui_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent_label_en-US" xlink:label="lab_icui_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Contingent Consideration, Percent</link:label>
    <link:label id="lab_icui_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent_documentation_en-US" xlink:label="lab_icui_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Contingent Consideration, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" xlink:href="icui-20211231.xsd#icui_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" xlink:to="lab_icui_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_fd630ba6-9950-49c7-a472-85209d078b3a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_593d4aaf-ae5c-4289-9ed8-813868657539_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_5e80ad9d-634a-48a2-a595-c95e07776be6_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER INCOME,NET</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_fad8571d-755d-42c0-962c-6e2c0a0033ac_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_1354051f-7374-476a-8ed4-675ca4f23bf5_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_fbd8bf86-9da7-4725-a4f9-6f5d9ea613cb_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_6665eca1-d6ef-4fd0-b74e-0d31f2ae0720_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4d72ba3a-cc45-4264-a3dc-0020b96b8d06_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_c284c90a-3a58-491a-b907-c0ff0db4fa04_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_389ea97c-ad09-4fe5-85e6-ab0bbd14d29a_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositAssets_ab071f9a-483a-4ae6-99b9-e7670518a313_terseLabel_en-US" xlink:label="lab_us-gaap_DepositAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposit Assets</link:label>
    <link:label id="lab_us-gaap_DepositAssets_label_en-US" xlink:label="lab_us-gaap_DepositAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposit Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositAssets" xlink:to="lab_us-gaap_DepositAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_812092c9-84ad-48b0-a9ac-644c270df3b8_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_c9877269-9d26-4cde-836b-7f39a3354753_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_PerformanceSharesEarned_cda7c424-6bc3-41e7-ad61-49a195f4da70_terseLabel_en-US" xlink:label="lab_icui_PerformanceSharesEarned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares Earned</link:label>
    <link:label id="lab_icui_PerformanceSharesEarned_label_en-US" xlink:label="lab_icui_PerformanceSharesEarned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares Earned</link:label>
    <link:label id="lab_icui_PerformanceSharesEarned_documentation_en-US" xlink:label="lab_icui_PerformanceSharesEarned" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares Earned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PerformanceSharesEarned" xlink:href="icui-20211231.xsd#icui_PerformanceSharesEarned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_PerformanceSharesEarned" xlink:to="lab_icui_PerformanceSharesEarned" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Hedge3MemberMember_73ef389f-7f73-427e-8360-90c3cf628634_terseLabel_en-US" xlink:label="lab_icui_Hedge3MemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 3 [Member] [Member]</link:label>
    <link:label id="lab_icui_Hedge3MemberMember_label_en-US" xlink:label="lab_icui_Hedge3MemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 3 [Member] [Member]</link:label>
    <link:label id="lab_icui_Hedge3MemberMember_documentation_en-US" xlink:label="lab_icui_Hedge3MemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge3MemberMember" xlink:href="icui-20211231.xsd#icui_Hedge3MemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Hedge3MemberMember" xlink:to="lab_icui_Hedge3MemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_6bcef837-bbd6-4b90-aa3f-410edeebd251_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_64c07b58-b653-41fa-9def-9c23d1d2aeb2_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_37f2dda6-79b6-4fe6-b0db-a177bc5306d2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_6c4570fa-1b5f-4c36-be0c-9b1839d1cc71_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_d00f35ae-b4dc-4911-92ef-89d215f42166_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_2fbdcd82-775e-4856-acb3-88aba2a8350a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_a9f0e5cb-f63f-4510-b64e-eef958e2f17a_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_DerivativeInterestRateFloor_a1883f29-f0ba-4626-b5a3-c3346cf0eed9_terseLabel_en-US" xlink:label="lab_icui_DerivativeInterestRateFloor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Interest Rate Floor</link:label>
    <link:label id="lab_icui_DerivativeInterestRateFloor_label_en-US" xlink:label="lab_icui_DerivativeInterestRateFloor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Interest Rate Floor</link:label>
    <link:label id="lab_icui_DerivativeInterestRateFloor_documentation_en-US" xlink:label="lab_icui_DerivativeInterestRateFloor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Interest Rate Floor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DerivativeInterestRateFloor" xlink:href="icui-20211231.xsd#icui_DerivativeInterestRateFloor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_DerivativeInterestRateFloor" xlink:to="lab_icui_DerivativeInterestRateFloor" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ef0dee9c-941e-4f75-aa00-a8bffe36bdbf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateTerms_a0108c3c-6cb7-4093-bb0d-c996338deb43_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate Terms</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateTerms_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateTerms" xlink:to="lab_us-gaap_DebtInstrumentInterestRateTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_e0510d22-aa71-4d81-9d9d-103a9386fa00_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_9d0b0877-7627-46f2-b35f-f5ecd9544a3a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f3b66aee-79bd-4c82-a9ec-04b5d144367e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_b89eaa69-83f0-4ea9-9698-71b453acab6c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SupplementalBalanceSheetInformationLeasesTableTextBlock_e4964ca3-8b17-40b0-a5d9-89c8dd708f1e_terseLabel_en-US" xlink:label="lab_icui_SupplementalBalanceSheetInformationLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information Leases</link:label>
    <link:label id="lab_icui_SupplementalBalanceSheetInformationLeasesTableTextBlock_label_en-US" xlink:label="lab_icui_SupplementalBalanceSheetInformationLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information Leases [Table Text Block]</link:label>
    <link:label id="lab_icui_SupplementalBalanceSheetInformationLeasesTableTextBlock_documentation_en-US" xlink:label="lab_icui_SupplementalBalanceSheetInformationLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SupplementalBalanceSheetInformationLeasesTableTextBlock" xlink:href="icui-20211231.xsd#icui_SupplementalBalanceSheetInformationLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SupplementalBalanceSheetInformationLeasesTableTextBlock" xlink:to="lab_icui_SupplementalBalanceSheetInformationLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_e93a58f9-895c-4e55-b5eb-e61f88f2c190_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorTable_d044685d-a249-413a-bf0c-ed4d99fcc3eb_terseLabel_en-US" xlink:label="lab_dei_AuditorTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor [Table]</link:label>
    <link:label id="lab_dei_AuditorTable_label_en-US" xlink:label="lab_dei_AuditorTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorTable" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorTable" xlink:to="lab_dei_AuditorTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_db03a84f-579c-4e13-b161-c31ebf592d07_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_c07dfa70-509a-4578-86c9-345481d226fc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Contractsettlements_b546da74-a2e4-439c-b149-44f0618420f0_terseLabel_en-US" xlink:label="lab_icui_Contractsettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractsettlements</link:label>
    <link:label id="lab_icui_Contractsettlements_label_en-US" xlink:label="lab_icui_Contractsettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractsettlements</link:label>
    <link:label id="lab_icui_Contractsettlements_documentation_en-US" xlink:label="lab_icui_Contractsettlements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractsettlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contractsettlements" xlink:href="icui-20211231.xsd#icui_Contractsettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Contractsettlements" xlink:to="lab_icui_Contractsettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_5cd21a2f-b2d9-478f-a15d-5f72917c2eb3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingImprovementsMember_1a938f92-8516-4758-8783-a10e77ce38e3_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building Improvements [Member]</link:label>
    <link:label id="lab_us-gaap_BuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_7db39015-df5b-4ce8-8961-45a113014aac_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_a3a76100-8cfe-493a-b67f-951a08ef7c07_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_c38f5b96-dc5f-4e4f-b72e-b604739bd7f1_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_328a2683-93b5-4423-89b8-bdf45ed614ae_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyAbstract_88f31ddb-aa86-4ffb-83a0-fb8ec0dc88de_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency [Abstract]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyAbstract_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyAbstract" xlink:to="lab_us-gaap_ForeignCurrencyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_acf565e9-d530-4158-9255-405abd05e051_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_PricingLevelIVMemberMember_3a485f76-a326-43f0-a86b-e97666247b99_terseLabel_en-US" xlink:label="lab_icui_PricingLevelIVMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV [Member] [Member]</link:label>
    <link:label id="lab_icui_PricingLevelIVMemberMember_label_en-US" xlink:label="lab_icui_PricingLevelIVMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV [Member] [Member]</link:label>
    <link:label id="lab_icui_PricingLevelIVMemberMember_documentation_en-US" xlink:label="lab_icui_PricingLevelIVMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIVMemberMember" xlink:href="icui-20211231.xsd#icui_PricingLevelIVMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_PricingLevelIVMemberMember" xlink:to="lab_icui_PricingLevelIVMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_8869419c-639b-46ba-9e87-31ce82414f79_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_c5741d4b-a621-419a-8a7d-4aeb599300ab_terseLabel_en-US" xlink:label="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes, including excess tax benefits and deferred income taxes</link:label>
    <link:label id="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_label_en-US" xlink:label="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease in income taxes, including excess tax benefits and deferred income taxes</link:label>
    <link:label id="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_documentation_en-US" xlink:label="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net change during the reporting period in the carrying amount as of the balance sheet date of payments made for taxes. Also includes the net change during the reporting period in the account that represents the temporary difference that results from income (loss) that is recognized for accounting purposes but not for tax purposes and vice versa.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:href="icui-20211231.xsd#icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:to="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_f9353bf1-682e-4a82-8781-0fc4e3ef6901_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_c08f2e44-7697-4faf-936b-d9e6a40f4ee1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LineOfCreditSpread_5ea17b3e-b3e6-45ed-9a5f-96277e90bbb2_terseLabel_en-US" xlink:label="lab_icui_LineOfCreditSpread" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">line of credit spread</link:label>
    <link:label id="lab_icui_LineOfCreditSpread_label_en-US" xlink:label="lab_icui_LineOfCreditSpread" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">line of credit spread</link:label>
    <link:label id="lab_icui_LineOfCreditSpread_documentation_en-US" xlink:label="lab_icui_LineOfCreditSpread" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">line of credit spread</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LineOfCreditSpread" xlink:href="icui-20211231.xsd#icui_LineOfCreditSpread"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LineOfCreditSpread" xlink:to="lab_icui_LineOfCreditSpread" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6c9c6ebc-64b7-4e16-993f-a1fd607b2bf1_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_eacc6aa7-a948-4548-8ba5-b0ec6091612c_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND CASH EQUIVALENTS, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3a81742f-beaf-49bd-a26a-26c57fd6d51c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND CASH EQUIVALENTS, end of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ModifiedPRSUIncrementalExpense_fb4d814a-81a2-4ca3-9f25-317bcacdc2ab_terseLabel_en-US" xlink:label="lab_icui_ModifiedPRSUIncrementalExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Modified PRSU Incremental Expense</link:label>
    <link:label id="lab_icui_ModifiedPRSUIncrementalExpense_label_en-US" xlink:label="lab_icui_ModifiedPRSUIncrementalExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Modified PRSU Incremental Expense</link:label>
    <link:label id="lab_icui_ModifiedPRSUIncrementalExpense_documentation_en-US" xlink:label="lab_icui_ModifiedPRSUIncrementalExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Modified PRSU Incremental Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ModifiedPRSUIncrementalExpense" xlink:href="icui-20211231.xsd#icui_ModifiedPRSUIncrementalExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ModifiedPRSUIncrementalExpense" xlink:to="lab_icui_ModifiedPRSUIncrementalExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_f20327c3-677d-4108-8a55-182b1883d642_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_a49ff6cb-2a84-4d04-9c7a-a1d7162bbe95_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_ee27309f-4c08-4bd3-847a-5e82b11f18c7_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_80d1713c-7b1b-4fff-822b-a7f95d9fbe4c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_22fae6b1-1be9-4fd7-97c3-17ef3bc392a1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the year for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_ddfb1883-8dc6-4b82-9e35-e6e9d62478a8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4855b1d7-42b4-42ef-adce-3521ee6f2294_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_IVSolutionsMember_3d3bb47e-054d-4e1c-8ce2-8e4986304f4b_terseLabel_en-US" xlink:label="lab_icui_IVSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IV Solutions [Member]</link:label>
    <link:label id="lab_icui_IVSolutionsMember_label_en-US" xlink:label="lab_icui_IVSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IV Solutions [Member]</link:label>
    <link:label id="lab_icui_IVSolutionsMember_documentation_en-US" xlink:label="lab_icui_IVSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IV Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IVSolutionsMember" xlink:href="icui-20211231.xsd#icui_IVSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_IVSolutionsMember" xlink:to="lab_icui_IVSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Noncurrentdeferredtaxasset_a5cebd84-c823-4be4-a320-1be865f37ddf_terseLabel_en-US" xlink:label="lab_icui_Noncurrentdeferredtaxasset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current deferred tax asset</link:label>
    <link:label id="lab_icui_Noncurrentdeferredtaxasset_label_en-US" xlink:label="lab_icui_Noncurrentdeferredtaxasset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current deferred tax asset</link:label>
    <link:label id="lab_icui_Noncurrentdeferredtaxasset_documentation_en-US" xlink:label="lab_icui_Noncurrentdeferredtaxasset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current deferred tax asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Noncurrentdeferredtaxasset" xlink:href="icui-20211231.xsd#icui_Noncurrentdeferredtaxasset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Noncurrentdeferredtaxasset" xlink:to="lab_icui_Noncurrentdeferredtaxasset" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_PursuitVascularInc.Member_c08c1584-d10c-42ad-8264-41263e82e383_terseLabel_en-US" xlink:label="lab_icui_PursuitVascularInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pursuit Vascular, Inc. [Member]</link:label>
    <link:label id="lab_icui_PursuitVascularInc.Member_label_en-US" xlink:label="lab_icui_PursuitVascularInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pursuit Vascular, Inc. [Member]</link:label>
    <link:label id="lab_icui_PursuitVascularInc.Member_documentation_en-US" xlink:label="lab_icui_PursuitVascularInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pursuit Vascular, Inc. [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member" xlink:href="icui-20211231.xsd#icui_PursuitVascularInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_PursuitVascularInc.Member" xlink:to="lab_icui_PursuitVascularInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_bddd984a-e144-4550-be99-9d50a39cce53_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_83db3a8c-945c-4762-99dc-d1693379448b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_b37c7208-5c61-4d3d-812b-5ccd4bc176cf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Outstanding, Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_7a3c13d6-4ba1-4fc2-ad51-09f7c78514bd_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_COntractLiabilityRollforwardRollForward_c66f5c88-ff2b-4b1d-8769-9cc16ac94c86_terseLabel_en-US" xlink:label="lab_icui_COntractLiabilityRollforwardRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COntract Liability Rollforward [Roll Forward]</link:label>
    <link:label id="lab_icui_COntractLiabilityRollforwardRollForward_label_en-US" xlink:label="lab_icui_COntractLiabilityRollforwardRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COntract Liability Rollforward [Roll Forward]</link:label>
    <link:label id="lab_icui_COntractLiabilityRollforwardRollForward_documentation_en-US" xlink:label="lab_icui_COntractLiabilityRollforwardRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COntract Liability Rollforward [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_COntractLiabilityRollforwardRollForward" xlink:href="icui-20211231.xsd#icui_COntractLiabilityRollforwardRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_COntractLiabilityRollforwardRollForward" xlink:to="lab_icui_COntractLiabilityRollforwardRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_PursuitVascularLLCMember_c722545c-d3cf-466e-b393-7f7bb98ba758_terseLabel_en-US" xlink:label="lab_icui_PursuitVascularLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pursuit Vascular LLC</link:label>
    <link:label id="lab_icui_PursuitVascularLLCMember_label_en-US" xlink:label="lab_icui_PursuitVascularLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pursuit Vascular LLC [Member]</link:label>
    <link:label id="lab_icui_PursuitVascularLLCMember_documentation_en-US" xlink:label="lab_icui_PursuitVascularLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pursuit Vascular LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularLLCMember" xlink:href="icui-20211231.xsd#icui_PursuitVascularLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_PursuitVascularLLCMember" xlink:to="lab_icui_PursuitVascularLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_05866a17-df2d-49d9-be49-240f0adeaab4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_b00e642b-aef5-4157-b5f6-b4166d3cea37_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_0ff27757-12c5-4494-946e-20bf64a05aff_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Optiontoextendinyears_d4e21e73-98e2-4082-bca7-4bbae67147b7_terseLabel_en-US" xlink:label="lab_icui_Optiontoextendinyears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optiontoextendinyears</link:label>
    <link:label id="lab_icui_Optiontoextendinyears_label_en-US" xlink:label="lab_icui_Optiontoextendinyears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optiontoextendinyears</link:label>
    <link:label id="lab_icui_Optiontoextendinyears_documentation_en-US" xlink:label="lab_icui_Optiontoextendinyears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optiontoextendinyears</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Optiontoextendinyears" xlink:href="icui-20211231.xsd#icui_Optiontoextendinyears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Optiontoextendinyears" xlink:to="lab_icui_Optiontoextendinyears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2e00c2ce-d1de-4ed9-b941-eccae4192191_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_47343e71-eb51-45bf-bd1e-4455b011ad64_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_a35598f2-b4f8-41d6-9a52-b45231911b3e_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_81137077-1acb-45dd-89d7-f48405baca21_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_094abadf-f84f-40dc-9bdf-a9b4d03d98b4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_074b8e88-f432-4326-821d-a242a36477a9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_PricingLevelIMember_db395230-a49c-48dd-9793-b97460ba136a_terseLabel_en-US" xlink:label="lab_icui_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I [Member]</link:label>
    <link:label id="lab_icui_PricingLevelIMember_label_en-US" xlink:label="lab_icui_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I [Member]</link:label>
    <link:label id="lab_icui_PricingLevelIMember_documentation_en-US" xlink:label="lab_icui_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIMember" xlink:href="icui-20211231.xsd#icui_PricingLevelIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_PricingLevelIMember" xlink:to="lab_icui_PricingLevelIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_066f32af-45f6-4930-8979-09a16c63a06d_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_818cd42f-29e6-45a3-89b3-90927a2c82e4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_a38daa37-bc9c-4f34-b322-8d8e537697e0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_7bd25555-f284-42e4-b3af-1e7dcc4ba1d6_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4c7f8c33-055e-46d2-833a-5090feb8d671_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-Free Interest Rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_e41163b8-1154-4cfa-b312-c425d943ec6d_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SharesAvailableInEmployeeStockPurchasePlan_89aabd6f-8784-4490-8abd-74e564e6b28e_terseLabel_en-US" xlink:label="lab_icui_SharesAvailableInEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available in employee stock purchase plan</link:label>
    <link:label id="lab_icui_SharesAvailableInEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_icui_SharesAvailableInEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available in employee stock purchase plan</link:label>
    <link:label id="lab_icui_SharesAvailableInEmployeeStockPurchasePlan_documentation_en-US" xlink:label="lab_icui_SharesAvailableInEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available in employee stock purchase plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SharesAvailableInEmployeeStockPurchasePlan" xlink:href="icui-20211231.xsd#icui_SharesAvailableInEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SharesAvailableInEmployeeStockPurchasePlan" xlink:to="lab_icui_SharesAvailableInEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TimebasedstockoptionMember_6e6873ee-48b3-4663-adda-682560f680c7_terseLabel_en-US" xlink:label="lab_icui_TimebasedstockoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-based stock option [Member]</link:label>
    <link:label id="lab_icui_TimebasedstockoptionMember_label_en-US" xlink:label="lab_icui_TimebasedstockoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-based stock option [Member]</link:label>
    <link:label id="lab_icui_TimebasedstockoptionMember_documentation_en-US" xlink:label="lab_icui_TimebasedstockoptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-based stock option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimebasedstockoptionMember" xlink:href="icui-20211231.xsd#icui_TimebasedstockoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TimebasedstockoptionMember" xlink:to="lab_icui_TimebasedstockoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_ea82442a-e838-48a9-ad9c-a86b8f007ad5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_f4298bf5-a674-4eb7-8472-a0096e8de645_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_IndirectTaxBenefitFromStockOptions_88184807-e421-4ab8-b5da-b4e9d02fd000_terseLabel_en-US" xlink:label="lab_icui_IndirectTaxBenefitFromStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indirect tax benefit</link:label>
    <link:label id="lab_icui_IndirectTaxBenefitFromStockOptions_label_en-US" xlink:label="lab_icui_IndirectTaxBenefitFromStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indirect tax benefit from stock options</link:label>
    <link:label id="lab_icui_IndirectTaxBenefitFromStockOptions_documentation_en-US" xlink:label="lab_icui_IndirectTaxBenefitFromStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indirect tax benefit from the stock compensation cost received upon the exercise of stock options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IndirectTaxBenefitFromStockOptions" xlink:href="icui-20211231.xsd#icui_IndirectTaxBenefitFromStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_IndirectTaxBenefitFromStockOptions" xlink:to="lab_icui_IndirectTaxBenefitFromStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_063ab065-b96a-4a97-8069-585aa238028b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a9ed3b9b-7b9b-439c-a034-0f00093b4c25_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c77a8d21-e90a-45de-be28-e05c471544a0_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_daa8463a-8754-4c77-aea9-e27c404da389_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_dbe4bd38-f68e-483d-a10c-f1638a511920_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_682b5dae-57a6-4a72-80ff-7ccaff96bbe7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_6713fbae-cd7f-4a63-beba-24ae3dfd80d1_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_0147ce32-fe7e-49da-ac06-018242f289e9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ShareawarddataAbstract_365e8dcd-96c1-4106-9308-fc97844c7a32_terseLabel_en-US" xlink:label="lab_icui_ShareawarddataAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share award data [Abstract]</link:label>
    <link:label id="lab_icui_ShareawarddataAbstract_label_en-US" xlink:label="lab_icui_ShareawarddataAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share award data [Abstract]</link:label>
    <link:label id="lab_icui_ShareawarddataAbstract_documentation_en-US" xlink:label="lab_icui_ShareawarddataAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share award data [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShareawarddataAbstract" xlink:href="icui-20211231.xsd#icui_ShareawarddataAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ShareawarddataAbstract" xlink:to="lab_icui_ShareawarddataAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_fa28cdeb-1fba-44d9-9892-f0482f87bdb9_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_88e94556-22b9-4ce2-a0cd-1a43ffab4e01_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_eca47ed9-6856-4561-9b0f-61b70ab5d99d_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_614a7289-e68e-46f9-89a4-ad4e0ed91457_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_9c6e38ba-969b-48b5-9009-fab1bfeb9238_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_5a4da50b-aa16-4649-899b-2030a214a8ff_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_23a8f70d-fd4d-4d57-940b-1e0119c5520c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_feb5983e-60dd-4a71-8134-0bf6d7617062_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_7183c7c1-64ce-401b-9b14-2fa865d64607_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Year Five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_ea1bb301-e7e1-48f1-8a61-d957dec4b43e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_7db12e99-bb3e-488b-8a54-f9fbdd9e7d95_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InterestMarginandCommitmentFeeTableTextBlock_de96da6c-afd6-4fc7-98ec-44905685c994_terseLabel_en-US" xlink:label="lab_icui_InterestMarginandCommitmentFeeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Margin and Commitment Fee [Table Text Block]</link:label>
    <link:label id="lab_icui_InterestMarginandCommitmentFeeTableTextBlock_label_en-US" xlink:label="lab_icui_InterestMarginandCommitmentFeeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Margin and Commitment Fee [Table Text Block]</link:label>
    <link:label id="lab_icui_InterestMarginandCommitmentFeeTableTextBlock_documentation_en-US" xlink:label="lab_icui_InterestMarginandCommitmentFeeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Margin and Commitment Fee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestMarginandCommitmentFeeTableTextBlock" xlink:href="icui-20211231.xsd#icui_InterestMarginandCommitmentFeeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InterestMarginandCommitmentFeeTableTextBlock" xlink:to="lab_icui_InterestMarginandCommitmentFeeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanAPaymentYear5_d340ce79-ff12-473a-ad3e-497355b7eee7_terseLabel_en-US" xlink:label="lab_icui_TermLoanAPaymentYear5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A Payment Year 5</link:label>
    <link:label id="lab_icui_TermLoanAPaymentYear5_label_en-US" xlink:label="lab_icui_TermLoanAPaymentYear5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A Payment Year 5</link:label>
    <link:label id="lab_icui_TermLoanAPaymentYear5_documentation_en-US" xlink:label="lab_icui_TermLoanAPaymentYear5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A Payment Year 5</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAPaymentYear5" xlink:href="icui-20211231.xsd#icui_TermLoanAPaymentYear5"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanAPaymentYear5" xlink:to="lab_icui_TermLoanAPaymentYear5" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_18435938-e45f-413c-b212-499fe3f8320d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, par value</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_08d81840-0646-4679-9201-935659d9f93c_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_be0a4a8d-d30c-49b1-9e1d-e6d3b2443d6b_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_1c161b1d-2dd8-4789-8120-24eba73f62cd_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ESPPAnnualIssuanceIncreaseLimit_e5c551fd-db8d-48ec-b571-7ba88e269881_terseLabel_en-US" xlink:label="lab_icui_ESPPAnnualIssuanceIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Annual Issuance Increase Limit</link:label>
    <link:label id="lab_icui_ESPPAnnualIssuanceIncreaseLimit_label_en-US" xlink:label="lab_icui_ESPPAnnualIssuanceIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Annual Issuance Increase Limit</link:label>
    <link:label id="lab_icui_ESPPAnnualIssuanceIncreaseLimit_documentation_en-US" xlink:label="lab_icui_ESPPAnnualIssuanceIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Annual Issuance Increase Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ESPPAnnualIssuanceIncreaseLimit" xlink:href="icui-20211231.xsd#icui_ESPPAnnualIssuanceIncreaseLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ESPPAnnualIssuanceIncreaseLimit" xlink:to="lab_icui_ESPPAnnualIssuanceIncreaseLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_b3efe6c3-9b90-4051-bd7f-419a4bef0c24_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_376c9268-9655-4095-a3d3-d131352bb423_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eb772015-a980-4321-9a41-5144d331503c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_eb0c0bf8-2b93-47fd-b9e5-6a97ba4b1393_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_14808946-5578-42d1-a1f1-c6dfb133ad11_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_571c8182-6b26-4ef3-ad53-3374b5abb605_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a1b63b9c-ab60-4400-9dbe-a5771464db58_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0c51e350-69bc-4873-9289-bbcebb2443e8_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_69bb91cc-cda1-46b6-925e-f3be64d62491_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_1331e851-05fd-454e-a238-b66023e4f6da_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditCurrent" xlink:to="lab_us-gaap_LinesOfCreditCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_651e848d-cf3a-4c74-af9a-c884f6b67222_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ba6b9745-69a5-4a1b-b6e7-2a2f43667194_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c2c7654d-909b-4318-96a5-bacd62116a93_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2878ea84-7f70-4b4f-8a7d-f729766e0ecf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_0623af1d-d46c-48b6-8677-319bbcd8d49f_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_OperatinglosscarryforwardsAbstract_5b9c766c-e49e-469f-a044-c9a30b97e61b_terseLabel_en-US" xlink:label="lab_icui_OperatinglosscarryforwardsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards [Abstract]</link:label>
    <link:label id="lab_icui_OperatinglosscarryforwardsAbstract_label_en-US" xlink:label="lab_icui_OperatinglosscarryforwardsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards [Abstract]</link:label>
    <link:label id="lab_icui_OperatinglosscarryforwardsAbstract_documentation_en-US" xlink:label="lab_icui_OperatinglosscarryforwardsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OperatinglosscarryforwardsAbstract" xlink:href="icui-20211231.xsd#icui_OperatinglosscarryforwardsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_OperatinglosscarryforwardsAbstract" xlink:to="lab_icui_OperatinglosscarryforwardsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_4e9a76ea-76a1-431f-ab70-cf7db3f0f92b_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_32225c72-ae3c-4a6f-9859-210e99292c79_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_bfb02248-26e0-490d-adca-04b44f8f0bc9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_0d1f9ad1-17f0-42d6-b613-21f6c45087fa_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_0af4257c-1953-4a80-897d-d29b12def145_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_PricingLevelIIIMemberMember_81efc322-4543-4a49-ada7-c58e871f14bb_terseLabel_en-US" xlink:label="lab_icui_PricingLevelIIIMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III [Member] [Member]</link:label>
    <link:label id="lab_icui_PricingLevelIIIMemberMember_label_en-US" xlink:label="lab_icui_PricingLevelIIIMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III [Member] [Member]</link:label>
    <link:label id="lab_icui_PricingLevelIIIMemberMember_documentation_en-US" xlink:label="lab_icui_PricingLevelIIIMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIIIMemberMember" xlink:href="icui-20211231.xsd#icui_PricingLevelIIIMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_PricingLevelIIIMemberMember" xlink:to="lab_icui_PricingLevelIIIMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Liabilitiesforcontracts_f3f51c5b-a018-4a64-b0d8-294cc83ee9bb_terseLabel_en-US" xlink:label="lab_icui_Liabilitiesforcontracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_icui_Liabilitiesforcontracts_label_en-US" xlink:label="lab_icui_Liabilitiesforcontracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities for contracts</link:label>
    <link:label id="lab_icui_Liabilitiesforcontracts_documentation_en-US" xlink:label="lab_icui_Liabilitiesforcontracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities for contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Liabilitiesforcontracts" xlink:href="icui-20211231.xsd#icui_Liabilitiesforcontracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Liabilitiesforcontracts" xlink:to="lab_icui_Liabilitiesforcontracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_3d6e6fe7-70cf-4b7c-9377-e5ed6ffbcde5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_2c45b3c2-f4cf-4edb-b9a6-b703818a4426_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:to="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb49f4ef-dfd6-4a36-9e55-277a62cee305_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_a318b4c1-96ab-499c-a9dd-d0de69722d05_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_eedab830-3c84-4d17-8370-5acbb6bf5d88_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_a1ce60aa-29c3-45e5-9afe-908c57f1c633_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_f2fc5bf0-c7bd-4c3c-9ed3-3dc3f1fa8f08_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_e44ff35f-199c-457a-8d04-409ce3ccdb30_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_ca3fb035-e356-4532-a1e1-80a3065b9eaa_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:to="lab_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsAndOtherAssets_f6b151b0-beb7-484d-b18a-622e5b2b500e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs and Other Assets</link:label>
    <link:label id="lab_us-gaap_DeferredCostsAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_DeferredCostsAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsAndOtherAssets" xlink:to="lab_us-gaap_DeferredCostsAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_50ac1f52-e543-4f44-8bff-43e909a48830_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a09c1bbb-03ba-46b3-85db-68e3ba7a27d2_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding (basic)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_bc13ba02-06d3-4b44-b492-3bbcca292da9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationDate1_40cedba4-5046-42bd-be08-62f685b26de8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Expiration Date</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationDate1_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="lab_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_5d3719ef-9abc-4210-b38d-f9a1750160f7_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_A2011PlanMember_01cd80f1-7177-4b6a-b6a1-122e969412ac_terseLabel_en-US" xlink:label="lab_icui_A2011PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 Plan [Member]</link:label>
    <link:label id="lab_icui_A2011PlanMember_label_en-US" xlink:label="lab_icui_A2011PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 Plan [Member]</link:label>
    <link:label id="lab_icui_A2011PlanMember_documentation_en-US" xlink:label="lab_icui_A2011PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_A2011PlanMember" xlink:href="icui-20211231.xsd#icui_A2011PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_A2011PlanMember" xlink:to="lab_icui_A2011PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4e81de4e-43dd-44de-8bb0-f87fce013057_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_e280636d-d8d1-4d44-805b-f0b05be0f284_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_08255755-4d78-401b-8ec5-e54f457ed7cf_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INTANGIBLE ASSETS, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_d0fab638-37a8-46ac-8ce3-65d55c607c25_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_d72c47cc-9eb7-481c-b8a2-874b21809338_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_bf345cad-293c-404e-8b89-19c2694ed4fc_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_a1901a07-7758-42cb-b34f-2e3b4823a475_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring accrual</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent" xlink:to="lab_us-gaap_RestructuringReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_3fde47bf-0276-4f13-ac7e-6e8563e1ca14_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_a0d02d96-403f-4ce8-bd43-ff6290c14b83_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_1acf8266-d791-48bf-be56-43900adba7b4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanBApplicableMarginDomain_eb77d7df-1261-4654-815a-0a1cbe225348_terseLabel_en-US" xlink:label="lab_icui_TermLoanBApplicableMarginDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Applicable Margin [Domain]</link:label>
    <link:label id="lab_icui_TermLoanBApplicableMarginDomain_label_en-US" xlink:label="lab_icui_TermLoanBApplicableMarginDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Applicable Margin [Domain]</link:label>
    <link:label id="lab_icui_TermLoanBApplicableMarginDomain_documentation_en-US" xlink:label="lab_icui_TermLoanBApplicableMarginDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Applicable Margin [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBApplicableMarginDomain" xlink:href="icui-20211231.xsd#icui_TermLoanBApplicableMarginDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanBApplicableMarginDomain" xlink:to="lab_icui_TermLoanBApplicableMarginDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_68946b7c-226c-43a2-ab3b-250b9f3e288b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossAttributableToParent_684dad3e-8cab-4dd7-8efe-354cc37b2e36_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossAttributableToParent_6dc30006-674b-4162-a23c-03585d94ffae_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossAttributableToParent_label_en-US" xlink:label="lab_us-gaap_IncomeLossAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) Attributable to Parent, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossAttributableToParent" xlink:to="lab_us-gaap_IncomeLossAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_0af8c3c5-4759-4d13-a4fd-e279ff1e2ca0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_404c1ff7-3d66-4531-97c0-a77dcd670e80_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_682e707a-076b-4e31-a695-dd63fa6809da_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InstrumentsPlacedwithCustomersMember_34a815ea-65f6-4a15-864e-59390d39e2b4_terseLabel_en-US" xlink:label="lab_icui_InstrumentsPlacedwithCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments Placed with Customers [Member]</link:label>
    <link:label id="lab_icui_InstrumentsPlacedwithCustomersMember_label_en-US" xlink:label="lab_icui_InstrumentsPlacedwithCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments Placed with Customers [Member]</link:label>
    <link:label id="lab_icui_InstrumentsPlacedwithCustomersMember_documentation_en-US" xlink:label="lab_icui_InstrumentsPlacedwithCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments Placed with Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InstrumentsPlacedwithCustomersMember" xlink:href="icui-20211231.xsd#icui_InstrumentsPlacedwithCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InstrumentsPlacedwithCustomersMember" xlink:to="lab_icui_InstrumentsPlacedwithCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_105eca14-e696-459c-89fa-e3cd61ba02c5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f4e06ba6-afe1-4eb4-86c7-24cfaa304db4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_2e37a2ce-c1af-46a3-bf84-d47d17d820f0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Noncurrentdeferredtaxassetaccruedrestructuring_8025a572-bd18-43e8-b6d0-693e399f9a1b_terseLabel_en-US" xlink:label="lab_icui_Noncurrentdeferredtaxassetaccruedrestructuring" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrentdeferredtaxassetaccruedrestructuring</link:label>
    <link:label id="lab_icui_Noncurrentdeferredtaxassetaccruedrestructuring_label_en-US" xlink:label="lab_icui_Noncurrentdeferredtaxassetaccruedrestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrentdeferredtaxassetaccruedrestructuring</link:label>
    <link:label id="lab_icui_Noncurrentdeferredtaxassetaccruedrestructuring_documentation_en-US" xlink:label="lab_icui_Noncurrentdeferredtaxassetaccruedrestructuring" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrentdeferredtaxassetaccruedrestructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Noncurrentdeferredtaxassetaccruedrestructuring" xlink:href="icui-20211231.xsd#icui_Noncurrentdeferredtaxassetaccruedrestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Noncurrentdeferredtaxassetaccruedrestructuring" xlink:to="lab_icui_Noncurrentdeferredtaxassetaccruedrestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_971c9bdc-b88c-489d-ad55-0a2a28c10238_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ForeignInfusionSystemSupplierMember_e2804bd2-40d8-4e46-b088-be0c303508dc_terseLabel_en-US" xlink:label="lab_icui_ForeignInfusionSystemSupplierMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Infusion System Supplier</link:label>
    <link:label id="lab_icui_ForeignInfusionSystemSupplierMember_label_en-US" xlink:label="lab_icui_ForeignInfusionSystemSupplierMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Infusion System Supplier [Member]</link:label>
    <link:label id="lab_icui_ForeignInfusionSystemSupplierMember_documentation_en-US" xlink:label="lab_icui_ForeignInfusionSystemSupplierMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Infusion System Supplier</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember" xlink:href="icui-20211231.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ForeignInfusionSystemSupplierMember" xlink:to="lab_icui_ForeignInfusionSystemSupplierMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_fda69ed1-ae6b-4b79-ba3f-1cbb28059ed6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_7acd12a8-58f6-46f7-918d-3cdaf6ae5cfb_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_76b49eca-90c5-44de-90df-da4f1e97d8ec_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_0d4466d7-ebf1-4f2f-bf19-3dbd7ab2ebf5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAssumed1" xlink:to="lab_us-gaap_LiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_17db0d8f-c4ea-4825-832e-c1c4267feb83_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods Sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_9f135054-0158-455d-9198-bccb4ef40b54_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent_f7015f4b-bc44-4dfa-9ace-74e353d20a9d_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranties and returns</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:to="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_5f3c87a7-c141-4577-adb0-534bc28b4397_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, $1.00 par value Authorized-500 shares; Issued and outstanding - none</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:to="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_15239f5b-8316-4373-b230-b3ea970c79d0_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_EquipmentrevenueMember_14c85e3b-505d-4fc9-9186-dd1d47a99607_terseLabel_en-US" xlink:label="lab_icui_EquipmentrevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment revenue [Member]</link:label>
    <link:label id="lab_icui_EquipmentrevenueMember_label_en-US" xlink:label="lab_icui_EquipmentrevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment revenue [Member]</link:label>
    <link:label id="lab_icui_EquipmentrevenueMember_documentation_en-US" xlink:label="lab_icui_EquipmentrevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EquipmentrevenueMember" xlink:href="icui-20211231.xsd#icui_EquipmentrevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_EquipmentrevenueMember" xlink:to="lab_icui_EquipmentrevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4dd16f9b-9b64-4bea-8551-dc8e6e54d16b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME PER SHARE</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_8dd2ad5a-48e5-45b8-ba1a-33a3b9def61b_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_50db66e3-a516-47ec-b365-96a329fabcf9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c2f4838b-5523-4fe8-85d3-b69356d8d4c3_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_a084a89d-bd0c-4cb8-b43f-af83ab05cdfc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_0fde401f-9f76-4b4d-aa34-ddcbc93d8978_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Prepaid Expense, Current</link:label>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:to="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ComputerEquipmentAndSoftwareMember_c781edcb-e9be-4869-974c-89bebd2e3d6a_terseLabel_en-US" xlink:label="lab_icui_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Software [Member]</link:label>
    <link:label id="lab_icui_ComputerEquipmentAndSoftwareMember_label_en-US" xlink:label="lab_icui_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Software [Member]</link:label>
    <link:label id="lab_icui_ComputerEquipmentAndSoftwareMember_documentation_en-US" xlink:label="lab_icui_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ComputerEquipmentAndSoftwareMember" xlink:href="icui-20211231.xsd#icui_ComputerEquipmentAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ComputerEquipmentAndSoftwareMember" xlink:to="lab_icui_ComputerEquipmentAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_c827ae40-680f-41a9-840b-4a0d97219b0b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_c4f08697-f618-46d8-bc25-0d8bd7c41cea_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_02f1016f-dda3-49fc-aaad-e344aafc3f33_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_9e41a99d-dfd6-45e0-be96-c2ecc63f9d06_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:to="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_6deb0af0-82cf-4a43-9d2c-7840e375fbf9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_4b0d54d4-97f8-4161-b33a-4b04d5af0368_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_112a6ab6-9aa7-4bf0-a2e7-b7571668953a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_019593aa-1a1a-4f6a-9ebd-bb34deee2b3b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis_5e486b5d-57c1-470c-9964-49751853b190_terseLabel_en-US" xlink:label="lab_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A and Credit Line Applicable Margin Spread [Axis]</link:label>
    <link:label id="lab_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis_label_en-US" xlink:label="lab_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A and Credit Line Applicable Margin Spread [Axis]</link:label>
    <link:label id="lab_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis_documentation_en-US" xlink:label="lab_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A and Credit Line Applicable Margin Spread</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis" xlink:href="icui-20211231.xsd#icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis" xlink:to="lab_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantyReservesMember_2e53b9f0-abd8-4cf9-8195-1dae488cf746_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantyReservesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Reserve, Warranty</link:label>
    <link:label id="lab_us-gaap_WarrantyReservesMember_label_en-US" xlink:label="lab_us-gaap_WarrantyReservesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Reserve, Warranty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantyReservesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantyReservesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantyReservesMember" xlink:to="lab_us-gaap_WarrantyReservesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFinancialInstrumentsAssetsMember_a99b7ca8-1821-4cc2-b63b-51529e697596_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFinancialInstrumentsAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments, Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeFinancialInstrumentsAssetsMember_label_en-US" xlink:label="lab_us-gaap_DerivativeFinancialInstrumentsAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments, Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember" xlink:to="lab_us-gaap_DerivativeFinancialInstrumentsAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_a46b5854-72cf-4ffe-b135-e3345cbba010_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_b55ed3a1-a153-4fb6-842f-09f43bde3c69_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_38b25ba9-a6ec-4ec4-9a21-609950fbced8_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_5c3ff707-8485-4cdf-92ff-83effd5739f6_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_f4b65320-0dcc-4cc9-bdbf-afa76258d7c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions_918920ff-990e-47cd-9efe-f0374e9f0cc0_terseLabel_en-US" xlink:label="lab_icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions</link:label>
    <link:label id="lab_icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions_label_en-US" xlink:label="lab_icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions</link:label>
    <link:label id="lab_icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions_documentation_en-US" xlink:label="lab_icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions" xlink:href="icui-20211231.xsd#icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions" xlink:to="lab_icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_87b660dd-f518-46a9-a424-a16bfcc61a70_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_18a852f6-e487-410d-b04f-1b12b138cf22_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Estimated Useful Lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Estimated Useful Lives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InfusionSystemsMember_e576a437-3fe6-40fe-b35a-fc041c05dc3f_terseLabel_en-US" xlink:label="lab_icui_InfusionSystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Systems [Member]</link:label>
    <link:label id="lab_icui_InfusionSystemsMember_label_en-US" xlink:label="lab_icui_InfusionSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Systems [Member]</link:label>
    <link:label id="lab_icui_InfusionSystemsMember_documentation_en-US" xlink:label="lab_icui_InfusionSystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Systems [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionSystemsMember" xlink:href="icui-20211231.xsd#icui_InfusionSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InfusionSystemsMember" xlink:to="lab_icui_InfusionSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Sparepartsusage_c95a285a-035c-4683-80fc-796d05e5acc5_terseLabel_en-US" xlink:label="lab_icui_Sparepartsusage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sparepartsusage</link:label>
    <link:label id="lab_icui_Sparepartsusage_label_en-US" xlink:label="lab_icui_Sparepartsusage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sparepartsusage</link:label>
    <link:label id="lab_icui_Sparepartsusage_documentation_en-US" xlink:label="lab_icui_Sparepartsusage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sparepartsusage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Sparepartsusage" xlink:href="icui-20211231.xsd#icui_Sparepartsusage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Sparepartsusage" xlink:to="lab_icui_Sparepartsusage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_13565ae5-8c7a-49cf-838e-7b8b6993813b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Prepaidinsuranceandpropertytaxes_5c56593a-bfef-402d-93b9-778dc7a32fff_terseLabel_en-US" xlink:label="lab_icui_Prepaidinsuranceandpropertytaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid insurance and property taxes</link:label>
    <link:label id="lab_icui_Prepaidinsuranceandpropertytaxes_label_en-US" xlink:label="lab_icui_Prepaidinsuranceandpropertytaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid insurance and property taxes</link:label>
    <link:label id="lab_icui_Prepaidinsuranceandpropertytaxes_documentation_en-US" xlink:label="lab_icui_Prepaidinsuranceandpropertytaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid insurance and property taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Prepaidinsuranceandpropertytaxes" xlink:href="icui-20211231.xsd#icui_Prepaidinsuranceandpropertytaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Prepaidinsuranceandpropertytaxes" xlink:to="lab_icui_Prepaidinsuranceandpropertytaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2f5d07d0-7631-4df1-b7e0-45984540dea0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_2a63c1b9-7cd3-4b9d-92c2-a593f4a3e602_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT ASSETS:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_4857d521-822a-41f6-9607-b6ea8bf37083_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare_a8240dd9-079b-4f03-be06-d4b79748b615_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Holiday, Income Tax Benefits Per Share</link:label>
    <link:label id="lab_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare_label_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Holiday, Income Tax Benefits Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare" xlink:to="lab_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_3c4b5fec-66da-44a7-9867-9819c4f4b0a6_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2e6679a5-1740-4c5a-9725-d9959bdc1076_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock and exercise of stock options, shares issued</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8ad21d1d-5e9a-4cc9-80aa-3d634d37e95d_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_6696f9db-4093-4110-8460-53529b77048e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c7a43e77-81ab-4eeb-8cc4-f90814eb91b8_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9cbbeb85-0304-4e1d-a0a0-a4303efe5e5a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_df4527b8-07e6-4fb4-8ac4-7895a4d6e134_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENT SECURITIES</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_34ce1f17-22bb-4f26-bddd-4a546c4855e0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3f68c133-a428-4c74-a111-84520c3ebda1_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_043c22e6-1905-45a8-95b5-cccbc94e348d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions_29ab9f3e-1a3f-48a9-aaac-948473c93c00_terseLabel_en-US" xlink:label="lab_icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent deferred tax asset - acquired future tax deductions</link:label>
    <link:label id="lab_icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions_label_en-US" xlink:label="lab_icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent deferred tax asset - acquired future tax deductions</link:label>
    <link:label id="lab_icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions_documentation_en-US" xlink:label="lab_icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent deferred tax asset - acquired future tax deductions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions" xlink:href="icui-20211231.xsd#icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions" xlink:to="lab_icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsTextBlock_a160d9a3-0807-4499-a172-eccd9089f961_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Text Block]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsTextBlock" xlink:to="lab_us-gaap_OtherCurrentAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_aa06857c-ae8f-43a8-8083-e0a52f987cc2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_835a3d82-f9c4-446f-b199-e314c9e5a190_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_4229bc48-29c0-4926-acab-b172d8dcc5ca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_bec39c24-9bcf-4a32-8b69-0aa1be7d2b29_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_a9258cf5-0d1a-4b34-9798-2e5795fde2de_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_f56e246c-e9e8-4cd0-aaec-c348a52c92c3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LongTermDebtDisclosureAbstract_1f0d9925-876f-447b-9901-019af926d82f_terseLabel_en-US" xlink:label="lab_icui_LongTermDebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_icui_LongTermDebtDisclosureAbstract_label_en-US" xlink:label="lab_icui_LongTermDebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_icui_LongTermDebtDisclosureAbstract_documentation_en-US" xlink:label="lab_icui_LongTermDebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermDebtDisclosureAbstract" xlink:href="icui-20211231.xsd#icui_LongTermDebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LongTermDebtDisclosureAbstract" xlink:to="lab_icui_LongTermDebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_bc0a7542-d280-4d46-92b3-d266011cd17d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b03e1f53-c3ee-434e-b93c-331e16392e78_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_816268ed-2fac-4667-8261-600084256b25_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_1dc3d5e4-5669-436a-ab2a-2ddb62fd9094_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_UnitedStatespropertyandequipmentMember_8466accc-71f9-4c7d-8b90-142f571178bd_terseLabel_en-US" xlink:label="lab_icui_UnitedStatespropertyandequipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States property and equipment [Member]</link:label>
    <link:label id="lab_icui_UnitedStatespropertyandequipmentMember_label_en-US" xlink:label="lab_icui_UnitedStatespropertyandequipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States property and equipment [Member]</link:label>
    <link:label id="lab_icui_UnitedStatespropertyandequipmentMember_documentation_en-US" xlink:label="lab_icui_UnitedStatespropertyandequipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States property and equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_UnitedStatespropertyandequipmentMember" xlink:href="icui-20211231.xsd#icui_UnitedStatespropertyandequipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_UnitedStatespropertyandequipmentMember" xlink:to="lab_icui_UnitedStatespropertyandequipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Accruedlegalfees_eda1d4e4-701a-42ec-9fe1-95e281caae6c_terseLabel_en-US" xlink:label="lab_icui_Accruedlegalfees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal accrual</link:label>
    <link:label id="lab_icui_Accruedlegalfees_label_en-US" xlink:label="lab_icui_Accruedlegalfees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued legal fees</link:label>
    <link:label id="lab_icui_Accruedlegalfees_documentation_en-US" xlink:label="lab_icui_Accruedlegalfees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued legal fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedlegalfees" xlink:href="icui-20211231.xsd#icui_Accruedlegalfees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Accruedlegalfees" xlink:to="lab_icui_Accruedlegalfees" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanAAndCreditLineSpread_234a5adb-7dbe-4bd6-93a9-d13b7747ee04_terseLabel_en-US" xlink:label="lab_icui_TermLoanAAndCreditLineSpread" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A and Credit Line Spread</link:label>
    <link:label id="lab_icui_TermLoanAAndCreditLineSpread_label_en-US" xlink:label="lab_icui_TermLoanAAndCreditLineSpread" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A and Credit Line Spread</link:label>
    <link:label id="lab_icui_TermLoanAAndCreditLineSpread_documentation_en-US" xlink:label="lab_icui_TermLoanAAndCreditLineSpread" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A and Credit Line Spread</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAAndCreditLineSpread" xlink:href="icui-20211231.xsd#icui_TermLoanAAndCreditLineSpread"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanAAndCreditLineSpread" xlink:to="lab_icui_TermLoanAAndCreditLineSpread" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Prepaidothertaxes_506b602f-fc71-492a-a3e9-beaedd3f8f29_terseLabel_en-US" xlink:label="lab_icui_Prepaidothertaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid other taxes</link:label>
    <link:label id="lab_icui_Prepaidothertaxes_label_en-US" xlink:label="lab_icui_Prepaidothertaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid other taxes</link:label>
    <link:label id="lab_icui_Prepaidothertaxes_documentation_en-US" xlink:label="lab_icui_Prepaidothertaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid other taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Prepaidothertaxes" xlink:href="icui-20211231.xsd#icui_Prepaidothertaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Prepaidothertaxes" xlink:to="lab_icui_Prepaidothertaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_BusinessCombinationConsiderationCashHoldback_911e5667-0fea-408b-82de-20e806b83592_terseLabel_en-US" xlink:label="lab_icui_BusinessCombinationConsiderationCashHoldback" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">business combination consideration - cash holdback</link:label>
    <link:label id="lab_icui_BusinessCombinationConsiderationCashHoldback_label_en-US" xlink:label="lab_icui_BusinessCombinationConsiderationCashHoldback" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">business combination consideration - cash holdback</link:label>
    <link:label id="lab_icui_BusinessCombinationConsiderationCashHoldback_documentation_en-US" xlink:label="lab_icui_BusinessCombinationConsiderationCashHoldback" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">business combination consideration - cash holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationConsiderationCashHoldback" xlink:href="icui-20211231.xsd#icui_BusinessCombinationConsiderationCashHoldback"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_BusinessCombinationConsiderationCashHoldback" xlink:to="lab_icui_BusinessCombinationConsiderationCashHoldback" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_1ee4897c-3304-43b8-a073-b38fa4d8fd5d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_d6a6e2fa-2831-4c7e-83c4-82834819ede9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_9cbb6931-0788-4bfb-a06a-67e5f8a77de6_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_f029ace9-c667-4a5b-9f67-d509730d9c0a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SupplementalCashFlowInformationLeasesTableTextBlock_bb7bae50-ab5e-47fb-9436-ebb0d627ff38_terseLabel_en-US" xlink:label="lab_icui_SupplementalCashFlowInformationLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information Leases</link:label>
    <link:label id="lab_icui_SupplementalCashFlowInformationLeasesTableTextBlock_label_en-US" xlink:label="lab_icui_SupplementalCashFlowInformationLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information Leases [Table Text Block]</link:label>
    <link:label id="lab_icui_SupplementalCashFlowInformationLeasesTableTextBlock_documentation_en-US" xlink:label="lab_icui_SupplementalCashFlowInformationLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SupplementalCashFlowInformationLeasesTableTextBlock" xlink:href="icui-20211231.xsd#icui_SupplementalCashFlowInformationLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SupplementalCashFlowInformationLeasesTableTextBlock" xlink:to="lab_icui_SupplementalCashFlowInformationLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LesseeOperatingAndFinanceLeaseTextBlock_ac000603-9577-487d-8a89-ddd5b0d8cee2_terseLabel_en-US" xlink:label="lab_icui_LesseeOperatingAndFinanceLeaseTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease</link:label>
    <link:label id="lab_icui_LesseeOperatingAndFinanceLeaseTextBlock_label_en-US" xlink:label="lab_icui_LesseeOperatingAndFinanceLeaseTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease [Text Block]</link:label>
    <link:label id="lab_icui_LesseeOperatingAndFinanceLeaseTextBlock_documentation_en-US" xlink:label="lab_icui_LesseeOperatingAndFinanceLeaseTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LesseeOperatingAndFinanceLeaseTextBlock" xlink:href="icui-20211231.xsd#icui_LesseeOperatingAndFinanceLeaseTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LesseeOperatingAndFinanceLeaseTextBlock" xlink:to="lab_icui_LesseeOperatingAndFinanceLeaseTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_b5b79f0a-40c4-47c8-95aa-ad213131bed6_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits</link:label>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_8f858b98-ccd5-4ae8-8216-0cd10bcf1f2a_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_88a4ff9b-39e1-42af-8b42-b96bf44916e2_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Accruedsalestaxes_d0043c3c-3b64-436c-9086-d43b9eb6be5c_terseLabel_en-US" xlink:label="lab_icui_Accruedsalestaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued sales taxes</link:label>
    <link:label id="lab_icui_Accruedsalestaxes_label_en-US" xlink:label="lab_icui_Accruedsalestaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued sales taxes</link:label>
    <link:label id="lab_icui_Accruedsalestaxes_documentation_en-US" xlink:label="lab_icui_Accruedsalestaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued sales taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedsalestaxes" xlink:href="icui-20211231.xsd#icui_Accruedsalestaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Accruedsalestaxes" xlink:to="lab_icui_Accruedsalestaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_7fa97282-5ec4-400f-85a2-20ad898d0c4d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation, Income Tax Expense (Benefit), at Federal Statutory Income Tax Rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_WarrantyAndReturnReserveInventory_11bd439f-eb26-453d-aa6e-7562c3e72ded_terseLabel_en-US" xlink:label="lab_icui_WarrantyAndReturnReserveInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty and return reserve - inventory</link:label>
    <link:label id="lab_icui_WarrantyAndReturnReserveInventory_label_en-US" xlink:label="lab_icui_WarrantyAndReturnReserveInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty and return reserve - inventory</link:label>
    <link:label id="lab_icui_WarrantyAndReturnReserveInventory_documentation_en-US" xlink:label="lab_icui_WarrantyAndReturnReserveInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty and return reserve - inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_WarrantyAndReturnReserveInventory" xlink:href="icui-20211231.xsd#icui_WarrantyAndReturnReserveInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_WarrantyAndReturnReserveInventory" xlink:to="lab_icui_WarrantyAndReturnReserveInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_8665f8bb-68e2-4395-9dbe-c9a704965c4c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at Beginning&#160;of Period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_0c229ace-73df-42b7-be80-42bf0408a932_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at&#160;End of&#160;Period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_73cae5dd-395b-45f6-b448-8e36e471536f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_f4a35e90-6800-4be8-84fc-b854a9976dbf_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_6ac6d666-8bad-45d3-a5d2-34ddf400b062_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock_31b2c190-9329-4ff7-a5b7-c62706c3e1d9_terseLabel_en-US" xlink:label="lab_icui_ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of stock compensation and related tax benefits [Table Text Block]</link:label>
    <link:label id="lab_icui_ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock_label_en-US" xlink:label="lab_icui_ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of stock compensation and related tax benefits [Table Text Block]</link:label>
    <link:label id="lab_icui_ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock_documentation_en-US" xlink:label="lab_icui_ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of stock compensation and related tax benefits [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock" xlink:href="icui-20211231.xsd#icui_ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock" xlink:to="lab_icui_ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_5f685348-1936-4fa4-adac-71ee5476ad0e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_8aad443d-1ed8-401a-b41e-dec5535e3c31_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment_25ee78d4-4bf1-4e04-b9cb-02bc5a0b9aee_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Other Property, Plant, and Equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Other Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_0f009703-1739-442f-a3a0-be01d33de83b_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueAdditions_ccd17234-fa6b-4b18-a967-1d9999cbee28_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Additions</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueAdditions_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueAdditions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueAdditions" xlink:to="lab_us-gaap_DeferredRevenueAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7d0f5ca1-926e-4915-8915-202c60eadfe9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>icui-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:79121b2d-e854-41aa-aab3-7b5c5847e030,g:aa7e8fee-abd8-4fff-b3c4-f8ba25538e22-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.icumed.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="icui-20211231.xsd#DocumentandEntityInformationDocument"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DocumentandEntityInformationDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_a904ff49-2ee3-4623-b40e-113447ae8570" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_DocumentType_a904ff49-2ee3-4623-b40e-113447ae8570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_0a7d4506-d00e-482f-a2e9-fb44d707fbed" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_DocumentAnnualReport_0a7d4506-d00e-482f-a2e9-fb44d707fbed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_3e353c59-c6c4-420c-aa4b-5f1eb7c47980" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_DocumentPeriodEndDate_3e353c59-c6c4-420c-aa4b-5f1eb7c47980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_d1bca985-251e-42f8-836b-145256b070ae" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_DocumentTransitionReport_d1bca985-251e-42f8-836b-145256b070ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_83440047-f5a3-440a-93c6-45d0d66f4541" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_EntityFileNumber_83440047-f5a3-440a-93c6-45d0d66f4541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_054f5df7-238a-44c6-a89f-b048d5bd5162" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_EntityRegistrantName_054f5df7-238a-44c6-a89f-b048d5bd5162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_dae4aff9-e67c-4725-9fcf-c1e3a7efe6f5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_EntityCentralIndexKey_dae4aff9-e67c-4725-9fcf-c1e3a7efe6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_917c0b9f-8756-4a1b-9bb7-778fbbde5d52" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_CurrentFiscalYearEndDate_917c0b9f-8756-4a1b-9bb7-778fbbde5d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_201da00e-a238-4f68-bd1f-04c2dcbd5b6f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_DocumentFiscalYearFocus_201da00e-a238-4f68-bd1f-04c2dcbd5b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_15a3dc24-14d0-41ce-9519-d690143bc186" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_15a3dc24-14d0-41ce-9519-d690143bc186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_2a5a879a-1e28-41f5-be64-859b53700991" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_AmendmentFlag_2a5a879a-1e28-41f5-be64-859b53700991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_be485dcb-b2e4-476b-82d7-0875ebc54cd2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_be485dcb-b2e4-476b-82d7-0875ebc54cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_50f245ad-fa73-403e-9110-67c63c2508db" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_EntityTaxIdentificationNumber_50f245ad-fa73-403e-9110-67c63c2508db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7ea43782-b804-428d-9607-5791fbfa27de" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_EntityAddressAddressLine1_7ea43782-b804-428d-9607-5791fbfa27de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2e39eabf-2cf3-4076-a3d8-e4ff59f56cf1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_EntityAddressCityOrTown_2e39eabf-2cf3-4076-a3d8-e4ff59f56cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_8edfeb2c-a87a-41ca-8c39-9903ffd56096" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_EntityAddressStateOrProvince_8edfeb2c-a87a-41ca-8c39-9903ffd56096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_8aba0481-556a-4548-ad66-7feea8eb8c48" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_EntityAddressPostalZipCode_8aba0481-556a-4548-ad66-7feea8eb8c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_464806c0-b270-42c1-b18b-5edf1859bb6e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_CityAreaCode_464806c0-b270-42c1-b18b-5edf1859bb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_e21fac38-1323-4003-9ed9-e441acd2945b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_LocalPhoneNumber_e21fac38-1323-4003-9ed9-e441acd2945b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_52c812a5-80bc-44b3-a311-6eeb8f3125d4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_Security12bTitle_52c812a5-80bc-44b3-a311-6eeb8f3125d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_dd60cec3-d8ed-43f4-a293-7c45957817a6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_TradingSymbol_dd60cec3-d8ed-43f4-a293-7c45957817a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_84bd88c8-a0c2-49be-b8d8-15af43cab32e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_SecurityExchangeName_84bd88c8-a0c2-49be-b8d8-15af43cab32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_1a3ca06d-832d-4aa5-a988-9b44c55ecbd3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_1a3ca06d-832d-4aa5-a988-9b44c55ecbd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_02002f52-4139-408a-8f7f-650ceb1dc155" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_EntityVoluntaryFilers_02002f52-4139-408a-8f7f-650ceb1dc155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_546e081e-69c7-41be-9135-3326dd3ee4f0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_EntityCurrentReportingStatus_546e081e-69c7-41be-9135-3326dd3ee4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_fc17ad30-84d8-440a-819a-85053e6b2309" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_EntityInteractiveDataCurrent_fc17ad30-84d8-440a-819a-85053e6b2309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_fe09085a-5a01-4b98-8fe9-136436fbf63f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_EntityFilerCategory_fe09085a-5a01-4b98-8fe9-136436fbf63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_bcfda914-961a-4552-b748-c9aafee372ba" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_EntitySmallBusiness_bcfda914-961a-4552-b748-c9aafee372ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d0f2a519-1801-438b-8d55-64286f7fbef3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_EntityEmergingGrowthCompany_d0f2a519-1801-438b-8d55-64286f7fbef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_09d5c919-dded-432e-9824-7b8a670a37a4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_IcfrAuditorAttestationFlag_09d5c919-dded-432e-9824-7b8a670a37a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_362eb78c-607a-46b1-8fe5-bfbc8997977f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_EntityShellCompany_362eb78c-607a-46b1-8fe5-bfbc8997977f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_513fae61-8cc6-4958-8bd4-53d4ff1a0070" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_EntityPublicFloat_513fae61-8cc6-4958-8bd4-53d4ff1a0070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_52299960-55af-4b63-90bc-7b7d6c172a81" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_52299960-55af-4b63-90bc-7b7d6c172a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_42425cb9-ec88-4714-9476-ee1bd9eb0d65" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_50c48129-b245-4404-85a4-30879f71488e" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_42425cb9-ec88-4714-9476-ee1bd9eb0d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AuditInformation" xlink:type="simple" xlink:href="icui-20211231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorTable_470b6a4c-0e56-497d-944d-85f18d275025" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorTable"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_7dee6a5c-fe5a-449c-aa27-a4c7e108d3a6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AuditorTable_470b6a4c-0e56-497d-944d-85f18d275025" xlink:to="loc_dei_LegalEntityAxis_7dee6a5c-fe5a-449c-aa27-a4c7e108d3a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f0afa126-6f6b-4ca9-a9cf-020711f649e7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_7dee6a5c-fe5a-449c-aa27-a4c7e108d3a6" xlink:to="loc_dei_EntityDomain_f0afa126-6f6b-4ca9-a9cf-020711f649e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLineItems_81a8c8fa-3747-4e21-bd78-7bea4c442447" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AuditorTable_470b6a4c-0e56-497d-944d-85f18d275025" xlink:to="loc_dei_AuditorLineItems_81a8c8fa-3747-4e21-bd78-7bea4c442447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_4b0fdbe3-360e-4d75-b76d-a89bf6b7613e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AuditorLineItems_81a8c8fa-3747-4e21-bd78-7bea4c442447" xlink:to="loc_dei_AuditorName_4b0fdbe3-360e-4d75-b76d-a89bf6b7613e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_510f5205-b47c-4c99-9b81-135cac9dd792" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AuditorLineItems_81a8c8fa-3747-4e21-bd78-7bea4c442447" xlink:to="loc_dei_AuditorLocation_510f5205-b47c-4c99-9b81-135cac9dd792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_56ade0b7-f3f9-4ad3-9aa8-1d12df4ff6f3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AuditorLineItems_81a8c8fa-3747-4e21-bd78-7bea4c442447" xlink:to="loc_dei_AuditorFirmId_56ade0b7-f3f9-4ad3-9aa8-1d12df4ff6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="icui-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_dc98cb53-1567-49a2-a397-2b54b6938f19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_815ba3f3-a9f2-4dc9-a758-c534636204a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc98cb53-1567-49a2-a397-2b54b6938f19" xlink:to="loc_us-gaap_StatementTable_815ba3f3-a9f2-4dc9-a758-c534636204a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_481d5305-d5f7-477d-bb68-baba7be3f41c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_815ba3f3-a9f2-4dc9-a758-c534636204a0" xlink:to="loc_srt_StatementScenarioAxis_481d5305-d5f7-477d-bb68-baba7be3f41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_52c6160d-f1a3-4a77-821c-a9fde3482144" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_481d5305-d5f7-477d-bb68-baba7be3f41c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_52c6160d-f1a3-4a77-821c-a9fde3482144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_15267072-2051-4318-8eab-eaaa4b65ddd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_815ba3f3-a9f2-4dc9-a758-c534636204a0" xlink:to="loc_us-gaap_StatementLineItems_15267072-2051-4318-8eab-eaaa4b65ddd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15267072-2051-4318-8eab-eaaa4b65ddd2" xlink:to="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_dfdce09e-b84a-45cb-94e8-a10f913ad8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:to="loc_us-gaap_AssetsCurrentAbstract_dfdce09e-b84a-45cb-94e8-a10f913ad8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e84c95fc-7ad0-4c29-a1f8-4965b697e73b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dfdce09e-b84a-45cb-94e8-a10f913ad8b4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e84c95fc-7ad0-4c29-a1f8-4965b697e73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_1108b5c2-257e-4ad7-898f-03d8c2af5887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dfdce09e-b84a-45cb-94e8-a10f913ad8b4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_1108b5c2-257e-4ad7-898f-03d8c2af5887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_0ffd47d9-a084-493b-89c2-9a418d7c5ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dfdce09e-b84a-45cb-94e8-a10f913ad8b4" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_0ffd47d9-a084-493b-89c2-9a418d7c5ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f56c79c3-c9ab-461a-af6e-3f2a56cc44b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dfdce09e-b84a-45cb-94e8-a10f913ad8b4" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f56c79c3-c9ab-461a-af6e-3f2a56cc44b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_67201777-b74f-4e52-b056-f86f669f6c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dfdce09e-b84a-45cb-94e8-a10f913ad8b4" xlink:to="loc_us-gaap_InventoryNet_67201777-b74f-4e52-b056-f86f669f6c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_77df12b3-ecd6-43ee-84c6-84512cab146a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dfdce09e-b84a-45cb-94e8-a10f913ad8b4" xlink:to="loc_us-gaap_PrepaidTaxes_77df12b3-ecd6-43ee-84c6-84512cab146a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_889a4ae1-b6b5-4ba9-9ef2-8164ad76a0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dfdce09e-b84a-45cb-94e8-a10f913ad8b4" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_889a4ae1-b6b5-4ba9-9ef2-8164ad76a0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9636c861-29d7-4d00-ba07-5f70f3dd40dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dfdce09e-b84a-45cb-94e8-a10f913ad8b4" xlink:to="loc_us-gaap_AssetsCurrent_9636c861-29d7-4d00-ba07-5f70f3dd40dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a8733971-c243-486f-9d50-f1cdc11f144f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a8733971-c243-486f-9d50-f1cdc11f144f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_eaff121e-1d78-49af-9ac2-b0ba58d5eab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_eaff121e-1d78-49af-9ac2-b0ba58d5eab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_f9970f7d-7842-4af3-8bd3-2bddceba6d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_f9970f7d-7842-4af3-8bd3-2bddceba6d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b03445a5-365b-4d21-83f5-894557e871b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:to="loc_us-gaap_Goodwill_b03445a5-365b-4d21-83f5-894557e871b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_29701989-1728-4bbe-aedc-0856a4607bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_29701989-1728-4bbe-aedc-0856a4607bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_510d6626-30b3-4ce9-af52-5fe43b8cb414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_510d6626-30b3-4ce9-af52-5fe43b8cb414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b86ce56a-a2cd-4586-bb19-53faf2b15cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b86ce56a-a2cd-4586-bb19-53faf2b15cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_bf9f80e3-7fa5-41a2-9b7a-cc1457c1def3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dedd0ab8-b22d-4e69-b6fb-068c36e6893f" xlink:to="loc_us-gaap_Assets_bf9f80e3-7fa5-41a2-9b7a-cc1457c1def3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a597816f-4a22-41ea-a7ba-45a2b8286807" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15267072-2051-4318-8eab-eaaa4b65ddd2" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a597816f-4a22-41ea-a7ba-45a2b8286807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_2702a891-0e11-4370-9b5e-24cee3edb01e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a597816f-4a22-41ea-a7ba-45a2b8286807" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_2702a891-0e11-4370-9b5e-24cee3edb01e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a4a5e46f-ea2a-4493-8db3-4ec6f2fde6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2702a891-0e11-4370-9b5e-24cee3edb01e" xlink:to="loc_us-gaap_AccountsPayableCurrent_a4a5e46f-ea2a-4493-8db3-4ec6f2fde6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_de33b207-53b2-4a23-bf6e-83e4f060c7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2702a891-0e11-4370-9b5e-24cee3edb01e" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_de33b207-53b2-4a23-bf6e-83e4f060c7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_3b5452f2-448a-4d1b-b9bd-f202ee09fd49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2702a891-0e11-4370-9b5e-24cee3edb01e" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_3b5452f2-448a-4d1b-b9bd-f202ee09fd49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_366f0699-6e3c-42e2-a742-f36422a27d72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2702a891-0e11-4370-9b5e-24cee3edb01e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_366f0699-6e3c-42e2-a742-f36422a27d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_37b8f6b0-6c04-4e6a-aae8-8a6118e5e02e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2702a891-0e11-4370-9b5e-24cee3edb01e" xlink:to="loc_us-gaap_LiabilitiesCurrent_37b8f6b0-6c04-4e6a-aae8-8a6118e5e02e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_ed369667-9db0-4b58-b35d-1379a0201ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a597816f-4a22-41ea-a7ba-45a2b8286807" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_ed369667-9db0-4b58-b35d-1379a0201ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_ac3e98a8-a51a-46a2-b8e0-56bea59f5f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a597816f-4a22-41ea-a7ba-45a2b8286807" xlink:to="loc_us-gaap_OtherLiabilities_ac3e98a8-a51a-46a2-b8e0-56bea59f5f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e47d39a4-789e-4389-bc2c-e51d6d3b56f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a597816f-4a22-41ea-a7ba-45a2b8286807" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e47d39a4-789e-4389-bc2c-e51d6d3b56f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_5b1ad894-0242-410a-9038-82c6d8bdf690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a597816f-4a22-41ea-a7ba-45a2b8286807" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_5b1ad894-0242-410a-9038-82c6d8bdf690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_92eaba50-a570-4c5d-a236-645ed88a7e70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a597816f-4a22-41ea-a7ba-45a2b8286807" xlink:to="loc_us-gaap_CommitmentsAndContingencies_92eaba50-a570-4c5d-a236-645ed88a7e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_aa019921-0952-4c17-bfe7-85dba7ea4b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a597816f-4a22-41ea-a7ba-45a2b8286807" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_aa019921-0952-4c17-bfe7-85dba7ea4b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_a2ecd64a-7451-416d-ad0c-a0745e458e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_aa019921-0952-4c17-bfe7-85dba7ea4b3b" xlink:to="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_a2ecd64a-7451-416d-ad0c-a0745e458e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3c90e86a-d931-4c79-967c-794243445186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_aa019921-0952-4c17-bfe7-85dba7ea4b3b" xlink:to="loc_us-gaap_CommonStockValue_3c90e86a-d931-4c79-967c-794243445186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1966b99a-c569-42b1-89f8-fd5f015089c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_aa019921-0952-4c17-bfe7-85dba7ea4b3b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1966b99a-c569-42b1-89f8-fd5f015089c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_79ea34e6-ed9f-4fac-afea-2d93f4765e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_aa019921-0952-4c17-bfe7-85dba7ea4b3b" xlink:to="loc_us-gaap_TreasuryStockValue_79ea34e6-ed9f-4fac-afea-2d93f4765e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3d0c3a30-fa3e-4007-b3ec-e802f7aa5a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_aa019921-0952-4c17-bfe7-85dba7ea4b3b" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3d0c3a30-fa3e-4007-b3ec-e802f7aa5a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3db2ae83-3655-4ac4-925e-55153fdd3182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_aa019921-0952-4c17-bfe7-85dba7ea4b3b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3db2ae83-3655-4ac4-925e-55153fdd3182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4f8f4883-308c-414d-b95d-8ac92fc1c786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_aa019921-0952-4c17-bfe7-85dba7ea4b3b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4f8f4883-308c-414d-b95d-8ac92fc1c786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_063264ba-8a9e-4098-bd3c-ae018987c338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a597816f-4a22-41ea-a7ba-45a2b8286807" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_063264ba-8a9e-4098-bd3c-ae018987c338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="icui-20211231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_4e3d0e74-25b1-4822-943b-ed8e7b175cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_2d0c33ac-b1dc-4efd-a2bd-488d445e25b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4e3d0e74-25b1-4822-943b-ed8e7b175cb5" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_2d0c33ac-b1dc-4efd-a2bd-488d445e25b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_176b2696-b3e6-43f3-8a0d-227d15761bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4e3d0e74-25b1-4822-943b-ed8e7b175cb5" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_176b2696-b3e6-43f3-8a0d-227d15761bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_7e985747-e1d3-47b1-a61e-ca382694f38d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4e3d0e74-25b1-4822-943b-ed8e7b175cb5" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_7e985747-e1d3-47b1-a61e-ca382694f38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_62976017-9af8-4fe0-a11c-6a16291ec205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4e3d0e74-25b1-4822-943b-ed8e7b175cb5" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_62976017-9af8-4fe0-a11c-6a16291ec205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_0bf4aac7-0328-40c6-9c4b-f5b0f3e6da34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4e3d0e74-25b1-4822-943b-ed8e7b175cb5" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_0bf4aac7-0328-40c6-9c4b-f5b0f3e6da34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_ed431748-4cf6-44c1-9d91-9a87977911ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4e3d0e74-25b1-4822-943b-ed8e7b175cb5" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_ed431748-4cf6-44c1-9d91-9a87977911ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_b47be1ff-5438-4289-b097-b7400edb7e86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4e3d0e74-25b1-4822-943b-ed8e7b175cb5" xlink:to="loc_us-gaap_CommonStockSharesIssued_b47be1ff-5438-4289-b097-b7400edb7e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_768aab7e-7646-46ad-b801-5a671ed59d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4e3d0e74-25b1-4822-943b-ed8e7b175cb5" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_768aab7e-7646-46ad-b801-5a671ed59d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_e529e5b7-a610-482f-9c62-10edbb2f1284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4e3d0e74-25b1-4822-943b-ed8e7b175cb5" xlink:to="loc_us-gaap_TreasuryStockShares_e529e5b7-a610-482f-9c62-10edbb2f1284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="icui-20211231.xsd#ConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_1541a67e-a3a1-4bfc-abad-6d75aa542085" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ca6c9532-38ca-45fa-8032-32ec45bdb0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1541a67e-a3a1-4bfc-abad-6d75aa542085" xlink:to="loc_us-gaap_StatementTable_ca6c9532-38ca-45fa-8032-32ec45bdb0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9ce8dd5e-82ec-4104-8973-a7afa8944a01" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ca6c9532-38ca-45fa-8032-32ec45bdb0b1" xlink:to="loc_srt_ProductOrServiceAxis_9ce8dd5e-82ec-4104-8973-a7afa8944a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b34cf841-81ac-4565-ae1e-3594d074b45b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_9ce8dd5e-82ec-4104-8973-a7afa8944a01" xlink:to="loc_srt_ProductsAndServicesDomain_b34cf841-81ac-4565-ae1e-3594d074b45b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ca6c9532-38ca-45fa-8032-32ec45bdb0b1" xlink:to="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_35d7a73e-c5cc-4e6f-bad5-fefd35f06ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_RevenuesAbstract_35d7a73e-c5cc-4e6f-bad5-fefd35f06ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0cdb274b-be8c-48c3-b7fa-8c3a9b018638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_35d7a73e-c5cc-4e6f-bad5-fefd35f06ef1" xlink:to="loc_us-gaap_Revenues_0cdb274b-be8c-48c3-b7fa-8c3a9b018638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4583ce40-b9df-4fdb-8356-2f3794ff8796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4583ce40-b9df-4fdb-8356-2f3794ff8796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a9137ded-e180-45c3-8581-5fb6cb60ee9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_GrossProfit_a9137ded-e180-45c3-8581-5fb6cb60ee9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_fe01fc27-0c06-48bc-a937-85a805f0e221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_OperatingExpensesAbstract_fe01fc27-0c06-48bc-a937-85a805f0e221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8dd99195-2f38-4fe6-8300-174516682659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fe01fc27-0c06-48bc-a937-85a805f0e221" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8dd99195-2f38-4fe6-8300-174516682659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_822428bc-0b39-4355-8eb5-bfb17175960d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fe01fc27-0c06-48bc-a937-85a805f0e221" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_822428bc-0b39-4355-8eb5-bfb17175960d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringandstrategictransactionexpense_c67f2b6e-0bba-488d-82e0-9946594cd7ee" xlink:href="icui-20211231.xsd#icui_Restructuringandstrategictransactionexpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fe01fc27-0c06-48bc-a937-85a805f0e221" xlink:to="loc_icui_Restructuringandstrategictransactionexpense_c67f2b6e-0bba-488d-82e0-9946594cd7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_fca80432-afcb-42a0-85d4-411fdbb0cdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fe01fc27-0c06-48bc-a937-85a805f0e221" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_fca80432-afcb-42a0-85d4-411fdbb0cdfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contractsettlements_aa9b22ff-b2f1-4c04-ac01-294ca582e5f8" xlink:href="icui-20211231.xsd#icui_Contractsettlements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fe01fc27-0c06-48bc-a937-85a805f0e221" xlink:to="loc_icui_Contractsettlements_aa9b22ff-b2f1-4c04-ac01-294ca582e5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6cdd707c-cf28-4cab-99c0-1aaeaea0d66a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fe01fc27-0c06-48bc-a937-85a805f0e221" xlink:to="loc_us-gaap_OperatingExpenses_6cdd707c-cf28-4cab-99c0-1aaeaea0d66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_59d6e0ac-4d73-467f-8b68-5fb54028d1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_OperatingIncomeLoss_59d6e0ac-4d73-467f-8b68-5fb54028d1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_4fb2a991-b917-4405-93c9-bbcbbb3b0be4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_InterestExpense_4fb2a991-b917-4405-93c9-bbcbbb3b0be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b6229e52-c4f3-40ed-bca0-7e4bc7ef0dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_b6229e52-c4f3-40ed-bca0-7e4bc7ef0dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_0b73c418-a252-473b-ad87-c144637f7938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_0b73c418-a252-473b-ad87-c144637f7938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9ffd0ca5-0df9-44bd-90ca-b57d507ec433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9ffd0ca5-0df9-44bd-90ca-b57d507ec433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6d033949-2f91-42d2-88d0-0fd765f5205c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_NetIncomeLoss_6d033949-2f91-42d2-88d0-0fd765f5205c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d88b9ca7-1252-4f1d-90cb-75f05c863877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_EarningsPerShareBasic_d88b9ca7-1252-4f1d-90cb-75f05c863877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_312c682e-c532-42b3-a9d5-d0099feb2127" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_EarningsPerShareDiluted_312c682e-c532-42b3-a9d5-d0099feb2127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ce2d1e10-5a04-4981-a057-f9ede068f28f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55711c27-926d-44ba-b79c-97a835974afe" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ce2d1e10-5a04-4981-a057-f9ede068f28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f7766a8a-9de6-4212-b04a-4cda3e8240db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ce2d1e10-5a04-4981-a057-f9ede068f28f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f7766a8a-9de6-4212-b04a-4cda3e8240db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_852ca4b6-e342-4d6c-86a7-43129639136c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ce2d1e10-5a04-4981-a057-f9ede068f28f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_852ca4b6-e342-4d6c-86a7-43129639136c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/StatementofComprehensiveIncome" xlink:type="simple" xlink:href="icui-20211231.xsd#StatementofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/StatementofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3b87abba-34c5-4cca-8a6e-41ca30599e53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d48127e5-0280-4b0f-b5d7-4838b739b40f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3b87abba-34c5-4cca-8a6e-41ca30599e53" xlink:to="loc_us-gaap_StatementTable_d48127e5-0280-4b0f-b5d7-4838b739b40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_3b531d8e-4cf5-4069-8975-1b9725f1f1ac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d48127e5-0280-4b0f-b5d7-4838b739b40f" xlink:to="loc_srt_StatementScenarioAxis_3b531d8e-4cf5-4069-8975-1b9725f1f1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_29f20c6a-0f88-465f-a9fe-60c6351aca79" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_3b531d8e-4cf5-4069-8975-1b9725f1f1ac" xlink:to="loc_srt_ScenarioUnspecifiedDomain_29f20c6a-0f88-465f-a9fe-60c6351aca79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2ac19b1d-966b-46d0-8aac-d42fc634eeb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d48127e5-0280-4b0f-b5d7-4838b739b40f" xlink:to="loc_us-gaap_StatementLineItems_2ac19b1d-966b-46d0-8aac-d42fc634eeb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c12087b1-799a-4a09-b0de-e9385ea158ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ac19b1d-966b-46d0-8aac-d42fc634eeb2" xlink:to="loc_us-gaap_NetIncomeLoss_c12087b1-799a-4a09-b0de-e9385ea158ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_abd44712-13fb-4f98-9cfd-e943fd8fe923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ac19b1d-966b-46d0-8aac-d42fc634eeb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_abd44712-13fb-4f98-9cfd-e943fd8fe923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d3e09bf7-e140-4da7-87a0-ae702b8bf84f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ac19b1d-966b-46d0-8aac-d42fc634eeb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d3e09bf7-e140-4da7-87a0-ae702b8bf84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_54b044e4-3f01-4c91-852a-4bf7f85bb050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ac19b1d-966b-46d0-8aac-d42fc634eeb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_54b044e4-3f01-4c91-852a-4bf7f85bb050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_373e8922-40eb-4bcd-8347-46a742e61852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ac19b1d-966b-46d0-8aac-d42fc634eeb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_373e8922-40eb-4bcd-8347-46a742e61852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_653521ef-edac-4867-864e-694fbc41c9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ac19b1d-966b-46d0-8aac-d42fc634eeb2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_653521ef-edac-4867-864e-694fbc41c9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/StatementofComprehensiveIncomeParenthetical" xlink:type="simple" xlink:href="icui-20211231.xsd#StatementofComprehensiveIncomeParenthetical"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/StatementofComprehensiveIncomeParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_33eec1f7-bb69-4965-a0ac-978d587fc17c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_b118e402-48f4-4389-9018-0d1b61a3c241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_33eec1f7-bb69-4965-a0ac-978d587fc17c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_b118e402-48f4-4389-9018-0d1b61a3c241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_1c84bc7d-e764-4ac0-ad49-534a89685d22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_33eec1f7-bb69-4965-a0ac-978d587fc17c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_1c84bc7d-e764-4ac0-ad49-534a89685d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_76899b21-036a-4d0d-84e8-fba70325dc69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_33eec1f7-bb69-4965-a0ac-978d587fc17c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_76899b21-036a-4d0d-84e8-fba70325dc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="icui-20211231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2e170f3a-f758-416e-8653-e22972c4620d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9cedd24a-765c-4e9f-b775-e824cd0f3182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2e170f3a-f758-416e-8653-e22972c4620d" xlink:to="loc_us-gaap_StatementTable_9cedd24a-765c-4e9f-b775-e824cd0f3182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9259a533-0559-484b-8b0a-d08bad3ecfe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9cedd24a-765c-4e9f-b775-e824cd0f3182" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9259a533-0559-484b-8b0a-d08bad3ecfe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c7f1cd4a-83e6-45bd-a8e2-7fb7391246d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9259a533-0559-484b-8b0a-d08bad3ecfe4" xlink:to="loc_us-gaap_EquityComponentDomain_c7f1cd4a-83e6-45bd-a8e2-7fb7391246d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CommonStockSharesMember_cd910e7b-15d3-44a3-84b1-7981bf8c7920" xlink:href="icui-20211231.xsd#icui_CommonStockSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c7f1cd4a-83e6-45bd-a8e2-7fb7391246d4" xlink:to="loc_icui_CommonStockSharesMember_cd910e7b-15d3-44a3-84b1-7981bf8c7920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2997ece3-dbfa-4156-b2b7-c928c2e18a72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c7f1cd4a-83e6-45bd-a8e2-7fb7391246d4" xlink:to="loc_us-gaap_CommonStockMember_2997ece3-dbfa-4156-b2b7-c928c2e18a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_c0c6501f-a40d-4414-8c05-76a5b0924b65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c7f1cd4a-83e6-45bd-a8e2-7fb7391246d4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_c0c6501f-a40d-4414-8c05-76a5b0924b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_c334cefc-9446-4c45-becf-5a9fa1e533b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c7f1cd4a-83e6-45bd-a8e2-7fb7391246d4" xlink:to="loc_us-gaap_TreasuryStockMember_c334cefc-9446-4c45-becf-5a9fa1e533b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1587ca18-3e41-493b-836e-2535b399c4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c7f1cd4a-83e6-45bd-a8e2-7fb7391246d4" xlink:to="loc_us-gaap_RetainedEarningsMember_1587ca18-3e41-493b-836e-2535b399c4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_37937f71-8773-4b6d-abb2-b8bf152eac02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c7f1cd4a-83e6-45bd-a8e2-7fb7391246d4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_37937f71-8773-4b6d-abb2-b8bf152eac02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6bbe099a-2065-460d-832c-ef43d21af34b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9cedd24a-765c-4e9f-b775-e824cd0f3182" xlink:to="loc_us-gaap_StatementLineItems_6bbe099a-2065-460d-832c-ef43d21af34b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6bbe099a-2065-460d-832c-ef43d21af34b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d2be5d13-e8ec-4368-80ea-b1261210618d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d2be5d13-e8ec-4368-80ea-b1261210618d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0709cba2-5e8c-4ef1-9ae3-d46e2fc3a635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:to="loc_us-gaap_StockholdersEquity_0709cba2-5e8c-4ef1-9ae3-d46e2fc3a635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6846bd8f-6dd7-48ad-8cb0-e088bd236ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6846bd8f-6dd7-48ad-8cb0-e088bd236ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_6500c7cf-da06-47e0-b7dc-a69074a5a174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_6500c7cf-da06-47e0-b7dc-a69074a5a174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_9229ed96-f993-484a-a90c-e537863ed7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_9229ed96-f993-484a-a90c-e537863ed7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_05486dfb-bf47-4d23-acb1-bf8aae89413c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_05486dfb-bf47-4d23-acb1-bf8aae89413c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_65bb2f85-6083-4c33-9a21-c26748a9ce0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_65bb2f85-6083-4c33-9a21-c26748a9ce0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_890056cf-5474-4e13-afb4-da7f19b51d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_890056cf-5474-4e13-afb4-da7f19b51d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b19cdaf2-8076-418b-bca2-776df9c728df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:to="loc_us-gaap_NetIncomeLoss_b19cdaf2-8076-418b-bca2-776df9c728df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cf1c2a9d-4c9b-4277-849b-e61eced54fec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:to="loc_us-gaap_StockholdersEquity_cf1c2a9d-4c9b-4277-849b-e61eced54fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a1a9f8c0-a9c5-41f7-9540-042b1c748391" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bd4d87d2-3a99-4eaf-97d0-f309b7adbd2f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a1a9f8c0-a9c5-41f7-9540-042b1c748391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="icui-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_526dfbfb-eff8-434a-86c4-a26ad54d71fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_34531e7b-49e5-43dc-9caa-ab46b2b01ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_526dfbfb-eff8-434a-86c4-a26ad54d71fe" xlink:to="loc_us-gaap_StatementTable_34531e7b-49e5-43dc-9caa-ab46b2b01ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_d99dd388-9c4b-4041-a528-79fb55852c03" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_34531e7b-49e5-43dc-9caa-ab46b2b01ebb" xlink:to="loc_srt_StatementScenarioAxis_d99dd388-9c4b-4041-a528-79fb55852c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_d7cff203-558c-466f-adcb-f5522dc6c4d6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_d99dd388-9c4b-4041-a528-79fb55852c03" xlink:to="loc_srt_ScenarioUnspecifiedDomain_d7cff203-558c-466f-adcb-f5522dc6c4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_63511aa3-6c0e-42b1-8a93-e73963d8f361" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_34531e7b-49e5-43dc-9caa-ab46b2b01ebb" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_63511aa3-6c0e-42b1-8a93-e73963d8f361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c081f08d-4b40-4bf1-819a-92269f800b81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_63511aa3-6c0e-42b1-8a93-e73963d8f361" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c081f08d-4b40-4bf1-819a-92269f800b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InternationalDistributorMember_ce5a28a1-d61d-4d11-a104-ddefb872ca35" xlink:href="icui-20211231.xsd#icui_InternationalDistributorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c081f08d-4b40-4bf1-819a-92269f800b81" xlink:to="loc_icui_InternationalDistributorMember_ce5a28a1-d61d-4d11-a104-ddefb872ca35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularLLCMember_dc613888-31cc-4624-b477-4f69ccc1e3ef" xlink:href="icui-20211231.xsd#icui_PursuitVascularLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c081f08d-4b40-4bf1-819a-92269f800b81" xlink:to="loc_icui_PursuitVascularLLCMember_dc613888-31cc-4624-b477-4f69ccc1e3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_c4e48f7c-78e2-4c02-88f3-da707157cc4b" xlink:href="icui-20211231.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c081f08d-4b40-4bf1-819a-92269f800b81" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_c4e48f7c-78e2-4c02-88f3-da707157cc4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TotalAcquisitionsMember_54ab4fbb-c472-4df7-8eaf-1317f06d70fa" xlink:href="icui-20211231.xsd#icui_TotalAcquisitionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c081f08d-4b40-4bf1-819a-92269f800b81" xlink:to="loc_icui_TotalAcquisitionsMember_54ab4fbb-c472-4df7-8eaf-1317f06d70fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5a888d6a-08d1-49fa-852c-3cb69e935ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_34531e7b-49e5-43dc-9caa-ab46b2b01ebb" xlink:to="loc_us-gaap_StatementLineItems_5a888d6a-08d1-49fa-852c-3cb69e935ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_d622effa-673e-481a-9b92-ebe88d6042e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5a888d6a-08d1-49fa-852c-3cb69e935ec0" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_d622effa-673e-481a-9b92-ebe88d6042e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_97a10eec-0aa2-4275-979e-42d6d81b797e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_d622effa-673e-481a-9b92-ebe88d6042e7" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_97a10eec-0aa2-4275-979e-42d6d81b797e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_97a10eec-0aa2-4275-979e-42d6d81b797e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_850f8e3a-c3ce-4fd8-8b48-c0e1479b8a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_NetIncomeLoss_850f8e3a-c3ce-4fd8-8b48-c0e1479b8a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_8661c320-e60f-41da-bf35-fcb7baa08ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_8661c320-e60f-41da-bf35-fcb7baa08ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Operatingleaserightofuseassetamortization_c1ae0339-5f0c-4b9f-8f09-d66ba1bc9f9a" xlink:href="icui-20211231.xsd#icui_Operatingleaserightofuseassetamortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_icui_Operatingleaserightofuseassetamortization_c1ae0339-5f0c-4b9f-8f09-d66ba1bc9f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_e6cd1e6b-f7ea-4fcf-9c39-d9a5e11ab4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_e6cd1e6b-f7ea-4fcf-9c39-d9a5e11ab4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProvisionForWarrantyAndReturns_5138c3c3-d9d6-4db4-8ee3-7da91baf6f5f" xlink:href="icui-20211231.xsd#icui_ProvisionForWarrantyAndReturns"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_icui_ProvisionForWarrantyAndReturns_5138c3c3-d9d6-4db4-8ee3-7da91baf6f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ae1472b1-096a-4138-83ed-6cd6a4776a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_ShareBasedCompensation_ae1472b1-096a-4138-83ed-6cd6a4776a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_bdd8f302-b0f1-4c38-ade9-872189784f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_bdd8f302-b0f1-4c38-ade9-872189784f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_e2eab5dd-8d87-49ab-a683-0fbaa3576c49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_e2eab5dd-8d87-49ab-a683-0fbaa3576c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_f6b50eab-060c-46c2-b162-7d90ab68ede3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_f6b50eab-060c-46c2-b162-7d90ab68ede3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b398f845-9bbd-45b7-9705-d05ee1d8b61f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b398f845-9bbd-45b7-9705-d05ee1d8b61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionRelatedImpairmentsOrCharges_4144d2b8-f83e-4cf1-b0fe-89726460f2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_ProductionRelatedImpairmentsOrCharges_4144d2b8-f83e-4cf1-b0fe-89726460f2d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Sparepartsusage_7d3df8c5-3d99-409b-b68e-e4df3232eacb" xlink:href="icui-20211231.xsd#icui_Sparepartsusage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_icui_Sparepartsusage_7d3df8c5-3d99-409b-b68e-e4df3232eacb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_a324b292-9f19-4da6-a0c8-d89f7c00c612" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_a324b292-9f19-4da6-a0c8-d89f7c00c612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5c89e122-735c-4c4e-bdc9-6c5be58cfe60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5c89e122-735c-4c4e-bdc9-6c5be58cfe60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_55b4535d-ab77-45c4-a4f6-719e48333e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_55b4535d-ab77-45c4-a4f6-719e48333e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1e6ad5d1-138c-4406-9236-f2c298119c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1e6ad5d1-138c-4406-9236-f2c298119c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e389c631-0853-49f0-98cb-3019d9511a87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e389c631-0853-49f0-98cb-3019d9511a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_bc173d4c-cdf6-4929-9119-c1c7bb0b91bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_bc173d4c-cdf6-4929-9119-c1c7bb0b91bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_d83a92e8-8c28-463c-b749-b8282d847570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_d83a92e8-8c28-463c-b749-b8282d847570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_8b6370af-b81f-42cf-961a-23dfc4ab1db5" xlink:href="icui-20211231.xsd#icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bad8afe9-a957-4c6e-a2ce-6e38b3688aa0" xlink:to="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_8b6370af-b81f-42cf-961a-23dfc4ab1db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_85ea4da9-a94d-48a0-bc36-f392b461312f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_97a10eec-0aa2-4275-979e-42d6d81b797e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_85ea4da9-a94d-48a0-bc36-f392b461312f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_92770442-25b5-4b7f-b14d-b3bb37aff145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_97a10eec-0aa2-4275-979e-42d6d81b797e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_92770442-25b5-4b7f-b14d-b3bb37aff145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e45805ea-5040-466b-937a-17f2a3de8bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_92770442-25b5-4b7f-b14d-b3bb37aff145" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e45805ea-5040-466b-937a-17f2a3de8bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment_527127d6-eb7a-4bde-9cf8-4e059c3bb8f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_92770442-25b5-4b7f-b14d-b3bb37aff145" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment_527127d6-eb7a-4bde-9cf8-4e059c3bb8f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_791a1d06-e3f4-46aa-896f-8c98498b907e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_92770442-25b5-4b7f-b14d-b3bb37aff145" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_791a1d06-e3f4-46aa-896f-8c98498b907e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_bc8399d4-f228-40a6-b2a3-c9c8bc35e358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_92770442-25b5-4b7f-b14d-b3bb37aff145" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_bc8399d4-f228-40a6-b2a3-c9c8bc35e358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_475b7e67-e4f6-4155-8714-2408e7c295bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_92770442-25b5-4b7f-b14d-b3bb37aff145" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_475b7e67-e4f6-4155-8714-2408e7c295bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_4b10d4f3-d8ff-4cda-96a0-3a464bdfc896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_92770442-25b5-4b7f-b14d-b3bb37aff145" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_4b10d4f3-d8ff-4cda-96a0-3a464bdfc896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_dc80af41-a849-48f8-ba05-fbb56c201c79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_92770442-25b5-4b7f-b14d-b3bb37aff145" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_dc80af41-a849-48f8-ba05-fbb56c201c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_281d6680-6751-485e-9fd1-bbb84ac29c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_97a10eec-0aa2-4275-979e-42d6d81b797e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_281d6680-6751-485e-9fd1-bbb84ac29c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b780457-97af-449b-bd63-4ccd0810eb5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_97a10eec-0aa2-4275-979e-42d6d81b797e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b780457-97af-449b-bd63-4ccd0810eb5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_35f4a0bd-de63-4251-89f9-6df85d6f3525" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b780457-97af-449b-bd63-4ccd0810eb5a" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_35f4a0bd-de63-4251-89f9-6df85d6f3525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_a383271a-4751-4748-b51b-45a8ff6df43a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b780457-97af-449b-bd63-4ccd0810eb5a" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_a383271a-4751-4748-b51b-45a8ff6df43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_d33c6ca2-daf7-4cce-bd33-fd7f1a13d980" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b780457-97af-449b-bd63-4ccd0810eb5a" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_d33c6ca2-daf7-4cce-bd33-fd7f1a13d980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_def8ba45-c1d0-4ddc-8bfd-7cdcc4382a45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b780457-97af-449b-bd63-4ccd0810eb5a" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_def8ba45-c1d0-4ddc-8bfd-7cdcc4382a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_855b0442-618d-482b-ad34-61e7a881dce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b780457-97af-449b-bd63-4ccd0810eb5a" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_855b0442-618d-482b-ad34-61e7a881dce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_733129f6-336c-49b7-9806-37d061048979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b780457-97af-449b-bd63-4ccd0810eb5a" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_733129f6-336c-49b7-9806-37d061048979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_721a7a2a-1ec0-40b0-8c3e-561e37787e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_97a10eec-0aa2-4275-979e-42d6d81b797e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_721a7a2a-1ec0-40b0-8c3e-561e37787e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAbstract_91c38c3c-6630-44c2-a838-0fcd64b252b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_d622effa-673e-481a-9b92-ebe88d6042e7" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAbstract_91c38c3c-6630-44c2-a838-0fcd64b252b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_6be183bd-1212-4082-ae0e-7572961ee2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAbstract_91c38c3c-6630-44c2-a838-0fcd64b252b3" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_6be183bd-1212-4082-ae0e-7572961ee2dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0a26fcf4-5a91-4987-9d23-7325e5fef86e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAbstract_91c38c3c-6630-44c2-a838-0fcd64b252b3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0a26fcf4-5a91-4987-9d23-7325e5fef86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0e59aa67-0796-4e1f-b7e5-07647e7acbfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5a888d6a-08d1-49fa-852c-3cb69e935ec0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0e59aa67-0796-4e1f-b7e5-07647e7acbfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_83909daa-9cca-4d30-9702-4a6bb44166e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5a888d6a-08d1-49fa-852c-3cb69e935ec0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_83909daa-9cca-4d30-9702-4a6bb44166e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_88687425-be68-470a-aac2-2af8c349529c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5a888d6a-08d1-49fa-852c-3cb69e935ec0" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_88687425-be68-470a-aac2-2af8c349529c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_a7de8e8b-1b29-4e01-b153-48662d66204d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_88687425-be68-470a-aac2-2af8c349529c" xlink:to="loc_us-gaap_IncomeTaxesPaid_a7de8e8b-1b29-4e01-b153-48662d66204d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_32710778-4608-4434-ac3f-0469c2cbb2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_88687425-be68-470a-aac2-2af8c349529c" xlink:to="loc_us-gaap_InterestPaidNet_32710778-4608-4434-ac3f-0469c2cbb2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f7d20094-45b9-4598-9d40-8641e0dd0282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5a888d6a-08d1-49fa-852c-3cb69e935ec0" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f7d20094-45b9-4598-9d40-8641e0dd0282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_ebf204fa-5759-4608-8d61-bece94408564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f7d20094-45b9-4598-9d40-8641e0dd0282" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_ebf204fa-5759-4608-8d61-bece94408564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_b7ecd8f5-32be-4f96-a3fc-14cde1641365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f7d20094-45b9-4598-9d40-8641e0dd0282" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_b7ecd8f5-32be-4f96-a3fc-14cde1641365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NetCashPaidReceivedforcurrentandprioracquisitions_c497f8a0-9900-4c4e-9f16-a3b45d823996" xlink:href="icui-20211231.xsd#icui_NetCashPaidReceivedforcurrentandprioracquisitions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f7d20094-45b9-4598-9d40-8641e0dd0282" xlink:to="loc_icui_NetCashPaidReceivedforcurrentandprioracquisitions_c497f8a0-9900-4c4e-9f16-a3b45d823996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_bd34d331-6628-4268-8e11-543c79ca8a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f7d20094-45b9-4598-9d40-8641e0dd0282" xlink:to="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_bd34d331-6628-4268-8e11-543c79ca8a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_d90773af-5522-4a08-b59c-b3ba76f0c7da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f7d20094-45b9-4598-9d40-8641e0dd0282" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_d90773af-5522-4a08-b59c-b3ba76f0c7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_3f5cbd41-4a70-4200-948d-e20ea9b0b520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f7d20094-45b9-4598-9d40-8641e0dd0282" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_3f5cbd41-4a70-4200-948d-e20ea9b0b520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_107fa45a-ec43-4971-843d-6dc5b7e3b03a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f7d20094-45b9-4598-9d40-8641e0dd0282" xlink:to="loc_us-gaap_LiabilitiesAssumed1_107fa45a-ec43-4971-843d-6dc5b7e3b03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c799a217-049d-4b61-80ba-e38d243c597f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_38cfc8ae-e75b-4c69-a4cb-d6ca98fa2889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c799a217-049d-4b61-80ba-e38d243c597f" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_38cfc8ae-e75b-4c69-a4cb-d6ca98fa2889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_663a0f84-9f5d-48d1-b72b-7dc5f07322ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_8ecb90e5-5853-4961-9392-922532e6e475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_663a0f84-9f5d-48d1-b72b-7dc5f07322ab" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_8ecb90e5-5853-4961-9392-922532e6e475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_fdda1d31-e251-4ef5-9b56-5c2072fdbe96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_663a0f84-9f5d-48d1-b72b-7dc5f07322ab" xlink:to="loc_us-gaap_UseOfEstimates_fdda1d31-e251-4ef5-9b56-5c2072fdbe96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_7325df73-2dfb-4e5c-ad45-d912372dd438" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_663a0f84-9f5d-48d1-b72b-7dc5f07322ab" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_7325df73-2dfb-4e5c-ad45-d912372dd438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_6b6f2c7d-44c1-4aa4-8059-5a250077dbf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_663a0f84-9f5d-48d1-b72b-7dc5f07322ab" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_6b6f2c7d-44c1-4aa4-8059-5a250077dbf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_d4856a81-2ee2-430b-af2e-c41b66183dde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_663a0f84-9f5d-48d1-b72b-7dc5f07322ab" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_d4856a81-2ee2-430b-af2e-c41b66183dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_d957c2d2-a51d-4ede-ae49-b98f095e649c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_663a0f84-9f5d-48d1-b72b-7dc5f07322ab" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_d957c2d2-a51d-4ede-ae49-b98f095e649c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_d5ca9cac-e28a-4ab6-a1af-83c46eae910f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_663a0f84-9f5d-48d1-b72b-7dc5f07322ab" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_d5ca9cac-e28a-4ab6-a1af-83c46eae910f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_743b3ab0-80bb-4846-bb7c-cd5c2bf37a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_663a0f84-9f5d-48d1-b72b-7dc5f07322ab" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_743b3ab0-80bb-4846-bb7c-cd5c2bf37a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_7035fb1b-19b0-4899-9e61-1144f7c5daf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_663a0f84-9f5d-48d1-b72b-7dc5f07322ab" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_7035fb1b-19b0-4899-9e61-1144f7c5daf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_30308433-65ff-4b38-8be3-fde743202ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_663a0f84-9f5d-48d1-b72b-7dc5f07322ab" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_30308433-65ff-4b38-8be3-fde743202ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_fa605b55-6206-4bbd-af6f-2cbe52aac0de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_663a0f84-9f5d-48d1-b72b-7dc5f07322ab" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_fa605b55-6206-4bbd-af6f-2cbe52aac0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_c318b5d0-092e-4d75-b136-8c94cef42822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_663a0f84-9f5d-48d1-b72b-7dc5f07322ab" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_c318b5d0-092e-4d75-b136-8c94cef42822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_a6a83b6b-f9e8-4966-aae0-acc571ccf1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_663a0f84-9f5d-48d1-b72b-7dc5f07322ab" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_a6a83b6b-f9e8-4966-aae0-acc571ccf1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_97061c28-3e32-4734-8385-4b20744eb653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_663a0f84-9f5d-48d1-b72b-7dc5f07322ab" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_97061c28-3e32-4734-8385-4b20744eb653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_9723a35e-381f-4130-ba73-88e9bddc9385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_663a0f84-9f5d-48d1-b72b-7dc5f07322ab" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_9723a35e-381f-4130-ba73-88e9bddc9385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_62e70aea-6f1e-440c-a4cd-7503099ecf70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_663a0f84-9f5d-48d1-b72b-7dc5f07322ab" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_62e70aea-6f1e-440c-a4cd-7503099ecf70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_6ecd2973-8ef2-4789-ae31-711336548077" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_663a0f84-9f5d-48d1-b72b-7dc5f07322ab" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_6ecd2973-8ef2-4789-ae31-711336548077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_7d0e5565-ec5e-4500-9be6-58222bc402ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_663a0f84-9f5d-48d1-b72b-7dc5f07322ab" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_7d0e5565-ec5e-4500-9be6-58222bc402ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d01cb63b-8371-4363-b7b9-c8494fedff17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_853dc98f-2587-4e18-98d8-65df9ae6c77a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d01cb63b-8371-4363-b7b9-c8494fedff17" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_853dc98f-2587-4e18-98d8-65df9ae6c77a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_5235757d-22e7-4fb5-a154-45d11a8191cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d01cb63b-8371-4363-b7b9-c8494fedff17" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_5235757d-22e7-4fb5-a154-45d11a8191cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_716f5835-5598-40e1-b2b8-99ea7753e5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d01cb63b-8371-4363-b7b9-c8494fedff17" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_716f5835-5598-40e1-b2b8-99ea7753e5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_88d76b25-a35b-4383-a73d-be9a1bc35d41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d01cb63b-8371-4363-b7b9-c8494fedff17" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_88d76b25-a35b-4383-a73d-be9a1bc35d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_cce186e3-3e53-4901-bf5f-76e8bd041d78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d01cb63b-8371-4363-b7b9-c8494fedff17" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_cce186e3-3e53-4901-bf5f-76e8bd041d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_2863f6b6-0772-41c4-85fc-ae1b4af61c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d01cb63b-8371-4363-b7b9-c8494fedff17" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_2863f6b6-0772-41c4-85fc-ae1b4af61c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_3487905c-2926-4b2f-95da-9319b2e504bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d01cb63b-8371-4363-b7b9-c8494fedff17" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_3487905c-2926-4b2f-95da-9319b2e504bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3944b513-efde-4be7-a3c2-be4e6c05af48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d01cb63b-8371-4363-b7b9-c8494fedff17" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3944b513-efde-4be7-a3c2-be4e6c05af48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesBasisofPresentationDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesBasisofPresentationDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesBasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7208f4ca-bd8a-49dc-9e32-a35e591ab307" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_eb8835d3-dcbb-4bf8-b9cf-522b261a6411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7208f4ca-bd8a-49dc-9e32-a35e591ab307" xlink:to="loc_us-gaap_NumberOfOperatingSegments_eb8835d3-dcbb-4bf8-b9cf-522b261a6411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInventoryDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesInventoryDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6487320a-2b2f-4728-9da1-0bc5ddbbd7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_16eebb56-3918-4e5d-9267-a76b3d213652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6487320a-2b2f-4728-9da1-0bc5ddbbd7b4" xlink:to="loc_us-gaap_InventoryRawMaterials_16eebb56-3918-4e5d-9267-a76b3d213652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_e33a201b-8516-4cde-b6d1-aa012deb4407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6487320a-2b2f-4728-9da1-0bc5ddbbd7b4" xlink:to="loc_us-gaap_InventoryWorkInProcess_e33a201b-8516-4cde-b6d1-aa012deb4407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_c8af31b5-a520-4e5b-a891-ff27b95321fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6487320a-2b2f-4728-9da1-0bc5ddbbd7b4" xlink:to="loc_us-gaap_InventoryFinishedGoods_c8af31b5-a520-4e5b-a891-ff27b95321fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b11fe459-cf47-4914-9d6b-f973ce591df6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6487320a-2b2f-4728-9da1-0bc5ddbbd7b4" xlink:to="loc_us-gaap_InventoryNet_b11fe459-cf47-4914-9d6b-f973ce591df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3c80bfb4-2139-42f9-a36b-c554d3ab3b69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eb630ccb-2338-4872-8001-7dc355c36e88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3c80bfb4-2139-42f9-a36b-c554d3ab3b69" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eb630ccb-2338-4872-8001-7dc355c36e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_371c564c-53d9-4e58-8972-2f8133bb0879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eb630ccb-2338-4872-8001-7dc355c36e88" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_371c564c-53d9-4e58-8972-2f8133bb0879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6984fa2b-0f31-47ae-a0a5-bde769b77bae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_371c564c-53d9-4e58-8972-2f8133bb0879" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6984fa2b-0f31-47ae-a0a5-bde769b77bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_e30f9182-5d6c-47eb-abfd-c6ba2df6a58a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6984fa2b-0f31-47ae-a0a5-bde769b77bae" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_e30f9182-5d6c-47eb-abfd-c6ba2df6a58a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember_52a8d358-5ac8-45ac-964f-8b4ee0222964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6984fa2b-0f31-47ae-a0a5-bde769b77bae" xlink:to="loc_us-gaap_LandBuildingsAndImprovementsMember_52a8d358-5ac8-45ac-964f-8b4ee0222964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MoldsMember_3e54a1e3-6fe3-43a4-89ed-e624917289ca" xlink:href="icui-20211231.xsd#icui_MoldsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6984fa2b-0f31-47ae-a0a5-bde769b77bae" xlink:to="loc_icui_MoldsMember_3e54a1e3-6fe3-43a4-89ed-e624917289ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ComputerEquipmentAndSoftwareMember_46285db6-7d4f-4443-a0a3-90c206278e7a" xlink:href="icui-20211231.xsd#icui_ComputerEquipmentAndSoftwareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6984fa2b-0f31-47ae-a0a5-bde769b77bae" xlink:to="loc_icui_ComputerEquipmentAndSoftwareMember_46285db6-7d4f-4443-a0a3-90c206278e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_c3c8f2a9-012d-491a-99cf-50565d9664d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6984fa2b-0f31-47ae-a0a5-bde769b77bae" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_c3c8f2a9-012d-491a-99cf-50565d9664d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InstrumentsPlacedwithCustomersMember_4de3f08d-91e9-4aa5-8e1b-9002f96d2268" xlink:href="icui-20211231.xsd#icui_InstrumentsPlacedwithCustomersMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6984fa2b-0f31-47ae-a0a5-bde769b77bae" xlink:to="loc_icui_InstrumentsPlacedwithCustomersMember_4de3f08d-91e9-4aa5-8e1b-9002f96d2268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_1462c414-94f8-4da1-81d4-288dcefaa9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6984fa2b-0f31-47ae-a0a5-bde769b77bae" xlink:to="loc_us-gaap_ConstructionInProgressMember_1462c414-94f8-4da1-81d4-288dcefaa9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_98909775-eb34-4264-8430-04bbb1148bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eb630ccb-2338-4872-8001-7dc355c36e88" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_98909775-eb34-4264-8430-04bbb1148bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_7726981d-46fd-4443-bde1-219a5cace5da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_98909775-eb34-4264-8430-04bbb1148bd5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_7726981d-46fd-4443-bde1-219a5cace5da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3f4cf066-34df-4d78-bc20-4fd55d3f1656" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_98909775-eb34-4264-8430-04bbb1148bd5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3f4cf066-34df-4d78-bc20-4fd55d3f1656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_edde4be2-7094-453e-97d7-c741f0997634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_98909775-eb34-4264-8430-04bbb1148bd5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_edde4be2-7094-453e-97d7-c741f0997634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5b6c99e6-02e5-4841-887f-5ffaf22d1a33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_42bbd676-97af-4d80-9063-d10d99d9bf2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5b6c99e6-02e5-4841-887f-5ffaf22d1a33" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_42bbd676-97af-4d80-9063-d10d99d9bf2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ec526f2-69e0-43bc-8306-ac5a5186def8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_42bbd676-97af-4d80-9063-d10d99d9bf2b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ec526f2-69e0-43bc-8306-ac5a5186def8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46222615-b6a1-4257-b1fe-3468b58476d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ec526f2-69e0-43bc-8306-ac5a5186def8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46222615-b6a1-4257-b1fe-3468b58476d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_f01c98d9-e179-457b-8189-c63f2f5ff82e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46222615-b6a1-4257-b1fe-3468b58476d9" xlink:to="loc_us-gaap_BuildingMember_f01c98d9-e179-457b-8189-c63f2f5ff82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember_1a7561e1-c089-45ce-bb8c-981c67c4b79e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46222615-b6a1-4257-b1fe-3468b58476d9" xlink:to="loc_us-gaap_BuildingImprovementsMember_1a7561e1-c089-45ce-bb8c-981c67c4b79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_78a6781a-c46e-4139-b189-f2924eff97a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46222615-b6a1-4257-b1fe-3468b58476d9" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_78a6781a-c46e-4139-b189-f2924eff97a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_FurniturefixturesandmoldsMember_c2f0e811-b9c1-411a-86ec-a14fb2557fe2" xlink:href="icui-20211231.xsd#icui_FurniturefixturesandmoldsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46222615-b6a1-4257-b1fe-3468b58476d9" xlink:to="loc_icui_FurniturefixturesandmoldsMember_c2f0e811-b9c1-411a-86ec-a14fb2557fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ComputerEquipmentAndSoftwareMember_952e002c-2eeb-427a-8d95-5a9b9f12f786" xlink:href="icui-20211231.xsd#icui_ComputerEquipmentAndSoftwareMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46222615-b6a1-4257-b1fe-3468b58476d9" xlink:to="loc_icui_ComputerEquipmentAndSoftwareMember_952e002c-2eeb-427a-8d95-5a9b9f12f786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InstrumentsPlacedwithCustomersMember_5ed0099e-27bc-4f41-b4fe-123917e239c9" xlink:href="icui-20211231.xsd#icui_InstrumentsPlacedwithCustomersMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46222615-b6a1-4257-b1fe-3468b58476d9" xlink:to="loc_icui_InstrumentsPlacedwithCustomersMember_5ed0099e-27bc-4f41-b4fe-123917e239c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6990349d-c357-4c40-81f7-abd0352cfc3c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_42bbd676-97af-4d80-9063-d10d99d9bf2b" xlink:to="loc_srt_RangeAxis_6990349d-c357-4c40-81f7-abd0352cfc3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9c89afc0-afbe-4e51-80cb-ebb6b70ded7c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6990349d-c357-4c40-81f7-abd0352cfc3c" xlink:to="loc_srt_RangeMember_9c89afc0-afbe-4e51-80cb-ebb6b70ded7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_304281aa-f9a2-4ca7-873f-69f3758068ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9c89afc0-afbe-4e51-80cb-ebb6b70ded7c" xlink:to="loc_srt_MinimumMember_304281aa-f9a2-4ca7-873f-69f3758068ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cd778607-b373-4a5b-815b-81e4aa7f5b2e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9c89afc0-afbe-4e51-80cb-ebb6b70ded7c" xlink:to="loc_srt_MaximumMember_cd778607-b373-4a5b-815b-81e4aa7f5b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a8664a63-182e-482e-bec8-0abd8cf9502a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_42bbd676-97af-4d80-9063-d10d99d9bf2b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a8664a63-182e-482e-bec8-0abd8cf9502a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_4e767a81-cc21-4fc5-aa96-fb47f1735314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a8664a63-182e-482e-bec8-0abd8cf9502a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_4e767a81-cc21-4fc5-aa96-fb47f1735314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment3Details" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment3Details"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment3Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6ee4ded2-96dd-47ac-a620-4ef74ca0d729" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_5efa8189-1efc-4757-adca-4ed447ea0292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6ee4ded2-96dd-47ac-a620-4ef74ca0d729" xlink:to="loc_us-gaap_Depreciation_5efa8189-1efc-4757-adca-4ed447ea0292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9e5c9ee0-e2a1-44eb-80b7-ec520a9ad68c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_3afd44fe-3564-4adc-9073-128ac93f8610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e5c9ee0-e2a1-44eb-80b7-ec520a9ad68c" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_3afd44fe-3564-4adc-9073-128ac93f8610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_16d243bf-f97a-4a49-81e7-d59ad6614415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_3afd44fe-3564-4adc-9073-128ac93f8610" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_16d243bf-f97a-4a49-81e7-d59ad6614415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16e029aa-5feb-4ad7-9b15-a378feeb91f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_16d243bf-f97a-4a49-81e7-d59ad6614415" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16e029aa-5feb-4ad7-9b15-a378feeb91f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularLLCMember_2bfa2c7d-4474-4d0f-a931-07632bcce6db" xlink:href="icui-20211231.xsd#icui_PursuitVascularLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16e029aa-5feb-4ad7-9b15-a378feeb91f9" xlink:to="loc_icui_PursuitVascularLLCMember_2bfa2c7d-4474-4d0f-a931-07632bcce6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignDistibutorMember_45871777-8663-452b-a1ec-7e42c7192dd3" xlink:href="icui-20211231.xsd#icui_ForeignDistibutorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16e029aa-5feb-4ad7-9b15-a378feeb91f9" xlink:to="loc_icui_ForeignDistibutorMember_45871777-8663-452b-a1ec-7e42c7192dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_367cb985-f3c0-4aaa-aa19-ad4cfec5526c" xlink:href="icui-20211231.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16e029aa-5feb-4ad7-9b15-a378feeb91f9" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_367cb985-f3c0-4aaa-aa19-ad4cfec5526c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_ba4490b6-a338-4e71-9cef-f9e5b619b209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_3afd44fe-3564-4adc-9073-128ac93f8610" xlink:to="loc_us-gaap_GoodwillLineItems_ba4490b6-a338-4e71-9cef-f9e5b619b209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_5ff6743f-b1b1-414b-b77f-d2c212b4f661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_ba4490b6-a338-4e71-9cef-f9e5b619b209" xlink:to="loc_us-gaap_GoodwillRollForward_5ff6743f-b1b1-414b-b77f-d2c212b4f661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_97cd1a43-4ba6-45c3-89ac-013f6908f1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5ff6743f-b1b1-414b-b77f-d2c212b4f661" xlink:to="loc_us-gaap_Goodwill_97cd1a43-4ba6-45c3-89ac-013f6908f1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_3a918e86-848e-4394-8997-d215d9b46665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5ff6743f-b1b1-414b-b77f-d2c212b4f661" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_3a918e86-848e-4394-8997-d215d9b46665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_ea8a43b4-8cee-4de5-993d-a30a17148f90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5ff6743f-b1b1-414b-b77f-d2c212b4f661" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_ea8a43b4-8cee-4de5-993d-a30a17148f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_b80b016a-cb29-44ab-83fa-619d10c78c58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5ff6743f-b1b1-414b-b77f-d2c212b4f661" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_b80b016a-cb29-44ab-83fa-619d10c78c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a7b07b22-2c73-4273-83e2-20930020e68a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5ff6743f-b1b1-414b-b77f-d2c212b4f661" xlink:to="loc_us-gaap_Goodwill_a7b07b22-2c73-4273-83e2-20930020e68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_dffd2229-f38b-4a88-879e-6a244b90c079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_aca22d7e-e365-4b0f-b6d7-0e38afea1898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dffd2229-f38b-4a88-879e-6a244b90c079" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_aca22d7e-e365-4b0f-b6d7-0e38afea1898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_88e260b5-0f2f-4306-b0ad-513ae291cb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_aca22d7e-e365-4b0f-b6d7-0e38afea1898" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_88e260b5-0f2f-4306-b0ad-513ae291cb9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_faf3a55f-80e9-4a80-8bd4-f3f2b2f37cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_88e260b5-0f2f-4306-b0ad-513ae291cb9e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_faf3a55f-80e9-4a80-8bd4-f3f2b2f37cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_1318570b-145e-46c5-a56f-58c235b5fb62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_faf3a55f-80e9-4a80-8bd4-f3f2b2f37cfa" xlink:to="loc_us-gaap_PatentsMember_1318570b-145e-46c5-a56f-58c235b5fb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_5efc319f-b785-4088-b26b-207fcf186116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_faf3a55f-80e9-4a80-8bd4-f3f2b2f37cfa" xlink:to="loc_us-gaap_CustomerContractsMember_5efc319f-b785-4088-b26b-207fcf186116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_dad797d1-06c6-4928-9638-5989864dcb40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_faf3a55f-80e9-4a80-8bd4-f3f2b2f37cfa" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_dad797d1-06c6-4928-9638-5989864dcb40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_d94f7cdc-8a75-4fa9-b9ca-c826968853c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_faf3a55f-80e9-4a80-8bd4-f3f2b2f37cfa" xlink:to="loc_us-gaap_TrademarksMember_d94f7cdc-8a75-4fa9-b9ca-c826968853c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_3c5e480c-433d-4407-a107-03e309c3340d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_faf3a55f-80e9-4a80-8bd4-f3f2b2f37cfa" xlink:to="loc_us-gaap_TradeNamesMember_3c5e480c-433d-4407-a107-03e309c3340d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_3075c419-f15f-477f-bec6-d57d4c3e69c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_faf3a55f-80e9-4a80-8bd4-f3f2b2f37cfa" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_3075c419-f15f-477f-bec6-d57d4c3e69c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_878cd86e-c5e9-476a-b198-9e6c31469297" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_faf3a55f-80e9-4a80-8bd4-f3f2b2f37cfa" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_878cd86e-c5e9-476a-b198-9e6c31469297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_68ce218d-422a-46ae-a024-c0584363fd75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_faf3a55f-80e9-4a80-8bd4-f3f2b2f37cfa" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_68ce218d-422a-46ae-a024-c0584363fd75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f10f0af0-eade-4581-adf7-f00178b9e6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_aca22d7e-e365-4b0f-b6d7-0e38afea1898" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f10f0af0-eade-4581-adf7-f00178b9e6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_a9fadbd8-050f-4350-8f47-01982dc1dfda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f10f0af0-eade-4581-adf7-f00178b9e6fa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_a9fadbd8-050f-4350-8f47-01982dc1dfda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_bc1e349e-50a1-48f1-9946-3d1065f75969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f10f0af0-eade-4581-adf7-f00178b9e6fa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_bc1e349e-50a1-48f1-9946-3d1065f75969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9a2dcaef-7194-4fed-9fbf-3bb2c6e877d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f10f0af0-eade-4581-adf7-f00178b9e6fa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9a2dcaef-7194-4fed-9fbf-3bb2c6e877d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a18c3c19-a825-4602-9cd9-bb60655f0dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f10f0af0-eade-4581-adf7-f00178b9e6fa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a18c3c19-a825-4602-9cd9-bb60655f0dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2f1f7e91-dd05-48c8-b01f-32e124a52b59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f10f0af0-eade-4581-adf7-f00178b9e6fa" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2f1f7e91-dd05-48c8-b01f-32e124a52b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7b8d5b2e-50b0-469a-b774-ec92f5508006" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f10f0af0-eade-4581-adf7-f00178b9e6fa" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7b8d5b2e-50b0-469a-b774-ec92f5508006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets2Details" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets2Details"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets2Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a900e86d-bf9d-452f-894d-81f88f794161" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_212300ff-b1e1-48a2-9c0b-d45124b62b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a900e86d-bf9d-452f-894d-81f88f794161" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_212300ff-b1e1-48a2-9c0b-d45124b62b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a90f27c0-c125-4977-bae4-76da9b65a377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e409fb9c-2ec7-460c-93a5-9176132a9f75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a90f27c0-c125-4977-bae4-76da9b65a377" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e409fb9c-2ec7-460c-93a5-9176132a9f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82d9711d-f00e-4b9a-8b68-524580035b89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e409fb9c-2ec7-460c-93a5-9176132a9f75" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82d9711d-f00e-4b9a-8b68-524580035b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_63d3608c-7c69-4b88-b344-f7ea7b3c7a65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82d9711d-f00e-4b9a-8b68-524580035b89" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_63d3608c-7c69-4b88-b344-f7ea7b3c7a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fd25ca95-c0b5-4e09-9b0d-2bf4d310d57d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e409fb9c-2ec7-460c-93a5-9176132a9f75" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fd25ca95-c0b5-4e09-9b0d-2bf4d310d57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d10b09c1-9684-4d46-a709-44526c1b811b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fd25ca95-c0b5-4e09-9b0d-2bf4d310d57d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d10b09c1-9684-4d46-a709-44526c1b811b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_4fc7aa1a-49a9-4b9d-8f68-f6c7b667b141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fd25ca95-c0b5-4e09-9b0d-2bf4d310d57d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_4fc7aa1a-49a9-4b9d-8f68-f6c7b667b141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0b1fd276-68e4-4f21-bbee-37da92410792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fd25ca95-c0b5-4e09-9b0d-2bf4d310d57d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0b1fd276-68e4-4f21-bbee-37da92410792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_19e839b0-1b2c-4147-bca4-2902eaa1aa0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fd25ca95-c0b5-4e09-9b0d-2bf4d310d57d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_19e839b0-1b2c-4147-bca4-2902eaa1aa0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_768a9cab-b5d1-4a68-99f5-3ce9bc48da38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fd25ca95-c0b5-4e09-9b0d-2bf4d310d57d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_768a9cab-b5d1-4a68-99f5-3ce9bc48da38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0cdcf654-d381-40da-a515-6a78d8b82be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fd25ca95-c0b5-4e09-9b0d-2bf4d310d57d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0cdcf654-d381-40da-a515-6a78d8b82be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0fdbc365-9872-48ac-a24c-6fbe5a5a6fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fd25ca95-c0b5-4e09-9b0d-2bf4d310d57d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0fdbc365-9872-48ac-a24c-6fbe5a5a6fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6567432b-b9ae-4447-b181-b736601639d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_6c079923-21d9-40a7-abbd-9738b014daac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6567432b-b9ae-4447-b181-b736601639d3" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_6c079923-21d9-40a7-abbd-9738b014daac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_f87292e2-f90a-4ab1-8341-85b0fb1c418a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_6c079923-21d9-40a7-abbd-9738b014daac" xlink:to="loc_us-gaap_InvestmentTypeAxis_f87292e2-f90a-4ab1-8341-85b0fb1c418a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_2afdcbbd-892e-4364-b46c-47eeaa22c523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_f87292e2-f90a-4ab1-8341-85b0fb1c418a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_2afdcbbd-892e-4364-b46c-47eeaa22c523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_a66eefbe-e597-4bc0-966e-cc7ff52fa5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2afdcbbd-892e-4364-b46c-47eeaa22c523" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_a66eefbe-e597-4bc0-966e-cc7ff52fa5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongtermInvestmentsDomain_bddf82bd-7bf6-4999-bffe-e19a5f73d706" xlink:href="icui-20211231.xsd#icui_LongtermInvestmentsDomain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2afdcbbd-892e-4364-b46c-47eeaa22c523" xlink:to="loc_icui_LongtermInvestmentsDomain_bddf82bd-7bf6-4999-bffe-e19a5f73d706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ba2794c4-31ee-4422-b3dd-1ee569fe8bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_6c079923-21d9-40a7-abbd-9738b014daac" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ba2794c4-31ee-4422-b3dd-1ee569fe8bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a5c46c1e-5a23-431b-ab19-a1fcfb4f8db1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ba2794c4-31ee-4422-b3dd-1ee569fe8bd6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a5c46c1e-5a23-431b-ab19-a1fcfb4f8db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_c3003860-d032-47dd-8999-87c0733c2ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ba2794c4-31ee-4422-b3dd-1ee569fe8bd6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_c3003860-d032-47dd-8999-87c0733c2ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ceb4a8a5-897e-41b1-aa7d-ebfc4501e636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ba2794c4-31ee-4422-b3dd-1ee569fe8bd6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ceb4a8a5-897e-41b1-aa7d-ebfc4501e636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsEquityMethodDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesInvestmentsEquityMethodDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsEquityMethodDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_73fa7924-e8e3-4fc5-83e9-deb66348ddce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_f25476d3-2543-47db-bb9b-e58b510492af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_73fa7924-e8e3-4fc5-83e9-deb66348ddce" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_f25476d3-2543-47db-bb9b-e58b510492af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_b0ef2e1f-0eb6-4142-91b7-8385cc0d964f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_73fa7924-e8e3-4fc5-83e9-deb66348ddce" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_b0ef2e1f-0eb6-4142-91b7-8385cc0d964f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_b149a29c-7eef-4702-b686-2936900aca10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_73fa7924-e8e3-4fc5-83e9-deb66348ddce" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_b149a29c-7eef-4702-b686-2936900aca10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesForeignCurrencyDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesForeignCurrencyDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesForeignCurrencyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyAbstract_a42e791a-5d9a-4a1b-81d6-d3facf5a0e68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_04121a42-fe0d-459b-8dbe-d4592219c61d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyAbstract_a42e791a-5d9a-4a1b-81d6-d3facf5a0e68" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_04121a42-fe0d-459b-8dbe-d4592219c61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesAdvertisingExpensesDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesAdvertisingExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesAdvertisingExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5c4141d8-dcd2-4b94-ae3f-eb3a6c568d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_f3cf43ef-55c9-4e5c-a2b8-cef379bc49f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5c4141d8-dcd2-4b94-ae3f-eb3a6c568d1b" xlink:to="loc_us-gaap_AdvertisingExpense_f3cf43ef-55c9-4e5c-a2b8-cef379bc49f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPostretirementandPostemploymentBenefitsDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesPostretirementandPostemploymentBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPostretirementandPostemploymentBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6dfbf342-c053-450b-88bd-e8d1e40bec59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_b2e6b185-87fe-46f5-aa45-bdb3807dca7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6dfbf342-c053-450b-88bd-e8d1e40bec59" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_b2e6b185-87fe-46f5-aa45-bdb3807dca7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_38f7b4ab-f1ce-4136-a1f6-bd9d14c0fed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1f47e962-b039-4069-b991-b0c3e5c5255a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_38f7b4ab-f1ce-4136-a1f6-bd9d14c0fed8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1f47e962-b039-4069-b991-b0c3e5c5255a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_df5c8904-84de-4001-b34e-5c0b6b95cc85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1f47e962-b039-4069-b991-b0c3e5c5255a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_df5c8904-84de-4001-b34e-5c0b6b95cc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_639cd4e7-12a8-432a-bdb5-5cdd5d9c3dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_38f7b4ab-f1ce-4136-a1f6-bd9d14c0fed8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_639cd4e7-12a8-432a-bdb5-5cdd5d9c3dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a68a24cd-f8b6-4b5a-8765-64e3a0a869eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_639cd4e7-12a8-432a-bdb5-5cdd5d9c3dd8" xlink:to="loc_us-gaap_NetIncomeLoss_a68a24cd-f8b6-4b5a-8765-64e3a0a869eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_33f2d535-0f05-4031-a13b-3c5eb05bb599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_639cd4e7-12a8-432a-bdb5-5cdd5d9c3dd8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_33f2d535-0f05-4031-a13b-3c5eb05bb599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_b1fe3c63-883c-4739-8f80-8ddd65d80da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_639cd4e7-12a8-432a-bdb5-5cdd5d9c3dd8" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_b1fe3c63-883c-4739-8f80-8ddd65d80da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_47761e4e-7eef-444e-839f-3c8912afb42b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_639cd4e7-12a8-432a-bdb5-5cdd5d9c3dd8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_47761e4e-7eef-444e-839f-3c8912afb42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_fc2e9975-dd60-486f-9962-ed80ea7c5c13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_639cd4e7-12a8-432a-bdb5-5cdd5d9c3dd8" xlink:to="loc_us-gaap_EarningsPerShareBasic_fc2e9975-dd60-486f-9962-ed80ea7c5c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_46ac474e-4cea-41b9-8eb2-b60cbd8a61c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_639cd4e7-12a8-432a-bdb5-5cdd5d9c3dd8" xlink:to="loc_us-gaap_EarningsPerShareDiluted_46ac474e-4cea-41b9-8eb2-b60cbd8a61c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_28498bbd-8841-4f21-996f-a886084cd694" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_639cd4e7-12a8-432a-bdb5-5cdd5d9c3dd8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_28498bbd-8841-4f21-996f-a886084cd694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNewAccountingPronouncementsDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#GeneralandSummaryofSignificantAccountingPoliciesNewAccountingPronouncementsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNewAccountingPronouncementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_aed3f9b3-1b50-4976-a817-091537dd56e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cfc382fa-f65a-41cf-9412-f18410d31f56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_aed3f9b3-1b50-4976-a817-091537dd56e0" xlink:to="loc_us-gaap_AccountingPoliciesAbstract_cfc382fa-f65a-41cf-9412-f18410d31f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_0a83f668-f7f8-4b47-a9f3-b96a6f47d4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cfc382fa-f65a-41cf-9412-f18410d31f56" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_0a83f668-f7f8-4b47-a9f3-b96a6f47d4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_64efb8fe-1219-46e0-9266-c471826aeee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AcquisitionsNotes" xlink:type="simple" xlink:href="icui-20211231.xsd#AcquisitionsNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AcquisitionsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_d8a52571-0306-4548-abeb-ac991ed3d10d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_b13725a4-1619-43ba-9b05-3cfcde0a297e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_d8a52571-0306-4548-abeb-ac991ed3d10d" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_b13725a4-1619-43ba-9b05-3cfcde0a297e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AcquisitionsPursuitVascularTables" xlink:type="simple" xlink:href="icui-20211231.xsd#AcquisitionsPursuitVascularTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AcquisitionsPursuitVascularTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_17b84120-b938-4329-869d-200157932dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9fae65fd-b297-4b54-9588-c31864a02431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_17b84120-b938-4329-869d-200157932dd5" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9fae65fd-b297-4b54-9588-c31864a02431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ccf0fe67-41c3-4519-b902-a430845cf819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9fae65fd-b297-4b54-9588-c31864a02431" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ccf0fe67-41c3-4519-b902-a430845cf819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a9ff3a3-bdd7-4a66-b4f7-e4e79f11b193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ccf0fe67-41c3-4519-b902-a430845cf819" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a9ff3a3-bdd7-4a66-b4f7-e4e79f11b193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_81c3035f-1bc3-4648-a801-5699b61d3f3e" xlink:href="icui-20211231.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a9ff3a3-bdd7-4a66-b4f7-e4e79f11b193" xlink:to="loc_icui_PursuitVascularInc.Member_81c3035f-1bc3-4648-a801-5699b61d3f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_57b35e04-831f-4fd3-9fe6-091e2d882654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9fae65fd-b297-4b54-9588-c31864a02431" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_57b35e04-831f-4fd3-9fe6-091e2d882654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_67076bb4-f61e-482c-83c6-646c5ff7232b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57b35e04-831f-4fd3-9fe6-091e2d882654" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_67076bb4-f61e-482c-83c6-646c5ff7232b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AcquisitionsTextDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#AcquisitionsTextDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AcquisitionsTextDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1739bb38-e117-4f5e-9907-4b718e013272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5512131d-cedc-4f04-b133-ee3351310164" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1739bb38-e117-4f5e-9907-4b718e013272" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5512131d-cedc-4f04-b133-ee3351310164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5d4107f0-95d2-4492-8560-64cf9c4362d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5512131d-cedc-4f04-b133-ee3351310164" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5d4107f0-95d2-4492-8560-64cf9c4362d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21c12abd-8d2a-46b0-aa68-211a9556bfa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5d4107f0-95d2-4492-8560-64cf9c4362d7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21c12abd-8d2a-46b0-aa68-211a9556bfa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_92baab59-ae00-48c0-9663-148006c07aa4" xlink:href="icui-20211231.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21c12abd-8d2a-46b0-aa68-211a9556bfa2" xlink:to="loc_icui_PursuitVascularInc.Member_92baab59-ae00-48c0-9663-148006c07aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignDistibutorMember_406752a7-4c0e-4dcd-8324-c41495bee62f" xlink:href="icui-20211231.xsd#icui_ForeignDistibutorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21c12abd-8d2a-46b0-aa68-211a9556bfa2" xlink:to="loc_icui_ForeignDistibutorMember_406752a7-4c0e-4dcd-8324-c41495bee62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularLLCMember_8f12d8d5-b694-4add-bfb3-64adaeeeca0b" xlink:href="icui-20211231.xsd#icui_PursuitVascularLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21c12abd-8d2a-46b0-aa68-211a9556bfa2" xlink:to="loc_icui_PursuitVascularLLCMember_8f12d8d5-b694-4add-bfb3-64adaeeeca0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f3eb0451-f227-4046-8af0-8b993b78b229" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5512131d-cedc-4f04-b133-ee3351310164" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_f3eb0451-f227-4046-8af0-8b993b78b229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b9a88792-1237-4755-aa6e-a0499c918d47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3eb0451-f227-4046-8af0-8b993b78b229" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b9a88792-1237-4755-aa6e-a0499c918d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_60708386-0295-468a-8532-29e52bf17796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3eb0451-f227-4046-8af0-8b993b78b229" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_60708386-0295-468a-8532-29e52bf17796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_0274679b-9d7d-451c-8bd1-8976706a7c41" xlink:href="icui-20211231.xsd#icui_Contingentconsiderationgross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3eb0451-f227-4046-8af0-8b993b78b229" xlink:to="loc_icui_Contingentconsiderationgross_0274679b-9d7d-451c-8bd1-8976706a7c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_051715f4-ab44-4a49-817c-ab60ebde4dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3eb0451-f227-4046-8af0-8b993b78b229" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_051715f4-ab44-4a49-817c-ab60ebde4dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#AcquisitionsPursuitVascularTableDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_e80cc046-7dc5-4323-9225-6aac87c990a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f63e9d31-95e2-418f-89ee-17bad071a347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_e80cc046-7dc5-4323-9225-6aac87c990a6" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f63e9d31-95e2-418f-89ee-17bad071a347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0581b8a7-2b44-462a-95e8-bbc29d5a28d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f63e9d31-95e2-418f-89ee-17bad071a347" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0581b8a7-2b44-462a-95e8-bbc29d5a28d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1be31d5b-5131-42cc-b299-80ff3e2760bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0581b8a7-2b44-462a-95e8-bbc29d5a28d7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1be31d5b-5131-42cc-b299-80ff3e2760bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_709dced6-e39c-4cee-9525-4dc26bbfc3c5" xlink:href="icui-20211231.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1be31d5b-5131-42cc-b299-80ff3e2760bb" xlink:to="loc_icui_PursuitVascularInc.Member_709dced6-e39c-4cee-9525-4dc26bbfc3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f63e9d31-95e2-418f-89ee-17bad071a347" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments_e4f78b5d-4b08-4b5a-aac5-7dd2b78758be" xlink:href="icui-20211231.xsd#icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments_e4f78b5d-4b08-4b5a-aac5-7dd2b78758be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_893a64bc-a04f-499c-abad-9301dee402bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_893a64bc-a04f-499c-abad-9301dee402bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_bcc70f06-73a8-446c-834f-def446c52778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_bcc70f06-73a8-446c-834f-def446c52778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesFairValue_0aaf5894-32da-4386-ae79-23c3de7e7865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquiredReceivablesFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationAcquiredReceivablesFairValue_0aaf5894-32da-4386-ae79-23c3de7e7865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_97f81b0a-4e3d-4059-9af4-79c414964879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_97f81b0a-4e3d-4059-9af4-79c414964879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_bbb2683d-cbf2-4d52-9a8d-8e28b85096ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_bbb2683d-cbf2-4d52-9a8d-8e28b85096ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_73be0025-2605-4a38-b7e8-98ced1634472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_73be0025-2605-4a38-b7e8-98ced1634472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7c540868-c885-44ee-9f97-ab17f2d4306c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7c540868-c885-44ee-9f97-ab17f2d4306c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_45f42ab5-cb42-4d2b-86ac-08350a34abe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_45f42ab5-cb42-4d2b-86ac-08350a34abe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_a84cbb97-d5d0-459e-8185-ca80760fa5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_a84cbb97-d5d0-459e-8185-ca80760fa5fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_edb8af83-5351-48bf-bf92-7ea79e2da5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_edb8af83-5351-48bf-bf92-7ea79e2da5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_03c5009d-e090-41d4-80dc-69c580f4a999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_03c5009d-e090-41d4-80dc-69c580f4a999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_149160d4-c3d9-438d-8bef-5a59ebf09944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c22b7e3-51e3-4248-9487-b6a9990aba6d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_149160d4-c3d9-438d-8bef-5a59ebf09944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AcquisitionsPursuitVascularIntangibleDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#AcquisitionsPursuitVascularIntangibleDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AcquisitionsPursuitVascularIntangibleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_ea4cdd19-8740-4fb7-aa95-81cd2c39f39a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_0e3c03dc-bf2f-4400-89e7-bfa1acf10b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_ea4cdd19-8740-4fb7-aa95-81cd2c39f39a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_0e3c03dc-bf2f-4400-89e7-bfa1acf10b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_81ada68c-0580-44f2-a917-643ecfbe8948" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_0e3c03dc-bf2f-4400-89e7-bfa1acf10b7d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_81ada68c-0580-44f2-a917-643ecfbe8948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9edb395d-70e9-463a-acf3-e1a9524a3669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_81ada68c-0580-44f2-a917-643ecfbe8948" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9edb395d-70e9-463a-acf3-e1a9524a3669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_bc7b86fb-e255-4415-8049-8605962096d2" xlink:href="icui-20211231.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9edb395d-70e9-463a-acf3-e1a9524a3669" xlink:to="loc_icui_PursuitVascularInc.Member_bc7b86fb-e255-4415-8049-8605962096d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ea4af82c-7a6f-48d7-b374-27b0914ac4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_0e3c03dc-bf2f-4400-89e7-bfa1acf10b7d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ea4af82c-7a6f-48d7-b374-27b0914ac4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dc8034f8-edb0-432a-8f79-ec8fb164b3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ea4af82c-7a6f-48d7-b374-27b0914ac4ba" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dc8034f8-edb0-432a-8f79-ec8fb164b3b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_177d0951-1359-41e3-a7b0-b11673f50894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dc8034f8-edb0-432a-8f79-ec8fb164b3b6" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_177d0951-1359-41e3-a7b0-b11673f50894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_be74d156-d319-4a57-b733-cdbfd8c6ac3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dc8034f8-edb0-432a-8f79-ec8fb164b3b6" xlink:to="loc_us-gaap_TradeNamesMember_be74d156-d319-4a57-b733-cdbfd8c6ac3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_4c95e8c9-0fcb-40c2-ae80-2ff07aa0ae1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dc8034f8-edb0-432a-8f79-ec8fb164b3b6" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_4c95e8c9-0fcb-40c2-ae80-2ff07aa0ae1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_23e25766-5a18-4a77-bf23-e9975a34bb8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_0e3c03dc-bf2f-4400-89e7-bfa1acf10b7d" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_23e25766-5a18-4a77-bf23-e9975a34bb8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_edf8058a-0b7c-4a84-87b9-b4a1072f07b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_23e25766-5a18-4a77-bf23-e9975a34bb8a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_edf8058a-0b7c-4a84-87b9-b4a1072f07b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_3a879f52-2114-43b2-8412-9a2468753bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_23e25766-5a18-4a77-bf23-e9975a34bb8a" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_3a879f52-2114-43b2-8412-9a2468753bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AcquisitionsForeignInfusionSystemsSupplierDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#AcquisitionsForeignInfusionSystemsSupplierDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AcquisitionsForeignInfusionSystemsSupplierDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ef15edf3-a2a9-4165-bed1-f6705064fc0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_fbb3e5f1-1076-427a-bca1-3843c0dff491" xlink:href="icui-20211231.xsd#icui_Contingentconsiderationgross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ef15edf3-a2a9-4165-bed1-f6705064fc0e" xlink:to="loc_icui_Contingentconsiderationgross_fbb3e5f1-1076-427a-bca1-3843c0dff491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a696eb6e-8120-4e4b-b6a2-c1388e2a2286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ef15edf3-a2a9-4165-bed1-f6705064fc0e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a696eb6e-8120-4e4b-b6a2-c1388e2a2286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bbae4c1f-196a-445e-b7a3-7cf14c993584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a696eb6e-8120-4e4b-b6a2-c1388e2a2286" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bbae4c1f-196a-445e-b7a3-7cf14c993584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_61d4c34d-281d-45af-b88b-afb4708420e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bbae4c1f-196a-445e-b7a3-7cf14c993584" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_61d4c34d-281d-45af-b88b-afb4708420e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_ea77c5ee-f77f-4524-ae7d-89bd21a5991b" xlink:href="icui-20211231.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_61d4c34d-281d-45af-b88b-afb4708420e3" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_ea77c5ee-f77f-4524-ae7d-89bd21a5991b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5cc7dd2b-e640-47ee-994d-9f240a312343" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a696eb6e-8120-4e4b-b6a2-c1388e2a2286" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_5cc7dd2b-e640-47ee-994d-9f240a312343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_9374c97e-af08-4a5d-8344-e2b7ae293116" xlink:href="icui-20211231.xsd#icui_Contingentconsiderationgross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5cc7dd2b-e640-47ee-994d-9f240a312343" xlink:to="loc_icui_Contingentconsiderationgross_9374c97e-af08-4a5d-8344-e2b7ae293116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermContingentConsiderationGross_64f1772f-b9b9-4d13-bfd7-c6fa7571d9a8" xlink:href="icui-20211231.xsd#icui_ShortTermContingentConsiderationGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5cc7dd2b-e640-47ee-994d-9f240a312343" xlink:to="loc_icui_ShortTermContingentConsiderationGross_64f1772f-b9b9-4d13-bfd7-c6fa7571d9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermContingentConsiderationGross_e61c000f-b32b-442b-9b07-6b606b85274e" xlink:href="icui-20211231.xsd#icui_LongTermContingentConsiderationGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5cc7dd2b-e640-47ee-994d-9f240a312343" xlink:to="loc_icui_LongTermContingentConsiderationGross_e61c000f-b32b-442b-9b07-6b606b85274e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_38d4a3d4-d027-4afd-93a4-b66ce323dc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5cc7dd2b-e640-47ee-994d-9f240a312343" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_38d4a3d4-d027-4afd-93a4-b66ce323dc8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationConsiderationCashHoldback_5875c9e6-9094-4481-abf4-c1ea04110748" xlink:href="icui-20211231.xsd#icui_BusinessCombinationConsiderationCashHoldback"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5cc7dd2b-e640-47ee-994d-9f240a312343" xlink:to="loc_icui_BusinessCombinationConsiderationCashHoldback_5875c9e6-9094-4481-abf4-c1ea04110748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes" xlink:type="simple" xlink:href="icui-20211231.xsd#RestructuringStrategicTransactionandIntegrationNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_12fa6736-0ff0-4b3d-9b12-0fea9fd2316e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_fa327b5b-5dc8-4101-b2b2-15265533a848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_12fa6736-0ff0-4b3d-9b12-0fea9fd2316e" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_fa327b5b-5dc8-4101-b2b2-15265533a848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationScheduleofRestructuringandRelatedCostsTables" xlink:type="simple" xlink:href="icui-20211231.xsd#RestructuringStrategicTransactionandIntegrationScheduleofRestructuringandRelatedCostsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationScheduleofRestructuringandRelatedCostsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c67d3778-9c84-44b1-9729-720f24fa4cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_8fd79d48-0531-48bb-a829-ca5ab4332135" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c67d3778-9c84-44b1-9729-720f24fa4cc8" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_8fd79d48-0531-48bb-a829-ca5ab4332135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails1" xlink:type="simple" xlink:href="icui-20211231.xsd#RestructuringStrategicTransactionandIntegrationDetails1"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c48fe2ae-abe1-4eae-9264-d81789b01a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringandstrategictransactionexpense_e8ca3026-577f-48b5-ba10-14a4c0bd8c14" xlink:href="icui-20211231.xsd#icui_Restructuringandstrategictransactionexpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c48fe2ae-abe1-4eae-9264-d81789b01a4a" xlink:to="loc_icui_Restructuringandstrategictransactionexpense_e8ca3026-577f-48b5-ba10-14a4c0bd8c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_880a1e15-68de-466a-97b5-653867a4305f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c48fe2ae-abe1-4eae-9264-d81789b01a4a" xlink:to="loc_us-gaap_RestructuringCharges_880a1e15-68de-466a-97b5-653867a4305f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_11c3103d-4d84-4be9-8605-4f890eb9340c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c48fe2ae-abe1-4eae-9264-d81789b01a4a" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_11c3103d-4d84-4be9-8605-4f890eb9340c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6182709b-4e98-41be-9c6f-e63a868061da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c48fe2ae-abe1-4eae-9264-d81789b01a4a" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6182709b-4e98-41be-9c6f-e63a868061da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_dbf05479-c297-4d56-aa68-5021005a9112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6182709b-4e98-41be-9c6f-e63a868061da" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_dbf05479-c297-4d56-aa68-5021005a9112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_2c6976d0-83dc-4490-86eb-ab16f80ddfbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_dbf05479-c297-4d56-aa68-5021005a9112" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_2c6976d0-83dc-4490-86eb-ab16f80ddfbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_c3c4e54a-49b9-4617-aaea-d24e22aea4b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_2c6976d0-83dc-4490-86eb-ab16f80ddfbb" xlink:to="loc_us-gaap_FacilityClosingMember_c3c4e54a-49b9-4617-aaea-d24e22aea4b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_641c0385-c7f9-497b-bd9c-2a98a8145787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6182709b-4e98-41be-9c6f-e63a868061da" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_641c0385-c7f9-497b-bd9c-2a98a8145787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_92478776-bd65-4dd8-84e9-77ef328c43d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_641c0385-c7f9-497b-bd9c-2a98a8145787" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_92478776-bd65-4dd8-84e9-77ef328c43d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RestructuringAdjustmentsSeveranceAndFacility_6fb68e56-0353-4d8d-b918-e70cd5af6fbd" xlink:href="icui-20211231.xsd#icui_RestructuringAdjustmentsSeveranceAndFacility"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_641c0385-c7f9-497b-bd9c-2a98a8145787" xlink:to="loc_icui_RestructuringAdjustmentsSeveranceAndFacility_6fb68e56-0353-4d8d-b918-e70cd5af6fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails2" xlink:type="simple" xlink:href="icui-20211231.xsd#RestructuringStrategicTransactionandIntegrationDetails2"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_df672eca-ca2c-476d-949e-9b3f29f5b286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8790be9f-4f8a-4b42-99e9-0fb1cf0ffdbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_df672eca-ca2c-476d-949e-9b3f29f5b286" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8790be9f-4f8a-4b42-99e9-0fb1cf0ffdbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_67e7d35f-c8cd-461a-b8c0-050e397e1687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8790be9f-4f8a-4b42-99e9-0fb1cf0ffdbb" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_67e7d35f-c8cd-461a-b8c0-050e397e1687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_bfb750fe-ad85-4e90-83d3-6575c1bebdfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_67e7d35f-c8cd-461a-b8c0-050e397e1687" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_bfb750fe-ad85-4e90-83d3-6575c1bebdfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_957025f5-a363-41c4-bf4f-6ac0b3976ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_bfb750fe-ad85-4e90-83d3-6575c1bebdfb" xlink:to="loc_us-gaap_EmployeeSeveranceMember_957025f5-a363-41c4-bf4f-6ac0b3976ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SpecialTerminationBenefitsMember_5b40b5c8-a0db-4206-9623-2a730add452d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SpecialTerminationBenefitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_bfb750fe-ad85-4e90-83d3-6575c1bebdfb" xlink:to="loc_us-gaap_SpecialTerminationBenefitsMember_5b40b5c8-a0db-4206-9623-2a730add452d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_3bb6a556-7d39-4faf-8707-9dbe9881cdd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_bfb750fe-ad85-4e90-83d3-6575c1bebdfb" xlink:to="loc_us-gaap_FacilityClosingMember_3bb6a556-7d39-4faf-8707-9dbe9881cdd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_59145e0a-8648-4e0f-a609-3f6b7b943311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8790be9f-4f8a-4b42-99e9-0fb1cf0ffdbb" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_59145e0a-8648-4e0f-a609-3f6b7b943311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_e761d2b8-c32b-4501-bbff-8943677cc319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_59145e0a-8648-4e0f-a609-3f6b7b943311" xlink:to="loc_us-gaap_RestructuringReserve_e761d2b8-c32b-4501-bbff-8943677cc319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_0c5b71a4-9afa-47f7-9697-89c477262f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_59145e0a-8648-4e0f-a609-3f6b7b943311" xlink:to="loc_us-gaap_RestructuringCosts_0c5b71a4-9afa-47f7-9697-89c477262f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_5f2a02f5-473e-4850-9e18-8e183ac743d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_59145e0a-8648-4e0f-a609-3f6b7b943311" xlink:to="loc_us-gaap_PaymentsForRestructuring_5f2a02f5-473e-4850-9e18-8e183ac743d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_3f9ce30c-3da0-4265-a4ac-434340abeaff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_59145e0a-8648-4e0f-a609-3f6b7b943311" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_3f9ce30c-3da0-4265-a4ac-434340abeaff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_f45e9dee-2d95-43b3-ba2c-b9bf0a399b54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_59145e0a-8648-4e0f-a609-3f6b7b943311" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_f45e9dee-2d95-43b3-ba2c-b9bf0a399b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationStrategicTransactionandIntegrationExpensesDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#RestructuringStrategicTransactionandIntegrationStrategicTransactionandIntegrationExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationStrategicTransactionandIntegrationExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d32af334-b7d9-49aa-8427-7102f09a7da9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_StrategicTransactionandIntegration_17edf59b-0cfe-4085-9bd1-4e36515d2051" xlink:href="icui-20211231.xsd#icui_StrategicTransactionandIntegration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d32af334-b7d9-49aa-8427-7102f09a7da9" xlink:to="loc_icui_StrategicTransactionandIntegration_17edf59b-0cfe-4085-9bd1-4e36515d2051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Supplychainrestructuringcosts_898991e9-84cb-4b17-825f-8ca4d688f350" xlink:href="icui-20211231.xsd#icui_Supplychainrestructuringcosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d32af334-b7d9-49aa-8427-7102f09a7da9" xlink:to="loc_icui_Supplychainrestructuringcosts_898991e9-84cb-4b17-825f-8ca4d688f350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Cleanupcosts_7676ace2-2e3b-423e-8fdf-a065c74e6fc7" xlink:href="icui-20211231.xsd#icui_Cleanupcosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d32af334-b7d9-49aa-8427-7102f09a7da9" xlink:to="loc_icui_Cleanupcosts_7676ace2-2e3b-423e-8fdf-a065c74e6fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueNotes" xlink:type="simple" xlink:href="icui-20211231.xsd#RevenueNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d8c6cded-1af8-41c7-866c-cc86c6d50865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_0c817908-7c25-4369-8248-e4a4a6d1e2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d8c6cded-1af8-41c7-866c-cc86c6d50865" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_0c817908-7c25-4369-8248-e4a4a6d1e2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueTables" xlink:type="simple" xlink:href="icui-20211231.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_37905abb-9324-4f67-8d2d-085ba69ac99a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_eee48ff6-3159-4ed1-b20b-9f23ea296739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_37905abb-9324-4f67-8d2d-085ba69ac99a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_eee48ff6-3159-4ed1-b20b-9f23ea296739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_05606f73-118b-4846-baa1-36e37122a909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_37905abb-9324-4f67-8d2d-085ba69ac99a" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_05606f73-118b-4846-baa1-36e37122a909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDisaggregationofRevenueProductLineDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#RevenueDisaggregationofRevenueProductLineDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueDisaggregationofRevenueProductLineDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a6739571-8ab3-449d-9fcb-4a48d3aa0201" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_f050c84b-d2ac-4c2e-956f-84b03b409ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a6739571-8ab3-449d-9fcb-4a48d3aa0201" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_f050c84b-d2ac-4c2e-956f-84b03b409ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_fba5e580-b566-4abc-9788-aea5862e57a8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f050c84b-d2ac-4c2e-956f-84b03b409ebf" xlink:to="loc_srt_ProductOrServiceAxis_fba5e580-b566-4abc-9788-aea5862e57a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7c9b333e-e2c8-41dd-841b-a2e9d7dee86b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_fba5e580-b566-4abc-9788-aea5862e57a8" xlink:to="loc_srt_ProductsAndServicesDomain_7c9b333e-e2c8-41dd-841b-a2e9d7dee86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionConsumablesMember_bff4c654-9dde-48ef-bdb9-107c4ddc83c4" xlink:href="icui-20211231.xsd#icui_InfusionConsumablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7c9b333e-e2c8-41dd-841b-a2e9d7dee86b" xlink:to="loc_icui_InfusionConsumablesMember_bff4c654-9dde-48ef-bdb9-107c4ddc83c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionSystemsMember_6a94d0f1-1173-43dc-b873-76332875be45" xlink:href="icui-20211231.xsd#icui_InfusionSystemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7c9b333e-e2c8-41dd-841b-a2e9d7dee86b" xlink:to="loc_icui_InfusionSystemsMember_6a94d0f1-1173-43dc-b873-76332875be45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IVSolutionsMember_a84d03f6-079c-401c-83b4-668636556319" xlink:href="icui-20211231.xsd#icui_IVSolutionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7c9b333e-e2c8-41dd-841b-a2e9d7dee86b" xlink:to="loc_icui_IVSolutionsMember_a84d03f6-079c-401c-83b4-668636556319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CriticalCareMember_8917d7ab-5790-4219-a324-5996bce7c5dd" xlink:href="icui-20211231.xsd#icui_CriticalCareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7c9b333e-e2c8-41dd-841b-a2e9d7dee86b" xlink:to="loc_icui_CriticalCareMember_8917d7ab-5790-4219-a324-5996bce7c5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c4b7cde9-5189-45e2-bef0-d3c31dc8bc74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f050c84b-d2ac-4c2e-956f-84b03b409ebf" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_c4b7cde9-5189-45e2-bef0-d3c31dc8bc74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_1e1d833c-8323-4b79-abab-5aab9ec35848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c4b7cde9-5189-45e2-bef0-d3c31dc8bc74" xlink:to="loc_us-gaap_Revenues_1e1d833c-8323-4b79-abab-5aab9ec35848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Percentageofrevenue_ce17f8ef-e7b1-4053-bfbc-1e7fb40bdd0f" xlink:href="icui-20211231.xsd#icui_Percentageofrevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c4b7cde9-5189-45e2-bef0-d3c31dc8bc74" xlink:to="loc_icui_Percentageofrevenue_ce17f8ef-e7b1-4053-bfbc-1e7fb40bdd0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDisaggregationofRevenuebyGeographyDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#RevenueDisaggregationofRevenuebyGeographyDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueDisaggregationofRevenuebyGeographyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6769616f-4b30-46a5-9077-8a709b3bcbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_79283f46-b9a1-4ebf-b2b5-6e5170b7a754" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6769616f-4b30-46a5-9077-8a709b3bcbb8" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_79283f46-b9a1-4ebf-b2b5-6e5170b7a754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f2327687-3ba1-40d0-b4ae-87c7d23abf17" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_79283f46-b9a1-4ebf-b2b5-6e5170b7a754" xlink:to="loc_srt_StatementGeographicalAxis_f2327687-3ba1-40d0-b4ae-87c7d23abf17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d2dbb542-e5b6-4b1f-a778-46e26f70b355" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f2327687-3ba1-40d0-b4ae-87c7d23abf17" xlink:to="loc_srt_SegmentGeographicalDomain_d2dbb542-e5b6-4b1f-a778-46e26f70b355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_7c4b4273-23a5-4bc5-bcb2-40426a17e41e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d2dbb542-e5b6-4b1f-a778-46e26f70b355" xlink:to="loc_us-gaap_EMEAMember_7c4b4273-23a5-4bc5-bcb2-40426a17e41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherforeigncountriesMember_626cff77-3124-4a61-975c-624a33933b77" xlink:href="icui-20211231.xsd#icui_OtherforeigncountriesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d2dbb542-e5b6-4b1f-a778-46e26f70b355" xlink:to="loc_icui_OtherforeigncountriesMember_626cff77-3124-4a61-975c-624a33933b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignMember_0bed0b9e-b506-4cf7-b491-fbe7db516abf" xlink:href="icui-20211231.xsd#icui_ForeignMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d2dbb542-e5b6-4b1f-a778-46e26f70b355" xlink:to="loc_icui_ForeignMember_0bed0b9e-b506-4cf7-b491-fbe7db516abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_44935cba-880c-46b6-985d-1808ee970e5f" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d2dbb542-e5b6-4b1f-a778-46e26f70b355" xlink:to="loc_country_US_44935cba-880c-46b6-985d-1808ee970e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InternationalSalesDomain_e383f2e3-ef22-4f63-b235-6ee071e60388" xlink:href="icui-20211231.xsd#icui_InternationalSalesDomain"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d2dbb542-e5b6-4b1f-a778-46e26f70b355" xlink:to="loc_icui_InternationalSalesDomain_e383f2e3-ef22-4f63-b235-6ee071e60388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_9e03a600-2247-47c2-a697-ad92375ab191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_79283f46-b9a1-4ebf-b2b5-6e5170b7a754" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_9e03a600-2247-47c2-a697-ad92375ab191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Percentoftotalrevenue_6975b757-a371-4f0e-976b-f78b64661129" xlink:href="icui-20211231.xsd#icui_Percentoftotalrevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9e03a600-2247-47c2-a697-ad92375ab191" xlink:to="loc_icui_Percentoftotalrevenue_6975b757-a371-4f0e-976b-f78b64661129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a590dcaa-b80f-4b68-b01e-381243289f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9e03a600-2247-47c2-a697-ad92375ab191" xlink:to="loc_us-gaap_Revenues_a590dcaa-b80f-4b68-b01e-381243289f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueContractLiabilitiesDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#RevenueContractLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueContractLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5d77b3a1-c191-4601-89f7-81290f46afbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesTable_66d914dc-d92f-48b9-bbbf-5dc2417f7308" xlink:href="icui-20211231.xsd#icui_ContractassetandliabilitybalancesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5d77b3a1-c191-4601-89f7-81290f46afbd" xlink:to="loc_icui_ContractassetandliabilitybalancesTable_66d914dc-d92f-48b9-bbbf-5dc2417f7308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_728bdeb9-929f-4d68-935b-1f152372ce89" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_66d914dc-d92f-48b9-bbbf-5dc2417f7308" xlink:to="loc_srt_ProductOrServiceAxis_728bdeb9-929f-4d68-935b-1f152372ce89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1d02e4dd-8f52-4bb0-ade6-e3e621ee3522" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_728bdeb9-929f-4d68-935b-1f152372ce89" xlink:to="loc_srt_ProductsAndServicesDomain_1d02e4dd-8f52-4bb0-ade6-e3e621ee3522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EquipmentrevenueMember_c0bc4a3f-3311-4f98-842c-7271389a52c7" xlink:href="icui-20211231.xsd#icui_EquipmentrevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1d02e4dd-8f52-4bb0-ade6-e3e621ee3522" xlink:to="loc_icui_EquipmentrevenueMember_c0bc4a3f-3311-4f98-842c-7271389a52c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SoftwarerevenueMember_727fd294-6336-4f15-96f2-25d67f49448d" xlink:href="icui-20211231.xsd#icui_SoftwarerevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1d02e4dd-8f52-4bb0-ade6-e3e621ee3522" xlink:to="loc_icui_SoftwarerevenueMember_727fd294-6336-4f15-96f2-25d67f49448d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesLineItems_2cf71310-0509-436f-9b0c-573c0c4978f6" xlink:href="icui-20211231.xsd#icui_ContractassetandliabilitybalancesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_66d914dc-d92f-48b9-bbbf-5dc2417f7308" xlink:to="loc_icui_ContractassetandliabilitybalancesLineItems_2cf71310-0509-436f-9b0c-573c0c4978f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_COntractLiabilityRollforwardRollForward_553b60be-69f3-499d-bfb7-04161c79e66a" xlink:href="icui-20211231.xsd#icui_COntractLiabilityRollforwardRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_2cf71310-0509-436f-9b0c-573c0c4978f6" xlink:to="loc_icui_COntractLiabilityRollforwardRollForward_553b60be-69f3-499d-bfb7-04161c79e66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_9051a92e-df9b-477f-b4c4-ea79a9b655c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_COntractLiabilityRollforwardRollForward_553b60be-69f3-499d-bfb7-04161c79e66a" xlink:to="loc_us-gaap_ContractWithCustomerLiability_9051a92e-df9b-477f-b4c4-ea79a9b655c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_5833759c-fa83-402d-b9a4-706c0f9bf271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_COntractLiabilityRollforwardRollForward_553b60be-69f3-499d-bfb7-04161c79e66a" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_5833759c-fa83-402d-b9a4-706c0f9bf271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueAdditions_c3f18b96-a30e-4a5a-9813-77166de458e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueAdditions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_COntractLiabilityRollforwardRollForward_553b60be-69f3-499d-bfb7-04161c79e66a" xlink:to="loc_us-gaap_DeferredRevenueAdditions_c3f18b96-a30e-4a5a-9813-77166de458e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_c364101d-ee51-4a6b-b8ed-291cd976c405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_COntractLiabilityRollforwardRollForward_553b60be-69f3-499d-bfb7-04161c79e66a" xlink:to="loc_us-gaap_ContractWithCustomerLiability_c364101d-ee51-4a6b-b8ed-291cd976c405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueContractLiabilitiesTextDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#RevenueContractLiabilitiesTextDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueContractLiabilitiesTextDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c84d8872-00bb-4ef6-bb46-2a4208bceb45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesTable_5e238cda-a8dd-4d37-89c7-55431a39411e" xlink:href="icui-20211231.xsd#icui_ContractassetandliabilitybalancesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c84d8872-00bb-4ef6-bb46-2a4208bceb45" xlink:to="loc_icui_ContractassetandliabilitybalancesTable_5e238cda-a8dd-4d37-89c7-55431a39411e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0a964030-9b18-46b8-b8a2-5220b413eb47" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_5e238cda-a8dd-4d37-89c7-55431a39411e" xlink:to="loc_srt_ProductOrServiceAxis_0a964030-9b18-46b8-b8a2-5220b413eb47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_92468c7f-1d72-4b64-b272-8997c7b61efa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_0a964030-9b18-46b8-b8a2-5220b413eb47" xlink:to="loc_srt_ProductsAndServicesDomain_92468c7f-1d72-4b64-b272-8997c7b61efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EquipmentrevenueMember_419d9707-e026-4661-ad03-ef5c97a541c9" xlink:href="icui-20211231.xsd#icui_EquipmentrevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_92468c7f-1d72-4b64-b272-8997c7b61efa" xlink:to="loc_icui_EquipmentrevenueMember_419d9707-e026-4661-ad03-ef5c97a541c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SoftwarerevenueMember_dfd3fbe4-a895-4382-8d0c-88dfa712eb74" xlink:href="icui-20211231.xsd#icui_SoftwarerevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_92468c7f-1d72-4b64-b272-8997c7b61efa" xlink:to="loc_icui_SoftwarerevenueMember_dfd3fbe4-a895-4382-8d0c-88dfa712eb74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesLineItems_9148698e-62fa-4bd9-89b3-75291de0ebec" xlink:href="icui-20211231.xsd#icui_ContractassetandliabilitybalancesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_5e238cda-a8dd-4d37-89c7-55431a39411e" xlink:to="loc_icui_ContractassetandliabilitybalancesLineItems_9148698e-62fa-4bd9-89b3-75291de0ebec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_0ff2b126-3324-400a-8733-711860a8966a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_9148698e-62fa-4bd9-89b3-75291de0ebec" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_0ff2b126-3324-400a-8733-711860a8966a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_d5413aff-ae5f-4f50-bd06-9c393a05aa35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_9148698e-62fa-4bd9-89b3-75291de0ebec" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_d5413aff-ae5f-4f50-bd06-9c393a05aa35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesNotes" xlink:type="simple" xlink:href="icui-20211231.xsd#LeasesNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7edee0a8-28ed-4d37-b96e-c6b156c43b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LesseeOperatingAndFinanceLeaseTextBlock_643ff89b-9fc7-455d-a283-dca36d3363b2" xlink:href="icui-20211231.xsd#icui_LesseeOperatingAndFinanceLeaseTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7edee0a8-28ed-4d37-b96e-c6b156c43b62" xlink:to="loc_icui_LesseeOperatingAndFinanceLeaseTextBlock_643ff89b-9fc7-455d-a283-dca36d3363b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesTables" xlink:type="simple" xlink:href="icui-20211231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_852fe3af-5e67-4cc4-b05a-3535d26f41c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_13101522-ef52-4032-8aff-e80cc5167b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_852fe3af-5e67-4cc4-b05a-3535d26f41c1" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_13101522-ef52-4032-8aff-e80cc5167b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SupplementalCashFlowInformationLeasesTableTextBlock_fa3b13e0-dece-4963-b775-3544c2ef6849" xlink:href="icui-20211231.xsd#icui_SupplementalCashFlowInformationLeasesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_852fe3af-5e67-4cc4-b05a-3535d26f41c1" xlink:to="loc_icui_SupplementalCashFlowInformationLeasesTableTextBlock_fa3b13e0-dece-4963-b775-3544c2ef6849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SupplementalBalanceSheetInformationLeasesTableTextBlock_5b8c40d4-28ed-4673-a8e0-18c096f30552" xlink:href="icui-20211231.xsd#icui_SupplementalBalanceSheetInformationLeasesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_852fe3af-5e67-4cc4-b05a-3535d26f41c1" xlink:to="loc_icui_SupplementalBalanceSheetInformationLeasesTableTextBlock_5b8c40d4-28ed-4673-a8e0-18c096f30552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_048e83c6-2d8e-4a7b-ab4f-a157324730e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_852fe3af-5e67-4cc4-b05a-3535d26f41c1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_048e83c6-2d8e-4a7b-ab4f-a157324730e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#LeasesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8b78ed22-b9a9-46bd-91a6-345f615e9ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_66102017-1f14-4b4e-a428-9919b715ab5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8b78ed22-b9a9-46bd-91a6-345f615e9ed4" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_66102017-1f14-4b4e-a428-9919b715ab5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ed5015d9-3f36-4196-9d59-9a3bdda0c7cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_66102017-1f14-4b4e-a428-9919b715ab5f" xlink:to="loc_srt_RangeAxis_ed5015d9-3f36-4196-9d59-9a3bdda0c7cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0a0acd3e-312f-4e5a-aef6-6de4fa51d7ba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ed5015d9-3f36-4196-9d59-9a3bdda0c7cc" xlink:to="loc_srt_RangeMember_0a0acd3e-312f-4e5a-aef6-6de4fa51d7ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_704e7962-445d-4eda-a5cb-9f78f82234e4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0a0acd3e-312f-4e5a-aef6-6de4fa51d7ba" xlink:to="loc_srt_MinimumMember_704e7962-445d-4eda-a5cb-9f78f82234e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e02cd580-00a9-4f5d-8373-84c5938e3173" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0a0acd3e-312f-4e5a-aef6-6de4fa51d7ba" xlink:to="loc_srt_MaximumMember_e02cd580-00a9-4f5d-8373-84c5938e3173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4b761bf-37a7-4598-a822-49187144d3be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_66102017-1f14-4b4e-a428-9919b715ab5f" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4b761bf-37a7-4598-a822-49187144d3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Optiontoextendinyears_3a164583-6108-45c6-a672-8f55aeaa5cfb" xlink:href="icui-20211231.xsd#icui_Optiontoextendinyears"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4b761bf-37a7-4598-a822-49187144d3be" xlink:to="loc_icui_Optiontoextendinyears_3a164583-6108-45c6-a672-8f55aeaa5cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_82779e3d-46b7-4b81-bf9b-b68a68f47eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4b761bf-37a7-4598-a822-49187144d3be" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_82779e3d-46b7-4b81-bf9b-b68a68f47eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#LeasesLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a69ab4fc-7751-45bf-b94d-831c25527e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_88beb15f-d443-4a1b-87cf-8b06fb9d2113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a69ab4fc-7751-45bf-b94d-831c25527e1b" xlink:to="loc_us-gaap_OperatingLeaseCost_88beb15f-d443-4a1b-87cf-8b06fb9d2113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_6f937ab7-905b-4218-bc85-0ae935014cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a69ab4fc-7751-45bf-b94d-831c25527e1b" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_6f937ab7-905b-4218-bc85-0ae935014cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_8e0ef936-b2ba-48f5-8d0c-905dc9cb7519" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a69ab4fc-7751-45bf-b94d-831c25527e1b" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_8e0ef936-b2ba-48f5-8d0c-905dc9cb7519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_8bdea4a9-681b-48da-854d-1a437b780647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a69ab4fc-7751-45bf-b94d-831c25527e1b" xlink:to="loc_us-gaap_ShortTermLeaseCost_8bdea4a9-681b-48da-854d-1a437b780647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_c06055d4-caad-429c-a416-66e6428dfb22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a69ab4fc-7751-45bf-b94d-831c25527e1b" xlink:to="loc_us-gaap_LeaseCost_c06055d4-caad-429c-a416-66e6428dfb22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesSupplementalCashFlowLeaseInformationDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#LeasesSupplementalCashFlowLeaseInformationDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesSupplementalCashFlowLeaseInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0e784408-f0a2-4352-8937-56f01ea70f54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_e5b804a4-3338-4d2c-9d0d-c020998769ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0e784408-f0a2-4352-8937-56f01ea70f54" xlink:to="loc_us-gaap_OperatingLeasePayments_e5b804a4-3338-4d2c-9d0d-c020998769ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_c2c1b552-9655-45fc-a032-04d239cc5382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0e784408-f0a2-4352-8937-56f01ea70f54" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_c2c1b552-9655-45fc-a032-04d239cc5382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_fba5fc30-98f8-4ddd-8e10-ccb05524f273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0e784408-f0a2-4352-8937-56f01ea70f54" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_fba5fc30-98f8-4ddd-8e10-ccb05524f273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_c3a52bf6-444a-4e2c-889c-cacad3e8a3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0e784408-f0a2-4352-8937-56f01ea70f54" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_c3a52bf6-444a-4e2c-889c-cacad3e8a3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesSupplementalBalanceSheetLeaseinformationDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#LeasesSupplementalBalanceSheetLeaseinformationDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesSupplementalBalanceSheetLeaseinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6aab481f-56bf-4425-9a49-71cec81c3a50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_f57e7704-4244-49fc-a1a8-f04b1450cea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6aab481f-56bf-4425-9a49-71cec81c3a50" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_f57e7704-4244-49fc-a1a8-f04b1450cea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7adda564-e415-4741-aefe-6f44b05ea236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6aab481f-56bf-4425-9a49-71cec81c3a50" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7adda564-e415-4741-aefe-6f44b05ea236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_28b3b654-0468-49b3-aa9f-97c57b598ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6aab481f-56bf-4425-9a49-71cec81c3a50" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_28b3b654-0468-49b3-aa9f-97c57b598ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_efb458fc-d0ec-4b52-8ecb-764580df53c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6aab481f-56bf-4425-9a49-71cec81c3a50" xlink:to="loc_us-gaap_OperatingLeaseLiability_efb458fc-d0ec-4b52-8ecb-764580df53c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_ed38549b-eb14-4174-b8f0-b53c19fa2986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6aab481f-56bf-4425-9a49-71cec81c3a50" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_ed38549b-eb14-4174-b8f0-b53c19fa2986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_4702a2a1-fb1d-4006-a212-9bb37260526e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6aab481f-56bf-4425-9a49-71cec81c3a50" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_4702a2a1-fb1d-4006-a212-9bb37260526e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_13304c42-df29-4c49-ae6c-927d63ba2049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6aab481f-56bf-4425-9a49-71cec81c3a50" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_13304c42-df29-4c49-ae6c-927d63ba2049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_b20d2f2c-8f58-44f1-b06e-82af87de1224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6aab481f-56bf-4425-9a49-71cec81c3a50" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_b20d2f2c-8f58-44f1-b06e-82af87de1224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FinanceLeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#FinanceLeasesSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FinanceLeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ef1e3e25-8d5c-4f0b-8698-ea49fa29891b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_4d058c92-e2d8-4a4f-a4d9-048c605aaeb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ef1e3e25-8d5c-4f0b-8698-ea49fa29891b" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_4d058c92-e2d8-4a4f-a4d9-048c605aaeb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_750fbe7c-bc4d-4a45-97ab-1266749577b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ef1e3e25-8d5c-4f0b-8698-ea49fa29891b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_750fbe7c-bc4d-4a45-97ab-1266749577b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_f0892dca-deb1-4b9c-91c8-759d22df5b61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ef1e3e25-8d5c-4f0b-8698-ea49fa29891b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_f0892dca-deb1-4b9c-91c8-759d22df5b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_5cb15e4c-b4d5-42db-a00c-bed1fa84601d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ef1e3e25-8d5c-4f0b-8698-ea49fa29891b" xlink:to="loc_us-gaap_FinanceLeaseLiability_5cb15e4c-b4d5-42db-a00c-bed1fa84601d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_47243e16-4b92-46ed-8815-c3e2f2e1eb5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ef1e3e25-8d5c-4f0b-8698-ea49fa29891b" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_47243e16-4b92-46ed-8815-c3e2f2e1eb5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_c3eea94d-ad2a-4ef4-a5c3-521d5e8139d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ef1e3e25-8d5c-4f0b-8698-ea49fa29891b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_c3eea94d-ad2a-4ef4-a5c3-521d5e8139d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_dcd541bf-5acd-4cf3-ad74-fecee2d541e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ef1e3e25-8d5c-4f0b-8698-ea49fa29891b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_dcd541bf-5acd-4cf3-ad74-fecee2d541e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_8aaf77d7-bee0-489a-b76e-5b15d8124393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ef1e3e25-8d5c-4f0b-8698-ea49fa29891b" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_8aaf77d7-bee0-489a-b76e-5b15d8124393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_cb5181b5-4061-403c-be06-c707409907d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ef1e3e25-8d5c-4f0b-8698-ea49fa29891b" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_cb5181b5-4061-403c-be06-c707409907d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesLeaseMaturityDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#LeasesLeaseMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f40f561d-5e31-40fc-b581-17a8667cb83c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8f2b12a3-bcc4-49b1-b4c0-77d7340396c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f40f561d-5e31-40fc-b581-17a8667cb83c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8f2b12a3-bcc4-49b1-b4c0-77d7340396c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_316c8c77-828d-439b-adc3-da2abf859559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f40f561d-5e31-40fc-b581-17a8667cb83c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_316c8c77-828d-439b-adc3-da2abf859559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_548ddfb8-6e12-4277-97c3-73fdf2f56c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f40f561d-5e31-40fc-b581-17a8667cb83c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_548ddfb8-6e12-4277-97c3-73fdf2f56c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3dc7d6db-d54a-4117-8a84-4dcc9fab6d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f40f561d-5e31-40fc-b581-17a8667cb83c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3dc7d6db-d54a-4117-8a84-4dcc9fab6d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d350da13-be17-47e5-a477-a5a2ad14af5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f40f561d-5e31-40fc-b581-17a8667cb83c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d350da13-be17-47e5-a477-a5a2ad14af5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3ab019b7-8bd7-4008-99d4-301a1ab2f61b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f40f561d-5e31-40fc-b581-17a8667cb83c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3ab019b7-8bd7-4008-99d4-301a1ab2f61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_21edc321-9a1b-4be9-a416-15aca5abea4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f40f561d-5e31-40fc-b581-17a8667cb83c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_21edc321-9a1b-4be9-a416-15aca5abea4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_24fd24ea-eca2-40f8-acf7-c8a481bd82c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f40f561d-5e31-40fc-b581-17a8667cb83c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_24fd24ea-eca2-40f8-acf7-c8a481bd82c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_263c930d-3e79-4873-a2d6-ee522d96a10d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f40f561d-5e31-40fc-b581-17a8667cb83c" xlink:to="loc_us-gaap_OperatingLeaseLiability_263c930d-3e79-4873-a2d6-ee522d96a10d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesFinanceLeaseMaturityDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#LeasesFinanceLeaseMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesFinanceLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_abca874a-a0d2-436a-8c33-609bcef553ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_e5a5b26e-1ec4-47e4-b826-057a6c3ef76b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_abca874a-a0d2-436a-8c33-609bcef553ae" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_e5a5b26e-1ec4-47e4-b826-057a6c3ef76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_085e1e48-d370-4d32-86c2-a9b47a5a3d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_abca874a-a0d2-436a-8c33-609bcef553ae" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_085e1e48-d370-4d32-86c2-a9b47a5a3d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_dd622e98-a983-48e2-bbfd-61254fa5f8fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_abca874a-a0d2-436a-8c33-609bcef553ae" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_dd622e98-a983-48e2-bbfd-61254fa5f8fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_15c29501-ad85-4053-8c32-944bbd3bedc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_abca874a-a0d2-436a-8c33-609bcef553ae" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_15c29501-ad85-4053-8c32-944bbd3bedc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_5735ddaa-108f-4620-83a8-0ef3cd09b733" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_abca874a-a0d2-436a-8c33-609bcef553ae" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_5735ddaa-108f-4620-83a8-0ef3cd09b733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_0d4202d2-6882-495a-b19a-02838b4b1902" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_abca874a-a0d2-436a-8c33-609bcef553ae" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_0d4202d2-6882-495a-b19a-02838b4b1902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_580f1867-ac56-4d0a-9e7c-0a8e3f55c241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_abca874a-a0d2-436a-8c33-609bcef553ae" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_580f1867-ac56-4d0a-9e7c-0a8e3f55c241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_650a918a-46fb-44b5-a44f-471621f347e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_abca874a-a0d2-436a-8c33-609bcef553ae" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_650a918a-46fb-44b5-a44f-471621f347e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_6e47a172-a32a-4420-b0be-c8d0da1f7591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_abca874a-a0d2-436a-8c33-609bcef553ae" xlink:to="loc_us-gaap_FinanceLeaseLiability_6e47a172-a32a-4420-b0be-c8d0da1f7591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ShareBasedAwardShareawardsNotes" xlink:type="simple" xlink:href="icui-20211231.xsd#ShareBasedAwardShareawardsNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/ShareBasedAwardShareawardsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_85f722be-9528-4af0-b9ce-5208dd1a0884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1eb4e772-b536-40de-9ebe-92e40418d0c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_85f722be-9528-4af0-b9ce-5208dd1a0884" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1eb4e772-b536-40de-9ebe-92e40418d0c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ShareBasedAwardTables" xlink:type="simple" xlink:href="icui-20211231.xsd#ShareBasedAwardTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/ShareBasedAwardTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c4e29771-f7b5-46bb-adad-80af93820213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock_67754d81-ecc4-4587-825d-64175a63db42" xlink:href="icui-20211231.xsd#icui_ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c4e29771-f7b5-46bb-adad-80af93820213" xlink:to="loc_icui_ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock_67754d81-ecc4-4587-825d-64175a63db42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_ad97b375-31e7-4e7e-a37e-990abec55982" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c4e29771-f7b5-46bb-adad-80af93820213" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_ad97b375-31e7-4e7e-a37e-990abec55982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_a4255fad-2977-4e5d-b5aa-e46c4e7c6c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c4e29771-f7b5-46bb-adad-80af93820213" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_a4255fad-2977-4e5d-b5aa-e46c4e7c6c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ExercisedOptionsDataTableTextBlock_bb82a433-1ccb-4d88-94ba-26962cd72625" xlink:href="icui-20211231.xsd#icui_ExercisedOptionsDataTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c4e29771-f7b5-46bb-adad-80af93820213" xlink:to="loc_icui_ExercisedOptionsDataTableTextBlock_bb82a433-1ccb-4d88-94ba-26962cd72625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_1c5321c3-3d20-49f3-8b86-b49d63e29ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c4e29771-f7b5-46bb-adad-80af93820213" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_1c5321c3-3d20-49f3-8b86-b49d63e29ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_a04fc47c-085c-49f5-a149-4deb0d1469df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c4e29771-f7b5-46bb-adad-80af93820213" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_a04fc47c-085c-49f5-a149-4deb0d1469df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ShareBasedAwardStockBasedCompensationDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#ShareBasedAwardStockBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/ShareBasedAwardStockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8544908f-85c6-4817-bd9d-f5079282a384" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_1c052545-5943-428b-b4ce-604727bac4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8544908f-85c6-4817-bd9d-f5079282a384" xlink:to="loc_us-gaap_ShareBasedCompensation_1c052545-5943-428b-b4ce-604727bac4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_79a65ada-1a5f-421b-bf71-02d5038a76d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8544908f-85c6-4817-bd9d-f5079282a384" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_79a65ada-1a5f-421b-bf71-02d5038a76d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IndirectTaxBenefitFromStockOptions_68f99f65-cbca-4d59-95cd-9e49943f2d8e" xlink:href="icui-20211231.xsd#icui_IndirectTaxBenefitFromStockOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8544908f-85c6-4817-bd9d-f5079282a384" xlink:to="loc_icui_IndirectTaxBenefitFromStockOptions_68f99f65-cbca-4d59-95cd-9e49943f2d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_619febcb-a2e6-4064-a887-7b2c984df578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8544908f-85c6-4817-bd9d-f5079282a384" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_619febcb-a2e6-4064-a887-7b2c984df578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8b91c4b8-6626-48fc-9912-cbf7e9b40933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8544908f-85c6-4817-bd9d-f5079282a384" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8b91c4b8-6626-48fc-9912-cbf7e9b40933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#ShareBasedAwardStockOptionPlansDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cfeaa0b4-2602-472c-980b-8105624aa9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_StockIncentivePlansTable_a143d03d-aaf7-497b-8ee9-72432479ccb4" xlink:href="icui-20211231.xsd#icui_StockIncentivePlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cfeaa0b4-2602-472c-980b-8105624aa9a9" xlink:to="loc_icui_StockIncentivePlansTable_a143d03d-aaf7-497b-8ee9-72432479ccb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_df719b4d-4abb-443f-b2cf-6439bc52b282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_StockIncentivePlansTable_a143d03d-aaf7-497b-8ee9-72432479ccb4" xlink:to="loc_us-gaap_AwardTypeAxis_df719b4d-4abb-443f-b2cf-6439bc52b282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_54efda05-001a-49f2-a98a-24139a1424b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_df719b4d-4abb-443f-b2cf-6439bc52b282" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_54efda05-001a-49f2-a98a-24139a1424b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8306b634-4686-4100-b320-805b5ffcfbf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_54efda05-001a-49f2-a98a-24139a1424b0" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8306b634-4686-4100-b320-805b5ffcfbf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_46db19f9-387b-485c-b7d0-9b1d437f717f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_54efda05-001a-49f2-a98a-24139a1424b0" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_46db19f9-387b-485c-b7d0-9b1d437f717f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b76405f2-ad71-4ff8-9d08-760008c9f3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_StockIncentivePlansTable_a143d03d-aaf7-497b-8ee9-72432479ccb4" xlink:to="loc_us-gaap_PlanNameAxis_b76405f2-ad71-4ff8-9d08-760008c9f3a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_206456c4-41d0-414c-a316-afd399c83710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_b76405f2-ad71-4ff8-9d08-760008c9f3a2" xlink:to="loc_us-gaap_PlanNameDomain_206456c4-41d0-414c-a316-afd399c83710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_A2011PlanMember_e139f772-1e1e-484c-9590-a6a7b09b07a3" xlink:href="icui-20211231.xsd#icui_A2011PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_206456c4-41d0-414c-a316-afd399c83710" xlink:to="loc_icui_A2011PlanMember_e139f772-1e1e-484c-9590-a6a7b09b07a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_A2003PlanMember_0a415448-270a-40b1-b896-bd9bd720c5fa" xlink:href="icui-20211231.xsd#icui_A2003PlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_206456c4-41d0-414c-a316-afd399c83710" xlink:to="loc_icui_A2003PlanMember_0a415448-270a-40b1-b896-bd9bd720c5fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_StockIncentivePlansLineItems_e9dcabfe-2dc9-4a42-8d57-2b0e7fc615d4" xlink:href="icui-20211231.xsd#icui_StockIncentivePlansLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_StockIncentivePlansTable_a143d03d-aaf7-497b-8ee9-72432479ccb4" xlink:to="loc_icui_StockIncentivePlansLineItems_e9dcabfe-2dc9-4a42-8d57-2b0e7fc615d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_58fd230d-3ada-478b-872a-5c06614410a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_StockIncentivePlansLineItems_e9dcabfe-2dc9-4a42-8d57-2b0e7fc615d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_58fd230d-3ada-478b-872a-5c06614410a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_fd980ffc-0a3a-42ea-9ef3-335f2ff5ecfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_StockIncentivePlansLineItems_e9dcabfe-2dc9-4a42-8d57-2b0e7fc615d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_fd980ffc-0a3a-42ea-9ef3-335f2ff5ecfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Sharestransferredfromsupersededplan_bda14d69-f8f8-4d9a-a0c7-4ca71ee93211" xlink:href="icui-20211231.xsd#icui_Sharestransferredfromsupersededplan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_StockIncentivePlansLineItems_e9dcabfe-2dc9-4a42-8d57-2b0e7fc615d4" xlink:to="loc_icui_Sharestransferredfromsupersededplan_bda14d69-f8f8-4d9a-a0c7-4ca71ee93211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_062b08f6-2782-4b8b-b86b-a5537168ac03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_StockIncentivePlansLineItems_e9dcabfe-2dc9-4a42-8d57-2b0e7fc615d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_062b08f6-2782-4b8b-b86b-a5537168ac03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#ShareBasedAwardStockOptionsGrantedandValuationDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a81f1f6f-76bb-4992-9839-5355afc99be7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1f3418-4a15-4c47-ab83-a186e4a93f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a81f1f6f-76bb-4992-9839-5355afc99be7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1f3418-4a15-4c47-ab83-a186e4a93f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b3f7d965-2858-42f2-93f6-eb397e7adc52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1f3418-4a15-4c47-ab83-a186e4a93f06" xlink:to="loc_us-gaap_PlanNameAxis_b3f7d965-2858-42f2-93f6-eb397e7adc52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e1b5ac3a-b04e-4d6b-9719-412e13205cce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_b3f7d965-2858-42f2-93f6-eb397e7adc52" xlink:to="loc_us-gaap_PlanNameDomain_e1b5ac3a-b04e-4d6b-9719-412e13205cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_A2011PlanMember_dc1d5007-938e-4f57-933e-630031db5ca8" xlink:href="icui-20211231.xsd#icui_A2011PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_e1b5ac3a-b04e-4d6b-9719-412e13205cce" xlink:to="loc_icui_A2011PlanMember_dc1d5007-938e-4f57-933e-630031db5ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_A2003PlanMember_e76abbce-e403-4fcd-b73e-fd2b5144ec5a" xlink:href="icui-20211231.xsd#icui_A2003PlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_e1b5ac3a-b04e-4d6b-9719-412e13205cce" xlink:to="loc_icui_A2003PlanMember_e76abbce-e403-4fcd-b73e-fd2b5144ec5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c71e8fcf-9910-44c6-b879-c3a9901a0c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1f3418-4a15-4c47-ab83-a186e4a93f06" xlink:to="loc_us-gaap_AwardTypeAxis_c71e8fcf-9910-44c6-b879-c3a9901a0c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d66b4d8-ff27-4932-8b4d-58149d8d4ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c71e8fcf-9910-44c6-b879-c3a9901a0c6a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d66b4d8-ff27-4932-8b4d-58149d8d4ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimebasedstockoptionMember_9f2a434a-4b8b-46ad-b2fc-f24daeade7e6" xlink:href="icui-20211231.xsd#icui_TimebasedstockoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d66b4d8-ff27-4932-8b4d-58149d8d4ab9" xlink:to="loc_icui_TimebasedstockoptionMember_9f2a434a-4b8b-46ad-b2fc-f24daeade7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_8fdd8fe3-127e-4e96-90c7-e7dd614137aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d66b4d8-ff27-4932-8b4d-58149d8d4ab9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_8fdd8fe3-127e-4e96-90c7-e7dd614137aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de5589b5-8cc3-4d37-8197-a3e38263ed3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1f3418-4a15-4c47-ab83-a186e4a93f06" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de5589b5-8cc3-4d37-8197-a3e38263ed3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_fe85bf0b-5e05-4558-bf70-b9ded66f6c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de5589b5-8cc3-4d37-8197-a3e38263ed3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_fe85bf0b-5e05-4558-bf70-b9ded66f6c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Timebasedoptionsgrantdatefairvalue_e94fe7e3-bea8-40a2-bbfc-2deb05e152dc" xlink:href="icui-20211231.xsd#icui_Timebasedoptionsgrantdatefairvalue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de5589b5-8cc3-4d37-8197-a3e38263ed3a" xlink:to="loc_icui_Timebasedoptionsgrantdatefairvalue_e94fe7e3-bea8-40a2-bbfc-2deb05e152dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_46efe5c6-c427-4b2f-8ac8-c0903270fab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de5589b5-8cc3-4d37-8197-a3e38263ed3a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_46efe5c6-c427-4b2f-8ac8-c0903270fab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_869b6672-7548-47e5-aae9-d68f7adefb72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de5589b5-8cc3-4d37-8197-a3e38263ed3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_869b6672-7548-47e5-aae9-d68f7adefb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ad25d547-ba6a-4291-8738-0df35a593449" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de5589b5-8cc3-4d37-8197-a3e38263ed3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ad25d547-ba6a-4291-8738-0df35a593449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e01c2b4d-7edf-4d39-8cb2-25b1580d600e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de5589b5-8cc3-4d37-8197-a3e38263ed3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e01c2b4d-7edf-4d39-8cb2-25b1580d600e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0c3a7946-012c-436d-9c34-fa8b5e89ef4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de5589b5-8cc3-4d37-8197-a3e38263ed3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0c3a7946-012c-436d-9c34-fa8b5e89ef4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ce249b3b-400e-4850-b8ac-671828ea4196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de5589b5-8cc3-4d37-8197-a3e38263ed3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ce249b3b-400e-4850-b8ac-671828ea4196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#ShareBasedAwardStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_363ac6d5-9b8b-434a-8b77-583c7c91b2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fab86346-a9bb-4527-8a9f-b5edf57656f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_363ac6d5-9b8b-434a-8b77-583c7c91b2b1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fab86346-a9bb-4527-8a9f-b5edf57656f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a0136923-4107-482a-8cb8-583f50ac718d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fab86346-a9bb-4527-8a9f-b5edf57656f5" xlink:to="loc_us-gaap_AwardTypeAxis_a0136923-4107-482a-8cb8-583f50ac718d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6244c363-4dc4-41e5-a30b-eafd2c1d001f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a0136923-4107-482a-8cb8-583f50ac718d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6244c363-4dc4-41e5-a30b-eafd2c1d001f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_40d47416-39a8-412c-be33-ba237ade23bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6244c363-4dc4-41e5-a30b-eafd2c1d001f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_40d47416-39a8-412c-be33-ba237ade23bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fab86346-a9bb-4527-8a9f-b5edf57656f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_70083047-ede1-409f-b83e-bc0739ebfcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_70083047-ede1-409f-b83e-bc0739ebfcc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_51bd39b5-9c88-4fef-8dcd-1da99d024f20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_51bd39b5-9c88-4fef-8dcd-1da99d024f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b4c58420-4c54-425b-8f97-4da7e65308af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b4c58420-4c54-425b-8f97-4da7e65308af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_f6957bf2-f559-451e-8736-1165209fa1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_f6957bf2-f559-451e-8736-1165209fa1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bea95758-edc3-4599-9a7f-90d09d5ee3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bea95758-edc3-4599-9a7f-90d09d5ee3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9fe469ee-f9bc-4a66-a7da-8c1139d78a08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9fe469ee-f9bc-4a66-a7da-8c1139d78a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_322376e2-943e-4d10-af78-1c1a9c2799e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_322376e2-943e-4d10-af78-1c1a9c2799e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_06cc6ba8-59df-4acb-8321-cb182fee76f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_06cc6ba8-59df-4acb-8321-cb182fee76f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9f570060-027a-4f2f-ae97-ea1e163f2f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9f570060-027a-4f2f-ae97-ea1e163f2f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6117838b-c547-43c2-90af-72132a5a7657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6117838b-c547-43c2-90af-72132a5a7657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_3e67e3e3-3ed9-4b33-b093-e5f37792eaf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_3e67e3e3-3ed9-4b33-b093-e5f37792eaf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d113bf8e-5c2b-4d61-b039-0fad5392da00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d113bf8e-5c2b-4d61-b039-0fad5392da00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_37451acb-3ad0-4c65-a2fa-73b1eabf317f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_37451acb-3ad0-4c65-a2fa-73b1eabf317f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_41b0d2f0-3ad1-4c63-ada9-02f7f68c838d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_41b0d2f0-3ad1-4c63-ada9-02f7f68c838d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_2ee57938-4f5a-4f3c-bd0c-410950dc0c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_2ee57938-4f5a-4f3c-bd0c-410950dc0c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4382b97b-8b58-4750-96ca-dd8f3117fc3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4382b97b-8b58-4750-96ca-dd8f3117fc3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_6244b9f4-424b-4b33-9977-83644923acdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_6244b9f4-424b-4b33-9977-83644923acdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a42cb44b-beee-49d0-8013-613fa8a07eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a42cb44b-beee-49d0-8013-613fa8a07eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ac119be7-da2b-4753-a010-0f1281c65a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ac119be7-da2b-4753-a010-0f1281c65a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2910b010-f5fd-48d1-bcf4-775605306425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53fb14b2-5983-4a31-ae57-00689229803a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2910b010-f5fd-48d1-bcf4-775605306425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ShareBasedAwardShareAwarddataDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#ShareBasedAwardShareAwarddataDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/ShareBasedAwardShareAwarddataDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShareawarddataAbstract_06a970cd-edb1-4af9-a577-d5b07d8425a9" xlink:href="icui-20211231.xsd#icui_ShareawarddataAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_622fb0b6-b404-46b0-95e9-2c0f68c4bc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ShareawarddataAbstract_06a970cd-edb1-4af9-a577-d5b07d8425a9" xlink:to="loc_us-gaap_SharePrice_622fb0b6-b404-46b0-95e9-2c0f68c4bc1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ShareBasedAwardOptionsexerciseddataDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#ShareBasedAwardOptionsexerciseddataDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/ShareBasedAwardOptionsexerciseddataDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_87a690cb-63f6-46bf-9e88-d9f544091235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0b80c80e-b9b3-45ac-a2e2-290675ebc3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_87a690cb-63f6-46bf-9e88-d9f544091235" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0b80c80e-b9b3-45ac-a2e2-290675ebc3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_552d7afb-c80e-449b-afd2-c430dcd43311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_87a690cb-63f6-46bf-9e88-d9f544091235" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_552d7afb-c80e-449b-afd2-c430dcd43311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_d9cbf05c-105f-4244-86e2-82cfcfb52e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_87a690cb-63f6-46bf-9e88-d9f544091235" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_d9cbf05c-105f-4244-86e2-82cfcfb52e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#ShareBasedAwardRSUandPRSUDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19a5f937-cccc-44c0-a569-7bc5c4ff855c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ac00d23-be41-49c6-91a2-a339117b45e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19a5f937-cccc-44c0-a569-7bc5c4ff855c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ac00d23-be41-49c6-91a2-a339117b45e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_25b0196c-6a6a-41ec-a1fd-9a0f2bd06742" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ac00d23-be41-49c6-91a2-a339117b45e4" xlink:to="loc_us-gaap_AwardTypeAxis_25b0196c-6a6a-41ec-a1fd-9a0f2bd06742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d193992d-3cf9-4d91-a759-2b603c013cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_25b0196c-6a6a-41ec-a1fd-9a0f2bd06742" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d193992d-3cf9-4d91-a759-2b603c013cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PerformanceRestrictedStockUnitsPRSUsMember_4fe37f10-e1b1-4ca0-bc26-cbeb4678b9b6" xlink:href="icui-20211231.xsd#icui_PerformanceRestrictedStockUnitsPRSUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d193992d-3cf9-4d91-a759-2b603c013cf6" xlink:to="loc_icui_PerformanceRestrictedStockUnitsPRSUsMember_4fe37f10-e1b1-4ca0-bc26-cbeb4678b9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_241f4a64-70e7-43ef-aed0-f229b3078d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d193992d-3cf9-4d91-a759-2b603c013cf6" xlink:to="loc_us-gaap_PerformanceSharesMember_241f4a64-70e7-43ef-aed0-f229b3078d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_de2e1d3b-5fe1-4a4c-956b-c5f1a74fd727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d193992d-3cf9-4d91-a759-2b603c013cf6" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_de2e1d3b-5fe1-4a4c-956b-c5f1a74fd727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_230b90e7-5e46-4c58-ab48-9d0d7177747c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ac00d23-be41-49c6-91a2-a339117b45e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_230b90e7-5e46-4c58-ab48-9d0d7177747c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2575ea4d-037c-476b-9149-544be5ff5962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_230b90e7-5e46-4c58-ab48-9d0d7177747c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2575ea4d-037c-476b-9149-544be5ff5962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PerformanceSharesEarned_d8fc194c-d0cb-4416-a7b6-c04715027752" xlink:href="icui-20211231.xsd#icui_PerformanceSharesEarned"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_230b90e7-5e46-4c58-ab48-9d0d7177747c" xlink:to="loc_icui_PerformanceSharesEarned_d8fc194c-d0cb-4416-a7b6-c04715027752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9c1a3876-c554-40fb-84fa-56a212957125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_230b90e7-5e46-4c58-ab48-9d0d7177747c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9c1a3876-c554-40fb-84fa-56a212957125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Grantdatefairvalueperformancerestrictedstockunits_49daa903-3fc1-4d4a-b64d-75cde174ca0a" xlink:href="icui-20211231.xsd#icui_Grantdatefairvalueperformancerestrictedstockunits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_230b90e7-5e46-4c58-ab48-9d0d7177747c" xlink:to="loc_icui_Grantdatefairvalueperformancerestrictedstockunits_49daa903-3fc1-4d4a-b64d-75cde174ca0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Grantdatefairvalueofrestrictedstockunitsgranted_354eb5d1-7936-4e52-b527-14ae850b44cd" xlink:href="icui-20211231.xsd#icui_Grantdatefairvalueofrestrictedstockunitsgranted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_230b90e7-5e46-4c58-ab48-9d0d7177747c" xlink:to="loc_icui_Grantdatefairvalueofrestrictedstockunitsgranted_354eb5d1-7936-4e52-b527-14ae850b44cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_eb0bee38-aefa-4433-824b-0dd8daf78abe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_230b90e7-5e46-4c58-ab48-9d0d7177747c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_eb0bee38-aefa-4433-824b-0dd8daf78abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ModifiedPRSUIncrementalExpense_2e0e0537-acbd-411d-a8af-9eee26f17c27" xlink:href="icui-20211231.xsd#icui_ModifiedPRSUIncrementalExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_230b90e7-5e46-4c58-ab48-9d0d7177747c" xlink:to="loc_icui_ModifiedPRSUIncrementalExpense_2e0e0537-acbd-411d-a8af-9eee26f17c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#ShareBasedAwardRSUandPRSURollforwardDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_781b601a-01ea-4958-b558-97ca500c9f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_83773412-6a27-4a30-9f00-5dbf40fec515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_781b601a-01ea-4958-b558-97ca500c9f5d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_83773412-6a27-4a30-9f00-5dbf40fec515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_806a3fe4-b4c3-495c-8299-0816b054675b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_83773412-6a27-4a30-9f00-5dbf40fec515" xlink:to="loc_us-gaap_AwardTypeAxis_806a3fe4-b4c3-495c-8299-0816b054675b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cdcb6780-7daf-4305-8602-1ea5142f5805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_806a3fe4-b4c3-495c-8299-0816b054675b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cdcb6780-7daf-4305-8602-1ea5142f5805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RestrictedStockAndPerformanceRestrictedStockUnitsMember_b875b2f5-af9f-4a6c-8805-b5c04607e7f3" xlink:href="icui-20211231.xsd#icui_RestrictedStockAndPerformanceRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cdcb6780-7daf-4305-8602-1ea5142f5805" xlink:to="loc_icui_RestrictedStockAndPerformanceRestrictedStockUnitsMember_b875b2f5-af9f-4a6c-8805-b5c04607e7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_83773412-6a27-4a30-9f00-5dbf40fec515" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_005c6dea-33eb-49e9-b49f-6f3e68e8d4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_005c6dea-33eb-49e9-b49f-6f3e68e8d4c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_54f64d2e-90f5-4f07-9799-cd2e04d1e614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_54f64d2e-90f5-4f07-9799-cd2e04d1e614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Changeinunitsduetoperformanceexpectations_8a623c21-7085-4745-8f80-91c78873ae90" xlink:href="icui-20211231.xsd#icui_Changeinunitsduetoperformanceexpectations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_icui_Changeinunitsduetoperformanceexpectations_8a623c21-7085-4745-8f80-91c78873ae90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue_70bbaf69-67ae-4bf5-abb2-5a0b1a75602a" xlink:href="icui-20211231.xsd#icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue_70bbaf69-67ae-4bf5-abb2-5a0b1a75602a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_129e8eac-6e3d-43cb-a343-22f262ca7de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_129e8eac-6e3d-43cb-a343-22f262ca7de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0ac0ffe3-e9e9-4b11-83f5-bfacbefb768c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0ac0ffe3-e9e9-4b11-83f5-bfacbefb768c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d513bce4-0dc5-46f1-850e-04af633e96c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d513bce4-0dc5-46f1-850e-04af633e96c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_6408eb8e-0bec-49dd-b388-dff672387ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_6408eb8e-0bec-49dd-b388-dff672387ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_51d838c2-3730-43bb-9a73-934e71a6eefd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_51d838c2-3730-43bb-9a73-934e71a6eefd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue_721aec4f-4c13-4e76-ac84-6d218c79f040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue_721aec4f-4c13-4e76-ac84-6d218c79f040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_acb38243-b9d1-487e-b7e6-ef588ad76f03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_acb38243-b9d1-487e-b7e6-ef588ad76f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_151ba53f-7772-41cf-93a6-2ec12fa1dbdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36265960-1f06-429d-aed8-f3561b6e031d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_151ba53f-7772-41cf-93a6-2ec12fa1dbdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/ShareBasedAwardESPPNarrativeDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#ShareBasedAwardESPPNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/ShareBasedAwardESPPNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_86304c78-2b71-411b-910a-6965c738a22b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ESPPOriginalIssuance_75245260-442b-4db2-ba7b-1cf133e27199" xlink:href="icui-20211231.xsd#icui_ESPPOriginalIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_86304c78-2b71-411b-910a-6965c738a22b" xlink:to="loc_icui_ESPPOriginalIssuance_75245260-442b-4db2-ba7b-1cf133e27199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ESPPAnnualIssuanceIncreaseLimit_c5dcbdd6-437b-42fb-9d42-1ca66d0d9541" xlink:href="icui-20211231.xsd#icui_ESPPAnnualIssuanceIncreaseLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_86304c78-2b71-411b-910a-6965c738a22b" xlink:to="loc_icui_ESPPAnnualIssuanceIncreaseLimit_c5dcbdd6-437b-42fb-9d42-1ca66d0d9541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SharesAvailableInEmployeeStockPurchasePlan_202340de-8e93-4ce5-ad17-86d3fd737425" xlink:href="icui-20211231.xsd#icui_SharesAvailableInEmployeeStockPurchasePlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_86304c78-2b71-411b-910a-6965c738a22b" xlink:to="loc_icui_SharesAvailableInEmployeeStockPurchasePlan_202340de-8e93-4ce5-ad17-86d3fd737425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativesandHedgingActivitiesNotes" xlink:type="simple" xlink:href="icui-20211231.xsd#DerivativesandHedgingActivitiesNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativesandHedgingActivitiesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c670d767-d6cb-41f5-a8fb-e194af49e98c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_f169f90b-2305-42f1-abc2-2bb394b7e613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c670d767-d6cb-41f5-a8fb-e194af49e98c" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_f169f90b-2305-42f1-abc2-2bb394b7e613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativesandHedgingActivitiesTables" xlink:type="simple" xlink:href="icui-20211231.xsd#DerivativesandHedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativesandHedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_52c7a115-6c0e-4510-b30e-652d5df54360" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_f031adcc-0a44-4a18-afb8-7c0efaa20146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_52c7a115-6c0e-4510-b30e-652d5df54360" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_f031adcc-0a44-4a18-afb8-7c0efaa20146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_deae7e01-e69d-4bd1-a2fc-24323d754fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_52c7a115-6c0e-4510-b30e-652d5df54360" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_deae7e01-e69d-4bd1-a2fc-24323d754fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#DerivativesandHedgingActivitiesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ad801635-b965-4d04-b125-6793862d4eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_8eed295c-b3c9-4e02-adcc-aebf81581e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ad801635-b965-4d04-b125-6793862d4eb7" xlink:to="loc_us-gaap_DerivativeTable_8eed295c-b3c9-4e02-adcc-aebf81581e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4ec07973-4981-47a2-9925-8379344d3252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8eed295c-b3c9-4e02-adcc-aebf81581e4f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4ec07973-4981-47a2-9925-8379344d3252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d12f9fb6-b8e1-4b4c-9965-da9934a3e477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4ec07973-4981-47a2-9925-8379344d3252" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d12f9fb6-b8e1-4b4c-9965-da9934a3e477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge1Member_d1f70b6f-26c0-47fc-9a65-d7c638baf8b1" xlink:href="icui-20211231.xsd#icui_Hedge1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d12f9fb6-b8e1-4b4c-9965-da9934a3e477" xlink:to="loc_icui_Hedge1Member_d1f70b6f-26c0-47fc-9a65-d7c638baf8b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge2Member_5f9075cc-5cc4-4f60-9aca-f24afd99b0c9" xlink:href="icui-20211231.xsd#icui_Hedge2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d12f9fb6-b8e1-4b4c-9965-da9934a3e477" xlink:to="loc_icui_Hedge2Member_5f9075cc-5cc4-4f60-9aca-f24afd99b0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge3MemberMember_0e419e68-b913-4f28-aedb-71722df29ba6" xlink:href="icui-20211231.xsd#icui_Hedge3MemberMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d12f9fb6-b8e1-4b4c-9965-da9934a3e477" xlink:to="loc_icui_Hedge3MemberMember_0e419e68-b913-4f28-aedb-71722df29ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge4Member_021d924d-21aa-4706-b01d-df2cfdf07e70" xlink:href="icui-20211231.xsd#icui_Hedge4Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d12f9fb6-b8e1-4b4c-9965-da9934a3e477" xlink:to="loc_icui_Hedge4Member_021d924d-21aa-4706-b01d-df2cfdf07e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge5Member_6dadb024-d533-43d6-af82-9b3fa089ac88" xlink:href="icui-20211231.xsd#icui_Hedge5Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d12f9fb6-b8e1-4b4c-9965-da9934a3e477" xlink:to="loc_icui_Hedge5Member_6dadb024-d533-43d6-af82-9b3fa089ac88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_fb7442ec-6027-4f4b-91e2-4aeba977c950" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d12f9fb6-b8e1-4b4c-9965-da9934a3e477" xlink:to="loc_us-gaap_InterestRateSwapMember_fb7442ec-6027-4f4b-91e2-4aeba977c950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_UsGaap_InterestRateSwap2Member_0808407a-6d38-4f75-8ffa-5e8a426e4b7f" xlink:href="icui-20211231.xsd#icui_UsGaap_InterestRateSwap2Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d12f9fb6-b8e1-4b4c-9965-da9934a3e477" xlink:to="loc_icui_UsGaap_InterestRateSwap2Member_0808407a-6d38-4f75-8ffa-5e8a426e4b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_968c9780-80fd-45c7-b0e1-2891618dccce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8eed295c-b3c9-4e02-adcc-aebf81581e4f" xlink:to="loc_srt_RangeAxis_968c9780-80fd-45c7-b0e1-2891618dccce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_35183fec-42d6-42f2-b1d1-5357b6391909" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_968c9780-80fd-45c7-b0e1-2891618dccce" xlink:to="loc_srt_RangeMember_35183fec-42d6-42f2-b1d1-5357b6391909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b80f9768-9afc-4154-9e3a-1b8cd6e445d3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_35183fec-42d6-42f2-b1d1-5357b6391909" xlink:to="loc_srt_MaximumMember_b80f9768-9afc-4154-9e3a-1b8cd6e445d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_61ea4afd-7410-4aa1-9147-a84189d6b01d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_35183fec-42d6-42f2-b1d1-5357b6391909" xlink:to="loc_srt_MinimumMember_61ea4afd-7410-4aa1-9147-a84189d6b01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_9c35f56b-8732-40be-84c9-1a60c6dee34a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8eed295c-b3c9-4e02-adcc-aebf81581e4f" xlink:to="loc_us-gaap_DerivativeLineItems_9c35f56b-8732-40be-84c9-1a60c6dee34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeForwardExchangeRate1_8eeebdd7-8aff-4283-8ddb-4a2397ccac96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeForwardExchangeRate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9c35f56b-8732-40be-84c9-1a60c6dee34a" xlink:to="loc_us-gaap_DerivativeForwardExchangeRate1_8eeebdd7-8aff-4283-8ddb-4a2397ccac96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_ff7b3e83-1bdb-47bf-a25c-4e4c7439117b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9c35f56b-8732-40be-84c9-1a60c6dee34a" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_ff7b3e83-1bdb-47bf-a25c-4e4c7439117b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_f8ae0bdb-67ab-474e-9164-f79aafb1d0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9c35f56b-8732-40be-84c9-1a60c6dee34a" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_f8ae0bdb-67ab-474e-9164-f79aafb1d0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_d6522698-b415-4803-8a47-64646876e0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9c35f56b-8732-40be-84c9-1a60c6dee34a" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_d6522698-b415-4803-8a47-64646876e0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DerivativeInterestRateFloor_73ae46ef-a428-47b2-a0d0-0e17327f4177" xlink:href="icui-20211231.xsd#icui_DerivativeInterestRateFloor"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9c35f56b-8732-40be-84c9-1a60c6dee34a" xlink:to="loc_icui_DerivativeInterestRateFloor_73ae46ef-a428-47b2-a0d0-0e17327f4177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_190961fa-59e9-42e2-bf5b-eec371ad4f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9c35f56b-8732-40be-84c9-1a60c6dee34a" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_190961fa-59e9-42e2-bf5b-eec371ad4f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_4f0329f5-0bd0-4aad-a941-26a51793380f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9c35f56b-8732-40be-84c9-1a60c6dee34a" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_4f0329f5-0bd0-4aad-a941-26a51793380f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c1aae110-b70b-4a03-aa70-339eff5fd2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_dc97b7d8-8588-4654-8448-608f23dbed45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c1aae110-b70b-4a03-aa70-339eff5fd2c6" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_dc97b7d8-8588-4654-8448-608f23dbed45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3d651f73-e39c-4a8a-9aba-36edf78074b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_dc97b7d8-8588-4654-8448-608f23dbed45" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3d651f73-e39c-4a8a-9aba-36edf78074b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bd0ff965-50d6-4b4f-846e-527f2d0a0c42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3d651f73-e39c-4a8a-9aba-36edf78074b9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bd0ff965-50d6-4b4f-846e-527f2d0a0c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_f0e5a28f-5b5c-419e-8d10-42dce2cbd354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd0ff965-50d6-4b4f-846e-527f2d0a0c42" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_f0e5a28f-5b5c-419e-8d10-42dce2cbd354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3df41b95-6780-4608-a636-f5dc0601fd8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd0ff965-50d6-4b4f-846e-527f2d0a0c42" xlink:to="loc_us-gaap_InterestRateSwapMember_3df41b95-6780-4608-a636-f5dc0601fd8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_098cbd38-24d2-4991-bcd5-53dcb42e644d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd0ff965-50d6-4b4f-846e-527f2d0a0c42" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_098cbd38-24d2-4991-bcd5-53dcb42e644d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_85619e68-7851-43c2-970a-015514bf8a26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd0ff965-50d6-4b4f-846e-527f2d0a0c42" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_85619e68-7851-43c2-970a-015514bf8a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsTotalMember_34a0e223-053e-4e1f-8173-26579517640f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsTotalMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd0ff965-50d6-4b4f-846e-527f2d0a0c42" xlink:to="loc_us-gaap_AssetsTotalMember_34a0e223-053e-4e1f-8173-26579517640f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_a0bdabcd-f27d-4046-8fd6-47f13ba36c40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_dc97b7d8-8588-4654-8448-608f23dbed45" xlink:to="loc_us-gaap_HedgingDesignationAxis_a0bdabcd-f27d-4046-8fd6-47f13ba36c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a91b4b8a-da47-40bc-acef-53bc8ada6e53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_a0bdabcd-f27d-4046-8fd6-47f13ba36c40" xlink:to="loc_us-gaap_HedgingDesignationDomain_a91b4b8a-da47-40bc-acef-53bc8ada6e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ba05110e-ae1c-4893-bc88-7718dd2e6a09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_a91b4b8a-da47-40bc-acef-53bc8ada6e53" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ba05110e-ae1c-4893-bc88-7718dd2e6a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d717c8a4-35e5-4927-aab6-95f9a11180cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_dc97b7d8-8588-4654-8448-608f23dbed45" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d717c8a4-35e5-4927-aab6-95f9a11180cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e0fc0518-bd2d-4e27-9bb2-198e66462592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d717c8a4-35e5-4927-aab6-95f9a11180cd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e0fc0518-bd2d-4e27-9bb2-198e66462592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_177fff04-44e1-40fe-986b-d1412df081be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e0fc0518-bd2d-4e27-9bb2-198e66462592" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_177fff04-44e1-40fe-986b-d1412df081be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_ff0cf67c-d567-49e9-a549-a91b25942f62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e0fc0518-bd2d-4e27-9bb2-198e66462592" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_ff0cf67c-d567-49e9-a549-a91b25942f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_efa80666-6b89-4cc5-a33c-d8dafd66bd81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e0fc0518-bd2d-4e27-9bb2-198e66462592" xlink:to="loc_us-gaap_OtherAssetsMember_efa80666-6b89-4cc5-a33c-d8dafd66bd81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_998e1221-ddf8-4bc0-88fa-9b57b3d67664" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e0fc0518-bd2d-4e27-9bb2-198e66462592" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_998e1221-ddf8-4bc0-88fa-9b57b3d67664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_d31ef893-0d5d-47be-845d-24f8234a91d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e0fc0518-bd2d-4e27-9bb2-198e66462592" xlink:to="loc_us-gaap_OtherLiabilitiesMember_d31ef893-0d5d-47be-845d-24f8234a91d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsTotalMember_988d2ef0-6c47-43a6-9a67-9dc7016e4927" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsTotalMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e0fc0518-bd2d-4e27-9bb2-198e66462592" xlink:to="loc_us-gaap_AssetsTotalMember_988d2ef0-6c47-43a6-9a67-9dc7016e4927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_c779450f-ece6-463d-a6de-d36d9281cd93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsAssetsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e0fc0518-bd2d-4e27-9bb2-198e66462592" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_c779450f-ece6-463d-a6de-d36d9281cd93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesTotalMember_58816ae1-51bd-4f5e-934d-a377d3c0797b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesTotalMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e0fc0518-bd2d-4e27-9bb2-198e66462592" xlink:to="loc_us-gaap_LiabilitiesTotalMember_58816ae1-51bd-4f5e-934d-a377d3c0797b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_c0df4992-ba9a-4d3c-bc98-eb7a642b49a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_dc97b7d8-8588-4654-8448-608f23dbed45" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_c0df4992-ba9a-4d3c-bc98-eb7a642b49a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_f131a96f-076e-472d-b6d8-fb5853027647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_c0df4992-ba9a-4d3c-bc98-eb7a642b49a4" xlink:to="loc_us-gaap_DerivativeAssets_f131a96f-076e-472d-b6d8-fb5853027647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_8c17dc40-8a8e-4b31-8ea2-f767a4e8d9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_c0df4992-ba9a-4d3c-bc98-eb7a642b49a4" xlink:to="loc_us-gaap_DerivativeLiabilities_8c17dc40-8a8e-4b31-8ea2-f767a4e8d9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_20aa5ee9-bc58-42ed-9161-134a0e32c377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_ed0737dd-64b4-497f-ba2a-dc6ac2adf579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_20aa5ee9-bc58-42ed-9161-134a0e32c377" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_ed0737dd-64b4-497f-ba2a-dc6ac2adf579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_6ecddaec-4488-4cdf-8085-ba4d632cf09a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_20aa5ee9-bc58-42ed-9161-134a0e32c377" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_6ecddaec-4488-4cdf-8085-ba4d632cf09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f05a1264-de9d-4d48-95fa-5f7cae5052b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1be7d52b-c0ff-4419-a056-45bf66f8b9af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f05a1264-de9d-4d48-95fa-5f7cae5052b6" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1be7d52b-c0ff-4419-a056-45bf66f8b9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_257e096e-2d1f-437f-a7b3-faab10a55ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1be7d52b-c0ff-4419-a056-45bf66f8b9af" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_257e096e-2d1f-437f-a7b3-faab10a55ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_aa8d7c8e-b43a-4c22-b0e9-4a06721ffabf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_257e096e-2d1f-437f-a7b3-faab10a55ab7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_aa8d7c8e-b43a-4c22-b0e9-4a06721ffabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_afaa4b91-05bd-4295-a880-878b72b80c43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_aa8d7c8e-b43a-4c22-b0e9-4a06721ffabf" xlink:to="loc_us-gaap_CashFlowHedgingMember_afaa4b91-05bd-4295-a880-878b72b80c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_22ae3b36-c454-461a-b8d1-38c7e6194813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1be7d52b-c0ff-4419-a056-45bf66f8b9af" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_22ae3b36-c454-461a-b8d1-38c7e6194813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b8911d47-ae7d-486a-8e46-a8e25ac8b8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_22ae3b36-c454-461a-b8d1-38c7e6194813" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b8911d47-ae7d-486a-8e46-a8e25ac8b8b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_0dd7d788-d292-447d-b8a1-fbfdddb9a982" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b8911d47-ae7d-486a-8e46-a8e25ac8b8b2" xlink:to="loc_us-gaap_CostOfSalesMember_0dd7d788-d292-447d-b8a1-fbfdddb9a982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f3d608d7-5177-4088-a0bc-4d9b8ec81803" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1be7d52b-c0ff-4419-a056-45bf66f8b9af" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f3d608d7-5177-4088-a0bc-4d9b8ec81803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e5ead52d-f434-43ce-aa02-e8a55f484597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f3d608d7-5177-4088-a0bc-4d9b8ec81803" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e5ead52d-f434-43ce-aa02-e8a55f484597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_310edbab-8453-46ca-a08e-1c04246af554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e5ead52d-f434-43ce-aa02-e8a55f484597" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_310edbab-8453-46ca-a08e-1c04246af554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_4ee30f43-4f9f-49e5-8dbe-167da8998e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e5ead52d-f434-43ce-aa02-e8a55f484597" xlink:to="loc_us-gaap_CashFlowHedgingMember_4ee30f43-4f9f-49e5-8dbe-167da8998e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_8a00c176-e131-490e-a6ef-96d45ca3bc6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e5ead52d-f434-43ce-aa02-e8a55f484597" xlink:to="loc_us-gaap_InterestRateSwapMember_8a00c176-e131-490e-a6ef-96d45ca3bc6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_ba015430-9e89-4ef0-88f2-2f9a7fcc5d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1be7d52b-c0ff-4419-a056-45bf66f8b9af" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_ba015430-9e89-4ef0-88f2-2f9a7fcc5d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_8e05069f-c9e2-4dc6-8636-69cb6235250d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_ba015430-9e89-4ef0-88f2-2f9a7fcc5d1d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_8e05069f-c9e2-4dc6-8636-69cb6235250d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e2ad9bcc-ac5d-4510-8e4e-0bf894a7543a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_ba015430-9e89-4ef0-88f2-2f9a7fcc5d1d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e2ad9bcc-ac5d-4510-8e4e-0bf894a7543a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_961aac4e-ef8e-4ac8-8c93-e605cba50a92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_ba015430-9e89-4ef0-88f2-2f9a7fcc5d1d" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_961aac4e-ef8e-4ac8-8c93-e605cba50a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasurementNotes" xlink:type="simple" xlink:href="icui-20211231.xsd#FairValueMeasurementNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasurementNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cf67b907-f6c6-48ee-8337-9a3cb4492ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_71a86be3-fc03-4ef9-a063-0e4278c46aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cf67b907-f6c6-48ee-8337-9a3cb4492ca1" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_71a86be3-fc03-4ef9-a063-0e4278c46aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasurementTables" xlink:type="simple" xlink:href="icui-20211231.xsd#FairValueMeasurementTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasurementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d25e76c3-b1ef-4d43-b754-022bd2e2eef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_959668a3-9357-416f-a414-65a24f7cdff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d25e76c3-b1ef-4d43-b754-022bd2e2eef2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_959668a3-9357-416f-a414-65a24f7cdff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_96108439-4678-4993-93ea-87cacd7d449f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_959668a3-9357-416f-a414-65a24f7cdff0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_96108439-4678-4993-93ea-87cacd7d449f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b44f9b7-89e6-48cc-b40c-2e8ee3addd87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_96108439-4678-4993-93ea-87cacd7d449f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b44f9b7-89e6-48cc-b40c-2e8ee3addd87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_HospiraMember_c89046d9-ddf2-49ac-8d90-dc34523e439b" xlink:href="icui-20211231.xsd#icui_HospiraMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b44f9b7-89e6-48cc-b40c-2e8ee3addd87" xlink:to="loc_icui_HospiraMember_c89046d9-ddf2-49ac-8d90-dc34523e439b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_da4c1cc7-2e86-4554-a974-fdfc7e2da134" xlink:href="icui-20211231.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b44f9b7-89e6-48cc-b40c-2e8ee3addd87" xlink:to="loc_icui_PursuitVascularInc.Member_da4c1cc7-2e86-4554-a974-fdfc7e2da134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2b542fe5-c53c-42a8-89b8-c243d9baf3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_959668a3-9357-416f-a414-65a24f7cdff0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2b542fe5-c53c-42a8-89b8-c243d9baf3e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_0f907446-1896-4ec1-a029-24212ebdfa30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2b542fe5-c53c-42a8-89b8-c243d9baf3e1" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_0f907446-1896-4ec1-a029-24212ebdfa30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_137f02ba-9508-480b-8d9c-4c69877b374b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2b542fe5-c53c-42a8-89b8-c243d9baf3e1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_137f02ba-9508-480b-8d9c-4c69877b374b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_02068a98-8a65-465b-9e25-041f6feac522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2b542fe5-c53c-42a8-89b8-c243d9baf3e1" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_02068a98-8a65-465b-9e25-041f6feac522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasurementTextDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#FairValueMeasurementTextDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasurementTextDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cb39e049-8120-40d2-9de2-0778b13a10e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_994d5384-d375-4798-9b5e-2978b47c39a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cb39e049-8120-40d2-9de2-0778b13a10e7" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_994d5384-d375-4798-9b5e-2978b47c39a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d986e72b-d458-4718-978d-56b610a2d050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_994d5384-d375-4798-9b5e-2978b47c39a5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d986e72b-d458-4718-978d-56b610a2d050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c45506a-3816-4a14-92ad-1195684ea57d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d986e72b-d458-4718-978d-56b610a2d050" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c45506a-3816-4a14-92ad-1195684ea57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_HospiraMember_5657ddb4-2667-4e04-907a-d61b531223c3" xlink:href="icui-20211231.xsd#icui_HospiraMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c45506a-3816-4a14-92ad-1195684ea57d" xlink:to="loc_icui_HospiraMember_5657ddb4-2667-4e04-907a-d61b531223c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_4f2ddd2c-b05d-492d-9b82-c5d5f7edee1b" xlink:href="icui-20211231.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c45506a-3816-4a14-92ad-1195684ea57d" xlink:to="loc_icui_PursuitVascularInc.Member_4f2ddd2c-b05d-492d-9b82-c5d5f7edee1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularLLCMember_0edaf43f-155b-44a8-b2f4-71726c5dae86" xlink:href="icui-20211231.xsd#icui_PursuitVascularLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c45506a-3816-4a14-92ad-1195684ea57d" xlink:to="loc_icui_PursuitVascularLLCMember_0edaf43f-155b-44a8-b2f4-71726c5dae86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignDistibutorMember_e737483e-c7a8-467d-8512-e35c0d584bcd" xlink:href="icui-20211231.xsd#icui_ForeignDistibutorMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c45506a-3816-4a14-92ad-1195684ea57d" xlink:to="loc_icui_ForeignDistibutorMember_e737483e-c7a8-467d-8512-e35c0d584bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_015d200d-5cbc-4c3c-84b3-fc425553775f" xlink:href="icui-20211231.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c45506a-3816-4a14-92ad-1195684ea57d" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_015d200d-5cbc-4c3c-84b3-fc425553775f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8e30bbc5-98c7-43c4-80bd-dfcc58143911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_994d5384-d375-4798-9b5e-2978b47c39a5" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8e30bbc5-98c7-43c4-80bd-dfcc58143911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_ceb2c863-5faf-4e1a-8e5d-83d00246ecbb" xlink:href="icui-20211231.xsd#icui_Contingentconsiderationgross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8e30bbc5-98c7-43c4-80bd-dfcc58143911" xlink:to="loc_icui_Contingentconsiderationgross_ceb2c863-5faf-4e1a-8e5d-83d00246ecbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0e03f2fc-a632-4110-aa8f-1adecbd15da1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8e30bbc5-98c7-43c4-80bd-dfcc58143911" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0e03f2fc-a632-4110-aa8f-1adecbd15da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermContingentConsiderationGross_c8932040-745a-42e3-a2f4-44f6a93c75a4" xlink:href="icui-20211231.xsd#icui_ShortTermContingentConsiderationGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8e30bbc5-98c7-43c4-80bd-dfcc58143911" xlink:to="loc_icui_ShortTermContingentConsiderationGross_c8932040-745a-42e3-a2f4-44f6a93c75a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermContingentConsiderationGross_6f07b017-f60b-4547-8a18-3e77de7f482e" xlink:href="icui-20211231.xsd#icui_LongTermContingentConsiderationGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8e30bbc5-98c7-43c4-80bd-dfcc58143911" xlink:to="loc_icui_LongTermContingentConsiderationGross_6f07b017-f60b-4547-8a18-3e77de7f482e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasurementDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#FairValueMeasurementDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasurementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d5c8373a-9625-4205-93e3-29698ac70683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_b4b5130c-2302-41f6-baae-eabcf6ade32c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d5c8373a-9625-4205-93e3-29698ac70683" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_b4b5130c-2302-41f6-baae-eabcf6ade32c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3a5835af-7000-4a5d-b6f4-28983ec1f9bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_b4b5130c-2302-41f6-baae-eabcf6ade32c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3a5835af-7000-4a5d-b6f4-28983ec1f9bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7fb117bb-7c74-4fab-aa09-fa2d43d7fe73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3a5835af-7000-4a5d-b6f4-28983ec1f9bf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7fb117bb-7c74-4fab-aa09-fa2d43d7fe73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_e2a7060f-7cf8-4c95-8b32-8c5b08f9a621" xlink:href="icui-20211231.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7fb117bb-7c74-4fab-aa09-fa2d43d7fe73" xlink:to="loc_icui_PursuitVascularInc.Member_e2a7060f-7cf8-4c95-8b32-8c5b08f9a621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_HospiraMember_e5e9d91b-3d13-459a-992b-5d46ca7116d8" xlink:href="icui-20211231.xsd#icui_HospiraMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7fb117bb-7c74-4fab-aa09-fa2d43d7fe73" xlink:to="loc_icui_HospiraMember_e5e9d91b-3d13-459a-992b-5d46ca7116d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularLLCMember_448dc160-04cf-4403-9631-e9ada09712f9" xlink:href="icui-20211231.xsd#icui_PursuitVascularLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7fb117bb-7c74-4fab-aa09-fa2d43d7fe73" xlink:to="loc_icui_PursuitVascularLLCMember_448dc160-04cf-4403-9631-e9ada09712f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6ac2bf80-5c53-4bf7-83b7-9b4ccdb9180a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_b4b5130c-2302-41f6-baae-eabcf6ade32c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6ac2bf80-5c53-4bf7-83b7-9b4ccdb9180a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5ce31398-8062-4031-8945-a10825c60f78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6ac2bf80-5c53-4bf7-83b7-9b4ccdb9180a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5ce31398-8062-4031-8945-a10825c60f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_f3101884-5633-49be-b6cf-892ed4997948" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6ac2bf80-5c53-4bf7-83b7-9b4ccdb9180a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_f3101884-5633-49be-b6cf-892ed4997948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_21e349cc-924d-4d77-a663-6365af7d1590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6ac2bf80-5c53-4bf7-83b7-9b4ccdb9180a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_21e349cc-924d-4d77-a663-6365af7d1590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_7c5ca3d7-bca4-4a94-b57f-e259239199d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6ac2bf80-5c53-4bf7-83b7-9b4ccdb9180a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_7c5ca3d7-bca4-4a94-b57f-e259239199d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesHospiraQuantitativeInformationDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#FairValueMeasurementFairValueInputsLiabilitiesHospiraQuantitativeInformationDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesHospiraQuantitativeInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_953c8a4c-44bd-4b3a-bb25-b4e42ac34b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_0c754a63-a655-454f-af4f-02ed58cbffd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_953c8a4c-44bd-4b3a-bb25-b4e42ac34b9e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_0c754a63-a655-454f-af4f-02ed58cbffd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_59d26c2a-ff80-414c-adae-086649e4acda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_0c754a63-a655-454f-af4f-02ed58cbffd9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_59d26c2a-ff80-414c-adae-086649e4acda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b2f926eb-1527-4dce-8588-9ac80f529901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_59d26c2a-ff80-414c-adae-086649e4acda" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b2f926eb-1527-4dce-8588-9ac80f529901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_HospiraMember_970df24d-0306-4333-83fc-a509af2ca86f" xlink:href="icui-20211231.xsd#icui_HospiraMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b2f926eb-1527-4dce-8588-9ac80f529901" xlink:to="loc_icui_HospiraMember_970df24d-0306-4333-83fc-a509af2ca86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_55fdf48b-845e-42d0-916a-6685ff116370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_0c754a63-a655-454f-af4f-02ed58cbffd9" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_55fdf48b-845e-42d0-916a-6685ff116370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_13b5fbbf-9a67-4fae-b3e4-713ce3e03307" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_55fdf48b-845e-42d0-916a-6685ff116370" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_13b5fbbf-9a67-4fae-b3e4-713ce3e03307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_c9023fc5-5846-49f0-9955-67a6641e3e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_13b5fbbf-9a67-4fae-b3e4-713ce3e03307" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_c9023fc5-5846-49f0-9955-67a6641e3e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2935ac32-cdcc-4cc3-9b5a-e8f8505850c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_0c754a63-a655-454f-af4f-02ed58cbffd9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2935ac32-cdcc-4cc3-9b5a-e8f8505850c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_6e0ad42c-eb26-47f8-8e23-5b7d7ef18658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2935ac32-cdcc-4cc3-9b5a-e8f8505850c7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_6e0ad42c-eb26-47f8-8e23-5b7d7ef18658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_41eb122f-97a6-44c9-9f60-6150442474ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fe464819-113d-45fc-b182-fb1a8e72dc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_41eb122f-97a6-44c9-9f60-6150442474ac" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fe464819-113d-45fc-b182-fb1a8e72dc9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_45afda0e-f0ad-431e-83c4-00bd3ab9e031" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fe464819-113d-45fc-b182-fb1a8e72dc9c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_45afda0e-f0ad-431e-83c4-00bd3ab9e031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_456c33c6-c8d5-4e70-b5a8-c21daedc4290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_45afda0e-f0ad-431e-83c4-00bd3ab9e031" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_456c33c6-c8d5-4e70-b5a8-c21daedc4290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_2a2bf8a5-8c47-4b53-8c56-bae3df78ce8f" xlink:href="icui-20211231.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_456c33c6-c8d5-4e70-b5a8-c21daedc4290" xlink:to="loc_icui_PursuitVascularInc.Member_2a2bf8a5-8c47-4b53-8c56-bae3df78ce8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_16720be0-ab80-4547-8caf-87f777ea0d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fe464819-113d-45fc-b182-fb1a8e72dc9c" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_16720be0-ab80-4547-8caf-87f777ea0d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_cf8126e0-6682-49bb-b905-b47a1927579c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_16720be0-ab80-4547-8caf-87f777ea0d3c" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_cf8126e0-6682-49bb-b905-b47a1927579c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RevenueGrossProfitVolatilityMember_14f559e5-9d6a-4ad3-b98b-b120ab18c7e6" xlink:href="icui-20211231.xsd#icui_RevenueGrossProfitVolatilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_cf8126e0-6682-49bb-b905-b47a1927579c" xlink:to="loc_icui_RevenueGrossProfitVolatilityMember_14f559e5-9d6a-4ad3-b98b-b120ab18c7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_ae94e771-bb13-408c-b5a2-8f9e67f50e06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_cf8126e0-6682-49bb-b905-b47a1927579c" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_ae94e771-bb13-408c-b5a2-8f9e67f50e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_01257086-1623-451b-b429-26a531fa0269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_cf8126e0-6682-49bb-b905-b47a1927579c" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_01257086-1623-451b-b429-26a531fa0269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditRiskMember_cc0ea43c-480d-45a7-9f7c-bbcdcea45d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditRiskMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_cf8126e0-6682-49bb-b905-b47a1927579c" xlink:to="loc_us-gaap_CreditRiskMember_cc0ea43c-480d-45a7-9f7c-bbcdcea45d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_f560d621-8157-4656-802b-b7d5f2327554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fe464819-113d-45fc-b182-fb1a8e72dc9c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_f560d621-8157-4656-802b-b7d5f2327554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_a0ac10e8-8db8-436b-8c44-cfaf0f39993e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_f560d621-8157-4656-802b-b7d5f2327554" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_a0ac10e8-8db8-436b-8c44-cfaf0f39993e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#FairValueMeasurementFairValueMeasurementsRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e1351d11-13d9-46cf-98c1-57ebca4b7202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c356bfbe-9638-4bf8-a267-e2ac61d62b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e1351d11-13d9-46cf-98c1-57ebca4b7202" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c356bfbe-9638-4bf8-a267-e2ac61d62b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_8831b74b-6585-43bb-b305-a3e230025d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c356bfbe-9638-4bf8-a267-e2ac61d62b8a" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_8831b74b-6585-43bb-b305-a3e230025d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a02e9c02-d264-4062-ab94-e91a9a64b078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_8831b74b-6585-43bb-b305-a3e230025d8b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a02e9c02-d264-4062-ab94-e91a9a64b078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EarnoutliabilityMember_a5b523d9-4b4c-4d2c-8acb-8332e958715b" xlink:href="icui-20211231.xsd#icui_EarnoutliabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a02e9c02-d264-4062-ab94-e91a9a64b078" xlink:to="loc_icui_EarnoutliabilityMember_a5b523d9-4b4c-4d2c-8acb-8332e958715b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesTotalMember_649abcfb-242f-45ab-93a5-cc3201eb0666" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesTotalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a02e9c02-d264-4062-ab94-e91a9a64b078" xlink:to="loc_us-gaap_LiabilitiesTotalMember_649abcfb-242f-45ab-93a5-cc3201eb0666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b941e21f-b340-4af0-a5c5-d68f80027237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c356bfbe-9638-4bf8-a267-e2ac61d62b8a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b941e21f-b340-4af0-a5c5-d68f80027237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0338e7d2-99aa-4efb-8e50-2336edf2904c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b941e21f-b340-4af0-a5c5-d68f80027237" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0338e7d2-99aa-4efb-8e50-2336edf2904c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_99f22829-7595-4f5d-8c17-cfd849794af6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0338e7d2-99aa-4efb-8e50-2336edf2904c" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_99f22829-7595-4f5d-8c17-cfd849794af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_91a47a0d-bbad-485c-828a-0f15c509329a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c356bfbe-9638-4bf8-a267-e2ac61d62b8a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_91a47a0d-bbad-485c-828a-0f15c509329a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d69c9cfa-13bd-4f56-be22-9d039cc07114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_91a47a0d-bbad-485c-828a-0f15c509329a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d69c9cfa-13bd-4f56-be22-9d039cc07114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_360e56d5-33e1-421b-b135-55490e86063f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d69c9cfa-13bd-4f56-be22-9d039cc07114" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_360e56d5-33e1-421b-b135-55490e86063f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d923f78e-b0cf-44fb-9347-e21cf92a94c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d69c9cfa-13bd-4f56-be22-9d039cc07114" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d923f78e-b0cf-44fb-9347-e21cf92a94c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_0822122f-dd87-40d7-bf73-f84d9ac45a59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d69c9cfa-13bd-4f56-be22-9d039cc07114" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_0822122f-dd87-40d7-bf73-f84d9ac45a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7c60e730-b0a3-42b7-82bf-1a5c16a117b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c356bfbe-9638-4bf8-a267-e2ac61d62b8a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7c60e730-b0a3-42b7-82bf-1a5c16a117b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_440d5bed-2d2c-4536-a811-52e43aaa1f38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7c60e730-b0a3-42b7-82bf-1a5c16a117b3" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_440d5bed-2d2c-4536-a811-52e43aaa1f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_3308f8ac-afbb-476d-aef3-f9734d4c09cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7c60e730-b0a3-42b7-82bf-1a5c16a117b3" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_3308f8ac-afbb-476d-aef3-f9734d4c09cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_ced2c7cf-9433-495c-9b2b-1a589d651a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonfinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7c60e730-b0a3-42b7-82bf-1a5c16a117b3" xlink:to="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_ced2c7cf-9433-495c-9b2b-1a589d651a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_c5423d64-2a8c-4c23-b9d8-d0ea2887d628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7c60e730-b0a3-42b7-82bf-1a5c16a117b3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_c5423d64-2a8c-4c23-b9d8-d0ea2887d628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesNoncurrent_3b8c2520-20e4-48df-a0ef-258e9f52e522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7c60e730-b0a3-42b7-82bf-1a5c16a117b3" xlink:to="loc_us-gaap_DebtSecuritiesNoncurrent_3b8c2520-20e4-48df-a0ef-258e9f52e522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_d478cd7f-fe31-40b0-a1c8-db7b3f7e1c97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativeLiabilitiesAtFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7c60e730-b0a3-42b7-82bf-1a5c16a117b3" xlink:to="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_d478cd7f-fe31-40b0-a1c8-db7b3f7e1c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes" xlink:type="simple" xlink:href="icui-20211231.xsd#PrepaidsandOtherCurrentAssetsNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0c709100-1399-4c95-b0ea-c3646b487489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsTextBlock_e5fa7636-7aba-4a0a-80a1-c574e9784671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0c709100-1399-4c95-b0ea-c3646b487489" xlink:to="loc_us-gaap_OtherCurrentAssetsTextBlock_e5fa7636-7aba-4a0a-80a1-c574e9784671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables" xlink:type="simple" xlink:href="icui-20211231.xsd#PrepaidsandOtherCurrentAssetsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_063acee7-6dd6-41df-9f9e-0c527b7df15c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_18a1061b-b6fb-423a-aa67-13116da5f935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_063acee7-6dd6-41df-9f9e-0c527b7df15c" xlink:to="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_18a1061b-b6fb-423a-aa67-13116da5f935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_4f8680dc-4059-4c0a-928d-394d51250f70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_4459d3dd-1e34-4be3-a793-c94818bbffd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_4f8680dc-4059-4c0a-928d-394d51250f70" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_4459d3dd-1e34-4be3-a793-c94818bbffd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsAndOtherAssets_4bf9458e-f6a7-4497-9ea9-4b2e56cca149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_4f8680dc-4059-4c0a-928d-394d51250f70" xlink:to="loc_us-gaap_DeferredCostsAndOtherAssets_4bf9458e-f6a7-4497-9ea9-4b2e56cca149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Prepaidinsuranceandpropertytaxes_56a7396c-566d-4137-ab26-af7808ac8a4e" xlink:href="icui-20211231.xsd#icui_Prepaidinsuranceandpropertytaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_4f8680dc-4059-4c0a-928d-394d51250f70" xlink:to="loc_icui_Prepaidinsuranceandpropertytaxes_56a7396c-566d-4137-ab26-af7808ac8a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Prepaidothertaxes_db63cea0-d7ee-4b88-be89-4f2e31d143ed" xlink:href="icui-20211231.xsd#icui_Prepaidothertaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_4f8680dc-4059-4c0a-928d-394d51250f70" xlink:to="loc_icui_Prepaidothertaxes_db63cea0-d7ee-4b88-be89-4f2e31d143ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Deferredtaxcharge_f801827c-ea7c-4207-978f-79b4428d7639" xlink:href="icui-20211231.xsd#icui_Deferredtaxcharge"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_4f8680dc-4059-4c0a-928d-394d51250f70" xlink:to="loc_icui_Deferredtaxcharge_f801827c-ea7c-4207-978f-79b4428d7639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_6e1c0d08-74bf-411b-a98f-e2bf71fddbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_4f8680dc-4059-4c0a-928d-394d51250f70" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_6e1c0d08-74bf-411b-a98f-e2bf71fddbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositAssets_e053c34c-ae87-49db-b315-1bb1fe3a285a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_4f8680dc-4059-4c0a-928d-394d51250f70" xlink:to="loc_us-gaap_DepositAssets_e053c34c-ae87-49db-b315-1bb1fe3a285a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_ddf5b61a-acd2-463f-b187-4c2baa016342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_4f8680dc-4059-4c0a-928d-394d51250f70" xlink:to="loc_us-gaap_OtherAssetsCurrent_ddf5b61a-acd2-463f-b187-4c2baa016342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bc3b74c0-8589-4a64-94ee-bc4d15678a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_4f8680dc-4059-4c0a-928d-394d51250f70" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bc3b74c0-8589-4a64-94ee-bc4d15678a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_62a12c60-be88-4f00-b427-e21d1e77b88d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_4f8680dc-4059-4c0a-928d-394d51250f70" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_62a12c60-be88-4f00-b427-e21d1e77b88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SpareParts_2bdf08c6-708d-4fb0-ae87-47ca63fe62c5" xlink:href="icui-20211231.xsd#icui_SpareParts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_4f8680dc-4059-4c0a-928d-394d51250f70" xlink:to="loc_icui_SpareParts_2bdf08c6-708d-4fb0-ae87-47ca63fe62c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_7011adb0-c86c-4e8f-8502-5ab1900d81a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_4f8680dc-4059-4c0a-928d-394d51250f70" xlink:to="loc_us-gaap_EquityMethodInvestments_7011adb0-c86c-4e8f-8502-5ab1900d81a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_5559bc73-b385-413c-aba8-7a736459b739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_4f8680dc-4059-4c0a-928d-394d51250f70" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_5559bc73-b385-413c-aba8-7a736459b739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_7f8f087f-67ef-4f19-ba8c-41cba50243df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_4f8680dc-4059-4c0a-928d-394d51250f70" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_7f8f087f-67ef-4f19-ba8c-41cba50243df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_7557664c-fc8c-43f6-b748-e47b745693ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_4f8680dc-4059-4c0a-928d-394d51250f70" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_7557664c-fc8c-43f6-b748-e47b745693ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_956feca8-b015-4b3e-8fea-fd5ba71754d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_4f8680dc-4059-4c0a-928d-394d51250f70" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_956feca8-b015-4b3e-8fea-fd5ba71754d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilities" xlink:type="simple" xlink:href="icui-20211231.xsd#AccruedLiabilitiesanOtherLongtermLiabilities"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_7648fd4c-5473-44e1-b399-0bd2b4c8f983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_65ece53c-19a2-4611-9255-0321bbe8e697" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_7648fd4c-5473-44e1-b399-0bd2b4c8f983" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_65ece53c-19a2-4611-9255-0321bbe8e697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesTables" xlink:type="simple" xlink:href="icui-20211231.xsd#AccruedLiabilitiesanOtherLongtermLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_75035896-656b-4617-b44e-907582224f29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_22350ff0-2876-4cc5-91be-3cf725cfb25b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_75035896-656b-4617-b44e-907582224f29" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_22350ff0-2876-4cc5-91be-3cf725cfb25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#AccruedLiabilitiesanOtherLongtermLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_5d554c96-40c0-4fdc-96e1-720993207f41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AccruedSalariesAndBenefits_cd4c494f-cd8e-4b4b-8916-bf554843dba6" xlink:href="icui-20211231.xsd#icui_AccruedSalariesAndBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_5d554c96-40c0-4fdc-96e1-720993207f41" xlink:to="loc_icui_AccruedSalariesAndBenefits_cd4c494f-cd8e-4b4b-8916-bf554843dba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedBonusesCurrent_6343d62c-ac0f-441f-91ee-c6703023d6b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedBonusesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_5d554c96-40c0-4fdc-96e1-720993207f41" xlink:to="loc_us-gaap_AccruedBonusesCurrent_6343d62c-ac0f-441f-91ee-c6703023d6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_84449394-5d69-47e3-8d9d-2cfa548700e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_5d554c96-40c0-4fdc-96e1-720993207f41" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_84449394-5d69-47e3-8d9d-2cfa548700e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_7d979b3c-f3c1-4927-869f-e98ff5b14f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_5d554c96-40c0-4fdc-96e1-720993207f41" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_7d979b3c-f3c1-4927-869f-e98ff5b14f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedlegalfees_21123053-51b2-48ad-93d2-1f82b06ba5ce" xlink:href="icui-20211231.xsd#icui_Accruedlegalfees"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_5d554c96-40c0-4fdc-96e1-720993207f41" xlink:to="loc_icui_Accruedlegalfees_21123053-51b2-48ad-93d2-1f82b06ba5ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedsalestaxes_303a9b08-3529-43fc-9f11-404d07c435fc" xlink:href="icui-20211231.xsd#icui_Accruedsalestaxes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_5d554c96-40c0-4fdc-96e1-720993207f41" xlink:to="loc_icui_Accruedsalestaxes_303a9b08-3529-43fc-9f11-404d07c435fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_2265288e-aae1-4497-9448-1f8366f9cac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_5d554c96-40c0-4fdc-96e1-720993207f41" xlink:to="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_2265288e-aae1-4497-9448-1f8366f9cac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_9c238216-a52f-4ba3-8ab7-df84636898e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_5d554c96-40c0-4fdc-96e1-720993207f41" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_9c238216-a52f-4ba3-8ab7-df84636898e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedothertaxes_e525cda0-6e21-4d34-86ec-ed3a33b7d048" xlink:href="icui-20211231.xsd#icui_Accruedothertaxes"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_5d554c96-40c0-4fdc-96e1-720993207f41" xlink:to="loc_icui_Accruedothertaxes_e525cda0-6e21-4d34-86ec-ed3a33b7d048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Outsidesalescommissions_705e29e8-714d-45fd-8cc9-61bd90e986af" xlink:href="icui-20211231.xsd#icui_Outsidesalescommissions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_5d554c96-40c0-4fdc-96e1-720993207f41" xlink:to="loc_icui_Outsidesalescommissions_705e29e8-714d-45fd-8cc9-61bd90e986af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedfreight_9071bd21-7bc3-4e26-8c29-5d1d0508115f" xlink:href="icui-20211231.xsd#icui_Accruedfreight"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_5d554c96-40c0-4fdc-96e1-720993207f41" xlink:to="loc_icui_Accruedfreight_9071bd21-7bc3-4e26-8c29-5d1d0508115f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_a2e2a4b6-3fec-4688-97e5-7cf531a69bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_5d554c96-40c0-4fdc-96e1-720993207f41" xlink:to="loc_us-gaap_RestructuringReserveCurrent_a2e2a4b6-3fec-4688-97e5-7cf531a69bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a0756dcb-bee7-47b6-a158-6778084a1657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_5d554c96-40c0-4fdc-96e1-720993207f41" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a0756dcb-bee7-47b6-a158-6778084a1657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4ae654b8-bed9-4d52-8ab4-a6555cb10d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_5d554c96-40c0-4fdc-96e1-720993207f41" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_4ae654b8-bed9-4d52-8ab4-a6555cb10d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesOtherLongtermLiabilitiesDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#AccruedLiabilitiesanOtherLongtermLiabilitiesOtherLongtermLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesOtherLongtermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherLongtermLiabilitiesAbstract_90ebc6da-5a90-4d9b-abf9-58231abf3e5e" xlink:href="icui-20211231.xsd#icui_OtherLongtermLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_284e4fb5-997c-4356-9290-f2aa7c7a5527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_OtherLongtermLiabilitiesAbstract_90ebc6da-5a90-4d9b-abf9-58231abf3e5e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_284e4fb5-997c-4356-9290-f2aa7c7a5527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_fe022876-a34f-4145-8073-c18f933a43ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_OtherLongtermLiabilitiesAbstract_90ebc6da-5a90-4d9b-abf9-58231abf3e5e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_fe022876-a34f-4145-8073-c18f933a43ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Liabilitiesforcontracts_e41689a1-ec28-40a5-8826-09b8d30f2408" xlink:href="icui-20211231.xsd#icui_Liabilitiesforcontracts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_OtherLongtermLiabilitiesAbstract_90ebc6da-5a90-4d9b-abf9-58231abf3e5e" xlink:to="loc_icui_Liabilitiesforcontracts_e41689a1-ec28-40a5-8826-09b8d30f2408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_10b4f10d-d974-4fe6-95de-e7ac182a3d13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativeLiabilitiesAtFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_OtherLongtermLiabilitiesAbstract_90ebc6da-5a90-4d9b-abf9-58231abf3e5e" xlink:to="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_10b4f10d-d974-4fe6-95de-e7ac182a3d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_0679678f-b209-429f-a54d-529f05c9f8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_OtherLongtermLiabilitiesAbstract_90ebc6da-5a90-4d9b-abf9-58231abf3e5e" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_0679678f-b209-429f-a54d-529f05c9f8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRentCurrentAndNoncurrent_e9ad87cc-5a52-4944-9d4c-e7973ac8366c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRentCurrentAndNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_OtherLongtermLiabilitiesAbstract_90ebc6da-5a90-4d9b-abf9-58231abf3e5e" xlink:to="loc_us-gaap_AccruedRentCurrentAndNoncurrent_e9ad87cc-5a52-4944-9d4c-e7973ac8366c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_937a83f7-23ae-4bf7-83a0-7058bd43b92c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_OtherLongtermLiabilitiesAbstract_90ebc6da-5a90-4d9b-abf9-58231abf3e5e" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_937a83f7-23ae-4bf7-83a0-7058bd43b92c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_efdbf52e-6ad2-42c5-9c1e-5a65fec93896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_OtherLongtermLiabilitiesAbstract_90ebc6da-5a90-4d9b-abf9-58231abf3e5e" xlink:to="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_efdbf52e-6ad2-42c5-9c1e-5a65fec93896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsNotes" xlink:type="simple" xlink:href="icui-20211231.xsd#LongTermObligationsNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermDebtDisclosureAbstract_8d63b515-c31b-48a0-821c-ab73a13ff191" xlink:href="icui-20211231.xsd#icui_LongTermDebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_2c4ac120-6a46-4b90-b09b-e6dbb944c05d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LongTermDebtDisclosureAbstract_8d63b515-c31b-48a0-821c-ab73a13ff191" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_2c4ac120-6a46-4b90-b09b-e6dbb944c05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsTables" xlink:type="simple" xlink:href="icui-20211231.xsd#LongTermObligationsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermDebtDisclosureAbstract_36a3a7bd-24fc-42f3-8655-6b28617116a9" xlink:href="icui-20211231.xsd#icui_LongTermDebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestMarginandCommitmentFeeTableTextBlock_77a7ba5d-07a5-4dd1-893f-d6e467d2b4ff" xlink:href="icui-20211231.xsd#icui_InterestMarginandCommitmentFeeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LongTermDebtDisclosureAbstract_36a3a7bd-24fc-42f3-8655-6b28617116a9" xlink:to="loc_icui_InterestMarginandCommitmentFeeTableTextBlock_77a7ba5d-07a5-4dd1-893f-d6e467d2b4ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#LongTermObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermDebtDisclosureAbstract_32067925-97e6-4f9f-9bcb-caafecdd9c1a" xlink:href="icui-20211231.xsd#icui_LongTermDebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a428f719-ab33-49f2-bc6b-5de6bfa3beda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LongTermDebtDisclosureAbstract_32067925-97e6-4f9f-9bcb-caafecdd9c1a" xlink:to="loc_us-gaap_DebtInstrumentTable_a428f719-ab33-49f2-bc6b-5de6bfa3beda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_74291fa6-6106-432e-b13d-1379653b5cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a428f719-ab33-49f2-bc6b-5de6bfa3beda" xlink:to="loc_us-gaap_DebtInstrumentAxis_74291fa6-6106-432e-b13d-1379653b5cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7d2da801-9023-44bc-8994-cd07c3cbad44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_74291fa6-6106-432e-b13d-1379653b5cb8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7d2da801-9023-44bc-8994-cd07c3cbad44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_06b2e41c-8345-4a9c-afef-0333f3bda914" xlink:href="icui-20211231.xsd#icui_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d2da801-9023-44bc-8994-cd07c3cbad44" xlink:to="loc_icui_TermLoanAMember_06b2e41c-8345-4a9c-afef-0333f3bda914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_295054af-d674-46ac-bf7e-ed387bce57ef" xlink:href="icui-20211231.xsd#icui_TermLoanBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d2da801-9023-44bc-8994-cd07c3cbad44" xlink:to="loc_icui_TermLoanBMember_295054af-d674-46ac-bf7e-ed387bce57ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_8d19fa72-7960-4826-9f59-b4950fa94784" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d2da801-9023-44bc-8994-cd07c3cbad44" xlink:to="loc_us-gaap_LineOfCreditMember_8d19fa72-7960-4826-9f59-b4950fa94784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ae98648d-9e92-45eb-aa78-98d318b565a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a428f719-ab33-49f2-bc6b-5de6bfa3beda" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ae98648d-9e92-45eb-aa78-98d318b565a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c30c280a-8dcb-48ce-99e1-fdc0ffa47925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ae98648d-9e92-45eb-aa78-98d318b565a7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c30c280a-8dcb-48ce-99e1-fdc0ffa47925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_229326ce-19cd-4fb4-803a-c191e9202783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c30c280a-8dcb-48ce-99e1-fdc0ffa47925" xlink:to="loc_us-gaap_SubsequentEventMember_229326ce-19cd-4fb4-803a-c191e9202783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_446acf90-e6f9-4fe9-9200-cab636150544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a428f719-ab33-49f2-bc6b-5de6bfa3beda" xlink:to="loc_us-gaap_DebtInstrumentLineItems_446acf90-e6f9-4fe9-9200-cab636150544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6d2656c7-b1b8-406d-be06-7b43616fc8df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_446acf90-e6f9-4fe9-9200-cab636150544" xlink:to="loc_us-gaap_LongTermDebt_6d2656c7-b1b8-406d-be06-7b43616fc8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8a78294b-13aa-40f6-afed-e1cb0ebe9146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LongTermDebtDisclosureAbstract_32067925-97e6-4f9f-9bcb-caafecdd9c1a" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8a78294b-13aa-40f6-afed-e1cb0ebe9146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_3b076686-db4c-4811-b48d-21415931da8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LongTermDebtDisclosureAbstract_32067925-97e6-4f9f-9bcb-caafecdd9c1a" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_3b076686-db4c-4811-b48d-21415931da8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationDate1_5ed9214e-5301-47a3-92ca-27d032839804" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LongTermDebtDisclosureAbstract_32067925-97e6-4f9f-9bcb-caafecdd9c1a" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationDate1_5ed9214e-5301-47a3-92ca-27d032839804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LineofCreditAccordion_9411dc83-c58c-46b7-9a2f-bca77433e1b4" xlink:href="icui-20211231.xsd#icui_LineofCreditAccordion"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LongTermDebtDisclosureAbstract_32067925-97e6-4f9f-9bcb-caafecdd9c1a" xlink:to="loc_icui_LineofCreditAccordion_9411dc83-c58c-46b7-9a2f-bca77433e1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross_231517e2-4e5e-41cc-82c9-da81860cc6e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LongTermDebtDisclosureAbstract_32067925-97e6-4f9f-9bcb-caafecdd9c1a" xlink:to="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross_231517e2-4e5e-41cc-82c9-da81860cc6e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateTerms_00c20312-2faa-4220-94f2-2c881ed0716b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateTerms"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LongTermDebtDisclosureAbstract_32067925-97e6-4f9f-9bcb-caafecdd9c1a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateTerms_00c20312-2faa-4220-94f2-2c881ed0716b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_9eb098f6-45bf-443f-8d51-72fad1c0ae3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LongTermDebtDisclosureAbstract_32067925-97e6-4f9f-9bcb-caafecdd9c1a" xlink:to="loc_us-gaap_LinesOfCreditCurrent_9eb098f6-45bf-443f-8d51-72fad1c0ae3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_1c2a0866-67a7-44db-a0f0-127dbce0adcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LongTermDebtDisclosureAbstract_32067925-97e6-4f9f-9bcb-caafecdd9c1a" xlink:to="loc_us-gaap_LongTermDebt_1c2a0866-67a7-44db-a0f0-127dbce0adcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsLineofCreditPricingDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#LongTermObligationsLineofCreditPricingDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsLineofCreditPricingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4c1820c7-6ede-4793-81c5-5874406b8b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_8bc3b17c-6851-415c-b6f0-f364efab41a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4c1820c7-6ede-4793-81c5-5874406b8b8d" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_8bc3b17c-6851-415c-b6f0-f364efab41a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2766b3c9-7a2b-4cb1-b7fe-f2088049594c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_8bc3b17c-6851-415c-b6f0-f364efab41a4" xlink:to="loc_us-gaap_CreditFacilityAxis_2766b3c9-7a2b-4cb1-b7fe-f2088049594c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b42be04c-079c-46bf-8b49-c75fcb3aef28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_2766b3c9-7a2b-4cb1-b7fe-f2088049594c" xlink:to="loc_us-gaap_CreditFacilityDomain_b42be04c-079c-46bf-8b49-c75fcb3aef28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIMember_16d51bcb-dfff-4388-a7e2-c1e2290d361c" xlink:href="icui-20211231.xsd#icui_PricingLevelIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b42be04c-079c-46bf-8b49-c75fcb3aef28" xlink:to="loc_icui_PricingLevelIMember_16d51bcb-dfff-4388-a7e2-c1e2290d361c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIIMemberMember_a6fbdf90-b6b6-4b44-9696-81a39fcd9147" xlink:href="icui-20211231.xsd#icui_PricingLevelIIMemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b42be04c-079c-46bf-8b49-c75fcb3aef28" xlink:to="loc_icui_PricingLevelIIMemberMember_a6fbdf90-b6b6-4b44-9696-81a39fcd9147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIIIMemberMember_c26a24e4-e328-4a93-a16c-5ca32d3e0d4e" xlink:href="icui-20211231.xsd#icui_PricingLevelIIIMemberMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b42be04c-079c-46bf-8b49-c75fcb3aef28" xlink:to="loc_icui_PricingLevelIIIMemberMember_c26a24e4-e328-4a93-a16c-5ca32d3e0d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIVMemberMember_07858faf-59c1-43c8-9710-e079c10c46d4" xlink:href="icui-20211231.xsd#icui_PricingLevelIVMemberMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b42be04c-079c-46bf-8b49-c75fcb3aef28" xlink:to="loc_icui_PricingLevelIVMemberMember_07858faf-59c1-43c8-9710-e079c10c46d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_d5fb409e-fb29-4f2b-ad24-65996c6d367a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_8bc3b17c-6851-415c-b6f0-f364efab41a4" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_d5fb409e-fb29-4f2b-ad24-65996c6d367a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_3edcfec4-7ea2-4a58-b9a1-f2e09c2ed852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d5fb409e-fb29-4f2b-ad24-65996c6d367a" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_3edcfec4-7ea2-4a58-b9a1-f2e09c2ed852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LIBORBasisSpreadonVariableRate_1c5eca87-4f64-41cc-a43c-6d6145241b08" xlink:href="icui-20211231.xsd#icui_LIBORBasisSpreadonVariableRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d5fb409e-fb29-4f2b-ad24-65996c6d367a" xlink:to="loc_icui_LIBORBasisSpreadonVariableRate_1c5eca87-4f64-41cc-a43c-6d6145241b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4fca441f-9d71-4ac8-b4fc-d0d004b49f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d5fb409e-fb29-4f2b-ad24-65996c6d367a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4fca441f-9d71-4ac8-b4fc-d0d004b49f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxes" xlink:type="simple" xlink:href="icui-20211231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1c932869-4a4e-4938-a013-1d44da7a8c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_22e609f3-0d4a-4a24-bf29-7b81f0455ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1c932869-4a4e-4938-a013-1d44da7a8c9b" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_22e609f3-0d4a-4a24-bf29-7b81f0455ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxesIncometaxdisclosureTables" xlink:type="simple" xlink:href="icui-20211231.xsd#IncomeTaxesIncometaxdisclosureTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/IncomeTaxesIncometaxdisclosureTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ce00a13f-c80d-44d1-a040-110f4e6fc893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_288df7c2-8b4c-429e-b1d6-0399a88c2eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ce00a13f-c80d-44d1-a040-110f4e6fc893" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_288df7c2-8b4c-429e-b1d6-0399a88c2eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_540c7303-d4c2-431d-a229-cf3775e2909f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ce00a13f-c80d-44d1-a040-110f4e6fc893" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_540c7303-d4c2-431d-a229-cf3775e2909f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_d4500bf1-aef3-47ed-b728-051f9dac79dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ce00a13f-c80d-44d1-a040-110f4e6fc893" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_d4500bf1-aef3-47ed-b728-051f9dac79dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_5e27924a-03df-46fd-8074-b262646a6e58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ce00a13f-c80d-44d1-a040-110f4e6fc893" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_5e27924a-03df-46fd-8074-b262646a6e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_cb9a508c-2bc7-44dd-bf79-eb004a3818ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ce00a13f-c80d-44d1-a040-110f4e6fc893" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_cb9a508c-2bc7-44dd-bf79-eb004a3818ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxesIncomeLossfromContinuingOperationsDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#IncomeTaxesIncomeLossfromContinuingOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/IncomeTaxesIncomeLossfromContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_28fd612e-6562-4b3c-a798-83b736ed67a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_188d8760-1a99-4374-b40e-064303ecad1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_28fd612e-6562-4b3c-a798-83b736ed67a5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_188d8760-1a99-4374-b40e-064303ecad1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_242b7484-7f4c-4e35-ad05-7afb2bd4693e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_28fd612e-6562-4b3c-a798-83b736ed67a5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_242b7484-7f4c-4e35-ad05-7afb2bd4693e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_5f47fe03-7615-4769-9ef7-d3346766fc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_28fd612e-6562-4b3c-a798-83b736ed67a5" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_5f47fe03-7615-4769-9ef7-d3346766fc8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxesTaxProvisionDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#IncomeTaxesTaxProvisionDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/IncomeTaxesTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f9152b28-7361-4349-8741-daaba7ebfbe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_3085ade9-d977-44bd-b372-e04c83eb37f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f9152b28-7361-4349-8741-daaba7ebfbe7" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_3085ade9-d977-44bd-b372-e04c83eb37f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_c2d34c44-aaf6-4172-9645-3388d3f4d2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f9152b28-7361-4349-8741-daaba7ebfbe7" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_c2d34c44-aaf6-4172-9645-3388d3f4d2d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_7405729f-1f76-4892-8e5a-262350754b37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f9152b28-7361-4349-8741-daaba7ebfbe7" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_7405729f-1f76-4892-8e5a-262350754b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_12ce6be3-c8b8-41ba-81d1-8a4b2add17a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f9152b28-7361-4349-8741-daaba7ebfbe7" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_12ce6be3-c8b8-41ba-81d1-8a4b2add17a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_305809d0-62a5-4b39-b310-b55ba32e1be8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f9152b28-7361-4349-8741-daaba7ebfbe7" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_305809d0-62a5-4b39-b310-b55ba32e1be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_ce2686ff-51f4-40a1-90c7-dc44d697ddb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f9152b28-7361-4349-8741-daaba7ebfbe7" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_ce2686ff-51f4-40a1-90c7-dc44d697ddb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_0df39d6f-04e7-4dce-ab51-daabc6891f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f9152b28-7361-4349-8741-daaba7ebfbe7" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_0df39d6f-04e7-4dce-ab51-daabc6891f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ff5d1911-3c6a-4dd7-803d-8c3000aa8593" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f9152b28-7361-4349-8741-daaba7ebfbe7" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ff5d1911-3c6a-4dd7-803d-8c3000aa8593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5de554f0-1d27-4938-9d21-54c95b8a88af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f9152b28-7361-4349-8741-daaba7ebfbe7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5de554f0-1d27-4938-9d21-54c95b8a88af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxesChangeintaxespayableDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#IncomeTaxesChangeintaxespayableDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/IncomeTaxesChangeintaxespayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4aea5cc6-4729-4c0f-95cc-27226aec1c43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_730a0512-0162-4068-8264-c7be5b08d992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4aea5cc6-4729-4c0f-95cc-27226aec1c43" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_730a0512-0162-4068-8264-c7be5b08d992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#IncomeTaxesEffectivetaxrateDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_50c2d13e-1875-4c3b-986c-cc548dc11963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_50c2d13e-1875-4c3b-986c-cc548dc11963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_ea70ff7c-d51b-45ea-8fab-be619bf9cab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_ea70ff7c-d51b-45ea-8fab-be619bf9cab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCredits_b446e540-4f7b-4e4b-a591-7d5d82fc0832" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCredits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCredits_b446e540-4f7b-4e4b-a591-7d5d82fc0832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GILTItaxexpense_65ec7841-3d02-4769-b902-acef3c102c3a" xlink:href="icui-20211231.xsd#icui_GILTItaxexpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_icui_GILTItaxexpense_65ec7841-3d02-4769-b902-acef3c102c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_2463de4c-1d2f-456f-a7cc-100d0f58100d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_2463de4c-1d2f-456f-a7cc-100d0f58100d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_c6e59482-e7ed-46e7-b090-805160a9cf66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_c6e59482-e7ed-46e7-b090-805160a9cf66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome_d44913c9-5bec-4e16-8cf9-704ce31f1e23" xlink:href="icui-20211231.xsd#icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome_d44913c9-5bec-4e16-8cf9-704ce31f1e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EffectiveIncomeTaxRateReconciliationIPMigration_05e34830-86ee-43b7-9529-de48061d767e" xlink:href="icui-20211231.xsd#icui_EffectiveIncomeTaxRateReconciliationIPMigration"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_icui_EffectiveIncomeTaxRateReconciliationIPMigration_05e34830-86ee-43b7-9529-de48061d767e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EffectiveIncomeTaxRateReconciliationContingentConsideration_9ee77e7f-7c14-4ad4-a1ff-0c6de81d98a3" xlink:href="icui-20211231.xsd#icui_EffectiveIncomeTaxRateReconciliationContingentConsideration"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_icui_EffectiveIncomeTaxRateReconciliationContingentConsideration_9ee77e7f-7c14-4ad4-a1ff-0c6de81d98a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Effectiveincometaxreconciliationnondeductiblecompensation_23e7fbcc-019e-457e-9012-a25123e8e41b" xlink:href="icui-20211231.xsd#icui_Effectiveincometaxreconciliationnondeductiblecompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_icui_Effectiveincometaxreconciliationnondeductiblecompensation_23e7fbcc-019e-457e-9012-a25123e8e41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_640708e4-83f8-47fe-9dd4-e51157dcdb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_640708e4-83f8-47fe-9dd4-e51157dcdb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d18ded12-0503-441b-9136-37be811e4cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d18ded12-0503-441b-9136-37be811e4cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_24c403da-9882-4909-8a4e-65cfaecb8ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_24c403da-9882-4909-8a4e-65cfaecb8ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1fe86a1c-39af-4c5c-bd67-c66c527719a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1fe86a1c-39af-4c5c-bd67-c66c527719a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_70fb2685-3de9-4e02-a0fa-a3a95353a2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_70fb2685-3de9-4e02-a0fa-a3a95353a2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GILTItaxexpensepercent_e9af6b25-8f2b-4412-890d-fd5736bbb0ea" xlink:href="icui-20211231.xsd#icui_GILTItaxexpensepercent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_icui_GILTItaxexpensepercent_e9af6b25-8f2b-4412-890d-fd5736bbb0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_68b8bbc8-7bba-4896-8db8-9a3b9c093771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_68b8bbc8-7bba-4896-8db8-9a3b9c093771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_443107ae-bbae-48d5-b43f-23f3b6a35ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_443107ae-bbae-48d5-b43f-23f3b6a35ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent_f7382665-44cc-40c8-a4e0-ed7cbc71301a" xlink:href="icui-20211231.xsd#icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent_f7382665-44cc-40c8-a4e0-ed7cbc71301a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EffectiveTaxRateReconciliationIPMigrationPercent_51dd7752-eb8a-4b3d-a903-2f405844892a" xlink:href="icui-20211231.xsd#icui_EffectiveTaxRateReconciliationIPMigrationPercent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_icui_EffectiveTaxRateReconciliationIPMigrationPercent_51dd7752-eb8a-4b3d-a903-2f405844892a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent_f16b823a-cdd2-4a30-b82c-3a5a4757231d" xlink:href="icui-20211231.xsd#icui_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_icui_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent_f16b823a-cdd2-4a30-b82c-3a5a4757231d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Effectivetaxratereconciliationnondeductiblecomppercent_66bc5aca-20f4-4f57-be04-ce6549254ae6" xlink:href="icui-20211231.xsd#icui_Effectivetaxratereconciliationnondeductiblecomppercent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_icui_Effectivetaxratereconciliationnondeductiblecomppercent_66bc5aca-20f4-4f57-be04-ce6549254ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_65357000-44e1-44ab-beec-442e68f4eee0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_65357000-44e1-44ab-beec-442e68f4eee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f0a1b490-8dda-4eb9-af5a-64d341f03aab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_58b37e33-3957-403e-9ccc-b029fc832dbb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f0a1b490-8dda-4eb9-af5a-64d341f03aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#IncomeTaxesDeferredincometaxassetsliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_IncomeTaxDisclosuredeferredtaxesAbstract_775f050e-64f6-463e-b73a-1643dacd1bf7" xlink:href="icui-20211231.xsd#icui_IncomeTaxDisclosuredeferredtaxesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DeferredtaxassetsandliabilitiesTable_fe05d425-8434-4b67-8252-49b2f386194b" xlink:href="icui-20211231.xsd#icui_DeferredtaxassetsandliabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_IncomeTaxDisclosuredeferredtaxesAbstract_775f050e-64f6-463e-b73a-1643dacd1bf7" xlink:to="loc_icui_DeferredtaxassetsandliabilitiesTable_fe05d425-8434-4b67-8252-49b2f386194b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c5b96e76-07ea-4cd1-bd95-93055cd07338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesTable_fe05d425-8434-4b67-8252-49b2f386194b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c5b96e76-07ea-4cd1-bd95-93055cd07338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_910068b6-a697-4244-a8e9-41859bb1f0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c5b96e76-07ea-4cd1-bd95-93055cd07338" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_910068b6-a697-4244-a8e9-41859bb1f0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NonCurrentDeferredTaxAssetGrossTotalMember_dd47e525-e9df-43ef-b756-79dec6fe762c" xlink:href="icui-20211231.xsd#icui_NonCurrentDeferredTaxAssetGrossTotalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_910068b6-a697-4244-a8e9-41859bb1f0aa" xlink:to="loc_icui_NonCurrentDeferredTaxAssetGrossTotalMember_dd47e525-e9df-43ef-b756-79dec6fe762c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NoncurrentDeferredTaxLiabilityMember_485c8b0b-791d-4f3b-913d-be092c930138" xlink:href="icui-20211231.xsd#icui_NoncurrentDeferredTaxLiabilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_910068b6-a697-4244-a8e9-41859bb1f0aa" xlink:to="loc_icui_NoncurrentDeferredTaxLiabilityMember_485c8b0b-791d-4f3b-913d-be092c930138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:href="icui-20211231.xsd#icui_DeferredtaxassetsandliabilitiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesTable_fe05d425-8434-4b67-8252-49b2f386194b" xlink:to="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_26c61cff-7ebc-4258-9eb8-831a1e7809b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_26c61cff-7ebc-4258-9eb8-831a1e7809b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions_ef82d5bb-62df-4487-8f83-e8eee0ba942f" xlink:href="icui-20211231.xsd#icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions_ef82d5bb-62df-4487-8f83-e8eee0ba942f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_fb7bd65f-7fc7-4915-b208-b95535bf9809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_fb7bd65f-7fc7-4915-b208-b95535bf9809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_6d173e8e-9b25-4526-999d-268d7887db49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_6d173e8e-9b25-4526-999d-268d7887db49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NoncurrentDeferredTaxAssetTaxCreditsState_2b12d513-f70b-40a4-9649-7c8704f00627" xlink:href="icui-20211231.xsd#icui_NoncurrentDeferredTaxAssetTaxCreditsState"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_icui_NoncurrentDeferredTaxAssetTaxCreditsState_2b12d513-f70b-40a4-9649-7c8704f00627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_41a68afe-c256-412c-9233-f146326e77e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_41a68afe-c256-412c-9233-f146326e77e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_5a0b8922-1c82-4a0b-98fe-4a27626b66e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_5a0b8922-1c82-4a0b-98fe-4a27626b66e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Noncurrentdeferredtaxassetaccruedrestructuring_59563d96-d734-4c7c-97ed-df9e8635c610" xlink:href="icui-20211231.xsd#icui_Noncurrentdeferredtaxassetaccruedrestructuring"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_icui_Noncurrentdeferredtaxassetaccruedrestructuring_59563d96-d734-4c7c-97ed-df9e8635c610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions_c2fec132-abf9-4824-9acf-11b38356c1e9" xlink:href="icui-20211231.xsd#icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions_c2fec132-abf9-4824-9acf-11b38356c1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_c2685d35-4478-4c66-9418-4b51d770f434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_c2685d35-4478-4c66-9418-4b51d770f434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Noncurrentdeferredtaxasset_c400b21c-1d25-4aec-ae43-422abeeeeb29" xlink:href="icui-20211231.xsd#icui_Noncurrentdeferredtaxasset"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_icui_Noncurrentdeferredtaxasset_c400b21c-1d25-4aec-ae43-422abeeeeb29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes_59ddfe4c-f0f2-4228-9208-79611300e648" xlink:href="icui-20211231.xsd#icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes_59ddfe4c-f0f2-4228-9208-79611300e648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NoncurrentDeferredTaxLiabilityForeign_b2a6147e-b173-429a-b573-80a84085ffe0" xlink:href="icui-20211231.xsd#icui_NoncurrentDeferredTaxLiabilityForeign"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_icui_NoncurrentDeferredTaxLiabilityForeign_b2a6147e-b173-429a-b573-80a84085ffe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization_98144daa-087b-447c-9b44-66877db27db7" xlink:href="icui-20211231.xsd#icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization_98144daa-087b-447c-9b44-66877db27db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Deferredtaxliabilitychangeinaccountingmethod_c734edd6-5b2a-465e-ab17-20fb0dacccbc" xlink:href="icui-20211231.xsd#icui_Deferredtaxliabilitychangeinaccountingmethod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_icui_Deferredtaxliabilitychangeinaccountingmethod_c734edd6-5b2a-465e-ab17-20fb0dacccbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_4529c9f2-ca0d-4d01-b8ef-223ca7b6269d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_us-gaap_DeferredTaxLiabilities_4529c9f2-ca0d-4d01-b8ef-223ca7b6269d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_44b63621-f600-48a2-a08d-baf2b74045cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DeferredtaxassetsandliabilitiesLineItems_24382016-91c8-4f16-946d-387d38c8e428" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_44b63621-f600-48a2-a08d-baf2b74045cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxesOperatingLossCarryforwardsDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#IncomeTaxesOperatingLossCarryforwardsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/IncomeTaxesOperatingLossCarryforwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_OperatinglosscarryforwardsAbstract_4f720704-7961-4519-a45e-d574bd65abfa" xlink:href="icui-20211231.xsd#icui_OperatinglosscarryforwardsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_b54bc055-5d12-47c7-87a3-4fe5566681f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_OperatinglosscarryforwardsAbstract_4f720704-7961-4519-a45e-d574bd65abfa" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_b54bc055-5d12-47c7-87a3-4fe5566681f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_96f7fa00-3763-4b1a-9f3f-0fe0ff057ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_b54bc055-5d12-47c7-87a3-4fe5566681f1" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_96f7fa00-3763-4b1a-9f3f-0fe0ff057ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_fb34bfe6-af53-4c9d-bdd9-a82fa8f95401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_96f7fa00-3763-4b1a-9f3f-0fe0ff057ddf" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_fb34bfe6-af53-4c9d-bdd9-a82fa8f95401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_861bfab8-ac6e-47da-8d6c-926b5846bfe9" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_fb34bfe6-af53-4c9d-bdd9-a82fa8f95401" xlink:to="loc_country_US_861bfab8-ac6e-47da-8d6c-926b5846bfe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_40457ac2-8d7c-4403-b18e-00629c965a42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_fb34bfe6-af53-4c9d-bdd9-a82fa8f95401" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_40457ac2-8d7c-4403-b18e-00629c965a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_43902eee-3391-4407-987e-96d4ac61fd63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_fb34bfe6-af53-4c9d-bdd9-a82fa8f95401" xlink:to="loc_us-gaap_ForeignCountryMember_43902eee-3391-4407-987e-96d4ac61fd63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_508454ac-20eb-494e-8028-840fcd903466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_b54bc055-5d12-47c7-87a3-4fe5566681f1" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_508454ac-20eb-494e-8028-840fcd903466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_741ac238-2242-47d1-aa5a-981f2556c7fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_508454ac-20eb-494e-8028-840fcd903466" xlink:to="loc_us-gaap_OperatingLossCarryforwards_741ac238-2242-47d1-aa5a-981f2556c7fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxesTaxCarryforwardsDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#IncomeTaxesTaxCarryforwardsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/IncomeTaxesTaxCarryforwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6ba70fd7-1c3b-4aa3-836a-8c2f6fdfe22b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_23328975-d615-421c-9914-ee293aa62caa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6ba70fd7-1c3b-4aa3-836a-8c2f6fdfe22b" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_23328975-d615-421c-9914-ee293aa62caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxesTaxHolidayDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#IncomeTaxesTaxHolidayDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/IncomeTaxesTaxHolidayDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fdb95e07-f458-4cda-a5e3-ee7b993288f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayTable_a279f898-6d82-4264-8207-61ebf7322f73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxHolidayTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fdb95e07-f458-4cda-a5e3-ee7b993288f9" xlink:to="loc_us-gaap_IncomeTaxHolidayTable_a279f898-6d82-4264-8207-61ebf7322f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_951b7387-5910-40a9-97b6-b782cc3603ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxHolidayTable_a279f898-6d82-4264-8207-61ebf7322f73" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_951b7387-5910-40a9-97b6-b782cc3603ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_79ed2118-f82d-46dd-9aa3-682629e36b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_951b7387-5910-40a9-97b6-b782cc3603ac" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_79ed2118-f82d-46dd-9aa3-682629e36b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayLineItems_34227461-0078-4717-99a1-948c4e315fce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxHolidayLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxHolidayTable_a279f898-6d82-4264-8207-61ebf7322f73" xlink:to="loc_us-gaap_IncomeTaxHolidayLineItems_34227461-0078-4717-99a1-948c4e315fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_8ef14d08-0272-4a53-a765-d892e1296b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxHolidayAggregateDollarAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxHolidayLineItems_34227461-0078-4717-99a1-948c4e315fce" xlink:to="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_8ef14d08-0272-4a53-a765-d892e1296b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare_c86f0791-0bc1-4c27-a783-5fe3ff60470b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxHolidayLineItems_34227461-0078-4717-99a1-948c4e315fce" xlink:to="loc_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare_c86f0791-0bc1-4c27-a783-5fe3ff60470b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxesUndistributedforeignearningsDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#IncomeTaxesUndistributedforeignearningsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/IncomeTaxesUndistributedforeignearningsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c63564c5-8797-4c7f-9828-d431621a5056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_cb485649-221e-4786-b18a-de2ea3675c01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c63564c5-8797-4c7f-9828-d431621a5056" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_cb485649-221e-4786-b18a-de2ea3675c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxesUnrecognizedtaxbenefitsDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#IncomeTaxesUnrecognizedtaxbenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/IncomeTaxesUnrecognizedtaxbenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_UnrecognizedTaxBenefitsRollForwardRollForward_d17990a9-a713-4102-a516-f2450f9d4d9d" xlink:href="icui-20211231.xsd#icui_UnrecognizedTaxBenefitsRollForwardRollForward"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_5f9c1922-1466-4425-8660-bf51c1431d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_UnrecognizedTaxBenefitsRollForwardRollForward_d17990a9-a713-4102-a516-f2450f9d4d9d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_5f9c1922-1466-4425-8660-bf51c1431d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c01ed4c1-5cfc-45be-81af-00c5f8c0ebe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_UnrecognizedTaxBenefitsRollForwardRollForward_d17990a9-a713-4102-a516-f2450f9d4d9d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c01ed4c1-5cfc-45be-81af-00c5f8c0ebe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_ed2b6f35-aa85-4451-bfa3-513cf6fcda20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_UnrecognizedTaxBenefitsRollForwardRollForward_d17990a9-a713-4102-a516-f2450f9d4d9d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_ed2b6f35-aa85-4451-bfa3-513cf6fcda20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_2c00c365-b112-4b55-b782-2486a85a79e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_UnrecognizedTaxBenefitsRollForwardRollForward_d17990a9-a713-4102-a516-f2450f9d4d9d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_2c00c365-b112-4b55-b782-2486a85a79e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_97a12630-46fb-411e-93b7-75d70106e834" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_UnrecognizedTaxBenefitsRollForwardRollForward_d17990a9-a713-4102-a516-f2450f9d4d9d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_97a12630-46fb-411e-93b7-75d70106e834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_c549be59-e2cd-4f22-8a1a-e63ae595e119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_UnrecognizedTaxBenefitsRollForwardRollForward_d17990a9-a713-4102-a516-f2450f9d4d9d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_c549be59-e2cd-4f22-8a1a-e63ae595e119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeographicInformationandSignificantCustomersGeographicInformationandSignificantCustomersNotes" xlink:type="simple" xlink:href="icui-20211231.xsd#GeographicInformationandSignificantCustomersGeographicInformationandSignificantCustomersNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeographicInformationandSignificantCustomersGeographicInformationandSignificantCustomersNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicAreasLongLivedAssetsAbstract_bda686b8-bd04-4fdc-8aac-89144916972f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicAreasLongLivedAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InformationbyGeographicAreaandCustomerConcentrationTextBlock_1da05f0f-f768-465e-83c1-c8fbe22da975" xlink:href="icui-20211231.xsd#icui_InformationbyGeographicAreaandCustomerConcentrationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicAreasLongLivedAssetsAbstract_bda686b8-bd04-4fdc-8aac-89144916972f" xlink:to="loc_icui_InformationbyGeographicAreaandCustomerConcentrationTextBlock_1da05f0f-f768-465e-83c1-c8fbe22da975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeographicInformationandSignificantCustomersGeographicInformationTables" xlink:type="simple" xlink:href="icui-20211231.xsd#GeographicInformationandSignificantCustomersGeographicInformationTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeographicInformationandSignificantCustomersGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicAreasLongLivedAssetsAbstract_9cbdfdf4-4959-48dc-b22b-c8fe07d9bbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicAreasLongLivedAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_3267d57d-cbcc-492e-9f9f-5d21750b9759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicAreasLongLivedAssetsAbstract_9cbdfdf4-4959-48dc-b22b-c8fe07d9bbe5" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_3267d57d-cbcc-492e-9f9f-5d21750b9759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicAreasLongLivedAssetsAbstract_758c9768-5af9-4393-baf3-86ad329dd008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicAreasLongLivedAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8520bc45-0d40-4075-a780-c41c6c281d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicAreasLongLivedAssetsAbstract_758c9768-5af9-4393-baf3-86ad329dd008" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8520bc45-0d40-4075-a780-c41c6c281d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_1f032593-f14a-41c5-900c-95c5ba944631" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8520bc45-0d40-4075-a780-c41c6c281d9e" xlink:to="loc_srt_StatementGeographicalAxis_1f032593-f14a-41c5-900c-95c5ba944631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_1f032593-f14a-41c5-900c-95c5ba944631" xlink:to="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CR_9dae563d-3da8-4d15-a54b-382583bc288a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:to="loc_country_CR_9dae563d-3da8-4d15-a54b-382583bc288a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MexicoPropertyAndEquipmentMember_c45a73a3-b1ff-4c9a-9916-dba12234b260" xlink:href="icui-20211231.xsd#icui_MexicoPropertyAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:to="loc_icui_MexicoPropertyAndEquipmentMember_c45a73a3-b1ff-4c9a-9916-dba12234b260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherLATAMMember_bce45535-d18f-4f34-b505-76e67fcfeab8" xlink:href="icui-20211231.xsd#icui_OtherLATAMMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:to="loc_icui_OtherLATAMMember_bce45535-d18f-4f34-b505-76e67fcfeab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_9b0a0411-f0db-44be-a8f0-0942cfc931c3" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:to="loc_country_CA_9b0a0411-f0db-44be-a8f0-0942cfc931c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ItalyPropertyAndEquipmentMember_29ec74b0-d80b-42f6-9f81-dda47accb481" xlink:href="icui-20211231.xsd#icui_ItalyPropertyAndEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:to="loc_icui_ItalyPropertyAndEquipmentMember_29ec74b0-d80b-42f6-9f81-dda47accb481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_ES_a13a2bb9-a814-4c9e-b8a0-701d629ced1d" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_ES"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:to="loc_country_ES_a13a2bb9-a814-4c9e-b8a0-701d629ced1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_085d8dfc-6d0c-47ac-8908-beac551ccf8b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:to="loc_srt_EuropeMember_085d8dfc-6d0c-47ac-8908-beac551ccf8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_5087dcc0-c85c-4f09-81d7-3c9bc0966b69" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:to="loc_srt_AsiaPacificMember_5087dcc0-c85c-4f09-81d7-3c9bc0966b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignMember_828f3e03-5bea-4455-95ac-2fed7b04530d" xlink:href="icui-20211231.xsd#icui_ForeignMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:to="loc_icui_ForeignMember_828f3e03-5bea-4455-95ac-2fed7b04530d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_UnitedStatespropertyandequipmentMember_fad2a4b8-1d78-41dc-8506-2bb00e6df992" xlink:href="icui-20211231.xsd#icui_UnitedStatespropertyandequipmentMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cf0b3fd3-ccda-44f6-9453-e147b74262d6" xlink:to="loc_icui_UnitedStatespropertyandequipmentMember_fad2a4b8-1d78-41dc-8506-2bb00e6df992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ad567993-7e2e-4593-ab62-e62a9577576b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8520bc45-0d40-4075-a780-c41c6c281d9e" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ad567993-7e2e-4593-ab62-e62a9577576b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_39880e11-059b-4ef8-9c36-ecaee53830ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ad567993-7e2e-4593-ab62-e62a9577576b" xlink:to="loc_us-gaap_NoncurrentAssets_39880e11-059b-4ef8-9c36-ecaee53830ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/StockholdersEquity" xlink:type="simple" xlink:href="icui-20211231.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_ece632b6-2465-472d-a66b-7952800b1ded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_5695bc79-e744-4f0a-a3b5-a4ea6f31e2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_ece632b6-2465-472d-a66b-7952800b1ded" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_5695bc79-e744-4f0a-a3b5-a4ea6f31e2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="icui-20211231.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_b839fdc3-de24-438a-88af-16fb573dbe4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_5a2496d7-e3e6-406e-a712-983c8428ead9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_b839fdc3-de24-438a-88af-16fb573dbe4c" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_5a2496d7-e3e6-406e-a712-983c8428ead9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#StockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/StockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_cd54c656-5338-4539-8ec9-09f424620e05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_5e840027-cab8-41f2-9caf-094ff93ccbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_cd54c656-5338-4539-8ec9-09f424620e05" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_5e840027-cab8-41f2-9caf-094ff93ccbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9cff217e-abf0-47ca-a9db-2eb862a6cec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_5e840027-cab8-41f2-9caf-094ff93ccbf3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9cff217e-abf0-47ca-a9db-2eb862a6cec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_879ab89c-b2f7-409f-af51-4cb797796cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9cff217e-abf0-47ca-a9db-2eb862a6cec0" xlink:to="loc_us-gaap_EquityComponentDomain_879ab89c-b2f7-409f-af51-4cb797796cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_24cdb581-0f55-4531-9f55-cc41c75f3a17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_5e840027-cab8-41f2-9caf-094ff93ccbf3" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_24cdb581-0f55-4531-9f55-cc41c75f3a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3ddbbd12-e32e-4dfd-ac85-b5a1b28f28c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_24cdb581-0f55-4531-9f55-cc41c75f3a17" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3ddbbd12-e32e-4dfd-ac85-b5a1b28f28c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_e6215a1b-b4db-4b6f-90d7-047e115fe8af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_24cdb581-0f55-4531-9f55-cc41c75f3a17" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_e6215a1b-b4db-4b6f-90d7-047e115fe8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_7c1496c8-5912-49ae-9e72-4156cf251c03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_24cdb581-0f55-4531-9f55-cc41c75f3a17" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_7c1496c8-5912-49ae-9e72-4156cf251c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_794d82fa-b493-4390-9a06-b3ee3cb5eb05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_24cdb581-0f55-4531-9f55-cc41c75f3a17" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_794d82fa-b493-4390-9a06-b3ee3cb5eb05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_725013eb-8e93-4fbe-b1e3-46e3ebfdda5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_24cdb581-0f55-4531-9f55-cc41c75f3a17" xlink:to="loc_us-gaap_TreasuryStockCommonShares_725013eb-8e93-4fbe-b1e3-46e3ebfdda5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_87d28d59-2a3c-44cb-bd86-4c16c1d65327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e8383c2f-d4f2-405d-af09-d0f08350d908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_87d28d59-2a3c-44cb-bd86-4c16c1d65327" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e8383c2f-d4f2-405d-af09-d0f08350d908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_73cf4de6-c901-42ff-8a11-f497fd10cd51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e8383c2f-d4f2-405d-af09-d0f08350d908" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_73cf4de6-c901-42ff-8a11-f497fd10cd51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_34c01fcb-5cfe-4b53-8cbd-9049d11aac1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_73cf4de6-c901-42ff-8a11-f497fd10cd51" xlink:to="loc_us-gaap_EquityComponentDomain_34c01fcb-5cfe-4b53-8cbd-9049d11aac1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_9ba0d6d7-b026-4f05-9e05-0d6fb17f30b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_34c01fcb-5cfe-4b53-8cbd-9049d11aac1c" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_9ba0d6d7-b026-4f05-9e05-0d6fb17f30b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_741f4381-ab76-4883-b8b1-451d673bf2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_34c01fcb-5cfe-4b53-8cbd-9049d11aac1c" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_741f4381-ab76-4883-b8b1-451d673bf2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3752b0ba-094b-4e91-bf20-6bf6ec1ba4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_34c01fcb-5cfe-4b53-8cbd-9049d11aac1c" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3752b0ba-094b-4e91-bf20-6bf6ec1ba4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4e8eead3-e2d2-4e9c-9401-6910bf360a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e8383c2f-d4f2-405d-af09-d0f08350d908" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4e8eead3-e2d2-4e9c-9401-6910bf360a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_efc5249e-cb0f-44bd-89a8-351b94c39915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4e8eead3-e2d2-4e9c-9401-6910bf360a63" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_efc5249e-cb0f-44bd-89a8-351b94c39915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_ab4ce26c-8050-41ad-bc26-92310004174c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4e8eead3-e2d2-4e9c-9401-6910bf360a63" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_ab4ce26c-8050-41ad-bc26-92310004174c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5663e0e4-8712-4a7c-b9aa-30da3bd7d0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4e8eead3-e2d2-4e9c-9401-6910bf360a63" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5663e0e4-8712-4a7c-b9aa-30da3bd7d0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a61fff28-4829-480e-ad16-bebad1179e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4e8eead3-e2d2-4e9c-9401-6910bf360a63" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a61fff28-4829-480e-ad16-bebad1179e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="icui-20211231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_830234dc-016d-4223-ac07-1aa9a55cc201" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7c4b0f90-5dc1-46fa-a84d-54cc9db47665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_830234dc-016d-4223-ac07-1aa9a55cc201" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7c4b0f90-5dc1-46fa-a84d-54cc9db47665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="icui-20211231.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CommitmentsandContingenciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#CommitmentsandContingenciesContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_51c7acf6-a154-47cc-9e63-e9528719a328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d74e37f0-21fe-400e-bcb2-4629867f4b36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_51c7acf6-a154-47cc-9e63-e9528719a328" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d74e37f0-21fe-400e-bcb2-4629867f4b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c4643712-cd03-4a96-be9e-7b0e62269007" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d74e37f0-21fe-400e-bcb2-4629867f4b36" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c4643712-cd03-4a96-be9e-7b0e62269007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6632443-0273-49b4-963e-5f9440a888ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c4643712-cd03-4a96-be9e-7b0e62269007" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6632443-0273-49b4-963e-5f9440a888ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_HospiraMember_b1f87c13-78ed-40d7-9c1c-aa04ba61d387" xlink:href="icui-20211231.xsd#icui_HospiraMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6632443-0273-49b4-963e-5f9440a888ec" xlink:to="loc_icui_HospiraMember_b1f87c13-78ed-40d7-9c1c-aa04ba61d387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_afdd86d0-7aa3-4edc-a828-4cfbc7972566" xlink:href="icui-20211231.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6632443-0273-49b4-963e-5f9440a888ec" xlink:to="loc_icui_PursuitVascularInc.Member_afdd86d0-7aa3-4edc-a828-4cfbc7972566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularLLCMember_f2a4e692-405e-428f-a31a-93c0c1c23424" xlink:href="icui-20211231.xsd#icui_PursuitVascularLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6632443-0273-49b4-963e-5f9440a888ec" xlink:to="loc_icui_PursuitVascularLLCMember_f2a4e692-405e-428f-a31a-93c0c1c23424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignDistibutorMember_199e429b-6f94-4cc6-b8f6-c65b8e067891" xlink:href="icui-20211231.xsd#icui_ForeignDistibutorMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6632443-0273-49b4-963e-5f9440a888ec" xlink:to="loc_icui_ForeignDistibutorMember_199e429b-6f94-4cc6-b8f6-c65b8e067891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_7f5fa587-1e1d-4d18-91f4-2d1685f3a290" xlink:href="icui-20211231.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6632443-0273-49b4-963e-5f9440a888ec" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_7f5fa587-1e1d-4d18-91f4-2d1685f3a290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5432938f-4b6c-408a-81e5-f161adfd2448" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d74e37f0-21fe-400e-bcb2-4629867f4b36" xlink:to="loc_srt_RangeAxis_5432938f-4b6c-408a-81e5-f161adfd2448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c9e5a6f9-fa93-4f41-9fa6-f1f2599f36b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5432938f-4b6c-408a-81e5-f161adfd2448" xlink:to="loc_srt_RangeMember_c9e5a6f9-fa93-4f41-9fa6-f1f2599f36b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bba7437d-b9c7-4dd3-aaa4-160f706277d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c9e5a6f9-fa93-4f41-9fa6-f1f2599f36b2" xlink:to="loc_srt_MinimumMember_bba7437d-b9c7-4dd3-aaa4-160f706277d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ac3d0b4d-c197-4831-b917-46de8424e1da" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c9e5a6f9-fa93-4f41-9fa6-f1f2599f36b2" xlink:to="loc_srt_MaximumMember_ac3d0b4d-c197-4831-b917-46de8424e1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_fc2e00de-94fa-4137-bd2f-5c97c55400ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d74e37f0-21fe-400e-bcb2-4629867f4b36" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_fc2e00de-94fa-4137-bd2f-5c97c55400ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_be5774a7-86cb-4aea-a586-cda4d845e635" xlink:href="icui-20211231.xsd#icui_Contingentconsiderationgross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc2e00de-94fa-4137-bd2f-5c97c55400ee" xlink:to="loc_icui_Contingentconsiderationgross_be5774a7-86cb-4aea-a586-cda4d845e635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b8c23235-657e-4805-b56d-98946f8369a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc2e00de-94fa-4137-bd2f-5c97c55400ee" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b8c23235-657e-4805-b56d-98946f8369a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermContingentConsiderationGross_c7c31fed-4671-4828-8a6a-4b93d9d2a81a" xlink:href="icui-20211231.xsd#icui_ShortTermContingentConsiderationGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc2e00de-94fa-4137-bd2f-5c97c55400ee" xlink:to="loc_icui_ShortTermContingentConsiderationGross_c7c31fed-4671-4828-8a6a-4b93d9d2a81a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermContingentConsiderationGross_4ae23257-6f88-4b38-9933-c391e5d9d602" xlink:href="icui-20211231.xsd#icui_LongTermContingentConsiderationGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc2e00de-94fa-4137-bd2f-5c97c55400ee" xlink:to="loc_icui_LongTermContingentConsiderationGross_4ae23257-6f88-4b38-9933-c391e5d9d602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes" xlink:type="simple" xlink:href="icui-20211231.xsd#CollaborativeandOtherArrangementsNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_CollaborativeandOtherArrangementsAbstract_8b403859-662f-4277-ab94-5dd7b898ce88" xlink:href="icui-20211231.xsd#icui_CollaborativeandOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_c8df5ecb-ce51-455e-a7f6-9f9f99459000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_CollaborativeandOtherArrangementsAbstract_8b403859-662f-4277-ab94-5dd7b898ce88" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_c8df5ecb-ce51-455e-a7f6-9f9f99459000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsTables" xlink:type="simple" xlink:href="icui-20211231.xsd#CollaborativeandOtherArrangementsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CollaborativeandOtherArrangementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#CollaborativeandOtherArrangementsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_CollaborativeandOtherArrangementsAbstract_bf51d2d9-8cef-471b-87ac-b380de2bf29c" xlink:href="icui-20211231.xsd#icui_CollaborativeandOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_9a0b060e-741e-4ad8-bb36-010392abf94a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_CollaborativeandOtherArrangementsAbstract_bf51d2d9-8cef-471b-87ac-b380de2bf29c" xlink:to="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_9a0b060e-741e-4ad8-bb36-010392abf94a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_UpFrontMaintenanceFee_5858ee15-bf46-43df-a5fc-a697e079ff2f" xlink:href="icui-20211231.xsd#icui_UpFrontMaintenanceFee"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_CollaborativeandOtherArrangementsAbstract_bf51d2d9-8cef-471b-87ac-b380de2bf29c" xlink:to="loc_icui_UpFrontMaintenanceFee_5858ee15-bf46-43df-a5fc-a697e079ff2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/SubsequentEvents" xlink:type="simple" xlink:href="icui-20211231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_0a06ae0b-f4d6-4efd-be08-165707675cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_59602c52-5260-49b7-89b2-0679c2c16c37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_0a06ae0b-f4d6-4efd-be08-165707675cbd" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_59602c52-5260-49b7-89b2-0679c2c16c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/SubsequentEventsTables" xlink:type="simple" xlink:href="icui-20211231.xsd#SubsequentEventsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/SubsequentEventsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_b213d795-9f6c-460f-89db-c7d15f8cee23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsequentEventsTextBlock_9ac330fe-744e-4592-998f-0e28fab234df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_b213d795-9f6c-460f-89db-c7d15f8cee23" xlink:to="loc_us-gaap_ScheduleOfSubsequentEventsTextBlock_9ac330fe-744e-4592-998f-0e28fab234df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_26ca85fb-a88a-4f6a-be8e-e4649ab57f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_8b79f191-d923-4db8-9044-7a215b07f5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_26ca85fb-a88a-4f6a-be8e-e4649ab57f23" xlink:to="loc_us-gaap_SubsequentEventTable_8b79f191-d923-4db8-9044-7a215b07f5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_3229d181-2c02-4ac1-82e4-cf96b26e2f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_8b79f191-d923-4db8-9044-7a215b07f5a5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_3229d181-2c02-4ac1-82e4-cf96b26e2f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_07fe0a59-e245-4c90-99b0-79128a948c69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3229d181-2c02-4ac1-82e4-cf96b26e2f2b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_07fe0a59-e245-4c90-99b0-79128a948c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_135bc26f-f9c0-4553-8e40-c9b7ddefe2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_07fe0a59-e245-4c90-99b0-79128a948c69" xlink:to="loc_us-gaap_SubsequentEventMember_135bc26f-f9c0-4553-8e40-c9b7ddefe2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4d01f249-17b7-44d9-8dcd-8b1ec82760c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_8b79f191-d923-4db8-9044-7a215b07f5a5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4d01f249-17b7-44d9-8dcd-8b1ec82760c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6db065dd-e4a0-48d8-b011-7e742cd47960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4d01f249-17b7-44d9-8dcd-8b1ec82760c2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6db065dd-e4a0-48d8-b011-7e742cd47960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_fcf51fbb-3153-478e-908a-360331becd5a" xlink:href="icui-20211231.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6db065dd-e4a0-48d8-b011-7e742cd47960" xlink:to="loc_icui_SmithsMedicalMember_fcf51fbb-3153-478e-908a-360331becd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_e5900682-975d-401a-9552-0b3965cca1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_8b79f191-d923-4db8-9044-7a215b07f5a5" xlink:to="loc_us-gaap_SubsequentEventLineItems_e5900682-975d-401a-9552-0b3965cca1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_6a8235c3-8568-42a6-a3a1-a2c985e47597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e5900682-975d-401a-9552-0b3965cca1f9" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_6a8235c3-8568-42a6-a3a1-a2c985e47597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_609c0583-7d7c-4655-b752-1333ee29af30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e5900682-975d-401a-9552-0b3965cca1f9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_609c0583-7d7c-4655-b752-1333ee29af30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f335a211-87ab-452e-b480-8ead9d0e6322" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e5900682-975d-401a-9552-0b3965cca1f9" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f335a211-87ab-452e-b480-8ead9d0e6322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_fe1dc53f-ed36-42a2-8c15-6a9bfa80f770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e5900682-975d-401a-9552-0b3965cca1f9" xlink:to="loc_us-gaap_CommonStockValue_fe1dc53f-ed36-42a2-8c15-6a9bfa80f770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_dbb285b1-87ad-47b8-8f9c-e4437aca5731" xlink:href="icui-20211231.xsd#icui_Contingentconsiderationgross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e5900682-975d-401a-9552-0b3965cca1f9" xlink:to="loc_icui_Contingentconsiderationgross_dbb285b1-87ad-47b8-8f9c-e4437aca5731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OwnershipShareMinimumRequirement_aa5ab0f3-9257-418a-b887-7c4b3536fe40" xlink:href="icui-20211231.xsd#icui_OwnershipShareMinimumRequirement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e5900682-975d-401a-9552-0b3965cca1f9" xlink:to="loc_icui_OwnershipShareMinimumRequirement_aa5ab0f3-9257-418a-b887-7c4b3536fe40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#SubsequentEventsCreditAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_c03cdb37-2d91-4492-b6c3-35976cbca1b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_e3274774-ac8f-4660-9f53-9ca2ce2b038a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_c03cdb37-2d91-4492-b6c3-35976cbca1b8" xlink:to="loc_us-gaap_SubsequentEventTable_e3274774-ac8f-4660-9f53-9ca2ce2b038a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b26fb542-64eb-40d1-ab12-b94cd4c5417c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_e3274774-ac8f-4660-9f53-9ca2ce2b038a" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b26fb542-64eb-40d1-ab12-b94cd4c5417c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9d5b4a97-40f9-4ef9-85c4-501b041a0b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b26fb542-64eb-40d1-ab12-b94cd4c5417c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9d5b4a97-40f9-4ef9-85c4-501b041a0b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_59aad036-7c87-44cf-a253-c5ca45daeff5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_9d5b4a97-40f9-4ef9-85c4-501b041a0b51" xlink:to="loc_us-gaap_SubsequentEventMember_59aad036-7c87-44cf-a253-c5ca45daeff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_95d96d6e-3904-4313-b074-365e6d9aa0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_e3274774-ac8f-4660-9f53-9ca2ce2b038a" xlink:to="loc_us-gaap_DebtInstrumentAxis_95d96d6e-3904-4313-b074-365e6d9aa0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fec06b46-c0d1-4e03-a940-5d9d0ed36e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_95d96d6e-3904-4313-b074-365e6d9aa0e2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fec06b46-c0d1-4e03-a940-5d9d0ed36e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoansLineOfCreditMember_86118222-7f74-4f9b-a479-8dcde1d3ee63" xlink:href="icui-20211231.xsd#icui_TermLoansLineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fec06b46-c0d1-4e03-a940-5d9d0ed36e8a" xlink:to="loc_icui_TermLoansLineOfCreditMember_86118222-7f74-4f9b-a479-8dcde1d3ee63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_0c640a14-b68a-4b76-8beb-7a99f1852761" xlink:href="icui-20211231.xsd#icui_TermLoanAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fec06b46-c0d1-4e03-a940-5d9d0ed36e8a" xlink:to="loc_icui_TermLoanAMember_0c640a14-b68a-4b76-8beb-7a99f1852761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_73ca755e-202f-4bd1-a0e1-2798f13b8366" xlink:href="icui-20211231.xsd#icui_TermLoanBMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fec06b46-c0d1-4e03-a940-5d9d0ed36e8a" xlink:to="loc_icui_TermLoanBMember_73ca755e-202f-4bd1-a0e1-2798f13b8366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_c2b78cf2-6131-4595-9647-17cfea971ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fec06b46-c0d1-4e03-a940-5d9d0ed36e8a" xlink:to="loc_us-gaap_LineOfCreditMember_c2b78cf2-6131-4595-9647-17cfea971ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_8809571c-7c14-492a-b1a3-b09f85a2be73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_e3274774-ac8f-4660-9f53-9ca2ce2b038a" xlink:to="loc_us-gaap_SubsequentEventLineItems_8809571c-7c14-492a-b1a3-b09f85a2be73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_54a2cb65-99a9-41c9-bd5b-129885c36300" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8809571c-7c14-492a-b1a3-b09f85a2be73" xlink:to="loc_us-gaap_LongTermDebt_54a2cb65-99a9-41c9-bd5b-129885c36300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt_31f905c9-f6c8-4e04-91ca-c34ef906fbeb" xlink:href="icui-20211231.xsd#icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8809571c-7c14-492a-b1a3-b09f85a2be73" xlink:to="loc_icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt_31f905c9-f6c8-4e04-91ca-c34ef906fbeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount_f1e7d07f-9db7-4ed0-b902-f047cbc8be34" xlink:href="icui-20211231.xsd#icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8809571c-7c14-492a-b1a3-b09f85a2be73" xlink:to="loc_icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount_f1e7d07f-9db7-4ed0-b902-f047cbc8be34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAPaymentYear5_6721ed40-fff0-4097-934e-0ff4a933a186" xlink:href="icui-20211231.xsd#icui_TermLoanAPaymentYear5"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8809571c-7c14-492a-b1a3-b09f85a2be73" xlink:to="loc_icui_TermLoanAPaymentYear5_6721ed40-fff0-4097-934e-0ff4a933a186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount_7b870b0b-cbda-4f51-ac67-b971fab4ffe6" xlink:href="icui-20211231.xsd#icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8809571c-7c14-492a-b1a3-b09f85a2be73" xlink:to="loc_icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount_7b870b0b-cbda-4f51-ac67-b971fab4ffe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LineOfCreditSpread_5e9d1766-b533-4b3e-9892-b2f75f1a9aa7" xlink:href="icui-20211231.xsd#icui_LineOfCreditSpread"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8809571c-7c14-492a-b1a3-b09f85a2be73" xlink:to="loc_icui_LineOfCreditSpread_5e9d1766-b533-4b3e-9892-b2f75f1a9aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAAndCreditLineSpread_6a5aa4e1-835d-456c-9fa3-9f5ac5a46b96" xlink:href="icui-20211231.xsd#icui_TermLoanAAndCreditLineSpread"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8809571c-7c14-492a-b1a3-b09f85a2be73" xlink:to="loc_icui_TermLoanAAndCreditLineSpread_6a5aa4e1-835d-456c-9fa3-9f5ac5a46b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBInitialSpread_1e30c274-413c-41f8-96e8-bc7adc521a17" xlink:href="icui-20211231.xsd#icui_TermLoanBInitialSpread"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8809571c-7c14-492a-b1a3-b09f85a2be73" xlink:to="loc_icui_TermLoanBInitialSpread_1e30c274-413c-41f8-96e8-bc7adc521a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#SubsequentEventsTermLoanACreditLineApplicableMarginDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_15708242-a97a-4c8b-bd5f-d1817a806f89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_24bea94c-de28-41a9-a68a-407f950e86ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_15708242-a97a-4c8b-bd5f-d1817a806f89" xlink:to="loc_us-gaap_SubsequentEventTable_24bea94c-de28-41a9-a68a-407f950e86ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9241b820-9925-4614-adc9-a032594e05d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_24bea94c-de28-41a9-a68a-407f950e86ac" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9241b820-9925-4614-adc9-a032594e05d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c6c3f33f-064d-430c-8a63-b6fb29267c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9241b820-9925-4614-adc9-a032594e05d8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c6c3f33f-064d-430c-8a63-b6fb29267c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_70445149-b5c0-471a-a94d-4bf4810f7f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c6c3f33f-064d-430c-8a63-b6fb29267c9f" xlink:to="loc_us-gaap_SubsequentEventMember_70445149-b5c0-471a-a94d-4bf4810f7f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis_1b97ffc0-5489-43a1-9f70-c6873de29ac0" xlink:href="icui-20211231.xsd#icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_24bea94c-de28-41a9-a68a-407f950e86ac" xlink:to="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis_1b97ffc0-5489-43a1-9f70-c6873de29ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain_8b47605c-1564-428a-a372-b8fe2a850530" xlink:href="icui-20211231.xsd#icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis_1b97ffc0-5489-43a1-9f70-c6873de29ac0" xlink:to="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain_8b47605c-1564-428a-a372-b8fe2a850530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevel5Member_5e109094-32a0-40ba-9d1d-50a77edc26ac" xlink:href="icui-20211231.xsd#icui_PricingLevel5Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain_8b47605c-1564-428a-a372-b8fe2a850530" xlink:to="loc_icui_PricingLevel5Member_5e109094-32a0-40ba-9d1d-50a77edc26ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIVMemberMember_71c73642-996f-4b4f-ab16-335f0b2f4983" xlink:href="icui-20211231.xsd#icui_PricingLevelIVMemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain_8b47605c-1564-428a-a372-b8fe2a850530" xlink:to="loc_icui_PricingLevelIVMemberMember_71c73642-996f-4b4f-ab16-335f0b2f4983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIIIMemberMember_0b682553-886a-4472-b69a-4514b1db63f1" xlink:href="icui-20211231.xsd#icui_PricingLevelIIIMemberMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain_8b47605c-1564-428a-a372-b8fe2a850530" xlink:to="loc_icui_PricingLevelIIIMemberMember_0b682553-886a-4472-b69a-4514b1db63f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIIMemberMember_a05ccb16-123e-4ad1-af67-5d9cc715b3f9" xlink:href="icui-20211231.xsd#icui_PricingLevelIIMemberMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain_8b47605c-1564-428a-a372-b8fe2a850530" xlink:to="loc_icui_PricingLevelIIMemberMember_a05ccb16-123e-4ad1-af67-5d9cc715b3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIMember_8becc828-bb4c-4dc2-9c29-baf2cf7d3e41" xlink:href="icui-20211231.xsd#icui_PricingLevelIMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain_8b47605c-1564-428a-a372-b8fe2a850530" xlink:to="loc_icui_PricingLevelIMember_8becc828-bb4c-4dc2-9c29-baf2cf7d3e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_3cddb6f4-2ed5-494d-8841-ae8ff0027aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_24bea94c-de28-41a9-a68a-407f950e86ac" xlink:to="loc_us-gaap_SubsequentEventLineItems_3cddb6f4-2ed5-494d-8841-ae8ff0027aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Spread_3a7c3ad5-d82e-4075-8351-72040f4f1523" xlink:href="icui-20211231.xsd#icui_Spread"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_3cddb6f4-2ed5-494d-8841-ae8ff0027aa6" xlink:to="loc_icui_Spread_3a7c3ad5-d82e-4075-8351-72040f4f1523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9fe75d5d-eb53-48bf-ac50-82e3f04c8df7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_3cddb6f4-2ed5-494d-8841-ae8ff0027aa6" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9fe75d5d-eb53-48bf-ac50-82e3f04c8df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7154dd13-0fd3-48ad-87dc-6b22bb4e582f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_3cddb6f4-2ed5-494d-8841-ae8ff0027aa6" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7154dd13-0fd3-48ad-87dc-6b22bb4e582f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAAndCreditLineSpread_fb671e45-026b-43e5-a4a6-91db15d3ead9" xlink:href="icui-20211231.xsd#icui_TermLoanAAndCreditLineSpread"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_3cddb6f4-2ed5-494d-8841-ae8ff0027aa6" xlink:to="loc_icui_TermLoanAAndCreditLineSpread_fb671e45-026b-43e5-a4a6-91db15d3ead9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/SubsequentEventsTermLoanBApplicableMarginDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#SubsequentEventsTermLoanBApplicableMarginDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/SubsequentEventsTermLoanBApplicableMarginDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_cc62547d-851f-4f81-a0a3-1cc225346d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_c9bfaacb-8dcd-4a3c-8eb4-053eb14580a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_cc62547d-851f-4f81-a0a3-1cc225346d6c" xlink:to="loc_us-gaap_SubsequentEventTable_c9bfaacb-8dcd-4a3c-8eb4-053eb14580a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6ecff371-a16a-43fa-83e3-b08130c80b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_c9bfaacb-8dcd-4a3c-8eb4-053eb14580a0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6ecff371-a16a-43fa-83e3-b08130c80b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_580e3582-dd6f-4937-8f88-893ae0e9a65f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6ecff371-a16a-43fa-83e3-b08130c80b8d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_580e3582-dd6f-4937-8f88-893ae0e9a65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_7f81f866-01b3-4c71-8dfe-f5006cfbd16c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_580e3582-dd6f-4937-8f88-893ae0e9a65f" xlink:to="loc_us-gaap_SubsequentEventMember_7f81f866-01b3-4c71-8dfe-f5006cfbd16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBApplicableMarginAxis_a8a9eac2-13d6-464a-9203-40726f8b1b67" xlink:href="icui-20211231.xsd#icui_TermLoanBApplicableMarginAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_c9bfaacb-8dcd-4a3c-8eb4-053eb14580a0" xlink:to="loc_icui_TermLoanBApplicableMarginAxis_a8a9eac2-13d6-464a-9203-40726f8b1b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBApplicableMarginDomain_63696b94-bdad-4477-a2a6-4ddd966e44f6" xlink:href="icui-20211231.xsd#icui_TermLoanBApplicableMarginDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanBApplicableMarginAxis_a8a9eac2-13d6-464a-9203-40726f8b1b67" xlink:to="loc_icui_TermLoanBApplicableMarginDomain_63696b94-bdad-4477-a2a6-4ddd966e44f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIIMemberMember_27283f12-b08f-46d5-b1d1-669aaa307648" xlink:href="icui-20211231.xsd#icui_PricingLevelIIMemberMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanBApplicableMarginDomain_63696b94-bdad-4477-a2a6-4ddd966e44f6" xlink:to="loc_icui_PricingLevelIIMemberMember_27283f12-b08f-46d5-b1d1-669aaa307648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PricingLevelIMember_a7ea4173-7bae-47b8-bf52-dee4d6a20d38" xlink:href="icui-20211231.xsd#icui_PricingLevelIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanBApplicableMarginDomain_63696b94-bdad-4477-a2a6-4ddd966e44f6" xlink:to="loc_icui_PricingLevelIMember_a7ea4173-7bae-47b8-bf52-dee4d6a20d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_8b8c710b-08db-4751-aa22-d32ceadafd09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_c9bfaacb-8dcd-4a3c-8eb4-053eb14580a0" xlink:to="loc_us-gaap_SubsequentEventLineItems_8b8c710b-08db-4751-aa22-d32ceadafd09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBEuroRateLoanSpread_4e407f02-09d7-4236-9825-e4b74e140717" xlink:href="icui-20211231.xsd#icui_TermLoanBEuroRateLoanSpread"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8b8c710b-08db-4751-aa22-d32ceadafd09" xlink:to="loc_icui_TermLoanBEuroRateLoanSpread_4e407f02-09d7-4236-9825-e4b74e140717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBBaseRateLoanSpread_aab33583-4ce0-47bb-af0a-ea7ad1deb78d" xlink:href="icui-20211231.xsd#icui_TermLoanBBaseRateLoanSpread"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8b8c710b-08db-4751-aa22-d32ceadafd09" xlink:to="loc_icui_TermLoanBBaseRateLoanSpread_aab33583-4ce0-47bb-af0a-ea7ad1deb78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBInitialSpread_ec122530-9d09-46ad-8eb3-feb57c7c3223" xlink:href="icui-20211231.xsd#icui_TermLoanBInitialSpread"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8b8c710b-08db-4751-aa22-d32ceadafd09" xlink:to="loc_icui_TermLoanBInitialSpread_ec122530-9d09-46ad-8eb3-feb57c7c3223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccounts" xlink:type="simple" xlink:href="icui-20211231.xsd#SECScheduleArticle1209ValuationandQualifyingAccounts"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccounts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_d6b1a92b-0e19-4203-bf6c-c2a347ec06cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_9087d8af-b7bc-489a-b4e8-761eb27fc2d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_d6b1a92b-0e19-4203-bf6c-c2a347ec06cc" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_9087d8af-b7bc-489a-b4e8-761eb27fc2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="icui-20211231.xsd#SECScheduleArticle1209ValuationandQualifyingAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_bfb22afc-541c-45e2-8db8-64d6976d21d5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_e2baaa03-0718-4aef-bbd1-997a68b19eca" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_bfb22afc-541c-45e2-8db8-64d6976d21d5" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_e2baaa03-0718-4aef-bbd1-997a68b19eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_26cbc099-69af-464c-b149-2d3fcdd96903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_e2baaa03-0718-4aef-bbd1-997a68b19eca" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_26cbc099-69af-464c-b149-2d3fcdd96903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_5718ecd5-b5bc-4d2e-8191-3cf4f544ced0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_26cbc099-69af-464c-b149-2d3fcdd96903" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_5718ecd5-b5bc-4d2e-8191-3cf4f544ced0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_6570b451-948a-43e4-b96f-42bfad321a24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_5718ecd5-b5bc-4d2e-8191-3cf4f544ced0" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_6570b451-948a-43e4-b96f-42bfad321a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantyReservesMember_3448eed1-e3e3-4c32-b26b-db3c83b58d72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantyReservesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_5718ecd5-b5bc-4d2e-8191-3cf4f544ced0" xlink:to="loc_us-gaap_WarrantyReservesMember_3448eed1-e3e3-4c32-b26b-db3c83b58d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_d5262aab-cf53-4489-a801-78a99238b2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_5718ecd5-b5bc-4d2e-8191-3cf4f544ced0" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_d5262aab-cf53-4489-a801-78a99238b2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_7ca6484e-522f-4ad8-937c-c925e6fe84f5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_e2baaa03-0718-4aef-bbd1-997a68b19eca" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_7ca6484e-522f-4ad8-937c-c925e6fe84f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_7ca6484e-522f-4ad8-937c-c925e6fe84f5" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_998289bb-f8ed-4e5d-957c-bfaa51483c22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_998289bb-f8ed-4e5d-957c-bfaa51483c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_755bfca8-e341-4206-9bde-842196ce572a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_755bfca8-e341-4206-9bde-842196ce572a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_74202e3a-5904-4381-9f3b-5820fb210cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_74202e3a-5904-4381-9f3b-5820fb210cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_0e6660b6-c5ac-47e2-9150-d37624c3d18a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_0e6660b6-c5ac-47e2-9150-d37624c3d18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_3553b4cc-dc48-47e9-b42b-33951a707ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_3553b4cc-dc48-47e9-b42b-33951a707ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_WarrantyAndReturnReserveInventoryWriteOffs_a903127c-307a-432d-a2e1-3229e5549c3c" xlink:href="icui-20211231.xsd#icui_WarrantyAndReturnReserveInventoryWriteOffs"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:to="loc_icui_WarrantyAndReturnReserveInventoryWriteOffs_a903127c-307a-432d-a2e1-3229e5549c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts_f022e6d2-4299-4e76-a28f-18aa729b34f9" xlink:href="icui-20211231.xsd#icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:to="loc_icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts_f022e6d2-4299-4e76-a28f-18aa729b34f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_WarrantyAndReturnReserveCosts_9985b3dc-c895-4caa-907b-6a7e723e7282" xlink:href="icui-20211231.xsd#icui_WarrantyAndReturnReserveCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:to="loc_icui_WarrantyAndReturnReserveCosts_9985b3dc-c895-4caa-907b-6a7e723e7282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_WarrantyAndReturnReserveInventory_1c2344dc-81f9-462d-87a8-63789d70f970" xlink:href="icui-20211231.xsd#icui_WarrantyAndReturnReserveInventory"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_71de8118-7292-4a03-ad50-8ad42a8d8180" xlink:to="loc_icui_WarrantyAndReturnReserveInventory_1c2344dc-81f9-462d-87a8-63789d70f970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171457014184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information Document - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ICU MEDICAL INC/DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000883984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0022692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">951 Calle Amanecer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Clemente<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">366-2183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.10 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ICUI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,104,813,741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,786,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the Proxy Statement for registrant&#8217;s 2022 Annual Meeting of Stockholders filed or to be filed pursuant to Regulation 14A within 120 days following registrant&#8217;s fiscal year ended December&#160;31, 2021, are incorporated by reference into Part III of this Report.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171552257976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLineItems', window );"><strong>Auditor [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">DELOITTE & TOUCHE LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Costa Mesa, California<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171460167448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 552,827<span></span>
</td>
<td class="nump">$ 396,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">14,420<span></span>
</td>
<td class="nump">14,687<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">TOTAL CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENT SECURITIES</a></td>
<td class="nump">567,247<span></span>
</td>
<td class="nump">410,784<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for doubtful accounts of $7,038 at December 31, 2021 and $21,490 at December 31, 2020</a></td>
<td class="nump">105,894<span></span>
</td>
<td class="nump">124,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">290,235<span></span>
</td>
<td class="nump">314,928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">19,586<span></span>
</td>
<td class="nump">29,480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">46,847<span></span>
</td>
<td class="nump">41,492<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,029,809<span></span>
</td>
<td class="nump">920,777<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">PROPERTY AND EQUIPMENT, net</a></td>
<td class="nump">468,365<span></span>
</td>
<td class="nump">466,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">39,847<span></span>
</td>
<td class="nump">46,571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term Investment Securities</a></td>
<td class="nump">4,620<span></span>
</td>
<td class="nump">12,974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">GOODWILL</a></td>
<td class="nump">43,439<span></span>
</td>
<td class="nump">33,001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">INTANGIBLE ASSETS, net</a></td>
<td class="nump">188,311<span></span>
</td>
<td class="nump">197,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred Income Tax Assets, Net</a></td>
<td class="nump">42,604<span></span>
</td>
<td class="nump">31,034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other Assets</a></td>
<td class="nump">63,743<span></span>
</td>
<td class="nump">55,475<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">1,880,738<span></span>
</td>
<td class="nump">1,763,691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">81,128<span></span>
</td>
<td class="nump">71,864<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">118,195<span></span>
</td>
<td class="nump">97,021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Accrued Income Taxes, Current</a></td>
<td class="nump">1,454<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Contingent earn-out liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">26,300<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">200,777<span></span>
</td>
<td class="nump">195,488<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent earn-out liability, Noncurrent</a></td>
<td class="nump">2,589<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other Liabilities</a></td>
<td class="nump">41,830<span></span>
</td>
<td class="nump">47,835<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred Income Tax Liabilities, Net</a></td>
<td class="nump">1,490<span></span>
</td>
<td class="nump">1,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Accrued Income Taxes, Noncurrent</a></td>
<td class="nump">18,021<span></span>
</td>
<td class="nump">16,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>STOCKHOLDERS' EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue', window );">Convertible preferred stock, $1.00 par value Authorized-500 shares; Issued and outstanding - none</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.10 par value - Authorized-80,000 shares; Issued 21,280 and 21,058 shares at December 31, 2021 and 2020, respectively, and outstanding 21,280 and 21,058 shares at December 31, 2021 and 2020, respectively.</a></td>
<td class="nump">2,128<span></span>
</td>
<td class="nump">2,106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">721,412<span></span>
</td>
<td class="nump">693,068<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury Stock, Value</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">911,787<span></span>
</td>
<td class="nump">808,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(19,269)<span></span>
</td>
<td class="num">(1,522)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">1,616,031<span></span>
</td>
<td class="nump">1,502,265<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="nump">$ 1,880,738<span></span>
</td>
<td class="nump">$ 1,763,691<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding nonredeemable convertible preferred stock or outstanding convertible preferred stock that is redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171457147992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,316,308<span></span>
</td>
<td class="nump">$ 1,271,004<span></span>
</td>
<td class="nump">$ 1,266,208<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Goods Sold</a></td>
<td class="nump">824,818<span></span>
</td>
<td class="nump">809,507<span></span>
</td>
<td class="nump">794,344<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">491,490<span></span>
</td>
<td class="nump">461,497<span></span>
</td>
<td class="nump">471,864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>OPERATING EXPENSES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">302,583<span></span>
</td>
<td class="nump">283,953<span></span>
</td>
<td class="nump">276,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">47,498<span></span>
</td>
<td class="nump">42,948<span></span>
</td>
<td class="nump">48,611<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Restructuringandstrategictransactionexpense', window );">Restructuring, strategic transaction and integration expenses</a></td>
<td class="nump">18,037<span></span>
</td>
<td class="nump">28,409<span></span>
</td>
<td class="nump">80,574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent earn-out</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="num">(47,400)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contractsettlements', window );">Contractsettlements</a></td>
<td class="nump">127<span></span>
</td>
<td class="num">(975)<span></span>
</td>
<td class="nump">5,737<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">368,245<span></span>
</td>
<td class="nump">363,335<span></span>
</td>
<td class="nump">364,504<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">123,245<span></span>
</td>
<td class="nump">98,162<span></span>
</td>
<td class="nump">107,360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="num">(858)<span></span>
</td>
<td class="num">(1,753)<span></span>
</td>
<td class="num">(549)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">OTHER INCOME,NET</a></td>
<td class="nump">799<span></span>
</td>
<td class="nump">1,085<span></span>
</td>
<td class="nump">7,896<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossAttributableToParent', window );">Income before income taxes</a></td>
<td class="nump">123,186<span></span>
</td>
<td class="nump">97,494<span></span>
</td>
<td class="nump">114,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(20,051)<span></span>
</td>
<td class="num">(10,624)<span></span>
</td>
<td class="num">(13,672)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">$ 103,135<span></span>
</td>
<td class="nump">$ 86,870<span></span>
</td>
<td class="nump">$ 101,035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="nump">$ 4.86<span></span>
</td>
<td class="nump">$ 4.16<span></span>
</td>
<td class="nump">$ 4.90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="nump">$ 4.74<span></span>
</td>
<td class="nump">$ 4.02<span></span>
</td>
<td class="nump">$ 4.69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>WEIGHTED AVERAGE NUMBER OF SHARES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">21,206<span></span>
</td>
<td class="nump">20,907<span></span>
</td>
<td class="nump">20,629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">21,781<span></span>
</td>
<td class="nump">21,591<span></span>
</td>
<td class="nump">21,545<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Contractsettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractsettlements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Contractsettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Restructuringandstrategictransactionexpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring and strategic transaction expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Restructuringandstrategictransactionexpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171457039096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statement of Comprehensive Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 103,135<span></span>
</td>
<td class="nump">$ 86,870<span></span>
</td>
<td class="nump">$ 101,035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</a></td>
<td class="num">(3,021)<span></span>
</td>
<td class="nump">904<span></span>
</td>
<td class="nump">1,242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment, net of taxes of $0 for all periods</a></td>
<td class="num">(14,664)<span></span>
</td>
<td class="nump">12,929<span></span>
</td>
<td class="nump">372<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Other adjustments, net of taxes of $0 for all periods</a></td>
<td class="num">(62)<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(17,747)<span></span>
</td>
<td class="nump">13,880<span></span>
</td>
<td class="nump">1,543<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 85,388<span></span>
</td>
<td class="nump">$ 100,750<span></span>
</td>
<td class="nump">$ 102,578<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171454295816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock Shares [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss) [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, Shares at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,491,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2018</a></td>
<td class="nump">$ 1,263,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,049<span></span>
</td>
<td class="nump">$ 657,899<span></span>
</td>
<td class="num">$ (95)<span></span>
</td>
<td class="nump">$ 620,747<span></span>
</td>
<td class="num">$ (16,945)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of restricted stock and exercise of stock options, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">331,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of restricted stock and exercise of stock options, including excess income tax benefits</a></td>
<td class="nump">7,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="num">(10,870)<span></span>
</td>
<td class="nump">18,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchase of treasury stock,treasury stock acquired in lieu of cash payment on stock option exercises and income tax withholding obligations</a></td>
<td class="num">(18,639)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(18,639)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</a></td>
<td class="nump">21,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">1,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,543<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">101,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">1,377,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,074<span></span>
</td>
<td class="nump">668,947<span></span>
</td>
<td class="num">(157)<span></span>
</td>
<td class="nump">721,782<span></span>
</td>
<td class="num">(15,402)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, Shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,742,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of restricted stock and exercise of stock options, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of restricted stock and exercise of stock options, including excess income tax benefits</a></td>
<td class="nump">13,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="nump">12,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(67,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchase of treasury stock,treasury stock acquired in lieu of cash payment on stock option exercises and income tax withholding obligations</a></td>
<td class="num">(12,876)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(12,876)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</a></td>
<td class="nump">23,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">13,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">86,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 1,502,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,106<span></span>
</td>
<td class="nump">693,068<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="nump">808,652<span></span>
</td>
<td class="num">(1,522)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, Shares at Dec. 31, 2020</a></td>
<td class="nump">21,058,000<span></span>
</td>
<td class="nump">21,058,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of restricted stock and exercise of stock options, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">262,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of restricted stock and exercise of stock options, including excess income tax benefits</a></td>
<td class="nump">$ 9,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">1,003<span></span>
</td>
<td class="nump">8,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchase of treasury stock,treasury stock acquired in lieu of cash payment on stock option exercises and income tax withholding obligations</a></td>
<td class="num">(8,335)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,335)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</a></td>
<td class="nump">27,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="num">(17,747)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,747)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">103,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 1,616,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,128<span></span>
</td>
<td class="nump">$ 721,412<span></span>
</td>
<td class="num">$ (27)<span></span>
</td>
<td class="nump">$ 911,787<span></span>
</td>
<td class="num">$ (19,269)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, Shares at Dec. 31, 2021</a></td>
<td class="nump">21,280,000<span></span>
</td>
<td class="nump">21,280,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171453856616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">$ 103,135<span></span>
</td>
<td class="nump">$ 86,870<span></span>
</td>
<td class="nump">$ 101,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">89,698<span></span>
</td>
<td class="nump">85,631<span></span>
</td>
<td class="nump">76,916<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Operatingleaserightofuseassetamortization', window );">Operatingleaserightofuseassetamortization</a></td>
<td class="nump">9,594<span></span>
</td>
<td class="nump">9,216<span></span>
</td>
<td class="nump">8,294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">345<span></span>
</td>
<td class="nump">7,137<span></span>
</td>
<td class="nump">14,882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ProvisionForWarrantyAndReturns', window );">Provision for warranty and returns</a></td>
<td class="nump">831<span></span>
</td>
<td class="num">(1,576)<span></span>
</td>
<td class="num">(134)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation</a></td>
<td class="nump">27,341<span></span>
</td>
<td class="nump">23,954<span></span>
</td>
<td class="nump">21,918<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain (Loss) on Disposition of Property Plant Equipment</a></td>
<td class="nump">1,652<span></span>
</td>
<td class="num">(1,789)<span></span>
</td>
<td class="nump">12,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeAmortizationOfPremium', window );">Bond premium amortization</a></td>
<td class="nump">655<span></span>
</td>
<td class="nump">231<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Debt issuance cost amortization</a></td>
<td class="nump">240<span></span>
</td>
<td class="nump">288<span></span>
</td>
<td class="nump">288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent earn-out</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="num">(47,400)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductionRelatedImpairmentsOrCharges', window );">Production Related Impairments or Charges</a></td>
<td class="nump">3,380<span></span>
</td>
<td class="nump">2,626<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Sparepartsusage', window );">Sparepartsusage</a></td>
<td class="nump">13,046<span></span>
</td>
<td class="nump">11,191<span></span>
</td>
<td class="nump">24,301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="nump">2,582<span></span>
</td>
<td class="nump">6,939<span></span>
</td>
<td class="nump">447<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Increase (Decrease) in Accounts Receivable</a></td>
<td class="nump">13,755<span></span>
</td>
<td class="nump">78,049<span></span>
</td>
<td class="num">(23,684)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Increase (Decrease) in Inventories</a></td>
<td class="nump">20,815<span></span>
</td>
<td class="nump">19,196<span></span>
</td>
<td class="num">(24,997)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Increase (Decrease) in Prepaid Expense and Other Assets</a></td>
<td class="num">(7,973)<span></span>
</td>
<td class="num">(4,311)<span></span>
</td>
<td class="nump">8,588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Increase (Decrease) in Other Operating Assets</a></td>
<td class="num">(21,038)<span></span>
</td>
<td class="num">(16,069)<span></span>
</td>
<td class="num">(29,837)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">2,347<span></span>
</td>
<td class="num">(46,415)<span></span>
</td>
<td class="num">(2,697)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">6,259<span></span>
</td>
<td class="num">(29,379)<span></span>
</td>
<td class="num">(43,689)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes', window );">Income taxes, including excess tax benefits and deferred income taxes</a></td>
<td class="nump">874<span></span>
</td>
<td class="num">(18,037)<span></span>
</td>
<td class="nump">4,680<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">267,538<span></span>
</td>
<td class="nump">222,752<span></span>
</td>
<td class="nump">101,918<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(68,542)<span></span>
</td>
<td class="num">(92,005)<span></span>
</td>
<td class="num">(97,312)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment', window );">Proceeds from Sale of Other Property, Plant, and Equipment</a></td>
<td class="nump">218<span></span>
</td>
<td class="nump">6,176<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Intangible asset additions</a></td>
<td class="num">(12,627)<span></span>
</td>
<td class="num">(8,385)<span></span>
</td>
<td class="num">(8,728)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="num">(14,452)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(76,133)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to Acquire Equity Method Investments</a></td>
<td class="num">(3,250)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of investment securities</a></td>
<td class="num">(10,034)<span></span>
</td>
<td class="num">(32,825)<span></span>
</td>
<td class="num">(26,040)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sale of investment securities</a></td>
<td class="nump">18,000<span></span>
</td>
<td class="nump">28,900<span></span>
</td>
<td class="nump">41,292<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(90,687)<span></span>
</td>
<td class="num">(98,139)<span></span>
</td>
<td class="num">(166,888)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from Long-term Lines of Credit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of Long-term obligations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(150,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">9,372<span></span>
</td>
<td class="nump">13,193<span></span>
</td>
<td class="nump">7,732<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Finance Lease, Principal Payments</a></td>
<td class="num">(607)<span></span>
</td>
<td class="num">(357)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment for Contingent Consideration Liability, Financing Activities</a></td>
<td class="num">(17,300)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchase of treasury stock</a></td>
<td class="num">(8,335)<span></span>
</td>
<td class="num">(12,876)<span></span>
</td>
<td class="num">(18,639)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(16,870)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="num">(10,907)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAbstract', window );"><strong>Effect of Exchange Rate on Cash [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="num">(3,251)<span></span>
</td>
<td class="nump">2,854<span></span>
</td>
<td class="num">(234)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total</a></td>
<td class="nump">156,730<span></span>
</td>
<td class="nump">127,427<span></span>
</td>
<td class="num">(76,111)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AND CASH EQUIVALENTS, beginning of period</a></td>
<td class="nump">396,097<span></span>
</td>
<td class="nump">268,670<span></span>
</td>
<td class="nump">344,781<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AND CASH EQUIVALENTS, end of period</a></td>
<td class="nump">552,827<span></span>
</td>
<td class="nump">396,097<span></span>
</td>
<td class="nump">268,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL DISCLSOURE OF CASH FLOW INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid during the year for income taxes</a></td>
<td class="nump">19,562<span></span>
</td>
<td class="nump">31,628<span></span>
</td>
<td class="nump">9,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest Paid, Excluding Capitalized Interest, Operating Activities</a></td>
<td class="nump">858<span></span>
</td>
<td class="nump">1,753<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accounts payable for property and equipment</a></td>
<td class="nump">9,338<span></span>
</td>
<td class="nump">2,211<span></span>
</td>
<td class="nump">13,912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">10,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,026<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_InternationalDistributorMember', window );">International Distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Liabilities Assumed</a></td>
<td class="nump">2,589<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularLLCMember', window );">Pursuit Vascular LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember', window );">Foreign Infusion System Supplier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair value of assets acquired</a></td>
<td class="nump">4,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_NetCashPaidReceivedforcurrentandprioracquisitions', window );">Cash paid for acquisitions, net of cash acquired</a></td>
<td class="num">(14,452)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Goodwill, Period Increase (Decrease)</a></td>
<td class="nump">10,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">10,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Liabilities Assumed</a></td>
<td class="nump">$ 766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_TotalAcquisitionsMember', window );">Total Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair value of assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_NetCashPaidReceivedforcurrentandprioracquisitions', window );">Cash paid for acquisitions, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76,133)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,300)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Liabilities Assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,612<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change during the reporting period in the carrying amount as of the balance sheet date of payments made for taxes. Also includes the net change during the reporting period in the account that represents the temporary difference that results from income (loss) that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_NetCashPaidReceivedforcurrentandprioracquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Cash Paid (Received) for current and prior acquisitions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_NetCashPaidReceivedforcurrentandprioracquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Operatingleaserightofuseassetamortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operatingleaserightofuseassetamortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Operatingleaserightofuseassetamortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ProvisionForWarrantyAndReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision for warranty and returns</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ProvisionForWarrantyAndReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Sparepartsusage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sparepartsusage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Sparepartsusage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount, measured at acquisition-date fair value, of all liabilities assumed that arise from contingencies and were recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeAmortizationOfPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization of purchase premium on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeAmortizationOfPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow for the sale of long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductionRelatedImpairmentsOrCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nonrecurring impairment charges related to the write-off of production-related equipment and inventory. This tag is used when an Entity charges this cost to cost of goods sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductionRelatedImpairmentsOrCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_InternationalDistributorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_InternationalDistributorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_TotalAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_TotalAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171460074296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 7,038,000<span></span>
</td>
<td class="nump">$ 21,490,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Convertible preferred stock, par value</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock, authorized shares</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Convertible preferred stock, outstanding shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">80,000,000<span></span>
</td>
<td class="nump">80,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">21,280,000<span></span>
</td>
<td class="nump">21,058,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares issued</a></td>
<td class="nump">21,280,000<span></span>
</td>
<td class="nump">21,058,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171457034280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statement of Comprehensive Income (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Other Comprehensive (Income) Loss, Other Adjustments, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</a></td>
<td class="num">$ (954,000)<span></span>
</td>
<td class="nump">$ 285,000<span></span>
</td>
<td class="nump">$ 392,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458362712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</a></td>
<td class="text">BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Basis of Presentation and Preparation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ICU Medical,&#160;Inc. ("ICU" or "we"), a Delaware corporation, operates in one business segment engaged in the development, manufacturing and sale of innovative medical devices used in infusion therapy and critical care applications. We are one of the world's leading pure-play infusion therapy companies with a wide-ranging product portfolio that includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needlefree connectors designed to help meet clinical, safety and workflow goals. We sell the majority of our products through our direct sales force and through independent distributors throughout the U.S. and internationally. Additionally, we sell our products on an original equipment manufacturer basis to other medical device manufacturers. The manufacturing for all product groups occurs in Salt Lake City, Utah, Austin, Texas, Mexico and Costa Rica. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All subsidiaries are wholly owned and are included in the consolidated financial statements.&#160; All intercompany accounts and transactions have been eliminated.  Results of operations of companies purchased are included from the dates of acquisition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation.  These consolidated financial statements were prepared in accordance with accounting principles generally accepted in the U.S. ("GAAP").  Preparing financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;Actual results could differ from those estimates.&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash, Cash Equivalents</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are short-term, highly liquid investments that are readily convertible to known amounts of cash and have original maturities of three months or less from the date of purchase. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounts Receivable</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are stated at net realizable value.&#160; An allowance is provided for estimated collection losses based on an assessment of various factors.&#160; We consider prior payment trends, the age of the accounts receivable balances, financial status and other factors to estimate the cash which ultimately will be received.&#160; Such amounts cannot be known with certainty at the financial statement date.&#160; We regularly review individual past due balances for collectability.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventories</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value with cost determined using the first-in, first-out method.&#160; Inventory costs include material, labor and overhead related to the manufacturing of our products.&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,235&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314,928&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Property, Plant and Equipment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consists of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, building and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments placed with customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,384&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,383&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, cost</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905,104&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843,096&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(436,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(376,468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468,365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466,628&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instruments placed with customers consist of drug-delivery and monitoring systems placed with customers under operating leases.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All property, plant and equipment are stated at cost.&#160; We use the straight-line method for depreciating property, plant  and equipment over their estimated useful lives.&#160; Estimated useful lives are:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 - 30 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building improvements</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 - 30 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and molds</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 - 15 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and office equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 - 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 5 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments placed with customers<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 10 years</span></div></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize expenditures that materially increase the life of the related assets; maintenance and repairs are expensed as incurred.&#160;The costs and related accumulated depreciation applicable to property, plant and equipment sold or retired are removed from the accounts and any gain or loss is reflected in the statements of operations at the time of disposal. Depreciation expense was $65.9 million, $62.4 million and $59.3 million in 2021, 2020 and 2019, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Goodwill</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We test goodwill for impairment on an annual basis in the month of November, or more frequently if an event occurs or circumstances change that would indicate that impairment may exist.&#160;Generally, we first perform a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If, based on an assessment of relevant qualitative factors, we determine that this is not the case, then the quantitative impairment test is not required to be performed. Conversely, if we determine based on the qualitative assessment that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, we will perform the quantitative impairment test. For the quantitative impairment test, we calculate the estimated fair value of the reporting unit. If the estimated fair value of the reporting unit is less than its carrying amount, the goodwill of the reporting unit is determined to be impaired. An impairment charge is recorded in an amount equal to the excess of the carrying amount over its estimated fair value, limited to the total amount of goodwill allocated to the reporting unit. For our annual impairment test for the year ended December 31, 2021, we performed a qualitative assessment and concluded that it was more likely than not that the fair value of our reporting unit exceeded its carrying amount, and therefore, no further impairment testing was required. There were no accumulated impairment losses as of December&#160;31, 2021, 2020 and 2019. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the carrying amount of our goodwill for 2021, 2020 and 2019 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:78.665%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,001&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,439&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we acquired Pursuit Vascular, Inc. ("Pursuit"), which resulted in $19.1&#160;million of goodwill. We also acquired a small foreign distributor, which resulted in $0.9&#160;million of goodwill.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, "Other" relates to a $1.3&#160;million measurement period adjustment to deferred taxes related to the Pursuit acquisition and foreign currency translation.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In 2021, we acquired a small foreign infusion systems supplier, which resulted in $10.6&#160;million of goodwill.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Intangible Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis, were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life<br/>in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,665&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,835&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,882&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,953&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,193&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,882&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,311&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life<br/>in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,056&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,741&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,311&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,443&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,868&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,674&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,443&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,231&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $23.8 million, $23.2 million and $17.7 million in 2021, 2020 and 2019, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, estimated annual amortization for our intangible assets for each of the next five years is approximately (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:78.665%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,953&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our intangible assets that are not subject to amortization are reviewed annually for impairment or more often if there are indications of possible impairment.  We perform our annual intangible assets impairment test in November of each year. We did not have any intangible asset impairments in 2021, 2020 or 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-Lived Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically evaluate the recoverability of long-lived assets whenever events and changes in circumstances indicate that the carrying amount of an asset may not be fully recoverable. When indicators of impairment are present, the carrying values of the assets are evaluated in relation to the operating performance and future undiscounted cash flows of the underlying business. The net book value of the underlying asset is adjusted to fair value if the sum of the expected discounted cash flows is less than book value. Fair values are based on estimates of market prices and assumptions concerning the amount and timing of estimated future cash flows and discount rates, reflecting varying degrees of perceived risk. We did not have any long-lived asset impairments in 2021, 2020 or 2019.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investment Securities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments, exclusive of cash equivalents, are marketable securities intended to be sold within one year and may include trading securities, available-for-sale securities, and held-to-maturity securities (if maturing within one year at </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the time of acquisition).  Long-term investments are marketable securities intended to be sold after one year and may include trading securities, available-for-sale securities, and held-to-maturity securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Available-for-sale Securities </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment securities are considered available-for-sale and currently consist of short-term and long-term corporate bonds. These securities are considered &#8220;investment grade&#8221; and are carried at fair value. We assess our investment in available-for-sale debt securities for impairment each reporting period. If an unrealized loss exists, we determine whether any portion of the decline in fair value below the carrying value is credit-related by reviewing several factors, including, but not limited to, the extent of the fair value decline and changes in the financial condition of the issuer. We record an impairment for credit-related losses through an allowance, limited to the amount of the unrealized loss. If we either intend to sell or it is more likely than not we will be required to sell the debt security before its anticipated recovery, any allowance is written off and the amortized cost basis is written down to fair value through a charge against net earnings. Unrealized gains and non-credit-related unrealized losses are recorded, net of tax, in other comprehensive income (loss). We did not have any investments in available-for-sale debt securities in unrealized loss positions as of December 31, 2021 or 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost of the debt securities is adjusted for the amortization of premiums computed under the effective interest method. Such amortization is included in other income, net in the consolidated statements of operations. Realized gains and losses are accounted for on the specific identification method. There have been no realized gains or losses on the disposal of these investments. The scheduled maturities of the debt securities are between 2022 and 2024. All short-term investment securities are callable within one year.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term and long-term investments in available-for-sale securities consist of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.943%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.821%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.016%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.821%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,040&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,040&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,661&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,661&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Non-Marketable Equity Securities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2021, we acquired approximately a 20.0% non-marketable equity interest in a nonpublic company and entered into a three-year distribution agreement where we have the exclusive rights to market, sell and distribute the company's products in exchange for a cash payment of $3.3&#160;million. In addition, we were granted an exclusive license for all of the seller's intellectual property. At the expiration of the distribution agreement we have the right but not the obligation to acquire the remaining interest in the business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the equity method of accounting for investments when we determine we have a significant influence, but not a controlling interest in the investee. We determine whether we have significant influence by considering key factors such as ownership interest, representation on the board of directors, participation in policy making decisions, business relationship and material intra-entity transactions, among other factors. Our equity method investment is reported at cost and adjusted each period for our share of the investee's income or (loss) and dividend paid, if any. We eliminate any intra-entity profits to the extent of our beneficial interest. We record our share of the investee's income or (loss) on a one quarter lag. We report our </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">proportionate share of the investee's income or (loss) resulting from this investment in other income, net in our consolidated statements of operations. The carrying value of our equity method investment is reported in other assets on the consolidated balance sheets. We assess our equity method investments for impairment on an annual basis or whenever events or circumstances indicate that the carrying value of the investment may not be recoverable. During 2021, there were no indications that our non-marketable equity method investment was impaired. Our recorded share of the investee's loss was not material for the year ended December 31, 2021. We did not receive any dividend distributions from this investment during 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-marketable equity method investment consists of the following (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Income Taxes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred taxes are determined based on the differences between the financial statements and the tax bases using rates as enacted in the laws. A valuation allowance is established if it is &#8220;more likely than not&#8221; that all or a portion of the deferred tax assets will not be realized.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize interest and penalties related to unrecognized tax benefits in the tax provision. We recognize liabilities for uncertain tax positions when it is more likely than not that a tax position will not be sustained upon examination and settlement with various taxing authorities. Liabilities for uncertain tax positions are measured based upon the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. We have not recorded any material interest or penalties during any of the years presented.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Foreign Currency</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, the functional currency of our international subsidiaries is the local currency. Generally, we translate the financial statements of these subsidiaries to U.S. dollars at the exchange rate in effect at the balance sheet date and revenues and expenses are translated at the average monthly exchange rates during the year. Certain of our international subsidiaries consolidate first with another subsidiary that utilizes a functional currency other than U.S. dollars.&#160;In those cases, we follow a step by step translation process utilizing the same sequence as the consolidation process.&#160;Translation adjustments are recorded as a component of accumulated other comprehensive loss, a separate component of stockholders' equity on our consolidated balance sheets and the effect of exchange rate changes on cash and cash equivalents are reflected on our consolidated statements of cash flows.&#160;Gains and losses for transactions denominated in a currency other than the functional currency of the entity are included in our consolidated statements of operations in other income, net. Foreign currency transaction losses (gains), net were $1.0 million, $7.2 million and $(0.7) million in 2021, 2020 and 2019, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revenue Recognition</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenues when we transfer control of promised goods to our customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods.  We offer certain volume-based rebates to our distribution customers, which we consider variable consideration when calculating the transaction price. Rebates are offered on both a fixed and tiered/variable basis. In both cases, we use information available at the time and our historical experience with each customer to estimate the most likely rebate amount. We also provide chargebacks to distributors that sell to end customers at prices determined under a contract between us and the end customer. Chargebacks are the difference between prices we charge our distribution customers and contracted prices we have with the end customer which are processed as credits to our distribution customers. In estimating the expected value of chargeback amounts for use in determining the transaction price, we use information available at the time, including our historical experience. We also warrant products against defects and have a policy permitting the return of defective products, for which we accrue and expense at the time of sale using information available and our historical experience. Our revenues are recorded at the net sales price, which includes an estimate for variable consideration related to rebates, chargebacks and product returns.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vast majority of our sales of Infusion Consumables, Infusion Systems, IV Solutions and Critical Care products are sold on a standalone basis and control of these products transfers to the customer upon shipment.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our software license renewals are considered to be transferred to a customer at a point in time at the start of each renewal period, therefore revenue is recognized at that time.&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Arrangements with Multiple Deliverables</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain circumstances, we enter into arrangements in which we provide multiple deliverables to our customers.  These bundled arrangements typically consist of the sale of infusion systems equipment, along with annual software licenses and related software implementation services, as well as infusion consumables, IV solutions and extended warranties. Our most significant judgments related to these arrangements are (i) identifying the various performance obligations and (ii) estimating the relative standalone selling price of each performance obligation, typically using a directly observable method or calculated on a cost plus margin basis method.  Revenue related to the bundled equipment, software and software implementation services are typically combined into a single performance obligation and recognized upon implementation. As annual software licenses are renewed, we recognize revenue for the license at a point in time, at the start of each annual renewal period. The transaction price allocated to the extended service-type warranty is recognized as revenue over the period the warranty service is provided. Consumables and solutions are separate performance obligations, recognized at a point in time.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Shipping Costs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs to ship finished goods to our customers are included in cost of goods sold on the consolidated statements of operations.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Advertising Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising expenses are expensed as incurred and reflected in selling, general and administrative expenses in our consolidated statements of operations and were $0.2 million, $0.2 million and $0.1 million in 2021, 2020 and 2019, respectively.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Post-retirement and Post-employment Benefits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sponsor a Section&#160;401(k)&#160;retirement plan ("plan") for employees.&#160;Our contributions to our 401(k) plan were approximately $11.0 million, $10.7 million and $11.4 million in 2021, 2020 and 2019, respectively. We also have post-retirement and post-employment obligations related to employees located in certain international countries. These obligations are immaterial to our financial statements taken as a whole.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Research and Development</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our research and development costs are expensed as incurred.  In certain circumstances when an asset will have an alternative future use we capitalize the costs related to those assets.  Research and development costs include salaries and related benefits, consulting fees, production supplies, samples, travel costs, utilities and other miscellaneous administrative costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net Income Per Share</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income per share is computed by dividing net income by the weighted-average number of common shares outstanding. Diluted net income per share is computed by dividing net income by the weighted-average number of common shares outstanding plus dilutive securities.&#160;Dilutive securities include outstanding common stock options and unvested restricted stock units, less the number of shares that could have been purchased with the proceeds from the exercise of the options, using the treasury stock method. Options that are anti-dilutive, where their exercise price exceeds the average market price of the common stock, are not included in the treasury stock method calculation. Restricted stock units that are anti-dilutive are not included in the treasury stock method. There were 12,354, 12,083 and 10,760 anti-dilutive shares in 2021, 2020 and 2019, respectively. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of net earnings per common share (&#8220;EPS&#8221;) &#8212; basic and diluted (in thousands, except per share data):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.246%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year&#160;ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,035&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding (basic)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,206&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,907&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,629&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common and common equivalent shares outstanding&#160;(diluted)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,781&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,591&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,545&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.86&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.16&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.90&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; diluted</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">New Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Standards </span></div>In March 2020, the Financial Accounting Standards Board ("FASB")  issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide optional guidance for a limited period of time to ease the potential burden for reference rate reform on financial reporting. Due to concerns about structural risks of interbank offered rates and, particularly, the risk of cessation of the London Interbank Offered Rate ("LIBOR"), regulators around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation. The amendments in this update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued as a result of reference rate reform. Optional expedients may be applied to contracts that are modified as a result of the reference rate reform. Modifications of contracts within the scope of Topic 470, Debt, should be accounted for by prospectively adjusting the effective interest rate. Modifications of contracts within the scope of ASC 842, Leases, should be accounted for as a continuation of the existing contracts with no reassessments of the lease classification and the discount rate (incremental borrowing rate). Exceptions to Topic 815, Derivatives and Hedging, results in not having a dedesignation of a hedging relationship if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. In November 2021, we entered into two forward-starting swaps whereby the variable leg of the swap references LIBOR, these swaps will be amended in early 2022 to transition to an alternative reference rate (see Note 7: Derivatives and Hedging Activities). The amendments in this ASU allow for certain expedients that will allow us to assume that our hedged interest payments are probable of occurring regardless of any expected modification in their terms related to reference rate reform and will allow us to continue hedge accounting for a cash flow hedge for which the hedged interest rate risk changes if the hedge is highly effective under ASC 815, Derivatives and Hedging or the optional expedient under this ASU is elected. The impact of this ASU on our contracts has not been and is not expected to be material.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458405480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combination Disclosure [Text Block]</a></td>
<td class="text">ACQUISITIONS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 Acquisitions</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2019, we acquired 100% interest in Pursuit for cash consideration of approximately $75.0 million.  Additionally, Pursuit's equity holders were potentially entitled up to $50.0 million in additional cash consideration contingent upon the achievement of certain sales and gross profit targets for specific customers. The earn-out paid was calculated as a percentage of gross profit achieved during the earn-out period against a pre-determined target gross profit, not to exceed $50.0 million. As of June 30, 2021, the earn-out measurement period ended and based on the actual sales and gross profit achieved during the measurement period, we calculated the actual earn-out amount to be $26.3&#160;million. The $26.3&#160;million earn-out calculation was finalized and accepted by Pursuit's former equity holders and was paid out in during the fourth quarter of 2021.  The acquisition of Pursuit and their ClearGuard HD is a natural extension of our needlefree IV connector and other infection control technologies, which together provides us the best of breed solutions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Final Purchase Price</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the final purchase price and the final allocation of the purchase price related to the assets and liabilities purchased (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration for acquired assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,833&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Final Purchase Price Allocation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,065)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - not tax deductible</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,462&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,769)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,833&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_______________________________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable intangible assets included $69.0 million of developed technology, $10.8 million of trade name and $2.5 million of non-compete agreement. The weighted-average amortization periods for the identifiable intangible assets are as follows: approximately fifteen years for developed technology, fifteen years for trade name and three years for the non-compete agreement. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The identifiable intangible assets acquired have been valued as Level 3 assets at fair market value. The estimated fair value of identifiable intangible assets were developed using the income approach and are based on critical estimates, judgments and assumptions derived from: analysis of market conditions; discount rate; discounted cash flows; royalty rates; and estimated useful lives. Fixed assets were valued with the consideration of remaining economic lives. The raw materials inventory was valued at historical cost and adjusted for any obsolescence and finished goods inventory was valued at estimated sales proceeds less a nominal profit and costs to sell. The trade receivables, prepaid expenses and other current assets and assumed liabilities were recorded at their carrying values as of the date of the acquisition, as their carrying values approximated their fair values due to their short-term nature.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, we also acquired a small foreign distributor for approximately $4.6&#160;million in cash.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Acquisitions</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During November 2021, we acquired a small foreign infusion systems supplier and paid an initial gross cash payment of approximately $15.4&#160;million. The total consideration and purchase price allocation is preliminary pending the finalization of the valuation. In addition to the initial cash consideration, total consideration for the acquisition includes an additional holdback of $0.5&#160;million, to be paid two years from the completion date of the acquisition, and also a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458392744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Strategic Transaction and Integration (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Related Activities Disclosure [Text Block]</a></td>
<td class="text">RESTRUCTURING, STRATEGIC TRANSACTION AND INTEGRATION<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, strategic transaction and integration expenses were $18.0 million, $28.4 million and $80.6 million in 2021, 2020 and 2019, respectively.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring charges were $(1.8) million, $7.9 million and $8.4 million in 2021, 2020 and 2019, respectively, and are included in the above restructuring, strategic transaction and integration expenses in our consolidated statement of operations.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we adjusted certain facility restructuring liabilities by $2.0&#160;million, shown in the table below under "Other adjustments," to reflect actual amounts owed which resulted in net restructuring credits of $(1.8)&#160;million. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, restructuring charges were primarily related to severance and costs related to office and other facility closures.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, restructuring charges were primarily related to severance and facility closure costs.  These charges were primarily related to a one-time charge to move our U.S. pump service depot to our existing Salt Lake City facility and other plant restructuring. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2015, we incurred restructuring charges related to an agreement with Dr. Lopez, a member of our Board of Directors and a former employee in our research and development department, pursuant to which we bought out Dr. Lopez's right to employment under his then-existing employment agreement. The buy-out, including payroll taxes, was paid in equal monthly installments until December 2020. This has been fully paid as of December 31, 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity in our restructuring-related accrual by major type of cost (in thousands): </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Severance Pay and Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Employment Agreement Buyout</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retention and Facility Closure Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,878&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,549&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges incurred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,331)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(460)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,570)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,361)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,563&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,421&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges incurred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(969)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(969)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(528)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,429)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,957)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_______________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated liabilities related to a prior year's facility closure restructuring were adjusted to actual amounts owed.</span></div>Strategic Transaction and Integration ExpensesWe incurred $19.8 million, $20.5 million and $72.2 million in strategic transaction and integration expenses in 2021, 2020 and 2019, respectively, which are included in restructuring, strategic transaction and integration expenses in our consolidated statement of operations. The strategic transaction and integration expenses during 2021 were related to integration costs associated with acquisitions, the Hospira Infusion Systems ("HIS") earn-out dispute with Pfizer, one-time costs incurred to comply with regulatory initiatives and transaction expenses incurred in connection with entering into a definitive agreement to acquire Smiths Medical 2020 Limited ("Smiths Medical")  (see Note 17: Subsequent Events). The integration expenses during 2020 were related to the integration of HIS and included expenses for the migration of IT systems at our Austin facility. The strategic transaction and integration expenses during 2019 were primarily related to HIS, including a one-time strategic supply chain restructuring charge of $22.1 million, which reduced our contracted commitments to our third party manufacturer and charges related to our Pfizer separation costs, which included a $12.7 million non-cash write-off of related assets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458367624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contract with Customer [Text Block]</a></td>
<td class="text">REVENUE<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary product lines are Infusion Consumables, Infusion Systems, IV Solutions and Critical Care. The vast majority of our sales of these products are made on a stand-alone basis to hospitals and distributors. Revenue is typically recognized upon transfer of control of the products, which we deem to be at point of shipment. However, for purposes of revenue recognition for our software licenses and  renewals, we consider the control of these products to be transferred to a customer at a certain point in time; therefore, we recognize revenue at the start of the applicable license term.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment is typically due in full within 30 days of delivery or the start of the contract term. Revenue is recorded in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We offer certain volume-based rebates to our distribution customers, which we record as variable consideration when calculating the transaction price. Rebates are offered on both a fixed and tiered/variable basis. In both cases, we use information available at the time and our historical experience with each customer to estimate the most likely rebate amount. We also provide chargebacks to distributors that sell to end customers at prices determined under a contract between us and the end customer. Chargebacks are the difference between the prices we charge our distribution customers and the contracted prices we have with the end customer which are processed as credits to our distribution customers. In estimating the expected value of chargeback amounts in order to determine the transaction price, we use information available at the time, including our historical experience.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also warrant products against defects and have a policy permitting the return of defective products, for which we accrue and expense at the time of sale using information available at that time and our historical experience. We also provide for extended service-type warranties, which we consider to be separate performance obligations. We allocate a portion of the transaction price to the extended service-type warranty based on its estimated relative selling price, and recognize revenue over the period the warranty service is provided. Our revenues are recorded at the net sales price, which includes an estimate for variable consideration related to rebates, chargebacks and product returns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Arrangements with Multiple Performance Obligations</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also enter into arrangements which include multiple performance obligations, (see Note 1: Basis of Presentation and Summary of Significant Accounting Policies). </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant judgments related to these arrangements include: </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Identifying the various performance obligations of these arrangements.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Estimating the relative standalone selling price of each performance obligation, typically using a directly observable method or calculated on a cost plus margin basis method. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue disaggregated</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents our revenues disaggregated by product line (in thousands) and our disaggregated product line revenue as a percentage of total revenue:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product line</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Consumables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555,189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,740&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328,282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,316,308&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266,208&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report revenue on a "where sold" basis, which reflects the revenue within the country or region in which the ultimate sale is made to our external customer.&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents our revenues disaggregated by geography (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:60.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.070%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.218%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geography</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,488&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Foreign</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374,499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,866&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941,809&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910,627&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923,342&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,316,308&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266,208&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Domestic sales accounted for 72%, 72% and 73% of total revenue in 2021, 2020 and 2019, respectively.  International sales accounted for 28%, 28% and 27% of total revenue in 2021, 2020 and 2019, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract balances</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contract balances (deferred revenue) are recorded in accrued liabilities and other long-term liabilities in our consolidated balance sheet (see Note 10: Accrued Liabilities and Other Long-term Liabilities). The following table presents the changes in our contract balances for the years ended December 31, 2021 and 2020, (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:79.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,855)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,341)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,363)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,430)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,725)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,615)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,461)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During 2021, we recognized $5.1&#160;million in revenue that was included in the opening contract balances as of December 31, 2020. As of December 31, 2021, revenue from remaining performance obligations related to implementation of software and equipment is $5.6 million. We expect to recognize substantially all of this revenue within the next three to six months dependent on implementation restrictions due to the novel coronavirus and its variants ("COVID-19").  Revenue from remaining performance obligations related to annual software licenses is $1.9 million. We expect to recognize substantially all of this revenue over the next twelve months. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs to Obtain a Contract with a Customer</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the cost to obtain a contract, we may pay incremental commissions to sales employees upon entering into a sales contract. Under ASC Topic 606, we have elected to expense these costs as incurred as the period of benefit is less than one year.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Practical expedients and exemptions</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the practical expedient applied to sales commissions, under ASC Topic 606, we elected to apply the practical expedient for shipping and handling costs incurred after the customer has obtained control of a good. We will continue to treat these costs as a fulfillment cost rather than as an additional promised service.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458406312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LesseeOperatingAndFinanceLeaseTextBlock', window );">Lessee, Operating and Finance Lease</a></td>
<td class="text">LEASES<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at inception. Our operating lease assets are separately stated in operating lease right-of-use ("ROU") assets and our financing lease assets are included in other assets on our consolidated balance sheets. Our lease liabilities are included in accrued liabilities, and other long-term liabilities on our consolidated balance sheets. We have elected not to recognize an ROU asset and lease liability for leases with terms of twelve months or less.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease ROU assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. Most of our leases do not provide an implicit rate, therefore we use our incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term based on the information available at commencement date. Our lease ROU assets exclude lease incentives and initial direct costs incurred. Our lease terms include options to extend when it is reasonably certain that we will exercise that option. All of our leases have stated lease payments, which may include fixed rental increases. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leases are for corporate, research and development and sales and support offices, a distribution facility, device service centers and certain equipment. Our leases have original lease terms of one year to fifteen years, some of which include options to extend the leases for up to an additional five years. For all of our leases, we do not include optional periods of extension in our current lease terms for the exercise of options to extend is not reasonably certain.&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of our lease cost (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; reduction of ROU asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,035&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,021&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense on our finance leases is included in other income (expense), net in our consolidated statements of operations. The reduction of the operating and finance ROU assets is included as noncash lease expense in selling, general and administrative expenses in our consolidated statements of operations.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental cash flow information related to our leases (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our operating leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,847</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,571</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,009</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,740</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,971</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,980</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,759</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our finance leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,915</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,388</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,942</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the maturities of our operating and finance lease liabilities for each of the next five years are approximately (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,396)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(342)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,980&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LesseeOperatingAndFinanceLeaseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LesseeOperatingAndFinanceLeaseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171463919640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Based Award Share awards (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-based Payment Arrangement [Text Block]</a></td>
<td class="text">SHARE-BASED AWARDS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a stock incentive plan for employees and directors and an employee stock purchase plan.&#160; Shares to be issued under these plans will be issued either from authorized but unissued shares or from treasury shares.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incur stock compensation expense for stock options, restricted stock units ("RSU"), performance restricted stock units ("PRSU") and in years prior to 2018 stock purchased under our employee stock purchase plan ("ESPP"), which was suspended in 2017. We receive a tax benefit on stock compensation expense and direct tax benefits from the exercise of stock options and vesting of restricted stock units. We also have indirect tax benefits upon exercise of stock options and vesting of restricted stock units related to research and development tax credits which are recorded as a reduction of income tax expense.&#160; </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes compensation costs and related tax benefits (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.246%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year&#160;ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit from stock-based compensation cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,840&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indirect tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had $31.2 million of unamortized stock compensation cost which we will recognize as an expense over a weighted-average period of approximately 0.9 years. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Option Plans</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 2011 Stock Incentive Plan ("2011 Plan") replaced our 2003 Stock Option Plan ("2003 Plan"). Our 2011 Plan initially had 650,000 shares available for issuance, plus the remaining available shares for grant from the 2003 Plan and any shares that were forfeited, terminated or expired that would have otherwise returned to the 2003 Plan. In 2012, 2014 and 2017, our stockholders approved amendments to the 2011 plan that increased the shares available for issuance by 3,275,000, bringing the initial shares available for issuance to 3,925,000, plus the remaining 248,700 shares that remained available for grant from the 2003 Plan. As of December&#160;31, 2021, the 2011 Plan has 4,188,300 shares of common stock reserved for issuance to employees, which includes 263,300 shares that transferred from the 2003 Plan.&#160;Shares issued as options or stock appreciation rights ("SARs") are charged against the 2011 Plan's share reserve as one share for one share issued.  Shares subject to awards other than options and SARs are charged against the 2011 Plan's share reserve as 2.09 shares for 1 share issued. Options may be granted with exercise prices at no less than fair market value at date of grant. Options granted under the 2011 Plan may be "non-statutory stock options" which expire no more than ten years from date of grant or "incentive stock options" as defined in Section&#160;422 of the Internal Revenue Code of 1986, as amended.&#160; </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Time-based Stock Options&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, all options granted under 2011 Plan and 2003 Plan have been non-statutory stock options. The majority of the time-based outstanding employee option grants vested 25% after one year from the grant date and the balance vested ratably on a monthly basis over 36 months. The outstanding employee option grants are all fully vested. The majority of the outstanding options granted to non-employee directors vest one year from the grant date. The options generally expire 10 years from the grant date.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of time-based option grants is calculated using the Black-Scholes option valuation model.&#160;The expected term for the option grants was based on historical experience and expected future employee behavior. We estimate the volatility of our common stock at the date of grant based on the historical volatility of our common stock, based on the average expected exercise term. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The table below summarizes the total time-based stock options granted, total valuation and the weighted-average assumptions (dollars in thousands, except per option amounts):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.039%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year&#160;ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of time-based options granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,910&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value of options granted (in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Weighted-average assumptions for stock option valuation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant-price per option</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant-date fair value per option</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our stock option activity as of and for the year ended December&#160;31, 2021 is as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Contractual Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December&#160;31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162,612)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December&#160;31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663,098&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656,483&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest, December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intrinsic values for options exercisable, outstanding and vested or expected to vest at December&#160;31, 2021 are based on our closing stock price of $237.34 at December&#160;31, 2021 and are before applicable taxes.&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information regarding stock option activity:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.246%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year&#160;ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value of options exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,534&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit from stock option exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Awards</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we granted PRSUs to our executive officers. For the executive officers other than the Chief Executive Officer ("CEO"), Chief Operations Officer ("COO") and the Chief Financial Officer ("CFO"), the PRSUs will vest subject to a three-year time vesting and further subject to a determination by the Compensation Committee that the officers have met their individual performance goals for the applicable years. For the CEO, COO and the CFO, the performance shares will cliff-vest ending on March 6, 2024 and further be subject to the achievement of minimum three-year cumulative revenue and EPS targets, commencing on January 1, 2021 and ending on December 31, 2023, which when reviewed against a predetermined vesting matrix could result in 0% to 250% of the awarded units that could vest. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we granted PRSUs to our executive officers. For the executive officers other than the CEO, COO and the CFO, the PRSUs will vest subject to a three-year time vesting and further subject to a determination by the Compensation Committee that the officers have met their individual performance goals for the applicable years. For the CEO, COO and the CFO, the performance shares will cliff-vest ending on March 6, 2023 and further be subject to the achievement of minimum three-year cumulative revenue and EPS targets, which when reviewed against a predetermined vesting matrix could result in 0% to 250% of the awarded units that could vest. On February 15, 2021, the Compensation Committee made the determination that the executive officers other than the CEO, COO and CFO met their individual performance goals for 2021, therefore one-third of their 2020 PRSU shares awarded vested during 2021. Additionally, during February 2021, the Compensation Committee, modified the potential vesting percentages related to the 2020 PRSU awards for the CEO, COO and CFO, as the original potential percentages were established immediately before the onset of the COVID-19 pandemic. The Compensation Committee determined to adjust the CEO, COO and CFO's potential to earn from between 0% and 250% of the award granted, to an increased potential to earn between 50% and 300% of the award granted, subject to the same minimum threshold revenue and EPS targets to be achieved by the Company. The additional compensation expense as a result of modifying the 2020 PRSUs granted to our CEO, COO and CFO totaled $2.1&#160;million recognized over the remaining amortization period from the date of modification.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we granted PRSUs to our executive officers. For the executive officers other than the CEO and the COO, the PRSUs will vest subject to a three-year time vesting and further subject to a determination by the Compensation Committee that </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the officers have met their individual performance goals for the applicable years.  For the CEO and the COO, the performance shares will cliff-vest ending on March 6, 2022 and further subject to the achievement of a minimum Cumulative Adjusted EBITDA. If for the three year period ending on December 31, 2021 the Cumulative Adjusted EBITDA has a growth of at least 6% to 8%, 50% of the awarded units will vest. If on the vesting date the Cumulative Adjusted EBITDA has a growth of between 8% to 10%, 100% of the awarded units will vest. If on the vesting date the Cumulative Adjusted EBITDA has a growth of over 10%, 200% of the awarded units will vest. In 2019, we also granted PRSUs to one of our non-executive employees. These PRSUs will vest at the end of a three-year period ending on March 31, 2022, if certain minimum performance goals are met. On February 15, 2021, the Compensation Committee made the determination that the executive officers other than the CEO and COO met their individual performance goals for 2021, therefore one-third of their 2019 PRSU shares awarded vested during 2021. The performance period related to the 2019 CEO and COO PRSUs ended on December 31, 2021 and based on the Cumulative Adjusted EBITDA achieved during the performance period zero payout is expected, subject to Compensation Committee review and determination. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018, we granted PRSUs to our executive officers. For the executive officers other than the CEO and the COO, the PRSUs were to vest subject to a three-year time vesting and further subject to a determination by the Compensation Committee that the officers have met their individual performance goals for the applicable year. For the CEO and the COO, the performance shares were to cliff-vest ending on February 15, 2021 and further subject to the achievement of a minimum Cumulative Adjusted EBITDA.  If for the three year period ending on December 31, 2020 the Cumulative Adjusted EBITDA has a growth of at least 6% to 8%, 50% of the awarded units will vest. If on the vesting date the Cumulative Adjusted EBITDA has a growth of between 8% to 10%, 100% of the awarded units will vest. If on the vesting date the Cumulative Adjusted EBITDA has a growth of over 10%, 200% of the awarded units will vest. On February 15, 2021, the Compensation Committee made the determination that the executive officers other than the CEO and COO met their individual performance goals for 2021, therefore one-third of their 2018 PRSU shares awarded vested during 2021. Also on February 15, 2021, the Compensation Committee determined that the CEO and COO's 2018 PRSUs were earned at 100% of the awards granted.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, we granted PRSUs to our executive officers. The PRSUs were scheduled to vest, if at all, upon the achievement of a minimum Cumulative Adjusted EBITDA, subject to a three-year cliff vesting ending on December 31, 2019.  If at that date, our Cumulative Adjusted EBITDA is at least $600 million but less than $650 million, 100% of the awarded units will vest.  If our Cumulative Adjusted EBITDA is at least $650 million but less than $700 million, 200% of the awarded units will vest. If our Cumulative Adjusted EBITDA is at least $700 million, 300% of the awarded units will vest. On January 17, 2020, the Compensation Committee made the determination that the 2017 PRSU shares were earned by our executive officers at the 300% achievement level.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, we granted PRSUs to our executive officers, which vested on December 31, 2018. During the first quarter of 2019, the Compensation Committee determined the award granted vested at 300%, as a minimum specified compound annual growth rate ("CAGR") in adjusted EBITDA per share of greater than 12% was reached for the 3-year performance period January 1, 2016 through December 31, 2018. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock units are granted annually to our Board of Directors and vest on the first anniversary of the grant date, or the date of our annual meeting, whichever occurs first. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, 2020 and 2019, we granted RSUs to certain employees that vest ratably on the anniversary of the grant over three years. We recognize forfeitures as they occur.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant-date fair market value of our PRSUs and RSUs is determined by our stock price on the grant date.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes our restricted stock award activity (dollars in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.246%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year&#160;ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except shares and per share amounts)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRSU</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares earned</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,654&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(a)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PRSU shares earned in 2019 were related to performance awards granted to executives in 2016 and 2018, PRSU shares earned in 2020 were related to performance awards granted to executives in 2017, 2018 and 2019. PRSU shares earned in 2021 were related to performance awards granted to executives in 2018, 2019 and 2020.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides a summary of our PRSU and RSU activity as of and for the year ended December&#160;31, 2021: &#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Grant-Date Fair Value Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Contractual Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,760&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in units due to performance expectations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,601&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209.64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,871)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested and expected to vest at December&#160;31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,761&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(a)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Relates to 2019-2021 PRSUs granted to a non-executive employee and 2021 and 2020 CEO, COO and CFO PRSUs granted, assumes attainment of an increased payout rate based on performance expectations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ESPP</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an ESPP under which U.S. employees may purchase up to $25,000 annually of common stock at 85% of its fair market value at the beginning or the end of a six-month offering period, whichever is lower. There are 750,000 shares of common stock reserved for issuance under the ESPP, which is subject to an annual increase of the least of 300,000 shares, two percent of the shares outstanding or such a number as determined by the Board.&#160;To date, there have been no increases.&#160;As of December&#160;31, 2021, there were 133,487 shares available for future issuance. The ESPP is intended to constitute an &#8220;employee stock purchase plan&#8221; within the meaning of Section&#160;423 of the Internal Revenue Code.  We suspended our ESPP in 2017.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458793128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Hedging Activities (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments and Hedging Activities Disclosure [Text Block]</a></td>
<td class="text">DERIVATIVES AND HEDGING ACTIVITIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Accounting and Hedging Program</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purposes of our cash flow hedging programs are to manage the foreign currency exchange rate risk on forecasted expenses denominated in currencies other than the functional currency of the operating unit, and to manage floating interest rate risk associated with future interest payments on variable-rate term loans issued in January 2022 subsequent to our fiscal year end. We do not issue derivatives for trading or speculative purposes.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on hedged transactions. The par forward contract and forward-starting interest rate swaps are designated and qualify as cash flow hedges. Our derivative instruments are recorded at fair value on the consolidated balance sheets and are classified based on the instrument's maturity date. We record changes in the fair value of the effective portion of the gain or loss on the derivative instrument as a component of other comprehensive income (loss) and we reclassify that gain or loss into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We began hedging a portion of our Mexico forecasted expenses denominated in Pesos ("MXN") in May 2017 by entering into a two-year cross-currency par forward contract. The term of this currency forward contract was May 1, 2017 to May 1, 2019. The derivative instrument had a fixed forward rate of 20.01 MXN/USD over the term of the two-year contract.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2018, we entered into a six-month cross-currency par forward contract. The term of this six-month contract was May 1, 2019 to November 1, 2019. The derivative instrument had a fixed forward rate of 20.43 MXN/USD over the term of the six-month contract.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we entered into a one-year cross-currency par forward contract. The term of the one-year hedge was November 1, 2019 to November 3, 2020. The derivative instrument matured in equal monthly amounts at a fixed forward rate of 22.11 MXN/USD.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, we entered into a one-year cross-currency par forward contract. The total notional amount of this outstanding derivative as of December 31, 2020 was approximately 436.8 million MXN. The term of this one-year contract was November 3, 2020 to December 1, 2021. The derivative instrument matured in equal monthly amounts at a fixed forward rate of 24.26 MXN/USD.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, we entered into a one-year cross-currency par forward contract. The total notional amount of this outstanding derivative as of December 31, 2021 was approximately 413.1 million MXN. The term of this one-year contract is December 1, 2021 to December 1, 2022. The derivative instrument matures in equal monthly amounts at a fixed forward rate of 21.60 MXN/USD.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Floating Interest Rate Risk</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, in anticipation of entering into new senior secured credit facilities in January 2022, which includes a variable-rate term loan A and a variable-rate term loan B (see Note 17: Subsequent Events for additional information), we entered into two forward-starting interest rate swaps. Under the interest rate swap agreements we exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount. The term loan A swap has an initial notional amount of $300.0&#160;million, reducing to $150.0&#160;million evenly on a quarterly basis through its final maturity in April 2027. We will pay a fixed rate of 1.49% and will receive the greater of 3-month USD LIBOR or 0%. The term loan B swap has an initial notional amount of $750.0&#160;million, reducing to $46.9&#160;million evenly on a quarterly basis through its final maturity in April 2026. We will pay a fixed rate of 1.31% and will receive the greater of 3-month USD LIBOR or 0.50%. These forward-starting swaps will effectively convert the relevant portion of the floating-rate term loans to fixed rates.&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair values of our derivative instruments included within the consolidated balance sheets (in thousands):  </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.132%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Balance Sheet Location</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Exchange Forward Contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward-Starting Interest Rate Swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Derivatives</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,555&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,555&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the amounts affecting the Consolidated Statements of Operations (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.262%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.746%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Gain in the Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">916&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized the following gains (losses) on our derivative instruments designated as cash flow hedges (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:18.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.070%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.460%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Other Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount of Gain Reclassified From Accumulated Other Comprehensive Income into Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain Reclassified From Accumulated Other Comprehensive Income into Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">916&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,480)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(530)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,444&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">916&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we expect an estimated $1.1 million in deferred gains on the outstanding foreign exchange forward contract and an estimated $5.6&#160;million in deferred losses on the forward-starting interest rate swaps will be reclassified from accumulated other comprehensive loss to net income during the next 12 months concurrent with the underlying hedged transactions also being reported in net income.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458479736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Disclosures [Text Block]</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1:  quoted prices in active markets for identical assets or liabilities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2:  inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3:  unobservable inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent earn-out liabilities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2019, we recognized an earn-out liability related to the acquisition of Pursuit (see Note 2: Acquisitions). Pursuit's former equity holders were entitled up to $50.0 million in additional cash consideration contingent upon the achievement of certain sales and gross profit targets for specific customers. The earn-out was calculated as a percentage of gross profit achieved during the earn-out period against a pre-determined target gross profit, not to exceed $50.0 million. During the earn-out period, we used a Monte Carlo simulation model to determine the fair value of the earn-out liability. The Monte Carlo simulation model utilized multiple input variables to determine the value of the earn-out liability including historical volatility, a risk-free interest rate, counter party credit risk and projected future gross profit (see the simulation input table below related to Pursuit). The historical volatility was based on the median of ICU and a certain peer group. The risk-free interest rate was equal to the yield, as of the valuation date, of the zero-coupon U.S. Treasury bill that was commensurate with the term of the earn-out. The counter party credit risk was based on a synthetic credit rating of B1. As of June 30, 2021, the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">earn-out measurement period ended. Based on the actual sales and gross profit achieved during the measurement period, we calculated the actual earn-out amount to be $26.3&#160;million. The $26.3&#160;million earn-out calculation was finalized and accepted by Pursuit's former equity holders and was paid out in the fourth quarter of 2021. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out payment shall not exceed $6.0&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of December 31, 2021, the fair value of the contingent earn-out was estimated at $2.6&#160;million. The estimated fair value of the contingent earn-out is calculated using a probability-weighted cash flow model based on historical revenue streams and the likelihood that the revenue targets will be met.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. The initial estimated fair value of the contingent consideration related to this acquisition is immaterial. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contingent earn-out liabilities are separately stated on our consolidated balance sheets.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of our Level 3 earn-out liabilities measured at estimated fair value based on an initial valuation and updated quarterly for the years ended December 31, 2021, 2020 and 2019 (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent earn-out liability, January 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition date fair value estimate of earn-out</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent earn-out (included in income from operations as a separate line item)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent earn-out liability, December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,300&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent earn-out (included in income from operations as a separate line item)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent earn-out liability, December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,300&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent earn-out &#8212; non-compete arrangement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfer of Pursuit earn-out liability into Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent earn-out liability, December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Relates to our acquisition of Pursuit (see Note 2: Acquisitions).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of the HIS earn-out related to our 2017 acquisition of HIS from Pfizer which was based on actual results as compared to the earn-out performance targets. This adjustment reduced the HIS earn-out to zero.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Pursuit earn-out increased during 2020 primarily due to changes in the probabilities within the valuation model.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pursuit earn-out was transferred out of Level 3 and into Level 2 in the third quarter of 2021 when the amount of the actual payment was known, and subsequently settled during the fourth quarter of 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides quantitative information about Level 3 inputs for fair value measurement of the Pursuit earn-out liability as of the acquisition date to December 31, 2020:</span></div><div><span><br/></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pursuit Earn-out</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.443%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.546%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of<br/>December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At Acquisition<br/>November 2, 2019</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Simulation Input</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue/Gross Profit Volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Counter Party Risk</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments, Foreign Currency Contracts and Interest Rate Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our investments, which consist of corporate bonds, is estimated using observable market-based inputs such as quoted prices, interest rates and yield curves or Level 2 inputs.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our Level 2 forward currency contracts is estimated using observable market inputs such as known notional value amounts, spot and forward exchange rates. These inputs relate to liquid, heavily traded currencies with active markets which are available for the full term of the derivative. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our Level 2 forward-starting interest rate swaps is estimated using a pricing model that reflects the terms of the contracts, including the period to maturity, and relies on observable market inputs such as known notional value amounts and USD interest rate curves. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the Pursuit earn-out liability described above, there were no transfers between levels in 2021 or 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our assets and liabilities measured at fair value on a recurring basis consisted of the following (Level 1, 2 and 3 inputs as defined above) (in thousands):&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forwards:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,069&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forwards:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,216&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,216&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earn-out liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458417784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaids and Other Current Assets (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentAssetsTextBlock', window );">Other Current Assets [Text Block]</a></td>
<td class="text">PREPAID EXPENSES AND OTHER CURRENT ASSETS AND OTHER ASSETS<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consist of the following (in thousands): &#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses and receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance and property taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT/GST receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forward contract</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,847&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,492&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pump lease receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spare parts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,743&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,475&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458508008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities an Other Long-term Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</a></td>
<td class="text">ACCRUED LIABILITIES AND OTHER LONG-TERM LIABILITIES<div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.546%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incentive compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-ST</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal accrual</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranties and returns</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued freight</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring accrual</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,195&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-LT</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liability-LT</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,830&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,835&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div>(1)&#160;&#160;&#160;&#160;Consists of contracts with customers and suppliers that were valued at below market at the time of the HIS acquisition.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458361400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LongTermDebtDisclosureAbstract', window );"><strong>Long-Term Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt Disclosure [Text Block]</a></td>
<td class="text">LONG-TERM OBLIGATIONS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Five-year Senior Secured Revolving Credit Facility ("Credit Facility")</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 8, 2017, we entered into a five-year Revolving Credit Facility ("Credit Facility") with various lenders for $150.0 million, with Wells Fargo Bank, N.A. as the administrative agent, swingline lender and issuing lender. During March 2020, as a result of market uncertainty caused by the COVID-19 pandemic, we preemptively borrowed $150.0 million on our Credit Facility as a conservative measure to manage any potential short-term liquidity risk. As of December 31, 2020, we had fully repaid all amounts borrowed. As of December 31, 2021 and 2020, we had no borrowings and $150.0 million of availability under the Credit Facility. The Credit Facility matures on November 8, 2022.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facility has an accordion feature that would enable us to increase the borrowing capacity of the Credit Facility by the greater of (i) $100.0 million and (ii) 2.00x Total Leverage.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Credit Facility, during the year ended December 31, 2017, we incurred $1.4 million in financing costs, which were capitalized and are included in prepaid expenses and other current assets and other assets on our consolidated balance sheets, in accordance with the appropriate short-term or long-term classification.  These fees are being amortized to interest expense over the remaining term of the Credit Facility.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we completed the acquisition of Smiths Medical which was partially financed by entering into Senior Secured Credit Facilities consisting of a term loan A facility of $850.0&#160;million, a term loan B facility of $850.0&#160;million and a revolving credit facility of $500.0&#160;million. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principal payments&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments, when drawn on the Credit Facility, are made at our discretion with the entire unpaid amount due at maturity.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, borrowing under the Credit Facility (other than Swingline loans) bears interest, at our option, based on the Base Rate plus applicable margin or the London Interbank Offered Rate ("LIBOR") rate plus applicable margin, as defined below: </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(A) Base Rate is defined as the highest of: (a) the Prime Rate; (b) the Federal Funds Rate plus 0.50%; and (c) the daily LIBOR (as defined below) for a one month Interest Period plus 1%. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(B) LIBOR Rate, as determined by the Administrative Agent, is defined as the rate per annum obtained by dividing (1) LIBOR by (2) 1.00 - Eurodollar Reserve Percentage. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Swingline loans will bear interest at the Base Rate plus the applicable Interest Margin. The Credit Facility has a per annum commitment fee (see table below) that will accrue on the unused amounts of the commitments under the Credit Facility.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable interest margins and the commitment fee with respect to the Credit Facility shall be based on the Total Leverage Ratio pursuant to the following pricing grid:&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total <br/>Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitment <br/>Fee</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIBOR <br/>+</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base Rate <br/>+</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.00 to 1.00</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 1.00 to 1.00 but less than 2.00 to 1.00</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 2.00 to 1.00 but less than 2.50 to 1.00</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 2.50 to 1.00</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantors and Collateral</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations under the Credit Facility are unconditionally guaranteed, on a joint and several basis, by ICU Medical, Inc. and certain of our existing subsidiaries.  Our obligations are secured by: (i) 100% of the equity interests of our guarantor subsidiaries; and (ii) all of the tangible and intangible personal property and assets related to us and our guarantor subsidiaries (including, without limitation, all accounts, equipment, inventory and other goods, all instruments, intellectual property and other general intangibles, deposit accounts, securities accounts and other investment property and cash), and (iii) all products, profits and proceeds of the foregoing.  Notwithstanding the foregoing, the collateral shall not include certain excluded property.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Covenants</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facility contains certain financial covenants pertaining to Consolidated Fixed Charge Coverage and Consolidated Total Leverage Ratios.  In addition, the Credit Facility has restrictions pertaining to limitations on debt, liens, negative pledges, loans, advances, acquisitions, other investments, dividends, distributions, redemptions, repurchases of equity interests, fundamental changes and asset sales and other dispositions, prepayments, redemptions and purchases of subordinated debt and other junior debt, transactions with affiliates, dividend and payment restrictions affecting subsidiaries, changes in line of business, fiscal year and accounting practices and amendment of organizational documents and junior debt documents. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Leverage Ratio is defined as the ratio of Consolidated Total Funded Indebtedness on such date, to Consolidated Adjusted EBITDA, as defined under the Credit Facility Agreement, for the most recently completed four fiscal quarters.  The maximum Consolidated Leverage Ratio is not more than 3.00 to 1.00.  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Fixed Charge Coverage Ratio is defined as the ratio of: (a) Consolidated Adjusted EBITDA less the sum of (i) capital expenditures, (ii) federal, state, local and foreign income taxes paid in cash and (iii) cash restricted payments made after the closing date, to (b) Consolidated Fixed Charges for the most recently completed four fiscal quarters, calculated on a pro forma basis.  The minimum Consolidated Fixed Charge Coverage Ratio is 2.00 to 1.00. </span></div> We entered into Senior Secured Credit Facilities in January 2022, which terminated our existing Credit Facility (see Note 17: Subsequent Events).<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LongTermDebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt Disclosure [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LongTermDebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458778152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes:<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax Disclosure [Text Block]</a></td>
<td class="text">INCOME TAXES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from continuing operations before taxes consisted of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.246%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,849&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,186&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,707&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision (benefit) for income taxes consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.246%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,744&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,154)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,319)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,720)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,815)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,850)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,275)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,120)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,705)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,051&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,624&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,672&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have accrued for tax contingencies for potential tax assessments, and in 2021 we recognized a $3.0 million net increase, most of which related to various federal, state and foreign tax reserves.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the provision for income taxes at the statutory rate to our effective tax rate is as follows (dollars in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:34.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.689%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal tax at the expected statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,869&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income tax, net of federal effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,443)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,269)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,896)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global intangible low-taxed income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income tax differential</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,983)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,888)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,939)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,686)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,446)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-derived intangible income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,775)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,718)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(516)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IP installment sale and repatriation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 162(m)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,051&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,624&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,672&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax credits in 2021, 2020 and 2019 consist principally of research and developmental tax credits.&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain intellectual property and assets were repatriated in 2019 from a liquidation of foreign subsidiaries to the U.S. parent. The tax effect of the repatriation is included as IP installment sale and repatriation.</span></div><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of our deferred income tax assets (liabilities) are as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.131%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals/other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired future tax deductions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chargebacks, discounts, customer concessions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,934)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,891)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,194&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,404&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 481(a) adjustment - change in accounting method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,080&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,033&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset, net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,114&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,371&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax Holidays and Carryforwards</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss ("NOL") carryforwards consist of: (a) federal NOL carryforwards of $2.5 million which will expire at various dates from 2023 to indefinite carryforward periods, (b) state NOL carryforwards of $8.2 million which will expire at various dates from 2022 to indefinite carryforward periods and (c) foreign NOL carryforwards of $15.0 million which will expire at various dates from 2022 to indefinite carryforward periods. Under Section&#160;382 of the Internal Revenue Code, certain ownership changes limit the utilization of the NOL carryforwards, and the amount of federal NOL carryforwards recorded is the net federal benefit available.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other carryforwards include state research and development (&#8220;R&amp;D&#8221;) tax credit carryforwards of $16.9 million, which have an indefinite carryforward period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A substantial portion of our manufacturing operations in Costa Rica operate under various tax holiday and tax incentive programs due to expire in whole or in part in 2027. Certain of the holidays may be extended if specific conditions are met. The net impact of these tax holiday and tax incentives was an increase to our net earnings by $9.8 million or $0.45 per diluted share in 2021 and by $8.0 million or $0.37 per diluted share in 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency translation adjustments, and related tax effects, are an element of &#8220;other comprehensive income&#8221; and are not included in net income other than the revaluation of the associated deferred tax asset due to the Tax Act.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we have estimated $98.6 million of undistributed foreign earnings and profits. Such earnings were previously subject to U.S. tax as a result of the Tax Act and much of any future remittances would generally be subject to no U.S. tax as a result of dividends received deductions and/or foreign tax credit relief. We intend to invest substantially all of our foreign subsidiary earnings, as well as our capital in our foreign subsidiaries, indefinitely outside of the U.S. in those jurisdictions in which we incur significant additional costs upon repatriation of such amounts.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to taxation in the U.S. and various states and foreign jurisdictions. Our U.S. federal income tax returns for tax years 2018 and forward are subject to examination by the Internal Revenue Service. Our principal state income tax returns for tax years 2012 and forward are subject to examination by the state tax authorities. The total gross amount of unrecognized tax benefits as of December&#160;31, 2021 was $21.5 million which, if recognized, would impact the effective tax rate.  We believe that adequate provision has been made for any adjustments that may result from tax examinations. However, the outcome of tax examinations cannot be predicted with certainty. As of December 31, 2021, it is not possible to estimate the amount of change, if any, in the unrecognized tax benefits that is reasonably possible within the next twelve months. We recognize accrued interest and penalties related to unrecognized tax benefits as a component of income tax expense. We have not accrued any penalties or interest as of December 31, 2021 or 2020.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cumulative gross unrecognized tax benefits (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.246%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,027&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases to prior year tax positions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases to current year tax positions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,987&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases to prior year tax positions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease related to lapse of statute of limitations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease related to settlements with tax authorities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c16ae;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c16ae;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c16ae;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,537&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,443&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,027&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458485832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Geographic Information and Significant Customers Geographic Information and Significant Customers (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasLongLivedAssetsAbstract', window );"><strong>Geographic Areas, Long-Lived Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_InformationbyGeographicAreaandCustomerConcentrationTextBlock', window );">Information by Geographic Area and Customer Concentration [Text Block]</a></td>
<td class="text">GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Significant Customers</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell products worldwide, on credit terms on an unsecured basis, as an OEM supplier, to independent medical supply distributors and directly to the end customer. The manufacturers and distributors, in turn, sell our products to healthcare providers. We do not currently derive a significant portion of our revenues from any one customer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Geographic Information</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents our gross long-lived assets, consisting of property, plant and equipment, by country or region (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.131%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costa Rica</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other LATAM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,295&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,701&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,795&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,836&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Foreign </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,730&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618,374&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577,490&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Worldwide Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905,104&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843,096&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_InformationbyGeographicAreaandCustomerConcentrationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information by Geographic Area and Customer Concentration [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_InformationbyGeographicAreaandCustomerConcentrationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicAreasLongLivedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicAreasLongLivedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458331944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity Note Disclosure [Text Block]</a></td>
<td class="text">STOCKHOLDERS' EQUITY<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August&#160;2019, our Board of Directors approved a common stock purchase plan to purchase up to $100.0 million of our common stock. This plan has no expiration date. We have $100.0 million remaining on this purchase plan. We did not purchase any of our common stock under our common stock purchase plan in 2021, 2020 or 2019. We are limited on share purchases in accordance with the terms and conditions of our Credit Facility (see Note 11: Long-Term Obligations).&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we withheld 40,350 shares of our common stock from employee vested restricted stock units in consideration for $8.3 million in payments for the employees' share award income tax withholding obligations. We had 119 shares remaining in treasury at December 31, 2021.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we withheld 67,041 shares of our common stock from employee vested restricted stock units in consideration for $12.9 million in payments for the employees' share award income tax withholding obligations. We had 209 shares remaining in treasury at December 31, 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we withheld 80,186 shares of our common stock from employee vested restricted stock units in consideration for $18.6 million in payments for the employees' share award income tax withholding obligations. We had 850 shares remaining in treasury at December 31, 2019.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use treasury stock to issue shares for stock option exercises and restricted stock grants.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive (Loss) Income ("AOCI")</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of AOCI, net of tax, were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,682)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,945)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,543&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,310)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,880&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,402)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,929&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(601)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(601)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,929&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,880&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,381)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,522)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,664)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(403)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,129)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,618)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,618)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,664)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,021)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,747)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,045)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,269)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458490680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies Disclosure [Text Block]</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are involved in various legal proceedings, most of which are routine litigation, in the normal course of business.&#160; Our management does not believe that the resolution of the unsettled legal proceedings that we are involved with will have a material adverse impact on our financial position or results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Off Balance Sheet Arrangements</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we have agreed to indemnify our officers and directors to the maximum extent permitted under Delaware law and to indemnify customers as to certain intellectual property matters related to sales of our products.&#160;There is no maximum limit on the indemnification that may be required under these agreements.&#160;We have never incurred, nor do we expect to incur, any liability for indemnification.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, we recognized an earn-out liability in connection with our acquisition of HIS from Pfizer. Pfizer was entitled to receive between $191.3&#160;million and $225.0 million in additional cash consideration based on the achievement of certain performance targets for the combined company for the three years ending December 31, 2019. As of December 31, 2019, we determined we did not meet the necessary performance targets that would require payout of any of the HIS earn-out liability. Pfizer disputed our determination that the performance targets requiring payout of the HIS earn-out liability were not met, therefore the dispute entered into binding arbitration. In August 2021, the arbitrator concluded that the necessary performance targets that would require payout of the HIS earn-out were not met, and as a result Pfizer is not entitled to any payments in connection with the HIS earn-out liability. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During November 2019, we acquired Pursuit (see Note 2: Acquisitions). Total consideration for the acquisition included a potential contractual earn-out of up to $50.0 million to be paid to former Pursuit equity holders, calculated based upon the achievement of certain performance targets during the earn-out period. As of June 30, 2021, the earn-out measurement period had ended and based on the actual sales and gross profit achieved during the measurement period we calculated the actual earn-out to be $26.3&#160;million. In October 2021, the $26.3&#160;million earn-out was finalized and paid to the former Pursuit equity holders (see Note 8: Fair Value Measurements).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out shall not exceed $6.0&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of December 31, 2021, the fair value of the contingent earn-out was estimated at $2.6&#160;million (see Note 8: Fair Value Measurements).</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. The initial estimated fair value of the contingent consideration related to this acquisition is immaterial.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have non-cancelable operating lease agreements where we are contractually obligated to pay certain lease payment amounts (see Note 5: Leases).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458355752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaborative and Other Arrangements (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_CollaborativeandOtherArrangementsAbstract', window );"><strong>Collaborative and Other Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaborative Arrangement Disclosure [Text Block]</a></td>
<td class="text">COLLABORATIVE AND OTHER ARRANGEMENTS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2017, we entered into two Manufacturing and Supply Agreements ("MSAs") whereby (i) Pfizer will manufacture and supply us with certain agreed upon products for an initial five-year term with a one-time two-year option to extend and (ii) we will manufacture and supply Pfizer certain agreed upon products for a term of five or ten years depending on the product, also with a one-time two-year option to extend. The MSAs provide each party with mutually beneficial interests and both of the MSAs are to be jointly managed by both Pfizer and ICU. The initial supply price, which will be annually updated, is in full consideration for all costs associated with the manufacture, documentation, packaging and certification of the products. On January 1, 2021, we amended our MSA with Pfizer, whereby we manufacture and supply certain agreed upon products to Pfizer. The amendments included a change to the term of the agreement to end on December 31, 2024 with Pfizer's unilateral election to extend through December 31, 2025. Other changes to the terms of the MSA included (i) amendments to our level of supply of products to Pfizer, (ii) certain changes to our manufacturing lines, (iii) updates to our supply price with added volume price tiers for annual periods and (iv) certain minimum purchase requirements for certain products. On February 1, 2022, effective as of January 1, 2022, upon our request, Pfizer executed a Product Addendum (the "Product Addendum") to our MSA agreement, whereby Pfizer manufactures and supplies to us certain agreed upon products. The Product Addendum includes the supply of additional product to us subject to certain time and pricing terms and conditions. The Product Addendum includes a minimum purchase obligation of $29.6&#160;million. The Product Addendum expires on November 30, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_CollaborativeandOtherArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative and Other Arrangements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_CollaborativeandOtherArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458335544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">SUBSEQUENT EVENTS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Smiths Medical 2020 Limited</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we completed the acquisition of Smiths Medical, the holding company of Smiths Group plc's global medical device business, from Smiths Group International Holdings Limited (the &#8220;Seller&#8221;). In accordance with the Share Sale and Purchase Agreement (the "Purchase Agreement"), we purchased 100% of the equity interests of Smiths Medical for approximately $1.9&#160;billion in cash and issued of 2.5&#160;million of fully paid and non-assessable shares of our common stock, par value $0.10 per share. The Purchase Agreement also includes a potential contingent earn-out payment of $100.0&#160;million in cash, which is to be based upon our common stock achieving a certain volume-weighted average price for certain periods from closing to the third or fourth anniversary of closing. The acquisition of Smiths Medical adds to and complements our current product portfolio and the combining of both businesses allows us to be a scaled U.S.-based global competitor that increases the stability of the medical supply chain and allows for future growth.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At closing, in connection with the issuance of the stock consideration to the Seller, we entered into a Shareholders Agreement (the &#8220;Shareholders Agreement&#8221;). The Shareholders Agreement imposes certain restrictions on the Seller including prohibiting certain transfers of the shares of our common stock issued (i) for 6 months following the closing of the acquisition transaction and (ii) to certain of our competitors and certain other parties, as well as customary standstill limitations. Under the Shareholders Agreement, the Seller has the right to designate one individual for election to our board of directors so long as the Seller beneficially owns at least 5.0% of the total outstanding shares of our common stock.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to account for the Smiths acquisition as a business combination, however the initial accounting for the business combination is incomplete. We are unable to provide preliminary estimates of asset and liability fair market values as the external valuation of the assets acquired and liabilities assumed is incomplete. We plan to file the required historical financial statements and the required pro forma financial statements of the combined results of ICU and Smiths Medical in a Form 8-K/A to amend the Current Report on Form 8-K filed on January 7, 2022 by March 22, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issuance of Senior Secured Credit Facilities</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, to partially finance the acquisition of Smiths Medical, we entered into a credit agreement (the "Credit Agreement") with Wells Fargo Bank, National Association, Wells Fargo Securities, LLC, Barclays Bank PLC and certain other financial institutions (the &#8220;Lenders&#8221;), pursuant to which, among other things, the Lenders provided us with credit facilities in the aggregate amount of $2.2&#160;billion consisting of (i) a five-year term loan A of $850.0&#160;million, (ii) a seven-year Term Loan B of $850.0&#160;million and (iii) a five-year Revolving Credit Facility of $500.0&#160;million. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principal Payments</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments on the term loan A and term loan B Facilities are due on the last day of each calendar quarter commencing on June 30, 2022. The term loan A Facility will amortize in an amount equal to 2.50% of the original principal amount in the first two years, 5.00% in the third and fourth years and 7.50% in the fifth year, with a final payment of the outstanding principal balance due on the respective maturity date. The term loan B Facility will mature in twenty-seven consecutive quarterly installments in an amount equal to 0.25% of the aggregate principal amount of the term loan B outstanding on the Closing Date, with a final payment of the outstanding principal balance due on the respective maturity date. All outstanding revolving loans over the term of the revolver are to be paid by the applicable maturity date.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Terms</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, U.S. dollar revolving and term loans under the credit facilities may bear interest, at our option, on either (1) the Base Rate, as defined in the Credit Agreement, plus the applicable margin, as indicated below or (2) Adjusted Term secured overnight financing rate, as defined in the Credit Agreement, plus applicable margin as indicated below.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility Commitment Fee</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revolving credit facility has a per annum commitment fee at an initial rate of 0.25% which is applied to the available amount of the revolving credit facility. The commitment fee after the quarter ending June 30, 2022 is calculated based on the leverage ratio as indicated below.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Applicable Interest Margins</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable interest margins with respect to revolving loans and the term loan A Facility shall initially be 1.75% for RFR Loans, as defined in the Credit Agreement. The following pricing grid for the revolving credit facility and the term loan A Facility will become effective after the quarter ending June 30, 2022 and will be based on changes in the Leverage Ratio as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Applicable Margin for RFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitment Fee Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt;4.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&lt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00 to 1.0 but &gt;3.00 to 1.0</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&lt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00 to 1.0 but &gt;2.50 to 1.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&lt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50 to 1.0 but &gt;2.00 to 1.0</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&lt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00 to 1.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15%</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable interest margins for the term loan B Facility shall initially be set at 2.50% for Eurocurrency Rate Loans. The following pricing grid will become effective on the Adjustment Date and will be based on changes in the Leverage Ratio as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.883%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Applicable Margin for Eurocurrency Rate Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Applicable Margin for Base Rate Loans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt;2.75 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&lt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75 to 1.0</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to the Loan Parties and the restricted subsidiaries of the Company, including, without limitation, restrictions on liens, indebtedness, investments, fundamental changes, dispositions, restricted payments and prepayment of junior indebtedness. The Credit Agreement contains financial covenants on the revolving credit facility and term loan A Facility that require the Loan Parties and the restricted subsidiaries of the Company to (i) not exceed a maximum secured net leverage ratio initially set at 4.50 to 1.00, with stepdowns to 4.00 to 1.00 on June 30, 2024 and (ii) a minimum interest coverage ratio of 3.00 to 1.00.</span></div>The Credit Agreement contains customary events of default, including, without limitation, payment defaults, covenant defaults, breaches of certain representations and warranties, cross defaults and cross-acceleration to certain material indebtedness, certain events of bankruptcy and insolvency, impairment of security, certain events under ERISA, material judgments and a change of control. If an event of default occurs and is not cured within any applicable grace period or is not waived, the administrative agent and the lenders are entitled to take various actions, including, without limitation, the acceleration of amounts due thereunder and termination of commitments under the Facilities.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458299640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEC Schedule, Article 12-09, Valuation and Qualifying Accounts<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:43.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.060%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.738%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.888%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Amounts&#160;in&#160;thousands)<br/>Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to<br/>Costs&#160;and<br/>Expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to<br/>Other&#160;Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write-off/<br/>Disposals</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance<br/>at&#160;End<br/>of&#160;Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the year ended December&#160;31, 2019:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,768&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty and return reserve - accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(458)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty and return reserve - inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,538)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(722)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,477)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,584)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the year ended December&#160;31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,866)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty and return reserve - accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,609)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty and return reserve - inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,477)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,613)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the year ended December&#160;31, 2021:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,797)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty and return reserve - accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(790)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty and return reserve - inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,613)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(957)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,934&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171457150792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Business Description and Basis of Presentation [Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Basis of Presentation and Preparation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ICU Medical,&#160;Inc. ("ICU" or "we"), a Delaware corporation, operates in one business segment engaged in the development, manufacturing and sale of innovative medical devices used in infusion therapy and critical care applications. We are one of the world's leading pure-play infusion therapy companies with a wide-ranging product portfolio that includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needlefree connectors designed to help meet clinical, safety and workflow goals. We sell the majority of our products through our direct sales force and through independent distributors throughout the U.S. and internationally. Additionally, we sell our products on an original equipment manufacturer basis to other medical device manufacturers. The manufacturing for all product groups occurs in Salt Lake City, Utah, Austin, Texas, Mexico and Costa Rica. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All subsidiaries are wholly owned and are included in the consolidated financial statements.&#160; All intercompany accounts and transactions have been eliminated.  Results of operations of companies purchased are included from the dates of acquisition.</span></div>The consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation.  These consolidated financial statements were prepared in accordance with accounting principles generally accepted in the U.S. ("GAAP").<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates, Policy [Policy Text Block]</a></td>
<td class="text">Preparing financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents, Policy [Policy Text Block]</a></td>
<td class="text">Cash equivalents are short-term, highly liquid investments that are readily convertible to known amounts of cash and have original maturities of three months or less from the date of purchase.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</a></td>
<td class="text">Accounts receivable are stated at net realizable value.&#160; An allowance is provided for estimated collection losses based on an assessment of various factors.&#160; We consider prior payment trends, the age of the accounts receivable balances, financial status and other factors to estimate the cash which ultimately will be received.&#160; Such amounts cannot be known with certainty at the financial statement date.&#160; We regularly review individual past due balances for collectability.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory, Policy [Policy Text Block]</a></td>
<td class="text">Inventories are stated at the lower of cost or net realizable value with cost determined using the first-in, first-out method.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment, Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All property, plant and equipment are stated at cost.&#160; We use the straight-line method for depreciating property, plant  and equipment over their estimated useful lives.&#160; Estimated useful lives are:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 - 30 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building improvements</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 - 30 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and molds</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 - 15 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and office equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 - 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 5 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments placed with customers<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 10 years</span></div></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize expenditures that materially increase the life of the related assets; maintenance and repairs are expensed as incurred.&#160;The costs and related accumulated depreciation applicable to property, plant and equipment sold or retired are removed from the accounts and any gain or loss is reflected in the statements of operations at the time of disposal. Depreciation expense was $65.9 million, $62.4 million and $59.3 million in 2021, 2020 and 2019, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Goodwill</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div>We test goodwill for impairment on an annual basis in the month of November, or more frequently if an event occurs or circumstances change that would indicate that impairment may exist.&#160;Generally, we first perform a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If, based on an assessment of relevant qualitative factors, we determine that this is not the case, then the quantitative impairment test is not required to be performed. Conversely, if we determine based on the qualitative assessment that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, we will perform the quantitative impairment test. For the quantitative impairment test, we calculate the estimated fair value of the reporting unit. If the estimated fair value of the reporting unit is less than its carrying amount, the goodwill of the reporting unit is determined to be impaired. An impairment charge is recorded in an amount equal to the excess of the carrying amount over its estimated fair value, limited to the total amount of goodwill allocated to the reporting unit. For our annual impairment test for the year ended December 31, 2021, we performed a qualitative assessment and concluded that it was more likely than not that the fair value of our reporting unit exceeded its carrying amount, and therefore, no further impairment testing was required.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</a></td>
<td class="text">Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-Lived Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically evaluate the recoverability of long-lived assets whenever events and changes in circumstances indicate that the carrying amount of an asset may not be fully recoverable. When indicators of impairment are present, the carrying values of the assets are evaluated in relation to the operating performance and future undiscounted cash flows of the underlying business. The net book value of the underlying asset is adjusted to fair value if the sum of the expected discounted cash flows is less than book value. Fair values are based on estimates of market prices and assumptions concerning the amount and timing of estimated future cash flows and discount rates, reflecting varying degrees of perceived risk. We did not have any long-lived asset impairments in 2021, 2020 or 2019.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment, Policy [Policy Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investment Securities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments, exclusive of cash equivalents, are marketable securities intended to be sold within one year and may include trading securities, available-for-sale securities, and held-to-maturity securities (if maturing within one year at </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the time of acquisition).  Long-term investments are marketable securities intended to be sold after one year and may include trading securities, available-for-sale securities, and held-to-maturity securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Available-for-sale Securities </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment securities are considered available-for-sale and currently consist of short-term and long-term corporate bonds. These securities are considered &#8220;investment grade&#8221; and are carried at fair value. We assess our investment in available-for-sale debt securities for impairment each reporting period. If an unrealized loss exists, we determine whether any portion of the decline in fair value below the carrying value is credit-related by reviewing several factors, including, but not limited to, the extent of the fair value decline and changes in the financial condition of the issuer. We record an impairment for credit-related losses through an allowance, limited to the amount of the unrealized loss. If we either intend to sell or it is more likely than not we will be required to sell the debt security before its anticipated recovery, any allowance is written off and the amortized cost basis is written down to fair value through a charge against net earnings. Unrealized gains and non-credit-related unrealized losses are recorded, net of tax, in other comprehensive income (loss). We did not have any investments in available-for-sale debt securities in unrealized loss positions as of December 31, 2021 or 2020.</span></div>The amortized cost of the debt securities is adjusted for the amortization of premiums computed under the effective interest method. Such amortization is included in other income, net in the consolidated statements of operations. Realized gains and losses are accounted for on the specific identification method. There have been no realized gains or losses on the disposal of these investments. The scheduled maturities of the debt securities are between 2022 and 2024. All short-term investment securities are callable within one year.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Tax, Policy [Policy Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Income Taxes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred taxes are determined based on the differences between the financial statements and the tax bases using rates as enacted in the laws. A valuation allowance is established if it is &#8220;more likely than not&#8221; that all or a portion of the deferred tax assets will not be realized.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize interest and penalties related to unrecognized tax benefits in the tax provision. We recognize liabilities for uncertain tax positions when it is more likely than not that a tax position will not be sustained upon examination and settlement with various taxing authorities. Liabilities for uncertain tax positions are measured based upon the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. We have not recorded any material interest or penalties during any of the years presented.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Transactions and Translations Policy [Policy Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Foreign Currency</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, the functional currency of our international subsidiaries is the local currency. Generally, we translate the financial statements of these subsidiaries to U.S. dollars at the exchange rate in effect at the balance sheet date and revenues and expenses are translated at the average monthly exchange rates during the year. Certain of our international subsidiaries consolidate first with another subsidiary that utilizes a functional currency other than U.S. dollars.&#160;In those cases, we follow a step by step translation process utilizing the same sequence as the consolidation process.&#160;Translation adjustments are recorded as a component of accumulated other comprehensive loss, a separate component of stockholders' equity on our consolidated balance sheets and the effect of exchange rate changes on cash and cash equivalents are reflected on our consolidated statements of cash flows.&#160;Gains and losses for transactions denominated in a currency other than the functional currency of the entity are included in our consolidated statements of operations in other income, net. Foreign currency transaction losses (gains), net were $1.0 million, $7.2 million and $(0.7) million in 2021, 2020 and 2019, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue [Policy Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revenue Recognition</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenues when we transfer control of promised goods to our customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods.  We offer certain volume-based rebates to our distribution customers, which we consider variable consideration when calculating the transaction price. Rebates are offered on both a fixed and tiered/variable basis. In both cases, we use information available at the time and our historical experience with each customer to estimate the most likely rebate amount. We also provide chargebacks to distributors that sell to end customers at prices determined under a contract between us and the end customer. Chargebacks are the difference between prices we charge our distribution customers and contracted prices we have with the end customer which are processed as credits to our distribution customers. In estimating the expected value of chargeback amounts for use in determining the transaction price, we use information available at the time, including our historical experience. We also warrant products against defects and have a policy permitting the return of defective products, for which we accrue and expense at the time of sale using information available and our historical experience. Our revenues are recorded at the net sales price, which includes an estimate for variable consideration related to rebates, chargebacks and product returns.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vast majority of our sales of Infusion Consumables, Infusion Systems, IV Solutions and Critical Care products are sold on a standalone basis and control of these products transfers to the customer upon shipment.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our software license renewals are considered to be transferred to a customer at a point in time at the start of each renewal period, therefore revenue is recognized at that time.&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Arrangements with Multiple Deliverables</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain circumstances, we enter into arrangements in which we provide multiple deliverables to our customers.  These bundled arrangements typically consist of the sale of infusion systems equipment, along with annual software licenses and related software implementation services, as well as infusion consumables, IV solutions and extended warranties. Our most significant judgments related to these arrangements are (i) identifying the various performance obligations and (ii) estimating the relative standalone selling price of each performance obligation, typically using a directly observable method or calculated on a cost plus margin basis method.  Revenue related to the bundled equipment, software and software implementation services are typically combined into a single performance obligation and recognized upon implementation. As annual software licenses are renewed, we recognize revenue for the license at a point in time, at the start of each annual renewal period. The transaction price allocated to the extended service-type warranty is recognized as revenue over the period the warranty service is provided. Consumables and solutions are separate performance obligations, recognized at a point in time.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Cost [Policy Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Advertising Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising expenses are expensed as incurred and reflected in selling, general and administrative expenses in our consolidated statements of operations and were $0.2 million, $0.2 million and $0.1 million in 2021, 2020 and 2019, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPolicy', window );">Pension and Other Postretirement Plans, Policy [Policy Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Post-retirement and Post-employment Benefits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sponsor a Section&#160;401(k)&#160;retirement plan ("plan") for employees.&#160;Our contributions to our 401(k) plan were approximately $11.0 million, $10.7 million and $11.4 million in 2021, 2020 and 2019, respectively. We also have post-retirement and post-employment obligations related to employees located in certain international countries. These obligations are immaterial to our financial statements taken as a whole.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expense, Policy [Policy Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Research and Development</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our research and development costs are expensed as incurred.  In certain circumstances when an asset will have an alternative future use we capitalize the costs related to those assets.  Research and development costs include salaries and related benefits, consulting fees, production supplies, samples, travel costs, utilities and other miscellaneous administrative costs.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share, Policy [Policy Text Block]</a></td>
<td class="text">Net Income Per ShareNet income per share is computed by dividing net income by the weighted-average number of common shares outstanding. Diluted net income per share is computed by dividing net income by the weighted-average number of common shares outstanding plus dilutive securities.&#160;Dilutive securities include outstanding common stock options and unvested restricted stock units, less the number of shares that could have been purchased with the proceeds from the exercise of the options, using the treasury stock method. Options that are anti-dilutive, where their exercise price exceeds the average market price of the common stock, are not included in the treasury stock method calculation. Restricted stock units that are anti-dilutive are not included in the treasury stock method.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Method Investments</a></td>
<td class="text">We apply the equity method of accounting for investments when we determine we have a significant influence, but not a controlling interest in the investee. We determine whether we have significant influence by considering key factors such as ownership interest, representation on the board of directors, participation in policy making decisions, business relationship and material intra-entity transactions, among other factors. Our equity method investment is reported at cost and adjusted each period for our share of the investee's income or (loss) and dividend paid, if any. We eliminate any intra-entity profits to the extent of our beneficial interest. We record our share of the investee's income or (loss) on a one quarter lag. We report our proportionate share of the investee's income or (loss) resulting from this investment in other income, net in our consolidated statements of operations. The carrying value of our equity method investment is reported in other assets on the consolidated balance sheets. We assess our equity method investments for impairment on an annual basis or whenever events or circumstances indicate that the carrying value of the investment may not be recoverable.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=d3e29149-114947<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6412939&amp;loc=d3e15145-114933<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171457486280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory, Current [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,235&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314,928&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consists of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, building and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments placed with customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,384&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,383&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, cost</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905,104&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843,096&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(436,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(376,468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468,365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466,628&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instruments placed with customers consist of drug-delivery and monitoring systems placed with customers under operating leases.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All property, plant and equipment are stated at cost.&#160; We use the straight-line method for depreciating property, plant  and equipment over their estimated useful lives.&#160; Estimated useful lives are:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 - 30 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building improvements</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 - 30 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and molds</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 - 15 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and office equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 - 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 5 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments placed with customers<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 10 years</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the carrying amount of our goodwill for 2021, 2020 and 2019 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:78.665%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,001&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,439&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we acquired Pursuit Vascular, Inc. ("Pursuit"), which resulted in $19.1&#160;million of goodwill. We also acquired a small foreign distributor, which resulted in $0.9&#160;million of goodwill.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, "Other" relates to a $1.3&#160;million measurement period adjustment to deferred taxes related to the Pursuit acquisition and foreign currency translation.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In 2021, we acquired a small foreign infusion systems supplier, which resulted in $10.6&#160;million of goodwill.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis, were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life<br/>in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,665&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,835&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,882&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,953&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,193&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,882&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,311&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life<br/>in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,056&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,741&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,311&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,443&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,868&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,674&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,443&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,231&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, estimated annual amortization for our intangible assets for each of the next five years is approximately (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:78.665%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,953&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Debt Securities, Available-for-sale</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term and long-term investments in available-for-sale securities consist of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.943%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.821%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.016%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.821%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,040&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,040&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,661&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,661&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Equity Method Investments</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-marketable equity method investment consists of the following (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of net earnings per common share (&#8220;EPS&#8221;) &#8212; basic and diluted (in thousands, except per share data):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.246%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year&#160;ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,035&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding (basic)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,206&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,907&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,629&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common and common equivalent shares outstanding&#160;(diluted)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,781&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,591&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,545&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.86&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.16&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.90&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; diluted</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171457011496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions Pursuit Vascular (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the final purchase price and the final allocation of the purchase price related to the assets and liabilities purchased (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration for acquired assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,833&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Final Purchase Price Allocation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,065)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - not tax deductible</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,462&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,769)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,833&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_______________________________________________</span></div>(1)&#160;&#160;&#160;&#160;Identifiable intangible assets included $69.0 million of developed technology, $10.8 million of trade name and $2.5 million of non-compete agreement. The weighted-average amortization periods for the identifiable intangible assets are as follows: approximately fifteen years for developed technology, fifteen years for trade name and three years for the non-compete agreement.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458408552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Strategic Transaction and Integration Schedule of Restructuring and Related Costs (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity in our restructuring-related accrual by major type of cost (in thousands): </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Severance Pay and Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Employment Agreement Buyout</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retention and Facility Closure Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,878&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,549&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges incurred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,331)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(460)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,570)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,361)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,563&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,421&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges incurred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(969)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(969)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(528)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,429)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,957)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_______________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated liabilities related to a prior year's facility closure restructuring were adjusted to actual amounts owed.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458470568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents our revenues disaggregated by product line (in thousands) and our disaggregated product line revenue as a percentage of total revenue:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product line</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Consumables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555,189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,740&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328,282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,316,308&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266,208&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report revenue on a "where sold" basis, which reflects the revenue within the country or region in which the ultimate sale is made to our external customer.&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents our revenues disaggregated by geography (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:60.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.070%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.218%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geography</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,488&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Foreign</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374,499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,866&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941,809&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910,627&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923,342&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,316,308&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266,208&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Domestic sales accounted for 72%, 72% and 73% of total revenue in 2021, 2020 and 2019, respectively.  International sales accounted for 28%, 28% and 27% of total revenue in 2021, 2020 and 2019, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Contract with Customer, Asset and Liability [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contract balances (deferred revenue) are recorded in accrued liabilities and other long-term liabilities in our consolidated balance sheet (see Note 10: Accrued Liabilities and Other Long-term Liabilities). The following table presents the changes in our contract balances for the years ended December 31, 2021 and 2020, (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:79.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,855)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,341)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,363)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,430)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,725)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,615)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,461)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171457046168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of our lease cost (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; reduction of ROU asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,035&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,021&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense on our finance leases is included in other income (expense), net in our consolidated statements of operations. The reduction of the operating and finance ROU assets is included as noncash lease expense in selling, general and administrative expenses in our consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_SupplementalCashFlowInformationLeasesTableTextBlock', window );">Supplemental Cash Flow Information Leases</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental cash flow information related to our leases (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_SupplementalBalanceSheetInformationLeasesTableTextBlock', window );">Supplemental Balance Sheet Information Leases</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our operating leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,847</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,571</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,009</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,740</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,971</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,980</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,759</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our finance leases (in thousands, except lease term and discount rate):</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,915</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,388</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,942</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the maturities of our operating and finance lease liabilities for each of the next five years are approximately (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,396)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(342)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,980&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_SupplementalBalanceSheetInformationLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_SupplementalBalanceSheetInformationLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_SupplementalCashFlowInformationLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Cash Flow Information Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_SupplementalCashFlowInformationLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171457053976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Based Award (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock', window );">Schedule of stock compensation and related tax benefits [Table Text Block]</a></td>
<td class="text">The table below summarizes compensation costs and related tax benefits (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.246%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year&#160;ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit from stock-based compensation cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,840&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indirect tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</a></td>
<td class="text">The table below summarizes the total time-based stock options granted, total valuation and the weighted-average assumptions (dollars in thousands, except per option amounts):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.039%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year&#160;ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of time-based options granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,910&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value of options granted (in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Weighted-average assumptions for stock option valuation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant-price per option</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant-date fair value per option</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Payment Arrangement, Option, Activity [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our stock option activity as of and for the year ended December&#160;31, 2021 is as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Contractual Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December&#160;31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162,612)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December&#160;31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663,098&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656,483&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest, December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ExercisedOptionsDataTableTextBlock', window );">Exercised Options Data [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information regarding stock option activity:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.246%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year&#160;ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value of options exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,534&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit from stock option exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</a></td>
<td class="text">The table below summarizes our restricted stock award activity (dollars in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.246%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year&#160;ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except shares and per share amounts)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRSU</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares earned</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,654&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Nonvested Restricted Stock Shares Activity [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides a summary of our PRSU and RSU activity as of and for the year ended December&#160;31, 2021: &#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Grant-Date Fair Value Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Contractual Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,760&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in units due to performance expectations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,601&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209.64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,871)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested and expected to vest at December&#160;31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,761&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ExercisedOptionsDataTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercised Options Data [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ExercisedOptionsDataTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of stock compensation and related tax benefits [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171457601496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</a></td>
<td class="text">The following table presents the fair values of our derivative instruments included within the consolidated balance sheets (in thousands):  <div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.132%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Balance Sheet Location</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Exchange Forward Contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward-Starting Interest Rate Swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Derivatives</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,555&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,555&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the amounts affecting the Consolidated Statements of Operations (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.262%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.746%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Gain in the Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">916&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized the following gains (losses) on our derivative instruments designated as cash flow hedges (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:18.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.070%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.460%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Other Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount of Gain Reclassified From Accumulated Other Comprehensive Income into Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain Reclassified From Accumulated Other Comprehensive Income into Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">916&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,480)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(530)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,444&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">916&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171454274104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock', window );">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of our Level 3 earn-out liabilities measured at estimated fair value based on an initial valuation and updated quarterly for the years ended December 31, 2021, 2020 and 2019 (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent earn-out liability, January 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition date fair value estimate of earn-out</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent earn-out (included in income from operations as a separate line item)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent earn-out liability, December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,300&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent earn-out (included in income from operations as a separate line item)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent earn-out liability, December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,300&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent earn-out &#8212; non-compete arrangement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfer of Pursuit earn-out liability into Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent earn-out liability, December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our assets and liabilities measured at fair value on a recurring basis consisted of the following (Level 1, 2 and 3 inputs as defined above) (in thousands):&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forwards:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,069&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forwards:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,216&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,216&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earn-out liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_HospiraMember', window );">Hospira [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</a></td>
<td class="text">The following table provides quantitative information about Level 3 inputs for fair value measurement of the Pursuit earn-out liability as of the acquisition date to December 31, 2020:<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</a></td>
<td class="text"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pursuit Earn-out</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.443%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.546%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of<br/>December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At Acquisition<br/>November 2, 2019</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Simulation Input</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue/Gross Profit Volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Counter Party Risk</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_HospiraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_HospiraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458504680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaids and Other Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Prepaid Expenses and Other Current Assets [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consist of the following (in thousands): &#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses and receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance and property taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT/GST receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forward contract</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,847&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,492&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pump lease receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spare parts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,743&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,475&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458399144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities an Other Long-term Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities [Table Text Block]</a></td>
<td class="text"><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.546%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incentive compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-ST</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal accrual</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranties and returns</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued freight</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring accrual</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,195&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-LT</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liability-LT</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,830&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,835&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div>(1)&#160;&#160;&#160;&#160;Consists of contracts with customers and suppliers that were valued at below market at the time of the HIS acquisition.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458304520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LongTermDebtDisclosureAbstract', window );"><strong>Long-Term Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_InterestMarginandCommitmentFeeTableTextBlock', window );">Interest Margin and Commitment Fee [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable interest margins and the commitment fee with respect to the Credit Facility shall be based on the Total Leverage Ratio pursuant to the following pricing grid:&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total <br/>Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitment <br/>Fee</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIBOR <br/>+</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base Rate <br/>+</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.00 to 1.00</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 1.00 to 1.00 but less than 2.00 to 1.00</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 2.00 to 1.00 but less than 2.50 to 1.00</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 2.50 to 1.00</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_InterestMarginandCommitmentFeeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Margin and Commitment Fee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_InterestMarginandCommitmentFeeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LongTermDebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt Disclosure [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LongTermDebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171456861272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Income tax disclosure (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from continuing operations before taxes consisted of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.246%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,849&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,186&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,707&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision (benefit) for income taxes consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.246%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,744&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,154)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,319)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,720)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,815)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,850)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,275)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,120)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,705)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,051&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,624&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,672&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the provision for income taxes at the statutory rate to our effective tax rate is as follows (dollars in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:34.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.689%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal tax at the expected statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,869&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income tax, net of federal effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,443)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,269)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,896)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global intangible low-taxed income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income tax differential</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,983)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,888)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,939)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,686)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,446)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-derived intangible income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,775)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,718)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(516)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IP installment sale and repatriation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 162(m)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,051&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,624&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,672&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</a></td>
<td class="text"><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of our deferred income tax assets (liabilities) are as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.131%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals/other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired future tax deductions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chargebacks, discounts, customer concessions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,934)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,891)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,194&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,404&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 481(a) adjustment - change in accounting method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,080&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,033&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset, net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,114&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,371&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Summary of Income Tax Contingencies [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cumulative gross unrecognized tax benefits (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.246%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,027&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases to prior year tax positions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases to current year tax positions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,987&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases to prior year tax positions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease related to lapse of statute of limitations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease related to settlements with tax authorities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c16ae;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c16ae;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c16ae;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,537&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,443&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,027&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458345128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Geographic Information and Significant Customers Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasLongLivedAssetsAbstract', window );"><strong>Geographic Areas, Long-Lived Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Long-lived Assets by Geographic Areas [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents our gross long-lived assets, consisting of property, plant and equipment, by country or region (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.131%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costa Rica</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other LATAM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,295&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,701&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,795&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,836&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Foreign </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,730&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618,374&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577,490&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Worldwide Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905,104&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843,096&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicAreasLongLivedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicAreasLongLivedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458301240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of AOCI, net of tax, were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,682)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,945)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,543&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,310)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,880&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,402)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,929&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(601)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(601)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,929&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,880&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,381)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,522)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,664)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(403)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,129)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,618)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,618)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,664)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,021)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,747)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,045)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,269)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458384136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSubsequentEventsTextBlock', window );">Schedule of Subsequent Events</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable interest margins with respect to revolving loans and the term loan A Facility shall initially be 1.75% for RFR Loans, as defined in the Credit Agreement. The following pricing grid for the revolving credit facility and the term loan A Facility will become effective after the quarter ending June 30, 2022 and will be based on changes in the Leverage Ratio as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Applicable Margin for RFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitment Fee Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt;4.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&lt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00 to 1.0 but &gt;3.00 to 1.0</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&lt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00 to 1.0 but &gt;2.50 to 1.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&lt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50 to 1.0 but &gt;2.00 to 1.0</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&lt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00 to 1.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15%</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable interest margins for the term loan B Facility shall initially be set at 2.50% for Eurocurrency Rate Loans. The following pricing grid will become effective on the Adjustment Date and will be based on changes in the Leverage Ratio as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.883%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Applicable Margin for Eurocurrency Rate Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Applicable Margin for Base Rate Loans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt;2.75 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&lt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75 to 1.0</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, losses resulting from fire or flood, losses on receivables, significant realized and unrealized gains and losses that result from changes in quoted market prices of securities, declines in market prices of inventory, changes in authorized or issued debt (SEC), significant foreign exchange rate changes, substantial loans to insiders or affiliates, significant long-term investments, and substantial dividends not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458489000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Summary of Significant Accounting Policies Basis of Presentation (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of Operating Segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171460052376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>General and Summary of Significant Accounting Policies Inventory (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw Materials</a></td>
<td class="nump">$ 135,528<span></span>
</td>
<td class="nump">$ 126,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in Process</a></td>
<td class="nump">36,490<span></span>
</td>
<td class="nump">33,053<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished Goods</a></td>
<td class="nump">118,217<span></span>
</td>
<td class="nump">155,376<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 290,235<span></span>
</td>
<td class="nump">$ 314,928<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171454465608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>General and Summary of Significant Accounting Policies Property and Equipment #1 (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">$ 905,104<span></span>
</td>
<td class="nump">$ 843,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="nump">436,739<span></span>
</td>
<td class="nump">376,468<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net property and equipment</a></td>
<td class="nump">468,365<span></span>
</td>
<td class="nump">466,628<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">321,078<span></span>
</td>
<td class="nump">291,331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember', window );">Land, Buildings and Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">243,377<span></span>
</td>
<td class="nump">241,199<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_MoldsMember', window );">Molds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">60,463<span></span>
</td>
<td class="nump">60,381<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_ComputerEquipmentAndSoftwareMember', window );">Computer Equipment and Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">102,979<span></span>
</td>
<td class="nump">98,311<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">7,670<span></span>
</td>
<td class="nump">7,767<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_InstrumentsPlacedwithCustomersMember', window );">Instruments Placed with Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">97,384<span></span>
</td>
<td class="nump">90,383<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">$ 72,153<span></span>
</td>
<td class="nump">$ 53,724<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_MoldsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_MoldsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_InstrumentsPlacedwithCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_InstrumentsPlacedwithCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171460215032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Summary of Significant Accounting Policies Property and Equipment #2 (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, Plant and Equipment, Estimated Useful Lives</a></td>
<td class="text">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, Plant and Equipment, Estimated Useful Lives</a></td>
<td class="text">30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building Improvements [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, Plant and Equipment, Estimated Useful Lives</a></td>
<td class="text">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building Improvements [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, Plant and Equipment, Estimated Useful Lives</a></td>
<td class="text">30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, Plant and Equipment, Estimated Useful Lives</a></td>
<td class="text">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, Plant and Equipment, Estimated Useful Lives</a></td>
<td class="text">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_FurniturefixturesandmoldsMember', window );">Furniture, fixtures and molds [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, Plant and Equipment, Estimated Useful Lives</a></td>
<td class="text">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_FurniturefixturesandmoldsMember', window );">Furniture, fixtures and molds [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, Plant and Equipment, Estimated Useful Lives</a></td>
<td class="text">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_ComputerEquipmentAndSoftwareMember', window );">Computer Equipment and Software [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, Plant and Equipment, Estimated Useful Lives</a></td>
<td class="text">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_ComputerEquipmentAndSoftwareMember', window );">Computer Equipment and Software [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, Plant and Equipment, Estimated Useful Lives</a></td>
<td class="text">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_InstrumentsPlacedwithCustomersMember', window );">Instruments Placed with Customers [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, Plant and Equipment, Estimated Useful Lives</a></td>
<td class="text">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_InstrumentsPlacedwithCustomersMember', window );">Instruments Placed with Customers [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, Plant and Equipment, Estimated Useful Lives</a></td>
<td class="text">10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123364984&amp;loc=d3e1205-110223<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_FurniturefixturesandmoldsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_FurniturefixturesandmoldsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_InstrumentsPlacedwithCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_InstrumentsPlacedwithCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458300328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Summary of Significant Accounting Policies Property and Equipment #3 (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 65.9<span></span>
</td>
<td class="nump">$ 62.4<span></span>
</td>
<td class="nump">$ 59.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171460186888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Summary of Significant Accounting Policies Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">GOODWILL</a></td>
<td class="nump">$ 33,001<span></span>
</td>
<td class="nump">$ 31,245<span></span>
</td>
<td class="nump">$ 11,195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">10,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill, Purchase Accounting Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Goodwill, Foreign Currency Translation Gain (Loss)</a></td>
<td class="num">(188)<span></span>
</td>
<td class="nump">1,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">GOODWILL</a></td>
<td class="nump">43,439<span></span>
</td>
<td class="nump">33,001<span></span>
</td>
<td class="nump">31,245<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularLLCMember', window );">Pursuit Vascular LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill, Purchase Accounting Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignDistibutorMember', window );">Foreign Distibutor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember', window );">Foreign Infusion System Supplier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">$ 10,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignDistibutorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_ForeignDistibutorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171461706696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Summary of Significant Accounting Policies Intangible Assets #1 (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 275,835<span></span>
</td>
<td class="nump">$ 267,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">112,882<span></span>
</td>
<td class="nump">89,443<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">162,953<span></span>
</td>
<td class="nump">177,868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">301,193<span></span>
</td>
<td class="nump">286,674<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">INTANGIBLE ASSETS, net</a></td>
<td class="nump">$ 188,311<span></span>
</td>
<td class="nump">$ 197,231<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-Average Amortization Life in Years</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 27,429<span></span>
</td>
<td class="nump">$ 24,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">16,764<span></span>
</td>
<td class="nump">15,056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 10,665<span></span>
</td>
<td class="nump">$ 9,741<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember', window );">Customer Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-Average Amortization Life in Years</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 10,412<span></span>
</td>
<td class="nump">$ 10,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">6,196<span></span>
</td>
<td class="nump">5,852<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 4,216<span></span>
</td>
<td class="nump">$ 4,513<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer-Related Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-Average Amortization Life in Years</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 57,316<span></span>
</td>
<td class="nump">$ 58,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">33,004<span></span>
</td>
<td class="nump">26,711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 24,312<span></span>
</td>
<td class="nump">$ 31,350<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-Average Amortization Life in Years</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 425<span></span>
</td>
<td class="nump">$ 425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">425<span></span>
</td>
<td class="nump">425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-Average Amortization Life in Years</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 18,260<span></span>
</td>
<td class="nump">$ 18,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">4,731<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 13,529<span></span>
</td>
<td class="nump">$ 14,770<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed Technology Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-Average Amortization Life in Years</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">13 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 152,893<span></span>
</td>
<td class="nump">$ 152,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">49,406<span></span>
</td>
<td class="nump">36,927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 103,487<span></span>
</td>
<td class="nump">$ 115,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-Average Amortization Life in Years</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 9,100<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2,356<span></span>
</td>
<td class="nump">972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">6,744<span></span>
</td>
<td class="nump">1,528<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 25,358<span></span>
</td>
<td class="nump">$ 19,363<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171542937272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Summary of Significant Accounting Policies Intangible Assets #2 (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 23.8<span></span>
</td>
<td class="nump">$ 23.2<span></span>
</td>
<td class="nump">$ 17.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171457400680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>General and Summary of Significant Accounting Policies Future Estimated Amortization Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</a></td>
<td class="nump">$ 25,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Two</a></td>
<td class="nump">24,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Three</a></td>
<td class="nump">23,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Four</a></td>
<td class="nump">16,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Five</a></td>
<td class="nump">15,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Finite-Lived Intangible Assets, Amortization Expense, after Year Five</a></td>
<td class="nump">58,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 162,953<span></span>
</td>
<td class="nump">$ 177,868<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171457345816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Summary of Significant Accounting Policies Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Investment Securities, Amortized Cost</a></td>
<td class="nump">$ 19,040<span></span>
</td>
<td class="nump">$ 27,661<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Investment Securities</a></td>
<td class="nump">19,040<span></span>
</td>
<td class="nump">27,661<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Investment Securities, Amortized Cost</a></td>
<td class="nump">14,420<span></span>
</td>
<td class="nump">14,687<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Investment Securities</a></td>
<td class="nump">14,420<span></span>
</td>
<td class="nump">14,687<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=icui_LongtermInvestmentsDomain', window );">Long-term Investments [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Investment Securities, Amortized Cost</a></td>
<td class="nump">4,620<span></span>
</td>
<td class="nump">12,974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Investment Securities</a></td>
<td class="nump">$ 4,620<span></span>
</td>
<td class="nump">$ 12,974<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=icui_LongtermInvestmentsDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=icui_LongtermInvestmentsDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171457179448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Summary of Significant Accounting Policies Investments-Equity Method (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to Acquire Equity Method Investments</a></td>
<td class="nump">$ 3,250<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Equity Method Investment, Aggregate Cost</a></td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171463913640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Summary of Significant Accounting Policies Foreign Currency (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyAbstract', window );"><strong>Foreign Currency [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealized', window );">Foreign Currency Transaction Gain (Loss), Realized</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 7.2<span></span>
</td>
<td class="num">$ (0.7)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171459715720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Summary of Significant Accounting Policies Advertising Expenses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising Expense</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171457492200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Summary of Significant Accounting Policies Post-retirement and Post-employment Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitExpense', window );">Pension and Other Postretirement Benefits Cost (Reversal of Cost)</a></td>
<td class="nump">$ 11.0<span></span>
</td>
<td class="nump">$ 10.7<span></span>
</td>
<td class="nump">$ 11.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost (reversal of cost) for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171454197912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Summary of Significant Accounting Policies Net Income Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>NET INCOME PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">$ 103,135<span></span>
</td>
<td class="nump">$ 86,870<span></span>
</td>
<td class="nump">$ 101,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding (basic)</a></td>
<td class="nump">21,206,000<span></span>
</td>
<td class="nump">20,907,000<span></span>
</td>
<td class="nump">20,629,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Weighted Average Number Diluted Shares Outstanding Adjustment</a></td>
<td class="nump">575,000<span></span>
</td>
<td class="nump">684,000<span></span>
</td>
<td class="nump">916,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average common and common equivalent shares outstandding (diluted)</a></td>
<td class="nump">21,781,000<span></span>
</td>
<td class="nump">21,591,000<span></span>
</td>
<td class="nump">21,545,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="nump">$ 4.86<span></span>
</td>
<td class="nump">$ 4.16<span></span>
</td>
<td class="nump">$ 4.90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="nump">$ 4.74<span></span>
</td>
<td class="nump">$ 4.02<span></span>
</td>
<td class="nump">$ 4.69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">12,354<span></span>
</td>
<td class="nump">12,083<span></span>
</td>
<td class="nump">10,760<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458304520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Summary of Significant Accounting Policies New Accounting Pronouncements (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Accounting Standards Update and Change in Accounting Principle</a></td>
<td class="text">Recently Issued Accounting Standards In March 2020, the Financial Accounting Standards Board ("FASB")  issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide optional guidance for a limited period of time to ease the potential burden for reference rate reform on financial reporting. Due to concerns about structural risks of interbank offered rates and, particularly, the risk of cessation of the London Interbank Offered Rate ("LIBOR"), regulators around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation. The amendments in this update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued as a result of reference rate reform. Optional expedients may be applied to contracts that are modified as a result of the reference rate reform. Modifications of contracts within the scope of Topic 470, Debt, should be accounted for by prospectively adjusting the effective interest rate. Modifications of contracts within the scope of ASC 842, Leases, should be accounted for as a continuation of the existing contracts with no reassessments of the lease classification and the discount rate (incremental borrowing rate). Exceptions to Topic 815, Derivatives and Hedging, results in not having a dedesignation of a hedging relationship if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. In November 2021, we entered into two forward-starting swaps whereby the variable leg of the swap references LIBOR, these swaps will be amended in early 2022 to transition to an alternative reference rate (see Note 7: Derivatives and Hedging Activities). The amendments in this ASU allow for certain expedients that will allow us to assume that our hedged interest payments are probable of occurring regardless of any expected modification in their terms related to reference rate reform and will allow us to continue hedge accounting for a cash flow hedge for which the hedged interest rate risk changes if the hedge is highly effective under ASC 815, Derivatives and Hedging or the optional expedient under this ASU is elected. The impact of this ASU on our contracts has not been and is not expected to be material.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (c)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171461675704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions Text (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Earn-out Liability</a></td>
<td class="nump">$ 2,589<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="nump">$ 17,300<span></span>
</td>
<td class="nump">$ 47,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business Acquisition, Percentage of Voting Interests Acquired</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignDistibutorMember', window );">Foreign Distibutor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Earn-out Liability</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularLLCMember', window );">Pursuit Vascular LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Earn-out Liability</a></td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Contingentconsiderationgross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>contingent consideration gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Contingentconsiderationgross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignDistibutorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_ForeignDistibutorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171454224200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions Pursuit Vascular Table (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent earn-out liability, Noncurrent</a></td>
<td class="nump">$ 2,589<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments', window );">Payment to acquire business, net of working capital adjustments</a></td>
<td class="nump">71,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent earn-out liability, Noncurrent</a></td>
<td class="nump">17,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="nump">88,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquiredReceivablesFairValue', window );">Business Combination, Acquired Receivable, Fair Value</a></td>
<td class="nump">973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="nump">2,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</a></td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="nump">609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">82,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</a></td>
<td class="num">(215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</a></td>
<td class="num">(2,065)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</a></td>
<td class="nump">84,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Business Acquisition, Goodwill, Expected Tax Deductible Amount</a></td>
<td class="nump">20,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent</a></td>
<td class="num">$ (15,769)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment to acquire business, net of working capital adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquiredReceivablesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of acquired receivable from business combination, excluding certain loans and debt securities acquired in transfer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquiredReceivablesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171461609304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions Pursuit Vascular Intangible (Details) - Pursuit Vascular, Inc. [Member]<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">$ 82,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Developed Technology Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">$ 69,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">$ 10,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">$ 2,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171454221464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions Foreign Infusion Systems Supplier (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ShortTermContingentConsiderationGross', window );">Short-term contingent consideration-gross</a></td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LongTermContingentConsiderationGross', window );">Long-term contingent consideration-gross</a></td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember', window );">Foreign Infusion System Supplier</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="nump">15,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_BusinessCombinationConsiderationCashHoldback', window );">business combination consideration - cash holdback</a></td>
<td class="nump">$ 500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_BusinessCombinationConsiderationCashHoldback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>business combination consideration - cash holdback</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_BusinessCombinationConsiderationCashHoldback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Contingentconsiderationgross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>contingent consideration gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Contingentconsiderationgross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LongTermContingentConsiderationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term contingent consideration-gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LongTermContingentConsiderationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ShortTermContingentConsiderationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short-term contingent consideration-gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ShortTermContingentConsiderationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171454318760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Strategic Transaction and Integration (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Restructuringandstrategictransactionexpense', window );">Restructuring, strategic transaction and integration expenses</a></td>
<td class="nump">$ 18,037<span></span>
</td>
<td class="nump">$ 28,409<span></span>
</td>
<td class="nump">$ 80,574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="num">(1,800)<span></span>
</td>
<td class="nump">$ 7,900<span></span>
</td>
<td class="nump">$ 8,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Restructuring Reserve, Accrual Adjustment</a></td>
<td class="nump">1,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Restructuring Reserve, Accrual Adjustment</a></td>
<td class="nump">1,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_RestructuringAdjustmentsSeveranceAndFacility', window );">Restructuring Adjustments - Severance and Facility</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember', window );">Facility Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Restructuring Reserve, Accrual Adjustment</a></td>
<td class="nump">1,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Restructuring Reserve, Accrual Adjustment</a></td>
<td class="nump">$ 1,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_RestructuringAdjustmentsSeveranceAndFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Adjustments - Severance and Facility</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_RestructuringAdjustmentsSeveranceAndFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Restructuringandstrategictransactionexpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring and strategic transaction expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Restructuringandstrategictransactionexpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAccrualAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAccrualAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171461748280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Strategic Transaction and Integration (Details 2) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">$ 664,000<span></span>
</td>
<td class="nump">$ 3,421,000<span></span>
</td>
<td class="nump">$ 5,549,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring Costs</a></td>
<td class="nump">140,000<span></span>
</td>
<td class="nump">7,929,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="num">(969,000)<span></span>
</td>
<td class="num">(10,361,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</a></td>
<td class="num">(29,000)<span></span>
</td>
<td class="num">(304,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Restructuring Reserve, Accrual Adjustment</a></td>
<td class="num">(1,957,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Severance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">499,000<span></span>
</td>
<td class="nump">1,858,000<span></span>
</td>
<td class="nump">3,878,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring Costs</a></td>
<td class="nump">140,000<span></span>
</td>
<td class="nump">4,288,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="num">(969,000)<span></span>
</td>
<td class="num">(6,331,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="num">(23,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Restructuring Reserve, Accrual Adjustment</a></td>
<td class="num">(528,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_SpecialTerminationBenefitsMember', window );">Special Termination Benefits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">460,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring Costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(460,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Restructuring Reserve, Accrual Adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember', window );">Facility Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">165,000<span></span>
</td>
<td class="nump">1,563,000<span></span>
</td>
<td class="nump">$ 1,211,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring Costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,641,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,570,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</a></td>
<td class="num">(31,000)<span></span>
</td>
<td class="num">$ (281,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Restructuring Reserve, Accrual Adjustment</a></td>
<td class="num">$ (1,429,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAccrualAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAccrualAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_SpecialTerminationBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_SpecialTerminationBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171460023592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Strategic Transaction and Integration Strategic Transaction and Integration Expenses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_StrategicTransactionandIntegration', window );">Strategic Transaction and Integration</a></td>
<td class="nump">$ 19.8<span></span>
</td>
<td class="nump">$ 20.5<span></span>
</td>
<td class="nump">$ 72.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Supplychainrestructuringcosts', window );">Supplychainrestructuringcosts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Cleanupcosts', window );">Cleanupcosts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Cleanupcosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cleanupcosts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Cleanupcosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_StrategicTransactionandIntegration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Strategic Transaction and Integration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_StrategicTransactionandIntegration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Supplychainrestructuringcosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplychainrestructuringcosts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Supplychainrestructuringcosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171454436520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Disaggregation of Revenue - Product Line (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,316,308<span></span>
</td>
<td class="nump">$ 1,271,004<span></span>
</td>
<td class="nump">$ 1,266,208<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Percentageofrevenue', window );">Percentage of revenue</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_InfusionConsumablesMember', window );">Infusion Consumables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 555,189<span></span>
</td>
<td class="nump">$ 473,740<span></span>
</td>
<td class="nump">$ 477,611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Percentageofrevenue', window );">Percentage of revenue</a></td>
<td class="nump">42.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_InfusionSystemsMember', window );">Infusion Systems [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 352,321<span></span>
</td>
<td class="nump">$ 359,691<span></span>
</td>
<td class="nump">$ 328,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Percentageofrevenue', window );">Percentage of revenue</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_IVSolutionsMember', window );">IV Solutions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 359,477<span></span>
</td>
<td class="nump">$ 388,971<span></span>
</td>
<td class="nump">$ 414,971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Percentageofrevenue', window );">Percentage of revenue</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_CriticalCareMember', window );">Critical Care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 49,321<span></span>
</td>
<td class="nump">$ 48,602<span></span>
</td>
<td class="nump">$ 45,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Percentageofrevenue', window );">Percentage of revenue</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Percentageofrevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Percentageofrevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_InfusionConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_InfusionConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_InfusionSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_InfusionSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_IVSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_IVSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_CriticalCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_CriticalCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171454102808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Disaggregation of Revenue by Geography (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,316,308<span></span>
</td>
<td class="nump">$ 1,271,004<span></span>
</td>
<td class="nump">$ 1,266,208<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">EMEA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">147,488<span></span>
</td>
<td class="nump">132,763<span></span>
</td>
<td class="nump">130,530<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=icui_OtherforeigncountriesMember', window );">Other foreign countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">227,011<span></span>
</td>
<td class="nump">227,614<span></span>
</td>
<td class="nump">212,336<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=icui_ForeignMember', window );">Foreign [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 374,499<span></span>
</td>
<td class="nump">$ 360,377<span></span>
</td>
<td class="nump">$ 342,866<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Percentoftotalrevenue', window );">Percent of total revenue</a></td>
<td class="nump">72.00%<span></span>
</td>
<td class="nump">72.00%<span></span>
</td>
<td class="nump">73.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 941,809<span></span>
</td>
<td class="nump">$ 910,627<span></span>
</td>
<td class="nump">$ 923,342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=icui_InternationalSalesDomain', window );">International Sales [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Percentoftotalrevenue', window );">Percent of total revenue</a></td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Percentoftotalrevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percent of total revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Percentoftotalrevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=icui_OtherforeigncountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=icui_OtherforeigncountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=icui_ForeignMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=icui_ForeignMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=icui_InternationalSalesDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=icui_InternationalSalesDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171454145608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Contract Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_COntractLiabilityRollforwardRollForward', window );"><strong>COntract Liability Rollforward [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="num">$ (6,430)<span></span>
</td>
<td class="num">$ (4,855)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="num">(7,461)<span></span>
</td>
<td class="num">(6,430)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_EquipmentrevenueMember', window );">Equipment revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_COntractLiabilityRollforwardRollForward', window );"><strong>COntract Liability Rollforward [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase (Decrease) in Deferred Revenue</a></td>
<td class="num">(10,048)<span></span>
</td>
<td class="num">(14,408)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueAdditions', window );">Deferred Revenue, Additions</a></td>
<td class="nump">13,725<span></span>
</td>
<td class="nump">14,341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_SoftwarerevenueMember', window );">Software revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_COntractLiabilityRollforwardRollForward', window );"><strong>COntract Liability Rollforward [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase (Decrease) in Deferred Revenue</a></td>
<td class="num">(7,261)<span></span>
</td>
<td class="num">(5,721)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueAdditions', window );">Deferred Revenue, Additions</a></td>
<td class="nump">$ 4,615<span></span>
</td>
<td class="nump">$ 7,363<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_COntractLiabilityRollforwardRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>COntract Liability Rollforward [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_COntractLiabilityRollforwardRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_EquipmentrevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_EquipmentrevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_SoftwarerevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_SoftwarerevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171457068104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Contract Liabilities Text (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContractassetandliabilitybalancesLineItems', window );"><strong>Contract asset and liability balances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">$ 5,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_EquipmentrevenueMember', window );">Equipment revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContractassetandliabilitybalancesLineItems', window );"><strong>Contract asset and liability balances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">5,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_SoftwarerevenueMember', window );">Software revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContractassetandliabilitybalancesLineItems', window );"><strong>Contract asset and liability balances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">$ 1,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContractassetandliabilitybalancesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Contract asset and liability balances [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContractassetandliabilitybalancesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_EquipmentrevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_EquipmentrevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_SoftwarerevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_SoftwarerevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171462988456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Optiontoextendinyears', window );">Optiontoextendinyears</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Optiontoextendinyears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Optiontoextendinyears</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Optiontoextendinyears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171457101528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Lease Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating Lease, Cost</a></td>
<td class="nump">$ 11,251<span></span>
</td>
<td class="nump">$ 11,284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Finance Lease, Interest Expense</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Finance Lease, Right-of-Use Asset, Amortization</a></td>
<td class="nump">648<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term Lease, Cost</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease, Cost</a></td>
<td class="nump">$ 12,035<span></span>
</td>
<td class="nump">$ 12,021<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171461871544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Supplemental Cash Flow Lease Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease, Payments</a></td>
<td class="nump">$ 11,256<span></span>
</td>
<td class="nump">$ 10,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Finance Lease, Interest Payment on Liability</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</a></td>
<td class="nump">2,589<span></span>
</td>
<td class="nump">20,847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</a></td>
<td class="nump">$ 558<span></span>
</td>
<td class="nump">$ 3,062<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171454145160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases Supplemental Balance Sheet Lease information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">$ 39,847<span></span>
</td>
<td class="nump">$ 46,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">9,009<span></span>
</td>
<td class="nump">8,740<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">33,971<span></span>
</td>
<td class="nump">41,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">$ 42,980<span></span>
</td>
<td class="nump">$ 49,759<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accrued liabilities<span></span>
</td>
<td class="text">Accrued liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other Liabilities<span></span>
</td>
<td class="text">Other Liabilities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
<td class="text">6 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">4.98%<span></span>
</td>
<td class="nump">5.02%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171454246936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Finance Leases Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</a></td>
<td class="nump">$ 2,673<span></span>
</td>
<td class="nump">$ 2,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance Lease, Liability, Current</a></td>
<td class="nump">643<span></span>
</td>
<td class="nump">554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance Lease, Liability, Noncurrent</a></td>
<td class="nump">2,067<span></span>
</td>
<td class="nump">2,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease, Liability</a></td>
<td class="nump">$ 2,710<span></span>
</td>
<td class="nump">$ 2,942<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other Assets<span></span>
</td>
<td class="text">Other Assets<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accrued liabilities<span></span>
</td>
<td class="text">Accrued liabilities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other Liabilities<span></span>
</td>
<td class="text">Other Liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
<td class="text">6 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">4.28%<span></span>
</td>
<td class="nump">4.27%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171454320648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases Lease Maturity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year</a></td>
<td class="nump">$ 10,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Lessee, Operating Lease, Liability, Payments, Due Year Two</a></td>
<td class="nump">9,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Lessee, Operating Lease, Liability, Payments, Due Year Three</a></td>
<td class="nump">8,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Lessee, Operating Lease, Liability, Payments, Due Year Four</a></td>
<td class="nump">5,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">Lessee, Operating Lease, Liability, Payments, Due Year Five</a></td>
<td class="nump">4,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Lessee, Operating Lease, Liability, Payments, Due after Year Five</a></td>
<td class="nump">10,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Lessee, Operating Lease, Liability, Payments, Due</a></td>
<td class="nump">49,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</a></td>
<td class="num">(6,396)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">$ 42,980<span></span>
</td>
<td class="nump">$ 49,759<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171454324264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases Finance Lease Maturity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Finance Lease, Liability, to be Paid, Year One</a></td>
<td class="nump">$ 749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">Finance Lease, Liability, to be Paid, Year Two</a></td>
<td class="nump">749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">Finance Lease, Liability, to be Paid, Year Three</a></td>
<td class="nump">458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">Finance Lease, Liability, to be Paid, Year Four</a></td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">Finance Lease, Liability, to be Paid, Year Five</a></td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Finance Lease, Liability, to be Paid, after Year Five</a></td>
<td class="nump">615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Finance Lease, Liability, Payment, Due</a></td>
<td class="nump">3,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Finance Lease, Liability, Undiscounted Excess Amount</a></td>
<td class="num">(342)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease, Liability</a></td>
<td class="nump">$ 2,710<span></span>
</td>
<td class="nump">$ 2,942<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171460200552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Based Award Stock Based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation</a></td>
<td class="nump">$ 27,341<span></span>
</td>
<td class="nump">$ 23,954<span></span>
</td>
<td class="nump">$ 21,918<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Tax benefit from stock-based compensation cost</a></td>
<td class="nump">6,391<span></span>
</td>
<td class="nump">5,564<span></span>
</td>
<td class="nump">4,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_IndirectTaxBenefitFromStockOptions', window );">Indirect tax benefit</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">$ 1,203<span></span>
</td>
<td class="nump">$ 680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</a></td>
<td class="nump">$ 31,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_IndirectTaxBenefitFromStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indirect tax benefit from the stock compensation cost received upon the exercise of stock options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_IndirectTaxBenefitFromStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171462587352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Based Award Stock Option Plans (Details) - shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2011</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=icui_A2011PlanMember', window );">2011 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_StockIncentivePlansLineItems', window );"><strong>Stock Incentive Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</a></td>
<td class="nump">3,925,000<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</a></td>
<td class="nump">3,275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Sharestransferredfromsupersededplan', window );">Shares transferred from superseded plan</a></td>
<td class="nump">263,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="nump">4,188,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=icui_A2003PlanMember', window );">2003 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_StockIncentivePlansLineItems', window );"><strong>Stock Incentive Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="nump">248,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Sharestransferredfromsupersededplan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares transferred from superseded plan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Sharestransferredfromsupersededplan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_StockIncentivePlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Stock Incentive Plans [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_StockIncentivePlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=icui_A2011PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=icui_A2011PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=icui_A2003PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=icui_A2003PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171453645688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Based Award Stock Options Granted and Valuation (Details) - Time-based stock option [Member] - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options granted</a></td>
<td class="nump">7,910<span></span>
</td>
<td class="nump">7,190<span></span>
</td>
<td class="nump">6,265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Timebasedoptionsgrantdatefairvalue', window );">Time based options grant date fair value</a></td>
<td class="nump">$ 528<span></span>
</td>
<td class="nump">$ 425<span></span>
</td>
<td class="nump">$ 424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-Free Interest Rate</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected Dividend Yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price</a></td>
<td class="nump">$ 200.07<span></span>
</td>
<td class="nump">$ 181.99<span></span>
</td>
<td class="nump">$ 225.27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value per option</a></td>
<td class="nump">$ 66.78<span></span>
</td>
<td class="nump">$ 59.09<span></span>
</td>
<td class="nump">$ 67.73<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Timebasedoptionsgrantdatefairvalue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Time based options grant date fair value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Timebasedoptionsgrantdatefairvalue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=icui_TimebasedstockoptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=icui_TimebasedstockoptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171452881528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Based Award Stock Option Activity (Details) - Share-based Payment Arrangement, Option [Member]<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options, Outstanding, Number | shares</a></td>
<td class="nump">817,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted | shares</a></td>
<td class="nump">7,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised | shares</a></td>
<td class="num">(162,612)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Forfeited or expired | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options, Outstanding, Number | shares</a></td>
<td class="nump">663,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable | shares</a></td>
<td class="nump">656,483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Vested and Expected to Vest | shares</a></td>
<td class="nump">663,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options, Outstanding, Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">$ 70.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">200.07<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options, Exercises in Period, Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">57.64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue', window );">Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options, Outstanding, Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">74.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise Price Range, Exercisable Options, Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">73.48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">$ 74.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options, Exercisable, Weighted Average Remaining Contractual Term</a></td>
<td class="text">2 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options, Outstanding, Intrinsic Value | $</a></td>
<td class="nump">$ 108,003<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options, Exercisable, Intrinsic Value | $</a></td>
<td class="nump">107,761<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 108,003<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171454411144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share Based Award Share Award data (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ShareawarddataAbstract', window );"><strong>Share award data [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="nump">$ 237.34<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ShareawarddataAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share award data [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ShareawarddataAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171460164152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Based Award Options exercised data (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised</a></td>
<td class="nump">$ 27,534<span></span>
</td>
<td class="nump">$ 32,915<span></span>
</td>
<td class="nump">$ 22,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Cash received from exercise of stock options</a></td>
<td class="nump">9,372<span></span>
</td>
<td class="nump">13,193<span></span>
</td>
<td class="nump">7,732<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Tax benefit from stock option exercises</a></td>
<td class="nump">$ 5,092<span></span>
</td>
<td class="nump">$ 5,179<span></span>
</td>
<td class="nump">$ 9,653<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171453469608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Based Award RSU and PRSU (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ModifiedPRSUIncrementalExpense', window );">Modified PRSU Incremental Expense</a></td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=icui_PerformanceRestrictedStockUnitsPRSUsMember', window );">Performance Restricted Stock Units (PRSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</a></td>
<td class="nump">53,246<span></span>
</td>
<td class="nump">38,633<span></span>
</td>
<td class="nump">37,657<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 198.16<span></span>
</td>
<td class="nump">$ 188.34<span></span>
</td>
<td class="nump">$ 231.63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Grantdatefairvalueperformancerestrictedstockunits', window );">Grant date fair value performance restricted stock units</a></td>
<td class="nump">$ 10,551<span></span>
</td>
<td class="nump">$ 7,276<span></span>
</td>
<td class="nump">$ 8,723<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested</a></td>
<td class="nump">$ 6,777<span></span>
</td>
<td class="nump">$ 15,627<span></span>
</td>
<td class="nump">$ 26,445<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_PerformanceSharesEarned', window );">Performance Shares Earned</a></td>
<td class="nump">32,013<span></span>
</td>
<td class="nump">80,654<span></span>
</td>
<td class="nump">114,032<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</a></td>
<td class="nump">84,388<span></span>
</td>
<td class="nump">87,830<span></span>
</td>
<td class="nump">61,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 199.13<span></span>
</td>
<td class="nump">$ 188.13<span></span>
</td>
<td class="nump">$ 227.42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Grantdatefairvalueofrestrictedstockunitsgranted', window );">Grant date fair value of restricted stock units granted</a></td>
<td class="nump">$ 16,804<span></span>
</td>
<td class="nump">$ 16,523<span></span>
</td>
<td class="nump">$ 14,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested</a></td>
<td class="nump">$ 13,681<span></span>
</td>
<td class="nump">$ 12,314<span></span>
</td>
<td class="nump">$ 16,753<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Grantdatefairvalueofrestrictedstockunitsgranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Grant date fair value of restricted stock units granted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Grantdatefairvalueofrestrictedstockunitsgranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Grantdatefairvalueperformancerestrictedstockunits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Grant date fair value performance restricted stock units</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Grantdatefairvalueperformancerestrictedstockunits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ModifiedPRSUIncrementalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Modified PRSU Incremental Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ModifiedPRSUIncrementalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_PerformanceSharesEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Performance Shares Earned</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_PerformanceSharesEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=icui_PerformanceRestrictedStockUnitsPRSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=icui_PerformanceRestrictedStockUnitsPRSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171461685336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Based Award RSU and PRSU Roll forward (Details) - Restricted Stock and Performance Restricted Stock Units [Member] - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</a></td>
<td class="nump">275,761<span></span>
</td>
<td class="nump">220,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 201.05<span></span>
</td>
<td class="nump">$ 209.77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Changeinunitsduetoperformanceexpectations', window );">Change in units due to performance expectations</a></td>
<td class="nump">24,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue', window );">ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue</a></td>
<td class="nump">$ 209.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</a></td>
<td class="nump">137,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 198.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</a></td>
<td class="num">(99,363)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Intrinsic Value, Amount Per Share</a></td>
<td class="nump">$ 219.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</a></td>
<td class="num">(7,871)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Intrinsic Value, Amount Per Share</a></td>
<td class="nump">$ 196.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</a></td>
<td class="nump">$ 65,449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Changeinunitsduetoperformanceexpectations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in units due to performance expectations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Changeinunitsduetoperformanceexpectations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average intrinsic value of award forfeited under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average intrinsic value of award vested under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=icui_RestrictedStockAndPerformanceRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=icui_RestrictedStockAndPerformanceRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458610952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share Based Award ESPP Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ESPPOriginalIssuance', window );">ESPP Original Issuance</a></td>
<td class="nump">750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ESPPAnnualIssuanceIncreaseLimit', window );">ESPP Annual Issuance Increase Limit</a></td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_SharesAvailableInEmployeeStockPurchasePlan', window );">Shares available in employee stock purchase plan</a></td>
<td class="nump">133,487<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ESPPAnnualIssuanceIncreaseLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ESPP Annual Issuance Increase Limit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ESPPAnnualIssuanceIncreaseLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ESPPOriginalIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ESPP Original Issuance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ESPPOriginalIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_SharesAvailableInEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares available in employee stock purchase plan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_SharesAvailableInEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171461818632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives and Hedging Activities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months', window );">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</a></td>
<td class="nump">$ 1,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</a></td>
<td class="nump">$ 5,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge1Member', window );">Hedge 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeForwardExchangeRate1', window );">Derivative, Forward Exchange Rate</a></td>
<td class="nump">20.01<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge2Member', window );">Hedge 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeForwardExchangeRate1', window );">Derivative, Forward Exchange Rate</a></td>
<td class="nump">20.43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge3MemberMember', window );">Hedge 3 [Member] [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeForwardExchangeRate1', window );">Derivative, Forward Exchange Rate</a></td>
<td class="nump">22.11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge4Member', window );">Hedge 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeForwardExchangeRate1', window );">Derivative, Forward Exchange Rate</a></td>
<td class="nump">24.26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative Asset, Notional Amount</a></td>
<td class="nump">$ 436,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge5Member', window );">Hedge 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeForwardExchangeRate1', window );">Derivative, Forward Exchange Rate</a></td>
<td class="nump">21.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative Asset, Notional Amount</a></td>
<td class="nump">$ 413,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative, Fixed Interest Rate</a></td>
<td class="nump">1.49%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_DerivativeInterestRateFloor', window );">Derivative Interest Rate Floor</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative Liability, Notional Amount</a></td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative Liability, Notional Amount</a></td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=icui_UsGaap_InterestRateSwap2Member', window );">us-gaap_InterestRateSwap 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative, Fixed Interest Rate</a></td>
<td class="nump">1.31%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_DerivativeInterestRateFloor', window );">Derivative Interest Rate Floor</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=icui_UsGaap_InterestRateSwap2Member', window );">us-gaap_InterestRateSwap 2 | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative Liability, Notional Amount</a></td>
<td class="nump">$ 750,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=icui_UsGaap_InterestRateSwap2Member', window );">us-gaap_InterestRateSwap 2 | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative Liability, Notional Amount</a></td>
<td class="nump">$ 46,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_DerivativeInterestRateFloor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Interest Rate Floor</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_DerivativeInterestRateFloor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeForwardExchangeRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual rate at which a foreign currency can be purchased or sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeForwardExchangeRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge3MemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge3MemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=icui_UsGaap_InterestRateSwap2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=icui_UsGaap_InterestRateSwap2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171454004904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives and Hedging Activities Derivative Balance Sheet Location (Details) - Designated as Hedging Instrument [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward [Member] | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">$ 1,061<span></span>
</td>
<td class="nump">$ 3,555<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward [Member] | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward [Member] | Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward [Member] | Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward [Member] | Assets, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">1,061<span></span>
</td>
<td class="nump">3,555<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward [Member] | Liabilities, Total [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">1,480<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Assets, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Liabilities, Total [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">1,480<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_DerivativeFinancialInstrumentsAssetsMember', window );">Derivative Financial Instruments, Assets | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">1,061<span></span>
</td>
<td class="nump">3,555<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_DerivativeFinancialInstrumentsAssetsMember', window );">Derivative Financial Instruments, Assets | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_DerivativeFinancialInstrumentsAssetsMember', window );">Derivative Financial Instruments, Assets | Assets, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">1,061<span></span>
</td>
<td class="nump">3,555<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember', window );">Derivative Financial Instruments, Liabilities [Member] | Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember', window );">Derivative Financial Instruments, Liabilities [Member] | Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">1,480<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember', window );">Derivative Financial Instruments, Liabilities [Member] | Liabilities, Total [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">$ 1,480<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilitiesTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilitiesTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_DerivativeFinancialInstrumentsAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_DerivativeFinancialInstrumentsAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458854744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Hedging Activities Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivative, Gain (Loss) on Derivative, Net</a></td>
<td class="nump">$ 3,444<span></span>
</td>
<td class="nump">$ 790<span></span>
</td>
<td class="nump">$ 916<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171454383928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Hedging Activities Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion', window );">Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion</a></td>
<td class="nump">$ 3,444<span></span>
</td>
<td class="nump">$ 790<span></span>
</td>
<td class="nump">$ 916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other Comprehensive Income (Loss), before Tax</a></td>
<td class="num">(530)<span></span>
</td>
<td class="nump">1,980<span></span>
</td>
<td class="nump">2,550<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Foreign Exchange Forward [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other Comprehensive Income (Loss), before Tax</a></td>
<td class="nump">950<span></span>
</td>
<td class="nump">1,980<span></span>
</td>
<td class="nump">2,550<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other Comprehensive Income (Loss), before Tax</a></td>
<td class="num">(1,480)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Cost of Sales [Member] | Foreign Exchange Forward [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion', window );">Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion</a></td>
<td class="nump">$ 3,444<span></span>
</td>
<td class="nump">$ 790<span></span>
</td>
<td class="nump">$ 916<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of gain reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net gains or losses on interest rate cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171454358904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement Text (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Earn-out Liability</a></td>
<td class="nump">$ 2,589<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="nump">$ 17,300<span></span>
</td>
<td class="nump">$ 47,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ShortTermContingentConsiderationGross', window );">Short-term contingent consideration-gross</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LongTermContingentConsiderationGross', window );">Long-term contingent consideration-gross</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularLLCMember', window );">Pursuit Vascular LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Earn-out Liability</a></td>
<td class="nump">26,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignDistibutorMember', window );">Foreign Distibutor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Earn-out Liability</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember', window );">Foreign Infusion System Supplier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Contingentconsiderationgross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>contingent consideration gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Contingentconsiderationgross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LongTermContingentConsiderationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term contingent consideration-gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LongTermContingentConsiderationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ShortTermContingentConsiderationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short-term contingent consideration-gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ShortTermContingentConsiderationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignDistibutorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_ForeignDistibutorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458579112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Earn-out Liability</a></td>
<td class="nump">$ 2,589<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="nump">$ 17,300<span></span>
</td>
<td class="nump">$ 47,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</a></td>
<td class="nump">2,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="num">$ (47,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3</a></td>
<td class="num">(26,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularLLCMember', window );">Pursuit Vascular LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Earn-out Liability</a></td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3) and still held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as a liability out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171454381896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement Fair Value Inputs, Liabilities, Pursuit Quantitative Information (Details) - Pursuit Vascular, Inc. [Member]<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 02, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Revenue/Gross Profit Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="nump">0.2500<span></span>
</td>
<td class="nump">0.2000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Measurement Input, Discount Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="nump">0.1250<span></span>
</td>
<td class="nump">0.1500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="nump">0.0009<span></span>
</td>
<td class="nump">0.0155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Credit Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="nump">0.0310<span></span>
</td>
<td class="nump">0.0600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=icui_RevenueGrossProfitVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=icui_RevenueGrossProfitVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_CreditRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_CreditRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171453311032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement Fair Value Measurements, Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">$ 20,101<span></span>
</td>
<td class="nump">$ 31,216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">14,420<span></span>
</td>
<td class="nump">14,687<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesNoncurrent', window );">Debt Securities, Noncurrent</a></td>
<td class="nump">4,620<span></span>
</td>
<td class="nump">12,974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue', window );">Interest Rate Derivative Liabilities, at Fair Value</a></td>
<td class="nump">1,480<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesNoncurrent', window );">Debt Securities, Noncurrent</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue', window );">Interest Rate Derivative Liabilities, at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">20,101<span></span>
</td>
<td class="nump">31,216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">14,420<span></span>
</td>
<td class="nump">14,687<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesNoncurrent', window );">Debt Securities, Noncurrent</a></td>
<td class="nump">4,620<span></span>
</td>
<td class="nump">12,974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue', window );">Interest Rate Derivative Liabilities, at Fair Value</a></td>
<td class="nump">1,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesNoncurrent', window );">Debt Securities, Noncurrent</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue', window );">Interest Rate Derivative Liabilities, at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">1,061<span></span>
</td>
<td class="nump">3,555<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">1,061<span></span>
</td>
<td class="nump">3,555<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=icui_EarnoutliabilityMember', window );">Earn-out liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">2,589<span></span>
</td>
<td class="nump">26,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=icui_EarnoutliabilityMember', window );">Earn-out liability [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=icui_EarnoutliabilityMember', window );">Earn-out liability [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=icui_EarnoutliabilityMember', window );">Earn-out liability [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">2,589<span></span>
</td>
<td class="nump">26,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_LiabilitiesTotalMember', window );">Liabilities, Total [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">4,069<span></span>
</td>
<td class="nump">26,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_LiabilitiesTotalMember', window );">Liabilities, Total [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_LiabilitiesTotalMember', window );">Liabilities, Total [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">1,480<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_LiabilitiesTotalMember', window );">Liabilities, Total [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">$ 2,589<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and investment in debt security measured at amortized cost (held-to-maturity), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of interest rate derivative liabilities, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateDerivativeLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations not classified as financial liabilities. Includes, but is not limited to, accounts payable and accrued liabilities, commitments, obligations, and other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonfinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=icui_EarnoutliabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=icui_EarnoutliabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_LiabilitiesTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_LiabilitiesTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171453412600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaids and Other Current Assets Prepaid Expenses and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Other Prepaid Expense, Current</a></td>
<td class="nump">$ 14,763<span></span>
</td>
<td class="nump">$ 14,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsAndOtherAssets', window );">Deferred Costs and Other Assets</a></td>
<td class="nump">12,746<span></span>
</td>
<td class="nump">6,402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Prepaidinsuranceandpropertytaxes', window );">Prepaid insurance and property taxes</a></td>
<td class="nump">6,310<span></span>
</td>
<td class="nump">6,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Prepaidothertaxes', window );">Prepaid other taxes</a></td>
<td class="nump">4,156<span></span>
</td>
<td class="nump">3,676<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Deferredtaxcharge', window );">Deferred tax charge</a></td>
<td class="nump">4,241<span></span>
</td>
<td class="nump">3,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative Asset, Current</a></td>
<td class="nump">1,061<span></span>
</td>
<td class="nump">3,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositAssets', window );">Deposit Assets</a></td>
<td class="nump">1,343<span></span>
</td>
<td class="nump">1,353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other Assets, Current</a></td>
<td class="nump">2,227<span></span>
</td>
<td class="nump">1,822<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">46,847<span></span>
</td>
<td class="nump">41,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived', window );">Lessor, Operating Lease, Payments to be Received</a></td>
<td class="nump">25,941<span></span>
</td>
<td class="nump">28,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_SpareParts', window );">Spare parts</a></td>
<td class="nump">28,538<span></span>
</td>
<td class="nump">22,725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="nump">3,238<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Debt Issuance Costs, Noncurrent, Net</a></td>
<td class="nump">2,827<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</a></td>
<td class="nump">2,673<span></span>
</td>
<td class="nump">2,915<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousNoncurrent', window );">Other Assets, Miscellaneous, Noncurrent</a></td>
<td class="nump">526<span></span>
</td>
<td class="nump">887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other Assets</a></td>
<td class="nump">$ 63,743<span></span>
</td>
<td class="nump">$ 55,475<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Deferredtaxcharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax charge</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Deferredtaxcharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Prepaidinsuranceandpropertytaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid insurance and property taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Prepaidinsuranceandpropertytaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Prepaidothertaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid other taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Prepaidothertaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_SpareParts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Spare parts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_SpareParts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred cost assets and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payments to be received by lessor for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171459752424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities an Other Long-term Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_AccruedSalariesAndBenefits', window );">Salaries and benefits</a></td>
<td class="nump">$ 27,304<span></span>
</td>
<td class="nump">$ 25,786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrent', window );">Incentive compensation</a></td>
<td class="nump">33,107<span></span>
</td>
<td class="nump">27,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">9,009<span></span>
</td>
<td class="nump">8,740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Accrued Professional Fees</a></td>
<td class="nump">773<span></span>
</td>
<td class="nump">1,273<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Accruedlegalfees', window );">Legal accrual</a></td>
<td class="nump">3,897<span></span>
</td>
<td class="nump">900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Accruedsalestaxes', window );">Accrued sales taxes</a></td>
<td class="nump">1,980<span></span>
</td>
<td class="nump">2,146<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent', window );">Warranties and returns</a></td>
<td class="nump">532<span></span>
</td>
<td class="nump">1,027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract with Customer, Liability, Current</a></td>
<td class="nump">12,646<span></span>
</td>
<td class="nump">5,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Accruedothertaxes', window );">Accrued other taxes</a></td>
<td class="nump">4,337<span></span>
</td>
<td class="nump">3,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Outsidesalescommissions', window );">Outside commissions</a></td>
<td class="nump">5,645<span></span>
</td>
<td class="nump">5,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Accruedfreight', window );">Accrued freight</a></td>
<td class="nump">9,194<span></span>
</td>
<td class="nump">6,784<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Restructuring accrual</a></td>
<td class="nump">664<span></span>
</td>
<td class="nump">3,421<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">9,107<span></span>
</td>
<td class="nump">5,515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">$ 118,195<span></span>
</td>
<td class="nump">$ 97,021<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_AccruedSalariesAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued salaries and benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_AccruedSalariesAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Accruedfreight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued freight</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Accruedfreight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Accruedlegalfees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued legal fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Accruedlegalfees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Accruedothertaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued other taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Accruedothertaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Accruedsalestaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued sales taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Accruedsalestaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Outsidesalescommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Outside sales commissions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Outsidesalescommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedBonusesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedBonusesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12524-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123377177&amp;loc=d3e11281-110244<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171454367720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities an Other Long-term Liabilities Other Long-term Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_OtherLongtermLiabilitiesAbstract', window );"><strong>Other Long-term Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">$ 33,971<span></span>
</td>
<td class="nump">$ 41,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance Lease, Liability, Noncurrent</a></td>
<td class="nump">2,067<span></span>
</td>
<td class="nump">2,388<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Liabilitiesforcontracts', window );">Contract liabilities</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue', window );">Interest Rate Derivative Liabilities, at Fair Value</a></td>
<td class="nump">1,480<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent', window );">Benefits</a></td>
<td class="nump">1,369<span></span>
</td>
<td class="nump">1,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRentCurrentAndNoncurrent', window );">Accrued rent</a></td>
<td class="nump">1,262<span></span>
</td>
<td class="nump">1,462<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent', window );">Other</a></td>
<td class="nump">1,479<span></span>
</td>
<td class="nump">1,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent', window );">OTHER LONG-TERM LIABILITIES</a></td>
<td class="nump">$ 41,830<span></span>
</td>
<td class="nump">$ 47,835<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Liabilitiesforcontracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liabilities for contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Liabilitiesforcontracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_OtherLongtermLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Long-term Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_OtherLongtermLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRentCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRentCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of interest rate derivative liabilities, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateDerivativeLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171453269016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 06, 2022</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of Credit Facility, Remaining Borrowing Capacity</a></td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Line of Credit Facility, Expiration Date</a></td>
<td class="text">Nov.  08,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LineofCreditAccordion', window );">Line of Credit Accordion</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross', window );">Debt Issuance Costs, Line of Credit Arrangements, Gross</a></td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateTerms', window );">Debt Instrument, Interest Rate Terms</a></td>
<td class="text">In general, borrowing under the Credit Facility (other than Swingline loans) bears interest, at our option, based on the Base Rate plus applicable margin or the London Interbank Offered Rate ("LIBOR") rate plus applicable margin, as defined below:<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of Credit, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=icui_TermLoanAMember', window );">Term Loan A | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=icui_TermLoanBMember', window );">Term Loan B | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LineofCreditAccordion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Accordion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LineofCreditAccordion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs related to line of credit arrangements. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section S45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68176171&amp;loc=SL68176184-208336<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=icui_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=icui_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=icui_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=icui_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171461794232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations Line of Credit Pricing (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=icui_PricingLevelIMember', window );">Pricing Level I [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.15%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LIBORBasisSpreadonVariableRate', window );">LIBOR Basis Spread on Variable Rate</a></td>
<td class="nump">1.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=icui_PricingLevelIIMemberMember', window );">Pricing Level II [Member] [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LIBORBasisSpreadonVariableRate', window );">LIBOR Basis Spread on Variable Rate</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=icui_PricingLevelIIIMemberMember', window );">Pricing Level III [Member] [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LIBORBasisSpreadonVariableRate', window );">LIBOR Basis Spread on Variable Rate</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="nump">0.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=icui_PricingLevelIVMemberMember', window );">Pricing Level IV [Member] [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LIBORBasisSpreadonVariableRate', window );">LIBOR Basis Spread on Variable Rate</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LIBORBasisSpreadonVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>LIBOR Basis Spread on Variable Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LIBORBasisSpreadonVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=icui_PricingLevelIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=icui_PricingLevelIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=icui_PricingLevelIIMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=icui_PricingLevelIIMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=icui_PricingLevelIIIMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=icui_PricingLevelIIIMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=icui_PricingLevelIVMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=icui_PricingLevelIVMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458623544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Income (Loss) from Continuing Operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Income (Loss) from Continuing Operations before Income Taxes, Domestic</a></td>
<td class="nump">$ 81,484<span></span>
</td>
<td class="nump">$ 41,194<span></span>
</td>
<td class="nump">$ 32,849<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Income (Loss) from Continuing Operations before Income Taxes, Foreign</a></td>
<td class="nump">41,702<span></span>
</td>
<td class="nump">56,300<span></span>
</td>
<td class="nump">81,858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossAttributableToParent', window );">Income before income taxes</a></td>
<td class="nump">$ 123,186<span></span>
</td>
<td class="nump">$ 97,494<span></span>
</td>
<td class="nump">$ 114,707<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171461794232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Tax Provision (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current Federal Tax Expense (Benefit)</a></td>
<td class="nump">$ 20,646<span></span>
</td>
<td class="nump">$ 6,032<span></span>
</td>
<td class="nump">$ 6,851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current State and Local Tax Expense (Benefit)</a></td>
<td class="nump">3,444<span></span>
</td>
<td class="nump">2,422<span></span>
</td>
<td class="nump">2,532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Current Foreign Tax Expense (Benefit)</a></td>
<td class="nump">7,236<span></span>
</td>
<td class="nump">7,290<span></span>
</td>
<td class="nump">7,994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current Income Tax Expense (Benefit)</a></td>
<td class="nump">31,326<span></span>
</td>
<td class="nump">15,744<span></span>
</td>
<td class="nump">17,377<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred Federal Income Tax Expense (Benefit)</a></td>
<td class="num">(8,154)<span></span>
</td>
<td class="num">(5,319)<span></span>
</td>
<td class="num">(6,720)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">Deferred State and Local Income Tax Expense (Benefit)</a></td>
<td class="num">(1,815)<span></span>
</td>
<td class="num">(1,850)<span></span>
</td>
<td class="num">(325)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Deferred Foreign Income Tax Expense (Benefit)</a></td>
<td class="num">(1,306)<span></span>
</td>
<td class="nump">2,049<span></span>
</td>
<td class="nump">3,340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred Income Tax Expense (Benefit)</a></td>
<td class="num">(11,275)<span></span>
</td>
<td class="num">(5,120)<span></span>
</td>
<td class="num">(3,705)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 20,051<span></span>
</td>
<td class="nump">$ 10,624<span></span>
</td>
<td class="nump">$ 13,672<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458283528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Change in taxes payable (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Increase (Decrease) in Income Taxes Payable</a></td>
<td class="nump">$ 3.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171453868040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Effective tax rate (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Percent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income Tax Reconciliation, Income Tax Expense (Benefit), at Federal Statutory Income Tax Rate</a></td>
<td class="nump">$ 25,869<span></span>
</td>
<td class="nump">$ 20,474<span></span>
</td>
<td class="nump">$ 24,088<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">Income Tax Reconciliation, State and Local Income Taxes</a></td>
<td class="nump">2,907<span></span>
</td>
<td class="nump">2,099<span></span>
</td>
<td class="nump">1,269<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCredits', window );">Income Tax Reconciliation, Tax Credits</a></td>
<td class="num">(2,443)<span></span>
</td>
<td class="num">(3,269)<span></span>
</td>
<td class="num">(2,896)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_GILTItaxexpense', window );">GILTItaxexpense</a></td>
<td class="nump">711<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="nump">6,634<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Income Tax Reconciliation, Foreign Income Tax Rate Differential</a></td>
<td class="num">(2,983)<span></span>
</td>
<td class="num">(3,888)<span></span>
</td>
<td class="num">(5,939)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount</a></td>
<td class="num">(4,263)<span></span>
</td>
<td class="num">(4,686)<span></span>
</td>
<td class="num">(8,446)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome', window );">EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome</a></td>
<td class="num">(3,775)<span></span>
</td>
<td class="num">(2,718)<span></span>
</td>
<td class="num">(516)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_EffectiveIncomeTaxRateReconciliationIPMigration', window );">EffectiveIncomeTaxRateReconciliationIPMigration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,118)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_EffectiveIncomeTaxRateReconciliationContingentConsideration', window );">Effective Income Tax Rate Reconciliation, Contingent Consideration</a></td>
<td class="num">(29)<span></span>
</td>
<td class="nump">1,566<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Effectiveincometaxreconciliationnondeductiblecompensation', window );">Effectiveincometaxreconciliation,nondeductiblecompensation</a></td>
<td class="nump">1,812<span></span>
</td>
<td class="nump">1,079<span></span>
</td>
<td class="nump">203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</a></td>
<td class="nump">2,245<span></span>
</td>
<td class="num">(196)<span></span>
</td>
<td class="nump">1,393<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 20,051<span></span>
</td>
<td class="nump">$ 10,624<span></span>
</td>
<td class="nump">$ 13,672<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">Effective Income Tax Rate Reconciliation, State and Local Income Taxes</a></td>
<td class="nump">2.40%<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">Effective Income Tax Rate Reconciliation, Tax Credits</a></td>
<td class="num">(2.00%)<span></span>
</td>
<td class="num">(3.40%)<span></span>
</td>
<td class="num">(2.50%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_GILTItaxexpensepercent', window );">GILTItaxexpensepercent</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential</a></td>
<td class="num">(2.40%)<span></span>
</td>
<td class="num">(4.00%)<span></span>
</td>
<td class="num">(5.20%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent', window );">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent</a></td>
<td class="num">(3.50%)<span></span>
</td>
<td class="num">(4.80%)<span></span>
</td>
<td class="num">(7.40%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent', window );">EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome,Percent</a></td>
<td class="num">(3.10%)<span></span>
</td>
<td class="num">(2.80%)<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_EffectiveTaxRateReconciliationIPMigrationPercent', window );">EffectiveTaxRateReconciliationIPMigrationPercent</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.018)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent', window );">Effective Income Tax Rate Reconciliation, Contingent Consideration, Percent</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Effectivetaxratereconciliationnondeductiblecomppercent', window );">Effectivetaxratereconciliationnondeductiblecomppercent</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income Tax Rate, Continuing Operations</a></td>
<td class="nump">16.30%<span></span>
</td>
<td class="nump">10.90%<span></span>
</td>
<td class="nump">11.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_EffectiveIncomeTaxRateReconciliationContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_EffectiveIncomeTaxRateReconciliationContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Contingent Consideration, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome,Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_EffectiveIncomeTaxRateReconciliationIPMigration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>EffectiveIncomeTaxRateReconciliationIPMigration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_EffectiveIncomeTaxRateReconciliationIPMigration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_EffectiveTaxRateReconciliationIPMigrationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>EffectiveTaxRateReconciliationIPMigrationPercent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_EffectiveTaxRateReconciliationIPMigrationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Effectiveincometaxreconciliationnondeductiblecompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effectiveincometaxreconciliation,nondeductiblecompensation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Effectiveincometaxreconciliationnondeductiblecompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Effectivetaxratereconciliationnondeductiblecomppercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effectivetaxratereconciliationnondeductiblecomppercent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Effectivetaxratereconciliationnondeductiblecomppercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_GILTItaxexpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>GILTItaxexpense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_GILTItaxexpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_GILTItaxexpensepercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>GILTItaxexpensepercent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_GILTItaxexpensepercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120384911&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120384911&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171452901016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Deferred income tax assets (liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_DeferredtaxassetsandliabilitiesLineItems', window );"><strong>Deferred tax assets and liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Noncurrentdeferredtaxasset', window );">Non-current deferred tax asset</a></td>
<td class="nump">$ 69,194<span></span>
</td>
<td class="nump">$ 67,404<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred Tax Assets, Net</a></td>
<td class="nump">41,114<span></span>
</td>
<td class="nump">29,371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=icui_NonCurrentDeferredTaxAssetGrossTotalMember', window );">Non-current deferred tax asset, gross total [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_DeferredtaxassetsandliabilitiesLineItems', window );"><strong>Deferred tax assets and liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther', window );">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other</a></td>
<td class="nump">6,866<span></span>
</td>
<td class="nump">4,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions', window );">Noncurrent deferred tax asset - acquired future tax deductions</a></td>
<td class="nump">5,440<span></span>
</td>
<td class="nump">7,781<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</a></td>
<td class="nump">7,283<span></span>
</td>
<td class="nump">7,138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses', window );">Deferred Tax Assets, Unrealized Currency Losses</a></td>
<td class="nump">3,360<span></span>
</td>
<td class="nump">2,406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_NoncurrentDeferredTaxAssetTaxCreditsState', window );">Noncurrent deferred tax asset - tax credits state</a></td>
<td class="nump">11,953<span></span>
</td>
<td class="nump">12,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Deferred Tax Assets, Inventory</a></td>
<td class="nump">8,199<span></span>
</td>
<td class="nump">8,493<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts</a></td>
<td class="nump">926<span></span>
</td>
<td class="nump">4,460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Noncurrentdeferredtaxassetaccruedrestructuring', window );">Noncurrentdeferredtaxassetaccruedrestructuring</a></td>
<td class="nump">131<span></span>
</td>
<td class="nump">1,293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions', window );">Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions</a></td>
<td class="nump">27,970<span></span>
</td>
<td class="nump">22,874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred Tax Assets, Valuation Allowance</a></td>
<td class="nump">2,934<span></span>
</td>
<td class="nump">3,891<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=icui_NoncurrentDeferredTaxLiabilityMember', window );">Noncurrent deferred tax liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_DeferredtaxassetsandliabilitiesLineItems', window );"><strong>Deferred tax assets and liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes', window );">Noncurrent deferred tax liability - state income taxes</a></td>
<td class="nump">2,724<span></span>
</td>
<td class="nump">2,398<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_NoncurrentDeferredTaxLiabilityForeign', window );">Noncurrent deferred tax liability - foreign</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization', window );">Noncurrent deferred tax liability - depreciation and amortization</a></td>
<td class="nump">20,483<span></span>
</td>
<td class="nump">25,113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Deferredtaxliabilitychangeinaccountingmethod', window );">Deferred tax liability, change in accounting method</a></td>
<td class="nump">4,873<span></span>
</td>
<td class="nump">9,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred Tax Liabilities, Net</a></td>
<td class="nump">$ 28,080<span></span>
</td>
<td class="nump">$ 38,033<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_DeferredtaxassetsandliabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Deferred tax assets and liabilities [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_DeferredtaxassetsandliabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Deferredtaxliabilitychangeinaccountingmethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liability, change in accounting method</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Deferredtaxliabilitychangeinaccountingmethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_NoncurrentDeferredTaxAssetTaxCreditsState">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncurrent deferred tax asset - tax credits state</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_NoncurrentDeferredTaxAssetTaxCreditsState</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncurrent deferred tax liability - depreciation and amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_NoncurrentDeferredTaxLiabilityForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncurrent deferred tax liability - foreign</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_NoncurrentDeferredTaxLiabilityForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncurrent deferred tax liability - state income taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Noncurrentdeferredtaxasset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-current deferred tax asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Noncurrentdeferredtaxasset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Noncurrentdeferredtaxassetaccruedrestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncurrentdeferredtaxassetaccruedrestructuring</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Noncurrentdeferredtaxassetaccruedrestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncurrent deferred tax asset - acquired future tax deductions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=icui_NonCurrentDeferredTaxAssetGrossTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=icui_NonCurrentDeferredTaxAssetGrossTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=icui_NoncurrentDeferredTaxLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=icui_NoncurrentDeferredTaxLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171456998264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes Operating Loss Carryforwards (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 2.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">8.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 15.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458782104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes Tax Carryforwards (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax Credit Carryforward, Amount</a></td>
<td class="nump">$ 16.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458418392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Tax Holiday (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxHolidayLineItems', window );"><strong>Income Tax Holiday [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxHolidayAggregateDollarAmount', window );">Income Tax Holiday, Aggregate Dollar Amount</a></td>
<td class="nump">$ 9.8<span></span>
</td>
<td class="nump">$ 8.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare', window );">Income Tax Holiday, Income Tax Benefits Per Share</a></td>
<td class="nump">$ 0.45<span></span>
</td>
<td class="nump">$ 0.37<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxHolidayAggregateDollarAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income taxes from which a reporting entity is exempt or for which it will receive a reduction in income taxes as a result of the income tax holiday granted by the taxing jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxHolidayAggregateDollarAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount effect of the income tax benefit resulting from the income tax holidays granted by taxing jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxHolidayLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxHolidayLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458367064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes Undistributed foreign earnings (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries', window );">Undistributed Earnings of Foreign Subsidiaries</a></td>
<td class="nump">$ 98.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6487024&amp;loc=d3e29054-158556<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6479915&amp;loc=d3e66715-112838<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123452999&amp;loc=d3e28200-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171459688120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Unrecognized tax benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_UnrecognizedTaxBenefitsRollForwardRollForward', window );"><strong>Unrecognized tax benefits roll forward [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized Tax Benefits</a></td>
<td class="nump">$ 21,537<span></span>
</td>
<td class="nump">$ 18,443<span></span>
</td>
<td class="nump">$ 15,027<span></span>
</td>
<td class="nump">$ 10,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Unrecognized Tax Benefits, Increases Resulting from Prior Period Tax Positions</a></td>
<td class="nump">231<span></span>
</td>
<td class="nump">502<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Unrecognized Tax Benefits, Increases Resulting from Current Period Tax Positions</a></td>
<td class="nump">3,242<span></span>
</td>
<td class="nump">2,987<span></span>
</td>
<td class="nump">4,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="num">(163)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</a></td>
<td class="nump">$ 348<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_UnrecognizedTaxBenefitsRollForwardRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized tax benefits roll forward</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_UnrecognizedTaxBenefitsRollForwardRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171453307672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Geographic Information and Significant Customers Long Lived Assets by Geographic Location (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">$ 905,104<span></span>
</td>
<td class="nump">$ 843,096<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CR', window );">COSTA RICA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">115,187<span></span>
</td>
<td class="nump">104,015<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=icui_MexicoPropertyAndEquipmentMember', window );">Mexico Property and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">79,567<span></span>
</td>
<td class="nump">76,004<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=icui_OtherLATAMMember', window );">Other LATAM [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">36,907<span></span>
</td>
<td class="nump">37,485<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">CANADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">4,716<span></span>
</td>
<td class="nump">4,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=icui_ItalyPropertyAndEquipmentMember', window );">Italy Property and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">12,435<span></span>
</td>
<td class="nump">11,098<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_ES', window );">SPAIN</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">13,295<span></span>
</td>
<td class="nump">8,701<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">4,171<span></span>
</td>
<td class="nump">3,795<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">20,452<span></span>
</td>
<td class="nump">19,836<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=icui_ForeignMember', window );">Foreign [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">286,730<span></span>
</td>
<td class="nump">265,606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=icui_UnitedStatespropertyandequipmentMember', window );">United States property and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">$ 618,374<span></span>
</td>
<td class="nump">$ 577,490<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=icui_MexicoPropertyAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=icui_MexicoPropertyAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=icui_OtherLATAMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=icui_OtherLATAMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=icui_ItalyPropertyAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=icui_ItalyPropertyAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_ES">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_ES</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=icui_ForeignMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=icui_ForeignMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=icui_UnitedStatespropertyandequipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=icui_UnitedStatespropertyandequipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171462582840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Treasury stock purchase plan</a></td>
<td class="nump">$ 100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Treasury stock purchase plan remaining available</a></td>
<td class="nump">$ 100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</a></td>
<td class="nump">40,350<span></span>
</td>
<td class="nump">67,041<span></span>
</td>
<td class="nump">80,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payment, Tax Withholding, Share-based Payment Arrangement</a></td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="nump">$ 12.9<span></span>
</td>
<td class="nump">$ 18.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury Stock, Common, Shares</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="nump">850<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171452994328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">$ (19,269)<span></span>
</td>
<td class="num">$ (1,522)<span></span>
</td>
<td class="num">$ (15,402)<span></span>
</td>
<td class="num">$ (16,945)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="num">(15,129)<span></span>
</td>
<td class="nump">14,481<span></span>
</td>
<td class="nump">2,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="num">(2,618)<span></span>
</td>
<td class="num">(601)<span></span>
</td>
<td class="num">(696)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(17,747)<span></span>
</td>
<td class="nump">13,880<span></span>
</td>
<td class="nump">1,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(19,045)<span></span>
</td>
<td class="num">(4,381)<span></span>
</td>
<td class="num">(17,310)<span></span>
</td>
<td class="num">(17,682)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="num">(14,664)<span></span>
</td>
<td class="nump">12,929<span></span>
</td>
<td class="nump">372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(14,664)<span></span>
</td>
<td class="nump">12,929<span></span>
</td>
<td class="nump">372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(237)<span></span>
</td>
<td class="nump">2,784<span></span>
</td>
<td class="nump">1,880<span></span>
</td>
<td class="nump">638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="num">(403)<span></span>
</td>
<td class="nump">1,505<span></span>
</td>
<td class="nump">1,938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="num">(2,618)<span></span>
</td>
<td class="num">(601)<span></span>
</td>
<td class="num">(696)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(3,021)<span></span>
</td>
<td class="nump">904<span></span>
</td>
<td class="nump">1,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="num">(62)<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="num">(71)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">$ (62)<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="num">$ (71)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171453198536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies Contingencies (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Earn-out Liability</a></td>
<td class="nump">$ 2,589<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="nump">$ 17,300<span></span>
</td>
<td class="nump">$ 47,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ShortTermContingentConsiderationGross', window );">Short-term contingent consideration-gross</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LongTermContingentConsiderationGross', window );">Long-term contingent consideration-gross</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_HospiraMember', window );">Hospira [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">191,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_HospiraMember', window );">Hospira [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularLLCMember', window );">Pursuit Vascular LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Earn-out Liability</a></td>
<td class="nump">26,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignDistibutorMember', window );">Foreign Distibutor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Earn-out Liability</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember', window );">Foreign Infusion System Supplier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Contingentconsiderationgross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>contingent consideration gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Contingentconsiderationgross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LongTermContingentConsiderationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term contingent consideration-gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LongTermContingentConsiderationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ShortTermContingentConsiderationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short-term contingent consideration-gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ShortTermContingentConsiderationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_HospiraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_HospiraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignDistibutorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_ForeignDistibutorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171458317304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaborative and Other Arrangements (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_CollaborativeandOtherArrangementsAbstract', window );"><strong>Collaborative and Other Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted', window );">Purchase Commitment, Remaining Minimum Amount Committed</a></td>
<td class="nump">$ 29.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_CollaborativeandOtherArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative and Other Arrangements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_CollaborativeandOtherArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171461825480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br> shares in Millions</strong></div></th>
<th class="th"><div>Jan. 06, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,128,000<span></span>
</td>
<td class="nump">$ 2,106,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_OwnershipShareMinimumRequirement', window );">Ownership Share % Minimum Requirement</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Smiths Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business Acquisition, Percentage of Voting Interests Acquired</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="nump">$ 1,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Contingentconsiderationgross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>contingent consideration gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Contingentconsiderationgross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_OwnershipShareMinimumRequirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ownership Share % Minimum Requirement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_OwnershipShareMinimumRequirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171453053080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events Credit Agreement (Details) - Subsequent Event<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jan. 06, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt', window );">Term Loan A Payment First Years as a % of Original Debt</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount', window );">Term Loan A Payment Year 3 and 4 as a % of Original Debt Amount</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAPaymentYear5', window );">Term Loan A Payment Year 5</a></td>
<td class="nump">7.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount', window );">Term Loan B Quarterly Payments as a % of Original Debt Amount</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LineOfCreditSpread', window );">line of credit spread</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAAndCreditLineSpread', window );">Term Loan A and Credit Line Spread</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanBInitialSpread', window );">Term Loan B Initial Spread</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Term Loans &amp; Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">$ 2,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">850,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Term Loan B</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">850,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LineOfCreditSpread">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>line of credit spread</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LineOfCreditSpread</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAAndCreditLineSpread">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term Loan A and Credit Line Spread</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAAndCreditLineSpread</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term Loan A Payment First Years as a % of Original Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term Loan A Payment Year 3 and 4 as a % of Original Debt Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAPaymentYear5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term Loan A Payment Year 5</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAPaymentYear5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanBInitialSpread">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term Loan B Initial Spread</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanBInitialSpread</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term Loan B Quarterly Payments as a % of Original Debt Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=icui_TermLoansLineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=icui_TermLoansLineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=icui_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=icui_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=icui_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=icui_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171452947640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events Term Loan A &amp; Credit Line Applicable Margin (Details) - Subsequent Event<br></strong></div></th>
<th class="th"><div>Jan. 06, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAAndCreditLineSpread', window );">Term Loan A and Credit Line Spread</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Pricing Level 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Spread', window );">spread</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="nump">1.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.35%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Pricing Level IV [Member] [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Spread', window );">spread</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Pricing Level III [Member] [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Spread', window );">spread</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="nump">0.75%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Pricing Level II [Member] [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Spread', window );">spread</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Pricing Level I [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Spread', window );">spread</a></td>
<td class="nump">1.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.15%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Spread">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>spread</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Spread</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAAndCreditLineSpread">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term Loan A and Credit Line Spread</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAAndCreditLineSpread</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis=icui_PricingLevel5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis=icui_PricingLevel5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis=icui_PricingLevelIVMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis=icui_PricingLevelIVMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis=icui_PricingLevelIIIMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis=icui_PricingLevelIIIMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis=icui_PricingLevelIIMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis=icui_PricingLevelIIMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis=icui_PricingLevelIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis=icui_PricingLevelIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171457068264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events Term Loan B Applicable Margin (Details) - Subsequent Event<br></strong></div></th>
<th class="th"><div>Jan. 06, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanBInitialSpread', window );">Term Loan B Initial Spread</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Pricing Level II [Member] [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanBEuroRateLoanSpread', window );">Term Loan B Euro Rate Loan Spread</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanBBaseRateLoanSpread', window );">Term Loan B Base Rate Loan Spread</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Pricing Level I [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanBEuroRateLoanSpread', window );">Term Loan B Euro Rate Loan Spread</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanBBaseRateLoanSpread', window );">Term Loan B Base Rate Loan Spread</a></td>
<td class="nump">1.25%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanBBaseRateLoanSpread">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term Loan B Base Rate Loan Spread</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanBBaseRateLoanSpread</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanBEuroRateLoanSpread">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term Loan B Euro Rate Loan Spread</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanBEuroRateLoanSpread</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanBInitialSpread">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term Loan B Initial Spread</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanBInitialSpread</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanBApplicableMarginAxis=icui_PricingLevelIIMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanBApplicableMarginAxis=icui_PricingLevelIIMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanBApplicableMarginAxis=icui_PricingLevelIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanBApplicableMarginAxis=icui_PricingLevelIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171452795848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_WarrantyAndReturnReserveInventoryWriteOffs', window );">Warranty and return reserve - inventory write-offs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts', window );">Warranty and return reserve - inventory - charged to other accounts</a></td>
<td class="num">(533)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
<td class="num">(722)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_WarrantyAndReturnReserveCosts', window );">Warranty and Return Reserve costs</a></td>
<td class="nump">263<span></span>
</td>
<td class="nump">2,033<span></span>
</td>
<td class="num">(217)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_WarrantyAndReturnReserveInventory', window );">Warranty and return reserve - inventory</a></td>
<td class="num">(1,883)<span></span>
</td>
<td class="num">(1,613)<span></span>
</td>
<td class="num">(3,477)<span></span>
</td>
<td class="num">$ (2,538)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">SEC Schedule, 12-09, Allowance, Credit Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance&#160;at Beginning&#160;of Period</a></td>
<td class="nump">21,490<span></span>
</td>
<td class="nump">20,219<span></span>
</td>
<td class="nump">5,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged&#160;to Costs&#160;and Expenses</a></td>
<td class="nump">345<span></span>
</td>
<td class="nump">7,137<span></span>
</td>
<td class="nump">14,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Charged&#160;to Other&#160;Accounts</a></td>
<td class="num">(14,797)<span></span>
</td>
<td class="num">(5,866)<span></span>
</td>
<td class="num">(431)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesAdjustments', window );">Write-off/ Disposals</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at&#160;End of&#160;Period</a></td>
<td class="nump">7,038<span></span>
</td>
<td class="nump">21,490<span></span>
</td>
<td class="nump">20,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_WarrantyReservesMember', window );">SEC Schedule, 12-09, Reserve, Warranty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance&#160;at Beginning&#160;of Period</a></td>
<td class="nump">2,707<span></span>
</td>
<td class="nump">6,377<span></span>
</td>
<td class="nump">6,752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged&#160;to Costs&#160;and Expenses</a></td>
<td class="nump">568<span></span>
</td>
<td class="num">(3,609)<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Charged&#160;to Other&#160;Accounts</a></td>
<td class="num">(790)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="num">(458)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesAdjustments', window );">Write-off/ Disposals</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at&#160;End of&#160;Period</a></td>
<td class="nump">2,485<span></span>
</td>
<td class="nump">2,707<span></span>
</td>
<td class="nump">6,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember', window );">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance&#160;at Beginning&#160;of Period</a></td>
<td class="nump">3,891<span></span>
</td>
<td class="nump">3,677<span></span>
</td>
<td class="nump">5,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged&#160;to Costs&#160;and Expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Charged&#160;to Other&#160;Accounts</a></td>
<td class="num">(957)<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="num">(1,584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesAdjustments', window );">Write-off/ Disposals</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(175)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at&#160;End of&#160;Period</a></td>
<td class="nump">$ 2,934<span></span>
</td>
<td class="nump">$ 3,891<span></span>
</td>
<td class="nump">$ 3,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_WarrantyAndReturnReserveCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warranty and Return Reserve costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_WarrantyAndReturnReserveCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_WarrantyAndReturnReserveInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warranty and return reserve - inventory</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_WarrantyAndReturnReserveInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warranty and return reserve - inventory - charged to other accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_WarrantyAndReturnReserveInventoryWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warranty and return reserve - inventory write-offs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_WarrantyAndReturnReserveInventoryWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_WarrantyReservesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_WarrantyReservesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>icui-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:icui="http://www.icumed.com/20211231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="icui-20211231.xsd" xlink:type="simple"/>
    <context id="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iff2e09ea6c244b5c8c8c4fdbeea287ee_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i111df2377a904008a8e4287e7d182606_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="iaec5d516f9924448a7889b3f61aba166_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4d447798df3d4ad09d5a02f448f0900b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie3327972bb1d4aee95a27cb29ac758f6_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iff400e2a4d53433e99e9a76ec4ff42c0_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i422a41397eba44439e3bee3a84f24f5e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3707592634d449b6b164fd6ab5039af3_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i9e68fd2b373c4657b269de98d476f2f3_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id9a14d7ab14041cd9287ff968eeab854_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ic2b82bbcf5cb45739937a1040ed30f6b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i8036f14fb1574f22a813b07a891d10cb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ief0e41eadf634f478517bbf4796fb3b7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifd39fbd084c64997a80b35884325a837_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icf8bb0aa0f8d4c368a4f3c52cf44f0fe_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ied11d81291954b6892d0bd3f457a6c62_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6f8426b518ec486c8093f691d9ae22b4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6b6766362c85475b9f3e56635902ffc6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia53abf8ff1024f4b9dbcd962fb14bb16_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8029282b701e4da19cb4312a7342adee_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iba8b292d4a8c426ea02ac921339f2ece_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i58538562a9b846b1a8eb28ee06dd457c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i12d0faf21deb41648f175a8130fa683f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i056b6066b5c84b8f82444aed64ff2939_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6a9e3ee9b34c4d4c81e04d5c21845153_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic917d118fe1544a48c9f7cdb26a0bafe_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaea909186292457f815372e15f122f61_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i319e066bf7c149958ff00b3b5180cad9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic1f24ebe96e244d1a070e358c2f9088e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6ee1c30a74b842b18319e3e21627fde1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i76af68ce1a5649a285c27467729f3ea8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i64123b55baa546a6ae8585911227ac9b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6257893a382b432986c682223e96eed6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i545572fcbd214019b1a486fff73e3d60_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib07f493ac3464b04ace456f723c0d4c1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i98729f24bb67493bbbb1a901004ee439_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i124369e0a3a6454fae9d78635beb32e1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i893bab2162e3420fa787264425d1b71f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i80df96ad8b8e4475847100ff81957f59_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia5dc13d8d15f4d6b9e43ee2747cf2dde_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id7594d76a22343b78ed45f29024ebce9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i675d4957f6a54a509db9f8b824f52efb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib79fc9d04ebf42eca924b5dba9ff0f88_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i33f36a22d5f5402fa34702e2b60d0b7c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i03ab38e8bc4e4afab23f9031aff6bbbc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7af9cf8a39fa459fb6db8a6392a90dd2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9f7846d15c1c45d0b3c2a14b3b40dbd8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i874c262496e7470aad6329cb331b77e1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9697a3ca30dd4537a13752d309cbf40a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:InternationalDistributorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0eb01a36c95d4e93ae0a960275048e71_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:InternationalDistributorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i034d4febd93748bfa4de828a28a09376_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:InternationalDistributorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignInfusionSystemSupplierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if41332d164fe48da8c8206c9a376b3d9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:TotalAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if148011629fb4765963a61b648e50f64_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignInfusionSystemSupplierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id0e931c53af9433c927233b79bd0bca8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:TotalAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i61afae90e5b84b36ad1ae6cc021d0eb0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6086d7242cd44ebcb7bd1c37761445d5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia714b658a4174f91844900438be27249_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i072ea93b43554548bfb1b2e60418ef0a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id27451c8315e494eb9d5b71d3102e1d3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:MoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i396219abad3d4dd5aecaca9b955a4a80_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:MoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7a69e96fceee4aa4a6456cdac483fa6b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2bb5314a15ad4728830028bd25e4817c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie2b2515c8fa54706a4876347394a8195_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iefe3d36c64db435783d6b6b62e9f4928_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i868fc2b21a40468eb90303a40fa1cde7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:InstrumentsPlacedwithCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0b8361146b8345eba9e837855e840ccf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:InstrumentsPlacedwithCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife75bb8b09044301a656828fd088ef78_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib215ff3938424c87b3535b21a2d24f0c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i822011b5ee894121826591876ad1fae1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i318960434e7e4294b988d5e93c86f870_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4df894472d734b8ea99f933093d6cae5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i50ca67d9370d4702bb30549193450259_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic799598d554f43749764085e6183fa72_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4fd10f7ed125461b83e7cc71c92b31ff_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1743cebe76c945e1b53dd6ed012b1f15_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:FurniturefixturesandmoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i980084a01dc24101ade4b0ce4d4f2ce3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:FurniturefixturesandmoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i40993659cc874b8bb50c9566a7d7ee5a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ica576ec13c89445ca41b2ba35b3a09d6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2faa6bd24f85459f9cccb242cb8eb478_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:InstrumentsPlacedwithCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib7d30235ed5b4d94bcfbe47e561d432b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:InstrumentsPlacedwithCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i89ee2db57d0940749f8358a063c8a2a1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia3bf6d7cdae3492fbe677ee76c1cb8ac_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignDistibutorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic5bfa62a49ec4bacbfe8ca5e5984c085_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8086db60836949cea234f284bb9446be_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ife577e5d213f40d098d9178ce5ed5c02_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3f08a7535a0c4ae593f5fdb4d1908ae3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i23400b23c1e244b8be1368b5b1d1feda_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia9ad9660b38a4c59af223be9f97ad9a2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i94bfb3c1291d4f5ea822b381ec4471a5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i67322613ac0a460da4f4187ecad1ca17_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iabdb763a977547f398fe485e2aa320a0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i51d012416f844ef69b4d06482f83559a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0ad98788582c4b17b4c46945d8400c45_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iac77f6f1c1154bc8a57fd11e9cacd63c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i61f07bcb26004cbfb2eb785632880532_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id5895f4898494fbcb93a3646e38e38e9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id2a1a60f23694878b292a8b8e642f7f7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6da6e9834cb04c8aa17f5c4e02ded7c8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib00800b3296448d1a1aaa2ee891468e8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if9c99a7ffc344097b04bba35817b6ec1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if022b8b9f44c46cc9f1a9647646caf11_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1c1c4ee566ca4ff0a0939c34c6f27d97_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i921788560f30477b876f3a224b358d25_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id4906e0126214b09aa3b35cb86a5cbd3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic0af18a5e59b4620b0a5bf6fba3fc7a7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4e2d8c5d74764c0c8112c9015c783cbe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i85668d0214784e5a8fb9f8869bea0496_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i84b90248fb4943b1a217759d4dab622c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8fa85a3402ad4c77b8d5f87d4e48cabc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2fabf3a8e3e34339833d25e4808ff80b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3dc15f5f21ee4966a24eaabd60b1d494_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i810debf07d694305bd3dc90b59bb25a0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4751e08bde88447d8b34bf752eed3cdc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2247e3aa5f7f425e92dffe9649cbcb7b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib1ed14983dc8444fb29c6fdb143af063_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iad22bdcd21ac4a51bb81dc8d8fc119a9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:LongtermInvestmentsDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib0aa1b29ef9844f29ed55e5350042310_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:LongtermInvestmentsDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5e6c4333e95b489298867ff378f75de9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iffa9110d543f4303a3b7762b85f661f3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i647dc634368041129731810420d0ebbc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:LongtermInvestmentsDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5b51175d4f8a42ccb2a3d0734e66cec3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:LongtermInvestmentsDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9ea7d76b8a79439aab91f9877efd14d5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8a64787f750d4031b14422894f232878_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i759cb9fbaf1d4095916b580d6bb94af5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4e8704f54a08458a9efc29f3cc118593_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i77e6107e400341429951759a6c1961be_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i950f58e7689540a3b89af236c51c45e0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1a9284e3c72d412b809403911420ec57_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i181ab8ea3259409b94a0dae321287166_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id188fafa38884adabaef94e04b547494_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignDistibutorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i71c95811c4714cd09165d99d35d0be39_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i62ae2a31a4354af79bd9d1817c9ee7bd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SpecialTerminationBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8e461e5413d14edd9b72b130ce815fe5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5a3cc5377db948c0a5ce1d48fee18dc4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i65b0aab89680416c8c6ea3f7a118a6bd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SpecialTerminationBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie4b6eb1be3574e0cb8dab5f37e8dedec_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5df89ac1ac0b4ffcaf4459845544da7b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9a26f1d531b748e2a99def41eaf38247_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SpecialTerminationBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0513f1469ce44ac7b878215e135b1461_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibc1517ed4db74def880ae3ff1b172041_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8eac04e1e58f46a1be1d57dae1515d50_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SpecialTerminationBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie475f7d09c704e268b2c10ef5f50cc45_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4a19a43c357247ff976618cccfe634e3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id18d76e7cad1483da6d29083e9a8f281_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SpecialTerminationBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i19701020e9b7421080322ea64ddfa6fc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9c2abd8a14954e2d908b7a6ad1bff678_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia9e8a812a73f4a1d8f7f8110a8759bf4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib25ed464299245f3a253cac238e6e16b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3c6cc917f0a04f9e98f2098b917cb28f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i52b0fc63199747a09f8aaf3d7b68b362_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i201b9c34887c4c05be4d0d4326d1e331_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9ce76eb5aa3f457a94d4842e2df5c4b4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:IVSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idb7d360b50434c90b1362f13d39de454_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:IVSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie65b63b2aa354165aa8b2d1156015ecd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:IVSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i47789bab6a1046d49538401de29b23ca_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:CriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iba69653f43264a18a0f9f7bbc4521bfb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:CriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i16a80a38aab0404bb60ce11730e5d9b2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:CriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4099adac88a94f2c844d6d0a67f5b93f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4fd4ad49e5ca42958f511cd87f3b86e1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4b6da943f3c548f58f42328ecef541e1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0ef1d9853e504ab394c35a1dda0b5652_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iba50cb76497a4bde9e14f5743b6475c3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i46c1f41659ba4557a83903554fac974b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i928b25071431497386ecd55fee9d4139_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibd6c4227c1cd44dc9eef66faca80e3c1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7d1cf0743c804ef8a6831ae5bd16c05a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9e571091fc1f4ae5aa5c04d2eccc5543_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7e8278d8b555471884d28845b03e9a66_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i62815f424b0f4a83a52362d984e6bdab_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i513e00d1325e4cbab47333544fe16795_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:InternationalSalesDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i43801ce9ae0d4d64b094552e36f505d8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:InternationalSalesDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i47aa34896b3a48b98371a8adb7a428c8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:InternationalSalesDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i07b1db2fc46e4252ad0d15476844f7ab_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i44cab7a364ba4dfeb44c1c2c019c7508_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ideea602385704c09a9de5340c5673d94_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i57358508c9e84334b935ca3d7b783237_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ief31f8281f40440b9b7259476db1babf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic2ba2c623a754ec09109f4e760fdc883_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie0c2e107da6f4265945c3cd1be9af667_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i14ae100f3ea54791b971967ebffeb16c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifc815bf8be984d60b72cea6a09a89ff5_I20111231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">icui:A2011PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2011-12-31</instant>
        </period>
    </context>
    <context id="i1f3ac8f1b7404ea9b5d205028ace120c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">icui:A2011PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia405cf3a4ef6453097157cd7f886bc0c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">icui:A2011PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic7101eb3934f4304b875384f0d2bf58d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">icui:A2003PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifa3af7f9a9464ef699356948deed2cb8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">icui:TimebasedstockoptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i67a16227998c4b09be060e7ac75710c0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">icui:TimebasedstockoptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6a3a1155df674ed5a67b00576eacf44c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">icui:TimebasedstockoptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id78700fe30fa41ee9a54f1ac70463ee7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i182dfcd4a48e49328d223a8303c254eb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib5f9119ec4544a9ab30550ab201d84f9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i87391b560fa94e0e87d7e644dc34a031_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">icui:PerformanceRestrictedStockUnitsPRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8bfb9cc3e6314f24bd71705af4bba7a2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">icui:PerformanceRestrictedStockUnitsPRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i518455bc726645ca83b1172f9d758adb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">icui:PerformanceRestrictedStockUnitsPRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4831e0eda5014d4185f0331a3269b612_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ied69c2626ecd45eebbc3a906d06e9175_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i785cacd032d543efb047f2c5a292c791_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7623b8fcbec644baa23b06274170ec0b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i51e354dd1c9a473aa838a7df3a9b11d5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0c17620dcf9644348c9d2eced453eca5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8e48c0d8b6804bfc8fcdb345373f3e79_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">icui:RestrictedStockAndPerformanceRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i376e73f5e55842518de67690861c3be5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">icui:RestrictedStockAndPerformanceRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5f1a091230074ec5961f1c78910f1b75_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">icui:RestrictedStockAndPerformanceRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i193283f0dbb449a3bd6eff38a5f33bd4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6091cecaf413499e962152be722b5f2f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia164440f0483491b8db221971138e931_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge3MemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i37ff8ade5acb448ea4d633f24092926d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4a83e789750f44daa32ae75c26ff6a9b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3abfe315de2d4710b658cda2c9136055_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6492f863fad145e99f24ecbdf6e97c41_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i33eac537b9e347e786d5a3bbfd58eaa1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5700616ce493458ca1d063d5449a9a0f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:UsGaap_InterestRateSwap2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibf93883b30164701858e3d30c68ab759_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:UsGaap_InterestRateSwap2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib3bc9bb5a4a44cc78110749aecdb5636_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:UsGaap_InterestRateSwap2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9398faa8a97348f0a664d0a940cc1df1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaeebd3cacab24dc38bf7ae3d6bb6c231_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0698571e6787437d90d0b0048700239f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie89eb1993f904410907120b3b745456d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6cb35882a84d40c69f565d43f607d507_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib612e7e55d2c4ebf87498ce95fb1a17a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0d5a1bdc1c724bc7b475abaf04f05670_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifa89d23d7e2a43d19cb3b0e7f251e771_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i48cb839aacc34533888f3bb68369bf70_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i275a397a6a9f4699b14f84e0917f5cf6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8d6c14d6d9e54ea98f1e56d587002e2b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7275aca2da2849a582d9e7ba1f1cedbe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9c479368de1144bfb45d95026be0cd76_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i62d03683ea954674a5322351789e0906_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i237a6bf9b93147d2ba3fd48effc174cc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i544809a7b69540748709fce0559278a0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3f8134bb52614717bbcc1d971c2e9f87_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i117c77f98cd34cbb84dd2f1e0aaf77ac_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie4eb6e79360c467f8c9a58e50160406d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i94cc3a526443461c92bb879f72405e63_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba75d31130ff4518a24b52c40ad06517_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic43efddee26741cfa82e26fbb5d22949_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i30a2923e460d49549d45431e449f5c22_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibb6f3d45751d49a59460c1b52b47c868_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0660e1ab42834fa5b8f6de068d1ac560_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6adeef3935784865bfb3756361fd2fe0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i70ee7aca58f04d14ba4afb3526f496a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iedb19205fd444f879bcad70f1358784e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iafc678f466ad4ed5a96daa25baf1c6f2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic7b4be9668d0488da88397ffbc79a2e8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i102a8b308c97481c8dc3ea2c01523124_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i765f5892367e40028ae56cc662e3184a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i61230b4e893e4a7d9cd519aeed4a1b65_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i054679d6ffef4f87a4f43e136c98ca11_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i06483eccc4414d90bd57c57ccef5aad0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id82c332d5c3f4a3aa2e643ec24082edb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4052c8cf471f453cbde9f738554a1b28_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i84762f9663364789a2d8c3ece37ff567_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0ddfa9b22060462886127f5b80779ec2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3c9c90aaec48427e913d473bf39547d4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i05bb705b5592489b842c36481960323d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i695d74244e1a4ea2809a46299c1c17d2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if00269ccb40e47d28d49e0860aba7a70_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie94168586b384dfe833911f3c4123fd5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i55daea74768c4c5f8155e5eaa03cc29c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idab760f167ab477b84968687e30e7446_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignDistibutorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib0473993225046b8a38d55e04612297f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignDistibutorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia4f13d3f94f44a08bc3233dd5ceb89a4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:HospiraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4d20c02b38e041509fe7e05408566fbd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">icui:RevenueGrossProfitVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8dcd382934d440328d704d280ebf3fa4_I20191102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">icui:RevenueGrossProfitVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-02</instant>
        </period>
    </context>
    <context id="i95dc6e540f5b4198be6fed8fbf400d56_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iec592b00b8524a088ab236591b84114e_I20191102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-02</instant>
        </period>
    </context>
    <context id="i83746611e0ea468aad18f290522ef413_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4a648c0e1a8241a38f2f3a48870c1bb0_I20191102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-02</instant>
        </period>
    </context>
    <context id="i3a0167f7320946b3a2e58b4124c3e79b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2c5018212e424aa8ad9252ca55f1861c_I20191102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-02</instant>
        </period>
    </context>
    <context id="i016a88407f61445a9ead2c5fe9666972_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iffbaa78bab214394916b2fcdbc6715c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id686138862cd4f2faa2e433db45c3af8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5ec7606edab34323b337692160cb6ced_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9b1af846c2bd49b2b73f2cce81980df9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic3279fafd14f4fafa391f0e6aebb36f4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if1ccba1757384a43b8a31386dda4223f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i375d2dcaee564df4bba09294bc8b4ce1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i96688b63cabc48858140503c0d9eb461_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i544bab0abcfd41739edc7808545eb541_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if18f162b786b481ead18bd1c0072862f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifbcc6f28c8de4784b50d3d46d2b1dc73_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iac9bf1a987b04a68a63b86dddb2a0ad7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7a4e9901f5af47dbac4bd58d52cec2e3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i76ecdfc58eff40d4b5a5696b57877d65_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id9d041120aa546daa089ac02aad807b6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9e58a71511c74a519d97f5aaf72d0d67_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3bb94fa0fb71402cbf3e8e652d8f7e4c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaf9c0633da1b47ee8d93b6e4abeff18b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i23cd4418967541a1a5d36e2d99a5356e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i24b5d0557ec344d89ca4d7fdcdfbfa6b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5809c6220648406e9d0413ce194ce911_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i322c2f5703b44dfebfc8fa4655888d5a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia8f6c1cca4c146c39148c7ba09392200_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaee1dd2e4cd844c88f833890aa55e7ea_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8a287e50d1874b7c8137eb644e17fa5c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib494916ad242431f84438805dad01887_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1fd62c35036b40778820f92e3d9b31f2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife8f7b6aa0ab423b9e32b2a38ffe5dd5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie770d12c9b6a464ca982cfc743bc4e2d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i01a24e6ac0b149afaca642972f237000_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic658275ab067426dbbc345457231980a_I20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">icui:TermLoanAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-06</instant>
        </period>
    </context>
    <context id="ia241e4af05fc4638bc449fe9c9c45c66_I20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">icui:TermLoanBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-06</instant>
        </period>
    </context>
    <context id="i39ca865e5711457ca9a490c54dd29de5_I20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-06</instant>
        </period>
    </context>
    <context id="i7d9fbc7afe1b4667b19bef534f27f322_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">icui:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6ee969a0a9d645a88b99b6c08a883d11_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">icui:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2b1d712704db4bc9b1287e528b4fed69_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">icui:PricingLevelIIMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id7d6cf9ceff24a8a9996f36321364cbb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">icui:PricingLevelIIMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3bfb75a2163f47d9a268020ba497c76a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">icui:PricingLevelIIIMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7211233eb22e4fb993b5b3ecf7bfb508_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">icui:PricingLevelIIIMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8bdd6b3003b648508919a57e2a1ae6fc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">icui:PricingLevelIVMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id5a860996ab84b0a8023cd70138248b9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">icui:PricingLevelIVMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9bbe71fc4ce44374909c77242133cc3c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">icui:NonCurrentDeferredTaxAssetGrossTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0e809f26dc1b4522960c604ea2772a74_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">icui:NonCurrentDeferredTaxAssetGrossTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3378e7cbe8924f58b0946d1751a4a296_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">icui:NoncurrentDeferredTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f1986d9725d4d0baf2ce688675446f5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">icui:NoncurrentDeferredTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3f5e02d0a1f949ef98ced46fdc0d1d50_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">icui:NoncurrentDeferredTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie7a407c6102b4d9782e78a7113bb6c88_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">icui:NoncurrentDeferredTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if9b8ee97cdce469498415c24ca271fac_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i01e4254c272a4140957a890acc5f08ce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia52cc31c151d481581d13119d97ac269_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifef2db95b0fe4155898c6b50b40a55f6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ide8f1f0b08d646aa86685a2ef40bd3b2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie1f2b53b42ec4dd496263af4d74f1006_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:MexicoPropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i469eea898b364fc3adb69caed769582e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:MexicoPropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2e940da7d7cb495fa0d13df19d4106c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherLATAMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i598572737bef40c49c83df77162958d2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherLATAMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i342c737b0a1648d6ba7796d841c38920_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i87f6347567e542658b4828a26d58c87f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f99fb6f9174410c9b82675718bfbea9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ItalyPropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i49906b818a8e4420af6213c3e7c5009b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ItalyPropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia092500ef9e34307ae74beb9776f0c1c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:ES</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5c52e251690c4d43bfe606ddbb907b05_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:ES</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i69deda722fca436a895908b95f39e170_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0af277c5a24e49468f57a06b083d2822_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i95f6b83243a54af7b0115785403ce5b4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5384480be0b946b0b4bd8da2f47aee38_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i84bcb872e0ac41e9a0c750276b31fe07_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ide1aa2e08f8e459ab222c3218dbdd087_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i76e08a5b358b42e5b6adbc18bbf17124_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:UnitedStatespropertyandequipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6bcbed561d384cd2aa2a8565325c8308_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:UnitedStatespropertyandequipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iacf190989aae41dc9261dadb464d18de_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ica0fe141910f4870ad2649c6e2c3aaab_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i294f1ac4a2cc4a3fac63275cef02abee_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i056e77d665474f4b8ca05d305c52c5db_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i120cd5defe214e6c86186272a3b74955_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic9263e86b21d4e6990c6889c0a2fd058_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8cc638a528464d0f81f7797bbcdbbbdd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9e04a8561492427c808a2ab01e617e39_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie681a10b3ae94591ac7dfed446027fb8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8eecf95d67de49c6b71ed63b59bd24ad_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0781799e0fe043e198c4b49c6f20f38d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i93f94790b59e412589fd19a9227e911d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ida1ac0b3c24f469f9c5c81ce2c02be68_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iea23642417df4dbfadbd0379840568e7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i99fa1bc9d43d4f38b2df61bedf27dda6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i584e4e98f720480b9d2272ffc9f61fad_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id83a5ec19c054e738002317e4071cb7c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6ecb60225e2140c6841d03b54d853f07_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ief758a58c87848b8a344c5b692208a0f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3f7b24069c454353805dd5bcf4122778_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id093068459e64f16a5340be5d8b2912d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7c08f27a7f1249ebb9616a92cf37d858_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:HospiraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i11985c61f5dd4877b3fb40210f033aa6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:HospiraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibf6924776c764e04bf39a28785afe1cd_I20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-06</instant>
        </period>
    </context>
    <context id="ib79ae2a24b744dc99c3023b42abeeff9_D20220106-20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-06</startDate>
            <endDate>2022-01-06</endDate>
        </period>
    </context>
    <context id="i9b2d21d6799a45898560ea2c84c80514_I20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-06</instant>
        </period>
    </context>
    <context id="i2140366dbbe94dc99b723319eb6c790e_I20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">icui:TermLoansLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-06</instant>
        </period>
    </context>
    <context id="i78e8a542027645189940c1af26b316ab_D20220106-20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-06</startDate>
            <endDate>2022-01-06</endDate>
        </period>
    </context>
    <context id="iafe2bcda32da45689d560de2ebd12309_D20220106-20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAAndCreditLineApplicableMarginSpreadAxis">icui:PricingLevel5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-06</startDate>
            <endDate>2022-01-06</endDate>
        </period>
    </context>
    <context id="i27a054a4a2d34e3b8e8d3b53146ca889_D20220106-20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAAndCreditLineApplicableMarginSpreadAxis">icui:PricingLevelIVMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-06</startDate>
            <endDate>2022-01-06</endDate>
        </period>
    </context>
    <context id="i3c133097393142f18b109c568537343f_D20220106-20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAAndCreditLineApplicableMarginSpreadAxis">icui:PricingLevelIIIMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-06</startDate>
            <endDate>2022-01-06</endDate>
        </period>
    </context>
    <context id="i7cf95c725a97468eb9aa94749e698281_D20220106-20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAAndCreditLineApplicableMarginSpreadAxis">icui:PricingLevelIIMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-06</startDate>
            <endDate>2022-01-06</endDate>
        </period>
    </context>
    <context id="ic553bac988d9412da422b9c62def2f16_D20220106-20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAAndCreditLineApplicableMarginSpreadAxis">icui:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-06</startDate>
            <endDate>2022-01-06</endDate>
        </period>
    </context>
    <context id="i595c992a5ff64197a1dedaa5a2c28018_D20220106-20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanBApplicableMarginAxis">icui:PricingLevelIIMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-06</startDate>
            <endDate>2022-01-06</endDate>
        </period>
    </context>
    <context id="ifd3bfc829b78437eb5cd91c39c6156b4_D20220106-20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanBApplicableMarginAxis">icui:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-06</startDate>
            <endDate>2022-01-06</endDate>
        </period>
    </context>
    <context id="iecae4385e0b9406785f4b23d06865339_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i870395a6aa054f6bacfe43ca3565e846_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib2c1a3da41264443b2bfbe1037ea8817_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6d12c957c1c943f3b34b05d9ed53aafe_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i0a98c1779cac4386957e351f01e76fa5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie20ee1ac93ab48868926f61f94817b56_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5bd524a6cefd4a91928cd5550b9aab92_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5aefe03f40c54e77a419eeec553d95eb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i245c4ea3235a4b6e8de7f653118777e4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id97bb342dec84b8eb092e237e601cbab_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idda3b662db294f219a192b0347c136af_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibf8bf1ccc2ee4806a1f944d440ddd63a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iea50319693fd4506aaf0fc2e7a8505fc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8a4c1f26c3014290b2257c8a6c97e92a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8dbfa44cf2124deea69cb9774393fdd6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieff747a718fd489ebe9871999b3764e6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5a1683bbea2043caa4198e6f9ed83d74_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i59cffeff11d847a38379503c52f7cf32_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib6a5483b520c4d7d8560fae11ca7ee8a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i673942985fc343f3ac8ca57d29d0dd83_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0fa8f3589249483da23fe23fa443806b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>icui:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF80L2ZyYWc6MzBhNTFjMjEyM2Q1NGM3ZDg1OThjMThhY2FkYTMyZjkvdGFibGU6YTJmYTVmNmI4YWNkNDRhMzg4NTZiYzcxZTgzZDMxZTMvdGFibGVyYW5nZTphMmZhNWY2YjhhY2Q0NGEzODg1NmJjNzFlODNkMzFlM18zLTEtMS0xLTg3NDU_af6f1b60-5599-477a-baf8-829ae9cfd993">0000883984</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF80L2ZyYWc6MzBhNTFjMjEyM2Q1NGM3ZDg1OThjMThhY2FkYTMyZjkvdGFibGU6YTJmYTVmNmI4YWNkNDRhMzg4NTZiYzcxZTgzZDMxZTMvdGFibGVyYW5nZTphMmZhNWY2YjhhY2Q0NGEzODg1NmJjNzFlODNkMzFlM180LTEtMS0xLTg3NDU_9f50cd5a-5e3c-4da9-8ad7-f2241ab8c301">ICU MEDICAL INC/DE</dei:EntityRegistrantName>
    <dei:AmendmentFlag
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF80L2ZyYWc6MzBhNTFjMjEyM2Q1NGM3ZDg1OThjMThhY2FkYTMyZjkvdGFibGU6YTJmYTVmNmI4YWNkNDRhMzg4NTZiYzcxZTgzZDMxZTMvdGFibGVyYW5nZTphMmZhNWY2YjhhY2Q0NGEzODg1NmJjNzFlODNkMzFlM182LTEtMS0xLTg3NDU_4751f54b-dba3-45de-a8a3-4fe840652c94">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF80L2ZyYWc6MzBhNTFjMjEyM2Q1NGM3ZDg1OThjMThhY2FkYTMyZjkvdGFibGU6YTJmYTVmNmI4YWNkNDRhMzg4NTZiYzcxZTgzZDMxZTMvdGFibGVyYW5nZTphMmZhNWY2YjhhY2Q0NGEzODg1NmJjNzFlODNkMzFlM183LTEtMS0xLTg3NDU_63cc9a07-a8b6-482c-ad4d-93ade5a9f9ea">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF80L2ZyYWc6MzBhNTFjMjEyM2Q1NGM3ZDg1OThjMThhY2FkYTMyZjkvdGFibGU6YTJmYTVmNmI4YWNkNDRhMzg4NTZiYzcxZTgzZDMxZTMvdGFibGVyYW5nZTphMmZhNWY2YjhhY2Q0NGEzODg1NmJjNzFlODNkMzFlM184LTEtMS0xLTg3NDU_d19e0aeb-0d06-4a86-9e4c-d4c206d8b780">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF80L2ZyYWc6MzBhNTFjMjEyM2Q1NGM3ZDg1OThjMThhY2FkYTMyZjkvdGFibGU6YTJmYTVmNmI4YWNkNDRhMzg4NTZiYzcxZTgzZDMxZTMvdGFibGVyYW5nZTphMmZhNWY2YjhhY2Q0NGEzODg1NmJjNzFlODNkMzFlM185LTEtMS0xLTg3NDU_7cb79e46-88c5-4c65-b864-d50d63a25dbc">FY</dei:DocumentFiscalPeriodFocus>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDg3L2ZyYWc6ODBlYzk2MTA3Y2IyNDY4MGI0NjA5NzE5MDM0NGI2OTYvdGFibGU6YmNmMzk5NmY1ZTlkNDYzMTlhM2YxMTFiN2Q5Nzk5ZmYvdGFibGVyYW5nZTpiY2YzOTk2ZjVlOWQ0NjMxOWEzZjExMWI3ZDk3OTlmZl8zLTAtMS0xLTY1Mzky_183f49ff-343a-4922-abb2-2ad39af1e6d0">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDg3L2ZyYWc6ODBlYzk2MTA3Y2IyNDY4MGI0NjA5NzE5MDM0NGI2OTYvdGFibGU6YmNmMzk5NmY1ZTlkNDYzMTlhM2YxMTFiN2Q5Nzk5ZmYvdGFibGVyYW5nZTpiY2YzOTk2ZjVlOWQ0NjMxOWEzZjExMWI3ZDk3OTlmZl8zLTAtMS0xLTY1Mzky_8bf0d2e1-4fd7-4ef6-987c-fd2590d2eb0c">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDg3L2ZyYWc6ODBlYzk2MTA3Y2IyNDY4MGI0NjA5NzE5MDM0NGI2OTYvdGFibGU6YmNmMzk5NmY1ZTlkNDYzMTlhM2YxMTFiN2Q5Nzk5ZmYvdGFibGVyYW5nZTpiY2YzOTk2ZjVlOWQ0NjMxOWEzZjExMWI3ZDk3OTlmZl80LTAtMS0xLTY1Mzk1_617451f3-58a4-4fb4-82aa-0e0b18483762">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDg3L2ZyYWc6ODBlYzk2MTA3Y2IyNDY4MGI0NjA5NzE5MDM0NGI2OTYvdGFibGU6YmNmMzk5NmY1ZTlkNDYzMTlhM2YxMTFiN2Q5Nzk5ZmYvdGFibGVyYW5nZTpiY2YzOTk2ZjVlOWQ0NjMxOWEzZjExMWI3ZDk3OTlmZl80LTAtMS0xLTY1Mzk1_6b3c7fb4-a72d-4140-b334-0b3ac4be28a9">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDg3L2ZyYWc6ODBlYzk2MTA3Y2IyNDY4MGI0NjA5NzE5MDM0NGI2OTYvdGFibGU6YmNmMzk5NmY1ZTlkNDYzMTlhM2YxMTFiN2Q5Nzk5ZmYvdGFibGVyYW5nZTpiY2YzOTk2ZjVlOWQ0NjMxOWEzZjExMWI3ZDk3OTlmZl80LTAtMS0xLTY1Mzk1_861eeb11-5630-4175-94e7-a84af39d07f5">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDg3L2ZyYWc6ODBlYzk2MTA3Y2IyNDY4MGI0NjA5NzE5MDM0NGI2OTYvdGFibGU6YmNmMzk5NmY1ZTlkNDYzMTlhM2YxMTFiN2Q5Nzk5ZmYvdGFibGVyYW5nZTpiY2YzOTk2ZjVlOWQ0NjMxOWEzZjExMWI3ZDk3OTlmZl80LTAtMS0xLTY1Mzk1_f114f16b-caea-4dbb-a129-02e6cdb2d05d">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDg3L2ZyYWc6ODBlYzk2MTA3Y2IyNDY4MGI0NjA5NzE5MDM0NGI2OTYvdGFibGU6YmNmMzk5NmY1ZTlkNDYzMTlhM2YxMTFiN2Q5Nzk5ZmYvdGFibGVyYW5nZTpiY2YzOTk2ZjVlOWQ0NjMxOWEzZjExMWI3ZDk3OTlmZl81LTAtMS0xLTY1Mzk4_4f79efad-b8df-4163-80b2-e84c5ca47c50">http://fasb.org/us-gaap/2021-01-31#OtherLiabilities</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDg3L2ZyYWc6ODBlYzk2MTA3Y2IyNDY4MGI0NjA5NzE5MDM0NGI2OTYvdGFibGU6YmNmMzk5NmY1ZTlkNDYzMTlhM2YxMTFiN2Q5Nzk5ZmYvdGFibGVyYW5nZTpiY2YzOTk2ZjVlOWQ0NjMxOWEzZjExMWI3ZDk3OTlmZl81LTAtMS0xLTY1Mzk4_a1df565a-dce3-420d-a71a-8ea4d9835108">http://fasb.org/us-gaap/2021-01-31#OtherLiabilities</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDg3L2ZyYWc6ODBlYzk2MTA3Y2IyNDY4MGI0NjA5NzE5MDM0NGI2OTYvdGFibGU6YmNmMzk5NmY1ZTlkNDYzMTlhM2YxMTFiN2Q5Nzk5ZmYvdGFibGVyYW5nZTpiY2YzOTk2ZjVlOWQ0NjMxOWEzZjExMWI3ZDk3OTlmZl81LTAtMS0xLTY1Mzk4_b3381cc5-8bc9-4010-9933-c35a4f0f1621">http://fasb.org/us-gaap/2021-01-31#OtherLiabilities</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDg3L2ZyYWc6ODBlYzk2MTA3Y2IyNDY4MGI0NjA5NzE5MDM0NGI2OTYvdGFibGU6YmNmMzk5NmY1ZTlkNDYzMTlhM2YxMTFiN2Q5Nzk5ZmYvdGFibGVyYW5nZTpiY2YzOTk2ZjVlOWQ0NjMxOWEzZjExMWI3ZDk3OTlmZl81LTAtMS0xLTY1Mzk4_da781fc6-cfa7-486c-8070-b39f7b1eca8d">http://fasb.org/us-gaap/2021-01-31#OtherLiabilities</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTQz_7948bac7-9b5c-4240-9f02-bffc20e6bce8">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTQ4_98dbb217-d44c-487e-bb09-46ce9c25ed57">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8yMDc_51c99447-4a97-4dc2-bb2f-653dcc2d5f70">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTM2_e713e252-046c-4681-b73a-a34dfbe5f813">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTQ2_53e87431-204f-4b1e-91c1-0507c8849e91">001-34634</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6Mjg4NDE2OGY5OWU5NGY1MjgwYjkyZTdjOGNlNDg1NjcvdGFibGVyYW5nZToyODg0MTY4Zjk5ZTk0ZjUyODBiOTJlN2M4Y2U0ODU2N18wLTAtMS0xLTg3NDU_00ac9b90-99ed-4a75-94a3-549ff895c274">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6Mjg4NDE2OGY5OWU5NGY1MjgwYjkyZTdjOGNlNDg1NjcvdGFibGVyYW5nZToyODg0MTY4Zjk5ZTk0ZjUyODBiOTJlN2M4Y2U0ODU2N18wLTItMS0xLTg3NDU_b134c60a-2381-4825-8bc7-c36f68208667">33-0022692</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6OTAxODdiMzY2N2YyNDYzZmIyZTVhMTAwOTRhNTE0MTUvdGFibGVyYW5nZTo5MDE4N2IzNjY3ZjI0NjNmYjJlNWExMDA5NGE1MTQxNV8wLTAtMS0xLTg3NDU_b431b0b3-a64d-406a-94ae-5aeb31c847f0">951 Calle Amanecer</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6OTAxODdiMzY2N2YyNDYzZmIyZTVhMTAwOTRhNTE0MTUvdGFibGVyYW5nZTo5MDE4N2IzNjY3ZjI0NjNmYjJlNWExMDA5NGE1MTQxNV8xLTAtMS0xLTg3NDU_526be72e-fa20-426f-8df5-6b2a22c59eaf">San Clemente</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6OTAxODdiMzY2N2YyNDYzZmIyZTVhMTAwOTRhNTE0MTUvdGFibGVyYW5nZTo5MDE4N2IzNjY3ZjI0NjNmYjJlNWExMDA5NGE1MTQxNV8xLTItMS0xLTg3NDU_04aaeadb-40c4-4797-a08c-46c008aff901">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6OTAxODdiMzY2N2YyNDYzZmIyZTVhMTAwOTRhNTE0MTUvdGFibGVyYW5nZTo5MDE4N2IzNjY3ZjI0NjNmYjJlNWExMDA5NGE1MTQxNV8xLTQtMS0xLTg3NDU_eeea12a8-a35b-4230-9d6b-1d08f182c488">92673</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTM3_08470f82-cda1-4165-aa07-1926548a2ff6">949</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTM4_c8818e66-b9d6-492f-a39b-a7dbb2782087">366-2183</dei:LocalPhoneNumber>
    <dei:SecurityExchangeName
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6MmFkZWU1MDhjMzI1NDI2ODllNzg3MDE5ZmY3YzY2ODcvdGFibGVyYW5nZToyYWRlZTUwOGMzMjU0MjY4OWU3ODcwMTlmZjdjNjY4N18xLTItMS0xLTg3NDU_15fd6a11-de56-44f8-ba2d-98b5a27761e7">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6MmFkZWU1MDhjMzI1NDI2ODllNzg3MDE5ZmY3YzY2ODcvdGFibGVyYW5nZToyYWRlZTUwOGMzMjU0MjY4OWU3ODcwMTlmZjdjNjY4N18yLTAtMS0xLTg3NDU_5df85aa3-5dd9-4d41-a900-fadb01328f7f">Common stock, par value $0.10 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6MmFkZWU1MDhjMzI1NDI2ODllNzg3MDE5ZmY3YzY2ODcvdGFibGVyYW5nZToyYWRlZTUwOGMzMjU0MjY4OWU3ODcwMTlmZjdjNjY4N18yLTEtMS0xLTg3NDU_921ddaa1-ccbd-422b-9e3f-b79619b59d8e">ICUI</dei:TradingSymbol>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTM5_655c2a58-1279-4bc8-8386-ae640fa21fb6">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTQw_ec926891-5264-4dd7-8ac1-2002bd588e95">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTQx_50fdc2d5-8014-497e-b534-0f12de1c6144">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTQy_2be813b4-a4ad-405a-94b9-7126f5155710">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6OTUwYzRkY2M5NGQzNGZkY2JkMGNmYTQ4ODAxMGUzODQvdGFibGVyYW5nZTo5NTBjNGRjYzk0ZDM0ZmRjYmQwY2ZhNDg4MDEwZTM4NF8wLTAtMS0xLTg3NDU_099f6956-2a73-4932-a891-70b5428ef63c">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6OTUwYzRkY2M5NGQzNGZkY2JkMGNmYTQ4ODAxMGUzODQvdGFibGVyYW5nZTo5NTBjNGRjYzk0ZDM0ZmRjYmQwY2ZhNDg4MDEwZTM4NF8yLTQtMS0xLTg3NDU_91ee0890-2fd3-464c-b6a3-ab33b5d7e64c">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGFibGU6OTUwYzRkY2M5NGQzNGZkY2JkMGNmYTQ4ODAxMGUzODQvdGFibGVyYW5nZTo5NTBjNGRjYzk0ZDM0ZmRjYmQwY2ZhNDg4MDEwZTM4NF80LTQtMS0xLTg3NDU_de2607f1-5525-43de-a395-51a126107cd9">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTQ1_fbecb50f-f619-4cea-9eb0-f449d57944b4">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTQ3_f9206899-7278-43b9-91aa-32d3090bd4e7">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="iff2e09ea6c244b5c8c8c4fdbeea287ee_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8yOTEy_e178d2c9-6737-4c9f-9b1f-0c3d3cd9de09"
      unitRef="usd">4104813741</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i111df2377a904008a8e4287e7d182606_I20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zMDEx_dc6a2021-645f-47c4-a4e5-4f4d1d0f7010"
      unitRef="shares">23786887</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xL2ZyYWc6ZDNiM2RhNDIwZDVmNGY0ZGIzZWExMmJiNTM5NjY1NmYvdGV4dHJlZ2lvbjpkM2IzZGE0MjBkNWY0ZjRkYjNlYTEyYmI1Mzk2NjU2Zl8zNTQ0_1adc27cf-f6d9-4575-99e8-dbe803dc9881">Portions of the Proxy Statement for registrant&#x2019;s 2022 Annual Meeting of Stockholders filed or to be filed pursuant to Regulation 14A within 120 days following registrant&#x2019;s fiscal year ended December&#160;31, 2021, are incorporated by reference into Part III of this Report.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorName
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF80OS9mcmFnOjNlMDM4Njc2ODgyNjQ1YzU5NzU3MjYwYmQ2YTY1MWU5L3RleHRyZWdpb246M2UwMzg2NzY4ODI2NDVjNTk3NTcyNjBiZDZhNjUxZTlfMTA5OTUxMTYzNDMzOA_bfac6f05-5717-41bb-916b-2f1b561129bf">DELOITTE &amp; TOUCHE LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF80OS9mcmFnOjNlMDM4Njc2ODgyNjQ1YzU5NzU3MjYwYmQ2YTY1MWU5L3RleHRyZWdpb246M2UwMzg2NzY4ODI2NDVjNTk3NTcyNjBiZDZhNjUxZTlfMTA5OTUxMTYzNDMzOQ_3f72d778-f913-47d1-8667-eb65f541c7ad">Costa Mesa, California</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNC0xLTEtMS04NzQ1_be862e00-5c80-421b-9a74-67e08c3a5bf0"
      unitRef="usd">552827000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNC0zLTEtMS04NzQ1_b5230bd8-d1b1-4b74-8ee0-86a6f0c831f0"
      unitRef="usd">396097000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNS0xLTEtMS04NzQ1_c5e959e9-7a65-4e4b-8c34-0413febc356b"
      unitRef="usd">14420000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNS0zLTEtMS04NzQ1_375af930-cbfc-4da2-a222-9dd0e5da66ef"
      unitRef="usd">14687000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNi0xLTEtMS04NzQ1_ee243567-9ba2-4f77-8537-8bee9ab03791"
      unitRef="usd">567247000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNi0zLTEtMS04NzQ1_6250ca6b-5cbb-459c-8f9f-955cf6c4a001"
      unitRef="usd">410784000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNy0wLTEtMS04NzQ1L3RleHRyZWdpb246MmM0ZjQ0ZGNmNjc3NDI1NGI3ZGNmNzViZTYxMWE5NjdfNjc_043e0510-ae9c-4e9d-acab-b8475cbdf614"
      unitRef="usd">7038000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNy0wLTEtMS04NzQ1L3RleHRyZWdpb246MmM0ZjQ0ZGNmNjc3NDI1NGI3ZGNmNzViZTYxMWE5NjdfNzQ_a725de35-4c6e-45f9-8945-ac93e1b2e165"
      unitRef="usd">21490000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNy0xLTEtMS04NzQ1_f2029a9e-3595-4b8f-8370-f055c5d208e8"
      unitRef="usd">105894000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNy0zLTEtMS04NzQ1_9aaebf11-c426-424a-a49e-f39483552233"
      unitRef="usd">124093000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfOC0xLTEtMS04NzQ1_8b5118d9-0082-4fa4-9091-0a71c5ecc207"
      unitRef="usd">290235000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfOC0zLTEtMS04NzQ1_2464f2f4-3f4d-4f48-b7fb-badfed502d59"
      unitRef="usd">314928000</us-gaap:InventoryNet>
    <us-gaap:PrepaidTaxes
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfOS0xLTEtMS04NzQ1_04aac45a-c878-4760-89dd-bb909f0e340d"
      unitRef="usd">19586000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfOS0zLTEtMS04NzQ1_74de9765-9aa2-490f-aec4-8108ac20930a"
      unitRef="usd">29480000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTAtMS0xLTEtODc0NQ_3b934c93-30e0-4dc4-92e9-30132f0665f4"
      unitRef="usd">46847000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTAtMy0xLTEtODc0NQ_773a865c-e480-492c-963f-77109437bb70"
      unitRef="usd">41492000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTQtMS0xLTEtODc0NQ_e60950da-01cc-44c9-a267-6f83293f72f2"
      unitRef="usd">1029809000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTQtMy0xLTEtODc0NQ_a17ee69b-da83-4931-b3be-cb9c80d5aa8d"
      unitRef="usd">920777000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTYtMS0xLTEtODc0NQ_50186003-65a9-43d6-8a00-0b55a9d231c2"
      unitRef="usd">468365000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTYtMy0xLTEtODc0NQ_7c47a791-49de-4c60-b0ac-52182336b856"
      unitRef="usd">466628000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTctMS0xLTEtODc0NQ_a20eb12c-1fd6-430b-8994-5879504e36f5"
      unitRef="usd">39847000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTctMy0xLTEtODc0NQ_9b817b6a-5e79-497e-8a6c-b75014fa171e"
      unitRef="usd">46571000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTgtMS0xLTEtODc0NQ_f93df599-8900-4e07-99ef-dbef51697c42"
      unitRef="usd">4620000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTgtMy0xLTEtODc0NQ_166338bf-3c43-4f26-9aa4-805cd4b41e89"
      unitRef="usd">12974000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:Goodwill
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTktMS0xLTEtODc0NQ_64c9654d-2ad3-492d-a592-5befc0adfffb"
      unitRef="usd">43439000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMTktMy0xLTEtODc0NQ_fbd34a96-24f8-493d-bb2e-69587a5ded6a"
      unitRef="usd">33001000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjAtMS0xLTEtODc0NQ_c488fb17-8b27-47c3-b4cd-cf7c5f21a824"
      unitRef="usd">188311000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjAtMy0xLTEtODc0NQ_a94ccf0f-9f4e-4577-a2b2-161cb73d81e8"
      unitRef="usd">197231000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjEtMS0xLTEtODc0NQ_dcd6f307-4023-43f4-bea8-79dad6919139"
      unitRef="usd">42604000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjEtMy0xLTEtODc0NQ_d62abc1a-5d92-4f38-bdb2-77bf77dc39c0"
      unitRef="usd">31034000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjItMS0xLTEtODc0NQ_c459ed8a-bc14-488b-9b65-04b410dbb961"
      unitRef="usd">63743000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjItMy0xLTEtODc0NQ_2032b903-f944-4395-b2b4-f7fc4aa0f363"
      unitRef="usd">55475000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjMtMS0xLTEtODc0NQ_61d44823-1c7b-4ab7-a595-089c40ce689f"
      unitRef="usd">1880738000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjMtMy0xLTEtODc0NQ_810ea136-b1b5-4627-b473-e6024ff44837"
      unitRef="usd">1763691000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjYtMS0xLTEtODc0NQ_9e82c8fa-30e0-4214-ad25-ab667c22153a"
      unitRef="usd">81128000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjYtMy0xLTEtODc0NQ_c2b56b56-5f54-4d72-8785-c647894f96eb"
      unitRef="usd">71864000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjctMS0xLTEtODc0NQ_2290d8d7-5f8b-4fc8-b919-656635fc9434"
      unitRef="usd">118195000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjctMy0xLTEtODc0NQ_3b7b951f-43c5-43a0-b1ae-12c9350a4863"
      unitRef="usd">97021000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjgtMS0xLTEtODc0NQ_1d48a509-b9f8-4572-82b3-0804a65347a6"
      unitRef="usd">1454000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjgtMy0xLTEtODc0NQ_4f71636d-d161-4060-8494-a4757ea5aa27"
      unitRef="usd">303000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjktMS0xLTEtODc0NQ_c851dbe2-e016-4c00-a1ba-739b12823c07"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMjktMy0xLTEtODc0NQ_91072bcd-03c6-41a2-bc90-37c571a244db"
      unitRef="usd">26300000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzAtMS0xLTEtODc0NQ_dd132f3b-f2d8-4110-acd9-5a3fb1de9221"
      unitRef="usd">200777000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzAtMy0xLTEtODc0NQ_f69c0710-3af0-420a-83cc-dbb2848cbd89"
      unitRef="usd">195488000</us-gaap:LiabilitiesCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzItMS0xLTEtODc0NQ_5f07b7da-4b63-4e04-9fa1-6999bb46caa2"
      unitRef="usd">2589000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzItMy0xLTEtODc0NQ_1ac3d8bd-b601-4f48-a686-1a1792122154"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:OtherLiabilities
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzQtMS0xLTEtODc0NQ_0953d799-aa18-4ede-9094-c1c45c52e891"
      unitRef="usd">41830000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzQtMy0xLTEtODc0NQ_b4a843c5-3f2a-43b0-b182-42a6e1e74aa5"
      unitRef="usd">47835000</us-gaap:OtherLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzUtMS0xLTEtODc0NQ_b8fc1301-798d-4d43-b393-8d507c13f2d0"
      unitRef="usd">1490000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzUtMy0xLTEtODc0NQ_9fd04d20-bde7-492e-aba2-48ec74f7373c"
      unitRef="usd">1663000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzYtMS0xLTEtODc0NQ_7aa986cc-18ef-4d9c-901f-3e60998d1205"
      unitRef="usd">18021000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzYtMy0xLTEtODc0NQ_3a3ec2d5-98a5-4c82-8b04-4b2cd664cdcb"
      unitRef="usd">16440000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzctMS0xLTEtODc0NQ_619a73cf-0fe1-4c6b-92f0-96ac17df34d1"
      unitRef="usd">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzctMy0xLTEtODc0NQ_e7265247-a13e-439c-947c-22577e6753b3"
      unitRef="usd">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzktMC0xLTEtODc0NS90ZXh0cmVnaW9uOmVkN2Q4ZGZmZTA1NDQ2YWRiMTE3MGQ3Zjg4MmRmZTA1XzMz_9ae021f8-f6b3-42ed-94ce-edb6d1e5b779"
      unitRef="usdPerShare">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzktMC0xLTEtODc0NS90ZXh0cmVnaW9uOmVkN2Q4ZGZmZTA1NDQ2YWRiMTE3MGQ3Zjg4MmRmZTA1XzMz_ab4ef109-64ed-489c-a7b8-786ea28e4c53"
      unitRef="usdPerShare">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzktMC0xLTEtODc0NS90ZXh0cmVnaW9uOmVkN2Q4ZGZmZTA1NDQ2YWRiMTE3MGQ3Zjg4MmRmZTA1XzU3_0c603099-ea2d-4511-9567-620d30f538a8"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzktMC0xLTEtODc0NS90ZXh0cmVnaW9uOmVkN2Q4ZGZmZTA1NDQ2YWRiMTE3MGQ3Zjg4MmRmZTA1XzU3_4359d950-8ca2-4bc6-ae0a-ff9a74c2c006"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzktMC0xLTEtODc0NS90ZXh0cmVnaW9uOmVkN2Q4ZGZmZTA1NDQ2YWRiMTE3MGQ3Zjg4MmRmZTA1Xzky_6c59eff7-1b73-4c48-95fd-38416d85fd18"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzktMC0xLTEtODc0NS90ZXh0cmVnaW9uOmVkN2Q4ZGZmZTA1NDQ2YWRiMTE3MGQ3Zjg4MmRmZTA1Xzky_ca3136af-ab9f-40e2-a688-4a5e07b4a2ad"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzktMS0xLTEtODc0NQ_783e8b57-50e4-48b3-93e4-75f63fc3ea5a"
      unitRef="usd">0</us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue>
    <us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfMzktMy0xLTEtODc0NQ_0d3e139a-5c00-493c-b04e-ed2b2e5d3187"
      unitRef="usd">0</us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDAtMC0xLTEtODc0NS90ZXh0cmVnaW9uOmNjNzYwYmU5MmI4MjRjMTlhOWM2NzVlNzY0MTI3NmNiXzE4_71f8b000-a7c4-44d6-a0aa-40e35b7bd9cd"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDAtMC0xLTEtODc0NS90ZXh0cmVnaW9uOmNjNzYwYmU5MmI4MjRjMTlhOWM2NzVlNzY0MTI3NmNiXzE4_b92537b7-15e7-48e7-ab78-138899c2ea1a"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDAtMC0xLTEtODc0NS90ZXh0cmVnaW9uOmNjNzYwYmU5MmI4MjRjMTlhOWM2NzVlNzY0MTI3NmNiXzQ0_513efa95-eeb5-4ccf-a6b5-1798bcde32d0"
      unitRef="shares">80000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDAtMC0xLTEtODc0NS90ZXh0cmVnaW9uOmNjNzYwYmU5MmI4MjRjMTlhOWM2NzVlNzY0MTI3NmNiXzQ0_6d1aea0d-ffd3-43e7-b19d-a4be465bff45"
      unitRef="shares">80000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDAtMC0xLTEtODc0NS90ZXh0cmVnaW9uOmNjNzYwYmU5MmI4MjRjMTlhOWM2NzVlNzY0MTI3NmNiXzEyMg_6b639fa2-f27a-4eba-b667-8ccf399e05b2"
      unitRef="shares">21058000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDAtMC0xLTEtODc0NS90ZXh0cmVnaW9uOmNjNzYwYmU5MmI4MjRjMTlhOWM2NzVlNzY0MTI3NmNiXzI3NDg3NzkwNjk3MDk_9a2b1036-b648-4663-863b-2f491f428af7"
      unitRef="shares">21280000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDAtMC0xLTEtODc0NS90ZXh0cmVnaW9uOmNjNzYwYmU5MmI4MjRjMTlhOWM2NzVlNzY0MTI3NmNiXzI3NDg3NzkwNjk3MDk_e5e41535-e7b0-4885-adfe-67b2c336731a"
      unitRef="shares">21280000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDAtMC0xLTEtODc0NS90ZXh0cmVnaW9uOmNjNzYwYmU5MmI4MjRjMTlhOWM2NzVlNzY0MTI3NmNiXzE2NA_cca48221-6d74-4dca-8b0b-3cc17c531ac1"
      unitRef="shares">21058000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDAtMS0xLTEtODc0NQ_3efe70d0-83a7-4fa3-bb4c-b05f522ea5c4"
      unitRef="usd">2128000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDAtMy0xLTEtODc0NQ_57a91be4-18ae-42ca-80e1-a9968f11bd22"
      unitRef="usd">2106000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDEtMS0xLTEtODc0NQ_468fba64-bacd-4e48-bd87-d2dd8fca9564"
      unitRef="usd">721412000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDEtMy0xLTEtODc0NQ_ec9cde76-7ac9-49fe-8e5b-8fadc6e60939"
      unitRef="usd">693068000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:TreasuryStockShares
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDItMC0xLTEtODc0NS90ZXh0cmVnaW9uOjQ2ZjcxZDNhZjZmMzRkMzI5MWMxZmIwYTYzODU1NmM2XzI5_d72bada5-33d1-42b0-ba3f-a826f5ef6848"
      unitRef="shares">119</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDItMC0xLTEtODc0NS90ZXh0cmVnaW9uOjQ2ZjcxZDNhZjZmMzRkMzI5MWMxZmIwYTYzODU1NmM2XzM2_eea72cd5-3af4-4658-9c18-100a004ff593"
      unitRef="shares">209</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDItMS0xLTEtODc0NQ_b4f5cc9f-0009-4ef3-840c-0cd6f4bd9bde"
      unitRef="usd">27000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDItMy0xLTEtODc0NQ_72fa09a5-12cf-405a-a98c-c802434534d4"
      unitRef="usd">39000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDMtMS0xLTEtODc0NQ_604fc261-5062-4fa0-8115-d2877d08fc4b"
      unitRef="usd">911787000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDMtMy0xLTEtODc0NQ_6be182b7-fa0a-4c00-898c-8a5f799290d3"
      unitRef="usd">808652000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDQtMS0xLTEtODc0NQ_2285dd33-5b73-49b6-aae5-d4b8ad55604e"
      unitRef="usd">-19269000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDQtMy0xLTEtODc0NQ_5985178c-6121-4140-bb01-3a0720ee7959"
      unitRef="usd">-1522000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDUtMS0xLTEtODc0NQ_322a70f8-b4b9-4562-b189-de80e8b4de0c"
      unitRef="usd">1616031000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDUtMy0xLTEtODc0NQ_e15173a5-1a8f-476c-9a07-53763d282642"
      unitRef="usd">1502265000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDYtMS0xLTEtODc0NQ_09e792ff-07d4-4175-9f68-edaf50a2a498"
      unitRef="usd">1880738000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81Mi9mcmFnOjI2MTA1ZWI2Y2IyMzQ4NGQ5ZGU3ZDk1ZmVlNDgzNWU4L3RhYmxlOjNjYjVhMDJjY2YzMTRiZDk5MWRlNGU2ODgzZWUxMmFiL3RhYmxlcmFuZ2U6M2NiNWEwMmNjZjMxNGJkOTkxZGU0ZTY4ODNlZTEyYWJfNDYtMy0xLTEtODc0NQ_b91d98fd-f653-42ae-b6d8-c1315b6086b1"
      unitRef="usd">1763691000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfNC0xLTEtMS04NzQ1_b4e46ad9-cc6c-4b54-8681-afbf79aa4449"
      unitRef="usd">1316308000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfNC0zLTEtMS04NzQ1_a9c5a9fb-5e1b-4479-ad5f-13df44db98d4"
      unitRef="usd">1271004000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfNC01LTEtMS04NzQ1_5c137366-f433-4233-bd22-de2e9b340dce"
      unitRef="usd">1266208000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfNS0xLTEtMS04NzQ1_f090fd48-b734-4ea9-93ff-9344c1c8008c"
      unitRef="usd">824818000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfNS0zLTEtMS04NzQ1_9ea999e7-46fb-4964-b98e-b713551975ec"
      unitRef="usd">809507000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfNS01LTEtMS04NzQ1_b8f8d7ce-cf5e-4b9b-bcfb-80c323f35fe8"
      unitRef="usd">794344000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfNi0xLTEtMS04NzQ1_237e63fa-ade1-44b7-97b3-607c621520ca"
      unitRef="usd">491490000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfNi0zLTEtMS04NzQ1_43ac3142-f8be-4f18-8d65-c0c1cddf2a5e"
      unitRef="usd">461497000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfNi01LTEtMS04NzQ1_06679ee7-2271-4eec-ad29-e08571d4b92f"
      unitRef="usd">471864000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfOC0xLTEtMS04NzQ1_2397c4ad-b3b5-4207-a512-1430da4da5b7"
      unitRef="usd">302583000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfOC0zLTEtMS04NzQ1_1cb2a1e0-9637-444a-9c69-9b576ffe9a0a"
      unitRef="usd">283953000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfOC01LTEtMS04NzQ1_87e2b29f-737e-4660-a684-26035e45a12d"
      unitRef="usd">276982000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfOS0xLTEtMS04NzQ1_dcb46f0c-8c86-4626-8b6c-2d20f72e22af"
      unitRef="usd">47498000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfOS0zLTEtMS04NzQ1_5f6a6fea-2875-4b45-8ca6-1e0846fb3ff3"
      unitRef="usd">42948000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfOS01LTEtMS04NzQ1_dbbdde5b-be38-42ba-8df5-d8f15b570264"
      unitRef="usd">48611000</us-gaap:ResearchAndDevelopmentExpense>
    <icui:Restructuringandstrategictransactionexpense
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTAtMS0xLTEtODc0NQ_10491053-583a-4a02-9fc0-10b76c2567e0"
      unitRef="usd">18037000</icui:Restructuringandstrategictransactionexpense>
    <icui:Restructuringandstrategictransactionexpense
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTAtMy0xLTEtODc0NQ_5293c252-453c-4acb-9101-146281d07d1d"
      unitRef="usd">28409000</icui:Restructuringandstrategictransactionexpense>
    <icui:Restructuringandstrategictransactionexpense
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTAtNS0xLTEtODc0NQ_feecece5-05d7-4d19-a0ed-33ccb2339497"
      unitRef="usd">80574000</icui:Restructuringandstrategictransactionexpense>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTEtMS0xLTEtODc0NQ_7a25e072-6574-4b17-ad9a-69a56148479f"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTEtMy0xLTEtODc0NQ_a7087672-8932-41d0-a9b8-e6ab5e83c3ca"
      unitRef="usd">9000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTEtNS0xLTEtODc0NQ_214d232e-a16f-47e3-aee1-681d05593e32"
      unitRef="usd">-47400000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <icui:Contractsettlements
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTItMS0xLTEtODc0NQ_51a750d2-0971-4825-9511-b9c168a5c1b5"
      unitRef="usd">127000</icui:Contractsettlements>
    <icui:Contractsettlements
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTItMy0xLTEtODc0NQ_4bef7c5e-3c56-4683-87ec-7b4b5297da16"
      unitRef="usd">-975000</icui:Contractsettlements>
    <icui:Contractsettlements
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTItNS0xLTEtODc0NQ_30d85500-025c-4daf-a571-8831e382bba7"
      unitRef="usd">5737000</icui:Contractsettlements>
    <us-gaap:OperatingExpenses
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTYtMS0xLTEtODc0NQ_dd461f8e-159f-4251-9857-6ba49d5889a5"
      unitRef="usd">368245000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTYtMy0xLTEtODc0NQ_dd426815-d871-4fd0-a5e9-b602b586a409"
      unitRef="usd">363335000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTYtNS0xLTEtODc0NQ_6afa7b28-dd7e-48e9-acd7-06d65461f38e"
      unitRef="usd">364504000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTctMS0xLTEtODc0NQ_ecd2228e-9d51-4981-b12a-e39d777941a9"
      unitRef="usd">123245000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTctMy0xLTEtODc0NQ_1c4e94ef-e61a-4301-8993-04e2d158c861"
      unitRef="usd">98162000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTctNS0xLTEtODc0NQ_51604cea-b94c-4b71-899c-a82b06acafa0"
      unitRef="usd">107360000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTktMS0xLTEtODc0NQ_b1ae97b9-b53d-4003-b9b1-2d5833d37da6"
      unitRef="usd">858000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTktMy0xLTEtODc0NQ_d0574d11-d35b-489b-8bd5-27cf7abd9a76"
      unitRef="usd">1753000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMTktNS0xLTEtODc0NQ_648ad2e3-bcf9-4e6b-8af3-0eb466ba7abe"
      unitRef="usd">549000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjAtMS0xLTEtODc0NQ_5db30ea8-7fae-4bec-843d-936d170bb6f6"
      unitRef="usd">799000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjAtMy0xLTEtODc0NQ_16f6cc9c-6661-4dd8-b582-d3eb59f401b9"
      unitRef="usd">1085000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjAtNS0xLTEtODc0NQ_ac9a0b43-88a7-4ab8-9a4d-b17a6468ff06"
      unitRef="usd">7896000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjEtMS0xLTEtODc0NQ_c28dae4b-eaff-493f-a2b1-bb00a7074a57"
      unitRef="usd">123186000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjEtMy0xLTEtODc0NQ_47d4b94e-96a1-42f7-88cd-ff208063473d"
      unitRef="usd">97494000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjEtNS0xLTEtODc0NQ_02db70e9-1116-47b6-8292-5d8cf53a8da3"
      unitRef="usd">114707000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjItMS0xLTEtODc0NQ_b77c0bd1-2883-4cab-9d0f-191469c4dd9f"
      unitRef="usd">20051000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjItMy0xLTEtODc0NQ_22347c32-70d1-481e-a038-a7efb697f80a"
      unitRef="usd">10624000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjItNS0xLTEtODc0NQ_715b6093-0156-4e47-b282-993b833e9a74"
      unitRef="usd">13672000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjMtMS0xLTEtODc0NQ_313eda6e-2fef-423e-bfab-c8a79b856b30"
      unitRef="usd">103135000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjMtMy0xLTEtODc0NQ_e0504d74-241c-4eb7-8d03-1407a541251f"
      unitRef="usd">86870000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjMtNS0xLTEtODc0NQ_b688684e-c7aa-4815-90a7-a20abe3117f1"
      unitRef="usd">101035000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjUtMS0xLTEtODc0NQ_5675b253-d24c-4a58-8bcf-4ac6046b3345"
      unitRef="usdPerShare">4.86</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjUtMy0xLTEtODc0NQ_6190e9b1-d79b-4c90-98a4-0bb192f787d5"
      unitRef="usdPerShare">4.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjUtNS0xLTEtODc0NQ_a339271e-eb55-4517-9883-e9b0938b761a"
      unitRef="usdPerShare">4.90</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjYtMS0xLTEtODc0NQ_a30ec008-6dec-48a7-a416-5b0382813d18"
      unitRef="usdPerShare">4.74</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjYtMy0xLTEtODc0NQ_4714c107-0c18-4939-a289-2c0e6e908dbd"
      unitRef="usdPerShare">4.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjYtNS0xLTEtODc0NQ_1633bdce-c8d5-49c2-953d-85e239a76025"
      unitRef="usdPerShare">4.69</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjgtMS0xLTEtODc0NQ_f5750c6f-5bf5-4d55-a75e-a197831edc81"
      unitRef="shares">21206000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjgtMy0xLTEtODc0NQ_0664f538-51ba-4803-9c32-2e483e50dcdd"
      unitRef="shares">20907000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjgtNS0xLTEtODc0NQ_1e836993-9cb0-4e78-8713-84f5adc46130"
      unitRef="shares">20629000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjktMS0xLTEtODc0NQ_2d5d79e9-0356-4310-957c-0a11b0e1d117"
      unitRef="shares">21781000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjktMy0xLTEtODc0NQ_4a2269bb-776f-4d0b-8580-6022db91127e"
      unitRef="shares">21591000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81NS9mcmFnOjAyODAzM2E2YWQ2MzRmODdiNjFlNzFkZjQ2MTFlZmQ1L3RhYmxlOmVjYzBhNGM4Yjk4MjQ5MjhiY2ViOWI2NTIwNzMxYzYxL3RhYmxlcmFuZ2U6ZWNjMGE0YzhiOTgyNDkyOGJjZWI5YjY1MjA3MzFjNjFfMjktNS0xLTEtODc0NQ_90987149-1555-4a1c-bb42-f6c94f0fe831"
      unitRef="shares">21545000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfMi0xLTEtMS04NzQ1_3a6d1cfd-8eca-4b4b-90f9-63c17825c496"
      unitRef="usd">103135000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfMi0zLTEtMS04NzQ1_f5f944e5-692a-4016-9c96-f8ecd7539ca7"
      unitRef="usd">86870000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfMi01LTEtMS04NzQ1_35af07ee-ffcc-4881-b9e7-59d09fd2d7c1"
      unitRef="usd">101035000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNC0wLTEtMS04NzQ1L3RleHRyZWdpb246NmUwMzMxZjEzZDg4NDVmYmE5NmI5OWJmM2I5OTZlMDhfNDc_0eb4c832-0e1f-4805-a0a9-2b7c2c2681a3"
      unitRef="usd">-954000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNC0wLTEtMS04NzQ1L3RleHRyZWdpb246NmUwMzMxZjEzZDg4NDVmYmE5NmI5OWJmM2I5OTZlMDhfNTE_6d26f057-e24d-4f54-8b6f-33eb73db0135"
      unitRef="usd">285000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNC0wLTEtMS04NzQ1L3RleHRyZWdpb246NmUwMzMxZjEzZDg4NDVmYmE5NmI5OWJmM2I5OTZlMDhfNTg_8d114ea6-a36d-44be-92e9-ae22a9b450bd"
      unitRef="usd">392000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNC0xLTEtMS04NzQ1_6d6ada08-c13d-44bd-a688-b2147beee773"
      unitRef="usd">-3021000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNC0zLTEtMS04NzQ1_bbdf4d68-cbe0-4704-8f6c-99c2a10edfbb"
      unitRef="usd">904000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNC01LTEtMS04NzQ1_7ebe92e8-7d14-4e88-83a7-763655aaf667"
      unitRef="usd">1242000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNS0wLTEtMS04NzQ1L3RleHRyZWdpb246OTQ0YzY4MmUxMGM5NDk3YTg3ZjhmY2QxZTE1ZGM5ZWFfNTk_54435ec0-03e5-4aca-a5fa-7d6e3b44672c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNS0wLTEtMS04NzQ1L3RleHRyZWdpb246OTQ0YzY4MmUxMGM5NDk3YTg3ZjhmY2QxZTE1ZGM5ZWFfNTk_72efd34a-a46f-4d9d-b378-2334b0e75abb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNS0wLTEtMS04NzQ1L3RleHRyZWdpb246OTQ0YzY4MmUxMGM5NDk3YTg3ZjhmY2QxZTE1ZGM5ZWFfNTk_e03cda36-5773-42f5-812f-6e3528386596"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNS0xLTEtMS04NzQ1_6de75926-c584-4882-a153-c81e7f2225fb"
      unitRef="usd">-14664000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNS0zLTEtMS04NzQ1_a854f0b5-5ab4-405f-862a-e8c7a6d5de7a"
      unitRef="usd">12929000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNS01LTEtMS04NzQ1_8019c7e9-d552-4c88-b226-587102be83a7"
      unitRef="usd">372000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNi0wLTEtMS04NzQ1L3RleHRyZWdpb246MzM3OTcwNGY1MDZhNGQ5MGJkMTdmOTYxYWI4OTFkMjRfMzc_367e71ee-5326-4fd9-8a4f-57dcabd3f98c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNi0wLTEtMS04NzQ1L3RleHRyZWdpb246MzM3OTcwNGY1MDZhNGQ5MGJkMTdmOTYxYWI4OTFkMjRfMzc_4dbe6494-2c50-44bf-976d-8a274332b045"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNi0wLTEtMS04NzQ1L3RleHRyZWdpb246MzM3OTcwNGY1MDZhNGQ5MGJkMTdmOTYxYWI4OTFkMjRfMzc_5158c52e-94d1-456c-8f72-9615a9d99ac6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNi0xLTEtMS04NzQ1_2852075f-a3e1-4ca0-8f7a-13e37b2b1373"
      unitRef="usd">62000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNi0zLTEtMS04NzQ1_68979b2a-61ff-4b83-b93d-0c3a3f5e5309"
      unitRef="usd">-47000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNi01LTEtMS04NzQ1_70266819-67ff-41f8-a3fd-1271ff4ea79a"
      unitRef="usd">71000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNy0xLTEtMS04NzQ1_f250a1b4-0868-4c68-86e7-1a4c018dee8f"
      unitRef="usd">-17747000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNy0zLTEtMS04NzQ1_66c4f158-b01a-45e4-aaa9-8ba2c426efe9"
      unitRef="usd">13880000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfNy01LTEtMS04NzQ1_e7050b96-220e-46a2-a24f-a3c1a7438425"
      unitRef="usd">1543000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfOC0xLTEtMS04NzQ1_e961a025-9885-435b-ad39-3913763b7916"
      unitRef="usd">85388000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfOC0zLTEtMS04NzQ1_1a219f54-83ec-4ee2-a21e-b2e63c209429"
      unitRef="usd">100750000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF81OC9mcmFnOmY0ZWEzOTYzYzhlMjQxOTU5ZWUxZTM1YzU2ZDAxNzBlL3RhYmxlOmUzMDhjNTBjOWI3OTQ5MDJiNzMxYmFiNTc0ZTVlMmNkL3RhYmxlcmFuZ2U6ZTMwOGM1MGM5Yjc5NDkwMmI3MzFiYWI1NzRlNWUyY2RfOC01LTEtMS04NzQ1_88031267-c106-4f22-ac06-3906cf8311b6"
      unitRef="usd">102578000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie3327972bb1d4aee95a27cb29ac758f6_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMy0yLTEtMS04NzQ1_17ecb8db-ecdd-474f-bbac-222764950366"
      unitRef="shares">20491000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iff400e2a4d53433e99e9a76ec4ff42c0_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMy00LTEtMS04NzQ1_af656856-ba12-4d30-baf7-ecc819ad2504"
      unitRef="usd">2049000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i422a41397eba44439e3bee3a84f24f5e_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMy02LTEtMS04NzQ1_2a9bdf93-8c5d-4af2-b250-ad39c3ffccf6"
      unitRef="usd">657899000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3707592634d449b6b164fd6ab5039af3_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMy04LTEtMS04NzQ1_28a16d62-379b-4a01-b97d-55b17eaf604b"
      unitRef="usd">-95000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9e68fd2b373c4657b269de98d476f2f3_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMy0xMC0xLTEtODc0NQ_b543ae7e-179c-4ba7-b929-7c5189bde1a7"
      unitRef="usd">620747000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id9a14d7ab14041cd9287ff968eeab854_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMy0xMi0xLTEtODc0NQ_be0d532d-632e-4d2f-b407-91db545f9e94"
      unitRef="usd">-16945000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic2b82bbcf5cb45739937a1040ed30f6b_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMy0xNC0xLTEtODc0NQ_a9c6a48a-9547-44ac-a088-5a5046439c00"
      unitRef="usd">1263655000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i8036f14fb1574f22a813b07a891d10cb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfNS0yLTEtMS04NzQ1_d4633d0e-78e0-48c8-8865-37d0a6da0347"
      unitRef="shares">331000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ief0e41eadf634f478517bbf4796fb3b7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfNS00LTEtMS04NzQ1_c942ae10-f33c-4904-8e91-dcd206d6ad02"
      unitRef="usd">25000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ifd39fbd084c64997a80b35884325a837_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfNS02LTEtMS04NzQ1_38ea1428-80cc-4d53-8b34-9ea34bf7ed02"
      unitRef="usd">-10870000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="icf8bb0aa0f8d4c368a4f3c52cf44f0fe_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfNS04LTEtMS04NzQ1_681440a9-faf6-4ef9-8120-7c981f051073"
      unitRef="usd">18577000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfNS0xNC0xLTEtODc0NQ_558dfecb-447d-481a-a337-0e0aec8c7f3e"
      unitRef="usd">7732000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i8036f14fb1574f22a813b07a891d10cb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfNi0yLTEtMS04NzQ1_e1d8736e-f0bf-4e0a-8300-bcb7f04eb79c"
      unitRef="shares">80000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ifd39fbd084c64997a80b35884325a837_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfNi02LTEtMS04NzQ1_b046dcd6-ce59-4250-8b10-8a9b6f8e97d1"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="icf8bb0aa0f8d4c368a4f3c52cf44f0fe_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfNi04LTEtMS04NzQ1_315523b9-6150-4e26-8211-a08b418fd762"
      unitRef="usd">18639000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfNi0xNC0xLTEtODc0NQ_ac7eb4da-0198-45f9-b8b1-0c1c4560bb83"
      unitRef="usd">18639000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifd39fbd084c64997a80b35884325a837_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfOC02LTEtMS04NzQ1_e75dcaaf-41a6-437f-aaf7-6efb3864dc06"
      unitRef="usd">21918000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfOC0xNC0xLTEtODc0NQ_5de07dc1-f67c-4274-ae5a-45d40c85ca9f"
      unitRef="usd">21918000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="ied11d81291954b6892d0bd3f457a6c62_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfOS0xMi0xLTEtODc0NQ_c0890074-292f-4c9b-9f51-b1d29b9d8c46"
      unitRef="usd">1543000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfOS0xNC0xLTEtODc0NQ_50adde52-3b70-4767-8fef-cd265a6c2f95"
      unitRef="usd">1543000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i6f8426b518ec486c8093f691d9ae22b4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTAtMTAtMS0xLTg3NDU_a8de4270-4718-4f7c-a311-f3186c07f56d"
      unitRef="usd">101035000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTAtMTQtMS0xLTg3NDU_d45b1d4f-6483-4342-9f9e-75494b7a2ff8"
      unitRef="usd">101035000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6b6766362c85475b9f3e56635902ffc6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTEtMi0xLTEtODc0NQ_48620ba0-201d-4ca3-8f41-4b5130bb76a8"
      unitRef="shares">20742000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ia53abf8ff1024f4b9dbcd962fb14bb16_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTEtNC0xLTEtODc0NQ_26401b19-d5aa-46e3-ad7b-91c610c4577d"
      unitRef="usd">2074000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8029282b701e4da19cb4312a7342adee_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTEtNi0xLTEtODc0NQ_46492de5-56ce-4b45-907c-6bff9f076917"
      unitRef="usd">668947000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iba8b292d4a8c426ea02ac921339f2ece_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTEtOC0xLTEtODc0NQ_56f03672-d721-462a-8eb5-66d34b93d496"
      unitRef="usd">-157000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i58538562a9b846b1a8eb28ee06dd457c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTEtMTAtMS0xLTg3NDU_8009841f-8870-405d-8fe1-2888e03edc31"
      unitRef="usd">721782000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i12d0faf21deb41648f175a8130fa683f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTEtMTItMS0xLTg3NDU_932aca02-fa4e-4ece-9224-9e373b58a6ab"
      unitRef="usd">-15402000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTEtMTQtMS0xLTg3NDU_3d20d010-f8e6-4326-9e19-8b4a2dc786df"
      unitRef="usd">1377244000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i6a9e3ee9b34c4d4c81e04d5c21845153_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTMtMi0xLTEtODc0NQ_5e57085d-f913-4474-b65f-20ca76e6827f"
      unitRef="shares">383000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic917d118fe1544a48c9f7cdb26a0bafe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTMtNC0xLTEtODc0NQ_44c9b78d-448b-4fec-ab16-6ac9111d147f"
      unitRef="usd">32000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iaea909186292457f815372e15f122f61_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTMtNi0xLTEtODc0NQ_5d5d0288-7c01-4b13-b7fe-0bead617fb91"
      unitRef="usd">167000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i319e066bf7c149958ff00b3b5180cad9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTMtOC0xLTEtODc0NQ_e90553da-e0a1-4dad-ac97-6c90c2066a6a"
      unitRef="usd">12994000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTMtMTQtMS0xLTg3NDU_b2719b09-cbdb-4a14-970d-f4799bd4477a"
      unitRef="usd">13193000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i6a9e3ee9b34c4d4c81e04d5c21845153_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTQtMi0xLTEtODc0NQ_aa929f3f-312a-46b2-b36d-e29183fe0574"
      unitRef="shares">67000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="iaea909186292457f815372e15f122f61_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTQtNi0xLTEtODc0NQ_24e199ed-1560-42f4-8523-dff200fd813d"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i319e066bf7c149958ff00b3b5180cad9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTQtOC0xLTEtODc0NQ_22fccf1f-db0f-47d5-8f2b-00ab7cbf3f3a"
      unitRef="usd">12876000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTQtMTQtMS0xLTg3NDU_5c00863c-80d5-4723-89da-6d733e57d6d6"
      unitRef="usd">12876000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iaea909186292457f815372e15f122f61_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTYtNi0xLTEtODc0NQ_8075773f-05ae-4251-b704-14f18a201baf"
      unitRef="usd">23954000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTYtMTQtMS0xLTg3NDU_48555ea2-eebc-4090-a270-a89d0cf1deab"
      unitRef="usd">23954000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="ic1f24ebe96e244d1a070e358c2f9088e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTctMTItMS0xLTg3NDU_bc3d4c74-54f5-4025-96ae-299c289dd4f6"
      unitRef="usd">13880000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTctMTQtMS0xLTg3NDU_219d8623-88f0-4930-b1d2-6ac39fd391e4"
      unitRef="usd">13880000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i6ee1c30a74b842b18319e3e21627fde1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTgtMTAtMS0xLTg3NDU_4d0f819a-2203-443f-aa83-89ded6c90891"
      unitRef="usd">86870000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTgtMTQtMS0xLTg3NDU_b05c36a3-9cc1-48da-bcb3-a1e8d29c7be9"
      unitRef="usd">86870000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i76af68ce1a5649a285c27467729f3ea8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTktMi0xLTEtODc0NQ_8cfe244c-663a-4a36-8843-945a68816849"
      unitRef="shares">21058000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i64123b55baa546a6ae8585911227ac9b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTktNC0xLTEtODc0NQ_a7547a83-1405-425d-92d4-f0b4a1b0535a"
      unitRef="usd">2106000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6257893a382b432986c682223e96eed6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTktNi0xLTEtODc0NQ_c2e850ad-fd36-4622-9f8c-09fcd48be898"
      unitRef="usd">693068000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i545572fcbd214019b1a486fff73e3d60_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTktOC0xLTEtODc0NQ_4cb9e3f9-e6fe-4bf4-9f0d-a98bb7f7ddab"
      unitRef="usd">-39000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib07f493ac3464b04ace456f723c0d4c1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTktMTAtMS0xLTg3NDU_7a981145-6fa6-420f-bf53-c3b7127d6a85"
      unitRef="usd">808652000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i98729f24bb67493bbbb1a901004ee439_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTktMTItMS0xLTg3NDU_7788378f-473a-4aeb-ab32-3d1ad1a581b0"
      unitRef="usd">-1522000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMTktMTQtMS0xLTg3NDU_c1868137-ad42-4e27-8965-25a49114a435"
      unitRef="usd">1502265000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i124369e0a3a6454fae9d78635beb32e1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjEtMi0xLTEtODc0NQ_70df0685-a9e4-4559-8b23-dd162aab78a0"
      unitRef="shares">262000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i893bab2162e3420fa787264425d1b71f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjEtNC0xLTEtODc0NQ_40af3370-480d-45fd-9484-7b11fb1364ec"
      unitRef="usd">22000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i80df96ad8b8e4475847100ff81957f59_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjEtNi0xLTEtODc0NQ_0b69cab9-f7d8-430e-8aff-8c63a2568627"
      unitRef="usd">1003000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia5dc13d8d15f4d6b9e43ee2747cf2dde_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjEtOC0xLTEtODc0NQ_b0992ed9-6631-4b66-9384-6c52fd1b6bce"
      unitRef="usd">8347000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjEtMTQtMS0xLTg3NDU_8a64b940-0e31-4ab6-ae22-f4137a90e7ee"
      unitRef="usd">9372000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i124369e0a3a6454fae9d78635beb32e1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjItMi0xLTEtODc0NQ_ccd9f3c5-c984-459d-be7d-c9ff3480abe9"
      unitRef="shares">40000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i80df96ad8b8e4475847100ff81957f59_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjItNi0xLTEtODc0NQ_1cbed48a-c73d-44d9-b427-ddedc19d1acf"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ia5dc13d8d15f4d6b9e43ee2747cf2dde_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjItOC0xLTEtODc0NQ_7e2f8dd5-fb07-45e3-bd59-bfcb58939f93"
      unitRef="usd">8335000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjItMTQtMS0xLTg3NDU_ad94aefd-aa5b-4f5b-8881-4e25256d5e32"
      unitRef="usd">8335000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i80df96ad8b8e4475847100ff81957f59_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjQtNi0xLTEtODc0NQ_761a1fed-f02c-4260-bac4-ea4552cafd45"
      unitRef="usd">27341000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjQtMTQtMS0xLTg3NDU_053cf07f-5c18-410d-88f4-b849b15b731a"
      unitRef="usd">27341000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="id7594d76a22343b78ed45f29024ebce9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjUtMTItMS0xLTg3NDU_123e8293-c7a6-4fdb-b067-a1bc50a92312"
      unitRef="usd">-17747000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjUtMTQtMS0xLTg3NDU_9de04528-3785-4f36-ab86-b2f08689caa8"
      unitRef="usd">-17747000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i675d4957f6a54a509db9f8b824f52efb_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjYtMTAtMS0xLTg3NDU_0ff00ac2-c45c-46ea-b99a-bd93399316cc"
      unitRef="usd">103135000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjYtMTQtMS0xLTg3NDU_dd873180-6fba-4054-b3e9-9263ea82278b"
      unitRef="usd">103135000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib79fc9d04ebf42eca924b5dba9ff0f88_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjctMi0xLTEtODc0NQ_eb13ca11-04f3-4a05-9b7b-582a800a016f"
      unitRef="shares">21280000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i33f36a22d5f5402fa34702e2b60d0b7c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjctNC0xLTEtODc0NQ_1cff1dc8-2e5c-43fb-89e8-01a53fef970e"
      unitRef="usd">2128000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i03ab38e8bc4e4afab23f9031aff6bbbc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjctNi0xLTEtODc0NQ_efbc4126-8e83-4c42-8a21-1d10050cda28"
      unitRef="usd">721412000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7af9cf8a39fa459fb6db8a6392a90dd2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjctOC0xLTEtODc0NQ_17a7aebb-78ce-4a62-87fb-c5b7b0b029c8"
      unitRef="usd">-27000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9f7846d15c1c45d0b3c2a14b3b40dbd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjctMTAtMS0xLTg3NDU_9597abb5-415e-458b-a5d3-c479d7b9135e"
      unitRef="usd">911787000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i874c262496e7470aad6329cb331b77e1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjctMTItMS0xLTg3NDU_713bfaae-83df-4026-9baa-be7eaf72057a"
      unitRef="usd">-19269000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82MS9mcmFnOjc5MjVlM2M0ZWM3MDRmNmZhNjQ4ZTcxZmI5MmI4Yzg0L3RhYmxlOjg5ZWFlOTQ0MTczNzQyNmZiNGIwOGVkM2UxNDViODcwL3RhYmxlcmFuZ2U6ODllYWU5NDQxNzM3NDI2ZmI0YjA4ZWQzZTE0NWI4NzBfMjctMTQtMS0xLTg3NDU_926a01e9-bee6-4796-a93b-b434265a75a7"
      unitRef="usd">1616031000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMy0xLTEtMS04NzQ1_3a6d1cfd-8eca-4b4b-90f9-63c17825c496"
      unitRef="usd">103135000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMy0zLTEtMS04NzQ1_f5f944e5-692a-4016-9c96-f8ecd7539ca7"
      unitRef="usd">86870000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMy01LTEtMS04NzQ1_35af07ee-ffcc-4881-b9e7-59d09fd2d7c1"
      unitRef="usd">101035000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNS0xLTEtMS04NzQ1_499554ce-cfc9-4c7b-99c2-db3c05912464"
      unitRef="usd">89698000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNS0zLTEtMS04NzQ1_9e07c5b7-2bef-4e8a-8fc8-b608b17789ae"
      unitRef="usd">85631000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNS01LTEtMS04NzQ1_9b49141a-cdb0-410c-9ed4-ca4cd559539c"
      unitRef="usd">76916000</us-gaap:DepreciationDepletionAndAmortization>
    <icui:Operatingleaserightofuseassetamortization
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNi0xLTEtMS04NzQ1_11d79424-f288-47e0-a1d6-1d84135ee61f"
      unitRef="usd">9594000</icui:Operatingleaserightofuseassetamortization>
    <icui:Operatingleaserightofuseassetamortization
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNi0zLTEtMS04NzQ1_6a17c61e-4ee1-443c-898f-638e3c390e34"
      unitRef="usd">9216000</icui:Operatingleaserightofuseassetamortization>
    <icui:Operatingleaserightofuseassetamortization
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNi01LTEtMS04NzQ1_a5c46bd5-62b4-41c6-a46f-4ecb96cf230d"
      unitRef="usd">8294000</icui:Operatingleaserightofuseassetamortization>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNy0xLTEtMS04NzQ1_e4e7d05b-92bf-408e-b8d1-2ae62717f92b"
      unitRef="usd">345000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNy0zLTEtMS04NzQ1_55ae0caa-3a86-4ae9-8560-65a390e8d87c"
      unitRef="usd">7137000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNy01LTEtMS04NzQ1_ccee6cb8-6bf3-40d5-83e7-1131f510237f"
      unitRef="usd">14882000</us-gaap:ProvisionForDoubtfulAccounts>
    <icui:ProvisionForWarrantyAndReturns
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfOC0xLTEtMS04NzQ1_b507b89a-df21-492d-88a5-542e67933daa"
      unitRef="usd">831000</icui:ProvisionForWarrantyAndReturns>
    <icui:ProvisionForWarrantyAndReturns
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfOC0zLTEtMS04NzQ1_40e7ddef-0f5e-4795-b1b3-21c4ae0ed996"
      unitRef="usd">-1576000</icui:ProvisionForWarrantyAndReturns>
    <icui:ProvisionForWarrantyAndReturns
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfOC01LTEtMS04NzQ1_09a292a7-2221-4dca-b407-6f7f39776151"
      unitRef="usd">-134000</icui:ProvisionForWarrantyAndReturns>
    <us-gaap:ShareBasedCompensation
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfOS0xLTEtMS04NzQ1_81f52037-07be-44ac-a337-72cc0ccad14b"
      unitRef="usd">27341000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfOS0zLTEtMS04NzQ1_1b48ae7b-dbd0-43a7-8af4-6de70d7c2696"
      unitRef="usd">23954000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfOS01LTEtMS04NzQ1_c0748ef3-1532-4326-95c3-84930b0d3644"
      unitRef="usd">21918000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTAtMS0xLTEtODc0NQ_c6ee09b4-a23b-4204-b147-cbfaece9a5dd"
      unitRef="usd">-1652000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTAtMy0xLTEtODc0NQ_dcbbef2c-bc9b-4b62-8cac-dd97066df83f"
      unitRef="usd">1789000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTAtNS0xLTEtODc0NQ_2dd59982-d357-481c-b8a7-22247844eea8"
      unitRef="usd">-12872000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:InvestmentIncomeAmortizationOfPremium
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTMtMS0xLTEtODc0NQ_a62e1a89-0b8d-4382-ab75-90b9d7bf1190"
      unitRef="usd">655000</us-gaap:InvestmentIncomeAmortizationOfPremium>
    <us-gaap:InvestmentIncomeAmortizationOfPremium
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTMtMy0xLTEtODc0NQ_00e8d4e4-7519-40df-a016-aa7499d2e492"
      unitRef="usd">231000</us-gaap:InvestmentIncomeAmortizationOfPremium>
    <us-gaap:InvestmentIncomeAmortizationOfPremium
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTMtNS0xLTEtODc0NQ_57b9edf7-a6cc-4945-91bd-71ca2d7e912a"
      unitRef="usd">135000</us-gaap:InvestmentIncomeAmortizationOfPremium>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTQtMS0xLTEtODc0NQ_947330ea-6f2b-4cda-b025-678f01b457df"
      unitRef="usd">240000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTQtMy0xLTEtODc0NQ_c1ad53de-8728-4870-b9f4-a1d113cc97d8"
      unitRef="usd">288000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTQtNS0xLTEtODc0NQ_1304a9f9-51fc-43fc-ab74-33029484e591"
      unitRef="usd">288000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTYtMS0xLTEtODc0NQ_e275091d-2127-4f1f-8b91-f05e75649c3a"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTYtMy0xLTEtODc0NQ_f1481d7c-7325-4a81-ba7e-d7976a506118"
      unitRef="usd">9000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTYtNS0xLTEtODc0NQ_ebf63212-f82e-421b-afb1-ce701b92dde3"
      unitRef="usd">-47400000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:ProductionRelatedImpairmentsOrCharges
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTctMS0xLTEtODc0NQ_69a4fffc-eda9-4b64-9c30-2768ca47cd21"
      unitRef="usd">3380000</us-gaap:ProductionRelatedImpairmentsOrCharges>
    <us-gaap:ProductionRelatedImpairmentsOrCharges
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTctMy0xLTEtODc0NQ_238e2dda-b211-4144-9fdb-30fbaa5ca9dd"
      unitRef="usd">2626000</us-gaap:ProductionRelatedImpairmentsOrCharges>
    <us-gaap:ProductionRelatedImpairmentsOrCharges
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTctNS0xLTEtODc0NQ_871f4d7a-f3f9-4fc6-867d-8050b9598272"
      unitRef="usd">0</us-gaap:ProductionRelatedImpairmentsOrCharges>
    <icui:Sparepartsusage
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTgtMS0xLTEtODc0NQ_bca70bd7-5fcc-4a77-b16c-a2d0f3279103"
      unitRef="usd">13046000</icui:Sparepartsusage>
    <icui:Sparepartsusage
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTgtMy0xLTEtODc0NQ_a1eb0871-b172-4440-aa3c-a3cfaf6fc448"
      unitRef="usd">11191000</icui:Sparepartsusage>
    <icui:Sparepartsusage
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTgtNS0xLTEtODc0NQ_cb74bea0-dbad-4a8c-8db2-ad3684b46dc1"
      unitRef="usd">24301000</icui:Sparepartsusage>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTktMS0xLTEtODc0NQ_9b40d17b-c906-4aa7-8fae-a16b57bb0c45"
      unitRef="usd">2582000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTktMy0xLTEtODc0NQ_b97d1b5b-d476-4d4a-ad75-18805f445cc0"
      unitRef="usd">6939000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMTktNS0xLTEtODc0NQ_239a72c8-8525-4a39-bff5-c5ae00021f87"
      unitRef="usd">447000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjEtMS0xLTEtODc0NQ_4f930708-d036-4aa3-89d1-37f9a1cab539"
      unitRef="usd">-13755000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjEtMy0xLTEtODc0NQ_d3b11d2f-47d4-43ab-b5c7-c76875a999ce"
      unitRef="usd">-78049000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjEtNS0xLTEtODc0NQ_e03d5ca2-a0b4-497c-89b5-ebc8c1562fa8"
      unitRef="usd">23684000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjItMS0xLTEtODc0NQ_9bd07f34-690f-484c-889a-a27cd9b451ac"
      unitRef="usd">-20815000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjItMy0xLTEtODc0NQ_5fa6544b-cd1b-4a8f-a2bd-6cb8594f128e"
      unitRef="usd">-19196000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjItNS0xLTEtODc0NQ_b8491991-4de8-4cf7-8221-6b0d0acb87ee"
      unitRef="usd">24997000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjMtMS0xLTEtODc0NQ_dfd5b0c4-f1fa-4787-89ff-f5a6d57c4f8c"
      unitRef="usd">7973000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjMtMy0xLTEtODc0NQ_bc0e4fe8-b4fb-43a3-93f0-635b9abaf7a0"
      unitRef="usd">4311000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjMtNS0xLTEtODc0NQ_9ceb76ea-6ab7-4219-a63f-50db35c1cb69"
      unitRef="usd">-8588000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjUtMS0xLTEtODc0NQ_a831c4a4-c881-4806-a88a-7b7dda565f5d"
      unitRef="usd">21038000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjUtMy0xLTEtODc0NQ_60ba61df-3431-4e58-b496-5fa6665b551d"
      unitRef="usd">16069000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjUtNS0xLTEtODc0NQ_6b7bf07e-2222-4778-b420-212921cba92d"
      unitRef="usd">29837000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjYtMS0xLTEtODc0NQ_c74f2860-8e29-42b9-9341-c5d4d6c41f54"
      unitRef="usd">2347000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjYtMy0xLTEtODc0NQ_1bb7a2c9-6382-4730-a6fe-4c08f7938da7"
      unitRef="usd">-46415000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjYtNS0xLTEtODc0NQ_9e04e485-33aa-49ee-b5f8-693156823e7c"
      unitRef="usd">-2697000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjctMS0xLTEtODc0NQ_12858dde-dd50-409a-92f1-e6d304c1e041"
      unitRef="usd">6259000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjctMy0xLTEtODc0NQ_db5df8ac-5760-4451-aea9-006eae6c2e0b"
      unitRef="usd">-29379000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjctNS0xLTEtODc0NQ_6f7006d4-133e-4136-a2fe-900a32806f4c"
      unitRef="usd">-43689000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjgtMS0xLTEtODc0NQ_dc6974a4-5ae6-4442-b96c-af9cf857db4d"
      unitRef="usd">874000</icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes>
    <icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjgtMy0xLTEtODc0NQ_7683dbe3-f1ac-48a0-af6e-1e89d5406422"
      unitRef="usd">-18037000</icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes>
    <icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjgtNS0xLTEtODc0NQ_cb138622-9c3e-40fb-ae9a-ea5ad2c13ca7"
      unitRef="usd">4680000</icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjktMS0xLTEtODc0NQ_c909aa2b-edd7-4101-a9f4-8d88127df4d5"
      unitRef="usd">267538000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjktMy0xLTEtODc0NQ_8cafd522-7bf7-4a1e-a427-e072ae976229"
      unitRef="usd">222752000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMjktNS0xLTEtODc0NQ_c80e1d46-e921-4bfc-85c9-09ce3fbac002"
      unitRef="usd">101918000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzEtMS0xLTEtODc0NQ_3f2b894a-04ae-4850-977f-05851fdbdb17"
      unitRef="usd">68542000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzEtMy0xLTEtODc0NQ_9fe36bb5-1d84-40dd-8669-c21bf64d8ad8"
      unitRef="usd">92005000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzEtNS0xLTEtODc0NQ_6ca88aaa-de34-4cee-a70b-97debec88842"
      unitRef="usd">97312000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfOtherPropertyPlantAndEquipment
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzItMS0xLTEtODc0NQ_10792096-30ad-403c-926c-8207bc05df3a"
      unitRef="usd">218000</us-gaap:ProceedsFromSaleOfOtherPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfOtherPropertyPlantAndEquipment
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzItMy0xLTEtODc0NQ_7a894dd9-daa3-47b7-8741-e02b3d527d11"
      unitRef="usd">6176000</us-gaap:ProceedsFromSaleOfOtherPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfOtherPropertyPlantAndEquipment
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzItNS0xLTEtODc0NQ_5aa0dfec-6aa9-42a6-898c-cf63458fdafe"
      unitRef="usd">33000</us-gaap:ProceedsFromSaleOfOtherPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzQtMS0xLTEtODc0NQ_dcc92de4-d900-4d5a-9f71-06a813f7c829"
      unitRef="usd">12627000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzQtMy0xLTEtODc0NQ_3a8b5f9f-c544-4fcd-9eaf-71bbe1f27035"
      unitRef="usd">8385000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzQtNS0xLTEtODc0NQ_d5ce28dc-1472-4483-8458-12410a6de5dc"
      unitRef="usd">8728000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzUtMS0xLTEtODc0NQ_42f98701-904d-4d1c-b729-91d393e489fe"
      unitRef="usd">14452000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzUtMy0xLTEtODc0NQ_f343aa70-19a1-4305-bb63-093bab342505"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzUtNS0xLTEtODc0NQ_feea72ee-3405-47fa-a80d-ec8eeda4dd31"
      unitRef="usd">76133000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzctMS0xLTEtMjQ5NTM_09526fa0-1282-4c5f-8d39-ab202a4191f9"
      unitRef="usd">3250000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzctMy0xLTEtMjQ5NTM_0fd2e8fa-3d03-4fd0-95f0-25feae44dc50"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzctNS0xLTEtMjQ5NTM_488d819e-b5d4-45a0-9e8d-a2e9128939c6"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzctMS0xLTEtODc0NQ_db751ebc-82b6-4f12-bdb0-96389afbff00"
      unitRef="usd">10034000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzctMy0xLTEtODc0NQ_1ed9b6ee-dd8c-4ae0-ad3c-4fce3dc38aa7"
      unitRef="usd">32825000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzctNS0xLTEtODc0NQ_dc835783-4a4e-43e9-a16f-b17165864f8c"
      unitRef="usd">26040000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzgtMS0xLTEtODc0NQ_5f628486-0389-43bd-93e2-049e2288c76d"
      unitRef="usd">18000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzgtMy0xLTEtODc0NQ_cd7f7cc8-dfca-451d-8168-2fdb9eb8c0ce"
      unitRef="usd">28900000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzgtNS0xLTEtODc0NQ_1d71d1e9-5432-4a41-ab0a-40c7f7cee20b"
      unitRef="usd">41292000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzktMS0xLTEtODc0NQ_03a5f077-08be-4c5a-9244-fda373e6af0a"
      unitRef="usd">-90687000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzktMy0xLTEtODc0NQ_b972ed5a-4b3d-4db2-8bea-5bd7c65e8fdc"
      unitRef="usd">-98139000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfMzktNS0xLTEtODc0NQ_ddf0aeb9-9ab9-4017-9b0c-ebf47f0a70e0"
      unitRef="usd">-166888000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDEtMS0xLTEtODc0NQ_f49d5334-d7ef-46e2-ade4-96c1e66c8a0d"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDEtMy0xLTEtODc0NQ_71c499e0-3caa-4812-b271-3e7a1896efc6"
      unitRef="usd">150000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDEtNS0xLTEtODc0NQ_54363569-e78d-4ec6-bef1-b9d1417179f9"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDItMS0xLTEtODc0NQ_65523de5-36f5-429c-9239-808e54a6da79"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDItMy0xLTEtODc0NQ_18506b43-2bf1-42d6-90c1-10968d73a446"
      unitRef="usd">150000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDItNS0xLTEtODc0NQ_d7694741-d453-4d0c-94ee-f27cf989e31f"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDMtMS0xLTEtODc0NQ_2b8600b2-398b-4493-8966-a40fd4906238"
      unitRef="usd">9372000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDMtMy0xLTEtODc0NQ_f95331b8-08b3-486c-abef-445d64f2ba84"
      unitRef="usd">13193000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDMtNS0xLTEtODc0NQ_8feb54f0-682a-4136-88a8-acfa8651b877"
      unitRef="usd">7732000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDQtMS0xLTEtODc0NQ_244f34be-8658-4c60-9271-61d66342a685"
      unitRef="usd">607000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDQtMy0xLTEtODc0NQ_4de97240-7a73-48ff-adbe-a2b1ecd9892c"
      unitRef="usd">357000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDQtNS0xLTEtODc0NQ_6c1b3465-748e-4797-bc01-d9c1da518a31"
      unitRef="usd">0</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDYtMS0xLTEtNTgxNjI_e1ce0975-bc6e-4634-8a02-70122512d843"
      unitRef="usd">17300000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDYtMy0xLTEtNTgxNjk_370b5aa1-5ffa-4098-b9db-51406c41342b"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDYtNS0xLTEtNTgxNzY_285dd73d-e147-4cc3-b0c2-d89b73bb196e"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDUtMS0xLTEtODc0NQ_fc68720b-173c-40d8-88ef-a3b95b920d6d"
      unitRef="usd">8335000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDUtMy0xLTEtODc0NQ_24cb3912-aa51-408f-9ca4-3b0353f168a9"
      unitRef="usd">12876000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDUtNS0xLTEtODc0NQ_a70eec36-eb74-407b-9bfd-88e6208ce621"
      unitRef="usd">18639000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDYtMS0xLTEtODc0NQ_a5484f9c-6db5-4401-bfad-514fbe59a4c4"
      unitRef="usd">-16870000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDYtMy0xLTEtODc0NQ_5d833182-629d-4693-aca9-de3b9b9dc011"
      unitRef="usd">-40000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDYtNS0xLTEtODc0NQ_6f268661-8cb6-48a0-964b-2f4c28fb2f08"
      unitRef="usd">-10907000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDctMS0xLTEtODc0NQ_125b9a67-6a57-46af-8c44-c9018b457af6"
      unitRef="usd">-3251000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDctMy0xLTEtODc0NQ_6df7fd78-4504-42af-94ed-11ea878ac78e"
      unitRef="usd">2854000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDctNS0xLTEtODc0NQ_fea31aad-6c6a-4f39-a805-d4b3decd2b5d"
      unitRef="usd">-234000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDgtMS0xLTEtODc0NQ_f15c9ed3-5d79-4971-a7c2-884a70ea2e01"
      unitRef="usd">156730000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDgtMy0xLTEtODc0NQ_6ad3267b-8475-4c92-8e6c-97836822edf0"
      unitRef="usd">127427000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDgtNS0xLTEtODc0NQ_fea1e88d-9b95-4a54-afc7-e6f244948457"
      unitRef="usd">-76111000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDktMS0xLTEtODc0NQ_b5230bd8-d1b1-4b74-8ee0-86a6f0c831f0"
      unitRef="usd">396097000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDktMy0xLTEtODc0NQ_a7fa5d51-29e2-47a4-9309-8ab5383d5dba"
      unitRef="usd">268670000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic2b82bbcf5cb45739937a1040ed30f6b_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNDktNS0xLTEtODc0NQ_282a475e-dbcf-455b-8e7f-3b7fdac439e8"
      unitRef="usd">344781000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNTAtMS0xLTEtODc0NQ_0618aa5d-e0e1-4d95-9c24-67b640d710e7"
      unitRef="usd">552827000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNTAtMy0xLTEtODc0NQ_5ad7c183-b5cd-4e55-95b6-19a9e902ebb3"
      unitRef="usd">396097000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOjFiNWVhYTdiNmM1ZDRhNTliOWM5OWU1Y2RhYjgyMWIzL3RhYmxlcmFuZ2U6MWI1ZWFhN2I2YzVkNGE1OWI5Yzk5ZTVjZGFiODIxYjNfNTAtNS0xLTEtODc0NQ_73c3a701-30af-4f63-a7d5-1aac36fa9755"
      unitRef="usd">268670000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:IncomeTaxesPaid
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMy0xLTEtMS04NzQ1_6c54b4ad-5f3a-47d7-9bdf-94065676dea2"
      unitRef="usd">19562000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMy0zLTEtMS04NzQ1_3138e347-5363-4167-88b6-2efcfec490d6"
      unitRef="usd">31628000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMy01LTEtMS04NzQ1_a6e2ffb5-48f7-4e1e-a03f-25b78c10c846"
      unitRef="usd">9675000</us-gaap:IncomeTaxesPaid>
    <us-gaap:InterestPaidNet
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfNC0xLTEtMS04NzQ1_c12bee9c-d73f-40fe-b6e2-8d243c59c161"
      unitRef="usd">858000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfNC0zLTEtMS04NzQ1_abb5bfc4-cad7-4401-bd4f-0dc8f882e496"
      unitRef="usd">1753000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfNC01LTEtMS04NzQ1_04b41d1c-80c0-4d6f-84a0-425483077ef2"
      unitRef="usd">549000</us-gaap:InterestPaidNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfNy0xLTEtMS04NzQ1_f20f0a42-b442-45dd-bf26-17376859959f"
      unitRef="usd">9338000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfNy0zLTEtMS04NzQ1_8bc48067-cfa3-4a06-857f-9dfc66d874f2"
      unitRef="usd">2211000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfNy01LTEtMS04NzQ1_3638bd7b-efc5-451a-9feb-e5b70e19b179"
      unitRef="usd">13912000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i9697a3ca30dd4537a13752d309cbf40a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfOC0xLTEtMS0yNTA3Ng_744de93a-1582-4e60-b135-1261ad3a8813"
      unitRef="usd">2589000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i0eb01a36c95d4e93ae0a960275048e71_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfOC0zLTEtMS0yNTA3Ng_88fae376-4ea6-48cb-b498-12f642328f96"
      unitRef="usd">0</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i034d4febd93748bfa4de828a28a09376_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfOC01LTEtMS0yNTA3Ng_5d507865-ea59-4e9f-a426-ebc56a0c47e3"
      unitRef="usd">0</us-gaap:LiabilitiesAssumed1>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMTEtMS0xLTEtNjQwNzY_1a0d6584-a27e-436f-9bd3-7a365bf414ac"
      unitRef="usd">4592000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="if41332d164fe48da8c8206c9a376b3d9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMTEtNS0xLTEtNjA4MjM_b99e56c0-a002-442d-b306-ca964d962c10"
      unitRef="usd">91019000</us-gaap:FairValueOfAssetsAcquired>
    <icui:NetCashPaidReceivedforcurrentandprioracquisitions
      contextRef="i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMTItMS0xLTEtNjQwNzY_652efa58-a329-478f-acec-a28043f2ad4b"
      unitRef="usd">14452000</icui:NetCashPaidReceivedforcurrentandprioracquisitions>
    <icui:NetCashPaidReceivedforcurrentandprioracquisitions
      contextRef="if41332d164fe48da8c8206c9a376b3d9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMTItNS0xLTEtNjA4MjM_1ccef729-430d-48c4-88ec-c80a186111da"
      unitRef="usd">76133000</icui:NetCashPaidReceivedforcurrentandprioracquisitions>
    <us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
      contextRef="if148011629fb4765963a61b648e50f64_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMTMtMS0xLTEtNjQwNzY_72e3b659-3bff-48bd-a425-01109c8c9c12"
      unitRef="usd">0</us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized>
    <us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
      contextRef="id0e931c53af9433c927233b79bd0bca8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMTMtNS0xLTEtNjA4MjM_14fd450d-f74a-4fd6-998c-f57d5f4c23f4"
      unitRef="usd">17300000</us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMTQtMS0xLTEtNjQwNzY_a2bac172-3786-40b0-8afc-88158eeb3523"
      unitRef="usd">10626000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="if41332d164fe48da8c8206c9a376b3d9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMTQtNS0xLTEtNjA4MjM_33636896-c5da-4b51-9d4b-fd45e103a5c0"
      unitRef="usd">20026000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMTUtMS0xLTEtNjQwNzY_ee8dbe94-6ba9-4ae7-828c-5dcb30b0b0f5"
      unitRef="usd">766000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="if41332d164fe48da8c8206c9a376b3d9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF82NC9mcmFnOjUwZTExN2ZkZGI0MzRjOTY5NDkyMTU2MWU1MmRhMmZhL3RhYmxlOmRiOTZhMzlkZDc0MTRmOTNiMDRkMmEwN2YxNTUwNTJkL3RhYmxlcmFuZ2U6ZGI5NmEzOWRkNzQxNGY5M2IwNGQyYTA3ZjE1NTA1MmRfMTUtNS0xLTEtNjA4MjM_67b6469a-adbc-44a9-99ad-96d43b5be456"
      unitRef="usd">17612000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1NjE_eb4f0da4-9f1a-4424-9d73-dc37f0be4ff3">BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Basis of Presentation and Preparation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ICU Medical,&#160;Inc. ("ICU" or "we"), a Delaware corporation, operates in one business segment engaged in the development, manufacturing and sale of innovative medical devices used in infusion therapy and critical care applications. We are one of the world's leading pure-play infusion therapy companies with a wide-ranging product portfolio that includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needlefree connectors designed to help meet clinical, safety and workflow goals. We sell the majority of our products through our direct sales force and through independent distributors throughout the U.S. and internationally. Additionally, we sell our products on an original equipment manufacturer basis to other medical device manufacturers. The manufacturing for all product groups occurs in Salt Lake City, Utah, Austin, Texas, Mexico and Costa Rica. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All subsidiaries are wholly owned and are included in the consolidated financial statements.&#160; All intercompany accounts and transactions have been eliminated.  Results of operations of companies purchased are included from the dates of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation.  These consolidated financial statements were prepared in accordance with accounting principles generally accepted in the U.S. ("GAAP").  Preparing financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;Actual results could differ from those estimates.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Cash, Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents are short-term, highly liquid investments that are readily convertible to known amounts of cash and have original maturities of three months or less from the date of purchase. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are stated at net realizable value.&#160; An allowance is provided for estimated collection losses based on an assessment of various factors.&#160; We consider prior payment trends, the age of the accounts receivable balances, financial status and other factors to estimate the cash which ultimately will be received.&#160; Such amounts cannot be known with certainty at the financial statement date.&#160; We regularly review individual past due balances for collectability.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost or net realizable value with cost determined using the first-in, first-out method.&#160; Inventory costs include material, labor and overhead related to the manufacturing of our products.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment consists of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land, building and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments placed with customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(436,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(376,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Instruments placed with customers consist of drug-delivery and monitoring systems placed with customers under operating leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All property, plant and equipment are stated at cost.&#160; We use the straight-line method for depreciating property, plant  and equipment over their estimated useful lives.&#160; Estimated useful lives are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 - 30 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 - 30 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery, equipment and molds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 - 15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 - 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments placed with customers&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We capitalize expenditures that materially increase the life of the related assets; maintenance and repairs are expensed as incurred.&#160;The costs and related accumulated depreciation applicable to property, plant and equipment sold or retired are removed from the accounts and any gain or loss is reflected in the statements of operations at the time of disposal. Depreciation expense was $65.9 million, $62.4 million and $59.3 million in 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We test goodwill for impairment on an annual basis in the month of November, or more frequently if an event occurs or circumstances change that would indicate that impairment may exist.&#160;Generally, we first perform a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If, based on an assessment of relevant qualitative factors, we determine that this is not the case, then the quantitative impairment test is not required to be performed. Conversely, if we determine based on the qualitative assessment that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, we will perform the quantitative impairment test. For the quantitative impairment test, we calculate the estimated fair value of the reporting unit. If the estimated fair value of the reporting unit is less than its carrying amount, the goodwill of the reporting unit is determined to be impaired. An impairment charge is recorded in an amount equal to the excess of the carrying amount over its estimated fair value, limited to the total amount of goodwill allocated to the reporting unit. For our annual impairment test for the year ended December 31, 2021, we performed a qualitative assessment and concluded that it was more likely than not that the fair value of our reporting unit exceeded its carrying amount, and therefore, no further impairment testing was required. There were no accumulated impairment losses as of December&#160;31, 2021, 2020 and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the carrying amount of our goodwill for 2021, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, we acquired Pursuit Vascular, Inc. ("Pursuit"), which resulted in $19.1&#160;million of goodwill. We also acquired a small foreign distributor, which resulted in $0.9&#160;million of goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, "Other" relates to a $1.3&#160;million measurement period adjustment to deferred taxes related to the Pursuit acquisition and foreign currency translation.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In 2021, we acquired a small foreign infusion systems supplier, which resulted in $10.6&#160;million of goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:27pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Life&lt;br/&gt;in Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-contractual customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internally developed software*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:27pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Life&lt;br/&gt;in Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-contractual customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internally developed software*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense was $23.8 million, $23.2 million and $17.7 million in 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, estimated annual amortization for our intangible assets for each of the next five years is approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our intangible assets that are not subject to amortization are reviewed annually for impairment or more often if there are indications of possible impairment.  We perform our annual intangible assets impairment test in November of each year. We did not have any intangible asset impairments in 2021, 2020 or 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We periodically evaluate the recoverability of long-lived assets whenever events and changes in circumstances indicate that the carrying amount of an asset may not be fully recoverable. When indicators of impairment are present, the carrying values of the assets are evaluated in relation to the operating performance and future undiscounted cash flows of the underlying business. The net book value of the underlying asset is adjusted to fair value if the sum of the expected discounted cash flows is less than book value. Fair values are based on estimates of market prices and assumptions concerning the amount and timing of estimated future cash flows and discount rates, reflecting varying degrees of perceived risk. We did not have any long-lived asset impairments in 2021, 2020 or 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Investment Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments, exclusive of cash equivalents, are marketable securities intended to be sold within one year and may include trading securities, available-for-sale securities, and held-to-maturity securities (if maturing within one year at &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the time of acquisition).  Long-term investments are marketable securities intended to be sold after one year and may include trading securities, available-for-sale securities, and held-to-maturity securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Available-for-sale Securities &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment securities are considered available-for-sale and currently consist of short-term and long-term corporate bonds. These securities are considered &#x201c;investment grade&#x201d; and are carried at fair value. We assess our investment in available-for-sale debt securities for impairment each reporting period. If an unrealized loss exists, we determine whether any portion of the decline in fair value below the carrying value is credit-related by reviewing several factors, including, but not limited to, the extent of the fair value decline and changes in the financial condition of the issuer. We record an impairment for credit-related losses through an allowance, limited to the amount of the unrealized loss. If we either intend to sell or it is more likely than not we will be required to sell the debt security before its anticipated recovery, any allowance is written off and the amortized cost basis is written down to fair value through a charge against net earnings. Unrealized gains and non-credit-related unrealized losses are recorded, net of tax, in other comprehensive income (loss). We did not have any investments in available-for-sale debt securities in unrealized loss positions as of December 31, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost of the debt securities is adjusted for the amortization of premiums computed under the effective interest method. Such amortization is included in other income, net in the consolidated statements of operations. Realized gains and losses are accounted for on the specific identification method. There have been no realized gains or losses on the disposal of these investments. The scheduled maturities of the debt securities are between 2022 and 2024. All short-term investment securities are callable within one year.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term and long-term investments in available-for-sale securities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Holding Gains (Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Holding Gains (Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Non-Marketable Equity Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the third quarter of 2021, we acquired approximately a 20.0% non-marketable equity interest in a nonpublic company and entered into a three-year distribution agreement where we have the exclusive rights to market, sell and distribute the company's products in exchange for a cash payment of $3.3&#160;million. In addition, we were granted an exclusive license for all of the seller's intellectual property. At the expiration of the distribution agreement we have the right but not the obligation to acquire the remaining interest in the business.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply the equity method of accounting for investments when we determine we have a significant influence, but not a controlling interest in the investee. We determine whether we have significant influence by considering key factors such as ownership interest, representation on the board of directors, participation in policy making decisions, business relationship and material intra-entity transactions, among other factors. Our equity method investment is reported at cost and adjusted each period for our share of the investee's income or (loss) and dividend paid, if any. We eliminate any intra-entity profits to the extent of our beneficial interest. We record our share of the investee's income or (loss) on a one quarter lag. We report our &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;proportionate share of the investee's income or (loss) resulting from this investment in other income, net in our consolidated statements of operations. The carrying value of our equity method investment is reported in other assets on the consolidated balance sheets. We assess our equity method investments for impairment on an annual basis or whenever events or circumstances indicate that the carrying value of the investment may not be recoverable. During 2021, there were no indications that our non-marketable equity method investment was impaired. Our recorded share of the investee's loss was not material for the year ended December 31, 2021. We did not receive any dividend distributions from this investment during 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our non-marketable equity method investment consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred taxes are determined based on the differences between the financial statements and the tax bases using rates as enacted in the laws. A valuation allowance is established if it is &#x201c;more likely than not&#x201d; that all or a portion of the deferred tax assets will not be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize interest and penalties related to unrecognized tax benefits in the tax provision. We recognize liabilities for uncertain tax positions when it is more likely than not that a tax position will not be sustained upon examination and settlement with various taxing authorities. Liabilities for uncertain tax positions are measured based upon the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. We have not recorded any material interest or penalties during any of the years presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Foreign Currency&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Generally, the functional currency of our international subsidiaries is the local currency. Generally, we translate the financial statements of these subsidiaries to U.S. dollars at the exchange rate in effect at the balance sheet date and revenues and expenses are translated at the average monthly exchange rates during the year. Certain of our international subsidiaries consolidate first with another subsidiary that utilizes a functional currency other than U.S. dollars.&#160;In those cases, we follow a step by step translation process utilizing the same sequence as the consolidation process.&#160;Translation adjustments are recorded as a component of accumulated other comprehensive loss, a separate component of stockholders' equity on our consolidated balance sheets and the effect of exchange rate changes on cash and cash equivalents are reflected on our consolidated statements of cash flows.&#160;Gains and losses for transactions denominated in a currency other than the functional currency of the entity are included in our consolidated statements of operations in other income, net. Foreign currency transaction losses (gains), net were $1.0 million, $7.2 million and $(0.7) million in 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenues when we transfer control of promised goods to our customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods.  We offer certain volume-based rebates to our distribution customers, which we consider variable consideration when calculating the transaction price. Rebates are offered on both a fixed and tiered/variable basis. In both cases, we use information available at the time and our historical experience with each customer to estimate the most likely rebate amount. We also provide chargebacks to distributors that sell to end customers at prices determined under a contract between us and the end customer. Chargebacks are the difference between prices we charge our distribution customers and contracted prices we have with the end customer which are processed as credits to our distribution customers. In estimating the expected value of chargeback amounts for use in determining the transaction price, we use information available at the time, including our historical experience. We also warrant products against defects and have a policy permitting the return of defective products, for which we accrue and expense at the time of sale using information available and our historical experience. Our revenues are recorded at the net sales price, which includes an estimate for variable consideration related to rebates, chargebacks and product returns.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The vast majority of our sales of Infusion Consumables, Infusion Systems, IV Solutions and Critical Care products are sold on a standalone basis and control of these products transfers to the customer upon shipment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our software license renewals are considered to be transferred to a customer at a point in time at the start of each renewal period, therefore revenue is recognized at that time.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Arrangements with Multiple Deliverables&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In certain circumstances, we enter into arrangements in which we provide multiple deliverables to our customers.  These bundled arrangements typically consist of the sale of infusion systems equipment, along with annual software licenses and related software implementation services, as well as infusion consumables, IV solutions and extended warranties. Our most significant judgments related to these arrangements are (i) identifying the various performance obligations and (ii) estimating the relative standalone selling price of each performance obligation, typically using a directly observable method or calculated on a cost plus margin basis method.  Revenue related to the bundled equipment, software and software implementation services are typically combined into a single performance obligation and recognized upon implementation. As annual software licenses are renewed, we recognize revenue for the license at a point in time, at the start of each annual renewal period. The transaction price allocated to the extended service-type warranty is recognized as revenue over the period the warranty service is provided. Consumables and solutions are separate performance obligations, recognized at a point in time.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Shipping Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs to ship finished goods to our customers are included in cost of goods sold on the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Advertising Expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising expenses are expensed as incurred and reflected in selling, general and administrative expenses in our consolidated statements of operations and were $0.2 million, $0.2 million and $0.1 million in 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Post-retirement and Post-employment Benefits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sponsor a Section&#160;401(k)&#160;retirement plan ("plan") for employees.&#160;Our contributions to our 401(k) plan were approximately $11.0 million, $10.7 million and $11.4 million in 2021, 2020 and 2019, respectively. We also have post-retirement and post-employment obligations related to employees located in certain international countries. These obligations are immaterial to our financial statements taken as a whole.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of our research and development costs are expensed as incurred.  In certain circumstances when an asset will have an alternative future use we capitalize the costs related to those assets.  Research and development costs include salaries and related benefits, consulting fees, production supplies, samples, travel costs, utilities and other miscellaneous administrative costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Net Income Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income per share is computed by dividing net income by the weighted-average number of common shares outstanding. Diluted net income per share is computed by dividing net income by the weighted-average number of common shares outstanding plus dilutive securities.&#160;Dilutive securities include outstanding common stock options and unvested restricted stock units, less the number of shares that could have been purchased with the proceeds from the exercise of the options, using the treasury stock method. Options that are anti-dilutive, where their exercise price exceeds the average market price of the common stock, are not included in the treasury stock method calculation. Restricted stock units that are anti-dilutive are not included in the treasury stock method. There were 12,354, 12,083 and 10,760 anti-dilutive shares in 2021, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of net earnings per common share (&#x201c;EPS&#x201d;) &#x2014; basic and diluted (in thousands, except per share data):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&#160;ended&#160;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares outstanding (basic)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common and common equivalent shares outstanding&#160;(diluted)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EPS &#x2014; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EPS &#x2014; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;New Accounting Pronouncements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Standards &lt;/span&gt;&lt;/div&gt;In March 2020, the Financial Accounting Standards Board ("FASB")  issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide optional guidance for a limited period of time to ease the potential burden for reference rate reform on financial reporting. Due to concerns about structural risks of interbank offered rates and, particularly, the risk of cessation of the London Interbank Offered Rate ("LIBOR"), regulators around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation. The amendments in this update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued as a result of reference rate reform. Optional expedients may be applied to contracts that are modified as a result of the reference rate reform. Modifications of contracts within the scope of Topic 470, Debt, should be accounted for by prospectively adjusting the effective interest rate. Modifications of contracts within the scope of ASC 842, Leases, should be accounted for as a continuation of the existing contracts with no reassessments of the lease classification and the discount rate (incremental borrowing rate). Exceptions to Topic 815, Derivatives and Hedging, results in not having a dedesignation of a hedging relationship if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. In November 2021, we entered into two forward-starting swaps whereby the variable leg of the swap references LIBOR, these swaps will be amended in early 2022 to transition to an alternative reference rate (see Note 7: Derivatives and Hedging Activities). The amendments in this ASU allow for certain expedients that will allow us to assume that our hedged interest payments are probable of occurring regardless of any expected modification in their terms related to reference rate reform and will allow us to continue hedge accounting for a cash flow hedge for which the hedged interest rate risk changes if the hedge is highly effective under ASC 815, Derivatives and Hedging or the optional expedient under this ASU is elected. The impact of this ASU on our contracts has not been and is not expected to be material.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1MDE_600e0f4f-7677-46a0-8bea-ce54dc997f37">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Basis of Presentation and Preparation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ICU Medical,&#160;Inc. ("ICU" or "we"), a Delaware corporation, operates in one business segment engaged in the development, manufacturing and sale of innovative medical devices used in infusion therapy and critical care applications. We are one of the world's leading pure-play infusion therapy companies with a wide-ranging product portfolio that includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needlefree connectors designed to help meet clinical, safety and workflow goals. We sell the majority of our products through our direct sales force and through independent distributors throughout the U.S. and internationally. Additionally, we sell our products on an original equipment manufacturer basis to other medical device manufacturers. The manufacturing for all product groups occurs in Salt Lake City, Utah, Austin, Texas, Mexico and Costa Rica. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All subsidiaries are wholly owned and are included in the consolidated financial statements.&#160; All intercompany accounts and transactions have been eliminated.  Results of operations of companies purchased are included from the dates of acquisition.&lt;/span&gt;&lt;/div&gt;The consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation.  These consolidated financial statements were prepared in accordance with accounting principles generally accepted in the U.S. ("GAAP").</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTgz_8f1e1524-f3c9-42b7-b200-59408e11d9dd"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:UseOfEstimates
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM2Njc_a95f7d9a-0fe9-49e8-b9b6-c9ab9c3a32e4">Preparing financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1NjI_704fb350-25da-4a4c-af8c-5de93f1b1c4d">Cash equivalents are short-term, highly liquid investments that are readily convertible to known amounts of cash and have original maturities of three months or less from the date of purchase.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM2NDY_95495be5-9970-48d8-85f5-efd1005f0aa8">Accounts receivable are stated at net realizable value.&#160; An allowance is provided for estimated collection losses based on an assessment of various factors.&#160; We consider prior payment trends, the age of the accounts receivable balances, financial status and other factors to estimate the cash which ultimately will be received.&#160; Such amounts cannot be known with certainty at the financial statement date.&#160; We regularly review individual past due balances for collectability.</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM2MTU_6c1cfc3f-b547-43a4-905c-ce425e55c9db">Inventories are stated at the lower of cost or net realizable value with cost determined using the first-in, first-out method.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM2Mzc_689ec4cf-c96a-4f79-b47c-6769f8aca576">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjJjZjFiYzFmZjRiMTQ1YWE5ZjcwMWM2NGU0OGQxMDQwL3RhYmxlcmFuZ2U6MmNmMWJjMWZmNGIxNDVhYTlmNzAxYzY0ZTQ4ZDEwNDBfMi0xLTEtMS04NzQ1_198b789e-b4a7-4ef3-8339-ca7f8f316162"
      unitRef="usd">135528000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjJjZjFiYzFmZjRiMTQ1YWE5ZjcwMWM2NGU0OGQxMDQwL3RhYmxlcmFuZ2U6MmNmMWJjMWZmNGIxNDVhYTlmNzAxYzY0ZTQ4ZDEwNDBfMi0zLTEtMS04NzQ1_1114882b-de67-428d-ba5a-01acb719cec3"
      unitRef="usd">126499000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjJjZjFiYzFmZjRiMTQ1YWE5ZjcwMWM2NGU0OGQxMDQwL3RhYmxlcmFuZ2U6MmNmMWJjMWZmNGIxNDVhYTlmNzAxYzY0ZTQ4ZDEwNDBfMy0xLTEtMS04NzQ1_afc0bd3a-bcb7-41c5-87d1-286e33cabfaa"
      unitRef="usd">36490000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjJjZjFiYzFmZjRiMTQ1YWE5ZjcwMWM2NGU0OGQxMDQwL3RhYmxlcmFuZ2U6MmNmMWJjMWZmNGIxNDVhYTlmNzAxYzY0ZTQ4ZDEwNDBfMy0zLTEtMS04NzQ1_d60f2400-97c8-4113-8b3d-0ac5536a4c7d"
      unitRef="usd">33053000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjJjZjFiYzFmZjRiMTQ1YWE5ZjcwMWM2NGU0OGQxMDQwL3RhYmxlcmFuZ2U6MmNmMWJjMWZmNGIxNDVhYTlmNzAxYzY0ZTQ4ZDEwNDBfNC0xLTEtMS04NzQ1_ab8604be-974c-4a53-9e3f-4bf188bb74aa"
      unitRef="usd">118217000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjJjZjFiYzFmZjRiMTQ1YWE5ZjcwMWM2NGU0OGQxMDQwL3RhYmxlcmFuZ2U6MmNmMWJjMWZmNGIxNDVhYTlmNzAxYzY0ZTQ4ZDEwNDBfNC0zLTEtMS04NzQ1_ef5b13d3-7615-4aac-9c8b-3cf091d4d77e"
      unitRef="usd">155376000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjJjZjFiYzFmZjRiMTQ1YWE5ZjcwMWM2NGU0OGQxMDQwL3RhYmxlcmFuZ2U6MmNmMWJjMWZmNGIxNDVhYTlmNzAxYzY0ZTQ4ZDEwNDBfNS0xLTEtMS04NzQ1_5675f141-a54d-4422-9248-c5a35ada4597"
      unitRef="usd">290235000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjJjZjFiYzFmZjRiMTQ1YWE5ZjcwMWM2NGU0OGQxMDQwL3RhYmxlcmFuZ2U6MmNmMWJjMWZmNGIxNDVhYTlmNzAxYzY0ZTQ4ZDEwNDBfNS0zLTEtMS04NzQ1_dcbda5a2-b9f8-4ce6-9717-c67dc36808b9"
      unitRef="usd">314928000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM2NDM_e1b71ad6-f842-4b40-9128-b60ed42f25c6">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment consists of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land, building and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments placed with customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(436,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(376,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Instruments placed with customers consist of drug-delivery and monitoring systems placed with customers under operating leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All property, plant and equipment are stated at cost.&#160; We use the straight-line method for depreciating property, plant  and equipment over their estimated useful lives.&#160; Estimated useful lives are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 - 30 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 - 30 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery, equipment and molds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 - 15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 - 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments placed with customers&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i61afae90e5b84b36ad1ae6cc021d0eb0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfMi0xLTEtMS04NzQ1_4431e0d7-b649-48f2-9989-83215198394f"
      unitRef="usd">321078000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6086d7242cd44ebcb7bd1c37761445d5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfMi0zLTEtMS04NzQ1_f76ab6bd-e088-4554-a572-af5fb0163b6c"
      unitRef="usd">291331000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia714b658a4174f91844900438be27249_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfMy0xLTEtMS04NzQ1_e3ead90e-ef1e-41cb-a225-1db4d035a20e"
      unitRef="usd">243377000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i072ea93b43554548bfb1b2e60418ef0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfMy0zLTEtMS04NzQ1_c6a07408-8be4-45e4-88ae-afde69068b21"
      unitRef="usd">241199000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id27451c8315e494eb9d5b71d3102e1d3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfNC0xLTEtMS04NzQ1_96236f73-e008-403a-a241-9e0b05cc4b89"
      unitRef="usd">60463000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i396219abad3d4dd5aecaca9b955a4a80_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfNC0zLTEtMS04NzQ1_57667333-35ee-48e9-9877-d59b9ab8ee2f"
      unitRef="usd">60381000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7a69e96fceee4aa4a6456cdac483fa6b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfNS0xLTEtMS04NzQ1_245491a3-2054-4cef-9868-7b203cf2bda5"
      unitRef="usd">102979000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2bb5314a15ad4728830028bd25e4817c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfNS0zLTEtMS04NzQ1_e6fdeff9-5e6b-402a-b6a8-9e015dfc968d"
      unitRef="usd">98311000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie2b2515c8fa54706a4876347394a8195_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfNi0xLTEtMS04NzQ1_3baf4b2f-bbb5-438c-8d2f-9ca5b99200ed"
      unitRef="usd">7670000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iefe3d36c64db435783d6b6b62e9f4928_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfNi0zLTEtMS04NzQ1_665dbe09-55b7-4081-a182-2f9a27857fdf"
      unitRef="usd">7767000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i868fc2b21a40468eb90303a40fa1cde7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfNy0xLTEtMS04NzQ1_8dcc3541-d9b2-47ce-82d7-d15a8c11d4ee"
      unitRef="usd">97384000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0b8361146b8345eba9e837855e840ccf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfNy0zLTEtMS04NzQ1_6fa195c7-4b56-4293-9e52-4c9f3dc68d5a"
      unitRef="usd">90383000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ife75bb8b09044301a656828fd088ef78_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfOC0xLTEtMS04NzQ1_e4bba9f9-436a-4c6d-8fa8-67931c58ef8d"
      unitRef="usd">72153000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib215ff3938424c87b3535b21a2d24f0c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfOC0zLTEtMS04NzQ1_23b2c603-e92e-4204-91ce-7c179b80809e"
      unitRef="usd">53724000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfOS0xLTEtMS04NzQ1_05c6ba87-af84-4685-9d22-90dcce91488a"
      unitRef="usd">905104000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfOS0zLTEtMS04NzQ1_d89dc577-3c91-4916-9d62-ef5fd4318471"
      unitRef="usd">843096000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfMTAtMS0xLTEtODc0NQ_392bebae-4823-4e20-9326-23497b538361"
      unitRef="usd">436739000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfMTAtMy0xLTEtODc0NQ_cd3f5d35-c594-4a58-bb0d-2fc6ef3bcb5e"
      unitRef="usd">376468000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfMTEtMS0xLTEtODc0NQ_b588747c-13ce-4d57-bb1b-97c9ca5320c7"
      unitRef="usd">468365000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2YTBmYThkYzczNzQ1M2Y4ZjU0YmM4OWY1ZmIwYjNmL3RhYmxlcmFuZ2U6YTZhMGZhOGRjNzM3NDUzZjhmNTRiYzg5ZjVmYjBiM2ZfMTEtMy0xLTEtODc0NQ_0443d440-ce92-45a7-9c19-83b30dcfee1d"
      unitRef="usd">466628000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1MjA_8f0d5009-9e98-4fa2-b209-d7546d0bbbfd">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All property, plant and equipment are stated at cost.&#160; We use the straight-line method for depreciating property, plant  and equipment over their estimated useful lives.&#160; Estimated useful lives are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 - 30 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 - 30 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery, equipment and molds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 - 15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 - 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments placed with customers&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We capitalize expenditures that materially increase the life of the related assets; maintenance and repairs are expensed as incurred.&#160;The costs and related accumulated depreciation applicable to property, plant and equipment sold or retired are removed from the accounts and any gain or loss is reflected in the statements of operations at the time of disposal. Depreciation expense was $65.9 million, $62.4 million and $59.3 million in 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="i822011b5ee894121826591876ad1fae1_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfMC0xLTEtMS04NzQ1L3RleHRyZWdpb246MWVkYTI2NGYwYTA1NDQ5ZTg0MzQzNTg2MTNiMzAxZGNfNA_915a3dc8-9f8a-487f-bb3a-0c7bc6d2ea85">15</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="i318960434e7e4294b988d5e93c86f870_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfMC0xLTEtMS04NzQ1L3RleHRyZWdpb246MWVkYTI2NGYwYTA1NDQ5ZTg0MzQzNTg2MTNiMzAxZGNfOQ_f97f0e4d-3d3c-4cc5-938f-15987f6c031e">30</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="i4df894472d734b8ea99f933093d6cae5_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfMS0xLTEtMS04NzQ1L3RleHRyZWdpb246YmMyN2EyM2FlYTIzNDE1MTkzNmYxMzhlZTc1YjM1MzNfNA_3f5a7a19-d1f7-42e1-871f-6d490f1abcf6">15</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="i50ca67d9370d4702bb30549193450259_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfMS0xLTEtMS04NzQ1L3RleHRyZWdpb246YmMyN2EyM2FlYTIzNDE1MTkzNmYxMzhlZTc1YjM1MzNfOQ_46ad0728-138c-40ba-be6b-5c45fb593d35">30</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="ic799598d554f43749764085e6183fa72_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfMi0xLTEtMS04NzQ1L3RleHRyZWdpb246ZGI0M2QwMzNlMzc1NDM5Nzk3NjY5NjIxM2Q0NGZkY2ZfNA_41cfc21d-2270-4f5d-aeca-d8accd6e1e54">2</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="i4fd10f7ed125461b83e7cc71c92b31ff_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfMi0xLTEtMS04NzQ1L3RleHRyZWdpb246ZGI0M2QwMzNlMzc1NDM5Nzk3NjY5NjIxM2Q0NGZkY2ZfOQ_5b38b0f0-2f5c-4c8d-b27e-4e551a9f873e">15</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="i1743cebe76c945e1b53dd6ed012b1f15_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfMy0xLTEtMS04NzQ1L3RleHRyZWdpb246MDM0YzMwNmJmOGE4NDExOWI2NmM4NGZkNWJhYzljN2VfNA_455655ad-5819-4f58-b050-84b3f0b4c904">2</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="i980084a01dc24101ade4b0ce4d4f2ce3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfMy0xLTEtMS04NzQ1L3RleHRyZWdpb246MDM0YzMwNmJmOGE4NDExOWI2NmM4NGZkNWJhYzljN2VfOQ_2dfb4496-411b-424d-852a-626111e75913">5</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="i40993659cc874b8bb50c9566a7d7ee5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfNC0xLTEtMS04NzQ1L3RleHRyZWdpb246MTYyYzQ3YzRkZDI5NDhlOGFkZmZlYjFhNDFiMTkwZDJfNA_94776586-0047-4c04-b526-12895ba12881">3</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="ica576ec13c89445ca41b2ba35b3a09d6_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfNC0xLTEtMS04NzQ1L3RleHRyZWdpb246MTYyYzQ3YzRkZDI5NDhlOGFkZmZlYjFhNDFiMTkwZDJfOQ_616e049b-973f-4f38-8031-c11e0359e64a">5</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="i2faa6bd24f85459f9cccb242cb8eb478_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfNS0xLTEtMS04NzQ1L3RleHRyZWdpb246NDUxODE3MjU1ZDIzNDQ0Mzk0YjVmYTEzNDQ1NTY0NGNfNA_fe1b31d3-10e0-4ce3-9701-bae62079055e">3</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="ib7d30235ed5b4d94bcfbe47e561d432b_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjE3MTFkMmNmMzlkZjRkOWJhYWE1MzYxMTkwM2UzY2I4L3RhYmxlcmFuZ2U6MTcxMWQyY2YzOWRmNGQ5YmFhYTUzNjExOTAzZTNjYjhfNS0xLTEtMS04NzQ1L3RleHRyZWdpb246NDUxODE3MjU1ZDIzNDQ0Mzk0YjVmYTEzNDQ1NTY0NGNfOQ_8f040703-3bb1-4cbd-9a81-bfc5c97b3875">10</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:Depreciation
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMzkzNQ_3c74f379-c13c-4369-a184-4161921f19df"
      unitRef="usd">65900000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMzkzOQ_2fac7ccb-7bd8-4ae3-aa12-f79b8a812dc9"
      unitRef="usd">62400000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMzk0Ng_d1f05750-1c33-41b8-970f-e3b7b0efda76"
      unitRef="usd">59300000</us-gaap:Depreciation>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1ODI_248ef9b1-4115-40ee-872f-d98f01c47f63">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;We test goodwill for impairment on an annual basis in the month of November, or more frequently if an event occurs or circumstances change that would indicate that impairment may exist.&#160;Generally, we first perform a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If, based on an assessment of relevant qualitative factors, we determine that this is not the case, then the quantitative impairment test is not required to be performed. Conversely, if we determine based on the qualitative assessment that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, we will perform the quantitative impairment test. For the quantitative impairment test, we calculate the estimated fair value of the reporting unit. If the estimated fair value of the reporting unit is less than its carrying amount, the goodwill of the reporting unit is determined to be impaired. An impairment charge is recorded in an amount equal to the excess of the carrying amount over its estimated fair value, limited to the total amount of goodwill allocated to the reporting unit. For our annual impairment test for the year ended December 31, 2021, we performed a qualitative assessment and concluded that it was more likely than not that the fair value of our reporting unit exceeded its carrying amount, and therefore, no further impairment testing was required.</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1NDE_7aa429b1-e043-467b-b339-cf2724b1d3e0">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the carrying amount of our goodwill for 2021, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, we acquired Pursuit Vascular, Inc. ("Pursuit"), which resulted in $19.1&#160;million of goodwill. We also acquired a small foreign distributor, which resulted in $0.9&#160;million of goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, "Other" relates to a $1.3&#160;million measurement period adjustment to deferred taxes related to the Pursuit acquisition and foreign currency translation.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In 2021, we acquired a small foreign infusion systems supplier, which resulted in $10.6&#160;million of goodwill.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ic2b82bbcf5cb45739937a1040ed30f6b_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2NmU4ZTg3MjU3YjQyZDhiY2I4MDhiMGQ4N2M1ZGMyL3RhYmxlcmFuZ2U6YTY2ZThlODcyNTdiNDJkOGJjYjgwOGIwZDg3YzVkYzJfMS0yLTEtMS04NzQ1_5b71ee5a-553a-4d72-922d-dbc5efe60f3f"
      unitRef="usd">11195000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2NmU4ZTg3MjU3YjQyZDhiY2I4MDhiMGQ4N2M1ZGMyL3RhYmxlcmFuZ2U6YTY2ZThlODcyNTdiNDJkOGJjYjgwOGIwZDg3YzVkYzJfMi0yLTEtMS04NzQ1_ee5b9311-6416-4d2b-964a-1091205675d6"
      unitRef="usd">20026000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2NmU4ZTg3MjU3YjQyZDhiY2I4MDhiMGQ4N2M1ZGMyL3RhYmxlcmFuZ2U6YTY2ZThlODcyNTdiNDJkOGJjYjgwOGIwZDg3YzVkYzJfMy0yLTEtMS04NzQ1_642d1632-4c52-4791-9d6b-e18e9d7c40e7"
      unitRef="usd">24000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2NmU4ZTg3MjU3YjQyZDhiY2I4MDhiMGQ4N2M1ZGMyL3RhYmxlcmFuZ2U6YTY2ZThlODcyNTdiNDJkOGJjYjgwOGIwZDg3YzVkYzJfNC0yLTEtMS04NzQ1_06dceb19-f689-432b-8f19-a4c56ae62218"
      unitRef="usd">31245000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2NmU4ZTg3MjU3YjQyZDhiY2I4MDhiMGQ4N2M1ZGMyL3RhYmxlcmFuZ2U6YTY2ZThlODcyNTdiNDJkOGJjYjgwOGIwZDg3YzVkYzJfNi0yLTEtMS04NzQ1_e5a8517d-f6df-4475-a1c7-e2e697408297"
      unitRef="usd">1756000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2NmU4ZTg3MjU3YjQyZDhiY2I4MDhiMGQ4N2M1ZGMyL3RhYmxlcmFuZ2U6YTY2ZThlODcyNTdiNDJkOGJjYjgwOGIwZDg3YzVkYzJfNy0yLTEtMS04NzQ1_fbd34a96-24f8-493d-bb2e-69587a5ded6a"
      unitRef="usd">33001000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2NmU4ZTg3MjU3YjQyZDhiY2I4MDhiMGQ4N2M1ZGMyL3RhYmxlcmFuZ2U6YTY2ZThlODcyNTdiNDJkOGJjYjgwOGIwZDg3YzVkYzJfOC0yLTEtMS04NzQ1_ba643052-a7ec-4b11-b2f6-45bc99dbce18"
      unitRef="usd">10626000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2NmU4ZTg3MjU3YjQyZDhiY2I4MDhiMGQ4N2M1ZGMyL3RhYmxlcmFuZ2U6YTY2ZThlODcyNTdiNDJkOGJjYjgwOGIwZDg3YzVkYzJfOS0yLTEtMS04NzQ1_192ee25c-e390-45cf-a483-d371aede3cf5"
      unitRef="usd">-188000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmE2NmU4ZTg3MjU3YjQyZDhiY2I4MDhiMGQ4N2M1ZGMyL3RhYmxlcmFuZ2U6YTY2ZThlODcyNTdiNDJkOGJjYjgwOGIwZDg3YzVkYzJfMTAtMi0xLTEtODc0NQ_64c9654d-2ad3-492d-a592-5befc0adfffb"
      unitRef="usd">43439000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i89ee2db57d0940749f8358a063c8a2a1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMzI5ODUzNDkyMjEwMg_80724b3b-8826-4236-b098-21dec644148f"
      unitRef="usd">19100000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia3bf6d7cdae3492fbe677ee76c1cb8ac_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMzI5ODUzNDkyMjExNw_22d89b3b-9330-4122-8f86-b61753cee06d"
      unitRef="usd">900000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ic5bfa62a49ec4bacbfe8ca5e5984c085_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfNDk3OA_19eaf289-2518-4ca9-bbe7-7ae023ef1383"
      unitRef="usd">1300000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjc0ODc3OTEyNTkzNA_cf2de229-cb73-447f-a284-61419713114a"
      unitRef="usd">10600000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM0OTk_85ad02c1-a550-415b-b8c1-8e261a1b1c9f">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:27pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Life&lt;br/&gt;in Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-contractual customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internally developed software*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:27pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Life&lt;br/&gt;in Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-contractual customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internally developed software*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1ODY_f9944f4e-6596-4280-bbea-9c558f57ce00">Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i8086db60836949cea234f284bb9446be_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMi0yLTEtMS04NzQ1_baff1868-f7f8-48c4-96c8-43d64c3ecb91">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ife577e5d213f40d098d9178ce5ed5c02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMi00LTEtMS04NzQ1_08af983d-5271-4af0-85cb-4a1fdb4d0036"
      unitRef="usd">27429000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ife577e5d213f40d098d9178ce5ed5c02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMi02LTEtMS04NzQ1_883782f6-d0ce-4115-bebd-b2800891d71e"
      unitRef="usd">16764000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ife577e5d213f40d098d9178ce5ed5c02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMi04LTEtMS04NzQ1_96ae8154-bc9b-4d1c-9b71-3b817ea08f2e"
      unitRef="usd">10665000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i3f08a7535a0c4ae593f5fdb4d1908ae3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMy0yLTEtMS04NzQ1_eca7e56b-5a82-4736-98d9-447427d237c9">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i23400b23c1e244b8be1368b5b1d1feda_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMy00LTEtMS04NzQ1_cd018c94-26cc-4e8b-8938-9f68aed39c12"
      unitRef="usd">10412000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i23400b23c1e244b8be1368b5b1d1feda_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMy02LTEtMS04NzQ1_c608d97d-5c3c-476d-bace-e6decdb6d3b0"
      unitRef="usd">6196000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i23400b23c1e244b8be1368b5b1d1feda_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMy04LTEtMS04NzQ1_9e1f9e60-effd-453c-9201-4e39080ef1ab"
      unitRef="usd">4216000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ia9ad9660b38a4c59af223be9f97ad9a2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNC0yLTEtMS04NzQ1_2c154102-df41-4abe-b96a-11eba540bf9a">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i94bfb3c1291d4f5ea822b381ec4471a5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNC00LTEtMS04NzQ1_86f658cc-07f8-465d-b4ab-481a185b56d6"
      unitRef="usd">57316000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i94bfb3c1291d4f5ea822b381ec4471a5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNC02LTEtMS04NzQ1_9e5e7da4-5b9e-49b4-8da9-a0c2f96bb0c9"
      unitRef="usd">33004000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i94bfb3c1291d4f5ea822b381ec4471a5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNC04LTEtMS04NzQ1_8c8e7c8b-6a0f-4605-b5f8-a795a5ad438a"
      unitRef="usd">24312000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i67322613ac0a460da4f4187ecad1ca17_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNS0yLTEtMS04NzQ1_62ebf4af-74f6-4690-93df-f902ceed0526">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iabdb763a977547f398fe485e2aa320a0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNS00LTEtMS04NzQ1_4ddecb94-23c7-4729-b8d7-df17882ecc00"
      unitRef="usd">425000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iabdb763a977547f398fe485e2aa320a0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNS02LTEtMS04NzQ1_a26ba8a4-e0f2-4223-ade6-5fb3aa8b2ef9"
      unitRef="usd">425000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iabdb763a977547f398fe485e2aa320a0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNS04LTEtMS04NzQ1_35f7f732-390e-4e92-89cb-77d19ac63850"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i51d012416f844ef69b4d06482f83559a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNi0yLTEtMS04NzQ1_65c71bdb-1cb7-4358-a2a9-4530d57d2d5b">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0ad98788582c4b17b4c46945d8400c45_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNi00LTEtMS04NzQ1_b953c626-1bcb-4c40-8006-9cd9f67d687d"
      unitRef="usd">18260000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0ad98788582c4b17b4c46945d8400c45_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNi02LTEtMS04NzQ1_59811b66-f73f-4a28-95b5-4eb53c172eb7"
      unitRef="usd">4731000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0ad98788582c4b17b4c46945d8400c45_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNi04LTEtMS04NzQ1_fa15407b-8651-4803-96a7-a6da58a98212"
      unitRef="usd">13529000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iac77f6f1c1154bc8a57fd11e9cacd63c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNy0yLTEtMS04NzQ1_11e9ef1f-1659-438f-9fb6-6ee14dafa22b">P13Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i61f07bcb26004cbfb2eb785632880532_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNy00LTEtMS04NzQ1_b49406b3-b8d2-4434-9400-8162fd0a2185"
      unitRef="usd">152893000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i61f07bcb26004cbfb2eb785632880532_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNy02LTEtMS04NzQ1_0d76be99-5907-4057-a2fd-b2443f1255dc"
      unitRef="usd">49406000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i61f07bcb26004cbfb2eb785632880532_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfNy04LTEtMS04NzQ1_b9c907d1-c0be-4aa3-965f-3ff0967c614a"
      unitRef="usd">103487000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="id5895f4898494fbcb93a3646e38e38e9_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfOC0yLTEtMS04NzQ1_a0350469-137b-45b2-b403-4f0bc7a39e53">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id2a1a60f23694878b292a8b8e642f7f7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfOC00LTEtMS04NzQ1_4b780244-6ac1-469a-b605-67d1170edc91"
      unitRef="usd">9100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id2a1a60f23694878b292a8b8e642f7f7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfOC02LTEtMS04NzQ1_9015ce54-cf77-42ce-91d3-85d06d9462a2"
      unitRef="usd">2356000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id2a1a60f23694878b292a8b8e642f7f7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfOC04LTEtMS04NzQ1_46f52efa-b869-409d-b26a-742083315138"
      unitRef="usd">6744000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfOS00LTEtMS04NzQ1_95669cf7-69df-4348-91ba-cf1e52ad4e87"
      unitRef="usd">275835000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfOS02LTEtMS04NzQ1_e414347e-6d82-4363-b2af-11d0ad087c8e"
      unitRef="usd">112882000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfOS04LTEtMS04NzQ1_ee1cc144-dcc6-4a0f-9869-fb700508d87b"
      unitRef="usd">162953000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6da6e9834cb04c8aa17f5c4e02ded7c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMTEtNC0xLTEtODc0NQ_dfa7d21d-8348-4a97-a2b6-1ef3640cf1e0"
      unitRef="usd">25358000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6da6e9834cb04c8aa17f5c4e02ded7c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMTEtOC0xLTEtODc0NQ_6f68045e-7625-497b-ab55-95f09c50a843"
      unitRef="usd">25358000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMTMtNC0xLTEtODc0NQ_3c25c24a-3f26-4bc7-a8e7-6e839c8b6187"
      unitRef="usd">301193000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMTMtNi0xLTEtODc0NQ_1c347630-f7b8-47e6-8246-25bb1a8dbbbb"
      unitRef="usd">112882000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjRjNDkwN2JmYzEwNDQ5ZjE5ZGY2MGYyMDUyOTg3OGQ0L3RhYmxlcmFuZ2U6NGM0OTA3YmZjMTA0NDlmMTlkZjYwZjIwNTI5ODc4ZDRfMTMtOC0xLTEtODc0NQ_4679d0fe-0e14-4053-a77a-b787d038385a"
      unitRef="usd">188311000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ib00800b3296448d1a1aaa2ee891468e8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMi0yLTEtMS04NzQ1_45cb6ac9-f25a-4401-a042-040bd418a2ee">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if9c99a7ffc344097b04bba35817b6ec1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMi00LTEtMS04NzQ1_0e29737a-e233-4db5-ad3e-548c2666e938"
      unitRef="usd">24797000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if9c99a7ffc344097b04bba35817b6ec1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMi02LTEtMS04NzQ1_7b80604f-5820-4842-8c5a-ce6c09ca3d3f"
      unitRef="usd">15056000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if9c99a7ffc344097b04bba35817b6ec1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMi04LTEtMS04NzQ1_725c9995-fcaa-4d8d-971f-724c88809ccc"
      unitRef="usd">9741000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if022b8b9f44c46cc9f1a9647646caf11_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMy0yLTEtMS04NzQ1_cfc32bfe-dcef-490b-b270-ab74c83419da">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1c1c4ee566ca4ff0a0939c34c6f27d97_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMy00LTEtMS04NzQ1_a5ece1ae-e6b5-4c2c-b34f-962c1b8702c9"
      unitRef="usd">10365000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1c1c4ee566ca4ff0a0939c34c6f27d97_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMy02LTEtMS04NzQ1_c5f4ce79-977b-4a7b-a169-a520009cbc2c"
      unitRef="usd">5852000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1c1c4ee566ca4ff0a0939c34c6f27d97_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMy04LTEtMS04NzQ1_dab0443f-5a29-4ba6-8066-31610da45f99"
      unitRef="usd">4513000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i921788560f30477b876f3a224b358d25_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNC0yLTEtMS04NzQ1_eb0d38be-5b29-43f0-8098-85380402f315">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id4906e0126214b09aa3b35cb86a5cbd3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNC00LTEtMS04NzQ1_d45c124f-91b4-4e58-8f89-161fd06722c9"
      unitRef="usd">58061000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id4906e0126214b09aa3b35cb86a5cbd3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNC02LTEtMS04NzQ1_f072f360-b337-4996-ab4d-06d30b40216f"
      unitRef="usd">26711000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id4906e0126214b09aa3b35cb86a5cbd3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNC04LTEtMS04NzQ1_43558b69-025d-40d7-a84b-67982cce75f3"
      unitRef="usd">31350000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic0af18a5e59b4620b0a5bf6fba3fc7a7_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNS0yLTEtMS04NzQ1_e86d3d6c-21e4-4e68-9ff3-815e7d68701e">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4e2d8c5d74764c0c8112c9015c783cbe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNS00LTEtMS04NzQ1_0da7c15d-1ba1-4c6d-8e73-d663acc88fbd"
      unitRef="usd">425000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4e2d8c5d74764c0c8112c9015c783cbe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNS02LTEtMS04NzQ1_b3556f5e-23cd-4de1-af8d-8ca21e2053a6"
      unitRef="usd">425000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4e2d8c5d74764c0c8112c9015c783cbe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNS04LTEtMS04NzQ1_ac890db8-1515-433d-bfde-1e54c4cfe480"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i85668d0214784e5a8fb9f8869bea0496_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNi0yLTEtMS04NzQ1_3aef9a87-09df-49d9-b29d-c534adff8c68">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i84b90248fb4943b1a217759d4dab622c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNi00LTEtMS04NzQ1_c72589be-746f-485f-9b49-4eb2e270d331"
      unitRef="usd">18270000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i84b90248fb4943b1a217759d4dab622c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNi02LTEtMS04NzQ1_d97cb2d9-20ca-4102-bfef-1fbdf84f9a83"
      unitRef="usd">3500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i84b90248fb4943b1a217759d4dab622c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNi04LTEtMS04NzQ1_e363f086-7fdb-4542-9531-8c9d9328e615"
      unitRef="usd">14770000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i8fa85a3402ad4c77b8d5f87d4e48cabc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNy0yLTEtMS04NzQ1_975a4818-a868-4370-a886-4168f21852d5">P13Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2fabf3a8e3e34339833d25e4808ff80b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNy00LTEtMS04NzQ1_3914b489-99bc-4a92-b3d1-2a5f46dd29be"
      unitRef="usd">152893000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2fabf3a8e3e34339833d25e4808ff80b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNy02LTEtMS04NzQ1_7d3f5d77-61b2-4825-beba-f47d04408ab5"
      unitRef="usd">36927000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2fabf3a8e3e34339833d25e4808ff80b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfNy04LTEtMS04NzQ1_8c6f2dae-b973-4b0e-afc1-d4679f08ecd1"
      unitRef="usd">115966000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i3dc15f5f21ee4966a24eaabd60b1d494_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfOC0yLTEtMS04NzQ1_4e11085d-99a6-4955-9f23-4034587a2110">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i810debf07d694305bd3dc90b59bb25a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfOC00LTEtMS04NzQ1_e527e393-44ee-4c98-b58f-5cd302f8dfd4"
      unitRef="usd">2500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i810debf07d694305bd3dc90b59bb25a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfOC02LTEtMS04NzQ1_84659ab7-f916-479b-ad96-b97f899ba6e8"
      unitRef="usd">972000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i810debf07d694305bd3dc90b59bb25a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfOC04LTEtMS04NzQ1_624cd94b-48e9-415f-82b5-287a491c185d"
      unitRef="usd">1528000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfOS00LTEtMS04NzQ1_143566c2-fa5b-42a2-9c0b-201a54d703f1"
      unitRef="usd">267311000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfOS02LTEtMS04NzQ1_e0c84a3f-b17c-4d36-86e9-5354dfe6d31c"
      unitRef="usd">89443000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfOS04LTEtMS04NzQ1_791f66e0-9b3a-4c90-a954-05400b11ae4f"
      unitRef="usd">177868000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4751e08bde88447d8b34bf752eed3cdc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMTEtNC0xLTEtODc0NQ_6ac9cdeb-b3d4-4607-8ea1-a46426228471"
      unitRef="usd">19363000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4751e08bde88447d8b34bf752eed3cdc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMTEtOC0xLTEtODc0NQ_0b7cc9c8-2be2-4974-aefe-ce0fa4e0e4a4"
      unitRef="usd">19363000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMTMtNC0xLTEtODc0NQ_0419da22-5dcf-4c6f-ac5b-dc9fb3563540"
      unitRef="usd">286674000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMTMtNi0xLTEtODc0NQ_c8a8334e-9f0a-4ca0-95f0-57416f239ade"
      unitRef="usd">89443000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOmNhZDc3YTIyN2E1YTQ2ZjJhZWUxMDYwMTMyOTAwNjdjL3RhYmxlcmFuZ2U6Y2FkNzdhMjI3YTVhNDZmMmFlZTEwNjAxMzI5MDA2N2NfMTMtOC0xLTEtODc0NQ_8c72c6e9-8882-4310-88fe-29e51ce18571"
      unitRef="usd">197231000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfNTYyNg_e1749a11-face-4814-bb5f-6616d406cd30"
      unitRef="usd">23800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfNTYzMA_e8ae960d-ea1e-4d3d-a7ed-54ed045427f6"
      unitRef="usd">23200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfNTYzNw_9d070d44-8d53-4a5e-9f9f-a1a953aeef95"
      unitRef="usd">17700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM2Nzc_45ed9156-3c49-4df3-bcf6-f3af104d18ce">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, estimated annual amortization for our intangible assets for each of the next five years is approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdiZjFhOGRiYTQyMDQ3MzhiNWYwODFjMGEzZTA0YjFlL3RhYmxlcmFuZ2U6N2JmMWE4ZGJhNDIwNDczOGI1ZjA4MWMwYTNlMDRiMWVfMC0yLTEtMS04NzQ1_8f28c5b7-1065-4dfb-8686-d198e1f5843c"
      unitRef="usd">25668000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdiZjFhOGRiYTQyMDQ3MzhiNWYwODFjMGEzZTA0YjFlL3RhYmxlcmFuZ2U6N2JmMWE4ZGJhNDIwNDczOGI1ZjA4MWMwYTNlMDRiMWVfMS0yLTEtMS04NzQ1_18c9dc9a-7916-4139-b081-2173e52581cb"
      unitRef="usd">24191000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdiZjFhOGRiYTQyMDQ3MzhiNWYwODFjMGEzZTA0YjFlL3RhYmxlcmFuZ2U6N2JmMWE4ZGJhNDIwNDczOGI1ZjA4MWMwYTNlMDRiMWVfMi0yLTEtMS04NzQ1_d8f471fa-812f-46b5-8575-fb5d220620fc"
      unitRef="usd">23551000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdiZjFhOGRiYTQyMDQ3MzhiNWYwODFjMGEzZTA0YjFlL3RhYmxlcmFuZ2U6N2JmMWE4ZGJhNDIwNDczOGI1ZjA4MWMwYTNlMDRiMWVfMy0yLTEtMS04NzQ1_78797b54-b39f-48ff-9807-5d4f9171ebbd"
      unitRef="usd">16057000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdiZjFhOGRiYTQyMDQ3MzhiNWYwODFjMGEzZTA0YjFlL3RhYmxlcmFuZ2U6N2JmMWE4ZGJhNDIwNDczOGI1ZjA4MWMwYTNlMDRiMWVfNC0yLTEtMS04NzQ1_0ba4a717-ee9b-4906-8a4d-8734e6abd7e6"
      unitRef="usd">15324000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdiZjFhOGRiYTQyMDQ3MzhiNWYwODFjMGEzZTA0YjFlL3RhYmxlcmFuZ2U6N2JmMWE4ZGJhNDIwNDczOGI1ZjA4MWMwYTNlMDRiMWVfNS0yLTEtMS04NzQ1_641a1126-72e6-4708-83d0-323423fd6a6f"
      unitRef="usd">58162000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdiZjFhOGRiYTQyMDQ3MzhiNWYwODFjMGEzZTA0YjFlL3RhYmxlcmFuZ2U6N2JmMWE4ZGJhNDIwNDczOGI1ZjA4MWMwYTNlMDRiMWVfNi0yLTEtMS04NzQ1_0b09df2f-d452-4d31-8627-56ceb0885dc8"
      unitRef="usd">162953000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1NjU_d3a12278-a4e4-486a-bb41-7fc2e25533ff">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We periodically evaluate the recoverability of long-lived assets whenever events and changes in circumstances indicate that the carrying amount of an asset may not be fully recoverable. When indicators of impairment are present, the carrying values of the assets are evaluated in relation to the operating performance and future undiscounted cash flows of the underlying business. The net book value of the underlying asset is adjusted to fair value if the sum of the expected discounted cash flows is less than book value. Fair values are based on estimates of market prices and assumptions concerning the amount and timing of estimated future cash flows and discount rates, reflecting varying degrees of perceived risk. We did not have any long-lived asset impairments in 2021, 2020 or 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM2MjM_35cde9f0-d1a5-42dd-a632-cdf38b814255">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Investment Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments, exclusive of cash equivalents, are marketable securities intended to be sold within one year and may include trading securities, available-for-sale securities, and held-to-maturity securities (if maturing within one year at &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the time of acquisition).  Long-term investments are marketable securities intended to be sold after one year and may include trading securities, available-for-sale securities, and held-to-maturity securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Available-for-sale Securities &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment securities are considered available-for-sale and currently consist of short-term and long-term corporate bonds. These securities are considered &#x201c;investment grade&#x201d; and are carried at fair value. We assess our investment in available-for-sale debt securities for impairment each reporting period. If an unrealized loss exists, we determine whether any portion of the decline in fair value below the carrying value is credit-related by reviewing several factors, including, but not limited to, the extent of the fair value decline and changes in the financial condition of the issuer. We record an impairment for credit-related losses through an allowance, limited to the amount of the unrealized loss. If we either intend to sell or it is more likely than not we will be required to sell the debt security before its anticipated recovery, any allowance is written off and the amortized cost basis is written down to fair value through a charge against net earnings. Unrealized gains and non-credit-related unrealized losses are recorded, net of tax, in other comprehensive income (loss). We did not have any investments in available-for-sale debt securities in unrealized loss positions as of December 31, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;The amortized cost of the debt securities is adjusted for the amortization of premiums computed under the effective interest method. Such amortization is included in other income, net in the consolidated statements of operations. Realized gains and losses are accounted for on the specific identification method. There have been no realized gains or losses on the disposal of these investments. The scheduled maturities of the debt securities are between 2022 and 2024. All short-term investment securities are callable within one year.</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1MDM_1a0d0e1b-f453-49c5-9fd8-a2196501fa41">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term and long-term investments in available-for-sale securities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Holding Gains (Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Holding Gains (Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2247e3aa5f7f425e92dffe9649cbcb7b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfMi0xLTEtMS04NzQ1_b8168d3e-4816-4ccf-83ed-5ebbbfc0f8a8"
      unitRef="usd">14420000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="ib1ed14983dc8444fb29c6fdb143af063_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfMi0zLTEtMS04NzQ1_96764c35-638f-4a52-8bfa-140f9ef9956a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2247e3aa5f7f425e92dffe9649cbcb7b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfMi01LTEtMS04NzQ1_178bb7b8-f808-40b5-8802-96371fc675d5"
      unitRef="usd">14420000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iad22bdcd21ac4a51bb81dc8d8fc119a9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfMy0xLTEtMS04NzQ1_c44d2d72-bc9a-4687-afaf-219eb8a59df0"
      unitRef="usd">4620000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="ib0aa1b29ef9844f29ed55e5350042310_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfMy0zLTEtMS04NzQ1_d232077d-f1e1-4c0e-8a08-5a182b1be091"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iad22bdcd21ac4a51bb81dc8d8fc119a9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfMy01LTEtMS04NzQ1_4be8e255-b909-41aa-b5e0-45711cb2fccd"
      unitRef="usd">4620000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfNC0xLTEtMS04NzQ1_dbc2aa74-f442-40bd-971a-09e46ab8753d"
      unitRef="usd">19040000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfNC0zLTEtMS04NzQ1_7bf86bdc-8c81-4be3-8596-e7be68298547"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfNC01LTEtMS04NzQ1_d0b2fa4a-04f6-4b04-b319-ba32467d3ba6"
      unitRef="usd">19040000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5e6c4333e95b489298867ff378f75de9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfOC0xLTEtMS04NzQ1_59f56800-78ee-4159-a5f6-f3113191b62c"
      unitRef="usd">14687000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="iffa9110d543f4303a3b7762b85f661f3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfOC0zLTEtMS04NzQ1_fdfe82e9-b0bf-4c82-8945-69ed1a746baa"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5e6c4333e95b489298867ff378f75de9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfOC01LTEtMS04NzQ1_1fff95b3-998f-45e4-86e7-1d1d4ff78d4b"
      unitRef="usd">14687000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i647dc634368041129731810420d0ebbc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfOS0xLTEtMS04NzQ1_912967b1-014c-41c3-af81-613282595016"
      unitRef="usd">12974000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i5b51175d4f8a42ccb2a3d0734e66cec3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfOS0zLTEtMS04NzQ1_dcb6ec73-4555-4749-8579-355996b7d663"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i647dc634368041129731810420d0ebbc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfOS01LTEtMS04NzQ1_a3f81aac-79a7-47c5-9774-12794ef922f2"
      unitRef="usd">12974000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfMTAtMS0xLTEtODc0NQ_c1abfe54-d837-43a6-b1b9-32f485c444e2"
      unitRef="usd">27661000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfMTAtMy0xLTEtODc0NQ_d5a5400f-f12a-418c-843e-69251a3405f0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjQwZThlMDdlMWI5YzRhZGZhOTc4ZWYwZjYwYjIyNzZlL3RhYmxlcmFuZ2U6NDBlOGUwN2UxYjljNGFkZmE5NzhlZjBmNjBiMjI3NmVfMTAtNS0xLTEtODc0NQ_c7a95891-412e-4427-8405-690a4302355c"
      unitRef="usd">27661000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTA5OTUxMTY4NjY3Mw_24c24164-9e56-42f5-a974-6426baf2f088"
      unitRef="number">0.200</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTA5OTUxMTY4NjY4MA_d5dcf0f6-35df-41f5-89ec-f8c18ee0ace3"
      unitRef="usd">3300000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTA5OTUxMTY4NjY5NQ_c752c77b-2c2a-49c3-9ae5-ec3e94622de8">We apply the equity method of accounting for investments when we determine we have a significant influence, but not a controlling interest in the investee. We determine whether we have significant influence by considering key factors such as ownership interest, representation on the board of directors, participation in policy making decisions, business relationship and material intra-entity transactions, among other factors. Our equity method investment is reported at cost and adjusted each period for our share of the investee's income or (loss) and dividend paid, if any. We eliminate any intra-entity profits to the extent of our beneficial interest. We record our share of the investee's income or (loss) on a one quarter lag. We report our proportionate share of the investee's income or (loss) resulting from this investment in other income, net in our consolidated statements of operations. The carrying value of our equity method investment is reported in other assets on the consolidated balance sheets. We assess our equity method investments for impairment on an annual basis or whenever events or circumstances indicate that the carrying value of the investment may not be recoverable.</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTA5OTUxMTY4NjY5OA_a0d992b6-c023-4249-8afa-b37d6f909b10">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our non-marketable equity method investment consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:EquityMethodInvestments
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjZhYThiNjA1YTcwOTQ1MzM4OTc5ZTc0MDQ5MmZjMmM5L3RhYmxlcmFuZ2U6NmFhOGI2MDVhNzA5NDUzMzg5NzllNzQwNDkyZmMyYzlfMi0xLTEtMS0yNjMwMQ_18fec6fc-ffde-4589-89ce-9f6c1b897a13"
      unitRef="usd">3238000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjZhYThiNjA1YTcwOTQ1MzM4OTc5ZTc0MDQ5MmZjMmM5L3RhYmxlcmFuZ2U6NmFhOGI2MDVhNzA5NDUzMzg5NzllNzQwNDkyZmMyYzlfMi0zLTEtMS0yNjI5NA_d4f4adf5-70a4-435c-a755-af4da5369c7a"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1MDQ_af8b5cb3-9a6b-4823-82c1-6f54bc7d8dbf">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred taxes are determined based on the differences between the financial statements and the tax bases using rates as enacted in the laws. A valuation allowance is established if it is &#x201c;more likely than not&#x201d; that all or a portion of the deferred tax assets will not be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize interest and penalties related to unrecognized tax benefits in the tax provision. We recognize liabilities for uncertain tax positions when it is more likely than not that a tax position will not be sustained upon examination and settlement with various taxing authorities. Liabilities for uncertain tax positions are measured based upon the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. We have not recorded any material interest or penalties during any of the years presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM2MzM_9f24bdb5-d42d-4379-ab1f-4c9d8aaaa98b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Foreign Currency&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Generally, the functional currency of our international subsidiaries is the local currency. Generally, we translate the financial statements of these subsidiaries to U.S. dollars at the exchange rate in effect at the balance sheet date and revenues and expenses are translated at the average monthly exchange rates during the year. Certain of our international subsidiaries consolidate first with another subsidiary that utilizes a functional currency other than U.S. dollars.&#160;In those cases, we follow a step by step translation process utilizing the same sequence as the consolidation process.&#160;Translation adjustments are recorded as a component of accumulated other comprehensive loss, a separate component of stockholders' equity on our consolidated balance sheets and the effect of exchange rate changes on cash and cash equivalents are reflected on our consolidated statements of cash flows.&#160;Gains and losses for transactions denominated in a currency other than the functional currency of the entity are included in our consolidated statements of operations in other income, net. Foreign currency transaction losses (gains), net were $1.0 million, $7.2 million and $(0.7) million in 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTA4MTA_7ccf9a78-bfb0-4b3a-b32f-f1101c52e1c5"
      unitRef="usd">-1000000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTA4MjA_a564638d-58b7-4478-89bd-55da3bdbf116"
      unitRef="usd">-7200000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjc0ODc3OTEwNzYxNw_604153f3-ab82-4277-9489-b802cd87b278"
      unitRef="usd">700000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM2NjM_08d29617-ea27-4ecb-8795-cbccf097bcad">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenues when we transfer control of promised goods to our customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods.  We offer certain volume-based rebates to our distribution customers, which we consider variable consideration when calculating the transaction price. Rebates are offered on both a fixed and tiered/variable basis. In both cases, we use information available at the time and our historical experience with each customer to estimate the most likely rebate amount. We also provide chargebacks to distributors that sell to end customers at prices determined under a contract between us and the end customer. Chargebacks are the difference between prices we charge our distribution customers and contracted prices we have with the end customer which are processed as credits to our distribution customers. In estimating the expected value of chargeback amounts for use in determining the transaction price, we use information available at the time, including our historical experience. We also warrant products against defects and have a policy permitting the return of defective products, for which we accrue and expense at the time of sale using information available and our historical experience. Our revenues are recorded at the net sales price, which includes an estimate for variable consideration related to rebates, chargebacks and product returns.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The vast majority of our sales of Infusion Consumables, Infusion Systems, IV Solutions and Critical Care products are sold on a standalone basis and control of these products transfers to the customer upon shipment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our software license renewals are considered to be transferred to a customer at a point in time at the start of each renewal period, therefore revenue is recognized at that time.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Arrangements with Multiple Deliverables&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In certain circumstances, we enter into arrangements in which we provide multiple deliverables to our customers.  These bundled arrangements typically consist of the sale of infusion systems equipment, along with annual software licenses and related software implementation services, as well as infusion consumables, IV solutions and extended warranties. Our most significant judgments related to these arrangements are (i) identifying the various performance obligations and (ii) estimating the relative standalone selling price of each performance obligation, typically using a directly observable method or calculated on a cost plus margin basis method.  Revenue related to the bundled equipment, software and software implementation services are typically combined into a single performance obligation and recognized upon implementation. As annual software licenses are renewed, we recognize revenue for the license at a point in time, at the start of each annual renewal period. The transaction price allocated to the extended service-type warranty is recognized as revenue over the period the warranty service is provided. Consumables and solutions are separate performance obligations, recognized at a point in time.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1OTY_2189f462-434c-47e9-b108-e0fcbee39336">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Advertising Expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising expenses are expensed as incurred and reflected in selling, general and administrative expenses in our consolidated statements of operations and were $0.2 million, $0.2 million and $0.1 million in 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTQzMTU_7d752931-c78c-41dc-a3e3-4c97e3ff8da1"
      unitRef="usd">200000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTQzMjU_7c0a5b3f-7693-48c7-bffc-d9cc10194728"
      unitRef="usd">200000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTQzMzg_7988845e-c467-473b-b929-292607e750cb"
      unitRef="usd">100000</us-gaap:AdvertisingExpense>
    <us-gaap:PensionAndOtherPostretirementPlansPolicy
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM2NjY_aff2d1f3-8671-43f6-b3c2-7b5cc58495e7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Post-retirement and Post-employment Benefits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sponsor a Section&#160;401(k)&#160;retirement plan ("plan") for employees.&#160;Our contributions to our 401(k) plan were approximately $11.0 million, $10.7 million and $11.4 million in 2021, 2020 and 2019, respectively. We also have post-retirement and post-employment obligations related to employees located in certain international countries. These obligations are immaterial to our financial statements taken as a whole.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementPlansPolicy>
    <us-gaap:PensionAndOtherPostretirementBenefitExpense
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTQ1MjA_f861a963-0c2f-4996-a99a-a21c68551bf9"
      unitRef="usd">11000000</us-gaap:PensionAndOtherPostretirementBenefitExpense>
    <us-gaap:PensionAndOtherPostretirementBenefitExpense
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTQ1MzA_82e4785a-8023-4f15-a5dc-916da3a0c5f7"
      unitRef="usd">10700000</us-gaap:PensionAndOtherPostretirementBenefitExpense>
    <us-gaap:PensionAndOtherPostretirementBenefitExpense
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTQ1NDM_a9e923bf-2b15-4879-a0cc-953c64cf70bc"
      unitRef="usd">11400000</us-gaap:PensionAndOtherPostretirementBenefitExpense>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM0OTY_5177003d-2be8-4eae-8a0e-4d8f33877766">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of our research and development costs are expensed as incurred.  In certain circumstances when an asset will have an alternative future use we capitalize the costs related to those assets.  Research and development costs include salaries and related benefits, consulting fees, production supplies, samples, travel costs, utilities and other miscellaneous administrative costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1MTk_286d4592-fc41-4ae9-9f11-6f338fe93042">Net Income Per ShareNet income per share is computed by dividing net income by the weighted-average number of common shares outstanding. Diluted net income per share is computed by dividing net income by the weighted-average number of common shares outstanding plus dilutive securities.&#160;Dilutive securities include outstanding common stock options and unvested restricted stock units, less the number of shares that could have been purchased with the proceeds from the exercise of the options, using the treasury stock method. Options that are anti-dilutive, where their exercise price exceeds the average market price of the common stock, are not included in the treasury stock method calculation. Restricted stock units that are anti-dilutive are not included in the treasury stock method.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTU5ODE_9357ce38-44a1-4ce9-b722-e375954eb383"
      unitRef="shares">12354</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMTU5ODU_1411b910-24af-4c88-b65f-4cb909bac165"
      unitRef="shares">12083</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMzI5ODUzNDkyMTc3MA_4d026c43-d5aa-425e-a786-518e7854b274"
      unitRef="shares">10760</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1MzM_a0dad772-ad3a-466b-a0d0-8aff66f390c6">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of net earnings per common share (&#x201c;EPS&#x201d;) &#x2014; basic and diluted (in thousands, except per share data):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&#160;ended&#160;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares outstanding (basic)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common and common equivalent shares outstanding&#160;(diluted)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EPS &#x2014; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EPS &#x2014; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfMi0yLTEtMS04NzQ1_3a6d1cfd-8eca-4b4b-90f9-63c17825c496"
      unitRef="usd">103135000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfMi00LTEtMS04NzQ1_f5f944e5-692a-4016-9c96-f8ecd7539ca7"
      unitRef="usd">86870000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfMi02LTEtMS04NzQ1_35af07ee-ffcc-4881-b9e7-59d09fd2d7c1"
      unitRef="usd">101035000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfMy0yLTEtMS04NzQ1_f5750c6f-5bf5-4d55-a75e-a197831edc81"
      unitRef="shares">21206000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfMy00LTEtMS04NzQ1_0664f538-51ba-4803-9c32-2e483e50dcdd"
      unitRef="shares">20907000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfMy02LTEtMS04NzQ1_1e836993-9cb0-4e78-8713-84f5adc46130"
      unitRef="shares">20629000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNC0yLTEtMS04NzQ1_f912632a-efd7-44d5-8e71-f6b26fa74834"
      unitRef="shares">575000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNC00LTEtMS04NzQ1_8fe0d04f-4cd8-422d-9d03-b297b6226b4b"
      unitRef="shares">684000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNC02LTEtMS04NzQ1_83ec19f9-5331-4a8a-ab07-dcffec5edebf"
      unitRef="shares">916000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNS0yLTEtMS04NzQ1_a9bd1780-f7c4-4e65-ab71-156df367843c"
      unitRef="shares">21781000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNS00LTEtMS04NzQ1_3a2ed1b5-78ef-4d33-9197-1d67ccf5145f"
      unitRef="shares">21591000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNS02LTEtMS04NzQ1_2eab2570-c0d1-4069-8c72-408d9c1666e5"
      unitRef="shares">21545000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNi0yLTEtMS04NzQ1_206e50a9-3bb0-419e-ac1e-67e010fa709f"
      unitRef="usdPerShare">4.86</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNi00LTEtMS04NzQ1_9cf2c877-92de-4b4f-8e4e-6edc367de1d4"
      unitRef="usdPerShare">4.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNi02LTEtMS04NzQ1_e7c6347d-2a79-4f93-a528-68c2457a728f"
      unitRef="usdPerShare">4.90</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNy0yLTEtMS04NzQ1_42c385a8-1dcc-44b3-892e-30d3195f1781"
      unitRef="usdPerShare">4.74</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNy00LTEtMS04NzQ1_b028fcec-5d1e-4aff-a113-aa7be7bff87e"
      unitRef="usdPerShare">4.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RhYmxlOjdkNGY2YjA1ZWQ4MjRiMGI5YmY3YjUyYTdlOTRhMjIxL3RhYmxlcmFuZ2U6N2Q0ZjZiMDVlZDgyNGIwYjliZjdiNTJhN2U5NGEyMjFfNy02LTEtMS04NzQ1_37254d23-e2f7-436c-8955-e6cbfeec69fa"
      unitRef="usdPerShare">4.69</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM1MDA_2a897739-de88-4141-b399-b2ea0fceaaa5"
      xsi:nil="true"/>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83MC9mcmFnOjM2NzY1N2MxYTRkMTRjNmM4YTRmMWJlMzZiZWM5N2QwL3RleHRyZWdpb246MzY3NjU3YzFhNGQxNGM2YzhhNGYxYmUzNmJlYzk3ZDBfMjM0OTU_ffeb54ee-0fdb-4851-87f0-fc415b523569">Recently Issued Accounting Standards In March 2020, the Financial Accounting Standards Board ("FASB")  issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide optional guidance for a limited period of time to ease the potential burden for reference rate reform on financial reporting. Due to concerns about structural risks of interbank offered rates and, particularly, the risk of cessation of the London Interbank Offered Rate ("LIBOR"), regulators around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation. The amendments in this update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued as a result of reference rate reform. Optional expedients may be applied to contracts that are modified as a result of the reference rate reform. Modifications of contracts within the scope of Topic 470, Debt, should be accounted for by prospectively adjusting the effective interest rate. Modifications of contracts within the scope of ASC 842, Leases, should be accounted for as a continuation of the existing contracts with no reassessments of the lease classification and the discount rate (incremental borrowing rate). Exceptions to Topic 815, Derivatives and Hedging, results in not having a dedesignation of a hedging relationship if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. In November 2021, we entered into two forward-starting swaps whereby the variable leg of the swap references LIBOR, these swaps will be amended in early 2022 to transition to an alternative reference rate (see Note 7: Derivatives and Hedging Activities). The amendments in this ASU allow for certain expedients that will allow us to assume that our hedged interest payments are probable of occurring regardless of any expected modification in their terms related to reference rate reform and will allow us to continue hedge accounting for a cash flow hedge for which the hedged interest rate risk changes if the hedge is highly effective under ASC 815, Derivatives and Hedging or the optional expedient under this ASU is elected. The impact of this ASU on our contracts has not been and is not expected to be material.</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMjM4Mg_23fdf71e-8351-438a-a2ca-b81480d7afb1">ACQUISITIONS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2019 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 2, 2019, we acquired 100% interest in Pursuit for cash consideration of approximately $75.0 million.  Additionally, Pursuit's equity holders were potentially entitled up to $50.0 million in additional cash consideration contingent upon the achievement of certain sales and gross profit targets for specific customers. The earn-out paid was calculated as a percentage of gross profit achieved during the earn-out period against a pre-determined target gross profit, not to exceed $50.0 million. As of June 30, 2021, the earn-out measurement period ended and based on the actual sales and gross profit achieved during the measurement period, we calculated the actual earn-out amount to be $26.3&#160;million. The $26.3&#160;million earn-out calculation was finalized and accepted by Pursuit's former equity holders and was paid out in during the fourth quarter of 2021.  The acquisition of Pursuit and their ClearGuard HD is a natural extension of our needlefree IV connector and other infection control technologies, which together provides us the best of breed solutions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Final Purchase Price&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the final purchase price and the final allocation of the purchase price related to the assets and liabilities purchased (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash consideration for acquired assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Final Purchase Price Allocation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill - not tax deductible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_______________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Identifiable intangible assets included $69.0 million of developed technology, $10.8 million of trade name and $2.5 million of non-compete agreement. The weighted-average amortization periods for the identifiable intangible assets are as follows: approximately fifteen years for developed technology, fifteen years for trade name and three years for the non-compete agreement. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The identifiable intangible assets acquired have been valued as Level 3 assets at fair market value. The estimated fair value of identifiable intangible assets were developed using the income approach and are based on critical estimates, judgments and assumptions derived from: analysis of market conditions; discount rate; discounted cash flows; royalty rates; and estimated useful lives. Fixed assets were valued with the consideration of remaining economic lives. The raw materials inventory was valued at historical cost and adjusted for any obsolescence and finished goods inventory was valued at estimated sales proceeds less a nominal profit and costs to sell. The trade receivables, prepaid expenses and other current assets and assumed liabilities were recorded at their carrying values as of the date of the acquisition, as their carrying values approximated their fair values due to their short-term nature.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2019, we also acquired a small foreign distributor for approximately $4.6&#160;million in cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2021 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During November 2021, we acquired a small foreign infusion systems supplier and paid an initial gross cash payment of approximately $15.4&#160;million. The total consideration and purchase price allocation is preliminary pending the finalization of the valuation. In addition to the initial cash consideration, total consideration for the acquisition includes an additional holdback of $0.5&#160;million, to be paid two years from the completion date of the acquisition, and also a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfODA_7dffff5f-bcfb-4207-8e4d-e4ec2804ee2c"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMTQz_8290d728-5c09-419f-aeac-a8493bc925a6"
      unitRef="usd">75000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <icui:Contingentconsiderationgross
      contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMjE4_1fd991da-2c26-418e-a1f4-bbdc65571e4d"
      unitRef="usd">50000000</icui:Contingentconsiderationgross>
    <icui:Contingentconsiderationgross
      contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfNTQy_206b6143-59ca-4425-a150-b26d3e4a9dc9"
      unitRef="usd">50000000</icui:Contingentconsiderationgross>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i8a64787f750d4031b14422894f232878_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMTA5OTUxMTYzMzg2MQ_0b8dc04b-3ae6-4935-88a5-9adcec66878c"
      unitRef="usd">26300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i8a64787f750d4031b14422894f232878_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMTA5OTUxMTYzMzg3Ng_d3eafc9b-1c0c-4541-90ad-ec8b73fbef7a"
      unitRef="usd">26300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMjM4NQ_0599bba2-685a-4331-b210-7c808fc1f35c">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the final purchase price and the final allocation of the purchase price related to the assets and liabilities purchased (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash consideration for acquired assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Final Purchase Price Allocation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill - not tax deductible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_______________________________________________&lt;/span&gt;&lt;/div&gt;(1)&#160;&#160;&#160;&#160;Identifiable intangible assets included $69.0 million of developed technology, $10.8 million of trade name and $2.5 million of non-compete agreement. The weighted-average amortization periods for the identifiable intangible assets are as follows: approximately fifteen years for developed technology, fifteen years for trade name and three years for the non-compete agreement.</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <icui:Paymenttoacquirebusinessnetofworkingcapitaladjustments
      contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfMC0yLTEtMS04NzQ1_7a8b36b3-88ff-4b40-8d90-7956fbe69064"
      unitRef="usd">71533000</icui:Paymenttoacquirebusinessnetofworkingcapitaladjustments>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfMS0yLTEtMS04NzQ1_38805567-3fd3-4762-aa8e-a28e1479f43e"
      unitRef="usd">17300000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfMi0yLTEtMS04NzQ1_61bc630d-3174-46da-bb61-c29180bb5748"
      unitRef="usd">88833000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationAcquiredReceivablesFairValue
      contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfNS0yLTEtMS04NzQ1_bd97424c-4137-443c-a9ff-1c41967d0e96"
      unitRef="usd">973000</us-gaap:BusinessCombinationAcquiredReceivablesFairValue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfNi0yLTEtMS04NzQ1_7ed9861a-836c-4415-b35f-b6024fd83090"
      unitRef="usd">2464000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfNy0yLTEtMS04NzQ1_24247c02-cad0-436f-a9c0-0b9e61cfab4d"
      unitRef="usd">74000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfOC0yLTEtMS04NzQ1_c12ab45b-15b5-40a4-9735-25ab3dfef251"
      unitRef="usd">609000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfOS0yLTEtMS04NzQ1_3591e892-676d-4288-827d-740d1c3194d3"
      unitRef="usd">82300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfMTAtMi0xLTEtODc0NQ_2bf402f5-0b19-4c37-81f5-070a15e1c494"
      unitRef="usd">215000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfMTEtMi0xLTEtODc0NQ_dad0ab4f-f8e1-4fad-89e8-37a421387967"
      unitRef="usd">2065000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfMTItMi0xLTEtODc0NQ_ecb1a16a-43ea-4405-944f-c7b29a449b11"
      unitRef="usd">84140000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfMTMtMi0xLTEtODc0NQ_90b9e8b5-3b16-4721-ac30-b144c8b18cbb"
      unitRef="usd">20462000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i9ea7d76b8a79439aab91f9877efd14d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfMTQtMi0xLTEtODc0NQ_132581ca-91da-4785-86ff-663876de74c4"
      unitRef="usd">15769000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RhYmxlOmE2NTQxZTc3MDVkOTQ4OTQ5NDE0NzRiZjc1ZjQwMWExL3RhYmxlcmFuZ2U6YTY1NDFlNzcwNWQ5NDg5NDk0MTQ3NGJmNzVmNDAxYTFfMTUtMi0xLTEtODc0NQ_2991d388-d3b6-4c13-af79-965fbe590943"
      unitRef="usd">88833000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i759cb9fbaf1d4095916b580d6bb94af5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMTAzNQ_7ef7f44c-c957-40e8-8859-ff30eab1bf08"
      unitRef="usd">69000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i4e8704f54a08458a9efc29f3cc118593_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMTA2Mw_e582951f-406d-4a14-9d5b-e6d9e84b6ec3"
      unitRef="usd">10800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i77e6107e400341429951759a6c1961be_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMTA4NA_65fac3e0-7d92-4267-93af-9af1a92bf669"
      unitRef="usd">2500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i950f58e7689540a3b89af236c51c45e0_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMTIwOQ_741c8900-4bd7-4ce7-9ec8-e2974c2c9925">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i1a9284e3c72d412b809403911420ec57_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMTI4OQ_e40e0fa5-c441-45b4-993a-d781c42615b1">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i181ab8ea3259409b94a0dae321287166_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMTM2Mw_0f3c1db5-011b-424a-9441-a344ca869d8a">P3Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="id188fafa38884adabaef94e04b547494_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMjM2Nw_37a56f60-54e4-4886-9910-83ae0cee96d1"
      unitRef="usd">4600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMjc0ODc3OTA3MjUzMg_af6bda2f-7672-4339-b419-e96ffe13f430"
      unitRef="usd">15400000</us-gaap:PaymentsToAcquireBusinessesGross>
    <icui:BusinessCombinationConsiderationCashHoldback
      contextRef="if148011629fb4765963a61b648e50f64_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMTA5OTUxMTYzMzg5MQ_78fd4fd8-bd84-4eb3-9532-83fba3b7e576"
      unitRef="usd">500000</icui:BusinessCombinationConsiderationCashHoldback>
    <icui:Contingentconsiderationgross
      contextRef="i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMjc0ODc3OTA3Mjk2NA_9405feed-5cd2-406c-b429-e99514b6e91f"
      unitRef="usd">2500000</icui:Contingentconsiderationgross>
    <icui:ShortTermContingentConsiderationGross
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMjc0ODc3OTA3Mzg1Nw_aeaabf28-0521-4c35-b2dc-83ac1f347eda"
      unitRef="usd">1000000</icui:ShortTermContingentConsiderationGross>
    <icui:LongTermContingentConsiderationGross
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83My9mcmFnOmI1Y2JmNDM3M2JhMjQ2NmRhZDQxMjFkMTY2ZmY3NDVjL3RleHRyZWdpb246YjVjYmY0MzczYmEyNDY2ZGFkNDEyMWQxNjZmZjc0NWNfMjc0ODc3OTA3Mzg4NQ_27801c87-1562-4c7c-b096-a73c036f381f"
      unitRef="usd">1500000</icui:LongTermContingentConsiderationGross>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMjk0MQ_4843cdc9-37d7-47d9-92d9-c382e8a9442f">RESTRUCTURING, STRATEGIC TRANSACTION AND INTEGRATION&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, strategic transaction and integration expenses were $18.0 million, $28.4 million and $80.6 million in 2021, 2020 and 2019, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring charges were $(1.8) million, $7.9 million and $8.4 million in 2021, 2020 and 2019, respectively, and are included in the above restructuring, strategic transaction and integration expenses in our consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2021, we adjusted certain facility restructuring liabilities by $2.0&#160;million, shown in the table below under "Other adjustments," to reflect actual amounts owed which resulted in net restructuring credits of $(1.8)&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, restructuring charges were primarily related to severance and costs related to office and other facility closures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, restructuring charges were primarily related to severance and facility closure costs.  These charges were primarily related to a one-time charge to move our U.S. pump service depot to our existing Salt Lake City facility and other plant restructuring. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2015, we incurred restructuring charges related to an agreement with Dr. Lopez, a member of our Board of Directors and a former employee in our research and development department, pursuant to which we bought out Dr. Lopez's right to employment under his then-existing employment agreement. The buy-out, including payroll taxes, was paid in equal monthly installments until December 2020. This has been fully paid as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity in our restructuring-related accrual by major type of cost (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Severance Pay and Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Employment Agreement Buyout&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retention and Facility Closure Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,570)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(969)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(969)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(528)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_______________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated liabilities related to a prior year's facility closure restructuring were adjusted to actual amounts owed.&lt;/span&gt;&lt;/div&gt;Strategic Transaction and Integration ExpensesWe incurred $19.8 million, $20.5 million and $72.2 million in strategic transaction and integration expenses in 2021, 2020 and 2019, respectively, which are included in restructuring, strategic transaction and integration expenses in our consolidated statement of operations. The strategic transaction and integration expenses during 2021 were related to integration costs associated with acquisitions, the Hospira Infusion Systems ("HIS") earn-out dispute with Pfizer, one-time costs incurred to comply with regulatory initiatives and transaction expenses incurred in connection with entering into a definitive agreement to acquire Smiths Medical 2020 Limited ("Smiths Medical")  (see Note 17: Subsequent Events). The integration expenses during 2020 were related to the integration of HIS and included expenses for the migration of IT systems at our Austin facility. The strategic transaction and integration expenses during 2019 were primarily related to HIS, including a one-time strategic supply chain restructuring charge of $22.1 million, which reduced our contracted commitments to our third party manufacturer and charges related to our Pfizer separation costs, which included a $12.7 million non-cash write-off of related assets.</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <icui:Restructuringandstrategictransactionexpense
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMTM2_131ca6c5-027a-40cb-860b-81015077ea5d"
      unitRef="usd">18000000</icui:Restructuringandstrategictransactionexpense>
    <icui:Restructuringandstrategictransactionexpense
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMTQx_4e8a091d-c87b-4d03-908a-52a34f303e02"
      unitRef="usd">28400000</icui:Restructuringandstrategictransactionexpense>
    <icui:Restructuringandstrategictransactionexpense
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMTQ5_b1c38b62-e7da-41dc-ad9d-b11b4402691d"
      unitRef="usd">80600000</icui:Restructuringandstrategictransactionexpense>
    <us-gaap:RestructuringCharges
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMjY2_62a63336-927f-4c17-a3bf-302d995436c9"
      unitRef="usd">-1800000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMjcw_d9e197ce-8a9b-4418-87ab-7e3dbed99b99"
      unitRef="usd">7900000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMjc3_dbe5410b-eb03-4ff8-89c1-7acb34a9ec4e"
      unitRef="usd">8400000</us-gaap:RestructuringCharges>
    <icui:RestructuringAdjustmentsSeveranceAndFacility
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMTY0OTI2NzQ0OTYxOQ_5b9247f8-9882-43d2-84ab-6727cfd21ff4"
      unitRef="usd">2000000</icui:RestructuringAdjustmentsSeveranceAndFacility>
    <us-gaap:RestructuringCharges
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMjc0ODc3OTA3NjM2OA_be2d69c0-4e3a-4114-b070-937c9b69dc63"
      unitRef="usd">-1800000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMjk0Nw_5932d11c-4666-4ce2-9b61-44a6723242b9">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity in our restructuring-related accrual by major type of cost (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Severance Pay and Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Employment Agreement Buyout&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retention and Facility Closure Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,570)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(969)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(969)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(528)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_______________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated liabilities related to a prior year's facility closure restructuring were adjusted to actual amounts owed.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i71c95811c4714cd09165d99d35d0be39_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMS0xLTEtMS04NzQ1_8c785520-fd16-4c2c-90a5-650dfede8508"
      unitRef="usd">3878000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i62ae2a31a4354af79bd9d1817c9ee7bd_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMS0zLTEtMS04NzQ1_376eb5fc-07bc-439e-8b9f-9d56cd121309"
      unitRef="usd">460000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i8e461e5413d14edd9b72b130ce815fe5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMS01LTEtMS04NzQ1_fe743d48-16f8-4c02-b387-8eeb548ef7f7"
      unitRef="usd">1211000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMS04LTEtMS02MTQ2MA_f0f9f4c0-a109-4f3a-a2a9-21331f57c744"
      unitRef="usd">5549000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCosts
      contextRef="i5a3cc5377db948c0a5ce1d48fee18dc4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMi0xLTEtMS04NzQ1_dd1f7a84-3b8e-4ba9-9500-0a59400014fa"
      unitRef="usd">4288000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i65b0aab89680416c8c6ea3f7a118a6bd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMi0zLTEtMS04NzQ1_7bd68306-9132-438f-a473-99dc01287a30"
      unitRef="usd">0</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="ie4b6eb1be3574e0cb8dab5f37e8dedec_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMi01LTEtMS04NzQ1_71fcf805-f052-41cc-824e-94b2b989ec07"
      unitRef="usd">3641000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMi04LTEtMS02MTQ3NQ_980b707b-58e5-48ed-a99e-c28cf858d717"
      unitRef="usd">7929000</us-gaap:RestructuringCosts>
    <us-gaap:PaymentsForRestructuring
      contextRef="i5a3cc5377db948c0a5ce1d48fee18dc4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMy0xLTEtMS04NzQ1_ec86afaa-be4e-49b1-b23f-7fe0206e25e0"
      unitRef="usd">6331000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i65b0aab89680416c8c6ea3f7a118a6bd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMy0zLTEtMS04NzQ1_6e7c371e-89f6-4808-8ca7-d3f1827cfcc3"
      unitRef="usd">460000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ie4b6eb1be3574e0cb8dab5f37e8dedec_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMy01LTEtMS04NzQ1_d2a54106-e7bd-44e3-bfe4-58f518f50067"
      unitRef="usd">3570000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMy04LTEtMS02MTQ4MQ_3f83dba9-63bf-46f3-932a-62a58485988f"
      unitRef="usd">10361000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i5a3cc5377db948c0a5ce1d48fee18dc4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNC0xLTEtMS04NzQ1_5f09adc9-97cb-402e-b279-d55dbdf296a9"
      unitRef="usd">-23000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i65b0aab89680416c8c6ea3f7a118a6bd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNC0zLTEtMS04NzQ1_93ebc8a8-8ac6-4c68-a70b-8e95cc449830"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="ie4b6eb1be3574e0cb8dab5f37e8dedec_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNC01LTEtMS04NzQ1_374d5454-e5b6-4046-8852-fc905fc73d9b"
      unitRef="usd">-281000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNC04LTEtMS02MTUwMQ_7055ca43-37be-43bc-96b3-b51dc9e15c86"
      unitRef="usd">-304000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="i5df89ac1ac0b4ffcaf4459845544da7b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNS0xLTEtMS04NzQ1_5358550d-05e8-46c1-8fc6-d9b1679f2f8b"
      unitRef="usd">1858000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i9a26f1d531b748e2a99def41eaf38247_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNS0zLTEtMS04NzQ1_7a2c509f-5033-4287-8e3b-010019ffc6be"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i0513f1469ce44ac7b878215e135b1461_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNS01LTEtMS04NzQ1_ab872cab-a0e7-4456-8589-84da5734f639"
      unitRef="usd">1563000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNS04LTEtMS02MTQ2Mw_20581f43-5772-4ad9-a2eb-c917149308e9"
      unitRef="usd">3421000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCosts
      contextRef="ibc1517ed4db74def880ae3ff1b172041_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNi0xLTEtMS04NzQ1_f5f4dc08-bee9-407f-b55b-e5595c2b8d08"
      unitRef="usd">140000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i8eac04e1e58f46a1be1d57dae1515d50_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNi0zLTEtMS04NzQ1_7bc03070-ab8d-48b2-81a8-3b67ff143f82"
      unitRef="usd">0</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="ie475f7d09c704e268b2c10ef5f50cc45_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNi01LTEtMS04NzQ1_74a06f13-f0ac-4478-a058-43a165db0107"
      unitRef="usd">0</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNi04LTEtMS02MTQ3OA_e1397216-6889-4b62-a6aa-4fe25523de8e"
      unitRef="usd">140000</us-gaap:RestructuringCosts>
    <us-gaap:PaymentsForRestructuring
      contextRef="ibc1517ed4db74def880ae3ff1b172041_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNy0xLTEtMS0yNzEyNQ_89402447-54b2-4f2f-a6e4-ba28c96a3814"
      unitRef="usd">969000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i8eac04e1e58f46a1be1d57dae1515d50_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNy0zLTEtMS0yNzE1MA_dc84f20c-7351-4b47-bf8d-86f46d1b222a"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ie475f7d09c704e268b2c10ef5f50cc45_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNy02LTEtMS0yNzIwNA_8ae1ee70-586c-4704-9fd3-26d4189f09eb"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfNy04LTEtMS02MTQ4NA_901cacad-4891-4ef5-a405-0b9308ec3d7d"
      unitRef="usd">969000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="ibc1517ed4db74def880ae3ff1b172041_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfOC0xLTEtMS0yNzEyOA_556a0539-b497-46ca-b74c-f128072ef453"
      unitRef="usd">2000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i8eac04e1e58f46a1be1d57dae1515d50_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfOC0zLTEtMS0yNzE1Mw_f411ad1b-cf9f-46f5-bb94-b355713aa459"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="ie475f7d09c704e268b2c10ef5f50cc45_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfOC02LTEtMS0yNzIwOQ_fbb43598-828d-4900-887f-faae80c8fa86"
      unitRef="usd">-31000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfOC04LTEtMS02MTQ5NA_3e2781d4-0f57-455c-b2c3-7f6665c1949c"
      unitRef="usd">-29000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="ibc1517ed4db74def880ae3ff1b172041_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfOS0xLTEtMS0yNzEzNQ_91fab4c3-cbbf-4654-b53a-99b0ae03e61e"
      unitRef="usd">528000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i8eac04e1e58f46a1be1d57dae1515d50_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfOS0zLTEtMS0yNzE2MA_0a239626-44d6-42c5-8bb6-cb29514a9baa"
      unitRef="usd">0</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="ie475f7d09c704e268b2c10ef5f50cc45_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfOS02LTEtMS0yNzIxNg_50bdfad6-8525-44c6-a889-1c3fcabba3e5"
      unitRef="usd">1429000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfOS04LTEtMS02MTQ5MQ_444f39f9-6a10-4bb5-8b2f-36edb50e2058"
      unitRef="usd">1957000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserve
      contextRef="i4a19a43c357247ff976618cccfe634e3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMTAtMi0xLTEtNjE0NTE_7687209c-1e8c-4f18-b3f1-e1e6154279fc"
      unitRef="usd">499000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="id18d76e7cad1483da6d29083e9a8f281_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMTAtNC0xLTEtNjE0NTc_f8a7a785-a7cb-41c9-81d5-228241d24c2d"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i19701020e9b7421080322ea64ddfa6fc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMTAtNi0xLTEtNjE0NzI_4b23a39f-2e06-4263-ada0-c0cc5370810c"
      unitRef="usd">165000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RhYmxlOjQ1YzE4MzQyYjNmNTRkYjJhYzIwZGM1N2M3NmVkNDBlL3RhYmxlcmFuZ2U6NDVjMTgzNDJiM2Y1NGRiMmFjMjBkYzU3Yzc2ZWQ0MGVfMTAtOC0xLTEtNjE0NjY_8ceeb7ad-f519-4639-a426-172ba1bd3f13"
      unitRef="usd">664000</us-gaap:RestructuringReserve>
    <icui:StrategicTransactionandIntegration
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMTk5NQ_61bda43d-edde-40b0-9305-aee8fda5b113"
      unitRef="usd">19800000</icui:StrategicTransactionandIntegration>
    <icui:StrategicTransactionandIntegration
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMTk5OQ_7f1ba574-5682-470c-9a7a-e96333132138"
      unitRef="usd">20500000</icui:StrategicTransactionandIntegration>
    <icui:StrategicTransactionandIntegration
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMjAwNg_6b8d08e5-183d-4f4b-9071-5c1e9461d388"
      unitRef="usd">72200000</icui:StrategicTransactionandIntegration>
    <icui:Supplychainrestructuringcosts
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMjUyMA_73cb04c7-e4a1-4ab6-b3b0-188f1d9791c7"
      unitRef="usd">22100000</icui:Supplychainrestructuringcosts>
    <icui:Cleanupcosts
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83Ni9mcmFnOjc4YWRkNmNlZWVjNjQwMjE4OGM4Y2M1MmNhZDhmMzZkL3RleHRyZWdpb246NzhhZGQ2Y2VlZWM2NDAyMTg4YzhjYzUyY2FkOGYzNmRfMjY2Ng_988c17ae-1ba2-4d5d-8c4e-47f4a9e4d40e"
      unitRef="usd">12700000</icui:Cleanupcosts>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfNDg4Nw_eaf4f141-d28c-4503-91b5-45338339509b">REVENUE&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our primary product lines are Infusion Consumables, Infusion Systems, IV Solutions and Critical Care. The vast majority of our sales of these products are made on a stand-alone basis to hospitals and distributors. Revenue is typically recognized upon transfer of control of the products, which we deem to be at point of shipment. However, for purposes of revenue recognition for our software licenses and  renewals, we consider the control of these products to be transferred to a customer at a certain point in time; therefore, we recognize revenue at the start of the applicable license term.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payment is typically due in full within 30 days of delivery or the start of the contract term. Revenue is recorded in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We offer certain volume-based rebates to our distribution customers, which we record as variable consideration when calculating the transaction price. Rebates are offered on both a fixed and tiered/variable basis. In both cases, we use information available at the time and our historical experience with each customer to estimate the most likely rebate amount. We also provide chargebacks to distributors that sell to end customers at prices determined under a contract between us and the end customer. Chargebacks are the difference between the prices we charge our distribution customers and the contracted prices we have with the end customer which are processed as credits to our distribution customers. In estimating the expected value of chargeback amounts in order to determine the transaction price, we use information available at the time, including our historical experience.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also warrant products against defects and have a policy permitting the return of defective products, for which we accrue and expense at the time of sale using information available at that time and our historical experience. We also provide for extended service-type warranties, which we consider to be separate performance obligations. We allocate a portion of the transaction price to the extended service-type warranty based on its estimated relative selling price, and recognize revenue over the period the warranty service is provided. Our revenues are recorded at the net sales price, which includes an estimate for variable consideration related to rebates, chargebacks and product returns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Arrangements with Multiple Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also enter into arrangements which include multiple performance obligations, (see Note 1: Basis of Presentation and Summary of Significant Accounting Policies). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The most significant judgments related to these arrangements include: &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Identifying the various performance obligations of these arrangements.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Estimating the relative standalone selling price of each performance obligation, typically using a directly observable method or calculated on a cost plus margin basis method. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue disaggregated&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents our revenues disaggregated by product line (in thousands) and our disaggregated product line revenue as a percentage of total revenue:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.606%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Product line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% of Revenue&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Infusion Consumables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;555,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Infusion Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IV Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Critical Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,316,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,266,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We report revenue on a "where sold" basis, which reflects the revenue within the country or region in which the ultimate sale is made to our external customer.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents our revenues disaggregated by geography (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geography&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, the Middle East and Africa&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;910,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;923,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,316,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,266,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Domestic sales accounted for 72%, 72% and 73% of total revenue in 2021, 2020 and 2019, respectively.  International sales accounted for 28%, 28% and 27% of total revenue in 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our contract balances (deferred revenue) are recorded in accrued liabilities and other long-term liabilities in our consolidated balance sheet (see Note 10: Accrued Liabilities and Other Long-term Liabilities). The following table presents the changes in our contract balances for the years ended December 31, 2021 and 2020, (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contract Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance, January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,855)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,725)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; During 2021, we recognized $5.1&#160;million in revenue that was included in the opening contract balances as of December 31, 2020. As of December 31, 2021, revenue from remaining performance obligations related to implementation of software and equipment is $5.6 million. We expect to recognize substantially all of this revenue within the next three to six months dependent on implementation restrictions due to the novel coronavirus and its variants ("COVID-19").  Revenue from remaining performance obligations related to annual software licenses is $1.9 million. We expect to recognize substantially all of this revenue over the next twelve months. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Costs to Obtain a Contract with a Customer&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the cost to obtain a contract, we may pay incremental commissions to sales employees upon entering into a sales contract. Under ASC Topic 606, we have elected to expense these costs as incurred as the period of benefit is less than one year.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Practical expedients and exemptions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the practical expedient applied to sales commissions, under ASC Topic 606, we elected to apply the practical expedient for shipping and handling costs incurred after the customer has obtained control of a good. We will continue to treat these costs as a fulfillment cost rather than as an additional promised service.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfNDg5MA_bf82b0fa-f50f-48f9-8a15-172eba753d98">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents our revenues disaggregated by product line (in thousands) and our disaggregated product line revenue as a percentage of total revenue:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.606%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Product line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% of Revenue&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Infusion Consumables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;555,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Infusion Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IV Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Critical Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,316,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,266,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We report revenue on a "where sold" basis, which reflects the revenue within the country or region in which the ultimate sale is made to our external customer.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents our revenues disaggregated by geography (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geography&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, the Middle East and Africa&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;910,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;923,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,316,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,266,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Domestic sales accounted for 72%, 72% and 73% of total revenue in 2021, 2020 and 2019, respectively.  International sales accounted for 28%, 28% and 27% of total revenue in 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="i9c2abd8a14954e2d908b7a6ad1bff678_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfMy0xLTEtMS04NzQ1_a73830d8-53b4-4862-8349-6d800f856df6"
      unitRef="usd">555189000</us-gaap:Revenues>
    <icui:Percentageofrevenue
      contextRef="i9c2abd8a14954e2d908b7a6ad1bff678_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfMy0zLTEtMS04NzQ1_ecf651ed-7d46-4d76-9271-c60650ce8da8"
      unitRef="number">0.42</icui:Percentageofrevenue>
    <us-gaap:Revenues
      contextRef="ia9e8a812a73f4a1d8f7f8110a8759bf4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfMy01LTEtMS04NzQ1_92fc1f7d-0c60-4e8d-bf78-9d4a669ddf4b"
      unitRef="usd">473740000</us-gaap:Revenues>
    <icui:Percentageofrevenue
      contextRef="ia9e8a812a73f4a1d8f7f8110a8759bf4_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfMy03LTEtMS04NzQ1_53328c33-8906-4e1f-a386-5db60b6c5997"
      unitRef="number">0.37</icui:Percentageofrevenue>
    <us-gaap:Revenues
      contextRef="ib25ed464299245f3a253cac238e6e16b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfMy05LTEtMS04NzQ1_d9c6467e-c791-46ea-916f-c8a939f1a71c"
      unitRef="usd">477611000</us-gaap:Revenues>
    <icui:Percentageofrevenue
      contextRef="ib25ed464299245f3a253cac238e6e16b_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfMy0xMS0xLTEtODc0NQ_80019bfe-1408-4bb9-822e-9054ea7674fb"
      unitRef="number">0.37</icui:Percentageofrevenue>
    <us-gaap:Revenues
      contextRef="i3c6cc917f0a04f9e98f2098b917cb28f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNC0xLTEtMS04NzQ1_a6ba308c-c4eb-4f22-b1ef-e26f84314b17"
      unitRef="usd">352321000</us-gaap:Revenues>
    <icui:Percentageofrevenue
      contextRef="i3c6cc917f0a04f9e98f2098b917cb28f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNC0zLTEtMS04NzQ1_3545c7bd-50d3-421d-8502-65d7b8cb0a77"
      unitRef="number">0.27</icui:Percentageofrevenue>
    <us-gaap:Revenues
      contextRef="i52b0fc63199747a09f8aaf3d7b68b362_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNC01LTEtMS04NzQ1_3449cb10-4a22-43ec-a83a-b554a69f5ab6"
      unitRef="usd">359691000</us-gaap:Revenues>
    <icui:Percentageofrevenue
      contextRef="i52b0fc63199747a09f8aaf3d7b68b362_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNC03LTEtMS04NzQ1_b75393e9-ef46-4930-9e91-b7d505b8f227"
      unitRef="number">0.28</icui:Percentageofrevenue>
    <us-gaap:Revenues
      contextRef="i201b9c34887c4c05be4d0d4326d1e331_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNC05LTEtMS04NzQ1_5815cb98-6e7d-467c-9d3b-5e8f7a1662e7"
      unitRef="usd">328282000</us-gaap:Revenues>
    <icui:Percentageofrevenue
      contextRef="i201b9c34887c4c05be4d0d4326d1e331_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNC0xMS0xLTEtODc0NQ_f23614be-6a85-4bf1-a643-c8baf74d95b1"
      unitRef="number">0.26</icui:Percentageofrevenue>
    <us-gaap:Revenues
      contextRef="i9ce76eb5aa3f457a94d4842e2df5c4b4_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNS0xLTEtMS04NzQ1_5cd18793-27ce-4690-9b4a-a35ad0c7ec32"
      unitRef="usd">359477000</us-gaap:Revenues>
    <icui:Percentageofrevenue
      contextRef="i9ce76eb5aa3f457a94d4842e2df5c4b4_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNS0zLTEtMS04NzQ1_b161586a-73f9-4c05-881c-397e846720ad"
      unitRef="number">0.27</icui:Percentageofrevenue>
    <us-gaap:Revenues
      contextRef="idb7d360b50434c90b1362f13d39de454_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNS01LTEtMS04NzQ1_d78bf9e4-a8d1-4d6f-af98-37b77cd57492"
      unitRef="usd">388971000</us-gaap:Revenues>
    <icui:Percentageofrevenue
      contextRef="idb7d360b50434c90b1362f13d39de454_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNS03LTEtMS04NzQ1_cb9b44f0-c777-4107-8e5f-ae37a0056b86"
      unitRef="number">0.31</icui:Percentageofrevenue>
    <us-gaap:Revenues
      contextRef="ie65b63b2aa354165aa8b2d1156015ecd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNS05LTEtMS04NzQ1_fab84c1e-2eba-4ec7-8ba6-06b7319cfb95"
      unitRef="usd">414971000</us-gaap:Revenues>
    <icui:Percentageofrevenue
      contextRef="ie65b63b2aa354165aa8b2d1156015ecd_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNS0xMS0xLTEtODc0NQ_9f98a69b-8baf-49dd-97f4-fa6f63b3d220"
      unitRef="number">0.33</icui:Percentageofrevenue>
    <us-gaap:Revenues
      contextRef="i47789bab6a1046d49538401de29b23ca_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNi0xLTEtMS04NzQ1_028a81de-e90c-4654-b72e-e716a5c2ce79"
      unitRef="usd">49321000</us-gaap:Revenues>
    <icui:Percentageofrevenue
      contextRef="i47789bab6a1046d49538401de29b23ca_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNi0zLTEtMS04NzQ1_f069fed1-92ee-4ec9-a088-eb1263b8a295"
      unitRef="number">0.04</icui:Percentageofrevenue>
    <us-gaap:Revenues
      contextRef="iba69653f43264a18a0f9f7bbc4521bfb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNi01LTEtMS04NzQ1_358b706e-c3a9-41dd-8478-0ed1b1446645"
      unitRef="usd">48602000</us-gaap:Revenues>
    <icui:Percentageofrevenue
      contextRef="iba69653f43264a18a0f9f7bbc4521bfb_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNi03LTEtMS04NzQ1_90b09fd9-4e19-4710-8152-120e21545602"
      unitRef="number">0.04</icui:Percentageofrevenue>
    <us-gaap:Revenues
      contextRef="i16a80a38aab0404bb60ce11730e5d9b2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNi05LTEtMS04NzQ1_737b45a2-6125-4157-9de7-be3c4a1b1392"
      unitRef="usd">45344000</us-gaap:Revenues>
    <icui:Percentageofrevenue
      contextRef="i16a80a38aab0404bb60ce11730e5d9b2_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfNi0xMS0xLTEtODc0NQ_0f168cb7-a5e8-4f30-8470-c6d8b22b392e"
      unitRef="number">0.04</icui:Percentageofrevenue>
    <us-gaap:Revenues
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfOC0xLTEtMS04NzQ1_473b3464-fd35-4b0f-b709-0158129afbc8"
      unitRef="usd">1316308000</us-gaap:Revenues>
    <icui:Percentageofrevenue
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfOC0zLTEtMS04NzQ1_4473ea01-4c1d-4674-b809-f24df9ed8f79"
      unitRef="number">1</icui:Percentageofrevenue>
    <us-gaap:Revenues
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfOC01LTEtMS04NzQ1_e720ce43-641f-480e-91f0-ef65772333e7"
      unitRef="usd">1271004000</us-gaap:Revenues>
    <icui:Percentageofrevenue
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfOC03LTEtMS04NzQ1_3ea19bc4-ba52-4472-a513-a5c7ad5b8dff"
      unitRef="number">1</icui:Percentageofrevenue>
    <us-gaap:Revenues
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfOC05LTEtMS04NzQ1_2645f623-5509-4a6a-909e-6af77740e803"
      unitRef="usd">1266208000</us-gaap:Revenues>
    <icui:Percentageofrevenue
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjNhMTZlNzUwYjFmMjRkNmJhZmZiOWI2MTBhNWI1NTgzL3RhYmxlcmFuZ2U6M2ExNmU3NTBiMWYyNGQ2YmFmZmI5YjYxMGE1YjU1ODNfOC0xMS0xLTEtODc0NQ_e651575d-b206-4fce-ad8a-951ded60a38e"
      unitRef="number">1</icui:Percentageofrevenue>
    <us-gaap:Revenues
      contextRef="i4099adac88a94f2c844d6d0a67f5b93f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfMi0xLTEtMS04NzQ1_9c4829e0-458c-4dec-9c2c-d8bb35082e45"
      unitRef="usd">147488000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4fd4ad49e5ca42958f511cd87f3b86e1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfMi0zLTEtMS04NzQ1_9e4f9896-a23b-4792-a767-1e8638c3e6f4"
      unitRef="usd">132763000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4b6da943f3c548f58f42328ecef541e1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfMi01LTEtMS04NzQ1_37da2e13-331e-451c-bb2f-b8e9dfe22f69"
      unitRef="usd">130530000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0ef1d9853e504ab394c35a1dda0b5652_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfMy0xLTEtMS04NzQ1_bedb31cd-38a6-4757-9d9b-7529e1bf0844"
      unitRef="usd">227011000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iba50cb76497a4bde9e14f5743b6475c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfMy0zLTEtMS04NzQ1_6da8a65d-a663-43b0-b712-06f7414c9968"
      unitRef="usd">227614000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i46c1f41659ba4557a83903554fac974b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfMy01LTEtMS04NzQ1_5f4cc54b-d59f-4400-9ff2-e430fe706881"
      unitRef="usd">212336000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i928b25071431497386ecd55fee9d4139_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfNC0xLTEtMS04NzQ1_98ada7b7-21b4-4f7c-9dc7-e552d9d6570c"
      unitRef="usd">374499000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibd6c4227c1cd44dc9eef66faca80e3c1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfNC0zLTEtMS04NzQ1_98b54372-7749-42b4-b064-90491843216d"
      unitRef="usd">360377000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7d1cf0743c804ef8a6831ae5bd16c05a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfNC01LTEtMS04NzQ1_1ce038c2-4b57-4b65-86bb-3528dc779583"
      unitRef="usd">342866000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9e571091fc1f4ae5aa5c04d2eccc5543_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfNS0xLTEtMS04NzQ1_f5516799-e6be-480d-bf51-18ab310b5d38"
      unitRef="usd">941809000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7e8278d8b555471884d28845b03e9a66_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfNS0zLTEtMS04NzQ1_890ebfdb-9dad-4be4-8072-4cf368a4e9e2"
      unitRef="usd">910627000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i62815f424b0f4a83a52362d984e6bdab_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfNS01LTEtMS04NzQ1_35700b98-674b-47b4-b270-da5cef8b4052"
      unitRef="usd">923342000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfNi0xLTEtMS04NzQ1_33080287-e38f-44ea-a9b3-eb69f9f6354e"
      unitRef="usd">1316308000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfNi0zLTEtMS04NzQ1_20fc5537-f77f-4fff-bba4-a1add7669938"
      unitRef="usd">1271004000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOjVhNTY2MjZjOGY3OTRmYmJiZWM2YTI1NWU1ZWJmNzUyL3RhYmxlcmFuZ2U6NWE1NjYyNmM4Zjc5NGZiYmJlYzZhMjU1ZTVlYmY3NTJfNi01LTEtMS04NzQ1_83021c07-206e-45f1-92db-5f0d19d4558f"
      unitRef="usd">1266208000</us-gaap:Revenues>
    <icui:Percentoftotalrevenue
      contextRef="i9e571091fc1f4ae5aa5c04d2eccc5543_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfMzE1MA_6422e6d5-e063-4a17-8394-125efebbe598"
      unitRef="number">0.72</icui:Percentoftotalrevenue>
    <icui:Percentoftotalrevenue
      contextRef="i7e8278d8b555471884d28845b03e9a66_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfMzE1NA_cd3822c2-4c6b-408f-b9cd-c9cf0ef5aa7d"
      unitRef="number">0.72</icui:Percentoftotalrevenue>
    <icui:Percentoftotalrevenue
      contextRef="i62815f424b0f4a83a52362d984e6bdab_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfMzE2MQ_e67bd440-8926-487d-bb7a-59ea90d0fa2e"
      unitRef="number">0.73</icui:Percentoftotalrevenue>
    <icui:Percentoftotalrevenue
      contextRef="i513e00d1325e4cbab47333544fe16795_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfMzI0OA_09a9ff0f-661b-4765-8125-d87d5b6142f6"
      unitRef="number">0.28</icui:Percentoftotalrevenue>
    <icui:Percentoftotalrevenue
      contextRef="i43801ce9ae0d4d64b094552e36f505d8_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfMzI1Mg_7c7cba33-62b2-4a8c-bfbf-d37cf8cf4360"
      unitRef="number">0.28</icui:Percentoftotalrevenue>
    <icui:Percentoftotalrevenue
      contextRef="i47aa34896b3a48b98371a8adb7a428c8_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfMzI1OQ_a30d7f26-7e8a-41cb-8d9d-73a957512cdf"
      unitRef="number">0.27</icui:Percentoftotalrevenue>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfNDg5Mg_105d9c12-c11c-44da-ac72-df93eb2bbebc">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our contract balances (deferred revenue) are recorded in accrued liabilities and other long-term liabilities in our consolidated balance sheet (see Note 10: Accrued Liabilities and Other Long-term Liabilities). The following table presents the changes in our contract balances for the years ended December 31, 2021 and 2020, (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contract Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance, January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,855)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,725)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfMS0xLTEtMS04NzQ1_717cb7d3-8bdf-4afb-955d-26fe77d76511"
      unitRef="usd">4855000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i07b1db2fc46e4252ad0d15476844f7ab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfMi0xLTEtMS04NzQ1_317cdbb6-11a1-45a8-93c3-c4d77f8d56bc"
      unitRef="usd">-14408000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:DeferredRevenueAdditions
      contextRef="i07b1db2fc46e4252ad0d15476844f7ab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfMy0xLTEtMS04NzQ1_06618e72-c875-474e-afaa-4cf5143f1a83"
      unitRef="usd">14341000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i44cab7a364ba4dfeb44c1c2c019c7508_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfNC0xLTEtMS04NzQ1_11150432-2dba-4838-b99b-634dddaa3aa9"
      unitRef="usd">-5721000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:DeferredRevenueAdditions
      contextRef="i44cab7a364ba4dfeb44c1c2c019c7508_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfNS0xLTEtMS04NzQ1_3b204e80-6e8a-43ba-8c74-8c346596ab6d"
      unitRef="usd">7363000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfNi0xLTEtMS04NzQ1_e81bc6a0-1c13-423e-a379-1505d65f8b86"
      unitRef="usd">6430000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ideea602385704c09a9de5340c5673d94_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfNy0xLTEtMS04NzQ1_190562ff-2ccb-4240-9edb-62e83486e5a3"
      unitRef="usd">-10048000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:DeferredRevenueAdditions
      contextRef="ideea602385704c09a9de5340c5673d94_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfOC0xLTEtMS04NzQ1_6e45e334-3c23-4382-819b-3ac9a39d0178"
      unitRef="usd">13725000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i57358508c9e84334b935ca3d7b783237_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfOS0xLTEtMS04NzQ1_b1522fe9-ed0b-4b94-a47a-eae41d13c905"
      unitRef="usd">-7261000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:DeferredRevenueAdditions
      contextRef="i57358508c9e84334b935ca3d7b783237_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfMTAtMS0xLTEtODc0NQ_6f74f640-1f0f-4133-a332-71c5634a13fc"
      unitRef="usd">4615000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:ContractWithCustomerLiability
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RhYmxlOmYxMjI0MTRmMmM1ODQ1ZjY4ZmI0ZDFmOWZkY2JkY2ZjL3RhYmxlcmFuZ2U6ZjEyMjQxNGYyYzU4NDVmNjhmYjRkMWY5ZmRjYmRjZmNfMTEtMS0xLTEtODc0NQ_085a3a40-4f0e-403b-ac73-57dd275cfe31"
      unitRef="usd">7461000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfMTA5OTUxMTYzNTI1Nw_7da68ab4-d43b-4e59-8fc9-daf665d74231"
      unitRef="usd">5100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ief31f8281f40440b9b7259476db1babf_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfMzkzNw_ded72942-07f6-48c7-9525-6b9457d739d3"
      unitRef="usd">5600000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ic2ba2c623a754ec09109f4e760fdc883_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF83OS9mcmFnOjczMjc4MTEwZGIwOTRmOGNhM2ZiMDZmMDNlODgxNmQ3L3RleHRyZWdpb246NzMyNzgxMTBkYjA5NGY4Y2EzZmIwNmYwM2U4ODE2ZDdfNDEyMg_a87698c8-8c5c-4474-a443-63faac880c39"
      unitRef="usd">1900000</us-gaap:RevenueRemainingPerformanceObligation>
    <icui:LesseeOperatingAndFinanceLeaseTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RleHRyZWdpb246MGQzYzA1ZmJhZDVkNDMxMGI0NTVmNDkzMTE5NmZmZDBfMTA5OTUxMTYzNTIxNg_bc4a5087-35b9-4762-9dc8-0a5108218071">LEASES&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine if an arrangement is a lease at inception. Our operating lease assets are separately stated in operating lease right-of-use ("ROU") assets and our financing lease assets are included in other assets on our consolidated balance sheets. Our lease liabilities are included in accrued liabilities, and other long-term liabilities on our consolidated balance sheets. We have elected not to recognize an ROU asset and lease liability for leases with terms of twelve months or less.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease ROU assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. Most of our leases do not provide an implicit rate, therefore we use our incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term based on the information available at commencement date. Our lease ROU assets exclude lease incentives and initial direct costs incurred. Our lease terms include options to extend when it is reasonably certain that we will exercise that option. All of our leases have stated lease payments, which may include fixed rental increases. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our leases are for corporate, research and development and sales and support offices, a distribution facility, device service centers and certain equipment. Our leases have original lease terms of one year to fifteen years, some of which include options to extend the leases for up to an additional five years. For all of our leases, we do not include optional periods of extension in our current lease terms for the exercise of options to extend is not reasonably certain.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of our lease cost (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost &#x2014; interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost &#x2014; reduction of ROU asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense on our finance leases is included in other income (expense), net in our consolidated statements of operations. The reduction of the operating and finance ROU assets is included as noncash lease expense in selling, general and administrative expenses in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental cash flow information related to our leases (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental balance sheet information related to our operating leases (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,847&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,571&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,009&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,740&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,971&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,980&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,759&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental balance sheet information related to our finance leases (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,915&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,388&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,710&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,942&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, the maturities of our operating and finance lease liabilities for each of the next five years are approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</icui:LesseeOperatingAndFinanceLeaseTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ie0c2e107da6f4265945c3cd1be9af667_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RleHRyZWdpb246MGQzYzA1ZmJhZDVkNDMxMGI0NTVmNDkzMTE5NmZmZDBfMTA5OTUxMTYzNTE5Nw_48d0bb3a-0b01-4254-bb56-1f813728137c">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i14ae100f3ea54791b971967ebffeb16c_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RleHRyZWdpb246MGQzYzA1ZmJhZDVkNDMxMGI0NTVmNDkzMTE5NmZmZDBfMjc1NA_84d0b303-da8b-4cf3-8bdf-ffbe615c7023">P15Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <icui:Optiontoextendinyears
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RleHRyZWdpb246MGQzYzA1ZmJhZDVkNDMxMGI0NTVmNDkzMTE5NmZmZDBfMjgzMw_1c7522e5-8bca-42c6-b6fd-8d0703e4dc05">P5Y</icui:Optiontoextendinyears>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RleHRyZWdpb246MGQzYzA1ZmJhZDVkNDMxMGI0NTVmNDkzMTE5NmZmZDBfMzY2Ng_f006110b-ec63-4ebf-a16a-8c47ffd4441f">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of our lease cost (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost &#x2014; interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost &#x2014; reduction of ROU asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense on our finance leases is included in other income (expense), net in our consolidated statements of operations. The reduction of the operating and finance ROU assets is included as noncash lease expense in selling, general and administrative expenses in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjNmMGVlZmVmYmM1YjQ2MzI5MjdlYTA0NWZmZjY1MjJmL3RhYmxlcmFuZ2U6M2YwZWVmZWZiYzViNDYzMjkyN2VhMDQ1ZmZmNjUyMmZfMi0xLTEtMS04NzQ1_dbeb0966-656a-4d05-9a50-4043516f683c"
      unitRef="usd">11251000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjNmMGVlZmVmYmM1YjQ2MzI5MjdlYTA0NWZmZjY1MjJmL3RhYmxlcmFuZ2U6M2YwZWVmZWZiYzViNDYzMjkyN2VhMDQ1ZmZmNjUyMmZfMi0zLTEtMS04NzQ1_c80d3ac2-ee20-414c-b476-117935a020ae"
      unitRef="usd">11284000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjNmMGVlZmVmYmM1YjQ2MzI5MjdlYTA0NWZmZjY1MjJmL3RhYmxlcmFuZ2U6M2YwZWVmZWZiYzViNDYzMjkyN2VhMDQ1ZmZmNjUyMmZfMy0xLTEtMS04NzQ1_12b81a0a-f452-4560-a509-8eeac2bb6040"
      unitRef="usd">122000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjNmMGVlZmVmYmM1YjQ2MzI5MjdlYTA0NWZmZjY1MjJmL3RhYmxlcmFuZ2U6M2YwZWVmZWZiYzViNDYzMjkyN2VhMDQ1ZmZmNjUyMmZfMy0zLTEtMS04NzQ1_5261c558-21e0-4eaa-a99f-092af63a08b2"
      unitRef="usd">91000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjNmMGVlZmVmYmM1YjQ2MzI5MjdlYTA0NWZmZjY1MjJmL3RhYmxlcmFuZ2U6M2YwZWVmZWZiYzViNDYzMjkyN2VhMDQ1ZmZmNjUyMmZfNC0xLTEtMS04NzQ1_899e2b8f-652d-431d-849f-6e7f86ff0e5c"
      unitRef="usd">648000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjNmMGVlZmVmYmM1YjQ2MzI5MjdlYTA0NWZmZjY1MjJmL3RhYmxlcmFuZ2U6M2YwZWVmZWZiYzViNDYzMjkyN2VhMDQ1ZmZmNjUyMmZfNC0zLTEtMS04NzQ1_f293d702-724d-44bc-abb2-9e073d4c4e86"
      unitRef="usd">383000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:ShortTermLeaseCost
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjNmMGVlZmVmYmM1YjQ2MzI5MjdlYTA0NWZmZjY1MjJmL3RhYmxlcmFuZ2U6M2YwZWVmZWZiYzViNDYzMjkyN2VhMDQ1ZmZmNjUyMmZfNS0xLTEtMS04NzQ1_b683b6e6-8321-4d0e-98b7-0af7ccf80e28"
      unitRef="usd">14000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjNmMGVlZmVmYmM1YjQ2MzI5MjdlYTA0NWZmZjY1MjJmL3RhYmxlcmFuZ2U6M2YwZWVmZWZiYzViNDYzMjkyN2VhMDQ1ZmZmNjUyMmZfNS0zLTEtMS04NzQ1_ad2a36ef-2f10-4783-a9bf-9305f86246d4"
      unitRef="usd">263000</us-gaap:ShortTermLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjNmMGVlZmVmYmM1YjQ2MzI5MjdlYTA0NWZmZjY1MjJmL3RhYmxlcmFuZ2U6M2YwZWVmZWZiYzViNDYzMjkyN2VhMDQ1ZmZmNjUyMmZfNi0xLTEtMS04NzQ1_d12f2362-359e-40ec-a757-5a84e5afd975"
      unitRef="usd">12035000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjNmMGVlZmVmYmM1YjQ2MzI5MjdlYTA0NWZmZjY1MjJmL3RhYmxlcmFuZ2U6M2YwZWVmZWZiYzViNDYzMjkyN2VhMDQ1ZmZmNjUyMmZfNi0zLTEtMS04NzQ1_99d884fd-b193-4f1e-b628-e76e0f8b2f35"
      unitRef="usd">12021000</us-gaap:LeaseCost>
    <icui:SupplementalCashFlowInformationLeasesTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RleHRyZWdpb246MGQzYzA1ZmJhZDVkNDMxMGI0NTVmNDkzMTE5NmZmZDBfMzY2Nw_9e480c01-80c2-4267-aee8-26712e29349a">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental cash flow information related to our leases (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</icui:SupplementalCashFlowInformationLeasesTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjAxMTQ5MzYzYzU5NjQ0ZmNiOWZlN2E4MjUzZWVhMGJiL3RhYmxlcmFuZ2U6MDExNDkzNjNjNTk2NDRmY2I5ZmU3YTgyNTNlZWEwYmJfMy0xLTEtMS04NzQ1_e9d67167-11ce-48c4-9a2e-6b432944868e"
      unitRef="usd">11256000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjAxMTQ5MzYzYzU5NjQ0ZmNiOWZlN2E4MjUzZWVhMGJiL3RhYmxlcmFuZ2U6MDExNDkzNjNjNTk2NDRmY2I5ZmU3YTgyNTNlZWEwYmJfMy0zLTEtMS04NzQ1_bfd9e4f0-561e-47ee-b561-41cd4b5572fb"
      unitRef="usd">10185000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjAxMTQ5MzYzYzU5NjQ0ZmNiOWZlN2E4MjUzZWVhMGJiL3RhYmxlcmFuZ2U6MDExNDkzNjNjNTk2NDRmY2I5ZmU3YTgyNTNlZWEwYmJfNC0xLTEtMS04NzQ1_01cf5826-de72-4040-9167-a2e288ad3b72"
      unitRef="usd">122000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjAxMTQ5MzYzYzU5NjQ0ZmNiOWZlN2E4MjUzZWVhMGJiL3RhYmxlcmFuZ2U6MDExNDkzNjNjNTk2NDRmY2I5ZmU3YTgyNTNlZWEwYmJfNC0zLTEtMS04NzQ1_68b5f99a-a733-4070-a851-f9c2a2d47f45"
      unitRef="usd">91000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjAxMTQ5MzYzYzU5NjQ0ZmNiOWZlN2E4MjUzZWVhMGJiL3RhYmxlcmFuZ2U6MDExNDkzNjNjNTk2NDRmY2I5ZmU3YTgyNTNlZWEwYmJfNy0xLTEtMS04NzQ1_dc2783c1-9ee9-454c-8bcb-b44db77fce94"
      unitRef="usd">2589000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjAxMTQ5MzYzYzU5NjQ0ZmNiOWZlN2E4MjUzZWVhMGJiL3RhYmxlcmFuZ2U6MDExNDkzNjNjNTk2NDRmY2I5ZmU3YTgyNTNlZWEwYmJfNy0zLTEtMS04NzQ1_bca0492c-0aa6-4a46-b383-0946aa095e7e"
      unitRef="usd">20847000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjAxMTQ5MzYzYzU5NjQ0ZmNiOWZlN2E4MjUzZWVhMGJiL3RhYmxlcmFuZ2U6MDExNDkzNjNjNTk2NDRmY2I5ZmU3YTgyNTNlZWEwYmJfOC0xLTEtMS04NzQ1_f70f3744-604c-4fe4-a603-1cdd153f3aa0"
      unitRef="usd">558000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjAxMTQ5MzYzYzU5NjQ0ZmNiOWZlN2E4MjUzZWVhMGJiL3RhYmxlcmFuZ2U6MDExNDkzNjNjNTk2NDRmY2I5ZmU3YTgyNTNlZWEwYmJfOC0zLTEtMS04NzQ1_9da6930e-9c74-4d52-81b2-d761b36a89c8"
      unitRef="usd">3062000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <icui:SupplementalBalanceSheetInformationLeasesTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RleHRyZWdpb246MGQzYzA1ZmJhZDVkNDMxMGI0NTVmNDkzMTE5NmZmZDBfMzY3NA_3f1c4c2b-98bd-4395-8940-21448bb9395e">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental balance sheet information related to our operating leases (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,847&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,571&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,009&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,740&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,971&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,980&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,759&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental balance sheet information related to our finance leases (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,915&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,388&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,710&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,942&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</icui:SupplementalBalanceSheetInformationLeasesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfMy0xLTEtMS04NzQ1_3e2d1dcf-4bd1-4306-86f0-91c641d2a9b9"
      unitRef="usd">39847000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfMy0zLTEtMS04NzQ1_94e46019-0cf4-40c8-9110-88a52ba2934c"
      unitRef="usd">46571000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfNS0xLTEtMS04NzQ1_6e0805e7-5a5e-44df-b32a-d647c632a5cf"
      unitRef="usd">9009000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfNS0zLTEtMS04NzQ1_1ef77f75-cc17-4632-9172-1b4335cdb208"
      unitRef="usd">8740000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfNi0xLTEtMS04NzQ1_f6ba3e63-0dc5-4fc4-bf36-94aec9e28b63"
      unitRef="usd">33971000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfNi0zLTEtMS04NzQ1_bf5d34f0-27a1-44f2-92a9-f07cb9a60786"
      unitRef="usd">41019000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfNy0xLTEtMS04NzQ1_4d134dd1-0aa8-4d04-96b3-da4db9a0bc8d"
      unitRef="usd">42980000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfNy0zLTEtMS04NzQ1_1bf667e7-7b06-41d9-8d10-b550cc5aa1c3"
      unitRef="usd">49759000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfMTAtMS0xLTEtODc0NQ_0d6e7357-db6d-413d-8c3b-cba5f799c182">P5Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfMTAtMy0xLTEtODc0NQ_ffc1b114-4470-4c21-8871-1e2350a43a6b">P6Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfMTMtMS0xLTEtODc0NQ_beeb8444-96aa-44b9-aa53-63540f57e9b9"
      unitRef="number">0.0498</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOmZkYWQ3MjEyMmZlOTRiM2VhZWI1YjRkNmIxNjBjZjY4L3RhYmxlcmFuZ2U6ZmRhZDcyMTIyZmU5NGIzZWFlYjViNGQ2YjE2MGNmNjhfMTMtMy0xLTEtODc0NQ_9c0373d3-cdc5-4afd-856a-19de239ac4e3"
      unitRef="number">0.0502</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfMy0xLTEtMS02MTI2NQ_2d5d1790-7c13-47ae-9153-48b1c1eae6d2"
      unitRef="usd">2673000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfMy0xLTEtMS04NzQ1_3fe7fe4d-f189-4404-a3a8-de8802b839bc"
      unitRef="usd">2915000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfNS0xLTEtMS02MTI2NQ_ac92e229-b12b-4608-b846-385602fd8e37"
      unitRef="usd">643000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfNS0xLTEtMS04NzQ1_9f17847e-a5b6-4fad-8fb8-6914f5cd99ce"
      unitRef="usd">554000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfNi0xLTEtMS02MTI2NQ_b6455b9a-0717-46bf-adfc-076a058caab4"
      unitRef="usd">2067000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfNi0xLTEtMS04NzQ1_ef988101-0e67-471f-8b3d-f104b97cabaa"
      unitRef="usd">2388000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfNy0xLTEtMS02MTI2NQ_241f9b0d-ee34-49df-bb3d-60480b96a63c"
      unitRef="usd">2710000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfNy0xLTEtMS04NzQ1_62233404-17b4-49b5-b23a-b8cc2a6fb78d"
      unitRef="usd">2942000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfMTAtMS0xLTEtNjEyNjU_365e61b8-9a0d-4b1b-855f-dcda4067474a">P5Y7M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfMTAtMS0xLTEtODc0NQ_487073e2-09f0-4e9b-8955-44c1fc7b4cf9">P6Y4M24D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfMTMtMS0xLTEtNjEyNjU_c9286d19-d7fd-4244-a026-e51479539d7f"
      unitRef="number">0.0428</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjE0MWRlZTgxN2Y5NTQ0ZDViNGI1ODE2NjZhY2I3YzRmL3RhYmxlcmFuZ2U6MTQxZGVlODE3Zjk1NDRkNWI0YjU4MTY2NmFjYjdjNGZfMTMtMS0xLTEtODc0NQ_6971c195-ab87-475e-a8fc-f6f729224cb5"
      unitRef="number">0.0427</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RleHRyZWdpb246MGQzYzA1ZmJhZDVkNDMxMGI0NTVmNDkzMTE5NmZmZDBfMzY3MQ_ac9ab9bf-06f9-4e06-ab1f-cc00ed52ca20">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, the maturities of our operating and finance lease liabilities for each of the next five years are approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfMS0xLTEtMS04NzQ1_9d52f08b-cb62-4712-a25c-613e52500be3"
      unitRef="usd">10887000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfMS0zLTEtMS04NzQ1_497dddfb-b332-4978-b4e3-3e70cba3b56e"
      unitRef="usd">749000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfMS0zLTEtMS04NzQ1_cf11f681-13a2-44a3-bb0d-9798153d9763"
      unitRef="usd">749000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfMi0xLTEtMS04NzQ1_a4e9b401-64c6-4330-9f05-53a028c4c94b"
      unitRef="usd">9453000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfMi0zLTEtMS04NzQ1_6d03e6fc-0504-4c50-89a7-9abb90ec175f"
      unitRef="usd">749000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfMy0xLTEtMS04NzQ1_8bfacd4d-ecdb-4e76-bec4-bd22ac898442"
      unitRef="usd">8488000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfMy0zLTEtMS04NzQ1_6c0ab786-ca49-467f-8b97-f090d3982cff"
      unitRef="usd">458000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfNC0xLTEtMS04NzQ1_e2a874b4-f687-47bb-b9b2-2eb63c7fe781"
      unitRef="usd">5129000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfNC0zLTEtMS04NzQ1_9209026b-43be-4e40-9011-01179985151c"
      unitRef="usd">267000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfNS0xLTEtMS04NzQ1_eae3fdeb-0c75-4633-a427-3d4c5626f3bf"
      unitRef="usd">4842000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfNS0zLTEtMS04NzQ1_873e6702-a501-4754-8df4-14f40e5777b1"
      unitRef="usd">214000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfNi0xLTEtMS04NzQ1_6a0410a5-af8c-4720-97a4-5c23b2cf5812"
      unitRef="usd">10577000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfNi0zLTEtMS04NzQ1_f6b1926e-6e77-4acd-ad48-bbea752f46e2"
      unitRef="usd">615000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfNy0xLTEtMS04NzQ1_a45b9c2a-1889-4c36-8d1c-26ef29d822cb"
      unitRef="usd">49376000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfNy0zLTEtMS04NzQ1_25096603-22c0-4f5d-a9cb-616bec1c06dd"
      unitRef="usd">3052000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfOC0xLTEtMS04NzQ1_e6d5b977-1f83-4a02-b9d7-9500975550a7"
      unitRef="usd">6396000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfOC0zLTEtMS04NzQ1_7664a121-2716-413a-97f7-8f832a4b3d8f"
      unitRef="usd">342000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfOS0xLTEtMS04NzQ1_c5d633c4-9279-46b0-9c1b-960edf1c84e5"
      unitRef="usd">42980000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84Mi9mcmFnOjBkM2MwNWZiYWQ1ZDQzMTBiNDU1ZjQ5MzExOTZmZmQwL3RhYmxlOjFlNDkzMDg5MzZlOTQwNzM4NWZjMjZhMmRjYmMzM2Y2L3RhYmxlcmFuZ2U6MWU0OTMwODkzNmU5NDA3Mzg1ZmMyNmEyZGNiYzMzZjZfOS0zLTEtMS04NzQ1_623ff3ee-711f-46c9-a54b-211c0918ce8a"
      unitRef="usd">2710000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTA0Nzg_2e65c1da-5ea9-4618-8b44-9993ab067205">SHARE-BASED AWARDS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have a stock incentive plan for employees and directors and an employee stock purchase plan.&#160; Shares to be issued under these plans will be issued either from authorized but unissued shares or from treasury shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We incur stock compensation expense for stock options, restricted stock units ("RSU"), performance restricted stock units ("PRSU") and in years prior to 2018 stock purchased under our employee stock purchase plan ("ESPP"), which was suspended in 2017. We receive a tax benefit on stock compensation expense and direct tax benefits from the exercise of stock options and vesting of restricted stock units. We also have indirect tax benefits upon exercise of stock options and vesting of restricted stock units related to research and development tax credits which are recorded as a reduction of income tax expense.&#160; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes compensation costs and related tax benefits (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&#160;ended&#160;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit from stock-based compensation cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indirect tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, we had $31.2 million of unamortized stock compensation cost which we will recognize as an expense over a weighted-average period of approximately 0.9 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Option Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our 2011 Stock Incentive Plan ("2011 Plan") replaced our 2003 Stock Option Plan ("2003 Plan"). Our 2011 Plan initially had 650,000 shares available for issuance, plus the remaining available shares for grant from the 2003 Plan and any shares that were forfeited, terminated or expired that would have otherwise returned to the 2003 Plan. In 2012, 2014 and 2017, our stockholders approved amendments to the 2011 plan that increased the shares available for issuance by 3,275,000, bringing the initial shares available for issuance to 3,925,000, plus the remaining 248,700 shares that remained available for grant from the 2003 Plan. As of December&#160;31, 2021, the 2011 Plan has 4,188,300 shares of common stock reserved for issuance to employees, which includes 263,300 shares that transferred from the 2003 Plan.&#160;Shares issued as options or stock appreciation rights ("SARs") are charged against the 2011 Plan's share reserve as one share for one share issued.  Shares subject to awards other than options and SARs are charged against the 2011 Plan's share reserve as 2.09 shares for 1 share issued. Options may be granted with exercise prices at no less than fair market value at date of grant. Options granted under the 2011 Plan may be "non-statutory stock options" which expire no more than ten years from date of grant or "incentive stock options" as defined in Section&#160;422 of the Internal Revenue Code of 1986, as amended.&#160; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Time-based Stock Options&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To date, all options granted under 2011 Plan and 2003 Plan have been non-statutory stock options. The majority of the time-based outstanding employee option grants vested 25% after one year from the grant date and the balance vested ratably on a monthly basis over 36 months. The outstanding employee option grants are all fully vested. The majority of the outstanding options granted to non-employee directors vest one year from the grant date. The options generally expire 10 years from the grant date.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of time-based option grants is calculated using the Black-Scholes option valuation model.&#160;The expected term for the option grants was based on historical experience and expected future employee behavior. We estimate the volatility of our common stock at the date of grant based on the historical volatility of our common stock, based on the average expected exercise term. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The table below summarizes the total time-based stock options granted, total valuation and the weighted-average assumptions (dollars in thousands, except per option amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.039%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&#160;ended&#160;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of time-based options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant-date fair value of options granted (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Weighted-average assumptions for stock option valuation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant-price per option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant-date fair value per option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of our stock option activity as of and for the year ended December&#160;31, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Contractual Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;817,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The intrinsic values for options exercisable, outstanding and vested or expected to vest at December&#160;31, 2021 are based on our closing stock price of $237.34 at December&#160;31, 2021 and are before applicable taxes.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents information regarding stock option activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&#160;ended&#160;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intrinsic value of options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received from exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit from stock option exercises&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Awards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2021, we granted PRSUs to our executive officers. For the executive officers other than the Chief Executive Officer ("CEO"), Chief Operations Officer ("COO") and the Chief Financial Officer ("CFO"), the PRSUs will vest subject to a three-year time vesting and further subject to a determination by the Compensation Committee that the officers have met their individual performance goals for the applicable years. For the CEO, COO and the CFO, the performance shares will cliff-vest ending on March 6, 2024 and further be subject to the achievement of minimum three-year cumulative revenue and EPS targets, commencing on January 1, 2021 and ending on December 31, 2023, which when reviewed against a predetermined vesting matrix could result in 0% to 250% of the awarded units that could vest. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, we granted PRSUs to our executive officers. For the executive officers other than the CEO, COO and the CFO, the PRSUs will vest subject to a three-year time vesting and further subject to a determination by the Compensation Committee that the officers have met their individual performance goals for the applicable years. For the CEO, COO and the CFO, the performance shares will cliff-vest ending on March 6, 2023 and further be subject to the achievement of minimum three-year cumulative revenue and EPS targets, which when reviewed against a predetermined vesting matrix could result in 0% to 250% of the awarded units that could vest. On February 15, 2021, the Compensation Committee made the determination that the executive officers other than the CEO, COO and CFO met their individual performance goals for 2021, therefore one-third of their 2020 PRSU shares awarded vested during 2021. Additionally, during February 2021, the Compensation Committee, modified the potential vesting percentages related to the 2020 PRSU awards for the CEO, COO and CFO, as the original potential percentages were established immediately before the onset of the COVID-19 pandemic. The Compensation Committee determined to adjust the CEO, COO and CFO's potential to earn from between 0% and 250% of the award granted, to an increased potential to earn between 50% and 300% of the award granted, subject to the same minimum threshold revenue and EPS targets to be achieved by the Company. The additional compensation expense as a result of modifying the 2020 PRSUs granted to our CEO, COO and CFO totaled $2.1&#160;million recognized over the remaining amortization period from the date of modification.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, we granted PRSUs to our executive officers. For the executive officers other than the CEO and the COO, the PRSUs will vest subject to a three-year time vesting and further subject to a determination by the Compensation Committee that &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the officers have met their individual performance goals for the applicable years.  For the CEO and the COO, the performance shares will cliff-vest ending on March 6, 2022 and further subject to the achievement of a minimum Cumulative Adjusted EBITDA. If for the three year period ending on December 31, 2021 the Cumulative Adjusted EBITDA has a growth of at least 6% to 8%, 50% of the awarded units will vest. If on the vesting date the Cumulative Adjusted EBITDA has a growth of between 8% to 10%, 100% of the awarded units will vest. If on the vesting date the Cumulative Adjusted EBITDA has a growth of over 10%, 200% of the awarded units will vest. In 2019, we also granted PRSUs to one of our non-executive employees. These PRSUs will vest at the end of a three-year period ending on March 31, 2022, if certain minimum performance goals are met. On February 15, 2021, the Compensation Committee made the determination that the executive officers other than the CEO and COO met their individual performance goals for 2021, therefore one-third of their 2019 PRSU shares awarded vested during 2021. The performance period related to the 2019 CEO and COO PRSUs ended on December 31, 2021 and based on the Cumulative Adjusted EBITDA achieved during the performance period zero payout is expected, subject to Compensation Committee review and determination. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2018, we granted PRSUs to our executive officers. For the executive officers other than the CEO and the COO, the PRSUs were to vest subject to a three-year time vesting and further subject to a determination by the Compensation Committee that the officers have met their individual performance goals for the applicable year. For the CEO and the COO, the performance shares were to cliff-vest ending on February 15, 2021 and further subject to the achievement of a minimum Cumulative Adjusted EBITDA.  If for the three year period ending on December 31, 2020 the Cumulative Adjusted EBITDA has a growth of at least 6% to 8%, 50% of the awarded units will vest. If on the vesting date the Cumulative Adjusted EBITDA has a growth of between 8% to 10%, 100% of the awarded units will vest. If on the vesting date the Cumulative Adjusted EBITDA has a growth of over 10%, 200% of the awarded units will vest. On February 15, 2021, the Compensation Committee made the determination that the executive officers other than the CEO and COO met their individual performance goals for 2021, therefore one-third of their 2018 PRSU shares awarded vested during 2021. Also on February 15, 2021, the Compensation Committee determined that the CEO and COO's 2018 PRSUs were earned at 100% of the awards granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2017, we granted PRSUs to our executive officers. The PRSUs were scheduled to vest, if at all, upon the achievement of a minimum Cumulative Adjusted EBITDA, subject to a three-year cliff vesting ending on December 31, 2019.  If at that date, our Cumulative Adjusted EBITDA is at least $600 million but less than $650 million, 100% of the awarded units will vest.  If our Cumulative Adjusted EBITDA is at least $650 million but less than $700 million, 200% of the awarded units will vest. If our Cumulative Adjusted EBITDA is at least $700 million, 300% of the awarded units will vest. On January 17, 2020, the Compensation Committee made the determination that the 2017 PRSU shares were earned by our executive officers at the 300% achievement level.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2016, we granted PRSUs to our executive officers, which vested on December 31, 2018. During the first quarter of 2019, the Compensation Committee determined the award granted vested at 300%, as a minimum specified compound annual growth rate ("CAGR") in adjusted EBITDA per share of greater than 12% was reached for the 3-year performance period January 1, 2016 through December 31, 2018. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock units are granted annually to our Board of Directors and vest on the first anniversary of the grant date, or the date of our annual meeting, whichever occurs first. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2021, 2020 and 2019, we granted RSUs to certain employees that vest ratably on the anniversary of the grant over three years. We recognize forfeitures as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The grant-date fair market value of our PRSUs and RSUs is determined by our stock price on the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes our restricted stock award activity (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&#160;ended&#160;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands, except shares and per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PRSU&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares earned&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant-date fair value per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant-date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intrinsic value vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant-date fair value per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant-date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intrinsic value vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(a)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;PRSU shares earned in 2019 were related to performance awards granted to executives in 2016 and 2018, PRSU shares earned in 2020 were related to performance awards granted to executives in 2017, 2018 and 2019. PRSU shares earned in 2021 were related to performance awards granted to executives in 2018, 2019 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides a summary of our PRSU and RSU activity as of and for the year ended December&#160;31, 2021: &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Grant-Date Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Contractual Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in units due to performance expectations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,871)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested and expected to vest at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(a)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Relates to 2019-2021 PRSUs granted to a non-executive employee and 2021 and 2020 CEO, COO and CFO PRSUs granted, assumes attainment of an increased payout rate based on performance expectations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;ESPP&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have an ESPP under which U.S. employees may purchase up to $25,000 annually of common stock at 85% of its fair market value at the beginning or the end of a six-month offering period, whichever is lower. There are 750,000 shares of common stock reserved for issuance under the ESPP, which is subject to an annual increase of the least of 300,000 shares, two percent of the shares outstanding or such a number as determined by the Board.&#160;To date, there have been no increases.&#160;As of December&#160;31, 2021, there were 133,487 shares available for future issuance. The ESPP is intended to constitute an &#x201c;employee stock purchase plan&#x201d; within the meaning of Section&#160;423 of the Internal Revenue Code.  We suspended our ESPP in 2017.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <icui:ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTA1MDI_1b455fbd-c4a2-4b09-856b-38599d5f6ad2">The table below summarizes compensation costs and related tax benefits (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&#160;ended&#160;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit from stock-based compensation cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indirect tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</icui:ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjBjMzhmYmIyM2Y4MDQ0OTZhMjJmYjEyZGMzZTFhMWIwL3RhYmxlcmFuZ2U6MGMzOGZiYjIzZjgwNDQ5NmEyMmZiMTJkYzNlMWExYjBfMi0yLTEtMS04NzQ1_81f52037-07be-44ac-a337-72cc0ccad14b"
      unitRef="usd">27341000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjBjMzhmYmIyM2Y4MDQ0OTZhMjJmYjEyZGMzZTFhMWIwL3RhYmxlcmFuZ2U6MGMzOGZiYjIzZjgwNDQ5NmEyMmZiMTJkYzNlMWExYjBfMi00LTEtMS04NzQ1_1b48ae7b-dbd0-43a7-8af4-6de70d7c2696"
      unitRef="usd">23954000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjBjMzhmYmIyM2Y4MDQ0OTZhMjJmYjEyZGMzZTFhMWIwL3RhYmxlcmFuZ2U6MGMzOGZiYjIzZjgwNDQ5NmEyMmZiMTJkYzNlMWExYjBfMi02LTEtMS04NzQ1_c0748ef3-1532-4326-95c3-84930b0d3644"
      unitRef="usd">21918000</us-gaap:ShareBasedCompensation>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjBjMzhmYmIyM2Y4MDQ0OTZhMjJmYjEyZGMzZTFhMWIwL3RhYmxlcmFuZ2U6MGMzOGZiYjIzZjgwNDQ5NmEyMmZiMTJkYzNlMWExYjBfMy0yLTEtMS04NzQ1_1e221adf-2c2d-4734-a5ef-9b610708fe92"
      unitRef="usd">6391000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjBjMzhmYmIyM2Y4MDQ0OTZhMjJmYjEyZGMzZTFhMWIwL3RhYmxlcmFuZ2U6MGMzOGZiYjIzZjgwNDQ5NmEyMmZiMTJkYzNlMWExYjBfMy00LTEtMS04NzQ1_a7f7c9ec-8f2c-480e-88d3-1d95f88b389a"
      unitRef="usd">5564000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjBjMzhmYmIyM2Y4MDQ0OTZhMjJmYjEyZGMzZTFhMWIwL3RhYmxlcmFuZ2U6MGMzOGZiYjIzZjgwNDQ5NmEyMmZiMTJkYzNlMWExYjBfMy02LTEtMS04NzQ1_2c53f403-c9f5-4a5f-bb35-9a8687013488"
      unitRef="usd">4840000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <icui:IndirectTaxBenefitFromStockOptions
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjBjMzhmYmIyM2Y4MDQ0OTZhMjJmYjEyZGMzZTFhMWIwL3RhYmxlcmFuZ2U6MGMzOGZiYjIzZjgwNDQ5NmEyMmZiMTJkYzNlMWExYjBfNC0yLTEtMS04NzQ1_6edddd7d-f970-4318-91cf-3e42fdb783fb"
      unitRef="usd">285000</icui:IndirectTaxBenefitFromStockOptions>
    <icui:IndirectTaxBenefitFromStockOptions
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjBjMzhmYmIyM2Y4MDQ0OTZhMjJmYjEyZGMzZTFhMWIwL3RhYmxlcmFuZ2U6MGMzOGZiYjIzZjgwNDQ5NmEyMmZiMTJkYzNlMWExYjBfNC00LTEtMS04NzQ1_68e12cde-b5d7-4b1c-be70-e3068ab4c74c"
      unitRef="usd">1203000</icui:IndirectTaxBenefitFromStockOptions>
    <icui:IndirectTaxBenefitFromStockOptions
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjBjMzhmYmIyM2Y4MDQ0OTZhMjJmYjEyZGMzZTFhMWIwL3RhYmxlcmFuZ2U6MGMzOGZiYjIzZjgwNDQ5NmEyMmZiMTJkYzNlMWExYjBfNC02LTEtMS04NzQ1_a1941d96-657c-4730-b08a-01720ba3b9ea"
      unitRef="usd">680000</icui:IndirectTaxBenefitFromStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfOTc4_0cbca6cd-a608-400c-ad7b-98faeb1acc56"
      unitRef="usd">31200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTEwNg_7fe20742-7907-4b11-84cd-214fe7ebc20f">P0Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ifc815bf8be984d60b72cea6a09a89ff5_I20111231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTI4Mg_45a94953-0ae0-4468-88b9-9e916caa9ed9"
      unitRef="shares">650000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i1f3ac8f1b7404ea9b5d205028ace120c_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTYyMg_c9c864eb-286a-4602-99ea-80f337777e0c"
      unitRef="shares">3275000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ia405cf3a4ef6453097157cd7f886bc0c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTY4MA_f05d0734-82e6-44f1-ba84-de289876b893"
      unitRef="shares">3925000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ic7101eb3934f4304b875384f0d2bf58d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTcwMw_7bdc1705-7952-494b-948e-b25cfede7df1"
      unitRef="shares">248700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ia405cf3a4ef6453097157cd7f886bc0c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTc5NQ_a858af0e-557c-4b6f-b017-69b081ad28d0"
      unitRef="shares">4188300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <icui:Sharestransferredfromsupersededplan
      contextRef="ia405cf3a4ef6453097157cd7f886bc0c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTg3Mg_23f98a7f-5794-4319-859c-56ccf02c828b"
      unitRef="shares">263300</icui:Sharestransferredfromsupersededplan>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTA0ODY_a0fdecfc-a373-404e-89a3-68ca4e79f0e0">The table below summarizes the total time-based stock options granted, total valuation and the weighted-average assumptions (dollars in thousands, except per option amounts):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.039%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&#160;ended&#160;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of time-based options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant-date fair value of options granted (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Weighted-average assumptions for stock option valuation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant-price per option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant-date fair value per option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ifa3af7f9a9464ef699356948deed2cb8_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfMi0yLTEtMS04NzQ1_d023d071-c53e-4e90-ae82-1ba9c1d7543d"
      unitRef="shares">7910</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i67a16227998c4b09be060e7ac75710c0_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfMi00LTEtMS04NzQ1_c61b5c21-801f-45a9-a497-0362a072eae3"
      unitRef="shares">7190</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i6a3a1155df674ed5a67b00576eacf44c_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfMi02LTEtMS04NzQ1_fa652edf-26d9-4737-9015-4917e240aae0"
      unitRef="shares">6265</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <icui:Timebasedoptionsgrantdatefairvalue
      contextRef="ifa3af7f9a9464ef699356948deed2cb8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfMy0yLTEtMS04NzQ1_3ac5033c-f0b7-4f0f-a339-bd441bb3dba9"
      unitRef="usd">528000</icui:Timebasedoptionsgrantdatefairvalue>
    <icui:Timebasedoptionsgrantdatefairvalue
      contextRef="i67a16227998c4b09be060e7ac75710c0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfMy00LTEtMS04NzQ1_b06cfc27-8c16-4487-ba59-bac659a0da55"
      unitRef="usd">425000</icui:Timebasedoptionsgrantdatefairvalue>
    <icui:Timebasedoptionsgrantdatefairvalue
      contextRef="i6a3a1155df674ed5a67b00576eacf44c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfMy02LTEtMS04NzQ1_ef6d39ab-6b81-4ec6-8187-81c506a6bc17"
      unitRef="usd">424000</icui:Timebasedoptionsgrantdatefairvalue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ifa3af7f9a9464ef699356948deed2cb8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfNS0yLTEtMS04NzQ1_b9139f8d-b990-4b41-9764-4de679bcc878">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i67a16227998c4b09be060e7ac75710c0_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfNS00LTEtMS04NzQ1_04a95bbb-814a-43b2-b096-d4762d79ecea">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i6a3a1155df674ed5a67b00576eacf44c_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfNS02LTEtMS04NzQ1_4d2eb19a-000d-41c1-813f-7be3f08a3237">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ifa3af7f9a9464ef699356948deed2cb8_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfNi0yLTEtMS04NzQ1_dc0f8aa1-4ff2-4bb0-8560-9b7c46a43d36"
      unitRef="number">0.350</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i67a16227998c4b09be060e7ac75710c0_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfNi00LTEtMS04NzQ1_b4b6e177-67ff-42ce-b8f3-a08d00ff505e"
      unitRef="number">0.350</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i6a3a1155df674ed5a67b00576eacf44c_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfNi02LTEtMS04NzQ1_c556d323-8210-4d50-972f-7352a94334b2"
      unitRef="number">0.280</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ifa3af7f9a9464ef699356948deed2cb8_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfNy0yLTEtMS04NzQ1_bad6c435-bf4d-446f-8f33-c30798ba5b50"
      unitRef="number">0.009</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i67a16227998c4b09be060e7ac75710c0_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfNy00LTEtMS04NzQ1_80ad430e-ac35-445a-a0b4-435a74f00fd9"
      unitRef="number">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i6a3a1155df674ed5a67b00576eacf44c_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfNy02LTEtMS04NzQ1_689e5190-6b44-43c7-8a5a-1a33b6c5e847"
      unitRef="number">0.022</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ifa3af7f9a9464ef699356948deed2cb8_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfOC0yLTEtMS04NzQ1_2fb908fa-958d-4ddd-add2-6924cb720544"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i67a16227998c4b09be060e7ac75710c0_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfOC00LTEtMS04NzQ1_5ac80ec9-0bca-4acb-b5ac-4475dd0682db"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i6a3a1155df674ed5a67b00576eacf44c_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfOC02LTEtMS04NzQ1_9011e748-036a-4dbc-adc2-0f83ed30b88b"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ifa3af7f9a9464ef699356948deed2cb8_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfOS0yLTEtMS04NzQ1_a6f4cbe3-e3fb-4fab-8d73-844e90317a5d"
      unitRef="usdPerShare">200.07</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i67a16227998c4b09be060e7ac75710c0_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfOS00LTEtMS04NzQ1_9205e02c-72e7-493d-928e-15df35fe4061"
      unitRef="usdPerShare">181.99</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i6a3a1155df674ed5a67b00576eacf44c_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfOS02LTEtMS04NzQ1_1c2125c9-99da-4213-8af6-b5ab595d41a4"
      unitRef="usdPerShare">225.27</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ifa3af7f9a9464ef699356948deed2cb8_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfMTAtMi0xLTEtODc0NQ_fe3433f5-61c8-4c94-a13d-d054e6bd35ad"
      unitRef="usdPerShare">66.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i67a16227998c4b09be060e7ac75710c0_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfMTAtNC0xLTEtODc0NQ_3f6b8c6b-396f-43b7-b329-6bff9febf16c"
      unitRef="usdPerShare">59.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6a3a1155df674ed5a67b00576eacf44c_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjc3YzUzMjI1M2ZmYzQ3ODQ4M2U4MmVkNDFmYjA0YTAyL3RhYmxlcmFuZ2U6NzdjNTMyMjUzZmZjNDc4NDgzZTgyZWQ0MWZiMDRhMDJfMTAtNi0xLTEtODc0NQ_4b3258e4-5775-425c-adfd-0199c345280b"
      unitRef="usdPerShare">67.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTA1MDU_17d8d7f5-c741-4970-9d4c-bd57f33fa5bf">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of our stock option activity as of and for the year ended December&#160;31, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Contractual Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;817,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="id78700fe30fa41ee9a54f1ac70463ee7_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfMS0yLTEtMS04NzQ1_405d4168-f230-4710-af8f-dbef9d6afc5c"
      unitRef="shares">817800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="id78700fe30fa41ee9a54f1ac70463ee7_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfMS00LTEtMS04NzQ1_eebad3e1-3a0f-4c48-9ecf-5bf93c54958e"
      unitRef="usdPerShare">70.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i182dfcd4a48e49328d223a8303c254eb_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfMi0yLTEtMS04NzQ1_02c48b66-4c3c-45ce-ba8a-54f52bbea15b"
      unitRef="shares">7910</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i182dfcd4a48e49328d223a8303c254eb_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfMi00LTEtMS04NzQ1_d7978f2c-dde5-4dc5-a859-aa0807691339"
      unitRef="usdPerShare">200.07</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i182dfcd4a48e49328d223a8303c254eb_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfMy0yLTEtMS04NzQ1_19bbc59e-665a-4854-a2cc-ce81443bae27"
      unitRef="shares">162612</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i182dfcd4a48e49328d223a8303c254eb_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfMy00LTEtMS04NzQ1_0ecbeed1-1e5e-44ce-b2e3-935798905aa0"
      unitRef="usdPerShare">57.64</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="i182dfcd4a48e49328d223a8303c254eb_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNC0yLTEtMS04NzQ1_ae6de64f-4945-4121-9df3-dc58f7d11c4e"
      unitRef="shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
      contextRef="i182dfcd4a48e49328d223a8303c254eb_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNC00LTEtMS04NzQ1_36c17165-11e6-4014-9eb3-f19d0786886d"
      unitRef="usdPerShare">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ib5f9119ec4544a9ab30550ab201d84f9_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNS0yLTEtMS04NzQ1_e499c96a-218b-448c-b247-fe85fa78d6e5"
      unitRef="shares">663098</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ib5f9119ec4544a9ab30550ab201d84f9_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNS00LTEtMS04NzQ1_ea2268a3-23c8-4385-a146-fcb5666c5bbf"
      unitRef="usdPerShare">74.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i182dfcd4a48e49328d223a8303c254eb_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNS02LTEtMS04NzQ1_d7b5ffbf-4c2d-40c9-99c9-53fea59c8311">P2Y7M6D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ib5f9119ec4544a9ab30550ab201d84f9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNS04LTEtMS04NzQ1_c6bce3ea-5f01-4dfb-a890-5e19c3a71ca3"
      unitRef="usd">108003000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="ib5f9119ec4544a9ab30550ab201d84f9_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNi0yLTEtMS04NzQ1_76d3960a-8eac-43f3-a0c7-7877d02749ab"
      unitRef="shares">656483</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="ib5f9119ec4544a9ab30550ab201d84f9_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNi00LTEtMS04NzQ1_0c54eea6-8554-4023-80bb-6ded7eaab11c"
      unitRef="usdPerShare">73.48</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i182dfcd4a48e49328d223a8303c254eb_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNi02LTEtMS04NzQ1_39238907-4034-4376-8423-eccbf1df0ee0">P2Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="ib5f9119ec4544a9ab30550ab201d84f9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNi04LTEtMS04NzQ1_3083cd9c-b27f-4e42-b8ee-7eef4fe37f81"
      unitRef="usd">107761000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="ib5f9119ec4544a9ab30550ab201d84f9_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNy0yLTEtMS04NzQ1_95560369-c22d-49b9-8502-4ee0e0351bf7"
      unitRef="shares">663098</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="ib5f9119ec4544a9ab30550ab201d84f9_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNy00LTEtMS04NzQ1_45588081-8efd-42dd-8533-839c83c386b6"
      unitRef="usdPerShare">74.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i182dfcd4a48e49328d223a8303c254eb_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNy02LTEtMS04NzQ1_19edd624-f91d-4775-876e-8c46c80a890d">P2Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="ib5f9119ec4544a9ab30550ab201d84f9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmVhYTk2NGMyZjkzYzQ0Yzc5MWJiNjg4ZmQ1Y2IzZGYwL3RhYmxlcmFuZ2U6ZWFhOTY0YzJmOTNjNDRjNzkxYmI2ODhmZDVjYjNkZjBfNy04LTEtMS04NzQ1_317ed89d-52ae-4f1a-8309-8c9941764ffc"
      unitRef="usd">108003000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:SharePrice
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfNDYxMw_bdc43451-6cf9-4d94-9c42-b4a336d09041"
      unitRef="usdPerShare">237.34</us-gaap:SharePrice>
    <icui:ExercisedOptionsDataTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTA0Njg_6753fe14-949a-4472-b6ca-f17ea12de3d0">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents information regarding stock option activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&#160;ended&#160;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intrinsic value of options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received from exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit from stock option exercises&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</icui:ExercisedOptionsDataTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmI5ZjI1ZGM5M2Q0NjRjNmNiM2EwNTI0Yzc1MjMwYzkzL3RhYmxlcmFuZ2U6YjlmMjVkYzkzZDQ2NGM2Y2IzYTA1MjRjNzUyMzBjOTNfMi0yLTEtMS04NzQ1_6d49c178-2c2a-4f82-9c93-e408b0059c04"
      unitRef="usd">27534000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmI5ZjI1ZGM5M2Q0NjRjNmNiM2EwNTI0Yzc1MjMwYzkzL3RhYmxlcmFuZ2U6YjlmMjVkYzkzZDQ2NGM2Y2IzYTA1MjRjNzUyMzBjOTNfMi00LTEtMS04NzQ1_e27f5c0c-bd7c-4e49-8291-4106b5745c13"
      unitRef="usd">32915000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmI5ZjI1ZGM5M2Q0NjRjNmNiM2EwNTI0Yzc1MjMwYzkzL3RhYmxlcmFuZ2U6YjlmMjVkYzkzZDQ2NGM2Y2IzYTA1MjRjNzUyMzBjOTNfMi02LTEtMS04NzQ1_f0160cb8-2f0a-4db5-ba3b-76753a26dc7f"
      unitRef="usd">22976000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmI5ZjI1ZGM5M2Q0NjRjNmNiM2EwNTI0Yzc1MjMwYzkzL3RhYmxlcmFuZ2U6YjlmMjVkYzkzZDQ2NGM2Y2IzYTA1MjRjNzUyMzBjOTNfMy0yLTEtMS04NzQ1_2b8600b2-398b-4493-8966-a40fd4906238"
      unitRef="usd">9372000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmI5ZjI1ZGM5M2Q0NjRjNmNiM2EwNTI0Yzc1MjMwYzkzL3RhYmxlcmFuZ2U6YjlmMjVkYzkzZDQ2NGM2Y2IzYTA1MjRjNzUyMzBjOTNfMy00LTEtMS04NzQ1_f95331b8-08b3-486c-abef-445d64f2ba84"
      unitRef="usd">13193000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmI5ZjI1ZGM5M2Q0NjRjNmNiM2EwNTI0Yzc1MjMwYzkzL3RhYmxlcmFuZ2U6YjlmMjVkYzkzZDQ2NGM2Y2IzYTA1MjRjNzUyMzBjOTNfMy02LTEtMS04NzQ1_8feb54f0-682a-4136-88a8-acfa8651b877"
      unitRef="usd">7732000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmI5ZjI1ZGM5M2Q0NjRjNmNiM2EwNTI0Yzc1MjMwYzkzL3RhYmxlcmFuZ2U6YjlmMjVkYzkzZDQ2NGM2Y2IzYTA1MjRjNzUyMzBjOTNfNC0yLTEtMS04NzQ1_e9f543ed-694d-4b9b-8cee-1ece81df3cfe"
      unitRef="usd">5092000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmI5ZjI1ZGM5M2Q0NjRjNmNiM2EwNTI0Yzc1MjMwYzkzL3RhYmxlcmFuZ2U6YjlmMjVkYzkzZDQ2NGM2Y2IzYTA1MjRjNzUyMzBjOTNfNC00LTEtMS04NzQ1_35a9ff9b-1b73-414d-a1d0-bdd6607629f3"
      unitRef="usd">5179000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOmI5ZjI1ZGM5M2Q0NjRjNmNiM2EwNTI0Yzc1MjMwYzkzL3RhYmxlcmFuZ2U6YjlmMjVkYzkzZDQ2NGM2Y2IzYTA1MjRjNzUyMzBjOTNfNC02LTEtMS04NzQ1_07f51bdc-4157-4900-8597-75ab8f6fd4e9"
      unitRef="usd">9653000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <icui:ModifiedPRSUIncrementalExpense
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTA5OTUxMTY0NTM4OA_fe5f79af-362a-4e4a-b2ab-8be5b70ee1db"
      unitRef="usd">2100000</icui:ModifiedPRSUIncrementalExpense>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTA0NjI_35d92019-d92b-48ae-a1dd-d224fa959cfe">The table below summarizes our restricted stock award activity (dollars in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&#160;ended&#160;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands, except shares and per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PRSU&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares earned&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant-date fair value per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant-date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intrinsic value vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant-date fair value per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant-date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intrinsic value vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i87391b560fa94e0e87d7e644dc34a031_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMy0yLTEtMS04NzQ1_5ad0ffb0-5d05-43d5-8a12-54f25c80fe16"
      unitRef="shares">53246</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i8bfb9cc3e6314f24bd71705af4bba7a2_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMy00LTEtMS04NzQ1_a6598ef8-6305-4acb-a743-5064e103a84a"
      unitRef="shares">38633</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i518455bc726645ca83b1172f9d758adb_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMy02LTEtMS04NzQ1_3966c4b0-86d1-4e82-b84d-74a4417be56b"
      unitRef="shares">37657</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <icui:PerformanceSharesEarned
      contextRef="i4831e0eda5014d4185f0331a3269b612_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNC0yLTEtMS04NzQ1_10ea7389-3747-4e2f-9d17-e963cfaa308f"
      unitRef="shares">32013</icui:PerformanceSharesEarned>
    <icui:PerformanceSharesEarned
      contextRef="ied69c2626ecd45eebbc3a906d06e9175_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNC00LTEtMS04NzQ1_d078a244-c733-4d44-868f-453c4f384d04"
      unitRef="shares">80654</icui:PerformanceSharesEarned>
    <icui:PerformanceSharesEarned
      contextRef="i785cacd032d543efb047f2c5a292c791_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNC02LTEtMS04NzQ1_f2918a69-caa9-48db-be49-aee8c95ce879"
      unitRef="shares">114032</icui:PerformanceSharesEarned>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i87391b560fa94e0e87d7e644dc34a031_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNS0yLTEtMS04NzQ1_4c789cfd-cce1-4576-9ac6-6dd9a08ccfc9"
      unitRef="usdPerShare">198.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8bfb9cc3e6314f24bd71705af4bba7a2_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNS00LTEtMS04NzQ1_93f00073-90d8-4d4a-9449-475712cb9c6b"
      unitRef="usdPerShare">188.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i518455bc726645ca83b1172f9d758adb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNS02LTEtMS04NzQ1_f2da1a03-a4ec-4880-a957-cde7cf9f227c"
      unitRef="usdPerShare">231.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <icui:Grantdatefairvalueperformancerestrictedstockunits
      contextRef="i87391b560fa94e0e87d7e644dc34a031_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNi0yLTEtMS04NzQ1_a9625752-a4b8-4c20-8722-b1456d4b12c6"
      unitRef="usd">10551000</icui:Grantdatefairvalueperformancerestrictedstockunits>
    <icui:Grantdatefairvalueperformancerestrictedstockunits
      contextRef="i8bfb9cc3e6314f24bd71705af4bba7a2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNi00LTEtMS04NzQ1_2be034cf-559f-4ac7-be3a-48a9f3076f1c"
      unitRef="usd">7276000</icui:Grantdatefairvalueperformancerestrictedstockunits>
    <icui:Grantdatefairvalueperformancerestrictedstockunits
      contextRef="i518455bc726645ca83b1172f9d758adb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNi02LTEtMS04NzQ1_214fb327-b794-4ef1-a5e9-9e8223702f9e"
      unitRef="usd">8723000</icui:Grantdatefairvalueperformancerestrictedstockunits>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
      contextRef="i87391b560fa94e0e87d7e644dc34a031_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNy0yLTEtMS04NzQ1_a234e387-beda-49c2-9f9f-d1e1fe7b6a0c"
      unitRef="usd">6777000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
      contextRef="i8bfb9cc3e6314f24bd71705af4bba7a2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNy00LTEtMS04NzQ1_306ead8e-c388-404b-b9ea-c305614dc084"
      unitRef="usd">15627000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
      contextRef="i518455bc726645ca83b1172f9d758adb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfNy02LTEtMS04NzQ1_49fb62cf-5dd7-4ff4-9011-73ec24cf3a7f"
      unitRef="usd">26445000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i7623b8fcbec644baa23b06274170ec0b_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTAtMi0xLTEtODc0NQ_ea1553f3-4693-4692-a39e-50f22e942719"
      unitRef="shares">84388</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i51e354dd1c9a473aa838a7df3a9b11d5_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTAtNC0xLTEtODc0NQ_697d40b5-3578-479c-989e-72ecd741ce87"
      unitRef="shares">87830</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i0c17620dcf9644348c9d2eced453eca5_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTAtNi0xLTEtODc0NQ_99a23e9c-7033-48c8-acfb-03b1b6a00517"
      unitRef="shares">61856</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i7623b8fcbec644baa23b06274170ec0b_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTEtMi0xLTEtODc0NQ_85826805-77eb-4f6b-9beb-057dc4d020ef"
      unitRef="usdPerShare">199.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i51e354dd1c9a473aa838a7df3a9b11d5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTEtNC0xLTEtODc0NQ_b1d08ff8-da8b-46e7-8780-34203287fcd8"
      unitRef="usdPerShare">188.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0c17620dcf9644348c9d2eced453eca5_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTEtNi0xLTEtODc0NQ_ab045430-018e-4aa4-8ea9-9b45a35cdc7f"
      unitRef="usdPerShare">227.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <icui:Grantdatefairvalueofrestrictedstockunitsgranted
      contextRef="i7623b8fcbec644baa23b06274170ec0b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTItMi0xLTEtODc0NQ_2f0ee0aa-620b-4366-9587-05d3ff02ee0b"
      unitRef="usd">16804000</icui:Grantdatefairvalueofrestrictedstockunitsgranted>
    <icui:Grantdatefairvalueofrestrictedstockunitsgranted
      contextRef="i51e354dd1c9a473aa838a7df3a9b11d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTItNC0xLTEtODc0NQ_b2572bc3-6453-490e-940d-bc2b15e9faad"
      unitRef="usd">16523000</icui:Grantdatefairvalueofrestrictedstockunitsgranted>
    <icui:Grantdatefairvalueofrestrictedstockunitsgranted
      contextRef="i0c17620dcf9644348c9d2eced453eca5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTItNi0xLTEtODc0NQ_a8a906e5-b5ce-4bb1-b932-54a60eb60ba1"
      unitRef="usd">14067000</icui:Grantdatefairvalueofrestrictedstockunitsgranted>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
      contextRef="i7623b8fcbec644baa23b06274170ec0b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTMtMi0xLTEtODc0NQ_1e97bc7e-00a2-44ba-9eba-19c15b94523d"
      unitRef="usd">13681000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
      contextRef="i51e354dd1c9a473aa838a7df3a9b11d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTMtNC0xLTEtODc0NQ_67ccbc9c-89a2-4d54-a47a-449551e78aa8"
      unitRef="usd">12314000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
      contextRef="i0c17620dcf9644348c9d2eced453eca5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjQ3YzA5YTQzZWYwZTQxOTZhZTljYTYxNmY2ZGQxYmZmL3RhYmxlcmFuZ2U6NDdjMDlhNDNlZjBlNDE5NmFlOWNhNjE2ZjZkZDFiZmZfMTMtNi0xLTEtODc0NQ_c94d2cf5-f486-4c0c-bffc-fa01e176eeb4"
      unitRef="usd">16753000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTA0NzQ_4f0701dd-e490-4f7f-93c6-f243c378d07a">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides a summary of our PRSU and RSU activity as of and for the year ended December&#160;31, 2021: &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Grant-Date Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Contractual Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in units due to performance expectations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,871)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested and expected to vest at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i8e48c0d8b6804bfc8fcdb345373f3e79_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfMS0yLTEtMS04NzQ1_4b53fdd2-0225-4582-8adf-9f4ba0c0169a"
      unitRef="shares">220760</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i8e48c0d8b6804bfc8fcdb345373f3e79_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfMS00LTEtMS04NzQ1_e853196a-15b1-4534-979a-4c6fd66667a8"
      unitRef="usdPerShare">209.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <icui:Changeinunitsduetoperformanceexpectations
      contextRef="i376e73f5e55842518de67690861c3be5_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfMi0yLTEtMS04NzQ1_737700ef-e45f-4aa6-a15e-c9bbe46773b1"
      unitRef="shares">24601</icui:Changeinunitsduetoperformanceexpectations>
    <icui:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue
      contextRef="i376e73f5e55842518de67690861c3be5_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfMi00LTEtMS04NzQ1_e50f2206-9c51-40e1-aa8d-61fc26866952"
      unitRef="usdPerShare">209.64</icui:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i376e73f5e55842518de67690861c3be5_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfMy0yLTEtMS04NzQ1_0030ebd8-7743-4bb3-99bd-d80328c5e23e"
      unitRef="shares">137634</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i376e73f5e55842518de67690861c3be5_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfMy00LTEtMS04NzQ1_da43825a-97a4-4adf-a288-32723a0343fb"
      unitRef="usdPerShare">198.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i376e73f5e55842518de67690861c3be5_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfNC0yLTEtMS04NzQ1_7e74f7b3-9f16-4cf7-8c92-b4069e8e23d7"
      unitRef="shares">99363</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue
      contextRef="i376e73f5e55842518de67690861c3be5_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfNC00LTEtMS04NzQ1_e5dcd8ee-15b4-48a4-b945-182c3261679e"
      unitRef="usdPerShare">219.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i376e73f5e55842518de67690861c3be5_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfNS0yLTEtMS04NzQ1_bb06aea0-86b2-4488-b7b6-13f52f4cfe6a"
      unitRef="shares">7871</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue
      contextRef="i376e73f5e55842518de67690861c3be5_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfNS00LTEtMS04NzQ1_1a85b3eb-a094-4929-a7a0-befcff816cd8"
      unitRef="usdPerShare">196.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i5f1a091230074ec5961f1c78910f1b75_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfNi0yLTEtMS04NzQ1_0af90cbc-4bc0-4cae-8821-76f80b171d6b"
      unitRef="shares">275761</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i5f1a091230074ec5961f1c78910f1b75_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfNi00LTEtMS04NzQ1_c31f62e0-085c-4895-9c53-5e0709eb27ec"
      unitRef="usdPerShare">201.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i376e73f5e55842518de67690861c3be5_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfNi02LTEtMS04NzQ1_62a1ad35-54a5-4177-bf77-e1f260e6abf8">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
      contextRef="i5f1a091230074ec5961f1c78910f1b75_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RhYmxlOjMyM2UyMDVkYTM5ZDQxMDY5NjczYTExMDAwY2E0NGJhL3RhYmxlcmFuZ2U6MzIzZTIwNWRhMzlkNDEwNjk2NzNhMTEwMDBjYTQ0YmFfNi04LTEtMS04NzQ1_37cbced4-5107-4910-97bb-6ff6ac8bcc99"
      unitRef="usd">65449000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
    <icui:ESPPOriginalIssuance
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfOTk3OA_11f26c48-0e2f-4966-a74c-98462c596894"
      unitRef="shares">750000</icui:ESPPOriginalIssuance>
    <icui:ESPPAnnualIssuanceIncreaseLimit
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTAwOTc_cf42d702-1008-4e51-8470-e016ff6d4fc8"
      unitRef="shares">300000</icui:ESPPAnnualIssuanceIncreaseLimit>
    <icui:SharesAvailableInEmployeeStockPurchasePlan
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84NS9mcmFnOjIzNjUzZWZkYjIwMDRmOGFiMmMzZjI3ODE4NGM2MzIyL3RleHRyZWdpb246MjM2NTNlZmRiMjAwNGY4YWIyYzNmMjc4MTg0YzYzMjJfMTAyNTE_c1f9b633-6a18-4235-bacb-96569091b447"
      unitRef="shares">133487</icui:SharesAvailableInEmployeeStockPurchasePlan>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDQwNQ_c44dfef8-8223-445c-a964-22f636bf604b">DERIVATIVES AND HEDGING ACTIVITIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Hedge Accounting and Hedging Program&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purposes of our cash flow hedging programs are to manage the foreign currency exchange rate risk on forecasted expenses denominated in currencies other than the functional currency of the operating unit, and to manage floating interest rate risk associated with future interest payments on variable-rate term loans issued in January 2022 subsequent to our fiscal year end. We do not issue derivatives for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on hedged transactions. The par forward contract and forward-starting interest rate swaps are designated and qualify as cash flow hedges. Our derivative instruments are recorded at fair value on the consolidated balance sheets and are classified based on the instrument's maturity date. We record changes in the fair value of the effective portion of the gain or loss on the derivative instrument as a component of other comprehensive income (loss) and we reclassify that gain or loss into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Exchange Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We began hedging a portion of our Mexico forecasted expenses denominated in Pesos ("MXN") in May 2017 by entering into a two-year cross-currency par forward contract. The term of this currency forward contract was May 1, 2017 to May 1, 2019. The derivative instrument had a fixed forward rate of 20.01 MXN/USD over the term of the two-year contract.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2018, we entered into a six-month cross-currency par forward contract. The term of this six-month contract was May 1, 2019 to November 1, 2019. The derivative instrument had a fixed forward rate of 20.43 MXN/USD over the term of the six-month contract.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2018, we entered into a one-year cross-currency par forward contract. The term of the one-year hedge was November 1, 2019 to November 3, 2020. The derivative instrument matured in equal monthly amounts at a fixed forward rate of 22.11 MXN/USD.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, we entered into a one-year cross-currency par forward contract. The total notional amount of this outstanding derivative as of December 31, 2020 was approximately 436.8 million MXN. The term of this one-year contract was November 3, 2020 to December 1, 2021. The derivative instrument matured in equal monthly amounts at a fixed forward rate of 24.26 MXN/USD.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, we entered into a one-year cross-currency par forward contract. The total notional amount of this outstanding derivative as of December 31, 2021 was approximately 413.1 million MXN. The term of this one-year contract is December 1, 2021 to December 1, 2022. The derivative instrument matures in equal monthly amounts at a fixed forward rate of 21.60 MXN/USD.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Floating Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, in anticipation of entering into new senior secured credit facilities in January 2022, which includes a variable-rate term loan A and a variable-rate term loan B (see Note 17: Subsequent Events for additional information), we entered into two forward-starting interest rate swaps. Under the interest rate swap agreements we exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount. The term loan A swap has an initial notional amount of $300.0&#160;million, reducing to $150.0&#160;million evenly on a quarterly basis through its final maturity in April 2027. We will pay a fixed rate of 1.49% and will receive the greater of 3-month USD LIBOR or 0%. The term loan B swap has an initial notional amount of $750.0&#160;million, reducing to $46.9&#160;million evenly on a quarterly basis through its final maturity in April 2026. We will pay a fixed rate of 1.31% and will receive the greater of 3-month USD LIBOR or 0.50%. These forward-starting swaps will effectively convert the relevant portion of the floating-rate term loans to fixed rates.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the fair values of our derivative instruments included within the consolidated balance sheets (in thousands):  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Cash Flow Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign Exchange Forward Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward-Starting Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the amounts affecting the Consolidated Statements of Operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Gain in the Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Derivatives designated as cash flow hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forward-starting interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognized the following gains (losses) on our derivative instruments designated as cash flow hedges (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount of Gain Reclassified From Accumulated Other Comprehensive Income into Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain Reclassified From Accumulated Other Comprehensive Income into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Derivatives designated as cash flow hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forward-starting interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as cash flow hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, we expect an estimated $1.1 million in deferred gains on the outstanding foreign exchange forward contract and an estimated $5.6&#160;million in deferred losses on the forward-starting interest rate swaps will be reclassified from accumulated other comprehensive loss to net income during the next 12 months concurrent with the underlying hedged transactions also being reported in net income.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeForwardExchangeRate1
      contextRef="i193283f0dbb449a3bd6eff38a5f33bd4_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTQ0Mw_1bd218be-e7e6-4dca-9937-5d40e70ffb5f"
      unitRef="number">20.01</us-gaap:DerivativeForwardExchangeRate1>
    <us-gaap:DerivativeForwardExchangeRate1
      contextRef="i6091cecaf413499e962152be722b5f2f_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTcwNQ_332fe69c-ad4a-41d5-a08c-fa641103a53d"
      unitRef="number">20.43</us-gaap:DerivativeForwardExchangeRate1>
    <us-gaap:DerivativeForwardExchangeRate1
      contextRef="ia164440f0483491b8db221971138e931_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDI2OQ_4804e659-6419-4bb3-bf0f-7673f7dc587f"
      unitRef="number">22.11</us-gaap:DerivativeForwardExchangeRate1>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i37ff8ade5acb448ea4d633f24092926d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMzg0ODI5MDcwMTYzMw_53e2abf7-df3c-42ad-94bd-7111963450a1"
      unitRef="usd">436800000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeForwardExchangeRate1
      contextRef="i37ff8ade5acb448ea4d633f24092926d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMjM2NA_8ec414d2-a652-4b8b-8ed6-562400ab1172"
      unitRef="number">24.26</us-gaap:DerivativeForwardExchangeRate1>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i4a83e789750f44daa32ae75c26ff6a9b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMjc0ODc3OTA3MzQwOQ_ba145a89-c036-45a3-8f49-3ee93d92f3c0"
      unitRef="usd">413100000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeForwardExchangeRate1
      contextRef="i4a83e789750f44daa32ae75c26ff6a9b_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMjc0ODc3OTA3MzYxNQ_17ae3af1-8cbb-4a60-ab44-41c42da810d0"
      unitRef="number">21.60</us-gaap:DerivativeForwardExchangeRate1>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i3abfe315de2d4710b658cda2c9136055_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDI3Nw_339fcddc-9c6a-47da-a310-6c10b5f1bcdf"
      unitRef="usd">300000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i6492f863fad145e99f24ecbdf6e97c41_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDI5Mw_51c0d6f9-5164-46e6-8366-3d6b000755f7"
      unitRef="usd">150000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i33eac537b9e347e786d5a3bbfd58eaa1_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDM0Nw_8bd147a4-8206-4cb1-b782-9b1cac15e566"
      unitRef="number">0.0149</us-gaap:DerivativeFixedInterestRate>
    <icui:DerivativeInterestRateFloor
      contextRef="i33eac537b9e347e786d5a3bbfd58eaa1_I20211231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDM1NA_7641ccce-156f-476a-b825-4bcd9ce0ed88"
      unitRef="number">0</icui:DerivativeInterestRateFloor>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i5700616ce493458ca1d063d5449a9a0f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDMwOQ_7ed20761-b728-44c6-8b34-f6b364c9cfc9"
      unitRef="usd">750000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ibf93883b30164701858e3d30c68ab759_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDMyNQ_42b6bf89-8a51-4f4e-8ec7-ce9ec1adcb29"
      unitRef="usd">46900000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ib3bc9bb5a4a44cc78110749aecdb5636_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDM1OA_b1e91806-2d3f-4bc3-91ac-177143865d5e"
      unitRef="number">0.0131</us-gaap:DerivativeFixedInterestRate>
    <icui:DerivativeInterestRateFloor
      contextRef="ib3bc9bb5a4a44cc78110749aecdb5636_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDM2NA_7c325978-d0ed-42c5-84e9-477f1f5a1a49"
      unitRef="number">0.5</icui:DerivativeInterestRateFloor>
    <us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMzA2NQ_b47ba99e-46fc-4397-a43d-df1e985798dd">The following table presents the fair values of our derivative instruments included within the consolidated balance sheets (in thousands):  &lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Cash Flow Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign Exchange Forward Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward-Starting Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the amounts affecting the Consolidated Statements of Operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Gain in the Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Derivatives designated as cash flow hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forward-starting interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeAssets
      contextRef="i9398faa8a97348f0a664d0a940cc1df1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNC0zLTEtMS04NzQ1_7752671f-45d4-4ea7-8c69-2c05b3d5aaf1"
      unitRef="usd">1061000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="iaeebd3cacab24dc38bf7ae3d6bb6c231_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNC01LTEtMS04NzQ1_b95719f3-666f-4d9a-bdd2-8dc2507921fe"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i0698571e6787437d90d0b0048700239f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNS02LTEtMS01NzcyOA_798684e4-8e5a-4279-a920-742d207bf8ff"
      unitRef="usd">1061000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ie89eb1993f904410907120b3b745456d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNS0zLTEtMS04NzQ1_28704dba-231d-40fc-8f48-4d88361006c0"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i6cb35882a84d40c69f565d43f607d507_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNS01LTEtMS04NzQ1_551fe5dc-edef-494f-b0b6-d0d5e3e745b1"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ib612e7e55d2c4ebf87498ce95fb1a17a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNi02LTEtMS01NzcyOA_904ff70b-63d7-4319-a63c-eb66f34fc68a"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i0d5a1bdc1c724bc7b475abaf04f05670_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNy0yLTEtMS01NzcyMA_b11ae1f9-98cb-4136-9c13-f79abf229bfe"
      unitRef="usd">1061000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ifa89d23d7e2a43d19cb3b0e7f251e771_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNy00LTEtMS01NzcyMg_3ba592d4-ebf1-4c6a-9d40-6c623397d8c0"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i48cb839aacc34533888f3bb68369bf70_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNy02LTEtMS01NzcyOA_7b624dcc-98b5-4457-963c-eefd250178f0"
      unitRef="usd">1061000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="i275a397a6a9f4699b14f84e0917f5cf6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNi0zLTEtMS04NzQ1_104cf0f8-13a7-4469-9492-156c6e3e8a6e"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i8d6c14d6d9e54ea98f1e56d587002e2b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNi01LTEtMS04NzQ1_e7360644-f514-443a-b5a7-d1854338d142"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i7275aca2da2849a582d9e7ba1f1cedbe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTAtNi0xLTEtNTc3Mjg_74a0e7bb-ab5a-4368-9db5-aa4d7cf77ec5"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i9c479368de1144bfb45d95026be0cd76_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNy0zLTEtMS04NzQ1_330df7c7-cb8d-49ca-a564-b74bb62a2a67"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i62d03683ea954674a5322351789e0906_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfNy01LTEtMS04NzQ1_e83f9396-eec3-4875-ad0e-3f9a0832f53a"
      unitRef="usd">1480000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i237a6bf9b93147d2ba3fd48effc174cc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTEtNi0xLTEtNTc3Mjg_a1526684-44ba-49b0-8ec4-cac1273ddbd7"
      unitRef="usd">1480000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i544809a7b69540748709fce0559278a0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfOC0zLTEtMS04NzQ1_4c6f23e3-0a54-41b0-8872-ea31bb4145b7"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i3f8134bb52614717bbcc1d971c2e9f87_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfOC01LTEtMS04NzQ1_a8e84e0c-8a52-4f10-a890-1ff1a363a522"
      unitRef="usd">1480000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i117c77f98cd34cbb84dd2f1e0aaf77ac_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTItNi0xLTEtNTc3Mjg_f885c478-2043-472f-8698-5eaebdf37327"
      unitRef="usd">1480000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssets
      contextRef="ie4eb6e79360c467f8c9a58e50160406d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTUtMi0xLTEtNTc3MDQ_944dd375-5866-4d9a-8b5e-cf01260b74d2"
      unitRef="usd">3555000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i94cc3a526443461c92bb879f72405e63_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTUtNC0xLTEtNTc3MTI_a4559e03-9b9c-4a26-b159-42cf7e5850e5"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="iba75d31130ff4518a24b52c40ad06517_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTUtNi0xLTEtNTc3Mjg_51285bfd-3c19-498e-b33b-c5374e62f51e"
      unitRef="usd">3555000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ic43efddee26741cfa82e26fbb5d22949_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTYtMi0xLTEtNTc3MDY_c989f3fa-ac33-41ad-95bf-8ab5d1571426"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i30a2923e460d49549d45431e449f5c22_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTYtNC0xLTEtNTc3MTI_8a3bfd32-7758-4b19-b919-2fb4d3eedbab"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ibb6f3d45751d49a59460c1b52b47c868_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTYtNi0xLTEtNTc3Mjg_87fbb9c5-58eb-44b3-befb-a7ec67179cfd"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i0660e1ab42834fa5b8f6de068d1ac560_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTctMi0xLTEtNTc3MjY_675c517f-f7a2-4390-bb52-46b4a071f5b7"
      unitRef="usd">3555000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i6adeef3935784865bfb3756361fd2fe0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTctNC0xLTEtNTc3MjQ_fb398232-8cda-4e11-81e1-869eba4965b7"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i70ee7aca58f04d14ba4afb3526f496a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMTctNi0xLTEtNTc3Mjg_359b109f-447b-427d-a945-559d67aa71e4"
      unitRef="usd">3555000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="iedb19205fd444f879bcad70f1358784e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMjAtMi0xLTEtNTc3MDg_32daed80-fa18-4d3c-9fd5-5373a7d59ce9"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="iafc678f466ad4ed5a96daa25baf1c6f2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMjAtNC0xLTEtNTc3MTI_05d1aeef-69c8-4a5d-be94-d9e8e7c65948"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ic7b4be9668d0488da88397ffbc79a2e8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMjAtNi0xLTEtNTc3Mjg_547cc8c1-d6dd-46db-978f-e640f32f77a1"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i102a8b308c97481c8dc3ea2c01523124_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMjEtMi0xLTEtNTc3MTA_9a9c0366-ee8d-47da-9f7e-0597578e76de"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i765f5892367e40028ae56cc662e3184a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMjEtNC0xLTEtNTc3MTI_6f14ac8a-cd43-4bf6-81bf-2d99c9c9c456"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i61230b4e893e4a7d9cd519aeed4a1b65_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMjEtNi0xLTEtNTc3Mjg_bacf4d3d-a361-4b4b-9e28-cb5e6f9f92db"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i054679d6ffef4f87a4f43e136c98ca11_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMjItMi0xLTEtNTc3MTg_10fcb31b-da39-4fe0-821d-0201fca0f5fa"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i06483eccc4414d90bd57c57ccef5aad0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMjItNC0xLTEtNTc3MTI_3ce2e50c-e3ab-451c-8aca-fbb8ce97a516"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="id82c332d5c3f4a3aa2e643ec24082edb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjlmODI2OWQ5ZjY0MjQ5Y2RhMjZiNDdlMWZiZDQ2NWUyL3RhYmxlcmFuZ2U6OWY4MjY5ZDlmNjQyNDljZGEyNmI0N2UxZmJkNDY1ZTJfMjItNi0xLTEtNTc3Mjg_376ddf7c-97d8-4722-b2a0-d9162d5cf175"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjFjNTYwY2U4YzMxYTRiY2Q5ODlmYjIxZTY4Mzc5N2I5L3RhYmxlcmFuZ2U6MWM1NjBjZThjMzFhNGJjZDk4OWZiMjFlNjgzNzk3YjlfMy0zLTEtMS04NzQ1_38830ac5-5ef7-4e7d-8d21-14aafb0150ef"
      unitRef="usd">3444000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjFjNTYwY2U4YzMxYTRiY2Q5ODlmYjIxZTY4Mzc5N2I5L3RhYmxlcmFuZ2U6MWM1NjBjZThjMzFhNGJjZDk4OWZiMjFlNjgzNzk3YjlfMy01LTEtMS04NzQ1_50536675-c3b2-4a1a-9e3f-6b475e5b5e5b"
      unitRef="usd">790000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjFjNTYwY2U4YzMxYTRiY2Q5ODlmYjIxZTY4Mzc5N2I5L3RhYmxlcmFuZ2U6MWM1NjBjZThjMzFhNGJjZDk4OWZiMjFlNjgzNzk3YjlfMy03LTEtMS04NzQ1_9439e5e6-6d2a-4b6b-b61c-833e8e45375a"
      unitRef="usd">916000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i4052c8cf471f453cbde9f738554a1b28_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjFjNTYwY2U4YzMxYTRiY2Q5ODlmYjIxZTY4Mzc5N2I5L3RhYmxlcmFuZ2U6MWM1NjBjZThjMzFhNGJjZDk4OWZiMjFlNjgzNzk3YjlfNC0zLTEtMS02MTgyMQ_5b64bb52-1fde-4ce7-ac99-82c48bec2be4"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i84762f9663364789a2d8c3ece37ff567_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjFjNTYwY2U4YzMxYTRiY2Q5ODlmYjIxZTY4Mzc5N2I5L3RhYmxlcmFuZ2U6MWM1NjBjZThjMzFhNGJjZDk4OWZiMjFlNjgzNzk3YjlfNC01LTEtMS02MTgyMw_1b72fa60-9739-47fb-99ae-023b408afb76"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i0ddfa9b22060462886127f5b80779ec2_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjFjNTYwY2U4YzMxYTRiY2Q5ODlmYjIxZTY4Mzc5N2I5L3RhYmxlcmFuZ2U6MWM1NjBjZThjMzFhNGJjZDk4OWZiMjFlNjgzNzk3YjlfNC03LTEtMS02MTgyNQ_cbae653a-7180-49d3-8d1e-6717a4431b0a"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMzA1OA_09a2f39b-c50c-4853-9c97-ca71c00d81ae">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognized the following gains (losses) on our derivative instruments designated as cash flow hedges (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount of Gain Reclassified From Accumulated Other Comprehensive Income into Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain Reclassified From Accumulated Other Comprehensive Income into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Derivatives designated as cash flow hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forward-starting interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as cash flow hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i3c9c90aaec48427e913d473bf39547d4_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNC0yLTEtMS04NzQ1_8f83b8ce-4a94-42ac-b9ee-6ab23e646709"
      unitRef="usd">950000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i05bb705b5592489b842c36481960323d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNC00LTEtMS04NzQ1_88256923-9bcb-4896-bb29-fb7de9e6390a"
      unitRef="usd">1980000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i695d74244e1a4ea2809a46299c1c17d2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNC02LTEtMS04NzQ1_2ade07a2-2007-4f7d-8010-65b4e23f7460"
      unitRef="usd">2550000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="if00269ccb40e47d28d49e0860aba7a70_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNC0xMC0xLTEtODc0NQ_1344950e-8041-4ff7-9e40-98f27d21c669"
      unitRef="usd">3444000</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="ie94168586b384dfe833911f3c4123fd5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNC0xMi0xLTEtODc0NQ_b40ed939-1749-468e-9764-a5c5b0f8a680"
      unitRef="usd">790000</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="i55daea74768c4c5f8155e5eaa03cc29c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNC0xNC0xLTEtODc0NQ_2c8b205a-8f3c-4abe-8215-baf76320b0e8"
      unitRef="usd">916000</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i4052c8cf471f453cbde9f738554a1b28_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNS0yLTEtMS01NzczMw_9d521997-0b8d-4ac5-b258-6c7f7d8c241f"
      unitRef="usd">-1480000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i84762f9663364789a2d8c3ece37ff567_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNS00LTEtMS02MTgyOQ_9bc6e235-d08c-4d11-ac24-2a95a1c01922"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i0ddfa9b22060462886127f5b80779ec2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNS02LTEtMS02MTgzMQ_c6919199-a916-475f-ad2c-d00a770a242d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i4052c8cf471f453cbde9f738554a1b28_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNS0xMC0xLTEtNjE4MzQ_f7bbd641-4347-44da-903f-ae72b84df74e"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i84762f9663364789a2d8c3ece37ff567_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNS0xMi0xLTEtNjE4Mzc_e8cd87c6-85b0-4018-961a-3753be47edce"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i0ddfa9b22060462886127f5b80779ec2_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNS0xNC0xLTEtNjE4NDA_b162d5b9-f3d1-4286-8cb4-45d975d63201"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNi0yLTEtMS02MTg0Mw_70133f90-593b-4920-ae39-6c84ab7d70b2"
      unitRef="usd">-530000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNi00LTEtMS02MTg0Ng_b0fa6d1a-fb1f-4f9c-b1db-ed4ddc94a549"
      unitRef="usd">1980000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNi02LTEtMS02MTg0OQ_2538243f-1dfa-43eb-b60e-56e4e42833ed"
      unitRef="usd">2550000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNi0xMC0xLTEtNjE4NTI_cf27d436-beac-46ef-801d-b11bb32d7cc3"
      unitRef="usd">3444000</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNi0xMi0xLTEtNjE4NTU_9eeea1c1-af1a-459d-9f9c-a607d3497f5f"
      unitRef="usd">790000</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RhYmxlOjA4ZDI5NzM4YWQ1MTRkMDhiNDI2Y2ZjNzY2NzFmZDViL3RhYmxlcmFuZ2U6MDhkMjk3MzhhZDUxNGQwOGI0MjZjZmM3NjY3MWZkNWJfNi0xNC0xLTEtNjE4NTg_252a98f4-6fda-48e9-b859-73324952b914"
      unitRef="usd">916000</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMjgwNw_3dcb73f1-8eda-46bf-8db8-e0b795d997d7"
      unitRef="usd">1100000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF84OC9mcmFnOmI3MTQ4YzA0ZWE2NjQ4Nzg5MGUzZWM5ZGJhNjYzZWZlL3RleHRyZWdpb246YjcxNDhjMDRlYTY2NDg3ODkwZTNlYzlkYmE2NjNlZmVfMTA5OTUxMTY0NDA5MA_02a106fa-67ff-4bdf-a7ea-ed5bbb4da93b"
      unitRef="usd">-5600000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfNjE4OQ_66e1b5f4-e58c-4259-ac5b-c96b2e40a091">FAIR VALUE MEASUREMENTS&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1:  quoted prices in active markets for identical assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2:  inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3:  unobservable inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent earn-out liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2019, we recognized an earn-out liability related to the acquisition of Pursuit (see Note 2: Acquisitions). Pursuit's former equity holders were entitled up to $50.0 million in additional cash consideration contingent upon the achievement of certain sales and gross profit targets for specific customers. The earn-out was calculated as a percentage of gross profit achieved during the earn-out period against a pre-determined target gross profit, not to exceed $50.0 million. During the earn-out period, we used a Monte Carlo simulation model to determine the fair value of the earn-out liability. The Monte Carlo simulation model utilized multiple input variables to determine the value of the earn-out liability including historical volatility, a risk-free interest rate, counter party credit risk and projected future gross profit (see the simulation input table below related to Pursuit). The historical volatility was based on the median of ICU and a certain peer group. The risk-free interest rate was equal to the yield, as of the valuation date, of the zero-coupon U.S. Treasury bill that was commensurate with the term of the earn-out. The counter party credit risk was based on a synthetic credit rating of B1. As of June 30, 2021, the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;earn-out measurement period ended. Based on the actual sales and gross profit achieved during the measurement period, we calculated the actual earn-out amount to be $26.3&#160;million. The $26.3&#160;million earn-out calculation was finalized and accepted by Pursuit's former equity holders and was paid out in the fourth quarter of 2021. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out payment shall not exceed $6.0&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of December 31, 2021, the fair value of the contingent earn-out was estimated at $2.6&#160;million. The estimated fair value of the contingent earn-out is calculated using a probability-weighted cash flow model based on historical revenue streams and the likelihood that the revenue targets will be met.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. The initial estimated fair value of the contingent consideration related to this acquisition is immaterial. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our contingent earn-out liabilities are separately stated on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of our Level 3 earn-out liabilities measured at estimated fair value based on an initial valuation and updated quarterly for the years ended December 31, 2021, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earn-out Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent earn-out liability, January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition date fair value estimate of earn-out&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent earn-out (included in income from operations as a separate line item)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent earn-out liability, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent earn-out (included in income from operations as a separate line item)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent earn-out liability, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent earn-out &#x2014; non-compete arrangement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfer of Pursuit earn-out liability into Level 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26,300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent earn-out liability, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Relates to our acquisition of Pursuit (see Note 2: Acquisitions).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the fair value of the HIS earn-out related to our 2017 acquisition of HIS from Pfizer which was based on actual results as compared to the earn-out performance targets. This adjustment reduced the HIS earn-out to zero.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the Pursuit earn-out increased during 2020 primarily due to changes in the probabilities within the valuation model.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pursuit earn-out was transferred out of Level 3 and into Level 2 in the third quarter of 2021 when the amount of the actual payment was known, and subsequently settled during the fourth quarter of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides quantitative information about Level 3 inputs for fair value measurement of the Pursuit earn-out liability as of the acquisition date to December 31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pursuit Earn-out&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;br/&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At Acquisition&lt;br/&gt;November 2, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Simulation Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue/Gross Profit Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Counter Party Risk&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments, Foreign Currency Contracts and Interest Rate Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our investments, which consist of corporate bonds, is estimated using observable market-based inputs such as quoted prices, interest rates and yield curves or Level 2 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our Level 2 forward currency contracts is estimated using observable market inputs such as known notional value amounts, spot and forward exchange rates. These inputs relate to liquid, heavily traded currencies with active markets which are available for the full term of the derivative. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our Level 2 forward-starting interest rate swaps is estimated using a pricing model that reflects the terms of the contracts, including the period to maturity, and relies on observable market inputs such as known notional value amounts and USD interest rate curves. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other than the Pursuit earn-out liability described above, there were no transfers between levels in 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our assets and liabilities measured at fair value on a recurring basis consisted of the following (Level 1, 2 and 3 inputs as defined above) (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&#160;value&#160;measurements&#160;as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&#160;carrying&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quoted&#160;prices&lt;br/&gt;in&#160;active&lt;br/&gt;markets&#160;for&lt;br/&gt;identical&lt;br/&gt;assets&#160;(level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;other&lt;br/&gt;observable&lt;br/&gt;inputs&#160;(level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&#160;(level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange forwards:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out liability - LT&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward-starting interest rate swaps:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&#160;value&#160;measurements&#160;as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&#160;carrying&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quoted&#160;prices&lt;br/&gt;in&#160;active&lt;br/&gt;markets&#160;for&lt;br/&gt;identical&lt;br/&gt;assets&#160;(level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;other&lt;br/&gt;observable&lt;br/&gt;inputs&#160;(level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&#160;(level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange forwards:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earn-out liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <icui:Contingentconsiderationgross
      contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfMjkyNg_0c9c7eeb-ceb7-41b9-ad54-d5e818d712c1"
      unitRef="usd">50000000</icui:Contingentconsiderationgross>
    <icui:Contingentconsiderationgross
      contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfMzIyNQ_02aae66d-7e04-4ad4-a291-99e178cbf782"
      unitRef="usd">50000000</icui:Contingentconsiderationgross>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i8a64787f750d4031b14422894f232878_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfMjc0ODc3OTA3ODEwOQ_63c0be6f-43f3-44a9-bf6f-63f51b68d9cb"
      unitRef="usd">26300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i8a64787f750d4031b14422894f232878_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfMjc0ODc3OTA3ODEyNA_3c9b437d-5fe8-4178-9fc0-b40908dd0acc"
      unitRef="usd">26300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <icui:Contingentconsiderationgross
      contextRef="idab760f167ab477b84968687e30e7446_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfMjc0ODc3OTA3OTEyMQ_fbe1507b-1ade-4972-a977-2c1c673608b7"
      unitRef="usd">6000000</icui:Contingentconsiderationgross>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ib0473993225046b8a38d55e04612297f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfMjc0ODc3OTA3OTE1OA_67e0d85b-32f0-4c5b-ae0a-47ed8396943c"
      unitRef="usd">2600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <icui:Contingentconsiderationgross
      contextRef="i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfMjc0ODc3OTA4Mjg5MQ_7868a7df-8834-42d0-99b3-15bf420e36df"
      unitRef="usd">2500000</icui:Contingentconsiderationgross>
    <icui:ShortTermContingentConsiderationGross
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfMjc0ODc3OTA4MjkwNQ_c0c8d9ce-19cd-4d3d-8ea0-e59a433ab70d"
      unitRef="usd">1000000</icui:ShortTermContingentConsiderationGross>
    <icui:LongTermContingentConsiderationGross
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfMjc0ODc3OTA4MjkxOQ_582af470-fabe-4ead-8178-d3913e7d517e"
      unitRef="usd">1500000</icui:LongTermContingentConsiderationGross>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfNjE5NQ_eac4c231-1cd4-459c-82b4-5d84eda4273f">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of our Level 3 earn-out liabilities measured at estimated fair value based on an initial valuation and updated quarterly for the years ended December 31, 2021, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earn-out Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent earn-out liability, January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition date fair value estimate of earn-out&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent earn-out (included in income from operations as a separate line item)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent earn-out liability, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent earn-out (included in income from operations as a separate line item)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent earn-out liability, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent earn-out &#x2014; non-compete arrangement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfer of Pursuit earn-out liability into Level 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26,300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent earn-out liability, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ic2b82bbcf5cb45739937a1040ed30f6b_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmZhZDY1YmQwYjRkNDQzZWI4ZDcyYTE3Zjk2MjY5NWE1L3RhYmxlcmFuZ2U6ZmFkNjViZDBiNGQ0NDNlYjhkNzJhMTdmOTYyNjk1YTVfMS0yLTEtMS04NzQ1_85a5bc1c-7346-42f3-a26f-5dc4d5caf6f2"
      unitRef="usd">47400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmZhZDY1YmQwYjRkNDQzZWI4ZDcyYTE3Zjk2MjY5NWE1L3RhYmxlcmFuZ2U6ZmFkNjViZDBiNGQ0NDNlYjhkNzJhMTdmOTYyNjk1YTVfMi0yLTEtMS04NzQ1_da2626b6-d912-48dd-942a-68fb26108114"
      unitRef="usd">17300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmZhZDY1YmQwYjRkNDQzZWI4ZDcyYTE3Zjk2MjY5NWE1L3RhYmxlcmFuZ2U6ZmFkNjViZDBiNGQ0NDNlYjhkNzJhMTdmOTYyNjk1YTVfMy0yLTEtMS04NzQ1_9a43f6bb-0c73-4acb-b2fe-ba90c9fc40d4"
      unitRef="usd">-47400000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmZhZDY1YmQwYjRkNDQzZWI4ZDcyYTE3Zjk2MjY5NWE1L3RhYmxlcmFuZ2U6ZmFkNjViZDBiNGQ0NDNlYjhkNzJhMTdmOTYyNjk1YTVfNC0yLTEtMS04NzQ1_32f36dbe-ca3f-457c-91af-c33f6d1db0f8"
      unitRef="usd">17300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmZhZDY1YmQwYjRkNDQzZWI4ZDcyYTE3Zjk2MjY5NWE1L3RhYmxlcmFuZ2U6ZmFkNjViZDBiNGQ0NDNlYjhkNzJhMTdmOTYyNjk1YTVfNi0yLTEtMS04NzQ1_16cb73ac-bf17-43e7-9f92-3889f8a60289"
      unitRef="usd">9000000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmZhZDY1YmQwYjRkNDQzZWI4ZDcyYTE3Zjk2MjY5NWE1L3RhYmxlcmFuZ2U6ZmFkNjViZDBiNGQ0NDNlYjhkNzJhMTdmOTYyNjk1YTVfNy0yLTEtMS04NzQ1_1d052c38-97a3-4e41-9b66-72d881d92ed9"
      unitRef="usd">26300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmZhZDY1YmQwYjRkNDQzZWI4ZDcyYTE3Zjk2MjY5NWE1L3RhYmxlcmFuZ2U6ZmFkNjViZDBiNGQ0NDNlYjhkNzJhMTdmOTYyNjk1YTVfOC0yLTEtMS04NzQ1_20bbd9f6-b200-4dd1-8b41-0217eb429c48"
      unitRef="usd">2589000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmZhZDY1YmQwYjRkNDQzZWI4ZDcyYTE3Zjk2MjY5NWE1L3RhYmxlcmFuZ2U6ZmFkNjViZDBiNGQ0NDNlYjhkNzJhMTdmOTYyNjk1YTVfMTAtMi0xLTEtNjIwMjE_57b3c7ef-c031-44b4-89fe-861fd4e86b9d"
      unitRef="usd">26300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmZhZDY1YmQwYjRkNDQzZWI4ZDcyYTE3Zjk2MjY5NWE1L3RhYmxlcmFuZ2U6ZmFkNjViZDBiNGQ0NDNlYjhkNzJhMTdmOTYyNjk1YTVfMTAtMi0xLTEtODc0NQ_c4e52b7e-fae6-46dd-b103-a7d5828840fc"
      unitRef="usd">2589000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="ia4f13d3f94f44a08bc3233dd5ceb89a4_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfNjIwNA_cefb7159-79c4-4621-b40b-ab4668d8fee1">The following table provides quantitative information about Level 3 inputs for fair value measurement of the Pursuit earn-out liability as of the acquisition date to December 31, 2020:</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfNjIxMQ_92977447-f4bf-44d3-9f85-7e44c273c5c5">&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pursuit Earn-out&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;br/&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At Acquisition&lt;br/&gt;November 2, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Simulation Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue/Gross Profit Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Counter Party Risk&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i4d20c02b38e041509fe7e05408566fbd_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjVjYmViYzkwNTgyZDRhNDFiOTAxMjU5MWFmZDMwNWU2L3RhYmxlcmFuZ2U6NWNiZWJjOTA1ODJkNGE0MWI5MDEyNTkxYWZkMzA1ZTZfMi0zLTEtMS04NzQ1_76d150d5-03c3-4d97-a1cd-c5529b2ca6b2"
      unitRef="number">0.2500</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i8dcd382934d440328d704d280ebf3fa4_I20191102"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjVjYmViYzkwNTgyZDRhNDFiOTAxMjU5MWFmZDMwNWU2L3RhYmxlcmFuZ2U6NWNiZWJjOTA1ODJkNGE0MWI5MDEyNTkxYWZkMzA1ZTZfMi01LTEtMS04NzQ1_a417f9bd-419f-439a-b973-c909a9de0a6f"
      unitRef="number">0.2000</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i95dc6e540f5b4198be6fed8fbf400d56_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjVjYmViYzkwNTgyZDRhNDFiOTAxMjU5MWFmZDMwNWU2L3RhYmxlcmFuZ2U6NWNiZWJjOTA1ODJkNGE0MWI5MDEyNTkxYWZkMzA1ZTZfMy0zLTEtMS04NzQ1_1d147760-dfcd-4d17-bb56-342f406e5410"
      unitRef="number">0.1250</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="iec592b00b8524a088ab236591b84114e_I20191102"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjVjYmViYzkwNTgyZDRhNDFiOTAxMjU5MWFmZDMwNWU2L3RhYmxlcmFuZ2U6NWNiZWJjOTA1ODJkNGE0MWI5MDEyNTkxYWZkMzA1ZTZfMy01LTEtMS04NzQ1_34571630-ee80-4b22-a396-46c2b3b7abb1"
      unitRef="number">0.1500</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i83746611e0ea468aad18f290522ef413_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjVjYmViYzkwNTgyZDRhNDFiOTAxMjU5MWFmZDMwNWU2L3RhYmxlcmFuZ2U6NWNiZWJjOTA1ODJkNGE0MWI5MDEyNTkxYWZkMzA1ZTZfNC0zLTEtMS04NzQ1_0e8d09b8-750c-4efe-8a41-23cda689ea6e"
      unitRef="number">0.0009</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i4a648c0e1a8241a38f2f3a48870c1bb0_I20191102"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjVjYmViYzkwNTgyZDRhNDFiOTAxMjU5MWFmZDMwNWU2L3RhYmxlcmFuZ2U6NWNiZWJjOTA1ODJkNGE0MWI5MDEyNTkxYWZkMzA1ZTZfNC01LTEtMS04NzQ1_0c062fa2-3fa5-4cfc-8526-90f7e8d226c6"
      unitRef="number">0.0155</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i3a0167f7320946b3a2e58b4124c3e79b_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjVjYmViYzkwNTgyZDRhNDFiOTAxMjU5MWFmZDMwNWU2L3RhYmxlcmFuZ2U6NWNiZWJjOTA1ODJkNGE0MWI5MDEyNTkxYWZkMzA1ZTZfNS0zLTEtMS04NzQ1_220713e4-ace6-445c-8275-ef123d928ada"
      unitRef="number">0.0310</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i2c5018212e424aa8ad9252ca55f1861c_I20191102"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjVjYmViYzkwNTgyZDRhNDFiOTAxMjU5MWFmZDMwNWU2L3RhYmxlcmFuZ2U6NWNiZWJjOTA1ODJkNGE0MWI5MDEyNTkxYWZkMzA1ZTZfNS01LTEtMS04NzQ1_ce0be3d2-ec6f-4e59-a9ab-34057bf0d4b7"
      unitRef="number">0.0600</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RleHRyZWdpb246OTJhYjMxMTAyZTVhNDE3NjlkMjNmYzE5ZGRmMzNjYjdfNjE5Nw_93ff939f-0413-4baa-b385-596db96e11f5">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our assets and liabilities measured at fair value on a recurring basis consisted of the following (Level 1, 2 and 3 inputs as defined above) (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&#160;value&#160;measurements&#160;as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&#160;carrying&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quoted&#160;prices&lt;br/&gt;in&#160;active&lt;br/&gt;markets&#160;for&lt;br/&gt;identical&lt;br/&gt;assets&#160;(level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;other&lt;br/&gt;observable&lt;br/&gt;inputs&#160;(level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&#160;(level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange forwards:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out liability - LT&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward-starting interest rate swaps:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&#160;value&#160;measurements&#160;as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&#160;carrying&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quoted&#160;prices&lt;br/&gt;in&#160;active&lt;br/&gt;markets&#160;for&lt;br/&gt;identical&lt;br/&gt;assets&#160;(level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;other&lt;br/&gt;observable&lt;br/&gt;inputs&#160;(level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&#160;(level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange forwards:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earn-out liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNC0xLTEtMS04NzQ1_f17370d7-e6b4-4272-a80d-f5bab7ec685f"
      unitRef="usd">14420000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i016a88407f61445a9ead2c5fe9666972_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNC0zLTEtMS04NzQ1_5a94689b-8f8a-445e-b085-e2ec4ac5a97f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="iffbaa78bab214394916b2fcdbc6715c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNC01LTEtMS04NzQ1_f1f5bb0a-37a7-49d8-9e2b-e3bd4deaddd6"
      unitRef="usd">14420000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="id686138862cd4f2faa2e433db45c3af8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNC03LTEtMS04NzQ1_cd9ded31-5e66-4a1d-9693-c45f0598b020"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesNoncurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNS0xLTEtMS04NzQ1_b0465f11-e595-4d1a-8e94-efad68637e58"
      unitRef="usd">4620000</us-gaap:DebtSecuritiesNoncurrent>
    <us-gaap:DebtSecuritiesNoncurrent
      contextRef="i016a88407f61445a9ead2c5fe9666972_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNS0zLTEtMS04NzQ1_63e042b5-aa6e-42aa-a8a4-34e62d6c8560"
      unitRef="usd">0</us-gaap:DebtSecuritiesNoncurrent>
    <us-gaap:DebtSecuritiesNoncurrent
      contextRef="iffbaa78bab214394916b2fcdbc6715c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNS01LTEtMS04NzQ1_c7ecf24f-73cc-4c62-97e3-233867030af4"
      unitRef="usd">4620000</us-gaap:DebtSecuritiesNoncurrent>
    <us-gaap:DebtSecuritiesNoncurrent
      contextRef="id686138862cd4f2faa2e433db45c3af8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNS03LTEtMS04NzQ1_3b11a1f4-7b0e-4192-8ca3-86b9993ce74f"
      unitRef="usd">0</us-gaap:DebtSecuritiesNoncurrent>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i5ec7606edab34323b337692160cb6ced_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNy0xLTEtMS04NzQ1_d5f6427b-3ca2-4fe4-9c71-e03c76d30a02"
      unitRef="usd">1061000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i9b1af846c2bd49b2b73f2cce81980df9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNy0zLTEtMS04NzQ1_cf0f0e0c-973d-4f5d-a669-67389152b970"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ic3279fafd14f4fafa391f0e6aebb36f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNy01LTEtMS04NzQ1_f94641aa-0d8d-4184-aba5-0f3c581072f6"
      unitRef="usd">1061000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="if1ccba1757384a43b8a31386dda4223f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfNy03LTEtMS04NzQ1_ffd32279-3e76-47f5-a58e-08801ff99a76"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfOS0xLTEtMS04NzQ1_2f183339-52fa-421a-bccf-683bef2c6b19"
      unitRef="usd">20101000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i016a88407f61445a9ead2c5fe9666972_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfOS0zLTEtMS04NzQ1_2ca7ecb3-a010-469e-bcc6-4b4fe7246a9c"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iffbaa78bab214394916b2fcdbc6715c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfOS01LTEtMS04NzQ1_0583d1ce-0aa6-4c4c-a847-3f3b55454154"
      unitRef="usd">20101000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id686138862cd4f2faa2e433db45c3af8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfOS03LTEtMS04NzQ1_79a8f853-2f26-429c-989f-287cfe443169"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i375d2dcaee564df4bba09294bc8b4ce1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTItMS0xLTEtODc0NQ_4c4c2a96-24de-4ff7-91f7-65b8f2f773ee"
      unitRef="usd">2589000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i96688b63cabc48858140503c0d9eb461_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTItMy0xLTEtODc0NQ_9822818f-7250-4854-9315-83bc48e7eda4"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i544bab0abcfd41739edc7808545eb541_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTItNS0xLTEtODc0NQ_37452b43-00ba-49ae-8484-2ec94f842834"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="if18f162b786b481ead18bd1c0072862f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTItNy0xLTEtODc0NQ_a608f6bf-23c8-41b3-a39b-40c4a2d90b05"
      unitRef="usd">2589000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:InterestRateDerivativeLiabilitiesAtFairValue
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTgtMS0xLTEtNjEyNzg_7a1a9fda-4e10-4acb-b5f9-84b2cb6c05ce"
      unitRef="usd">1480000</us-gaap:InterestRateDerivativeLiabilitiesAtFairValue>
    <us-gaap:InterestRateDerivativeLiabilitiesAtFairValue
      contextRef="i016a88407f61445a9ead2c5fe9666972_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTgtMy0xLTEtNjEyODI_4284d136-51c8-42ad-bb9d-32b37b5ed86f"
      unitRef="usd">0</us-gaap:InterestRateDerivativeLiabilitiesAtFairValue>
    <us-gaap:InterestRateDerivativeLiabilitiesAtFairValue
      contextRef="iffbaa78bab214394916b2fcdbc6715c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTgtNS0xLTEtNjEyODY_7e7812c2-56d8-4b09-babc-d47e0d843369"
      unitRef="usd">1480000</us-gaap:InterestRateDerivativeLiabilitiesAtFairValue>
    <us-gaap:InterestRateDerivativeLiabilitiesAtFairValue
      contextRef="id686138862cd4f2faa2e433db45c3af8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTgtNy0xLTEtNjEyODg_98767c89-7cb3-45ff-b79b-6210ea496184"
      unitRef="usd">0</us-gaap:InterestRateDerivativeLiabilitiesAtFairValue>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="ifbcc6f28c8de4784b50d3d46d2b1dc73_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTYtMS0xLTEtODc0NQ_3298d46e-cb6f-4ab5-9fb3-01a8a5c3b70d"
      unitRef="usd">4069000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="iac9bf1a987b04a68a63b86dddb2a0ad7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTYtMy0xLTEtODc0NQ_a17dd16e-686a-4c80-884e-8fa337ea3c3c"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i7a4e9901f5af47dbac4bd58d52cec2e3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTYtNS0xLTEtODc0NQ_40518cc8-2662-49d9-a456-36f81e844f69"
      unitRef="usd">1480000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i76ecdfc58eff40d4b5a5696b57877d65_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOmNhNTZkMTM1Yzc0MzQ1YTU4MDYyMDkyZWMxMjYyOTFkL3RhYmxlcmFuZ2U6Y2E1NmQxMzVjNzQzNDVhNTgwNjIwOTJlYzEyNjI5MWRfMTYtNy0xLTEtODc0NQ_cbd17b10-0333-4bd4-9c6b-75ca6bdab93e"
      unitRef="usd">2589000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNC0xLTEtMS04NzQ1_b0de9108-a280-4c26-8c37-8b3e7c59490f"
      unitRef="usd">14687000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="id9d041120aa546daa089ac02aad807b6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNC0zLTEtMS04NzQ1_95e705d7-f471-4f3d-ba8f-633407448644"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i9e58a71511c74a519d97f5aaf72d0d67_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNC01LTEtMS04NzQ1_c9297711-8e04-468a-914c-3974d0d7bbfa"
      unitRef="usd">14687000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i3bb94fa0fb71402cbf3e8e652d8f7e4c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNC03LTEtMS04NzQ1_50841f0a-2e2a-4d80-ab8e-9a3cd2105437"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesNoncurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNS0xLTEtMS04NzQ1_df7b6939-d296-4356-818f-56ae7e8d9484"
      unitRef="usd">12974000</us-gaap:DebtSecuritiesNoncurrent>
    <us-gaap:DebtSecuritiesNoncurrent
      contextRef="id9d041120aa546daa089ac02aad807b6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNS0zLTEtMS04NzQ1_794e22a6-ec7a-4bef-b670-7f20255f6201"
      unitRef="usd">0</us-gaap:DebtSecuritiesNoncurrent>
    <us-gaap:DebtSecuritiesNoncurrent
      contextRef="i9e58a71511c74a519d97f5aaf72d0d67_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNS01LTEtMS04NzQ1_cb2b63c7-d701-421d-8509-c5d1d4be3dc6"
      unitRef="usd">12974000</us-gaap:DebtSecuritiesNoncurrent>
    <us-gaap:DebtSecuritiesNoncurrent
      contextRef="i3bb94fa0fb71402cbf3e8e652d8f7e4c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNS03LTEtMS04NzQ1_33872d85-a282-4ad9-ab90-8df423095fbb"
      unitRef="usd">0</us-gaap:DebtSecuritiesNoncurrent>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="iaf9c0633da1b47ee8d93b6e4abeff18b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNy0xLTEtMS04NzQ1_e00cdbf8-2ece-44e8-99e9-e6ec52d16683"
      unitRef="usd">3555000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i23cd4418967541a1a5d36e2d99a5356e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNy0zLTEtMS04NzQ1_d7a22d4f-17d5-4dc5-a00e-d0949f93c77a"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i24b5d0557ec344d89ca4d7fdcdfbfa6b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNy01LTEtMS04NzQ1_6f11c7b6-7a3d-47e8-a2d7-9891d892f433"
      unitRef="usd">3555000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i5809c6220648406e9d0413ce194ce911_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfNy03LTEtMS04NzQ1_767e8007-471a-43ea-8e76-c0c1a16a38a2"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfOS0xLTEtMS04NzQ1_f2a738b5-f06b-48e8-aa6e-7bb5aa584cd6"
      unitRef="usd">31216000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id9d041120aa546daa089ac02aad807b6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfOS0zLTEtMS04NzQ1_495239cd-279b-41d4-9aa3-413a126be564"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9e58a71511c74a519d97f5aaf72d0d67_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfOS01LTEtMS04NzQ1_6c5a4ddd-a50c-41d6-9793-46750448922b"
      unitRef="usd">31216000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3bb94fa0fb71402cbf3e8e652d8f7e4c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfOS03LTEtMS04NzQ1_8c8acdef-c3cd-40aa-85b1-0c2c1713bfda"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i322c2f5703b44dfebfc8fa4655888d5a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfMTMtMS0xLTEtODc0NQ_6835e5ec-248d-4729-9304-0435f640a873"
      unitRef="usd">26300000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="ia8f6c1cca4c146c39148c7ba09392200_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfMTMtMy0xLTEtODc0NQ_b1b6f735-716b-423e-b3ec-41e96552da32"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="iaee1dd2e4cd844c88f833890aa55e7ea_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfMTMtNS0xLTEtODc0NQ_7ac8102b-3b3c-43c4-a871-e14f7a9dcf9f"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i8a287e50d1874b7c8137eb644e17fa5c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfMTMtNy0xLTEtODc0NQ_28db5419-8d0a-40f4-871b-2d66313e693c"
      unitRef="usd">26300000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="ib494916ad242431f84438805dad01887_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfMTctMS0xLTEtODc0NQ_2a7b4333-e469-46e1-bdb3-6c33eab9b222"
      unitRef="usd">26300000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i1fd62c35036b40778820f92e3d9b31f2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfMTctMy0xLTEtODc0NQ_43ef41f5-21e7-43a6-b8d3-9089baeb1bd0"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="ife8f7b6aa0ab423b9e32b2a38ffe5dd5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfMTctNS0xLTEtODc0NQ_5d3fbd62-785b-427d-9b18-3ab67fa1c469"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="ie770d12c9b6a464ca982cfc743bc4e2d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85MS9mcmFnOjkyYWIzMTEwMmU1YTQxNzY5ZDIzZmMxOWRkZjMzY2I3L3RhYmxlOjY3YTgyMWE4ZTFjOTQ1MTBhOTIwNmYxNmU3MWZjNjQ0L3RhYmxlcmFuZ2U6NjdhODIxYThlMWM5NDUxMGE5MjA2ZjE2ZTcxZmM2NDRfMTctNy0xLTEtODc0NQ_56ce8680-5674-40f1-bcca-09f4c0cb4c94"
      unitRef="usd">26300000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:OtherCurrentAssetsTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RleHRyZWdpb246MGFlZjM5YWY3ODMwNGVhMGI2ZjkxZGQ2MmM2NjI0YzJfMTQ2_1407fa98-f4f3-475d-b2d3-f6cf08a83d72">PREPAID EXPENSES AND OTHER CURRENT ASSETS AND OTHER ASSETS&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets consist of the following (in thousands): &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other prepaid expenses and receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid insurance and property taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VAT/GST receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax charge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange forward contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pump lease receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spare parts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherCurrentAssetsTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RleHRyZWdpb246MGFlZjM5YWY3ODMwNGVhMGI2ZjkxZGQ2MmM2NjI0YzJfMTQ5_caa24563-c564-48a0-8d8b-995a47ba050b">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets consist of the following (in thousands): &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other prepaid expenses and receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid insurance and property taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VAT/GST receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax charge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange forward contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pump lease receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spare parts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfMi0xLTEtMS04NzQ1_ef86b563-8101-4b5d-86af-083d9947da73"
      unitRef="usd">14763000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfMi0zLTEtMS04NzQ1_532ba96b-757c-4f55-a0da-d12ec2eacfda"
      unitRef="usd">14964000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:DeferredCostsAndOtherAssets
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfMy0xLTEtMS04NzQ1_ab8cf6c1-2e77-4d24-9409-351a8840c2fb"
      unitRef="usd">12746000</us-gaap:DeferredCostsAndOtherAssets>
    <us-gaap:DeferredCostsAndOtherAssets
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfMy0zLTEtMS04NzQ1_96aaf74e-d1d9-4e42-b859-fe676a0c07e9"
      unitRef="usd">6402000</us-gaap:DeferredCostsAndOtherAssets>
    <icui:Prepaidinsuranceandpropertytaxes
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfNC0xLTEtMS04NzQ1_03e1efb4-456f-41dc-af03-100325a13498"
      unitRef="usd">6310000</icui:Prepaidinsuranceandpropertytaxes>
    <icui:Prepaidinsuranceandpropertytaxes
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfNC0zLTEtMS04NzQ1_ed8776b8-52fc-4d4c-a393-877b250fcf61"
      unitRef="usd">6178000</icui:Prepaidinsuranceandpropertytaxes>
    <icui:Prepaidothertaxes
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfNS0xLTEtMS04NzQ1_fe4ad8f0-ea55-4603-841f-4c0c234250c1"
      unitRef="usd">4156000</icui:Prepaidothertaxes>
    <icui:Prepaidothertaxes
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfNS0zLTEtMS04NzQ1_3bc0fa7a-a277-4c16-b2da-617e492a4fac"
      unitRef="usd">3676000</icui:Prepaidothertaxes>
    <icui:Deferredtaxcharge
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfNi0xLTEtMS04NzQ1_828546ec-a745-4d86-bc0c-3f0bb814350b"
      unitRef="usd">4241000</icui:Deferredtaxcharge>
    <icui:Deferredtaxcharge
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfNi0zLTEtMS04NzQ1_072e16db-752a-4415-8d70-98584bf0845e"
      unitRef="usd">3542000</icui:Deferredtaxcharge>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfNy0xLTEtMS04NzQ1_25360d2a-3181-4560-99ed-fcbc1d4ec937"
      unitRef="usd">1061000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfNy0zLTEtMS04NzQ1_4b9551f1-5ade-4f79-bd39-68100b82a183"
      unitRef="usd">3555000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DepositAssets
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfOC0xLTEtMS04NzQ1_fd2d1868-89a1-47bf-9e92-a04c893fc878"
      unitRef="usd">1343000</us-gaap:DepositAssets>
    <us-gaap:DepositAssets
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfOC0zLTEtMS04NzQ1_fb5fc987-96fe-4230-8541-ead4e058124b"
      unitRef="usd">1353000</us-gaap:DepositAssets>
    <us-gaap:OtherAssetsCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfOS0xLTEtMS04NzQ1_9f539fc5-5c54-44de-b926-30c81f62fb3d"
      unitRef="usd">2227000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfOS0zLTEtMS04NzQ1_452b2595-1b5d-4f7a-943c-d7a23b9b0d1a"
      unitRef="usd">1822000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfMTAtMS0xLTEtODc0NQ_819fc570-d610-4e32-89ae-f44c7de31bcf"
      unitRef="usd">46847000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjg5M2RmNWUwMjY5MjRjM2RiNTI2ZGM3ZGQ5OTMzMWJlL3RhYmxlcmFuZ2U6ODkzZGY1ZTAyNjkyNGMzZGI1MjZkYzdkZDk5MzMxYmVfMTAtMy0xLTEtODc0NQ_ec29d4af-471e-43e3-9a10-00ae64603748"
      unitRef="usd">41492000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceived
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfMi0xLTEtMS0yODcyNA_19809c8e-a26a-4c98-ae4b-322a34b8b617"
      unitRef="usd">25941000</us-gaap:LessorOperatingLeasePaymentsToBeReceived>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceived
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfMi0zLTEtMS0yODcxNg_73f1a394-6eda-470b-89ac-9752e40ca667"
      unitRef="usd">28948000</us-gaap:LessorOperatingLeasePaymentsToBeReceived>
    <icui:SpareParts
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfMy0xLTEtMS0yODcyNA_32658603-5dc8-40dc-86ca-602486a77451"
      unitRef="usd">28538000</icui:SpareParts>
    <icui:SpareParts
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfMy0zLTEtMS0yODcxNg_5a11f361-1304-4bc6-853b-a6626e269a44"
      unitRef="usd">22725000</icui:SpareParts>
    <us-gaap:EquityMethodInvestments
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfNC0xLTEtMS0yODcyNA_6cd969dc-3c96-43a0-b28d-958148305423"
      unitRef="usd">3238000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfNC0zLTEtMS0yODcxNg_b1717af8-bc2b-4683-948d-f8a614b9ebea"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfNi0xLTEtMS01NjYyNQ_01520fb2-7f81-4bcf-9d85-d0587de89e45"
      unitRef="usd">2827000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfNi0zLTEtMS01NjYyNQ_c2dc6bfe-3a95-46a6-b064-56e466a40e50"
      unitRef="usd">0</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfNS0xLTEtMS0yODcyNA_b31bf858-a1cd-4400-afc8-a343474324f2"
      unitRef="usd">2673000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfNS0zLTEtMS0yODcxNg_e96fe446-9b2b-478f-8d8e-0acd7421d464"
      unitRef="usd">2915000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfNi0xLTEtMS0yODcyNA_d524931b-8188-406c-aa3a-8c15f5d5f143"
      unitRef="usd">526000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfNi0zLTEtMS0yODcxNg_fb66df6a-ff87-45ed-b6b8-c8f3ada0e9d8"
      unitRef="usd">887000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfNy0xLTEtMS0yODcyNA_82ffcc3e-a041-4ced-805c-725d0117d698"
      unitRef="usd">63743000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85NC9mcmFnOjBhZWYzOWFmNzgzMDRlYTBiNmY5MWRkNjJjNjYyNGMyL3RhYmxlOjM5OGM1YmFhN2JlZDRmODhiNDJkNjVhM2NiMDczZmU2L3RhYmxlcmFuZ2U6Mzk4YzViYWE3YmVkNGY4OGI0MmQ2NWEzY2IwNzNmZTZfNy0zLTEtMS0yODcxNg_3fc08143-9002-4970-913f-9f7bc8f5d49e"
      unitRef="usd">55475000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RleHRyZWdpb246YmZmZWNlNWYwYzhkNDA5Nzk5NDFmNTkzZDQ2ZjI5YzlfMzg2_8425368c-48e8-4baa-aa51-1ae1d3c6be45">ACCRUED LIABILITIES AND OTHER LONG-TERM LIABILITIES&lt;div style="margin-top:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salaries and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incentive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability-ST&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warranties and returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued other taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued freight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term liabilities consist of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability-LT&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liability-LT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward-starting interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;(1)&#160;&#160;&#160;&#160;Consists of contracts with customers and suppliers that were valued at below market at the time of the HIS acquisition.</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RleHRyZWdpb246YmZmZWNlNWYwYzhkNDA5Nzk5NDFmNTkzZDQ2ZjI5YzlfMzc2_61d5010e-f66a-45d3-9d13-6727af18d9c3">&lt;div style="margin-top:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salaries and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incentive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability-ST&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warranties and returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued other taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued freight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term liabilities consist of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability-LT&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liability-LT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward-starting interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;(1)&#160;&#160;&#160;&#160;Consists of contracts with customers and suppliers that were valued at below market at the time of the HIS acquisition.</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <icui:AccruedSalariesAndBenefits
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMi0yLTEtMS04NzQ1_74c06152-821c-4a1f-b78e-560a61886f66"
      unitRef="usd">27304000</icui:AccruedSalariesAndBenefits>
    <icui:AccruedSalariesAndBenefits
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMi00LTEtMS04NzQ1_8923d686-5eea-4d64-a881-ae56f894740c"
      unitRef="usd">25786000</icui:AccruedSalariesAndBenefits>
    <us-gaap:AccruedBonusesCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMy0yLTEtMS04NzQ1_762979db-fc86-4201-b2c8-59ebc8db07fb"
      unitRef="usd">33107000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedBonusesCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMy00LTEtMS04NzQ1_164f6ebd-54ea-41fb-8aea-1f2d995eb1bf"
      unitRef="usd">27023000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfNS0yLTEtMS04NzQ1_e10b96e8-f03d-466b-9900-796852709a48"
      unitRef="usd">9009000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfNS00LTEtMS04NzQ1_7badadb7-6b92-4d62-89f8-9361f7777165"
      unitRef="usd">8740000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfNi0yLTEtMS04NzQ1_c181e898-7e31-4818-b06b-3eac649ebfb5"
      unitRef="usd">773000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfNi00LTEtMS04NzQ1_a6f37dda-cd52-4485-b3a0-e1a1f92328f6"
      unitRef="usd">1273000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <icui:Accruedlegalfees
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTAtMi0xLTEtODc0NQ_fc24ef3b-7791-42d8-8917-ab9ff946da2e"
      unitRef="usd">3897000</icui:Accruedlegalfees>
    <icui:Accruedlegalfees
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTAtNC0xLTEtODc0NQ_4b7765de-40da-489e-8dea-152daa7bbbf6"
      unitRef="usd">900000</icui:Accruedlegalfees>
    <icui:Accruedsalestaxes
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTEtMi0xLTEtODc0NQ_e95d80a9-378f-4195-817e-b828bea981f4"
      unitRef="usd">1980000</icui:Accruedsalestaxes>
    <icui:Accruedsalestaxes
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTEtNC0xLTEtODc0NQ_a908f9a1-314e-48a7-82fe-7a4d29b85f81"
      unitRef="usd">2146000</icui:Accruedsalestaxes>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTItMi0xLTEtODc0NQ_7411c481-1d3f-49c0-a83a-a221175d718d"
      unitRef="usd">532000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTItNC0xLTEtODc0NQ_00c09305-9906-4ae7-878b-13b638b770e6"
      unitRef="usd">1027000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTMtMi0xLTEtODc0NQ_792bc508-1de4-4e4d-953c-d1c63295f955"
      unitRef="usd">12646000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTMtNC0xLTEtODc0NQ_761e4dc9-2a6f-45ee-a192-2342148dce55"
      unitRef="usd">5566000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <icui:Accruedothertaxes
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTQtMi0xLTEtODc0NQ_afee36dd-a57d-49d2-88db-67cc95c7b8d0"
      unitRef="usd">4337000</icui:Accruedothertaxes>
    <icui:Accruedothertaxes
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTQtNC0xLTEtODc0NQ_80072b3b-e3ef-4ab4-9d16-a8754067a9d8"
      unitRef="usd">3540000</icui:Accruedothertaxes>
    <icui:Outsidesalescommissions
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTUtMi0xLTEtODc0NQ_d63da7c6-2c79-4815-be00-8269e2239cd3"
      unitRef="usd">5645000</icui:Outsidesalescommissions>
    <icui:Outsidesalescommissions
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTUtNC0xLTEtODc0NQ_566c7912-957e-4f31-9249-94b0138abffd"
      unitRef="usd">5300000</icui:Outsidesalescommissions>
    <icui:Accruedfreight
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTYtMi0xLTEtODc0NQ_72f1ee34-268f-4c2a-8633-4e9771f53380"
      unitRef="usd">9194000</icui:Accruedfreight>
    <icui:Accruedfreight
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTYtNC0xLTEtODc0NQ_d517c4b1-7a56-4a8a-8f55-548e186503da"
      unitRef="usd">6784000</icui:Accruedfreight>
    <us-gaap:RestructuringReserveCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTctMi0xLTEtODc0NQ_7a1759d7-ccdd-4e5a-b16d-877289ca1fef"
      unitRef="usd">664000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMTctNC0xLTEtODc0NQ_c9d86939-8190-4801-8b1f-9a08db455aaa"
      unitRef="usd">3421000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMjMtMi0xLTEtODc0NQ_45cd9f8f-e32b-485e-bb33-217d23d7e6ef"
      unitRef="usd">9107000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMjMtNC0xLTEtODc0NQ_2ebe1e8d-2a59-4cdf-b846-1d9d1f0ad5ef"
      unitRef="usd">5515000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMjQtMi0xLTEtODc0NQ_71acd713-12ff-46cb-8c45-a32fb9656085"
      unitRef="usd">118195000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjdmNzdiNGJmNzE3MzRjOWM5NWYzZTUwZjU2YTJiYmY1L3RhYmxlcmFuZ2U6N2Y3N2I0YmY3MTczNGM5Yzk1ZjNlNTBmNTZhMmJiZjVfMjQtNC0xLTEtODc0NQ_ab77a4a2-1376-4375-abf3-f19ce615a0a4"
      unitRef="usd">97021000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfMi0xLTEtMS04NzQ1_9f2c89a2-320f-4d5f-96d3-128bb73e8e1b"
      unitRef="usd">33971000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfMi0zLTEtMS04NzQ1_288d4430-e680-4e4f-8d11-b697cf239acd"
      unitRef="usd">41019000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfMy0xLTEtMS04NzQ1_a78e77fa-dd2a-4c66-9ac8-19ab74bb695f"
      unitRef="usd">2067000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfMy0zLTEtMS04NzQ1_1408c4d9-f550-4ec9-919d-7dc17754751b"
      unitRef="usd">2388000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <icui:Liabilitiesforcontracts
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfNC0xLTEtMS04NzQ1_52784a85-c0c4-4ffa-b69f-84a546527c1d"
      unitRef="usd">202000</icui:Liabilitiesforcontracts>
    <icui:Liabilitiesforcontracts
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfNC0zLTEtMS04NzQ1_63660187-42d2-4b16-bad8-6a8876535b7c"
      unitRef="usd">337000</icui:Liabilitiesforcontracts>
    <us-gaap:InterestRateDerivativeLiabilitiesAtFairValue
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfNi0xLTEtMS01NTk1Ng_cd54e1ad-620f-45fd-828e-997b0caf1c4c"
      unitRef="usd">1480000</us-gaap:InterestRateDerivativeLiabilitiesAtFairValue>
    <us-gaap:InterestRateDerivativeLiabilitiesAtFairValue
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfNi0zLTEtMS01NTk1Ng_2ab6ad55-5c16-420e-bfea-904da1c7a4ff"
      unitRef="usd">0</us-gaap:InterestRateDerivativeLiabilitiesAtFairValue>
    <us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfNi0xLTEtMS04NzQ1_28a087fc-8a4f-4259-a5ec-8ddd48b96a40"
      unitRef="usd">1369000</us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfNi0zLTEtMS04NzQ1_1c55b083-dd67-4d48-82ce-9385031e975e"
      unitRef="usd">1183000</us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent>
    <us-gaap:AccruedRentCurrentAndNoncurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfOC0xLTEtMS04NzQ1_a9fbcd7b-469e-4227-a710-cacbee7acf5b"
      unitRef="usd">1262000</us-gaap:AccruedRentCurrentAndNoncurrent>
    <us-gaap:AccruedRentCurrentAndNoncurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfOC0zLTEtMS04NzQ1_2e57784d-fad1-4119-8e48-bc082dda3c3e"
      unitRef="usd">1462000</us-gaap:AccruedRentCurrentAndNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfMTAtMS0xLTEtODc0NQ_d88bcc04-95d2-4664-9eb2-5a617cfd028f"
      unitRef="usd">1479000</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfMTAtMy0xLTEtODc0NQ_caa1b2cd-148e-405f-8ddf-cfacd51c9a11"
      unitRef="usd">1446000</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfMTEtMS0xLTEtODc0NQ_31d501c4-ef87-4c55-ae89-8f34ec73ddae"
      unitRef="usd">41830000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF85Ny9mcmFnOmJmZmVjZTVmMGM4ZDQwOTc5OTQxZjU5M2Q0NmYyOWM5L3RhYmxlOjkzYWM3ZGY3MjhlNzQ1NTViOTY3MjBiNWQ1MjEyNjMyL3RhYmxlcmFuZ2U6OTNhYzdkZjcyOGU3NDU1NWI5NjcyMGI1ZDUyMTI2MzJfMTEtMy0xLTEtODc0NQ_c9c23fbe-3d36-490c-9067-35eff81ea2f9"
      unitRef="usd">47835000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzUwMTU_21a3a7ae-b7c5-4610-a73a-ea804e491788">LONG-TERM OBLIGATIONS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Five-year Senior Secured Revolving Credit Facility ("Credit Facility")&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 8, 2017, we entered into a five-year Revolving Credit Facility ("Credit Facility") with various lenders for $150.0 million, with Wells Fargo Bank, N.A. as the administrative agent, swingline lender and issuing lender. During March 2020, as a result of market uncertainty caused by the COVID-19 pandemic, we preemptively borrowed $150.0 million on our Credit Facility as a conservative measure to manage any potential short-term liquidity risk. As of December 31, 2020, we had fully repaid all amounts borrowed. As of December 31, 2021 and 2020, we had no borrowings and $150.0 million of availability under the Credit Facility. The Credit Facility matures on November 8, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Facility has an accordion feature that would enable us to increase the borrowing capacity of the Credit Facility by the greater of (i) $100.0 million and (ii) 2.00x Total Leverage.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Credit Facility, during the year ended December 31, 2017, we incurred $1.4 million in financing costs, which were capitalized and are included in prepaid expenses and other current assets and other assets on our consolidated balance sheets, in accordance with the appropriate short-term or long-term classification.  These fees are being amortized to interest expense over the remaining term of the Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 6, 2022, we completed the acquisition of Smiths Medical which was partially financed by entering into Senior Secured Credit Facilities consisting of a term loan A facility of $850.0&#160;million, a term loan B facility of $850.0&#160;million and a revolving credit facility of $500.0&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Principal payments&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Principal payments, when drawn on the Credit Facility, are made at our discretion with the entire unpaid amount due at maturity.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest rate&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In general, borrowing under the Credit Facility (other than Swingline loans) bears interest, at our option, based on the Base Rate plus applicable margin or the London Interbank Offered Rate ("LIBOR") rate plus applicable margin, as defined below: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;(A) Base Rate is defined as the highest of: (a) the Prime Rate; (b) the Federal Funds Rate plus 0.50%; and (c) the daily LIBOR (as defined below) for a one month Interest Period plus 1%. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;(B) LIBOR Rate, as determined by the Administrative Agent, is defined as the rate per annum obtained by dividing (1) LIBOR by (2) 1.00 - Eurodollar Reserve Percentage. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Swingline loans will bear interest at the Base Rate plus the applicable Interest Margin. The Credit Facility has a per annum commitment fee (see table below) that will accrue on the unused amounts of the commitments under the Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The applicable interest margins and the commitment fee with respect to the Credit Facility shall be based on the Total Leverage Ratio pursuant to the following pricing grid:&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Total &lt;br/&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Commitment &lt;br/&gt;Fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LIBOR &lt;br/&gt;+&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Base Rate &lt;br/&gt;+&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 1.00 to 1.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than or equal to 1.00 to 1.00 but less than 2.00 to 1.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.20%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than or equal to 2.00 to 1.00 but less than 2.50 to 1.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than or equal to 2.50 to 1.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Guarantors and Collateral&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our obligations under the Credit Facility are unconditionally guaranteed, on a joint and several basis, by ICU Medical, Inc. and certain of our existing subsidiaries.  Our obligations are secured by: (i) 100% of the equity interests of our guarantor subsidiaries; and (ii) all of the tangible and intangible personal property and assets related to us and our guarantor subsidiaries (including, without limitation, all accounts, equipment, inventory and other goods, all instruments, intellectual property and other general intangibles, deposit accounts, securities accounts and other investment property and cash), and (iii) all products, profits and proceeds of the foregoing.  Notwithstanding the foregoing, the collateral shall not include certain excluded property.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt Covenants&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Facility contains certain financial covenants pertaining to Consolidated Fixed Charge Coverage and Consolidated Total Leverage Ratios.  In addition, the Credit Facility has restrictions pertaining to limitations on debt, liens, negative pledges, loans, advances, acquisitions, other investments, dividends, distributions, redemptions, repurchases of equity interests, fundamental changes and asset sales and other dispositions, prepayments, redemptions and purchases of subordinated debt and other junior debt, transactions with affiliates, dividend and payment restrictions affecting subsidiaries, changes in line of business, fiscal year and accounting practices and amendment of organizational documents and junior debt documents. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Consolidated Leverage Ratio is defined as the ratio of Consolidated Total Funded Indebtedness on such date, to Consolidated Adjusted EBITDA, as defined under the Credit Facility Agreement, for the most recently completed four fiscal quarters.  The maximum Consolidated Leverage Ratio is not more than 3.00 to 1.00.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Consolidated Fixed Charge Coverage Ratio is defined as the ratio of: (a) Consolidated Adjusted EBITDA less the sum of (i) capital expenditures, (ii) federal, state, local and foreign income taxes paid in cash and (iii) cash restricted payments made after the closing date, to (b) Consolidated Fixed Charges for the most recently completed four fiscal quarters, calculated on a pro forma basis.  The minimum Consolidated Fixed Charge Coverage Ratio is 2.00 to 1.00. &lt;/span&gt;&lt;/div&gt; We entered into Senior Secured Credit Facilities in January 2022, which terminated our existing Credit Facility (see Note 17: Subsequent Events).</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzIzMA_dde3f2de-7372-4e7d-ac6a-039b2c2dc49c"
      unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LinesOfCreditCurrent
      contextRef="i01a24e6ac0b149afaca642972f237000_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzEwOTk1MTE2MzYwOTg_2b88d309-8618-4b25-adff-043b4cb9af43"
      unitRef="usd">150000000.0</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzY4MA_7dc10177-4b96-4393-8f4a-16317d3f65f1"
      unitRef="usd">150000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzc1Nw_facecaaa-67e1-45d1-b652-f2d807f81fda">2022-11-08</us-gaap:LineOfCreditFacilityExpirationDate1>
    <icui:LineofCreditAccordion
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzkwOQ_89bafa92-9e44-40ef-8419-33d8ce144e5b"
      unitRef="usd">100000000</icui:LineofCreditAccordion>
    <us-gaap:DebtIssuanceCostsLineOfCreditArrangementsGross
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzEwMzU_02dcfc08-d469-49e9-8881-dd94589158af"
      unitRef="usd">1400000</us-gaap:DebtIssuanceCostsLineOfCreditArrangementsGross>
    <us-gaap:LongTermDebt
      contextRef="ic658275ab067426dbbc345457231980a_I20220106"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzEwOTk1MTE2MzYxMDA_e47246c5-a38d-4967-85a9-ddb26beb6e4d"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ia241e4af05fc4638bc449fe9c9c45c66_I20220106"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzEwOTk1MTE2MzYwNjc_f340cb40-ec1f-4854-890d-c51e644c14d0"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i39ca865e5711457ca9a490c54dd29de5_I20220106"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzI3NDg3NzkwNzUwNTY_f6a487b9-05b2-4818-b27d-22c3fa8f3381"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateTerms
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzUwMTg_d9f7404c-283c-493a-acf3-6189f085c30e">In general, borrowing under the Credit Facility (other than Swingline loans) bears interest, at our option, based on the Base Rate plus applicable margin or the London Interbank Offered Rate ("LIBOR") rate plus applicable margin, as defined below:</us-gaap:DebtInstrumentInterestRateTerms>
    <icui:InterestMarginandCommitmentFeeTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90ZXh0cmVnaW9uOjQ1MGE3NjEyOGY2ZTRiM2Y5Y2NkMTg5YjU5ODBhZjdhXzUwMjE_9ea84cf8-db2b-4a2d-b184-859957cfe375">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The applicable interest margins and the commitment fee with respect to the Credit Facility shall be based on the Total Leverage Ratio pursuant to the following pricing grid:&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Total &lt;br/&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Commitment &lt;br/&gt;Fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LIBOR &lt;br/&gt;+&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Base Rate &lt;br/&gt;+&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 1.00 to 1.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than or equal to 1.00 to 1.00 but less than 2.00 to 1.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.20%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than or equal to 2.00 to 1.00 but less than 2.50 to 1.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than or equal to 2.50 to 1.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</icui:InterestMarginandCommitmentFeeTableTextBlock>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i7d9fbc7afe1b4667b19bef534f27f322_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzEtMi0xLTEtODc0NQ_4e22e868-8f80-44b0-8963-e47e9444cee0"
      unitRef="number">0.0015</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:LIBORBasisSpreadonVariableRate
      contextRef="i6ee969a0a9d645a88b99b6c08a883d11_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzEtMy0xLTEtODc0NQ_6b0cdca3-00c6-4585-88ea-ac43712ce0c5"
      unitRef="number">0.0125</icui:LIBORBasisSpreadonVariableRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i7d9fbc7afe1b4667b19bef534f27f322_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzEtNC0xLTEtODc0NQ_ea8412eb-3aeb-47ed-8c15-dccda3769391"
      unitRef="number">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i2b1d712704db4bc9b1287e528b4fed69_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzItMi0xLTEtODc0NQ_ef3a3ba3-750b-4964-bef3-fa4566828150"
      unitRef="number">0.0020</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:LIBORBasisSpreadonVariableRate
      contextRef="id7d6cf9ceff24a8a9996f36321364cbb_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzItMy0xLTEtODc0NQ_31f7d533-b98d-4079-b670-822e5642444a"
      unitRef="number">0.0150</icui:LIBORBasisSpreadonVariableRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2b1d712704db4bc9b1287e528b4fed69_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzItNC0xLTEtODc0NQ_ae1f2cde-a4d3-43d0-8839-138e20de2ff2"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i3bfb75a2163f47d9a268020ba497c76a_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzMtMi0xLTEtODc0NQ_74d9c8cf-be34-4a40-a918-e3395aff806e"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:LIBORBasisSpreadonVariableRate
      contextRef="i7211233eb22e4fb993b5b3ecf7bfb508_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzMtMy0xLTEtODc0NQ_dffd4976-9fbc-4154-8e01-49d8a62e7c79"
      unitRef="number">0.0175</icui:LIBORBasisSpreadonVariableRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i3bfb75a2163f47d9a268020ba497c76a_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzMtNC0xLTEtODc0NQ_eeb0dd8c-30f9-40c6-8a42-78d75fd032d5"
      unitRef="number">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i8bdd6b3003b648508919a57e2a1ae6fc_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzQtMi0xLTEtODc0NQ_390480bc-c944-4dd4-9eac-42a17c9ab096"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:LIBORBasisSpreadonVariableRate
      contextRef="id5a860996ab84b0a8023cd70138248b9_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzQtMy0xLTEtODc0NQ_6dff69f7-b7a8-4124-bed3-d3182231bafa"
      unitRef="number">0.0200</icui:LIBORBasisSpreadonVariableRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i8bdd6b3003b648508919a57e2a1ae6fc_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDAvZnJhZzo0NTBhNzYxMjhmNmU0YjNmOWNjZDE4OWI1OTgwYWY3YS90YWJsZTo1ZWRlMzE0NjFmZTk0ZWQ3OWU0ZGRhNWU4NTVkYThmZC90YWJsZXJhbmdlOjVlZGUzMTQ2MWZlOTRlZDc5ZTRkZGE1ZTg1NWRhOGZkXzQtNC0xLTEtODc0NQ_de283985-3afc-4a95-be4f-efa054780450"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzQxODE_12bd2e35-c785-45e1-a793-3d70e90953fd">INCOME TAXES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income from continuing operations before taxes consisted of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision (benefit) for income taxes consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,720)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,815)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,275)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have accrued for tax contingencies for potential tax assessments, and in 2021 we recognized a $3.0 million net increase, most of which related to various federal, state and foreign tax reserves.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the provision for income taxes at the statutory rate to our effective tax rate is as follows (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Percent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Percent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Percent&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal tax at the expected statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income tax, net of federal effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,896)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Global intangible low-taxed income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign income tax differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,686)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,446)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign-derived intangible income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,775)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IP installment sale and repatriation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 162(m)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax credits in 2021, 2020 and 2019 consist principally of research and developmental tax credits.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain intellectual property and assets were repatriated in 2019 from a liquidation of foreign subsidiaries to the U.S. parent. The tax effect of the repatriation is included as IP installment sale and repatriation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of our deferred income tax assets (liabilities) are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.131%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals/other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired future tax deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chargebacks, discounts, customer concessions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,934)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 481(a) adjustment - change in accounting method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-31.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tax Holidays and Carryforwards&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net operating loss ("NOL") carryforwards consist of: (a) federal NOL carryforwards of $2.5 million which will expire at various dates from 2023 to indefinite carryforward periods, (b) state NOL carryforwards of $8.2 million which will expire at various dates from 2022 to indefinite carryforward periods and (c) foreign NOL carryforwards of $15.0 million which will expire at various dates from 2022 to indefinite carryforward periods. Under Section&#160;382 of the Internal Revenue Code, certain ownership changes limit the utilization of the NOL carryforwards, and the amount of federal NOL carryforwards recorded is the net federal benefit available.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other carryforwards include state research and development (&#x201c;R&amp;amp;D&#x201d;) tax credit carryforwards of $16.9 million, which have an indefinite carryforward period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A substantial portion of our manufacturing operations in Costa Rica operate under various tax holiday and tax incentive programs due to expire in whole or in part in 2027. Certain of the holidays may be extended if specific conditions are met. The net impact of these tax holiday and tax incentives was an increase to our net earnings by $9.8 million or $0.45 per diluted share in 2021 and by $8.0 million or $0.37 per diluted share in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency translation adjustments, and related tax effects, are an element of &#x201c;other comprehensive income&#x201d; and are not included in net income other than the revaluation of the associated deferred tax asset due to the Tax Act.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, we have estimated $98.6 million of undistributed foreign earnings and profits. Such earnings were previously subject to U.S. tax as a result of the Tax Act and much of any future remittances would generally be subject to no U.S. tax as a result of dividends received deductions and/or foreign tax credit relief. We intend to invest substantially all of our foreign subsidiary earnings, as well as our capital in our foreign subsidiaries, indefinitely outside of the U.S. in those jurisdictions in which we incur significant additional costs upon repatriation of such amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to taxation in the U.S. and various states and foreign jurisdictions. Our U.S. federal income tax returns for tax years 2018 and forward are subject to examination by the Internal Revenue Service. Our principal state income tax returns for tax years 2012 and forward are subject to examination by the state tax authorities. The total gross amount of unrecognized tax benefits as of December&#160;31, 2021 was $21.5 million which, if recognized, would impact the effective tax rate.  We believe that adequate provision has been made for any adjustments that may result from tax examinations. However, the outcome of tax examinations cannot be predicted with certainty. As of December 31, 2021, it is not possible to estimate the amount of change, if any, in the unrecognized tax benefits that is reasonably possible within the next twelve months. We recognize accrued interest and penalties related to unrecognized tax benefits as a component of income tax expense. We have not accrued any penalties or interest as of December 31, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our cumulative gross unrecognized tax benefits (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decreases to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease related to lapse of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease related to settlements with tax authorities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c16ae;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c16ae;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c16ae;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzQxOTM_18563d6f-7342-430f-a919-20e8076117d9">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income from continuing operations before taxes consisted of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpjMmIyYjMzNjU5OTc0ZjQ1YWZkNWZmNzY0MzFlYjk5Yi90YWJsZXJhbmdlOmMyYjJiMzM2NTk5NzRmNDVhZmQ1ZmY3NjQzMWViOTliXzItMi0xLTEtODc0NQ_4771cff0-b563-4422-9dec-43e1f813fdef"
      unitRef="usd">81484000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpjMmIyYjMzNjU5OTc0ZjQ1YWZkNWZmNzY0MzFlYjk5Yi90YWJsZXJhbmdlOmMyYjJiMzM2NTk5NzRmNDVhZmQ1ZmY3NjQzMWViOTliXzItNC0xLTEtODc0NQ_70a2ec1f-5da8-421c-9956-667f404fb8e1"
      unitRef="usd">41194000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpjMmIyYjMzNjU5OTc0ZjQ1YWZkNWZmNzY0MzFlYjk5Yi90YWJsZXJhbmdlOmMyYjJiMzM2NTk5NzRmNDVhZmQ1ZmY3NjQzMWViOTliXzItNi0xLTEtODc0NQ_d7bc5974-3452-4e48-a942-a6f02caac1d5"
      unitRef="usd">32849000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpjMmIyYjMzNjU5OTc0ZjQ1YWZkNWZmNzY0MzFlYjk5Yi90YWJsZXJhbmdlOmMyYjJiMzM2NTk5NzRmNDVhZmQ1ZmY3NjQzMWViOTliXzMtMi0xLTEtODc0NQ_2534f9ff-c13f-4d9d-ab2b-40e85f506282"
      unitRef="usd">41702000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpjMmIyYjMzNjU5OTc0ZjQ1YWZkNWZmNzY0MzFlYjk5Yi90YWJsZXJhbmdlOmMyYjJiMzM2NTk5NzRmNDVhZmQ1ZmY3NjQzMWViOTliXzMtNC0xLTEtODc0NQ_4ba42786-80a2-411a-8824-9bb73410f869"
      unitRef="usd">56300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpjMmIyYjMzNjU5OTc0ZjQ1YWZkNWZmNzY0MzFlYjk5Yi90YWJsZXJhbmdlOmMyYjJiMzM2NTk5NzRmNDVhZmQ1ZmY3NjQzMWViOTliXzMtNi0xLTEtODc0NQ_96d81df7-a218-400e-aeda-743eb8820db7"
      unitRef="usd">81858000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpjMmIyYjMzNjU5OTc0ZjQ1YWZkNWZmNzY0MzFlYjk5Yi90YWJsZXJhbmdlOmMyYjJiMzM2NTk5NzRmNDVhZmQ1ZmY3NjQzMWViOTliXzQtMi0xLTEtODc0NQ_1a71dfb1-33fa-481e-9847-f40601a9673d"
      unitRef="usd">123186000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpjMmIyYjMzNjU5OTc0ZjQ1YWZkNWZmNzY0MzFlYjk5Yi90YWJsZXJhbmdlOmMyYjJiMzM2NTk5NzRmNDVhZmQ1ZmY3NjQzMWViOTliXzQtNC0xLTEtODc0NQ_5eb38968-0b37-4490-8443-62a435fac82a"
      unitRef="usd">97494000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpjMmIyYjMzNjU5OTc0ZjQ1YWZkNWZmNzY0MzFlYjk5Yi90YWJsZXJhbmdlOmMyYjJiMzM2NTk5NzRmNDVhZmQ1ZmY3NjQzMWViOTliXzQtNi0xLTEtODc0NQ_04a560a1-08ac-4b59-9471-4f4a697924f7"
      unitRef="usd">114707000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzQxNzQ_1a79eaa9-6987-42c8-bd27-4dfe5a6e4bea">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision (benefit) for income taxes consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,720)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,815)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,275)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzMtMi0xLTEtODc0NQ_8ed9de1b-4a98-4530-884c-ea2c29fd7091"
      unitRef="usd">20646000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzMtNC0xLTEtODc0NQ_f3cd6006-9702-411d-ac2f-e2b841e6bcd1"
      unitRef="usd">6032000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzMtNi0xLTEtODc0NQ_cb712c2f-e3a8-4dae-b318-7d7895ea32e9"
      unitRef="usd">6851000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzQtMi0xLTEtODc0NQ_ce7f4b1a-3fa4-4bed-b5ec-a5ba97059f52"
      unitRef="usd">3444000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzQtNC0xLTEtODc0NQ_bbf3c7d7-6974-4fc7-b7cf-75ec64464f60"
      unitRef="usd">2422000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzQtNi0xLTEtODc0NQ_355371db-a145-4b36-b049-3b88c097ec0e"
      unitRef="usd">2532000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzUtMi0xLTEtODc0NQ_88334d7e-f83b-4b11-835d-6b24e99e6aa8"
      unitRef="usd">7236000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzUtNC0xLTEtODc0NQ_1f1ead00-db50-4384-9b63-0692e5448aab"
      unitRef="usd">7290000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzUtNi0xLTEtODc0NQ_18d8abac-6a8d-484d-bbca-89c66ce43aa4"
      unitRef="usd">7994000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzYtMi0xLTEtODc0NQ_ee0b0af4-00c6-41fd-93cf-2d90d45c468e"
      unitRef="usd">31326000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzYtNC0xLTEtODc0NQ_66417cdd-1d16-4fef-9afa-fee5add8d0aa"
      unitRef="usd">15744000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzYtNi0xLTEtODc0NQ_44432ef6-cc6f-49db-bfeb-5f5e814a022d"
      unitRef="usd">17377000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzgtMi0xLTEtODc0NQ_b462c746-c87b-4f38-af88-cf142705ec3c"
      unitRef="usd">-8154000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzgtNC0xLTEtODc0NQ_f68929da-92f8-4b6f-8d6d-3c024eb3d930"
      unitRef="usd">-5319000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzgtNi0xLTEtODc0NQ_976154cf-973d-4dd9-ac0a-cda233f2051a"
      unitRef="usd">-6720000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzktMi0xLTEtODc0NQ_a86a33c4-9027-4773-aa91-5248af909550"
      unitRef="usd">-1815000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzktNC0xLTEtODc0NQ_c6c92d1a-2b3b-4a7b-aefe-90f34e908562"
      unitRef="usd">-1850000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzktNi0xLTEtODc0NQ_5a16848c-8235-466d-911d-817eb0953d54"
      unitRef="usd">-325000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzEwLTItMS0xLTg3NDU_a2dda1a8-afc7-4167-910f-a3e3a17063df"
      unitRef="usd">-1306000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzEwLTQtMS0xLTg3NDU_7d2d9680-c0d9-4b17-845b-7ba5b8ed55d2"
      unitRef="usd">2049000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzEwLTYtMS0xLTg3NDU_e94e9193-3b23-456e-964b-4785bbc02a19"
      unitRef="usd">3340000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzExLTItMS0xLTg3NDU_7c161c68-7051-4a9a-99a8-6ff7cad3cb9e"
      unitRef="usd">-11275000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzExLTQtMS0xLTg3NDU_cd694d1c-f3a5-4520-930c-1742a1c446e4"
      unitRef="usd">-5120000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzExLTYtMS0xLTg3NDU_afaef56e-fdf5-4365-9459-f2cc37273dce"
      unitRef="usd">-3705000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzEyLTItMS0xLTg3NDU_af42b095-e6e2-4732-aebe-73e9744bb734"
      unitRef="usd">20051000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzEyLTQtMS0xLTg3NDU_e6237a91-d8d0-4b36-a4cf-a460f6e078ef"
      unitRef="usd">10624000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTpmOGM4ZTRhNDNiNmQ0M2FmOTcyODc3NWNmZjVjNDEzNC90YWJsZXJhbmdlOmY4YzhlNGE0M2I2ZDQzYWY5NzI4Nzc1Y2ZmNWM0MTM0XzEyLTYtMS0xLTg3NDU_ee0f954b-8aee-44b2-9787-4d8b02ab0b0d"
      unitRef="usd">13672000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzMwOA_91675bc9-e423-4d8d-98f5-722aa72f5678"
      unitRef="usd">3000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzQxNjU_81b18f6a-6c62-4322-a00d-9aa5426c9412">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the provision for income taxes at the statutory rate to our effective tax rate is as follows (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Percent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Percent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Percent&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal tax at the expected statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income tax, net of federal effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,896)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Global intangible low-taxed income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign income tax differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,686)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,446)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign-derived intangible income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,775)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IP installment sale and repatriation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 162(m)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzMtMi0xLTEtODc0NQ_6b13d40b-0ebd-4594-be72-8a36506fb46c"
      unitRef="usd">25869000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzMtNC0xLTEtODc0NQ_2b1a4c6f-512c-4f34-a2a7-79c8c9bc162b"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzMtNi0xLTEtODc0NQ_68a48be3-75ca-42d9-b7b1-6480214afb14"
      unitRef="usd">20474000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzMtOC0xLTEtODc0NQ_48d482c6-bde5-48ec-9591-d1b5ba3f1148"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzMtMTAtMS0xLTg3NDU_6ed3247d-91fd-4872-b3e7-a007f927ddd6"
      unitRef="usd">24088000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzMtMTItMS0xLTg3NDU_e79943c5-b47b-4a23-ac68-cd93b31c4b21"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzQtMi0xLTEtODc0NQ_78e9a81a-305d-44f3-ac98-588dfa22a1ef"
      unitRef="usd">2907000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzQtNC0xLTEtODc0NQ_8834a0e5-569a-43fe-8074-d5aa4443bb4e"
      unitRef="number">0.024</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzQtNi0xLTEtODc0NQ_8d1b8b60-4ed4-4dc8-9247-bb071befca13"
      unitRef="usd">2099000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzQtOC0xLTEtODc0NQ_42e42437-2618-4d5e-82c1-0f6953860ce2"
      unitRef="number">0.022</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzQtMTAtMS0xLTg3NDU_7590a8ca-e147-410e-b200-71d13f7325d1"
      unitRef="usd">1269000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzQtMTItMS0xLTg3NDU_55fc5614-9c4f-4f96-bd57-10f11c68c1b5"
      unitRef="number">0.011</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationTaxCredits
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzUtMi0xLTEtODc0NQ_1815cdfd-d6bb-4001-99ab-b24152b8bb95"
      unitRef="usd">2443000</us-gaap:IncomeTaxReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzUtNC0xLTEtODc0NQ_2860017f-f52b-40f0-8745-40429ba88eb3"
      unitRef="number">0.020</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:IncomeTaxReconciliationTaxCredits
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzUtNi0xLTEtODc0NQ_ffcc7921-da68-4c8d-903d-e2d38be0ab0b"
      unitRef="usd">3269000</us-gaap:IncomeTaxReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzUtOC0xLTEtODc0NQ_ed59297b-24a3-4fa8-b1cf-be39af50cb34"
      unitRef="number">0.034</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:IncomeTaxReconciliationTaxCredits
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzUtMTAtMS0xLTg3NDU_4647ddda-42e9-4360-9e90-11c08ae39984"
      unitRef="usd">2896000</us-gaap:IncomeTaxReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzUtMTItMS0xLTg3NDU_206c0adf-4809-4d07-8f47-d68e5d63b77e"
      unitRef="number">0.025</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <icui:GILTItaxexpense
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzctMi0xLTEtODc0NQ_fc980aad-4067-4ecb-a961-a819bcb20bf2"
      unitRef="usd">711000</icui:GILTItaxexpense>
    <icui:GILTItaxexpensepercent
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzctNC0xLTEtODc0NQ_716f6275-3bcb-4a54-beb6-329dec456758"
      unitRef="number">0.006</icui:GILTItaxexpensepercent>
    <icui:GILTItaxexpense
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzctNi0xLTEtODc0NQ_21f0cc2c-7ae2-4d5b-9a29-c77dff10a8f7"
      unitRef="usd">163000</icui:GILTItaxexpense>
    <icui:GILTItaxexpensepercent
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzctOC0xLTEtODc0NQ_1248ab3d-f8cd-424d-bd8c-ae47346e0b3f"
      unitRef="number">0.002</icui:GILTItaxexpensepercent>
    <icui:GILTItaxexpense
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzctMTAtMS0xLTg3NDU_9118ca45-9c67-4bdf-bf59-14641cc1a5f8"
      unitRef="usd">6634000</icui:GILTItaxexpense>
    <icui:GILTItaxexpensepercent
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzctMTItMS0xLTg3NDU_b70faabd-2844-4a07-9d02-5960422171cd"
      unitRef="number">0.058</icui:GILTItaxexpensepercent>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzgtMi0xLTEtODc0NQ_0ba83ddd-6131-4c69-aec0-749694b8f629"
      unitRef="usd">-2983000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzgtNC0xLTEtODc0NQ_b2f8f967-2a7d-4072-8fb3-ffee0383fe45"
      unitRef="number">-0.024</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzgtNi0xLTEtODc0NQ_a9c746cc-7050-44fb-b585-f04d04fbeba6"
      unitRef="usd">-3888000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzgtOC0xLTEtODc0NQ_ae651bcd-6100-410b-bb74-c1ed075a797b"
      unitRef="number">-0.040</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzgtMTAtMS0xLTg3NDU_c9bb84d8-e5c6-4b65-8abb-b4d47c4c1ca3"
      unitRef="usd">-5939000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzgtMTItMS0xLTg3NDU_e2c391fe-7e48-4885-89f7-7e3828d1ece3"
      unitRef="number">-0.052</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzktMi0xLTEtODc0NQ_896ee625-ee71-4683-8ade-9b031aebfeed"
      unitRef="usd">-4263000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzktNC0xLTEtODc0NQ_492daa03-0d4c-4be7-aa9c-261d61148b95"
      unitRef="number">-0.035</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzktNi0xLTEtODc0NQ_041d9fde-e3ed-4d1a-bbed-027071b7e753"
      unitRef="usd">-4686000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzktOC0xLTEtODc0NQ_587f87d2-69a3-4b7a-b65e-e83970bb3abd"
      unitRef="number">-0.048</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzktMTAtMS0xLTg3NDU_a543819c-cadd-4a9e-9025-0a140c6e9fcf"
      unitRef="usd">-8446000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzktMTItMS0xLTg3NDU_3ab37661-ad8f-4491-a193-963c0025dbe2"
      unitRef="number">-0.074</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <icui:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEwLTItMS0xLTg3NDU_50f7cef9-0690-4ee7-a7b0-72ebedb3984b"
      unitRef="usd">-3775000</icui:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome>
    <icui:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEwLTQtMS0xLTg3NDU_dbba470f-9815-4798-93a9-3721130d1d47"
      unitRef="number">-0.031</icui:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent>
    <icui:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEwLTYtMS0xLTg3NDU_104a0850-7429-4810-af61-d537aceb686d"
      unitRef="usd">-2718000</icui:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome>
    <icui:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEwLTgtMS0xLTg3NDU_f07de74f-1657-46e9-8824-c49606e41581"
      unitRef="number">-0.028</icui:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent>
    <icui:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEwLTEwLTEtMS04NzQ1_5675c494-87db-47c2-966f-a5b07389b69a"
      unitRef="usd">-516000</icui:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome>
    <icui:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEwLTEyLTEtMS04NzQ1_1c16af71-6f0f-4c44-9714-33b2b495afcf"
      unitRef="number">-0.005</icui:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent>
    <icui:EffectiveIncomeTaxRateReconciliationIPMigration
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzExLTItMS0xLTg3NDU_9a1e2623-d550-464f-9e12-cf6c8fb7cf2e"
      unitRef="usd">0</icui:EffectiveIncomeTaxRateReconciliationIPMigration>
    <icui:EffectiveTaxRateReconciliationIPMigrationPercent
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzExLTQtMS0xLTg3NDU_18cacd4e-57c5-4725-99b6-7d142f1b9ce8"
      unitRef="number">0</icui:EffectiveTaxRateReconciliationIPMigrationPercent>
    <icui:EffectiveIncomeTaxRateReconciliationIPMigration
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzExLTYtMS0xLTg3NDU_bc5fb965-2a51-4836-9287-d0800b4a5754"
      unitRef="usd">0</icui:EffectiveIncomeTaxRateReconciliationIPMigration>
    <icui:EffectiveTaxRateReconciliationIPMigrationPercent
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzExLTgtMS0xLTg3NDU_c00cb337-afe9-4bd6-9a81-247098165ed8"
      unitRef="number">0</icui:EffectiveTaxRateReconciliationIPMigrationPercent>
    <icui:EffectiveIncomeTaxRateReconciliationIPMigration
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzExLTEwLTEtMS04NzQ1_34a24609-64b6-48bb-a99f-26f3dfe55371"
      unitRef="usd">-2118000</icui:EffectiveIncomeTaxRateReconciliationIPMigration>
    <icui:EffectiveTaxRateReconciliationIPMigrationPercent
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzExLTEyLTEtMS04NzQ1_d0000759-bedd-4442-a2d6-35526f8094f5"
      unitRef="number">-0.018</icui:EffectiveTaxRateReconciliationIPMigrationPercent>
    <icui:EffectiveIncomeTaxRateReconciliationContingentConsideration
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEyLTItMS0xLTg3NDU_01585964-fad6-4fbb-9470-d87ca7d40695"
      unitRef="usd">29000</icui:EffectiveIncomeTaxRateReconciliationContingentConsideration>
    <icui:EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEyLTQtMS0xLTg3NDU_8314ff06-223b-4f94-a04c-3eb1ebe45a30"
      unitRef="number">0</icui:EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent>
    <icui:EffectiveIncomeTaxRateReconciliationContingentConsideration
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEyLTYtMS0xLTg3NDU_86959650-45ad-41cb-9ce9-b23148be0426"
      unitRef="usd">-1566000</icui:EffectiveIncomeTaxRateReconciliationContingentConsideration>
    <icui:EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEyLTgtMS0xLTg3NDU_9fd43a79-717e-439e-a69b-63c364859980"
      unitRef="number">0.016</icui:EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent>
    <icui:EffectiveIncomeTaxRateReconciliationContingentConsideration
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEyLTEwLTEtMS04NzQ1_747a6605-41f2-4a3c-93cf-4943ac4e7672"
      unitRef="usd">0</icui:EffectiveIncomeTaxRateReconciliationContingentConsideration>
    <icui:EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEyLTEyLTEtMS04NzQ1_3ed433ce-3785-458a-9b40-79daa0ba1638"
      unitRef="number">0</icui:EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent>
    <icui:Effectiveincometaxreconciliationnondeductiblecompensation
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEzLTItMS0xLTg3NDU_57bab3bf-c306-4599-b8f5-58f2006728d3"
      unitRef="usd">1812000</icui:Effectiveincometaxreconciliationnondeductiblecompensation>
    <icui:Effectivetaxratereconciliationnondeductiblecomppercent
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEzLTQtMS0xLTg3NDU_e2a6ca72-dec0-499a-8a6d-0ff3d0fd3b82"
      unitRef="number">0.015</icui:Effectivetaxratereconciliationnondeductiblecomppercent>
    <icui:Effectiveincometaxreconciliationnondeductiblecompensation
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEzLTYtMS0xLTg3NDU_d4c8d1e1-422c-4c62-8239-99109ea293c2"
      unitRef="usd">1079000</icui:Effectiveincometaxreconciliationnondeductiblecompensation>
    <icui:Effectivetaxratereconciliationnondeductiblecomppercent
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEzLTgtMS0xLTg3NDU_564dd772-3d3d-4443-a0ac-59a920c5e891"
      unitRef="number">0.011</icui:Effectivetaxratereconciliationnondeductiblecomppercent>
    <icui:Effectiveincometaxreconciliationnondeductiblecompensation
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEzLTEwLTEtMS04NzQ1_f7ce07d6-62c5-4d29-a09e-a98e6cafe1e5"
      unitRef="usd">203000</icui:Effectiveincometaxreconciliationnondeductiblecompensation>
    <icui:Effectivetaxratereconciliationnondeductiblecomppercent
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzEzLTEyLTEtMS04NzQ1_b5a03e39-a8bc-4f3b-8d05-9a47c9c4a8ff"
      unitRef="number">0.002</icui:Effectivetaxratereconciliationnondeductiblecomppercent>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE0LTItMS0xLTg3NDU_63fb3e22-34ef-4b62-ac53-3a24149731ba"
      unitRef="usd">2245000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE0LTQtMS0xLTg3NDU_cbcc03c6-35e7-4b2e-82eb-5ac460acbc06"
      unitRef="number">0.018</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE0LTYtMS0xLTg3NDU_9e7083cd-43da-437f-84b3-02171f4703be"
      unitRef="usd">-196000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE0LTgtMS0xLTg3NDU_c62935b4-78d8-4158-a543-aba5eb2a3dd0"
      unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE0LTEwLTEtMS04NzQ1_6d4027b0-0141-4acc-8f61-b7959f3a81cb"
      unitRef="usd">1393000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE0LTEyLTEtMS04NzQ1_9d527ab4-1aa4-4aa8-aeef-46f443c93e98"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE1LTItMS0xLTg3NDU_86c8baa9-ecdf-4114-be96-8e1b2eb7fbd5"
      unitRef="usd">20051000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE1LTQtMS0xLTg3NDU_b01569e0-f8a5-4099-886a-1d170743a143"
      unitRef="number">0.163</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE1LTYtMS0xLTg3NDU_90685b6f-3a5a-438e-a611-be1275679621"
      unitRef="usd">10624000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE1LTgtMS0xLTg3NDU_6205db58-3bb5-448d-9898-386cdcf44dbf"
      unitRef="number">0.109</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE1LTEwLTEtMS04NzQ1_239b7af1-0bdc-41fb-9022-2a2fa9aff0f4"
      unitRef="usd">13672000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZToxNDY5Mzg1NjYyYzc0OTk0OGJkMWVmYWY5YjQ4ZDgxMy90YWJsZXJhbmdlOjE0NjkzODU2NjJjNzQ5OTQ4YmQxZWZhZjliNDhkODEzXzE1LTEyLTEtMS04NzQ1_9a3550ea-3c2c-4704-bec6-fb0cbf597dc0"
      unitRef="number">0.119</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzQyMDc_3a02d5d8-d742-4958-9a2f-be3b8d12719a">&lt;div style="margin-top:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of our deferred income tax assets (liabilities) are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.131%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals/other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired future tax deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chargebacks, discounts, customer concessions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,934)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 481(a) adjustment - change in accounting method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-31.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
      contextRef="i9bbe71fc4ce44374909c77242133cc3c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzUtMi0xLTEtODc0NQ_7bd41e25-393b-4ce4-8f23-354b061058b8"
      unitRef="usd">6866000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
      contextRef="i0e809f26dc1b4522960c604ea2772a74_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzUtNC0xLTEtODc0NQ_b5aea8d2-5bd9-4f0d-bbcf-00700b5b1373"
      unitRef="usd">4406000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <icui:Noncurrentdeferredtaxassetacquiredfuturetaxdeductions
      contextRef="i9bbe71fc4ce44374909c77242133cc3c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzktMi0xLTEtODc0NQ_e732697d-10d1-4c41-8d9e-ce206444d4f0"
      unitRef="usd">5440000</icui:Noncurrentdeferredtaxassetacquiredfuturetaxdeductions>
    <icui:Noncurrentdeferredtaxassetacquiredfuturetaxdeductions
      contextRef="i0e809f26dc1b4522960c604ea2772a74_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzktNC0xLTEtODc0NQ_ad001d0d-749c-4380-8ec4-4bacd1efbc59"
      unitRef="usd">7781000</icui:Noncurrentdeferredtaxassetacquiredfuturetaxdeductions>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i9bbe71fc4ce44374909c77242133cc3c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzEwLTItMS0xLTg3NDU_097231f4-afb1-4764-bf6d-689f00ddb07b"
      unitRef="usd">7283000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i0e809f26dc1b4522960c604ea2772a74_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzEwLTQtMS0xLTg3NDU_6f6cbcb8-f740-46ef-b798-63f44be8b692"
      unitRef="usd">7138000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses
      contextRef="i9bbe71fc4ce44374909c77242133cc3c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzExLTItMS0xLTg3NDU_2faebc92-e995-431f-acbb-6fa9e01cd109"
      unitRef="usd">3360000</us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses>
    <us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses
      contextRef="i0e809f26dc1b4522960c604ea2772a74_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzExLTQtMS0xLTg3NDU_faf081eb-a2db-44e2-822d-6a7fafa07111"
      unitRef="usd">2406000</us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses>
    <icui:NoncurrentDeferredTaxAssetTaxCreditsState
      contextRef="i9bbe71fc4ce44374909c77242133cc3c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzEyLTItMS0xLTg3NDU_a0ecbfc2-4c54-45e3-9bc6-8f2970164910"
      unitRef="usd">11953000</icui:NoncurrentDeferredTaxAssetTaxCreditsState>
    <icui:NoncurrentDeferredTaxAssetTaxCreditsState
      contextRef="i0e809f26dc1b4522960c604ea2772a74_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzEyLTQtMS0xLTg3NDU_29ab9d1e-8d29-4bdd-ba97-0790aa12580c"
      unitRef="usd">12444000</icui:NoncurrentDeferredTaxAssetTaxCreditsState>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i9bbe71fc4ce44374909c77242133cc3c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE0LTItMS0xLTg3NDU_e3f4230b-e2d1-49d8-8951-37a724c8d39d"
      unitRef="usd">8199000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i0e809f26dc1b4522960c604ea2772a74_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE0LTQtMS0xLTg3NDU_505dd009-0287-47a2-b931-5d890ebf0360"
      unitRef="usd">8493000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i9bbe71fc4ce44374909c77242133cc3c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE1LTItMS0xLTg3NDU_e1f7a3b5-4cd1-42fa-aeb6-83d57fff7f47"
      unitRef="usd">926000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i0e809f26dc1b4522960c604ea2772a74_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE1LTQtMS0xLTg3NDU_fc1e9344-7740-42ca-916e-82a49aab8f34"
      unitRef="usd">4460000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <icui:Noncurrentdeferredtaxassetaccruedrestructuring
      contextRef="i9bbe71fc4ce44374909c77242133cc3c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE2LTItMS0xLTg3NDU_da732b9a-4294-4051-9837-3b4c9377d989"
      unitRef="usd">131000</icui:Noncurrentdeferredtaxassetaccruedrestructuring>
    <icui:Noncurrentdeferredtaxassetaccruedrestructuring
      contextRef="i0e809f26dc1b4522960c604ea2772a74_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE2LTQtMS0xLTg3NDU_1fc20443-212e-4bb7-95d8-5175bd51e61a"
      unitRef="usd">1293000</icui:Noncurrentdeferredtaxassetaccruedrestructuring>
    <icui:Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions
      contextRef="i9bbe71fc4ce44374909c77242133cc3c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE3LTItMS0xLTg3NDU_be881679-fc06-4270-aa56-5071d82f2a3e"
      unitRef="usd">27970000</icui:Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions>
    <icui:Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions
      contextRef="i0e809f26dc1b4522960c604ea2772a74_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE3LTQtMS0xLTg3NDU_526f4e67-1622-43f0-8e1a-3973342242a6"
      unitRef="usd">22874000</icui:Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i9bbe71fc4ce44374909c77242133cc3c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE4LTItMS0xLTg3NDU_ad6eb11f-f6e6-42d9-8267-2e931b84ca63"
      unitRef="usd">2934000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i0e809f26dc1b4522960c604ea2772a74_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE4LTQtMS0xLTg3NDU_938a14ee-11c0-4c65-9ac9-c48cbb67a849"
      unitRef="usd">3891000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <icui:Noncurrentdeferredtaxasset
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE5LTItMS0xLTg3NDU_cfb576f7-b97d-4e58-856c-cbbee0d57423"
      unitRef="usd">69194000</icui:Noncurrentdeferredtaxasset>
    <icui:Noncurrentdeferredtaxasset
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzE5LTQtMS0xLTg3NDU_8fcccd78-9d5b-4696-bc40-1fff522b63c3"
      unitRef="usd">67404000</icui:Noncurrentdeferredtaxasset>
    <icui:NoncurrentDeferredTaxLiabilityStateIncomeTaxes
      contextRef="i3378e7cbe8924f58b0946d1751a4a296_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzIxLTItMS0xLTg3NDU_7ff6605b-4f58-4e87-9084-0658ece4ce02"
      unitRef="usd">2724000</icui:NoncurrentDeferredTaxLiabilityStateIncomeTaxes>
    <icui:NoncurrentDeferredTaxLiabilityStateIncomeTaxes
      contextRef="i6f1986d9725d4d0baf2ce688675446f5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzIxLTQtMS0xLTg3NDU_ab1fc8a2-bcd0-4b8b-845f-b11861a83235"
      unitRef="usd">2398000</icui:NoncurrentDeferredTaxLiabilityStateIncomeTaxes>
    <icui:NoncurrentDeferredTaxLiabilityForeign
      contextRef="i3378e7cbe8924f58b0946d1751a4a296_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzIyLTItMS0xLTg3NDU_95cbda3e-2467-4ad1-86a8-870d18393bfc"
      unitRef="usd">0</icui:NoncurrentDeferredTaxLiabilityForeign>
    <icui:NoncurrentDeferredTaxLiabilityForeign
      contextRef="i6f1986d9725d4d0baf2ce688675446f5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzIyLTQtMS0xLTg3NDU_18452de3-1d07-48f7-9da6-4b61b6b4af6e"
      unitRef="usd">776000</icui:NoncurrentDeferredTaxLiabilityForeign>
    <icui:NoncurrentDeferredTaxLiabilityDepreciationAndAmortization
      contextRef="i3378e7cbe8924f58b0946d1751a4a296_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzI0LTItMS0xLTg3NDU_364e2b26-093e-47b8-a535-362e183bb481"
      unitRef="usd">20483000</icui:NoncurrentDeferredTaxLiabilityDepreciationAndAmortization>
    <icui:NoncurrentDeferredTaxLiabilityDepreciationAndAmortization
      contextRef="i6f1986d9725d4d0baf2ce688675446f5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzI0LTQtMS0xLTg3NDU_1cb62b57-93a3-4d48-9926-b970eafa25b9"
      unitRef="usd">25113000</icui:NoncurrentDeferredTaxLiabilityDepreciationAndAmortization>
    <icui:Deferredtaxliabilitychangeinaccountingmethod
      contextRef="i3f5e02d0a1f949ef98ced46fdc0d1d50_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzI1LTItMS0xLTg3NDU_99aef881-729a-42d5-b536-23df52a40d88"
      unitRef="usd">4873000</icui:Deferredtaxliabilitychangeinaccountingmethod>
    <icui:Deferredtaxliabilitychangeinaccountingmethod
      contextRef="ie7a407c6102b4d9782e78a7113bb6c88_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzI1LTQtMS0xLTg3NDU_72e62832-d9a3-42d0-bcb7-e122e2dd3898"
      unitRef="usd">9746000</icui:Deferredtaxliabilitychangeinaccountingmethod>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i3378e7cbe8924f58b0946d1751a4a296_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzI5LTItMS0xLTg3NDU_a1a9944d-bcfa-48aa-8b85-bc41d4b1bc71"
      unitRef="usd">28080000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i6f1986d9725d4d0baf2ce688675446f5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzI5LTQtMS0xLTg3NDU_92e30b94-c4e2-4f18-abc1-1286f1a822c7"
      unitRef="usd">38033000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzMxLTItMS0xLTg3NDU_438fd2be-66b4-4eee-b90b-697f701a00a1"
      unitRef="usd">41114000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo1YTA4ZjI1OWJjNTA0MWY5YjZmYjU4ZGExN2I3YjcxNS90YWJsZXJhbmdlOjVhMDhmMjU5YmM1MDQxZjliNmZiNThkYTE3YjdiNzE1XzMxLTQtMS0xLTg3NDU_dab4cebd-2cf5-4e0e-9bb9-3f7553d6fb72"
      unitRef="usd">29371000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:OperatingLossCarryforwards
      contextRef="if9b8ee97cdce469498415c24ca271fac_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzEwNzY_a858019d-310e-49ff-8960-27bfaa74472d"
      unitRef="usd">2500000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i01e4254c272a4140957a890acc5f08ce_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzExOTE_fb4e0e0e-a7fe-46ae-8818-196a020263c0"
      unitRef="usd">8200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ia52cc31c151d481581d13119d97ac269_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzEzMTE_7e631e8e-5fad-4201-b42b-ef5f46cd9eca"
      unitRef="usd">15000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzE3MDY_f3974699-0c45-4375-a7c5-731f99b5b3bc"
      unitRef="usd">16900000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:IncomeTaxHolidayAggregateDollarAmount
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzIwOTY_5a82f3b3-5fbf-4bac-9a9c-a6fd51a0d78f"
      unitRef="usd">9800000</us-gaap:IncomeTaxHolidayAggregateDollarAmount>
    <us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzIxMDI_11345b2d-6420-4944-b7c9-d10e550dcc13"
      unitRef="usdPerShare">0.45</us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare>
    <us-gaap:IncomeTaxHolidayAggregateDollarAmount
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzIxMzg_98e22a5f-94c1-424f-b1e3-9a7a90440e46"
      unitRef="usd">8000000</us-gaap:IncomeTaxHolidayAggregateDollarAmount>
    <us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzIxNDQ_bbe0ebb3-ede8-4896-b0c4-e94cc40cb4d9"
      unitRef="usdPerShare">0.37</us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare>
    <us-gaap:UndistributedEarningsOfForeignSubsidiaries
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzI0NTQ_15d27cfc-14b0-4011-a72a-48da6ca35f95"
      unitRef="usd">98600000</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzM0MjQ_e3fd3db3-1eec-4516-b772-40a661db8a9a"
      unitRef="usd">21500000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90ZXh0cmVnaW9uOjczNGM2NzE2Yjk2MDQzODNiNWFjZjkwZGQ5NTRlYjI3XzQxOTY_06102cd2-bf6a-4737-8701-8dccef2046c3">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our cumulative gross unrecognized tax benefits (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decreases to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease related to lapse of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease related to settlements with tax authorities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c16ae;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c16ae;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c16ae;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzItMi0xLTEtODc0NQ_dac4f8d8-96c2-4024-a94e-e40c388ebce9"
      unitRef="usd">18443000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzItNC0xLTEtODc0NQ_f7f23c8d-224d-402c-be84-0d09c3dcc691"
      unitRef="usd">15027000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic2b82bbcf5cb45739937a1040ed30f6b_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzItNi0xLTEtODc0NQ_dc9c2fcb-db23-46a7-be94-bf0f772b50d1"
      unitRef="usd">10824000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzMtMi0xLTEtODc0NQ_dec7d3e0-345d-4bf4-806a-6309d494674c"
      unitRef="usd">231000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzMtNC0xLTEtODc0NQ_98b0801f-1060-47a8-bda4-492de22f9f41"
      unitRef="usd">502000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzMtNi0xLTEtODc0NQ_ca5931d2-0be7-45b1-af0c-d94d10f0791d"
      unitRef="usd">138000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzUtMi0xLTEtODc0NQ_13f1cc9d-8fcf-413f-b180-7598463b7ab5"
      unitRef="usd">3242000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzUtNC0xLTEtODc0NQ_9a21ba16-ba02-47cb-8e11-d71ac6c98142"
      unitRef="usd">2987000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzUtNi0xLTEtODc0NQ_640943b1-5829-49e5-bd30-afadb95fcd78"
      unitRef="usd">4231000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzctMi0xLTEtODc0NQ_4dd87a1b-16f6-41d7-ac45-a3f07dbe642f"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzctNC0xLTEtODc0NQ_c0688b1e-4cf0-49aa-a8ee-a9f2f77115d8"
      unitRef="usd">15000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzctNi0xLTEtODc0NQ_e605820c-e21f-4c8f-8f6f-5cf452d541e9"
      unitRef="usd">3000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzktMi0xLTEtODc0NQ_6c149858-67c5-40fe-ad98-5f83037155f3"
      unitRef="usd">31000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzktNC0xLTEtODc0NQ_f148e662-3fd0-4f51-b0e9-fce82f11eb30"
      unitRef="usd">58000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzktNi0xLTEtODc0NQ_34909606-a20d-4233-a12b-c004942e9b9c"
      unitRef="usd">163000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzEwLTItMS0xLTY3NjEy_7a749f8d-40b2-4f11-b106-ba2fe60e88f7"
      unitRef="usd">348000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzEwLTQtMS0xLTY3NjE5_91fb2266-5dd8-414d-918a-ad05d7f50260"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzEwLTYtMS0xLTY3NjI2_f5223f96-2158-47a3-85c6-3d2ba70a1d60"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzEwLTItMS0xLTg3NDU_49f7b9aa-4806-4a1f-87ac-5bc1ff267fce"
      unitRef="usd">21537000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzEwLTQtMS0xLTg3NDU_9179e950-5f4d-4c7a-87c8-a13a075b341f"
      unitRef="usd">18443000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDMvZnJhZzo3MzRjNjcxNmI5NjA0MzgzYjVhY2Y5MGRkOTU0ZWIyNy90YWJsZTo2OGNmNGY3Y2JiMmY0NGJkYTQ1ODUxNjk3YzI2YTdiOC90YWJsZXJhbmdlOjY4Y2Y0ZjdjYmIyZjQ0YmRhNDU4NTE2OTdjMjZhN2I4XzEwLTYtMS0xLTg3NDU_c8e14c66-f492-425e-8eee-ee9d83183ecf"
      unitRef="usd">15027000</us-gaap:UnrecognizedTaxBenefits>
    <icui:InformationbyGeographicAreaandCustomerConcentrationTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90ZXh0cmVnaW9uOjdhY2I1MzE0YzQ5YTQxOWRhYzU3NTU4MzU0NGEyODc2XzYwNg_6b5262dd-1f7f-489b-a459-1e74c0aee5d2">GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Significant Customers&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sell products worldwide, on credit terms on an unsecured basis, as an OEM supplier, to independent medical supply distributors and directly to the end customer. The manufacturers and distributors, in turn, sell our products to healthcare providers. We do not currently derive a significant portion of our revenues from any one customer.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Geographic Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents our gross long-lived assets, consisting of property, plant and equipment, by country or region (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.131%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costa Rica&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other LATAM&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Italy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Foreign &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Worldwide Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</icui:InformationbyGeographicAreaandCustomerConcentrationTextBlock>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90ZXh0cmVnaW9uOjdhY2I1MzE0YzQ5YTQxOWRhYzU3NTU4MzU0NGEyODc2XzYwMA_0cbd30e7-3338-42bf-9b58-0b1d298174d7">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents our gross long-lived assets, consisting of property, plant and equipment, by country or region (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.131%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costa Rica&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other LATAM&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Italy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Foreign &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Worldwide Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:NoncurrentAssets
      contextRef="ifef2db95b0fe4155898c6b50b40a55f6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzItMi0xLTEtODc0NQ_451815a3-c87e-448f-9ce9-30033ef7d08e"
      unitRef="usd">115187000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ide8f1f0b08d646aa86685a2ef40bd3b2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzItNC0xLTEtODc0NQ_8798f425-41f6-4c92-8a57-006862a50b7d"
      unitRef="usd">104015000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ie1f2b53b42ec4dd496263af4d74f1006_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzMtMi0xLTEtODc0NQ_a8173345-a282-4d7d-87dc-178960506dde"
      unitRef="usd">79567000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i469eea898b364fc3adb69caed769582e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzMtNC0xLTEtODc0NQ_63a4f3a4-f77f-40da-9c48-8fda03b5f7a6"
      unitRef="usd">76004000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i2e940da7d7cb495fa0d13df19d4106c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzQtMi0xLTEtODc0NQ_e8f7a779-e754-4fef-bfd0-e2a59b8fdf33"
      unitRef="usd">36907000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i598572737bef40c49c83df77162958d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzQtNC0xLTEtODc0NQ_a06ad6ad-b3e7-4e25-a663-366b543b486e"
      unitRef="usd">37485000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i342c737b0a1648d6ba7796d841c38920_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzUtMi0xLTEtODc0NQ_950672eb-15e0-4885-80a5-d6dc46b98026"
      unitRef="usd">4716000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i87f6347567e542658b4828a26d58c87f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzUtNC0xLTEtODc0NQ_bceed620-d186-4454-a352-748e9743501a"
      unitRef="usd">4672000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i7f99fb6f9174410c9b82675718bfbea9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzYtMi0xLTEtODc0NQ_141cc189-b607-4cf8-a5ef-27984ce5ff05"
      unitRef="usd">12435000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i49906b818a8e4420af6213c3e7c5009b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzYtNC0xLTEtODc0NQ_b63c6a25-3e31-4dd6-bda5-3adf8adaa884"
      unitRef="usd">11098000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ia092500ef9e34307ae74beb9776f0c1c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzEwLTItMS0xLTg3NDU_925a64ad-a455-420b-a42e-094e523e1ad4"
      unitRef="usd">13295000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i5c52e251690c4d43bfe606ddbb907b05_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzEwLTQtMS0xLTg3NDU_79638230-a653-4e66-8001-b3f67d2eafd3"
      unitRef="usd">8701000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i69deda722fca436a895908b95f39e170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzExLTItMS0xLTg3NDU_45b65bb0-1e75-453e-9bc9-014517e73a3f"
      unitRef="usd">4171000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i0af277c5a24e49468f57a06b083d2822_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzExLTQtMS0xLTg3NDU_016f5eb3-3a7e-4e5c-9fb1-d510398569be"
      unitRef="usd">3795000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i95f6b83243a54af7b0115785403ce5b4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzEyLTItMS0xLTg3NDU_a39f2408-8566-4ca9-a303-42df82f5d9b1"
      unitRef="usd">20452000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i5384480be0b946b0b4bd8da2f47aee38_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzEyLTQtMS0xLTg3NDU_dfed95f8-9405-4a9a-a2fa-29b03a5207b1"
      unitRef="usd">19836000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i84bcb872e0ac41e9a0c750276b31fe07_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzEzLTItMS0xLTg3NDU_73883340-00ae-4267-b870-78e1a3b61eab"
      unitRef="usd">286730000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ide1aa2e08f8e459ab222c3218dbdd087_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzEzLTQtMS0xLTg3NDU_10ae6c7a-3c37-44ab-aa0a-d1a62e812f4c"
      unitRef="usd">265606000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i76e08a5b358b42e5b6adbc18bbf17124_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzE0LTItMS0xLTg3NDU_1775b0ee-f203-4cfd-be10-63db22c5ce5d"
      unitRef="usd">618374000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i6bcbed561d384cd2aa2a8565325c8308_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzE0LTQtMS0xLTg3NDU_126770e7-b40d-40f1-9a18-356ddb0aa165"
      unitRef="usd">577490000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzE1LTItMS0xLTg3NDU_38f6ffac-726b-411c-884d-5a010dc971aa"
      unitRef="usd">905104000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDYvZnJhZzo3YWNiNTMxNGM0OWE0MTlkYWM1NzU1ODM1NDRhMjg3Ni90YWJsZTpkNjA1OGY3N2FjMDk0ODlkOTgxOTFhOGRhMmMxOTY0Mi90YWJsZXJhbmdlOmQ2MDU4Zjc3YWMwOTQ4OWQ5ODE5MWE4ZGEyYzE5NjQyXzE1LTQtMS0xLTg3NDU_2477e080-ac4c-43f9-91f9-14d1688e0ca3"
      unitRef="usd">843096000</us-gaap:NoncurrentAssets>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0XzE1MTk_5c20f30b-ce8b-4a96-a9bb-c0e4c6096c02">STOCKHOLDERS' EQUITY&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Treasury Stock&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August&#160;2019, our Board of Directors approved a common stock purchase plan to purchase up to $100.0 million of our common stock. This plan has no expiration date. We have $100.0 million remaining on this purchase plan. We did not purchase any of our common stock under our common stock purchase plan in 2021, 2020 or 2019. We are limited on share purchases in accordance with the terms and conditions of our Credit Facility (see Note 11: Long-Term Obligations).&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2021, we withheld 40,350 shares of our common stock from employee vested restricted stock units in consideration for $8.3 million in payments for the employees' share award income tax withholding obligations. We had 119 shares remaining in treasury at December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, we withheld 67,041 shares of our common stock from employee vested restricted stock units in consideration for $12.9 million in payments for the employees' share award income tax withholding obligations. We had 209 shares remaining in treasury at December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, we withheld 80,186 shares of our common stock from employee vested restricted stock units in consideration for $18.6 million in payments for the employees' share award income tax withholding obligations. We had 850 shares remaining in treasury at December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use treasury stock to issue shares for stock option exercises and restricted stock grants.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive (Loss) Income ("AOCI")&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of AOCI, net of tax, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,682)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,945)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,664)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,664)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0XzE0OA_d3088025-d0ff-46ed-9ed9-a22951a57dc2"
      unitRef="usd">100000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0XzIxNA_75ae42ae-c004-4aae-b94b-dd74c17545a0"
      unitRef="usd">100000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0XzUyOA_84d5bda5-b1cb-4b0b-be5b-e60347fb8625"
      unitRef="shares">40350</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0XzYyMw_7240e4b7-03e1-4460-a655-64b2202f009f"
      unitRef="usd">8300000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockCommonShares
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0XzE1MjQ_c61f09e4-c8a6-4ad3-8bbd-db78f78a1eb8"
      unitRef="shares">119</us-gaap:TreasuryStockCommonShares>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0Xzc4OQ_5ab98c8d-5b26-4094-9013-38b45feee425"
      unitRef="shares">67041</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0Xzg4NA_7c987d6d-c3ab-4fab-844d-ef9865297f1c"
      unitRef="usd">12900000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0Xzk3NA_d9aebdab-9a6b-4857-80bb-dfa16b77e5ea"
      unitRef="shares">209</us-gaap:TreasuryStockCommonShares>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0XzEwNTA_64dbe780-86b5-4282-af76-5cbb5bd45ab9"
      unitRef="shares">80186</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0XzExNDU_eb7f642e-372f-4c92-a94d-6ee0c4722e53"
      unitRef="usd">18600000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0XzEyMzQ_c11a52c1-1085-4d6d-8a41-f8691171ff6f"
      unitRef="shares">850</us-gaap:TreasuryStockCommonShares>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90ZXh0cmVnaW9uOjc1MDAxNTUxMzM0NjQ4MTE4YzU2MzVmYTRjZWQzZWQ0XzE1MTY_a8fecf79-4081-4eb6-b946-bd0f13571c2b">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of AOCI, net of tax, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,682)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,945)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,664)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,664)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iacf190989aae41dc9261dadb464d18de_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEtMi0xLTEtODc0NQ_5d9c6cca-1fbc-4301-a9b5-de8478cecb44"
      unitRef="usd">-17682000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ica0fe141910f4870ad2649c6e2c3aaab_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEtNC0xLTEtODc0NQ_ff43df70-b986-4084-acc9-d36c3aba0f36"
      unitRef="usd">638000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i294f1ac4a2cc4a3fac63275cef02abee_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEtNi0xLTEtODc0NQ_9555e995-0147-464d-8fef-bac3fa88eee7"
      unitRef="usd">99000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic2b82bbcf5cb45739937a1040ed30f6b_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEtOC0xLTEtODc0NQ_a68099b7-bffa-4449-980c-730b1dd8686e"
      unitRef="usd">-16945000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i056e77d665474f4b8ca05d305c52c5db_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzItMi0xLTEtODc0NQ_18a7c4f5-ffc7-4164-9f62-081a9192dc94"
      unitRef="usd">372000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i120cd5defe214e6c86186272a3b74955_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzItNC0xLTEtODc0NQ_67136bf6-bd2d-40e8-823a-ea842539818f"
      unitRef="usd">1938000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic9263e86b21d4e6990c6889c0a2fd058_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzItNi0xLTEtODc0NQ_80be2a29-ffb5-490f-96c4-b7b6c1de2980"
      unitRef="usd">-71000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzItOC0xLTEtODc0NQ_b946a809-f3a4-4703-a25b-32bce32c6178"
      unitRef="usd">2239000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i056e77d665474f4b8ca05d305c52c5db_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzMtMi0xLTEtODc0NQ_40943115-d0e5-4932-a955-ceb9b9152e18"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i120cd5defe214e6c86186272a3b74955_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzMtNC0xLTEtODc0NQ_b5ebd7b1-6048-45b1-95b4-e4883c98bb67"
      unitRef="usd">-696000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic9263e86b21d4e6990c6889c0a2fd058_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzMtNi0xLTEtODc0NQ_59eda68e-24e3-419d-9092-b480e3b36ae3"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzMtOC0xLTEtODc0NQ_684cb740-3220-48f4-a064-fbd80a25db67"
      unitRef="usd">-696000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i056e77d665474f4b8ca05d305c52c5db_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzQtMi0xLTEtODc0NQ_6bc3e15f-532f-4dc9-b2e7-cbfbb0091586"
      unitRef="usd">372000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i120cd5defe214e6c86186272a3b74955_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzQtNC0xLTEtODc0NQ_00bb20c0-7933-40e5-91c4-869550860ce8"
      unitRef="usd">1242000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic9263e86b21d4e6990c6889c0a2fd058_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzQtNi0xLTEtODc0NQ_8f1163ab-0c77-4fe7-8ed1-fb06367121b5"
      unitRef="usd">-71000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzQtOC0xLTEtODc0NQ_db5e7191-5a95-4b7f-a574-8c5384fe13d1"
      unitRef="usd">1543000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i8cc638a528464d0f81f7797bbcdbbbdd_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzUtMi0xLTEtODc0NQ_7df4e480-e706-40e8-88c8-ce5471f5853b"
      unitRef="usd">-17310000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9e04a8561492427c808a2ab01e617e39_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzUtNC0xLTEtODc0NQ_04c15b5d-3b03-4712-a6b3-4f18a80533d0"
      unitRef="usd">1880000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie681a10b3ae94591ac7dfed446027fb8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzUtNi0xLTEtODc0NQ_ac047456-a4d2-4105-af2d-68c9baa8e019"
      unitRef="usd">28000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzUtOC0xLTEtODc0NQ_d4e7b0c1-626a-4029-8c46-6a63b9c04049"
      unitRef="usd">-15402000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8eecf95d67de49c6b71ed63b59bd24ad_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzYtMi0xLTEtODc0NQ_3b74d520-a667-4a65-b583-2ba75b08ad70"
      unitRef="usd">12929000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i0781799e0fe043e198c4b49c6f20f38d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzYtNC0xLTEtODc0NQ_814358a3-0e06-4b63-b912-eb965362864a"
      unitRef="usd">1505000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i93f94790b59e412589fd19a9227e911d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzYtNi0xLTEtODc0NQ_b9010282-ce70-4851-909b-fca26037bacc"
      unitRef="usd">47000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzYtOC0xLTEtODc0NQ_69534f41-7eaa-415e-abea-2203c7f4066a"
      unitRef="usd">14481000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8eecf95d67de49c6b71ed63b59bd24ad_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzctMi0xLTEtODc0NQ_4dd4203f-6d88-4b5a-b74f-03029cc727b0"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0781799e0fe043e198c4b49c6f20f38d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzctNC0xLTEtODc0NQ_3edb662b-f8ed-453c-b8f9-643ea65e3531"
      unitRef="usd">-601000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i93f94790b59e412589fd19a9227e911d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzctNi0xLTEtODc0NQ_12e53d41-39a0-495e-83c9-e7e05e3b7876"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzctOC0xLTEtODc0NQ_3feed551-a250-4543-988d-5380add721f7"
      unitRef="usd">-601000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8eecf95d67de49c6b71ed63b59bd24ad_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzgtMi0xLTEtODc0NQ_0f8e3d1e-dbd5-4e8d-a126-114dc4348c64"
      unitRef="usd">12929000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0781799e0fe043e198c4b49c6f20f38d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzgtNC0xLTEtODc0NQ_1f8c1f1b-06fd-4a17-a29d-7d58de9755b4"
      unitRef="usd">904000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i93f94790b59e412589fd19a9227e911d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzgtNi0xLTEtODc0NQ_d3586411-e6a0-400f-b6e9-c05b57aa574c"
      unitRef="usd">47000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzgtOC0xLTEtODc0NQ_56425810-eec5-445e-9bb1-11b97aafd6ed"
      unitRef="usd">13880000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ida1ac0b3c24f469f9c5c81ce2c02be68_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzktMi0xLTEtODc0NQ_4152a8c9-b540-41de-81b7-b1d0a0faabee"
      unitRef="usd">-4381000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iea23642417df4dbfadbd0379840568e7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzktNC0xLTEtODc0NQ_ec1dc8a6-07d7-4bef-946a-db52f3033e51"
      unitRef="usd">2784000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i99fa1bc9d43d4f38b2df61bedf27dda6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzktNi0xLTEtODc0NQ_ce46aaed-b08f-4d10-b121-1bde0e9ae241"
      unitRef="usd">75000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzktOC0xLTEtODc0NQ_5b84fc90-ece8-4427-8294-bdb89c193bd8"
      unitRef="usd">-1522000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i584e4e98f720480b9d2272ffc9f61fad_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEwLTItMS0xLTg3NDU_dc71e4e7-7782-40b6-a282-2717c58549c4"
      unitRef="usd">-14664000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id83a5ec19c054e738002317e4071cb7c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEwLTQtMS0xLTg3NDU_4d0c7454-b121-400a-bdc8-2c7166eda97c"
      unitRef="usd">-403000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6ecb60225e2140c6841d03b54d853f07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEwLTYtMS0xLTg3NDU_33e5d188-a44b-4fd6-8b29-22f98d9327a7"
      unitRef="usd">-62000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEwLTgtMS0xLTg3NDU_f98fda9b-ec34-48cd-9c7a-003ac263db47"
      unitRef="usd">-15129000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i584e4e98f720480b9d2272ffc9f61fad_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzExLTItMS0xLTg3NDU_28dd2a2c-49c1-49de-95b2-5e0434fd2470"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id83a5ec19c054e738002317e4071cb7c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzExLTQtMS0xLTg3NDU_7e807a33-efe8-4bef-ba60-1cc86d7d4970"
      unitRef="usd">-2618000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6ecb60225e2140c6841d03b54d853f07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzExLTYtMS0xLTg3NDU_1d57acda-b637-4532-8c63-d3bd939f941b"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzExLTgtMS0xLTg3NDU_11630af3-6d1e-4121-90bf-571dd0de5fc4"
      unitRef="usd">-2618000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i584e4e98f720480b9d2272ffc9f61fad_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEyLTItMS0xLTg3NDU_48d139d5-4ba1-4c26-9ed9-a2707c98ed18"
      unitRef="usd">-14664000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id83a5ec19c054e738002317e4071cb7c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEyLTQtMS0xLTg3NDU_5ebe9935-e2fd-4a01-bc2a-0e2b1a2b442b"
      unitRef="usd">-3021000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6ecb60225e2140c6841d03b54d853f07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEyLTYtMS0xLTg3NDU_f8e711ff-17e8-40e2-858d-6b839cff2070"
      unitRef="usd">-62000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEyLTgtMS0xLTg3NDU_673019f0-9c10-460d-b69f-0931355460b9"
      unitRef="usd">-17747000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ief758a58c87848b8a344c5b692208a0f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEzLTItMS0xLTg3NDU_8b69f861-1cbf-4382-86fa-336824c5e7cb"
      unitRef="usd">-19045000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i3f7b24069c454353805dd5bcf4122778_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEzLTQtMS0xLTg3NDU_b8a8b141-1202-4cc0-a81d-90861409754c"
      unitRef="usd">-237000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id093068459e64f16a5340be5d8b2912d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEzLTYtMS0xLTg3NDU_da100dd4-e4f2-471b-9298-895c5c61b34a"
      unitRef="usd">13000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMDkvZnJhZzo3NTAwMTU1MTMzNDY0ODExOGM1NjM1ZmE0Y2VkM2VkNC90YWJsZTo0MDM0Njk1ZWE4NDI0YjRkYTNlZDI4OGE1MWE0NTM0MS90YWJsZXJhbmdlOjQwMzQ2OTVlYTg0MjRiNGRhM2VkMjg4YTUxYTQ1MzQxXzEzLTgtMS0xLTg3NDU_997e5801-5605-407c-bdd8-215313fd57f0"
      unitRef="usd">-19269000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzE5NDI_a2e445bc-b63d-44a0-b6d0-d4a584964935">COMMITMENTS AND CONTINGENCIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we are involved in various legal proceedings, most of which are routine litigation, in the normal course of business.&#160; Our management does not believe that the resolution of the unsettled legal proceedings that we are involved with will have a material adverse impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Off Balance Sheet Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, we have agreed to indemnify our officers and directors to the maximum extent permitted under Delaware law and to indemnify customers as to certain intellectual property matters related to sales of our products.&#160;There is no maximum limit on the indemnification that may be required under these agreements.&#160;We have never incurred, nor do we expect to incur, any liability for indemnification.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2017, we recognized an earn-out liability in connection with our acquisition of HIS from Pfizer. Pfizer was entitled to receive between $191.3&#160;million and $225.0 million in additional cash consideration based on the achievement of certain performance targets for the combined company for the three years ending December 31, 2019. As of December 31, 2019, we determined we did not meet the necessary performance targets that would require payout of any of the HIS earn-out liability. Pfizer disputed our determination that the performance targets requiring payout of the HIS earn-out liability were not met, therefore the dispute entered into binding arbitration. In August 2021, the arbitrator concluded that the necessary performance targets that would require payout of the HIS earn-out were not met, and as a result Pfizer is not entitled to any payments in connection with the HIS earn-out liability. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During November 2019, we acquired Pursuit (see Note 2: Acquisitions). Total consideration for the acquisition included a potential contractual earn-out of up to $50.0 million to be paid to former Pursuit equity holders, calculated based upon the achievement of certain performance targets during the earn-out period. As of June 30, 2021, the earn-out measurement period had ended and based on the actual sales and gross profit achieved during the measurement period we calculated the actual earn-out to be $26.3&#160;million. In October 2021, the $26.3&#160;million earn-out was finalized and paid to the former Pursuit equity holders (see Note 8: Fair Value Measurements).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out shall not exceed $6.0&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of December 31, 2021, the fair value of the contingent earn-out was estimated at $2.6&#160;million (see Note 8: Fair Value Measurements).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. The initial estimated fair value of the contingent consideration related to this acquisition is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commitments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have non-cancelable operating lease agreements where we are contractually obligated to pay certain lease payment amounts (see Note 5: Leases).&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <icui:Contingentconsiderationgross
      contextRef="i7c08f27a7f1249ebb9616a92cf37d858_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzEwOTk1MTE2MzUxODQ_77415147-7a33-435f-955b-2ec3f87535c5"
      unitRef="usd">191300000</icui:Contingentconsiderationgross>
    <icui:Contingentconsiderationgross
      contextRef="i11985c61f5dd4877b3fb40210f033aa6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzMyOTg1MzQ4ODgxNDc_e8ce2a7a-921c-4d7c-9679-f671945c3982"
      unitRef="usd">225000000</icui:Contingentconsiderationgross>
    <icui:Contingentconsiderationgross
      contextRef="i9eced5028f684ec0ac18244892f3f859_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzE4Mzg_1965395e-2241-4cb9-a48a-3db4e9cda0cc"
      unitRef="usd">50000000</icui:Contingentconsiderationgross>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i8a64787f750d4031b14422894f232878_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzEwOTk1MTE2MzUxOTk_40d7e3a5-70f4-4011-b7ff-cab03a8e81cc"
      unitRef="usd">26300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i8a64787f750d4031b14422894f232878_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzEwOTk1MTE2MzUyMTQ_31bb5b28-6821-4e7a-b646-dae31951a100"
      unitRef="usd">26300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <icui:Contingentconsiderationgross
      contextRef="idab760f167ab477b84968687e30e7446_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzI3NDg3NzkwNzI2NDE_559aad0b-66e0-407d-80d2-f86494635378"
      unitRef="usd">6000000</icui:Contingentconsiderationgross>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ib0473993225046b8a38d55e04612297f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzI3NDg3NzkwNzI3MDg_8e33cd98-bde4-45d8-a194-4ed17a4c9e70"
      unitRef="usd">2600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <icui:Contingentconsiderationgross
      contextRef="i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzI3NDg3NzkwNzY0OTk_a85ff838-8d62-4fd1-adda-091dbf3f525b"
      unitRef="usd">2500000</icui:Contingentconsiderationgross>
    <icui:ShortTermContingentConsiderationGross
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzI3NDg3NzkwNzY1MTM_124aa700-24bd-486a-8dc4-6a8f9279fc63"
      unitRef="usd">1000000</icui:ShortTermContingentConsiderationGross>
    <icui:LongTermContingentConsiderationGross
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTIvZnJhZzo2NmQyNDc5ZjEwZDU0MmRjYWViZDc3NDU3ZDZmNDY1OS90ZXh0cmVnaW9uOjY2ZDI0NzlmMTBkNTQyZGNhZWJkNzc0NTdkNmY0NjU5XzI3NDg3NzkwNzY1Mjc_411fe575-248f-49b9-bb27-d1c68588810e"
      unitRef="usd">1500000</icui:LongTermContingentConsiderationGross>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTUvZnJhZzo5MzBkZjFjOWMyMDU0Mjk5OTg4YmQ4Y2M0YmI4NmEyYy90ZXh0cmVnaW9uOjkzMGRmMWM5YzIwNTQyOTk5ODhiZDhjYzRiYjg2YTJjXzEwNDg_b309d593-c7d4-4aaa-959a-5e31fe2fd024">COLLABORATIVE AND OTHER ARRANGEMENTS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 3, 2017, we entered into two Manufacturing and Supply Agreements ("MSAs") whereby (i) Pfizer will manufacture and supply us with certain agreed upon products for an initial five-year term with a one-time two-year option to extend and (ii) we will manufacture and supply Pfizer certain agreed upon products for a term of five or ten years depending on the product, also with a one-time two-year option to extend. The MSAs provide each party with mutually beneficial interests and both of the MSAs are to be jointly managed by both Pfizer and ICU. The initial supply price, which will be annually updated, is in full consideration for all costs associated with the manufacture, documentation, packaging and certification of the products. On January 1, 2021, we amended our MSA with Pfizer, whereby we manufacture and supply certain agreed upon products to Pfizer. The amendments included a change to the term of the agreement to end on December 31, 2024 with Pfizer's unilateral election to extend through December 31, 2025. Other changes to the terms of the MSA included (i) amendments to our level of supply of products to Pfizer, (ii) certain changes to our manufacturing lines, (iii) updates to our supply price with added volume price tiers for annual periods and (iv) certain minimum purchase requirements for certain products. On February 1, 2022, effective as of January 1, 2022, upon our request, Pfizer executed a Product Addendum (the "Product Addendum") to our MSA agreement, whereby Pfizer manufactures and supplies to us certain agreed upon products. The Product Addendum includes the supply of additional product to us subject to certain time and pricing terms and conditions. The Product Addendum includes a minimum purchase obligation of $29.6&#160;million. The Product Addendum expires on November 30, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xMTUvZnJhZzo5MzBkZjFjOWMyMDU0Mjk5OTg4YmQ4Y2M0YmI4NmEyYy90ZXh0cmVnaW9uOjkzMGRmMWM5YzIwNTQyOTk5ODhiZDhjYzRiYjg2YTJjXzEwOTk1MTE2MzA4Mzc_82052778-a82c-418a-950b-4067eafaec00"
      unitRef="usd">29600000</us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MTQ1_ee5fe2f1-2e44-46cf-82a7-533c76025dc1">SUBSEQUENT EVENTS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of Smiths Medical 2020 Limited&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 6, 2022, we completed the acquisition of Smiths Medical, the holding company of Smiths Group plc's global medical device business, from Smiths Group International Holdings Limited (the &#x201c;Seller&#x201d;). In accordance with the Share Sale and Purchase Agreement (the "Purchase Agreement"), we purchased 100% of the equity interests of Smiths Medical for approximately $1.9&#160;billion in cash and issued of 2.5&#160;million of fully paid and non-assessable shares of our common stock, par value $0.10 per share. The Purchase Agreement also includes a potential contingent earn-out payment of $100.0&#160;million in cash, which is to be based upon our common stock achieving a certain volume-weighted average price for certain periods from closing to the third or fourth anniversary of closing. The acquisition of Smiths Medical adds to and complements our current product portfolio and the combining of both businesses allows us to be a scaled U.S.-based global competitor that increases the stability of the medical supply chain and allows for future growth.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At closing, in connection with the issuance of the stock consideration to the Seller, we entered into a Shareholders Agreement (the &#x201c;Shareholders Agreement&#x201d;). The Shareholders Agreement imposes certain restrictions on the Seller including prohibiting certain transfers of the shares of our common stock issued (i) for 6 months following the closing of the acquisition transaction and (ii) to certain of our competitors and certain other parties, as well as customary standstill limitations. Under the Shareholders Agreement, the Seller has the right to designate one individual for election to our board of directors so long as the Seller beneficially owns at least 5.0% of the total outstanding shares of our common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expect to account for the Smiths acquisition as a business combination, however the initial accounting for the business combination is incomplete. We are unable to provide preliminary estimates of asset and liability fair market values as the external valuation of the assets acquired and liabilities assumed is incomplete. We plan to file the required historical financial statements and the required pro forma financial statements of the combined results of ICU and Smiths Medical in a Form 8-K/A to amend the Current Report on Form 8-K filed on January 7, 2022 by March 22, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Issuance of Senior Secured Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 6, 2022, to partially finance the acquisition of Smiths Medical, we entered into a credit agreement (the "Credit Agreement") with Wells Fargo Bank, National Association, Wells Fargo Securities, LLC, Barclays Bank PLC and certain other financial institutions (the &#x201c;Lenders&#x201d;), pursuant to which, among other things, the Lenders provided us with credit facilities in the aggregate amount of $2.2&#160;billion consisting of (i) a five-year term loan A of $850.0&#160;million, (ii) a seven-year Term Loan B of $850.0&#160;million and (iii) a five-year Revolving Credit Facility of $500.0&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Principal Payments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Principal payments on the term loan A and term loan B Facilities are due on the last day of each calendar quarter commencing on June 30, 2022. The term loan A Facility will amortize in an amount equal to 2.50% of the original principal amount in the first two years, 5.00% in the third and fourth years and 7.50% in the fifth year, with a final payment of the outstanding principal balance due on the respective maturity date. The term loan B Facility will mature in twenty-seven consecutive quarterly installments in an amount equal to 0.25% of the aggregate principal amount of the term loan B outstanding on the Closing Date, with a final payment of the outstanding principal balance due on the respective maturity date. All outstanding revolving loans over the term of the revolver are to be paid by the applicable maturity date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest Rate Terms&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In general, U.S. dollar revolving and term loans under the credit facilities may bear interest, at our option, on either (1) the Base Rate, as defined in the Credit Agreement, plus the applicable margin, as indicated below or (2) Adjusted Term secured overnight financing rate, as defined in the Credit Agreement, plus applicable margin as indicated below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facility Commitment Fee&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The revolving credit facility has a per annum commitment fee at an initial rate of 0.25% which is applied to the available amount of the revolving credit facility. The commitment fee after the quarter ending June 30, 2022 is calculated based on the leverage ratio as indicated below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Applicable Interest Margins&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The applicable interest margins with respect to revolving loans and the term loan A Facility shall initially be 1.75% for RFR Loans, as defined in the Credit Agreement. The following pricing grid for the revolving credit facility and the term loan A Facility will become effective after the quarter ending June 30, 2022 and will be based on changes in the Leverage Ratio as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Applicable Margin for RFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitment Fee Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt;4.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;&amp;lt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00 to 1.0 but &amp;gt;3.00 to 1.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;&amp;lt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00 to 1.0 but &amp;gt;2.50 to 1.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;&amp;lt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50 to 1.0 but &amp;gt;2.00 to 1.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.20%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;&amp;lt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00 to 1.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The applicable interest margins for the term loan B Facility shall initially be set at 2.50% for Eurocurrency Rate Loans. The following pricing grid will become effective on the Adjustment Date and will be based on changes in the Leverage Ratio as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Applicable Margin for Eurocurrency Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt;2.75 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;&amp;lt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75 to 1.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to the Loan Parties and the restricted subsidiaries of the Company, including, without limitation, restrictions on liens, indebtedness, investments, fundamental changes, dispositions, restricted payments and prepayment of junior indebtedness. The Credit Agreement contains financial covenants on the revolving credit facility and term loan A Facility that require the Loan Parties and the restricted subsidiaries of the Company to (i) not exceed a maximum secured net leverage ratio initially set at 4.50 to 1.00, with stepdowns to 4.00 to 1.00 on June 30, 2024 and (ii) a minimum interest coverage ratio of 3.00 to 1.00.&lt;/span&gt;&lt;/div&gt;The Credit Agreement contains customary events of default, including, without limitation, payment defaults, covenant defaults, breaches of certain representations and warranties, cross defaults and cross-acceleration to certain material indebtedness, certain events of bankruptcy and insolvency, impairment of security, certain events under ERISA, material judgments and a change of control. If an event of default occurs and is not cured within any applicable grace period or is not waived, the administrative agent and the lenders are entitled to take various actions, including, without limitation, the acceleration of amounts due thereunder and termination of commitments under the Facilities.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="ibf6924776c764e04bf39a28785afe1cd_I20220106"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MDMz_30d029a5-4592-4d74-baed-57bbb8300c4e"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ib79ae2a24b744dc99c3023b42abeeff9_D20220106-20220106"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MDM5_3cbfa684-a28d-4151-8554-fe946a916f49"
      unitRef="usd">1900000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="ib79ae2a24b744dc99c3023b42abeeff9_D20220106-20220106"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MDUz_8441f4bb-be73-425f-ba96-8483d648f844"
      unitRef="shares">2500000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i9b2d21d6799a45898560ea2c84c80514_I20220106"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MDY2_dbb077c5-dddb-43ae-bded-37757e0b21db"
      unitRef="usd">0.10</us-gaap:CommonStockValue>
    <icui:Contingentconsiderationgross
      contextRef="ib79ae2a24b744dc99c3023b42abeeff9_D20220106-20220106"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MDcz_957a78a8-8a33-4179-9e73-7ceeaea4e623"
      unitRef="usd">100000000</icui:Contingentconsiderationgross>
    <icui:OwnershipShareMinimumRequirement
      contextRef="i9b2d21d6799a45898560ea2c84c80514_I20220106"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MDg5_d88c9a5e-e024-4f75-a8bf-6fdd121d6f29"
      unitRef="number">0.050</icui:OwnershipShareMinimumRequirement>
    <us-gaap:LongTermDebt
      contextRef="i2140366dbbe94dc99b723319eb6c790e_I20220106"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8yNzQ4Nzc5MDc5MDc4_b95df4f7-1823-43c2-8b4c-94d90f6dc863"
      unitRef="usd">2200000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ic658275ab067426dbbc345457231980a_I20220106"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8yNzQ4Nzc5MDc5MTM4_b1d7de4e-4c09-46dc-894c-ac21d68dfc3d"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ia241e4af05fc4638bc449fe9c9c45c66_I20220106"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8yNzQ4Nzc5MDc5MTA3_875f47ec-af64-428a-b818-ac6679172f40"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i39ca865e5711457ca9a490c54dd29de5_I20220106"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8yNzQ4Nzc5MDc5MTY5_c616c9f3-e763-4177-bc3f-f79e7f3178fc"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <icui:TermLoanAPaymentFirstYearsAsAOfOriginalDebt
      contextRef="i78e8a542027645189940c1af26b316ab_D20220106-20220106"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MDk1_ae03c055-bebd-4273-a027-c75657d45f34"
      unitRef="number">0.0250</icui:TermLoanAPaymentFirstYearsAsAOfOriginalDebt>
    <icui:TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount
      contextRef="i78e8a542027645189940c1af26b316ab_D20220106-20220106"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MTAy_46080f1a-68e0-485c-9d23-1c0de82ae93e"
      unitRef="number">0.0500</icui:TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount>
    <icui:TermLoanAPaymentYear5
      contextRef="i78e8a542027645189940c1af26b316ab_D20220106-20220106"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MTMx_cace5567-c855-402b-96fc-7bda0b92c6f8"
      unitRef="number">0.0750</icui:TermLoanAPaymentYear5>
    <icui:TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount
      contextRef="i78e8a542027645189940c1af26b316ab_D20220106-20220106"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MTA5_f1135b41-0d29-44a9-9b83-6bbc0505ef61"
      unitRef="number">0.0025</icui:TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount>
    <icui:LineOfCreditSpread
      contextRef="i78e8a542027645189940c1af26b316ab_D20220106-20220106"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MTE2_3792f850-9612-44ef-88cf-7e2d143b516e"
      unitRef="number">0.0025</icui:LineOfCreditSpread>
    <us-gaap:ScheduleOfSubsequentEventsTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MTQ2_8506daab-de5c-462f-89a7-c66ec3096327">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The applicable interest margins with respect to revolving loans and the term loan A Facility shall initially be 1.75% for RFR Loans, as defined in the Credit Agreement. The following pricing grid for the revolving credit facility and the term loan A Facility will become effective after the quarter ending June 30, 2022 and will be based on changes in the Leverage Ratio as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Applicable Margin for RFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitment Fee Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt;4.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;&amp;lt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00 to 1.0 but &amp;gt;3.00 to 1.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;&amp;lt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00 to 1.0 but &amp;gt;2.50 to 1.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;&amp;lt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50 to 1.0 but &amp;gt;2.00 to 1.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.20%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;&amp;lt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00 to 1.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The applicable interest margins for the term loan B Facility shall initially be set at 2.50% for Eurocurrency Rate Loans. The following pricing grid will become effective on the Adjustment Date and will be based on changes in the Leverage Ratio as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Applicable Margin for Eurocurrency Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt;2.75 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;&amp;lt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75 to 1.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSubsequentEventsTextBlock>
    <icui:TermLoanAAndCreditLineSpread
      contextRef="i78e8a542027645189940c1af26b316ab_D20220106-20220106"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MTIz_0ee7ac62-7e32-4e2f-847c-e18effd39e2d"
      unitRef="number">0.0175</icui:TermLoanAAndCreditLineSpread>
    <icui:Spread
      contextRef="iafe2bcda32da45689d560de2ebd12309_D20220106-20220106"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY18xLTEtMS0xLTY4MDkz_3fcaf2a9-1730-4308-be0c-fd9b33b89368"
      unitRef="number">0.0225</icui:Spread>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iafe2bcda32da45689d560de2ebd12309_D20220106-20220106"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY18xLTItMS0xLTY4MDg0_34d80ffd-0f5d-42dc-aa92-a92651154508"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="iafe2bcda32da45689d560de2ebd12309_D20220106-20220106"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY18xLTMtMS0xLTY3OTQ5_3b074242-cd8c-4a77-8f84-8f2d2a738c38"
      unitRef="number">0.0035</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:Spread
      contextRef="i27a054a4a2d34e3b8e8d3b53146ca889_D20220106-20220106"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY18yLTEtMS0xLTY4MDkz_b9271095-4ac5-4c10-b3e8-d00de9d6ae84"
      unitRef="number">0.0200</icui:Spread>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i27a054a4a2d34e3b8e8d3b53146ca889_D20220106-20220106"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY18yLTItMS0xLTY4MDg0_b38878c6-00e6-4cf9-b97b-6ea566168e13"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i27a054a4a2d34e3b8e8d3b53146ca889_D20220106-20220106"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY18yLTMtMS0xLTY4MDcx_c0f51381-1162-4272-a3c4-2bcda1dcb639"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:Spread
      contextRef="i3c133097393142f18b109c568537343f_D20220106-20220106"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY18zLTEtMS0xLTY4MDkz_ac1410c0-c0c8-4406-b395-7e0a22b22faa"
      unitRef="number">0.0175</icui:Spread>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i3c133097393142f18b109c568537343f_D20220106-20220106"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY18zLTItMS0xLTY4MDg0_ea3be2c3-9563-439c-9073-86f4340a6c18"
      unitRef="number">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i3c133097393142f18b109c568537343f_D20220106-20220106"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY18zLTMtMS0xLTY4MDc1_d3dc4369-4965-4f65-97e6-db80f01ef6e8"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:Spread
      contextRef="i7cf95c725a97468eb9aa94749e698281_D20220106-20220106"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY180LTEtMS0xLTY4MDkz_06ca3f7a-264b-446d-af94-3e9eb1919271"
      unitRef="number">0.0150</icui:Spread>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i7cf95c725a97468eb9aa94749e698281_D20220106-20220106"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY180LTItMS0xLTY4MDg0_fe0baf1f-7f00-4823-ab4d-86f87e467398"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i7cf95c725a97468eb9aa94749e698281_D20220106-20220106"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY180LTMtMS0xLTY4MDc4_aed99cbc-49a8-41f0-a77f-7fadb837fb0b"
      unitRef="number">0.0020</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:Spread
      contextRef="ic553bac988d9412da422b9c62def2f16_D20220106-20220106"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY181LTEtMS0xLTY4MDkz_e142b531-ea27-4fb0-a239-94f5d4f8e44f"
      unitRef="number">0.0125</icui:Spread>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ic553bac988d9412da422b9c62def2f16_D20220106-20220106"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY181LTItMS0xLTY4MDg0_59aa1f82-6ec7-4ab1-991b-3d7301b9be74"
      unitRef="number">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ic553bac988d9412da422b9c62def2f16_D20220106-20220106"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6M2Y0MjgzNWZiZWEyNDk2OWJjMmY4MDI2NDFjZjUxMmMvdGFibGVyYW5nZTozZjQyODM1ZmJlYTI0OTY5YmMyZjgwMjY0MWNmNTEyY181LTMtMS0xLTY4MDgx_ff3fb11e-eb05-42aa-b7df-a2cd3de1142e"
      unitRef="number">0.0015</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:TermLoanBInitialSpread
      contextRef="i78e8a542027645189940c1af26b316ab_D20220106-20220106"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGV4dHJlZ2lvbjpmNTY2MjJlNzFlYzc0NjA4YjNjNmIxODc3OWU3MWFlMl8xMDk5NTExNjY0MTM5_b3e2f434-8b4c-43c0-ae78-e224327db97f"
      unitRef="number">0.0250</icui:TermLoanBInitialSpread>
    <icui:TermLoanBEuroRateLoanSpread
      contextRef="i595c992a5ff64197a1dedaa5a2c28018_D20220106-20220106"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6ZWRmNTg1ZjU4YThiNDdhNGE4ZTAzMGZmMzRlYTMwZTYvdGFibGVyYW5nZTplZGY1ODVmNThhOGI0N2E0YThlMDMwZmYzNGVhMzBlNl8xLTEtMS0xLTY4MTM0_7e7ffd2b-5658-4d3d-b127-4c3a31bf9cbb"
      unitRef="number">0.0250</icui:TermLoanBEuroRateLoanSpread>
    <icui:TermLoanBBaseRateLoanSpread
      contextRef="i595c992a5ff64197a1dedaa5a2c28018_D20220106-20220106"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6ZWRmNTg1ZjU4YThiNDdhNGE4ZTAzMGZmMzRlYTMwZTYvdGFibGVyYW5nZTplZGY1ODVmNThhOGI0N2E0YThlMDMwZmYzNGVhMzBlNl8xLTItMS0xLTY4MTM0_19a6a478-c533-4284-9874-1569dfa0c692"
      unitRef="number">0.0150</icui:TermLoanBBaseRateLoanSpread>
    <icui:TermLoanBEuroRateLoanSpread
      contextRef="ifd3bfc829b78437eb5cd91c39c6156b4_D20220106-20220106"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6ZWRmNTg1ZjU4YThiNDdhNGE4ZTAzMGZmMzRlYTMwZTYvdGFibGVyYW5nZTplZGY1ODVmNThhOGI0N2E0YThlMDMwZmYzNGVhMzBlNl8yLTEtMS0xLTY4MTE4_13703c56-0fb3-4b8e-88c5-07dab0c17ed7"
      unitRef="number">0.0225</icui:TermLoanBEuroRateLoanSpread>
    <icui:TermLoanBBaseRateLoanSpread
      contextRef="ifd3bfc829b78437eb5cd91c39c6156b4_D20220106-20220106"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDU5L2ZyYWc6ZjU2NjIyZTcxZWM3NDYwOGIzYzZiMTg3NzllNzFhZTIvdGFibGU6ZWRmNTg1ZjU4YThiNDdhNGE4ZTAzMGZmMzRlYTMwZTYvdGFibGVyYW5nZTplZGY1ODVmNThhOGI0N2E0YThlMDMwZmYzNGVhMzBlNl8yLTItMS0xLTY4MTE4_ef0f6660-b4f3-49e2-9e5e-0ed9faf8507b"
      unitRef="number">0.0125</icui:TermLoanBBaseRateLoanSpread>
    <dei:AuditorFirmId
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNDUvZnJhZzowNGY4MzEyZDJlOTA0YTFiYjM4MzVjNmRkNmM3NjM0Ni90ZXh0cmVnaW9uOjA0ZjgzMTJkMmU5MDRhMWJiMzgzNWM2ZGQ2Yzc2MzQ2XzEwOTk1MTE2MjgyMjA_f7af1fea-1467-4bc9-90b1-18dad723dd03">34</dei:AuditorFirmId>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90ZXh0cmVnaW9uOjU5Yjc1ZGIwZjdkNTRjMGZhMGNiZjFiM2FmMzNiZDY1Xzc4_b12573c0-a727-499e-8666-5ff6dfe0a008">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.687%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Amounts&#160;in&#160;thousands)&lt;br/&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&#160;of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Charged&#160;to&lt;br/&gt;Costs&#160;and&lt;br/&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Charged&#160;to&lt;br/&gt;Other&#160;Accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Write-off/&lt;br/&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&lt;br/&gt;at&#160;End&lt;br/&gt;of&#160;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the year ended December&#160;31, 2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warranty and return reserve - accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warranty and return reserve - inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(722)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the year ended December&#160;31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,866)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warranty and return reserve - accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,609)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warranty and return reserve - inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,613)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the year ended December&#160;31, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,797)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warranty and return reserve - accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(790)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warranty and return reserve - inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,613)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(533)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,883)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iecae4385e0b9406785f4b23d06865339_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzMtMi0xLTEtODc0NQ_dcce6ac2-3eb0-4422-86e7-ff2d3e548c18"
      unitRef="usd">5768000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i870395a6aa054f6bacfe43ca3565e846_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzMtNC0xLTEtODc0NQ_0dd2e18f-d41c-40db-aa51-ca4742baf0bd"
      unitRef="usd">14882000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i870395a6aa054f6bacfe43ca3565e846_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzMtNi0xLTEtODc0NQ_e4b4c6dc-f1c6-4d9a-bb79-ca07ccfa1c89"
      unitRef="usd">-431000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="i870395a6aa054f6bacfe43ca3565e846_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzMtOC0xLTEtODc0NQ_200cd97f-4a7f-4c9b-a7c8-561c4ea9af39"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ib2c1a3da41264443b2bfbe1037ea8817_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzMtMTAtMS0xLTg3NDU_bcb51693-916e-4386-ac4c-e74761dcade5"
      unitRef="usd">20219000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i6d12c957c1c943f3b34b05d9ed53aafe_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzQtMi0xLTEtODc0NQ_45cc1cc8-2ded-4081-a289-c4c2a9802a85"
      unitRef="usd">6752000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i0a98c1779cac4386957e351f01e76fa5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzQtNC0xLTEtODc0NQ_c772a6a2-4775-41f3-9cd6-9ded31163815"
      unitRef="usd">83000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i0a98c1779cac4386957e351f01e76fa5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzQtNi0xLTEtODc0NQ_4f892952-4d3f-42fa-82b6-440a942f9c65"
      unitRef="usd">-458000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="i0a98c1779cac4386957e351f01e76fa5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzQtOC0xLTEtODc0NQ_473cf296-f05b-469c-837e-894c1f2bae00"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ie20ee1ac93ab48868926f61f94817b56_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzQtMTAtMS0xLTg3NDU_c5e515ec-d525-498b-bbfe-8fa88643b8b0"
      unitRef="usd">6377000</us-gaap:ValuationAllowancesAndReservesBalance>
    <icui:WarrantyAndReturnReserveInventory
      contextRef="ic2b82bbcf5cb45739937a1040ed30f6b_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzUtMi0xLTEtODc0NQ_c61f9357-7a24-4baa-a42f-ac8a14eb69c9"
      unitRef="usd">-2538000</icui:WarrantyAndReturnReserveInventory>
    <icui:WarrantyAndReturnReserveCosts
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzUtNC0xLTEtODc0NQ_b827dbfe-8e6f-44bc-a245-6e9e32ed1ef6"
      unitRef="usd">-217000</icui:WarrantyAndReturnReserveCosts>
    <icui:WarrantyAndReturnReserveInventoryChargedToOtherAccounts
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzUtNi0xLTEtODc0NQ_4064917b-9b20-466f-803c-8b25873236ab"
      unitRef="usd">722000</icui:WarrantyAndReturnReserveInventoryChargedToOtherAccounts>
    <icui:WarrantyAndReturnReserveInventoryWriteOffs
      contextRef="i841c9704b8714c68901ca3920f8c5f73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzUtOC0xLTEtODc0NQ_f7200423-974f-4488-aa2f-04b7ae3ec10c"
      unitRef="usd">0</icui:WarrantyAndReturnReserveInventoryWriteOffs>
    <icui:WarrantyAndReturnReserveInventory
      contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzUtMTAtMS0xLTg3NDU_168b19f4-286e-4fc3-9699-f95ef1dca9b1"
      unitRef="usd">-3477000</icui:WarrantyAndReturnReserveInventory>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i5bd524a6cefd4a91928cd5550b9aab92_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzYtMi0xLTEtODc0NQ_af0353f6-5dec-4c3e-b1c6-325974decc24"
      unitRef="usd">5436000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i5aefe03f40c54e77a419eeec553d95eb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzYtNC0xLTEtODc0NQ_588b18f9-3817-46b2-b5f8-e362a793048e"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i5aefe03f40c54e77a419eeec553d95eb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzYtNi0xLTEtODc0NQ_128cc6c4-f9a9-4098-9ac6-54bd7ab6608a"
      unitRef="usd">-1584000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="i5aefe03f40c54e77a419eeec553d95eb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzYtOC0xLTEtODc0NQ_359a5c56-3aae-403f-a822-c3bdc77f5138"
      unitRef="usd">-175000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i245c4ea3235a4b6e8de7f653118777e4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzYtMTAtMS0xLTg3NDU_5b59ae3e-6298-4971-bc82-f0a624561da6"
      unitRef="usd">3677000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ib2c1a3da41264443b2bfbe1037ea8817_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzktMi0xLTEtODc0NQ_82eff267-2a16-4236-a2f8-4e361423b610"
      unitRef="usd">20219000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="id97bb342dec84b8eb092e237e601cbab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzktNC0xLTEtODc0NQ_0eb469d1-50f1-4191-9b32-570119d2be42"
      unitRef="usd">7137000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="id97bb342dec84b8eb092e237e601cbab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzktNi0xLTEtODc0NQ_66f6ab93-d878-4261-bbe1-b6595d5e7f3f"
      unitRef="usd">-5866000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="id97bb342dec84b8eb092e237e601cbab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzktOC0xLTEtODc0NQ_e6aaeace-e059-4d2b-9c88-0b34f66f66c8"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="idda3b662db294f219a192b0347c136af_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzktMTAtMS0xLTg3NDU_60929999-fc11-4ae0-b2af-574582f3704b"
      unitRef="usd">21490000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ie20ee1ac93ab48868926f61f94817b56_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzEwLTItMS0xLTg3NDU_9ca0e14e-9b9a-4f9f-9379-80b3cbf4278f"
      unitRef="usd">6377000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ibf8bf1ccc2ee4806a1f944d440ddd63a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzEwLTQtMS0xLTg3NDU_61ca3563-e300-4675-8472-1189449549a0"
      unitRef="usd">-3609000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ibf8bf1ccc2ee4806a1f944d440ddd63a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzEwLTYtMS0xLTg3NDU_849377c8-7908-496b-b743-ea237dc64416"
      unitRef="usd">-61000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="ibf8bf1ccc2ee4806a1f944d440ddd63a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzEwLTgtMS0xLTg3NDU_995d637a-03f8-42c2-b202-ab54cc04e6a9"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iea50319693fd4506aaf0fc2e7a8505fc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzEwLTEwLTEtMS04NzQ1_01b4db63-4d09-4103-a159-7a8f34d44b12"
      unitRef="usd">2707000</us-gaap:ValuationAllowancesAndReservesBalance>
    <icui:WarrantyAndReturnReserveInventory
      contextRef="i056b6066b5c84b8f82444aed64ff2939_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzExLTItMS0xLTg3NDU_91f09e61-0aa0-4ec2-b2e3-6fa690504caa"
      unitRef="usd">-3477000</icui:WarrantyAndReturnReserveInventory>
    <icui:WarrantyAndReturnReserveCosts
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzExLTQtMS0xLTg3NDU_a528984a-8c59-4095-8a34-991239406957"
      unitRef="usd">2033000</icui:WarrantyAndReturnReserveCosts>
    <icui:WarrantyAndReturnReserveInventoryChargedToOtherAccounts
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzExLTYtMS0xLTg3NDU_cc36cee9-5fe1-4899-b480-f53302d3b14a"
      unitRef="usd">169000</icui:WarrantyAndReturnReserveInventoryChargedToOtherAccounts>
    <icui:WarrantyAndReturnReserveInventoryWriteOffs
      contextRef="i0deb7b38debd4b27929f56cec50aae4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzExLTgtMS0xLTg3NDU_2360b59b-3309-468c-942c-61be419ee09c"
      unitRef="usd">0</icui:WarrantyAndReturnReserveInventoryWriteOffs>
    <icui:WarrantyAndReturnReserveInventory
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzExLTEwLTEtMS04NzQ1_28e9a7c5-20ac-4cca-8197-f6a363240ae5"
      unitRef="usd">-1613000</icui:WarrantyAndReturnReserveInventory>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i245c4ea3235a4b6e8de7f653118777e4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzEyLTItMS0xLTg3NDU_277aedca-d14f-4f04-a7ab-cc228138e5c1"
      unitRef="usd">3677000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i8a4c1f26c3014290b2257c8a6c97e92a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzEyLTQtMS0xLTg3NDU_d785e735-43d3-4a88-93bf-0d4e01eb895e"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i8a4c1f26c3014290b2257c8a6c97e92a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzEyLTYtMS0xLTg3NDU_75b72f1c-4ac5-4668-90e8-11ae1698967f"
      unitRef="usd">214000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="i8a4c1f26c3014290b2257c8a6c97e92a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzEyLTgtMS0xLTg3NDU_987054f9-381d-4797-ac86-ea591d41a150"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i8dbfa44cf2124deea69cb9774393fdd6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzEyLTEwLTEtMS04NzQ1_7d01c229-47fd-4b46-84fe-f04b264bd373"
      unitRef="usd">3891000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="idda3b662db294f219a192b0347c136af_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE1LTItMS0xLTg3NDU_390bc84e-5793-40ec-997a-5fd930c26f5f"
      unitRef="usd">21490000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ieff747a718fd489ebe9871999b3764e6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE1LTQtMS0xLTg3NDU_9a910ba1-fb74-48a1-918a-9f59f69233da"
      unitRef="usd">345000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ieff747a718fd489ebe9871999b3764e6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE1LTYtMS0xLTg3NDU_256e0ca7-5d4a-4979-8e1e-d6a3294da132"
      unitRef="usd">-14797000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="ieff747a718fd489ebe9871999b3764e6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE1LTgtMS0xLTg3NDU_7effe8b9-6ec0-4608-809f-e9be76e9b66e"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i5a1683bbea2043caa4198e6f9ed83d74_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE1LTEwLTEtMS04NzQ1_50a822c3-8119-4be3-90bf-9b52f771ca67"
      unitRef="usd">7038000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iea50319693fd4506aaf0fc2e7a8505fc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE2LTItMS0xLTg3NDU_d104e589-4462-4566-8571-8694ff234e7a"
      unitRef="usd">2707000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i59cffeff11d847a38379503c52f7cf32_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE2LTQtMS0xLTg3NDU_aed17a6c-fe33-4884-89f5-f3334a0a3a2d"
      unitRef="usd">568000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i59cffeff11d847a38379503c52f7cf32_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE2LTYtMS0xLTg3NDU_69977e55-f132-4c71-b7b6-70bb0e7d6b83"
      unitRef="usd">-790000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="i59cffeff11d847a38379503c52f7cf32_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE2LTgtMS0xLTg3NDU_dde593d2-fc97-41ca-93bc-15935d08152e"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ib6a5483b520c4d7d8560fae11ca7ee8a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE2LTEwLTEtMS04NzQ1_71ec5740-b707-4c06-b139-a2a2ea12bdbe"
      unitRef="usd">2485000</us-gaap:ValuationAllowancesAndReservesBalance>
    <icui:WarrantyAndReturnReserveInventory
      contextRef="i4d447798df3d4ad09d5a02f448f0900b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE3LTItMS0xLTg3NDU_382bee80-6b0d-425e-9160-e4347e1f29a4"
      unitRef="usd">-1613000</icui:WarrantyAndReturnReserveInventory>
    <icui:WarrantyAndReturnReserveCosts
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE3LTQtMS0xLTg3NDU_75d455fc-36eb-4171-bbef-324b747c35ca"
      unitRef="usd">263000</icui:WarrantyAndReturnReserveCosts>
    <icui:WarrantyAndReturnReserveInventoryChargedToOtherAccounts
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE3LTYtMS0xLTg3NDU_83fba672-d8e5-4b7b-9636-5744a5cd500f"
      unitRef="usd">533000</icui:WarrantyAndReturnReserveInventoryChargedToOtherAccounts>
    <icui:WarrantyAndReturnReserveInventoryWriteOffs
      contextRef="i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE3LTgtMS0xLTg3NDU_7b286c85-2f65-41ea-b9a8-19d05be3c08e"
      unitRef="usd">0</icui:WarrantyAndReturnReserveInventoryWriteOffs>
    <icui:WarrantyAndReturnReserveInventory
      contextRef="iaec5d516f9924448a7889b3f61aba166_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE3LTEwLTEtMS04NzQ1_7c6de01f-878c-4a08-9156-0e4b83f66ac8"
      unitRef="usd">-1883000</icui:WarrantyAndReturnReserveInventory>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i8dbfa44cf2124deea69cb9774393fdd6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE4LTItMS0xLTg3NDU_f1e977e6-c48f-4bfb-8d52-d223609ab3f4"
      unitRef="usd">3891000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i673942985fc343f3ac8ca57d29d0dd83_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE4LTQtMS0xLTg3NDU_351925d6-63bf-4c70-aec9-442939e4e2f3"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i673942985fc343f3ac8ca57d29d0dd83_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE4LTYtMS0xLTg3NDU_bd033e44-5cfc-4866-bb0d-32d100c2f5c0"
      unitRef="usd">-957000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="i673942985fc343f3ac8ca57d29d0dd83_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE4LTgtMS0xLTg3NDU_767ba1e2-67e7-47b7-89a3-df0661e06930"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0fa8f3589249483da23fe23fa443806b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMDBmMDk3MGJhZTQ0NTc4MjgwODc0N2EzZWMzOTFkL3NlYzpjMTAwZjA5NzBiYWU0NDU3ODI4MDg3NDdhM2VjMzkxZF8xNTcvZnJhZzo1OWI3NWRiMGY3ZDU0YzBmYTBjYmYxYjNhZjMzYmQ2NS90YWJsZTo3OWFiMzg5MWNhMTk0ODdiYjc5ZGZiZDI1NGYzZGEwOS90YWJsZXJhbmdlOjc5YWIzODkxY2ExOTQ4N2JiNzlkZmJkMjU0ZjNkYTA5XzE4LTEwLTEtMS04NzQ1_d9510bf7-7b0e-4de6-962c-82a1c599e505"
      unitRef="usd">2934000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>134
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M#7.7F.Q8US$LD <'O&QG.!J,1L,CK"IE=]KU=M3!?@E6],*T,I8<%*N^.FU
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MV1(3V9$YG:]&\Z_3V]GDL, Q)ZM*.!0$!*&N4HU=Z&-BDMJB$-E9>$>W5)2
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M2;P FCR$&"0Y6,?[1 !.*U4EJH^1@W!7K&KGA01Z!IB1%KWD _068CM<%;]
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MB049+LFFE'=L^QD;/:'F2UDIS"]L&UO'@G0C)*L:L/*@*FC]3YZ;..P W.@
MP&L 7A<0' #X#<!_*R!H (&)3"W%Q&%.))F..=L"U]:*30],, U:R2^H/O:%
MY.IKH7!RNI!$HCI&"6P),U:INY/K0WU"N*8IJQ#>P<-B#J<G9W "!87[G&T$
MH9D8VU+MKUGLM-GKJM[+.["7Z\%71F4NX /-,-LGL)7CK??>B_=7WE'&.:87
MX+OGX#F>.^#0[.UP9P ^?S/<'1U1X[=GX1N^X #?C<KRP@1]*+8U-C18G<Q/
M4]?Q73\<VT^[BOMF293$SK[5?(A,T;V2[0D(6@'!40'?9(Y\^!:=?F%"G)W#
MC(@</JIB Y\Q6^$Y?%*EJ?U*EE(1W&%:$B&*99&2NCC0#.[)\U!4:H>B'2'O
M?',7]H+2MQHY02<D?1O7"[SA@(1M0,*C 5&E214>JA*9<Z3I'Y"<4%$VJK*?
M*K]U[IT#19. DCRCT(,3!U1)!U*6L$9>L.%T"_OBW2"*.LIF?3/7&WFCCOZ^
ME1\?D!^U\J,WW(=7G>)?A49]H9'74=FW">*.Q &:V!V6&+<2X_^]\C>UY ,7
M.!XXPSCNNC[KF[E^DG33>L J#/QAA4FK,#FJ<%_;X?J4] M/J%SLZ.A;N8X3
MAUTA0V9>&"<=*?;.PU<A7YD&0D#*-E36KTB[VO8H[\W3W%F_4KU+W6J\TM2-
MSU?"5P454.)243H7L7**U\U$/9%L;9[71R;58VV&N>J_D&L#]7W)F'R9Z W:
MCF[Z%U!+ P04    " "RAEE4*3RF)XD&  #+(   &    'AL+W=O<FMS:&5E
M=',O<VAE970V+GAM;-5:VV[;.!#]%<)88%L@KD52U\(QD#A78+L;).WN0[$/
MC$3;0B71%>DX^?LE)5FR*,K*-BW2OL26?&9X.#,<'E&9;EG^A:\H%> Q33)^
M/%H)L7X_F?!P15/"W[$US>0O"Y:G1,C+?#GAZYR2J#!*DPFR+'>2DC@;S:;%
MO9M\-F4;D<09O<D!WZ0IR9].:<*VQR,XVMVXC9<KH6Y,9M,U6=([*CZM;W)Y
M-:F]1'%*,QZS#.1T<3PZ@>^O,%8&!>+OF&[YWG>@IG+/V!=U<1T=CRS%B"8T
M%,H%D1\/=$Z31'F2/+Y63D?UF,IP__O.^T4Q>3F9>\+IG"7_Q)%8'8_\$8CH
M@FP2<<NV5[2:D*/\A2SAQ5^PK;#6"(0;+EA:&4L&:9R5G^2Q"L2> <0]!J@R
M0)H!"GH,<&6 =0/48V!7!K9F@-T> Z<R</01[!X#MS)P=0.OQ\"K##S-P'%Z
M#/S*P"^R6Z:CR.49$60VS=D6Y HMO:DO14$4UC*%<:9J]T[D\M=8VHG9G&6<
M)7%$!(W G9 ?LC %!VPAKUCX9<62B.8<G'_=Q.()C,&GNS/PYK>WX#<09^#C
MBFTXR2(^G0A)1KF<A-7 I^7 J&?@CTR0Q& V/VPV9VDJ2[[@!NY6)*<<?/Y
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MTW ;8H-17FSRPN +:@@?09,$R,FTNJM+[*@L5:E7A!JELQ6T2$R_5_<:DOD
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M8;F;5!#B,D1-2P)6(%.EJ1^#>\*Z/0H4:T/WVD*CH2IK4&I:X6*@EUT0W'G
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M"V[@O6 /U95(.*= L0AC8&MJ=Z(43,'5Q 4%)2]+:?,F8 *QEB;@D=E,&ZN
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MW3SI-8JA52V<7OD7_9EV^&SP/Q-\IPE# CA?:+RVEPMR4'_YG?\'4$L#!!0
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M#:9J323+$C(3(EK91:5,/A2W<D<&.;1]0LZ VG66,;1Q'8Y$(G=LH41E2+9
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M];M/G>>\4J;*[^@9KJ"2L-\9""AY$IBQ 9!GX(6:8??@^64&O<Z2'$@1C\+
ML1S',4XPN4^RG+60/!HY2/)/<%9Y6[/A5I+R+K*9?JB>2S/N$&":WLP[-+2+
M-TX5+Q.P6E:\SAQ>6J:6:&2%?(-UFH+%XPIJD.JA99NGRMA+\N@/9-*5;-JJ
M4,8Y6LT&"XEBCQ3"G?#BY,\L9AI+?E'F\).U$M,]62E,.25SKGMP8!D[2T8!
M1DN1@3&2^_DE;I^$;WE10*RUQ&T%?A'+:*)F_Z\   HP+D\#V,)];Q);42\W
MQE"])5I&0'?)Q-YM0!WY+#M$#9BF&\>6WZ^(B3">91<'R#M6Q,AU.KJ@;T(-
M&)FW*4!XH3^$R#0@_RGJN:Q(\MM0UEF #MU S+CS+@"31.4L4R9=D7U2(+TY
MO:XID$+C$ 6K.YI\!V[!XD?$_J%6Z!AZ>(E"RYMIZ[\I)#J<ZO;V%W9;I<EE
M656)KF(4=0B7K\/$LYWIT-S<-4PN]2K+Y(F2()8\X#\@"^HC(?*'&6E>(XI2
MY+*N%8;S)*LPL?J"?=E]DK>21J2P1A(U0^KA&\!=_C70%KWV05$6QW63-"U2
MO*=Q[#W0FJ!,G-" 6Y8*C4::/(?%/T* A'S0YY5K,,$?;([8 ! $;_0F;.)Y
M-)]P_ 2<JP*V=XW@78# \S)EX.XT#BWV\$L.E8C&V ;JP#5TK[7X7#)*&(WH
M4&YE1\\*Y7>,"V3O=2M!WQ[6J$1@F?R"3+5Y,I@W/3K8YF(J0B2<0)?AJ<D*
MCYJS&HST@E<BF3=2J2SQM+<HQ4YF+B%)/]TF.9NLGETEE(T\4:*70#S86.$+
M4,AJ%?S\4/VJ,7X&6KS) ]?F+04?M<QV<H? UGD,ZR+V=6OTNPB"N)=4C:D!
MB,RBXCBHU=!UAHJW;2J;B+(-PG0@E!&A8-$LR6>M2L_:VKC^,P3N+\<W,\0>
M:1P7@U.^:@EMS-5"E&9P*DHAD2V]6:RSDS)VO3IT*X,6P:ZAW#2WRB2)DD3;
M@9JWB):R%\ZMA$)B)\&Y-.7!E*KP.O<E,,]R+1 *F2-/GRA'-;;,#A-Z-<!F
M/RQK/,]D41W.G<\B/NS-D=E*R@8K#L0R3OBU!EEZ7,]X8P$;V5P"M[K4LX_2
M,L]).X8)M@4,9W+54-YGQ(,4LX5\]N3>:\GV#RV_V:91O=I'R+ =?+I3!VFS
M%P;BC_3FF*4PULOUJ>,M :7;7DS)MA?PYP3RWT/W^LZVY]L;\6&DID=L/:]%
M8 ?=_VZ$WH-2Z!GJA!_8CGAE_G@Q_[G.ZB_'\TI2L@3(9-85D4E)]"M\3F@H
M,OM7/?@TN\]2L%H\91*)XK__6^RYWG<8L>UI@U[FU+%";B#)0W+>MA/1MB-V
M[>F4?O$"VXMV@5B7Q@A8&-H1,3Z84A3']\B.?'%JJI/&/D;,YA(B,2KAC(LT
MU7B#IWW:!1>4D.QRF$G]QF0H'=:G&NL/QKZNF/8K@%#%N(V1Y_#U5)IJ83G_
MD<VE./J+DO;IW5TE[XANA%<DNG4V$S\Q\6MZ=SEPZG AZS@[(D:"'B,=/!21
M8[N^4O!.]3MA&)RAV&[H6:'KL4Y'-K:0'\UF8KB!,((_[)Y^!147HO(M9TK"
MBB9V%$#;0E(")[8HFFL,V!%MGQZ$UB2F;6KDVY,8TWGKZD16%+KB)Q5@1\X9
M48W"E_5B7#[SEL(PGK5.V:SQ K)'UAH%5E/_Z)@UPF0[8:0:G<=F9YZ7'-Z&
MY@T]/?3\R/8G.X#05I  R3EE?<C7<X0*8B8V_%+G$TIU.7+RJQ5EP1Q<"W4N
MH$KT=\BS^_77C.9KJQ^?QOP<^E39*1_700*?RA:^!PT-V#E8TR@4YTF],&4S
MO8O9788Z%%/+CSP2J0_OSDIC1;ZWHYIB:#0 :RZ?.%./_[K1E &&@2D+G*J=
M".^'=6G$Q 6J+?)FEXN%CW+6<E9=SN>0(E4J/FI/L_ENN+.A$>>+3,[)+O2X
M2S4.^Z[S#Y=49%0#+N$/$T7V8,3EI:YP]I ^9@5R4=HF#\9]9$@T2&'.!1K6
MU>'."P,0.8[9.U(\[6I\[#O;BA$?34BE*3P08[%U9SR&A2%\669-(Z7>HRX&
MG."L?BGY5_A]*D4B%)&;'!9X[\HDKSO7/5!Y710RK :[P*S+RYX?'R\5S4-H
M>@?(#)CEV7Q^S&R0.F,NQ/=<IPS9X"8CRK$S&Q#/R,S \GMU* #M!".R9;L<
MLG'6+BF7)<%6>N=$(#]<W< XL8%MD =15H><4Z__YZ1H*:0-3;[';MTE^%T1
M>B')J.\S^3#8%2=D_$9(LB_:P@E4V2-6IM(0^-'F5*01SBNNC0?XJ[<3O!OG
M[1E52%F$:A)!TK4BS_EFMK%3I/]2XQ>HL?]/4>/?4P\O"_%1WE;*<()A*6Z'
M%)=)JC9L8]%WPGVA;D)&+]& #KU*Q7'LO(^;15:EFMRL4B&5M+RK=FH.Z+PC
M;2NN90*2+4[3-"/\:4MNF5<=0WZ-&19MG[-YILNSJ[*A(E&2=U("$50W0BX[
M.M11M2N#IJ[;S;>I,:MPHG::V-S>951)ZM<9PN?"-M:%:63U@NI1<(YIIHX"
M=-K#8(I:-D8[SB]_^G1QC/1CA=7D,INI1&B'[ =Z2-:?_M+J^N$ZSG^H!TA2
M.3:I"I5/W,KF@:I14% N5*UKZG##+/C@P!3 -P$:6($&YCL[@:W9;9W N0VM
MM:;2_"X+U<>_VMC3H9M+BB?%L:13I!V'D^H\CNV4/ 7IS9.IT72Z,*HX4138
ML!4N(U FZ-EN=\K4'1BEJDRV=F:BCI\4/OJLJ*LVF8**4N09#S(G&=-O&)UZ
M)WWY_R$P;9+[U3')VT7TEH"4=$I^WL>A4[9;2/3#V:?/%Z>0]KPC@OFL=OE:
M4W9G4*XB:"=@/L))H#_E0[-@;!J1PY8;$7*4BE]98F>@ZO2 T=.E.B/UU!0-
M7["X<18QK^TZ6-Q=]Q??;G4V2U[4>]:B _OCCH--(RRDJ=UP9;JSN>[DB_U2
MO6E7)DX7ZL1X:%H;(E=ZI^7M62*;"]A' \?2*=:F0= V&[;S>^46RE5>_N/3
M"D3)YZ85G]<,7#-V(P4 R"'&2E2J=+#5X&C@J'B]1P6[<*4Q6W<Z&J>_RZI$
M]'\JVX8*>*8D,PJ9.\2EDE7=F3(0F-'?^/>('Y0%F7+2__(0\A411%._-8AL
MV.+_E$#B_"N0?*M \G_-!<?/W]E1V-RF]7O)'^YP#,D#@K"OZ9 P.ZZ$NX$P
M=D,+NFS>.,3H90[Q\]BK4:=ZVN;#PGW&MH#-JZ4:#[_2<JV=GI(=2:>P.TW8
MG;)^,\-T X=J>]JCV5G=V_%AZ#C=;H;Z9/L.D<,PZ%Z]P-)>LG:P<^W(&:S]
MO,SM96N/%MC8O^ZPZ*[0&5FZB/@;#)K4<F140ZU&T-NNG":+9)2'&I=3BZK1
M]_ E^F[J8.9X:%/)8EM<]+G,/*O P;^!$XTZR%89\W.->ZU$8)8%7423:LSI
M3*=&4J3J/+2Y+UON*RS(F6G/S$?%1P?GIW^\/GA-A;AD3>IT**O:IKA[02:-
M\9FN]XK;*O ;&7@70?TN)U]/V4:%;C<D>RW;N\4V?EUO;S F/ SABI#\R4CF
MK$R4T[T8M<KK1I<!ZS$1\JMJ?8Q,+_K>%4MH,DR!@4!KGBVE)'>B!2XIHI6S
M64M-, 38[@^..#G0C93C:H31);,=Z;O\6;/O]?F]Z29B>>_"5]=,3,)2FPYT
MW82KFT5;CCA<BGM2^"H/O7X(/^IFTX0KU2="^"&KA[JHC6QTFEFLL7-O&PK-
MWN@D5]K='>5O[21Y;JMVUW%BXBX(Z17:])ZLGVBR4]%- $9L@6]YDU#XL17Z
MOO C*PPB,T;[G*/D-1UN.JXO8@?O)\)U)Y;C>SN:3WI$#JFGSG;YI#J.;3XF
M]7S7#OT=4^E$VPH"EX\_O8@FQE;D^1N'L=HY4/-X%'%K1F"%'CUXH369!&(+
MJ?'$\N-8Q)$5^XX(72L.PF>1,*4^!$4"/WA>9$]V48]QH14[$_40>#P3[ JC
MW42XOA7&1+3K6;ZKIT:!+_YK_S\6S3!4:(FIBQM3%3D&>]RAZQHG1%S"-1&@
MU@!"8^G8-^Y:!;KU&U>)E&OLO(J]>RWWMZX5J]Q(K^4YFU9,?> 9M24GZQTY
MZFA >8RO[<AY,VCS^I$=OU*B"U*BCZ1$JFGFF[;@_% 6QWUPW=S[>4A@HE#U
MVDQM6-?Y@NZ+$0M5L$I;N<Y[5:70I_JDE=[$"AU7PP@G71N/2RZ&'0&YAB@P
M?3!'TZGEA_YKOD?"J_9=/$>PV,A]S7-"&U"'%&SIG]G><$*-^-1X0RBYMA,(
M?) #"> OIL^RM&O6NUI?NIH>,]B-4X)D1_W/*)W;:=_F8<((F*4Z\+A)FT)J
MMX$8'<*H0A&G.UTA:I=D;$'7O?H[>H7ZKAJ65;+WHWUC#V(WM7%W5\;:%=%W
MJ.XC]&G*^AT <#\..&_FRU[;&LK)3F[E75;P>8@I,YD":)T]'G-7,:6BLM+G
M=DBTA@D*0C;L5:J83T$/_Z/Q-9;G74[HN]>)&=WUA'$G?V%2)<-YD["H;0.^
M($D=K(VT]Z$TIX%FK$%KV-=,=1ZZ*B8*Y1B2]4R$)G(&:/==Y[PI'W62=WC5
M^^]S5%*Y4-?WK4D<;;]_HGN$#8>4DV1-R6INQF3G1KD>=*I!(L;]X]Q7YSG?
M[;MPR$/<[_@J0J92JJ5,"GWYKF_6]_<VZW,ZV%]3).>LL-/W%;?=FST97%5>
MRNJ.+V33I3ID2NK6<O=K=^?[5%UU[H>K"^/?)Q4T%^HGYYCJP(D=J!LFYDM3
MKOCB\VW9-.62'Q<2N[Z*!N#]O"P;\X46Z&["O_]O4$L#!!0    ( +*&6518
M>/.0Q D  "L?   9    >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;,U9:W/;
MN!7]*Q@UV]HSMB1*\BMU/"._$NW$CL=VLNUT]@-$0A(F)*$ H&7WU_=< *2H
ME^UULYU^D40(N(]SW^#Q3.GO9B*$98]9FIL/C8FUT_>MEHDG(N.FJ:8BQS\C
MI3-N\:C'+3/5@B?N4):V.NWV?BOC,F^<'+NU&WURK J;RES<:&:*+./ZZ52D
M:O:A$37*A5LYGEA::)T<3_E8W G[=7JC\=2JJ"0R$[F1*F=:C#XT^M'[TQ[M
M=QN^23$SM=^,-!DJ]9T>!LF'1IL$$JF(+5'@^'H09R)-B1#$^!%H-BJ6=+#^
MNZ1^Z72'+D-NQ)E*?Y.)G7QH'#98(D:\2.VMFGT209\]HA>KU+A/-O-[#]H-
M%A?&JBP<A@29S/TW?PPXU X<;CK0"0<Z3F[/R$EYSBT_.=9JQC3M!C7ZX51U
MIR&<S,DH=U;C7XES]N1<:/G "1G#>)ZP3R(9RWS,^H26M!++6]?*"K-]W++@
M1Z=:<:!]ZFEW-M"..NQ*Y79BV$6>B&210 N"5M)V2FE/.\]2/!=QDW6C'=9I
M=Z)GZ'4K[;N.7O=%[=D@-U87<#>[$8AS:>)4F4(+]J_^$-OA4K\_(T6ODJ+G
MI.C]="GNQ:-EIZF*O_^^SCPOL+VX'7SKWP^^7=RQ_O4Y^W1Q_G%P_9'US[ V
MN!]@F=@+,(]5D5N2HR[3C59CS3-V/Q%L6NBI,I!.C9@J-(NYF; 1(IY-PNZI
MWPVU(+A5\.$<0<\L#B.U('ARN+O6(H^?F'B,)SS'OYI;?$CSG2& :1OH6I%@
M Y(2L4M$KA 5G!9E18%@4J"L09[GGD>1NS3 TSD;R$I_(<&!#\E8Y-+N.!WG
M D()_Z?,K=#"V)I0W!@52\=\)BT4+BR9I=HYY4_>E)#^@6O)AZG8=<>Q(6.@
MG!LFC2F\]+_RO$!B).?N($L.C?A1X#@)0YB.8'B(_R2X9B)/FNPWP1+%<F4]
M#8 QCV6 Q>"@"4F.GV8JXB+U/E;:JLGN%?)J+&AQXBS-YY:V2/&6I <@:5J9
M40NBHG(SD5-O2U<8TO0)LL3.<Z$,MPY9F<=BZI)O@-IQ"0B7CX9E2'-LB$=D
M4- 1HY%PN9HP4:.1$=9)Y'W"$!P!Z,K+',*.6D):YX8[8Y.*Y)P #%+.N$Y8
MC(1$<>MD"(N[QG*]QL9FQH..B3!P4&=H.O>CX*D</<'^2XY.H'Z!J>:6 ,E:
M1(,4 %<Z\1B-N-1PC!2V4]Y-(9Y1J4P<JR%/.1!D+KO[?$ 4XA1^)T?2[3#X
M#&?GG/X&3#D0DA96 2GG*IYQA:(,<5$3P=MH#O]4Z;KQQISLH>&VQI0\URI*
MN'"HDDU53H^4$UPTTI(6$RKI[@">!=LB>MM.NYF3TJOW1+%K%YG"/(K!_7/8
MJM+ <!"AW,:D%=E*3)8))F2.FG<XEG4BR -2)2P!</"%V43&D[F;+AUU()E*
MF":[#$GLK,PN%V42NR5?NJ5\ 2L,Q9CG533Q.L84XU?B4<;J-:GN1AB%VMRX
M^L=U8YL6KCAECNB #1%"Y,?!H16XV)G:=7DCUL!QM\J ZR+#QXQ+4,[PTLPS
MYDH4S6!J8NQ*,GB#V_SQR)-:[R,3#F]&3GL451SZJ /33KO9CA@T:WV].V?J
MP27RNDRBIE$E]J">0:/#'7(G!X0#S.%@Y.-N1BW)&X&HG5^/P!$A< V)LR&$
M_N]AZ'6?AV%5((=#)<$F(!"8;W8(,3_MJP9!L*SS @Y=U["UG\/!Y2OOV8+2
M*W-:H1KPC"J2H72Y$:=.,ZK<Q>E_Q35BEWC^).65A4BHM+Z#\#)57H%9!Q4D
M=[6VIAUWW1!:U@"";UO;#BX^13_T**&U@(Z][G[S$-U]FE(J@")K7&\N=-WS
MEB$FV"N.H4_^TV#O-3O["[#7W*X3_=\A'ZU#/NHVHS^,/!:705X#?.=EX,W;
M@(^:^^TY\)=EASHHNY=YQ5DUBJ2Z9V4LI[PL/(O5(L<D;40NJ6M$TTC6B_$A
MJ5V)9>J'D*5N=2=42Y3TM$AHE-S4[[*^[V,V_G_*MHP0C&9.%AV\9W?S/OCB
MP751U-KR! )YEY"YOYK T_:JSZ%.O*K-:[*OF%%U:*26_V9\K(7P31QQ"*5]
MAZQ$K;7OQMPY]%)FQ_=&$DT"^3=5?3L3(@_V=*WGREA1&AX]OFO5J;U[HGN/
M0(,"*/>")+L%6JOEJ*BY;D#:B3XAI\_!!X"M#Z5WW38*;AD%.^"9%+&; 11[
M%^W5_F,")H"34@=$7; &-SRB#45(V(E6Q1A.0#:2Q*)J0N$N_:F6*3G+@>M&
M9R!(\U'EY*5S1\W>T2^^&Z0MY7SB&E :26 C[.J&JD>%\?/@],LM]8CM7Y8A
M.'TU! =[FR'H[3>/?B8"^R\AT(W>BD!S+X!@Q*K;^WG&$:V:?,B.M(;6PD]L
M&._$ _+#<N]?NNO*]$K#6"5]F+=&*L5 Y-"C",?H#W'(M1<'CNJR8,.T%)*)
M[^/ER_/1EMNC"@/HS/9[5K_:.J\-<(:=T=!V24-;>9=1OW<YJ_,X#3SNW WI
M9Q7[K%EV^U63?QER]%FH$:9<V;TKX5],SW?.&!^I#BY(NC6H:\'Z&TK9C193
M+FOC ?E+F+)<5:4IS! L[U".VOL1OO_ZE\-.U/E[M?+%;0_;RC^7O^]= 7Z1
M5C^.-5UCI$CJ99&H[UK]Y;FG"D[E_:EVLMP3[?0.V^'3"[*)OM]3?J]'K?V'
M4.ON[.WM+?#P*V]!;1.M/P>U]<*\GL>+,5SU*#Z+T":L+L0-O-Z&@@E+?/%7
M;-BP$J552&';1QKV0Z2_CMH_J2]SM\MK8L29W TC]0!+%E+!ZD5E+06]K^*\
MNI%<[E(I71A70L9*)9@059HX\_9Z/7P?')%3'D7[53IX]JZI2A'!05\P5+C5
M&>?RWR()-QVEV>CBQ/C+%8$\0@!O3K7/82)6;=:OZJ:SV-9G=X-S.Q<%B]Y1
MSQ9N? ;^QF?I^*VHW6A=:I516!19Z(&>H>,:O/![DR.\TD%6O/"G"/4_]$(X
MV9[/?T<N#W:07]H_U3>W7&K=7LDN*S[[?!I*W@8")-W:ZX+]LHKK]-E0-/UT
M "G=]2^#S&X,!"91;0B$\1-JNFF$\$$4[CKKP^;H)8OX*6>!R5YS?RT3'Z(E
MEU?=2;L>;EB[+24O'9&7\IJ7KKMT=?>H;LJSY05LN.\DYCF]3XHZ?A@UI$Q9
M%JN[U(+&I/2)3JRY<&>8?A0D\Z\*J(GTV6#.KKGNA5FK]@(S$WKL7M,2?^0)
M_RZS6JW>!/?]"]#Y=O\:^8KK,1DM%2,<;3</]AI,^U>S_L&JJ7L=.E36JLS]
MG @.I6@#_A\IC)[A@1A4[\=/_@-02P,$%     @ LH995"6?>?])#0  ,B8
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MOP0&I.)&/5CSH/.EN,"M#N*33+3182WZO:TGO3UQG8NO]D%E<^7$>PK^^-U
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M=I]%W8WM]OPI<M-9VS5\N5. *4T#\'[;=7:X(07CM^E7_P502P,$%     @
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MVO&,G+_H.WC"'](P^&>ZT$9A=7QZ(DR\"Q.[,/%WASGG.A-2-PHCSMF-@9G
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M6L5X ;K&UX[&!5..7W43SCU505HBY>2\6Y*(497/D6IYO\PI$M!%H 2:"=7
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M=3R93%V((4U0!;0:8[I)4Q#X&([-:^ASE/I!*_"K]("]*.@W]@<4] @1D_N
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M2R71A]( O)];&YH;FJ#]I'OT'U!+ P04    " "RAEE4!,%&1)H#  "8"0
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MP]'9)+')Y)I9P^\%@R2Y'?<0HC%>=&3=55=33DIGH("88DDJ-*5]\+5!7$<
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M# +P-5@.4Q\&41_N"M%?N,.&[FT-0FNE;$MOD<H-'U#IIO8+[/Y/!8[3Y*'
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M:Q:U2Z#X1BE[>G$%VHM[]A]02P,$%     @ LH995--*\\2W P  . @  !D
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;*U52X_;-A#^*P,U*!)
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M45D%DE=2FM/!.IA^O,M_ %!+ P04    " "RAEE4PBKHE+0#   4"   &0
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M>GZ:CGN'KR>_>*S%X 3G;0:9SA' 5H82))8A:("S# *6 FN@#,+XDF--\2V
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M#6]-PQ2L9(='J+&U_87!I:ADQV#RN]3:AP\N^7##;@TL.9+]^+7/<#KZ3<,
M,7=2,&&TX_!V=1F P%..AJ&W >R98D U;"3'DZEAT@HPC>PU%;7VSP&+'DM:
MP*I7BHGJ#FX4%1I5V,.TJ/_&VNP<^GN!MP%O_T%UO^(MH <A6#Z &U=4-_ *
M \!K5F^9'A/PV/]&&LIA23D5E6.$#'^CHL<[ MQWCTOX$29Q'F0%\7&:)04^
MRV$U"\ITZH^PU9.\MF->N<OKFN$5QO BJ3C5NMVTE9.B(<D)QBD1=)+'/I"
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M +HOF?W JM:7J4Q9*GJ^6]-?!FIG0.NE4O8X<!N,_RWK?P%02P,$%     @
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MMN@.#?UCB5YLB>+==[Q/]XF\\5JJ+WH)8-!S70E]G2R-6;U+4YTOH6;Z7*Y
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M>2P=!=.NM7T)%AO3/DM@\C[OC<K9LD6_-8WIP?Q=UKJ;=K*BR?O^1R0VA$E
M\5I3.C<#K4GDK70^4'QKFLL55[I5-8^Q_OW (C/0[]><J_T@^T#Y0S/] U!+
M P04    " "RAEE40(-3 7$&   ?(P  &0   'AL+W=O<FMS:&5E=',O<VAE
M970U,"YX;6R]6EUOHS@4_2M6=AYFI.D$?_ U2BNE:;=;J5-536='J]4^4.(D
M: !GP6EF]M>O(10'L)T,;?/2!G+OY=CXG(-O&&U8]CU?4LK!CR1.\]/!DO/5
MY^$P#Y<T"?)/;$53\<V<94G Q6&V&.:KC :S,BF)A\BRG&$21.G@;%2>N\O.
M1FS-XRBE=QG(UTD29#_/:<PVIP,X>#YQ'RV6O#@Q/!NM@@6=4OYU=9>)HV%=
M918E-,TCEH*,SD\'8_AY8N,BH8SX,Z*;?.<S*(;RR-CWXN!Z=CJP"D0TIB$O
M2@3BWQ.=T#@N*@D<_U9%!_4UB\3=S\_5?R\'+P;S&.1TPN)OT8PO3P?> ,SH
M/%C'_)YM_J#5@.RB7LCBO/P+-E6L-0#A.N<LJ9(%@B1*M_^#']5$["1 1Y.
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MRJL1S=4F+.>JF[#-LLNL@OE/9\BU/6R/AD^[4Z,(<UP,81W6 &77H&PC*+'
MULDZ#KB8@7'",A[]%Q0<5P'=5G)V$$"(/ ^U@';#/)\0K,;IU#@=(T[SK?H(
M;JER;ITN9 ?Y-FY!5H2YKN=X:LQNC=DU8E; O,I8GH/WES_">#TK6'W%V&P3
MQ?$'%7JW PM;$/IM]-TPY#F.2]3HO1J]9T9_^S"^O;H^O[D$X^GT\F'Z$:3J
M2?8Z*Q-ZWN[*W,)4A/DNPIH%[-<P?2/,.[%TTX*L7VCR2#,34:$EA=DZ@C#
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M;=_&V!YPMBI?:'ADG+.D_+BD8I>3%0'B^SEC_/F@N$#]3LS9_U!+ P04
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M60[@Y4*+I9MA9T*;B=A=9N:C!:4U,/?G0NCGA0U0?P:-_@-02P,$%     @
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M<FMS:&5E=',O<VAE970U-2YX;6R-5-MNVS ,_17"Z$,+M/$EZ65%8B")MZ[
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M&*5U,/>E$'IKV >ZZ9[^ U!+ P04    " "RAEE48 ]FOU<"  #2!0  &0
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M?ZQH=X-Q!G1?:(U[P3GH_PV2?U!+ P04    " "RAEE4HK+;QK\#  !."P
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M<I #>+_T*(!^(0:&"^GIOU!+ P04    " "RAEE4*7"[W'0#  "%#   &0
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M^2)WGZ$(J&?Y0AGK[)?L<MO =TB8:B.3 HP*$B[R?_98;$0-0(,&@%\ _.>
M;@.@4P ZIP*Z!:![*J!7 ++0W3SV;.-FS+#Q4,D=4=8:V>P@V_T,C?O%A3TH
M=T;A4XXX,[X*?Z=<<YLT3;["HR'O9F 8C_5[\H%\NYN1=V_>DS>$"_)U(U/-
M1*2'KD'/%N^&A9=)[L5O\$)]<BN%V6@R%Q%$AP0N2BYU^WO=$[^5<0;A.>G0
M,^)[/CTB:'HZW#L"GYT,IQ='X//3X8.6S>B42>QD?)T&ODFJ<45K4LLF^7&#
M:^3:0*)_MOCHECZZF8]N@X\IYH^+-0A#YDR)#UATR UG2QYS\W3L1.1TO8S.
MEJN'L=\;X&8]U+-TQ"CH>-ZAU>RE%>V_L)J_M.KVNS6K@[![9=B]UK 7J=(I
M-^2>Z3"-F3HCUP*3]^,6DB6HMHT-2@_!JR6O7_KHMT9QS,<968 *,9]X'Q"Y
M(O?2YA?#,Z! F\)6/7];\^2VNZ.>=^YY;UN$#TKA@_;M9T]X*Z$8(_=ZR#X8
MT&?DDY+Z:#T:O#@,_9[7=!@N2C47K6K"ZAW H>81*):E:]TD(^<+:C*LB@89
MU*N*MM<J!.](O $%F7%M^#(U4IUR(FGM4J"O=B:I7WGQ7R6YTX+WX%4/&G>U
MJJ*T\Y_36Q#6\QLTI[<JM?0_U]J"+SBHHXTZJMI'_ZWXD9N;:5OFJY)'7Z_F
MT:KHT?8R]._;V/_+=90+<6OM5@)JG?6Y&L],*DS>P92K92]]E760S]8G]'*:
M=\053=Z@WS*UYMB1Q;!"2N^\CYI4WO/F$R.W65.WE 9;Q&RXP>\$4-8 GZ^D
M-/N)=5!^>8S_ %!+ P04    " "RAEE4$([EWDH$  #?#P  &0   'AL+W=O
M<FMS:&5E=',O<VAE970V,2YX;6S-5]]OXC@0_E<LM ^[$FWB  %6%*F%]JY2
MNX?:[M[#ZAY,,H!O$YNU'6CWK[^QDX9L2:)33]7>"\0_9N;[QIX9SV0OU3>]
M 3#D,4V$/NMLC-E^]#P=;2!E^E1N0>#*2JJ4&1RJM:>W"ECLA-+$"WP_]%+&
M16<Z<7,+-9W(S"1<P$(1G:4I4T\7D,C]68=VGB?N^'IC[(0WG6S9&N[!?-XN
M%(Z\4DO,4Q":2T$4K,XZY_3CC(ZM@-OQA<->5[Z)I;*4\IL=7,=G'=\B@@0B
M8U4P_-O!#)+$:D(<WPNEG=*F%:Q^/VN_<N21S))IF,GD3QZ;S5EGU"$QK%B6
MF#NY_QT*0@.K+Y*)=K]D7^SU.R3*M)%I(8P(4B[R?_98.*(B0,,&@: 0"%X*
M]!L$>H5 SQ'-D3E:<V;8=*+DGBB[&[79#^<;)XULN+#'>&\4KG*4,]/SZ'O&
M-;<NU621*9UQ0[XP'64)4^2!+1,@[^=@&$_T!W)"/M_/R?MW'\@[P@5YV,A,
M,Q'KB6<0B]7H187=B]QNT&"7!N16"K/1Y%+$$/^LP$,2)9/@F<E%T*IQ#M$I
MZ=$N"?R U@":_7MQOP5.KW1LS^GK->B[R#3.:$TJ'B9?;W".7!M(]5\M-OJE
MC;ZST6^P,4,/<K$&80@P)4XP3$G"V9(GW#QUR2<IHDPI7*X[GUSUP*FVP;Z;
M!H/1>.+MJCX[WN27.WZ"/"@A#UHAO[QB77(MT/%?;R%=@FIS2EA:"-_,\</2
MQK"=!7M*K=>-Q#R$5A2096&V2P0F7[ERZ0L/AT1LRPU+"(O_QG"V8K7ADAL,
M*YX>TD&O5^_M48ES]'879'2$B Y[?L/YCTM$XU9$Y>G,9+KD@MG3Z>( ZT(,
MR@W)@V)"KP"!Q76XQD>X1J-1DZ>H?TB$_BN0G>?'&Y,[B(#O;#[LDBO&%=[@
M)(/:Q.<? 1P/F^!5\C1]!3Q$)=>"_T" US&>(U]QE[+/M0:C#^@Q29.;XN Y
M:+N>I1#;Z-NAF%1/M4SH$9.@'_8;J 0'*L&OH#++KW(AT"4+!5O&8W+YB&\>
M#4[P#[,!5>RH91P<AV$3WT,EH+U?P7>A\#&G;!PO$B9,U^V\1*EMVA#1!<XJ
MN] ?-] [%"':7H7>B-X5%]S R0V^\E"%,$RL.2JH/[;^<4X(&G,5/10KVEZM
MWOBF5A9MIHEDAL6!8'&QZFIY#HYXG@1TT$#S4#%I^+^AZ2*PEEM8P\T/F\@=
M2C5MK]5O1.X3U(?8<1T?]6F_Z28>"CEMK^1UKYHN^4W*>,^3I.N27&00\ -[
M)'.(,VR/')_47JI:I,?U/?#[8=" ]%#@Z6LJ_'_V]QSR%X$C6-W1_H@IP%9?
ML"=T, Q?9CVOTD*EH-:NL]3$A63>396S9?=Z[GHV[[ ];WUOF5IS[*826*&H
M?SI$XRKO)O.!D5O7D"VEP?;.?6ZP P=E-^#Z2DKS/+ &RIY^^@]02P,$%
M  @ LH995,_"W7A  P  9@P  !D   !X;"]W;W)K<VAE971S+W-H965T-C(N
M>&ULS5=+;]I $/XK*ZN'5J*QUP1"(D""T*J1DBK*HSE4/2SV8*^Z#[J[AJ:_
MOK-K8F@3W)S27/ ^YO%],\-X/%QK\]V6 ([\E$+9450ZMSR)8YN5()D]T$M0
M>+/01C*'6U/$=FF Y4%)BCA-DGXL&5?1>!C.+LUXJ"LGN()+0VPE)3/W4Q!Z
M/8IH]'!PQ8O2^8-X/%RR J[!W2XO#>[BQDK.)2C+M2(&%J-H0D^FM.\5@L07
M#FN[LR:>RESK[WYSEH^BQ"," 9GS)A@^5G *0GA+B./'QFC4^/2*N^L'ZQ\#
M>20S9Q9.M;CCN2M'T2 B.2Q8)=R57G^"#:&>MY=I8<,O66]DDXADE75:;I01
M@>2J?K*?FT#L**1TCT*Z44@#[MI10#ECCHV'1J^)\=)HS2\"U:"-X+CR6;EV
M!F\YZKGQ)/M1<<M]A"RYK(RMN"-?F,TJP0PY4XZI@L\%D+<S<(P+^XZ\?R37
M0<'L@'R] #D'\XV\(5R1FU)7EJG<#F.'0+V[.-N FM:@TCV@:$HNM'*E)1]4
M#OF?!F)DV-!,'VA.TU:+,T!\7=HA:9+2V^L9>?OF78O9;A.];C#;;8N>@9Q\
MY(H[>'^.%9;O1FUB+3A+OIZC(CES(.VW%K>'C=O#X/9PC]MI9?'$6G*JY9PK
MYK/7(5>0Z4+Q7QY!#LKQ!6<[&!JLF!-RCE=<8-K!^OM*0M[91^+)!-8 >P&@
M_^>OQH.TFR3#>/4$KU[#J]?*:P8K;!-+]'X#6:FTT,4]"8W"-L75$KY^XZ;_
MDED[:MP>O?:L'3W*6O\XV9>U0<-KT,KK[W"*I\/9(7>A1>+=9 4&6SZYM;"H
M!-):P%-HV]W2'KD'9FQ+9HX;!L>MIFX,RX%\9A*>56<TV3;7Y"4KC>YT=?K:
M:VV#<+?8:#+85VPTW5)+_T^Y_</O,^J-;M\;M-MJ[+-6F99+< BW,  XYSRO
MQ]'M.X(>OFCM;9LX;>_BKZ'V>H]J+^WM+;WM>X/V_U/IM?OM[J^\>&?TDV"*
M,.!:DNE*N7H*;$Z;(7I2CXY;\7H"OV"FX#@%"EB@:G)PA.$S]5!;;YQ>AD%R
MKAV.I6%9XH< &"^ ]PNMW</&.V@^+<:_ 5!+ P04    " "RAEE4O*X@XN$"
M  "9"   &0   'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6RU5EU/VS 4_2M7
M$0], I*XGZ"V4DOW@0121<?V,.W!36X3B\0.MD/AW\]VVA $B="TO32VXWO.
MN<?NO9GLA+Q7*:*&ISSC:NJE6A<7OJ^B%'.JSD2!W+S9"IE3;:8R\54AD<8N
M*,]\$@1#/Z>,>[.)6UO)V424.F,<5Q)4F>=4/B\P$[NI%WJ'A5N6I-HN^+-)
M01-<H[XK5M+,_!HE9CERQ00'B=NI-P\O%B&Q 6['#X8[U1B#364CQ+V=7,53
M+["*,,-(6PAJ'H]XB5EFD8R.ASVH5W/:P.;X@/[%)6^2V5"%ER+[R6*=3KVQ
M!S%N:9GI6['[AON$!A8O$IERO["K]HZ(!U&IM,CWP49!SGCUI$][(QH!)&P)
M(/L 9X1?$3F52ZKI;"+%#J3=;=#LP*7JHHTXQNVIK+4T;YF)T[-Y]% RQ:Q#
M"DR>)@L.5WQ;.MO7STICKF!=%D7&4,+Q$C5EF?H$1\ X?$]%J2B/U<371HR%
M]*,]\:(B)BW$(8$;P76JX#./,7X-X)LLZE3((94%Z41<8G0&O? $2$#"N_42
MCH\^=<#V:H=Z#K;7 KLP5G!4"AI6P:]KLP97UIS?'1S]FJ/O./HM'.M42'VJ
M4>80&5,83Y!K.U0L1DDMY6DBA7K7YPIZX*#MG_!Q%@9!,/$?WQ$TJ 4-.@5=
M"Y[\K9X*>=C4,VC3,ZSU##OUM-S,^F)VG,&HIAA][)PO1;YAG%9%@\<P5\I4
MQU>G/]\H+4U!Z3K[<<T[[DRMS6!H-7C\QF#2:O!YK>+\O]WR,'@I-L$_SG4/
M^+%DPT;5"SN%K.BS:2U:@195QA+A8 &J$_C:JB=\YW;W6P61%T&D4]#FX'_4
MN'VO/3J%B*H44I'%&QK=OZN.O*D%;\WR&]TB1YFXGFB)2ZZKQE&OUGUW7G6;
ME^U5T[ZA,F&F<62X-:'!V<@PRZH/5A,M"M=[-D*;3N:&J?EV0&DWF/=;(?1A
M8@GJKY'9'U!+ P04    " "RAEE4A=J\U$T#  !<"P  &0   'AL+W=O<FMS
M:&5E=',O<VAE970V-"YX;6R]5MN.VC 0_14KZD,K;3=Q"+<*D%AHU96ZTFJW
MEX=5'TPR$+>)36T'MG_?L1,""P%!I?8%8GO.S#F>R60&:ZE^ZA3 D.<\$WKH
MI<8LW_F^CE/(F;Z62Q!X,I<J9P:7:N'KI0*6.%">^6$0=/R<<>&-!F[O7HT&
MLC 9%W"OB"[RG*G?-Y#)]="CWF;C@2]28S?\T6#)%O (YLOR7N'*K[TD/ >A
MN11$P7SHC>F[*8TLP%E\Y;#6.\_$2IE)^=,N;I.A%UA&D$%LK N&?RN80)99
M3\CC5^74JV-:X.[SQOL')Q[%S)B&B<R^\<2D0Z_GD03FK,C,@UQ_A$I0V_J+
M9:;=+UE7MH%'XD(;F5=@9)!S4?ZSY^HB=@"T<P005H!P'Q = ;0J0.M<0%0!
MW%7[I11W#U-FV&B@Y)HH:XW>[(.[3(=&^5S8O#\:A:<<<6;T -JH(C:%XF)Q
M1?"(&5CPF'Q63&A6)4<DY%;@/A[:]>LI&,8S3>@;\I9\>9R2UZ_>D%>$"_(Y
ME85&>SWP#=*S0?RXHG)34@F/4*$AN9/"I)J\%PDD+QWXJ*L6%V[$W80G/4XA
MOB8M>D7"(*0-A";GPX,&^/1L..V?4-.J4]5R_EKGI,KEY $RS%9"QO;EX8:#
M)D_C&5IAWKZ?B!C5$2,7,3JO.'1='&:O./A.<< S]B0-C050AFN[<+8CK4:T
M%[2Z W^UFY5#J[ 7!?V75M-#JU[0[D:UU0O%[5IQ^WS%9)(RM6A64KKI[$1_
MBU*"/27M X[=_K[1]- (U0;-.CJUCLX%.G %:@576"BQ*EA&QLD/;"W8ODV3
MMLZ!-MIO=YL)=6M"W0N*=R*UJ2K8,2-/G]">W!K(]:G"[=71>O].?N\"^?V:
M4/\"0MOX&OOG(ZP WZ<8W(U\8#'/N/G=Q*Q_P P_[T<JA0;;+T!PDMLF(IED
M4EMZ3W>0ST"=2@3=^;[0_]2U:+B-&?Z[]%>^7^0_"OM';GG;O.DEW?MO7P"Z
M;=WT@MY]\1TT-.K#._!WQHX<L%/:\4V36!;"E!_I>K<>$<=N,-K;O[&CHQMG
MMF[*N?,.&S 7FF0P1Y?!=1<IJ7*4*Q=&+MUP,Y,&1R7WF.+X"\H:X/E<2K-9
MV #U0#WZ U!+ P04    " "RAEE4V\)WZHD$  "/%0  &0   'AL+W=O<FMS
M:&5E=',O<VAE970V-2YX;6R]6%U/XS@4_2M6M0^,-"6Q\]$&E4K0SNPB#1*"
MF=V'U3Z8]+;-3A)W;9<._W[M)"0!.Z$MB!=(G'NOS[E.SXD]V3'^4ZP!)/J5
MI;DX'ZREW)PYCHC7D%%QRC:0JR=+QC,JU2U?.6+#@2Z*I"QUB.N&3D:3?#"=
M%&,W?#IA6YDF.=QP)+991OGC):1L=S[ @Z>!VV2UEGK F4XV= 5W(']L;KBZ
M<^HJBR2#7"0L1QR6YX,+?#8GD4XH(OY,8"=:UTA3N6?LI[ZY6IP/7(T(4HBE
M+D'5OP>809KJ2@K'?U7103VG3FQ?/U7_6I!79.ZI@!E+_TH6<GT^& _0 I9T
MF\I;MOL#*D*!KA>S5!1_T:Z,'04#%&^%9%F5K!!D25[^I[^J1K02<-B10*H$
M\C+![TCPJ@1OWP2_2O"+SI14BC[,J:33"6<[Q'6TJJ8OBF86V8I^DNMUOY-<
M/4U4GIS>@I!\&\LM3_+59Z0>40FK)$;?.<T%K18G7Z"K7(VKA_K^9 Z2)JE
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M_@+G?#.6_],TE\0]53D3FG#8(&7H7V(Q5#-X&\/(RHVBM30XV-RRP+L*E'7
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M=#8X+GAM;+5746^C.!#^*Q;:DW:EO6(; LDJB=26[&ZE[6[5M'</JWMPDDE
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M]"0E5DXMY4;0M7[X%U3('JN7L9ST@"D!^7U)J=ANE(%Z=AS] 5!+ P04
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M/^/1JRB.'$I;A]*7.?35W;=F)V;W9F8'Z!9L$])&H"\@BZ[T+Z^3H$<@4J$
MHT)PG2L4QFA#'CMMN$PU:*A&3TQ!V,%TY$: _[V%\2O]6%"5B<J4RJVIF1Y:
M@LS.G&4_62KNIZ.WG3?L95S2Q^';KF3]@^[#MGZ_$[FC7"$&6T.$^T-S#LFZ
MFZH'6I2N(5D+;=H;]YB;#A2D#3#S6R'TT\#V.&U/._T'4$L#!!0    ( +*&
M650FYT=<9@,   P,   9    >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;*U7
M[V_:.A3]5ZZB3=HDVOP@"70") J;WJ1N0V5]^S#M@PD78LV)>;93VO?7/]M)
M\Z U="O[0N+DGN-S3Z[MRV#+Q4^9(RJX*U@IAUZNU.:=[\LLQX+(<[[!4K]9
M<5$0I8=B[<N-0+*TH(+Y41"D?D%HZ8T&]ME,C :\4HR6.!,@JZ(@XOX2&=\.
MO=![>'!-U[DR#_S18$/6.$=ULYD)/?);EB4ML)24ER!P-?3&X;M): $VXF^*
M6[ES#R:5!><_S>#C<N@%1A$RS)2A(/IRBQ-DS#!I'?\TI%X[IP'NWC^P?[#)
MZV061.*$LV]TJ?*AU_=@B2M2,77-MW]ADU!B^#+.I/V%;1,;>)!54O&B 6L%
M!2WK*[EKC-@!1/$!0-0 HL> Y "@VP"Z-M%:F4UK2A09#03?@C#1FLW<6&\L
M6F=#2_,9YTKHMU3CU.@#+4F9(5RA]D+"O-IL&.K/I B#2\+LN[FMIX]E733&
M_#=35(0R^1;.X&8^A3>OWL(KH"5\S7DE2;F4 U]I=68./VN47-9*H@-*IIB=
M0S?L0!1$H0,^^75XL _WM2>M,5%K3&3YN@?X&D.^CQ=2"5UL/XYP=EO.KN6,
M?\7L#M@U<\979S<282PEJ@Z0E4(!XRRKBHH1A4L8%UPH^J\UWN5J/65BIS2+
M]G84I;WNP+_=]<X1=!$F;=!>-G&;3?P[V5Q1LJ",JOL.3"HA= FYU-:4Z8Z0
M-'XL]FE,DL1NK4FK-7FAUL^\S [+39Y(B8*T]TBO(ZC;[[L%IZW@]$6"72+3
MIQ^W%P:/1#J"+N+(+;+7BNR=6L]SI8O8["? 5U#'4[VUS+BD=B?Y_OY.F4-A
MP1#>EU6!PA;Z#U>>Q\5\4;E9.69:U^XS>2EZSYE^ZTS_M+7Q9YTY+D;O)J+2
M.PEK5%!T&G0BR9Y/%ZU/%R>ORS]KU7$]=1E<'3?J)(H]F\+@_V,Z^!VCOMGV
MQ)P.MSK9-<(UFIZ-ENLZ KZB*)QG\/%I$KA'(B3TH."ERB6DL"3W3A>>84H;
MIOB!*8H=5/MN[#0MX4EN3*G,>*7KY5H73@=F*+(#&_PS$\7G4?^U,_MG<;W7
MKE3]G5;-],F?B%C34@+#E28*SGMZAQ9UZUD/%-_8[FW!E>X%[6VNVW44)D"_
M7W&N'@:F(6S_ (S^ U!+ P04    " "RAEE4(<Q!,-4"  "0"0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970W-BYX;6RUEEUOFS 4AO^*A7;12FGY#E"12&VR
M:I-:+>K'IFG:A0.'8!5P9INF_?>S#679XD25UMX$'_#[GN>8V(=T0]D#+P$$
M>JJKAD^L4HCUF6WSK(0:\U.ZAD8^*2BKL9 A6]E\S0#G6E17MN<X8[O&I+&F
MJ;ZW8-.4MJ(B#2P8XFU=8_9\ 17=3"S7>KEQ0U:E4#?L:;K&*[@%<;]>,!G9
M@TM.:F@XH0UB4$RL<_=LYFJ!GO&5P(9OC9$J94GI@PH^YQ/+441002:4!9:7
M1YA!52DGR?&K-[6&G$JX/7YQO]3%RV*6F,.,5M](+LJ)%5LHAP*WE;BAFT_0
M%Q0JOXQ67/^B33<WDAFSE@M:]V(9UZ3IKOBI7X@M@1OL$7B]P'NMP.\%OBZT
M(]-ES;' TY31#6)JMG13 [TV6BVK(8UZC;>"R:=$ZL3T"N0:<*0OZ!J+EA'Q
MC([F(#"I^#$Z0?>W<W3TX1A]0*1!=R5M.6YRGMI"9E<>=M9GNN@R>7LRS2$[
M1;X[0I[CN0;Y[/5RYV^Y+6L>"O>&PCWMYQ\N_,?YD@LF_TP_#WCZ@Z>O/8.]
MGIP#C-"7-3 L2+/JUG6$K@A>DDJN[ @M\+/<!8*/T VH;98#0[1 EX1GN$+?
M 3/3TG9Y0YU7[<S'J>O$<93:CP;<8, -WA!WWH+&0W<;:D+L<HVW$),@],V$
MX4 8O@MAR0!,C.$.8QS$L9EQ/#".WX/QDK;&-SW>00Q=+S$C1@-B]"Z(\H U
M(48[B$$<>&;$>$",WQ@1%T)NG8.@\0ZHZX31GEV3#*3)VY*:R)+=)4S\:&PF
M<YT_A[GSWVSW32[/&MHV G+T\2F3$G1>J]AXICL[I"=C/]E'NM5VW(.D^PF-
M%.[.^1=X2>P,%'T',4Q+HO#?W6-OM4OUK7*-V8HT'%502)US&DD#UK7_+A!T
MK3OHD@K9C_6PE)],P-0$^;R@5+P$JBD/'V'3WU!+ P04    " "RAEE4>>)O
M8+<"   A"0  &0   'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6RMEEU/VS 4
MAO^*%7$!4B'?:8O:2M .;1)H%1^;IFD7;G+:6"1V9SL$_OUL)V1%<1%"O6E\
M'+^OGW/:^GA2,_XH<@")GLN"BJF32[D]=UV1YE!B<<:V0-6;->,EEBKD&U=L
M.>#,B,K"#3PO<4M,J#.;F+DEGTU8)0M"8<F1J,H2\Y=+*%@]=7SG=>*6;'*I
M)]S99(LW< ?R8;OD*G([EXR40 5A%'%83YT+_WSN&X%9\8- +7;&2*>R8NQ1
M!]^RJ>-I(B@@E=H"J\<3S*$HM)/B^-N:.MV>6K@[?G6_,LFK9%98P)P5/TDF
M\ZDS<E &:UP5\I;57Z%-*-9^*2N$^41ULS:)'9160K*R%2N"DM#FB9_;0NP(
M_&B/(&@%P4<%82L(3:(-F4EK@26>33BK$=>KE9L>F-H8M<J&4/TUWDFNWA*E
MD[-K4#40Z(I03%- )D0W6%:<R!=TO ")22%.T"EZN%N@XZ,3=(0(1?<YJP2F
MF9BX4E%H+S=M=[QL=@SV[+B ] R%_@ %7N!;Y/./R[VW<E?EWA4@Z H0&+_P
M_0+\OE@)R=6/ZL\[GF'G&1K/:(_GFVH.T#7!*U*H>@Z09&@%:(E)-D"_ '/T
MG8*MA(U_;/SU/_%I-HS&$_?) A5U4-&AH.YK9H-J_)./0,4=5'PPJ)R#M59Q
M#RN*1W:LI,-*#H5UQ2INHTIZ5$$RM%,-.ZKAP:C4V6BC&O:I_,A.->JH1@>@
MPFL)_'VV48\M\6,[V[AC&W^2;8E?5#.2 [2HK##C'DSHQ8&=QO?^'[;>)WD>
M:$9$RBHJ(4-?GE,0 EV4.K:>L%X/[S2,]N'M] +_4WA6!+]W1 5#W^L0VK/<
MLFK< W5W^I>^/-Q@OB%4H +62N:=#96>-_VX"23;FI:V8E(U2#/,U1T&N%Z@
MWJ\9DZ^![I+=K6CV#U!+ P04    " "RAEE4\JYBZQ,#   ("0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970W."YX;6R]5M]OVC 0_E>LJ ^MU#8_"6D%2% V
MK0^;4%FWAVD/)CF(U<1FMBGM_OJ=G9!2"%&?]@+VY;[O[KN+?1ELA7Q2.8 F
M+V7!U=#)M5[?NJY*<RBINA9KX/AD*61)-6[ERE5K"32SH+)P \^+W9(R[HP&
MUC:3HX'8Z()QF$FB-F5)Y>L$"K$=.KZS,SRP5:Z-P1T-UG0%<]"/ZYG$G=NP
M9*P$KIC@1,)RZ(S]VVEB_*W##P9;M;<F1LE"B">SN<^&CF<2@@)2;1@H_CW#
M'12%(<(T_M2<3A/2 /?7._;/5CMJ65 %=Z+XR3*=#YW$(1DLZ:;0#V+[!6H]
M/<.7BD+97[*M?3V'I!NE15F#,8.2\>J?OM1UV /XR0E 4 ."0T!T A#6@/"C
M@*@&1+8RE11;ARG5=#208DND\48VL[#%M&B4S[AI^UQ+?,H0IT?SG$H@$ZQ<
M1L9;*C,RUR)]JBUWHL3W2U';HO,I:,H*=4&NR.-\2L[/+L@989Q\S\5&49ZI
M@:LQ)4/LIG7X214^.!'>#\A7P76NR">>0?:>P$4MC:!@)V@2=#).(;TFH7])
M B_P6Q*Z^SC<:X%//PSW;SK4A$U[0LL7=K7G:F&;,:.O>-XT&4M)^0KL^M=X
MH;3$P_.[(UC4!(MLL.A4,-OY=*_G;0VM.'J6PUPJSZ.@'T98ZN?]*K=XA3>]
MZ+W7M,7+O_&3QNN=C%XCH]<IXSM](0O@L&2:+*4HB3*ZZB+NJ\.-TFT2*_YX
M+ZTXO#E4>.S4Z\6' H^=HB3RVO7%C;ZX4]\]SYC$:Y/H-Z%M*N*CV$'2.Q 1
M'S7 #[SP0,2Q4YR<T-!O-/2[7[7N]_J2?!/\&93>W4J7>!4IC59-7G$6/D J
M5IS]!7PP+L6&MQ:@?Y1WB.I.9)XTF2?_*_,92"8R@K-[9SYUYKI3\CU25I=H
M$)&,OJJVN\#=FQ$ER)6=M0J/ !:ONET;:S/.QW:*'=@G..:KJ?Q&4WTC?*5R
MQ;@B!2R1TKON8^EE-7>KC19K.XD60N-<L\L</U5 &@=\OA1"[S8F0//Q,_H'
M4$L#!!0    ( +*&651'(. W]0(  &,)   9    >&PO=V]R:W-H965T<R]S
M:&5E=#<Y+GAM;,U676_:,!3]*U:>-JEMOB#0"I" [J/2V%#1MH=J#R:Y(5'M
M.+,-M/OUNW9"2DM#^[)J+V []YQ[CJ^_!ELA;U4&H,D=9X4:.IG6Y87KJC@#
M3M69**' +ZF0G&KLRI6K2@DTL2#.W,#S(I?3O'!& SLVEZ.!6&N6%S"71*TY
MI_)^ DQLAX[O[ :N\U6FS8 [&I1T!0O0W\NYQ)[;L"0YAT+EHB 2TJ$S]B^F
MO@78B!\Y;-5>FQ@K2R%N3><J&3J>400,8FTH*/YM8 J,&2;4\;LF=9J<!KC?
MWK%_M.;1S)(JF KV,T]T-G3Z#DD@I6NFK\7V,]2&NH8O%DS97[*M8SV'Q&NE
M!:_!J(#G1?5/[^J)V /X40L@J '!4T"G!1#6@- :K9196Y=4T]% BBV1)AK9
M3,/.C46CF[PP95QHB5]SQ.G1(J,2R 0G(B'C+94)66@1WY)OI9WE.:.%(N\N
M0=.<J??DE"@#4 -78W)#X<9UHDF5*&A)Y =D)@J=*?*A2"!Y3."BZD9ZL),^
M"8XR7D)\1D+_A 1>X#\C:/IJN.\?D1,V,QE:ODX+GZ&Q\T5N9L"7('\=(>TT
MI!U+&K:5QQ;CJHBA,,N]KL?-%PPC5QJX.I:DVR3I'E5NU\#ITJZ!J>!X0BAJ
MJS^6DA8KP%VKR?*>[,?-Z;T=MFOFA'Q=&\=$I%60(N.USH3,_SRM=%782D]D
M]9B#9C,*SX.NYWD#=[-?P<.XR$0]A#WR&S5^H[?S.TZ2W( I>YWUZ-!ZT.NV
M>NHUGGHO>U)$HP&5@I0H.96"X_%<@D0#V"]Q[3RGJ'>@*(C"L$U0OQ'4?_M%
MM<%3B"X9$+R_R"?DT<\9ZA\8ZOC]?JNC\\;1^0L;W M?O<%][^$ ]O[=%O?W
MSGG_?ZU'K>S1"NOT>P?U</>N,0YR96]W16*Q+G1UHS6CS0MB;.]-]R&\>G[,
MJ%SE.(T,4H1Z9ST\261UHU<=+4I[*2Z%QBO6-C-\!8$T ?@]%4+O.B9!\ZX:
M_0502P,$%     @ LH995!4A+1[F P  \PP  !D   !X;"]W;W)K<VAE971S
M+W-H965T.# N>&ULI5=M;^(X$/XK([0GM=(V;Q "*XK4-NW=2M>[JFQW=5KM
M!T,&L)K$G&V@_?<W=M(L4#?'[GX!VYGGR3PS]G@RV@KYJ):(&IZ*O%3GG:76
MJP^^KV9++)CRQ I+>C(7LF":IG+AJY5$EEE0D?M1$/3]@O&R,Q[9M3LY'HFU
MSGF)=Q+4NBB8?+[$7&S/.V'G9>&>+Y;:+/CCT8HM<(+Z874G:>8W+!DOL%1<
ME"!Q?MZY"#^DH058B\\<MVIG#$;*5(A',_F8G7<"XQ'F.-.&@M'?!J\PSPT3
M^?%O3=IIWFF N^,7]ALKGL1,F<(KD7_AF5Z>=P8=R'#.UKF^%]L_L!84&[Z9
MR)7]A6UM&W1@ME9:%#68/"AX6?VSISH0.X P>0,0U8#H6$"W!G2/!?1J0,]&
MII)BXY RS<8C*;8@C36QF8$-ID63?%Z:O$^TI*><<'H\63*)<$F1R^!BRV0&
M$RUFC_#WRJ1%P>^2E9J>L3*#SRQ?,YNMDQ0UX[DZA3/X1-O@;&H)E(4*"X6O
MMUA,47XCDX=)"B?O3N$=^*#,"Q7P$AY*KM5[6J3QIZ58*WJ'&OF:5!G?_%FM
MX+)2$+VA((S@5I1ZJ>"ZS##;)_ I'$U,HI>87$:MC"G./.B&[R$*HM#AT-7Q
M\, !3X^&A\,6-=TFPUW+UVW+<)V@*U%0P5!5$B\DY7:!=(@U3)]AU^Z./=OE
M:D=\_9,HX:/&0GUK<:C7.-2S#O7><.BOM=D7(.;U3E&PJ#:9*_<55=]2F1JV
M&2?#D**ZV<V'PR@<'ABEKXWZ43]NC/:DQ(V4N%6*V?M0A6Q/"V1,(\P9E["A
M0X,N915SO.-/' T.A+VVZ47Q@2Z73<\MJ]_(ZK?*NGY:45DF41IE 2?/R*0Z
M=6EHIXG!(J$/A3V@KJ/TRPSIKS#L12=IHI,<%YVJW*TDGR%L1$ZG*N?ZV16G
M=L)N[ 7!;Z[H_"0N;<=%@]>XO4@,FD@,6HGNN7H\NY%(Q8'.+Y5U#?>T\5T1
M:"<*O*$[ /\'Z[GUM\,B+VJ5/VSD#X_;""G?\ SIAOR'8^XL8^U$P5OY_SE8
M^L.P/?EA\+UW"%J9OMBNRG0.&Y34)<+U$\H95PAWYE X[_**,=DI5]2B>D%R
M4/D<=N$@](;#@^KGXHMB+TK<%3#<Z8O"']-F.R%(36&_,87==$,(*W.3V=+O
M5!N^\J[?]Y+#,N\PBX=>\$JK@RWQDNZ!5'^G&RQ0+FQ7K6 FUJ6NFJ!FM>G<
M+VR_>K!^:3IZVV5^IZD^!VZ97'"Z['*<$V7@)73]R*K#KB9:K&S/.16:.E@[
M7-)7"4IC0,_G0NB7B7E!\YTS_@]02P,$%     @ LH995&HE>AAV!   LQ$
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M!9L;8,AW7:_'AT<3"#RY@"_+N>*$0@U1HQ^=1ZF&33.'SO\U^0ZSHB>(3K<
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MQX'DQ,KKEO)!T*V^@%A1(6BNEPG!,6$*(-^O*17O#^H#]:77[#]02P,$%
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MY0]R\3B]@H\?/L$'<$"9,!0D>;GMC"9I_!"+0I%C-7 T8341._,MKLL2EW<
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M95H@R[MP^:#%REXG9T+3Y=0.8^012K.!UA="Z+<'\X+J/Q+#OP%02P,$%
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M)^CC*\[5\\"\F2M?K,[^ U!+ P04    " "RAEE41.?H[OX$  !2'P  &0
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M$'A22=50@TNU\/52 2T=J>%^% 1G?D.9\++4[=VH+)6MX4S C2*Z;1JJ_DV
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MIC@44J$!^#SA7&TV^@7UF#G]!U!+ P04    " "RAEE4)F&E:9L#  !&#@
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MF,I^85?8>@Z$J=(B*< F@H3R_)]\+Q)1 ?B](X"@  2O 9TC@'8!:)\+Z!2
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MX#Z_5LK>7Q2/J-6/),[^!U!+ P04    " "RAEE48*?_#R\$  #B#@  &0
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MN[MOW1U5J;9<I"T7J>)YX^4Z%J-3B[H&%VU-_KU>"\G5+/UO)*W7IO6JM/Y
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M"EP;J/=;QN3Q1A]SVF/MXG]02P,$%     @ LH995"[XI\._ P  XPP  !D
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M0'=SSC+J4J71C3V%Y *-%:3,H*EB"<LS]/D:#&5<?^E'QG([A"C9\HQ*'G*
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M>R+ ^ "WO]<:3XXGZ!^=_ ]02P,$%     @ LH995';BZ:<,!@  2AX  !H
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M<ZMQJ:'J^[*XZQ&HV+7R#J":K>Z3+HI;E-;\)3Z;EK="M9GRDNI&T4F<"93
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M;&!A#/3[.>=J.S$.JL^7P3]02P,$%     @ LH995,M4'&[K!   :Q@  !H
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M%S]6CM@1@&Z' *H$D"I@=PA8E8!UK(!="=C'"CB50$G=V'(O'1=@@<<C1C>
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MF";J';@"7U=S\/;-._ &4 Z^Q")3!JW&KC8YY9[=L(Q_6\1'+?$A O<F2*S
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M+'L@L@XYFRB^M%WIF"O=X]KA0LLK$6:#?C[C7&TFIM$M_J=T?P-02P,$%
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M"YKRXA,<*JS= XL=%W13!<L,-DE6?N/':B!. J!_)@!5 :@;X)X)<*H Y](
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M_$+Y1)JWV*'7-3T-2FYKNJPT34$O=,\P:SP=/?-.?*E^JIZKS,VSD$@#&<#
M.T.B<6YD=NX72FBHO&*CH>-V6:DHM>0B'<I7)-0Z.>/=$+FB\L-U#HH%5)Z$
MUD_K _Q)<6S=>3Z%UU%Y#-\T4_XK<"L7:I)QD)*E;-*^"F1*K#QH+V\$W18G
MR=^H$'137*X)C@G+ ?+W):7B>)-W4/_=,?X74$L#!!0    ( +*&653!8V"[
M-0,  - 3   -    >&PO<W1Y;&5S+GAM;-U8T4[;,!3]E<A,$T@329L1FM%6
MVBHA3=HF)/JP-^0V3FO)L3/'92U?/]\X3=KBRQ@/6UDJ&ON>G'./[1ML&%9F
M(]CMDC$3K LAJQ%9&E-^",-JOF0%K<Y5R:1%<J4+:FQ7+\*JU(QF%9 *$?:C
M* D+RB49#^6JN"Y,%<S52IH12=I0X&Z?LQ'I)>])X.0F*F,C<G?Z]L=*F:LW
M@;N?O#LYB>[.K@[CIS5P1D*OZ,4S1,\C7-=BF'3R+.DGE#'ARWWA3NAWQ(&7
M&$6[W @?4(K0]]@U.6Q6=#S,E>P6-B8N8-5IP8)[*D9D0@6?:0ZLG!9<;%RX
M#X&Y$DH'QE:43=>#2/7@X)[K0;$U.@672M>Y70;W/6L>/P"V/3#(A6@-]HD+
MC(<E-89I>6T[]<-U\!$4-.WIIK0.%YIN>OT+TA'JFTTR4SICNDW3(]O0>"A8
M#G8T7RSA;E09 FB,*FPCXW2A)*T];!E-P\K.F1"W\"9^S_>TU_G.ND6P:K)M
M6D--T\FX#NCOJCGM7=GX1;I!R>^5^;2RPY%U'PJ<W6B6\W7=7^>M 4R]AZO3
MLA2;CX(O9,'<X)^=<#RD6UZP5)H_V&Q0*G,;8)H$]TP;/M^-_-2TG+*UV9;3
M.L<]]U^AY[\[SPLFF:9BU[2M_6.>Y1<[;K:N?^&Y_K5RZ-AK,KX\?H_-=GWL
M)I/78/(5+'><'K_'YE!U[":/<R;#YI"Q<Y+9.\>TT0#.BR/R#4Z?HDL:S%9<
M&"Z;WI)G&9./CC-6WM"9_7-E3]\^G[&<KH29MN"(=.VO+..K(FV?NH&):)[J
MVE]@>+VD/:S:7%QF;,VR2=/5BUG=#&S#9FTN(!PBU_7E1S".P_P(8%@>S '&
M<2PLS_\TG@$Z'H=AW@9>9(!R!BC'L7S(I/Y@>?R<U%[^D:9I'"<)-J.3B=?!
M!)NW)($?OQKF#1A8'LCT9W.-KS9>(4_7 ;:F3U4(-E*\$K&1XG,-B'_>@)&F
M_M7&\@ #6P6L=B"_/P_4E)\3Q["JF#?L#<:1-,40J$5_C28),CL)?/SK@[TE
M<9RF?@0POX,XQA!X&W$$<P >,"2.ZWWP8#\*M_M4V/T/;_P+4$L#!!0    (
M +*&6527BKL<P    !,"   +    7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP
M!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T0
M4FE:U;@!2+8ECVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7
MG:4]VR]/06^ KSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B
M6!::1<G3HAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!0
M2P,$%     @ LH995,81J71G"   G$X   \   !X;"]W;W)K8F]O:RYX;6S%
MG%USXC@6AO^*BHO=3%7/Q@9LH+?351F2='=5II-J,GU+"5N JOW!2':2GE^_
MD@FS1P'>W9L3;CK8T.9!LO7H2$?Z\%2;'XNZ_B&>RZ*R%[UUTVS>GY_;;*U*
M:?]5;U3EWEG6II2-.S2K<[LQ2N9VK513%N?]*$K/2ZFKWL</NVO=FW-Z4#<J
M:W1=N9/^Q'>MGNQ_W_>'XE%;O="%;GY>]+K7A>J)4E>ZU'^I_*(7]81=UT^?
M:Z/_JJM&%K/,U$5QT8NW;WQ7IM'9WNF9AWR0"]N=:>3BFW0@%[TT<A=<:F.;
M[A/=]:5C?%3NP]NCMJEO=-$H<R4;]<G4[497*W\9]RO.R<_HRF'W=UN([\W_
M4XSU<JDS=55G;:FJ9EN.1A4>L+)KO;$]4<E27?1V'Q&RRL5UU;A"$E^J[:7<
M9_TO=5_])=_^ZL;ADC(T[[5[PWS).W ^R,LVU\T1K#[ ZO-B3=UQ7>C<?7LN
M?I.%K#(ENCJW!'    =O"#CS$/X_6%$O76%F-8$< L@A+^3?7!YK6I>N 5BK
MRKK'Y35D B"3DY7DK*DS ID"R/1DD%-IUP1R!"!')WMHQ-F]))!C #D^X3TY
M[Q/("8"<\$)^4I4RLNA:[EE;EM+\[.Y'O:JTNP1MNB/4=D?,C7?V9^N^M#LO
MSKXZ7]M?*!OT"K-8OBG;F#9K6N/\^\X],\:!K'0F'HRL++T98^29F%DTW]2C
MJEIUJ/2076)FO=PJ:=7!.D4ZB;E]LI9&N9;%NO;E\DD:]W!T9Z1_;07%1$*)
MF8URI8Q^E+Y7:+LG^+/*5^XF%)>^IZ@;BHF4$C,[Y49J([[+PMU]O[OJ;LVV
M63Q0Y\@I,;-4[HW:2)UO2_*N62LCIJTQGO326D4QD55B9JU<9IEIW6UYJV47
MC^BN[E^ ;VE7)T9>B9G%<EM7JU\?E"G%W:+0*WFLZ>XCK?29M>+[AJ42#_)9
MV3F%0C[I,_ODDZI71F[6SB D6MD:VFF98L*XA=DGOLOZ8UT7N3+VG^+:^;GY
M2=F05/KL,4M9ZF;;<?7EYOJ+C6L7596YIX5"(L?TF1TSK8M"+FK3M=^DT;DT
MKM^PHNU-'SFFS^R86;NPZL_6-X/7C[Y$*1BR2I_9*K/KJ9BYZ^1MH=ZY4FMT
M5B@1]W^-)N^<;2@FTDJ?62NPAQV$ 7VDE3ZS5C#F@&(BK?29M1($ O>ML:[9
M<95ML[:01IS1(1,DE@&S6&!,$%3Z *EFP!ZZO,0$#])]<>#E 7++@-DMNZ#@
M !8<"6/6RGY4<(@0.67 [!08$(3W'7+*@-DIQP*" Z6)##-@-@R,",+21(89
M,!L&1@0A)C+,@-DP1R*" W6.!#-@%@P-"<3+02.?1:YM5M2T\S-$@ADR"P8&
M"4&=#Y%@ALR".10D'*KR(;+-D#N2>=W#/4B(Q#-D%@_NG TI)IR$8;8/QDPH
M)K+/D-D^&#.EF,@^0V;[8,P1Q43V&9XTOAE33&2?X4GCFPG%1/H9GG ^9MY-
MP?P]D8GTD[#K!V'&%!/I)V$?2D.8U)()$E#"+"",26/O!%DH.:&%YC&U4((L
ME)S00O.86BB!R0 GM- \IA9*D(62$UIH'E,+)<A"R0DM-(^IA1)DH>2$%IK'
MU$()LE#REJ-L#^K9A>97JI&Z"+K$*3)0^I89 7L#@0\4$QDHY<XZ@YA?*"8R
M4,ILH #SIC;*W9 ^L&RMCRIG%!,9*&4V$!Y6I:),D8%29@-A3"K*%!DH9380
MQJ2B3&%"&K.!=H/45]K*U<JH[<B1;S:[=R@F,E#*;""(&8S(I,A *;.!=IA^
M2M3(K E&#<^N*"8R4,IL((CY0"='1\A"(V8+[28J#MAQA+0S8M;."U?WQY6A
M/2SP$5+.Z&WF>&;M9E-TP_^N6^0S3,5-43^)6XJ)E#-ZF_RT )-DG%),I)P1
MLW)N=-4A'<&EF$@Y(V;E!/?E[]*KQP\('[HWD7)&S,IYP0P*E>!23)@%S:R<
M UF*?KS]Y<R48B+EC+@3H8]@WFTZ0U),I)P1LW(P)IWY&2/EC)F5 S&#?L88
M&6C,/?-S)(-V^SJGF,A"8^ZYGSW,E^H6ZED9FO\^1A8:OWGFP;?9']THPKU_
M03&1A<9OGC9-,,-[$UEHS)W2MH=Y/;N_%U^EZ9+Q*":RT)C90CB9@T:[8V2A
M,;.%,":-=L=P-0ZSA3 FC7;'R$)C9@MA3#HL/$$6FC!;Z$@&SVZLD&(B"TV8
M+70LT>BEPTDQD84FS!8Z@KD[33&1A2;,%H*8X8HV9*$)LX5PVA9M-R?(0A-F
M"^&TK0 366C";"&,29OW";+0A-E"1[++#D26$V2AR4F2X&YUI;I5HA03K@H]
M01;<V6UM[2]B:>J28,817A?ZABMX_+_BWM0>P\65ONX#4+A(-&(V40 Z7?L5
M'D)7/K70'6^"5:(17"8:,;LH +U>+E6WZT27 ^GG!P)0N' T8K91 'JEELHU
M\;DKTY>4S0 4KB6-F'T4@-YME \R7(_./TYB*DT "E>31LQ&VGN8')WYZ2ZU
MO^HU@NM)(V8G[8%^[G8#V(TD!J!P26G$;*4 ](\JU[8Q>M'Z;0O<]<*'"2XJ
MC9B]] K4J*Q>57YGF^[!7P2@<%EIQ)X@AQ*?::\IQCL6<&]9<#CU^4!_)/X?
MNQ><(D7;=?K:LBU>M?=X_P+N#0S@HLZ@ZQ3C'0VXMS2 "SN#,"G&FQRP[W*P
MG_A^\/Z$4N+>XV ?<NH\KUTLMS)*!5U1O,D!]RX'^Z!=/_^V=M'2I?B'+#?_
M#F"AF+@W.T"POXG+ !2*B7N[ [C*]]7#!,6TW?#@O/NX_?@A5TL7=.5?W9=8
M=SZ3179OA/_37:L_3/SEEFU13-VYN\J53+[;7&VW,=S'_P!02P,$%     @
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MX[C_Q_'+->ZK=GC-3Y9_OKCY"5!+ 0(4 Q0    ( +*&650'04UB@0   +$
M   0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%
M  @ LH995-I(:XON    *P(  !$              ( !KP   &1O8U!R;W!S
M+V-O<F4N>&UL4$L! A0#%     @ LH995)E<G",0!@  G"<  !,
M     ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " "RAEE4
M1MT#SX<&  #S&0  &               @($-"   >&PO=V]R:W-H965T<R]S
M:&5E=#$N>&UL4$L! A0#%     @ LH995!WA:[TF @  ;04  !@
M     ("!R@X  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    (
M +*&650A"JX+:0<  ,@<   8              " @281  !X;"]W;W)K<VAE
M971S+W-H965T,RYX;6Q02P$"% ,4    " "RAEE4F/_OO8D%  #M%   &
M            @('%&   >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#
M%     @ LH995)[8E*PW P  W0D  !@              ("!A!X  'AL+W=O
M<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( +*&650I/*8GB08  ,L@
M   8              " @?$A  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q0
M2P$"% ,4    " "RAEE4'-*X]$P,   K.   &               @(&P*
M>&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ LH995,D7*RH%
M P  ! H  !@              ("!,C4  'AL+W=O<FMS:&5E=',O<VAE970X
M+GAM;%!+ 0(4 Q0    ( +*&652-_*?"Q (  -L'   8              "
M@6TX  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " "RAEE4
M>!N,^T8@   #8   &0              @(%G.P  >&PO=V]R:W-H965T<R]S
M:&5E=#$P+GAM;%!+ 0(4 Q0    ( +*&652%B]+%=P@  %44   9
M      " @>1;  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%
M  @ LH995'Z&GY[D!0  !0X  !D              ("!DF0  'AL+W=O<FMS
M:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " "RAEE4\V[<'X(+  #:'0
M&0              @(&M:@  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+
M 0(4 Q0    ( +*&653>O]71MP<  '\4   9              " @69V  !X
M;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ LH995&JK^V]K
M$@  %3\  !D              ("!5'X  'AL+W=O<FMS:&5E=',O<VAE970Q
M-2YX;6Q02P$"% ,4    " "RAEE46'CSD,0)   K'P  &0
M@('VD   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( +*&
M650EGWG_20T  #(F   9              " @?&:  !X;"]W;W)K<VAE971S
M+W-H965T,3<N>&UL4$L! A0#%     @ LH995/SOZ?Z> P  HP<  !D
M         ("!<:@  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4
M    " "RAEE4\F/<PN #  !-"   &0              @(%&K   >&PO=V]R
M:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( +*&6526RD;N> H  "8:
M   9              " @5VP  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL
M4$L! A0#%     @ LH995"Y$K5R0#   IQX  !D              ("!#+L
M 'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " "RAEE48CD>
MCCD$  !C"   &0              @('3QP  >&PO=V]R:W-H965T<R]S:&5E
M=#(R+GAM;%!+ 0(4 Q0    ( +*&652NGDY6:P4  "(.   9
M  " @4/,  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @
MLH995#V4^0SG!P   10  !D              ("!Y=$  'AL+W=O<FMS:&5E
M=',O<VAE970R-"YX;6Q02P$"% ,4    " "RAEE4RUXF>_<$  #9"P  &0
M            @($#V@  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4
M Q0    ( +*&651TDON'*0L  -X=   9              " @3'?  !X;"]W
M;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ LH995 3!1D2: P
MF D  !D              ("!D>H  'AL+W=O<FMS:&5E=',O<VAE970R-RYX
M;6Q02P$"% ,4    " "RAEE4;/AZ4% 7  !<2   &0              @(%B
M[@  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( +*&6528
MW--\C0H  "@>   9              " @>D% 0!X;"]W;W)K<VAE971S+W-H
M965T,CDN>&UL4$L! A0#%     @ LH995'^3(7B! P  Q <  !D
M     ("!K1 ! 'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4
M" "RAEE4TTKSQ+<#   X"   &0              @(%E% $ >&PO=V]R:W-H
M965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( +*&653R)-E8:@4  )0-   9
M              " @5,8 0!X;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L!
M A0#%     @ LH995-L. 0RO!0   !   !D              ("!]!T! 'AL
M+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " "RAEE4%+$SE1T'
M  "J%   &0              @(':(P$ >&PO=V]R:W-H965T<R]S:&5E=#,T
M+GAM;%!+ 0(4 Q0    ( +*&652^"#RYI 0  '\.   9              "
M@2XK 0!X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ LH99
M5&-DD!(6!@  &A,  !D              ("!"3 ! 'AL+W=O<FMS:&5E=',O
M<VAE970S-BYX;6Q02P$"% ,4    " "RAEE4'DX1V74#  "$!P  &0
M        @(%6-@$ >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0
M   ( +*&653"*NB4M ,  !0(   9              " @0(Z 0!X;"]W;W)K
M<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ LH995"&,0B_> @  ;08
M !D              ("![3T! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q0
M2P$"% ,4    " "RAEE4C! *\=H'  "#$P  &0              @($"00$
M>&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( +*&652N)_@>
M20,  (H&   9              " @1-) 0!X;"]W;W)K<VAE971S+W-H965T
M-#$N>&UL4$L! A0#%     @ LH995!]-<1NK P  A0@  !D
M ("!DTP! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " "R
MAEE4$9./)FT#  ##"   &0              @(%U4 $ >&PO=V]R:W-H965T
M<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( +*&650?.*D[(@(  (D$   9
M          " @1E4 0!X;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#
M%     @ LH995(BVQ-2" @  8@8  !D              ("!<E8! 'AL+W=O
M<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " "RAEE4:"O[5@8$  #6
M$   &0              @($K60$ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM
M;%!+ 0(4 Q0    ( +*&652((B:UW0,  *46   9              " @6A=
M 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ LH995*6,
M@R5K @  X 4  !D              ("!?&$! 'AL+W=O<FMS:&5E=',O<VAE
M970T."YX;6Q02P$"% ,4    " "RAEE4_ O\F:D#  #<#   &0
M    @($>9 $ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    (
M +*&651 @U,!<08  !\C   9              " @?YG 0!X;"]W;W)K<VAE
M971S+W-H965T-3 N>&UL4$L! A0#%     @ LH995%IF=LYI @  XP4  !D
M             ("!IFX! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q02P$"
M% ,4    " "RAEE4#8^)W=("  #6"   &0              @(%&<0$ >&PO
M=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( +*&651[^ !1;P,
M !(-   9              " @4]T 0!X;"]W;W)K<VAE971S+W-H965T-3,N
M>&UL4$L! A0#%     @ LH995-=C+)6M @  * <  !D              ("!
M]7<! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4    " "RAEE4
M:D\:&'("  #I!0  &0              @('9>@$ >&PO=V]R:W-H965T<R]S
M:&5E=#4U+GAM;%!+ 0(4 Q0    ( +*&651@#V:_5P(  -(%   9
M      " @8)] 0!X;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%
M  @ LH995%J1*HB$ @  &08  !D              ("!$( ! 'AL+W=O<FMS
M:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " "RAEE4HK+;QK\#  !."P
M&0              @('+@@$ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+
M 0(4 Q0    ( +*&653.O+P\+P8  )P.   9              " @<&& 0!X
M;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ LH995"EPN]QT
M P  A0P  !D              ("!)XT! 'AL+W=O<FMS:&5E=',O<VAE970V
M,"YX;6Q02P$"% ,4    " "RAEE4$([EWDH$  #?#P  &0
M@('2D $ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( +*&
M653/PMUX0 ,  &8,   9              " @5.5 0!X;"]W;W)K<VAE971S
M+W-H965T-C(N>&UL4$L! A0#%     @ LH995+RN(.+A @  F0@  !D
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M=#8W+GAM;%!+ 0(4 Q0    ( +*&653D>R-PI@,  *T.   9
M  " @?:J 0!X;"]W;W)K<VAE971S+W-H965T-C@N>&UL4$L! A0#%     @
MLH995,T HL0< P  1PH  !D              ("!TZX! 'AL+W=O<FMS:&5E
M=',O<VAE970V.2YX;6Q02P$"% ,4    " "RAEE4)A"%\JT"  !V!P  &0
M            @($FL@$ >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4
M Q0    ( +*&6523A[[P6P(  !T'   9              " @0JU 0!X;"]W
M;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ LH995.C" ^RW @
MFP<  !D              ("!G+<! 'AL+W=O<FMS:&5E=',O<VAE970W,BYX
M;6Q02P$"% ,4    " "RAEE4F^MXFLL"  !X!P  &0              @(&*
MN@$ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0    ( +*&653F
M=F+]4 ,  -\*   9              " @8R] 0!X;"]W;W)K<VAE971S+W-H
M965T-S0N>&UL4$L! A0#%     @ LH995";G1UQF P  # P  !D
M     ("!$\$! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +*&6505(2T>Y@,  /,,   9              "
M@2#1 0!X;"]W;W)K<VAE971S+W-H965T.# N>&UL4$L! A0#%     @ LH99
M5&HE>AAV!   LQ$  !D              ("!/=4! 'AL+W=O<FMS:&5E=',O
M<VAE970X,2YX;6Q02P$"% ,4    " "RAEE4H>#H2-4!  #& P  &0
M        @('JV0$ >&PO=V]R:W-H965T<R]S:&5E=#@R+GAM;%!+ 0(4 Q0
M   ( +*&65081.Q0T (  (L'   9              " @?;; 0!X;"]W;W)K
M<VAE971S+W-H965T.#,N>&UL4$L! A0#%     @ LH995-N2[AZ%!    !,
M !D              ("!_=X! 'AL+W=O<FMS:&5E=',O<VAE970X-"YX;6Q0
M2P$"% ,4    " "RAEE41<ZTABX$  "=$   &0              @(&YXP$
M>&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4 Q0    ( +*&650HE8&)
M00(   $%   9              " @1[H 0!X;"]W;W)K<VAE971S+W-H965T
M.#8N>&UL4$L! A0#%     @ LH995'C*Y/]#!   9!4  !D
M ("!ENH! 'AL+W=O<FMS:&5E=',O<VAE970X-RYX;6Q02P$"% ,4    " "R
MAEE41.?H[OX$  !2'P  &0              @($0[P$ >&PO=V]R:W-H965T
M<R]S:&5E=#@X+GAM;%!+ 0(4 Q0    ( +*&6521@7!RA@(  $L&   9
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M970Y,RYX;6Q02P$"% ,4    " "RAEE4?_4MQ,$%  ">*   &0
M    @(&2!0( >&PO=V]R:W-H965T<R]S:&5E=#DT+GAM;%!+ 0(4 Q0    (
M +*&651@I_\/+P0  .(.   9              " @8H+ @!X;"]W;W)K<VAE
M971S+W-H965T.34N>&UL4$L! A0#%     @ LH995"[XI\._ P  XPP  !D
M             ("!\ \" 'AL+W=O<FMS:&5E=',O<VAE970Y-BYX;6Q02P$"
M% ,4    " "RAEE4M[74^PD#   X"0  &0              @('F$P( >&PO
M=V]R:W-H965T<R]S:&5E=#DW+GAM;%!+ 0(4 Q0    ( +*&651"*#-=,00
M  \/   9              " @287 @!X;"]W;W)K<VAE971S+W-H965T.3@N
M>&UL4$L! A0#%     @ LH995 0*^ 84 P  CPX  !D              ("!
MCAL" 'AL+W=O<FMS:&5E=',O<VAE970Y.2YX;6Q02P$"% ,4    " "RAEE4
MIOT6XKP"  ##!P  &@              @('9'@( >&PO=V]R:W-H965T<R]S
M:&5E=#$P,"YX;6Q02P$"% ,4    " "RAEE4QM5>48 #  "N#   &@
M        @('-(0( >&PO=V]R:W-H965T<R]S:&5E=#$P,2YX;6Q02P$"% ,4
M    " "RAEE4]AL':QL"  " !   &@              @(&%)0( >&PO=V]R
M:W-H965T<R]S:&5E=#$P,BYX;6Q02P$"% ,4    " "RAEE4=N+IIPP&  !*
M'@  &@              @('8)P( >&PO=V]R:W-H965T<R]S:&5E=#$P,RYX
M;6Q02P$"% ,4    " "RAEE4*WY7; H%  ")$P  &@              @($<
M+@( >&PO=V]R:W-H965T<R]S:&5E=#$P-"YX;6Q02P$"% ,4    " "RAEE4
M$F.#86X"  #\!@  &@              @(%>,P( >&PO=V]R:W-H965T<R]S
M:&5E=#$P-2YX;6Q02P$"% ,4    " "RAEE4_^(Y</(!  #D P  &@
M        @($$-@( >&PO=V]R:W-H965T<R]S:&5E=#$P-BYX;6Q02P$"% ,4
M    " "RAEE4!A3C\G("   #!@  &@              @($N. ( >&PO=V]R
M:W-H965T<R]S:&5E=#$P-RYX;6Q02P$"% ,4    " "RAEE4C.HOY@4"   -
M!   &@              @('8.@( >&PO=V]R:W-H965T<R]S:&5E=#$P."YX
M;6Q02P$"% ,4    " "RAEE4J/5E=60#  !O"P  &@              @($5
M/0( >&PO=V]R:W-H965T<R]S:&5E=#$P.2YX;6Q02P$"% ,4    " "RAEE4
M<-Y<F2D$   "%   &@              @(&Q0 ( >&PO=V]R:W-H965T<R]S
M:&5E=#$Q,"YX;6Q02P$"% ,4    " "RAEE4-E(I6!,#  #*"   &@
M        @($210( >&PO=V]R:W-H965T<R]S:&5E=#$Q,2YX;6Q02P$"% ,4
M    " "RAEE4RU0<;NL$  !K&   &@              @(%=2 ( >&PO=V]R
M:W-H965T<R]S:&5E=#$Q,BYX;6Q02P$"% ,4    " "RAEE48SR@M<4#  #7
M#P  &@              @(& 30( >&PO=V]R:W-H965T<R]S:&5E=#$Q,RYX
M;6Q02P$"% ,4    " "RAEE45S4!3 ("   1!   &@              @(%]
M40( >&PO=V]R:W-H965T<R]S:&5E=#$Q-"YX;6Q02P$"% ,4    " "RAEE4
M$,9[$C8#   0"@  &@              @(&W4P( >&PO=V]R:W-H965T<R]S
M:&5E=#$Q-2YX;6Q02P$"% ,4    " "RAEE4IB1XP3 #  "S#   &@
M        @($E5P( >&PO=V]R:W-H965T<R]S:&5E=#$Q-BYX;6Q02P$"% ,4
M    " "RAEE4&O.Q@E@#   K$0  &@              @(&-6@( >&PO=V]R
M:W-H965T<R]S:&5E=#$Q-RYX;6Q02P$"% ,4    " "RAEE4N2K1?UT"  #P
M!P  &@              @($=7@( >&PO=V]R:W-H965T<R]S:&5E=#$Q."YX
M;6Q02P$"% ,4    " "RAEE4L*-M#5\%  #Z&   &@              @(&R
M8 ( >&PO=V]R:W-H965T<R]S:&5E=#$Q.2YX;6Q02P$"% ,4    " "RAEE4
MP6-@NS4#  #0$P  #0              @ %)9@( >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    ( +*&6527BKL<P    !,"   +              "  :EI @!?
M<F5L<R\N<F5L<U!+ 0(4 Q0    ( +*&653&$:ET9P@  )Q.   /
M      "  9)J @!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "RAEE42>T4
M]D8#  #610  &@              @ $F<P( >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    " "RAEE4T9'O&I4"   !0P  $P
M    @ &D=@( 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     ?P!_  0C  !J
%>0(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>401</ContextCount>
  <ElementCount>639</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>122</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010001 - Document - Document and Entity Information Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DocumentandEntityInformationDocument</Role>
      <ShortName>Document and Entity Information Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>000020002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100010003 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030004 - Statement - Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/ConsolidatedStatementsofIncome</Role>
      <ShortName>Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040005 - Statement - Statement of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/StatementofComprehensiveIncome</Role>
      <ShortName>Statement of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100060006 - Statement - Consolidated Statements of Stockholders Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100070007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>140024001 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>140054002 - Statement - Statement of Comprehensive Income (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/StatementofComprehensiveIncomeParenthetical</Role>
      <ShortName>Statement of Comprehensive Income (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>210011001 - Disclosure - General and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>General and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>210201002 - Disclosure - Acquisitions (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/AcquisitionsNotes</Role>
      <ShortName>Acquisitions (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>210261003 - Disclosure - Restructuring, Strategic Transaction and Integration (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes</Role>
      <ShortName>Restructuring, Strategic Transaction and Integration (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>210311004 - Disclosure - Revenue (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/RevenueNotes</Role>
      <ShortName>Revenue (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>210371005 - Disclosure - Leases (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/LeasesNotes</Role>
      <ShortName>Leases (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>210461006 - Disclosure - Share Based Award Share awards (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/ShareBasedAwardShareawardsNotes</Role>
      <ShortName>Share Based Award Share awards (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>210571007 - Disclosure - Derivatives and Hedging Activities (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/DerivativesandHedgingActivitiesNotes</Role>
      <ShortName>Derivatives and Hedging Activities (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>210631008 - Disclosure - Fair Value Measurement (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasurementNotes</Role>
      <ShortName>Fair Value Measurement (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>210701009 - Disclosure - Prepaids and Other Current Assets (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes</Role>
      <ShortName>Prepaids and Other Current Assets (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>210731010 - Disclosure - Accrued Liabilities an Other Long-term Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilities</Role>
      <ShortName>Accrued Liabilities an Other Long-term Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>210771011 - Disclosure - Long-Term Obligations (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsNotes</Role>
      <ShortName>Long-Term Obligations (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>210811012 - Disclosure - Income Taxes:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>210931013 - Disclosure - Geographic Information and Significant Customers Geographic Information and Significant Customers (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/GeographicInformationandSignificantCustomersGeographicInformationandSignificantCustomersNotes</Role>
      <ShortName>Geographic Information and Significant Customers Geographic Information and Significant Customers (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>210961014 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>211001015 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>211031016 - Disclosure - Collaborative and Other Arrangements (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes</Role>
      <ShortName>Collaborative and Other Arrangements (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>211061017 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>211121018 - Disclosure - SEC Schedule, Article 12-09, Valuation and Qualifying Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccounts</Role>
      <ShortName>SEC Schedule, Article 12-09, Valuation and Qualifying Accounts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>220022001 - Disclosure - General and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>General and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>230033001 - Disclosure - General and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>General and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>230213002 - Disclosure - Acquisitions Pursuit Vascular (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/AcquisitionsPursuitVascularTables</Role>
      <ShortName>Acquisitions Pursuit Vascular (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>230273003 - Disclosure - Restructuring, Strategic Transaction and Integration Schedule of Restructuring and Related Costs (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationScheduleofRestructuringandRelatedCostsTables</Role>
      <ShortName>Restructuring, Strategic Transaction and Integration Schedule of Restructuring and Related Costs (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>230323004 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/RevenueNotes</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>230383005 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/LeasesNotes</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>230473006 - Disclosure - Share Based Award (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/ShareBasedAwardTables</Role>
      <ShortName>Share Based Award (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/ShareBasedAwardShareawardsNotes</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>230583007 - Disclosure - Derivatives and Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativesandHedgingActivitiesTables</Role>
      <ShortName>Derivatives and Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/DerivativesandHedgingActivitiesNotes</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>230643008 - Disclosure - Fair Value Measurement (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasurementTables</Role>
      <ShortName>Fair Value Measurement (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/FairValueMeasurementNotes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>230713009 - Disclosure - Prepaids and Other Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables</Role>
      <ShortName>Prepaids and Other Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>230743010 - Disclosure - Accrued Liabilities an Other Long-term Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesTables</Role>
      <ShortName>Accrued Liabilities an Other Long-term Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilities</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>230783011 - Disclosure - Long-Term Obligations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsTables</Role>
      <ShortName>Long-Term Obligations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/LongTermObligationsNotes</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>230823012 - Disclosure - Income Taxes Income tax disclosure (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/IncomeTaxesIncometaxdisclosureTables</Role>
      <ShortName>Income Taxes Income tax disclosure (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>230943013 - Disclosure - Geographic Information and Significant Customers Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeographicInformationandSignificantCustomersGeographicInformationTables</Role>
      <ShortName>Geographic Information and Significant Customers Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/GeographicInformationandSignificantCustomersGeographicInformationandSignificantCustomersNotes</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>230973014 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/StockholdersEquity</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>231073017 - Disclosure - Subsequent Events (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/SubsequentEventsTables</Role>
      <ShortName>Subsequent Events (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/SubsequentEvents</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>240044003 - Disclosure - General and Summary of Significant Accounting Policies Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesBasisofPresentationDetails</Role>
      <ShortName>General and Summary of Significant Accounting Policies Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>240054004 - Disclosure - General and Summary of Significant Accounting Policies Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInventoryDetails</Role>
      <ShortName>General and Summary of Significant Accounting Policies Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>240064005 - Disclosure - General and Summary of Significant Accounting Policies Property and Equipment #1 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details</Role>
      <ShortName>General and Summary of Significant Accounting Policies Property and Equipment #1 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>240074006 - Disclosure - General and Summary of Significant Accounting Policies Property and Equipment #2 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details</Role>
      <ShortName>General and Summary of Significant Accounting Policies Property and Equipment #2 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>240084007 - Disclosure - General and Summary of Significant Accounting Policies Property and Equipment #3 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment3Details</Role>
      <ShortName>General and Summary of Significant Accounting Policies Property and Equipment #3 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>240094008 - Disclosure - General and Summary of Significant Accounting Policies Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails</Role>
      <ShortName>General and Summary of Significant Accounting Policies Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>240104009 - Disclosure - General and Summary of Significant Accounting Policies Intangible Assets #1 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details</Role>
      <ShortName>General and Summary of Significant Accounting Policies Intangible Assets #1 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>240114010 - Disclosure - General and Summary of Significant Accounting Policies Intangible Assets #2 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets2Details</Role>
      <ShortName>General and Summary of Significant Accounting Policies Intangible Assets #2 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>240124011 - Disclosure - General and Summary of Significant Accounting Policies Future Estimated Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails</Role>
      <ShortName>General and Summary of Significant Accounting Policies Future Estimated Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>240134012 - Disclosure - General and Summary of Significant Accounting Policies Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsDetails</Role>
      <ShortName>General and Summary of Significant Accounting Policies Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>240144013 - Disclosure - General and Summary of Significant Accounting Policies Investments-Equity Method (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsEquityMethodDetails</Role>
      <ShortName>General and Summary of Significant Accounting Policies Investments-Equity Method (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>240154014 - Disclosure - General and Summary of Significant Accounting Policies Foreign Currency (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesForeignCurrencyDetails</Role>
      <ShortName>General and Summary of Significant Accounting Policies Foreign Currency (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>240164015 - Disclosure - General and Summary of Significant Accounting Policies Advertising Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesAdvertisingExpensesDetails</Role>
      <ShortName>General and Summary of Significant Accounting Policies Advertising Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>240174016 - Disclosure - General and Summary of Significant Accounting Policies Post-retirement and Post-employment Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPostretirementandPostemploymentBenefitsDetails</Role>
      <ShortName>General and Summary of Significant Accounting Policies Post-retirement and Post-employment Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>240184017 - Disclosure - General and Summary of Significant Accounting Policies Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails</Role>
      <ShortName>General and Summary of Significant Accounting Policies Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>240194018 - Disclosure - General and Summary of Significant Accounting Policies New Accounting Pronouncements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNewAccountingPronouncementsDetails</Role>
      <ShortName>General and Summary of Significant Accounting Policies New Accounting Pronouncements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>240224019 - Disclosure - Acquisitions Text (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/AcquisitionsTextDetails</Role>
      <ShortName>Acquisitions Text (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240234020 - Disclosure - Acquisitions Pursuit Vascular Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails</Role>
      <ShortName>Acquisitions Pursuit Vascular Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/AcquisitionsPursuitVascularTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240244021 - Disclosure - Acquisitions Pursuit Vascular Intangible (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/AcquisitionsPursuitVascularIntangibleDetails</Role>
      <ShortName>Acquisitions Pursuit Vascular Intangible (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240254022 - Disclosure - Acquisitions Foreign Infusion Systems Supplier (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/AcquisitionsForeignInfusionSystemsSupplierDetails</Role>
      <ShortName>Acquisitions Foreign Infusion Systems Supplier (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240284023 - Disclosure - Restructuring, Strategic Transaction and Integration (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails1</Role>
      <ShortName>Restructuring, Strategic Transaction and Integration (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationScheduleofRestructuringandRelatedCostsTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240294024 - Disclosure - Restructuring, Strategic Transaction and Integration (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails2</Role>
      <ShortName>Restructuring, Strategic Transaction and Integration (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationScheduleofRestructuringandRelatedCostsTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240304025 - Disclosure - Restructuring, Strategic Transaction and Integration Strategic Transaction and Integration Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationStrategicTransactionandIntegrationExpensesDetails</Role>
      <ShortName>Restructuring, Strategic Transaction and Integration Strategic Transaction and Integration Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240334026 - Disclosure - Revenue Disaggregation of Revenue - Product Line (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RevenueDisaggregationofRevenueProductLineDetails</Role>
      <ShortName>Revenue Disaggregation of Revenue - Product Line (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240344027 - Disclosure - Revenue Disaggregation of Revenue by Geography (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RevenueDisaggregationofRevenuebyGeographyDetails</Role>
      <ShortName>Revenue Disaggregation of Revenue by Geography (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240354028 - Disclosure - Revenue Contract Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RevenueContractLiabilitiesDetails</Role>
      <ShortName>Revenue Contract Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240364029 - Disclosure - Revenue Contract Liabilities Text (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RevenueContractLiabilitiesTextDetails</Role>
      <ShortName>Revenue Contract Liabilities Text (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240394030 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/LeasesTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>240404031 - Disclosure - Leases Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesLeaseCostDetails</Role>
      <ShortName>Leases Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>240414032 - Disclosure - Leases Supplemental Cash Flow Lease Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesSupplementalCashFlowLeaseInformationDetails</Role>
      <ShortName>Leases Supplemental Cash Flow Lease Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>240424033 - Disclosure - Leases Supplemental Balance Sheet Lease information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesSupplementalBalanceSheetLeaseinformationDetails</Role>
      <ShortName>Leases Supplemental Balance Sheet Lease information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>240434034 - Disclosure - Finance Leases Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FinanceLeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Finance Leases Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>240444035 - Disclosure - Leases Lease Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesLeaseMaturityDetails</Role>
      <ShortName>Leases Lease Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>240454036 - Disclosure - Leases Finance Lease Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesFinanceLeaseMaturityDetails</Role>
      <ShortName>Leases Finance Lease Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>240484037 - Disclosure - Share Based Award Stock Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/ShareBasedAwardStockBasedCompensationDetails</Role>
      <ShortName>Share Based Award Stock Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>240494038 - Disclosure - Share Based Award Stock Option Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails</Role>
      <ShortName>Share Based Award Stock Option Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>240504039 - Disclosure - Share Based Award Stock Options Granted and Valuation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails</Role>
      <ShortName>Share Based Award Stock Options Granted and Valuation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>240514040 - Disclosure - Share Based Award Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails</Role>
      <ShortName>Share Based Award Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>240524041 - Disclosure - Share Based Award Share Award data (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/ShareBasedAwardShareAwarddataDetails</Role>
      <ShortName>Share Based Award Share Award data (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>240534042 - Disclosure - Share Based Award Options exercised data (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/ShareBasedAwardOptionsexerciseddataDetails</Role>
      <ShortName>Share Based Award Options exercised data (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>240544043 - Disclosure - Share Based Award RSU and PRSU (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails</Role>
      <ShortName>Share Based Award RSU and PRSU (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>240554044 - Disclosure - Share Based Award RSU and PRSU Roll forward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails</Role>
      <ShortName>Share Based Award RSU and PRSU Roll forward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240564045 - Disclosure - Share Based Award ESPP Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/ShareBasedAwardESPPNarrativeDetails</Role>
      <ShortName>Share Based Award ESPP Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240594046 - Disclosure - Derivatives and Hedging Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails</Role>
      <ShortName>Derivatives and Hedging Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/DerivativesandHedgingActivitiesTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240604047 - Disclosure - Derivatives and Hedging Activities Derivative Balance Sheet Location (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails</Role>
      <ShortName>Derivatives and Hedging Activities Derivative Balance Sheet Location (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240614048 - Disclosure - Derivatives and Hedging Activities Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails</Role>
      <ShortName>Derivatives and Hedging Activities Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240624049 - Disclosure - Derivatives and Hedging Activities Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Derivatives and Hedging Activities Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240654050 - Disclosure - Fair Value Measurement Text (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasurementTextDetails</Role>
      <ShortName>Fair Value Measurement Text (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/FairValueMeasurementTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240664051 - Disclosure - Fair Value Measurement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasurementDetails</Role>
      <ShortName>Fair Value Measurement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/FairValueMeasurementTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240684053 - Disclosure - Fair Value Measurement Fair Value Inputs, Liabilities, Pursuit Quantitative Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails</Role>
      <ShortName>Fair Value Measurement Fair Value Inputs, Liabilities, Pursuit Quantitative Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240694054 - Disclosure - Fair Value Measurement Fair Value Measurements, Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurement Fair Value Measurements, Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240724055 - Disclosure - Prepaids and Other Current Assets Prepaid Expenses and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails</Role>
      <ShortName>Prepaids and Other Current Assets Prepaid Expenses and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240754056 - Disclosure - Accrued Liabilities an Other Long-term Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesDetails</Role>
      <ShortName>Accrued Liabilities an Other Long-term Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240764057 - Disclosure - Accrued Liabilities an Other Long-term Liabilities Other Long-term Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesOtherLongtermLiabilitiesDetails</Role>
      <ShortName>Accrued Liabilities an Other Long-term Liabilities Other Long-term Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240794058 - Disclosure - Long-Term Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsDetails</Role>
      <ShortName>Long-Term Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/LongTermObligationsTables</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>240804059 - Disclosure - Long-Term Obligations Line of Credit Pricing (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsLineofCreditPricingDetails</Role>
      <ShortName>Long-Term Obligations Line of Credit Pricing (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>240834060 - Disclosure - Income Taxes Income (Loss) from Continuing Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/IncomeTaxesIncomeLossfromContinuingOperationsDetails</Role>
      <ShortName>Income Taxes Income (Loss) from Continuing Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/IncomeTaxesIncometaxdisclosureTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>240844061 - Disclosure - Income Taxes Tax Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/IncomeTaxesTaxProvisionDetails</Role>
      <ShortName>Income Taxes Tax Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>240854062 - Disclosure - Income Taxes Change in taxes payable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/IncomeTaxesChangeintaxespayableDetails</Role>
      <ShortName>Income Taxes Change in taxes payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>240864063 - Disclosure - Income Taxes Effective tax rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails</Role>
      <ShortName>Income Taxes Effective tax rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>240874064 - Disclosure - Income Taxes Deferred income tax assets (liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails</Role>
      <ShortName>Income Taxes Deferred income tax assets (liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>240884065 - Disclosure - Income Taxes Operating Loss Carryforwards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/IncomeTaxesOperatingLossCarryforwardsDetails</Role>
      <ShortName>Income Taxes Operating Loss Carryforwards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>240894066 - Disclosure - Income Taxes Tax Carryforwards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/IncomeTaxesTaxCarryforwardsDetails</Role>
      <ShortName>Income Taxes Tax Carryforwards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>240904067 - Disclosure - Income Taxes Tax Holiday (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/IncomeTaxesTaxHolidayDetails</Role>
      <ShortName>Income Taxes Tax Holiday (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>240914068 - Disclosure - Income Taxes Undistributed foreign earnings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/IncomeTaxesUndistributedforeignearningsDetails</Role>
      <ShortName>Income Taxes Undistributed foreign earnings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>240924069 - Disclosure - Income Taxes Unrecognized tax benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/IncomeTaxesUnrecognizedtaxbenefitsDetails</Role>
      <ShortName>Income Taxes Unrecognized tax benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>240954070 - Disclosure - Geographic Information and Significant Customers Long Lived Assets by Geographic Location (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails</Role>
      <ShortName>Geographic Information and Significant Customers Long Lived Assets by Geographic Location (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>240984071 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/StockholdersEquityTables</ParentRole>
      <Position>111</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>240994072 - Disclosure - Stockholders' Equity Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Stockholders' Equity Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>241024073 - Disclosure - Commitments and Contingencies Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>241054074 - Disclosure - Collaborative and Other Arrangements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails</Role>
      <ShortName>Collaborative and Other Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes</ParentRole>
      <Position>114</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>241084075 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/SubsequentEventsTables</ParentRole>
      <Position>115</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>241094076 - Disclosure - Subsequent Events Credit Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails</Role>
      <ShortName>Subsequent Events Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>241104077 - Disclosure - Subsequent Events Term Loan A &amp; Credit Line Applicable Margin (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails</Role>
      <ShortName>Subsequent Events Term Loan A &amp; Credit Line Applicable Margin (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>241114078 - Disclosure - Subsequent Events Term Loan B Applicable Margin (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/SubsequentEventsTermLoanBApplicableMarginDetails</Role>
      <ShortName>Subsequent Events Term Loan B Applicable Margin (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>118</Position>
    </Report>
    <Report instance="icui-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>241134079 - Disclosure - SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails</Role>
      <ShortName>SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccounts</ParentRole>
      <Position>119</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="icui-20211231.htm">icui-20211231.htm</File>
    <File>exhibit103executiveofficer.htm</File>
    <File>exhibit104non-employeedire.htm</File>
    <File>exhibit21subsidiariesofreg.htm</File>
    <File>exhibit231consentofdeloitt.htm</File>
    <File>exhibit311123121.htm</File>
    <File>exhibit312123121.htm</File>
    <File>exhibit32123121.htm</File>
    <File>icui-20211231.xsd</File>
    <File>icui-20211231_cal.xml</File>
    <File>icui-20211231_def.xml</File>
    <File>icui-20211231_lab.xml</File>
    <File>icui-20211231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="1401">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>140
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "icui-20211231.htm": {
   "axisCustom": 2,
   "axisStandard": 24,
   "contextCount": 401,
   "dts": {
    "calculationLink": {
     "local": [
      "icui-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "icui-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "icui-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "icui-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "icui-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "icui-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 844,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 10,
    "http://xbrl.sec.gov/dei/2021q4": 6,
    "total": 16
   },
   "keyCustom": 86,
   "keyStandard": 553,
   "memberCustom": 50,
   "memberStandard": 64,
   "nsprefix": "icui",
   "nsuri": "http://www.icumed.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010001 - Document - Document and Entity Information Document",
     "role": "http://www.icumed.com/role/DocumentandEntityInformationDocument",
     "shortName": "Document and Entity Information Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210011001 - Disclosure - General and Summary of Significant Accounting Policies",
     "role": "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPolicies",
     "shortName": "General and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240834060 - Disclosure - Income Taxes Income (Loss) from Continuing Operations (Details)",
     "role": "http://www.icumed.com/role/IncomeTaxesIncomeLossfromContinuingOperationsDetails",
     "shortName": "Income Taxes Income (Loss) from Continuing Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240844061 - Disclosure - Income Taxes Tax Provision (Details)",
     "role": "http://www.icumed.com/role/IncomeTaxesTaxProvisionDetails",
     "shortName": "Income Taxes Tax Provision (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240854062 - Disclosure - Income Taxes Change in taxes payable (Details)",
     "role": "http://www.icumed.com/role/IncomeTaxesChangeintaxespayableDetails",
     "shortName": "Income Taxes Change in taxes payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240864063 - Disclosure - Income Taxes Effective tax rate (Details)",
     "role": "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails",
     "shortName": "Income Taxes Effective tax rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:Noncurrentdeferredtaxasset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240874064 - Disclosure - Income Taxes Deferred income tax assets (liabilities) (Details)",
     "role": "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails",
     "shortName": "Income Taxes Deferred income tax assets (liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:Noncurrentdeferredtaxasset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "if9b8ee97cdce469498415c24ca271fac_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240884065 - Disclosure - Income Taxes Operating Loss Carryforwards (Details)",
     "role": "http://www.icumed.com/role/IncomeTaxesOperatingLossCarryforwardsDetails",
     "shortName": "Income Taxes Operating Loss Carryforwards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "if9b8ee97cdce469498415c24ca271fac_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TaxCreditCarryforwardAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240894066 - Disclosure - Income Taxes Tax Carryforwards (Details)",
     "role": "http://www.icumed.com/role/IncomeTaxesTaxCarryforwardsDetails",
     "shortName": "Income Taxes Tax Carryforwards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TaxCreditCarryforwardAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxHolidayAggregateDollarAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240904067 - Disclosure - Income Taxes Tax Holiday (Details)",
     "role": "http://www.icumed.com/role/IncomeTaxesTaxHolidayDetails",
     "shortName": "Income Taxes Tax Holiday (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxHolidayAggregateDollarAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UndistributedEarningsOfForeignSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240914068 - Disclosure - Income Taxes Undistributed foreign earnings (Details)",
     "role": "http://www.icumed.com/role/IncomeTaxesUndistributedforeignearningsDetails",
     "shortName": "Income Taxes Undistributed foreign earnings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UndistributedEarningsOfForeignSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240924069 - Disclosure - Income Taxes Unrecognized tax benefits (Details)",
     "role": "http://www.icumed.com/role/IncomeTaxesUnrecognizedtaxbenefitsDetails",
     "shortName": "Income Taxes Unrecognized tax benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210201002 - Disclosure - Acquisitions (Notes)",
     "role": "http://www.icumed.com/role/AcquisitionsNotes",
     "shortName": "Acquisitions (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240954070 - Disclosure - Geographic Information and Significant Customers Long Lived Assets by Geographic Location (Details)",
     "role": "http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails",
     "shortName": "Geographic Information and Significant Customers Long Lived Assets by Geographic Location (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240984071 - Disclosure - Stockholders' Equity (Details)",
     "role": "http://www.icumed.com/role/StockholdersEquityDetails",
     "shortName": "Stockholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240994072 - Disclosure - Stockholders' Equity Accumulated Other Comprehensive Income (Loss) (Details)",
     "role": "http://www.icumed.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Stockholders' Equity Accumulated Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i056b6066b5c84b8f82444aed64ff2939_I20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241024073 - Disclosure - Commitments and Contingencies Contingencies (Details)",
     "role": "http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails",
     "shortName": "Commitments and Contingencies Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i7c08f27a7f1249ebb9616a92cf37d858_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "icui:Contingentconsiderationgross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241054074 - Disclosure - Collaborative and Other Arrangements (Details)",
     "role": "http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails",
     "shortName": "Collaborative and Other Arrangements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241084075 - Disclosure - Subsequent Events (Details)",
     "role": "http://www.icumed.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i9b2d21d6799a45898560ea2c84c80514_I20220106",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R116": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i78e8a542027645189940c1af26b316ab_D20220106-20220106",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "icui:TermLoanAPaymentFirstYearsAsAOfOriginalDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241094076 - Disclosure - Subsequent Events Credit Agreement (Details)",
     "role": "http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails",
     "shortName": "Subsequent Events Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i78e8a542027645189940c1af26b316ab_D20220106-20220106",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "icui:TermLoanAPaymentFirstYearsAsAOfOriginalDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R117": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfSubsequentEventsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i78e8a542027645189940c1af26b316ab_D20220106-20220106",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "icui:TermLoanAAndCreditLineSpread",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241104077 - Disclosure - Subsequent Events Term Loan A & Credit Line Applicable Margin (Details)",
     "role": "http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails",
     "shortName": "Subsequent Events Term Loan A & Credit Line Applicable Margin (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSubsequentEventsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iafe2bcda32da45689d560de2ebd12309_D20220106-20220106",
      "decimals": "4",
      "lang": "en-US",
      "name": "icui:Spread",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R118": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfSubsequentEventsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i78e8a542027645189940c1af26b316ab_D20220106-20220106",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "icui:TermLoanBInitialSpread",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241114078 - Disclosure - Subsequent Events Term Loan B Applicable Margin (Details)",
     "role": "http://www.icumed.com/role/SubsequentEventsTermLoanBApplicableMarginDetails",
     "shortName": "Subsequent Events Term Loan B Applicable Margin (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSubsequentEventsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i595c992a5ff64197a1dedaa5a2c28018_D20220106-20220106",
      "decimals": "3",
      "lang": "en-US",
      "name": "icui:TermLoanBEuroRateLoanSpread",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R119": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:WarrantyAndReturnReserveInventoryWriteOffs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241134079 - Disclosure - SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Details)",
     "role": "http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails",
     "shortName": "SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:WarrantyAndReturnReserveInventoryWriteOffs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210261003 - Disclosure - Restructuring, Strategic Transaction and Integration (Notes)",
     "role": "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes",
     "shortName": "Restructuring, Strategic Transaction and Integration (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210311004 - Disclosure - Revenue (Notes)",
     "role": "http://www.icumed.com/role/RevenueNotes",
     "shortName": "Revenue (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:LesseeOperatingAndFinanceLeaseTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210371005 - Disclosure - Leases (Notes)",
     "role": "http://www.icumed.com/role/LeasesNotes",
     "shortName": "Leases (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:LesseeOperatingAndFinanceLeaseTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210461006 - Disclosure - Share Based Award Share awards (Notes)",
     "role": "http://www.icumed.com/role/ShareBasedAwardShareawardsNotes",
     "shortName": "Share Based Award Share awards (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210571007 - Disclosure - Derivatives and Hedging Activities (Notes)",
     "role": "http://www.icumed.com/role/DerivativesandHedgingActivitiesNotes",
     "shortName": "Derivatives and Hedging Activities (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210631008 - Disclosure - Fair Value Measurement (Notes)",
     "role": "http://www.icumed.com/role/FairValueMeasurementNotes",
     "shortName": "Fair Value Measurement (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210701009 - Disclosure - Prepaids and Other Current Assets (Notes)",
     "role": "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes",
     "shortName": "Prepaids and Other Current Assets (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210731010 - Disclosure - Accrued Liabilities an Other Long-term Liabilities",
     "role": "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilities",
     "shortName": "Accrued Liabilities an Other Long-term Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "000020002 - Document - Audit Information",
     "role": "http://www.icumed.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210771011 - Disclosure - Long-Term Obligations (Notes)",
     "role": "http://www.icumed.com/role/LongTermObligationsNotes",
     "shortName": "Long-Term Obligations (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210811012 - Disclosure - Income Taxes:",
     "role": "http://www.icumed.com/role/IncomeTaxes",
     "shortName": "Income Taxes:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:InformationbyGeographicAreaandCustomerConcentrationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210931013 - Disclosure - Geographic Information and Significant Customers Geographic Information and Significant Customers (Notes)",
     "role": "http://www.icumed.com/role/GeographicInformationandSignificantCustomersGeographicInformationandSignificantCustomersNotes",
     "shortName": "Geographic Information and Significant Customers Geographic Information and Significant Customers (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:InformationbyGeographicAreaandCustomerConcentrationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210961014 - Disclosure - Stockholders' Equity",
     "role": "http://www.icumed.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211001015 - Disclosure - Commitments and Contingencies",
     "role": "http://www.icumed.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211031016 - Disclosure - Collaborative and Other Arrangements (Notes)",
     "role": "http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes",
     "shortName": "Collaborative and Other Arrangements (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211061017 - Disclosure - Subsequent Events",
     "role": "http://www.icumed.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211121018 - Disclosure - SEC Schedule, Article 12-09, Valuation and Qualifying Accounts",
     "role": "http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccounts",
     "shortName": "SEC Schedule, Article 12-09, Valuation and Qualifying Accounts",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220022001 - Disclosure - General and Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "General and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230033001 - Disclosure - General and Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesTables",
     "shortName": "General and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010003 - Statement - Consolidated Balance Sheets",
     "role": "http://www.icumed.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i9eced5028f684ec0ac18244892f3f859_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230213002 - Disclosure - Acquisitions Pursuit Vascular (Tables)",
     "role": "http://www.icumed.com/role/AcquisitionsPursuitVascularTables",
     "shortName": "Acquisitions Pursuit Vascular (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i9eced5028f684ec0ac18244892f3f859_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230273003 - Disclosure - Restructuring, Strategic Transaction and Integration Schedule of Restructuring and Related Costs (Tables)",
     "role": "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationScheduleofRestructuringandRelatedCostsTables",
     "shortName": "Restructuring, Strategic Transaction and Integration Schedule of Restructuring and Related Costs (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230323004 - Disclosure - Revenue (Tables)",
     "role": "http://www.icumed.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230383005 - Disclosure - Leases (Tables)",
     "role": "http://www.icumed.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230473006 - Disclosure - Share Based Award (Tables)",
     "role": "http://www.icumed.com/role/ShareBasedAwardTables",
     "shortName": "Share Based Award (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230583007 - Disclosure - Derivatives and Hedging Activities (Tables)",
     "role": "http://www.icumed.com/role/DerivativesandHedgingActivitiesTables",
     "shortName": "Derivatives and Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230643008 - Disclosure - Fair Value Measurement (Tables)",
     "role": "http://www.icumed.com/role/FairValueMeasurementTables",
     "shortName": "Fair Value Measurement (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230713009 - Disclosure - Prepaids and Other Current Assets (Tables)",
     "role": "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables",
     "shortName": "Prepaids and Other Current Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230743010 - Disclosure - Accrued Liabilities an Other Long-term Liabilities (Tables)",
     "role": "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesTables",
     "shortName": "Accrued Liabilities an Other Long-term Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:InterestMarginandCommitmentFeeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230783011 - Disclosure - Long-Term Obligations (Tables)",
     "role": "http://www.icumed.com/role/LongTermObligationsTables",
     "shortName": "Long-Term Obligations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:InterestMarginandCommitmentFeeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030004 - Statement - Consolidated Statements of Income",
     "role": "http://www.icumed.com/role/ConsolidatedStatementsofIncome",
     "shortName": "Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230823012 - Disclosure - Income Taxes Income tax disclosure (Tables)",
     "role": "http://www.icumed.com/role/IncomeTaxesIncometaxdisclosureTables",
     "shortName": "Income Taxes Income tax disclosure (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230943013 - Disclosure - Geographic Information and Significant Customers Geographic Information (Tables)",
     "role": "http://www.icumed.com/role/GeographicInformationandSignificantCustomersGeographicInformationTables",
     "shortName": "Geographic Information and Significant Customers Geographic Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230973014 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.icumed.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231073017 - Disclosure - Subsequent Events (Tables)",
     "role": "http://www.icumed.com/role/SubsequentEventsTables",
     "shortName": "Subsequent Events (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240044003 - Disclosure - General and Summary of Significant Accounting Policies Basis of Presentation (Details)",
     "role": "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesBasisofPresentationDetails",
     "shortName": "General and Summary of Significant Accounting Policies Basis of Presentation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240054004 - Disclosure - General and Summary of Significant Accounting Policies Inventory (Details)",
     "role": "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInventoryDetails",
     "shortName": "General and Summary of Significant Accounting Policies Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240064005 - Disclosure - General and Summary of Significant Accounting Policies Property and Equipment #1 (Details)",
     "role": "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details",
     "shortName": "General and Summary of Significant Accounting Policies Property and Equipment #1 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i822011b5ee894121826591876ad1fae1_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240074006 - Disclosure - General and Summary of Significant Accounting Policies Property and Equipment #2 (Details)",
     "role": "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details",
     "shortName": "General and Summary of Significant Accounting Policies Property and Equipment #2 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i822011b5ee894121826591876ad1fae1_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240084007 - Disclosure - General and Summary of Significant Accounting Policies Property and Equipment #3 (Details)",
     "role": "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment3Details",
     "shortName": "General and Summary of Significant Accounting Policies Property and Equipment #3 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i4d447798df3d4ad09d5a02f448f0900b_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240094008 - Disclosure - General and Summary of Significant Accounting Policies Goodwill (Details)",
     "role": "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails",
     "shortName": "General and Summary of Significant Accounting Policies Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "ic2b82bbcf5cb45739937a1040ed30f6b_I20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040005 - Statement - Statement of Comprehensive Income",
     "role": "http://www.icumed.com/role/StatementofComprehensiveIncome",
     "shortName": "Statement of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240104009 - Disclosure - General and Summary of Significant Accounting Policies Intangible Assets #1 (Details)",
     "role": "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details",
     "shortName": "General and Summary of Significant Accounting Policies Intangible Assets #1 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240114010 - Disclosure - General and Summary of Significant Accounting Policies Intangible Assets #2 (Details)",
     "role": "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets2Details",
     "shortName": "General and Summary of Significant Accounting Policies Intangible Assets #2 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240124011 - Disclosure - General and Summary of Significant Accounting Policies Future Estimated Amortization Expense (Details)",
     "role": "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails",
     "shortName": "General and Summary of Significant Accounting Policies Future Estimated Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240134012 - Disclosure - General and Summary of Significant Accounting Policies Investments (Details)",
     "role": "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsDetails",
     "shortName": "General and Summary of Significant Accounting Policies Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "1",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240144013 - Disclosure - General and Summary of Significant Accounting Policies Investments-Equity Method (Details)",
     "role": "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsEquityMethodDetails",
     "shortName": "General and Summary of Significant Accounting Policies Investments-Equity Method (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "1",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossRealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240154014 - Disclosure - General and Summary of Significant Accounting Policies Foreign Currency (Details)",
     "role": "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesForeignCurrencyDetails",
     "shortName": "General and Summary of Significant Accounting Policies Foreign Currency (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossRealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:AdvertisingCostsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdvertisingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240164015 - Disclosure - General and Summary of Significant Accounting Policies Advertising Expenses (Details)",
     "role": "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesAdvertisingExpensesDetails",
     "shortName": "General and Summary of Significant Accounting Policies Advertising Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:AdvertisingCostsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdvertisingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PensionAndOtherPostretirementPlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240174016 - Disclosure - General and Summary of Significant Accounting Policies Post-retirement and Post-employment Benefits (Details)",
     "role": "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPostretirementandPostemploymentBenefitsDetails",
     "shortName": "General and Summary of Significant Accounting Policies Post-retirement and Post-employment Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PensionAndOtherPostretirementPlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240184017 - Disclosure - General and Summary of Significant Accounting Policies Net Income Per Share (Details)",
     "role": "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails",
     "shortName": "General and Summary of Significant Accounting Policies Net Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240194018 - Disclosure - General and Summary of Significant Accounting Policies New Accounting Pronouncements (Details)",
     "role": "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNewAccountingPronouncementsDetails",
     "shortName": "General and Summary of Significant Accounting Policies New Accounting Pronouncements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "ie3327972bb1d4aee95a27cb29ac758f6_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060006 - Statement - Consolidated Statements of Stockholders Equity",
     "role": "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "ie3327972bb1d4aee95a27cb29ac758f6_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240224019 - Disclosure - Acquisitions Text (Details)",
     "role": "http://www.icumed.com/role/AcquisitionsTextDetails",
     "shortName": "Acquisitions Text (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i9ea7d76b8a79439aab91f9877efd14d5_I20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240234020 - Disclosure - Acquisitions Pursuit Vascular Table (Details)",
     "role": "http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails",
     "shortName": "Acquisitions Pursuit Vascular Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i9eced5028f684ec0ac18244892f3f859_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "icui:Paymenttoacquirebusinessnetofworkingcapitaladjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i9ea7d76b8a79439aab91f9877efd14d5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240244021 - Disclosure - Acquisitions Pursuit Vascular Intangible (Details)",
     "role": "http://www.icumed.com/role/AcquisitionsPursuitVascularIntangibleDetails",
     "shortName": "Acquisitions Pursuit Vascular Intangible (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i759cb9fbaf1d4095916b580d6bb94af5_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "icui:ShortTermContingentConsiderationGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240254022 - Disclosure - Acquisitions Foreign Infusion Systems Supplier (Details)",
     "role": "http://www.icumed.com/role/AcquisitionsForeignInfusionSystemsSupplierDetails",
     "shortName": "Acquisitions Foreign Infusion Systems Supplier (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i2d7085fd04aa448ea67964cb6da681f8_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:Restructuringandstrategictransactionexpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240284023 - Disclosure - Restructuring, Strategic Transaction and Integration (Details 1)",
     "role": "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails1",
     "shortName": "Restructuring, Strategic Transaction and Integration (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240294024 - Disclosure - Restructuring, Strategic Transaction and Integration (Details 2)",
     "role": "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails2",
     "shortName": "Restructuring, Strategic Transaction and Integration (Details 2)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "icui:StrategicTransactionandIntegration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240304025 - Disclosure - Restructuring, Strategic Transaction and Integration Strategic Transaction and Integration Expenses (Details)",
     "role": "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationStrategicTransactionandIntegrationExpensesDetails",
     "shortName": "Restructuring, Strategic Transaction and Integration Strategic Transaction and Integration Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "icui:StrategicTransactionandIntegration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240334026 - Disclosure - Revenue Disaggregation of Revenue - Product Line (Details)",
     "role": "http://www.icumed.com/role/RevenueDisaggregationofRevenueProductLineDetails",
     "shortName": "Revenue Disaggregation of Revenue - Product Line (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "2",
      "lang": "en-US",
      "name": "icui:Percentageofrevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240344027 - Disclosure - Revenue Disaggregation of Revenue by Geography (Details)",
     "role": "http://www.icumed.com/role/RevenueDisaggregationofRevenuebyGeographyDetails",
     "shortName": "Revenue Disaggregation of Revenue by Geography (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i4099adac88a94f2c844d6d0a67f5b93f_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i4d447798df3d4ad09d5a02f448f0900b_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240354028 - Disclosure - Revenue Contract Liabilities (Details)",
     "role": "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
     "shortName": "Revenue Contract Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i056b6066b5c84b8f82444aed64ff2939_I20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070007 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240364029 - Disclosure - Revenue Contract Liabilities Text (Details)",
     "role": "http://www.icumed.com/role/RevenueContractLiabilitiesTextDetails",
     "shortName": "Revenue Contract Liabilities Text (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:Optiontoextendinyears",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240394030 - Disclosure - Leases (Details)",
     "role": "http://www.icumed.com/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:Optiontoextendinyears",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240404031 - Disclosure - Leases Lease Cost (Details)",
     "role": "http://www.icumed.com/role/LeasesLeaseCostDetails",
     "shortName": "Leases Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:SupplementalCashFlowInformationLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240414032 - Disclosure - Leases Supplemental Cash Flow Lease Information (Details)",
     "role": "http://www.icumed.com/role/LeasesSupplementalCashFlowLeaseInformationDetails",
     "shortName": "Leases Supplemental Cash Flow Lease Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:SupplementalCashFlowInformationLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:SupplementalBalanceSheetInformationLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240424033 - Disclosure - Leases Supplemental Balance Sheet Lease information (Details)",
     "role": "http://www.icumed.com/role/LeasesSupplementalBalanceSheetLeaseinformationDetails",
     "shortName": "Leases Supplemental Balance Sheet Lease information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:SupplementalBalanceSheetInformationLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240434034 - Disclosure - Finance Leases Supplemental Balance Sheet Information (Details)",
     "role": "http://www.icumed.com/role/FinanceLeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Finance Leases Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240444035 - Disclosure - Leases Lease Maturity (Details)",
     "role": "http://www.icumed.com/role/LeasesLeaseMaturityDetails",
     "shortName": "Leases Lease Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240454036 - Disclosure - Leases Finance Lease Maturity (Details)",
     "role": "http://www.icumed.com/role/LeasesFinanceLeaseMaturityDetails",
     "shortName": "Leases Finance Lease Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240484037 - Disclosure - Share Based Award Stock Based Compensation (Details)",
     "role": "http://www.icumed.com/role/ShareBasedAwardStockBasedCompensationDetails",
     "shortName": "Share Based Award Stock Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "ia405cf3a4ef6453097157cd7f886bc0c_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240494038 - Disclosure - Share Based Award Stock Option Plans (Details)",
     "role": "http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails",
     "shortName": "Share Based Award Stock Option Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "ia405cf3a4ef6453097157cd7f886bc0c_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "140024001 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.icumed.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "ifa3af7f9a9464ef699356948deed2cb8_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240504039 - Disclosure - Share Based Award Stock Options Granted and Valuation (Details)",
     "role": "http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails",
     "shortName": "Share Based Award Stock Options Granted and Valuation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "ifa3af7f9a9464ef699356948deed2cb8_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "id78700fe30fa41ee9a54f1ac70463ee7_I20201231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240514040 - Disclosure - Share Based Award Stock Option Activity (Details)",
     "role": "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails",
     "shortName": "Share Based Award Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "id78700fe30fa41ee9a54f1ac70463ee7_I20201231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240524041 - Disclosure - Share Based Award Share Award data (Details)",
     "role": "http://www.icumed.com/role/ShareBasedAwardShareAwarddataDetails",
     "shortName": "Share Based Award Share Award data (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:ExercisedOptionsDataTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240534042 - Disclosure - Share Based Award Options exercised data (Details)",
     "role": "http://www.icumed.com/role/ShareBasedAwardOptionsexerciseddataDetails",
     "shortName": "Share Based Award Options exercised data (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:ExercisedOptionsDataTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:ModifiedPRSUIncrementalExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240544043 - Disclosure - Share Based Award RSU and PRSU (Details)",
     "role": "http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails",
     "shortName": "Share Based Award RSU and PRSU (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:ModifiedPRSUIncrementalExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i5f1a091230074ec5961f1c78910f1b75_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240554044 - Disclosure - Share Based Award RSU and PRSU Roll forward (Details)",
     "role": "http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails",
     "shortName": "Share Based Award RSU and PRSU Roll forward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i5f1a091230074ec5961f1c78910f1b75_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "icui:ESPPOriginalIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240564045 - Disclosure - Share Based Award ESPP Narrative (Details)",
     "role": "http://www.icumed.com/role/ShareBasedAwardESPPNarrativeDetails",
     "shortName": "Share Based Award ESPP Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "icui:ESPPOriginalIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240594046 - Disclosure - Derivatives and Hedging Activities (Details)",
     "role": "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails",
     "shortName": "Derivatives and Hedging Activities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i9398faa8a97348f0a664d0a940cc1df1_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240604047 - Disclosure - Derivatives and Hedging Activities Derivative Balance Sheet Location (Details)",
     "role": "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails",
     "shortName": "Derivatives and Hedging Activities Derivative Balance Sheet Location (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i9398faa8a97348f0a664d0a940cc1df1_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240614048 - Disclosure - Derivatives and Hedging Activities Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details)",
     "role": "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
     "shortName": "Derivatives and Hedging Activities Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "140054002 - Statement - Statement of Comprehensive Income (Parenthetical)",
     "role": "http://www.icumed.com/role/StatementofComprehensiveIncomeParenthetical",
     "shortName": "Statement of Comprehensive Income (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240624049 - Disclosure - Derivatives and Hedging Activities Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details)",
     "role": "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Derivatives and Hedging Activities Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240654050 - Disclosure - Fair Value Measurement Text (Details)",
     "role": "http://www.icumed.com/role/FairValueMeasurementTextDetails",
     "shortName": "Fair Value Measurement Text (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240664051 - Disclosure - Fair Value Measurement (Details)",
     "role": "http://www.icumed.com/role/FairValueMeasurementDetails",
     "shortName": "Fair Value Measurement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i0bf6b6e287df4c9491af75069acc07ef_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i4d20c02b38e041509fe7e05408566fbd_I20201231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240684053 - Disclosure - Fair Value Measurement Fair Value Inputs, Liabilities, Pursuit Quantitative Information (Details)",
     "role": "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails",
     "shortName": "Fair Value Measurement Fair Value Inputs, Liabilities, Pursuit Quantitative Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i4d20c02b38e041509fe7e05408566fbd_I20201231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240694054 - Disclosure - Fair Value Measurement Fair Value Measurements, Recurring Basis (Details)",
     "role": "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails",
     "shortName": "Fair Value Measurement Fair Value Measurements, Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherPrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240724055 - Disclosure - Prepaids and Other Current Assets Prepaid Expenses and Other Current Assets (Details)",
     "role": "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails",
     "shortName": "Prepaids and Other Current Assets Prepaid Expenses and Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherPrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:AccruedSalariesAndBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240754056 - Disclosure - Accrued Liabilities an Other Long-term Liabilities (Details)",
     "role": "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesDetails",
     "shortName": "Accrued Liabilities an Other Long-term Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:AccruedSalariesAndBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:SupplementalBalanceSheetInformationLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLiabilityNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240764057 - Disclosure - Accrued Liabilities an Other Long-term Liabilities Other Long-term Liabilities (Details)",
     "role": "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesOtherLongtermLiabilitiesDetails",
     "shortName": "Accrued Liabilities an Other Long-term Liabilities Other Long-term Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "icui:Liabilitiesforcontracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240794058 - Disclosure - Long-Term Obligations (Details)",
     "role": "http://www.icumed.com/role/LongTermObligationsDetails",
     "shortName": "Long-Term Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "iaec5d516f9924448a7889b3f61aba166_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:InterestMarginandCommitmentFeeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i7d9fbc7afe1b4667b19bef534f27f322_D20210101-20211231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityCommitmentFeePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240804059 - Disclosure - Long-Term Obligations Line of Credit Pricing (Details)",
     "role": "http://www.icumed.com/role/LongTermObligationsLineofCreditPricingDetails",
     "shortName": "Long-Term Obligations Line of Credit Pricing (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:InterestMarginandCommitmentFeeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20211231.htm",
      "contextRef": "i7d9fbc7afe1b4667b19bef534f27f322_D20210101-20211231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityCommitmentFeePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 122,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "CANADA"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_CR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "COSTA RICA",
        "terseLabel": "COSTA RICA"
       }
      }
     },
     "localname": "CR",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_ES": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SPAIN",
        "terseLabel": "SPAIN"
       }
      }
     },
     "localname": "ES",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesOperatingLossCarryforwardsDetails",
      "http://www.icumed.com/role/RevenueDisaggregationofRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r763",
      "r764",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]",
        "terseLabel": "Auditor [Line Items]"
       }
      }
     },
     "localname": "AuditorLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/AuditInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r763",
      "r764",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r763",
      "r764",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]",
        "terseLabel": "Auditor [Table]"
       }
      }
     },
     "localname": "AuditorTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r763",
      "r764",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/AuditInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r763",
      "r764",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/AuditInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "icui_A2003PlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2003 Plan [Member]",
        "label": "2003 Plan [Member]",
        "terseLabel": "2003 Plan [Member]"
       }
      }
     },
     "localname": "A2003PlanMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails",
      "http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_A2011PlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2011 Plan [Member]",
        "label": "2011 Plan [Member]",
        "terseLabel": "2011 Plan [Member]"
       }
      }
     },
     "localname": "A2011PlanMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails",
      "http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_AccruedSalariesAndBenefits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued salaries and benefits",
        "label": "Accrued salaries and benefits",
        "terseLabel": "Salaries and benefits"
       }
      }
     },
     "localname": "AccruedSalariesAndBenefits",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Accruedfreight": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued freight",
        "label": "Accrued freight",
        "terseLabel": "Accrued freight"
       }
      }
     },
     "localname": "Accruedfreight",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Accruedlegalfees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued legal fees",
        "label": "Accrued legal fees",
        "terseLabel": "Legal accrual"
       }
      }
     },
     "localname": "Accruedlegalfees",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Accruedothertaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued other taxes",
        "label": "Accrued other taxes",
        "terseLabel": "Accrued other taxes"
       }
      }
     },
     "localname": "Accruedothertaxes",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Accruedsalestaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued sales taxes",
        "label": "Accrued sales taxes",
        "terseLabel": "Accrued sales taxes"
       }
      }
     },
     "localname": "Accruedsalestaxes",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_BusinessCombinationConsiderationCashHoldback": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "business combination consideration - cash holdback",
        "label": "business combination consideration - cash holdback",
        "terseLabel": "business combination consideration - cash holdback"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationCashHoldback",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsForeignInfusionSystemsSupplierDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_COntractLiabilityRollforwardRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COntract Liability Rollforward [Roll Forward]",
        "label": "COntract Liability Rollforward [Roll Forward]",
        "terseLabel": "COntract Liability Rollforward [Roll Forward]"
       }
      }
     },
     "localname": "COntractLiabilityRollforwardRollForward",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_Changeinunitsduetoperformanceexpectations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in units due to performance expectations",
        "label": "Change in units due to performance expectations",
        "terseLabel": "Change in units due to performance expectations"
       }
      }
     },
     "localname": "Changeinunitsduetoperformanceexpectations",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "icui_Cleanupcosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cleanupcosts",
        "label": "Cleanupcosts",
        "terseLabel": "Cleanupcosts"
       }
      }
     },
     "localname": "Cleanupcosts",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationStrategicTransactionandIntegrationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_CollaborativeandOtherArrangementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative and Other Arrangements [Abstract]",
        "label": "Collaborative and Other Arrangements [Abstract]",
        "terseLabel": "Collaborative and Other Arrangements [Abstract]"
       }
      }
     },
     "localname": "CollaborativeandOtherArrangementsAbstract",
     "nsuri": "http://www.icumed.com/20211231",
     "xbrltype": "stringItemType"
    },
    "icui_CommonStockSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Shares [Member]",
        "label": "Common Stock Shares [Member]",
        "terseLabel": "Common Stock Shares [Member]"
       }
      }
     },
     "localname": "CommonStockSharesMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_ComputerEquipmentAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer Equipment and Software [Member]",
        "label": "Computer Equipment and Software [Member]",
        "terseLabel": "Computer Equipment and Software [Member]"
       }
      }
     },
     "localname": "ComputerEquipmentAndSoftwareMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Contingentconsiderationgross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "contingent consideration gross",
        "label": "contingent consideration gross",
        "terseLabel": "contingent consideration gross"
       }
      }
     },
     "localname": "Contingentconsiderationgross",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsForeignInfusionSystemsSupplierDetails",
      "http://www.icumed.com/role/AcquisitionsTextDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails",
      "http://www.icumed.com/role/FairValueMeasurementTextDetails",
      "http://www.icumed.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ContractassetandliabilitybalancesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Contract asset and liability balances [Table]",
        "label": "Contract asset and liability balances [Line Items]",
        "terseLabel": "Contract asset and liability balances [Line Items]"
       }
      }
     },
     "localname": "ContractassetandliabilitybalancesLineItems",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_ContractassetandliabilitybalancesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract asset and liability balances [Table]",
        "label": "Contract asset and liability balances [Table]",
        "terseLabel": "Contract asset and liability balances [Table]"
       }
      }
     },
     "localname": "ContractassetandliabilitybalancesTable",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_Contractsettlements": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractsettlements",
        "label": "Contractsettlements",
        "terseLabel": "Contractsettlements"
       }
      }
     },
     "localname": "Contractsettlements",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_CriticalCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Critical Care [Member]",
        "label": "Critical Care [Member]",
        "terseLabel": "Critical Care [Member]"
       }
      }
     },
     "localname": "CriticalCareMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregationofRevenueProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_DeferredtaxassetsandliabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Deferred tax assets and liabilities [Table]",
        "label": "Deferred tax assets and liabilities [Line Items]",
        "terseLabel": "Deferred tax assets and liabilities [Line Items]"
       }
      }
     },
     "localname": "DeferredtaxassetsandliabilitiesLineItems",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_DeferredtaxassetsandliabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets and liabilities [Table]",
        "label": "Deferred tax assets and liabilities [Table]",
        "terseLabel": "Deferred tax assets and liabilities [Table]"
       }
      }
     },
     "localname": "DeferredtaxassetsandliabilitiesTable",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_Deferredtaxcharge": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax charge",
        "label": "Deferred tax charge",
        "terseLabel": "Deferred tax charge"
       }
      }
     },
     "localname": "Deferredtaxcharge",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Deferredtaxliabilitychangeinaccountingmethod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liability, change in accounting method",
        "label": "Deferred tax liability, change in accounting method",
        "terseLabel": "Deferred tax liability, change in accounting method"
       }
      }
     },
     "localname": "Deferredtaxliabilitychangeinaccountingmethod",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_DerivativeInterestRateFloor": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Interest Rate Floor",
        "label": "Derivative Interest Rate Floor",
        "terseLabel": "Derivative Interest Rate Floor"
       }
      }
     },
     "localname": "DerivativeInterestRateFloor",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "icui_ESPPAnnualIssuanceIncreaseLimit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ESPP Annual Issuance Increase Limit",
        "label": "ESPP Annual Issuance Increase Limit",
        "terseLabel": "ESPP Annual Issuance Increase Limit"
       }
      }
     },
     "localname": "ESPPAnnualIssuanceIncreaseLimit",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardESPPNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "icui_ESPPOriginalIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ESPP Original Issuance",
        "label": "ESPP Original Issuance",
        "terseLabel": "ESPP Original Issuance"
       }
      }
     },
     "localname": "ESPPOriginalIssuance",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardESPPNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "icui_EarnoutliabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earn-out liability [Member]",
        "label": "Earn-out liability [Member]",
        "terseLabel": "Earn-out liability [Member]"
       }
      }
     },
     "localname": "EarnoutliabilityMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_EffectiveIncomeTaxRateReconciliationContingentConsideration": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Contingent Consideration",
        "label": "Effective Income Tax Rate Reconciliation, Contingent Consideration",
        "negatedTerseLabel": "Effective Income Tax Rate Reconciliation, Contingent Consideration"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationContingentConsideration",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Contingent Consideration, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Contingent Consideration, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Contingent Consideration, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome",
        "label": "EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome",
        "terseLabel": "EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome,Percent",
        "label": "EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome,Percent",
        "terseLabel": "EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome,Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "icui_EffectiveIncomeTaxRateReconciliationIPMigration": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EffectiveIncomeTaxRateReconciliationIPMigration",
        "label": "EffectiveIncomeTaxRateReconciliationIPMigration",
        "terseLabel": "EffectiveIncomeTaxRateReconciliationIPMigration"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationIPMigration",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_EffectiveTaxRateReconciliationIPMigrationPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EffectiveTaxRateReconciliationIPMigrationPercent",
        "label": "EffectiveTaxRateReconciliationIPMigrationPercent",
        "terseLabel": "EffectiveTaxRateReconciliationIPMigrationPercent"
       }
      }
     },
     "localname": "EffectiveTaxRateReconciliationIPMigrationPercent",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_Effectiveincometaxreconciliationnondeductiblecompensation": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effectiveincometaxreconciliation,nondeductiblecompensation",
        "label": "Effectiveincometaxreconciliation,nondeductiblecompensation",
        "terseLabel": "Effectiveincometaxreconciliation,nondeductiblecompensation"
       }
      }
     },
     "localname": "Effectiveincometaxreconciliationnondeductiblecompensation",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Effectivetaxratereconciliationnondeductiblecomppercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effectivetaxratereconciliationnondeductiblecomppercent",
        "label": "Effectivetaxratereconciliationnondeductiblecomppercent",
        "terseLabel": "Effectivetaxratereconciliationnondeductiblecomppercent"
       }
      }
     },
     "localname": "Effectivetaxratereconciliationnondeductiblecomppercent",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "icui_EquipmentrevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment revenue [Member]",
        "label": "Equipment revenue [Member]",
        "terseLabel": "Equipment revenue [Member]"
       }
      }
     },
     "localname": "EquipmentrevenueMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_ExercisedOptionsDataTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercised Options Data [Table Text Block]",
        "label": "Exercised Options Data [Table Text Block]",
        "terseLabel": "Exercised Options Data [Table Text Block]"
       }
      }
     },
     "localname": "ExercisedOptionsDataTableTextBlock",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_ForeignDistibutorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Distibutor",
        "label": "Foreign Distibutor [Member]",
        "terseLabel": "Foreign Distibutor [Member]"
       }
      }
     },
     "localname": "ForeignDistibutorMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsTextDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails",
      "http://www.icumed.com/role/FairValueMeasurementTextDetails",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_ForeignInfusionSystemSupplierMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Infusion System Supplier",
        "label": "Foreign Infusion System Supplier [Member]",
        "terseLabel": "Foreign Infusion System Supplier"
       }
      }
     },
     "localname": "ForeignInfusionSystemSupplierMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsForeignInfusionSystemsSupplierDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails",
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/FairValueMeasurementTextDetails",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_ForeignMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign [Member]",
        "label": "Foreign [Member]",
        "terseLabel": "Foreign [Member]"
       }
      }
     },
     "localname": "ForeignMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails",
      "http://www.icumed.com/role/RevenueDisaggregationofRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_FurniturefixturesandmoldsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Furniture, fixtures and molds [Member]",
        "label": "Furniture, fixtures and molds [Member]",
        "terseLabel": "Furniture, fixtures and molds [Member]"
       }
      }
     },
     "localname": "FurniturefixturesandmoldsMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_GILTItaxexpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GILTItaxexpense",
        "label": "GILTItaxexpense",
        "terseLabel": "GILTItaxexpense"
       }
      }
     },
     "localname": "GILTItaxexpense",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_GILTItaxexpensepercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GILTItaxexpensepercent",
        "label": "GILTItaxexpensepercent",
        "terseLabel": "GILTItaxexpensepercent"
       }
      }
     },
     "localname": "GILTItaxexpensepercent",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "icui_Grantdatefairvalueofrestrictedstockunitsgranted": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant date fair value of restricted stock units granted",
        "label": "Grant date fair value of restricted stock units granted",
        "terseLabel": "Grant date fair value of restricted stock units granted"
       }
      }
     },
     "localname": "Grantdatefairvalueofrestrictedstockunitsgranted",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Grantdatefairvalueperformancerestrictedstockunits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant date fair value performance restricted stock units",
        "label": "Grant date fair value performance restricted stock units",
        "terseLabel": "Grant date fair value performance restricted stock units"
       }
      }
     },
     "localname": "Grantdatefairvalueperformancerestrictedstockunits",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Hedge1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge 1 [Member]",
        "label": "Hedge 1 [Member]",
        "terseLabel": "Hedge 1 [Member]"
       }
      }
     },
     "localname": "Hedge1Member",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Hedge2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge 2 [Member]",
        "label": "Hedge 2 [Member]",
        "terseLabel": "Hedge 2 [Member]"
       }
      }
     },
     "localname": "Hedge2Member",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Hedge3MemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge 3 [Member]",
        "label": "Hedge 3 [Member] [Member]",
        "terseLabel": "Hedge 3 [Member] [Member]"
       }
      }
     },
     "localname": "Hedge3MemberMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Hedge4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge 4",
        "label": "Hedge 4 [Member]",
        "terseLabel": "Hedge 4"
       }
      }
     },
     "localname": "Hedge4Member",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Hedge5Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge 5",
        "label": "Hedge 5 [Member]",
        "terseLabel": "Hedge 5"
       }
      }
     },
     "localname": "Hedge5Member",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_HospiraMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hospira [Member]",
        "label": "Hospira [Member]",
        "terseLabel": "Hospira [Member]"
       }
      }
     },
     "localname": "HospiraMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails",
      "http://www.icumed.com/role/FairValueMeasurementDetails",
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesHospiraQuantitativeInformationDetails",
      "http://www.icumed.com/role/FairValueMeasurementTables",
      "http://www.icumed.com/role/FairValueMeasurementTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_IVSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IV Solutions [Member]",
        "label": "IV Solutions [Member]",
        "terseLabel": "IV Solutions [Member]"
       }
      }
     },
     "localname": "IVSolutionsMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregationofRevenueProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_IncomeTaxDisclosuredeferredtaxesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Disclosure deferred taxes [Abstract]",
        "label": "Income Tax Disclosure deferred taxes [Abstract]",
        "terseLabel": "Income Tax Disclosure deferred taxes [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosuredeferredtaxesAbstract",
     "nsuri": "http://www.icumed.com/20211231",
     "xbrltype": "stringItemType"
    },
    "icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change during the reporting period in the carrying amount as of the balance sheet date of payments made for taxes. Also includes the net change during the reporting period in the account that represents the temporary difference that results from income (loss) that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase Decrease in income taxes, including excess tax benefits and deferred income taxes",
        "terseLabel": "Income taxes, including excess tax benefits and deferred income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_IndirectTaxBenefitFromStockOptions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indirect tax benefit from the stock compensation cost received upon the exercise of stock options",
        "label": "Indirect tax benefit from stock options",
        "terseLabel": "Indirect tax benefit"
       }
      }
     },
     "localname": "IndirectTaxBenefitFromStockOptions",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_InformationbyGeographicAreaandCustomerConcentrationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by Geographic Area and Customer Concentration [Text Block]",
        "label": "Information by Geographic Area and Customer Concentration [Text Block]",
        "terseLabel": "Information by Geographic Area and Customer Concentration [Text Block]"
       }
      }
     },
     "localname": "InformationbyGeographicAreaandCustomerConcentrationTextBlock",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/GeographicInformationandSignificantCustomersGeographicInformationandSignificantCustomersNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_InfusionConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infusion Consumables [Member]",
        "label": "Infusion Consumables [Member]",
        "terseLabel": "Infusion Consumables [Member]"
       }
      }
     },
     "localname": "InfusionConsumablesMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregationofRevenueProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_InfusionSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infusion Systems [Member]",
        "label": "Infusion Systems [Member]",
        "terseLabel": "Infusion Systems [Member]"
       }
      }
     },
     "localname": "InfusionSystemsMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregationofRevenueProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_InstrumentsPlacedwithCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instruments Placed with Customers [Member]",
        "label": "Instruments Placed with Customers [Member]",
        "terseLabel": "Instruments Placed with Customers [Member]"
       }
      }
     },
     "localname": "InstrumentsPlacedwithCustomersMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_InterestMarginandCommitmentFeeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Margin and Commitment Fee [Table Text Block]",
        "label": "Interest Margin and Commitment Fee [Table Text Block]",
        "terseLabel": "Interest Margin and Commitment Fee [Table Text Block]"
       }
      }
     },
     "localname": "InterestMarginandCommitmentFeeTableTextBlock",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_InternationalDistributorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Distributor",
        "label": "International Distributor [Member]",
        "terseLabel": "International Distributor"
       }
      }
     },
     "localname": "InternationalDistributorMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_InternationalSalesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Sales [Domain]",
        "label": "International Sales [Domain]",
        "terseLabel": "International Sales [Domain]"
       }
      }
     },
     "localname": "InternationalSalesDomain",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregationofRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_ItalyPropertyAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign property and equipment: Italy",
        "label": "Italy Property and Equipment [Member]",
        "terseLabel": "Italy Property and Equipment [Member]"
       }
      }
     },
     "localname": "ItalyPropertyAndEquipmentMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_LIBORBasisSpreadonVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "LIBOR Basis Spread on Variable Rate",
        "label": "LIBOR Basis Spread on Variable Rate",
        "terseLabel": "LIBOR Basis Spread on Variable Rate"
       }
      }
     },
     "localname": "LIBORBasisSpreadonVariableRate",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsLineofCreditPricingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "icui_LesseeOperatingAndFinanceLeaseTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating and Finance Lease",
        "label": "Lessee, Operating and Finance Lease [Text Block]",
        "terseLabel": "Lessee, Operating and Finance Lease"
       }
      }
     },
     "localname": "LesseeOperatingAndFinanceLeaseTextBlock",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/LeasesNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_Liabilitiesforcontracts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liabilities for contracts",
        "label": "Liabilities for contracts",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "Liabilitiesforcontracts",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_LineOfCreditSpread": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "line of credit spread",
        "label": "line of credit spread",
        "terseLabel": "line of credit spread"
       }
      }
     },
     "localname": "LineOfCreditSpread",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "icui_LineofCreditAccordion": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Accordion",
        "label": "Line of Credit Accordion",
        "terseLabel": "Line of Credit Accordion"
       }
      }
     },
     "localname": "LineofCreditAccordion",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_LongTermContingentConsiderationGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term contingent consideration-gross",
        "label": "Long-term contingent consideration-gross",
        "terseLabel": "Long-term contingent consideration-gross"
       }
      }
     },
     "localname": "LongTermContingentConsiderationGross",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsForeignInfusionSystemsSupplierDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails",
      "http://www.icumed.com/role/FairValueMeasurementTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_LongTermDebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt Disclosure [Abstract]",
        "label": "Long-Term Debt Disclosure [Abstract]",
        "terseLabel": "Long-Term Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "LongTermDebtDisclosureAbstract",
     "nsuri": "http://www.icumed.com/20211231",
     "xbrltype": "stringItemType"
    },
    "icui_LongtermInvestmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Investments [Domain]",
        "label": "Long-term Investments [Domain]",
        "terseLabel": "Long-term Investments [Domain]"
       }
      }
     },
     "localname": "LongtermInvestmentsDomain",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_MexicoPropertyAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign property and equipment: Mexico",
        "label": "Mexico Property and Equipment [Member]",
        "terseLabel": "Mexico Property and Equipment [Member]"
       }
      }
     },
     "localname": "MexicoPropertyAndEquipmentMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_ModifiedPRSUIncrementalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Modified PRSU Incremental Expense",
        "label": "Modified PRSU Incremental Expense",
        "terseLabel": "Modified PRSU Incremental Expense"
       }
      }
     },
     "localname": "ModifiedPRSUIncrementalExpense",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_MoldsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Molds [Member]",
        "label": "Molds [Member]",
        "terseLabel": "Molds [Member]"
       }
      }
     },
     "localname": "MoldsMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_NetCashPaidReceivedforcurrentandprioracquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Cash Paid (Received) for current and prior acquisitions",
        "label": "Net Cash Paid (Received) for current and prior acquisitions",
        "negatedTerseLabel": "Cash paid for acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "NetCashPaidReceivedforcurrentandprioracquisitions",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_NonCurrentDeferredTaxAssetGrossTotalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of gross non-current deferred tax asset",
        "label": "Non-current deferred tax asset, gross total [Member]",
        "terseLabel": "Non-current deferred tax asset, gross total [Member]"
       }
      }
     },
     "localname": "NonCurrentDeferredTaxAssetGrossTotalMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_NoncurrentDeferredTaxAssetTaxCreditsState": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncurrent deferred tax asset - tax credits state",
        "label": "Noncurrent deferred tax asset - tax credits state",
        "terseLabel": "Noncurrent deferred tax asset - tax credits state"
       }
      }
     },
     "localname": "NoncurrentDeferredTaxAssetTaxCreditsState",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_NoncurrentDeferredTaxLiabilityDepreciationAndAmortization": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncurrent deferred tax liability - depreciation and amortization",
        "label": "Noncurrent deferred tax liability - depreciation and amortization",
        "terseLabel": "Noncurrent deferred tax liability - depreciation and amortization"
       }
      }
     },
     "localname": "NoncurrentDeferredTaxLiabilityDepreciationAndAmortization",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_NoncurrentDeferredTaxLiabilityForeign": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncurrent deferred tax liability - foreign",
        "label": "Noncurrent deferred tax liability - foreign",
        "terseLabel": "Noncurrent deferred tax liability - foreign"
       }
      }
     },
     "localname": "NoncurrentDeferredTaxLiabilityForeign",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_NoncurrentDeferredTaxLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncurrent deferred tax liability [Member]",
        "label": "Noncurrent deferred tax liability [Member]",
        "terseLabel": "Noncurrent deferred tax liability [Member]"
       }
      }
     },
     "localname": "NoncurrentDeferredTaxLiabilityMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_NoncurrentDeferredTaxLiabilityStateIncomeTaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncurrent deferred tax liability - state income taxes",
        "label": "Noncurrent deferred tax liability - state income taxes",
        "terseLabel": "Noncurrent deferred tax liability - state income taxes"
       }
      }
     },
     "localname": "NoncurrentDeferredTaxLiabilityStateIncomeTaxes",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Noncurrentdeferredtaxasset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-current deferred tax asset",
        "label": "Non-current deferred tax asset",
        "terseLabel": "Non-current deferred tax asset"
       }
      }
     },
     "localname": "Noncurrentdeferredtaxasset",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Noncurrentdeferredtaxassetaccruedrestructuring": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncurrentdeferredtaxassetaccruedrestructuring",
        "label": "Noncurrentdeferredtaxassetaccruedrestructuring",
        "terseLabel": "Noncurrentdeferredtaxassetaccruedrestructuring"
       }
      }
     },
     "localname": "Noncurrentdeferredtaxassetaccruedrestructuring",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Noncurrentdeferredtaxassetacquiredfuturetaxdeductions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncurrent deferred tax asset - acquired future tax deductions",
        "label": "Noncurrent deferred tax asset - acquired future tax deductions",
        "terseLabel": "Noncurrent deferred tax asset - acquired future tax deductions"
       }
      }
     },
     "localname": "Noncurrentdeferredtaxassetacquiredfuturetaxdeductions",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions",
        "label": "Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions",
        "terseLabel": "Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions"
       }
      }
     },
     "localname": "Noncurrentdeferredtaxassetchargebacksdiscountscustomerconcessions",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Operatingleaserightofuseassetamortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operatingleaserightofuseassetamortization",
        "label": "Operatingleaserightofuseassetamortization",
        "terseLabel": "Operatingleaserightofuseassetamortization"
       }
      }
     },
     "localname": "Operatingleaserightofuseassetamortization",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_OperatinglosscarryforwardsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating loss carryforwards [Abstract]",
        "label": "Operating loss carryforwards [Abstract]",
        "terseLabel": "Operating loss carryforwards [Abstract]"
       }
      }
     },
     "localname": "OperatinglosscarryforwardsAbstract",
     "nsuri": "http://www.icumed.com/20211231",
     "xbrltype": "stringItemType"
    },
    "icui_Optiontoextendinyears": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Optiontoextendinyears",
        "label": "Optiontoextendinyears",
        "terseLabel": "Optiontoextendinyears"
       }
      }
     },
     "localname": "Optiontoextendinyears",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "icui_OtherLATAMMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other LATAM [Member]",
        "label": "Other LATAM [Member]",
        "terseLabel": "Other LATAM [Member]"
       }
      }
     },
     "localname": "OtherLATAMMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_OtherLongtermLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Long-term Liabilities [Abstract]",
        "label": "Other Long-term Liabilities [Abstract]",
        "terseLabel": "Other Long-term Liabilities [Abstract]"
       }
      }
     },
     "localname": "OtherLongtermLiabilitiesAbstract",
     "nsuri": "http://www.icumed.com/20211231",
     "xbrltype": "stringItemType"
    },
    "icui_OtherforeigncountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other foreign countries [Member]",
        "label": "Other foreign countries [Member]",
        "terseLabel": "Other foreign countries [Member]"
       }
      }
     },
     "localname": "OtherforeigncountriesMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregationofRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Outsidesalescommissions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outside sales commissions",
        "label": "Outside sales commissions",
        "terseLabel": "Outside commissions"
       }
      }
     },
     "localname": "Outsidesalescommissions",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_OwnershipShareMinimumRequirement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership Share % Minimum Requirement",
        "label": "Ownership Share % Minimum Requirement",
        "terseLabel": "Ownership Share % Minimum Requirement"
       }
      }
     },
     "localname": "OwnershipShareMinimumRequirement",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "icui_Paymenttoacquirebusinessnetofworkingcapitaladjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment to acquire business, net of working capital adjustments",
        "label": "Payment to acquire business, net of working capital adjustments",
        "terseLabel": "Payment to acquire business, net of working capital adjustments"
       }
      }
     },
     "localname": "Paymenttoacquirebusinessnetofworkingcapitaladjustments",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Percentageofrevenue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of revenue",
        "label": "Percentage of revenue",
        "terseLabel": "Percentage of revenue"
       }
      }
     },
     "localname": "Percentageofrevenue",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregationofRevenueProductLineDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "icui_Percentoftotalrevenue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent of total revenue",
        "label": "Percent of total revenue",
        "terseLabel": "Percent of total revenue"
       }
      }
     },
     "localname": "Percentoftotalrevenue",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregationofRevenuebyGeographyDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "icui_PerformanceRestrictedStockUnitsPRSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Restricted Stock Units (PRSUs) stock units issued if the measurement period goal is met.",
        "label": "Performance Restricted Stock Units (PRSUs) [Member]",
        "terseLabel": "Performance Restricted Stock Units (PRSUs) [Member]"
       }
      }
     },
     "localname": "PerformanceRestrictedStockUnitsPRSUsMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_PerformanceSharesEarned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Shares Earned",
        "label": "Performance Shares Earned",
        "terseLabel": "Performance Shares Earned"
       }
      }
     },
     "localname": "PerformanceSharesEarned",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "icui_Prepaidinsuranceandpropertytaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid insurance and property taxes",
        "label": "Prepaid insurance and property taxes",
        "terseLabel": "Prepaid insurance and property taxes"
       }
      }
     },
     "localname": "Prepaidinsuranceandpropertytaxes",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Prepaidothertaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid other taxes",
        "label": "Prepaid other taxes",
        "terseLabel": "Prepaid other taxes"
       }
      }
     },
     "localname": "Prepaidothertaxes",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_PricingLevel5Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level 5",
        "label": "Pricing Level 5 [Member]",
        "terseLabel": "Pricing Level 5"
       }
      }
     },
     "localname": "PricingLevel5Member",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_PricingLevelIIIMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Pricing Level III [Member] [Member]",
        "terseLabel": "Pricing Level III [Member] [Member]"
       }
      }
     },
     "localname": "PricingLevelIIIMemberMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsLineofCreditPricingDetails",
      "http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_PricingLevelIIMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level II [Member] [Member]",
        "label": "Pricing Level II [Member] [Member]",
        "terseLabel": "Pricing Level II [Member] [Member]"
       }
      }
     },
     "localname": "PricingLevelIIMemberMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsLineofCreditPricingDetails",
      "http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails",
      "http://www.icumed.com/role/SubsequentEventsTermLoanBApplicableMarginDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_PricingLevelIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level I [Member]",
        "label": "Pricing Level I [Member]",
        "terseLabel": "Pricing Level I [Member]"
       }
      }
     },
     "localname": "PricingLevelIMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsLineofCreditPricingDetails",
      "http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails",
      "http://www.icumed.com/role/SubsequentEventsTermLoanBApplicableMarginDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_PricingLevelIVMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level IV [Member]",
        "label": "Pricing Level IV [Member] [Member]",
        "terseLabel": "Pricing Level IV [Member] [Member]"
       }
      }
     },
     "localname": "PricingLevelIVMemberMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsLineofCreditPricingDetails",
      "http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_ProvisionForWarrantyAndReturns": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision for warranty and returns",
        "label": "Provision for warranty and returns",
        "terseLabel": "Provision for warranty and returns"
       }
      }
     },
     "localname": "ProvisionForWarrantyAndReturns",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_PursuitVascularInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pursuit Vascular, Inc. [Member] [Member]",
        "label": "Pursuit Vascular, Inc. [Member]",
        "terseLabel": "Pursuit Vascular, Inc. [Member]"
       }
      }
     },
     "localname": "PursuitVascularInc.Member",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularIntangibleDetails",
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails",
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTables",
      "http://www.icumed.com/role/AcquisitionsTextDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails",
      "http://www.icumed.com/role/FairValueMeasurementDetails",
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails",
      "http://www.icumed.com/role/FairValueMeasurementTables",
      "http://www.icumed.com/role/FairValueMeasurementTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_PursuitVascularLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pursuit Vascular LLC",
        "label": "Pursuit Vascular LLC [Member]",
        "terseLabel": "Pursuit Vascular LLC"
       }
      }
     },
     "localname": "PursuitVascularLLCMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsTextDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails",
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/FairValueMeasurementDetails",
      "http://www.icumed.com/role/FairValueMeasurementTextDetails",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_RestrictedStockAndPerformanceRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock and Performance Restricted Stock Units [Member]",
        "label": "Restricted Stock and Performance Restricted Stock Units [Member]",
        "terseLabel": "Restricted Stock and Performance Restricted Stock Units [Member]"
       }
      }
     },
     "localname": "RestrictedStockAndPerformanceRestrictedStockUnitsMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_RestructuringAdjustmentsSeveranceAndFacility": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Adjustments - Severance and Facility",
        "label": "Restructuring Adjustments - Severance and Facility",
        "terseLabel": "Restructuring Adjustments - Severance and Facility"
       }
      }
     },
     "localname": "RestructuringAdjustmentsSeveranceAndFacility",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Restructuringandstrategictransactionexpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and strategic transaction expense",
        "label": "Restructuring and strategic transaction expense",
        "terseLabel": "Restructuring, strategic transaction and integration expenses"
       }
      }
     },
     "localname": "Restructuringandstrategictransactionexpense",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_RevenueGrossProfitVolatilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue/Gross Profit Volatility [Member]",
        "label": "Revenue/Gross Profit Volatility [Member]",
        "terseLabel": "Revenue/Gross Profit Volatility [Member]"
       }
      }
     },
     "localname": "RevenueGrossProfitVolatilityMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of stock compensation and related tax benefits [Table Text Block]",
        "label": "Schedule of stock compensation and related tax benefits [Table Text Block]",
        "terseLabel": "Schedule of stock compensation and related tax benefits [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleofstockcompensationandrelatedtaxbenefitsTableTextBlock",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue",
        "terseLabel": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceExpectationAdditionsIntrinsicValue",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "icui_ShareawarddataAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share award data [Abstract]",
        "label": "Share award data [Abstract]",
        "terseLabel": "Share award data [Abstract]"
       }
      }
     },
     "localname": "ShareawarddataAbstract",
     "nsuri": "http://www.icumed.com/20211231",
     "xbrltype": "stringItemType"
    },
    "icui_SharesAvailableInEmployeeStockPurchasePlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares available in employee stock purchase plan",
        "label": "Shares available in employee stock purchase plan",
        "terseLabel": "Shares available in employee stock purchase plan"
       }
      }
     },
     "localname": "SharesAvailableInEmployeeStockPurchasePlan",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardESPPNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "icui_Sharestransferredfromsupersededplan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares transferred from superseded plan",
        "label": "Shares transferred from superseded plan",
        "terseLabel": "Shares transferred from superseded plan"
       }
      }
     },
     "localname": "Sharestransferredfromsupersededplan",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "icui_ShortTermContingentConsiderationGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term contingent consideration-gross",
        "label": "Short-term contingent consideration-gross",
        "terseLabel": "Short-term contingent consideration-gross"
       }
      }
     },
     "localname": "ShortTermContingentConsiderationGross",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsForeignInfusionSystemsSupplierDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails",
      "http://www.icumed.com/role/FairValueMeasurementTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_SmithsMedicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Smiths Medical",
        "label": "Smiths Medical [Member]",
        "terseLabel": "Smiths Medical"
       }
      }
     },
     "localname": "SmithsMedicalMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_SoftwarerevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Software revenue [Member]",
        "label": "Software revenue [Member]",
        "terseLabel": "Software revenue [Member]"
       }
      }
     },
     "localname": "SoftwarerevenueMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_SpareParts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Spare parts",
        "label": "Spare parts",
        "terseLabel": "Spare parts"
       }
      }
     },
     "localname": "SpareParts",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Sparepartsusage": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sparepartsusage",
        "label": "Sparepartsusage",
        "terseLabel": "Sparepartsusage"
       }
      }
     },
     "localname": "Sparepartsusage",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Spread": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "spread",
        "label": "spread",
        "terseLabel": "spread"
       }
      }
     },
     "localname": "Spread",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "icui_StockIncentivePlansLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Stock Incentive Plans [Table]",
        "label": "Stock Incentive Plans [Line Items]",
        "terseLabel": "Stock Incentive Plans [Line Items]"
       }
      }
     },
     "localname": "StockIncentivePlansLineItems",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_StockIncentivePlansTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Incentive Plans [Table]",
        "label": "Stock Incentive Plans [Table]",
        "terseLabel": "Stock Incentive Plans [Table]"
       }
      }
     },
     "localname": "StockIncentivePlansTable",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_StrategicTransactionandIntegration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strategic Transaction and Integration",
        "label": "Strategic Transaction and Integration",
        "terseLabel": "Strategic Transaction and Integration"
       }
      }
     },
     "localname": "StrategicTransactionandIntegration",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationStrategicTransactionandIntegrationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_SupplementalBalanceSheetInformationLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Balance Sheet Information Leases",
        "label": "Supplemental Balance Sheet Information Leases [Table Text Block]",
        "terseLabel": "Supplemental Balance Sheet Information Leases"
       }
      }
     },
     "localname": "SupplementalBalanceSheetInformationLeasesTableTextBlock",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_SupplementalCashFlowInformationLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Cash Flow Information Leases",
        "label": "Supplemental Cash Flow Information Leases [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow Information Leases"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationLeasesTableTextBlock",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_Supplychainrestructuringcosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplychainrestructuringcosts",
        "label": "Supplychainrestructuringcosts",
        "terseLabel": "Supplychainrestructuringcosts"
       }
      }
     },
     "localname": "Supplychainrestructuringcosts",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationStrategicTransactionandIntegrationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_TermLoanAAndCreditLineApplicableMarginSpreadAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan A and Credit Line Applicable Margin Spread",
        "label": "Term Loan A and Credit Line Applicable Margin Spread [Axis]",
        "terseLabel": "Term Loan A and Credit Line Applicable Margin Spread [Axis]"
       }
      }
     },
     "localname": "TermLoanAAndCreditLineApplicableMarginSpreadAxis",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_TermLoanAAndCreditLineApplicableMarginSpreadDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan A and Credit Line Applicable Margin Spread [Domain]",
        "label": "Term Loan A and Credit Line Applicable Margin Spread [Domain]",
        "terseLabel": "Term Loan A and Credit Line Applicable Margin Spread [Domain]"
       }
      }
     },
     "localname": "TermLoanAAndCreditLineApplicableMarginSpreadDomain",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_TermLoanAAndCreditLineSpread": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan A and Credit Line Spread",
        "label": "Term Loan A and Credit Line Spread",
        "terseLabel": "Term Loan A and Credit Line Spread"
       }
      }
     },
     "localname": "TermLoanAAndCreditLineSpread",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails",
      "http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "icui_TermLoanAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan A",
        "label": "Term Loan A [Member]",
        "terseLabel": "Term Loan A"
       }
      }
     },
     "localname": "TermLoanAMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_TermLoanAPaymentFirstYearsAsAOfOriginalDebt": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan A Payment First Years as a % of Original Debt",
        "label": "Term Loan A Payment First Years as a % of Original Debt",
        "terseLabel": "Term Loan A Payment First Years as a % of Original Debt"
       }
      }
     },
     "localname": "TermLoanAPaymentFirstYearsAsAOfOriginalDebt",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "icui_TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan A Payment Year 3 and 4 as a % of Original Debt Amount",
        "label": "Term Loan A Payment Year 3 and 4 as a % of Original Debt Amount",
        "terseLabel": "Term Loan A Payment Year 3 and 4 as a % of Original Debt Amount"
       }
      }
     },
     "localname": "TermLoanAPaymentYear3And4AsAOfOriginalDebtAmount",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "icui_TermLoanAPaymentYear5": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan A Payment Year 5",
        "label": "Term Loan A Payment Year 5",
        "terseLabel": "Term Loan A Payment Year 5"
       }
      }
     },
     "localname": "TermLoanAPaymentYear5",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "icui_TermLoanBApplicableMarginAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B Applicable Margin",
        "label": "Term Loan B Applicable Margin [Axis]",
        "terseLabel": "Term Loan B Applicable Margin [Axis]"
       }
      }
     },
     "localname": "TermLoanBApplicableMarginAxis",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsTermLoanBApplicableMarginDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_TermLoanBApplicableMarginDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B Applicable Margin [Domain]",
        "label": "Term Loan B Applicable Margin [Domain]",
        "terseLabel": "Term Loan B Applicable Margin [Domain]"
       }
      }
     },
     "localname": "TermLoanBApplicableMarginDomain",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsTermLoanBApplicableMarginDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_TermLoanBBaseRateLoanSpread": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B Base Rate Loan Spread",
        "label": "Term Loan B Base Rate Loan Spread",
        "terseLabel": "Term Loan B Base Rate Loan Spread"
       }
      }
     },
     "localname": "TermLoanBBaseRateLoanSpread",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsTermLoanBApplicableMarginDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "icui_TermLoanBEuroRateLoanSpread": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B Euro Rate Loan Spread",
        "label": "Term Loan B Euro Rate Loan Spread",
        "terseLabel": "Term Loan B Euro Rate Loan Spread"
       }
      }
     },
     "localname": "TermLoanBEuroRateLoanSpread",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsTermLoanBApplicableMarginDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "icui_TermLoanBInitialSpread": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B Initial Spread",
        "label": "Term Loan B Initial Spread",
        "terseLabel": "Term Loan B Initial Spread"
       }
      }
     },
     "localname": "TermLoanBInitialSpread",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails",
      "http://www.icumed.com/role/SubsequentEventsTermLoanBApplicableMarginDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "icui_TermLoanBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B",
        "label": "Term Loan B [Member]",
        "terseLabel": "Term Loan B"
       }
      }
     },
     "localname": "TermLoanBMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B Quarterly Payments as a % of Original Debt Amount",
        "label": "Term Loan B Quarterly Payments as a % of Original Debt Amount",
        "terseLabel": "Term Loan B Quarterly Payments as a % of Original Debt Amount"
       }
      }
     },
     "localname": "TermLoanBQuarterlyPaymentsAsAOfOriginalDebtAmount",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "icui_TermLoansLineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loans &amp; Line of Credit",
        "label": "Term Loans &amp; Line of Credit [Member]",
        "terseLabel": "Term Loans &amp; Line of Credit"
       }
      }
     },
     "localname": "TermLoansLineOfCreditMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Timebasedoptionsgrantdatefairvalue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Time based options grant date fair value",
        "label": "Time based options grant date fair value",
        "terseLabel": "Time based options grant date fair value"
       }
      }
     },
     "localname": "Timebasedoptionsgrantdatefairvalue",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_TimebasedstockoptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Time-based stock option [Member]",
        "label": "Time-based stock option [Member]",
        "terseLabel": "Time-based stock option [Member]"
       }
      }
     },
     "localname": "TimebasedstockoptionMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_TotalAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Acquisitions",
        "label": "Total Acquisitions [Member]",
        "terseLabel": "Total Acquisitions"
       }
      }
     },
     "localname": "TotalAcquisitionsMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_UnitedStatespropertyandequipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States property and equipment [Member]",
        "label": "United States property and equipment [Member]",
        "terseLabel": "United States property and equipment [Member]"
       }
      }
     },
     "localname": "UnitedStatespropertyandequipmentMember",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_UnrecognizedTaxBenefitsRollForwardRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized tax benefits roll forward",
        "label": "Unrecognized tax benefits roll forward [Roll Forward]"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsRollForwardRollForward",
     "nsuri": "http://www.icumed.com/20211231",
     "xbrltype": "stringItemType"
    },
    "icui_UpFrontMaintenanceFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Up front maintenance fee",
        "label": "Up front maintenance fee",
        "terseLabel": "Up front maintenance fee"
       }
      }
     },
     "localname": "UpFrontMaintenanceFee",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_UsGaap_InterestRateSwap2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "us-gaap_InterestRateSwap 2",
        "label": "us-gaap_InterestRateSwap 2 [Member]",
        "terseLabel": "us-gaap_InterestRateSwap 2"
       }
      }
     },
     "localname": "UsGaap_InterestRateSwap2Member",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_WarrantyAndReturnReserveCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warranty and Return Reserve costs",
        "label": "Warranty and Return Reserve costs",
        "terseLabel": "Warranty and Return Reserve costs"
       }
      }
     },
     "localname": "WarrantyAndReturnReserveCosts",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_WarrantyAndReturnReserveInventory": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warranty and return reserve - inventory",
        "label": "Warranty and return reserve - inventory",
        "terseLabel": "Warranty and return reserve - inventory"
       }
      }
     },
     "localname": "WarrantyAndReturnReserveInventory",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_WarrantyAndReturnReserveInventoryChargedToOtherAccounts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warranty and return reserve - inventory - charged to other accounts",
        "label": "Warranty and return reserve - inventory - charged to other accounts",
        "negatedTerseLabel": "Warranty and return reserve - inventory - charged to other accounts"
       }
      }
     },
     "localname": "WarrantyAndReturnReserveInventoryChargedToOtherAccounts",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_WarrantyAndReturnReserveInventoryWriteOffs": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warranty and return reserve - inventory write-offs",
        "label": "Warranty and return reserve - inventory write-offs",
        "terseLabel": "Warranty and return reserve - inventory write-offs"
       }
      }
     },
     "localname": "WarrantyAndReturnReserveInventoryWriteOffs",
     "nsuri": "http://www.icumed.com/20211231",
     "presentation": [
      "http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region of Asia Pacific.",
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia Pacific [Member]"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Continent of Europe.",
        "label": "Europe [Member]",
        "terseLabel": "Europe [Member]"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r321",
      "r354",
      "r419",
      "r422",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r715",
      "r718",
      "r756",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails",
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details",
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r321",
      "r354",
      "r419",
      "r422",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r715",
      "r718",
      "r756",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails",
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details",
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r211",
      "r388",
      "r392",
      "r667",
      "r714",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesTextDetails",
      "http://www.icumed.com/role/RevenueDisaggregationofRevenueProductLineDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r211",
      "r388",
      "r392",
      "r667",
      "r714",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesTextDetails",
      "http://www.icumed.com/role/RevenueDisaggregationofRevenueProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r321",
      "r354",
      "r404",
      "r419",
      "r422",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r715",
      "r718",
      "r756",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails",
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details",
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r321",
      "r354",
      "r404",
      "r419",
      "r422",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r715",
      "r718",
      "r756",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails",
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details",
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r164",
      "r169",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets",
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/StatementofComprehensiveIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r150",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r212",
      "r213",
      "r388",
      "r393",
      "r717",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r768",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails",
      "http://www.icumed.com/role/RevenueDisaggregationofRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r212",
      "r213",
      "r388",
      "r393",
      "r717",
      "r743",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r768",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails",
      "http://www.icumed.com/role/RevenueDisaggregationofRevenuebyGeographyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r164",
      "r169",
      "r303",
      "r420",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]",
        "terseLabel": "Statement, Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets",
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/StatementofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r148",
      "r149",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Changes and Error Corrections [Abstract]",
        "terseLabel": "Accounting Changes and Error Corrections [Abstract]"
       }
      }
     },
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r47",
      "r650"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r7",
      "r27",
      "r217",
      "r218"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable, net of allowance for doubtful accounts of $7,038 at December 31, 2021 and $21,490 at December 31, 2020"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedBonusesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r50"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Bonuses, Current",
        "terseLabel": "Incentive compensation"
       }
      }
     },
     "localname": "AccruedBonusesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent": {
     "auth_ref": [
      "r682",
      "r707"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them.",
        "label": "Accrued Employee Benefits",
        "terseLabel": "Benefits"
       }
      }
     },
     "localname": "AccruedEmployeeBenefitsCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r21",
      "r676",
      "r699"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Accrued Income Taxes, Current"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r23",
      "r676",
      "r699"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Accrued Income Taxes, Noncurrent"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesDetails",
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities [Abstract]",
        "terseLabel": "Accrued Liabilities [Abstract]"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": {
     "auth_ref": [
      "r682",
      "r707"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.",
        "label": "Accrued Professional Fees",
        "terseLabel": "Accrued Professional Fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRentCurrentAndNoncurrent": {
     "auth_ref": [
      "r21",
      "r23",
      "r677",
      "r698"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements.",
        "label": "Accrued Rent",
        "terseLabel": "Accrued rent"
       }
      }
     },
     "localname": "AccruedRentCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r74",
      "r80",
      "r88",
      "r89",
      "r90",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r45",
      "r278"
     ],
     "calculation": {
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Accumulated Depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r71",
      "r80",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r30",
      "r77",
      "r79",
      "r80",
      "r702",
      "r723",
      "r726"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets",
      "http://www.icumed.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r88",
      "r89",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r76",
      "r80",
      "r88",
      "r89",
      "r90",
      "r152",
      "r153",
      "r154",
      "r550",
      "r719",
      "r720",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r69",
      "r80",
      "r88",
      "r89",
      "r90",
      "r550",
      "r611",
      "r612",
      "r613",
      "r614",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularIntangibleDetails",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularIntangibleDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r456",
      "r457",
      "r458",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r423",
      "r425",
      "r462",
      "r463"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Cost [Policy Text Block]"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r467"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising Expense"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesAdvertisingExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r148",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "terseLabel": "SEC Schedule, 12-09, Allowance, Credit Loss"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r34",
      "r219",
      "r245"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r99",
      "r123",
      "r341",
      "r623"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Debt issuance cost amortization"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r123",
      "r261",
      "r269"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets2Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "NET INCOME PER SHARE"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r137",
      "r200",
      "r204",
      "r209",
      "r240",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r547",
      "r551",
      "r599",
      "r648",
      "r650",
      "r674",
      "r697"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r12",
      "r64",
      "r137",
      "r240",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r547",
      "r551",
      "r599",
      "r648",
      "r650"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "CURRENT ASSETS:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r586"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets, Fair Value Disclosure"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsTotalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total assets, when it serves as a benchmark in a concentration of risk calculation, representing the sum of all reported assets as of the balance sheet date.",
        "label": "Assets, Total [Member]",
        "terseLabel": "Assets, Total"
       }
      }
     },
     "localname": "AssetsTotalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r227",
      "r247"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "terseLabel": "Investment Securities, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r224",
      "r228",
      "r247",
      "r681"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Investment Securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r226",
      "r247"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheetsParenthetical": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Current",
        "terseLabel": "Short-term investment securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets",
      "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "auth_ref": [
      "r226",
      "r247"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-sale, Noncurrent",
        "terseLabel": "Long-term Investment Securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r426",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails",
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails",
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails",
      "http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails",
      "http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails",
      "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails",
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r563",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails",
      "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails",
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingImprovementsMember": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Addition, improvement, or renovation to a facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building Improvements [Member]",
        "terseLabel": "Building Improvements [Member]"
       }
      }
     },
     "localname": "BuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building [Member]"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r417",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsForeignInfusionSystemsSupplierDetails",
      "http://www.icumed.com/role/AcquisitionsPursuitVascularIntangibleDetails",
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails",
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTables",
      "http://www.icumed.com/role/AcquisitionsTextDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails",
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/FairValueMeasurementDetails",
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesHospiraQuantitativeInformationDetails",
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails",
      "http://www.icumed.com/role/FairValueMeasurementTables",
      "http://www.icumed.com/role/FairValueMeasurementTextDetails",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails",
      "http://www.icumed.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r417",
      "r421",
      "r519",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsForeignInfusionSystemsSupplierDetails",
      "http://www.icumed.com/role/AcquisitionsPursuitVascularIntangibleDetails",
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails",
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTables",
      "http://www.icumed.com/role/AcquisitionsTextDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails",
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/FairValueMeasurementDetails",
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesHospiraQuantitativeInformationDetails",
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails",
      "http://www.icumed.com/role/FairValueMeasurementTables",
      "http://www.icumed.com/role/FairValueMeasurementTextDetails",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails",
      "http://www.icumed.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsForeignInfusionSystemsSupplierDetails",
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails",
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTables",
      "http://www.icumed.com/role/AcquisitionsTextDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Business Acquisition, Percentage of Voting Interests Acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsTextDetails",
      "http://www.icumed.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r537"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Business Acquisition, Goodwill, Expected Tax Deductible Amount"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquiredReceivablesFairValue": {
     "auth_ref": [
      "r522"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of acquired receivable from business combination, excluding certain loans and debt securities acquired in transfer.",
        "label": "Business Combination, Acquired Receivable, Fair Value",
        "terseLabel": "Business Combination, Acquired Receivable, Fair Value"
       }
      }
     },
     "localname": "BusinessCombinationAcquiredReceivablesFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r531",
      "r532",
      "r534"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Business Combination, Consideration Transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r122",
      "r538"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in fair value of contingent earn-out"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r530",
      "r533"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Contingent earn-out liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Measurement Input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesHospiraQuantitativeInformationDetails",
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r530",
      "r533"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Contingent earn-out liability, Noncurrent"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails",
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combination Disclosure [Text Block]"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized": {
     "auth_ref": [
      "r524"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount, measured at acquisition-date fair value, of all liabilities assumed that arise from contingencies and were recognized by the entity.",
        "label": "Business Combination, Liabilities Arising from Contingencies, Amount Recognized",
        "negatedTerseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r523"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r521",
      "r523"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularIntangibleDetails",
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r521",
      "r523"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r521",
      "r523"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r521",
      "r523"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r4",
      "r151",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "Business Description and Basis of Presentation [Text Block]"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r128",
      "r129",
      "r130"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accounts payable for property and equipment"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r5",
      "r41",
      "r125"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheetsParenthetical": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS, end of period",
        "periodStartLabel": "CASH AND CASH EQUIVALENTS, beginning of period",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets",
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]",
        "terseLabel": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect [Abstract]",
        "terseLabel": "Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r17",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.icumed.com/role/ConsolidatedBalanceSheetsParenthetical": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-term Investments",
        "terseLabel": "TOTAL CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENT SECURITIES"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r118",
      "r608"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging [Member]"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r372",
      "r373",
      "r374",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r540",
      "r541",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Collaborative Arrangement Disclosure [Text Block]"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r54",
      "r302",
      "r684",
      "r706"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r304",
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies Disclosure [Text Block]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r152",
      "r153",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r26",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance, Shares",
        "periodStartLabel": "Balance, Shares",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r26",
      "r650"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $0.10 par value - Authorized-80,000 shares; Issued 21,280 and 21,058 shares at December 31, 2021 and 2020, respectively, and outstanding 21,280 and 21,058 shares at December 31, 2021 and 2020, respectively."
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets",
      "http://www.icumed.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r83",
      "r85",
      "r86",
      "r96",
      "r687",
      "r710"
     ],
     "calculation": {
      "http://www.icumed.com/role/StatementofComprehensiveIncomeParenthetical": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "terseLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StatementofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in Progress [Member]"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Contract with Customer, Asset and Liability [Table Text Block]"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r377",
      "r378",
      "r389"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "negatedPeriodEndLabel": "Contract with Customer, Liability",
        "negatedPeriodStartLabel": "Contract with Customer, Liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r377",
      "r378",
      "r389"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Contract with Customer, Liability, Current"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r390"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Contract with Customer, Liability, Revenue Recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue": {
     "auth_ref": [
      "r25",
      "r367"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding nonredeemable convertible preferred stock or outstanding convertible preferred stock that is redeemable solely at the option of the issuer.",
        "label": "Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value",
        "verboseLabel": "Convertible preferred stock, $1.00 par value Authorized-500 shares; Issued and outstanding - none"
       }
      }
     },
     "localname": "ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r102",
      "r667"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of Goods Sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsLineofCreditPricingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsLineofCreditPricingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditRiskMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk that a borrower will fail to pay interest or principal on a loan or debt security when due.",
        "label": "Credit Risk [Member]",
        "terseLabel": "Credit Risk [Member]"
       }
      }
     },
     "localname": "CreditRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r138",
      "r496",
      "r506"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Current Federal Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r138",
      "r496"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Current Foreign Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r138",
      "r496",
      "r506",
      "r508"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "terseLabel": "Current Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r138",
      "r496",
      "r506"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "Current State and Local Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerContractsMember": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's established relationships with its customers through contracts.",
        "label": "Customer Contracts [Member]",
        "terseLabel": "Customer Contracts [Member]"
       }
      }
     },
     "localname": "CustomerContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelatedIntangibleAssetsMember": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.",
        "label": "Customer-Related Intangible Assets [Member]",
        "terseLabel": "Customer-Related Intangible Assets [Member]"
       }
      }
     },
     "localname": "CustomerRelatedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r134",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r335",
      "r342",
      "r343",
      "r345",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt Disclosure [Text Block]"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r20",
      "r21",
      "r22",
      "r136",
      "r142",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r331",
      "r332",
      "r333",
      "r334",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r347",
      "r348",
      "r349",
      "r350",
      "r624",
      "r675",
      "r678",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt Instrument, Basis Spread on Variable Rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsLineofCreditPricingDetails",
      "http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateTerms": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.",
        "label": "Debt Instrument, Interest Rate Terms",
        "terseLabel": "Debt Instrument, Interest Rate Terms"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateTerms",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r53",
      "r136",
      "r142",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r331",
      "r332",
      "r333",
      "r334",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r347",
      "r348",
      "r349",
      "r350",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r53",
      "r136",
      "r142",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r331",
      "r332",
      "r333",
      "r334",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r344",
      "r347",
      "r348",
      "r349",
      "r350",
      "r367",
      "r368",
      "r369",
      "r370",
      "r621",
      "r622",
      "r624",
      "r625",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross": {
     "auth_ref": [
      "r626"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs related to line of credit arrangements. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Line of Credit Arrangements, Gross",
        "terseLabel": "Debt Issuance Costs, Line of Credit Arrangements, Gross"
       }
      }
     },
     "localname": "DebtIssuanceCostsLineOfCreditArrangementsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Debt Securities, Available-for-sale"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesNoncurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and investment in debt security measured at amortized cost (held-to-maturity), classified as noncurrent.",
        "label": "Debt Securities, Noncurrent",
        "terseLabel": "Debt Securities, Noncurrent"
       }
      }
     },
     "localname": "DebtSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCostsAndOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred cost assets and assets classified as other.",
        "label": "Deferred Costs and Other Assets",
        "terseLabel": "Deferred Costs and Other Assets"
       }
      }
     },
     "localname": "DeferredCostsAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "terseLabel": "Prepaid Expenses and Other Current Assets [Table Text Block]"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r138",
      "r497",
      "r506"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Deferred Federal Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNoncurrentNet": {
     "auth_ref": [
      "r46",
      "r623"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Noncurrent, Net",
        "terseLabel": "Debt Issuance Costs, Noncurrent, Net"
       }
      }
     },
     "localname": "DeferredFinanceCostsNoncurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r138",
      "r497",
      "r506"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Deferred Foreign Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r473",
      "r474"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred Income Tax Assets, Net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r123",
      "r138",
      "r497",
      "r506",
      "r507",
      "r508"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r473",
      "r474"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred Income Tax Liabilities, Net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueAdditions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.",
        "label": "Deferred Revenue, Additions",
        "terseLabel": "Deferred Revenue, Additions"
       }
      }
     },
     "localname": "DeferredRevenueAdditions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r138",
      "r497",
      "r506"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "Deferred State and Local Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r494",
      "r495"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Deferred Tax Assets, Inventory"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r489"
     ],
     "calculation": {
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Deferred Tax Assets, Net"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r494",
      "r495"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r494",
      "r495"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther": {
     "auth_ref": [
      "r494",
      "r495"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other",
        "terseLabel": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses": {
     "auth_ref": [
      "r494",
      "r495"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions.",
        "label": "Deferred Tax Assets, Unrealized Currency Losses",
        "terseLabel": "Deferred Tax Assets, Unrealized Currency Losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsUnrealizedCurrencyLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r488"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "terseLabel": "Deferred Tax Assets, Valuation Allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r474",
      "r489"
     ],
     "calculation": {
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "terseLabel": "Deferred Tax Liabilities, Net"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesDeferredincometaxassetsliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositAssets": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.",
        "label": "Deposit Assets",
        "terseLabel": "Deposit Assets"
       }
      }
     },
     "localname": "DepositAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r123",
      "r276"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r123",
      "r198"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r556",
      "r557",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Derivative Asset, Notional Amount"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r65",
      "r66",
      "r67",
      "r598"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative Asset"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsCurrent": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset, Current",
        "terseLabel": "Derivative Asset, Current"
       }
      }
     },
     "localname": "DerivativeAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails",
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFinancialInstrumentsAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents types of derivative financial instruments which are financial instruments or other contractual arrangements with all three of the following characteristics: (a) it has (1) one or more underlyings and (2) one or more notional amounts or payment provisions or both. Those terms determine the amount of the settlement or settlements, and, in some cases, whether or not a settlement is required; (b) it requires no initial net investment or an initial net investment that is smaller than would be required for other types of contracts that would be expected to have a similar response to changes in market factors; and (c) its terms require or permit net settlement, it can readily be settled net by a means outside the contract, or it provides for delivery of an asset that puts the recipient in a position not substantially different from net settlement. Notwithstanding the above characteristics, loan commitments that relate to the origination of mortgage loans that will be held for sale are accounted for as derivative instruments by the issuer of the loan commitment (that is, the potential lender).",
        "label": "Derivative Financial Instruments, Assets [Member]",
        "terseLabel": "Derivative Financial Instruments, Assets"
       }
      }
     },
     "localname": "DerivativeFinancialInstrumentsAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents derivative instrument obligations meeting the definition of a liability which are reported as of the balance sheet date. Derivative instrument obligations are generally measured at fair value, and adjustments to the carrying amount of hedged items reflect changes in their fair value (that is, losses) that are attributable to the risk being hedged and that arise while the hedge is in effect.",
        "label": "Derivative Financial Instruments, Liabilities [Member]",
        "terseLabel": "Derivative Financial Instruments, Liabilities [Member]"
       }
      }
     },
     "localname": "DerivativeFinancialInstrumentsLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed interest rate related to the interest rate derivative.",
        "label": "Derivative, Fixed Interest Rate",
        "terseLabel": "Derivative, Fixed Interest Rate"
       }
      }
     },
     "localname": "DerivativeFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeForwardExchangeRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual rate at which a foreign currency can be purchased or sold.",
        "label": "Derivative, Forward Exchange Rate",
        "terseLabel": "Derivative, Forward Exchange Rate"
       }
      }
     },
     "localname": "DerivativeForwardExchangeRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Derivative, Gain (Loss) on Derivative, Net"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r67",
      "r564",
      "r566",
      "r571",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails",
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r580",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Text Block]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r561",
      "r564",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion": {
     "auth_ref": [
      "r570"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of gain reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion",
        "terseLabel": "Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r65",
      "r66",
      "r67",
      "r598"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative Liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityNotionalAmount": {
     "auth_ref": [
      "r556",
      "r557",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative liability.",
        "label": "Derivative Liability, Notional Amount",
        "terseLabel": "Derivative Liability, Notional Amount"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r555",
      "r558",
      "r559",
      "r561",
      "r562",
      "r568",
      "r571",
      "r575",
      "r576",
      "r578",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed Technology Rights [Member]"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularIntangibleDetails",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregationofRevenueProductLineDetails",
      "http://www.icumed.com/role/RevenueDisaggregationofRevenuebyGeographyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r388",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregationofRevenueProductLineDetails",
      "http://www.icumed.com/role/RevenueDisaggregationofRevenuebyGeographyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-based Payment Arrangement [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardShareawardsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "EMEA [Member]"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregationofRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r97",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r172",
      "r174",
      "r177",
      "r178",
      "r179",
      "r182",
      "r183",
      "r583",
      "r584",
      "r688",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r97",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r174",
      "r177",
      "r178",
      "r179",
      "r182",
      "r183",
      "r583",
      "r584",
      "r688",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r180",
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect of Exchange Rate on Cash [Abstract]",
        "terseLabel": "Effect of Exchange Rate on Cash [Abstract]"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r608"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective Income Tax Rate, Continuing Operations"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Percent [Abstract]"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r140",
      "r476",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r476",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r476",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r464",
      "r476"
     ],
     "calculation": {
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": {
     "auth_ref": [
      "r464",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r476",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": {
     "auth_ref": [
      "r476",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent",
        "negatedTerseLabel": "Effective Income Tax Rate Reconciliation, Tax Credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r453"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockBasedCompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r452"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "verboseLabel": "Tax benefit from stock-based compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r455"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Exercise of Option, Tax Benefit",
        "verboseLabel": "Tax benefit from stock option exercises"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardOptionsexerciseddataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Severance [Member]"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Share-based Payment Arrangement, Option [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails",
      "http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r88",
      "r89",
      "r90",
      "r152",
      "r153",
      "r154",
      "r158",
      "r166",
      "r168",
      "r185",
      "r242",
      "r366",
      "r371",
      "r456",
      "r457",
      "r458",
      "r499",
      "r500",
      "r582",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r617",
      "r719",
      "r720",
      "r721",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.icumed.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.icumed.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentAggregateCost": {
     "auth_ref": [
      "r42"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Aggregate Cost",
        "terseLabel": "Equity Method Investment, Aggregate Cost"
       }
      }
     },
     "localname": "EquityMethodInvestmentAggregateCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsEquityMethodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity Method Investment, Ownership Percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsEquityMethodDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r42",
      "r201",
      "r236"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r42",
      "r117",
      "r239",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FacilityClosingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Facility Closing [Member]",
        "terseLabel": "Facility Closing [Member]"
       }
      }
     },
     "localname": "FacilityClosingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails1",
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r586",
      "r587",
      "r588",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesHospiraQuantitativeInformationDetails",
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails",
      "http://www.icumed.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesHospiraQuantitativeInformationDetails",
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails",
      "http://www.icumed.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementDetails",
      "http://www.icumed.com/role/FairValueMeasurementTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r591",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementDetails",
      "http://www.icumed.com/role/FairValueMeasurementTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r333",
      "r347",
      "r348",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r413",
      "r587",
      "r655",
      "r656",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r595",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Disclosures [Text Block]"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r333",
      "r405",
      "r406",
      "r411",
      "r413",
      "r587",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r333",
      "r347",
      "r348",
      "r405",
      "r406",
      "r411",
      "r413",
      "r587",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r333",
      "r347",
      "r348",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r413",
      "r587",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": {
     "auth_ref": [
      "r594"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3) and still held.",
        "label": "Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)",
        "terseLabel": "Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3": {
     "auth_ref": [
      "r593"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as a liability out of level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3",
        "negatedTerseLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "auth_ref": [
      "r592"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances",
        "terseLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r591"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "terseLabel": "Contingent Earn-out Liability"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsTextDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails",
      "http://www.icumed.com/role/FairValueMeasurementDetails",
      "http://www.icumed.com/role/FairValueMeasurementTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r333",
      "r347",
      "r348",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r413",
      "r655",
      "r656",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": {
     "auth_ref": [
      "r591",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r128",
      "r129",
      "r130"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Fair Value of Assets Acquired",
        "terseLabel": "Fair value of assets acquired"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r563",
      "r568",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r630",
      "r636",
      "r645"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Finance Lease, Interest Expense"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r632",
      "r639"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Finance Lease, Interest Payment on Liability"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesSupplementalCashFlowLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r628",
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Finance Lease, Liability"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FinanceLeasesSupplementalBalanceSheetInformationDetails",
      "http://www.icumed.com/role/LeasesFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r628"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance Lease, Liability, Current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FinanceLeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FinanceLeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r628"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesOtherLongtermLiabilitiesDetails",
      "http://www.icumed.com/role/FinanceLeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability.",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FinanceLeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "terseLabel": "Finance Lease, Liability, Payment, Due"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Finance Lease, Liability, to be Paid, after Year Five"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "Finance Lease, Liability, to be Paid, Year One"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "Finance Lease, Liability, to be Paid, Year Five"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Finance Lease, Liability, to be Paid, Year Four"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Finance Lease, Liability, to be Paid, Year Three"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Finance Lease, Liability, to be Paid, Year Two"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Finance Lease, Liability, Undiscounted Excess Amount"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r631",
      "r639"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Finance Lease, Principal Payments"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r627"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FinanceLeasesSupplementalBalanceSheetInformationDetails",
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r630",
      "r636",
      "r645"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FinanceLeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r642",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FinanceLeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r641",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FinanceLeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Weighted-Average Amortization Life in Years"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table containing detailed characteristics of finite-lived intangible assets acquired during a business combination. Finite-lived intangible assets are assets that have no physical form, but have expected future economic benefit, and are expected to be used over a defined period. Acquired finite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the Entity) and in total. Additionally, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period are also disclosed.",
        "label": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]",
        "terseLabel": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularIntangibleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, after Year Five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r270"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r270"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r270"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Four"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r270"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Three"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r270"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Two"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r262",
      "r264",
      "r268",
      "r272",
      "r668",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularIntangibleDetails",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r268",
      "r672"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r262",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularIntangibleDetails",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r268",
      "r668"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Finite-Lived Intangible Assets, Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority [Member]"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesOperatingLossCarryforwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency [Abstract]",
        "terseLabel": "Foreign Currency [Abstract]"
       }
      }
     },
     "localname": "ForeignCurrencyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months",
        "terseLabel": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Foreign Currency Contract, Asset, Fair Value Disclosure"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossRealized": {
     "auth_ref": [
      "r605",
      "r607"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Realized",
        "negatedTerseLabel": "Foreign Currency Transaction Gain (Loss), Realized"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossRealized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesForeignCurrencyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Transactions and Translations Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Exchange Forward [Member]"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails",
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and Fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedTerseLabel": "Gain (Loss) on Disposition of Property Plant Equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicAreasLongLivedAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographic Areas, Long-Lived Assets [Abstract]",
        "terseLabel": "Geographic Areas, Long-Lived Assets [Abstract]"
       }
      }
     },
     "localname": "GeographicAreasLongLivedAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r253",
      "r254",
      "r650",
      "r673"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "GOODWILL",
        "periodStartLabel": "GOODWILL",
        "terseLabel": "GOODWILL"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill, Acquired During Period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r256"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Goodwill, Foreign Currency Translation Gain (Loss)"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Period Increase (Decrease)",
        "terseLabel": "Goodwill, Period Increase (Decrease)"
       }
      }
     },
     "localname": "GoodwillPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r257",
      "r517"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Goodwill, Purchase Accounting Adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r100",
      "r137",
      "r200",
      "r203",
      "r205",
      "r208",
      "r210",
      "r240",
      "r307",
      "r308",
      "r309",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r599"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r561",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r274",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In Process Research and Development [Member]"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossAttributableToParent": {
     "auth_ref": [
      "r90",
      "r103"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.",
        "label": "Income (Loss) Attributable to Parent, before Tax",
        "terseLabel": "Income before income taxes",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/IncomeTaxesIncomeLossfromContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r139",
      "r509"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Income (Loss) from Continuing Operations before Income Taxes, Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesIncomeLossfromContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r139",
      "r509"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Income (Loss) from Continuing Operations before Income Taxes, Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesIncomeLossfromContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r280",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesOperatingLossCarryforwardsDetails",
      "http://www.icumed.com/role/IncomeTaxesTaxHolidayDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesOperatingLossCarryforwardsDetails",
      "http://www.icumed.com/role/IncomeTaxesTaxHolidayDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r140",
      "r477",
      "r486",
      "r491",
      "r504",
      "r511",
      "r513",
      "r514",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Tax Disclosure [Text Block]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r141",
      "r167",
      "r168",
      "r199",
      "r475",
      "r505",
      "r512",
      "r713"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Provision for income taxes",
        "terseLabel": "Provision for income taxes",
        "totalLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails",
      "http://www.icumed.com/role/IncomeTaxesTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxHolidayAggregateDollarAmount": {
     "auth_ref": [
      "r511"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income taxes from which a reporting entity is exempt or for which it will receive a reduction in income taxes as a result of the income tax holiday granted by the taxing jurisdiction.",
        "label": "Income Tax Holiday, Aggregate Dollar Amount",
        "terseLabel": "Income Tax Holiday, Aggregate Dollar Amount"
       }
      }
     },
     "localname": "IncomeTaxHolidayAggregateDollarAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesTaxHolidayDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount effect of the income tax benefit resulting from the income tax holidays granted by taxing jurisdictions.",
        "label": "Income Tax Holiday, Income Tax Benefits Per Share",
        "terseLabel": "Income Tax Holiday, Income Tax Benefits Per Share"
       }
      }
     },
     "localname": "IncomeTaxHolidayIncomeTaxBenefitsPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesTaxHolidayDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeTaxHolidayLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Holiday [Line Items]",
        "terseLabel": "Income Tax Holiday [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxHolidayLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesTaxHolidayDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxHolidayTable": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax-exemptions and reductions which may be granted by a taxing authority for a specified period. Such \"tax holidays\" are typically granted to induce business investment in the tax jurisdiction.",
        "label": "Income Tax Holiday [Table]",
        "terseLabel": "Income Tax Holiday [Table]"
       }
      }
     },
     "localname": "IncomeTaxHolidayTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesTaxHolidayDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r87",
      "r471",
      "r472",
      "r486",
      "r487",
      "r490",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Tax, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Income Tax Reconciliation, Foreign Income Tax Rate Differential"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Income Tax Reconciliation, Income Tax Expense (Benefit), at Federal Statutory Income Tax Rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "Income Tax Reconciliation, State and Local Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCredits": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount",
        "negatedTerseLabel": "Income Tax Reconciliation, Tax Credits"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r120",
      "r127"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid during the year for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Increase (Decrease) in Accounts Receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Increase (Decrease) in Income Taxes Payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesChangeintaxespayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Increase (Decrease) in Deferred Revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Increase (Decrease) in Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Increase (Decrease) in Other Operating Assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Increase (Decrease) in Prepaid Expense and Other Assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Intangible Assets, Gross (Excluding Goodwill)"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r260",
      "r266"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "INTANGIBLE ASSETS, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r92",
      "r197",
      "r620",
      "r623",
      "r689"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r115",
      "r119",
      "r127"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest Paid, Excluding Capitalized Interest, Operating Activities"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet": {
     "auth_ref": [
      "r570"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net gains or losses on interest rate cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net",
        "terseLabel": "Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "negatedTerseLabel": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateDerivativeLiabilitiesAtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of interest rate derivative liabilities, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as liabilities.",
        "label": "Interest Rate Derivative Liabilities, at Fair Value",
        "terseLabel": "Interest Rate Derivative Liabilities, at Fair Value"
       }
      }
     },
     "localname": "InterestRateDerivativeLiabilitiesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesOtherLongtermLiabilitiesDetails",
      "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails",
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished Goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r6",
      "r60",
      "r650"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r16",
      "r61",
      "r131",
      "r184",
      "r248",
      "r249",
      "r250",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "terseLabel": "Raw Materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "terseLabel": "Work in Process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeAmortizationOfPremium": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization of purchase premium on nonoperating securities.",
        "label": "Investment Income, Amortization of Premium",
        "terseLabel": "Bond premium amortization"
       }
      }
     },
     "localname": "InvestmentIncomeAmortizationOfPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r239",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investment, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LandBuildingsAndImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real estate held and additions or improvements to real estate held and structures used in the conduct of business.",
        "label": "Land, Buildings and Improvements [Member]",
        "terseLabel": "Land, Buildings and Improvements [Member]"
       }
      }
     },
     "localname": "LandBuildingsAndImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r643",
      "r645"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due after Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Four"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Three"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Two"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lessee, Operating Lease, Term of Contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceived": {
     "auth_ref": [
      "r646"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payments to be received by lessor for operating lease.",
        "label": "Lessor, Operating Lease, Payments to be Received",
        "terseLabel": "Lessor, Operating Lease, Payments to be Received"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r33",
      "r137",
      "r240",
      "r599",
      "r650",
      "r680",
      "r704"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r128",
      "r129",
      "r130"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities Assumed",
        "terseLabel": "Liabilities Assumed"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r51",
      "r137",
      "r240",
      "r307",
      "r308",
      "r309",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r548",
      "r551",
      "r552",
      "r599",
      "r648",
      "r649",
      "r650"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "CURRENT LIABILITIES:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.",
        "label": "Liabilities, Other than Long-term Debt, Noncurrent",
        "terseLabel": "OTHER LONG-TERM LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesOtherThanLongtermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesTotalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of total liabilities, when it serves as a benchmark in a concentration of risk calculation. Sum of all reported liabilities as of the balance sheet date.",
        "label": "Liabilities, Total [Member]",
        "terseLabel": "Liabilities, Total [Member]"
       }
      }
     },
     "localname": "LiabilitiesTotalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails",
      "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Line of Credit Facility, Commitment Fee Percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsLineofCreditPricingDetails",
      "http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityExpirationDate1": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.",
        "label": "Line of Credit Facility, Expiration Date",
        "terseLabel": "Line of Credit Facility, Expiration Date"
       }
      }
     },
     "localname": "LineOfCreditFacilityExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsLineofCreditPricingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Remaining Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r49",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsLineofCreditPricingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LinesOfCreditCurrent": {
     "auth_ref": [
      "r20",
      "r675"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Line of Credit, Current",
        "terseLabel": "Line of Credit, Current"
       }
      }
     },
     "localname": "LinesOfCreditCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.",
        "label": "Long-lived Assets by Geographic Areas [Table Text Block]",
        "terseLabel": "Long-lived Assets by Geographic Areas [Table Text Block]"
       }
      }
     },
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeographicInformationandSignificantCustomersGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r22",
      "r332",
      "r346",
      "r347",
      "r348",
      "r678",
      "r700"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and Equipment [Member]"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Measurement Input, Discount Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "terseLabel": "Measurement Input, Risk Free Interest Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesHospiraQuantitativeInformationDetails",
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesHospiraQuantitativeInformationDetails",
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesHospiraQuantitativeInformationDetails",
      "http://www.icumed.com/role/FairValueMeasurementFairValueInputsLiabilitiesPursuitQuantitativeInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in) provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r118",
      "r121",
      "r124"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r3",
      "r81",
      "r84",
      "r90",
      "r94",
      "r124",
      "r137",
      "r157",
      "r161",
      "r162",
      "r163",
      "r164",
      "r167",
      "r168",
      "r176",
      "r200",
      "r203",
      "r205",
      "r208",
      "r210",
      "r240",
      "r307",
      "r308",
      "r309",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r584",
      "r599",
      "r685",
      "r708"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.icumed.com/role/StatementofComprehensiveIncomeParenthetical": {
       "order": 4.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net Income",
        "totalLabel": "Net Income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails",
      "http://www.icumed.com/role/StatementofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r2",
      "r155",
      "r156",
      "r159",
      "r160",
      "r169",
      "r170",
      "r171",
      "r222",
      "r223",
      "r243",
      "r244",
      "r399",
      "r400",
      "r401",
      "r402",
      "r459",
      "r501",
      "r502",
      "r503",
      "r581",
      "r600",
      "r601",
      "r602",
      "r647",
      "r669",
      "r670",
      "r671",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Noncompete Agreements [Member]"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularIntangibleDetails",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r213"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonfinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of obligations not classified as financial liabilities. Includes, but is not limited to, accounts payable and accrued liabilities, commitments, obligations, and other liabilities.",
        "label": "Nonfinancial Liabilities Fair Value Disclosure",
        "terseLabel": "Nonfinancial Liabilities Fair Value Disclosure"
       }
      }
     },
     "localname": "NonfinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "OTHER INCOME,NET"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "terseLabel": "Nonvested Restricted Stock Shares Activity [Table Text Block]"
       }
      }
     },
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of Operating Segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesBasisofPresentationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "OPERATING EXPENSES:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r200",
      "r203",
      "r205",
      "r208",
      "r210"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r637",
      "r645"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating Lease, Cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r628"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating Lease, Liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesLeaseMaturityDetails",
      "http://www.icumed.com/role/LeasesSupplementalBalanceSheetLeaseinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r628"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating Lease, Liability, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesDetails",
      "http://www.icumed.com/role/LeasesSupplementalBalanceSheetLeaseinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesSupplementalBalanceSheetLeaseinformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r628"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesOtherLongtermLiabilitiesDetails",
      "http://www.icumed.com/role/LeasesSupplementalBalanceSheetLeaseinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesSupplementalBalanceSheetLeaseinformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r633",
      "r639"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesSupplementalCashFlowLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r627"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets",
      "http://www.icumed.com/role/LeasesSupplementalBalanceSheetLeaseinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r642",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesSupplementalBalanceSheetLeaseinformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r641",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesSupplementalBalanceSheetLeaseinformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r492"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating Loss Carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesOperatingLossCarryforwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesOperatingLossCarryforwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesOperatingLossCarryforwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r4",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r50"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r682",
      "r707"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other.",
        "label": "Other Accrued Liabilities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r62",
      "r650"
     ],
     "calculation": {
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other Assets, Current"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r563",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets [Member]"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousNoncurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Noncurrent",
        "terseLabel": "Other Assets, Miscellaneous, Noncurrent"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets",
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r545",
      "r546",
      "r549"
     ],
     "calculation": {
      "http://www.icumed.com/role/StatementofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      },
      "http://www.icumed.com/role/StatementofComprehensiveIncomeParenthetical": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation adjustment, net of taxes of $0 for all periods"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StatementofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r70",
      "r77",
      "r603",
      "r604",
      "r609"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Other comprehensive income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax": {
     "auth_ref": [
      "r72",
      "r73",
      "r77"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r80",
      "r88",
      "r89",
      "r91",
      "r610",
      "r612",
      "r617"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r88",
      "r89",
      "r95",
      "r237",
      "r610",
      "r615",
      "r617",
      "r686",
      "r709"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r71",
      "r77"
     ],
     "calculation": {
      "http://www.icumed.com/role/StatementofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      },
      "http://www.icumed.com/role/StatementofComprehensiveIncomeParenthetical": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StatementofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r78"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StatementofComprehensiveIncomeParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r68",
      "r78",
      "r606",
      "r616"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StatementofComprehensiveIncomeParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r82",
      "r85",
      "r88",
      "r89",
      "r91",
      "r95",
      "r366",
      "r610",
      "r615",
      "r617",
      "r686",
      "r709"
     ],
     "calculation": {
      "http://www.icumed.com/role/StatementofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other Comprehensive Income (Loss), Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StatementofComprehensiveIncome",
      "http://www.icumed.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r75",
      "r77"
     ],
     "calculation": {
      "http://www.icumed.com/role/StatementofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      },
      "http://www.icumed.com/role/StatementofComprehensiveIncomeParenthetical": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Other adjustments, net of taxes of $0 for all periods"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StatementofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r75",
      "r78",
      "r545"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Other Adjustments, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StatementofComprehensiveIncomeParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other current assets.",
        "label": "Other Current Assets [Text Block]",
        "terseLabel": "Other Current Assets [Text Block]"
       }
      }
     },
     "localname": "OtherCurrentAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilities": {
     "auth_ref": [
      "r683"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other.",
        "label": "Other Liabilities",
        "terseLabel": "Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r563",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "auth_ref": [
      "r8",
      "r11",
      "r252"
     ],
     "calculation": {
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Other Prepaid Expense, Current",
        "terseLabel": "Other Prepaid Expense, Current"
       }
      }
     },
     "localname": "OtherPrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Payment for Contingent Consideration Liability, Financing Activities"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Purchase of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r116",
      "r285"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Payments for Restructuring"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "terseLabel": "Payment, Tax Withholding, Share-based Payment Arrangement"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r108",
      "r535"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to Acquire Businesses, Gross"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsForeignInfusionSystemsSupplierDetails",
      "http://www.icumed.com/role/AcquisitionsTextDetails",
      "http://www.icumed.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Business acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedTerseLabel": "Payments to Acquire Equity Method Investments",
        "terseLabel": "Payments to Acquire Equity Method Investments"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsEquityMethodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedTerseLabel": "Intangible asset additions"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r225"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedTerseLabel": "Purchases of investment securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost (reversal of cost) for pension and other postretirement benefits.",
        "label": "Pension and Other Postretirement Benefits Cost (Reversal of Cost)",
        "terseLabel": "Pension and Other Postretirement Benefits Cost (Reversal of Cost)"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPostretirementandPostemploymentBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "auth_ref": [
      "r412",
      "r414",
      "r415",
      "r416",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "terseLabel": "Pension and Other Postretirement Plans, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares [Member]"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r426",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails",
      "http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails",
      "http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Convertible preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Convertible preferred stock, authorized shares"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Convertible preferred stock, outstanding shares"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r10",
      "r39",
      "r40"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets",
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current [Abstract]",
        "terseLabel": "Prepaid Expense and Other Assets, Current [Abstract]"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets [Member]"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesDerivativeBalanceSheetLocationDetails",
      "http://www.icumed.com/role/FairValueMeasurementFairValueMeasurementsRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r9",
      "r11",
      "r251",
      "r252"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-term Lines of Credit",
        "terseLabel": "Proceeds from Long-term Lines of Credit"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from sale of investment securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow for the sale of long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.",
        "label": "Proceeds from Sale of Other Property, Plant, and Equipment",
        "terseLabel": "Proceeds from Sale of Other Property, Plant, and Equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfOtherPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r110",
      "r455"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options",
        "verboseLabel": "Cash received from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/ShareBasedAwardOptionsexerciseddataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualClassifiedCurrent": {
     "auth_ref": [
      "r50",
      "r305",
      "r306"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Product Warranty Accrual, Current",
        "terseLabel": "Warranties and returns"
       }
      }
     },
     "localname": "ProductWarrantyAccrualClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductionRelatedImpairmentsOrCharges": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonrecurring impairment charges related to the write-off of production-related equipment and inventory. This tag is used when an Entity charges this cost to cost of goods sold.",
        "label": "Production Related Impairments or Charges",
        "terseLabel": "Production Related Impairments or Charges"
       }
      }
     },
     "localname": "ProductionRelatedImpairmentsOrCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r45",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment by Type [Axis]",
        "verboseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).",
        "label": "Property, Plant and Equipment, Estimated Useful Lives",
        "terseLabel": "Property, Plant and Equipment, Estimated Useful Lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r44",
      "r277"
     ],
     "calculation": {
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Total property and equipment, cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r18",
      "r19",
      "r279",
      "r650",
      "r693",
      "r705"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "PROPERTY AND EQUIPMENT, net",
        "totalLabel": "Net property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r43",
      "r279",
      "r745",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r18",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment [Table Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r18",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r98",
      "r246"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted": {
     "auth_ref": [
      "r24",
      "r679",
      "r701"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations.",
        "label": "Purchase Commitment, Remaining Minimum Amount Committed",
        "terseLabel": "Purchase Commitment, Remaining Minimum Amount Committed"
       }
      }
     },
     "localname": "PurchaseCommitmentRemainingMinimumAmountCommitted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r35",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "terseLabel": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r80",
      "r88",
      "r89",
      "r91",
      "r610",
      "r614",
      "r617"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Repayments of Long-term obligations"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r468",
      "r666",
      "r758"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Expense, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs) [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails",
      "http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails",
      "http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r283",
      "r285",
      "r288",
      "r297",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and Related Activities Disclosure [Text Block]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r123",
      "r282",
      "r291",
      "r294"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r284",
      "r285",
      "r294",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails1",
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails2"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails1",
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails2"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r123"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "terseLabel": "Restructuring Costs"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r285",
      "r292"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "terseLabel": "Restructuring Reserve"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAccrualAdjustment1": {
     "auth_ref": [
      "r285",
      "r295"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.",
        "label": "Restructuring Reserve, Accrual Adjustment",
        "negatedTerseLabel": "Restructuring Reserve, Accrual Adjustment",
        "terseLabel": "Restructuring Reserve, Accrual Adjustment"
       }
      }
     },
     "localname": "RestructuringReserveAccrualAdjustment1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails1",
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveCurrent": {
     "auth_ref": [
      "r21",
      "r285",
      "r295"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Current",
        "terseLabel": "Restructuring accrual"
       }
      }
     },
     "localname": "RestructuringReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveTranslationAdjustment": {
     "auth_ref": [
      "r285",
      "r295"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.",
        "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r29",
      "r371",
      "r460",
      "r650",
      "r703",
      "r722",
      "r726"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r152",
      "r153",
      "r154",
      "r158",
      "r166",
      "r168",
      "r242",
      "r456",
      "r457",
      "r458",
      "r499",
      "r500",
      "r582",
      "r719",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r386",
      "r387",
      "r391",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contract with Customer [Text Block]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r132",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue [Policy Text Block]"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, Remaining Performance Obligation, Amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r93",
      "r137",
      "r195",
      "r196",
      "r202",
      "r206",
      "r207",
      "r211",
      "r212",
      "r216",
      "r240",
      "r307",
      "r308",
      "r309",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r599",
      "r690"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/RevenueDisaggregationofRevenueProductLineDetails",
      "http://www.icumed.com/role/RevenueDisaggregationofRevenuebyGeographyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "REVENUES:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r640",
      "r645"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesSupplementalCashFlowLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r640",
      "r645"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesSupplementalCashFlowLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesanOtherLongtermLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r80",
      "r615",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesFutureEstimatedAmortizationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r691",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r519",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsForeignInfusionSystemsSupplierDetails",
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTableDetails",
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTables",
      "http://www.icumed.com/role/AcquisitionsTextDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r519",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativesandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesIncometaxdisclosureTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesIncometaxdisclosureTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": {
     "auth_ref": [
      "r174",
      "r175",
      "r177",
      "r179",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesIncometaxdisclosureTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r586",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r262",
      "r267",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r258",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r258",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesIncometaxdisclosureTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r271",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r16",
      "r36",
      "r37",
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory, Current [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r45",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment1Details",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPropertyandEquipment2Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r284",
      "r285",
      "r286",
      "r287",
      "r294",
      "r295",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails1",
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails2"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r289",
      "r290",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationScheduleofRestructuringandRelatedCostsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r93",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeographicInformationandSignificantCustomersLongLivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r426",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails",
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails",
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails",
      "http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r430",
      "r440",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Option, Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSubsequentEventsTextBlock": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, losses resulting from fire or flood, losses on receivables, significant realized and unrealized gains and losses that result from changes in quoted market prices of securities, declines in market prices of inventory, changes in authorized or issued debt (SEC), significant foreign exchange rate changes, substantial loans to insiders or affiliates, significant long-term investments, and substantial dividends not in the ordinary course of business.",
        "label": "Schedule of Subsequent Events [Table Text Block]",
        "terseLabel": "Schedule of Subsequent Events"
       }
      }
     },
     "localname": "ScheduleOfSubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/ShareBasedAwardStockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average intrinsic value of award forfeited under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Intrinsic Value, Amount Per Share",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Intrinsic Value, Amount Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails",
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails",
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average intrinsic value of award vested under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Intrinsic Value, Amount Per Share",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Intrinsic Value, Amount Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected Dividend Yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected stock price volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-Free Interest Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails",
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails",
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails",
      "http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r442"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardOptionsexerciseddataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted",
        "verboseLabel": "Number of options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails",
      "http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted Average Grant Date Fair Value per option"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r454"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Options, Outstanding, Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r432",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options, Outstanding, Number",
        "periodStartLabel": "Options, Outstanding, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options, Outstanding, Weighted Average Exercise Price",
        "periodStartLabel": "Options, Outstanding, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Vested and Expected to Vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r424",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails",
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails",
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails",
      "http://www.icumed.com/role/ShareBasedAwardStockOptionPlansDetails",
      "http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Options, Exercises in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails",
      "http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share Price"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardShareAwarddataDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSURollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardRSUandPRSUDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r447",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionsGrantedandValuationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r454"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Options, Exercisable, Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options, Exercisable, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options forfeited.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares",
        "negatedTerseLabel": "Forfeited or expired"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options forfeited.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value",
        "terseLabel": "Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercise Price Range, Exercisable Options, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "terseLabel": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r739",
      "r740",
      "r741",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-term Investments [Member]",
        "terseLabel": "Short-term Investments [Member]"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r638",
      "r645"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term Lease, Cost",
        "terseLabel": "Short-term Lease, Cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SpecialTerminationBenefitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Special benefits offered to employees to terminate employment.",
        "label": "Special Termination Benefits [Member]",
        "terseLabel": "Special Termination Benefits [Member]"
       }
      }
     },
     "localname": "SpecialTerminationBenefitsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction [Member]"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesOperatingLossCarryforwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r56",
      "r88",
      "r89",
      "r90",
      "r152",
      "r153",
      "r154",
      "r158",
      "r166",
      "r168",
      "r185",
      "r242",
      "r366",
      "r371",
      "r456",
      "r457",
      "r458",
      "r499",
      "r500",
      "r582",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r617",
      "r719",
      "r720",
      "r721",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]",
        "verboseLabel": "Statement, Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.icumed.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.icumed.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets",
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.icumed.com/role/StatementofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r185",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets",
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.icumed.com/role/StatementofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r25",
      "r26",
      "r366",
      "r371",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised",
        "terseLabel": "Issuance of restricted stock and exercise of stock options, shares issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.icumed.com/role/ShareBasedAwardStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r56",
      "r366",
      "r371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of restricted stock and exercise of stock options, including excess income tax benefits"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Treasury stock purchase plan"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Treasury stock purchase plan remaining available"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r26",
      "r31",
      "r32",
      "r137",
      "r221",
      "r240",
      "r599",
      "r650"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r89",
      "r137",
      "r152",
      "r153",
      "r154",
      "r158",
      "r166",
      "r240",
      "r242",
      "r371",
      "r456",
      "r457",
      "r458",
      "r499",
      "r500",
      "r543",
      "r544",
      "r553",
      "r582",
      "r599",
      "r610",
      "r611",
      "r617",
      "r720",
      "r721",
      "r780"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "STOCKHOLDERS' EQUITY:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r135",
      "r353",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r371",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity Note Disclosure [Text Block]"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails",
      "http://www.icumed.com/role/SubsequentEventsDetails",
      "http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails",
      "http://www.icumed.com/role/SubsequentEventsTermLoanBApplicableMarginDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r618",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails",
      "http://www.icumed.com/role/SubsequentEventsDetails",
      "http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails",
      "http://www.icumed.com/role/SubsequentEventsTermLoanBApplicableMarginDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r618",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails",
      "http://www.icumed.com/role/SubsequentEventsDetails",
      "http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails",
      "http://www.icumed.com/role/SubsequentEventsTermLoanBApplicableMarginDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r618",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails",
      "http://www.icumed.com/role/SubsequentEventsDetails",
      "http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails",
      "http://www.icumed.com/role/SubsequentEventsTermLoanBApplicableMarginDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r618",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/SubsequentEventsCreditAgreementDetails",
      "http://www.icumed.com/role/SubsequentEventsDetails",
      "http://www.icumed.com/role/SubsequentEventsTermLoanACreditLineApplicableMarginDetails",
      "http://www.icumed.com/role/SubsequentEventsTermLoanBApplicableMarginDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r651",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r478",
      "r485",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Summary of Income Tax Contingencies [Table Text Block]"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesIncometaxdisclosureTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLSOURE OF CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r492"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax Credit Carryforward, Amount"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesTaxCarryforwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade Names [Member]"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AcquisitionsPursuitVascularIntangibleDetails",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks [Member]"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesIntangibleAssets1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury Stock, Common, Shares"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r55",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r55",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury Stock, Shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r26",
      "r366",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Treasury Stock, Shares"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r55",
      "r372",
      "r375"
     ],
     "calculation": {
      "http://www.icumed.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury Stock, Value"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r366",
      "r371",
      "r372"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Purchase of treasury stock,treasury stock acquired in lieu of cash payment on stock option exercises and income tax withholding obligations"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r284",
      "r285",
      "r294",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails1",
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UndistributedEarningsOfForeignSubsidiaries": {
     "auth_ref": [
      "r469",
      "r515",
      "r695",
      "r727"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.",
        "label": "Undistributed Earnings of Foreign Subsidiaries",
        "terseLabel": "Undistributed Earnings of Foreign Subsidiaries"
       }
      }
     },
     "localname": "UndistributedEarningsOfForeignSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesUndistributedforeignearningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r470",
      "r480"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesUnrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r481"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesUnrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r483"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "terseLabel": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesUnrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r482"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Unrecognized Tax Benefits, Increases Resulting from Current Period Tax Positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesUnrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r481"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Unrecognized Tax Benefits, Increases Resulting from Prior Period Tax Positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesUnrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r484"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesUnrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r148",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.",
        "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset"
       }
      }
     },
     "localname": "ValuationAllowanceOfDeferredTaxAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesAdjustments": {
     "auth_ref": [
      "r150"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment",
        "terseLabel": "Write-off/ Disposals"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r143",
      "r149"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at\u00a0End of\u00a0Period",
        "periodStartLabel": "Balance\u00a0at Beginning\u00a0of Period"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r146"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Charged\u00a0to Costs\u00a0and Expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account",
        "terseLabel": "Charged\u00a0to Other\u00a0Accounts"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r148",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r148",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WarrantyReservesMember": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r148",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reserve for expected cost from warranty provided on specific product or service.",
        "label": "SEC Schedule, 12-09, Reserve, Warranty [Member]",
        "terseLabel": "SEC Schedule, 12-09, Reserve, Warranty"
       }
      }
     },
     "localname": "WarrantyReservesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Weighted Average Number Diluted Shares Outstanding Adjustment"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r173",
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "verboseLabel": "Weighted Average common and common equivalent shares outstandding (diluted)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "WEIGHTED AVERAGE NUMBER OF SHARES"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r172",
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average number of common shares outstanding (basic)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/ConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/GeneralandSummaryofSignificantAccountingPoliciesNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.20)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27340-111563"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123364984&loc=d3e1205-110223"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123377177&loc=d3e11281-110244"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12524-110249"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123452999&loc=d3e28200-109314"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "http://asc.fasb.org/topic&trid=5833765"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=68176171&loc=SL68176184-208336"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8,17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(17))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r759": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r760": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r761": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r762": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r763": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r764": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r765": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r766": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r767": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r768": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r769": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r770": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r771": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r772": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r773": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r774": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r775": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r776": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r777": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r778": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r779": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>141
<FILENAME>0000883984-22-000014-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000883984-22-000014-xbrl.zip
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M2!1]WU]Q2]KD)<;&P4 ,1=J%J*V4IE%%%?5I-7BN893QC'=F#'%_?:]M:)I
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M459P2D8G)J,KT=.PHX].O5I_,;CDE%\,>RW;BE.I-_:>:_7(:1ROEZT; Y&
MH> 6$0P_%:J%+$$$$5)RXE6B>U!6""_]A12/GB">@+UOKGY\BZJQB%S! "^H
MEYK]BD4E;4]AK:C/&)_P]U<ROR^5^B=BQ+C2^VDH^5PUS.311:C:<)0VXQ64
MWB# $/K?QUSEAHJI(;Z/\6C43-NJ9)&GL &"48) 9N4O29O:L[A==&[ -XQT
M;4 ?4BP.%X@Y:]#I17PVX-G_'N-33.$,<KP;\4;Q)T]V+W,+875Y3WQV"/J.
MOKMV0#>^Z#A_;L>T1X!LQ;3\@9J@N!<-RY'5RU0ZFW(6844C[M"?KE%YPE!"
M.C=1@]1TCZ)=^S4SU68_75<.V\J2WGPFR&>@*Y'5FK7QNPF)7HRY5-5%+#!1
M=#+V?,5<93<'7X/AN16>M2%,83-:=[8=&)LI.5=83C"G,$3"9+TYF>IE2$H@
M.&=4&R! 3\Y!EP1:D:T"K0WJ DC3-$@S*8! .)$#?CA,?:T*K0U>CVD%,EF
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MR9S=IVHF(1I#V?NY<'"DT(1484''$3 .T?]SEJ=6YX SP!+OJCTZG;,$G[1
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M95JC++L*V66&(] ]@^5L,.U'TSBR;:NT>206[@6J3!)A+<"?U)"10NI"[9%
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MUQ^V3V'COMUR<5U-J2^[\!&N<&YW=]EU4VSGY;WBTU\E=)<:+_X/4$L#!!0
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M^"UB"ANW,9>3ZS-+==F$CG"&,[N[R:Y[A#NO=N:?X:*IO_)Z_C]02P,$%
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M/C</7CW?WSU[\?+5Z_+]@VGZ_IE_OO^/X^?[/Q[O'3^$YS_MO=K;>7*X^_8
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MA5CKQ(*E"41C)I22F1@J-E+5[(O8^F^/+?SGX]4A+]:@+??FLWP>B7\/@:"
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M=<TYFF*@JK$(P@ZQVF#D:BU2=7+,&$&;UCK512V*D(JN-*C=CK\+M,LAI=^
MZ3>_?+E8W7E"LX.+T[=?=Z>SZ?'I\1BGMZW&Z!58X,!@(J2(6!Q'F]%7#&H
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MKDG2E&0<#:"I0H_AO1++A. T*TR%$0%"P60AU> ,<[&YC%7E=#F5M3GPC('
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M4[5H8  U/7KI4J\$*^6TK1I\S Q N57T0*,=:^N2O#R 2DC]<8Y7 E#*VNG
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M+7NKH1I()>B@'%5(B0(-H690SV'MICF!;HT(4@[&>W!98F#2.I@:2W!MZ<S
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MDB?1/OGY48Q[\^7J<7U*1]<]W7?#](ZC.4?0'AWZ9!%*9;0V:EUM!B%U+6Y
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M7TV5GEH#! H:Q;5BY,01@XXQ)MNV.0UASUO?%4_W6]<<:8\V)2:CVOQ6&V1
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M%B>'\3W.JNDTH;]5/J,9YRM!^V1._9X$[<+);O\@KWB+;;J'QOV5"/I"Q'B
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M NZHI+99$PJ4")OZ1!&V@.9P5]C!.44 @\VVEY/T1"&]WE$%MYUU#9*$C^1
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M#^, L?-CC%,O5^;Y-1C_X.2A+> SA2<805#>F$4[@0R[/%UJWN2<O50T]F6
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M2ZSLSR2;)U.5V>E1:=/OF9'A(_%)[-!21@NCRK?U"8W2:"\!OJB:#RBM^7)
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M=%)HP)OS7$MO2B"_R"H<@K%XTUHGP@KB]4>OB.I&(\$MH]5*J!L([N+65\)
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MC@YR/Q>\&(%&QQ2\1%7A24%!#=%9DQP(<$43E L/,+G1IJ$I<,V7X.G'!/3
MV4*"LF*SY]IMJWO"UVP?N]% <3H=<[4?78.(;&.997?3/5H4ZU)(78FJ'.&+
MO:>6HH<SU==^7.YZJ5,?=Z,4[!(92](11"WIH++M1V8,;ATCOU/#A9^W!%!R
M9 6ZKW Y@[58 W,X:TA#YJ)6W!;'WS(/P2NNFBM?SPD,+F)$,XMI%.-00A 7
M.-^SUVD,Y*@5B5&_FM\,BOV*8&V%/GXI-V,4A7))DW>"\_?.#?NDL/IHA.A3
MZ%P0]5+T<F$\_<A4P)P N[I:M?<(1(K%F/P1QN9IXOC:(38/6\3"U@HE!X6
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MH9$O=]( <TG/L-AO2F*.#0!"O5;6W'V(TN*6+: [LLP- #YGT6L);;Y[^::
M))8F[!FO523/M5]5PMS%_(,<@'6[4X"D:]!Q:NP3=LCDMN"Z[4KU(3FT0FN_
MQEGX07)F"HW.?DR#"$H6\LJ!+@J-N_H%A(6=X[SQL-*E/>3DHLW-28F'X =\
M_(S-ZNP'C !^]^39HV(FJF&@"%(A:*1\P,@B6$7*R*5HY?4RS4FK6SP-;M #
M\E*OI44VA.S>G*TJ';1TI3.$F&%,3;5,ITA_H2$70BDI%@_ $+'+#;P4*9YH
M5B32:%VN84$45BI9UA0"!FC U*32+:)YB[8OJ_L0_DPEIB%IPY$,\D'YQS!I
M\:.$^MIM<$O^N"%X@**6M&%^F;N-;B<'IMMQLI8 C^(?"^QRPD\6*J=1NIB'
M.N-#XBP*#W]E"!!R;6N.)#F#2;XOBT X>A,T22I1J\EBQ+NZ9O@Y0H-_- HJ
MD GHF2\K"W2&1RV:VW$8R<5&Z>U>=U/:1&6G3?$&GQBMW= W"VQBX=C,;IZ&
M1,W#>!Q9@AEX[CZ+OF3M]7@FG&.2OE6ZFJ;U!](7&#P,+ BPT 2>((.5 BW&
MI!IKQ2*$43:H+1J B>:=,</R@+7Q&HP?SY.\MB1,?8;ZVC5(HA_B8'OJBM ?
MG1NGK"'L?=R:]W!=R"693[HD\#3.KO4TQJX/(NFQ^R,(F<G6X)C"^HGC:L'3
M9H4+#/'6!MA',"^71XHOW)/KT1N]-\UD.;?-[=W(TG]\<R_H;M@Z6E$TF#.5
M>^%518@,Q@^GX2??4_4MJA6ZG7H^N;9I+9I .10]9&\0E;)#H#OMX8(=$19<
M6_=B_#S9:(O^OJ ?"_I?W+:"_BU;RG<C#'@KI$V2[(_./&G!GBEE\%G99B&N
MQ644#*#73%HSDBO1FYL04*^AU*O@*CE%_F'W,4:2 5 Q/A5E[\0*<"Q" 4/:
MTQ*^T(:UPD>A7>9.JL,Z/A7:XF;E&>%&1:&,L4G8^E8I(,RQ.3QB.\1GLJ)$
M<!CH3SBY _W3M//$UY(!>"XV7R_I64PT:81YX+-"H?.,CXHU>2U.U KL#2[:
MS,XW98^6[U?5N_3%9$RZ*G)VVO?\D%*79R>?RVH7U(_/_)N(?O"/S#\3GT<4
MW<.IY\&*GGY.1),IJ/)P96WCZFLJ&=8B#)>(/HNM5QY#H\T*XRKKE/E."F:=
M0],@[G_E$M<UQ/V8(0CCEJ3@2LO;R)DD+R.,*<,IOF+MH^@7E[PM]T-ASBVQ
M?+]/:O1-57;"R/;G_TZN8EIIR;'[@=VHVSU@M_*H8 K=S.IT,L3683'(,SB2
M: XF.P+?0YEON:+BB9N[#15_2X)<(3,AFP T]&WM'T.O,C')R8'4HPXMQA]%
M>++I4Z0_5$QNJ>C#6-;DX)U\_Z^7WQP]^3I=)PTP92%3X'BF%/5TA)DCKD1-
MR?H(A#UT@1--J8!2.S1VGF7@)-JJI"2W8,Y F%0%G5+__P:=RNCDDZ0'>B3
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M2=MBL^BJ7LG.L2>T(U#SS\18GJ)<QT7*%>PM3].VV6RX398ZS&^*X+EE*WT
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MV*L\I^!;(Z-R>#X_KZL+#8(FXWL-?]UDVY^@2+_::T\5MUIT)@UY*"J/(?-
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MO3&D^"NKPZ]10:--*OL12Q+P#TO1"LXA+?)M-NNC3'),&C^?YNNEF=*-28^
M$<$&35NMO P/?)C7]SWF9+9+[[.BD# M0S$ NE7WG#?8[%7Z(XV^I$OJ:N&O
M2S^%,M]EIF[=LNT)K+28(D/%9^]BZ92,P##M52ZC>S5PA:P7DU$;TRWZJM"Z
M9(I;PNV$! +:O:MVSH,4/T(Y$@9[,;4BYS=UF?)S^GC+\W'*E&?'2>TI5Z%-
MJ*?5OI$<JD!X0I1MQK [W_7(74IC @A6>@Z6"$1+H?F2&XPH[!)^;W1D=90W
M+5@"ONM3W)U<YO0S0]@ @J%?X'7.J"X!P6KDQ\XT,I-#''L,>]]]%=%6'B8B
M_0-%%H\%M@LQ"<)8-GBKC,-<D S>2Q:4 S(*XTW5TVMFW1V-E$@[SBX-:ZSY
M+F&JH_6VV6!++B2KF@V2XZMP41OW.WXR6$F'=G1_O8"F% /RC1719U2N"H,[
M&,5LWF1GP#Y*17&U/YZ]8$ AE3(+WR",>S1#U7I-@4WQ#H^W;KAJ6&YX]:#9
M!BNG;J?QGF1D1\955:38(HS[5ILYU</J)=>OA;,J -LSM@KJ"@0D@&NN7176
M6A%686.M?%)%Q>7E<$M?3(]URAU5&V1&MIR2!H*H[E-PGUXEFTYI;@DJ/2^^
M>9ZU/ 1VYSR84% G7FEX7NACN(4?&UV<S71\1==,6]B%J9C<2)-!'[AK?&.@
M_4)6-T>B&AVQ.Q$WCR8]%?<-;WNZYX1PA-/KX0-@QYYS=ER*W9H4AWUPY@_!
M@ UZK),;/6,W>EONF_; Z99"*TI7-FYU&#3") 84?)&7%DP7G3"9:?-O:/6'
MW@U=%UAH6F'7QT.+FKV%(!G?[P::'LSZJ914<0X&%*[UZ%<6P@BA3\8'K%^0
M3N;ELF.FO*Z:>!<-B+N>(=JZDK49-@37!UW_7^[MWY90SK4 @C;'59( ;H!U
M'4R=JS*69/F3$1U7  "-C]OPM@S?U23+@_\]3\;W@CS2RZK$J@($H9 EAMW/
MQ<1TYR,TN!)DI>N!Z,C4%8+?XP/L8C#-KD?F$GFUN@-'RL.\+W5T!C]Z/T>.
M._G;/'26\H[6(*Y:#[DA1OC?D!@A5&*EJGD=B/A7Z!H_(.1-3 H@55G(8=]7
MQ#A8MFEQP%,&"LF*PLR9XC JRLP+RP%@X/)Y@=HP>NB 9%5^3N2';-HG!&7T
M #DXR8?=';C= J+2#RDFCVKG$\ P\<(6#KIR=3W5;^4C5?Q7&\'DJU;S+ QM
M*5+=H)+2-W/J +G37JQA(S1S-;G(]UPL3G-YLJ)/6Y@+A@QFYWB3CO79/P@T
M<X)6TQ_[\IR1=?E?_)I(XHH5[$*&5L]+!5Z.]UY.+O6J^JF>-YB@DW2>E;,?
MD@FA7/">[__R7[,W6M;#&1O\H,5,TAT'WCM=_OF.*H_%[&WU4\G+ ,7>Z(A$
M[[J8O5ZF"6BQOG]HYN_VLU?DY1:S?R:#<SX[*9-SDS;UR&I($T;F8+\<;D9!
M%6  3E>L/P)[2S-(%FT ? U-\)-@] .YC*R)>)#:J$/:17JZCJSW6^A-'-B6
MW>"=+9U95Z[H!4<12WQ5\0HI3&$G]A(] S@\V3>>F#KG2@[<($'?O+V"&!K]
M:GQ6HZF%4GIW>W]/.C891#8['-%!,S@>-5@D@A4Z/MQ#/9C]PNC%X%*Z &DV
MTR&^W<$V.R=+/WBL=(Y=-M>Z8;05U !MJG1XL_9N^E=_GBSU.XJ:Z!CX.1D4
M:0-*W\CAN L>'R1(_8O:8-ZBR*YE&]IJBTPTBD$<<H;<%Z-C,?K);2M&_S[C
M$.*$@9B TC+575AB"DGCF,\9 @^TP<EJG(Q'!H;4;ZOWT.P][J7]1=+\%,%T
MC3P-%KSADJ3BJJE,?FA/9QX ?GON98R@NR6ASPTCQ]?I-&\VU#' !Z_4[R7%
M>:-\RJ\I G=+CA]S+_-Z_;#KSQ@O0>@L@V2N8!A."QDRY&SXJZ<U@HCHLL4S
M<5B&TXU3.,?)7]30X,IX0TL&X:X>5/ +5RQ8+X^BI1V"B$76%I%&R/NUPP4T
MJV-8\DUU5BK'FH>',3/H;&63 6$,N6!)UN7_-&U@1H,CQK7'%&#N4'O9[MIN
M5_+FI]7-3;^:3.[RJA1/<$\AI6 OB$9XK>P+NL;CKAB6CC4II7?8,<6 "+!*
MA5,E6NA2V'*M5VUDZY%1M!RT/*PD 6$ON^3*E^"A2VM LGG ,L?R8UQ/GC5+
MKD;]KEK5YTVSF)ENBN77P]-J1XV"EHE0ANO%5>Q?S"C2O":B+O^!H9BXN/R5
M3*P@D.B[:?]SQ3$GD1DD'0<U,*M]#9BS?@O+=5L,^N$,BI<CN7.HF,CZY EK
M;2VR]ON=("?I%\2\Q%N,PURX JBQ3R>"&",T.=1%6IS)W5[4XHKB1$\7FJ;)
M:BOJZ>H\"7);9NH:WNPG7SQ^-O[_*S)> .KF\%;1]4.&(B2!.%[UGCRS_P@$
M=!JY@KKR>L7XOMA49'2R?2*9,JMMKZ5" +/2*-#A\IR3J,5$V6-8Z(&ESK W
M14Q]'<BI47YO["G&=80G2P8&/%B2#>/@C4[!M53 \#7B &\Z.',:U%,Y>MFL
MZN9.KZA7%"J?-QU:&27,U!Y ;T#APFCPLJF(GWQBMK4Y(RVHS=.G?I8T=?JB
MX:PSY1 L*)(@K[G$Z7QMP1&0],U@.BR:/MW[XP*-G:NA\WGOST=DC]59TU-8
M ;A*3BZCN'L_3W/B8X<XC'R\N.^\QD2'5'ATQ1UY,H!!<"*BBSJA;P4"VNM8
M5H(G3YM<^U9\X+@(6JTD*Q7T!Y#M/Z^70V*8'%VWA,-H^]L+E.NT!77#TBE)
M6?5A,\*"4Q7)4WT\O1&9Q5U'@7(/NMS"N^K$OE24_PGR5+3ANK1%-T<+(.)A
MX:I>BP[QPL,+O!%%AOR+P[3\(2@#>(LT_J-E.)5/M*0AD=ESB^H>.PA.B^6-
M9'7Q5DCG7OHX4&_4?\V57\X/WF4S\OTP=S5%;+5;;XV%>)#:\NY.<!OG'K,$
M%+2O"8&HIIKFCH@9;.X-3QC*[KK5GI$?4Z&Q6A=I7[ZK-F%/$A6_NH?KY#;F
M"A[LSGI7/,WL3^[Y=^6R<KOC--C2&6U.\54GT@=*DZW+]JS>'$D"[0EEW>X%
M06XF"!+U_+;G^PZKB!:PD*_H<CBLX',_";]X$JK->8D3XWQ_ELZ.4'94-B2!
M@RPIWYX.%Z9!657EQFHAB_M9^LBS9&U]D2$1#E8(WB]"(>M^-C[B; CJ#=DT
MZ;J:[P6G+V22LH58PR%J-,Q2^$WGZ_T$?<0).J]6VR %H1'%>;U:,"RPZP@R
MJUCB^7G3<!BU*/<<#ZR::XZ>^SFYZ6E/]!$("<K9!74W(DE>'1&UZ7Z6CI:.
M[-JFK%E&B0ETO!J4@AM,B2* 0RGW+KOP_TYKL@(RT_+#GOLE)# WOIMG3(M3
MH56,(A8,\I98BD3^5]M;/!M(SKKF  EA=<#O1FXP^5] I7!B*>.R0+2+*(!J
MW^$L\N?KI$/5N3.&5;H,LBZFU*0B-!W/;(Q[S4E:RR(_1\_,.11?;].O+3 9
M!97%E46..ZZ<\L')S*DDL>0*IW%UKD(Q#MNY.9'92WBR BA<*TW6!,:08UFL
MC(U"5IJ11&7H;!W(NXQOK!#A*[+6[YVJ]DRM,!#B>=/C["L\-O><2;^4+WO5
MU,-+,BL8);$ :5HP'G4??J7+="CB=LT;^C(]D)H_M'H]92\\#X51_\.\2B$Q
MB['OP^'?ZX!<,5+^HB* 0Y,QNG'1=HC-J&IN XFEY#YF:G4=9$FA'%6<HY%C
M>ZY4JF/CEB.V1EU:30:L'&2,[WW=C[ELAECS')Y\$Z#QX7GZCP28/;UM +/[
M7?.K[9KEBD2GRU&]B/R<4!?-]U*YR7!$X<#NN;MYL4Z1I5[2ZWO2*'6J/7-S
M>D;Z"-58KKC*O=W\J#D"*U?XA,.16U3+BE6(P=AKLDW59+4/<9&WLKDOEO69
M*HIQT$&X5T"1TC$#M&@JR%:R1)%KNVO3D=Q5B_NLQ*^V"B+<-!0V:PMF%/@E
MN2(*)HYD(H2N.BN-ARK9-'3C  KP?JM_Q$E6>(DZUS))TA*>YL$J4<9-R!2M
M4M7NI*J-:')#;W*VSWH+K+;N4!M#MC!U,H6Z ';<3_3'M.D,N!RJV@?2KH'B
M7K7IA&2'M#BD-IRW@QP*H/9H;$F'QOV,?L09=30=:-"5IZVPO2Q%2N#.>,LI
M?X)PY.UGF:\'NDJ[Z/W<?=2$!IVH^>24@INJ6;%WUI474%M+UI3IR2:Z:_NV
MO!"8&Q(@&4@@YVOR>/=.)VFOF,FGGSY9/OVH=,7LO2AV^* CHT:5TIO)EX'W
M:F6 C!9_B.)JJS-8X((Z]]D6H^6:V8,,(NOZ% /B-]&"S9HEZ#D_)$_:#1*E
MZ1N[[EK8->#KQA+)N*:L$4$;+E"[D;Y(;[):5-T\'2?<U8ST]P,B*22-%$HG
M/R!*&L_/K[J*<;OZX>>;#6'V?X D&B6)7U"?ZI/'1W^WP&%/S8K43[D8"_L,
MA;;YF082=4#:J:[:GFZ2J:8]$\:)2.>=>;;-X:[*9\Y0;OEOK<],S?Y X [T
M:@2=/)@VU\O;:F3,F145"3W=;5,8O^")#NC 6+=*R[1LC5C[@Y+PU.MJ2RL3
M[>96DYY?6M[D:OS])+-J6+CM2/>\F9* P +7SG#C3;CMO)\WY\T<!=NJUPKR
M<J:,]J6>L]1HZ:]O=[I\53!638$F!=@UD9N=[]I^.+2!>7R-9?MKR(??KM/*
M&.@@5[.8J2B.#1Y5;R]JY=MB=JFNMYR(R]SP"K[NR[Q/M&3<[[>5*&5<,X?A
M2MR,1E'?3^B'<I6BC/(^B,PK6>6A2PZ(9@[>65DJ8QG;7XJ9EUF2C  LPT8^
MXSJWM01WBHN-095XX?0(@VIHP/<*=X$U'0T,K1)-C0M/F>3/P3?E1ZQ^FA-:
MF%]IBLW,J:U#;":F4+1B;LON^##VWD#Q=J#'F@0E37/PIFW*MZP?]ZWKI)5G
M;26..;-8ZEF:2\)QL].UXG+B9Q;404[7Z;FUDJ*'PO#D[*$1IL4TJRZX_YSD
M7&7WL1<PH ZY4D5+G,0*_4M56I)!!,<IO[D(*KI_SG=+/(QG:J) /%>86L:(
M-!P,)OK-P#!>(%F<IIMX7$D5$94Q%DZ8% ?# Z;C);T@J>"(+ Q]@I+;C397
M52HFS:&7NM/1V9"Q.YX95LE(F4@+K&YV'='C)LLS/Q=V66W'<'Y@DK;")YR8
M-;.7/D4RSWR.<(/!8#6-B<_/N)A95:[Z04@F>%M\5^5VU+L,CI([O>7RYIK!
MNL8IMS?VY&P0)B1F0*PVQ8 [C!HFH%99 ) #"TA<8"A+6&TNZK9!X!@O[NW#
MN(IV2G.>A]0HZ92G):T.0%PZ8"&BF&QRCT.*RX0'I2-\+*A +6K9[F_:0@@_
M<_Y$4S)M3E?"UHWX(.>EH8V+A;[K*6O!@M?"@L$]X](C!GE1?CAQ$-QW%%*B
MY6Z3J_GE:@!1J^^BNFI339E@^OVU9I@>2^\QXANDIOY<YM"DMV[/*7Y(0P![
MZ15R"ZP@ ,/T[4^BTW:'901>3JQ=57G+_%T^U89*;E/DI]9@Q\F869<\M0K!
MN?AV5"/W9E"-?2%A>V4,]8MCHUMFG-^:&#"&;BT:0ZRGE"S2653AC2VI&76M
ML ?6++TD"%LN3ED=2F:B9G6&#<8PDN3B.IW7JJ%UE2S,[+QIZY\;$(PC.UZU
MW-!'C]VLZD5I;>I.#U^.-K\N*,6#[K;IX3:[Y"XU)!4J2$FS\P?\N$993+3A
MN]YLFHL 5!2>?GPT63?ECT4^LAXT(@<91&NJSDHY2I%-WA72G<Z#H5W5[)*_
M#5W.X5V-E(Y:V1T'.Q@9 @) HZ\NATQWIVBM8LKEKG)1M^"*#6ULE<X*G4[&
M/Z-P=0_=BM"M3V\;=.OW&0>$'JB#2N::-=6QEYT:/1,#4(/A7.N2;F=;@8S9
MBJ+R67("DDFK.W+Z!V8MYX(W8%6W)J6!$.\<SUYY<ERXUSF4$EG.GKD[%YDA
ML]V#XVI9E2Q#&QC'%HJU8B.A#7-6L:?$4]6?$Z[#VL=9(XZKQ$K,.'LE-!HQ
M R0=7I ^8"_+SDK)@ZF'ZT()3@00Z'*2T5!%5% $I4\XB2"V?QQBB5@FR,V/
MD[L&C#M/3)%]+3Y=0W8H141-Z?:5%HV01-&SGY+JK_L$6 -@E$<./SD)1\"N
M#;@:<JXM%ZD,%!=4X$DGP786P3/M69KMGYT302((9Z6KV]%!EU7\;D8,?\T#
M/'SPM]??0YZ^-0U D)*LTJ7:O5)NTP=??O-/^J .0\8*:@[30/E5F/E1&1'G
MR<F=&I7\Q7B"06M&3X.!H[NE(ZR%OE(\/IP-):<YE9B&XBCHBXOF/%8ROS(D
M-_?T1PR*^O7@T!1'0DCH1^P?"+Y/]P/JZLR9TUS!.:J[4).7%Y7EDEZ-!B*]
M&*)X*0[1\<C^(H(K6D6B+9+<#?\*JF]U-Z%XQIP =(&+=%"M9>*;+K,9+'JF
M<T!IS[<H%MGM0.H6AH7: X435A!XL7#@VRM@OY@M/SVNR@IAZ[%=PN5S!WLZ
M'1J1HH%'C<U/'.PL;9OQ8PSA:>QDG]6;G)2%48?"B<&HQ_+LC,BZI&<*NA8B
M",S),D;!FG9'?)P7HB21W2(GIFA;RHEQ;E 7R>(B&8^T2LE=5-HUJVKE3W@%
MW? -M?3RTB+B)!+"$#45T>L^_.PQ>@J<9N!LD03 JNFJ+$HR60=? G30M%4#
MH@S.;4TN[^&"LR17?JC8[/BID\[E1A!0 ]F.8L3*S,\JX$9;.=&J6ICH8J]O
MSZOLV!@!ZI@I4=,!>]H(T']I>;GI&1O>[AHN>YGSW1^N>'FX'"73II)(HH!#
M14UC<: R4'JP8*S+7GO<1E.8?1+:TRX4$]7E9][P?BI)J2CD@15NC4N95CR>
MU%$3$Y3=R AD&2,3$F>(P1\A 3!PCRVT)PF]9!*(LJWE,SD=PN6V=O=L*+#C
MTS)GKD2:=CM"X+4.? 2:?P*7T ZC^*WJYA0S,W&]4V^J0KD?+S.&P'42V7)
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MO;>A?KAM,,!%\#WT&.C4#V;)1G^P'G-[D)L"5^J)R]=:_7<"J3KP6FQ @8X
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M:,Y9Z)28(JKCL^/"5$F)-\^DAIO6V Y26/_H>.;NZ7#'LCJDQ6-96)B^S,Q
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MM^L&-7EQ:754@VN;]08H!,5] LLYGWII9?)D#HT')C]CJ;^NV;5IV*\=I_S
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M]RH1PA[/9B]&(IWIL")5W+;3-@X@!1K6GR9($/63TJHI6(]WI&6K=$-TTTA
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MG/(2",<KC+5#+./^$5KT?"%#]K]GMPNS.ZEP\4(1AW\791:-LA"X_) ZTU5
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M?"TB('HZV5$"M+12WYZXIV0U,40L>S0#,;4O*V]&^W(@8]YALFTB2T QRN?
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M,A9 >"64 '+SY_7;H\ZE1P$!\+L:DY>Z?C3R@?@BXYS:L/JD =XKFKY)4M0
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M]7"KHLJ!\A?/!%>Z<!ZZ3W=YX&HD9OI'"1-?+* 5$P.GAF*2FWUGLKIBG(>
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MN^ 3;]$/G^-\2?- D?K3R\-.ETOY4VVN@'$RC,,!N,)P"C)%8F LY'5B8F3
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M>9R4+1; .U-$ (2Y%0/X@;/.>&QXZN, II>J;#'\@D(]Q)0LSF8TD(M9,9G
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MHSM%)<8%K3-JDLRP;M<NY.==AZ46@>SK1G(P(I4 $WA#3H +6M_EHS#M4\?
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MC^?'#CCMSJRXY7T0&%SQ+4ZMT-\DD\ZRD[Z>X2A0=][;'E)#*^B9BS5TB2D
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MEM'5\M:Y&F"U:!%F7"W4TY3/]$-AEA5\G:M*^,"G!PKY]0!T94#@!:[+AN'
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M@.<QBA$"51"*IXC+JI5L5+MQO9<49<.42T*?Z7$>( :EY5?8=RJWH;0*JVQ
MQ]22M 3:\W77$:S!T5L4)QA1*:A76E:"BV, IBR(FS<:[S0P59DZ"[,K**%@
M(.Z2E/^$X_A>."#HDRCBP)D&38<O:):<+4TP7.ES9(@S@I*48U<<N%+-V\R<
M[$(%NK$#@3?)RYF E$1$=)QU'W8XPQ(DSGO">!:%_# ,AX%,+&M+,<K<EP'E
M/2GDMKX<JXMN5;=$6+R91R6%?(>.0)]Q,#6HNT4&PI,J""VD9)]A=<-$A<X5
M0WZ54RO"S9EW^+U:% S?3FNWV C64L0EZ:V\+6S(P9EG+3BZTON(4<!K.$6(
M.=>Y:GF?PNPKGN(\23,%*T(K[(<9S#ZS<4SA29831:SR>CA-O=9\B]'V8</,
MYNQHH=$?V4-51KM]ZZ@+&M]90F>G+QEO2)G,YJZHPMBRS!KFENF[-$1CS&6L
M0_VV:FAY7T9A))<*3JY?4,6PI=Z>.PT&Q>@:^:D1(0DYC2L"*FU%G\.R[-N[
M+[:N@8DS#IE]]U4I21RC@@(9.ZT!OBEY4W:EHCO3TA2 S]\D62Y -@3"]]X5
M6,+M>[^!+1(DQE"@<E_K?@<O(ECK*8O%R$>%,1[JUGO8)%(IG*',L6PST++#
M$IA%CK>+YE5<B_1%*L.&-8Y\H)B* #+C?F5'3(JM&O)*-VL%C4=[1<I$6@7.
MG-U*U>SF"=3+U:1VABW0EZI))G4;V*W!K39%;A /7UFYUCLM-,">O 5+P5R]
M=>95)*W7>I$OJ.*9M 7&(B@OQ.]52WG*0Z+C;9!GZ=*RT[HTE\_$V[5K>,W*
M>)F-U_2YR8!0[0)@\)YN><,XD+6;_P>->F%.SX(SQF8%7V[BYS_P?G_)P3K(
M=,'+9J8+-ER:Z4XR*-XMV.W]K'2^J>(M6&TKYU7DF=PF.!4CKORE,XZ>,9<
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MN==006'FR@7 FJ:72H@O;>+J.@IG ]K2&&W*<^46CJ1M_!NRD\>L=[\@)<4
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MGFIS7$J6 [ -T@M BWTPRGX 6" 3W(W&7F3"@+VN"0-KPO&@:A0*<I1FT62
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M=MI*R,F?]\L. SLSSL?I[_75*L2'*<R_@#;+VKE"NNV42U1Y8#M3)7L'\^M
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MPJNH!U%HW;AJ@&MO%OY857QT\I$H<$.= ?:$50^L$N%.D8H35Z&R:!&C>Z,
MT6.C(35,8/HUE-1#V&W=+:0JJJ=1E0KM+% !BY=3SMF?0^DVDXXWZ:<8SFG%
M-?UU:B)B*5-%+:QL@:+MRJ-E)X<!:$&G:=[75*!K.3 F#0^^+ 3=K*4YJX[H
MF1Q:[-1K# N:165&Y=YHY5FIK:5V7WY:,8?Q\U$FD$.4M0)"'=!@),M%:F&J
M5"8)Z045UY0MJ# >OZ.$MURGRAE6OYWS3@,7P>9+W;[V8M.7+XWT(H%G"#AG
MC'^*/I9+R/S6G?+K5:_0SE3% ,+ MNGP,1RDU'Z!2Z2[I80:I75(4JTHXJ.L
MKH?+T@HQ&$X5YEHJ?J5#$O)PK9OBJLW\%YESX*QKSL&:!,5TK(\LB 'HOI2E
M?8X,6?@RBVI5V4IT&BZ5DX=F0IZJEYGL*#?;R%$EXL<J=J;[TF$VH'2=E"O1
MK6J,-VF6C[%.&=5^6:=9UB&K)..HU";44HM(6=E9LQI0. -;%A%!LJQDXY]I
M;3$JWH;A!%QD>7= P_+U58@H3>2:,+%R5*8J#@S5BVM2]K&4L9(Q()XL4RVC
M)SHTM*2R%#=UR>:I]B#*251%R%O7F&Y&]/88B\3CEA9%>!2:"(!MXR)7;%DX
M2]9"#,_AX%33P2+1ZP@SP=[HHZW1H<R@,-NW;%%MM/OYJ%4PP/(PAFQ5')[K
M@(,2(J#@8-;N<+R DHL0FJX<O\!N>)$T]G7?K:JZM2CBI?8'6PG@O+H;G75C
M?CV8^375N\NF#,6D-@.C'@)[(>!DMKPU']O'.IRJ)_>T/PI1D5$]%$0E]_.&
M@8+FQ&YX8G7OZZR)>:G.4<UA,$(A$VQ1("!^IQ$P?DMZ9XCJA*3,:>G/*>1"
M$0ALSFUEYZ9Y8=IA9*9)=M%NI*7:PVH] ;V@\U&2AJ%6>#"381GVKL1,I3=G
MKI7?^P0>EBEO==%%1$5KI@ZFYF16=3*+/5#-_JXL>#SC@9]WAZA&UV7O(:4"
M8E??$0J-$KT:<'JH(RJ"B/'4R:EGC.7?TSYVL4.76P,[J]SS6LZ 3BDL8\&R
M:H?_+&W@W!@*U0"@XB6N1:^;DUFI[CL-0.J&/#)I(1'CRWHW[KS(%ZUXLHO>
M,LV1K.Q(JK&7,N!2)!P5_N=IU*,EH[1C$9T-8=&GTFE7SVVLQ2NPZ US+W16
M"9ZWR$9YHP:LFJO@Q#!^A47%LQE!T^.9R0IJCF"%-DBU+DB'^/*S--%):*K
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M;'!:#@?^;4N=\I;RG39%C.GZ,A%7CO+F@DR^J9YV./U4'V,Y@0XGI!:3T>6
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M=UQ)L&[C2H(;%<]5<]4>:'S+C::3;,1FH95Z [WE]N-87L#&T=M0%SHF3S.
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M]03U(YL[84*W=AW':OF65_C/"P)9Y$*\)4<4H'<+SEBEA&_PZ9GB$XL9\[S
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M7$K\((Y)&((*D5!A,QJ#V1*T'-]=(ZNE\3ZLJ>K0L.T#L6U==?!8+ +/=4C
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M=YSWC0N>QB0=&A&_2,>\WY2W/W@3G7+OW\/6=X=[:N,K(-7@T^KPJ3.K6S!
MH9"[C  9QX0)YI,P]CT26W'L)Q$/'!=T"P\T=&9::Y3ET&0TK:EVT?#S(_/S
M3-E[%$2Q\%SB\2@@+$@$\843$C_A<>1B?RP[V-IU [M%W54-P6JREE8UN3,3
M/)]DET7>$A_#7N1CXX\G\?X6JZFXW9I,DUMQ9_=Z=]KY!^OK>?3KZW[O[.OY
MU\'!U='W@ZLNK./@U]=!]^>7DR]7A_L?S=[@P/HW_/Y;[%DAC[E#;#LVP9;
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M!Z9=OT>;_,UF$UY4G.ZH\ZG3^UBQKV[GPGGI'N&7Y/"E8>*&KK!\+TY8%+#
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MXH>Q0RPO2CP>Q@'W@'O-EK>@'7?#O\^"?U=N"C4"]GXL.ANW83Z/+6'CM.&
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MX!IBMX;N^8J)"@H#$@.>\@:> 5 9 XY1H5V,4>OLH/!^TZ70!<'INE6\ZT6
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M A0D!6&)8KR(U_>YOG;O><U9=A?4-[J/K(+ZQD&],);<2LZI,Z7?.GLB1GE
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MB>#&$=\!IGRPC_'X YY--OXU=TXG@^'%FW.5/WWQW+]]\W<  OJ2RS,C@[Q
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MTXR37V('5EH6 _@^G@ZN%GZ)@[^MO%M?_V?E]]5RV4P.[UKQT"Z'C_VXF[8
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M/"WGKYY!TYW]CY^E)SYYEI 37"'.<HP#%A[YR*F(0G@3W*Q^F%C9,WHA0Q9
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M"?2<DH"CPW?=2;F5I[_K=5]%--W)%CW8_^OD8/_HZ\&%O\C..R#Q_/#X(SZ
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MD"H;\F47\;F>DO^J?4]4@.#SC_^[M:3 :(10AMPW1(]Q>%11 >6_++I'=PC
MIO<)P*X6VO6?#Q)-?L?I^6FH^[A&1,Z 'WK#+X!9;>CS*!7V21=@M=O+.0;[
MY_U!/+GM*64AEB+C(PP97-V.,#+]U1_7\KE>/N.6FC9/42#E'Q!H?_Z*RZ20
MG>/USZ B@\#8(!.-1CSE2FH4/@8EN S8.9?";/T@Q3F1W.K(8^!>"$,UQS8
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ME<&B/%<WIQ)Q*C!,F8A!.!X,=SZYR%44D@3.J*O7S;->-Z!$=,(<*\P0<X[
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MN",$.9HDXL)Y8X+S,3L]"&[(^^^\+1]#?2X[;V/CK1A<66]/S5"?(;[]]K@
MUX<.PV_W,<QK:+L[M,W&AQ%#8Z3"H\@,!D#S"5FN&0I,$1M#9#[E_$KZ>KG>
MWY]Q,,%2X]B/C6[RA#&^=3GW1QB@Y=8.<R@'&[T(@LAD3-[/TU9I;1Q+DEAG
MB92EBV(.TEL3W(5%9^RO#\:E*D:EVR6H;REX0-0&AKBA 5EA*!(N)H]M  !W
M*VN<-3B[GD?J7G'"=>7V!ZK<?JW]?TZY3NI:[@\U8=N=49:ELW@9G5W\,^SU
MAZU!\5_;SQD@>HUBN^-7B]]61E^L_ [7'[7\4<[--&R/,OK-E:G+ ),+3JB
M#<>*FZ29T!9+YK6EECQ!G._KR]RU+78WX6^;7\]WCK?.=KY\UCB?2V4.:4TE
MXI1)Y+#1B!(8+,DYX3H?P#"KM_E^QZF\)O):K.;:Y3!IW:OE98L^#'QY$#3;
M2SF]XZ#7<L-!MW??=6496'E!^6 C \607)1*Q5QCAGBGK:_7U6.OJ^_-L\^4
MALRF',KE21$GE"*=-"PN291@H&&Q#"MK^(:LC[<OJ]>L2NCRJA**&\5*&1BS
M,DI!V\_Y;.Q<4NR%2U92RTWT'#B92U%[*Z(PFGNLQ=Q9.^\8-%V+\W5Q!C%F
MN^N?B8DV46T0%40C[JU!SD6%E(V8LI@(TPQ4PPWY':=%^"3:_K!7)OW-B8@
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M3Y)K"_WA97OF,#DFPD?!D4\*+'3J(S(D,*1%P#(8+JFE*VNTP42=***6[=I
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M&-%X:C!ND1E2R\P"+IW'[%SN1;31[0_NLC-_EPZ_JH&;\.Z7B#2)4_6 _L*
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M!).WO+9?VL7]*PJ4KVE?2@HPP--, L%BZW9"95?VXP_>^O_^/YI2_.=$"[^
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MS2,5&RF3(B,Z3E+"$@PW5DZ1(LU-YF0L"QHOVAV/T-C=OP'3>2.C#A")/./
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M.Q^C#;?NNW6\F;1U7[D!?_3AG^C%VIO-@S_67D91V6S6P8>HT]_PSR$Q6X^
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MT4N)5\*K@.W*P:0=Z?<)00T& #']'OP(.S%$G;=>CTZL.492#UW,^KWZI!S
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M.<]RDCJ3$I9G"5$*3\ 382G+I6,I6$TT7T]71-O<$/]68U!;"_D2+CWL8VK
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MYW7 .QU,ML&O,9H5"3CH B;IQHK85TR.#36G7]"%+(56?7TNB#VEWC9.\.X
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M7Y1N?/?,-"[ QL]L(G+CF)9,4N5R'F=2:1WGUEWCS/2]K8<58+)W.VWVS/L
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M)0O)X,7H'$,1UQMM&"\>J/.JW^UBW4M,$L)<)!\""1.Q_T71>@KK?P*D6O9
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MZ<^MP"RY1*?CI;B$N=9GW?>OHC^\T0"<]5<%.G-OJ":^\(/1J;=]X+N#$IC
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M-?&<R?'/84\*>"ZP1K-W# ]J N2')CRS=3$JYU(.T^[%_H@Z-G;_WMY$Q!0
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M)6(J2"O) 'YD=EVM/*TW\RLH &-T^B^)<3'RO;E!?KG7JQCEOZ08OS4G?I0
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M+<'2[A+GIQP',I92!\RU#E9K9E1*SBMC:;Q'U$&-18^ 1;/QR5QYKSU!08:
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M*H%QKWYFT]? M73 1:: Z_R0.$63E1@9E3.A5'+(&!L1ILQQK&URZC5GL]?
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M#2MI5=P]*V]'6:V(MMM&'9# $ZNZGS!=$JUN>V3L#KI@5_YG &H5X (<8O;
ME[X] +<.G/B/6'E;9C?@ CY06;E#8K#^/X-FKSEJ8_S7H-L;-/O%+SW0AQH
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MY$OPC!S7SPO1#1OMP6!4E/2O.P0]:(>@#^UNGO:BQ4BSUQVWY&[&%Q'C]T!
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M^O8!;+4']K @R1>'%E5[X#<<9N:DL=L(??N[\!V?:P)E5K=O0\PQ/YE9AO8
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MDQ,QL#+(205F)AB>0O*<X&<SFQ:UV#_:-E 3YOM2AAG";"-)U(>(+ \,<19
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MY)35P(II/CX)# 5&-(6%R;7]%M[2 O1KL7^<;:!FQ?>E##.L.$2JF=$",9L
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M=H6NFD-7,ST/E03AY!,RB@7$0S#(>FR1#Y8REB@6Q.;,9$4O1]<]"5V]M"2
MNR<EO^S0PF;9CU.Y3H7G'ISGOLQ:D59+RYCGR.!<95XIAJPU! G*M4T&&R%
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M1#F!F2?K3/MS- @((W,DB+!@L1$/ L-',.!@8KEV$7,JP6)K"7DYO/9).*?
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MOS.[)"9:K_9$U];N#Q3 2O^?_C?XGD&KOAI04&-+-5UZ)>BQ7K9M72UD,T_
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M0H:*)[Z;) K40QIP-TH"YA)!940CIE7$WWSTPM=Q+N K96C*B-*^-HEAE)M
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M'I&)YP;8^()CJ","NG#]D&I-M/$3C%^ND!;PFO,ZGCI]XZ65_*Y^;D<%@@\
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MC'.]S4PI9:5B. "]JS>:*(5]=)\#C9^9SB_C=F%+CQ:I8E-N LM:QCD"5C;
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M2T9SLL#]<+:1+#XMG;C%.#5<)L1/% \\$2O.H\1$"H^*547B5D46#T(6->]
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M-UU58JM.;LOI77EARU^*;;*K;3?'07URLC1.#<QUFQIX;-28:)#B9M-39Q4
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MU.WTUB0%24%6%G-\*+\\\%"24#).$WP=T_DEGJ TY"1I]'N*0C(A..!:$&+
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M&K_G-<F+5 2L#P#X^I"3X/!VU9*<%G3PTP'C,(18]HW+#5]0;-MP3L+X]"6
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M.+RUA5>'&B[Q@F)?AL*XFS4T.8?T"HYO[KS]>,C[B/DS/$<__? O4$L#!!0
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M*UGP$HDM)?7),+PET#%Y[B.@7T\Q]SAXWI[[J8!!&EEW:D':5UM)W@//K&!
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MH_#,)Z25'8S7+H!VIN/EHY=B&M=6W)8YE];*[2^9AFU0-P51Z_Z^Y_H= ,3
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M]Q#'CLKHY/OUKPA+_,??_C]02P,$%     @ LH995*[V^NV/K@  F;X' !4
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MW]?)/LSO/HS&T_<XOGPY_(23:3UJ)SU6R)ZSF:C.G"*JRTA(";@/BCQCFW3
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M %;55!ROO>XR2Q 8_0"5=NA:;8)'@W^(7.;#\>?6EGI:Y;?H T"GPF@X![W
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MW>\CWH?L3[BAA?0!R8P]/KU9W\+[5K*6Y' *N46A>"$;C*PSCP&94U):EGU
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M0%9X :7H*R=]H9?(>9):B4JT.4?W!/J=A9VKL\'=K'4A+#;JD@1Z;S70&\!
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MX1$ESSI"O7-'NW-*M>N;)VNS%(F"7/G8UO%]&E>+VK)E'R6<[FJ1)?\C83:
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M0;:]=+%;D&T?039PXNXX4G_^\EOXK]%X/@)TSG,,*I0ZI<D&0T>GRW1J2JM
MV,@\5R&I1E>D]@#YK9HFK?38HJWO=JC70&],0-P%;E/C94_ #V/*-"/ [D3K
M3'NGC1%LA)V38U(5![3CL\6T;U>L!TRN1&Y4E+%-B_E'0;9[#*''RK5]E-:
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M-%D:X[N VB<0NH_^;\,Y;?"S&TW=5GM'8CX9!VSR44J)@"+5FP<YUP%F$8)
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M9WU=@2_;V$5-.BBGJ>@^#74.I_UHD<_;8EW]=/XK+>>+\K?E8K6:50HV59'
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MF-_<WG7L8,@&NV;V=-_B<1*$1H35 1.%IL/$DP0_"D4Q"P5%L95GVFP\3-$
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MD*K74(,I$;.Q:#M/PKI+U$N#R3ZRF&(:Z,^+\_>_T_+C+^EL_GYML1Y2C/?
MUPXNM!M*Z4817<V2S:&:9*)L4C*QEBA]23;*:E3&V0/?/3PC^*?SU<7RLD'M
MYR_Y6L8XY"M! +D:&5H4(2HA(&-RVDDKK.FC(VXAZ."XUS4#V^=GKBAG7694
MR]8\53A6Y$@X\,GPWES-H?317&Y3,?WE,H:L[T2F]N5K!RWDV_U=>1G0J%"]
MC(!I7?-1%:3LVM!J<JFB3M1INMP]Q$R5N=E#SH?R]E2R*;_=Q]J8\T;Q-8L.
MG%S/*U+4=.?"CZJ/SNID<^J3LG.7EF-Y]0Z6[H-HV9G+'53/;RGZ!W[\,DM]
M %U=W6[;*#N.A^U0R3T(A /9/BDLBBH86%IM!@A;2BE#B-% +L)GG1.62?2?
MWG!XQ!TV&1IVX/;8J7)->_EY@>=O;HP?EQ09R11H8\%@;#7*5$%HK2O;61@W
MO:-;<N0V/GQL?6]?=B]&XM6("M\WM'QWTSTU-@4&V6AUWD!3=9K12D!%!Y\R
M64_#VM!N?/@YR6T?7G6X=9M*^DN]ZA-T35$H,E;T"O@6$6""<A"KC<"VL!45
MH_&ASWU[EY8G+O"1F-PAW^O=95K1OR]YBS_\V=3,FS:62#$X$PI$B@J,I02(
M/D ,1<N0K+/8)UUP"T'/10L?@]_3P. F178 85UU\:VD'4<9'T6 CX/B .YW
M>!RV$YBUR"H(A%!RXNLK$\1($FK)HE8T/BK['&#QB%(^+2IV87I_--SH+RIJ
MY9@4&7,+?"0#06B$+*/DS0OE0Y]&;/>2,[W",)*X'@;!'KS>JN/W#08U56=Q
MK>K\NISG^?G[<>-##RS0(V0T=#\;420RT2O/1UY:;S#X:&-U1FMT-295RWU1
MI >6&D_'_Q'SNASFJRNZ6,:1B 0UJ>:*5GQ7%67 V1A==D6[3DVU'B1K3+OF
MYN-O%Q\_SB_632^)?F5ED'_"]S335'*E;, 3\FV--D"*R =5D8A940FV3\>=
M'8B<_F(;#S4/F4-CRF9LM\;//WWWRV_K--EWGY:$97'^3US.FRW0&K7,9+:4
ML47E:ZLBDSG#NK6N*TX:JXQ,(CQVP0U8YSE(?FQV=G<_WR+SEV_(E#-3,QHC
M*\3B)2,R,R+Y]Z"((H1I"0-JBC#F=@J? V"Z2J6#(7T?!ZZ\!B%EG:1G' ?+
MA$F;(;DJH&IGV(!+1F)_;]HW)$T5^Y[V =F=VZ<2!_]V'VO[47GGDLX1/#)?
M3$X2DJ_,*R5"$(:UR4X%=7=I.98';B09W]L0?V]>=WAWOJ7HVG0<0E-7[]M]
M5!W'\7:HQ!X$P 'LG@H*R:A$PF00/F8P+E4(_)Q!]K;FI)%JI]:STT'@$2?;
M% C8A<MC1[VO;?UUVN]/-T.@7+$RY02EU@I&AP#H24&6I%04_#K*/,BVN.?C
MT^N'A[-\,2*_QC83OZ'GFJ";#C.NIM+2_))+KK69,1!==! DZEASB=+XW<7X
MS1K/2IK[<Z_KH=R@*RN'RI !TBJT5 L-*%T&FU&KHDD4\ZAG\[%%GI=8]^??
MB+;:7;K^^0U9P@<;*E:P,;->J=F$C%X*H+9W*;)Q95BVT?8UGI54]^?>%).E
M?CKG'^EW_*OU?Z^T;'Q8_]8%_H7K@OFSK]7R!X0H]EKGX$C%X;O;G!T52]88
M2Q">#:B84W:D3(W*IZJK\;.]5CS@H-XL\N7S>%YNK?#5D:#XM5=".HBM"[:I
M[2<&&^C@BPXYD-E4D+<<VZ$K'NYIO%J'>7G5N8%_N/F]ZZ8=OU%K:K;NW?$F
MY^4EGJW6/3QFRF769%C%\93XY"K+IXQ2@* E2O)!Q-2GC\H!1$]WZ?4#SEV_
MY#0R'%M7_3K!H&RP"?._+^?\ZWIY<;ELAYKOALN\#DS.J 95;$K@5&FUJL%#
MJ$$#!2(2":-1P_(Y]UK^.>%G(B%TB8\\BOBWBX_MWU=MK\[+=W3.LKI8O?N
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M9O-Z/D@ /<(:^0.5RS/ZI>[(CNLY3%:QE6HLB&+:2^5MLU4%9".SRRK($OO
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MI35B8@T50Q4@HE&YYJAE?B@ZN..]^N8IBW!/KHT]NN"G"SS[_,!=H")E;Y*
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M";,OC#YI(%-%I3M>"CD0P%OWG@%H>>Q*![=@>Q)S#7+G-:TR4>7$D@^&Z03
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M?7>[S(2N.! '>HXUY54M6U4J)Z7JVK&R-1K.5$Q3I)I!9:;ZUR\0!QFDR"
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M8;(H'^CO=7(A'U?\:$;CGE<<+T:(M2Y[^&FU_%IPP=\\_UKJHM)751K]*L?
MNOBZ6^Q-(AI0M76!/,EBB+),[69(DD >8A%113HAL[L@82W"U"CG[>7MG\&'
MZYO?;L&'SS>_@*N/?WE_>W?U\6=P^?;NZB^5??0GR_L1]N-B1D7#HCTP0RGA
MZ^JMK?BZ ,H?M :@6/P(-DJ K19>DX6>#Z+?>Q3V8HQ[G\(9IA?W*MQ;<HB)
MO-3*:F=0L\BC/(DB%B<P$5(7P,(8XB3#,$M0E(F<<1(8Q14<:GQJ7*9[ Y6'
MT>'6YCYP_91T+AP#DXU7)"Q"'L] 9*1H1PMD["(=CZC>&^2X_\YX\8U'I-T)
M;3SVC)NU5M=%[5PMR/)88,PH3,*$082#6.WX!($9#7.>,RQP;E13XE@'4V.G
MIA3O5D [J^H%?F8VTSFH#$Q2YH!8&SG'M/9JPKSH9%0#Y9B*^^;'T>?.R8MQ
MM5!MD?GMXTH0/DM295N0@$-"]1D1BQC,$6,PB7'*8XYX%IHG53O<Q]0F<S=%
M1",HJ"5U212Q"Z>!Y7$^2 //[2'Q<<FGX8S3^&DU3/%RS+)Q$ FS9!N[K[Y"
MSHV#LA].O7'X4=?2#FSY(.[(]^T5^(WG@JJ]51Q%&8R2B$"$9 !SR2.("8U)
MQB-&8RLKIJ>OJ7%@+6IUI;*;P]6REHP)R&:FCB?H!F9&9]0<RD"<Q,-S,8CC
M_8U<$N*DXB\+0YQ^Y4SRV"W8=ZM6%'&YX-=J&.>;9_2V*"6AX"B$/*+Z^"O)
M8,Z3$*8D$()%F42!E8O:LO\)D\Q^O<U*A>K^0J4$V#YJN[>R'2-+/O*/_, <
M]5Y*P:HJ5EWX-=HV8W !+A]TDN<!&,T.T6%8SE"&UV$^.X".LJ%E,Z[W76\?
MR'S^YJDL%J(L9W&$ B*IONA*,41)%$#"2 A#EH0L0G&8$J,;_$?:GQK#-5<Z
M*QE!*Z3M3===!/OYR0,N0_./%20.=UP/*G[F#=?=-D>^WWI0H9>W6P\_YF;8
MZ,2K;/EEH5.O*AIX(Q9"%NNRO4%8?A;ETUP?<'U0\M:Y6=>?Q*I8ZJ<_+<NB
MJEL\2W-$XSB)8)QD$B*A)CIE-(6"A7$6IR$/D=4M #]B38TDNEI5JW&KU_;*
MIBY(WJ@&]"?29#9>@UJ[ZJV-?G;VD:>A-C.;QA_ @=G,8.R\#)VU.>47::]6
MEB?11C6^_,*Y;Y-Y;MW!^[^-_CR0RNGYG7A4 A9MJ1=E^J_6Q=]K'VT2"XIY
ME,)$2K6GS8,$XBP5D.1"<D22*#2SZ,X38VJ<OE4$\#8_V5K-]'FK"X#J#UMU
MJFT6Z2ADX4IW'SN#TXA11F1@DO['& R+HX]1!F6DTY'A!L?N$.5L3'O/6=Q;
M'^\HYFP$=DYKSF_-\?I!L2C6XKKXJ@/QUNI+*^A<U.4DKM76Z&HM'LI9D-(8
M,\HABR,.41Q'D B<PRS*HY B&HC$[AZ"0:=36Z)JF6$E--A*W=11 ;]KP4$E
MN>V]!),1,-LO^,9UX(7&!Z3V%Q8L,/)[<\&DXW&O,%A \>(N@\V[;M14I5P0
M_--J*459*JHC\P]"E(U!KVBP<[U0H!1)PD-( GWVS&FH':42AEF0IIPG46Y6
MEL:A[ZD152,ZZ,H.M/!VM&2#OAD[#83IP"1E#Z<U)3D XY69;/H?E: <@-GG
M*9<FW.CJY^62?ROF\]K3T#HCVMQQ,T+"6&(60L:05#84BB!E>0QEB*,DRW,2
M(Z."UF;=38V46FDO6C_>@>QZ=OQT FXS2O('XL L=!9^UH1D!HM7#CK1Y:BT
M8Z;^/M,8ON5&+ILPA.UY-%F+O3/I>[(2;U1?_.WRX5$LRNJW[[\S17Q;-VD=
MB# +:,9R+E.8",5$*(UB2!##,"8$I5SMQVENE$=Y* &G1F#F<2#Z#^^_:_74
MY&QT^O$"5,I#JK4'G\AS59GE<K52?0C]\\D(D7$^"S/:?,W!'OJ\_;7'V9JL
MAQH,K_3N7<A1%X2A(-Y?0@;KQV[1*5?K617@I#_86R861*UH5<(]GL8Q(LJ(
MS9(P@"A42P>A:INM4ZA2G. XC(U2H!WM86JTOQ%23>Q&3*NTA<>A[&=:+P -
M3)6F@!@SVDFE^RA)O=RA(_6O?2HZWOHH7')2N98,3C_H7#R5:<98B\LO*U&U
M7C;7FD6&(I[%" :9%#K/4 "ISKB?I6F49GF,A+!*C7:\JZG-[ZVD8"NJ8X*A
M'H#-S"H_L(UP.NR F$MQTQ-@^"YF>JR[L8N7GE#[0+'24V^<G5OQ<L%OUTOV
MU_OE7+U?ZCJ&Z^?-G:20AFF6YBE$(L 0Q2R'1-(<YKD@"&&4"VSEVC+M>&ID
MTLFC""X_O@.W=S=O_]>?;Z[?O?]\^S_ ^__X]>KN/YT3+/8/@1G!# 'LP'33
M+:?<EC5=/P]R2<P6G:$R*?9W_EIY%(T@Z<FB:/:^0RS>K6IA+;X4[$YMLDO5
MF';R+_2II/BRJJ.#6!YG$O$,"L&9LF^(@"3(L!J&0(B YC&-S&_EG^YO:KRT
MD1AT1*YF4T=HBZ M \3[^6@ '(?>ZXP/H46 FU\H1XID.P]2NV@U<X!ZP](,
MFADO_LQ<IYU ,XO7G&_Y[IQ\7"TN&=/>J/(3>29T+F8\)5&@4V]SD680I22&
M)$<9S.,\#PG%*$)6X60G>YP:(;?B@<=:/NLKNB< -K,&O<(V,/\>*L96+, &
MR$\G@'2Y7VL&CN\;M2=Z'?L.K1D(!V[-&K[H8/#5:9PN[RY_:=-D\Y RA2C4
MM7(@HCF"A(3*QLN20.0RY!$QVG\>;'UJW-&D"M,"NF0T? &>@:5V#B0#\X)O
M-"R,KG-0&<G$LD+'SJ(ZIGVO_?3BI?&LI6/R[MA&1Q]RLX3^+/B7JH+8O!KG
M\KYX?+=\(,5B)H6,:"X8C'FU(4TI)''.8!CF82!YBM+(*E72T9ZFQEZ-H* K
M*?B]EM72W7X<73/SQPMF ].;&US6QLY)*+P:.<=[&]6X.:GTOE%S^@77#9.:
M>:)<Z[/^VV_DL5F*LICQ1& )!4ISB$C&(0U)HE!%*$XQ"HEM.K5#W4R-(%HI
MZY@;+:?MYN@@F*8[HG,A&GP;M(_. "=O_2AXWN\<[&KD34Z?NB]W-KU/VP?:
M; M5+_A_/)%Y(9^K3/CU=FF;@^VNVMG')&(R$A0B+)7A@#(!\SR+840)2H(H
MBS Q(@7KGJ?&$R>JNFLWXE:GK9^@FV>PTLLBCL=NI/H99U#\A_:%#PZ]5<20
M$XQG1Q+9]3I:A)$3&-W(([<&W R?]B.ZD;HJR(?Y\ILVL81.Y#%_XOIBH>KW
MZ>%IKJNA5WLS'?*X$O=B46Z")*^7.NY1"7,GOJ_?*!S^.B,RQSRB"9292"'2
M@X=I%$-E4.$LBO* 2*/COH'EG!RE-FJ"I:S+\VA-0:TJ:'5MO*ZMMDV]PQU]
MV\CI/VB5?VPF.]!J@TIORWW>4%^)F4DX@;$?FLY??=BM+=2!!\6KB3N4K*/:
MR ,#OF]D#]V=:W+.RO@G583^.[(FS27269QF,LT$@80PI"QS3B%.!8-2($((
M#5E$+;-T'NYH:@M&DYNR(RS0TK8IVVP3=QY!MY^G?6(V,-&ZPN60U+,?BS.S
M>QYI?.0TG_TJOLSW>>)Y[]ESNCEZFFMB_RG(ZH/ZG&94YD&": P)"X7:Q<<2
MYAQ',!0TRJE@>2HS3_ET>L28&IWTIX.I+LYM5&EOWET K0W0ZGC+NM,W<F9&
MX_#C,3!5]0[%104^TV9@5QN3H?"9K<< R;'R]_2),I6,/@9P6>3X,6G-:R[E
M-I)D-[GGK5BOY_65A]^*];UZ7CLKGM;WRU5=&2YE<99C$L((2Z(3J$N(=7(@
M*@*:DH#CG!(/*97=I)L: ?=DYVT5W,_.VU$1?%,Z@EI)T-'22WYEQ^$WH^M7
M&]2!67SD\?25=/D\W,?(O>PHX112,)\'KF$FYC,[<?0FZ]LE5V7Y)/B[IY5J
MND[$HAW:HOK;S6-U;/_^NUBQHA1\ADF"TB +(2*)A"BGF5H<$@H1DX$@813Q
MV*J^D+4$4UL M.Q$?5W:%:@/.5=%9>656O;J7$<TDNL'ZM\N:Y4N0%'Y9C17
MB"H7@?Z%=@?JY+2T^2XL';_6 VKHTAURF(9VUE:@U\*#6OHF(U1]!"=T'2+]
M2*,#V"CAT?OJBI]?OZJU%.-Z3%U!>N$+=6[(D48?=:+AN:X>62PJ^[YE]2:4
M1M$DSV0FH.":-7F>0T*3#!(ALC0(\I!2JV0!ISJ<&DDV\H*.P!O#RC%SP$G,
M#8G-(Y)#\]A9(-I3EB$R?AGJ5*?C$I(A!"_XQ_2],XIH5RF#;^3;E>#%NOGD
MPXQF488HC!A6.W=,!,0LTNDS<2)#%&(1F1?*Z.EH:O2R*7]<@O].'A[_!6B1
MJ[/92FB'FM&'T.TG%)^8#4PD)^!RN132AYM#P>TS\1N[ZK;E9^=6>KL'$Z/Z
MVX?>'[\(=X\6!RMQ]SWO9JS=K+Z01>.&?:N,P.6\X&WTUB?U>;3?S8W\H,A[
MH8E\DUJJ&\RU"8J)0TDS@G.89"*!*,.*=7,:PY#D41JF+,1V)7=]"S@UMN[J
M=P%V-*PVS%T=]6S:: FV:NY&1KJ&27G_%,QLSM<<X(&7EE<96VO3=J@!\&H*
M>Q=R5--Y*(CW3>W!^G%;7-KBJ&^7#[0Q_954VINK^M/R%:JM6KYM?MOR[;W^
M\6I19R!5J]WA5S:EC<)9Q)(X35@"4Q$H2S\F(<29C&&J9B@6'#,:6=7N&$GN
MJ2U%M0(Z4%.28@6^:@>1IB6V400(LEK Y9-EDNFQO@.S!6>"HSOP.M1J##HJ
M5^M1.ZP[*G2339?JL<U74:M>F?1'7KT &_W]K4\CCY?796LLV4==S48>D/U%
M;NSN'=<^,M<'8;?W0JRO]3>N&F]NEX<<!3E&"8R1""!BF8 $IP2&<1")G+ @
M1E8A)<>[FMH*TT@**E%!*ZOC]?T>A T7 B^X#<W=CI#9T^Q)-/PRX_'NQB6S
MDVJ_X)_3;SAXLC^M"J;XZ%I\%?.D]6!C&8<LRB"-2*R( G&(14RA8''$LBB.
M<6:4YNQ8!U.CAT9$4,D($@N/ZR'T##S49V(R\-3?@\/%$WT(%PL/])GXC.1Y
M-OUL[#S-/;KW>I@/O3>>9[E'ZAV/<M]S7L-N9WD8!E% U.8\)RE$>8Y@GD4I
M9#(E,B<X(#CT$$ [-2X[&CKI)9KUO+C4"7&</4R^@D0'L6J.]36%P,UC]LRI
MQYV3N-8%B-KXS.?&-D<QCE*:YS#.DTQ'_U"U^\DQU(=#*(PYB@.KNG''.IH:
M(72J@6TD==SY',76C!5\(#8P+;B!Y9*CM1<)WZE9#W<V=D;67I4/)&+M?][U
M*O3;Y</#<E$%(%85R<J;IW6Y)@L= 3P3*$N#G,<P2C5)Y'D&<<)3J-K*D@CA
M.!9&68K,NIL:533W?&N1ZW#<IBQ@"3IBVUZ/[D6\GSK\XS@P@9P+H<.5:1-D
MSKPXW=O%R->G3=1]>8G:Z"W'J]3+E2B^+.I[V>QY)_'#SXJQJG0.RS>Z&N*<
ME&4ABS8@^J/XO@ZC7Y:+]7TYBQ(A(J&KF"G;!*(@I)#F+(4Q9KF^5QUD5%A=
MK?8BUM0HJM$*M&KM)WX!6K4VD\MZ"6A5_G2C8'OS0*L(P@C42EI>P/8SWF8V
MT_BC.#!!CCN ]M>VO>+M]QJW']'&O=;M%<X7U[S]MNY&_^_$JOA*=':.^H)Y
MF_TED5&41JF$.%8&)$*4PSSB G*9,D$RS FU\C\=Z6=J!+T5L\VY8)54YQ2J
M9JSI :N!:= >)FLJ.P&"5VXZUM>H9'-"X7WV./6XZP;SDG/UI915@-O-ZM-J
M^;50XL_2!&'!*88"!QPBS @DD:0P82*@3- <!T:Y'4]U-#5":'9$C; 7=8BI
M@A2T MMN)X_@:[J1/!^U<;:0#H Y;![[T3ASVWBD\9$WC/TJOMPJGGC>S4KX
MK"^E/[%U97VH?XC55S$+PH3@((UAG.J;8DQB10D!A3R-!<.9(H30*IO6H4ZF
M1@<[,H)&2#O;X""69H;!N0@-//7MP+&V"/JT]VH.'.QH5%N@3]5]0Z#W6==-
M@13*FN!;+W9E8GP4ZUE&:)(&/(;*($@@"I"$-&0(1@(CK A!A)E5CN?C74UM
MZK>2@NXI2Y,B3XEKNT$XBK#I'L$';H-O$]P@<]@LG$+#\W[A:'<C;QE.J?UR
MUW#RC;.+UC<[D4V-]%3(!*>4P5BB$**0I9!*D4,IXYC+A',9N9:IW^MJ:I3Q
M]M?/G]]_O .= O5_<BY$OP^K&4_X 6M@GN@(N?$D#%UJ_@@:0Q67W^_NM<K)
M'U&[IX#\L3<<HG7?ZH1CC,S?DI5HPRHERS(2YC"(.84(A1Q2E@2089YE42)Y
MQ*1QL.[+]B?'"(V$0(OH$IIZ ,)^(O  S,"S?PA,+*)US\-FI&!=2XSL8G:/
M(] ;LGO@M?$B=H_+O!.PV_.8FYW35.31^<"6\X(I?MPLR$&6,1Y+"ED4!A E
M<09I$F$H.1&,YSFAU(C*3G<U-5;;2@I:44V6;UN S2P>/[ -S'F.B%D;/*?!
M\&KP]'0WJL%S6NU]@\?@#3O"J)I;/<_>W\Y8QF6<D03&*>40I5C?7.08(A%C
MG!%.>6Z4N6_;Y-0(X/;3Y=5'LWG>P:5_/KMI._"\[5?4>'J^U*WGK*)YN)Z%
MS3^J"5A-O4Y3HTRQEZ*W4^G 7\Z-2;A::-^FMJ\^%^5?+[\7Y4P&<893&< X
M$U)M&!()"<\PS&7*,\D#@:FE _)X9U.;9IUC]ZVP:MU0HEJNLKT0FWH@_0 W
MN _2 ;,SHA6.@S%0R,*!#E\I;N&XZL>#%WK><7 P-"%5[XIR7= G-63-=C"0
M>4S2D$(9AQ%$$4>0YDD,*2$Y(DA(;%8IK*^3J9%%&ZJXE=-E;WT,40.G@P><
M!N:&82&R\$%X@&HD1\1+R#PY(4Y T.N)./;N>.Z($]+O^"1./>O >]?%0BR;
M!)=Z)[/B^I/+<)BA,(AA1"15K!=1F <A@9BP+$T3&2-A=/!RO(NI<=[U;A+:
MC9P6L_DPE 9T=S9 @Q^R#(2-!<^=C=%(+&>-E1W7]<+0RW2'WQR/YWHEWV&Y
M_B?=-H;-4=0'H?-.S>_(]Z8$6G/Y>H;#$-&$8DCC-(0HD P2$2C6DUE$4)2S
M*+>*2#O1W]38KSTY;>2MPBT:B<$?&IE_M-LGGD+<;*OH$<>ASZ+.@M!ZVV@(
MC->=XZD^1]T\&@*POW\T?<TQN_=CE=9.YWDA:M*VN>UF/$(I3\($)D(H>D&,
M0I(0 =,LD^IOE 3"J@++D7ZF1BL;,4$EITFV2BM8S3C$ U@#<X<#3O99I_M1
M\)L\^DA?X^: [E?X12KG$X_;WXIYUUB<=RNR* MM=GX6C\O5>A;KT]X41Y *
MG6P!IYH-,@R9,ME8(G,6Y$;Y*/LZF1H5M'*"K:"@EM3\&LQ10/MYP!=,0[N;
M[1&RNO=R"@+G.R]'&Q[MOLLIU;IW74X^Z[C!V.99J J]S>(@2P+.<JB6=PI1
MG@601A&'(H_SB 24\@C/OHH571KO*?:ZL/EVNQT-: /7V3_*.OO'?PO^& ;@
MD;29S6&;6NCO@L,\N B" )153HI_:>LC1N%%E =5K0;U8Y#DS0. K'4!W,K;
M!>+P NA/L'XLB((+7?I2US<OOHKY\T7U^^4VS8675O]HN?O9_QS"("1(AS+3
MD!&((J;8/Y,"AEF"XI RFL9662[.^1A&V5'N)()I"EW6HWPFDH8;QS/P&7JG
MZ "-_?[PB/Y^-X3[G8R[ SRBXHLMW['G'-/>D&)5M=.)=/Y%V8Q/*\%OU&+"
MU Y3L<X;4A:;).@ZY1^9:^)KTS/,&,*"ADD*)<%(;0G32'%BG*C_82+,4)ZD
MTFI+Z$>LJ=&(UJJ=(AN;_ )LU &5/OJN<#&?@S^+.;\ 6ZVZ.54L<]WX&60S
MKAI_Z(8^'1U^U.P3W'@%V6^"&S^BC9O@QBN<+Q+<^&W=D>BKDDVB\@?\)HHO
M]VO!+Y4A3;X(7;I)QZQ])FOQ2:A9LUC/4AD$22H2*"@3VN /88Z4K9<&-(EI
M)&G,C9+'NW4_.>*NI6\=6JT"H-$ M"H K<,%:+2P)&F[ 3(DX\%@'YIT_2)N
M3[!.P/DE4CL1QB5,)WA>$*-;*ZXII;^*<JV=)?6EW\N'Y6K=5+N[D9]6XJ%X
M>ICI"O(XSS$,2)! )'$("<MR2'C $\%Q@(156*U1KU.CNS?+!0>/M6R ="2V
M331M@K@9D7G'<6#^VLK;7/J_ %V1=5!%([3/?-06&'E.3FW2\\B9JBW >)FV
MVN9E-SYZ__ X7SX+<2M67PM=$(BLA#(!!5<[?'V(6W7V<5E)HFCQ&UGQ\FZY
M)O/NW]\NR_7'Y?H_Q?KS)@N_HLMBR3\L5\VO]'/A# 622)*G, ZPSDXK),0T
M22#+9$ SGA-N=RMO7/&GQI"5NI!J?<$G\ES-\TZ]N NPT1Q4JNMZB>5:_78-
MGL4:;+6M3!>E+Y#+%>AH;,>T(W]+9I0]W2]D8.Y_O8_#>LEXG3'RNO:,K,*H
MB]CK#,_^:OA*4K@MJX>EZTR_-\_;1YK968G\_F]/Q?IY>P^GO%G?B]7=/5G<
M/.HFRHV&>UN5GU73ZW=JG[+Q\\S"E'.&N( RC0.(>)1#&F<A3!5UQ&&>2$R8
MS6([!:6FO 1W4>E2+:#/X" ;U[1;H].Y#U>""A^P5@"!!J$.71_P0U0X 0T4
MV/J)[1;O*0RNX9(^!5$GNM#_HWR"UB;"E,;<J^$P"<5&-2<FH?$1(V-2LCE<
M/6LS"JZ):J,Y)&3584ZQ()ND&@]B?;_DLS0+,\3C''(I=&G>C$.,.(,!5<9!
MBH)($F1\(\VFYZDMXIO,F$IX,-\>KM;R@V(!MAJ 6@6+>UI68]*_ @Z*],#+
MU(1 MK@C-Q38(UV=\PFZW:TZ%^!Z+]M9-3C>'3P7/7>NYCDU</[I^V>]"MW(
M7\NZ8D77MSP3 :84A1+F0:86!BP"2#GF,)$RY2QC).1&"X-EOU-;%O9.?RO)
MX5)")7M;:.72^5C*="SL3]@](3SNT;HSN&>=J1M -=AA>E_?KW:*;@!(W_&Y
MR>MNU/7FJ2P6HBR564Y5A[I%?3@_7^KXI3OQ??U&J?37&<]C)$.<0(RI8JXT
MCR&-(P2CF'/*%7M%H=$U(+MNIT9<K=2@(S;8R@U^UY*#2G3+3%6&PV!&6O[!
M'9BSO.!J35AV,'GE*\.N1Z4K.SCVV<KR;?L;BE=,KBZ?>*'&]'*]5CO^JH\/
M<_)EAF,1X3#+8):'!*(X4 865P96D*4T96F8AS(PO:-XO)NID='5VP^?02,J
MZ,@*M+#F%Q5[<.UG&W]H#1VLXP24U7W%TS@XWUCL:7JT.XNGU>O>6C1XVG[Z
M-PU>*Y*Y6HN'<A8*'M%4)\>4@4XR*QC$2<1@0M*(2HJ1Q$8AS(<:G]I4;S_>
MW[6$H!+1T+XX"-WI>7T.( //9BLLK";Q,:6=I^Z+!D>;L,=4Z4[3H\\XGLRS
M>\&?YN)&'G;D5W?:&I^]=L?7!P!E^?10_^Z.T'EWPY'FB#&UDDNU[U#3.Q,P
M#T@"94[3%(E(1-PHE^4PXDV-(%KM=.!ISW%DI>3VV'&C)^@HJHQMK2IPWLIX
M_A ,CZY?;7B'/H1^G9&U/T<>9 #\G@C[%7'<L]U!X'UQ2CM,+X[YJ?1!KSXM
M7HE[L2BK+,HZ6EO?ECM81?Y2*JK=EI%GE71WY/N,QUF>9#2"02(RB!!6^\-(
M?2))G"1<$L*DL'*[>Y-L:LM('9NRHUE;U+"^XGH!M'Y *P@J#2^Z%V O -&*
M@GU-+W2".<LL6MX&WVS]>)4A'7CI>)71M,_UY1MYO]G!O$DW;CXQWZ"^R$#F
MO0/'0E6+=<&+^9-.?'.KKUI7UZ\_JEGQ;OF@NIX%.&29#$-(PBR'*!*Z7%42
M0<7Y.,]RSK+0:A]QJL.I47I77K 5^ )HD<'OM="VQ:M.@6[&N3ZA'-KI<!Z*
M]@6M#*'Q6];J5*?C%K<RA.!%B2O3]\XK&MZDM]]4&-[+&)QD 9<2,8A#$N@"
MXA',LPA!3A)$THSE86)E<IIU.S7RV41)M?44.A6RSTS9;#@.9DSD']V!^<@/
ML,X%R,UP&J08^8FN7Z4PN1D<QXJ4&[YM?V1R+;Z0^7M%A^OGJN 59C(424I@
MDBM["!$10)*F3/TS$S3#21J%H>F)R5[;4R.>2CQ0RV=5.>P0;J>/2\Y 8V"B
ML '"ZK#DB,K.9R7[[8UV5')$D>Y)R;%'W"R(GY=+_JV8SSM'F3+&+,\(#+(D
M57N4-(5Y&DN81*$(*,$B2ZSV*"]ZF-KT; 5T.- \CJ+94G\6-@-/5CM8K%?O
MHZI[7:A?]C+JFGQ4R?WE]_B#;M/ZFBSXFZ=BKK/XEI<+?O7PN%I^K>XVE6U]
MOI2S. FEVA0$.FY!A)!PI&\(29V F:0X,ZI49=[EU":^EO@";&2N\A=WI;8L
M3&>!O1D[^$5TZ+7];#"M*<0<'Z^<8M#MJ"1C#L,^ZUB\Z1B&\?3P0%;/-W*S
MGWB[K"ZZB(4N][T]5T<!B4BDR"B*)($H2SC$&0K5$ B><<82D5EE##+M>&J4
MU,BMS]<[F^@=V<\/B3 =%,-@AP&@'CJ,P2_*]N$)EI#Y#3PP[7S<D )+2%X$
M"]B^[YK8L6F]*<C0;,J#1.2$(@))CAE$G"M;2E $99R&6,@DC4,K^CK<S=3(
MJC-W-G(Z548_@JH9_YR/U<!LXP*30S[&/A0\)V \V-7(&1?[U'V98K'W:8<,
M#+</Q?I>V4B\8&3>&/4L1XBAE$$>244"(F8P3W(,"4UB7<0N(K%YHH4#'4QM
M^M<B@D9&BUO\A\#KG^L^(!G:IMA!PZ6F^2%8+'(8G G/2*D*##\:NRP$/:KW
M)ALX]-YX.05ZI-Y)'=#WW/D9 C95)IK0RO+=DZC"8_Y3D-6'XJN8Y5'*98P%
MI!G&$*DAAC3)I/J)XH2&88 0=\T3<++WJ9'>WH7V3HV.]1)0 3Z1@K>Q:EH'
MH)5PSQEP>G3,C*3!,!^85?W"?586 6/8!LLE<%J"5\LH8 Q.7UX!\T;<:._3
M2CRJ[Z4YTKY<\"INL,IA4#;5C6>"9VF:$344(M5><<YA3@(.<2!1)C.:A-S*
M*V[0Y]0HKA$9B%KFVI6[K,)W65.JFU3RV]&:"?IJ^XRB,"(P3*I )1;#'$>\
MJOJ'0\1#213Z.MWKZZ"_Z?G_2?3-EA+/F Z\@+1PMG%(&LTZ%+V6^ (T,OM;
M-"P \KI4F/0[Z@)A <3^LF#SJL/V?>,;7"M5RH)7!:R7BR\K77H.*X-7I%D$
MHRA6]BY*8DC3D$"U%C",F(@8-4K@<+*GJ1$_V\@*=H0%E;06.]E>> UV^KY
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MDN<\PE9EI2S[G]J:T(H/_M J\*.:.:"KP_\ M1;@=ZT':!2QK[5I-4QF!O"
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M59EF7EY_H,^*,,:9)5]NM;E0YZS3L_YB$8;=:B03;>-C/7&)4@S F'! ,6-
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M:X>A+47?C3?]**B)?=3VU2?Y37]H7VA1!4U^754%[.9)JJ(0LA1P'E-C$"E
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M[HIB$))9L-,IV"M5)JQJU)H%N_OA65#I&#3C%-1:]L=R72#NE?R\!!F5$[M
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MC!, !<X S3 %2:84PY$*66A?V.EB%Y,CFDI(<\A>BAG4<KHYD5^ TN(2MC-
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MXI #**0"4,H0,$8D0!SIK;1 ,+7+Z^'5^]0FKI$_, H$=[M-2)GQ*RE/NV%
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M=?=3XZY]4-RK8*=#<]=Y-2;.*6#?<YPLV'!0] >FS.D"[Q$0.L@ C!X6VN=
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M=;QS+#-_74Q"&[!2HX-TJE);?(U6/G<S?D/I<GTS^ "-<\,SU-AXW@!U0G6
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M-3XL-^M\6>2\W$_.,X%@*"(3-YQ$VKR+0Q,A$P.9B0BQ6%"13B'5S6U-ID:
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M**[MQ5NOCT*+ECHTS&C[N <YOGMX]>'303[QU5$^\3DA)!$RB4&L[2( .<:
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M[G.LVU[:4L4[N>YME.<%4LP($U 6C*F_$4RE0%3]YR8U<VZXJ5'DSMJ[;2W
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M-&G3Z MD:?M?HTF0VX1XZQCD.+S;>V_W/CUXVZH?M+LJM5J^))27$ %6E F
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M9=#FJ=6([Z7AWU4O%1>*E[2N&X8RQGDB ":*,J#NQD<@HR#&K$QX&A>HL(I
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M17V">9)<ZO7F-W;R>O/S4T5H-:_6/]_.25TW118ISF4F"P12C B D.: RD(
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MM29.&XB\$J+1P*,2G0T4QP1F=:WC28:HZ^7JO [_]^4;T:H3"#Y#15FF,D%
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M$*=2 B@3#$A!J>*8,F<E@E*8Y6Q>&VAJQ-(FSG2V1EMC+;,$KL)K</3H";3
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MDL >RK%N L[O+H:5!>/N8;B <[*#X703YYW;U4;P;<F7J#\K3[LGB>$2H;3
M /.T )!Q <JLH #)#),LRR'*K4*3H<$F1V"MK7N%D$WS@*V]UONQEV$VWGSU
M EYX?G+#S65#]2H@OG=/+P\X]E;I5=?/[(M>O\9!]^ D^^0]62T$GS%.$(,I
M! 5E&8")0(#P(@$0DP3G$JI?&YWY#@TR-=(XDP[5&FI1QGX)SV&6\(528'8(
M"9!%\;X'H$:JR+<'S*Z^_@H2@T7SEZX=KQ+^BO4'Y>W7/NM ?7\3_%%TDE)=
M8B?*A,Q*+%6,A!3KI:@)F6* 8Y8Q6:1ED1F=^URX_]0(K[%P3^G,,DWV$HH&
M7'<;-H%I+A L%@QW&SPCD=LQ3)XX[;+O@W1VYK+QF.RRS0<D-O Q^_/K^PVO
M%(R?U0S-5) F9)DA0"E72SV*8T!()E7<%NL.J)2GN5'GAJ/[3HVO.M,B;9OY
M:?0^4,/4=(/[H==E)IY;G2V?\=/Y+'G_7J.='9]Q8/^L^-RO[1^RM\L7L=JU
M%88L1C0O 2URO2B2!& N), LS7C"4R)H:OJ8'=QY:@]:8YQU[]]3P*X_;LXP
M!'[@C!&P>NC.>NO\V!W>;;0'[ZP3^X_>^0^X[7!VA?CU!V7"^S_5=W]!YF\W
M]7KYI!X#K2NR7#Q^JEX$;X^,/FW5)#(D4\Y) 1"FA<[;* "-.04D08BR/(L+
M;O2LWFK(U![MWH](3VK4>Q)M76EJ/+0SH/&F.^.\0??#>0;--E;'F)? 7!-R
M2JSW96_%T^N>K;,QH^[GW@K9\5[OS?=SH]JA?-LW0BY76DU0)]54LF+-VG*7
M@5XPF*-8Q4,)S=6R@V6*;47, *9)F6&>,(:L6L?=8,O4"-<@89TV'D4G+AFE
MLGN?2S/>'6F& E-OZ,FQIE\/L'IEX%OL&96$/0!WS,,^;NFHI5HM]$[W)T$4
M/77*>3^[E(%O:[)N9!T?9/NQBLR_Z*0I-;Y^6RA#Z5Q=5:]G/(YEEA,!*.1,
MES$D *=JO5IBGB:YA&E26!5J^3%K:@3=>14U;MU%6\>VV3=WT=8Y_;QOW8MZ
M_Z+?=QY&[Q>;ITY8UU8OU<^LF_'W^',9F,I?8QKM-5&]HNY7^=2/:>/JFWJ%
M\T3%U._='2M32/U#%_FK/][_>U.]D+DN^_^RG%?LYZXI72HI9[Q, 4*Y +#,
M"T 8S4!9$DI24F9Y;%>E8C+JU(A<6]M*5.B_[-E]%[661[]W?SHW#S2;#3,&
M]HYQZ"U1K_#:5[W8P.6W L9HY'&K86S .*F,L;K8C;8.RF[:C(T9P3(6.:-
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M9=_Z_0H,?GN_7QILW.;O5UP^Z?Y^[?/.PI#M8H['$!9ES@%)(08PR0B@,F9
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M5KW7/WY9/2S_6LPBI9*BT"H0)USK 2(($J2G4$G$5(YHE%%EM=/:8V-J6M#
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M9RCV!I9%?^*<9<Z&D:#RU6MP5%FR<?VUW%C=XUN46S]*-]9/K6.S/#8Q,IA
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M5-.OARPQS&*$1)K&662W=^1J>&I29K)W54V VQ:D8Q9C6\[M1&H()H=>>];
M=NB[ AL?H%JN8*6]")A?V)&?L#F$;8V/FR?8D9*#7,"N]_NFMV/K;7&E36$:
MR2(>,85APD@*4:$$9$1F,*>D8'H:%:?$:41UW,S4A*?^9K8PO4NGG2#53FLN
MIVH,97%CR2/Q7!\)@1/-'34U<F*Y/G</$\GU7NV9.*Y<E&OYJ7R1XG:QUNUM
M@LG:7$3\7\_E2HKKZHZNUE_4D2-O3=[J&.$($Y3#+"LP1(F((8U5#'DNE):,
ME(K8J;Q# $Q3DYC&)5C[!+9.=:G%.K< K4S$69V@Y=@15+^DXR':V$[$1FZY
M@15OK$9S3_L6CN:PR=X"X!HWQ5LX(@\2NP5\M)^T?Y5<EB_F0=7#B@JI)[AU
MCIYKSI?/BW6U_??-)%@/.C\LG]E:/<^[J^Z6\Y+_G&5%S'&,$YBS)(=(JA12
MD:4P30O$,LI8'ED=,1X"W-3$?L>W*U![5Z\*-;F^.NA@>]75=OT(Z$D:Z+S<
M7'L%&D?!G^U_G0_;#?).V/4);]72 W<.TVADYZYCB-8(VH<$!3AJ9S($M:][
ME4%L^)[463[)U?KGG?XLUAK'C>[4GLSJW;N?#_J)=3X%&K,\981#JOL'B% 4
M02*8A#0KBACE2+ ,NQW3.6MS:IU!!UE_W@9T+1(;V"8FU #W*OAITP 1SV*9
M9A',">,0X2*%Q)1D88Q+5D<W2SQ[D2NV?*,FV+7]1HUP-6P3V/62@6D=N//[
MM%P\MO.BA[U94? JJ Z\!#X5==[NR$>BK(DX/ ]E?^MEU5(>Z(]FBG.XOS;3
M"L1(S#GD@L80Y2S74I1)J%(F=4^0)X@XK1)9V)Q:7[ IYV'J=S2@C^XB^Y5(
MZ2/?=@TZ**6#+TA?R*9W710+?@8IBM)G]TTJHE@0<:H<BLVMGFE^S6+*%_5>
M&RG7[]OTA7&:QA)GFMU,"8@RI >A28HAR_,H2252N:!.67R/&)F:W!B,9E&R
M 7G59A!W/&MQE$T[.;F4HZ$',8[TN"?$[?$_;+[;8X;&36?;X^I!MMJ^:WV7
M.JOUZIFOZYSAYB#'-ICGTR:P-==3(8RP@%RE%")>($@5H9!CK#]_EA=)XE1Z
MPL;HU"1A#W-]OF@W8.V"0&*K%K!=, S+Z^ +@9=3ZK&,9\]1X.4Y"\,C+[O9
M4W&XG.9PK^^A3[J2[V@E37HP4_&M&>NL5OH=DLTD;'M)FTCG^B^Z$E^>S(75
MK_I"<S*UJ83PZVI953-&<T8*E,&<T PB&C,]CI$%3&BB4)KG14R0VZK. "BG
MMPKT^=E42C==_K)!#1X-;"E<3Y^&;U&>\"+/D( D,I5_T]@$M>NV993KF7$<
MY]0M\.J-VW.,KNS7J;2=7:_VQBTR<"=80]=OJ\8.=OT#.PZ:Q>[=Z[J\:[67
MIGY%[><5:#P%Y6)3LJCV-N1!Z,&:(O!)ZO X1SZ*/1C1AV>YAS/EV?&WQT6V
M\1UUW$=5UO;>_=SY6Q-BE> "2XH1+%010<20@I@6 JHB(46>RTARIUK2K@"F
M)O =_KVXJET7KHRB[/S"+SK.N9TL]7Y ]H<6\^#$NTNT)WMA]=<5Q+CBZDG1
M@7+Z/L<_*5=S,/RK?%JNUK,H3U*J8@$%RLT6-<LASHM"-P9AC LL$+&2O5,&
MIB9K'<8N$T&#TCV[UAZ)_9H4@IJA-W/<6/'*C'7,]8N38.T]=/1\5\=<.I;:
MZNAU'DEN-C7&YGJ Q.EJ]5,M5V8856V.NV2,Z+FL_I0E(A*BG"A((X0@)S2-
M&"ED'EOET[.T-[7/>UN&ST &>YB=3Q;9<M[_^0_ Y,!J\"8D.N2^"4OF2.EO
M+B75+06./46]67 L'C->(AQ[G_9RX3C<YGG4O-Y(GR%):)%+"HO<1-BDL59>
MIJ>27!6"I2I2)-'*NUS3N=T$LGFLD\!N'C[<:_SPY>'Z$[B^O[]YN'<\'=[0
M9#=_<W=^8$UL  4\O+WG8-BCV<VCQSUXO>?.P;'J_7_UC'C6[?%9MU"7?B9)
MDHP7":0RU1,7FBM(<$9@$D>2D(0DO"!.P<U[CY_:N,:@ P:>9^Z85^39?83^
ME S\,3JPX1[R>M3IL-&M^R;&#60]ZMY!S.KQJ_P^W*Y2DRF _5FN9TRQ*$D0
MADDN(XA()" 5G,((,8045A'C3E_NJ^=/[=/=5!-K"H#?_.#S9U$'*]"G4G?8
MY7\UYUOKBW8+B5_S=?GBD8;E-=]V'_L%+ [\M0])H+,\G* IJ#Z\MC&J0)QP
M\+5"G+K,O:;NO7PTTZ]?Y?)Q19^^E9S.VUXJ$K$B5,0P+E1D,AODD.5QJKMX
ME7.41;A05E&CO5:F)A>["!T[^WXV^V4@&$<#BX$;/4[5=<^Z?W&)W=,61JNS
M>];)W6*[YR_V#AB5^J9OUPOQ0;[(^;(^#W/SP^P<RUE$%4JR@L.89*D>V>,(
M8E((*!+"XD1(%2/'P^X]UJ;V^7=@ZRA&L87K' _:0[#=@" 8;0,KPAYC.TA!
M"S5HV.=Y1D+'>_98'#O0\[SS1R(\+6[RV FY6Y5<#_$^F8?>WM[^)DUL8?/G
M#,=2\31)S#D3HQ^(Z/D%+2#/L,1%K.6#V6^!]!B:FG2T4$&-%6BPX,\&Z/^[
M^<%AR;Z/88L-CT"\#;V0,!IE#ML;@:@;:5\CT(:%A=.].Q5]]X^W16'AQ=[>
MA,WU'NKXJ:2LG-<S7[5<:>#U-D<U4ZG*8IXQ2*,8FS53!%DD,$P(XARG4A('
M93QA9&JJ^+X%!N9;O [?]"DJ+20P $$#R]\.PCHKS@9C ((<!"\ 42.)G3MA
M;BIXAHE>!3QU[WCJ=P;]GO*=N]8W$\*J?-'OP(OL/GN38J';,1*YS)4L8!%Q
M!1'3,TR2%@64F12Y4HP+Z32O[#,V-17<8@4;0?3;2>JEV&YF&8JX@=71BS./
MK ;GR0B<SJ#'X,AY#,Z[?IC P.(>/_'X?2'*:KTJV?-:BANZ6NB16?5%?5RN
M9/FXN']F52E*NC()[!..,I;R!"IDI$0*!AFA.61%E.(84X22W$5*[$U/35CV
MD(,.NHE=;\&#7?1N4N/0(';",PS- \M0((:=A<F=K* RY6!^5-%RI^6UA'D\
MP4_0/LOU>UI]NULM7TIA:NK^7IETN)L-TNW^Z(PQ1!22"@HE<CTS3'-(9);!
MI"AHGG I4Y-@UCYXS=ZTDZ"-$."FD0.NH8.G%KLY;;/<["E3STUYA[:PT[)A
M&!Y8RPRY!C6XVR'W%X,<E(N_#;QU[\Y84$%S,#^JH+G3\EK0/)[@)V@/]$>;
MMV8GC/?ZN\FJ.J-IC!GBL3FYSR B)NTI$0**2,B<%$DBW%)D]]B:VAC,9&!K
ML()=L%>@@>LF5'T<VRE3(.8&EB)?TIQEQX*.H#K39V]48;%P_+62V-SB66F%
MEBN3ZZXK K 0.RM0OTEJBKJ(+XNOIL2324>C+_B\7*RZO[ZC55DU!Y"E%)3A
M-((IQP@B$1<0IT4$,\H9RYG*!';*JAP,V=1DR3A69X245V"#OMZEW\7O650E
M6'/::=J;--+ "ABH?=SKIX3F,FP5E6#HQJVE$IK4@XHJP0UX"OFSGC"O30FN
MA?A8_C _5>T>.XVYS"-*84)X"E$F,TBHDI!$F&>%BGF>.J5Q.FUJ<E+;(:T_
MWPZK8PR#!<.68AF$MZ'5SY,R=[D[RT98_3IM;EQ!.NOV@<*<O\._W.;MPN0:
M-%O$3;>O$L4SIB+("R8@XBF'1(H4IH*G*E84J\AI%'?$QM1$8C>Q3%U"0!O]
M#NK"DEODE=]X[!C%MIN!%Q$WL$H$XLRK%.<)5H+7X7QM9_0BG"<</5:!\]2E
MGDG"GEDE__5L0E)?]!^?-JER)4)*I9F"L5E'0EE!(1:1GNU%A,N4<\'2R"D9
MV E#DY.(#4Y0 [T@)?%);NUD(01C0VN#%UGNR;C.,!$VZ=8I8^,FUSKC\D$2
MK7/77QI-M*/UO]+23'+FM*I*54KQ4:._YOSY^_.<KO4,Z/WM[6*]O%WPY7=Y
MHY0T:]_R;KFJP^ X316+T@S*-,NUKJ0)I+&,(8YH&N49(Y(ZU4$(CG!J@K03
M@[/CX14P/H)=)X%YB\".FT#["4KM*&@\O0(;7T'KK&_@4ZBWP7: ](9M/+"$
MODWS7A"C%;@)!@KL"H7RC:+! I-\.H0LM*'+RG>9#/C5IJ1DDRU'Y2S.8A9!
M)ED!$48"LAA3F">)S%C"LBB2/F6[CMB:GO2W!:9JK+OE7?M3\3AS;"O#09@;
M7%#]2/,NQM5#QR!%N([9>Y/B6SV.GRJZU7>+GW3\4Y:/W[0\7;_(%7V438F%
M+ZK.M5U]>5Y7:_T&M*OO?)9%E,<J2Z"L#T8JA"!F2D&42A(1BC!VF]4Z69^:
MO-2@P"]ZG%'5>/_F)BANS-.(\)@Q!J.445-],84X$PSF6.I?%#0I1.)6,F0P
M[L<I!M+!![3!#Q:;ZB"ZA_V^[%H%++>N@%^8<6;0AK+K"P8C?^#>8<-Z"QQL
M:[(TV,$.^"M0PP_797BQ%K03<4,P:K?B1<[KCL;O(7Y=3Q>X?"=7]?,_E',3
MSSQC/-:2%B4PRD5JZB@@R!!)8,H8YS0AB:!.V;U.V)E:=]+"<M.F4QS:J5
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M.>UX'C<SM5[B_N8]Z%(!7($X@1&Y BWDJTT&?;?QYPF"[0:?E],VL,3;,3;
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M(&KK,FA]KL,>MUZ[R>L0;XB=$+]5@X\CV3:-/$ ;.^O[@*T0M"<8 N>H?<:
M1+_N788T%;2:#.6Z[]-_5\]KW>GIWXH-Q%E"*",JE3"FJ8((FV3ZE')($$9%
MRDG*HQ 59'H@3&V@O74"=%Z8Q"R@]@- T+D"&E_J?]MZ$Z0J25^#]:O^.,TP
ML*A/O 6"U(()U!*CUW\)VB*ABK]8D.E9\*7OR5,H\F+AN65A%YLG71+ZTF8C
MJ(^*;!<3:)Q'@M 41C@J($)$=S]QD4#)N2 1)HKD3LL[/;:FUL^T\0#M9]6
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M[,7C]4+LGAG;J>#"HRC*HQ22K-##2&S..5!,H! BTWT)YE+:;T):&IU:[]'
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MK]\7\W3E-'I/9ZO-8)T2H$*1M9I2@HB93O483.:-W/:]:>W!F1_FT:6MFCH
MXE\7B_S'=#:;1":5TD&#-#K2C4Y0<+)H<%YI;=%9'A\K;ST<7E<4].#1#P*:
M@T3: 11>D+CG9U-"^X4PZ(+^]5.:;6I)[C5/@M#-O?/ ;9W9%"-"P)R .6V"
M,LS&W"KX\VWJ>G#[!X'0X*KH %[/+I>M];KG^"Y\NF:M)OIG8X0!R2*9@0D]
MA-KQ4!=4,KH45:.K[6&:>O#Z!X'20&+O $ WXA0W[MOH3,(Z6R&(1++1SD",
MW(.6)101.3FY;5YN[R6G!Z]_&&O[:&%W@)@+^B>Q^.(82K"%+F/%@P ?;8"4
MN-(V\?QX4[!C T+CC'5MEH*TES@[B/V\G(8XG6W-]/JZ6SN.O%_,2.BK&HI8
M?[X63=#>.FX*&>VB=MM%@KF--4X61'3"&<?:G"2[4MA);NS+05(?FZBE@S/G
M!E^WPZ_",A&<)P@@K^*RC#:.1A!T]:+$'!E_K"!X$(!UE1[9!@,/ ^T8A70
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M@YBJY2R]B,IPR1L-7=R=QG%S_[_/.J>]]'HX8FNA?TO$7F2FW'\T>&$M4TJ
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M9'A6VG_']:2^QC-K:T\11G\HJ2 D68 IXY-(,8K2)D_B%B$CFU,G <[ADN\
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M3!J58XDL4%G3#9F%P.D/)E$RGZ14K,TK^&U*Q@WGGAQ#A^J@ PP]PX\X6WS
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M:CVX*QR\5P9DYLSH8K4W;5(0OD59M[';UF [0#%] ^W&(,2; P\G/M"&"5C
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MG8KC;2I3GB"HEZ+I%BAXXK@\1"2=(FO;F^6J/%:18U9D(-\L9UL'=AF(JEA
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M&1$&@F0(*N@ WG$)UG(R-5!IAVV&5S]%T32U,D=#UBB"Z !0SZOE)(WBC&=
MU+P6@$6(#C,(SU/VUB3%>CTI1R_%Z>2D'"*2<4[*MXM\_#Q9;=36)%=V^\%-
M\V5/KN#(.;/D5';."F LDFF%Q9"GJ0R(H 1S,6&\W^KB]>7,- KI4@X07,Z@
MLMQ,'K.@M9(\2*_X_=KQOT#.; @P]LF9#6%Z'SF0NY%^%KQ13#)RI7DMK8N.
M-&T0H(5@47%)_!GO.M-IYLP&B?BEG-D0?O>!ET="PEXHXQ*YKSS;&A(V"J*@
M3\Y[FVPT',M.?9I?5<YLD&1WRID-8?/4H<TG$CZ*>[+7F 5DPD"M>8.062W
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MX]Z S]J#)]LNY\"233NU2=FI"N+ZM5/C820A+@_E: \PN&HK&%A(66+M(%E
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M964WFN9NI.43KK[^4:YJ)V9.6.M1UOA>) 9%QR'6N\71N&!<41;C3M7[HT3
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M"U""ENHM+=#*DHL@/B?>ZDP82&I7.9&C87"PD$X,A>^6%ZN9S,EFDR.0IQU
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MW'6>= RNRWUU.)Q.)\:Q/7C?GX7%>N3HQB-/;A37>&D-?40T4L$06%0@#!-
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M/PW![]![V6U T('A<C>X+XO-WF@03M,"1"$.2CI],$IOT8:<="?IL':% -,
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M.C"![M8'!L:E\4+69I66SA(1JI_D*@N+9B'1D=(F;=U!'^:)H?!L4? 0N70
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M%MPEZPM3[#2WW</%[I:9[GG45M?[[T!TO>KS;OATVO6,/&#IA)(0?>:@R#B
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MS#!>LFN3X#N@?'F:.TV' &D$YG< H=LI@,N&,;=-X9J\7%_5W'I7=X #H;(
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M<62$-1))AR![)B#+N-"6.0/<B-IX@Q/C5)WL;%!+7I )TR:->^28>;-0XHE
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M$=L.(UGV4M+>M+-<#QN&^/3W.\%6'PA8CBN.#M3N/;Y^6E[BQ7871OG:)#>
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MH3YC5&\7]&/^M!E(>4 $ZOY_/D)\:2<U(T6/;K__1,B 1T_>E"&LH,J@O'2
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M1%=?K&*IS>VLT,8,@L#.)::-TC2$PSA,[0P:[]Z]N>E +5!EXS=I '03"U<
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M@+.S.9 @3T*1+#K:U4J!I$GB?[]%C32V-8>[6VHU)\E#@CA!1%;5UV0='ZL
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M!   97AH:6)I=#$P-&YO;BUE;7!L;WEE961I<F4N:'1M4$L! A0#%     @
MLH995#'8+]30!0  >E@  !X              ( !Q@<  &5X:&EB:70R,7-U
M8G-I9&EA<FEE<V]F<F5G+FAT;5!+ 0(4 Q0    ( +*&652L9'$3$P0  *X3
M   >              "  =(-  !E>&AI8FET,C,Q8V]N<V5N=&]F9&5L;VET
M="YH=&U02P$"% ,4    " "RAEE4*YBZ?3((   O*0  %
M@ $A$@  97AH:6)I=#,Q,3$R,S$R,2YH=&U02P$"% ,4    " "RAEE4KH%_
M:3T(  !-*P  %               @ &%&@  97AH:6)I=#,Q,C$R,S$R,2YH
M=&U02P$"% ,4    " "RAEE4TY@,.%0%  !#)@  $P              @ 'T
M(@  97AH:6)I=#,R,3(S,3(Q+FAT;5!+ 0(4 Q0    ( +*&650C-8T^SHX$
M (CO,  1              "  7DH  !I8W5I+3(P,C$Q,C,Q+FAT;5!+ 0(4
M Q0    ( +*&652?157RMAX  "YY 0 1              "  7:W! !I8W5I
M+3(P,C$Q,C,Q+GAS9%!+ 0(4 Q0    ( +*&653'#@P7IQX  #8J 0 5
M          "  5O6! !I8W5I+3(P,C$Q,C,Q7V-A;"YX;6Q02P$"% ,4
M" "RAEE4KO;Z[8^N  "9O@< %0              @ $U]00 :6-U:2TR,#(Q
M,3(S,5]D968N>&UL4$L! A0#%     @ LH995*C59@:7>P$ -(X0 !4
M         ( !]Z,% &EC=6DM,C R,3$R,S%?;&%B+GAM;%!+ 0(4 Q0    (
M +*&652WC'&$O_@  %V5"P 5              "  <$?!P!I8W5I+3(P,C$Q
A,C,Q7W!R92YX;6Q02P4&      T #0!_ P  LQ@(

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
